PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Albert, MJ; Haridas, S; Ebenezer, M; Raghupathy, R; Khan, I				Albert, M. John; Haridas, Shilpa; Ebenezer, Mathew; Raghupathy, Raj; Khan, Islam			Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; IMMUNOGENICITY; ADJUVANT; ANTIBODIES; IMMUNITY; SAFETY; IDENTIFICATION; INFECTION; RESPONSES; VACCINE	We have previously shown that antibodies to cholera toxin (CT) reacted with the major outer membrane proteins (MOMPs) from Campylobacter jejuni strains on Western blot. Further, oral immunization with CT significantly protected against challenge with C. jejuni in an adult mouse colonization model of infection. CT and the heat-labile enterotoxin (LT) of enterotoxigenic Escherichia coli are structurally and functionally related. LT and its mutants including the double-mutant LT (R192G/L211A) (dmLT), are powerful mucosal adjuvants. Unlike LT which is reactogenic, dmLT has been shown to be safe for human use. In the current study, we determined whether rabbit anti-dmLT antibodies reacted with MOMPs from C. jejuni strains and whether immunization with dmLT would afford protection against C. jejuni. On Western blot, the MOMPs from C. jejuni 48 (Penner serotype O:19), C. jejuni 75 (O: 3) and C. jejuni 111 (O: 1,44) were probed with rabbit antibodies to dmLT or LT-E112K (a non-toxic LT mutant), which showed a lack of reaction. Adult BALB/c mice were orally immunized with dmLT and orally challenged with C. jejuni 48 or 111. Protection from colonization with the challenge bacteria was studied by enumerating Campylobacter colonies in feces daily for 9 days. Vaccination produced robust serum and stool antibody responses to dmLT and no antibody responses to C. jejuni MOMP. Vaccinated mice showed reduced colonization and excretion of both challenge strains compared to control mice. However, the differences were not statistically significant. The protective efficacy of the dmLT vaccine varied from 9.1% to 54.5%. The lack of cross-reaction between the MOMP and dmLT suggests that protection is not mediated by cross-reacting antibodies, but may be due to activation of innate immunity. As dmLT is safe for humans, it could be incorporated into a C. jejuni vaccine to enhance its efficacy.	[Albert, M. John; Haridas, Shilpa; Ebenezer, Mathew; Raghupathy, Raj] Kuwait Univ, Dept Microbiol, Fac Med, Jabriya, Kuwait; [Khan, Islam] Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait	Kuwait University; Kuwait University	Albert, MJ (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Jabriya, Kuwait.	john@hsc.edu.kw			Kuwait University [MI03/13]	Kuwait University	This work was supported by Kuwait University grant no. MI03/13.	Albert MJ, 2008, CLIN VACCINE IMMUNOL, V15, P859, DOI 10.1128/CVI.00471-07; Albert MJ, 2007, INFECT IMMUN, V75, P3070, DOI 10.1128/IAI.00139-07; Albert MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00246-13; Albert MJ, 2009, MICROB DRUG RESIST, V15, P115, DOI 10.1089/mdr.2009.0892; ALBERT MJ, 2014, AUSTIN CLIN IMMUNOL, V1, P1013; BAQAR S, 1995, VACCINE, V13, P22, DOI 10.1016/0264-410X(95)80006-Y; Baqar S, 1996, INFECT IMMUN, V64, P4933, DOI 10.1128/IAI.64.12.4933-4939.1996; BAQAR S, 1993, ANTIMICROB AGENTS CH, V37, P2688, DOI 10.1128/AAC.37.12.2688; Baqar S, 2008, INFECT IMMUN, V76, P3170, DOI 10.1128/IAI.00076-08; BLACK RE, 1992, CAMPLYLOBACTER JEJUNI, P207; BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; BLASER MJ, 1984, INFECT IMMUN, V43, P986, DOI 10.1128/IAI.43.3.986-993.1984; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; BLASER MJ, 1983, INFECT IMMUN, V42, P276, DOI 10.1128/IAI.42.1.276-284.1983; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; El-Kamary SS, 2013, CLIN VACCINE IMMUNOL, V20, P1764, DOI 10.1128/CVI.00464-13; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Friedman C.R., 2000, CAMPYLOBACTER, P121; Holmner A, 2011, J MOL BIOL, V406, P387, DOI 10.1016/j.jmb.2010.11.060; HONDA T, 1981, INFECT IMMUN, V34, P333, DOI 10.1128/IAI.34.2.333-336.1981; Huang SX, 2007, FEMS MICROBIOL LETT, V272, P137, DOI 10.1111/j.1574-6968.2007.00752.x; Islam A, 2010, CLIN VACCINE IMMUNOL, V17, P1666, DOI 10.1128/CVI.00255-10; Jertborn M, 2001, INFECT IMMUN, V69, P4125, DOI 10.1128/IAI.69.6.4125-4128.2001; Katz JM, 1997, J INFECT DIS, V175, P352, DOI 10.1093/infdis/175.2.352; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051718; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Oberhelman RA, 2000, CAMPYLOBACTER, V2nd, P139, DOI 10.1016/s0360-3016(00)00774-4; Ottsjo LS, 2013, INFECT IMMUN, V81, P1532, DOI 10.1128/IAI.01407-12; PANIGRAHI P, 1992, INFECT IMMUN, V60, P4938, DOI 10.1128/IAI.60.11.4938-4944.1992; Patton WA, 2000, HANDB EXP PHARM, V145, P133; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Schroder W, 1997, FEMS MICROBIOL LETT, V150, P141, DOI 10.1016/S0378-1097(97)00111-0; Scott DA, 1997, J INFECT DIS, V176, pS183, DOI 10.1086/513791; TAYLOR DN, 1992, CAMPLYLOBACTER JEJUNI, P20; TAYLOR DN, 1993, J INFECT DIS, V168, P754, DOI 10.1093/infdis/168.3.754; Tribble DR, 2008, CAMPYLOBACTER, 3RD EDITION, P429; Verweij WR, 1998, VACCINE, V16, P2069, DOI 10.1016/S0264-410X(98)00076-0; World Health Organization, 2006, WHOIVB061; Zhang QJ, 2000, INFECT IMMUN, V68, P5679, DOI 10.1128/IAI.68.10.5679-5689.2000	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142090	10.1371/journal.pone.0142090	http://dx.doi.org/10.1371/journal.pone.0142090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540197	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800054
J	Lopes-Silva, JP; Santos, JFD; Branco, BHM; Abad, CCC; de Oliveira, LF; Loturco, I; Franchini, E				Paulo Lopes-Silva, Joao; da Silva Santos, Jonatas Ferreira; Magnani Branco, Braulio Henrique; Cal Abad, Cesar Cavinato; de Oliveira, Luana Farias; Loturco, Irineu; Franchini, Emerson			Caffeine Ingestion Increases Estimated Glycolytic Metabolism during Taekwondo Combat Simulation but Does Not Improve Performance or Parasympathetic Reactivation	PLOS ONE			English	Article							HEART-RATE RECOVERY; ENERGY SYSTEM CONTRIBUTIONS; ANAEROBIC PERFORMANCE; PERCEIVED EXERTION; RESPONSES; EXERCISE; POSTEXERCISE; ENERGETICS	Objectives The aim of this study was to evaluate the effect of caffeine ingestion on performance and estimated energy system contribution during simulated taekwondo combat and on post-exercise parasympathetic reactivation. Methods Ten taekwondo athletes completed two experimental sessions separated by at least 48 hours. Athletes consumed a capsule containing either caffeine (5 mg.kg(-1)) or placebo (cellulose) one hour before the combat simulation (3 rounds of 2 min separated by 1 min passive recovery), in a double-blind, randomized, repeated-measures crossover design. All simulated combat was filmed to quantify the time spent fighting in each round. Lactate concentration and rating of perceived exertion were measured before and after each round, while heart rate (HR) and the estimated contribution of the oxidative (W-AER), ATP-PCr (W-PCR), and glycolytic (W[La-]) systems were calculated during the combat simulation. Furthermore, parasympathetic reactivation after the combat simulation was evaluated through 1) taking absolute difference between the final HR observed at the end of third round and the HR recorded 60-s after (HRR60s), 2) taking the time constant of HR decay obtained by fitting the 6-min post-exercise HRR into a first-order exponential decay curve (HRR tau), or by 3) analyzing the first 30-s via logarithmic regression analysis (T30). Results Caffeine ingestion increased estimated glycolytic energy contribution in relation to placebo (12.5 +/- 1.7 kJ and 8.9 +/- 1.2 kJ, P = 0.04). However, caffeine did not improve performance as measured by attack number (CAF: 26. 7 +/- 1.9; PLA: 27.3 +/- 2.1, P = 0.48) or attack time (CAF: 33.8 +/- 1.9 s; PLA: 36.6 +/- 4.5 s, P = 0.58). Similarly, RPE (CAF: 11.7 +/- 0.4 a.u.; PLA: 11.5 +/- 0.3 a.u., P = 0.62), HR (CAF: 170 +/- 3.5 bpm; PLA: 174.2 bpm, P = 0.12), oxidative (CAF: 109.3 +/- 4.5 kJ; PLA: 107.9 kJ, P = 0.61) and ATP-PCr energy contributions (CAF: 45.3 +/- 3.4 kJ; PLA: 46.8 +/- 3.6 kJ, P = 0.72) during the combat simulation were unaffected. Furthermore, T30 (CAF: 869.1 +/- 323.2 s; PLA: 735.5 +/- 232.2 s, P = 0.58), HRR60s (CAF: 34 +/- 8 bpm; PLA: 38 +/- 9 bpm, P = 0.44), HRRt (CAF: 182.9 +/- 40.5 s, PLA: 160.3 +/- 62.2 s, P = 0.23) and HRRamp (CAF: 70.2 +/- 17.4 bpm; PLA: 79.2 +/- 17.4 bpm, P = 0.16) were not affected by caffeine ingestion. Conclusions Caffeine ingestion increased the estimated glycolytic contribution during taekwondo combat simulation, but this did not result in any changes in performance, perceived exertion or parasympathetic reactivation.	[Paulo Lopes-Silva, Joao; da Silva Santos, Jonatas Ferreira; Magnani Branco, Braulio Henrique; Loturco, Irineu; Franchini, Emerson] Univ Sao Paulo, Sch Phys Educ & Sport, Martial Arts & Combat Sports Res Grp, Sao Paulo, Brazil; [Cal Abad, Cesar Cavinato; Loturco, Irineu] NAR Nucleus High Performance Sport, Sao Paulo, Brazil; [de Oliveira, Luana Farias] Univ Sao Paulo, Sch Phys Educ & Sport, Lab Appl Nutr & Metab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Lopes-Silva, JP (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Martial Arts & Combat Sports Res Grp, Sao Paulo, Brazil.	joao_judo@hotmail.com	Loturco, Irineu/AAH-4916-2019; da Silva Santos, Jonatas Ferreira/O-6956-2019; Franchini, Emerson/B-9119-2012; de Oliveira, Luana Farias/AAS-3124-2021; de Oliveira, Luana Farias/O-8142-2016; Silva, João Paulo/L-4396-2017; Branco, Braulio/AAA-1747-2019; Lopes-Silva, João/R-6909-2016; Magnani Branco, Braulio Henrique/B-8178-2017	Loturco, Irineu/0000-0003-1309-2568; da Silva Santos, Jonatas Ferreira/0000-0002-3309-4731; Franchini, Emerson/0000-0002-0769-8398; de Oliveira, Luana Farias/0000-0001-8225-5784; de Oliveira, Luana Farias/0000-0001-8225-5784; Silva, João Paulo/0000-0002-2033-365X; Lopes-Silva, João/0000-0002-2033-365X; Magnani Branco, Braulio Henrique/0000-0002-4625-9128	FAPESP [2011/19513-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to Dr. Bryan Saunders (FAPESP grant number: 2011/19513-2) for the proofreading of the manuscript.	Aedma M, 2013, INT J SPORT NUTR EXE, V23, P601, DOI 10.1123/ijsnem.23.6.601; Beneke R, 2004, EUR J APPL PHYSIOL, V92, P518, DOI 10.1007/s00421-004-1073-x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bridge CA, 2014, SPORTS MED, V44, P713, DOI 10.1007/s40279-014-0159-9; Bridge CA, 2009, INT J SPORT PHYSIOL, V4, P485, DOI 10.1123/ijspp.4.4.485; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Bunsawat K, 2014, EUR J PREV CARDIOL, V8; Cohen J., 1977, STAT POWER ANAL BEHA, P24; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; COLLOMP K, 1991, INT J SPORTS MED, V12, P439, DOI 10.1055/s-2007-1024710; Crowe MJ, 2006, INT J SPORT NUTR EXE, V16, P528, DOI 10.1123/ijsnem.16.5.528; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002; Bertuzzi RCD, 2007, EUR J APPL PHYSIOL, V101, P293, DOI 10.1007/s00421-007-0501-0; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Campos FAD, 2012, EUR J APPL PHYSIOL, V112, P1221, DOI 10.1007/s00421-011-2071-4; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Felippe LC, 2015, INT J SPORTS PHYSL P, V13; Franchini E, 2011, INT J SPORT PHYSIOL, V6, P334, DOI 10.1123/ijspp.6.3.334; Gastin P, 2011, SPORTS MED, V31, P725; Goldberger JJ, 2006, AM J PHYSIOL-HEART C, V290, pH2446, DOI 10.1152/ajpheart.01118.2005; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Hausswirth C, 1997, INT J SPORTS MED, V18, P449; Lopes-Silva JP, 2014, NUTRIENTS, V6, P2931, DOI 10.3390/nu6072931; Pallares JG, 2013, MED SCI SPORT EXER, V45, P2184, DOI 10.1249/MSS.0b013e31829a6672; Pierpont GL, 2000, J AUTONOM NERV SYST, V80, P169, DOI 10.1016/S0165-1838(00)00090-4; SantAna J, 2014, INT SPORTMED J, V15, P492, DOI DOI 10.1080/14763141.2016.1217347; Santos VGF, 2014, NUTRIENTS, V6, P637, DOI 10.3390/nu6020637; Santos VGF, 2011, J STRENGTH COND RES, V25, P1743, DOI 10.1519/JSC.0b013e3181ddfb0f; Silva-Cavalcante MD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075399, 10.1371/journal.pone.0072025]; Simmonds MJ, 2010, EUR J APPL PHYSIOL, V109, P287, DOI 10.1007/s00421-009-1351-8; Vecchio FB, 2011, BIOL SPORT, V28, P75	33	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142078	10.1371/journal.pone.0142078	http://dx.doi.org/10.1371/journal.pone.0142078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539982	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800051
J	Li, M; Arner, A				Li, Mei; Arner, Anders			Immobilization of Dystrophin and Laminin alpha 2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy	PLOS ONE			English	Article							CONTRACTION-INDUCED INJURY; SKELETAL-MUSCLE; MDX MOUSE; MICE; PROTEIN; EMBRYO; MODEL	Muscular dystrophies are often caused by genetic alterations in the dystrophin-dystroglycan complex or its extracellular ligands. These structures are associated with the cell membrane and provide mechanical links between the cytoskeleton and the matrix. Mechanical stress is considered a pathological mechanism and muscle immobilization has been shown to be beneficial in some mouse models of muscular dystrophy. The zebrafish enables novel and less complex models to examine the effects of extended immobilization or muscle relaxation in vivo in different dystrophy models. We have examined effects of immobilization in larvae from two zebrafish strains with muscular dystrophy, the Sapje dystrophin-deficient and the Candyfloss laminin alpha 2-chain-deficient strains. Larvae (4 days post fertilization, dpf) of both mutants have significantly lower active force in vitro, alterations in the muscle structure with gaps between muscle fibers and altered birefringence patterns compared to their normal siblings. Complete immobilization (18 hrs to 4 dpf) was achieved using a small molecular inhibitor of actin-myosin interaction (BTS, 50 mu M). This treatment resulted in a significantly weaker active contraction at 4 dpf in both mutated larvae and normal siblings, most likely reflecting a general effect of immobilization on myofibrillogenesis. The immobilization also significantly reduced the structural damage in the mutated strains, showing that muscle activity is an important pathological mechanism. Following one-day washout of BTS, muscle tension partly recovered in the Candyfloss siblings and caused structural damage in these mutants, indicating activity-induced muscle recovery and damage, respectively.	[Li, Mei; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet	Arner, A (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	anders.arner@ki.se			Swedish Research Council [2013-3003]; Karolinska Institutet; French Muscular Dystrophy Association (AFM)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Swedish Research Council (www.vr.se) for AA, 2013-3003; the Karolinska Institutet (www.ki.se) for AA; and The French Muscular Dystrophy Association (AFM, http://www.afm-telethon.com/) for AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Berger J, 2012, BIOCHEM BIOPH RES CO, V423, P785, DOI 10.1016/j.bbrc.2012.06.040; Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4; Brooks SV, 1998, J MUSCLE RES CELL M, V19, P179, DOI 10.1023/A:1005364713451; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Dou Y, 2008, J GEN PHYSIOL, V131, P445, DOI 10.1085/jgp.200809982; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Head SI, 2004, EXP PHYSIOL, V89, P531, DOI 10.1113/expphysiol.2004.027383; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Kim HR, 2009, DEV DYNAM, V238, P56, DOI 10.1002/dvdy.21812; Li M, 2014, FASEB J, V28, P1593, DOI 10.1096/fj.13-240044; Li M, 2013, J GEN PHYSIOL, V141, P335, DOI 10.1085/jgp.201210915; Lim JH, 2004, MUSCLE NERVE, V30, P456, DOI 10.1002/mus.20139; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Petrof BJ, 1993, P NATL ACAD SCI USA, V90, P3710; Ramachandran I, 2003, CELL MOTIL CYTOSKEL, V55, P61, DOI 10.1002/cm.10113; Selsby JT, 2013, J APPL PHYSIOL, V115, P660, DOI 10.1152/japplphysiol.00252.2013; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; Waugh TA, 2014, HUM MOL GENET, V23, P4651, DOI 10.1093/hmg/ddu185	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139483	10.1371/journal.pone.0139483	http://dx.doi.org/10.1371/journal.pone.0139483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536238	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400008
J	Mamidi, AS; Arora, P; Surolia, A				Mamidi, Ashalatha Sreshty; Arora, Prerna; Surolia, Avadhesha			Multivariate PLS Modeling of Apicomplexan FabD-Ligand Interaction Space for Mapping Target-Specific Chemical Space and Pharmacophore Fingerprints	PLOS ONE			English	Article							CARRIER PROTEIN TRANSACYLASE; FATTY-ACID SYNTHASE; ACP DOCKING SITE; MALONYL-COA; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; MOLECULAR-DYNAMICS; DRUG DISCOVERY; FORCE-FIELD; DESIGN	Biomolecular recognition underlying drug-target interactions is determined by both binding affinity and specificity. Whilst, quantification of binding efficacy is possible, determining specificity remains a challenge, as it requires affinity data for multiple targets with the same ligand dataset. Thus, understanding the interaction space by mapping the target space to model its complementary chemical space through computational techniques are desirable. In this study, active site architecture of FabD drug target in two apicomplexan parasites viz. Plasmodium falciparum (PfFabD) and Toxoplasma gondii (TgFabD) is explored, followed by consensus docking calculations and identification of fifteen best hit compounds, most of which are found to be derivatives of natural products. Subsequently, machine learning techniques were applied on molecular descriptors of six FabD homologs and sixty ligands to induce distinct multivariate partial-least square models. The biological space of FabD mapped by the various chemical entities explain their interaction space in general. It also highlights the selective variations in FabD of apicomplexan parasites with that of the host. Furthermore, chemometric models revealed the principal chemical scaffolds in PfFabD and TgFabD as pyrrolidines and imidazoles, respectively, which render target specificity and improve binding affinity in combination with other functional descriptors conducive for the design and optimization of the leads.	[Mamidi, Ashalatha Sreshty; Arora, Prerna; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Surolia, A (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@mbu.iisc.ernet.in			Department of Biotechnology (DBT), Government of India; University Grants Commission (UGC), India; Council of Scientific and Industrial Research (CSIR), India; UGC, India; Indian Council of Medical Research (ICMR); University Grants Commission (UGC), India [63/84/2001-BMS, F.4-2/2006(BSR)/13-545/2011(BSR)]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University Grants Commission (UGC), India(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); UGC, India(University Grants Commission, India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grants Commission (UGC), India(University Grants Commission, India)	The authors thank Department of Biotechnology (DBT), Government of India to AS and University Grants Commission (UGC), India for the financial support to carry out this work. AS thanks Council of Scientific and Industrial Research (CSIR), India for Bhatnagar Fellowship, and ASM thanks UGC, India for Dr. D. S. Kothari Fellowship.; Authors thank Indian Council of Medical Research (ICMR) and University Grants Commission (UGC), India 63/84/2001-BMS and F.4-2/2006(BSR)/13-545/2011(BSR) for financial support to AS and ASM, respectively. AS thanks Council of Scientific and Industrial Research (CSIR), India for Bhatnagar Fellowship and ASM thanks UGC, India for Dr. D. S. Kothari Fellowship.	Baell JB, 2013, J CHEM INF MODEL, V53, P39, DOI 10.1021/ci300461a; BARONI M, 1993, QUANT STRUCT-ACT REL, V12, P9, DOI 10.1002/qsar.19930120103; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blake James F, 2005, Med Chem, V1, P649, DOI 10.2174/157340605774598081; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Eriksson L, 1997, SETAC SP P, P381; Eriksson L, 1999, MULTI MEGAVARIATE DA; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Ermondi G, 2006, BIOCHEM PHARMACOL, V72, P1633, DOI 10.1016/j.bcp.2006.05.022; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Junaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014353; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muench SP, 2007, ACTA CRYSTALLOGR D, V63, P328, DOI 10.1107/S0907444906053625; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Oprea TL, 2002, MOLECULES, V7, P51, DOI 10.3390/70100051; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Sinha I, 2004, J ANTIMICROB CHEMOTH, V53, P1072, DOI 10.1093/jac/dkh241; Sreshty MAL, 2012, MOL INFORM, V31, P281, DOI 10.1002/minf.201100051; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Yan ZQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00309; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	57	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141674	10.1371/journal.pone.0141674	http://dx.doi.org/10.1371/journal.pone.0141674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535573	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000364298400076
J	Schossleitner, K; Habertheuer, A; Finsterwalder, R; Friedl, HP; Rauscher, S; Groger, M; Kocher, A; Wagner, C; Wagner, SN; Fischer, G; Schultz, MJ; Wiedemann, D; Petzelbauer, P				Schossleitner, Klaudia; Habertheuer, Andreas; Finsterwalder, Richard; Friedl, Heinz P.; Rauscher, Sabine; Groeger, Marion; Kocher, Alfred; Wagner, Christine; Wagner, Stephan N.; Fischer, Gottfried; Schultz, Marcus J.; Wiedemann, Dominik; Petzelbauer, Peter			A Peptide to Reduce Pulmonary Edema in a Rat Model of Lung Transplantation	PLOS ONE			English	Article							ENDOTHELIAL BARRIER FUNCTION; ISCHEMIA-REPERFUSION INJURY; PRIMARY GRAFT DYSFUNCTION; OXIDIZED PHOSPHOLIPIDS; INTERNATIONAL SOCIETY; IMPROVES SURVIVAL; PERMEABILITY; ACTIVATION; JUNCTIONS; REGISTRY	Background Despite significant advances in organ preservation, surgical techniques and perioperative care, primary graft dysfunction is a serious medical problem in transplantation medicine in general and a specific problem in patients undergoing lung transplantation. As a result, patients develop lung edema, causing reduced tissue oxygenation capacity, reduced lung compliance and increased requirements for mechanical ventilatory support. Yet, there is no effective strategy available to protect the grafted organ from stress reactions induced by ischemia/reperfusion and by the surgical procedure itself. Methods We assessed the effect of a cingulin-derived peptide, XIB13 or a random peptide in an established rat model of allogeneic lung transplantation. Donor lungs and recipients received therapeutic peptide at the time of transplantation and outcome was analyzed 100min and 28 days post grafting. Results XIB13 improved blood oxygenation and reduced vascular leak 100min post grafting. Even after 28 days, lung edema was significantly reduced by XIB13 and lungs had reduced fibrotic or necrotic zones. Moreover, the induction of an allogeneic T cell response was delayed indicating a reduced antigen exchange between the donor and the host. Conclusions In summary, we provide a new tool to strengthen endothelial barrier function thereby improving outcomes in lung transplantation.	[Schossleitner, Klaudia; Finsterwalder, Richard; Friedl, Heinz P.; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div SERD, Vienna, Austria; [Habertheuer, Andreas; Kocher, Alfred; Wiedemann, Dominik] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria; [Rauscher, Sabine; Groeger, Marion] Med Univ Vienna, Core Facil Imaging, Vienna, Austria; [Wagner, Christine; Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Fischer, Gottfried] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol LEICA, NL-1105 AZ Amsterdam, Netherlands	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Petzelbauer, P (corresponding author), Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div SERD, Vienna, Austria.	Peter.Petzelbauer@meduniwien.ac.at	Schossleitner, Klaudia/AFQ-7865-2022; Wiedemann, Dominik/AAH-2649-2020; Schultz, Marcus/AAB-6379-2021; petzelbauer, peter/GLU-3941-2022	Wiedemann, Dominik/0000-0002-2055-8293; Schultz, Marcus/0000-0003-3969-7792; Wagner, Stephan/0000-0003-4941-7029; Schossleitner, Klaudia/0000-0003-1202-5961; Petzelbauer, Peter/0000-0001-7080-5259; Habertheuer, Andreas/0000-0001-7310-8838	Vienna Science and Technology Fund (WWTF) [LS11-8, LS11-045]; Burgermeisterfond [14088]; Hochschuljubilaumsstiftung [H-289325/2013]; Austrian Science Fund [F5408-B21]	Vienna Science and Technology Fund (WWTF); Burgermeisterfond; Hochschuljubilaumsstiftung; Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by the Vienna Science and Technology Fund (WWTF, www.wwtf.at) LS11-8 to PP and in part by projects WWTF LS11-045 to SNW, Burgermeisterfond (www.wien.gv.at/gesundheit/einrichtungen/med-wiss-fonds) 14088 and Hochschuljubilaumsstiftung (www.wien.gv.at/amtshelfer/kultur/archiv/forschung/hochschuljubilaeumsstiftung.html) H-289325/2013 to DW and the Austrian Science Fund (www.fwf.ac.at) F5408-B21 to PP.	Aigner C, 2007, EUR J CARDIO-THORAC, V31, P468, DOI 10.1016/j.ejcts.2006.11.049; Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Chen WG, 2014, AM J RESP CELL MOL, V50, P328, DOI 10.1165/rcmb.2013-0058OC; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Goertz O, 2014, MICROVASC RES, V93, P98, DOI 10.1016/j.mvr.2014.04.003; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Habertheuer A, 2013, J SURG RES, V185, P419, DOI 10.1016/j.jss.2013.05.006; Jaksch P, 2013, TRANSPL INT, V26, P34, DOI 10.1111/j.1432-2277.2012.01570.x; Jing HR, 2014, J SURG RES, V187, P252, DOI 10.1016/j.jss.2013.10.009; Kage H, 2014, AM J PHYSIOL-LUNG C, V307, pL524, DOI 10.1152/ajplung.00077.2014; Meng F, 2014, AM J PHYSL LUNG CELL, V2014; Neto ASF R.R., 2014, F1000PRIME REP; Okazaki M, 2007, AM J TRANSPLANT, V7, P751, DOI 10.1111/j.1600-6143.2006.01710.x; Prakash A, 2012, ANESTHESIOLOGY, V117, P822, DOI 10.1097/ALN.0b013e31826a4ae3; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Sugimoto R, 2012, AM J TRANSPLANT, V12, P2938, DOI 10.1111/j.1600-6143.2012.04169.x; Suzuki Y, 2013, SEMIN RESP CRIT CARE, V34, P305, DOI 10.1055/s-0033-1348474; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tian ZG, 2013, ANN THORAC SURG, V95, P1028, DOI 10.1016/j.athoracsur.2012.11.023; Yamane M, 2005, AM J TRANSPLANT, V5, P2160, DOI 10.1111/j.1600-6143.2005.01017.x	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142115	10.1371/journal.pone.0142115	http://dx.doi.org/10.1371/journal.pone.0142115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536466	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400136
J	Zhang, CS; Tan, HY; Zhang, GS; Zhang, AL; Xue, CC; Xie, YM				Zhang, Claire Shuiqing; Tan, Hsiewe Ying; Zhang, George Shengxi; Zhang, Anthony Lin; Xue, Charlie Changli; Xie, Yi Min			Placebo Devices as Effective Control Methods in Acupuncture Clinical Trials: A Systematic Review	PLOS ONE			English	Article							SHAM ACUPUNCTURE; SINGLE-BLIND; COMPARING ACUPUNCTURE; MANUAL ACUPUNCTURE; NEEDLE; PAIN; VALIDATION; REAL; PROPHYLAXIS; EFFICACY	While the use of acupuncture has been recognised by the World Health Organisation, its efficacy for many of the common clinical conditions is still undergoing validation through randomised controlled trials (RCTs). A credible placebo control for such RCTs to enable meaningful evaluation of its efficacy is to be established. While several non-penetrating acupuncture placebo devices, namely the Streitberger, the Park and the Takakura Devices, have been developed and used in RCTs, their suitability as inert placebo controls needs to be rigorously determined. This article systematically reviews these devices as placebo interventions. Electronic searches were conducted on four English and two Chinese data-bases from their inceptions to July 2014; hand searches of relevant references were also conducted. RCTs, in English or Chinese language, comparing acupuncture with one of the aforementioned devices as the control intervention on human participants with any clinical condition and evaluating clinically related outcomes were included. Thirty-six studies were included for qualitative analysis while 14 were in the meta-analysis. The meta-analysis does not support the notion of either the Streitberger or the Park Device being inert control interventions while none of the studies involving the Takakura Device was included in the meta-analysis. Sixteen studies reported the occurrence of adverse events, with no significant difference between verum and placebo acupuncture. Author-reported blinding credibility showed that participant blinding was successful in most cases; however, when blinding index was calculated, only one study, which utilised the Park Device, seemed to have an ideal blinding scenario. Although the blinding index could not be calculated for the Takakura Device, it was the only device reported to enable practitioner blinding. There are limitations with each of the placebo devices and more rigorous studies are needed to further evaluate their effects and blinding credibility.	[Zhang, Claire Shuiqing; Tan, Hsiewe Ying; Zhang, George Shengxi; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, RMIT Hlth Innovat Res Inst, Sch Hlth Sci, Tradit & Complementary Med Res Program, Bundoora, Vic, Australia; [Xie, Yi Min] RMIT Univ, Sch Civil Environm & Chem Engn, Ctr Innovat Struct & Mat, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Xie, YM (corresponding author), RMIT Univ, Sch Civil Environm & Chem Engn, Ctr Innovat Struct & Mat, Melbourne, Vic, Australia.	mike.xie@rmit.edu.au	Tan, Hsiewe Ying/AAD-6255-2019; Xie, Yi M/A-3615-2012; Zhang, Anthony Lin/AAR-6673-2021; Xue, Charlie C/F-1244-2014	Tan, Hsiewe Ying/0000-0003-1289-3646; Xie, Yi M/0000-0001-5720-6649; Zhang, Anthony Lin/0000-0002-0968-9380; Zhang, Claire Shuiqing/0000-0003-3866-602X; Xue, Charlie/0000-0001-6937-9088				Andersen D, 2010, REPROD BIOMED ONLINE, V21, P366, DOI 10.1016/j.rbmo.2010.03.029; Anna E, 2008, COMPLEMENT THER MED, V16, P288, DOI 10.1016/j.ctim.2008.02.012; BANG H, 2010, CLIN RES REGUL AFF, V27, P42, DOI DOI 10.3109/10601331003777444; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Birch S., 2003, CLIN ACUPUNCT ORIENT, V3, P207, DOI [DOI 10.1016/S1461-1449(02)00044-0, 10.1016/S1461-1449(02)00044-0]; Bishop FL, 2008, J ACUPUNCT MERIDIAN, V1, P1, DOI 10.1016/S2005-2901(09)60001-7; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Chen LX, 2013, JCR-J CLIN RHEUMATOL, V19, P308, DOI 10.1097/RHU.0b013e3182a21848; Chou LW, 2009, ARCH PHYS MED REHAB, V90, P905, DOI 10.1016/j.apmr.2008.12.020; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Dorsher PT, 2010, ARCH PHYS MED REHAB, V91, P1306, DOI 10.1016/j.apmr.2010.04.025; Downs NM, 2005, ARCH PHYS MED REHAB, V86, P1252, DOI 10.1016/j.apmr.2004.10.037; Elden H, 2008, BJOG-INT J OBSTET GY, V115, P1655, DOI 10.1111/j.1471-0528.2008.01904.x; Enblom A, 2011, EVIDENCE BASED COMPL; Freed B, 2014, PSYCHIAT RES, V219, P241, DOI 10.1016/j.psychres.2014.05.023; Goddard G, 2005, J PAIN, V6, P237, DOI 10.1016/j.jpain.2004.12.009; Goldman RH, 2008, CLIN J PAIN, V24, P211, DOI 10.1097/AJP.0b013e31815ec20f; Gong X, 2014, J ACUPUNCT TUINA SCI, V12, P8, DOI [10.1007/s11726-014-0738-1, DOI 10.1007/S11726-014-0738-1]; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Kaptchuk TJ, 1998, LANCET, V352, P992, DOI 10.1016/S0140-6736(05)61551-6; Karst M, 2000, PAIN, V88, P199, DOI 10.1016/S0304-3959(00)00315-8; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kim S, 2008, J ACUPUNCT MERIDIAN, V1, P36, DOI 10.1016/S2005-2901(09)60005-4; Kleinhenz J, 1999, PAIN, V83, P235, DOI 10.1016/S0304-3959(99)00107-4; Kreiner M, 2010, ACUPUNCT MED, V28, P33, DOI 10.1136/aim.2009.001735; Lao L, 1996, J Altern Complement Med, V2, P23, DOI 10.1089/acm.1996.2.23; Lathia AT, 2009, J ALTERN COMPLEM MED, V15, P613, DOI 10.1089/acm.2008.0272; Linde M, 2005, CEPHALALGIA, V25, P41, DOI 10.1111/j.1468-2982.2004.00803.x; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; Manni L, 2010, AUTON NEUROSCI-BASIC, V157, P9, DOI 10.1016/j.autneu.2010.03.020; Modlock J, 2010, BJOG-INT J OBSTET GY, V117, P1255, DOI 10.1111/j.1471-0528.2010.02647.x; Moffet HH, 2008, J CLIN EPIDEMIOL, V61, P741, DOI 10.1016/j.jclinepi.2008.02.013; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Moroz A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/708251; Organization WH., 2003, PARKINSONISM RELAT D, pS163, DOI [10.1016/S1353-8020(11)70706-4, DOI 10.1016/S1353-8020(11)70706-4]; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park J, 2005, ARCH INTERN MED, V165, P2026, DOI 10.1001/archinte.165.17.2026; Park J, 2004, PAIN, V109, P195, DOI 10.1016/j.pain.2004.02.010; Park J, 1999, ACUPUNCTURE MED; Rebhorn C, 2012, PAIN, V153, P1852, DOI 10.1016/j.pain.2012.05.026; Rogha M, 2011, J RES MED SCI, V16, P1217; Schliessbach J, 2012, EVID BASED COMPLEMEN, V785613; Schliessbach J, 2011, PAIN MED, V12, P268, DOI 10.1111/j.1526-4637.2010.01051.x; Smith MJ, 2005, ARCH PHYS MED REHAB, V86, P1741, DOI 10.1016/j.apmr.2004.11.044; Smith P, 2007, J DENT, V35, P259, DOI 10.1016/j.jdent.2006.09.004; So EWS, 2009, DTSCH Z AKUPUNKT, V52, P49, DOI 10.1016/j.dza.2009.02.008; So EWS, 2010, REPROD BIOMED ONLINE, V20, P814, DOI 10.1016/j.rbmo.2010.02.024; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Streitberger K, 2003, CLIN CANCER RES, V9, P2538; Sunay D, 2011, ACUPUNCT MED, V29, P27, DOI 10.1136/aim.2010.003285; Sunay D, 2011, EUR UROL, V59, P765, DOI 10.1016/j.eururo.2011.01.019; Suzuki M, 2012, ARCH INTERN MED, V172, P878, DOI 10.1001/archinternmed.2012.1233; Takakura N, 2009, OPEN MED, V3, P54; Takakura N, 2011, ACUPUNCT MED, V29, P203, DOI 10.1136/aim.2010.002857; Takakura N, 2010, ACUPUNCT MED, V28, P144, DOI 10.1136/aim.2009.001230; Takakura N, 2008, ACUPUNCT MED, V26, P224, DOI 10.1136/aim.26.4.224; Takakura Nobuari, 2007, BMC Complement Altern Med, V7, P31, DOI 10.1186/1472-6882-7-31; Tong J, 2010, GUANGZHOU ZHONGYIYAO, V27, P579; [童娟 TONG Juan], 2006, [针刺研究, Acupuncture Research], V31, P176; Tough EA, 2009, ACUPUNCT MED, V27, P118, DOI 10.1136/aim.2009.000737; Vase L, 2013, PAIN, V154, P1659, DOI 10.1016/j.pain.2013.05.008; Vickers AJ, 2002, EVAL HEALTH PROF, V25, P421, DOI 10.1177/0163278702238055; [张明敏 Zhang Mingmin], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P3; White P, 2003, PAIN, V106, P401, DOI 10.1016/j.pain.2003.08.013; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; Xie YM, 2014, ACUPUNCT MED, V32, P146, DOI 10.1136/acupmed-2013-010472; Yao E, 2012, PM&R, V4, P367, DOI 10.1016/j.pmrj.2012.01.008; Zhang CS, 2014, ACUPUNCT MED, V32, P520, DOI 10.1136/acupmed-2014-010671; Zhang CS, 2014, ACUPUNCT MED, V32, P400, DOI 10.1136/acupmed-2014-010586; [张维 ZHANG Wei], 2010, [中医杂志, Journal of Traditional Chinese Medicine], V51, P139; Zheng S, 2011, GUIDING J TRADITIONA, V17, P66; Zhu D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/628907	74	60	63	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140825	10.1371/journal.pone.0140825	http://dx.doi.org/10.1371/journal.pone.0140825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536619	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400039
J	Anderegg, MCJ; de Groof, EJ; Gisbertz, SS; Bennink, RJ; Lagarde, SM; Klinkenbijl, JHG; Dijkgraaf, MGW; Bergman, JJGHM; Hulshof, MCCM; van Laarhoven, HWM; Henegouwen, MIV				Anderegg, Maarten C. J.; de Groof, Elisabeth J.; Gisbertz, Suzanne S.; Bennink, Roel J.; Lagarde, Sjoerd M.; Klinkenbijl, Jean H. G.; Dijkgraaf, Marcel G. W.; Bergman, Jacques J. G. H. M.; Hulshof, Maarten C. C. M.; van Laarhoven, Hanneke W. M.; Henegouwen, Mark I. van Berge			F-18-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; THORACIC ESOPHAGUS; CARCINOMA; IMPACT; INTERVAL; UTILITY; RECOMMENDATIONS; CHEMOTHERAPY; METASTASES	Background Prognosis of esophageal cancer patients can be significantly improved by neoadjuvant chemoradiotherapy (nCRT). Given the aggressive nature of esophageal tumors, it is conceivable that in a significant portion of patients treated with nCRT, dissemination already becomes manifest during the period of nCRT. The aim of this retrospective study was to determine the value and diagnostic accuracy of PET-CT after neoadjuvant chemoradiotherapy to identify patients with metastases preoperatively in order to prevent non-curative surgery. Methods From January 2011 until February 2013 esophageal cancer patients deemed eligible for a curative approach with nCRT and surgical resection underwent a PET-CT after completion of nCRT. If abnormalities on PET-CT were suspected metastases, histological proof was acquired. A clinical decision model was designed to assess the cost-effectiveness of this diagnostic strategy. Results 156 patients underwent a PET-CT after nCRT. In 31 patients (19.9%) PET-CT showed abnormalities suspicious for dissemination, resulting in 17 cases of proven metastases (10.9%). Of the patients without proven metastases 133 patients were operated. In 6 of these 133 cases distant metastases were detected intraoperatively, corresponding to 4.5% false-negative results. The standard introduction of a post-neoadjuvant therapy PET-CT led to a reduction of overall health care costs per patient compared to a scenario without restaging with PET-CT ($34,088 vs. $36,490). Conclusion In 10.9% of esophageal cancer patients distant metastases were detected by standard PET-CT after neoadjuvant chemoradiotherapy. To avoid non-curative resections we advocate post-neoadjuvant therapy PET-CT as a cost-effective step in the standard work-up of candidates for surgery.	[Anderegg, Maarten C. J.; de Groof, Elisabeth J.; Gisbertz, Suzanne S.; Lagarde, Sjoerd M.; Klinkenbijl, Jean H. G.; Henegouwen, Mark I. van Berge] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Bennink, Roel J.] Univ Amsterdam, Acad Med Ctr, Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Bergman, Jacques J. G. H. M.] Univ Amsterdam, Acad Med Ctr, Gastroenterl & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Hulshof, Maarten C. C. M.] Univ Amsterdam, Acad Med Ctr, Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Med Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Henegouwen, MIV (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.	m.c.anderegg@amc.nl; m.i.vanbergehenegouwen@amc.uva.nl	De Groof, Joline/AAK-7613-2020; van Laarhoven, Hanneke/AAW-3464-2021; Gisbertz, Suzanne/AAG-5370-2020; Bergman, Jacques/AAS-2500-2021	Gisbertz, Suzanne/0000-0001-9655-7601; Bergman, Jacques/0000-0001-7548-6955; Hulshof, Maarten CCM/0000-0001-5240-3467	Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship [UVA 2013-5853]	Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship	This work was supported by Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society) Fellowship, UVA 2013-5853 to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TW, 2012, J NUCL MED, V53, P864, DOI 10.2967/jnumed.111.101568; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Blencowe NS, 2013, BRIT J CANCER, V109, P1445, DOI 10.1038/bjc.2013.478; Blom RLGM, 2011, EJSO-EUR J SURG ONC, V37, P774, DOI 10.1016/j.ejso.2011.06.002; Bruzzi JF, 2007, CANCER, V109, P125, DOI 10.1002/cncr.22397; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V129, P1232, DOI 10.1016/j.jtcvs.2004.12.042; Chowdhury FU, 2008, CLIN RADIOL, V63, P1297, DOI 10.1016/j.crad.2008.05.010; Flamen P, 2002, ANN ONCOL, V13, P361, DOI 10.1093/annonc/mdf081; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim JY, 2012, ANN THORAC SURG, V93, P207, DOI 10.1016/j.athoracsur.2011.05.021; Kordes S, 2014, INT J RADIAT ONCOL, V90, P190, DOI 10.1016/j.ijrobp.2014.05.022; Lagarde SM, 2008, ANN SURG, V247, P71, DOI 10.1097/SLA.0b013e31815b695e; LIEBERMAN MD, 1995, J THORAC CARDIOV SUR, V109, P130, DOI 10.1016/S0022-5223(95)70428-0; Maas KW, 2012, REV ESP ENFERM DIG, V104, P197, DOI 10.4321/s1130-01082012000400005; Malik V, 2012, CLIN NUCL MED, V37, P1152, DOI 10.1097/RLU.0b013e31827083ba; Metser U, 2014, ANN NUCL MED, V28, P295, DOI 10.1007/s12149-014-0812-2; Meyers BF, 2007, J THORAC CARDIOV SUR, V133, P738, DOI 10.1016/j.jtcvs.2006.09.079; Monjazeb AM, 2010, J CLIN ONCOL, V28, P4714, DOI 10.1200/JCO.2010.30.7702; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Ruol A, 2010, ANN SURG, V252, P788, DOI 10.1097/SLA.0b013e3181fc7f86; Salahudeen HM, 2008, CLIN RADIOL, V63, P765, DOI 10.1016/j.crad.2008.02.002; Thurau K, 2011, WORLD J SURG, V35, P608, DOI 10.1007/s00268-010-0946-x; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; van Westreenen HL, 2007, BRIT J SURG, V94, P1515, DOI 10.1002/bjs.5708; van Westreenen HL, 2004, J CLIN ONCOL, V22, P3805, DOI 10.1200/JCO.2004.01.083; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Wong R, 2012, CLIN ONCOL-UK, V24, P86, DOI 10.1016/j.clon.2011.09.006; Yanagawa M, 2012, J NUCL MED, V53, P872, DOI 10.2967/jnumed.111.098699	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0133690	10.1371/journal.pone.0133690	http://dx.doi.org/10.1371/journal.pone.0133690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529313	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600001
J	Chowdhary, K; Kaushik, N				Chowdhary, Kanika; Kaushik, Nutan			Fungal Endophyte Diversity and Bioactivity in the Indian Medicinal Plant Ocimum sanctum Linn	PLOS ONE			English	Article							ALTERNARIA-ALTERNATA; ANTIFUNGAL ACTIVITY; NATURAL-PRODUCTS; ANALYSIS REVEALS; IN-VITRO; 6-PENTYL-2H-PYRAN-2-ONE; METABOLITES; PHYLOGENIES; HOST	Endophytic mycopopulation isolated from India's Queen of herbs Tulsi (Ocimum sanctum) were explored and investigated for their diversity and antiphytopathogenic activity against widespread plant pathogens Botrytis cinerea, Sclerotinia sclerotiorum, Rhizoctonia solani and Fusarium oxysporum. 90 fungal isolates, representing 17 genera were recovered from 313 disease-free and surface sterilised plant segments (leaf and stem tissues) from three different geographic locations (Delhi, Hyderabad and Mukteshwar) during distinct sampling times in consequent years 2010 and 2011 in India. Fungal endophytes were subjected to molecular identification based on rDNA ITS sequence analysis. Plant pathogens such as F. verticillioides, B. maydis, C. coarctatum, R. bataticola, Hypoxylon sp., Diaporthe phaseolorum, Alternaria tenuissima and A. alternata have occurred as endophyte only during second sampling (second sampling in 2011) in the present study. Bi-plot generated by principal component analysis suggested tissue specificity of certain fungal endophytes. Dendrogram revealed species abundance as a function of mean temperature of the location at the time of sampling. Shannon diversity in the first collection is highest in Hyderabad leaf tissues (H' = 1.907) whereas in second collection it was highest from leaf tissues of Delhi (H' = 1.846). Mukteshwar (altitude: 7500 feet) reported least isolation rate in second collection. Nearly 23% of the total fungal isolates were considered as potent biocontrol agent. Hexane extract of M. phaseolina recovered from Hyderabad in first collection demonstrated highest activity against S. sclerotiorum with IC50 value of 0.38 mg/ml. Additionally, its components 2H-pyran-2-one, 5,6-dihydro-6-pentyl and palmitic acid, methyl ester as reported by GC-MS Chromatogram upon evaluation for their antiphytopathogenic activity exhibited IC50 value of 1.002 and 0.662 against respectively S. sclerotiorum indicating their significant role in antiphytopathogenic activity of hexane extract. The production of 2H-pyran-2-one, 5,6-dihydro-6-pentyl from M. phaseolina, an endophytic fungus is being reported for the first time.	[Chowdhary, Kanika] TERI Univ, New Delhi, India; [Kaushik, Nutan] Energy & Resources Inst TERI, India Habitat Ctr, New Delhi, India	TERI University; TERI University	Kaushik, N (corresponding author), Energy & Resources Inst TERI, India Habitat Ctr, Lodhi Rd, New Delhi, India.	kaushikn@teri.res.in	Kaushik, Nutan/H-7271-2012	Chowdhary, Kanika/0000-0002-2142-8757; Kaushik, Nutan/0000-0002-3870-8093	Council of Scientific and Industrial Research, New Delhi [09/550 (0037)2009-EMR-1]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by the host institution, Council of Scientific and Industrial Research, New Delhi in the form of JRF and SRF (09/550 (0037)2009-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubacker Maghdu Nainamohamed, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS661; Ahluwalia V, 2014, NAT PROD RE IN PRESS; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bashyal B, 1999, MYCOTAXON, V72, P33; BERTONI MD, 1988, NOVA HEDWIGIA, V46, P491; Bezerra JDP, 2015, BRAZ J MICROBIOL, V46, P49, DOI 10.1590/S1517-838246120130657; Brown Kenneth B., 1998, Fungal Diversity, V1, P27; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; CARROLL GC, 1978, CAN J BOT, V56, P3034, DOI 10.1139/b78-367; Chowdhary K, 2012, PHYTOCHEM REV, V11, P467, DOI 10.1007/s11101-012-9264-2; Cosoveanu A., 2012, Journal of Horticulture, Forestry and Biotechnology, V16, P87; Daoubi M, 2009, TETRAHEDRON, V65, P4834, DOI 10.1016/j.tet.2009.04.051; Debdulal Banerjee, 2011, Research Journal of Microbiology, V6, P54, DOI 10.3923/jm.2011.54.62; Diaz Arias MM, 2011, DIS NOTES, V95, P1316; Dreyfuss M M, 1994, Biotechnology, V26, P49; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Edison S, 2002, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.2002.583.26; Ekta Singh, 2012, Journal of Natural Product and Plant Resources, V2, P39; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia E, 2013, FUNGAL DIVERS, V60, P71, DOI 10.1007/s13225-012-0219-0; Gat T, 2012, PLANT DIS, V96, P1513, DOI 10.1094/PDIS-12-11-1041-RE; Gazis R, 2011, MOL ECOL, V20, P3001, DOI 10.1111/j.1365-294X.2011.05110.x; Gibbs RD., 1974, CHEMOTAXONOMY FLOWER, V1; Gibbs RD, 1974, CHEMOTAXONOMY FLOWER, VIII; Gond SK, 2012, MYCOSCIENCE, V53, P113, DOI 10.1007/s10267-011-0146-z; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Gupta SK, 2002, J EXP BIOL, V40, P765; Hawksworth DL, 2004, STUD MYCOL, P9; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hoffman Michele, 2008, Journal of the Arizona-Nevada Academy of Science, V40, P91, DOI 10.2181/1533-6085(2008)40[91:MARADF]2.0.CO;2; Huang WY, 2008, FUNGAL DIVERS, V33, P61; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Isaac S, 1992, FUNGAL PLANT INTERAC; Jayasinghe CK, 1998, MYCOPATHOLOGIA, V143, P93, DOI 10.1023/A:1006958623733; Kaur R., 2007, Asian Journal of Plant Sciences, V6, P446; Khanna N, 2003, J ETHNOPHARMACOL, V88, P293, DOI 10.1016/S0378-8741(03)00215-0; Kumar S, 2011, WORLD J MICROB BIOT, V27, P571, DOI 10.1007/s11274-010-0492-6; Kumar Susheel, 2008, V3, P365, DOI 10.1007/978-1-4020-8571-0_17; Kumar S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052416, 10.1371/journal.pone.0056202]; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Liu D, 2013, HELV CHIM ACTA, V96, P437, DOI 10.1002/hlca.201200195; Liu SY, 2008, MYCOPATHOLOGIA, V166, P93, DOI 10.1007/s11046-008-9124-1; MAHESHWARI R, 2012, BULL ENVIRON PHARMAC, V1, P67; Min Chang-lil, 2014, Zhongguo Zhong Yao Za Zhi, V39, P4288; Musetti R, 2007, MICRON, V38, P643, DOI 10.1016/j.micron.2006.09.001; Nuryanti WH, 2015, INT J PHARMACOGN PHY, V7, P132; Parker SR, 1997, J AGR FOOD CHEM, V45, P2774, DOI 10.1021/jf960681a; Pena PA, 2013, CROP PROT, V54, P92, DOI 10.1016/j.cropro.2013.04.014; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Photita W, 2004, FUNGAL DIVERS, V16, P131; Pretsch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097929; Ramgopal D, 2013, PLANT GENET RESOUR-C, V11, P212, DOI 10.1017/S1479262112000470; Reina M, 1997, PHYTOCHEMISTRY, V46, P845, DOI 10.1016/S0031-9422(97)00354-3; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savithramma N., 2011, Middle East Journal of Scientific Research, V8, P579; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Sethi S., 2013, Indian Journal of Natural Products and Resources, V4, P392; Shah CS, 1995, TXB PHARMACOGNOSY, P155; Shweta S, 2013, PHYTOMEDICINE, V20, P913, DOI 10.1016/j.phymed.2013.04.004; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Strobel G, 2006, CURR OPIN MICROBIOL, V9, P240, DOI 10.1016/j.mib.2006.04.001; Suganthi RU, 2013, INDIAN J ANIM SCI, V83, P888; Suryanarayanan TS, 2000, MYCOL RES, V104, P1465, DOI 10.1017/S0953756200002859; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tao G, 2008, FUNGAL DIVERS, V33, P101; Trejo-Estrada SR, 1998, WORLD J MICROB BIOT, V14, P865, DOI 10.1023/A:1008877224089; Tripathi AK, 2009, VEGETOS, V22, P1; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Valente AMMP, 2013, AN ACAD BRAS CIENC, V85, P487, DOI 10.1590/S0001-37652013005000024; Vico I, 2014, PLANT DIS, V98, P1430, DOI 10.1094/PDIS-02-14-0179-PDN; Vuorela P, 2004, CURR MED CHEM, V11, P1375, DOI 10.2174/0929867043365116; Walters D, 2004, MYCOPATHOLOGIA, V157, P87, DOI 10.1023/B:MYCO.0000012222.68156.2c; Wang Y, 2014, FITOTERAPIA, V99, P153, DOI 10.1016/j.fitote.2014.09.015; Whittaker R.H., 1977, Evolutionary Biol, V10, P1; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Yadav MS, 2011, PLANT DIS RES, V26, P202; Zhang HW, 2006, NAT PROD REP, V23, P753, DOI 10.1039/b609472b	86	56	68	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141444	10.1371/journal.pone.0141444	http://dx.doi.org/10.1371/journal.pone.0141444			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529087	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600029
J	Liu, CD; Zhang, YL; Wang, LC; Zhang, XH; Chen, QY; Wu, BL				Liu, Chundong; Zhang, Yanli; Wang, Lichao; Zhang, Xinhua; Chen, Qiuyue; Wu, Buling			A Strontium-Modified Titanium Surface Produced by a New Method and Its Biocompatibility In Vitro	PLOS ONE			English	Article							DENTAL IMPLANTS; POSTMENOPAUSAL OSTEOPOROSIS; HYDROXYAPATITE COATINGS; OSTEOBLAST RESPONSE; ZOLEDRONIC ACID; GENE-EXPRESSION; CANCELLOUS BONE; RANELATE; OSSEOINTEGRATION; RABBIT	Objective To present a new and effective method of producing titanium surfaces modified with strontium and to investigate the surface characteristics and in vitro biocompatibility of titanium (Ti) surfaces modified with strontium (Sr) for bone implant applications. Materials and Methods Sr-modified Ti surfaces were produced by sequential treatments with NaOH, strontium acetate, heat and water. The surface characteristics and the concentration of the Sr ions released from the samples were examined. Cell adhesion, morphology and growth were investigated using osteoblasts isolated from the calvaria of neonatal Sprague-Dawley rats. Expression of osteogenesis-related genes and proteins was examined to assess the effect of the Sr-modified Ti surfaces on osteoblasts. Results The modified titanium surface had a mesh structure with significantly greater porosity, and approximately 5.37 +/- 0.35 at.% of Sr was incorporated into the surface. The hydrophilicity was enhanced by the incorporation of Sr ions and water treatment. The average amounts of Sr released from the Sr-modified plates subjected to water treatment were slight higher than the plates without water treatment. Sr promoted cellular adhesion, spreading and growth compared with untreated Ti surfaces. The Sr-modified Ti plates also promoted expression of osteogenesis-related genes, and expression of OPN and COL-I by osteoblasts. Ti plates heat treated at 700 degrees C showed increased bioactivity in comparison with those treated at 600 degrees C. Water treatment upregulated the expression of osteogenesis-related genes. Conclusions These results show that Sr-modification of Ti surfaces may improve bioactivity in vitro. Water treatment has enhanced the response of osteoblasts. The Sr-modified Ti heat-treated at 700 degrees C exhibited better bioactivity compared with that heated at 600 degrees C.	[Liu, Chundong; Zhang, Yanli; Wang, Lichao; Chen, Qiuyue; Wu, Buling] Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Chundong; Zhang, Yanli; Wang, Lichao; Chen, Qiuyue; Wu, Buling] Southern Med Univ, Coll Stomatol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xinhua] Guangzhou Med Univ, Affiliated Hosp 2, Dept Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou Medical University	Wu, BL (corresponding author), Southern Med Univ, Dept Stomatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	bulingwu@smu.edu.cn	Liu, Chun Dong/P-6322-2015	Liu, Chun Dong/0000-0003-2166-2487				Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013; Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005; Cardemil C, 2013, BIOMATERIALS, V34, P1546, DOI 10.1016/j.biomaterials.2012.11.003; Carvalho Carine M, 2010, Indian J Dent Res, V21, P349, DOI 10.4103/0970-9290.70798; Chen B, 2013, OSTEOPOROSIS INT, V24, P2115, DOI 10.1007/s00198-013-2288-7; Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004; Dao T T, 1993, Int J Oral Maxillofac Implants, V8, P137; Deeks ED, 2010, DRUGS, V70, P733, DOI 10.2165/10481900-000000000-00000; Fahlgren A, 2013, BONE, V52, P718, DOI 10.1016/j.bone.2012.05.005; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; Gaetti-Jardim EC, 2011, J CRANIOFAC SURG, V22, P1111, DOI 10.1097/SCS.0b013e3182108ec9; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068086; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Giro G, 2011, CLIN ORAL IMPLAN RES, V22, P259, DOI 10.1111/j.1600-0501.2010.01989.x; Hamouda IM, 2012, INT J ORAL MAX IMPL, V27, P776; Hurtel-Lemaire AS, 2009, J BIOL CHEM, V284, P575, DOI 10.1074/jbc.M801668200; Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309; Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007; Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033; Li YF, 2012, CLIN ORAL IMPLAN RES, V23, P1038, DOI 10.1111/j.1600-0501.2011.02252.x; Li YF, 2010, J ORTHOP RES, V28, P578, DOI 10.1002/jor.21050; Maimoun L, 2010, BONE, V46, P1436, DOI 10.1016/j.bone.2010.01.379; Marie PJ, 2011, OSTEOPOROSIS INT, V22, P1659, DOI 10.1007/s00198-010-1369-0; Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; Mellado-Valero A, 2010, MED ORAL PATOL ORAL, V15, pE52, DOI 10.4317/medoral.15.e52; Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Ni GX, 2007, J BIOMED MATER RES A, V83A, P570, DOI 10.1002/jbm.a.31294; Ni GX, 2011, J MATER SCI-MATER M, V22, P961, DOI 10.1007/s10856-011-4264-0; Orriss IR, 2012, METHODS MOL BIOL, V816, P31, DOI 10.1007/978-1-61779-415-5_3; Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580; Ozeki K, 2014, BIO-MED MATER ENG, V24, P1447, DOI 10.3233/BME-130949; Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412; Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433; Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017; Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x; Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reginster JY, 2012, OSTEOPOROSIS INT, V23, P1115, DOI 10.1007/s00198-011-1847-z; Roux C, 2008, ANN RHEUM DIS, V67, P1736, DOI 10.1136/ard.2008.094516; Seeman E, 2006, J BONE MINER RES, V21, P1113, DOI 10.1359/JBMR.060404; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Tsolaki IN, 2009, J PROSTHODONT, V18, P309, DOI 10.1111/j.1532-849X.2008.00433.x; Tsukimura N, 2011, ACTA BIOMATER, V7, P4267, DOI 10.1016/j.actbio.2011.08.016; Xin YC, 2009, ACS NANO, V3, P3228, DOI 10.1021/nn9007675; Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815; Yamaguchi S, 2013, BIOACTIVE TI METAL C; Yamaguchi S, 2010, J MATER SCI-MATER M, V21, P439, DOI 10.1007/s10856-009-3904-0; Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031; Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041	54	12	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140669	10.1371/journal.pone.0140669	http://dx.doi.org/10.1371/journal.pone.0140669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529234	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600010
J	Wang, M; Altinoglu, S; Takeda, YS; Xu, QB				Wang, Ming; Altinoglu, Sarah; Takeda, Yuji S.; Xu, Qiaobing			Integrating Protein Engineering and Bioorthogonal Click Conjugation for Extracellular Vesicle Modulation and Intracellular Delivery	PLOS ONE			English	Article							NEWLY SYNTHESIZED PROTEINS; CANCER-THERAPY; MAMMALIAN-CELLS; IN-VIVO; EXOSOMES; CHEMISTRY; MOUSE; NANOPARTICLES; SIRNA	Exosomes are small, cell-secreted vesicles that transfer proteins and genetic information between cells. This intercellular transmission regulates many physiological and pathological processes. Therefore, exosomes have emerged as novel biomarkers for disease diagnosis and as nanocarriers for drug delivery. Here, we report an easy-to-adapt and highly versatile methodology to modulate exosome composition and conjugate exosomes for intracellular delivery. Our strategy combines the metabolic labeling of newly synthesized proteins or glycan/glycoproteins of exosome-secreting cells with active azides and bioorthogonal click conjugation to modify and functionalize the exosomes. The azide-integrated can be conjugated to a variety of small molecules and proteins and can efficiently deliver conjugates into cells. The metabolic engineering of exosomes diversifies the chemistry of exosomes and expands the functions that can be introduced into exosomes, providing novel, powerful tools to study the roles of exosomes in biology and expand the biomedical potential of exosomes.	[Wang, Ming; Altinoglu, Sarah; Takeda, Yuji S.; Xu, Qiaobing] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Xu, QB (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	Qiaobing.xu@tufts.edu	; Wang, Ming/G-8269-2012	Takeda, Yuji/0000-0002-0065-2063; Wang, Ming/0000-0002-2783-9426	NSF CAREER Award [DMR1452122]	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the NSF CAREER Award (Grant No. DMR1452122). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Escrevente C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078631; Hangauer MJ, 2008, ANGEW CHEM INT EDIT, V47, P2394, DOI 10.1002/anie.200704847; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smyth T, 2014, BIOCONJUGATE CHEM, V25, P1777, DOI 10.1021/bc500291r; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Wang M, 2014, ANGEW CHEM INT EDIT, V53, P13444, DOI 10.1002/anie.201407234; Wang M, 2014, ANGEW CHEM INT EDIT, V53, P2893, DOI 10.1002/anie.201311245; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yoshioka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4591	24	77	77	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141860	10.1371/journal.pone.0141860	http://dx.doi.org/10.1371/journal.pone.0141860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529317	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600071
J	Ferrer, A; Sebastian, R; Sanchez-Quintana, D; Rodriguez, JF; Godoy, EJ; Martinez, L; Saiz, J				Ferrer, Ana; Sebastian, Rafael; Sanchez-Quintana, Damian; Rodriguez, Jose F.; Godoy, Eduardo J.; Martinez, Laura; Saiz, Javier			Detailed Anatomical and Electrophysiological Models of Human Atria and Torso for the Simulation of Atrial Activation	PLOS ONE			English	Article							BODY-SURFACE; CONDUCTION-VELOCITY; SINUS RHYTHM; VOLUME CONDUCTOR; RATE-DEPENDENCE; CANINE RIGHT; HUMAN HEART; REPOLARIZATION; FIBRILLATION; ARCHITECTURE	Atrial arrhythmias, and specifically atrial fibrillation (AF), induce rapid and irregular activation patterns that appear on the torso surface as abnormal P-waves in electrocardiograms and body surface potential maps (BSPM). In recent years both P-waves and the BSPM have been used to identify the mechanisms underlying AF, such as localizing ectopic foci or high-frequency rotors. However, the relationship between the activation of the different areas of the atria and the characteristics of the BSPM and P-wave signals are still far from being completely understood. In this work we developed a multi-scale framework, which combines a highly-detailed 3D atrial model and a torso model to study the relationship between atrial activation and surface signals in sinus rhythm. Using this multi scale model, it was revealed that the best places for recording P-waves are the frontal upper right and the frontal and rear left quadrants of the torso. Our results also suggest that only nine regions (of the twenty-one structures in which the atrial surface was divided) make a significant contribution to the BSPM and determine the main P-wave characteristics.	[Ferrer, Ana; Godoy, Eduardo J.; Martinez, Laura; Saiz, Javier] Univ Politecn Valencia, Ctr Invest & Innovac Bioingn Ci2B, E-46071 Valencia, Spain; [Sebastian, Rafael] Univ Valencia, Dept Comp Sci, Computat Multiscale Physiol Lab CoMMLab, Valencia, Spain; [Sanchez-Quintana, Damian] Univ Extremadura, Fac Med, Dept Anat & Cell Biol, Badajoz, Spain; [Rodriguez, Jose F.] Univ Zaragoza, Appl Mech & Bioengn Grp AMB, Zaragoza, Spain; [Rodriguez, Jose F.] Politecn Milan, Dipartimento Chim Mat & Ingn Chim Giulio Natta, I-20133 Milan, Italy	Universitat Politecnica de Valencia; University of Valencia; Universidad de Extremadura; University of Zaragoza; Polytechnic University of Milan	Ferrer, A (corresponding author), Univ Politecn Valencia, Ctr Invest & Innovac Bioingn Ci2B, E-46071 Valencia, Spain.	anferal0@upvnet.upv.es	Matas, Jose F Rodriguez/H-4589-2011; Godoy, Eduardo Jorge/AAP-7659-2020; Martinez-Mateu, Laura/AAB-2815-2020; Sebastian, Rafael/E-9386-2011; Saiz, Javier/I-1295-2015	Matas, Jose F Rodriguez/0000-0001-7612-266X; Godoy, Eduardo Jorge/0000-0001-5625-2846; Martinez-Mateu, Laura/0000-0003-0291-7683; Sebastian, Rafael/0000-0001-6746-5740; Sanchez-Quintana, Damian/0000-0002-5374-8317; Saiz, Javier/0000-0002-9850-0825; Sanchez-Quintana, Damian/0000-0002-6714-5322	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds - ERDF - FEDER) [TIN2012-37546-C03-01, TIN2014-59932-JIN]; "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad; "Programa Prometeo" from the Generalitat Valenciana [2012/030]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain(Spanish Government); European Commission (European Regional Development Funds - ERDF - FEDER); "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad; "Programa Prometeo" from the Generalitat Valenciana	This work was partially supported by the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain and the European Commission (European Regional Development Funds - ERDF - FEDER), Award Number: TIN2012-37546-C03-01 (Recipient: Ana Ferrer); the "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad and the European Commission (European Regional Development Funds - ERDF - FEDER), Award Number: TIN2014-59932-JIN (Recipient: Rafael Sebastion); and the "Programa Prometeo" from the Generalitat Valenciana, Award Number: 2012/030 (Recipient: Laura Martinez).	ABBOUD S, 1991, CIRC RES, V68, P1751, DOI 10.1161/01.RES.68.6.1751; Cabrera JA, 2013, HEART, V99, P417, DOI 10.1136/heartjnl-2011-301154; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Aslanidi OV, 2012, EUR J PHARM SCI, V46, P209, DOI 10.1016/j.ejps.2011.08.014; Aslanidi OV, 2011, IEEE ENG MED BIO, P1693, DOI 10.1109/IEMBS.2011.6090486; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Bradley CP, 2000, ANN BIOMED ENG, V28, P721, DOI 10.1114/1.1289467; Bressler SL, 2006, WILEY ENCY BIOMEDICA, P1; Burdumy M, 2012, BIOMED ENG-BIOMED TE, V57, P79, DOI 10.1515/bmt-2011-0059; Cabrera JA, 2008, EUR HEART J, V29, P356, DOI 10.1093/eurheartj/ehm606; Cha TJ, 2005, CIRCULATION, V111, P728, DOI 10.1161/01.CIR.0000155240.05251.D0; Cibc, 2013, SEG3D VOL IM SEGM VI; Colman M, 2014, CARDIOLOGY, DOI [10.1007/978-3-319-01643-6, DOI 10.1007/978-3-319-01643-6]; Guillem MD, 2009, IEEE T INF TECHNOL B, V13, P330, DOI 10.1109/TITB.2008.2011894; Deng DD, 2012, J ZHEJIANG UNIV-SC B, V13, P676, DOI 10.1631/jzus.B1100339; Dobrev D, 2001, CIRCULATION, V104, P2551, DOI 10.1161/hc4601.099466; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Fedorov VV, 2010, J AM COLL CARDIOL, V56, P1386, DOI 10.1016/j.jacc.2010.03.098; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Fereniec M, 2011, MED SCI MONITOR, V17, pMT26, DOI 10.12659/MSM.881436; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gozolits S, 2002, J CARDIOVASC ELECTR, V13, P1240, DOI 10.1046/j.1540-8167.2002.01240.x; Hansson A, 1998, EUR HEART J, V19, P293, DOI 10.1053/euhj.1997.0742; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Ho SY, 2012, CIRC-ARRHYTHMIA ELEC, V5, P220, DOI 10.1161/CIRCEP.111.962720; Ho SY, 2010, PACE, V33, P620, DOI 10.1111/j.1540-8159.2009.02659.x; Huo Y, 2014, J ELECTROCARDIOL, V47, P275, DOI 10.1016/j.jelectrocard.2014.01.011; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; Klepfer RN, 1997, IEEE T BIO-MED ENG, V44, P706, DOI 10.1109/10.605427; Kojodjojo P, 2006, J CARDIOVASC ELECTR, V17, P120, DOI 10.1111/j.1540-8167.2005.00293.x; Kozlikova K, 2007, PHYSIOL RES, V56, pS123, DOI 10.33549/physiolres.931310; Krogh-Madsen T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002390; Krueger MW, 2013, MED BIOL ENG COMPUT, V51, P1105, DOI 10.1007/s11517-013-1090-1; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Krueger MW, 2010, BIOMED TECH ENG, V55, P1, DOI [10.1515/bmt.2010.712, DOI 10.1515/BMT.2010.712]; Kruger M., 2012, PERSONALIZED MULTISC; Lamata P, 2013, IEEE T MED IMAGING, V32, P130, DOI 10.1109/TMI.2012.2231094; Lemery R, 2007, J CARDIOVASC ELECTR, V18, P402, DOI 10.1111/j.1540-8167.2007.00762.x; Lenkova J, 2012, J ELECTROCARDIOL, V45, P231, DOI 10.1016/j.jelectrocard.2012.01.006; LEON LJ, 1991, J ELECTROCARDIOL, V24, P1, DOI 10.1016/0022-0736(91)90077-Y; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Lian J, 2002, MED BIOL ENG COMPUT, V40, P650, DOI 10.1007/BF02345304; Lux RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085689; MACLEOD RS, 1991, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 13, PTS 1-5, P688, DOI 10.1109/IEMBS.1991.684145; Maesen B, 2013, CIRC-ARRHYTHMIA ELEC, V6, P967, DOI 10.1161/CIRCEP.113.000050; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Malmivuo P., 1995, BIOELECTROMAGNETISM; Nygren A, 1998, CIRC RES, V82, P63; Poletti E, 2009, IFMBE PROC, V25, P137, DOI 10.1007/978-3-642-03891-4_37; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Rodrigo M, 2014, HEART RHYTHM, V11, P1584, DOI 10.1016/j.hrthm.2014.05.013; RUDY Y, 1980, CIRC RES, V46, P283, DOI 10.1161/01.RES.46.2.283; Safdarian Naser, 2013, J Med Signals Sens, V3, P129; SAFFITZ JE, 1994, CIRC RES, V74, P1065, DOI 10.1161/01.RES.74.6.1065; Sanchez-Quintana D, 2013, J CARDIOVASC TRANSL, V6, P124, DOI 10.1007/s12265-013-9447-2; Sanchez-Quintana D, 2012, CURR CARDIOL REV, V8, P310, DOI 10.2174/157340312803760721; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Si H, 2005, PROCEEDINGS OF THE 14TH INTERNATIONAL MESHING ROUNDTABLE, P147, DOI 10.1007/3-540-29090-7_9; SippensGroenewegen A, 1998, CIRCULATION, V97, P369; SPACH MS, 1988, CIRC RES, V62, P811, DOI 10.1161/01.RES.62.4.811; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; van Dam Peter M, 2005, Europace, V7 Suppl 2, P30, DOI 10.1016/j.eupc.2005.03.013; van der Graaf AWM, 2014, ANN NONINVAS ELECTRO, V19, P105, DOI 10.1111/anec.12140; WANG Z, 1990, CIRCULATION, V82, P274, DOI 10.1161/01.CIR.82.1.274; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P265, DOI 10.1109/TBME.2010.2090151; Wilhelms Mathias, 2012, Front Physiol, V3, P487, DOI 10.3389/fphys.2012.00487; Zarychta P, 2007, COMPUT CARDIOL, V34, P181, DOI 10.1109/CIC.2007.4745451; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950	73	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141573	10.1371/journal.pone.0141573	http://dx.doi.org/10.1371/journal.pone.0141573			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523732	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800012
J	Foguet-Boreu, Q; Violan, C; Rodriguez-Blanco, T; Roso-Llorach, A; Pons-Vigues, M; Pujol-Ribera, E; Gil, YC; Valderas, JM				Foguet-Boreu, Quinti; Violan, Concepcion; Rodriguez-Blanco, Teresa; Roso-Llorach, Albert; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta; Cossio Gil, Yolima; Valderas, Jose M.			Multimorbidity Patterns in Elderly Primary Health Care Patients in a South Mediterranean European Region: A Cluster Analysis	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PREVALENCE; POPULATION; DISORDERS; SERVICES; GENDER; LIFE; AGE	Objective The purpose of this study was to identify clusters of diagnoses in elderly patients with multimorbidity, attended in primary care. Design Cross-sectional study. Setting 251 primary care centres in Catalonia, Spain. Participants Individuals older than 64 years registered with participating practices. Main outcome measures Multimorbidity, defined as the coexistence of 2 or more ICD-10 disease categories in the electronic health record. Using hierarchical cluster analysis, multimorbidity clusters were identified by sex and age group (65-79 and >= 80 years). Results 322,328 patients with multimorbidity were included in the analysis (mean age, 75.4 years [Standard deviation, SD: 7.4], 57.4% women; mean of 7.9 diagnoses [SD: 3.9]). For both men and women, the first cluster in both age groups included the same two diagnoses: Hypertensive diseases and Metabolic disorders. The second cluster contained three diagnoses of the musculoskeletal system in the 65- to 79-year-old group, and five diseases coincided in the >= 80 age group: varicose veins of the lower limbs, senile cataract, dorsalgia, functional intestinal disorders and shoulder lesions. The greatest overlap (54.5%) between the three most common diagnoses was observed in women aged 65-79 years. Conclusion This cluster analysis of elderly primary care patients with multimorbidity, revealed a single cluster of circulatory-metabolic diseases that were the most prevalent in both age groups and sex, and a cluster of second-most prevalent diagnoses that included musculoskeletal diseases. Clusters unknown to date have been identified. The clusters identified should be considered when developing clinical guidance for this population.	[Foguet-Boreu, Quinti; Violan, Concepcion; Rodriguez-Blanco, Teresa; Roso-Llorach, Albert; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta; Cossio Gil, Yolima] Univ Autonoma Barcelona, Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, E-08193 Barcelona, Spain; [Foguet-Boreu, Quinti; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta] Univ Girona, Girona, Catalonia, Spain; [Valderas, Jose M.] Univ Exeter, Sch Med, Hlth Serv & Policy Res Grp, Exeter, Devon, England	Autonomous University of Barcelona; Universitat de Girona; University of Exeter	Foguet-Boreu, Q (corresponding author), Univ Autonoma Barcelona, Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Gran Via Corts Catalanes,587 Atic, E-08193 Barcelona, Spain.	42292qfb@comb.cat	Pons-Vigués, Mariona/D-6079-2019; Valderas, Jose M/Y-9814-2019; Violán, Concepcion/HHC-2893-2022; Martín, Teresa Rodríguez/GZL-1938-2022; Valderas, Jose M/G-7967-2014; Violan, Concepcion/I-4493-2019	Pons-Vigués, Mariona/0000-0002-7929-3701; Violán, Concepcion/0000-0003-3309-5360; Valderas, Jose M/0000-0002-9299-1555; Violan, Concepcion/0000-0003-3309-5360; Rodriguez-Blanco, Teresa/0000-0003-1395-9723; Roso-Llorach, Albert/0000-0002-9264-0405; Foguet-Boreu, Quinti/0000-0002-6069-5305; Pujol Ribera, Enriqueta/0000-0002-9475-0755	Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) under the National Plan for Scientific Research, Development and Technological Innovation; European Regional Development Fund, Primary Care Prevention and Health Promotion Research Network (rediAPP) [IP12/00427]; ISCiii-RETICS [RD12/0005]; Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research Clinician Scientist Award [NIHR/CS/010/024]; XIX by Agrupacio Mutua Foundation; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) under the National Plan for Scientific Research, Development and Technological Innovation; European Regional Development Fund, Primary Care Prevention and Health Promotion Research Network (rediAPP); ISCiii-RETICS; Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research Clinician Scientist Award; XIX by Agrupacio Mutua Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant from the Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) in the 2012 call for Strategic Health Action proposals under the National Plan for Scientific Research, Development and Technological Innovation 2008-2011; by the European Union through the European Regional Development Fund (IP12/00427), as part of the Primary Care Prevention and Health Promotion Research Network (rediAPP), by ISCiii-RETICS (RD12/0005), by a 2011-2013 scholarship that aims to promote research in Primary Health Care by health professionals who have completed their specialty training, awarded by Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol), by a National Institute for Health Research Clinician Scientist Award (Jose M Valderas, NIHR/CS/010/024) and by a grant from the XIX call for research projects in the elderly population by Agrupacio Mutua Foundation (Premio ambito para las personas mayores, 2012). The funders had no role in the study design, collection, analysis and interpretation of data, writing of the manuscript or decision to submit for publication.	Aldenderfer MS, 1984, CLUSTER ANAL QUANTIT; Blozik E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-352; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Foguet-Boreu Q, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-55; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Freund T, 2012, POPUL HEALTH MANAG, V15, P119, DOI 10.1089/pop.2011.0026; Frost H. M., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P201; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Gatchel R.J., 2011, PRACT PAIN MANAG, V11, P1; Haregu T, 2012, INTERNET J EPIDEMIOL; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; SAS Institute Inc, 2008, STAT AN SYST SAS STA; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Velasco S, 2006, REV ESP SALUD PUBLIC, V80, P317, DOI 10.1590/S1135-57272006000400003; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Weiss CO, 2014, J GEN INTERN MED, V29, P653, DOI 10.1007/s11606-013-2660-5	32	30	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141155	10.1371/journal.pone.0141155	http://dx.doi.org/10.1371/journal.pone.0141155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524599	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800007
J	Tremblay-Franco, M; Cabaton, NJ; Canlet, C; Gautier, R; Schaeberle, CM; Jourdan, F; Sonnenschein, C; Vinson, F; Soto, AM; Zalko, D				Tremblay-Franco, Marie; Cabaton, Nicolas J.; Canlet, Cecile; Gautier, Roselyne; Schaeberle, Cheryl M.; Jourdan, Fabien; Sonnenschein, Carlos; Vinson, Florence; Soto, Ana M.; Zalko, Daniel			Dynamic Metabolic Disruption in Rats Perinatally Exposed to Low Doses of Bisphenol-A	PLOS ONE			English	Article							CD-1 MICE; ASCA; CHEMICALS; NETWORKS; DISORDERS; HORMONES; DESIGN	Along with the well-established effects on fertility and fecundity, perinatal exposure to endocrine disrupting chemicals, and notably to xeno-estrogens, is strongly suspected of modulating general metabolism. The metabolism of a perinatally exposed individual may be durably altered leading to a higher susceptibility of developing metabolic disorders such as obesity and diabetes; however, experimental designs involving the long term study of these dynamic changes in the metabolome raise novel challenges. H-1-NMR-based metabolomics was applied to study the effects of bisphenol-A (BPA, 0; 0.25; 2.5, 25 and 250 mu g/kg BW/day) in rats exposed perinatally. Serum and liver samples of exposed animals were analyzed on days 21, 50, 90, 140 and 200 in order to explore whether maternal exposure to BPA alters metabolism. Partial Least Squares-Discriminant Analysis (PLS-DA) was independently applied to each time point, demonstrating a significant pair-wise discrimination for liver as well as serum samples at all time-points, and highlighting unequivocal metabolic shifts in rats perinatally exposed to BPA, including those exposed to lower doses. In BPA exposed animals, metabolism of glucose, lactate and fatty acids was modified over time. To further explore dynamic variation, ANOVA-Simultaneous Component Analysis (A-SCA) was used to separate data into blocks corresponding to the different sources of variation (Time, Dose and Time*Dose interaction). A-SCA enabled the demonstration of a dynamic, time/age dependent shift of serum metabolome throughout the rats' lifetimes. Variables responsible for the discrimination between groups clearly indicate that BPA modulates energy metabolism, and suggest alterations of neurotransmitter signaling, the latter finding being compatible with the neurodevelopmental effect of this xenoestrogen. In conclusion, long lasting metabolic effects of BPA could be characterized over 200 days, despite physiological (and thus metabolic) changes connected with sexual maturation and aging.	[Tremblay-Franco, Marie; Cabaton, Nicolas J.; Canlet, Cecile; Gautier, Roselyne; Jourdan, Fabien; Vinson, Florence; Zalko, Daniel] Univ Toulouse, INRA, Res Ctr Food Toxicol, TOXALIM,UMR1331, Toulouse, France; [Schaeberle, Cheryl M.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Tufts University	Zalko, D (corresponding author), Univ Toulouse, INRA, Res Ctr Food Toxicol, TOXALIM,UMR1331, Toulouse, France.	daniel.zalko@toulouse.inra.fr	Jourdan, Fabien/AAW-5075-2021	Jourdan, Fabien/0000-0001-9401-2894; Schaeberle, Cheryl/0000-0001-9635-429X	National Institute of Environmental Health Sciences [R01ES08314];  [RC2ES018822]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018822, R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Award Number RC2ES018822 and its supplement, as well as R01ES08314 from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Garcia-Arevalo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100214; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Jansen JJ, 2005, J CHEMOMETR, V19, P469, DOI 10.1002/cem.952; Jourdan F, 2010, METABOLOMICS, V6, P312, DOI 10.1007/s11306-009-0196-9; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; McCombie G, 2009, METABOLOMICS, V5, P363, DOI 10.1007/s11306-009-0161-7; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Smilde AK, 2008, J CHEMOMETR, V22, P464, DOI 10.1002/cem.1175; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; SOTO AM, 1992, ADV MOD ENV, V21, P295; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Thissen U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-52; Vandenberg LN, 2014, VITAM HORM, V94, P129, DOI 10.1016/B978-0-12-800095-3.00005-5; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vis DJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-322; vom Saal FS, 2008, JAMA-J AM MED ASSOC, V300, P1353, DOI 10.1001/jama.300.11.1353; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zeng J, 2013, ENVIRON SCI TECHNOL, V47, P7457, DOI 10.1021/es400490f	35	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141698	10.1371/journal.pone.0141698	http://dx.doi.org/10.1371/journal.pone.0141698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517871	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800070
J	Mastalerz, L; Celinska-Lowenhoff, M; Krawiec, P; Batko, B; Tlustochowicz, W; Undas, A				Mastalerz, Lucyna; Celinska-Loewenhoff, Magdalena; Krawiec, Piotr; Batko, Bogdan; Tlustochowicz, Witold; Undas, Anetta			Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; CATIONIC PROTEIN; DISEASE; VASCULITIS; ARCHITECTURE; STRUCTURE/FUNCTION; HYPOFIBRINOLYSIS	Objectives Given reports on the increased prevalence of thromboembolic incidents in patients with eosinophilic granulomatosis with polyangiitis (EGPA; Churg-Strauss syndrome), we investigated whether fibrin clot properties are unfavorably altered in EGPA. Methods Ex vivo plasma fibrin clot characteristics, including clot permeability, turbidimetry and efficiency of fibrinolysis using two assays, were investigated in 34 consecutive patients with remission in EGPA according to the Birmingham Vasculitis Activity Score version 3 (23 female, 11 male), aged 48 (range, 21-80) years. The control group comprised 34 age-and sex-matched volunteers. Results Compared with controls, patients with EGPA were characterized by denser fiber clots (estimated pore size, Ks, 7.30 +/- 0.93 vs 10.14 +/- 1.07 10(-9) cm(2)), faster fibrin polymerization (lag phase in a turbidimetric curve, 41.8 +/- 3.6 vs 47.4 +/- 2.9 s), thicker fibrin fibers (maximum absorbance,Delta Abs, 0.87 +/- 0.09 vs 0.72 +/- 0.07), higher maximum levels of D-dimer released from clots (DDmax 4.10 +/- 0.46 vs 3.54 +/- 0.35 mg/L), and prolonged clot lysis time (t(50%); 9.50 +/- 1.45 vs 7.56 +/- 0.87 min); all p<0.0001. Scanning electron microscopy images confirmed denser plasma fibrin networks composed of thinner fibers formed in EGPA. Antineutrophil cytoplasmic antibody status and C-reactive protein did not affect clot variables. Multivariate analysis adjusted for fibrinogen showed that Ks was predicted by eosinophil count, peak thrombin generation, factor VIII, and soluble CD40 ligand, whereas eosinophil count, peak thrombin generation and antiplasmin predicted t(50%). Conclusion This study is the first to show that EGPA is associated with prothrombotic plasma fibrin clot phenotype, which may contribute to thromboembolic manifestations reported in this disease.	[Mastalerz, Lucyna; Celinska-Loewenhoff, Magdalena] Jagiellonian Univ, Coll Med, Dept Med 2, Krakow, Poland; [Krawiec, Piotr; Batko, Bogdan] Dietl Hosp, Dept Rheumatol, Krakow, Poland; [Tlustochowicz, Witold] Cent Clin Hosp, Mil Inst, Dept Internal Dis & Rheumatol, Dept Natl Def,Hlth Serv, Warsaw, Poland; [Undas, Anetta] Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), Jagiellonian Univ, Coll Med, Inst Cardiol, Krakow, Poland.	mmundas@cyf-kr.edu.pl	Batko, Bogdan/D-5548-2019; Krawiec, Piotr/A-7578-2015; Mastalerz, Lucyna/U-5974-2018	Batko, Bogdan/0000-0003-3999-8093; Mastalerz, Lucyna/0000-0002-8994-0036	Jagiellonian University Medical College [K/ZDS/002936]	Jagiellonian University Medical College	The study was funded by Jagiellonian University Medical College (grant K/ZDS/002936 to AU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Allenbach Y, 2009, ANN RHEUM DIS, V68, P564, DOI 10.1136/ard.2008.099051; Ames PRJ, 2010, CLIN APPL THROMB-HEM, V16, P628, DOI 10.1177/1076029609348647; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Celinska-Lowenhoff M, 2014, THROMB HAEMOSTASIS, V112, P287, DOI 10.1160/TH13-11-0980; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 1999, THROMB HAEMOSTASIS, V82, P1482; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Cugno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111862; Dejaco C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121737; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Flossmann O, 2007, ANN RHEUM DIS, V66, P283, DOI 10.1136/ard.2005.051078; FREDENS K, 1991, ALLERGY, V46, P27, DOI 10.1111/j.1398-9995.1991.tb00538.x; FRIES JF, 1990, ARTHRITIS RHEUM, V33, P1135; Garcia G, 2005, ALLERGY, V60, P409, DOI 10.1111/j.1398-9995.2004.00691.x; Grayson PC, 2015, RHEUMATOLOGY, V54, P1351, DOI 10.1093/rheumatology/keu427; Keceoglu S, 2014, CLIN APPL THROMB-HEM, V20, P285, DOI 10.1177/1076029613483208; Khoury P, 2014, NAT REV RHEUMATOL, V10, P474, DOI 10.1038/nrrheum.2014.98; Kojima K, 1995, INTERNAL MED, V34, P1194, DOI 10.2169/internalmedicine.34.1194; Kurdee Z, 2014, POL ARCH MED WEWN, V124, P617, DOI 10.20452/pamw.2501; Kwasny-Krochin B, 2010, THROMB RES, V126, pE11, DOI 10.1016/j.thromres.2010.04.007; Mahr A, 2004, ARTHRIT RHEUM-ARTHR, V51, P92, DOI 10.1002/art.20077; Maino A, 2012, CURR VASC PHARMACOL, V10, P670, DOI 10.2174/157016112801784594; Miedinger D, 2011, CURR MED RES OPIN, V27, P2301, DOI 10.1185/03007995.2011.630722; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Pagnoux C, 2007, CURR OPIN RHEUMATOL, V19, P25, DOI 10.1097/BOR.0b013e3280119854; Sovershaev MA, 2008, J THROMB HAEMOST, V6, P1742, DOI 10.1111/j.1538-7836.2008.03105.x; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2014, THROMB HAEMOSTASIS, V112, P32, DOI 10.1160/TH14-01-0032; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2010, ARTERIOSCL THROM VAS, V30, P276, DOI 10.1161/ATVBAHA.109.194936; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; Vaglio A, 2013, ALLERGY, V68, P261, DOI 10.1111/all.12088; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Xu X, 2000, CLIN EXP ALLERGY, V30, P794; Zolcinski M, 2010, J HEART VALVE DIS, V19, P596	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142167	10.1371/journal.pone.0142167	http://dx.doi.org/10.1371/journal.pone.0142167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540111	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800062
J	Villalpando, DM; Navarro, R; del Campo, L; Largo, C; Munoz, D; Tabernero, M; Baeza, R; Otero, C; Garcia, HS; Ferrer, M				Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Largo, Carlota; Munoz, David; Tabernero, Maria; Baeza, Ramiro; Otero, Cristina; Garcia, Hugo S.; Ferrer, Mercedes			Effect of Dietary Docosahexaenoic Acid Supplementation on the Participation of Vasodilator Factors in Aorta from Orchidectomized Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACETYLCHOLINE-INDUCED RELAXATION; ENDOTHELIUM-DEPENDENT VASORELAXATION; NITRIC-OXIDE RELEASE; POTASSIUM CHANNELS; MESENTERIC-ARTERY; FISH-OIL; HYPERCHOLESTEROLEMIC RATS; SUPEROXIDE-DISMUTASE; CORONARY-ARTERIES	Benefits of n-3 polyunsaturated fatty acids (PUFAs) against cardiovascular diseases have been reported. Vascular tone regulation is largely mediated by endothelial factors whose release is modulated by sex hormones. Since the incidence of cardiovascular pathologies has been correlated with decreased levels of sex hormones, the aim of this study was to analyze whether a diet supplemented with the specific PUFA docosahexaenoic acid (DHA) could prevent vascular changes induced by an impaired gonadal function. For this purpose, control and orchidectomized rats were fed with a standard diet supplemented with 5% (w/w) sunflower oil or with 3% (w/w) sunflower oil plus 2% (w/w) DHA. The lipid profile, the blood pressure, the production of prostanoids and nitric oxide (NO), and the redox status of biological samples from control and orchidectomized rats, fed control or DHA-supplemented diet, were analyzed. The vasodilator response and the contribution of NO, prostanoids and hyperpolarizing mechanisms were also studied. The results showed that orchidectomy negatively affected the lipid profile, increased the production of prostanoids and reactive oxygen species (ROS), and decreased NO production and the antioxidant capacity, as well as the participation of hyperpolarizing mechanisms in the vasodilator responses. The DHA-supplemented diet of the orchidectomized rats decreased the release of prostanoids and ROS, while increasing NO production and the antioxidant capacity, and it also improved the lipid profile. Additionally, it restored the participation of hyperpolarizing mechanisms by activating potassium. Since the modifications induced by the DHA-supplemented diet were observed in the orchidectomized, but not in the healthy group, DHA seems to exert cardio-protective effects in physiopathological situations in which vascular dysfunction exists.	[Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Ferrer, Mercedes] Hosp Univ La Paz IdiPAZ, Inst Invest, Area Cardiovasc, Madrid, Spain; [Largo, Carlota; Tabernero, Maria] Hosp Univ La Paz IdiPAZ, Inst Invest, Cirugia Expt, Madrid, Spain; [Munoz, David] Univ Autonoma Madrid, Fac Med, Gabinete Vet, Madrid, Spain; [Baeza, Ramiro; Otero, Cristina] CSIC, Inst Catalisis & Petr Quim, Madrid, Spain; [Garcia, Hugo S.] Inst Tecnol Veracruz, Veracruz, Veracruz, Mexico	Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	del Campo, Lara/A-8317-2015; Navarro, Rocío/N-5505-2016; Ferrer, Mercedes/E-3556-2018; Parra, Mercedes Ferrer/AAE-1746-2020; Villalpando, Diva/AAG-6337-2020; del Campo Milán, Lara/ABD-4219-2021	del Campo, Lara/0000-0002-0394-116X; Navarro, Rocío/0000-0002-0083-7711; Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milán, Lara/0000-0002-0394-116X; Largo, Carlota/0000-0003-3306-7925	Fondo de Investigaciones Sanitarias [PI1100406]; Comunidad de Madrid [S2013/ABI-2783]; Fondo Europeo de Desarrollo Regional; Centro de Estudios America Latina (Grupo Santander-UAM)	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission); Centro de Estudios America Latina (Grupo Santander-UAM)	This study was supported by grants to MF from the Fondo de Investigaciones Sanitarias (PI1100406), Comunidad de Madrid (S2013/ABI-2783, "INSPIRA1-CM"), Fondo Europeo de Desarrollo Regional, and Centro de Estudios America Latina (Grupo Santander-UAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Bian K, 2014, NITRIC OXIDE-BIOL CH, V43, P3, DOI 10.1016/j.niox.2014.08.006; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; Casos K, 2010, FREE RADICAL RES, V44, P821, DOI 10.3109/10715762.2010.485992; Chen JN, 2012, ATHEROSCLEROSIS, V221, P397, DOI 10.1016/j.atherosclerosis.2012.01.005; Chen LY, 2000, J CARDIOVASC PHARM, V35, P502, DOI 10.1097/00005344-200003000-00022; Cohen AT, 2015, THROMB RES, V135, P217, DOI 10.1016/j.thromres.2014.11.036; Das UN, 2004, EUR J CLIN NUTR, V58, P195, DOI 10.1038/sj.ejcn.1601766; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Engler M B, 2000, Biol Res Nurs, V2, P85, DOI 10.1177/109980040000200202; Engler MM, 2003, EXP BIOL MED, V228, P299, DOI 10.1177/153537020322800309; Enns JE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-70; Farre LA, 2006, REV ESP CARDIOL S6, p31D; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Ferrer M, 1999, CLIN SCI, V97, P625, DOI 10.1042/CS19990102; Freese R, 1997, AM J CLIN NUTR, V66, P591, DOI 10.1093/ajcn/66.3.591; Goirand F, 2005, CLIN EXP PHARMACOL P, V32, P184, DOI 10.1111/j.1440-1681.2005.04169.x; Guder G, 2010, HEART, V96, P504, DOI 10.1136/hrt.2009.181065; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Guzik B, 2013, INT J CARDIOL, V168, P2389, DOI 10.1016/j.ijcard.2013.01.278; Hashimoto M, 1999, J NUTR, V129, P70, DOI 10.1093/jn/129.1.70; Hirafuji M, 2003, J PHARMACOL SCI, V92, P308; Ishikado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069415; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Khan SA, 1996, J PHARMACOL EXP THER, V267, P1327; Lagarde M, 2013, PROSTAG LEUKOTR ESS, V88, P49, DOI 10.1016/j.plefa.2012.04.001; Lee TC, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-196; Lucas A, 2008, METABOLISM, V57, P233, DOI 10.1016/j.metabol.2007.09.006; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Matesanz N, 2010, INVEST OPHTH VIS SCI, V51, P6815, DOI 10.1167/iovs.10-5339; McDonald DM, 2013, DIABETES CARE, V36, P998, DOI 10.2337/dc12-0304; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Papapostolou L, 2004, ANAL BIOCHEM, V332, P290, DOI 10.1016/j.ab.2004.06.022; Richard D, 2009, BIOCHEM BIOPH RES CO, V389, P516, DOI 10.1016/j.bbrc.2009.09.013; Rousseau-Ralliard D, 2009, PROSTAG LEUKOTR ESS, V80, P269, DOI 10.1016/j.plefa.2009.03.003; Ruan DN, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-143; Sagredo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073474; Sato K, 2014, PHARMACOLOGY, V93, P229, DOI 10.1159/000360543; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Seyrek M, 2007, J PHARMACOL SCI, V103, P309, DOI 10.1254/jphs.FP0060883; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Tabernero M, 2014, FOOD FUNCT, V5, P1556, DOI 10.1039/c3fo60677e; Tabernero M, 2013, J FUNCT FOODS, V5, P755, DOI 10.1016/j.jff.2013.01.021; Tagawa T, 2002, HYPERTENS RES, V25, P823; Tep-areenan P, 2002, BRIT J PHARMACOL, V135, P735, DOI 10.1038/sj.bjp.0704522; Trebble TM, 2003, AM J CLIN NUTR, V78, P376, DOI 10.1093/ajcn/78.3.376; Vanhoutte PM, 2003, CIRC J, V67, P572; Varagic J, 2014, INTEGR BLOOD PRESS C, V7, P61, DOI 10.2147/IBPC.S50954; Vogt A, 2015, APPL CLIN GENET, V8, P27, DOI 10.2147/TACG.S44315; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wu KT, 2007, CHINESE J PHYSIOL, V50, P164; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Yan JC, 2014, PULM PHARMACOL THER, V28, P9, DOI 10.1016/j.pupt.2013.11.004; YUE P, 1995, CIRCULATION, V91, P1154, DOI 10.1161/01.CIR.91.4.1154; Zebrowska A., 2014, EUR J SPORT SCI, P1; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	69	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142039	10.1371/journal.pone.0142039	http://dx.doi.org/10.1371/journal.pone.0142039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540339	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800047
J	Liu, LL; Li, F; Pao, W; Michor, F				Liu, Lin L.; Li, Fei; Pao, William; Michor, Franziska			Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							DRUG-RESISTANCE; MATHEMATICAL-MODEL; TARGETED THERAPIES; STOCHASTIC-MODEL; CHEMOTHERAPY; EVOLUTION; IMATINIB; QUIESCENCE; GENERATION; APOPTOSIS	Background The advent of targeted therapy for cancer treatment has brought about a paradigm shift in the clinical management of human malignancies. Agents such as erlotinib used for EGFR-mutant non-small cell lung cancer or imatinib for chronic myeloid leukemia, for instance, lead to rapid tumor responses. Unfortunately, however, resistance often emerges and renders these agents ineffective after a variable amount of time. The FDA-approved dosing schedules for these drugs were not designed to optimally prevent the emergence of resistance. To this end, we have previously utilized evolutionary mathematical modeling of treatment responses to elucidate the dosing schedules best able to prevent or delay the onset of resistance. Here we expand on our approaches by taking into account dose-dependent mutation rates at which resistant cells emerge. The relationship between the serum drug concentration and the rate at which resistance mutations arise can lead to non-intuitive results about the best dose administration strategies to prevent or delay the emergence of resistance. Methods We used mathematical modeling, available clinical trial data, and different considerations of the relationship between mutation rate and drug concentration to predict the effectiveness of different dosing strategies. Results We designed several distinct measures to interrogate the effects of different treatment dosing strategies and found that a low-dose continuous strategy coupled with high-dose pulses leads to the maximal delay until clinically observable resistance. Furthermore, the response to treatment is robust against different assumptions of the mutation rate as a function of drug concentration. Conclusions For new and existing targeted drugs, our methodology can be employed to compare the effectiveness of different dose administration schedules and investigate the influence of changing mutation rates on outcomes.	[Liu, Lin L.; Li, Fei; Michor, Franziska] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Liu, Lin L.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN 27232 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Michor, F (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	michor@jimmy.harvard.edu			Dana-Farber Cancer Institute Physical Sciences-Oncology Center [NCI U54CA143798]; US National Cancer Institute [R01CA121210, P01CA129243]; NATIONAL CANCER INSTITUTE [P01CA129243, U54CA143798, R01CA121210] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (NCI U54CA143798) and from US National Cancer Institute grants R01CA121210 and P01CA129243.	Agur Z, 1986, ANN NY ACAD SCI, V504, P274, DOI 10.1111/j.1749-6632.1987.tb48738.x; Allgayer H, 2008, ADV MED SCI-POLAND, V53, P130, DOI 10.2478/v10039-008-0025-9; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Coldman AJ, 2000, MATH BIOSCI, V168, P187, DOI 10.1016/S0025-5564(00)00045-6; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Comen E, 2012, J MAMMARY GLAND BIOL, V17, P241, DOI 10.1007/s10911-012-9267-z; COSTA MIS, 1995, MATH BIOSCI, V125, P191, DOI 10.1016/0025-5564(94)00027-W; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; DAY RS, 1986, CANCER RES, V46, P3876; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; de Pillis LG, 2001, J THEO MED, V24, P79, DOI [10.1080/10273660108833067, DOI 10.1080/10273660108833067]; DEMPSEY JL, 1985, CANCER RES, V45, P2873; DeVita V T Jr, 1975, CA Cancer J Clin, V25, P152; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; DIBROV BF, 1983, MATH BIOSCI, V66, P167, DOI 10.1016/0025-5564(83)90087-1; England K, 2006, FREE RADICAL RES, V40, P1124, DOI 10.1080/10715760600838209; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000557; Gardner SN, 2003, MOL CANCER THER, V2, P1079; Gardner SN, 2002, J THEOR BIOL, V214, P181, DOI 10.1006/jtbi.2001.2459; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Haeno H, 2007, GENETICS, V177, P2209, DOI 10.1534/genetics.107.078915; Hahnfeldt P, 2003, J THEOR BIOL, V220, P545, DOI 10.1006/jtbi.2003.3162; Hofmann WK, 2003, BLOOD, V102, P659, DOI 10.1182/blood-2002-06-1756; Hug H, 1997, J BIOL CHEM, V272, P28191, DOI 10.1074/jbc.272.45.28191; Hutson TE, 2008, ONCOLOGIST, V13, P1084, DOI 10.1634/theoncologist.2008-0120; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Iwasa Y, 2003, P ROY SOC LOND B BIO, V270, P2572; Jia PL, 2013, GENOME RES, V23, P1434, DOI 10.1101/gr.152322.112; Kohandel M, 2006, J THEOR BIOL, V242, P62, DOI 10.1016/j.jtbi.2006.02.001; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; LEWIS PAW, 1979, NAV RES LOG, V26, P403, DOI 10.1002/nav.3800260304; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Martin R. B., 1994, OPTIMAL CONTROL DRUG; NORTON L, 1986, CANCER TREAT REP, V70, P163; NORTON L, 1977, CANCER TREAT REP, V61, P1307; Panetta JC, 1996, B MATH BIOL, V58, P425, DOI 10.1016/0092-8240(95)00346-0; R Core Team, 2021, R LANGUAGE ENV STAT; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; Tortora Giampaolo, 2011, Journal of the National Cancer Institute Monographs, P95, DOI 10.1093/jncimonographs/lgr026; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022	51	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141665	10.1371/journal.pone.0141665	http://dx.doi.org/10.1371/journal.pone.0141665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536620	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400075
J	Wall, BT; Gorissen, SH; Pennings, B; Koopman, R; Groen, BBL; Verdijk, LB; van Loon, LJC				Wall, Benjamin Toby; Gorissen, Stefan H.; Pennings, Bart; Koopman, Rene; Groen, Bart B. L.; Verdijk, Lex B.; van Loon, Luc J. C.			Aging Is Accompanied by a Blunted Muscle Protein Synthetic Response to Protein Ingestion	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ANABOLIC RESISTANCE; INSULIN-RESISTANCE; ABSORPTION; CARBOHYDRATE; MYOFIBRILLAR; DIGESTION; YOUNG; MEN; METABOLISM	Purpose Progressive loss of skeletal muscle mass with aging (sarcopenia) forms a global health concern. It has been suggested that an impaired capacity to increase muscle protein synthesis rates in response to protein intake is a key contributor to sarcopenia. We assessed whether differences in post-absorptive and/or post-prandial muscle protein synthesis rates exist between large cohorts of healthy young and older men. Procedures We performed a cross-sectional, retrospective study comparing in vivo post-absorptive muscle protein synthesis rates determined with stable isotope methodologies between 34 healthy young (22 +/- 1 y) and 72 older (75 +/- 1 y) men, and post-prandial muscle protein synthesis rates between 35 healthy young (22 +/- 1 y) and 40 older (74 +/- 1 y) men. Findings Post-absorptive muscle protein synthesis rates did not differ significantly between the young and older group. Post-prandial muscle protein synthesis rates were 16% lower in the older subjects when compared with the young. Muscle protein synthesis rates were >3 fold more responsive to dietary protein ingestion in the young. Irrespective of age, there was a strong negative correlation between post-absorptive muscle protein synthesis rates and the increase in muscle protein synthesis rate following protein ingestion. Conclusions Aging is associated with the development of muscle anabolic inflexibility which represents a key physiological mechanism underpinning sarcopenia.	[Wall, Benjamin Toby; Gorissen, Stefan H.; Pennings, Bart; Koopman, Rene; Groen, Bart B. L.; Verdijk, Lex B.; van Loon, Luc J. C.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	van Loon, LJC (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands.	l.vanloon@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; Gorissen, Stefan/ABA-1008-2021; van Loon, Luc J C/G-5920-2010; Verdijk, Lex B/H-4468-2016	van Loon, Luc J.C./0000-0002-6768-9231; Gorissen, Stefan/0000-0003-3737-9053; van Loon, Luc J C/0000-0002-6768-9231; Verdijk, Lex B/0000-0002-9196-8767				Areta JL, 2014, AM J PHYSIOL-ENDOC M, V306, pE989, DOI 10.1152/ajpendo.00590.2013; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5; Burd NA, 2012, J APPL PHYSIOL, V112, P1233, DOI 10.1152/japplphysiol.01343.2011; Chevalier S, 2011, J GERONTOL A-BIOL, V66, P681, DOI 10.1093/gerona/glr036; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Denti L, 2000, J AM GERIATR SOC, V48, P51, DOI 10.1111/j.1532-5415.2000.tb03028.x; Dillon EL, 2011, AM J PHYSIOL-REG I, V301, pR1408, DOI 10.1152/ajpregu.00211.2011; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Gorissen SHM, 2014, J CLIN ENDOCR METAB, V99, P2250, DOI 10.1210/jc.2013-3970; Guillet C, 2004, FASEB J, V18, P1586, DOI 10.1096/fj.03-1341fje; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kiskini A, 2013, AGE, V35, P2389, DOI 10.1007/s11357-013-9522-2; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Koopman R, 2009, J NUTR, V139, P1707, DOI 10.3945/jn.109.109173; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; LUNDHOLM K, 1975, EXP GERONTOL, V10, P155, DOI 10.1016/0531-5565(75)90045-5; Manders RJ, 2008, J NUTR, V138, P1079, DOI 10.1093/jn/138.6.1079; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller N, 2008, DIABETES, V57, P3, DOI 10.2337/db07-1581; Moore D.R., 2014, J GERONTOL A; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Pennings B, 2013, AM J CLIN NUTR, V98, P121, DOI 10.3945/ajcn.112.051201; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; Petersen AMW, 2007, AM J PHYSIOL-ENDOC M, V293, pE843, DOI 10.1152/ajpendo.00301.2007; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; RENNIE MJ, 1982, CLIN SCI, V63, P519, DOI 10.1042/cs0630519; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; Volpi E, 1998, J CLIN INVEST, V101, P2000, DOI 10.1172/JCI939; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210; Yarasheski KE, 2011, AM J CLIN NUTR, V94, P172, DOI 10.3945/ajcn.110.010959	56	181	187	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140903	10.1371/journal.pone.0140903	http://dx.doi.org/10.1371/journal.pone.0140903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536130	Green Published, gold			2022-12-27	WOS:000364298400043
J	Derrible, S; Ahmad, N				Derrible, Sybil; Ahmad, Nasir			Network-Based and Binless Frequency Analyses	PLOS ONE			English	Article								We introduce and develop a new network-based and binless methodology to perform frequency analyses and produce histograms. In contrast with traditional frequency analysis techniques that use fixed intervals to bin values, we place a range +/-zeta around each individual value in a data set and count the number of values within that range, which allows us to compare every single value of a data set with one another. In essence, the methodology is identical to the construction of a network, where two values are connected if they lie within a given a range (+/-zeta). The value with the highest degree (i.e., most connections) is therefore assimilated to the mode of the distribution. To select an optimal range, we look at the stability of the proportion of nodes in the largest cluster. The methodology is validated by sampling 12 typical distributions, and it is applied to a number of real-world data sets with both spatial and temporal components. The methodology can be applied to any data set and provides a robust means to uncover meaningful patterns and trends. A free python script and a tutorial are also made available to facilitate the application of the method.	[Derrible, Sybil; Ahmad, Nasir] Univ Illinois, Complex & Sustainable Urban Networks CSUN Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Derrible, S (corresponding author), Univ Illinois, Complex & Sustainable Urban Networks CSUN Lab, Chicago, IL 60607 USA.	derrible@uic.edu		Derrible, Sybil/0000-0002-2939-6016; Ahmad, Nasir/0000-0001-5067-7368	NSF Award [CCF-1331800]; University of Illinois at Chicago Institute for Environmental Science and Policy (IESP) Pre-Doctoral Fellowship; Department of Civil and Materials Engineering at the University of Illinois at Chicago	NSF Award(National Science Foundation (NSF)); University of Illinois at Chicago Institute for Environmental Science and Policy (IESP) Pre-Doctoral Fellowship; Department of Civil and Materials Engineering at the University of Illinois at Chicago	This research was supported, in part, by NSF Award CCF-1331800, by the University of Illinois at Chicago Institute for Environmental Science and Policy (IESP) Pre-Doctoral Fellowship, and by the Department of Civil and Materials Engineering at the University of Illinois at Chicago.	Baraniuk RG, 2011, SCIENCE, V331, P717, DOI 10.1126/science.1197448; Ben-Gal I, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P131, DOI 10.1007/0-387-25465-X_7; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Han J, 2012, MOR KAUF D, P1; Lohr Steve., 2015, DATA ISM REVOLUTION; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pimentel MAF, 2014, SIGNAL PROCESS, V99, P215, DOI 10.1016/j.sigpro.2013.12.026; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Scott DW, 2010, WIRES COMPUT STAT, V2, P44, DOI 10.1002/wics.59; Swetz FJ, 2012, SEARCH CERTAINTY JOU; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37	13	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142108	10.1371/journal.pone.0142108	http://dx.doi.org/10.1371/journal.pone.0142108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529207	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600100
J	Hwang, JI; Lee, SE; Kim, JE				Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok			Plant Uptake and Distribution of Endosulfan and Its Sulfate Metabolite Persisted in Soil	PLOS ONE			English	Article							ALPHA-ENDOSULFAN; PESTICIDES; DEGRADATION; FATE; BIODEGRADATION; ACCUMULATION; VEGETATION	The distributions of endosulfan (ED) residues (alpha-, beta-isomers, and sulfate-metabolite) in cucumbers grown in soils treated with ED at concentrations of 20 and 40 mg kg(-1) were assessed using indoor and outdoor experiments. In all treatments, degradation rates of the a-isomer in soils were higher than that of the beta-isomer. In the indoor tests, uptake amounts of total ED by cucumbers, after 15 d of growth, were 7.8 and 14.5 mg kg(-1) in 20 and 40 mg kg(-1)-treated pots, respectively. For growth time from 15 to 30 d, uptake amounts in 20 and 40 mg kg(-1)-treated pots were 3.8 and 7.9 mg kg(-1), respectively. Outdoor tests resulted in smaller ED residues in cucumbers than those in indoor tests. In both indoor and outdoor tests, ED residues absorbed were highest in roots, and the a-isomer was the more frequently absorbed isomer. These results will be useful for determining management criteria for soil persistent pesticides.	[Hwang, Jeong-In; Lee, Sung-Eun; Kim, Jang-Eok] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	Kyungpook National University	Kim, JE (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jekim@knu.ac.kr	Hwang, Jeong-In/D-8504-2017	Hwang, Jeong-In/0000-0002-3929-0688	grant (Research Cooperating for Agricultural Science & Technology Development), from Rural Development Administration, Republic of Korea [PJ011435]	grant (Research Cooperating for Agricultural Science & Technology Development), from Rural Development Administration, Republic of Korea	This work was funded by a grant (Research Cooperating for Agricultural Science & Technology Development; Project No. PJ011435), from the Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J. W., 2012, KOREAN J ENV AGR, V31, P164; Anderson JJ, 2013, J AGR FOOD CHEM, V61, P9027, DOI 10.1021/jf4025757; Awasthi N, 2000, SOIL BIOL BIOCHEM, V32, P1697, DOI 10.1016/S0038-0717(00)00087-0; Barriada-Pereira M, 2005, CHEMOSPHERE, V58, P1571, DOI 10.1016/j.chemosphere.2004.10.016; Pereira RC, 2006, ENVIRON POLLUT, V144, P210, DOI 10.1016/j.envpol.2005.12.030; El Bakouri H, 2007, WATER ENVIRON RES, V79, P2578, DOI 10.2175/106143007X184528; Esteve-Turrillas FA, 2005, J ENVIRON MONITOR, V7, P1093, DOI 10.1039/b507414b; Ihm JN, 2000, ANAL METHOD SOIL PLA, P103; Juraske R, 2008, CHEMOSPHERE, V70, P1748, DOI 10.1016/j.chemosphere.2007.08.047; Juraske R, 2011, ENVIRON SCI TECHNOL, V45, P651, DOI 10.1021/es102907v; Kim H. Y., 2011, KOREAN J ENV AGR, V30, P440; Ortiz-Hernandez ML, 2010, REV INT CONTAM AMBIE, V26, P27; Lee JB, 2006, J AGR FOOD CHEM, V54, P8824, DOI 10.1021/jf061276e; 황정인, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P148, DOI 10.7585/kjps.2014.18.3.148; 전상오, 2014, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V18, P314, DOI 10.7585/kjps.2014.18.4.314; Leonard AW, 2001, J ENVIRON QUAL, V30, P750, DOI 10.2134/jeq2001.303750x; Liu YP, 2012, B ENVIRON CONTAM TOX, V88, P902, DOI 10.1007/s00128-012-0610-2; MACBEAN C, 2012, PESTICIDE MANUAL, P414; Ministry of Food and Drug Safety, 2015, PEST RES DAT; Rice CP, 1997, J AGR FOOD CHEM, V45, P2291, DOI 10.1021/jf960834u; Sethunathan N, 2004, J AGR FOOD CHEM, V52, P3030, DOI 10.1021/jf035173x; Shivaramaiah HM, 2006, J ENVIRON SCI HEAL B, V41, P895, DOI 10.1080/03601230600806004; SINGH NC, 1991, J AGR FOOD CHEM, V39, P575, DOI 10.1021/jf00003a028; Singh V, 2014, ECOTOX ENVIRON SAFE, V104, P189, DOI 10.1016/j.ecoenv.2014.02.025; Walse SS, 2003, J ENVIRON MONITOR, V5, P373, DOI 10.1039/b212165d; Wang CJ, 2007, PESTIC BIOCHEM PHYS, V87, P1, DOI 10.1016/j.pestbp.2006.04.004; Weber J, 2010, SCI TOTAL ENVIRON, V408, P2966, DOI 10.1016/j.scitotenv.2009.10.077; Xu XM, 2012, FOOD CHEM, V135, P161, DOI 10.1016/j.foodchem.2012.04.052	28	42	48	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141728	10.1371/journal.pone.0141728	http://dx.doi.org/10.1371/journal.pone.0141728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529511	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600053
J	Incalzi, RA; Aucella, F; Leosco, D; Brunori, G; Dalmartello, M; Paolisso, G				Incalzi, Raffaele Antonelli; Aucella, Filippo; Leosco, Dario; Brunori, Giuliano; Dalmartello, Michela; Paolisso, Giuseppe			Assessing Nephrological Competence among Geriatricians: A Proof of Concept Internet Survey	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONTRAST-INDUCED NEPHROPATHY; RENAL-INSUFFICIENCY; HEART-FAILURE; MORTALITY; AGE; ADULTS; DEATH; RISK; CARE	Chronic kidney disease (CKD) is highly prevalent in the elderly and negatively impacts survival and health status. Thus, nephrological competence is mandatory for a skilled geriatrician. The present study aimed to assess nephrological competence in a sample of geriatricians recruited through a web survey. To this aim, a 12-items questionnaire was produced by an expert panel of nephrologists and geriatricians and was available online for members of the Italian Society of Gerontology and Geriatrics (SIGG). Two-hundred-eightyseven geriatricians volunteered to fill in the questionnaire. The majority of them indirectly estimated the glomerular filtration rate (GFR) using mainly the Cockroft-Gault (C-G) formula. Selected nephrological exams, such as urinary Na and serum D-vitamin measurements, did not qualify as routine exams although the majority of geriatricians supplemented their patients with fat-soluble secosteroids. Ten percent of geriatricians asked for nephrological consultation only for stage 5 CKD patients and 30,9% only for stage 4 or 5. Erythropoietin supplementation was common practice for the majority of geriatricians, while only one third of them systematically used a procedure intended to prevent the contrast induced nephropathy (CIN). Finally, an alleged 50% adherence to the international guidelines for the management of CKD patients emerged from the questionnaire. Overall, results from this survey strongly recommend promoting nephrological education among geriatricians. Didactic standards for in training geriatricians need to be updated and the cooperation between geriatrics and nephrological societies promoted.	[Incalzi, Raffaele Antonelli] Campus Biomedico Univ, Dept Geriatr, Rome, Italy; [Aucella, Filippo] IRCCS, Casa Sollievo Sofferenza Hosp, Dept Nephrol & Dialysis, Foggia, Italy; [Leosco, Dario] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Brunori, Giuliano] Santa Chiara Hosp, Dept Nephrol & Dialysis, Trento, Italy; [Dalmartello, Michela] Dept Hlth & Social Serv, Naples, Provincia Auton, Italy; [Paolisso, Giuseppe] Univ Naples 2, Dept Med Surg Neurol Aging & Metab Sci, Naples, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; Santa Chiara Hospital; Universita della Campania Vanvitelli	Leosco, D (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	dleosco@unina.it	paolisso, giuseppe/AAP-8516-2020	paolisso, giuseppe/0000-0002-2137-455X; DALMARTELLO, MICHELA/0000-0001-8764-9299; Aucella, Filippo/0000-0003-1027-7049				Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P73; [Anonymous], 2013, KIDNEY INT S, V3, P91, DOI DOI 10.1038/kisup.2012.67; Au TH, 2014, ANN PHARMACOTHER, V48, P1332, DOI 10.1177/1060028014541996; Boudville N, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-43; Chonchol M, 2007, KIDNEY INT, V71, P134, DOI 10.1038/sj.ki.5002002; Conte G, 2014, NEPHROL DIAL TRANSPL, V29, P770, DOI 10.1093/ndt/gft324; Corsonello A, 2005, ARCH INTERN MED, V165, P790, DOI 10.1001/archinte.165.7.790; De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174; Franco G, 2014, J CARDIOVASC MED, V15, P491, DOI 10.2459/JCM.0000000000000038; Giannelli SV, 2007, J AM GERIATR SOC, V55, P816, DOI 10.1111/j.1532-5415.2007.01196.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Istituto Superiore di Sanita, 2012, ID PREV GEST MAL REN; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Murray J E Jr, 1996, Endocr Pract, V2, P211; Navaneethan SD, 2010, CLIN NEPHROL, V73, P260; Pedone C, 2008, AGING CLIN EXP RES, V20, P496; Poelzl G, 2014, INT J CARDIOL, V175, P83, DOI 10.1016/j.ijcard.2014.04.255; Rengo F, 2012, J NEPHROL, V25, pS73, DOI 10.5301/jn.5000164; Steinman MA, 2013, MED CARE, V51, P901, DOI 10.1097/MLR.0b013e3182a3e525; Viazzi F, 2010, CLIN J AM SOC NEPHRO, V5, P1099, DOI 10.2215/CJN.07271009	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141388	10.1371/journal.pone.0141388	http://dx.doi.org/10.1371/journal.pone.0141388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528530	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600025
J	Lafferty, DJR; Laudenslager, ML; Mowat, G; Heard, D; Belant, JL				Lafferty, Diana J. R.; Laudenslager, Mark L.; Mowat, Garth; Heard, Doug; Belant, Jerrold L.			Sex, Diet, and the Social Environment: Factors Influencing Hair Cortisol Concentration in Free-Ranging Black Bears (Ursus americanus)	PLOS ONE			English	Article							LONG-TERM STRESS; POLAR BEARS; BIOMARKER; REPRODUCTION; RANK; GLUCOCORTICOIDS; CONSTRAINTS; ISOTOPES; SURVIVAL; ECOLOGY	Increasingly, measures of glucocorticoid levels (e.g., cortisol), key components of the neuroendocrine stress axis, are being used to measure past hypothalamic-pituitary-adrenal (HPA) activity to index psychological and physiological stress exhibited by wildlife for assessing individual and population-level well-being. However, many intrinsic and extrinsic factors affect HPA activity in animals. Using American black bears (Ursus americanus; n = 116) as an ecological model and hair cortisol concentration (HCC) as an integrative measure of past HPA activity, we evaluated the influence of diet, sex and the social environment on black bear HCC in a free-ranging population that spanned adjoining ecoregions with differing densities of potential conspecific and heterospecific competitors. HCC varied by sex, with female HCC ranging from 0.6 to 10.7 pg/mg (median = 4.5 +/- 1.2 mean absolute deviation [MAD]) and male HCC ranging from 0.5 to 35.1 pg/mg (median = 6.2 +/- 2.6 MAD). We also observed a three-way interaction among sex, delta C-14 and ecoregion, which may indicate that some differences in HCC between female and male black bears results from variability in the nutritional needs of larger-bodied males relative to smaller-bodied females, slight differences in food resources use between ecoregions as well as sex-based differences regarding the social environment. Once we understand what drives sex-specific differences in HCC, HCC may aid our understanding of the physiological responses by bears and other wildlife to diverse environmental challenges.	[Lafferty, Diana J. R.; Belant, Jerrold L.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Laudenslager, Mark L.] Univ Colorado Denver, Dept Psychiat, Behav Immunol & Endocrinol Lab, Aurora, CO USA; [Mowat, Garth] British Columbia Minist Forests Lands & Nat Resou, Nelson, BC, Canada; [Heard, Doug] British Columbia Minist Forests Lands & Nat Resou, Prince George, BC, Canada; [Lafferty, Diana J. R.] N Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC 27695 USA	Mississippi State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina State University	Lafferty, DJR (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	djr.lafferty@gmail.com	Belant, Jerrold/HDM-7749-2022; Laudenslager, Mark L/D-1057-2018	Laudenslager, Mark L/0000-0002-9815-3026	province of British Columbia; Hauser Bears	province of British Columbia; Hauser Bears	The province of British Columbia funded initial field work for this project. Funding for stable isotope and hair cortisol analysis was provided to DJRL, JLB and GM by Hauser Bears. Funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; [Anonymous], DEMOGRAPHY HABITAT S; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Ayers CR, 2013, POLAR BIOL, V36, P169, DOI 10.1007/s00300-012-1247-7; Barrett GM, 2002, HORM BEHAV, V42, P85, DOI 10.1006/hbeh.2002.1804; Bechshoft TO, 2012, ENVIRON INT, V45, P15, DOI 10.1016/j.envint.2012.04.005; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; BOONSTRA R, 1993, GEN COMP ENDOCR, V91, P126, DOI 10.1006/gcen.1993.1113; Boonstra R, 2005, J MAMMAL, V86, P236, DOI 10.1644/BHE-001.1; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Bryan HM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou010; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Cattet M, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou026; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Chi DK, 1999, EFFECTS SALMON AVAIL; COY PL, 1992, CAN J ZOOL, V70, P2150, DOI 10.1139/z92-290; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 1996, SOCIAL STRESS DOMINA; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Derocher AE, 1996, CAN J ZOOL, V74, P1246, DOI 10.1139/z96-138; Derocher AE, 2010, BEHAV ECOL SOCIOBIOL, V64, P939, DOI 10.1007/s00265-010-0909-0; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Dettmer AM, 2009, DEV PSYCHOBIOL, V51, P706, DOI 10.1002/dev.20405; Fairbanks LA, 2011, PSYCHONEUROENDOCRINO, V36, P1201, DOI 10.1016/j.psyneuen.2011.02.013; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hoffman MC, 2014, CLIN INVEST MED, V37, pE252, DOI 10.25011/cim.v37i4.21731; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jones ES, 2006, WILDLIFE SOC B, V34, P1320, DOI 10.2193/0091-7648(2006)34[1320:TVISCA]2.0.CO;2; KASWORM WF, 1994, BEARS - THEIR BIOLOGY AND MANAGEMENT, P223; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Lafferty DJ, 2014, OIKOS; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Macbeth BJ, 2012, WILDLIFE SOC B, V36, P747, DOI 10.1002/wsb.219; Malcolm KD, 2013, GEN COMP ENDOCR, V185, P97, DOI 10.1016/j.ygcen.2013.01.014; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MILLER SD, 1994, BEARS - THEIR BIOLOGY AND MANAGEMENT, P263; Moberg GP, 1999, DOES STRESS BECOME D; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Woods JG, 1999, WILDLIFE SOC B, V27, P616	62	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141489	10.1371/journal.pone.0141489	http://dx.doi.org/10.1371/journal.pone.0141489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529405	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600032
J	Lorenzi, GM; Braffett, BH; Arends, VL; Danis, RP; Diminick, L; Klumpp, KA; Morrison, AD; Soliman, EZ; Steffes, MW; Cleary, PA				Lorenzi, Gayle M.; Braffett, Barbara H.; Arends, Valerie L.; Danis, Ronald P.; Diminick, Lisa; Klumpp, Kandace A.; Morrison, Anthony D.; Soliman, Elsayed Z.; Steffes, Michael W.; Cleary, Patricia A.		DCCT-EDIC Res Grp	Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study	PLOS ONE			English	Article							FOLLOW-UP; ASSURANCE; TRIAL/EPIDEMIOLOGY; PROGRESSION; RETINOPATHY; SEVERITY; MELLITUS	Implementation of multicenter and/or longitudinal studies requires an effective quality assurance program to identify trends, data inconsistencies and process variability of results over time. The Diabetes Control and Complications Trial (DCCT) and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study represent over 30 years of data collection among a cohort of participants across 27 clinical centers. The quality assurance plan is overseen by the Data Coordinating Center and is implemented across the clinical centers and central reading units. Each central unit incorporates specific DCCT/EDIC quality monitoring activities into their routine quality assurance plan. The results are reviewed by a data quality assurance committee whose function is to identify variances in quality that may impact study results from the central units as well as within and across clinical centers, and to recommend implementation of corrective procedures when necessary. Over the 30-year period, changes to the methods, equipment, or clinical procedures have been required to keep procedures current and ensure continued collection of scientifically valid and clinically relevant results. Pilot testing to compare historic processes with contemporary alternatives is performed and comparability is validated prior to incorporation of new procedures into the study. Details of the quality assurance plan across and within the clinical and central reading units are described, and quality outcomes for core measures analyzed by the central reading units (e.g. biochemical samples, fundus photographs, ECGs) are presented.	[Lorenzi, Gayle M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Braffett, Barbara H.; Diminick, Lisa; Klumpp, Kandace A.; Cleary, Patricia A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Arends, Valerie L.; Steffes, Michael W.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Danis, Ronald P.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Morrison, Anthony D.] Univ S Florida, Dept Med, Tampa, FL USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA	University of California System; University of California San Diego; George Washington University; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of South Florida; Wake Forest University	Lorenzi, GM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	glorenzi@ucsd.edu	Soliman, Elsayed Z/AAD-7135-2020	Soliman, Elsayed Z/0000-0001-5632-8150; Lyons, Timothy/0000-0003-2106-1622; Chaum, Edward/0000-0003-3542-8376; Pop-Busui, Rodica/0000-0002-2042-1350; hamdy, osama/0000-0002-1919-0268; Sivitz, William/0000-0002-7829-0189; Songer, Thomas/0000-0002-5253-2514; Johnson, Mark W/0000-0001-9720-8761; orchard, trevor/0000-0001-9552-3215; Shamoon, Harry/0000-0002-5014-5211; Luttrell, Louis/0000-0003-2805-6949; Kiss, Szilard/0000-0003-3433-8432; Lachin, John/0000-0001-9838-2841	Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease [U01 DK094157, U01 DK094176]; National Eye Institute; National Institute of Neurologic Disorders and Stroke; General Clinical Research Centers Program; Clinical Translational Science Center Program, Bethesda, Maryland, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK094157, U01DK094176] Funding Source: NIH RePORTER	Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Translational Science Center Program, Bethesda, Maryland, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The DCCT/EDIC has been supported by cooperative agreement grants (1982-1993, 2012-2017), and contracts (1982-2012) with the Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease (current grant numbers U01 DK094176 and U01 DK094157), and through support by the National Eye Institute, the National Institute of Neurologic Disorders and Stroke, the General Clinical Research Centers Program (1993-2007), and Clinical Translational Science Center Program (2006-present), Bethesda, Maryland, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Carletta J, 1996, COMPUT LINGUIST, V22, P249; CUSHMAN M, 1995, CLIN CHEM, V41, P264; DCCT Res Grp, 1986, DIABETES, V35, P530; de Boer IH, 2014, J AM SOC NEPHROL, V25, P810, DOI 10.1681/ASN.2013050557; Early Treatment Diabetic Retinopathy Study Research Group, 1978, OPHTHALMOLOGY, V85, P82; GASSMAN JJ, 1995, CONTROL CLIN TRIALS, V16, pS104; Genuth S, 1999, DIABETES CARE, V22, P99; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; HILNER JE, 1992, CONTROL CLIN TRIALS, V13, P156, DOI 10.1016/0197-2456(92)90021-Q; Hubbard LD, 2008, INVEST OPHTH VIS SCI, V49, P3269, DOI 10.1167/iovs.07-1267; Hubbard LD, 2011, ARCH OPHTHALMOL-CHIC, V129, P718, DOI 10.1001/archophthalmol.2011.136; Kemperman FAW, 2000, J INTERN MED, V248, P511, DOI 10.1046/j.1365-2796.2000.00768.x; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; Kramer JR, 2012, CLIN TRIALS, V9, P798, DOI 10.1177/1740774512458986; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Neta G, 2014, QUALITY CONTROL GOOD; Prineas RJ, 2010, MINNESOTA CODE MANUA; PRUDHOMME GJ, 1989, CONTROL CLIN TRIALS, V10, pS84, DOI 10.1016/0197-2456(89)90044-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Whitney CW, 1998, EPIDEMIOL REV, V20, P71, DOI 10.1093/oxfordjournals.epirev.a017973; Younes N, 2010, CLIN J AM SOC NEPHRO, V5, P1235, DOI 10.2215/CJN.07901109	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141286	10.1371/journal.pone.0141286	http://dx.doi.org/10.1371/journal.pone.0141286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529311	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600021
J	Shu, J; Chiang, K; Zempleni, J; Cui, J				Shu, Jiang; Chiang, Kevin; Zempleni, Janos; Cui, Juan			Computational Characterization of Exogenous MicroRNAs that Can Be Transferred into Human Circulation	PLOS ONE			English	Article							DETECTABLE ORAL BIOAVAILABILITY; BLOOD MONONUCLEAR-CELLS; TARGET INTERACTIONS; MANIFOLD-RANKING; PLANT MICRORNAS; MESSENGER-RNAS; HUMAN GENES; EXPRESSION; DATABASE; CLASSIFICATION	MicroRNAs have been long considered synthesized endogenously until very recent discoveries showing that human can absorb dietary microRNAs from animal and plant origins while the mechanism remains unknown. Compelling evidences of microRNAs from rice, milk, and honeysuckle transported to human blood and tissues have created a high volume of interests in the fundamental questions that which and how exogenous microRNAs can be transferred into human circulation and possibly exert functions in humans. Here we present an integrated genomics and computational analysis to study the potential deciding features of transportable microRNAs. Specifically, we analyzed all publicly available microRNAs, a total of 34,612 from 194 species, with 1,102 features derived from the microRNA sequence and structure. Through in-depth bioinformatics analysis, 8 groups of discriminative features have been used to characterize human circulating microRNAs and infer the likelihood that a microRNA will get transferred into human circulation. For example, 345 dietary microRNAs have been predicted as highly transportable candidates where 117 of them have identical sequences with their homologs in human and 73 are known to be associated with exosomes. Through a milk feeding experiment, we have validated 9 cow-milk microRNAs in human plasma using microRNA-sequencing analysis, including the top ranked microRNAs such as bta-miR-487b, miR-181b, and miR-421. The implications in health-related processes have been illustrated in the functional analysis. This work demonstrates the data-driven computational analysis is highly promising to study novel molecular characteristics of transportable microRNAs while bypassing the complex mechanistic details.	[Shu, Jiang; Chiang, Kevin; Cui, Juan] Univ Nebraska, Dept Comp Sci & Engn, Lincoln, NE 68588 USA; [Zempleni, Janos] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Cui, J (corresponding author), Univ Nebraska, Dept Comp Sci & Engn, Lincoln, NE 68588 USA.	jcui@unl.edu		Shu, Jiang/0000-0001-7677-721X	National Institutes of Health [1P20GM104320]; National Institute of Food and Agriculture [2015-67017-23181]; Gerber Foundation; Egg Nutrition Center; University of Nebraska Agricultural Research Division (Hatch Act); USDA multistate group W3002; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Gerber Foundation; Egg Nutrition Center; University of Nebraska Agricultural Research Division (Hatch Act)(United States Department of Agriculture (USDA)); USDA multistate group W3002; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is support by National Institutes of Health (1P20GM104320), National Institute of Food and Agriculture (2015-67017-23181), the Gerber Foundation, the Egg Nutrition Center, the University of Nebraska Agricultural Research Division (Hatch Act), and USDA multistate group W3002.	Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; Brank J., 2002, P 3 INT C DAT MIN ME; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Chang C.-C., 2011, ACM T INTELLIGENT SY; Chawla Nitesh V., 2002, J ARTIFICIAL INTELLI; Chen X, 2013, NAT BIOTECHNOL, V31, P967, DOI 10.1038/nbt.2741; Chiang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128089; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Ding JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511-S11; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He J, 2004, MANIFOLD RANKING BAS; He JR, 2006, IEEE T IMAGE PROCESS, V15, P3170, DOI 10.1109/TIP.2006.877491; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Knudsen V, 2008, NUCLEIC ACIDS RES, V36, pW85, DOI 10.1093/nar/gkn220; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-250; Liu RJ, 2012, J CLIN ENDOCR METAB, V97, pE968, DOI 10.1210/jc.2011-2982; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mathelier A, 2013, NUCLEIC ACIDS RES, V41, P4392, DOI 10.1093/nar/gkt112; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mor E, 2013, BIOESSAYS, V35, P881, DOI 10.1002/bies.201200157; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Tang ZQ, 2007, CANCER RES, V67, P9996, DOI 10.1158/0008-5472.CAN-07-1601; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao YF, 2014, CHIN J INTEGR MED, V20, P394, DOI 10.1007/s11655-013-1659-4; Zhou D, RANKING DATA MANIFOL	66	36	37	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140587	10.1371/journal.pone.0140587	http://dx.doi.org/10.1371/journal.pone.0140587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528912	Green Published, gold			2022-12-27	WOS:000364032600008
J	Ellis, RJ; Ng, YS; Zhu, SG; Tan, DM; Anderson, B; Schlaug, G; Wang, Y				Ellis, Robert J.; Ng, Yee Sien; Zhu, Shenggao; Tan, Dawn M.; Anderson, Boyd; Schlaug, Gottfried; Wang, Ye			A Validated Smartphone-Based Assessment of Gait and Gait Variability in Parkinson's Disease	PLOS ONE			English	Article							RHYTHMIC AUDITORY-STIMULATION; OLDER-ADULTS; EFFECT SIZE; SPATIOTEMPORAL PARAMETERS; MOVEMENT-DISORDERS; WEARABLE SENSORS; FALLS; WALKING; PEOPLE; MOTOR	Background A well-established connection exists between increased gait variability and greater fall likelihood in Parkinson's disease (PD); however, a portable, validated means of quantifying gait variability (and testing the efficacy of any intervention) remains lacking. Furthermore, although rhythmic auditory cueing continues to receive attention as a promising gait therapy for PD, its widespread delivery remains bottlenecked. The present paper describes a smart-phone-based mobile application ("SmartMOVE") to address both needs. Methods The accuracy of smartphone-based gait analysis (utilizing the smartphone's built-in tri-axial accelerometer and gyroscope to calculate successive step times and step lengths) was validated against two heel contact-based measurement devices: heel-mounted footswitch sensors (to capture step times) and an instrumented pressure sensor mat (to capture step lengths). 12 PD patients and 12 age-matched healthy controls walked along a 26-m path during self-paced and metronome-cued conditions, with all three devices recording simultaneously. Results Four outcome measures of gait and gait variability were calculated. Mixed-factorial analysis of variance revealed several instances in which between-group differences (e.g., increased gait variability in PD patients relative to healthy controls) yielded medium-to-large effect sizes (eta-squared values), and cueing-mediated changes (e.g., decreased gait variability when PD patients walked with auditory cues) yielded small-to-medium effect sizes-while at the same time, device-related measurement error yielded small-to-negligible effect sizes. Conclusion These findings highlight specific opportunities for smartphone-based gait analysis to serve as an alternative to conventional gait analysis methods (e.g., footswitch systems or sensor-embedded walkways), particularly when those methods are cost-prohibitive, cumbersome, or inconvenient.	[Ellis, Robert J.; Anderson, Boyd; Wang, Ye] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore; [Zhu, Shenggao; Wang, Ye] NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Yee Sien; Tan, Dawn M.] Singapore Gen Hosp, Dept Rehabil Med, Singapore 117456, Singapore; [Schlaug, Gottfried] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Schlaug, Gottfried] Harvard Univ, Sch Med, Boston, MA 02215 USA	National University of Singapore; National University of Singapore; Singapore General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Wang, Y (corresponding author), Natl Univ Singapore, Sch Comp, Comp 1,13 Comp Dr, Singapore 117417, Singapore.	wangye@comp.nus.edu.sg			National Research Foundation (NRF) [R-253-300-001-490]; Agency for Science, Technology and Research (A*STAR) [R-252-000-510-305]; Singapore 544 Ministry of Education (MOE) [R-252-000-516-112]	National Research Foundation (NRF); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore 544 Ministry of Education (MOE)(Ministry of Education, Singapore)	This project was partially funded by a grant from the National Research Foundation (NRF; http://www.nrf.gov.sg/) under grant R-253-300-001-490 (to Y.W.) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO) hosted by the Media Development Authority of Singapore (MDA; http://www.mda.gov.sg/) under the Center of Social Media Innovations for Communities (COSMIC; http://cosmiccentres.org/); and by a grant from the Agency for Science, Technology and Research (A*STAR; http://www.a-star.edu.sg/) under grant R-252-000-510-305 (to Y.W. and G.S.) and by the Singapore 544 Ministry of Education (MOE) under grant R-252-000-516-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achey M, 2014, MOVEMENT DISORD, V29, P871, DOI 10.1002/mds.25903; Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Bello O, 2014, J PARKINSON DIS, V4, P33, DOI 10.3233/JPD-130251; Bello O, 2010, GAIT POSTURE, V32, P118, DOI 10.1016/j.gaitpost.2010.04.015; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bryant MS, 2011, NEUROL RES, V33, P959, DOI 10.1179/1743132811Y.0000000044; Cai Z, 2013, P 14 INT C MUS INF R, P541; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Callisaya ML, 2010, AGE AGEING; Casamassima F, 2014, SENSORS-BASEL, V14, P6229, DOI 10.3390/s140406229; Chan H. K. Y., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P184, DOI 10.4108/icst.pervasivehealth.2011.245995; Cohen J.E., 1988, STAT POWER ANAL BEHA; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Danoudis M, 2012, PARKINSONISM RELAT D, V18, P543, DOI 10.1016/j.parkreldis.2012.02.005; de Dreu M J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS114, DOI 10.1016/S1353-8020(11)70036-0; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dorsey ER, 2013, JAMA NEUROL, V70, P565, DOI 10.1001/jamaneurol.2013.123; Ellis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110452; Espay AJ, 2010, J REHABIL RES DEV, V47, P573, DOI 10.1682/JRRD.2009.10.0165; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedland RL, 2002, NEUROREHABILITATION, V17, P81; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2005, SCI BASIS TREATMENT, P321; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 2001, J APPL PHYSIOL, V90, P2117, DOI 10.1152/jappl.2001.90.6.2117; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; How TV, 2013, INT CONF PER COMP, P73, DOI 10.4108/icst.pervasivehealth.2013.252118; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Howell D. C., 2007, SAGE HDB SOCIAL SCI, P208; Kirchner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085787; Klucken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056956; Lemoyne R, 2008, J MECH MED BIOL, V8, P137, DOI 10.1142/S0219519408002656; LeMoyne R, 2011, IEEE ENG MED BIO, P7904, DOI 10.1109/IEMBS.2011.6091949; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Lord SR, 2007, FALLS IN OLDER PEOPLE: RISK FACTORS AND STRATEGIES FOR PREVENTION, 2ND EDITION, P1, DOI 10.1017/CBO9780511722233; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Lord S, 2013, MOVEMENT DISORD, V28, P634, DOI 10.1002/mds.25338; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Mazilu S, 2015, ACM T INTERACT INTEL, V5, DOI 10.1145/2701431; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Moe-Nilssen R, 2010, GAIT POSTURE, V32, P98, DOI 10.1016/j.gaitpost.2010.03.019; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Ozinga SJ, 2015, MOVEMENT DISORDERS; Palmerini L, 2013, IEEE T NEUR SYS REH, V21, P664, DOI 10.1109/TNSRE.2012.2236577; Palmerini L, 2011, IEEE ENG MED BIO, P7179, DOI 10.1109/IEMBS.2011.6091814; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Picelli A, 2010, NEUROL SCI, V31, P423, DOI 10.1007/s10072-010-0228-2; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Pogorelc B, 2012, MULTIMED TOOLS APPL, V58, P333, DOI 10.1007/s11042-011-0786-1; Rdio API, 2014, RDI AP; Rochester L, 2011, MOVEMENT DISORD, V26, P430, DOI 10.1002/mds.23450; Rochester L, 2009, MOVEMENT DISORD, V24, P839, DOI 10.1002/mds.22400; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Shenggao Zhu, 2012, Advances in Multimedia Information Processing - PCM 2012. 13th Pacific-Rim Conference on Multimedia. Proceedings, P93, DOI 10.1007/978-3-642-34778-8_9; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Tahir N.M., 2012, J APPL SCI, V12, P180, DOI [10.3923/jas.2012.180.185, DOI 10.3923/JAS.2012.180.185, DOI 10.3923/jas.2012.180.185]; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Wagner R, 2012, IEEE ENG MED BIO, P280, DOI 10.1109/EMBC.2012.6345924; Weiss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068885; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yang MJ, 2012, HEALTH TECHNOL-GER, V2, P81, DOI 10.1007/s12553-012-0021-8; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhu S, 2015, ERRATUM VALIDATING I; Zhu S, 2015, VALIDATING IOS BASED; Zhu SG, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P487, DOI 10.1145/2647868.2654952; Zijlstra W, 2004, EUR J APPL PHYSIOL, V92, P39, DOI 10.1007/s00421-004-1041-5; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	108	60	61	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141694	10.1371/journal.pone.0141694	http://dx.doi.org/10.1371/journal.pone.0141694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517720	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800068
J	Smaldini, PL; Delgado, MLO; Fossati, CA; Docena, GH				Smaldini, Paola Lorena; Delgado, MarIa LucIa Orsini; Fossati, Carlos Alberto; Docena, Guillermo Horacio			Orally-Induced Intestinal CD4(+) CD25(+) FoxP3(+) Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions	PLOS ONE			English	Article							COWS MILK ALLERGY; TOLERANCE INDUCTION; DOUBLE-BLIND; MOUSE MODEL; B-CELLS; IMMUNOTHERAPY; CHILDREN; EFFICACY; MECHANISMS; MICE	The induction of peripheral tolerance may constitute a disease-modifying treatment for allergic patients. We studied how oral immunotherapy (OIT) with milk proteins controlled allergy in sensitized mice (cholera toxin plus milk proteins) upon exposure to the allergen. Symptoms were alleviated, skin test was negativized, serum specific IgE and IgG1 were abrogated, a substantial reduction in the secretion of IL-5 and IL-13 by antigen-stimulated spleen cells was observed, while IL-13 gene expression in jejunum was down-regulated, and IL-10 and TGF-beta were increased. In addition, we observed an induction of CD4(+)CD25(+)FoxP3(+) cells and IL-10- and TGF-beta-producing regulatory T cells in the lamina propria. Finally, transfer experiments confirmed the central role of these cells in tolerance induction. We demonstrated that the oral administration of milk proteins pre- or post-sensitization controlled the Th2-immune response through the elicitation of mucosal IL-10- and TGF-beta-producing Tregs that inhibited hypersensitivity symptoms and the allergic response.	[Docena, Guillermo Horacio] Univ Nacl La Plata, Fac Ciencias Exactas, Inst Estudios Inmunol & Fisiopatol IIFP, La Plata, Argentina; Consejo Nacl Invest Cient & Tecn, La Plata, Argentina	National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docena, GH (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Inst Estudios Inmunol & Fisiopatol IIFP, La Plata, Argentina.	guidoc@biol.unlp.edu.ar		Smaldini, Paola/0000-0002-2734-516X; Orsini Delgado, Maria Lucia/0000-0003-4655-1695	National Agency for Research [PICT 2012-1772]; University of La Plata [X455]	National Agency for Research(French National Research Agency (ANR)); University of La Plata(National University of La Plata)	This study was supported with grants to G.H.D. from the National Agency for Research (PICT 2012-1772) and to C.A.F. from the University of La Plata (X455). The funders had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, ALLERGY, V66, P1312, DOI 10.1111/j.1398-9995.2011.02653.x; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Berin MC, 2013, TRENDS IMMUNOL, V34, P390, DOI 10.1016/j.it.2013.04.003; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Brozek JL, 2012, CLIN EXP ALLERGY, V42, P363, DOI 10.1111/j.1365-2222.2011.03948.x; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Curciarello R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082341; Docena G, 2010, CLIN EXP IMMUNOL, V162, P108, DOI 10.1111/j.1365-2249.2010.04203.x; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1097/WOX.0b013e3181defeb9, 10.1111/j.1399-3038.2010.01068.x]; Fischer JAA, 2015, ARTHRITIS RHEUMATOL, V67, P51, DOI 10.1002/art.38896; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Ibanez AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069438; Isolauri E, 1998, J PEDIATR-US, V132, P1004, DOI 10.1016/S0022-3476(98)70399-3; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Kobayashi I, 2011, CLIN IMMUNOL, V141, P83, DOI 10.1016/j.clim.2011.05.010; Krogulska A, 2011, J CLIN IMMUNOL, V31, P205, DOI 10.1007/s10875-010-9487-1; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Moran TP, 2013, CURR OPIN IMMUNOL, V25, P781, DOI 10.1016/j.coi.2013.07.011; Nguyen KD, 2009, J ALLERGY CLIN IMMUN, V123, P933, DOI 10.1016/j.jaci.2008.11.037; Pajno GB, 2010, ANN ALLERG ASTHMA IM, V105, P376, DOI 10.1016/j.anai.2010.03.015; Rolinck-Werninghaus C, 2005, ALLERGY, V60, P1320, DOI 10.1111/j.1398-9995.2005.00882.x; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Sanchez-Garcia S, 2012, ISR MED ASSOC J, V14, P43; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Smaldini P, 2012, INT ARCH ALLERGY IMM, V158, P335, DOI 10.1159/000333562; Smaldini PL, 2013, INNATE IMMUNITY; Smaldini PL, 2014, HUMAN VACCINES IMMUN, V10, P1; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Xu L, 2010, MUCOSAL IMMUNOL, V3, P230, DOI 10.1038/mi.2010.7; Yamada Takaya, 2012, J Allergy (Cairo), V2012, P490905, DOI 10.1155/2012/490905	42	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141116	10.1371/journal.pone.0141116	http://dx.doi.org/10.1371/journal.pone.0141116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517875	Green Published, gold			2022-12-27	WOS:000363920800022
J	Buckley, M; Farina, RA; Lawless, C; Tambusso, PS; Varela, L; Carlini, AA; Powell, JE; Martinez, JG				Buckley, Michael; Farina, Richard A.; Lawless, Craig; Sebastian Tambusso, P.; Varela, Luciano; Carlini, Alfredo A.; Powell, Jaime E.; Martinez, Jorge G.			Collagen Sequence Analysis of the Extinct Giant Ground Sloths Lestodon and Megatherium	PLOS ONE			English	Article							AMERICAN BIOTIC INTERCHANGE; MOLECULAR PHYLOGENY; XENARTHRA; MITOCHONDRIAL; DIET; DIVERSIFICATION; PLEISTOCENE; TARDIGRADA; ARMADILLOS; RADIATION	For over 200 years, fossils of bizarre extinct creatures have been described from the Americas that have ranged from giant ground sloths to the 'native' South American ungulates, groups of mammals that evolved in relative isolation on South America. Ground sloths belong to the South American xenarthrans, a group with modern although morphologically and ecologically very different representatives (anteaters, armadillos and sloths), which has been proposed to be one of the four main eutherian clades. Recently, proteomics analyses of bone collagen have recently been used to yield a molecular phylogeny for a range of mammals including the unusual 'Malagasy aardvark' shown to be most closely related to the afrotherian tenrecs, and the south American ungulates supporting their morphological association with condylarths. However, proteomics results generate partial sequence information that could impact upon the phylogenetic placement that has not been appropriately tested. For comparison, this paper examines the phylogenetic potential of proteomics-based sequencing through the analysis of collagen extracted from two extinct giant ground sloths, Lestodon and Megatherium. The ground sloths were placed as sister taxa to extant sloths, but with a closer relationship between Lestodon and the extant sloths than the basal Megatherium. These results highlight that proteomics methods could yield plausible phylogenies that share similarities with other methods, but have the potential to be more useful in fossils beyond the limits of ancient DNA survival.	[Buckley, Michael] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Farina, Richard A.; Sebastian Tambusso, P.; Varela, Luciano] Univ Republica, Secc Paleontol, Fac Ciencias, Montevideo, Uruguay; [Lawless, Craig] Univ Manchester, Manchester, Lancs, England; [Carlini, Alfredo A.] Museo La Plata, Fac Ciencias Nat & Museo, Buenos Aires, DF, Argentina; [Powell, Jaime E.] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Martinez, Jorge G.] Inst Arqueol & Museo UNT, Inst Super Estudios Sociales CONICET, San Miguel De Tucuman, Argentina	University of Manchester; Universidad de la Republica, Uruguay; University of Manchester; National University of La Plata; Museo La Plata; Universidad Nacional de Tucuman	Buckley, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	m.buckley@manchester.ac.uk	Fariña, Richard/GRF-6009-2022; Varela, Luciano/R-2111-2018	Varela, Luciano/0000-0002-9481-6558; Tambusso, Pablo Sebastian/0000-0001-7349-5292; Martinez, Jorge Gabriel/0000-0001-6642-4074; Buckley, Michael/0000-0002-4166-8213	Royal Society; Comision Sectorial de Investigacion Cientifica; Universidad de la Republica; Comuna Canaria; Municipio de Sauce;  [CIUNT 26G522]; Natural Environment Research Council [NE/K000799/1] Funding Source: researchfish; NERC [NE/K000799/1] Funding Source: UKRI	Royal Society(Royal Society of London); Comision Sectorial de Investigacion Cientifica; Universidad de la Republica; Comuna Canaria; Municipio de Sauce; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors gratefully acknowledge the Royal Society for fellowship funding to MB. This is a contribution to the project "Prospeccion de nuevos sitios fosiliferos y arqueologicos en el area del Arroyo del Vizcaino" funded by the Comision Sectorial de Investigacion Cientifica, Universidad de la Republica and both Comuna Canaria and Municipio de Sauce partially funded the excavations of RF and his team. The authors are grateful to funding for recovery of one of the Megatherium specimens under the grant CIUNT 26G522 to JP.	Barros MC, 2003, GENET MOL BIOL, V26, P5, DOI 10.1590/S1415-47572003000100002; Buckley M, 2014, PALAEOGEOGR PALAEOCL, V416, P69, DOI 10.1016/j.palaeo.2014.06.026; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M, 2008, SCIENCE, V319; Buckley M, 2015, P ROYAL SOC B, V282; Buckley M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059614; Buckley M, 2013, RAPID COMMUN MASS SP, V27, P531, DOI 10.1002/rcm.6481; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Clack AA, 2012, METHODS MOL BIOL, V840, P51, DOI 10.1007/978-1-61779-516-9_7; Cuvier G., 1796, MAGASIN ENCY J SCI L, V7, P303; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2001, P ROY SOC B-BIOL SCI, V268, P1605, DOI 10.1098/rspb.2001.1702; Engelmann G.F., 1985, P51; Faria RA., 2013, MEGAFAUNA GIANT BEAS; Farina Richard A., 2003, Senckenbergiana Biologica, V83, P3; Farina RA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2211; Gaudin Timothy J., 2003, Senckenbergiana Biologica, V83, P27; Gaudin Timothy J., 2008, P24; Gaudin TJ, 2004, ZOOL J LINN SOC-LOND, V140, P255, DOI 10.1111/j.1096-3642.2003.00100.x; Gervais P., 1855, RECHARCHES MAMMIFERE; Greenwood AD, 2001, MOL PHYLOGENET EVOL, V18, P94, DOI 10.1006/mpev.2000.0860; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hofreiter M, 2003, QUATERNARY RES, V59, P364, DOI 10.1016/S0033-5894(03)00030-9; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lessa EP, 1996, PALAEONTOLOGY, V39, P651; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; Martinez J, 2005, SERIE MONOGR DID FCN, V45, P25; McDonald H. Gregory, 2008, P39; Nielsen-Marsh C., 2002, BIOCHEMISTRY-US, V24, P12, DOI [10.1042/BIO02403012, DOI 10.1042/BIO02403012]; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pujos F, 2007, J VERTEBR PALEONTOL, V27, P132, DOI 10.1671/0272-4634(2007)27[132:LOMFMX]2.0.CO;2; Pujos F, 2007, ZOOL J LINN SOC-LOND, V149, P179, DOI 10.1111/j.1096-3642.2007.00240.x; Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516; Sarich V.M., 1985, P77; SHOSHANI J, 1985, PALEOBIOLOGY, V11, P429, DOI 10.1017/S0094837300011714; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; van Dijk MAM, 1999, SYST BIOL, V48, P94, DOI 10.1080/106351599260463; Vizcaino Sergio F., 2008, P1; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Webb SD, 2006, ANN MO BOT GARD, V93, P245; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	50	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0139611	10.1371/journal.pone.0139611	http://dx.doi.org/10.1371/journal.pone.0139611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540101	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800002
J	He, M; Zhang, YN; He, P				He, Ming; Zhang, Ya-Nan; He, Peng			Molecular Characterization and Differential Expression of an Olfactory Receptor Gene Family in the White-Backed Planthopper Sogatella furcifera Based on Transcriptome Analysis	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; DROSOPHILA ODORANT RECEPTORS; SEX-PHEROMONE RECEPTORS; STREAKED DWARF VIRUS; FUNCTIONAL-CHARACTERIZATION; ANTENNAL TRANSCRIPTOME; BINDING-PROTEINS; IDENTIFICATION; SUPERFAMILY; SPECIATION	The white-backed planthopper, Sogatella furcifera, a notorious rice pest in Asia, employs host plant volatiles as cues for host location. In insects, odor detection is mediated by two types of olfactory receptors: odorant receptors (ORs) and ionotropic receptors (IRs). In this study, we identified 63 SfurORs and 14 SfurIRs in S. furcifera based on sequences obtained from the head transcriptome and bioinformatics analysis. The motif-pattern of 130 hemiptera ORs indicated an apparent differentiation in this order. Phylogenetic trees of the ORs and IRs were constructed using neighbor-joining estimates. Most of the ORs had orthologous genes, but a specific OR clade was identified in S. furcifera, which suggests that these ORs may have specific olfactory functions in this species. Our results provide a basis for further investigations of how S. furcifera coordinates its olfactory receptor genes with its plant hosts, thereby providing a foundation for novel pest management approaches based on these genes.	[He, Ming; He, Peng] Guizhou Univ, Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Guizhou University; Huaibei Normal University	He, P (corresponding author), Guizhou Univ, Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Peoples R China.	fcc.phe@gzu.edu.cn			Natural Science Foundation of China [31360528, 31401750]; Natural Science Foundation of Guizhou Province of China [QKH-J [2014]2062]; Scientific Research Foundation of Guizhou University, China (RJH Project) [2013-28]; Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province [SY [2010]3004]; Science and Technology Project of Guizhou Province (QKH Major Project) [(2012) 6012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guizhou Province of China; Scientific Research Foundation of Guizhou University, China (RJH Project); Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province; Science and Technology Project of Guizhou Province (QKH Major Project)	Support was provided by Natural Science Foundation of China (Grant Nos. 31360528 and 31401750 for PH), Natural Science Foundation of Guizhou Province of China (Grant No. QKH-J [2014]2062 for PH), Scientific Research Foundation of Guizhou University, China (RJH Project Grant No. 2013-28 for PH), Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province (Grant No. SY [2010]3004 for MH), and Science and Technology Project of Guizhou Province (QKH Major Project Grant No. (2012) 6012 for MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Cao DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101187; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Glaser N, 2013, INT J BIOL SCI, V9, P481, DOI 10.7150/ijbs.6109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; He P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-136; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jacquin-Joly E, SHORT VIEWS INSECT M, P147; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu CC, 2013, INSECT BIOCHEM MOLEC, V43, P747, DOI 10.1016/j.ibmb.2013.05.009; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; OBATA T, 1983, APPL ENTOMOL ZOOL, V18, P161, DOI 10.1303/aez.18.161; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smadja CM, 2012, EVOLUTION, V66, P2723, DOI 10.1111/j.1558-5646.2012.01612.x; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogt RG, COMPREHENSIVE INSECT, V3, P753; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang YN, 2014, INSECT MOL BIOL, V23, P611, DOI 10.1111/imb.12109; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou GH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00270; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006	55	21	25	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140605	10.1371/journal.pone.0140605	http://dx.doi.org/10.1371/journal.pone.0140605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540266	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800005
J	Hou, JC; Fu, JH; Li, D; Han, X; Li, L; Song, WT; Yao, MJ; Liu, JX				Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun			Transcriptomic Analysis of Myocardial Ischemia Using the Blood of Rat	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; HEART; ULTRAFAST; SEQUENCES; ALIGNMENT; PROTECTS; GENOME	Myocardial ischemia is a pathological state of heart with reduced blood flow to heart and abnormal myocardial energy metabolism. This disease occurs commonly in middle aged and elderly people. Several studies have indicated that the rat was an appropriate animal model used to study myocardial ischemia. In this study, in order to gain insights into the pathogenesis of myocardial ischemia, we sequenced the transcriptomes of three normal rats as control and the same number of myocardial ischemia rats. We sequenced the genomes of 6 rats, including 3 cases (myocardial ischemia) and 3 controls using Illumina HiSeq 2000. Then we calculated the gene expression values and identified differentially expressed genes based on reads per kilobase transcriptome per million (RPKM). Meanwhile we performed a GO enrichment analysis and predicted novel transcripts. In our study, we found that 707 genes were up-regulated and 21 genes were down-regulated in myocardial ischemia rats by at least 2-fold compared with controls. By the distribution of reads and the annotation of reference genes, we found 1,703 and 1,552 novel transcripts in cases and controls, respectively. At the same time, we refined the structure of 9,587 genes in controls and 10,301 in cases. According to the results of GO term and pathway analysis of differentially expressed genes, we found that the immune response, stimulus response, response to stress and some diseases may be associated with myocardial ischemia. Since many diseases, especially immune diseases, are associated with myocardial ischemia, we should pay more attention to the complications which might result from myocardial ischemia.	[Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun] China Acad Chinese Med Sci, Inst Basic Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Hou, Jincai; Fu, Jianhua; Li, Dan; Han, Xiao; Li, Lei; Song, Wenting; Yao, Mingjiang; Liu, Jianxun] Beijing Key Lab Pharmacol Chinese Mat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS	Liu, JX (corresponding author), China Acad Chinese Med Sci, Inst Basic Med Sci, Xiyuan Hosp, Beijing, Peoples R China.	liujx0324@sina.com			National Natural Science Foundation of China [81173582]; National Science & Technology Major Project of China [2012ZX09103201-049, 2012zx09301002-004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project of China	This work was funded by National Natural Science Foundation of China (No. 81173582), National Science & Technology Major Project of China (Nos. 2012ZX09103201-049), and National Science & Technology Major Project of China (2012zx09301002-004-002).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; DAS DK, 1995, J MOL CELL CARDIOL, V27, P181, DOI 10.1016/S0022-2828(08)80017-X; Ferrari R, 1998, AM J CARDIOL, V82, p2K, DOI 10.1016/S0002-9149(98)00531-1; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Goldman S, 1995, J Card Fail, V1, P169, DOI 10.1016/1071-9164(95)90019-5; Gottlieb RA, 1999, ANN NY ACAD SCI, V874, P412, DOI 10.1111/j.1749-6632.1999.tb09255.x; Guzel S, 2013, DIABETES VASC DIS RE, V10, P25, DOI 10.1177/1479164112440815; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Kelle I, 2015, EUR REV MED PHARMACO, V19, P2468; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TC, 2014, PHARMAZIE, V69, P850, DOI 10.1691/ph.2014.4598; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Lin YL, 2015, EXP THER MED, V9, P1537, DOI 10.3892/etm.2015.2290; Liu PY, 2014, J GERIATR CARDIOL, V11, P303, DOI 10.11909/j.issn.1671-5411.2014.04.005; Liu Qian-Ping, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P326; Lyn D, 2000, PHYSIOL GENOMICS, V2, P93, DOI 10.1152/physiolgenomics.2000.2.3.93; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Tarzami ST, 2002, J MOL CELL CARDIOL, V34, P209, DOI 10.1006/jmcc.2001.1503; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Yu LM, 2015, J PINEAL RES, V59, P420, DOI 10.1111/jpi.12272; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhou MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/481405	31	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141915	10.1371/journal.pone.0141915	http://dx.doi.org/10.1371/journal.pone.0141915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540270	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800036
J	Huang, D; Peng, WJ; Ye, Q; Liu, XP; Zhao, L; Fan, L; Xia-Hou, K; Jia, HJ; Luo, J; Zhou, LT; Li, BB; Wang, SL; Xu, WT; Chen, Z; Tan, WS				Huang, Ding; Peng, Wen-Juan; Ye, Qian; Liu, Xu-Ping; Zhao, Liang; Fan, Li; Xia-Hou, Kang; Jia, Han-Jing; Luo, Jian; Zhou, Lin-Ting; Li, Bei-Bei; Wang, Shi-Lei; Xu, Wen-Ting; Chen, Ze; Tan, Wen-Song			Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; VERO CELLS; FREE MEDIA; A-VIRUS; GROWTH; LINE; APOPTOSIS; ADHERENT; SYSTEM	Development of serum-free suspension cell culture processes is very important for influenza vaccine production. Previously, we developed a MDCK suspension cell line in a serum-free medium. In the present study, the growth kinetics of suspension MDCK cells and influenza virus production in the serum-free medium were investigated, in comparison with those of adherent MDCK cells in both serum-containing and serum-free medium. It was found that the serum-free medium supported the stable subculture and growth of both adherent and suspension cells. In batch culture, for both cell lines, the growth kinetics in the serum-free medium was comparable with those in the serum-containing medium and a commercialized serum-free medium. In the serum-free medium, peak viable cell density (VCD), haemagglutinin (HA) and median tissue culture infective dose (TCID50) titers of the two cell lines reached 4.51x10(6) cells/mL, 2.94Log(10)(HAU/50 mu L) and 8.49Log(10)(virions/mL), and 5.97x10(6) cells/mL, 3.88Log(10)(HAU/50 mu L), and 10.34Log(10)(virions/mL), respectively. While virus yield of adherent cells in the serum-free medium was similar to that in the serum-containing medium, suspension culture in the serum-free medium showed a higher virus yield than adherent cells in the serum-containing medium and suspension cells in the commercialized serum-free medium. However, the percentage of infectious viruses was lower for suspension culture in the serum-free medium. These results demonstrate the great potential of this suspension MDCK cell line in serum-free medium for influenza vaccine production and further improvements are warranted.	[Huang, Ding; Peng, Wen-Juan; Ye, Qian; Liu, Xu-Ping; Zhao, Liang; Fan, Li; Xia-Hou, Kang; Jia, Han-Jing; Tan, Wen-Song] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Luo, Jian; Zhou, Lin-Ting; Li, Bei-Bei; Wang, Shi-Lei; Xu, Wen-Ting; Chen, Ze] Shanghai Inst Biol Prod Co Ltd, Shanghai 200052, Peoples R China	East China University of Science & Technology	Liu, XP (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	xupingliu@ecust.edu.cn; wstan@ecust.edu.cn	Zhao, Liang/J-6986-2012	Zhao, Liang/0000-0001-8077-3617	National Natural Science Foundation of China [21206040, 21406066]; National High Technology Research and Development Program of China (863 Program) [2012AA02A303]; National Science and Technology Major Project [2013ZX10004003-003-003]; Fundamental Research Funds for the Central Universities [WF1214035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Nos. 21206040, 21406066)(http://www.nsfc.gov.cn/), the National High Technology Research and Development Program of China (863 Program) (No. 2012AA02A303) (http://www.863.gov.cn/), the National Science and Technology Major Project (No. 2013ZX10004003-003-003) (http://www.nmp.gov.cn/), and the Fundamental Research Funds for the Central Universities (WF1214035) (http://jkw.mof.gov.cn/).	ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; Bock A, 2011, BIOTECHNOL PROGR, V27, P241, DOI 10.1002/btpr.539; Bock A, 2009, BIOTECHNOL PROGR, V25, P1717, DOI 10.1002/btpr.262; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Chen A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-81; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2014, VACCINE; Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Henry O, 2004, BIOTECHNOL BIOENG, V86, P765, DOI 10.1002/bit.20074; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huang D, 2014, VACCINE, V32, P7091, DOI 10.1016/j.vaccine.2014.10.067; Huang Ding, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P645; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; INFL WA, WHO MAN AN INFL DIAG; Isken B, 2012, VACCINE, V30, P5253, DOI 10.1016/j.vaccine.2012.05.065; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; Lee J-S, 2009, Google Patents, Patent No. [WO 2009152181A12009, 2009152181]; Li N, 2011, ACTA VIROL, V55, P147, DOI 10.4149/av_2011_02_147; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Lohr V, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-79; Mehtali M, 2006, WO Patent, Patent No. [2,006,108,846, 20006108846]; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Ngunjiri JM, 2008, J VIROL, V82, P2673, DOI 10.1128/JVI.02221-07; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Peschel B, 2013, VACCINE, V31, P5693, DOI 10.1016/j.vaccine.2013.09.051; Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84; Pohscheidt M, 2008, VACCINE, V26, P1552, DOI 10.1016/j.vaccine.2008.01.032; Reisinger KS, 2009, J INFECT DIS, V200, P849, DOI 10.1086/605506; Tan W, 2010, Serum-free medium for large-scale adherent and single-cell culture of MDCK cells2010, Patent No. [ZL 201010022834.4, 201010022834]; Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044; van Wielink R, 2011, J VIROL METHODS, V171, P53, DOI 10.1016/j.jviromet.2010.09.029; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037	40	28	36	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141686	10.1371/journal.pone.0141686	http://dx.doi.org/10.1371/journal.pone.0141686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540170	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800023
J	Komoto, S; Tacharoenmuang, R; Guntapong, R; Ide, T; Haga, K; Katayama, K; Kato, T; Ouchi, Y; Kurahashi, H; Tsuji, T; Sangkitporn, S; Taniguchi, K				Komoto, Satoshi; Tacharoenmuang, Ratana; Guntapong, Ratigorn; Ide, Tomihiko; Haga, Kei; Katayama, Kazuhiko; Kato, Takema; Ouchi, Yuya; Kurahashi, Hiroki; Tsuji, Takao; Sangkitporn, Somchai; Taniguchi, Koki			Emergence and Characterization of Unusual DS-1-Like G1P[8] Rotavirus Strains in Children with Diarrhea in Thailand	PLOS ONE			English	Article							WHOLE-GENOMIC ANALYSIS; GENOTYPE CONSTELLATION; PORCINE; CLASSIFICATION; IDENTIFICATION; PREVALENCE; SPREAD; JAPAN; NSP4; GENE	The emergence and rapid spread of unusual DS-1-like G1P[8] rotaviruses in Japan have been recently reported. During rotavirus surveillance in Thailand, three DS-1-like G1P[8] strains (RVA/Human-wt/THA/PCB-180/2013/G1P[8], RVA/Human-wt/THA/SKT-109/2013/G1P[8], and RVA/Human-wt/THA/SSKT-41/2013/G1P[8]) were identified in stool specimens from hospitalized children with severe diarrhea. In this study, we sequenced and characterized the complete genomes of strains PCB-180, SKT-109, and SSKT-41. On whole genomic analysis, all three strains exhibited a unique genotype constellation including both genogroup 1 and 2 genes: G1-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. This novel genotype constellation is shared with Japanese DS-1-like G1P[8] strains. Phylogenetic analysis revealed that the G/P genes of strains PCB-180, SKT-109, and SSKT-41 appeared to have originated from human Wa-like G1P[8] strains. On the other hand, the non-G/P genes of the three strains were assumed to have originated from human DS-1-like strains. Thus, strains PCB-180, SKT-109, and SSKT-41 appeared to be derived through reassortment event(s) between Wa-like G1P[8] and DS-1-like human rotaviruses. Furthermore, strains PCB-180, SKT-109, and SSKT-41 were found to have the 11-segment genome almost indistinguishable from one another in their nucleotide sequences and phylogenetic lineages, indicating the derivation of the three strains from a common origin. Moreover, all the 11 genes of the three strains were closely related to those of Japanese DS-1-like G1P[8] strains. Therefore, DS-1-like G1P[8] strains that have emerged in Thailand and Japan were assumed to have originated from a recent common ancestor. To our knowledge, this is the first report on whole genome-based characterization of DS-1-like G1P[8] strains that have emerged in an area other than Japan. Our observations will provide important insights into the evolutionary dynamics of emerging DS-1-like G1P[8] rotaviruses.	[Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Haga, Kei; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Kato, Takema; Kurahashi, Hiroki] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Ouchi, Yuya; Kurahashi, Hiroki] Fujita Hlth Univ, Genome & Transcriptome Anal Ctr, Toyoake, Aichi, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan	Fujita Health University; Ministry of Public Health - Thailand; National Institute of Infectious Diseases (NIID); Fujita Health University; Fujita Health University; Fujita Health University	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp		Katayama, Kazuhiko/0000-0002-7692-1151	MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doro R, 2014, INFECT GENET EVOL, V28, P495, DOI 10.1016/j.meegid.2014.09.016; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Ghosh S, 2011, J GEN VIROL, V92, P1222, DOI 10.1099/vir.0.029868-0; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	30	44	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141739	10.1371/journal.pone.0141739	http://dx.doi.org/10.1371/journal.pone.0141739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540260	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800025
J	Fonseca, SAS; Costas, RM; Morato-Marques, M; Costa, S; Alegretti, JR; Rosenberg, C; da Motta, ELA; Serafini, PC; Pereira, LV				Siqueira Fonseca, Simone Aparecida; Costas, Roberta Montero; Morato-Marques, Mariana; Costa, Silvia; Alegretti, Jose Roberto; Rosenberg, Carla; Alves da Motta, Eduardo Leme; Serafini, Paulo C.; Pereira, Lygia V.			A Euploid Line of Human Embryonic Stem Cells Derived from a 43,XX,dup(9q),+12,-14,-15,-18,-21 Embryo	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; SELF-CORRECTION; DERIVATION; ANEUPLOIDY; PGD	Aneuploid embryos diagnosed by FISH-based preimplantation genetic screening (PGS) have been shown to yield euploid lines of human embryonic stem cells (hESCs) with a relatively high frequency. Given that the diagnostic procedure is usually based on the analysis of 1-2 blastomeres of 5 to 10-cell cleavage-stage embryos, mosaicism has been a likely explanation for the phenomena. However, FISH-based PGS can have a significant rate of misdiagnosis, and therefore some of those lines may have been derived from euploid embryos misdiagnosed as aneuploid. More recently, coupling of trophectoderm (TE) biopsy at the blastocyst stage and array-CGH lead to a more informative form of PGS. Here we describe the establishment of a new line of hESCs from an embryo with a 43, XX, dup(9q), +12,-14,-15,-18,-21 chromosomal content based on array-CGH of TE biopsy. We show that, despite the complex chromosomal abnormality, the corresponding hESC line BR-6 is euploid (46, XX). Single nucleotide polymorphism analysis showed that the embryo's missing chromosomes were not duplicated in BR-6, suggesting the existence of extensive mosaicism in the TE lineage.	[Siqueira Fonseca, Simone Aparecida; Costas, Roberta Montero; Morato-Marques, Mariana; Pereira, Lygia V.] Univ Sao Paulo, Natl Lab Embryon Stem Cell LaNCE, Sao Paulo, Brazil; [Siqueira Fonseca, Simone Aparecida; Morato-Marques, Mariana; Costa, Silvia; Rosenberg, Carla; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Alegretti, Jose Roberto; Alves da Motta, Eduardo Leme; Serafini, Paulo C.] Huntington Ctr Human Reprod, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, LV (corresponding author), Univ Sao Paulo, Natl Lab Embryon Stem Cell LaNCE, Sao Paulo, Brazil.	lpereira@usp.br	Fonseca, Simone/AAD-7393-2019; rosenberg, carla/N-4148-2015; Pereira, Lygia V/C-1049-2012; Costa, Silvia F/K-4768-2012; Motta, Eduardo/M-1264-2014	rosenberg, carla/0000-0003-3253-4448; Pereira, Lygia V/0000-0002-0002-725X; Costa, Silvia F/0000-0003-1087-752X; Fonseca, Simone/0000-0003-3301-222X; Motta, Eduardo/0000-0001-9029-9138	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT) [13/08135-2]; Banco Nacional de Desenvolvimento Economico e Social (BNDES); Financiadora de Estudos e Projetos (FINEP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT); Banco Nacional de Desenvolvimento Economico e Social (BNDES); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-CEPID 13/08135-2) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT), Banco Nacional de Desenvolvimento Economico e Social (BNDES) and Financiadora de Estudos e Projetos (FINEP).	Barbash-Hazan S, 2009, FERTIL STERIL, V92, P890, DOI 10.1016/j.fertnstert.2008.07.1761; Bazrgar M, 2013, STEM CELLS DEV, V22, P2449, DOI 10.1089/scd.2013.0053; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Georges JAD, 2014, STEM CELL REV REP, V10, P472, DOI 10.1007/s12015-014-9505-4; Doss MX, 2004, J CELL MOL MED, V8, P465, DOI 10.1111/j.1582-4934.2004.tb00471.x; Fraga AM, 2011, CELL TRANSPLANT, V20, P431, DOI 10.3727/096368910X522261; Fragouli E, 2008, HUM REPROD, V23, P2596, DOI 10.1093/humrep/den287; Fritz MA, 2008, HUM REPROD, V23, P2617, DOI 10.1093/humrep/den400; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gosden C., 1992, HUMAN CYTOGENETICS, P37; Hansis C, 2006, REPROD BIOMED ONLINE, V6, P215; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mitalipova M, 2006, METH MOL B, V331, P55; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Peura T, 2008, CLONING STEM CELLS, V10, P203, DOI 10.1089/clo.2007.0062; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Scott R, 2008, FERTIL STERIL, V90, P77, DOI 10.1016/j.fertnstert.2007.11.058; Shetty Ronak, 2012, Methods Mol Biol, V873, P151, DOI 10.1007/978-1-61779-794-1_9; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Treff NR, 2010, MOL HUM REPROD, V16, P583, DOI 10.1093/molehr/gaq039; Tropel P, 2010, IN VITRO CELL DEV-AN, V46, P376, DOI 10.1007/s11626-010-9300-8; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026	27	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140999	10.1371/journal.pone.0140999	http://dx.doi.org/10.1371/journal.pone.0140999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540511	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800008
J	Geuskens, RREG; Borst, J; Lucas, M; Boers, AMM; Berkhemer, OA; Roos, YBWEM; van Walderveen, MAA; Jenniskens, SFM; van Zwam, WH; Dippel, DWJ; Majoie, CBLM; Marquering, HA				Geuskens, Ralph R. E. G.; Borst, Jordi; Lucas, Marit; Boers, A. M. Merel; Berkhemer, Olvert A.; Roos, Yvo B. W. E. M.; van Walderveen, Marianne A. A.; Jenniskens, Sjoerd F. M.; van Zwam, Wim H.; Dippel, Diederik W. J.; Majoie, Charles B. L. M.; Marquering, Henk A.		MR CLEAN Trial Investigators	Characteristics of Misclassified CT Perfusion Ischemic Core in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CEREBRAL-BLOOD-FLOW; TECHNICAL IMPLEMENTATIONS; ENDOVASCULAR THERAPY; IMAGING SELECTION; BRAIN PERFUSION; THEORETIC BASIS; INFARCT VOLUME; PART 1; PENUMBRA	Background CT perfusion (CTP) is used to estimate the extent of ischemic core and penumbra in patients with acute ischemic stroke. CTP reliability, however, is limited. This study aims to identify regions misclassified as ischemic core on CTP, using infarct on follow-up noncontrast CT. We aim to assess differences in volumetric and perfusion characteristics in these regions compared to areas that ended up as infarct on follow-up. Materials and Methods This study included 35 patients with >100 mm brain coverage CTP. CTP processing was performed using Philips software (IntelliSpace 7.0). Final infarct was automatically segmented on follow-up noncontrast CT and used as reference. CTP and follow-up noncontrast CT image data were registered. This allowed classification of ischemic lesion agreement (core on CTP: rMTT >= 145%, aCBV<2.0 ml/100g and infarct on follow-up noncontrast CT) and misclassified ischemic core (core on CTP, not identified on follow-up noncontrast CT) regions. False discovery ratio (FDR), defined as misclassified ischemic core volume divided by total CTP ischemic core volume, was calculated. Absolute and relative CTP parameters (CBV, CBF, and MTT) were calculated for both misclassified CTP ischemic core and ischemic lesion agreement regions and compared using paired rank-sum tests. Results Median total CTP ischemic core volume was 49.7ml (IQR: 29.9ml-132ml); median misclassified ischemic core volume was 30.4ml (IQR: 20.9ml-77.0ml). Median FDR between patients was 62% (IQR: 49%-80%). Median relative mean transit time was 243% (IQR: 198%-289%) and 342% (IQR: 249%-432%) for misclassified and ischemic lesion agreement regions, respectively. Median absolute cerebral blood volume was 1.59 (IQR: 1.43-1.79) ml/100g (P<0.01) and 1.38 (IQR: 1.15-1.49) ml/100g (P<0.01) for misclassified ischemic core and ischemic lesion agreement, respectively. All CTP parameter values differed significantly. Conclusion For all patients a considerable region of the CTP ischemic core is misclassified. CTP parameters significantly differed between ischemic lesion agreement and misclassified CTP ischemic core, suggesting that CTP analysis may benefit from revisions.	[Geuskens, Ralph R. E. G.; Lucas, Marit; Boers, A. M. Merel; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Borst, Jordi; Berkhemer, Olvert A.; Majoie, Charles B. L. M.; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Roos, Yvo B. W. E. M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [van Walderveen, Marianne A. A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Jenniskens, Sjoerd F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [van Zwam, Wim H.] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [Dippel, Diederik W. J.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Geuskens, RREG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.r.geuskens@amc.uva.nl	Roos, Yvo BWEM/B-9843-2013; Jenniskens, S.F.M./L-4415-2015; Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; Marquering, Henk/0000-0002-1414-6313	ITEA2 project; Dutch Heart Foundation; AngioCare; Covidien/ev3; Medac/Lamepro; Penumbra	ITEA2 project; Dutch Heart Foundation(Netherlands Heart Foundation); AngioCare; Covidien/ev3; Medac/Lamepro; Penumbra	Part of this research has been sponsored by the ITEA2 project, label 10004: MEDUSA - Medical Distributed Utilization of Services & Applications (https://itea3.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The MRCLEAN trial is supported by the Dutch Heart Foundation and by unrestricted grants from AngioCare, Covidien/ev3, Medac/Lamepro, and Penumbra.	Allmendinger AM, 2012, AM J ROENTGENOL, V198, P52, DOI 10.2214/AJR.10.7255; Benson J, 2015, EUR J RADIOL, V84, P682, DOI 10.1016/j.ejrad.2014.12.026; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Best AC, 2012, RADIOGRAPHICS, V32, P1179, DOI 10.1148/rg.324105742; Boers AM, 2013, AM J NEURORADIOL, V34, P1522, DOI 10.3174/ajnr.A3463; Borst J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119409; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2015, INT J STROKE, V10, P51, DOI 10.1111/ijs.12381; Campbell BCV, 2012, STROKE, V43, P2648, DOI 10.1161/STROKEAHA.112.660548; Campbell BCV, 2012, ARCH NEUROL-CHICAGO, V69, P46, DOI 10.1001/archneurol.2011.232; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Dani KA, 2011, ANN NEUROL, V70, P384, DOI 10.1002/ana.22500; Fahmi F, 2013, EUR J RADIOL, V82, P2334, DOI 10.1016/j.ejrad.2013.08.039; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Finitsis S, 2014, NEURORADIOLOGY, V56, P325, DOI 10.1007/s00234-014-1329-z; Gonzalez RG, 2012, J NEUROINTERV SURG, V4, P242, DOI 10.1136/neurintsurg-2012-010404; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Grand S, 2013, Diagn Interv Imaging, V94, P1241, DOI 10.1016/j.diii.2013.06.009; Hacke W, 2008, NEW ENGL J MED, V359, P877; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2015, THROMBECTOMY 8 HOURS, P1, DOI [10.1056/NEJMoa1503780, DOI 10.1056/NEJM0A1503780]; Kamalian S, 2011, STROKE, V42, P1923, DOI 10.1161/STROKEAHA.110.610618; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lui YW, 2010, AM J NEURORADIOL, V31, P1552, DOI 10.3174/ajnr.A2026; Man FY, 2015, NEURORADIOLOGY, V57, P573, DOI 10.1007/s00234-015-1507-7; Mangla R, 2014, EMERG RADIOL, V21, P49, DOI 10.1007/s10140-013-1125-9; Olivot JM, 2009, STROKE, V40, P469, DOI 10.1161/STROKEAHA.108.526954; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Saver JL, 1999, STROKE, V30, P293, DOI 10.1161/01.STR.30.2.293; Saver JL, 2015, STENT RETRIVER THROM, P1, DOI [10.1056/NEJMoa1415061, DOI 10.1056/NEJM0A1415061]; SCHAEFER PW, 2015, LTD RELIABILITY COMP, V46, P419, DOI DOI 10.1161/STR0KEAHA.114.007117; Song SS, 2013, SEMIN NEUROL, V33, P436, DOI 10.1055/s-0033-1364214; Tarpley J, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0336-6; Wintermark M, 2007, NEUROLOGY, V68, P694, DOI 10.1212/01.wnl.0000255959.30107.08; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Yoo AJ, 2013, J NEUROINTERV SURG, V5, P1, DOI 10.1136/neurintsurg-2013-010741; Zhao LM, 2011, INT J STROKE, V6, P544, DOI 10.1111/j.1747-4949.2011.00681.x; Zhu GM, 2013, STROKE, V44, P1014, DOI 10.1161/STROKEAHA.111.000229	46	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141571	10.1371/journal.pone.0141571	http://dx.doi.org/10.1371/journal.pone.0141571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536226	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400071
J	Kong, WW; Chen, N; Liu, TT; Zhu, J; Wang, JQ; He, XQ; Jin, Y				Kong, Weiwen; Chen, Nan; Liu, Tingting; Zhu, Jing; Wang, Jingqi; He, Xiaoqing; Jin, Yi			Large-Scale Transcriptome Analysis of Cucumber and Botrytis cinerea during Infection	PLOS ONE			English	Article							OXIDATIVE BURST; PLANT IMMUNITY; BIOTIC STRESS; ABSCISIC-ACID; RESISTANCE; ARABIDOPSIS; JASMONATE; ETHYLENE; DEFENSE; GENE	Cucumber gray mold caused by Botrytis cinerea is considered one of the most serious cucumber diseases. With the advent of Hi-seq technology, it is possible to study the plant-pathogen interaction at the transcriptome level. To the best of our knowledge, this is the first application of RNA-seq to identify cucumber and B. cinerea differentially expressed genes (DEGs) before and after the plant-pathogen interaction. In total, 248,908,688 raw reads were generated; after removing low-quality reads and those containing adapter and poly-N, 238,341,648 clean reads remained to map the reference genome. There were 3,512 cucumber DEGs and 1,735 B. cinerea DEGs. GO enrichment and KEGG enrichment analysis were performed on these DEGs to study the interaction between cucumber and B. cinerea. To verify the reliability and accuracy of our transcriptome data, 5 cucumber DEGs and 5 B. cinerea DEGs were chosen for RT-PCR verification. This is the first systematic transcriptome analysis of components related to the B. cinerea-cucumber interaction. Functional genes and putative pathways identified herein will increase our understanding of the mechanism of the pathogen-host interaction.	[Kong, Weiwen; Chen, Nan; Liu, Tingting; Zhu, Jing; Wang, Jingqi; He, Xiaoqing; Jin, Yi] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing 100083, Peoples R China	Beijing Forestry University	He, XQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, POB 162, Beijing 100083, Peoples R China.	lenahe@bjfu.edu.cn; wizard.jin@163.com	He, Xiaoqing/AGM-1178-2022	He, Xiaoqing/0000-0001-9098-9980	Fundamental Research Funds for the Central University [TD2012-03]; non-profit Industry Financial Program of Ministry Of Water Resources [201201032]; Natural Science Foundation of China [51108029]	Fundamental Research Funds for the Central University; non-profit Industry Financial Program of Ministry Of Water Resources; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central University (TD2012-03), non-profit Industry Financial Program of Ministry Of Water Resources (201201032), and Natural Science Foundation of China (51108029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Anders S., HTSEQ ANAL HIGH THRO; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Balint-Kurti PJ, 2015, NAT GENET, V47, P101, DOI 10.1038/ng.3203; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Blanco-Ulate B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00435; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Elad Y, 1997, BIOL REV, V72, P381, DOI 10.1017/S0006323197005057; Elad Y, 2007, BOTRYTIS BIOL PATHOL, P1, DOI DOI 10.1007/978-1-4020-2626-3_1; Esquinas-Alcazar J.T., 1983, GENETIC RESOURCES CU; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2006, PHYTOPATHOLOGY, V96, P299, DOI 10.1094/PHYTO-96-0299; GUO Z, 1993, PLANT PHYSIOL, V102, P45, DOI 10.1104/pp.102.1.45; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Leroux P., 2007, BOTRYTIS BIOL PATHOL, P195, DOI [10.1007/978-1-4020-2626-3_12, DOI 10.1007/978-1-4020-2626-3_12]; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Smith JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-334; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; ten Have A, 2001, FUNGAL GENET BIOL, V33, P97, DOI 10.1006/fgbi.2001.1269; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Wang H, 2013, MOL PLANT PATHOL, V14, P453, DOI 10.1111/mpp.12017; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang L., 2013, AGR APPL, P361, DOI [10.1007/978-3-642-36821-9_14, DOI 10.1007/978-3-642-36821-9_14]; Zhu S, 2013, BRIEF BIOINFORM, V14, P713, DOI 10.1093/bib/bbs047	43	37	41	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142221	10.1371/journal.pone.0142221	http://dx.doi.org/10.1371/journal.pone.0142221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536465	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400145
J	Lee, YT; Nfor, ON; Tantoh, DM; Huang, JY; Ku, WY; Hsu, SY; Ko, PC; Hung, HC; Jan, CF; Liaw, YP				Lee, Yuan-Ti; Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Hung, Hung-Chang; Jan, Cheng-Feng; Liaw, Yung-Po			Herpes Zoster as a Predictor of HIV Infection in Taiwan: A Population-Based Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION	This study aimed to investigate the association between herpes zoster (HZ) and human immunodeficiency virus (HIV). Data were retrieved from the Longitudinal Health Insurance Databases (LHID 2005 and 2010), Taiwan. The International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] codes were used to identify Hz from 2001-2004. Identification of HIV infection was from 2005-2010. The hazard ratios of HIV among herpes zoster infected and non-herpes zoster infected patients were estimated using multiple Cox proportional hazard model. In general, 19685 participants were identified with Hz. The HIV incidence rates (per 104 person-months) in herpes zoster infected and non-infected patients were 0.191(95% CI 0.130-0.280) and 0.079 (95% CI 0.074-0.084), respectively while the hazard ratio (HR) of HIV among infected individuals was 3.518 (95% CI 2.375-5.211). This study concludes that herpes zoster could be considered as a predictor of HIV infection especially among Asian populations, hence it is vital to test herpes zoster infected individuals for HIV antibodies.	[Lee, Yuan-Ti] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung 40201, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan; [Lee, Yuan-Ti] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan; [Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan; [Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Taichung 40201, Taiwan; [Hung, Hung-Chang] Nantou Hosp, Dept Internal Med, Div Gastroenterol, Minist Hlth & Welf, Nantou, Taiwan; [Jan, Cheng-Feng] Chung Yuan Christian Univ, Off Phys Educ, Chungli, Taiwan; [Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung 40201, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Yuan Christian University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan.	Liawyp@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021; Lee, Yuan-Ti/ABH-7837-2020	Lee, Yuan-Ti/0000-0003-4577-4379; Huang, Jing-Yang/0000-0002-0794-9388				BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; COLEBUNDERS R, 1988, J INFECT DIS, V157, P314, DOI 10.1093/infdis/157.2.314; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; HELGASON S, 1996, EUR J GEN PRACT, V2, P12; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P87; Hope-Simpson RE, 1965, J ROY SOC MED, V58, P9; Laskin OL, 1986, AM J MED, V81; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; Moanna A, 2013, CLIN INFECT DIS, V57, P122, DOI 10.1093/cid/cit165; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rubben A, 1997, BRIT J DERMATOL, V137, P259, DOI 10.1046/j.1365-2133.1997.18161913.x; TYNDALL MW, 1995, CLIN INFECT DIS, V21, P1035, DOI 10.1093/clinids/21.4.1035; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006	13	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142254	10.1371/journal.pone.0142254	http://dx.doi.org/10.1371/journal.pone.0142254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535574	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400148
J	Segev, A; Mimouni-Bloch, A; Ross, S; Silman, Z; Maoz, H; Bloch, Y				Segev, Aviv; Mimouni-Bloch, Aviva; Ross, Sharon; Silman, Zmira; Maoz, Hagai; Bloch, Yuval			Evaluating Computer Screen Time and Its Possible Link to Psychopathology in the Context of Age: A Cross-Sectional Study of Parents and Children	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; VIDEO GAMES; MEDIA USE; HEALTH; STRENGTHS; YOUTH; PERFORMANCE; TELEVISION; COMMUNITY; DISORDER	Background Several studies have suggested that high levels of computer use are linked to psychopathology. However, there is ambiguity about what should be considered normal or over-use of computers. Furthermore, the nature of the link between computer usage and psychopathology is controversial. The current study utilized the context of age to address these questions. Our hypothesis was that the context of age will be paramount for differentiating normal from excessive use, and that this context will allow a better understanding of the link to psychopathology. Methods In a cross-sectional study, 185 parents and children aged 3-18 years were recruited in clinical and community settings. They were asked to fill out questionnaires regarding demographics, functional and academic variables, computer use as well as psychiatric screening questionnaires. Using a regression model, we identified 3 groups of normal-use, over-use and under-use and examined known factors as putative differentiators between the over-users and the other groups. Results After modeling computer screen time according to age, factors linked to over-use were: decreased socialization (OR 3.24, Confidence interval [CI] 1.23-8.55, p = 0.018), difficulty to disengage from the computer (OR 1.56, CI 1.07-2.28, p = 0.022) and age, though border-line-significant (OR 1.1 each year, CI 0.99-1.22, p = 0.058). While psychopathology was not linked to over-use, post-hoc analysis revealed that the link between increased computer screen time and psychopathology was age-dependent and solidified as age progressed (p = 0.007). Unlike computer usage, the use of small-screens and smartphones was not associated with psychopathology. Conclusions The results suggest that computer screen time follows an age-based course. We conclude that differentiating normal from over-use as well as defining over-use as a possible marker for psychiatric difficulties must be performed within the context of age. If verified by additional studies, future research should integrate those views in order to better understand the intricacies of computer over-use.	[Segev, Aviv; Maoz, Hagai; Bloch, Yuval] Shalvata Mental Hlth Ctr, Hod Hasharon, Israel; [Mimouni-Bloch, Aviva; Ross, Sharon] Loewenstein Hosp & Rehabil Ctr, Pediat Neurol & Dev Unit, Raanana, Israel; [Segev, Aviv; Mimouni-Bloch, Aviva; Maoz, Hagai; Bloch, Yuval] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Segev, A (corresponding author), Shalvata Mental Hlth Ctr, Hod Hasharon, Israel.	aviv@segev.name		Mimouni Bloch, Aviva/0000-0001-6457-0262	Loewenstein Rehabilitation Hospital Research Fund	Loewenstein Rehabilitation Hospital Research Fund	Funding: Funding was provided by Loewenstein Rehabilitation Hospital Research Fund (AMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric A, 2013, DIAGN STAT MAN MENT, VFifth; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Biel MG, 2015, PARENT REPORTS MENTA; Bioulac S, 2008, EUR PSYCHIAT, V23, P134, DOI 10.1016/j.eurpsy.2007.11.002; Carlson SA, 2010, PEDIATRICS, V126, pE89, DOI 10.1542/peds.2009-3374; Chastang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133604; Christakis DA, 2004, J PEDIATR-US, V145, P652, DOI 10.1016/j.jpeds.2004.06.078; Clinton C SJ, 2012, CNN; Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920; Eagle TF, 2010, AM HEART J, V160, P1185, DOI 10.1016/j.ahj.2010.09.019; Elson M, 2013, BRIT J PSYCHIAT, V203, P322, DOI 10.1192/bjp.bp.113.128652; Fink E, 2015, J ADOLESCENT HEALTH, V56, P502, DOI 10.1016/j.jadohealth.2015.01.023; Fuld GL, 2009, PEDIATRICS, V124, P1495, DOI 10.1542/peds.2009-2146; Gentile D.A., 2011, PEDIATRICS, V127, P319, DOI [10.1542/peds.2010-1353, DOI 10.1542/peds.2010-1353]; Gentile DA, 2004, J ADOLESCENCE, V27, P5, DOI 10.1016/j.adolescence.2003.10.002; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Greenberg BS, 2010, SIMULAT GAMING, V41, P238, DOI 10.1177/1046878108319930; Greitemeyer T, 2010, EMOTION, V10, P796, DOI 10.1037/a0020194; Griffiths M, 2004, J HEALTH PSYCHOL, V9, P339, DOI 10.1177/1359105304042344; Han DH, 2009, COMPR PSYCHIAT, V50, P251, DOI 10.1016/j.comppsych.2008.08.011; Huget JL, 2010, WASHINGTON POST; Mark Amy E, 2006, Paediatr Child Health, V11, P595; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Mossle T, 2010, BRIT J DEV PSYCHOL, V28, P699, DOI 10.1348/026151009X475307; Przybylski AK, 2014, PEDIATRICS, V134, pE716, DOI 10.1542/peds.2013-4021; Richards R, 2010, ARCH PEDIAT ADOL MED, V164, P258, DOI 10.1001/archpediatrics.2009.280; Riley M, 2011, AM FAM PHYSICIAN, V83, P689; Romer D, 2013, J ADOLESCENT HEALTH, V52, P613, DOI 10.1016/j.jadohealth.2012.11.012; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; Wack E, 2009, CYBERPSYCHOL BEHAV, V12, P241, DOI 10.1089/cpb.2008.0151; Yang F, 2013, EUR J PUBLIC HEALTH, V23, P492, DOI 10.1093/eurpub/cks102	37	10	10	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140542	10.1371/journal.pone.0140542	http://dx.doi.org/10.1371/journal.pone.0140542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536037	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400024
J	Jackson, MM; Gergel, SE; Martin, K				Jackson, Michelle M.; Gergel, Sarah E.; Martin, Kathy			Effects of Climate Change on Habitat Availability and Configuration for an Endemic Coastal Alpine Bird	PLOS ONE			English	Article							VANCOUVER-ISLAND; MODEL PROJECTIONS; ENVELOPE MODELS; PTARMIGAN; RANGE; IMPACTS; NICHE; CLASSIFICATION; DISTRIBUTIONS; CONTRACTIONS	North America's coastal mountains are particularly vulnerable to climate change, yet harbour a number of endemic species. With little room "at the top" to track shifting climate envelopes, alpine species may be especially negatively affected by climate-induced habitat fragmentation. We ask how climate change will affect the total amount, mean patch size, and number of patches of suitable habitat for Vancouver Island White-tailed Ptarmigan (Lagopus leucura saxatilis; VIWTP), a threatened, endemic alpine bird. Using a Random Forest model and a unique dataset consisting of citizen science observations combined with field surveys, we predict the distribution and configuration of potential suitable summer habitat for VIWTP under baseline and future (2020s, 2050s, and 2080s) climates using three general circulation models and two greenhouse gas scenarios. VIWTP summer habitat is predicted to decline by an average of 25%, 44%, and 56% by the 2020s, 2050s, and 2080s, respectively, under the low greenhouse gas scenario and 27%, 59%, and 74% under the high scenario. Habitat patches are predicted to become fragmented, with a 5279% reduction in mean patch size. The average elevation of suitable habitat patches is expected to increase, reflecting a loss of patches at lower elevations. Thus ptarmigan are in danger of being "squeezed off the mountain", as their remaining suitable habitat will be increasingly confined to mountaintops in the center of the island. The extent to which ptarmigan will be able to persist in increasingly fragmented habitat is unclear. Much will depend on their ability to move throughout a more heterogeneous landscape, utilize smaller breeding areas, and survive increasingly variable climate extremes. Our results emphasize the importance of continued monitoring and protection for high elevation specialist species, and suggest that White-tailed Ptarmigan should be considered an indicator species for alpine ecosystems in the face of climate change.	[Jackson, Michelle M.; Gergel, Sarah E.; Martin, Kathy] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Martin, Kathy] Environm Canada, Delta, BC V4K 3N2, Canada	University of British Columbia; Environment & Climate Change Canada	Jackson, MM (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, 2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.	michellegooch@gmail.com	Jackson, Michelle/AAA-8442-2021		TerreWEB; Natural Sciences and Engineering Research Council of Canada (NSERC); Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia; NSERC [147390-2010]; Forest Renewal British Columbia [16R81811]; Environment Canada [16R31929]	TerreWEB; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Forest Renewal British Columbia; Environment Canada(CGIAR)	Funding for this research was provided by TerreWEB (http://terreweb.ubc.ca), a Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca) Collaborative Research and Training Experience (CREATE) fellowship program at the University of British Columbia to M.J. NSERC provided support to several undergraduate student technicians (Undergraduate Research Student Assistantships). Additional support came from NSERC Discovery Grants (147390-2010), Forest Renewal British Columbia (16R81811) and Environment Canada support (16R31929) to K.M. and an NSERC Discovery Grant to S.G.	Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; Boyle WA, 2016, BIOL REV, V91, P469, DOI 10.1111/brv.12180; Bradbury W. C., 1915, Condor Hollywood, V17, DOI 10.2307/1362307; Braunisch V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097718; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell RW, 1990, NONPASSERINES DIURNA; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Coppack T, 2002, ARDEA, V90, P369; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Duursma DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084222; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Essl F, 2009, BIOL CONSERV, V142, P2547, DOI 10.1016/j.biocon.2009.05.027; Fedy BC, 2008, MOL ECOL, V17, P1905, DOI 10.1111/j.1365-294X.2008.03720.x; Fedy B, 2011, CONDOR, V113, P306, DOI 10.1525/cond.2011.100070; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Flower A, 2013, ENVIRON SCI POLICY, V26, P63, DOI 10.1016/j.envsci.2012.07.024; Fraser D, 1999, RARE BIRDS BRIT COLU; Gage GS, 2004, ANIM CONSERV, V7, P161, DOI 10.1017/S1367943004001246; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hallinger M, 2010, NEW PHYTOL, V186, P890, DOI 10.1111/j.1469-8137.2010.03223.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Host P., 1942, Auk, V59, P388; Jackson MM, 2015, BIOL CONSERV, V181, P162, DOI 10.1016/j.biocon.2014.11.010; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; JANZ DW, 2000, 19 REC NAT END WILDL; Jiguet F, 2013, BIRD STUDY, V60, P60, DOI 10.1080/00063657.2012.733337; JOHNSON RE, 1968, COMP BIOCHEM PHYSIOL, V24, P1003, DOI 10.1016/0010-406X(68)90813-X; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; Kullman L, 2009, J ECOL, V97, P415, DOI 10.1111/j.1365-2745.2009.01488.x; Laroque CP, 2003, FOREST ECOL MANAG, V183, P313, DOI 10.1016/S0378-1127(03)00110-5; LAROQUE CP, 2000, W GEOGRAPHY, V10, P43; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Martin K, 2000, CONDOR, V102, P503, DOI 10.1650/0010-5422(2000)102[0503:RDADRI]2.0.CO;2; Martin K, 2004, J FIELD ORNITHOL, V75, P239, DOI 10.1648/0273-8570-75.3.239; Martin K, 1998, USE ALPINE HABITATS; McTaggart-Cowan, 1939, CONDOR, V41, P82; Mignatti A, 2012, WILDLIFE BIOL, V18, P318, DOI 10.2981/11-084; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pedersen AO, 2014, J ORNITHOL, V155, P195, DOI 10.1007/s10336-013-1001-0; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rodenhuis D, 2007, CLIMATE OVERVIEW 200; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Saunders DA, 2005, CONSERV BIOL, V5, P18; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218; Snall T, 2011, BIOL CONSERV, V144, P804, DOI 10.1016/j.biocon.2010.11.010; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Topp E, 2014, THESIS U PADOVA BRIT; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; VEGHTE JH, 1965, PHYSIOL ZOOL, V38, P267, DOI 10.1086/physzool.38.3.30152838; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wiebe KL, 1998, ANIM BEHAV, V56, P1137, DOI 10.1006/anbe.1998.0862; Wilson S, 2011, POPUL ECOL, V53, P459, DOI 10.1007/s10144-011-0261-x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zarnetske PL, 2007, ECOL APPL, V17, P1714, DOI 10.1890/06-1312.1; ZWICKEL FC, 1967, J WILDLIFE MANAGE, V31, P202, DOI 10.2307/3798382	81	23	24	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142110	10.1371/journal.pone.0142110	http://dx.doi.org/10.1371/journal.pone.0142110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529306	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600101
J	Zhao, WJ; Yu, XY; Ma, H; Zhu, QK; Zhang, Y; Qin, W; Ai, N; Wang, Y				Zhao, Weijun; Yu, Xinyang; Ma, Huan; Zhu, Qingke; Zhang, Yan; Qin, Wei; Ai, Ning; Wang, Yu			Analysis of Precipitation Characteristics during 1957-2012 in the Semi-Arid Loess Plateau, China	PLOS ONE			English	Article							RAINFALL TRENDS; DROUGHT; PREDICTION	Precipitation is the only water supply and most important factor affecting vegetation growth on the slopes of semi-arid Loess Plateau of China. Based on precipitation data from 7 synoptic stations in the study area over the period 1957-2012, the trends of precipitation and standardized precipitation index (SPI) were analyzed by using linear regression, Mann-Kendall, and Spearman's Rho tests at the 5% significance level. The results show that (1) the precipitation fluctuation of monthly precipitation was intense (coefficients of variation>100%), and the drier years were recorded as 1965 and 1995 at all stations. (2) The significant change trend of different stations varied on different time scales: the Changwu station had a significant decreasing trend in April (-0.488 mm/year) and November (-0.249 mm/year), while Luochuan station was in April (-0.457 mm/year); Changwu station displayed a significant increasing trends in winter (0.220 mm/year) and a significant decreasing trends in spring (-0.770 mm/year). The significant decreasing trends in annual precipitation were detected at the Suide (-2.034 mm/year) and Yan'an (-2.129 mm/year) stations. (3) The SPI-12 series analysis suggests that the drought degree of Yulin and Changwu was the lowest and that of Hengshan was the highest among the 7 synoptic stations.	[Zhao, Weijun] Taishan Univ, Key Lab Tourism & Resources Environm Coll & Univ, Tai An 271021, Shandong, Peoples R China; [Zhao, Weijun; Ma, Huan; Zhu, Qingke; Zhang, Yan; Ai, Ning; Wang, Yu] Beijing Forestry Univ, Forestry Ecol Engn Res Ctr, Minist Educ, Beijing, Peoples R China; [Yu, Xinyang] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Qin, Wei] China Inst Water Resources & Hydropower Res, Dept Sedimentat, Beijing 100044, Peoples R China	Taishan University; Beijing Forestry University; Shandong Agricultural University; China Institute of Water Resources & Hydropower Research	Zhu, QK (corresponding author), Beijing Forestry Univ, Forestry Ecol Engn Res Ctr, Minist Educ, Beijing, Peoples R China.	zhuqingke@sohu.com	Ma, Huan/AAA-9466-2021		China National Scientific and Technical Innovation Research Project for 12th Five Year Plan [2011BAD38B0601]; National Natural Science Foundation of China [41472313]; Natural Science Foundation of Shandong Province [ZR2011DM012, ZR2014DL002]	China National Scientific and Technical Innovation Research Project for 12th Five Year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The financial support for the study was from China National Scientific and Technical Innovation Research Project for 12th Five Year Plan (2011BAD38B0601), the National Natural Science Foundation of China (41472313), and the Natural Science Foundation of Shandong Province (ZR2011DM012, ZR2014DL002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006887; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [傅朝 Fu Zhu], 2008, [干旱区研究, Arid Zone Research], V25, P447; Gemmer M, 2004, THEOR APPL CLIMATOL, V77, P39, DOI 10.1007/s00704-003-0018-3; Gocic M, 2013, J HYDROL, V494, P32, DOI 10.1016/j.jhydrol.2013.04.044; GRIGG NS, 1993, J WATER RES PL-ASCE, V119, P531, DOI 10.1061/(ASCE)0733-9496(1993)119:5(531); Guhathakurta P, 2008, INT J CLIMATOL, V28, P1453, DOI 10.1002/joc.1640; Helsel D. R., 1992, STAT METHODS WATER R; Hisdal H, 2001, INT J CLIMATOL, V21, P317, DOI 10.1002/joc.619; Huang WanHua, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P50; KENDALL M. G., 1948, Rank correlation methods.; Kendall MG, 1968, ADV THEORY STAT DESI, V3; Khalili D, 2011, WATER RESOUR MANAG, V25, P1737, DOI 10.1007/s11269-010-9772-z; KOHLER M. A., 1949, BULL AMER METEOROL SOC, V30, P188; Krishnakumar KN, 2009, ATMOS ENVIRON, V43, P1940, DOI 10.1016/j.atmosenv.2008.12.053; [李春晖 Li Chunhui], 2004, [地理研究, Geographical Research], V23, P753; Liu Q, 2008, J HYDROL, V361, P330, DOI 10.1016/j.jhydrol.2008.08.002; [刘艳丽 Liu Yanli], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P75; [刘引鸽 LIU Yinge], 2007, [干旱区研究, Arid Zone Research], V24, P49; Lloyd-Hughes B, 2002, INT J CLIMATOL, V22, P1571, DOI 10.1002/joc.846; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; MCKEE TB, 1993, P 8 C APPL CLIM AN C; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Moreira EE, 2008, J HYDROL, V354, P116, DOI 10.1016/j.jhydrol.2008.03.002; Naidu CV, 1999, METEOROL APPL, V6, P395, DOI 10.1017/S1350482799001358; Oguntunde PG, 2011, J HYDROL, V411, P207, DOI 10.1016/j.jhydrol.2011.09.037; Partal T, 2006, HYDROL PROCESS, V20, P2011, DOI 10.1002/hyp.5993; Paulo AA, 2012, NAT HAZARD EARTH SYS, V12, P1481, DOI 10.5194/nhess-12-1481-2012; Paulo AA, 2008, WATER RESOUR MANAG, V22, P1277, DOI 10.1007/s11269-007-9225-5; Pereira L.S., 2009, COPING WATER SCARCIT; Phillips CL., 2008, SIGNALS SYSTEMS TRAN, V4; Rosa RD, 2010, TRATAMENTO QUALIDADE, P119; Sales JD, 1980, APPL MODELING HYDROL; Shahid S, 2008, HYDROL PROCESS, V22, P2235, DOI 10.1002/hyp.6820; She DongLi, 2011, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V42, P73; Sneyers R., STAT ANAL SERIES OBS; Storch HV, ANAL CLIMATE VARIABI; [孙智辉 Sun Zhihui], 2013, [中国沙漠, Journal of Desert Research], V33, P1560; Tabari H, 2012, HYDROL PROCESS, V26, P3351, DOI 10.1002/hyp.8460; Tabari H, 2011, J HYDROL, V396, P313, DOI 10.1016/j.jhydrol.2010.11.034; [王媛媛 Wang Yuanyuan], 2012, [自然资源学报, Journal of Natural Resources], V27, P2135; [姚雪玲 Yao Xueling], 2012, [生态学报, Acta Ecologica Sinica], V32, P4961; Zou WenXiu, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P196	45	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141662	10.1371/journal.pone.0141662	http://dx.doi.org/10.1371/journal.pone.0141662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528917	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600048
J	Allais, L; Kumar, S; Debusschere, K; Verschuere, S; Maes, T; De Smet, R; Conickx, G; De Vos, M; Laukens, D; Joos, GF; Brusselle, GG; Elewaut, D; Cuvelier, CA; Bracke, KR				Allais, Liesbeth; Kumar, Smitha; Debusschere, Karlijn; Verschuere, Stephanie; Maes, Tania; De Smet, Rebecca; Conickx, Griet; De Vos, Martine; Laukens, Debby; Joos, Guy F.; Brusselle, Guy G.; Elewaut, Dirk; Cuvelier, Claude A.; Bracke, Ken R.			The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNF Delta ARE Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED PULMONARY INFLAMMATION; CYTOKINE MESSENGER-RNA; BOWEL-DISEASE; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; EXTRAINTESTINAL MANIFESTATIONS; IMMUNE-RESPONSE; TOBACCO-SMOKE; SPONDYLOARTHRITIS	The inflammatory cytokine TNF-alpha is a central mediator in many immune-mediated diseases, such as Crohn's disease (CD), spondyloarthritis (SpA) and chronic obstructive pulmonary disease (COPD). Epidemiologic studies have shown that cigarette smoking (CS) is a prominent common risk factor in these TNF-dependent diseases. We exposed TNF Delta ARE mice; in which a systemic TNF-alpha overexpression leads to the development of inflammation; to 2 or 4 weeks of air or CS. We investigated the effect of deregulated TNF expression on CS-induced pulmonary inflammation and the effect of CS exposure on the initiation and progression of gut and joint inflammation. Upon 2 weeks of CS exposure, inflammation in lungs of TNF Delta ARE mice was significantly aggravated. However, upon 4 weeks of CS-exposure, this aggravation was no longer observed. TNF Delta ARE mice have no increases in CD4+ and CD8+ T cells and a diminished neutrophil response in the lungs after 4 weeks of CS exposure. In the gut and joints of TNF Delta ARE mice, 2 or 4 weeks of CS exposure did not modulate the development of inflammation. In conclusion, CS exposure does not modulate gut and joint inflammation in TNF Delta ARE mice. The lung responses towards CS in TNF Delta ARE mice however depend on the duration of CS exposure.	[Allais, Liesbeth; De Smet, Rebecca; Cuvelier, Claude A.] Univ Ghent, Dept Med & Forens Pathol, B-9000 Ghent, Belgium; [Kumar, Smitha; Maes, Tania; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Debusschere, Karlijn; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium; [Verschuere, Stephanie] Acad Hosp St Jan, Dept Pathol, Brugge, Belgium; [De Vos, Martine; Laukens, Debby] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Debusschere, Karlijn; Elewaut, Dirk] Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Allais, L (corresponding author), Univ Ghent, Dept Med & Forens Pathol, B-9000 Ghent, Belgium.	liesbeth.allais@ugent.be; ken.bracke@ugent.be	Maes, Tania/M-8675-2016; Elewaut, Dirk/K-6831-2014; Bracke, Ken R/GSN-7630-2022	Maes, Tania/0000-0002-3037-6928; Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505; Conickx, Griet/0000-0002-9475-8749; Elewaut, Dirk/0000-0002-7468-974X; Laukens, Debby/0000-0002-1984-5850; Allais, Liesbeth/0000-0003-2663-8566	Special Research Fund of Ghent University [01D41012]; Concerted Research Action of Ghent University [BOF/GOA 01251504]; Interuniversity Attraction Poles (IUAP) - Belgian Science Policy [P6/35, P7/30]; Fund for Scientific Research Flanders Belgium [G.0329.11N]	Special Research Fund of Ghent University(Ghent University); Concerted Research Action of Ghent University; Interuniversity Attraction Poles (IUAP) - Belgian Science Policy; Fund for Scientific Research Flanders Belgium(FWO)	This study was supported by the Special Research Fund of Ghent University (01D41012), the Concerted Research Action of Ghent University (BOF/GOA 01251504), Interuniversity Attraction Poles (IUAP) - Belgian Science Policy P6/35 and P7/30, and Fund for Scientific Research Flanders Belgium (G.0329.11N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais L, 2015, ENV MICROBIOL; Ananthakrishnan AN, 2013, GASTROENTEROL HEPATO, V9, P367; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Callhoff J, 2014, ANN RHEUM DIS; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; D'hulst AI, 2006, EUR RESPIR J, V28, P102, DOI 10.1183/09031936.06.00059305; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; De Vos M, 2011, BEST PRACT RES CL GA, V25, pS19, DOI 10.1016/S1521-6918(11)70006-3; Dupont LL, 2014, PULM PHARMACOL THER, V28, P60, DOI 10.1016/j.pupt.2013.10.003; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Hreggvidsdottir HS, 2014, MOL IMMUNOL, V57, P28, DOI 10.1016/j.molimm.2013.07.016; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Jacques P, 2012, RHEUM DIS CLIN N AM, V38, P569, DOI 10.1016/j.rdc.2012.08.012; Karczewski J, 2014, PRZ GASTROENTEROL, V9, P153, DOI 10.5114/pg.2014.43577; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Laukens D, 2006, ANN RHEUM DIS, V65, P1293, DOI 10.1136/ard.2005.047738; Laukens D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013795; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Macdonald G, 2004, RADIOTHER ONCOL, V73, P367, DOI 10.1016/j.radonc.2004.09.002; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; Montbarbon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062208; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002; Ott C, 2014, WORLD J GASTROENTERO, V20, P12269, DOI 10.3748/wjg.v20.i34.12269; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Peng JC, 2014, J DIGEST DIS, V15, P585, DOI 10.1111/1751-2980.12193; Perry E, 2014, RHEUMATOLOGY, V53, P1940, DOI 10.1093/rheumatology/keu195; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Peschon JJ, 1998, J IMMUNOL, V160, P943; Poddubnyy D, 2013, ANN RHEUM DIS, V72, P1430, DOI 10.1136/annrheumdis-2012-203148; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Raddatz D, 2005, EUR J GASTROEN HEPAT, V17, P547, DOI 10.1097/00042737-200505000-00012; Roberts H, 2014, DIGESTION, V90, P122, DOI 10.1159/000363228; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suissa S, 2008, PULM PHARMACOL THER, V21, P234, DOI 10.1016/j.pupt.2007.03.003; Tangedal S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0138-6; Thomson EM, 2012, AM J PATHOL, V180, P1413, DOI 10.1016/j.ajpath.2011.12.020; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Verschuere S, 2012, HISTOCHEM CELL BIOL, V137, P293, DOI 10.1007/s00418-011-0902-3; Verschuere S, 2011, LAB INVEST, V91, P1056, DOI 10.1038/labinvest.2011.74; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Vuillemenot BR, 2004, AM J RESP CELL MOL, V30, P438, DOI 10.1165/rcmb.2003-0062OC; Wendling D, 2013, EXPERT REV CLIN IMMU, V9, P511, DOI [10.1586/ECI.13.35, 10.1586/eci.13.35]	55	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141570	10.1371/journal.pone.0141570	http://dx.doi.org/10.1371/journal.pone.0141570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523550	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800011
J	Reynaud, Y; Millet, J; Rastogi, N				Reynaud, Yann; Millet, Julie; Rastogi, Nalin			Genetic Structuration, Demography and Evolutionary History of Mycobacterium tuberculosis LAM9 Sublineage in the Americas as Two Distinct Subpopulations Revealed by Bayesian Analyses	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; POPULATION-STRUCTURE; MOLECULAR EPIDEMIOLOGY; 1ST INSIGHT; SPOLIGOTYPING DATA; FRENCH-GUIANA; MUTATION-RATE; MIRU-VNTRS; DIVERSITY; COMPLEX	Tuberculosis (TB) remains broadly present in the Americas despite intense global efforts for its control and elimination. Starting from a large dataset comprising spoligotyping (n = 21183 isolates) and 12-loci MIRU-VNTRs data (n = 4022 isolates) from a total of 31 countries of the Americas (data extracted from the SITVIT2 database), this study aimed to get an overview of lineages circulating in the Americas. A total of 17119 (80.8%) strains belonged to the Euro-American lineage 4, among which the most predominant genotypic family belonged to the Latin American and Mediterranean (LAM) lineage (n = 6386, 30.1% of strains). By combining classical phylogenetic analyses and Bayesian approaches, this study revealed for the first time a clear genetic structuration of LAM9 sublineage into two subpopulations named LAM9C1 and LAM9C2, with distinct genetic characteristics. LAM9C1 was predominant in Chile, Colombia and USA, while LAM9C2 was predominant in Brazil, Dominican Republic, Guadeloupe and French Guiana. Globally, LAM9C2 was characterized by higher allelic richness as compared to LAM9C1 isolates. Moreover, LAM9C2 sublineage appeared to expand close to twenty times more than LAM9C1 and showed older traces of expansion. Interestingly, a significant proportion of LAM9C2 isolates presented typical signature of ancestral LAM-RDRio MIRU-VNTR type (224226153321). Further studies based on Whole Genome Sequencing of LAM strains will provide the needed resolution to decipher the biogeographical structure and evolutionary history of this successful family.	[Reynaud, Yann; Millet, Julie; Rastogi, Nalin] WHO, Supranat TB Reference Lab, TB & Mycobacteria Unit, Inst Pasteur Guadeloupe, Abymes, Guadeloupe, France	World Health Organization	Reynaud, Y (corresponding author), WHO, Supranat TB Reference Lab, TB & Mycobacteria Unit, Inst Pasteur Guadeloupe, Abymes, Guadeloupe, France.	yreynaud@pasteur-guadeloupe.fr; nrastogi@pasteur-guadeloupe.fr	RASTOGI, NALIN/AAP-1958-2020; Reynaud, Yann/ABD-7936-2021	RASTOGI, NALIN/0000-0002-7199-7747; Reynaud, Yann/0000-0002-1966-7249	Institut Pasteur	Institut Pasteur(European Commission)	Yann Reynaud was awarded a Calmette and Yersin postdoctoral fellowship by the Institut Pasteur. No additional external funding was received for this study	[Anonymous], 2014, TRACER V1 6; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Baboolal S, 2009, J CLIN MICROBIOL, V47, P1911, DOI 10.1128/JCM.00535-09; Santos ACB, 2013, INT J MYCOBACT, V2, P156, DOI 10.1016/j.ijmyco.2013.06.003; Beaumont MA, 1999, GENETICS, V153, P2013; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caceres O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112789; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Balcells ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118007; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferdinand S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-364; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Guernier V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-46; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lopes JS, 2013, INFECT GENET EVOL, V18, P238, DOI 10.1016/j.meegid.2013.04.028; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Millet J, 2011, BMC P, V5, pP81; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718496; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/689852; Millet J, 2011, J CLIN MICROBIOL, V49, P2685, DOI 10.1128/JCM.00708-11; Millet J, 2009, INFECT GENET EVOL, V9, P1336, DOI 10.1016/j.meegid.2009.09.006; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Ocheretina O, 2012, REV PANAM SALUD PUBL, V31, P221, DOI 10.1590/S1020-49892012000300006; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Pritchard JK, 2000, GENETICS, V155, P945; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Storz JF, 2002, EVOLUTION, V56, P154; Streit E, 2015, INFECT GENET EVOL, V30, P114, DOI 10.1016/j.meegid.2014.12.015; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Valcheva V, 2015, INT J MYCOBACT, V4, P191, DOI 10.1016/j.ijmyco.2015.04.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2014, WHOHTMTB201408	60	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140911	10.1371/journal.pone.0140911	http://dx.doi.org/10.1371/journal.pone.0140911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517715	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800012
J	Akiyama, Y; Agata, K; Inoue, T				Akiyama, Yoshitaro; Agata, Kiyokazu; Inoue, Takeshi			Spontaneous Behaviors and Wall-Curvature Lead to Apparent Wall Preference in Planarian	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DUGESIA-JAPONICA; SIGNALING SYSTEM; NEURAL-NETWORK; REGENERATION; LOCOMOTION; BRAIN; CELLS; IDENTIFICATION; REPRODUCTION	The planarian Dugesia japonica tends to stay near the walls of its breeding containers and experimental dishes in the laboratory, a phenomenon called "wall preference". This behavior is thought to be important for environmental adaptation, such as hiding by planarians in nature. However, the mechanisms regulating wall-preference behavior are not well understood, since this behavior occurs in the absence of any particular stimulation. Here we show the mechanisms of wall-preference behavior. Surprisingly, planarian wall-preference behavior was also shown even by the head alone and by headless planarians. These results indicate that planarian "wall-preference" behavior only appears to be a "preference" behavior, and is actually an outcome of spontaneous behaviors, rather than of brain function. We found that in the absence of environmental cues planarians moved basically straight ahead until they reached a wall, and that after reaching a wall, they changed their direction of movement to one tangential to the wall, suggesting that this spontaneous behavior may play a critical role in the wall preference. When we tested another spontaneous behavior, the wigwag movement of the planarian head, using computer simulation with various wigwag angles and wigwag intervals, large wigwag angle and short wigwag interval reduced wall-preference behavior. This indicated that wigwag movement may determine the probability of staying near the wall or leaving the wall. Furthermore, in accord with this simulation, when we tested planarian wall-preference behavior using several assay fields with different curvature of the wall, we found that concavity and sharp curvature of walls negatively impacted wall preference by affecting the permissible angle of the wigwag movement. Together, these results indicate that planarian wall preference may be involuntarily caused by the combination of two spontaneous planarian behaviors: moving straight ahead until reaching a wall and then moving along it in the absence of environmental cues, and wigwag movements of the head.	[Akiyama, Yoshitaro; Agata, Kiyokazu; Inoue, Takeshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan	Kyoto University	Inoue, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan.	inoue@mdb.biophys.kyoto-u.ac.jp	Inoue, Takeshi/S-5623-2019	Inoue, Takeshi/0000-0003-3289-4478; Agata, Kiyokazu/0000-0002-5195-2576	Takeda Science Foundation funds;  [22124001];  [22124002];  [22700336];  [15K07];  [148]	Takeda Science Foundation funds; ; ; ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22124001, 22124002) to KA, a Grant-in-Aid for Scientific Research (22700336, 15K07 and148) to TI, and The Takeda Science Foundation funds to TI.	Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Blackiston D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014370; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Hoshi M, 2003, INTEGR COMP BIOL, V43, P242, DOI 10.1093/icb/43.2.242; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Inoue T, 2007, DEVELOPMENT, V134, P1679, DOI 10.1242/dev.02835; Inoue T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0010-z; Inoue T, 2014, J NEUROSCI, V34, P15701, DOI 10.1523/JNEUROSCI.5379-13.2014; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Nishimura K, 2008, NEUROSCIENCE, V153, P1103, DOI 10.1016/j.neuroscience.2008.03.026; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nishimura K, 2008, NEUROCHEM INT, V53, P184, DOI 10.1016/j.neuint.2008.09.006; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Paskin TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114708; Pearl R, 1903, Q J MICROSC SCI, V46, P509; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Sakurai T, 2012, INT J DEV BIOL, V56, P173, DOI 10.1387/ijdb.113439ts; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Shibata T, 2013, BIOPHYS J, V105, P2199, DOI 10.1016/j.bpj.2013.09.024; Shibata T, 2012, J CELL SCI, V125, P5138, DOI 10.1242/jcs.108373; Stringer CE, 1917, P NATL ACAD SCI USA, V3, P691, DOI 10.1073/pnas.3.12.691; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Taliaferro WH, 1920, J EXP ZOOL, V31, P59; Tazaki A, 1999, BIOCHEM BIOPH RES CO, V260, P426, DOI 10.1006/bbrc.1999.0933; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; Umesono Y, 2011, EUR J NEUROSCI, V34, P863, DOI 10.1111/j.1460-9568.2011.07819.x; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; Walter HE, 1907, J EXP ZOOL, V5, P35, DOI 10.1002/jez.1400050104; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221	39	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142214	10.1371/journal.pone.0142214	http://dx.doi.org/10.1371/journal.pone.0142214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539715	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800069
J	Jackrel, SL; Wootton, JT				Jackrel, Sara L.; Wootton, J. Timothy			Diversity of Riparian Plants among and within Species Shapes River Communities	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION; ECOSYSTEM; BIODIVERSITY; TRAITS	Organismal diversity among and within species may affect ecosystem function with effects transmitting across ecosystem boundaries. Whether recipient communities adjust their composition, in turn, to maximize their function in response to changes in donor composition at these two scales of diversity is unknown. We use small stream communities that rely on riparian subsidies as a model system. We used leaf pack experiments to ask how variation in plants growing beside streams in the Olympic Peninsula of Washington State, USA affects stream communities via leaf subsidies. Leaves from red alder (Alnus rubra), vine maple (Acer cinereus), bigleaf maple (Acer macrophyllum) and western hemlock (Tsuga heterophylla) were assembled in leaf packs to contrast low versus high diversity, and deployed in streams to compare local versus non-local leaf sources at the among and within species scales. Leaves from individuals within species decomposed at varying rates; most notably thin leaves decomposed rapidly. Among deciduous species, vine maple decomposed most rapidly, harbored the least algal abundance, and supported the greatest diversity of aquatic invertebrates, while bigleaf maple was at the opposite extreme for these three metrics. Recipient communities decomposed leaves from local species rapidly: leaves from early successional plants decomposed rapidly in stream reaches surrounded by early successional forest and leaves from later successional plants decomposed rapidly adjacent to later successional forest. The species diversity of leaves inconsistently affected decomposition, algal abundance and invertebrate metrics. Intraspecific diversity of leaf packs also did not affect decomposition or invertebrate diversity. However, locally sourced alder leaves decomposed more rapidly and harbored greater levels of algae than leaves sourced from conspecifics growing in other areas on the Olympic Peninsula, but did not harbor greater aquatic invertebrate diversity. In contrast to alder, local intraspecific differences via decomposition, algal or invertebrate metrics were not observed consistently among maples. These results emphasize that biodiversity of riparian subsidies at the within and across species scale have the potential to affect aquatic ecosystems, although there are complex species- specific effects.	[Jackrel, Sara L.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Jackrel, SL (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	sjackrel@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344; Jackrel, Sara/0000-0001-7326-4996	National Science Foundation Graduate Research Fellowship Program fellowship; University of Chicago Hinds Fund grant; ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter; Olympic National Resources Grant; NSF [DEB 09-19420]	National Science Foundation Graduate Research Fellowship Program fellowship; University of Chicago Hinds Fund grant; ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter; Olympic National Resources Grant; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation Graduate Research Fellowship Program fellowship, University of Chicago Hinds Fund grant, and ARCS1 (Achievement Rewards for College Scientists) Foundation, Inc.'s Scholar Illinois Chapter [2014 and 2015] to S.L. Jackrel and an Olympic National Resources Grant and NSF grant DEB 09-19420 to J.T. Wootton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fonte SJ, 2004, BIOTROPICA, V36, P474, DOI 10.1111/j.1744-7429.2004.tb00343.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hutchens JJ, 2000, AM MIDL NAT, V143, P397, DOI 10.1674/0003-0031(2000)143[0397:EOFDBT]2.0.CO;2; IRONS JG, 1991, CAN J FISH AQUAT SCI, V48, P442, DOI 10.1139/f91-058; Jackrel SL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2522; Jackrel SL, 2014, ECOLOGY, V95, P37, DOI 10.1890/13-0804.1; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Merritt R. W., 2008, INTRO AQUATIC INSECT; Schindler MH, 2009, ECOLOGY, V90, P1641, DOI 10.1890/08-1597.1; Swan CM, 2009, ECOLOGY, V90, P1650, DOI 10.1890/08-0329.1; TRISKA FJ, 1976, ECOLOGY, V57, P783, DOI 10.2307/1936191; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WARD GM, 1979, ECOLOGY, V60, P57, DOI 10.2307/1936468; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051839; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043561	23	8	8	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142362	10.1371/journal.pone.0142362	http://dx.doi.org/10.1371/journal.pone.0142362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539714	Green Published, gold			2022-12-27	WOS:000364303800089
J	Kaiser, A; Langer, B; Przyborski, J; Kersting, D; Kruger, M				Kaiser, Annette; Langer, Barbara; Przyborski, Jude; Kersting, David; Krueger, Mirko			A Putative Non-Canonical Ras-Like GTPase from P. falciparum: Chemical Properties and Characterization of the Protein	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SCHISTOSOMA-MANSONI; COUPLED RECEPTOR; BINDING PROTEINS; IDENTIFICATION; COMMITMENT; EXPRESSION	During its development the malaria parasite P. falciparum has to adapt to various different environmental contexts. Key cellular mechanisms involving G-protein coupled signal transduction chains are assumed to act at these interfaces. Heterotrimeric G-proteins are absent in Plasmodium. We here describe the first cloning and expression of a putative, non-canonical Ras-like G protein (acronym PfG) from Plasmodium. PfG reveals an open reading frame of 2736 bp encoding a protein of 912 amino acids with a theoretical pI of 8.68 and a molecular weight of 108.57 kDa. Transcript levels and expression are significantly increased in the erythrocytic phase in particular during schizont and gametocyte formation. Most notably, PfG has GTP binding capacity and GTPase activity due to an EngA2 domain present in small Ras-like GTPases in a variety of Bacillus species and Mycobacteria. By contrast, plasmodial PfG is divergent from any human alpha-subunit. PfG was expressed in E. coli as a histidine-tagged fusion protein and was stable only for 3.5 hours. Purification was only possible under native conditions by Nickel-chelate chromatography and subsequent separation by Blue Native PAGE. Binding of a fluorescent GTP analogue BODIPY1FL guanosine 5'O-(thiotriphosphate) was determined by fluorescence emission. Mastoparan stimulated GTP binding in the presence of Mg2+. GTPase activity was determined colorimetrically. Activity expressed as absolute fluorescence was 50% higher for the human paralogue than the activity of the parasitic enzyme. The PfG protein is expressed in the erythrocytic stages and binds GTP after immunoprecipitation. Immunofluorescence using specific antiserum suggests that PfG localizes to the parasite cytosol. The current data suggest that the putitative, Ras-like G-protein might be involved in a non-canonical signaling pathway in Plasmodium. Research on the function of PfG with respect to pathogenesis and antimalarial chemotherapy is currently under way.	[Kaiser, Annette; Langer, Barbara; Kersting, David; Krueger, Mirko] Univ Duisburg Essen, Inst Pharmacogenet, Med Res Ctr, D-45147 Essen, Germany; [Langer, Barbara] Inst Pharmacol, D-45147 Essen, Germany; [Przyborski, Jude] Univ Marburg, Dept Parasitol, FB Biol, D-34043 Marburg, Germany	University of Duisburg Essen; Philipps University Marburg	Kaiser, A (corresponding author), Univ Duisburg Essen, Inst Pharmacogenet, Med Res Ctr, Hufelandstr 55, D-45147 Essen, Germany.	kaiser@microbiology-bonn.de	Kersting, David/ABA-5198-2020; Przyborski, Jude/ABC-9498-2021	Kersting, David/0000-0002-8451-1830; Przyborski, Jude/0000-0002-3494-7767; Kaiser, Annette/0000-0001-7873-3958	DAAD, Hans und Gertie Fischer Stiftung [56154387]	DAAD, Hans und Gertie Fischer Stiftung	DAAD No. 56154387, Hans und Gertie Fischer Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034571; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Auburn S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010017; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Blisnick T, 2005, MOL BIOCHEM PARASIT, V141, P39, DOI 10.1016/j.molbiopara.2005.01.013; Bosch ED, 2012, PLOS PATHOG, V8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; El-Shehabi F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilchrist A, 2007, TRENDS PHARMACOL SCI, V28, P431, DOI 10.1016/j.tips.2007.06.012; GILLISON SL, 1994, DIABETES, V43, P24, DOI 10.2337/diabetes.43.1.24; Hall A, GTPASES FRONTIERS MO; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Huber SM, 2012, MICROBES INFECT, V14, P779, DOI 10.1016/j.micinf.2012.04.009; Jameson EE, 2005, J BIOL CHEM, V280, P7712, DOI 10.1074/jbc.M413810200; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Lolupiman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089424; MANSOUR JM, 1989, MOL BIOCHEM PARASIT, V36, P11, DOI 10.1016/0166-6851(89)90195-3; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Miao J, 2013, EXP PARASITOL, V135, P541, DOI 10.1016/j.exppara.2013.09.010; Millholland MG, 2013, CELL HOST MICROBE, V13, P15, DOI 10.1016/j.chom.2012.12.001; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Peatey CL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-134; Salazar E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039769; Schwank S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014470; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shields MJ, 2009, BIOCHEMISTRY-US, V48, P10793, DOI 10.1021/bi901074h; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Sprague RS, 2011, ACTA PHYSIOL, V202, P285, DOI 10.1111/j.1748-1716.2010.02182.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Susa MH, 1992, INT J MOL MED, V3, P115; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang JY, 2003, P NATL ACAD SCI USA, V100, P3035, DOI 10.1073/pnas.262792899; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004	54	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140994	10.1371/journal.pone.0140994	http://dx.doi.org/10.1371/journal.pone.0140994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540393	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800007
J	Mahdi, LK; Van der Hoek, MB; Ebrahimie, E; Paton, JC; Ogunniyi, AD				Mahdi, Layla K.; Van der Hoek, Mark B.; Ebrahimie, Esmaeil; Paton, James C.; Ogunniyi, Abiodun D.			Characterization of Pneumococcal Genes Involved in Bloodstream Invasion in a Mouse Model	PLOS ONE			English	Article							SERINE-PROTEASE PRTA; STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; VIRULENCE PROTEINS; NASOPHARYNGEAL COLONIZATION; CAPSULAR POLYSACCHARIDE; COMPARATIVE EFFICACY; OXIDATIVE STRESS; MICROARRAY DATA; PHASE VARIATION	Streptococcus pneumoniae (the pneumococcus) continues to account for significant morbidity and mortality worldwide, causing life-threatening diseases such as pneumonia, bacteremia and meningitis, as well as less serious infections such as sinusitis, conjunctivitis and otitis media. Current polysaccharide vaccines are strictly serotype-specific and also drive the emergence of non-vaccine serotype strains. In this study, we used microarray analysis to compare gene expression patterns of either serotype 4 or serotype 6A pneumococci in the nasopharynx and blood of mice, as a model to identify genes involved in invasion of blood in the context of occult bacteremia in humans. In this manner, we identified 26 genes that were significantly up-regulated in the nasopharynx and 36 genes that were significantly up-regulated in the blood that were common to both strains. Gene Ontology classification revealed that transporter and DNA binding (transcription factor) activities constitute the significantly different molecular functional categories for genes up-regulated in the nasopharynx and blood. Targeted mutagenesis of selected genes from both niches and subsequent virulence and pathogenesis studies identified the manganese-dependent superoxide dismutase (SodA) as most likely to be essential for colonization, and the cell wall-associated serine protease (PrtA) as important for invasion of blood. This work extends our previous analyses and suggests that both PrtA and SodA warrant examination in future studies aimed at prevention and/or control of pneumococcal disease.	[Mahdi, Layla K.; Paton, James C.; Ogunniyi, Abiodun D.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Van der Hoek, Mark B.] Univ Adelaide, Adelaide Microarray Ctr, Adelaide, SA, Australia; [Van der Hoek, Mark B.] SA Pathol, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Biol Sci, Dept Genet & Evolut, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; SA Pathology; University of Adelaide	Ogunniyi, AD (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	david.ogunniyi@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Ogunniyi, Abiodun/0000-0001-9308-5629; Mahdi, Layla/0000-0002-5878-8385	Meningitis Research Foundation [0802.0]; National Health and Medical Research Council of Australia (NHMRC) [565526, 627142]; Wellcome Trust	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Meningitis Research Foundation (GB; www.meningitis.org) Research Grant 0802.0 to ADO, JCP and LKM, as well as by National Health and Medical Research Council of Australia (NHMRC; http://www.nhmrc.gov.au) Program Grant 565526 to JCP, a Senior Principal Research Fellow, and Project Grant 627142 to JCP and ADO. The authors acknowledge B mu G@S (the Bacterial Microarray Group at St George's, University of London; www.bugs.sgul.ac.uk) for supply of the microarray slides and advice and The Wellcome Trust for funding the multi-collaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; ARTHUR M, 1995, GENE, V154, P87, DOI 10.1016/0378-1119(94)00851-I; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; de Stoppelaar SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080062; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hendriksen WT, 2009, MICROBIOL-SGM, V155, P1569, DOI 10.1099/mic.0.025072-0; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kuppermann N, 1999, PEDIATR CLIN N AM, V46, P1073, DOI 10.1016/S0031-3955(05)70176-0; Kwon HY, 2004, INFECT IMMUN, V72, P5646, DOI 10.1128/IAI.72.10.5646-5653.2004; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; LOCK RA, 1992, MICROB PATHOGENESIS, V12, P137, DOI 10.1016/0882-4010(92)90116-6; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Paton JC, 2004, PNEUMOCCOCUS, P382; Pettigrew MM, 2014, INFECT IMMUN, V82, P4607, DOI 10.1128/IAI.02225-14; Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 2005, INFECT IMMUN, V73, P7775, DOI 10.1128/IAI.73.11.7775-7778.2005; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization Media Centre, 2013, PNEUMONIA; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Zysk G, 2000, INFECT IMMUN, V68, P3740, DOI 10.1128/IAI.68.6.3740-3743.2000; Zysk G, 2003, J INFECT DIS, V187, P330, DOI 10.1086/367701	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141816	10.1371/journal.pone.0141816	http://dx.doi.org/10.1371/journal.pone.0141816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539717	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800029
J	Mrakic-Sposta, S; Gussoni, M; Moretti, S; Pratali, L; Giardini, G; Tacchini, P; Dellanoce, C; Tonacci, A; Mastorci, F; Borghini, A; Montorsi, M; Vezzoli, A				Mrakic-Sposta, Simona; Gussoni, Maristella; Moretti, Sarah; Pratali, Lorenza; Giardini, Guido; Tacchini, Philippe; Dellanoce, Cinzia; Tonacci, Alessandro; Mastorci, Francesca; Borghini, Andrea; Montorsi, Michela; Vezzoli, Alessandra			Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques	PLOS ONE			English	Article							ENDURANCE EXERCISE; SKELETAL-MUSCLE; IMMUNE-SYSTEM; REDOX BIOLOGY; STRESS; NITRITE; PLASMA; MECHANISMS; NEOPTERIN; RUN	Purpose Aiming to gain a detailed insight into the physiological mechanisms involved under extreme conditions, a group of experienced ultra-marathon runners, performing the mountain Tor des Geants (R) ultra-marathon: 330 km trail-run in Valle d'Aosta, 24000 m of positive and negative elevation changes, was monitored. ROS production rate, antioxidant capacity, oxidative damage and inflammation markers were assessed, adopting micro-invasive analytic techniques. Methods Forty-six male athletes (45.04 +/- 8.75 yr, 72.6 +/- 8.4 kg, 1.76 +/- 0.05 m) were tested. Capillary blood and urine were collected before (Pre-), in the middle (Middle-) and immediately after (Post-) Race. Samples were analyzed for: Reactive Oxygen Species (ROS) production by Electron Paramagnetic Resonance; Antioxidant Capacity by Electrochemistry; oxidative damage (8-hydroxy-2-deoxy Guanosine: 8-OH-dG; 8-isoprostane: 8-isoPGF2 alpha) and nitric oxide metabolites by enzymatic assays; inflammatory biomarkers (plasma and urine interleukin-6: IL-6-P and IL-6-U) by enzyme-linked immunosorbent assays (ELISA); Creatinine and Neopterin by HPLC, hematologic (lactate, glucose and hematocrit) and urine parameters by standard analyses. Results Twenty-five athletes finished the race, while twenty-one dropped out of it. A significant increase (Post-Race vs Pre) of the ROS production rate (2.20 +/- 0.27 vs 1.65 +/- 0.22 mu mol. min-1), oxidative damage biomarkers (8-OH-dG: 6.32 +/- 2.38 vs 4.16 +/- 1.25 ng.mg(-1) Creatinine and 8-isoPGF2 alpha: 1404.0 +/- 518.30 vs 822.51 +/- 448.91 pg.mg(-1)Creatinine), inflammatory state (IL-6-P: 66.42 +/- 36.92 vs 1.29 +/- 0.54 pg.mL(-1) and IL-6-U: 1.33 +/- 0.56 vs 0.71 +/- 0.17 pg.mL(-1)) and lactate production (+190%), associated with a decrease of both antioxidant capacity (-7%) and renal function (i.e. Creatinine level +76%) was found. Conclusions The used micro-invasive analytic methods allowed us to perform most of them before, during and immediately after the race directly in the field, by passing the need of storing and transporting samples for further analysis. Considered altogether the investigated variables showed up that exhaustive and prolonged exercise not only promotes the generation of ROS but also induces oxidative stress, transient renal impairment and inflammation.	[Mrakic-Sposta, Simona; Moretti, Sarah; Vezzoli, Alessandra] CNR, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy; [Gussoni, Maristella] Univ Milan, Dept Pathophysiol & Transplantat, Physiol Sect, Milan, Italy; [Pratali, Lorenza; Dellanoce, Cinzia; Tonacci, Alessandro; Mastorci, Francesca; Borghini, Andrea] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Giardini, Guido] Valle dAosta Reg Hosp Umberto Parini, Neurol & Neurophysiol Dept, Mt Med Ctr, Aosta, Italy; [Tacchini, Philippe] EDEL Therapeut SA, PSE EPFL B, CH-1015 Lausanne, Switzerland; [Montorsi, Michela] Univ Telemat S Raffaele Roma, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Universita Telematica San Raffaele	Vezzoli, A (corresponding author), CNR, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy.	alessandra.vezzoli@ibfm.cnr.it	Montorsi, Michela/K-7299-2016; moretti, sarah/K-9953-2016; Mrakic-Sposta, Simona/AAA-2991-2019; Tonacci, Alessandro/J-7996-2016; Pratali, Lorenza/AAQ-6094-2020	Montorsi, Michela/0000-0001-5152-761X; moretti, sarah/0000-0002-4260-7404; Mrakic-Sposta, Simona/0000-0001-7359-2690; Tonacci, Alessandro/0000-0001-8335-5541; Borghini, Andrea/0000-0003-1061-8309				Bailey DM, 2007, FREE RADICAL RES, V41, P182, DOI 10.1080/10715760601028867; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Brun JF, 2010, BIORHEOLOGY, V47, P95, DOI 10.3233/BIR-2010-0563; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Comassi M, 2015, INTERN MED J, V45, P74, DOI 10.1111/imj.12625; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Dikalov SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P218, DOI 10.1016/S0003-9861(02)00064-4; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fernstrom M, 2007, J APPL PHYSIOL, V102, P1844, DOI 10.1152/japplphysiol.01173.2006; Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Halliwell B., 2007, FREE RADICALS BIOL M; HOLLEY AE, 1993, BRIT MED BULL, V49, P494, DOI 10.1093/oxfordjournals.bmb.a072626; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; KANTER MM, 1993, J APPL PHYSIOL, V74, P965, DOI 10.1152/jappl.1993.74.2.965; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Klapcinska B, 2013, EUR J APPL PHYSIOL, V113, P2781, DOI 10.1007/s00421-013-2714-8; Larsen FJ, 2012, FREE RADICAL BIO MED, V53, P1919, DOI 10.1016/j.freeradbiomed.2012.08.580; Lippi G, 2012, BLOOD TRANSFUS-ITALY, V10, P377, DOI 10.2450/2012.0167-11; Liu JF, 2005, ANAL CHEM, V77, P7687, DOI 10.1021/ac0509298; Liu JF, 2006, ANAL CHEM, V78, P6879, DOI 10.1021/ac0608624; Liu ML, 1999, AM J PHYSIOL-ENDOC M, V276, pE1083, DOI 10.1152/ajpendo.1999.276.6.E1083; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Mrakic-Sposta S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804794; Mrakic-Sposta S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/306179; Mrakic-Sposta S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/973927; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nieman DC, 2003, INT J SPORTS MED, V24, P541; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Radak Z, 2003, EUR J CLIN INVEST, V33, P726, DOI 10.1046/j.1365-2362.2003.01202.x; Reichhold S, 2009, MUTAT RES-REV MUTAT, V682, P28, DOI 10.1016/j.mrrev.2009.02.002; REID RI, 1987, BRIT J UROL, V59, P133, DOI 10.1111/j.1464-410X.1987.tb04803.x; Robach P, 2014, SCAND J MED SCI SPOR, V24, P18, DOI 10.1111/j.1600-0838.2012.01481.x; Rodriguez-Plaza L G, 1997, J Cardiovasc Risk, V4, P367, DOI 10.1097/00043798-199710000-00009; Sajfutdinov R.G., 2001, ELECT PARAMAGNETIC R; Scotney B, 2014, CLIN J SPORT MED; Shao ZL, 2014, AM J CARDIOL, V113, P1839, DOI 10.1016/j.amjcard.2014.03.016; Steensberg A, 2002, EUR J APPL PHYSIOL, V87, P38, DOI 10.1007/s00421-002-0584-6; Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356; Sugama K, 2015, EXERC IMMUNOL REV, V21, P130; Sugama K, 2013, EXERC IMMUNOL REV, V19, P29; Tacchini P, 2013, ELECTROANAL, V25, P922, DOI 10.1002/elan.201200590; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V27, P75, DOI 10.1016/j.niox.2012.05.003; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; TSIKAS D, 1994, J CHROMATOGR B, V661, P185, DOI 10.1016/0378-4347(94)00374-2; Turner JE, 2014, BIOCHEM SOC T, V42, P989, DOI 10.1042/BST20140120; Turner JE, 2011, MED SCI SPORT EXER, V43, P1770, DOI 10.1249/MSS.0b013e31821240bb; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassalle C, 2014, BIOMARK MED, V8, P881, DOI [10.2217/BMM.13.152, 10.2217/bmm.13.152]	56	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141780	10.1371/journal.pone.0141780	http://dx.doi.org/10.1371/journal.pone.0141780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540518	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800028
J	Siman, R; Cocca, R; Dong, Y				Siman, Robert; Cocca, Ryan; Dong, Yina			The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy	PLOS ONE			English	Article							ENTORHINAL CORTEX NEURONS; MAMMALIAN TARGET; MEMORY IMPAIRMENT; IN-VITRO; TAU; AUTOPHAGY; DISEASE; PATHOLOGY; TOXICITY; STIMULATION	The perforant pathway projection from layer II of the entorhinal cortex to the hippocampal dentate gyrus is especially important for long-term memory formation, and is preferentially vulnerable to developing a degenerative tauopathy early in Alzheimer's disease (AD) that may spread over time trans-synaptically. Despite the importance of the perforant pathway to the clinical onset and progression of AD, a therapeutic has not been identified yet that protects it from tau-mediated toxicity. Here, we used an adeno-associated viral vector-based mouse model of early-stage AD-type tauopathy to investigate effects of the mTOR inhibitor and autophagy stimulator rapamycin on the tau-driven loss of perforant pathway neurons and synapses. Focal expression of human tau carrying a P301L mutation but not eGFP as a control in layer II of the lateral entorhinal cortex triggered rapid degeneration of these neurons, loss of lateral perforant pathway synapses in the dentate gyrus outer molecular layer, and activation of neuroinflammatory microglia and astroglia in the two locations. Chronic systemic rapamycin treatment partially inhibited phosphorylation of a mechanistic target of rapamycin substrate in brain and stimulated LC3 cleavage, a marker of autophagic flux. Compared with vehicle-treated controls, rapamycin protected against the tau-induced neuronal loss, synaptotoxicity, reactive microgliosis and astrogliosis, and activation of innate neuroimmunity. It did not alter human tau mRNA or total protein levels. Finally, rapamycin inhibited trans-synaptic transfer of human tau expression to the dentate granule neuron targets for the perforant pathway, likely by preventing the synaptic spread of the AAV vector in response to pathway degeneration. These results identify systemic rapamycin as a treatment that protects the entorhinal cortex and perforant pathway projection from tau-mediated neurodegeneration, axonal and synapse loss, and neuroinflammatory reactive gliosis. The findings support the potential for slowing the progression of AD by abrogating tau-mediated neurotoxicity at its earliest neuropathological stages.	[Siman, Robert; Cocca, Ryan; Dong, Yina] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Siman, R (corresponding author), Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA.	siman@mail.med.upenn.edu			Alzheimer's Association [ZEN-12-239284]; NIH [DK019525]	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by a grant from the Alzheimer's Association to RS (ZEN-12-239284). The Penn Viral Vector Core facility generated, purified, sequenced, and titrated the AAV vectors. The Core is supported in part by NIH grant DK019525 to Dr. Mitchell Lazar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; COLEMAN PD, 1987, J COMP NEUROL, V266, P300, DOI 10.1002/cne.902660213; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fath T, 2002, J NEUROSCI, V22, P9733; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Jiang T, 2014, NEUROPHARMACOLOGY, V85, P121, DOI 10.1016/j.neuropharm.2014.05.032; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Lee VMY, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006437; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ozcelik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062459; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Robinson JL, 2014, BRAIN, V137, P2578, DOI 10.1093/brain/awu190; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Schultz H, 2012, J NEUROSCI, V32, P4716, DOI 10.1523/JNEUROSCI.5126-11.2012; Siman R, 2004, NEUROSCIENCE, V129, P615, DOI 10.1016/j.neuroscience.2004.08.028; Siman R, 2013, J NEUROPATH EXP NEUR, V72, P1062, DOI 10.1097/NEN.0000000000000006; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; STAUBLI U, 1984, P NATL ACAD SCI-BIOL, V81, P5885, DOI 10.1073/pnas.81.18.5885; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; TIMM F, 1958, Z ZELLFORSCH MIK ANA, V48, P548, DOI 10.1007/BF00342730; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018	59	85	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142340	10.1371/journal.pone.0142340	http://dx.doi.org/10.1371/journal.pone.0142340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540269	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800086
J	Wang, J; Jiang, ZL; Lam, W; Gullen, EA; Yu, Z; Wei, Y; Wang, LH; Zeiss, C; Beck, A; Cheng, EC; Wu, CF; Cheng, YC; Zhang, YX				Wang, Jing; Jiang, Zaoli; Lam, Wing; Gullen, Elizabeth A.; Yu, Zhe; Wei, Ying; Wang, Lihui; Zeiss, Caroline; Beck, Amanda; Cheng, Ee-Chun; Wu, Chunfu; Cheng, Yung-Chi; Zhang, Yixuan			Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug	PLOS ONE			English	Article							DNA-DAMAGE; CELLS; TROXACITABINE; ACTIVATION; METABOLITE; EXPRESSION; CANCER; KINASE	Malformin C, a fungal cyclic pentapeptide, has been claimed to have anti-cancer potential, but no in vivo study was available to substantiate this property. Therefore, we conducted in vitro and in vivo experiments to investigate its anti-cancer effects and toxicity. Our studies showed Malformin C inhibited Colon 38 and HCT 116 cell growth dose-dependently with an IC50 of 0.27 +/- 0.07 mu M and 0.18 +/- 0.023 mu M respectively. This inhibition was explicated by Malformin C's effect on G2/M arrest. Moreover, we observed up-regulated expression of phospho-histone H2A.X, p53, cleaved CASPASE 3 and LC3 after Malformin C treatment, while the apoptosis assay indicated an increased population of necrotic and late apoptotic cells. In vivo, the pathological study exhibited the acute toxicity of Malformin C at lethal dosage in BDF1 mice might be caused by an acute yet subtle inflammatory response, consistent with elevated IL-6 in the plasma cytokine assay. Further anti-tumor and toxicity experiments proved that 0.3mg/kg injected weekly was the best therapeutic dosage of Malformin C in Colon 38 xenografted BDF1 mice, whereas 0.1mg/kg every other day showed no effect with higher resistance, and 0.9mg/kg per week either led to fatal toxicity in seven-week old mice or displayed no advantage over 0.3mg/kg group in nine-week old mice. Overall, we conclude that Malformin C arrests Colon 38 cells in G2/M phase and induces multiple forms of cell death through necrosis, apoptosis and autophagy. Malformin C has potent cell growth inhibition activity, but the therapeutic index is too low to be an anti-cancer drug.	[Wang, Jing; Jiang, Zaoli; Lam, Wing; Gullen, Elizabeth A.; Cheng, Ee-Chun; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Yu, Zhe; Wei, Ying; Wang, Lihui; Wu, Chunfu; Zhang, Yixuan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Zeiss, Caroline; Beck, Amanda] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Wang, Jing] Beijing Univ Chinese Med, Dept Hematol & Oncol, Dongzhimen Hosp, Beijing, Peoples R China	Yale University; Shenyang Pharmaceutical University; Yale University; Beijing University of Chinese Medicine	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	yccheng@yale.edu; zhangyxzsh@163.com	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110; Wang, Jing/0000-0002-2735-7283	NCI [CA-154295]; Yung-Chi Cheng's lab at Yale University; NATIONAL CANCER INSTITUTE [P01CA154295] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yung-Chi Cheng's lab at Yale University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Yung-Chi Cheng is a Fellow of the National Foundation for Cancer Research, USA. Part of his salary is from the NCI grant from CA-154295. Most of the research support is funded by a trust fund to Yung-Chi Cheng's lab at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderegg RJ, 1976, J AM CHEM SOC, V26, P6; Beidler DR, 1996, CANCER RES, V56, P9; BODANSZK.M, 1974, P NATL ACAD SCI USA, V71, P2791, DOI 10.1073/pnas.71.7.2791; Chen HX, 1993, CANCER RES, V53, P4; CURTIS RW, 1958, PLANT PHYSIOL, V33, P17, DOI 10.1104/pp.33.1.17; CURTIS RW, 1958, SCIENCE, V128, P661, DOI 10.1126/science.128.3325.661; Ferguson PJ, 1988, CANCER RES, V48, P9; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P13; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Giles FJ, 2002, J CLIN ONCOLOGY OFFI, V20, P8; Grove KL, 1996, CANCER RES, V56, P5; Hagimori K, 2007, BIOL PHARM BULL, V30, P1379, DOI 10.1248/bpb.30.1379; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; HERBERT JM, 1994, BIOCHEM PHARMACOL, V48, P1211, DOI 10.1016/0006-2952(94)90158-9; JOHN WW, 1974, EXPERIENTIA, V30, P1392, DOI 10.1007/BF01919652; KIM KW, 1993, BIOSCI BIOTECH BIOCH, V57, P787, DOI 10.1271/bbb.57.787; KOBBE B, 1977, APPL ENVIRON MICROB, V33, P996, DOI 10.1128/AEM.33.4.996-997.1977; Koizumi Y, 2002, J ANTIBIOT, V55, P78, DOI 10.7164/antibiotics.55.78; Koizumi Y, 2011, BIOL PHARM BULL, V34, P1426, DOI 10.1248/bpb.34.1426; Kojima Y, 2008, J ANTIBIOT, V61, P297, DOI 10.1038/ja.2008.42; Kojima Y, 2009, J ANTIBIOT, V62, P681, DOI 10.1038/ja.2009.100; Lam W, 2009, MOL CANCER THER, V8, P415, DOI 10.1158/1535-7163.MCT-08-0692; Lapointe R, 2005, ANN ONCOL, V16, P289, DOI 10.1093/annonc/mdi061; Lee Y, 2004, J MED CHEM, V47, P5555, DOI 10.1021/jm049949c; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Park SY, 2002, CANCER RES, V62, P7; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SUDA S, 1966, APPL MICROBIOL, V14, P475, DOI 10.1128/AEM.14.3.475-476.1966; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zhan JX, 2007, PHYTOCHEMISTRY, V68, P368, DOI 10.1016/j.phytochem.2006.09.038	36	15	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140069	10.1371/journal.pone.0140069	http://dx.doi.org/10.1371/journal.pone.0140069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540166	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800003
J	Allie, E; Pelissier, R; Engel, J; Petronelli, P; Freycon, V; Deblauwe, V; Soucemarianadin, L; Weigel, J; Baraloto, C				Allie, Elodie; Pelissier, Raphael; Engel, Julien; Petronelli, Pascal; Freycon, Vincent; Deblauwe, Vincent; Soucemarianadin, Laure; Weigel, Jean; Baraloto, Christopher			Pervasive Local-Scale Tree-Soil Habitat Association in a Tropical Forest Community	PLOS ONE			English	Article							RAIN-FOREST; FUNCTIONAL TRAITS; SPATIAL VARIATION; PLANT DIVERSITY; HETEROGENEITY; DISTRIBUTIONS; GRADIENT; AMAZON; TOPOGRAPHY; DISPERSAL	We examined tree-soil habitat associations in lowland forest communities at Paracou, French Guiana. We analyzed a large dataset assembling six permanent plots totaling 37.5 ha, in which extensive LIDAR-derived topographical data and soil chemical and physical data have been integrated with precise botanical determinations. Map of relative elevation from the nearest stream summarized both soil fertility and hydromorphic characteristics, with seasonally inundated bottomlands having higher soil phosphate content and base saturation, and plateaus having higher soil carbon, nitrogen and aluminum contents. We employed a statistical test of correlations between tree species density and environmental maps, by generating Monte Carlo simulations of random raster images that preserve auto-correlation of the original maps. Nearly three fourths of the 94 taxa with at least one stem per ha showed a significant correlation between tree density and relative elevation, revealing contrasted species-habitat associations in term of abundance, with seasonally inundated bottomlands (24.5% of species) and well-drained plateaus (48.9% of species). We also observed species preferences for environments with or without steep slopes (13.8% and 10.6%, respectively). We observed that closely-related species were frequently associated with different soil habitats in this region (70% of the 14 genera with congeneric species that have a significant association test) suggesting species-habitat associations have arisen multiple times in this tree community. We also tested if species with similar habitat preferences shared functional strategies. We found that seasonally inundated forest specialists tended to have smaller stature (maximum diameter) than species found on plateaus. Our results underline the importance of tree-soil habitat associations in structuring diverse communities at fine spatial scales and suggest that additional studies are needed to disentangle community assembly mechanisms related to dispersal limitation, biotic interactions and environmental filtering from species-habitat associations. Moreover, they provide a framework to generalize across tropical forest sites.	[Allie, Elodie] Univ Antilles Guyane, UMR EcoFoG, Kourou, France; [Pelissier, Raphael] IRD, UMR AMAP, Montpellier, France; [Engel, Julien] CNRS, UMR EcoFoG, Kourou, France; [Petronelli, Pascal; Soucemarianadin, Laure] Cirad, UMR EcoFoG, Kourou, France; [Freycon, Vincent] Cirad, UPR BSEF, Montpellier, France; [Deblauwe, Vincent] UMR Diade, Montpellier, France; [Weigel, Jean] AgroParisTech, UMR EcoFoG, Kourou, France; [Baraloto, Christopher] INRA, UMR EcoFoG, Kourou, France; [Baraloto, Christopher] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Universite de Montpellier; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; State University System of Florida; Florida International University	Allie, E (corresponding author), Univ Antilles Guyane, UMR EcoFoG, Kourou, France.	elodie.allie@ecofog.gf	Deblauwe, Vincent/E-5683-2010; Pélissier, Raphaël/C-1224-2008; Baraloto, Christopher/ABG-2500-2020; Soucemarianadin, Laure N./E-2978-2019	Deblauwe, Vincent/0000-0001-9881-1052; Pélissier, Raphaël/0000-0003-4845-5090; Baraloto, Christopher/0000-0001-7322-8581; Soucemarianadin, Laure N./0000-0002-9340-3268; Allie, Elodie/0000-0001-8807-7982; Engel, Julien/0000-0002-8078-9309	European Social Fund; French Guiana region; Centre National d'Etudes Spatiales (CNES); Universite des Antilles et de la Guyane; "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	European Social Fund(European Social Fund (ESF)); French Guiana region; Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Universite des Antilles et de la Guyane; "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This study was carried out within the framework of EA's PhD project co-funded by European Social Fund, French Guiana region, Centre National d'Etudes Spatiales (CNES) and Universite des Antilles et de la Guyane. It is a contribution to Centre d'Etude de la Biodiversite Amazonienne (CEBA) biodiscovery program funded by an "Investissement d'Avenir" grant Agence Nationale de la Recherche (CEBA, ANR-10-LABX-25-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEXAGON BINNING OVER; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Baldeck CA, 2013, OECOLOGIA, V173, P1491, DOI 10.1007/s00442-013-2709-5; Baldwin DS, 2000, REGUL RIVER, V16, P457, DOI 10.1002/1099-1646(200009/10)16:5&lt;457::AID-RRR597&gt;3.0.CO;2-B; Baraloto C, 2004, OECOLOGIA, V141, P701, DOI 10.1007/s00442-004-1691-3; Baraloto C, 2007, ECOLOGY, V88, P478, DOI 10.1890/0012-9658(2007)88[478:SWSTAH]2.0.CO;2; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bivand R, 2013, R PACKAGE VERSION, V1; Boehner J, 2006, GOETTINGER GEOGRAPHI, P130; Bohlman SA, 2008, J VEG SCI, V19, P863, DOI 10.3170/2008-8-18463; Bohner J., 2006, GOTTINGER GEOGRAPHIS, V115, P13; Bonal D, 2000, OECOLOGIA, V124, P454, DOI 10.1007/PL00008871; Brown C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0502; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Couteron P, 2003, FOREST ECOL MANAG, V172, P89, DOI 10.1016/S0378-1127(02)00310-9; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Deblauwe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048766; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Epron D, 2006, J TROP ECOL, V22, P565, DOI 10.1017/S0266467406003415; FAO, 2020, SOILS PORTAL WORLD R; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Fine PVA, 2006, AM NAT, V168, P796, DOI 10.1086/508635; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2014, EVOLUTION, V68, P1988, DOI 10.1111/evo.12414; Fortunel C, 2014, NEW PHYTOL, V202, P79, DOI 10.1111/nph.12632; Garzon-Lopez CX, 2014, J VEG SCI, V25, P349, DOI 10.1111/jvs.12090; Gruber S, 2009, DEV SOIL SCI, V33, P171, DOI 10.1016/S0166-2481(08)00007-X; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Hijmans R. J, 2014, GEOGRAPHIC DATA ANAL; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Horn S, 2015, ACTA OECOL, V63, P56, DOI 10.1016/j.actao.2015.01.004; IncTM, 2010, MATLAB; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Miyamoto K, 2003, J TROP ECOL, V19, P43, DOI 10.1017/S0266467403003067; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Pelissier R, 2002, PLANT ECOL, V162, P143, DOI 10.1023/A:1020399603500; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; R Core Team, 2021, R LANGUAGE ENV STAT; Renard D., 2014, RGEOSTATS MANUAL; Russo SE, 2010, AM J BOT, V97, P1109, DOI 10.3732/ajb.0900344; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Sabatier D, 1997, PLANT ECOL, V131, P81, DOI 10.1023/A:1009775025850; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Traissac S, 2014, J VEG SCI, V25, P491, DOI 10.1111/jvs.12080; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; van Scholl L, 2004, FOREST ECOL MANAG, V195, P301, DOI 10.1016/j.foreco.2004.03.020; Vincent G, 2011, ANN FOREST SCI, V68, P357, DOI 10.1007/s13595-011-0024-z; Vleminckx J, 2015, J VEG SCI, V26, P134, DOI 10.1111/jvs.12209; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Xia SW, 2015, PLANT SOIL, V391, P51, DOI 10.1007/s11104-015-2402-z	69	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141488	10.1371/journal.pone.0141488	http://dx.doi.org/10.1371/journal.pone.0141488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535570	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400067
J	Burgi, R; Tomatis, L; Murer, K; de Bruin, ED				Buergi, Rahel; Tomatis, Laura; Murer, Kurt; de Bruin, Eling D.			Localization of Physical Activity in Primary School Children Using Accelerometry and Global Positioning System	PLOS ONE			English	Article							UNITED-STATES; HEALTH; ENVIRONMENT; TIME; GPS; YOUTH; ADOLESCENTS; PEOPLE; RECESS	Background Ecological approaches have highlighted the importance of the built environment as a factor affecting physical activity. However, knowledge on children's activity patterns is still incomplete. Particularly, data on the spatial context of physical activity is limited, which limits the potential to design location-based interventions effectively. Using global positioning system (GPS) and accelerometry, this study aimed to identify locations where children engage in moderate-vigorous physical activity (MVPA). Methods Participants included 119 children (11-14 years, 57% girls) from public schools in Winterthur, Switzerland. During a regular school week between February and April 2013, children wore an accelerometer and GPS sensor for seven consecutive days. Time-matched accelerometer and GPS data was mapped with a geographic information system and each data point was assigned to one of seven defined activity settings. Both the absolute amount of MVPA and proportion of time in MVPA were calculated for every setting. Multilevel analyses accounting for the hierarchical structure of the data were conducted to investigate any gender differences. Results Children achieved most MVPA on streets (34.5%) and on school grounds (33.4%). The proportion children spent in MVPA was highest in recreational facilities (19.4%), at other schools (19.2%) and on streets (18.6%). Boys accumulated significantly more MVPA overall and on other school grounds (p < 0.05) and showed a significantly higher proportion of time in MVPA at own school and outside of Winterthur (p < 0.05). Conclusions The results indicate the importance of streets and school grounds as activity-promoting environments. The high use of streets may be an indicator for active transportation, which appears to contribute to an active lifestyle in both genders. In contrast, the school setting is more likely to encourage physical activity in boys. Recreational facilities seem to be conducive for MVPA among both genders, although infrequently visited during the week of measurement.	[Buergi, Rahel; Tomatis, Laura; Murer, Kurt; de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Burgi, R (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.	rahel.buergi@hest.ethz.ch	de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385				Almanza E, 2012, HEALTH PLACE, V18, P46, DOI 10.1016/j.healthplace.2011.09.003; Andersen HB, 2015, LANDSCAPE URBAN PLAN, V134, P83, DOI 10.1016/j.landurbplan.2014.10.005; Andersen LB, 2011, BRIT J SPORT MED, V45, P871, DOI 10.1136/bjsports-2011-090333; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; Bringolf-Isler B, 2008, PREV MED, V46, P67, DOI 10.1016/j.ypmed.2007.06.015; Bringolf-Isler B, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-50; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Cerin E, 2011, J PLAN LIT, V26, P151, DOI 10.1177/0885412210386229; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Currie C., 2012, SOCIAL DETERMINANTS; Dessing D, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-97; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dossegger A, 2014, MED SCI SPORT EXER, V46, P1140, DOI 10.1249/MSS.0000000000000215; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Federal Statistical Office, 2015, SWISS STAT 2015; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jankowska MM, 2015, EXERC SPORT SCI REV, V43, P48, DOI 10.1249/JES.0000000000000035; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jones AP, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-42; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Lachowycz K, 2012, HEALTH PLACE, V18, P586, DOI 10.1016/j.healthplace.2012.01.006; Lamprecht M., 2015, SPORT SCHWEIZ 2014 K; Maas J, 2013, NEIGHBOURHOOD STRUCT, P153; Maddison R, 2010, PEDIATR EXERC SCI, V22, P392, DOI 10.1123/pes.22.3.392; McCrorie PRW, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0093-0; Murer SB, 2014, EUR J NUTR, V53, P865, DOI 10.1007/s00394-013-0590-y; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Oreskovic NM, 2012, GEOSPATIAL HEALTH, V6, P263, DOI 10.4081/gh.2012.144; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; Quigg R, 2010, PREV MED, V50, P235, DOI 10.1016/j.ypmed.2010.02.002; Rainham DG, 2012, AM J PREV MED, V42, pE87, DOI 10.1016/j.amepre.2012.02.011; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Rodriguez DA, 2005, MED SCI SPORT EXER, V37, pS572, DOI 10.1249/01.mss.0000185297.72328.ce; Schipperijn J, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00021; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195; WELK GJ, 2002, PHYS ACTIVITY ASSESS, P125	49	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142223	10.1371/journal.pone.0142223	http://dx.doi.org/10.1371/journal.pone.0142223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536595	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400146
J	Feng, SQ; Sun, SS; Chen, XL; Wu, SJ; Wang, DY; Chen, XS				Feng, Shouqian; Sun, Shasha; Chen, Xiaoliu; Wu, Shujing; Wang, Deyun; Chen, Xuesen			PyMYB10 and PyMYB10.1 Interact with bHLH to Enhance Anthocyanin Accumulation in Pears	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; FLAVONOL ACCUMULATION; TRANSGENIC TOBACCO; REGULATORY GENES; PYRUS-COMMUNIS; RED APPLES; BIOSYNTHESIS; EXPRESSION; PATHWAY	Color is an important agronomic trait of pears, and the anthocyanin content of fruit is immensely significant for pear coloring. In this study, an anthocyanin-activating R2R3-MYB transcription factor gene, PyMYB10.1, was isolated from fruits of red sand pear (Pyrus pyrifolia cv. Aoguan). Alignments of the nucleotide and amino acid sequences suggested that PyMYB10.1 was involved in anthocyanin regulation. Similar to PyMYB10, PyMYB10.1 was predominantly expressed in red tissues, including the skin, leaf and flower, but it was minimally expressed in non-red fruit flesh. The expression of this gene could be induced by light. Dual-luciferase assays indicated that both PyMYB10 and PyMYB10.1 activated the AtDFR promoter. The activation of AtDFR increased to a greater extent when combined with a bHLH co-factor, such as PybHLH, MrbHLH1, MrbHLH2, or AtbHLH2. However, the response of this activation depended on the protein complex formed. PyMYB10-AtbHLH2 activated the AtDFR promoter to a greater extent than other combinations of proteins. PyMYB10-AtbHLH2 also induced the highest anthocyanin accumulation in tobacco transient-expression assays. Moreover, PybHLH interacted with PyMYB10 and PyMYB10.1. These results suggest that both PyMYB10 and PyMYB10.1 are positive anthocyanin biosynthesis regulators in pears that act via the formation of a ternary complex with PybHLH. The functional characterization of PyMYB10 and PyMYB10.1 will aid further understanding of the anthocyanin regulation in pears.	[Feng, Shouqian; Sun, Shasha; Chen, Xiaoliu; Wu, Shujing; Wang, Deyun; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [31201593]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31201593).	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; Cheng S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Chiu LW, 2012, PLANTA, V236, P1153, DOI 10.1007/s00425-012-1665-3; DAYTON DF, 1966, P AM SOC HORTIC SCI, V89, P110; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; DUSSI MC, 1995, J AM SOC HORTIC SCI, V120, P785, DOI 10.21273/JASHS.120.5.785; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hichri I, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-117; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; Huang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070778; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Steyn WJ, 2005, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2005.671.9; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Tao B, 2004, SW CHIN J AGR SCI, V47, P409; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang HuiCong, 2004, Scientia Agricultura Sinica, V37, P2028; Wu BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105959; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yang YN, 2013, TREE GENET GENOMES, V9, P1351, DOI 10.1007/s11295-013-0644-6; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	42	31	34	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142112	10.1371/journal.pone.0142112	http://dx.doi.org/10.1371/journal.pone.0142112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536358	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400135
J	Foygel, K; Sekar, TV; Paulmurugan, R				Foygel, Kira; Sekar, Thillai V.; Paulmurugan, Ramasamy			Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; NRF2 ACTIVATORS; DARK SIDE; CELLS; PATHWAY; GROWTH; OVEREXPRESSION; SULFASALAZINE; TRANSFERASE; GATEKEEPER	Chemotherapy often fails due to cellular detoxifying mechanisms, including phase-II enzymes. Activation of Nrf2-Keap1 pathway induces phase-II enzymes expression through ARE-signaling and prevents cancer development. Nrf2-overexpression in cancer cells results in chemo- and/or radioresistance. This necessitates understanding of Nrf2-regulation, and identification of Nrf2 activators/inhibitors sensitizing cancer cells to improve chemotherapy. N-terminal 435-amino acids of Nrf2 are crucial for Keap1 binding during ubiquitination. Identification of a minimum Nrf2-domain required for Keap1 binding without altering endogenous ARE-signaling would be a novel tool to study Nrf2-signaling. Current study developed firefly-luciferase reporter fusion with N-terminal Nrf2-domain of different lengths and examined its response to Nrf2-activators in cells. The results identified FLuc2 fusion with N-terminal 100-aa of Nrf2 is sufficient for measuring Nrf2-activation in cancer cells. We used MDA-MB231 cells expressing this particular construct for studying antioxidant induced Nrf2-activation and chemosensitization in triple-negative breast cancer therapy. While antioxidant EGCG showed chemosensitization of MDA-MB231 cells to cisplatin by activating Nrf2-ARE signaling, PTS, another antioxidant showed chemoprotection. Tumor xenograft study in mouse demonstrates that combinational treatment by cisplatin/EGCG resulted in tumor growth reduction, compared to cisplatin alone treatment. The results of this study highlight the importance of identifying selective combination of antioxidants/chemotherapeutic agents for customized treatment strategy.	[Foygel, Kira; Sekar, Thillai V.; Paulmurugan, Ramasamy] Stanford Univ, Sch Med, BioX Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA	Stanford University	Paulmurugan, R (corresponding author), Stanford Univ, Sch Med, BioX Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	paulmur8@stanford.edu		Paulmurugan, Ramasamy/0000-0001-7155-4738	National Institute of Health-National Cancer Institute [RO1CA161091]; NATIONAL CANCER INSTITUTE [R01CA161091] Funding Source: NIH RePORTER	National Institute of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institute of Health-National Cancer Institute grant RO1CA161091 awarded to Ramasamy Paulmurugan.	BACH MK, 1985, BIOCHEM PHARMACOL, V34, P2695, DOI 10.1016/0006-2952(85)90570-2; BATIST G, 1986, J BIOL CHEM, V261, P5544; Canning P, 2015, FREE RADICAL BIO MED, V88, P101, DOI 10.1016/j.freeradbiomed.2015.05.034; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; CHAO CCK, 1992, MOL PHARMACOL, V41, P69; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; DIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215, DOI 10.2165/00003088-198916040-00002; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Khan K, 2010, HEAD NECK-J SCI SPEC, V32, P381, DOI 10.1002/hed.21195; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88; Liu L, 1999, CLIN CANCER RES, V5, P2908; Marchan R, 2013, ARCH TOXICOL, V87, P2047, DOI 10.1007/s00204-013-1165-7; Ning SC, 2012, CANCER RES, V72, P2600, DOI 10.1158/0008-5472.CAN-11-2303; OConnor PM, 1997, CANCER RES, V57, P4285; Ramkumar KM, 2013, ANAL CHEM, V85, P7542, DOI 10.1021/ac401569j; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807	29	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141913	10.1371/journal.pone.0141913	http://dx.doi.org/10.1371/journal.pone.0141913			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536456	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400100
J	Rabago, CA; Dingwell, JB; Wilken, JM				Rabago, Christopher A.; Dingwell, Jonathan B.; Wilken, Jason M.			Reliability and Minimum Detectable Change of Temporal-Spatial, Kinematic, and Dynamic Stability Measures during Perturbed Gait	PLOS ONE			English	Article							TRANSTIBIAL AMPUTATION WALKING; RETEST RELIABILITY; DIVIDED ATTENTION; HEALTHY-YOUNG; OLDER-ADULTS; TASK; VARIABILITY; TREADMILL; INDIVIDUALS; AGE	Temporal-spatial, kinematic variability, and dynamic stability measures collected during perturbation-based assessment paradigms are often used to identify dysfunction associated with gait instability. However, it remains unclear which measures are most reliable for detecting and tracking responses to perturbations. This study systematically determined the between-session reliability and minimum detectable change values of temporal-spatial, kinematic variability, and dynamic stability measures during three types of perturbed gait. Twenty young healthy adults completed two identical testing sessions two weeks apart, comprised of an unperturbed and three perturbed (cognitive, physical, and visual) walking conditions in a virtual reality environment. Within each session, perturbation responses were compared to unperturbed walking using paired t-tests. Between-session reliability and minimum detectable change values were also calculated for each measure and condition. All temporal-spatial, kinematic variability and dynamic stability measures demonstrated fair to excellent between-session reliability. Minimal detectable change values, normalized to mean values ranged from 1-50%. Step width mean and variability measures demonstrated the greatest response to perturbations with excellent between-session reliability and low minimum detectable change values. Orbital stability measures demonstrated specificity to perturbation direction and sensitivity with excellent between-session reliability and low minimum detectable change values. We observed substantially greater between-session reliability and lower minimum detectable change values for local stability measures than previously described which may be the result of averaging across trials within a session and using velocity versus acceleration data for reconstruction of state spaces. Across all perturbation types, temporal-spatial, orbital and local measures were the most reliable measures with the lowest minimum detectable change values, supporting their use for tracking changes over multiple testing sessions. The between-session reliability and minimum detectable change values reported here provide an objective means for interpreting changes in temporal-spatial, kinematic variability, and dynamic stability measures during perturbed walking which may assist in identifying instability.	[Rabago, Christopher A.; Wilken, Jason M.] Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA; [Rabago, Christopher A.; Wilken, Jason M.] Dept Def & Vet Affairs Extrem Trauma, Jbsa Ft Sam Houston, TX USA; [Rabago, Christopher A.; Wilken, Jason M.] Amputat Ctr Excellence, Jbsa Ft Sam Houston, TX USA; [Dingwell, Jonathan B.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; University of Texas System; University of Texas Austin	Rabago, CA (corresponding author), Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA.	Christopher.A.Rabago.civ@mail.mil	Wilken, Jason/ABA-3309-2021	Wilken, Jason/0000-0002-5556-7667; Dingwell, Jonathan/0000-0001-6990-4153; Rabago, Christopher/0000-0002-4484-0613	Medical Research and Materiel Command's Military Operational Medicine Research Program [W81XWH-09-P-0874]	Medical Research and Materiel Command's Military Operational Medicine Research Program	Support provided by Medical Research and Materiel Command's Military Operational Medicine Research Program, http://mrmc.amedd.army.mil, Grant W81XWH-09-P-0874 (to JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Arellano CJ, 2009, MED SCI SPORT EXER, V41, P620, DOI 10.1249/MSS.0b013e31818a0ea4; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beltran EJ, 2014, J BIOMECH, V47, P1138, DOI 10.1016/j.jbiomech.2013.12.011; Beurskens R, 2014, J BIOMECH, V47, P3072, DOI 10.1016/j.jbiomech.2014.06.041; Beurskens R, 2014, J BIOMECH, V47, P1675, DOI 10.1016/j.jbiomech.2014.02.033; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Oliveira ASC, 2012, GAIT POSTURE, V36, P301, DOI 10.1016/j.gaitpost.2012.03.016; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB., 2006, WILEY ENCY BIOMEDICA; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Gates DH, 2009, J BIOMECH, V42, P1345, DOI 10.1016/j.jbiomech.2009.03.015; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grabiner Mark D, 2005, J Neuroeng Rehabil, V2, P25, DOI 10.1186/1743-0003-2-25; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hak L, 2012, GAIT POSTURE, V36, P260, DOI 10.1016/j.gaitpost.2012.03.005; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; HOLM S, 1979, SCAND J STAT, V6, P65; Hurmuzlu Y, 1996, J BIOMECH ENG-T ASME, V118, P405, DOI 10.1115/1.2796024; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kim H, 2012, J BIOMECH, V45, P1850, DOI 10.1016/j.jbiomech.2012.05.003; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mayer-Kress G, 1986, DIMENSIONS ENTROPIES, P82, DOI DOI 10.1007/978-3-642-71001-8_11; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; McFadyen BJ, 2007, EXP BRAIN RES, V179, P235, DOI 10.1007/s00221-006-0784-0; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Melnyk BM, 2005, EVIDENCE BASED PRACT; Mersmann F, 2013, GAIT POSTURE, V37, P373, DOI 10.1016/j.gaitpost.2012.08.005; Nayfeh A.H., 2008, APPL NONLINEAR DYNAM; Nnodim JO, 2013, GAIT POSTURE, V37, P61, DOI 10.1016/j.gaitpost.2012.06.002; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Reynard P, 2014, J BIOMECH, V47, P74, DOI 10.1016/j.jbiomech.2013.10.011; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sheehan RC, 2015, GAIT POSTURE, V41, P795, DOI 10.1016/j.gaitpost.2015.02.008; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Szturm T, 2013, GAIT POSTURE, V38, P596, DOI 10.1016/j.gaitpost.2013.02.004; Terrier P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-94; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Terry K, 2012, J BIOMECH, V45, P1979, DOI 10.1016/j.jbiomech.2012.05.006; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	71	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142083	10.1371/journal.pone.0142083	http://dx.doi.org/10.1371/journal.pone.0142083			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535580	Green Published, gold			2022-12-27	WOS:000364298400130
J	Tropea, T; De Francesco, EM; Rigiracciolo, D; Maggiolini, M; Wareing, M; Osol, G; Mandala, M				Tropea, Teresa; De Francesco, Ernestina Marianna; Rigiracciolo, Damiano; Maggiolini, Marcello; Wareing, Mark; Osol, George; Mandala, Maurizio			Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; SMOOTH-MUSCLE; GPR30 ANTAGONIST; EXPRESSION; AGONISTS; ALPHA; ENDOTHELIUM; ACTIVATION; GENE; BETA	Background The regulation of vascular tone in the uterine circulation is a key determinant of appropriate uteroplacental blood perfusion and successful pregnancy outcome. Estrogens, which increase in the maternal circulation throughout pregnancy, can exert acute vasodilatory actions. Recently a third estrogen receptor named GPER (G protein-coupled estrogen receptor) was identified and, although several studies have shown vasodilatory effects in several vascular beds, nothing is known about its role in the uterine vasculature. Aim The aim of this study was to determine the function of GPER in uterine arteries mainly during pregnancy. Uterine arteries were isolated from nonpregnant and pregnant rats. Methods Vessels were contracted with phenylephrine and then incubated with incremental doses (10(-12)-10(-5) M) of the selective GPER agonist G1. Results G1 induced a dose-dependent vasodilation which was: 1) significantly increased in pregnancy, 2) endothelium-dependent, 3) primarily mediated by NO/cGMP pathway and 4) unaffected by BKca channel inhibition. Conclusion This is the first study to show the potential importance of GPER signaling in reducing uterine vascular tone during pregnancy. GPER may therefore play a previously unrecognized role in the regulation of uteroplacental blood flow and normal fetus growth.	[Tropea, Teresa; Mandala, Maurizio] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [De Francesco, Ernestina Marianna; Rigiracciolo, Damiano; Maggiolini, Marcello] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, Italy; [Wareing, Mark] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Osol, George] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA	University of Calabria; University of Calabria; University of Manchester; University of Vermont	Mandala, M (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy.	m.mandala@unical.it	Maggiolini, Marcello/Z-4729-2019; Rigiracciolo, Damiano Cosimo/GRS-9234-2022	Tropea, Teresa/0000-0003-3972-3313; Rigiracciolo, Damiano Cosimo/0000-0003-1161-6380	University of Calabria	University of Calabria	This work was supported by the University of Calabria with a contribution named "ex 60%" to MM. The funder had a role in study design and in analysis and interpretation of data.	Albanito L, 2015, ENV HLTH PE IN PRESS; Arefin S, 2014, MATURITAS, V78, P123, DOI 10.1016/j.maturitas.2014.04.002; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Byers MJ, 2005, J PHYSIOL-LONDON, V565, P85, DOI 10.1113/jphysiol.2005.085753; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Colton I, 2012, CELL PHYSIOL BIOCHEM, V29, P883, DOI 10.1159/000178465; Corcoran JJ, 2014, MOL HUM REPROD, V20, P433, DOI 10.1093/molehr/gat095; De Francesco EM, 2014, CANCER RES, V74, P4053, DOI 10.1158/0008-5472.CAN-13-3590; De Francesco EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3458; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Kvingedal AM, 1997, FEBS LETT, V407, P59, DOI 10.1016/S0014-5793(97)00278-0; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Lindsey SH, 2011, J CARDIOVASC PHARM, V57, P598, DOI 10.1097/FJC.0b013e3182135f1c; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; MAGNESS RR, 1986, AM J OBSTET GYNECOL, V155, P897, DOI 10.1016/S0002-9378(86)80047-3; Mandala M, 2012, BASIC CLIN PHARMACOL, V110, P12, DOI 10.1111/j.1742-7843.2011.00793.x; Meyer MR, 2011, VASC PHARMACOL, V55, P17, DOI 10.1016/j.vph.2011.06.003; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Owman C, 1996, BIOCHEM BIOPH RES CO, V228, P285, DOI 10.1006/bbrc.1996.1654; Pastore MB, 2012, SEMIN REPROD MED, V30, P46, DOI 10.1055/s-0031-1299597; Patkar S, 2011, NEUROSCI RES, V71, P78, DOI 10.1016/j.neures.2011.05.006; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; van der Heijden OWH, 2005, BIOL REPROD, V73, P1289, DOI 10.1095/biolreprod.105.044438; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011	35	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141997	10.1371/journal.pone.0141997	http://dx.doi.org/10.1371/journal.pone.0141997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536245	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400116
J	Cho, KH; Kim, YS; Nam, CM; Kim, TH; Kim, SJ; Han, KT; Park, EC				Cho, Kyoung Hee; Kim, Young Sam; Nam, Chung Mo; Kim, Tae Hyun; Kim, Sun Jung; Han, Kyu-Tae; Park, Eun-Cheol			The Association between Continuity of Care and All-Cause Mortality in Patients with Newly Diagnosed Obstructive Pulmonary Disease: A Population-Based Retrospective Cohort Study, 2005-2012	PLOS ONE			English	Article							AMBULATORY-CARE; ADULT PATIENTS; PREDICTORS; SURVIVAL; OUTCOMES; KOREA; COSTS; COPD	Background The disease burden is increasing for chronic obstructive pulmonary disease (COPD) due to increasing of the growth rate of prevalence and mortality. But the empirical researches are a little for COPD that studied the association between continuity of care and death and about predictors effect on mortality. Objective To investigate the association between continuity of care (COC) and chronic obstructive pulmonary disease (COPD) mortality and to identify other mortality-related factors in COPD patients. Methods We conducted a longitudinal, population-based retrospective cohort study in adult patients with COPD from 2002 to 2012 using a nationwide health insurance claims database. The study sample included individuals aged 40 years and over who developed COPD in 2005 and survived until 2006. We performed a Cox proportional hazard regression analysis with COC analyzed as a time-dependent covariate. Results Of the 3,090 participants, 60.8% died before the end of study (N = 1,879). The median years of survival for individuals with high COC (COC index >= 0.75) was 3.92, and that for patients with low COC (COC index<0.75) was 2.58 in a Kaplan Meier analysis. In a multivariate, time-dependent analysis, low COC was associated with a 22% increased risk of all-cause mortality (HR, 1.22; 95% CI, 1.09-1.36). Not receiving oxygen therapy at home was associated with a 23% increased risk of all-cause mortality (HR, 1.23; 95% CI, 1.01-1.49). Moreover, the risk of all-cause mortality for individuals who admitted one time increased 38%(HR, 1.38; 95% CI, 1.21-1.59), two times was 63%(HR, 1.63; 95% CI, 1.34-1.99) and 3+times was 96%(HR, 1.96; 95% CI, 1.63-2.36) relative to the reference group (no admission). Conclusions High COC was associated with a decreased risk of all-cause mortality. In addition, home oxygen therapy and number of hospital admissions may predict mortality in patients with COPD.	[Cho, Kyoung Hee; Kim, Sun Jung; Han, Kyu-Tae] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Cho, Kyoung Hee; Kim, Tae Hyun; Kim, Sun Jung; Han, Kyu-Tae; Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Kim, Young Sam] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nam, Chung Mo] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Tae Hyun] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.	ECPARK@yuhs.ac	Kim, Sun Jung/AAM-7334-2020; Park, Eun-Cheol/O-5644-2019	Kim, Sun Jung/0000-0003-1756-1376; Park, Eun-Cheol/0000-0002-2306-5398; Nam, Chung Mo/0000-0003-0985-0928; Cho, Kyoung Hee/0000-0003-0753-1560; Kim, Tae Hyun/0000-0003-1053-8958; Han, Kyu-Tae/0000-0002-5817-1203; Kim, Young Sam/0000-0001-9656-8482				Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Celli BR, 2008, RESP MED, V102, pS27, DOI 10.1016/S0954-6111(08)70005-2; Chen CC, 2012, BMC HEALTH SERV RES, V12, P405; Dela Coleta K, 2008, RESP MED, V102, P512, DOI 10.1016/j.rmed.2007.12.003; Esteban C, 2008, J GEN INTERN MED, V23, P1829, DOI 10.1007/s11606-008-0783-x; Gill James M, 2003, Ann Fam Med, V1, P162, DOI 10.1370/afm.22; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hjalmarsen A, 1999, INT J TUBERC LUNG D, V3, P1120; Hong JS, 2014, MED CARE, V52, P446, DOI 10.1097/MLR.0000000000000110; Hong JS, 2013, HEALTH POLICY, V109, P158, DOI 10.1016/j.healthpol.2012.09.009; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Hussey PS, 2014, JAMA INTER MED, P17; Kim RY, 2011, INTRO NATL PATIENTS; Knight JC, 2009, POPUL HEALTH MANAG, V12, P81, DOI 10.1089/pop.2008.0020; Korea National Statistical Office, 2013, STAT ALL CAUS MORT 2; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Malcolm JC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-303; Menec Verena H, 2006, J Health Serv Res Policy, V11, P196, DOI 10.1258/135581906778476562; 김재용, 2006, Diabetes and Metabolism Journal, V30, P377; Parchman ML, 2002, MED CARE, V40, P137, DOI 10.1097/00005650-200202000-00008; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Uijen AA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X649115; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141465	10.1371/journal.pone.0141465	http://dx.doi.org/10.1371/journal.pone.0141465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529224	gold, Green Published			2022-12-27	WOS:000364032600030
J	Pham, DD; Lee, JH; Lee, YB; Park, ES; Kim, KY; Song, JY; Kim, JE; Leem, CH				Duong Duc Pham; Lee, Jeong Hoon; Lee, Young Boum; Park, Eun Seok; Kim, Ka Yul; Song, Ji Yeon; Kim, Ji Eun; Leem, Chae Hun			Novel Anthropometry-Based Calculation of the Body Heat Capacity in the Korean Population	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; HUMAN THERMOREGULATION; STORAGE; TEMPERATURE; ACCURACY	Heat capacity (HC) has an important role in the temperature regulation process, particularly in dealing with the heat load. The actual measurement of the body HC is complicated and is generally estimated by body-composition-specific data. This study compared the previously known HC estimating equations and sought how to define HC using simple anthropometric indices such as weight and body surface area (BSA) in the Korean population. Six hundred participants were randomly selected from a pool of 902 healthy volunteers aged 20 to 70 years for the training set. The remaining 302 participants were used for the test set. Body composition analysis using multi-frequency bioelectrical impedance analysis was used to access body components including body fat, water, protein, and mineral mass. Four different HCs were calculated and compared using a weight-based HC (HC_Eq1), two HCs estimated from fat and fat-free mass (HC_Eq2 and HC_Eq3), and an HC calculated from fat, protein, water, and mineral mass (HC_Eq4). HC_Eq1 generally produced a larger HC than the other HC equations and had a poorer correlation with the other HC equations. HC equations using body composition data were well-correlated to each other. If HC estimated with HC_Eq4 was regarded as a standard, interestingly, the BSA and weight independently contributed to the variation of HC. The model composed of weight, BSA, and gender was able to predict more than a 99% variation of HC_Eq4. Validation analysis on the test set showed a very high satisfactory level of the predictive model. In conclusion, our results suggest that gender, BSA, and weight are the independent factors for calculating HC. For the first time, a predictive equation based on anthropometry data was developed and this equation could be useful for estimating HC in the general Korean population without body-composition measurement.	[Duong Duc Pham; Lee, Jeong Hoon; Lee, Young Boum; Park, Eun Seok; Kim, Ka Yul; Song, Ji Yeon; Kim, Ji Eun; Leem, Chae Hun] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea	University of Ulsan	Leem, CH (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, 88 Olymp Ro 43 Gil, Seoul, South Korea.	leemch@amc.seoul.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) -Ministry of Science, ICT & Future Planning [2012-0009829, 2015M3A9B6028310, 2014M3A9D7034366]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) -Ministry of Science, ICT & Future Planning	This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (Fund receiver Chae Hun Leem, No. 2012-0009829, No. 2015M3A9B6028310 and No. 2014M3A9D7034366).	Aoyagi Y, 1996, INT ARCH OCC ENV HEA, V68, P325, DOI 10.1007/BF00409418; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Blaxter K, 1989, ENERGY METABOLISM AN, P40; Burton AC, 1935, J NUTR, V9, P261, DOI 10.1093/jn/9.3.261; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; deDear RJ, 1997, INT J BIOMETEOROL, V40, P141, DOI 10.1007/s004840050035; DUBOIS D, 1989, NUTRITION, V5, P303; Furstenberg A, 2011, AM J NEPHROL, V33, P150, DOI 10.1159/000324111; Havenith G, 2001, J APPL PHYSIOL, V90, P1943, DOI 10.1152/jappl.2001.90.5.1943; Havenith G, 1998, EUR J APPL PHYSIOL, V77, P231, DOI 10.1007/s004210050327; Herman I. P., 2007, PHYS HUMAN BODY, P319; Jin HJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0553-3; KAKITSUBA N, 1987, AVIAT SPACE ENVIR MD, V58, P301; Kim H, 2011, NUTR RES PRACT, V5, P246, DOI 10.4162/nrp.2011.5.3.246; Kurazumi Y, 2008, BUILD ENVIRON, V43, P1555, DOI 10.1016/j.buildenv.2007.09.001; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; MINARD D, 1970, PHYSL BEHAVIORAL TEM, P345; Nakao T, 2007, CONTRIB NEPHROL, V155, P18, DOI 10.1159/000100993; Pham DD, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/879272; Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049; Scott CB, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-1; THOMPSON DL, 1991, J SPORT MED PHYS FIT, V31, P565; WEBB P, 1993, EUR J APPL PHYSIOL O, V66, P18, DOI 10.1007/BF00863394	24	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141498	10.1371/journal.pone.0141498	http://dx.doi.org/10.1371/journal.pone.0141498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529594	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600034
J	Tokuyama, E; Nagai, Y; Takahashi, K; Kimata, Y; Naruse, K				Tokuyama, Eijiro; Nagai, Yusuke; Takahashi, Ken; Kimata, Yoshihiro; Naruse, Keiji			Mechanical Stretch on Human Skin Equivalents Increases the Epidermal Thickness and Develops the Basement Membrane	PLOS ONE			English	Article							UNIAXIAL CYCLIC STRETCH; KERATINOCYTES IN-VITRO; FIBROBLAST PROLIFERATION; DERMAL FIBROBLASTS; ENDOTHELIAL-CELLS; UP-REGULATION; STRAIN; MODEL; EXPRESSION; TENSILE	All previous reports concerning the effect of stretch on cultured skin cells dealt with experiments on epidermal keratinocytes or dermal fibroblasts alone. The aim of the present study was to develop a system that allows application of stretch stimuli to human skin equivalents (HSEs), prepared by coculturing of these two types of cells. In addition, this study aimed to analyze the effect of a stretch on keratinization of the epidermis and on the basement membrane. HSEs were prepared in a gutter-like structure created with a porous silicone sheet in a silicone chamber. After 5-day stimulation with stretching, HSEs were analyzed histologically and immunohistologically. Stretch-stimulated HSEs had a thicker epidermal layer and expressed significantly greater levels of laminin 5 and collagen IV/VII in the basal layer compared with HSEs not subjected to stretch stimulation. Transmission electron microscopy revealed that the structure of the basement membrane was more developed in HSEs subjected to stretching. Our model may be relevant for extrapolating the effect of a stretch on the skin in a state similar to an in vivo system. This experimental system may be useful for analysis of the effects of stretch stimuli on skin properties and wound healing and is also expected to be applicable to an in vitro model of a hypertrophic scar in the future.	[Tokuyama, Eijiro; Kimata, Yoshihiro] Okayama Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Okayama, Japan; [Nagai, Yusuke] Menicon Co Ltd, Aichi, Japan; [Naruse, Keiji] Okayama Univ, Dept Cardiovasc Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University	Tokuyama, E (corresponding author), Okayama Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Okayama, Japan.	tokuyamaeijiro@gmail.com	TAKAHASHI, Ken/B-1622-2011; Sokabe, Masahiro/I-1565-2012	TAKAHASHI, Ken/0000-0002-7580-8691; naruse, keiji/0000-0003-4100-6444	Japan Society for the Promotion of Science (JSPS) [24592713]; Menicon Co., Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Menicon Co., Ltd.	This study was supported by a Grant-in-Aid for Scientific Research (C), 24592713 provided by the Japan Society for the Promotion of Science (JSPS) and Menicon Co., Ltd. provided support in the form of salaries for authors YN and KN (who is a research/adviser for Menicon Co., Ltd). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amano S, 2001, EXP CELL RES, V271, P249, DOI 10.1006/excr.2001.5387; Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; BOXMAN I, 1993, J INVEST DERMATOL, V101, P316, DOI 10.1111/1523-1747.ep12365474; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054; Derderian CA, 2005, ANN PLAS SURG, V55, P69, DOI 10.1097/01.sap.0000168160.86221.e9; Eagan TS, 2007, J MANIP PHYSIOL THER, V30, P584, DOI 10.1016/j.jmpt.2007.07.013; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Gauvin R, 2011, ACTA BIOMATER, V7, P3294, DOI 10.1016/j.actbio.2011.05.034; GAY R, 1992, TOXICOL IN VITRO, V6, P303, DOI 10.1016/0887-2333(92)90020-R; Grymes RA, 1997, IN VITRO CELL DEV-AN, V33, P392, DOI 10.1007/s11626-997-0011-8; Hirano Y, 2008, J BIOTECHNOL, V133, P245, DOI 10.1016/j.jbiotec.2007.07.955; Huang CY, 2013, J PLAST RECONSTR AES, V66, pE351, DOI 10.1016/j.bjps.2013.08.002; HUNT CC, 1975, J PHYSIOL-LONDON, V252, P259, DOI 10.1113/jphysiol.1975.sp011143; Kato T, 1998, BIOCHEM BIOPH RES CO, V244, P615, DOI 10.1006/bbrc.1998.8335; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Knies Y, 2006, EXP DERMATOL, V15, P347, DOI 10.1111/j.0906-6705.2006.00422.x; Kurita M, 2011, BIOCHEM BIOPH RES CO, V409, P103, DOI 10.1016/j.bbrc.2011.04.118; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Naruse K, 1998, FEBS LETT, V441, P111, DOI 10.1016/S0014-5793(98)01528-2; Netzlaff F, 2007, EUR J PHARM BIOPHARM, V66, P127, DOI 10.1016/j.ejpb.2006.08.012; Nishimura K, 2007, WOUND REPAIR REGEN, V15, P646, DOI 10.1111/j.1524-475X.2007.00295.x; Nishimura K, 2009, J SURG RES, V155, P125, DOI 10.1016/j.jss.2008.07.029; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; STOCKBRIDGE LL, 1988, BIOPHYS J, V54, P187, DOI 10.1016/S0006-3495(88)82944-8; Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takei T, 1997, J CELL BIOCHEM, V67, P327, DOI 10.1002/(SICI)1097-4644(19971201)67:3<327::AID-JCB5>3.0.CO;2-Y; Takei T, 1997, J CELL PHYSIOL, V173, P64, DOI 10.1002/(SICI)1097-4652(199710)173:1<64::AID-JCP8>3.0.CO;2-H; Tsunenaga M, 1998, MATRIX BIOL, V17, P603, DOI 10.1016/S0945-053X(98)90111-1; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951; Wen HA, 2009, INT WOUND J, V6, P149, DOI 10.1111/j.1742-481X.2009.00591.x; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005; Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x	44	31	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141989	10.1371/journal.pone.0141989	http://dx.doi.org/10.1371/journal.pone.0141989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528823	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600087
J	Erbel, C; Korosoglou, G; Ler, P; Akhavanpoor, M; Domschke, G; Linden, F; Doesch, AO; Buss, SJ; Giannitsis, E; Katus, HA; Gleissner, CA				Erbel, Christian; Korosoglou, Grigorios; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.			CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology	PLOS ONE			English	Article							PLATELET FACTOR 4; BETA-THROMBOGLOBULIN; INFLAMMATORY MECHANISMS; PLATELET-FACTOR-4; ATHEROSCLEROSIS; ACTIVATION; FACTOR-4; CHEMOKINES; PF4	Background CXCL4 is a platelet chemokine released at micromolar concentrations upon platelet activation. CXCL4 has been shown to promote atherogenesis by various mechanisms. However, data on CXCL4 plasma levels in patients with coronary artery disease are largely inconclusive. Computed coronary artery angiography (CCTA) represents an excellent tool to quantify and characterize coronary atherosclerotic plaques. We hypothesized that increased CXCL4 plasma levels may be associated with features of plaque instability resulting in adverse cardiovascular events. Specifically, we sought to determine whether CXCL4 levels are correlated with specific features of coronary artery disease including (1) plaque volume, (2) calcium score, (3) degree of stenosis, or (4) vascular remodeling. Methods and Results CXCL4 plasma levels were measured by ELISA in 217 patients undergoing CCTA for suspected CAD (mean age 64.2 +/- 9.4 years, 107 (49.3%) male). Mean CXCL4 plasma levels were 12.5 +/- 4.6 ng/mL. There was no significant correlation between CXCL4 levels and any clinical or demographic parameters including cardiovascular risk factors. CXCL4 plasma levels did not differ between patient with or without coronary artery disease (CAD: 12.5 +/- 4.5 ng/ml, no CAD: 12.5 +/- 4.8 ng/ml). Neither univariate nor multivariate analysis showed an association between CXCL4 levels and plaque volume, total calcium score, degree of stenosis, or vascular remodeling. Subgroup analysis of patients with CAD as confirmed by CCTA did not show any association of CXCL4 levels with the extent of CAD. Conclusions While CXCL4 may be present and active within the arterial wall, local increase of CXCL4 may not translate into systemically elevated CXCL4 levels. Further studies will have to test whether CXCL4 may still represent a suitable therapeutic target in human atherosclerosis.	[Erbel, Christian; Korosoglou, Grigorios; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany; [Erbel, Christian; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Gleissner, CA (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	christian.gleissner@med.uni-heidelberg.de			Ernst und Berta Grimmke-Stiftung [10/14]; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)	Ernst und Berta Grimmke-Stiftung; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was funded by the Ernst und Berta Grimmke-Stiftung (10/14) to F.L. and C.A.G. and by the DZHK (German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research) to H.A.K.	ABE S, 1994, INT J CARDIOL, V47, pS7, DOI 10.1016/0167-5273(94)90320-4; Akhavanpoor M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00296; Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; CELLA G, 1983, THROMB RES, V29, P499, DOI 10.1016/0049-3848(83)90345-6; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DECATERINA R, 1988, EUR HEART J, V9, P913, DOI 10.1093/oxfordjournals.eurheartj.a062587; Erbel C, 2014, INNATE IMMUN; Erbel C, 2015, INT J CARDI IN PRESS; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; FUSTER V, 1975, THROMB DIATH HAEMOST, V34, P601; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gleissner CA, 2012, CURR VASC P IN PRESS; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gleissner CA, 2015, CLIN RES CARDIOL, V104, P13, DOI 10.1007/s00392-014-0750-y; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9; LEVINE SP, 1977, THROMB RES, V11, P673, DOI 10.1016/0049-3848(77)90025-1; LEVINE SP, 1981, CIRCULATION, V64, P626, DOI 10.1161/01.CIR.64.3.626; NICHOLS AB, 1982, BLOOD, V60, P650; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; SADAYASU T, 1991, CLIN CARDIOL, V14, P725, DOI 10.1002/clc.4960140906; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; STRAUSS WE, 1985, AM HEART J, V110, P293, DOI 10.1016/0002-8703(85)90147-4; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141693	10.1371/journal.pone.0141693	http://dx.doi.org/10.1371/journal.pone.0141693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524462	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800018
J	Neves, MP; Delariva, RL; Guimaraes, ATB; Sanches, PV				Neves, Mayara Pereira; Delariva, Rosilene Luciana; Bittencourt Guimaraes, Ana Tereza; Sanches, Paulo Vanderlei			Carnivory during Ontogeny of the Plagioscion squamosissimus: A Successful Non-Native Fish in a Lentic Environment of the Upper Parana River Basin	PLOS ONE			English	Article							TEMPORAL DISTRIBUTION; FEEDING SELECTIVITY; MATO-GROSSO; LARVAE; CANNIBALISM; ASSEMBLAGES; PATTERNS; ICHTHYOPLANKTON; PERCIFORMES; SCIANIDAE	This study evaluated feeding patterns and ontogenetic variations in a non-native fish species (Plagioscion squamosissimus) in an isolated lake in the Upper Parana River floodplain. Quarterly samplings were performed from April 2005 to February 2006 using plankton nets to capture larvae, seining nets for juveniles, and gill nets and trammel for adults. Stomach contents (n = 378) were examined according to the volumetric method in which the volume of each food item was estimated using graduated test tubes or a glass counting plate. During early development (larval stage), P. squamosissimus consumed mainly Cladocera and Copepoda. Juveniles showed a more diverse diet, including shrimp (Macrobrachium amazonicum), fish, aquatic insects (Trichoptera, Ephemeroptera, Chironomidae and pupae of Diptera) and plants. It was notable the high proportion of cannibalism (23.3%) in this stage. Adults consumed predominantly shrimp and fish. The use of food resources varied significantly between development stages (ANOSIM; r = 0.458; p<0.005), showing changes in food preferences during ontogeny. The Similarity Percentage Analysis (SIMPER) indicated that Cladocera and Copepoda were responsible for the differences observed between the larval stages of pre-flexion, flexion and post-flexion. M. amazonicum and Chironomidae were responsible for the differences between juvenile and larval stages, while M. amazonicum and other fishes caused the differences between adults and other ontogenetic stages. These results are confirmed by the relationship between standard length and developmental periods (ANCOVA; r(2) = 0.94; p<0.0001). In general, there were low values of trophic niche breadth. The essentially carnivorous habit from the early stages of P. squamosissimus and the predominant use of M. amazonicum by adults have important roles in feeding patterns of the species, suggesting a major contribution to its success and establishment, especially in lentic environments.	[Neves, Mayara Pereira; Delariva, Rosilene Luciana; Bittencourt Guimaraes, Ana Tereza] Univ Estadual Oeste Parana, Ctr Ciencias Biol & Saude, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil; [Sanches, Paulo Vanderlei] Univ Estadual Oeste Parana, Posgrad Recursos Pesqueiros & Engn Pesca, Toledo, Parana, Brazil	Universidade Estadual do Oeste do Parana; Universidade Estadual do Oeste do Parana	Neves, MP (corresponding author), Univ Estadual Oeste Parana, Ctr Ciencias Biol & Saude, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil.	mayara-nevesbio@hotmail.com	Guimarães, Ana Tereza T B Bittencourt/C-1053-2019; Delariva, Rosilene L/L-2000-2016; Guimarães, Ana Tereza Bittencourt/AAI-5021-2021; Neves, Mayara Pereira/AAD-4449-2019	Guimarães, Ana Tereza T B Bittencourt/0000-0002-3633-6484; Delariva, Rosilene L/0000-0002-6489-2437; Guimarães, Ana Tereza Bittencourt/0000-0002-3633-6484; Neves, Mayara Pereira/0000-0003-2523-3874; Sanches, Paulo Vanderlei/0000-0003-2159-9115				Ahlstrom E. H., 1954, Fishery Bulletin United States, V56, P209; Baras E, 2014, AQUAT LIVING RESOUR, V27, P51, DOI 10.1051/alr/2014006; Baumgartner G, 2010, WETLANDS, V30, P309, DOI 10.1007/s13157-010-0031-0; Baumgartner MST, 2003, BRAZ J BIOL, V63, P381; Bennemann Sirlei T., 2006, Iheringia, Sér. Zool., V96, P115, DOI 10.1590/S0073-47212006000100020; Bialetzki A, 2004, J PLANKTON RES, V26, P1327, DOI 10.1093/plankt/fbh123; BIALETZKI A., 2002, Braz. J. Biol., V62, P211, DOI 10.1590/S1519-69842002000200004; Bialetzki Andrea, 1997, Revista Brasileira de Zoologia, V14, P379; Bicudo CEM., 1970, ALGAS AGUAS CONTINEN; Bozza AN, 2010, BIOTA NEOTROP, V10, P217, DOI 10.1590/S1676-06032010000300025; CAMPOS JB, 2001, PARQUE NACL ILHA GRA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COSTA S. A. G. L., 2009, ACTA SCI-BIOL SCI, V31, P285; CRUZ JA, 1990, LEVANTAMENTO ICTIOFA; DABROWSKI K, 1984, REPROD NUTR DEV, V24, P807, DOI 10.1051/rnd:19840701; Daga VS, 2015, HYDROBIOLOGIA, V746, P327, DOI 10.1007/s10750-014-2032-0; Daga VS, 2009, NEOTROP ICHTHYOL, V7, P429, DOI 10.1590/S1679-62252009000300010; deAlmeida VLL, 1997, ECOL FRESHW FISH, V6, P123; Delariva RL, 2009, RAMA, V2, P141; Félix Renata Triane da Silva, 2009, Biota Neotrop., V9, P131, DOI 10.1590/S1676-06032009000300012; Ferreira VP, 2014, IHERINGIA SER ZOOL, V104, P134, DOI 10.1590/1678-476620141042134142; Fessehaye Y, 2006, AQUACULTURE, V255, P314, DOI 10.1016/j.aquaculture.2005.11.033; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Freire A. G., 2001, ACTA LIMNOL BRAS, V13, P1; Gallagher CP, 2015, HYDROBIOLOGIA, P1; Garutti Valdener, 2000, Iheringia Serie Zoologia, V88, P25; Gerking SD., 2014, FEEDING ECOLOGY FISH; Gogola TM, 2010, NEOTROP ICHTHYOL, V8, P341, DOI 10.1590/S1679-62252010000200013; Goulding M., 1984, Revista Brasileira de Zoologia, V2, P85; Hahn Norma Segatti, 1999, Acta Scientiarum, V21, P309; Hahn Norma Segatti, 2007, Oecologia Brasiliensis, V11, P469; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HELLAWELL JM, 1971, J FISH BIOL, V3, P29, DOI 10.1111/j.1095-8649.1971.tb05903.x; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Kamler E., 1992, EARLY LIFE HIST FISH; Langeani Francisco, 2007, Biota Neotrop., V7, P181, DOI 10.1590/S1676-06032007000300020; Lima A.F., 2013, IHERINGIA S RIE ZOOL, V103, P214; Makrakis MC, 2008, J FISH BIOL, V72, P1690, DOI 10.1111/j.1095-8649.2008.01845.x; Makrakis MC, 2005, ENVIRON BIOL FISH, V72, P99, DOI 10.1007/s10641-004-6596-9; Mugnai R., 2010, MANUAL IDENTIFICACAO; Nakatani K, 2001, OVOS LARVAR PEIXES A; Nunn AD, 2012, REV FISH BIOL FISHER, V22, P377, DOI 10.1007/s11160-011-9240-8; Pavanelli CS., 2007, PEIXES PLANICIE INUN; Pepin P, 2015, ICES J MAR SCI, V72, P359, DOI 10.1093/icesjms/fsu201; Pereira LS, 2015, HYDROBIOLOGIA, V746, P223, DOI 10.1007/s10750-014-2031-1; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reynalte-Tataje DA, 2011, NEOTROP ICHTHYOL, V9, P427, DOI 10.1590/S1679-62252011005000017; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; SANTOS N. C. L., 2014, BOL I PESCA, V40, P397; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; STATSOFT INC, 2004, STAT DAT AN SOFTW SY; Teixeira I, 2007, BIOTA NEOTROP, V7, P68; Thomaz SM, 2015, HYDROBIOLOGIA, V746, P1, DOI 10.1007/s10750-014-2150-8; Torloni CEC, 1994, PRODUCAO PESQUEIRA C; Uieda VS, 2011, COMMUNITY ECOL, V12, P31, DOI 10.1556/ComEc.12.2011.1.5; Wittenrich ML, 2009, AQUACULTURE, V294, P221, DOI 10.1016/j.aquaculture.2009.06.006; WOOTON RJ, 1990, ECOLOGY TELEOST FISH; Yaniv S, 2014, J EXP BIOL, V217, P3748, DOI 10.1242/jeb.104331; Zar JH, 1999, BIOSTATISTICAL ANAL	61	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141651	10.1371/journal.pone.0141651	http://dx.doi.org/10.1371/journal.pone.0141651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524336	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800017
J	Yang, HK; Han, K; Cho, JH; Yoon, KH; Cha, BY; Lee, SH				Yang, Hae Kyung; Han, Kyungdo; Cho, Jae-Hyoung; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Seung-Hwan			Ambient Temperature and Prevalence of Obesity: A Nationwide Population-Based Study in Korea	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; ENERGY-EXPENDITURE; INDUCED THERMOGENESIS; INDOOR TEMPERATURE; ADULT HUMANS; ASSOCIATION; INCREASE; COLD; FAT	Background Recent studies have suggested a possible association between outdoor or indoor temperature and obesity. We aimed to examine whether ambient temperature is associated with the prevalence of obesity or abdominal obesity in the Korean population. Methods Data on anthropometric, socio-demographic, laboratory and lifestyle factors were retrieved from National Health Insurance System data obtained in 2009-2010. Thirty years (1981 to 2010) of meteorological parameters for 71 observation areas were acquired from the Korea Meteorological Administration. Included in this analysis were 124,354 individuals. A body mass index (BMI) >= 25 kg/m(2) and a waist circumference (WC) >= 90 cm (men) or 85 cm (women) were considered to represent obesity and abdominal obesity, respectively. Results The mean annual temperature (MAT) ranged from 6.6 degrees C to 16.6 degrees C, and BMI was positively correlated with MAT (r = 0.0078, P = 0.0065). WC was positively correlated with MAT (r = 0.0165, P < 0.0001) and negatively correlated with the number of days with mean temperature < 0 degrees C (DMT0; r = -0.0129, P = 0.0002). After adjusting for age, sex, smoking status, alcohol consumption, exercise, income, residential area and altitude, the odds ratios (95% CI) for obesity and abdominal obesity in the highest quintile MAT group were 1.045 (1.010, 1.081) and 1.082 (1.042, 1.124), respectively, compared with the lower four quintiles of the MAT group. Similarly, subjects in the area of the lowest quintile of DMT0 had significantly higher odds of abdominal obesity compared with the higher four quintile groups of DMT0. Conclusion This study finds an association between ambient temperature and prevalence of obesity in the Korean population when controlling for several confounding factors. Adaptive thermogenesis might be a possible explanation for this phenomenon.	[Yang, Hae Kyung; Cho, Jae-Hyoung; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Seung-Hwan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Med Stat, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.	hwanx2@catholic.ac.kr	Lee, Seung-Hwan/AAG-1361-2019; Lee, Seung-Hwan/C-7568-2018	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2013M3C8A2075675]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP, 2013M3C8A2075675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bakker LEH, 2014, LANCET DIABETES ENDO, V2, P210, DOI 10.1016/S2213-8587(13)70156-6; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Carobbio S, 2013, J MOL ENDOCRINOL, V51, pT75, DOI 10.1530/JME-13-0158; Celi FS, 2010, EUR J ENDOCRINOL, V163, P863, DOI 10.1530/EJE-10-0627; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Choi NK, 2007, ANN PHARMACOTHER, V41, P667, DOI 10.1345/aph.1H247; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daly M, 2014, OBESITY, V22, P626, DOI 10.1002/oby.20546; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Foster F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072269; Hansen JC, 2010, MED HYPOTHESES, V75, P250, DOI 10.1016/j.mehy.2010.02.033; Johnson F, 2011, OBES REV, V12, P543, DOI 10.1111/j.1467-789X.2010.00851.x; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kern PA, 2014, J CLIN ENDOCR METAB, V99, pE2772, DOI 10.1210/jc.2014-2440; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Rintamaki Hannu, 2007, Alaska Med, V49, P245; ROBERTS WC, 1988, AM J CARDIOL, V62, P345, DOI 10.1016/0002-9149(88)90248-2; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scheffers FR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1119; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Ulijaszek SJ, 2006, ANNU REV ANTHROPOL, V35, P337, DOI 10.1146/annurev.anthro.35.081705.123301; Valdes S, 2014, OBESITY, V22, P2328, DOI 10.1002/oby.20866; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Wasse LK, 2013, APPL PHYSIOL NUTR ME, V38, P905, DOI 10.1139/apnm-2013-0008; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yoon YS, 2014, ENDOCRINOL METAB, V29, P418, DOI 10.3803/EnM.2014.29.4.418; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	42	23	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141724	10.1371/journal.pone.0141724	http://dx.doi.org/10.1371/journal.pone.0141724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524686	gold, Green Published, Green Submitted			2022-12-27	WOS:000364029800020
J	Martins, CHZ; Cunha, BP; Solferini, VN; Trigo, JR				Martins, Carlos H. Z.; Cunha, Beatriz P.; Solferini, Vera N.; Trigo, Jose R.			Feeding on Host Plants with Different Concentrations and Structures of Pyrrolizidine Alkaloids Impacts the Chemical-Defense Effectiveness of a Specialist Herbivore	PLOS ONE			English	Article							UTETHEISA-ORNATRIX; LEPIDOPTERA; MOTH; CHEMISTRY; BUTTERFLIES; PALATABILITY; ACQUISITION; ARTHROPODS; MECHANISMS; NOCTUIDAE	Sequestration of chemical defenses from host plants is a strategy widely used by herbivorous insects to avoid predation. Larvae of the arctiine moth Utetheisa omatrix feeding on unripe seeds and leaves of many species of Crotalaria (Leguminosae) sequester N-oxides of pyrrolizidine alkaloids (PAs) from these host plants, and transfer them to adults through the pupal stage. PAs confer protection against predation on all life stages of U. omatrix. As U. ornatrix also uses other Crotalaria species as host plants, we evaluated whether the PA chemical defense against predation is independent of host plant use. We fed larvae from hatching to pupation with either leaves or seeds of one of eight Crotalaria species (C. incana, C. juncea, C. micans, C. ochroleuca, C. pallida, C. paulina, C. spectabilis, and C. vitellina), and tested if adults were preyed upon or released by the orb-weaving spider Nephila clavipes. We found that the protection against the spider was more effective in adults whose larvae fed on seeds, which had a higher PA concentration than leaves. The exceptions were adults from larvae fed on C. paulina, C. spectabilis and C. vitellina leaves, which showed high PA concentrations. With respect to the PA profile, we describe for the first time insect-PAs in U. ornatrix. These PAs, biosynthesized from the necine base retronecine of plant origin, or monocrotaline-and senecionine-type PAs sequestered from host plants, were equally active in moth chemical defense, in a dose-dependent manner. These results are also partially explained by host plant phylogeny, since PAs of the host plants do have a phylogenetic signal (clades with high and low PA concentrations in leaves) which is reflected in the adult defense.	[Martins, Carlos H. Z.; Trigo, Jose R.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Ecol Quim, BR-13083970 Campinas, SP, Brazil; [Martins, Carlos H. Z.] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Func & Mol, BR-13084970 Campinas, SP, Brazil; [Cunha, Beatriz P.; Solferini, Vera N.] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Trigo, JR (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Ecol Quim, Caixa Postal 6109, BR-13083970 Campinas, SP, Brazil.	trigo@unicamp.br	UNICAMP, CCES -/J-7787-2015; Martins, Carlos Henrique H.Z. Zanini/H-6022-2018; Solferini, Vera/E-9121-2012; Trigo, Jose R/B-8398-2012	Martins, Carlos Henrique H.Z. Zanini/0000-0003-1422-055X; Solferini, Vera/0000-0001-6582-1449; Trigo, Jose R/0000-0003-3028-5353	FAPESP [11/17708-0, 12/02526-7]; CNPq [306103/2013-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FAPESP to JRT (11/17708-0) and VNS (12/02526-7), and CNPq to JRT (306103/2013-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2009, EVOLUTION, V63, P663, DOI 10.1111/j.1558-5646.2008.00573.x; [Anonymous], 2014, TRACER V1 6; Avise JC, 2006, EVOLUTIONARY PATHWAYS IN NATURE: A PHYLOGENETIC APPROACH, P1, DOI 10.1017/CBO9780511606939; Bogner FX, 1996, J CHEM ECOL, V22, P1439, DOI 10.1007/BF02027723; Bowers M.D., 1988, P273; BOWERS MD, 1980, EVOLUTION, V34, P586, DOI 10.1111/j.1558-5646.1980.tb04846.x; BROWER LP, 1968, SCIENCE, V161, P1349, DOI 10.1126/science.161.3848.1349; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cogni R, 2012, MOL ECOL, V21, P6152, DOI 10.1111/mec.12086; Cogni R, 2010, BIOTROPICA, V42, P188, DOI 10.1111/j.1744-7429.2009.00570.x; CONNER WE, 1981, BEHAV ECOL SOCIOBIOL, V9, P227, DOI 10.1007/BF00302942; Conner WE, 2015, PHEROMONE C IN PRESS; Conner William E., 2009, P155; CRAIG JC, 1970, J ORG CHEM, V35, P1721, DOI 10.1021/jo00830a121; Crawley M.J., 2007, R BOOK; DaCosta MA, 2010, INVERTEBR SYST, V24, P113, DOI 10.1071/IS08006; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; Edgar JA, 2007, J CHEM ECOL, V33, P2266, DOI 10.1007/s10886-007-9378-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISNER T, 1982, BIOSCIENCE, V32, P321, DOI 10.2307/1308848; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Eisner T, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P91; EISNER T, 1991, Psyche (Cambridge), V98, P111, DOI 10.1155/1991/95350; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferro VG, 2006, ENTOMOL EXP APPL, V121, P23, DOI 10.1111/j.1570-8703.2006.00450.x; Flores AS, 2009, BIOCHEM SYST ECOL, V37, P459, DOI 10.1016/j.bse.2009.06.001; Flores AS, 2004, THESIS U ESTADUL CAM; Franco MS, 2013, NEOTROP ENTOMOL, V42, P223, DOI 10.1007/s13744-013-0114-8; Gomes CEM, 2005, PLANT PHYSIOL BIOCH, V43, P1095, DOI 10.1016/j.plaphy.2005.11.004; Gonzalez A, 1999, P NATL ACAD SCI USA, V96, P5570, DOI 10.1073/pnas.96.10.5570; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Guimaraes PR, 2006, AUSTRAL ECOL, V31, P776, DOI 10.1111/j.1442-9993.2006.01639.x; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P1083, DOI 10.1016/j.ibmb.2005.05.011; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P391, DOI 10.1016/j.ibmb.2004.12.010; Hartmann T, 2004, CHEMOECOLOGY, V14, P207, DOI 10.1007/s00049-004-0276-2; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; Hartmann Thomas, 2009, P55; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Hay-Roe MM, 2007, J CHEM ECOL, V33, P319, DOI 10.1007/s10886-006-9234-5; Hoina A, 2013, ARTHROPOD-PLANT INTE, V7, P169, DOI 10.1007/s11829-012-9232-1; Hristov N, 2005, CHEMOECOLOGY, V15, P105, DOI 10.1007/s00049-005-0301-0; le Roux MM, 2013, TAXON, V62, P957, DOI 10.12705/625.1; Macel M, 2011, PHYTOCHEM REV, V10, P75, DOI 10.1007/s11101-010-9181-1; Malcolm S. B., 1995, Chemoecology, V5/6, P101; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Pando LA, 2004, PROTEIN J, V23, P437, DOI 10.1007/s10930-004-5219-9; Pereira MF, 2013, ACTA OECOL, V51, P49, DOI 10.1016/j.actao.2013.05.012; PILBEAM DJ, 1979, PHYTOCHEMISTRY, V18, P973, DOI 10.1016/S0031-9422(00)91460-2; POLHILL R. M., 1982, CROTALARIA AFRICA MA; R Core Team, 2021, R LANGUAGE ENV STAT; RITLAND DB, 1994, ECOLOGY, V75, P732, DOI 10.2307/1941731; ROBINSON M H, 1971, Psyche (Cambridge), V78, P123, DOI 10.1155/1971/57182; Roque-Albelo Lazaro, 2009, P207; Roque-Albelo L, 2009, ZOOKEYS, P55, DOI 10.3897/zookeys.21.201; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Silva KL, 2002, J CHEM ECOL, V28, P657, DOI 10.1023/A:1015214422971; Sourakov A, 2015, J NAT HIST, V49, P2397, DOI 10.1080/00222933.2015.1006700; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Travassos Lauro, 1946, REV BRASIL BIOL, V6, P343; Trigo JR, 2011, PHYTOCHEM REV, V10, P83, DOI 10.1007/s11101-010-9191-z; Trigo JR, 2000, J BRAZIL CHEM SOC, V11, P551, DOI 10.1590/S0103-50532000000600002; Trigo JR, 1996, BIOL J LINN SOC, V58, P99, DOI 10.1111/j.1095-8312.1996.tb01663.x; TRIGO JR, 1993, J CHEM ECOL, V19, P669, DOI 10.1007/BF00985000; VASCONCELLOSNETO J, 1984, ECOL ENTOMOL, V9, P337, DOI 10.1111/j.1365-2311.1984.tb00857.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	71	25	27	9	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141480	10.1371/journal.pone.0141480	http://dx.doi.org/10.1371/journal.pone.0141480			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517873	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800046
J	O'Leary, RA; Low-Choy, S; Fisher, R; Mengersen, K; Caley, MJ				O'Leary, Rebecca A.; Low-Choy, Samantha; Fisher, Rebecca; Mengersen, Kerrie; Caley, M. Julian			Characterising Uncertainty in Expert Assessments: Encoding Heavily Skewed Judgements	PLOS ONE			English	Article							SPECIES RICHNESS; PROBABILITY-DISTRIBUTIONS; KNOWLEDGE; ELICITATION; HOMELESS; TOOL	When limited or no observed data are available, it is often useful to obtain expert knowledge about parameters of interest, including point estimates and the uncertainty around these values. However, it is vital to elicit this information appropriately in order to obtain valid estimates. This is particularly important when the experts' uncertainty about these estimates is strongly skewed, for instance when their best estimate is the same as the lowest value they consider possible. Also this is important when interest is in the aggregation of elicited values. In this paper, we compare alternative distributions for describing such estimates. The distributions considered include the lognormal, mirror lognormal, Normal and scaled Beta. The case study presented here involves estimation of the number of species in coral reefs, which requires eliciting counts within broader taxonomic groups, with highly skewed uncertainty estimates. This paper shows substantial gain in using the scaled Beta distribution, compared with Normal or lognormal distributions. We demonstrate that, for this case study on counting species, applying the novel encoding methodology developed in this paper can facilitate the acquisition of more rigorous estimates of (hierarchical) count data and credible bounds. The approach can also be applied to the more general case of enumerating a sampling frame via elicitation.	[O'Leary, Rebecca A.; Fisher, Rebecca] Australian Inst Marine Sci, UWA Oceans Inst M096, Crawley, WA 6009, Australia; [Low-Choy, Samantha; Mengersen, Kerrie] Queensland Univ Technol, Fac Sci & Engn, Sch Math Sci, Brisbane, Qld 4001, Australia; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Queensland University of Technology (QUT); Australian Institute of Marine Science	O'Leary, RA (corresponding author), Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6151, Australia.	rebecca.oleary@agric.wa.gov.au	Fisher, Rebecca/C-5459-2011; Mengersen, Kerrie/AHC-4096-2022; Caley, Julian/A-4042-2008	Fisher, Rebecca/0000-0001-5148-6731; Caley, Julian/0000-0001-5739-749X; Low Choy, Samantha/0000-0002-1722-4428; Mengersen, Kerrie/0000-0001-8625-9168	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life)	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life)	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life) supported RAO, RF, and MJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2012, BAYESIAN ANAL, V7, P541, DOI 10.1214/12-BA717REJ; Berk RA, 2008, IMS COLLECTIONS PROB, V2, P127, DOI DOI 10.1214/193940307000000428; Berry B, 2007, EVALUATION REV, V31, P166, DOI 10.1177/0193841X06296947; Bowley AL, 1920, ELEMENTS STAT; Boxshall G., 2010, HARPACTICOIDA; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Caley MJ, 2014, ECOL EVOL, V4, P231, DOI 10.1002/ece3.926; Chamberlain C, 2006, AUSTR CENSUS ANAL PR; Chambers JM., 1992, STAT MODELS S; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; CHOY SJL, 2008, J APPL PROBABILITY S, V3, P1; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Cowen DD, 1991, HOUS POLICY DEBATE, V2, P869; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; Fisher R, 2012, ENVIRON MODELL SOFTW, V30, P1, DOI 10.1016/j.envsoft.2011.11.011; FUNTOWICZ SO, 1994, ENVIRON TOXICOL CHEM, V13, P1881, DOI 10.1002/etc.5620131203; GARTHWAITE PH, 1985, J ECONOMETRICS, V29, P149, DOI 10.1016/0304-4076(85)90036-3; Garthwaite PH, 2000, J ROY STAT SOC D-STA, V49, P455, DOI 10.1111/1467-9884.00246; GAVASAKAR U, 1988, MANAGE SCI, V34, P784, DOI 10.1287/mnsc.34.6.784; Girard M. C., 2006, CANADIAN REV SOCIAL, V58, P101; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; Hammond TR, 2001, ICES J MAR SCI, V58, P1133, DOI 10.1006/jmsc.2001.1103; Hughes G, 2002, CROP PROT, V21, P203, DOI 10.1016/S0261-2194(01)00087-4; James A, 2010, ENVIRON MODELL SOFTW, V25, P129, DOI 10.1016/j.envsoft.2009.07.003; Kadane JB, 2006, BAYESIAN ANAL, V1, P363, DOI 10.1214/06-BA113; Kynn M, 2008, J ROY STAT SOC A STA, V171, P239; LOW-CHOY S, 2010, OXFORD HDB APPL BAYE, P511; Malcolm C, 1959, OPER RES, V7, P646, DOI [10.1287/opre.7.5.646, DOI 10.1287/0PRE.7.5.646]; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McKenzie DJ, 2009, J R STAT SOC A STAT, V172, P339, DOI 10.1111/j.1467-985X.2009.00584.x; Morris DE, 2014, ENVIRON MODELL SOFTW, V52, P1, DOI 10.1016/j.envsoft.2013.10.010; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; O'Hagan A, 1998, J ROY STAT SOC D-STA, V47, P21, DOI 10.1111/1467-9884.00114; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; O'Leary RA, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P2149; Perera AH, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P1, DOI 10.1007/978-1-4614-1034-8_1; Phillips LD, 1993, ELICITATION JUDGMENT; Reaka-Kudla Marjorie L., 1997, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; RECKHOW KH, 1990, ECOLOGY, V71, P2053, DOI 10.2307/1938619; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; SPETZLER CS, 1975, MANAGE SCI, V22, P340, DOI 10.1287/mnsc.22.3.340; Vose D., 2000, RISK ANAL QUANTITATI; WRIGHT JD, 1992, EVALUATION REV, V16, P355, DOI 10.1177/0193841X9201600401	48	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141697	10.1371/journal.pone.0141697	http://dx.doi.org/10.1371/journal.pone.0141697			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517835	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800069
J	Cossu-Rocca, P; Orru, S; Muroni, MR; Sanges, F; Sotgiu, G; Ena, S; Pira, G; Murgia, L; Manca, A; Uras, MG; Sarobba, MG; Urru, S; De Miglio, MR				Cossu-Rocca, Paolo; Orru, Sandra; Muroni, Maria Rosaria; Sanges, Francesca; Sotgiu, Giovanni; Ena, Sara; Pira, Giovanna; Murgia, Luciano; Manca, Alessandra; Uras, Maria Gabriela; Sarobba, Maria Giuseppina; Urru, Silvana; De Miglio, Maria Rosaria			Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ONCOGENIC MUTATIONS; TARGETED THERAPIES; SIGNALING PATHWAY; HIGH-FREQUENCY; PTEN LOSS; GENE; EXPRESSION; CARCINOMA; SUBTYPES	Background Triple Negative Breast Cancer (TNBC) accounts for 12-24% of all breast carcinomas, and shows worse prognosis compared to other breast cancer subtypes. Molecular studies demonstrated that TNBCs are a heterogeneous group of tumors with different clinical and pathologic features, prognosis, genetic-molecular alterations and treatment responsivity. The PI3K/AKT is a major pathway involved in the regulation of cell survival and proliferation, and is the most frequently altered pathway in breast cancer, apparently with different biologic impact on specific cancer subtypes. The most common genetic abnormality is represented by PIK3CA gene activating mutations, with an overall frequency of 20-40%. The aims of our study were to investigate PIK3CA gene mutations on a large series of TNBC, to perform a wider analysis on genetic alterations involving PI3K/AKT and BRAF/RAS/MAPK pathways and to correlate the results with clinical-pathologic data. Materials and Methods PIK3CA mutation analysis was performed by using cobas (R) PIK3CA Mutation Test. EGFR, AKT1, BRAF, and KRAS genes were analyzed by sequencing. Immunohistochemistry was carried out to identify PTEN loss and to investigate for PI3K/AKT pathways components. Results PIK3CA mutations were detected in 23.7% of TNBC, whereas no mutations were identified in EGFR, AKT1, BRAF, and KRAS genes. Moreover, we observed PTEN loss in 11.3% of tumors. Deregulation of PI3K/AKT pathways was revealed by consistent activation of pAKT and p-p44/42 MAPK in all PIK3CA mutated TNBC. Conclusions Our data shows that PIK3CA mutations and PI3K/AKT pathway activation are common events in TNBC. A deeper investigation on specific TNBC genomic abnormalities might be helpful in order to select patients who would benefit from current targeted therapy strategies.	[Cossu-Rocca, Paolo; Muroni, Maria Rosaria; Sanges, Francesca; Murgia, Luciano; De Miglio, Maria Rosaria] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Orru, Sandra] A Businco Oncol Hosp, Dept Pathol, ASL Cagliari, Cagliari, Italy; [Sotgiu, Giovanni] Univ Sassari, Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Ena, Sara; Pira, Giovanna] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Manca, Alessandra; Uras, Maria Gabriela] AOU Sassari, Dept Pathol, Sassari, Italy; [Sarobba, Maria Giuseppina] ASL Nuoro, Dept Med Oncol, Nuoro, Italy; [Urru, Silvana] Ctr Adv Studies Res & Dev Sardinia Technol Pk Pol, Biomed Sect, Cagliari, Italy	University of Sassari; University of Sassari; University of Sassari	Cossu-Rocca, P (corresponding author), Giovanni Paolo II Hosp, Dept Diagnost Serv, Surg Pathol Unit, ASL Olbia, Olbia, Italy.	pcossurocca@yahoo.it	Sotgiu, Giovanni/N-1032-2017	Sotgiu, Giovanni/0000-0002-1600-4474; COSSU ROCCA, Paolo Alessandro/0000-0002-8472-6946; urru, silvana anna maria/0000-0001-6213-1290; Ena, Sara/0000-0003-1861-7845	Fondazione Banco di Sardegna, Italy; Regione Autonoma della Sardegna, Italy - Anno	Fondazione Banco di Sardegna, Italy(Fondazione Banco di Sardegna); Regione Autonoma della Sardegna, Italy - Anno	This work was supported in part by grants from Fondazione Banco di Sardegna, Italy and from Regione Autonoma della Sardegna, Italy - Anno 2011, Legge Regionale 7 agosto 2007, n.7: "Promozione della Ricerca Scientifica e dell'Innovazione Tecnologica in Sardegna". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson VG, 2014, BREAST CANCER RES TR, V145, P389, DOI 10.1007/s10549-014-2945-3; Arsenic R, 2014, APPL IMMUNOHISTO M M, V22, P50, DOI 10.1097/PDM.0b013e318297afea; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Boyault S, 2012, BREAST CANCER RES TR, V132, P29, DOI 10.1007/s10549-011-1518-y; Buttitta F, 2006, J PATHOL, V208, P350, DOI 10.1002/path.1908; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cizkova M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3113; De Abreu FB, 2013, AM J PATHOL, V183, P1075, DOI 10.1016/j.ajpath.2013.07.002; De Miglio MR, 2010, DIAGN MOL PATHOL, V19, P201, DOI 10.1097/PDM.0b013e3181db67d5; Fink LS, 2015, MOL CANCER THER, V14, P298, DOI 10.1158/1535-7163.MCT-14-0529; Gonzalez-Angulo AM, 2013, CANCER-AM CANCER SOC, V119, P7, DOI 10.1002/cncr.27608; Gordon V, 2013, CLIN CANCER RES, V19, P3738, DOI 10.1158/1078-0432.CCR-12-0274; Grob TJ, 2012, BREAST CANCER RES TR, V134, P561, DOI 10.1007/s10549-012-2092-7; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hashimoto K, 2014, ANN ONCOL, V25, P1973, DOI 10.1093/annonc/mdu247; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kandula M, 2013, ASIAN PAC J CANCER P, V14, P5067, DOI 10.7314/APJCP.2013.14.9.5067; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kriegsmann M, 2014, ONCOTARGET, V5, P9952, DOI 10.18632/oncotarget.2481; Lai YL, 2008, ANN SURG ONCOL, V15, P1064, DOI 10.1245/s10434-007-9751-7; Lakhani SR., 2012, WHO CLASSIFICATION T, P14; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Loi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053292; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Maruyama N, 2007, CLIN CANCER RES, V13, P408, DOI 10.1158/1078-0432.CCR-06-0267; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Millis SZ, 2015, CLIN BREAST CANCER, V15, P473, DOI 10.1016/j.clbc.2015.04.008; Moulder SL, 2010, CLIN BREAST CANCER, V10, pS66, DOI 10.3816/CBC.2010.s.014; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Ordonez NG, 1998, AM J SURG PATHOL, V22, P1215, DOI 10.1097/00000478-199810000-00006; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; SAR M, 1990, ENDOCRINOLOGY, V127, P3180, DOI 10.1210/endo-127-6-3180; Secq V, 2014, BRIT J CANCER, V110, P1045, DOI 10.1038/bjc.2013.794; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tanaka Y, 2006, ONCOGENE, V25, P2950, DOI 10.1038/sj.onc.1209311; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407	59	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141763	10.1371/journal.pone.0141763	http://dx.doi.org/10.1371/journal.pone.0141763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540293	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800026
J	Delobel-Ayoub, M; Ehlinger, V; Klapouszczak, D; Maffre, T; Raynaud, JP; Delpierre, C; Arnaud, C				Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Maffre, Thierry; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine			Socioeconomic Disparities and Prevalence of Autism Spectrum Disorders and Intellectual Disability	PLOS ONE			English	Article							SOCIODEMOGRAPHIC RISK-FACTORS; NON-HISPANIC WHITE; MENTAL-RETARDATION; CHILDREN; POPULATION; EPIDEMIOLOGY; ASSOCIATION; DEPRIVATION; DIAGNOSIS; ETHNICITY	Background and Objectives Study of the impact of socioeconomic status on autism spectrum disorders (ASD) and severe intellectual disabilities (ID) has yielded conflicting results. Recent European studies suggested that, unlike reports from the United States, low socioeconomic status is associated with an increased risk of ASD. For intellectual disabilities, the links with socioeconomic status vary according to the severity. We wished to clarify the links between socioeconomic status and the prevalence of ASD (with or without ID) and isolated severe ID. Methods 500 children with ASD and 245 children with severe ID (IQ <50) aged 8 years, born 1995 to 2004, were recruited from a French population-based registry. Inclusions were based on clinical diagnoses reported in medical records according to the International Classification of Diseases, 10th Revision. Socioeconomic status was measured by indicators available at block census level which characterize the population of the child's area of residence. Measures of deprivation, employment, occupation, education, immigration and family structure were used. Prevalences were compared between groups of census units defined by the tertiles of socioeconomic level in the general population. Results Prevalence of ASD with associated ID was higher in areas with the highest level of deprivation and the highest percentage of unemployed adults, persons with no diploma, immigrants and single-parent families. No association was found when using occupational class. Regarding ASD without associated ID, a higher prevalence was found in areas with the highest percentage of immigrants. No association was found for other socioeconomic indicators. The prevalence of isolated severe ID was likely to be higher in the most disadvantaged groups defined by all indicators. Conclusion The prevalence of ASD with associated ID and of severe isolated ID is more likely to be higher in areas with the highest level of deprivation.	[Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Arnaud, Catherine] CHU Toulouse, Registre Handicaps Enfant Haute Garonne, Toulouse, France; [Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine] Fac Med Toulouse, INSERM, U1027, F-31073 Toulouse, France; [Delobel-Ayoub, Malika; Ehlinger, Virginie; Klapouszczak, Dana; Raynaud, Jean-Philippe; Delpierre, Cyrille; Arnaud, Catherine] Univ Toulouse 3, F-31062 Toulouse, France; [Maffre, Thierry; Raynaud, Jean-Philippe] Hop La Grave, Serv Univ Psychiat Enfant & Adolescent, CHU Toulouse, Toulouse, France; [Maffre, Thierry] Hop La Grave, Ctr Ressources Autisme Midipyrenees, Toulouse, France; [Arnaud, Catherine] CHU Purpan, Dept Epidemiol Clin, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; CHU de Toulouse	Delobel-Ayoub, M (corresponding author), CHU Toulouse, Registre Handicaps Enfant Haute Garonne, Toulouse, France.	delobel.m@chu-toulouse.fr	Delobel-Ayoub, Malika/AAC-2047-2020; Romanova, Raisa/O-5724-2018; KLAPOUSZCZAK, DANA/AAC-8311-2019; ARNAUD, Catherine/AAC-5646-2019; Delobel-Ayoub, Malika/AAC-4341-2019	ARNAUD, Catherine/0000-0002-4002-802X; Delobel-Ayoub, Malika/0000-0002-0090-8313; delpierre, cyrille/0000-0002-0831-080X; Raynaud, Jean-Philippe/0000-0002-6101-7370				Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bhasin TK, 2007, J AUTISM DEV DISORD, V37, P667, DOI 10.1007/s10803-006-0194-y; Bilder D, 2009, PEDIATRICS, V123, P1293, DOI 10.1542/peds.2008-0927; Burd L, 1999, J PERINAT MED, V27, P441, DOI 10.1515/JPM.1999.059; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e86; Decoufle Pierre, 1995, Annals of Epidemiology, V5, P347, DOI 10.1016/1047-2797(95)00031-2; Delobel-Ayoub M., 2010, Bulletin Epidemiologique Hebdomadaire, P180; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; DREWS CD, 1995, AM J PUBLIC HEALTH, V85, P329, DOI 10.2105/AJPH.85.3.329; Durkin MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011551; Emerson E, 2012, J EPIDEMIOL COMMUN H, V66, P218, DOI 10.1136/jech.2010.111773; Fountain C, 2011, J EPIDEMIOL COMMUN H, V65, P503, DOI 10.1136/jech.2009.104588; Harrison MJ, 2006, ARCH DIS CHILD, V91, P16, DOI 10.1136/adc.2004.049601; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Maenner Matthew J, 2009, WMJ, V108, P253; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; Nicholas JS, 2009, ANN EPIDEMIOL, V19, P808, DOI 10.1016/j.annepidem.2009.04.005; Ouellette-Kuntz H., 2006, J POLICY PRACT INTEL, V3, P164, DOI [10.1111/j.1741-1130.2006.00076.x, DOI 10.1111/J.1741-1130.2006.00076.X]; Pedersen A, 2012, PEDIATRICS, V129, pE629, DOI 10.1542/peds.2011-1145; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Russell G, 2011, SOC PSYCH PSYCH EPID, V46, P1283, DOI 10.1007/s00127-010-0294-z; Saint-Georges C., 2013, NEUROPSYCHIAT ENFAN, V61, P400, DOI DOI 10.1016/J.NEURENF.2013.05.005; Schieve LA, 2012, DISABIL HEALTH J, V5, P18, DOI 10.1016/j.dhjo.2011.09.001; Stromme P, 2000, SOC PSYCH PSYCH EPID, V35, P12, DOI 10.1007/s001270050003; Thomas P, 2012, AUTISM, V16, P201, DOI 10.1177/1362361311413397; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; van Bakel MME, 2015, J AUTISM DEV DISORD, V45, P3255, DOI 10.1007/s10803-015-2486-6; Windham GC, 2011, J AUTISM DEV DISORD, V41, P1362, DOI 10.1007/s10803-010-1160-2; Wingate M, 2014, MMWR SURVEILL SUMM, V63; YEARGINALLSOPP M, 1995, AM J PUBLIC HEALTH, V85, P324, DOI 10.2105/AJPH.85.3.324	39	84	86	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141964	10.1371/journal.pone.0141964	http://dx.doi.org/10.1371/journal.pone.0141964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540408	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800038
J	Lu, JY; Yu, HY; Mo, YF; Ma, XJ; Hao, YP; Lu, W; Li, HT; Bao, YQ; Zhou, J; Jia, WP				Lu, Jingyi; Yu, Haoyong; Mo, Yifei; Ma, Xiaojing; Hao, Yaping; Lu, Wei; Li, Huating; Bao, Yuqian; Zhou, Jian; Jia, Weiping			Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes	PLoS One			English	Article							SERUM FGF21 LEVELS; METABOLIC REGULATOR; FATTY-ACIDS; DISEASE; OBESITY; HUMANS; MICE; MELLITUS	Background Fibroblast growth factor 21 (FGF21) exerts wide-range effects on carbohydrate and lipid metabolism. However, its perturbation in type 2 diabetes mellitus (T2DM) remains elusive. Besides, previous human studies in T2DM simply investigated fasting or stimulated levels of FGF21. The current study sought to evaluate the temporal changes of circulating FGF21 in subjects with and without T2DM. Methods Ten patients with T2DM and 16 normal controls (NC) were recruited. Participants were categorized as obese (BMI >= 25 kg/m(2)) or lean (BMI<25 kg/m(2)). Blood samples were drawn every 30 min within 7 hours (8 a. m.-3 p.m.). Serum FGF21, blood glucose, insulin, free fatty acids (FFAs) and adiponectin were measured in all subjects. Results The peak levels of FGF21 were observed in the fasting state (8 a.m.) both in T2DM and NC groups (267.35 +/- 158.72 ng/L vs. 178.93 +/- 121.37 ng/L, P = 0.096). FGF21 AUC did not differ significantly between the two groups (T2DM: 949.4 +/- 471.47 ng/L; NC: 883.13 +/- 561.40 ng/L, P = 0.770). Obese subjects had higher FGF21 levels than lean ones in patients either with or without T2DM. The pattern of FFAs closely resembled that of FGF21. Correlation analysis showed that temporal levels of FGF21 were significantly related to FFAs (r = 0.749, P = 0.002), but not blood glucose, insulin or adiponectin (all P> 0.05). Conclusions These findings suggest that the pattern of circulating FGF21 does not differ significantly between T2DM and NC, although T2DM patients showed a trend toward higher fasting FGF21 than healthy subjects. The pattern of circulating FFAs is significantly associated with that of FGF21.	[Lu, Jingyi; Yu, Haoyong; Mo, Yifei; Ma, Xiaojing; Hao, Yaping; Lu, Wei; Li, Huating; Bao, Yuqian; Zhou, Jian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus, Affiliated Peoples Hosp 6,Shanghai Diabet Inst,Sh, Shanghai 200030, Peoples R China; [Zhou, Jian] Kashgar Prefecture Second Peoples Hosp, Dept Endocrinol & Metab, Kashi, Xinjiang, Peoples R China	Shanghai Jiao Tong University	Zhou, J (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus, Affiliated Peoples Hosp 6,Shanghai Diabet Inst,Sh, Shanghai 200030, Peoples R China.	zhoujian@sjtu.edu.cn; wpjia@sjtu.edu.cn			National Natural Science Foundation of China [81300666, 81100590]; Shanghai Rising-Star Program [12QA1402500]; Shanghai Medical Program for Outstanding Young Talent [XYQ2011013]; MSD China Holding Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Medical Program for Outstanding Young Talent; MSD China Holding Co., Ltd.	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 81300666 to JL and 81100590 to JZ), Shanghai Rising-Star Program (12QA1402500), Shanghai Medical Program for Outstanding Young Talent (XYQ2011013) and MSD China Holding Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Berti L, 2015, MOL METAB, V4, P519, DOI 10.1016/j.molmet.2015.04.002; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kok SW, 2002, J CLIN ENDOCR METAB, V87, P805, DOI 10.1210/jc.87.2.805; Lee CH, 2015, J CLIN ENDOCR METAB, V100, P1368, DOI 10.1210/jc.2014-3465; Li XS, 2011, DIABETES RES CLIN PR, V93, P10, DOI 10.1016/j.diabres.2011.02.034; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Roesch SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116928; Xiao Y, 2012, J CLIN ENDOCR METAB, V97, pE54, DOI 10.1210/jc.2011-1930; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zibar K, 2015, ENDOCRINE, V48, P848, DOI 10.1007/s12020-014-0413-9	24	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142207	10.1371/journal.pone.0142207	http://dx.doi.org/10.1371/journal.pone.0142207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540514	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800068
J	Neuberger, A; van Veen, HW				Neuberger, Arthur; van Veen, Hendrik W.			Hoechst 33342 Is a Hidden "Janus" amongst Substrates for the Multidrug Efflux Pump LmrP	PLoS One			English	Article							TRANSPORTER LMRP; RESISTANCE; BINDING; MEMBRANES; SYSTEMS; PROTEIN	Multidrug transporters mediate the active extrusion of antibiotics and toxic ions from the cell. This reaction is thought to be based on a switch of the transporter between two conformational states, one in which the interior substrate binding cavity is available for substrate binding at the inside of the cell, and another in which the cavity is exposed to the outside of the cell to enable substrate release. Consistent with this model, cysteine cross-linking studies with the Major Facilitator Superfamily drug/proton antiporter LmrP from Lactococcus lactis demonstrated binding of transported benzalkonium to LmrP in its inward-facing state. The fluorescent dye Hoechst 33342 is a substrate for many multidrug transporters and is extruded by efflux pumps in microbial and mammalian cells. Surprisingly, and in contrast to other multidrug transporters, LmrP was found to actively accumulate, rather than extrude, Hoechst 33342 in lactococcal cells. Consistent with this observation, LmrP expression was associated with cellular sensitivity, rather than resistance to Hoechst 33342. Thus, we discovered a hidden "Janus" amongst LmrP substrates that is translocated in reverse direction across the membrane by binding to outward-facing LmrP followed by release from inward-facing LmrP. These findings are in agreement with distance measurements by electron paramagnetic resonance in which Hoechst 33342 binding was found to stabilize LmrP in its outward-facing conformation. Our data have important implications for the use of multidrug exporters in selective targeting of "Hoechst 33342-like" drugs to cells and tissues in which these transporters are expressed.	[Neuberger, Arthur; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; Neuberger, Arthur/0000-0002-7744-6559	Herchel-Smith Scholarship; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Human Frontier Science Program (HFSP); British Society for Antimicrobial Chemotherapy (BSAC); Commonwealth Trust; BBSRC [BB/I002383/1, BB/K017713/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017713/1, BB/I002383/1] Funding Source: researchfish	Herchel-Smith Scholarship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); British Society for Antimicrobial Chemotherapy (BSAC); Commonwealth Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AN is a recipient of a Herchel-Smith Scholarship. Research in the Van Veen group is also supported by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Human Frontier Science Program (HFSP), the British Society for Antimicrobial Chemotherapy (BSAC), and the Commonwealth Trust.	Aleman C, 2005, J BIOMOL STRUCT DYN, V23, P29, DOI 10.1080/07391102.2005.10507044; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Gbaguidi B, 2004, CELL MOL LIFE SCI, V61, P2646, DOI 10.1007/s00018-004-4298-2; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Masureel M, 2014, NAT CHEM BIOL, V10, P149, DOI 10.1038/nchembio.1408; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038715; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d	26	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141991	10.1371/journal.pone.0141991	http://dx.doi.org/10.1371/journal.pone.0141991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540112	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800042
J	White, SR; Bird, SM; Merrall, ELC; Hutchinson, SJ				White, Simon R.; Bird, Sheila M.; Merrall, Elizabeth L. C.; Hutchinson, Sharon J.			Drugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-Factors	PLOS ONE			English	Article							MORTALITY; SUICIDE; INFECTION; DIAGNOSIS; PRISONERS; OVERDOSE; NALOXONE; RELEASE	We validate that the 28 days after hospital-discharge are high-risk for drugs-related death (DRD) among drug users in Scotland and investigate key risk-factors for DRDs soon after hospital-discharge. Using data from an anonymous linkage of hospitalisation and death records to the Scottish Drugs Misuse Database (SDMD), including over 98,000 individuals registered for drug treatment during 1 April 1996 to 31 March 2010 with 705,538 person-years, 173,107 hospital-stays, and 2,523 DRDs. Time-at-risk of DRD was categorised as: during hospitalization, within 28 days, 29-90 days, 91 days-1 year, >1 year since most recent hospital discharge versus 'never admitted'. Factors of interest were: having ever injected, misuse of alcohol, length of hospital-stay (0-1 versus 2+ days), and main discharge-diagnosis. We confirm SDMD clients' high DRD-rate soon after hospital-discharge in 2006-2010. DRD-rate in the 28 days after hospital-discharge did not vary by length of hospital-stay but was significantly higher for clients who had ever-injected versus otherwise. Three leading discharge-diagnoses accounted for only 150/290 DRDs in the 28 days after hospital-discharge, but ever-injectors for 222/290. Hospital-discharge remains a period of increased DRD-vulnerability in 2006-2010, as in 1996-2006, especially for those with a history of injecting.	[White, Simon R.; Bird, Sheila M.] Cambridge Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England; [Merrall, Elizabeth L. C.] Novartis Vaccines & Diagnost, Novartis Pharam BV, NL-1101 CL Amsterdam, Netherlands; [Hutchinson, Sharon J.] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland	MRC Biostatistics Unit; University of Cambridge; Novartis	White, SR (corresponding author), Cambridge Inst Publ Hlth, Med Res Council Biostat Unit, Cambridge, England.	Simon.White@mrc-bsu.cam.ac.uk	Hutchinson, Sharon/Y-3949-2019	Hutchinson, Sharon/0000-0002-6891-6758; White, Simon/0000-0001-8642-7037	Medical Research Council [MC_US_A030_0007 / 01]; Chief Scientist Office of the Scottish Executive; MRC [MC_U105260794, MC_U105292687] Funding Source: UKRI; Medical Research Council [MC_U105292687, MC_U105260794] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Executive; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (reference: MC_US_A030_0007 / 01). The data for this work were made available as a result of research funded by a grant from the Chief Scientist Office of the Scottish Executive. No sponsor had any role in the study design, data collection, data analysis, data interpretation, or writing of the report.; The authors are grateful to Information Services Division for provision of the linked data. The data for this work were made available as a result of research funded by a grant from the Chief Scientist Office of the Scottish Executive.	Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; COX DR, 1972, J R STAT SOC B, V34, P187; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Degenhardt L, 2009, DRUG ALCOHOL DEPEN, V105, P9, DOI 10.1016/j.drugalcdep.2009.05.021; Hall W, 2010, ADDICTION, V105, P1332, DOI 10.1111/j.1360-0443.2010.02919.x; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; Information Services Division, 2009, IMP CHANG WE PRES OU; Information Services Division, 2014, NAT NAL PROGR SCOTL; Jackson G. W. L., 2001, 5 GEN REG OFF SCOTL; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2007, MED J AUSTRALIA, V187, P387, DOI 10.5694/j.1326-5377.2007.tb01307.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; McDonald SA, 2010, EPIDEMIOL INFECT, V138, P393, DOI 10.1017/S0950268809990616; McDonald SA, 2009, STAT METHODS MED RES, V18, P271, DOI 10.1177/0962280208094690; Merrall E. L. C., 2012, THESIS U CAMBRIDGE; Merrall E, 2013, ADDICT RES THEORY, V21, P52, DOI 10.3109/16066359.2012.690052; Merrall ELC, 2012, INT J DRUG POLICY, V23, P24, DOI 10.1016/j.drugpo.2011.05.010; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Merralll ELC, 2013, ADDICTION, V108, P377, DOI 10.1111/j.1360-0443.2012.04066.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rome A., 2008, REDUCING DRUG USERS; Strang J, 2013, J URBAN HEALTH, V90, P983, DOI 10.1007/s11524-013-9803-1; Workshop C, 2010, ADDICT RES THEORY, V18, P194, DOI 10.3109/16066350902825948	25	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141073	10.1371/journal.pone.0141073	http://dx.doi.org/10.1371/journal.pone.0141073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539701	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800009
J	Narvaez, I; Brochu, CA; Escaso, F; Perez-Garcia, A; Ortega, F				Narvaez, Ivan; Brochu, Christopher A.; Escaso, Fernando; Perez-Garcia, Adan; Ortega, Francisco			New Crocodyliforms from Southwestern Europe and Definition of a Diverse Clade of European Late Cretaceous Basal Eusuchians	PLOS ONE			English	Article							SOUTHERN FRANCE; BIOGEOGRAPHY; MORPHOLOGY; CUENCA; ORIGIN; MARSH; BIOTA	The late Campanian-early Maastrichtian site of Lo Hueco (Cuenca, Spain) has provided a set of well-preserved crocodyliform skull and lower jaw remains, which are described here and assigned to a new basal eusuchian taxon, Lohuecosuchus megadontos gen. et sp. nov. The reevaluation of a complete skull from the synchronous site of Fox-Amphoux (Department of Var, France) allows us to define a second species of this new genus. Phylogenetic analysis places Lohuecosuchus in a clade exclusively composed by European Late Cretaceous taxa. This new clade, defined here as Allodaposuchidae, is recognized as the sister group of Hylaeochampsidae, also comprised of European Cretaceous forms. Allodaposuchidae and Hylaeochampsidae are grouped in a clade identified as the sister group of Crocodylia, the only crocodyliform lineage that reaches our days. Allodaposuchidae shows a vicariant distribution pattern in the European Late Cretaceous archipelago, with several Ibero-Armorican forms more closely related to each other than with to Romanian Allodaposuchus precedens.	[Narvaez, Ivan; Escaso, Fernando; Perez-Garcia, Adan; Ortega, Francisco] Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain; [Brochu, Christopher A.] Univ Iowa, Dept Earth & Environm Sci, Iowa City, IA USA	Universidad Nacional de Educacion a Distancia (UNED); University of Iowa	Narvaez, I (corresponding author), Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain.	inarvaez@ccia.uned.es	Escaso, Fernando/H-9782-2015; García, Adán Pérez/AAM-6680-2021; Narvaez, Ivan/D-8147-2018; Ortega, Francisco/B-5760-2009; Ortega, Francisco/K-3255-2015	Escaso, Fernando/0000-0001-7642-1555; García, Adán Pérez/0000-0002-9074-6855; Narvaez, Ivan/0000-0003-0114-7058; Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X	Spanish Ministerio de Economia y Competitividad [CGL2012-35199]; US National Science Foundation [DEB 1257786-125748]; project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)" [CGL2012-35199]; SYNTHESYS Project - European Community	Spanish Ministerio de Economia y Competitividad(Spanish Government); US National Science Foundation(National Science Foundation (NSF)); project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)"; SYNTHESYS Project - European Community	Funding: This work was supported by the Spanish Ministerio de Economia y Competitividad CGL2012-35199: IN, FE, APG, FO (http://www.mineco.gob.es/portal/site/mineco/), US National Science Foundation DEB 1257786-125748: CAB (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the project "Estudio paleoambiental, faunistico y floristico del yacimiento del Cretacico Superior de Lo Hueco (Fuentes, Cuenca)" (CGL2012-35199). We thank J.M. Gasca, I. Canudo and E. Puertolas (Museo Paleontologico Universidad de Zaragoza); J. Le Loeuff (Musee des Dinosaures d'Esperaza, France); A. D. Buscalioni and J.L. Sanz (Universidad Autonoma de Madrid); T. Tortosa (Museum d'Histoire Naturelle d'Aix-en-Provence); E. Buffetaut, F. Fages, D. Clavel and members of Association Culturelle Archeologique et Paleontologique (Musee de Cruzy); A. and P. Mechin (Vitrolles); M. Padilla (Museo de Anatomia de Vertebrados Universidad Complutense de Madrid); S. Bailon (Museum national d'Histoire naturelle, Paris); L. Steel and S. Chapman (Natural History Museum, London), A. Osi and M. Rabi (Magyar Termeszettudomanyi Muzeum, Budapest), and L. Makadi (Magyar Allami Foldtani Intezet, Budapest) for access to collections. We thank the editor T. Smith and the reviewers M. Delfino and S. Jouve for comments and suggestions. Special thanks to members of Grupo de Biologia Evolutiva UNED: F. Marcos for preparation of the specimens and P. Mocho and A. Paramo for their suggestions. The comparative studies have been supported by the SYNTHESYS Project (http://www.synthesys.info), financed by the European Community Research Infrastructure Action under the FP7 Integrating Activities Programme. CAB was supported by US National Science Foundation DEB 1257786-125748.	Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; Blanco A, 2015, PEERJ, V3, DOI 10.7717/peerj.1171; Blanco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115837; Brochu CA, 2006, J PALEONTOL, V80, P162, DOI 10.1666/0022-3360(2006)080[0162:OAPSOE]2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2012, J VERTEBR PALEONTOL, V32, P587, DOI 10.1080/02724634.2012.652324; Brochu CA, 2012, J VERTEBR PALEONTOL, V32, P105, DOI 10.1080/02724634.2012.633585; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buscalioni AD, 1997, CR ACAD SCI II A, V325, P525, DOI 10.1016/S1251-8050(97)89872-2; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Buscalioni Angela D., 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P213; CLARK J M, 1992, American Museum Novitates, P1; Csiki-Sava Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.469.8439; Delfino M, 2008, PALAEONTOLOGY, V51, P1091, DOI 10.1111/j.1475-4983.2008.00800.x; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Escaso F, 2012, FUNDAMENTAL, V20, P71; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; Houssaye A, 2013, PALAEONTOL Z, V87, P415, DOI 10.1007/s12542-013-0164-6; Huxley TH, 1875, Q J GEOL SOC LOND, V3, P423; Iordansky N.N., 1973, P201; Koken E., 1888, Z DTSCH GEOLOGISCHEN, P754; Laurent Y., 2001, Developments in Palaeontology and Stratigraphy, V19, P657; Laurent Yves, 2000, Oryctos, V3, P19; Leidy J., 1852, P ACAD NAT SCI PHILA, V6, P35; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Martin JE, 2015, ZOOLOGICAL J LINNEAN, DOI [10.1111/zoj.12331, DOI 10.1111/Z0J.12331]; Martin JE, 2008, ZOOL J LINN SOC-LOND, V152, P567, DOI 10.1111/j.1096-3642.2007.00358.x; Martin JE, 2007, J VERTEBR PALEONTOL, V27, P362, DOI 10.1671/0272-4634(2007)27[362:NMOTLC]2.0.CO;2; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; Matheron P., 1869, MEMOIRES ACAD IMPERI, P1; Mook C.C., 1924, AM MUS NOVIT, V117, P1; Narvaez I., 2015, THESIS; Narvaez I, 2014, 74 ANN M SOC VERT PA, P194; Narvaez I., 2013, 6 JORN INT PAL DIN E, P96; Narvaez I., 2011, VIAJANDO MUNDOS PRET, P75; Narvaez Ivan, 2010, Cidaris, V30, P205; Nopcsa F., 1928, GEOL HUNG SER PALAEO, V1, P75; Ortega F, 2015, J IBER GEOL, V41, P83, DOI 10.5209/rev_JIGE.2015.v41.n1.48657; Ortega F., 2008, PUBLICACIONES SEMINA, V8, P331; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Owen R., 1874, PALAEONTOGRAPHICAL S, VXXVII, P1; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Perez-Garcia A, 2012, GEOBIOS-LYON, V45, P219, DOI 10.1016/j.geobios.2011.03.001; Pol D, 2009, B AM MUS NAT HIST, P1; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Serrano H, 2012, FUNDAMENTAL, V20, P237; Smith T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132550; Storrs Glenn W., 2000, P402; Torices A, 2010, MESOGEE, V66, P74; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024	57	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140679	10.1371/journal.pone.0140679	http://dx.doi.org/10.1371/journal.pone.0140679			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535893	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400032
J	Stevely, A; Dimairo, M; Todd, S; Julious, SA; Nicholl, J; Hind, D; Cooper, CL				Stevely, Abigail; Dimairo, Munyaradzi; Todd, Susan; Julious, Steven A.; Nicholl, Jonathan; Hind, Daniel; Cooper, Cindy L.			An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review	PLOS ONE			English	Review							METASTATIC PANCREATIC-CANCER; MULTIPLE TESTING PROCEDURE; CLINICAL-TRIALS; ADAPTIVE DESIGNS; FLOW DIAGRAMS; QUALITY; BENEFIT; OPPORTUNITIES; GEMCITABINE; BOUNDARIES	Background It can be argued that adaptive designs are underused in clinical research. We have explored concerns related to inadequate reporting of such trials, which may influence their uptake. Through a careful examination of the literature, we evaluated the standards of reporting of group sequential (GS) randomised controlled trials, one form of a confirmatory adaptive design. Methods We undertook a systematic review, by searching Ovid MEDLINE from the 1st January 2001 to 23rd September 2014, supplemented with trials from an audit study. We included parallel group, confirmatory, GS trials that were prospectively designed using a Frequentist approach. Eligible trials were examined for compliance in their reporting against the CONSORT 2010 checklist. In addition, as part of our evaluation, we developed a supplementary checklist to explicitly capture group sequential specific reporting aspects, and investigated how these are currently being reported. Results Of the 284 screened trials, 68(24%) were eligible. Most trials were published in "high impact" peer-reviewed journals. Examination of trials established that 46(68%) were stopped early, predominantly either for futility or efficacy. Suboptimal reporting compliance was found in general items relating to: access to full trials protocols; methods to generate randomisation list(s); details of randomisation concealment, and its implementation. Benchmarking against the supplementary checklist, GS aspects were largely inadequately reported. Only 3(7%) trials which stopped early reported use of statistical bias correction. Moreover, 52(76%) trials failed to disclose methods used to minimise the risk of operational bias, due to the knowledge or leakage of interim results. Occurrence of changes to trial methods and outcomes could not be determined in most trials, due to inaccessible protocols and amendments. Discussion and Conclusions There are issues with the reporting of GS trials, particularly those specific to the conduct of interim analyses. Suboptimal reporting of bias correction methods could potentially imply most GS trials stopping early are giving biased results of treatment effects. As a result, research consumers may question credibility of findings to change practice when trials are stopped early. These issues could be alleviated through a CONSORT extension. Assurance of scientific rigour through transparent adequate reporting is paramount to the credibility of findings from adaptive trials. Our systematic literature search was restricted to one database due to resource constraints.	[Stevely, Abigail] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England; [Dimairo, Munyaradzi; Julious, Steven A.; Nicholl, Jonathan; Hind, Daniel; Cooper, Cindy L.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Todd, Susan] Univ Reading, Dept Math & Stat, Reading, Berks, England	University of Sheffield; University of Sheffield; University of Reading	Dimairo, M (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	m.dimairo@sheffield.ac.uk	Hind, Daniel/AAE-1769-2020; Hind, Daniel/A-2180-2010; Dimairo, Munya/U-6905-2019; Dimairo, Munyaradzi/H-4329-2019; Stevely, Abigail/AAW-3647-2020	Hind, Daniel/0000-0002-6409-4793; Hind, Daniel/0000-0002-6409-4793; Stevely, Abigail/0000-0002-5637-5245; Dimairo, Munyaradzi/0000-0002-9311-6920	National Institute for Health Research [DRF-2012-05-182]; University of Sheffield; University of Reading; National Institute for Health Research [NF-SI-0512-10050] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Sheffield; University of Reading; National Institute for Health Research(National Institute for Health Research (NIHR))	The National Institute for Health Research fully funded MD as part of a Doctoral Research Fellowship (Grant Number: DRF-2012-05-182). The University of Sheffield funded SAJ, JN, CLC and DH. The University of Reading funded ST. AS contributed to this work as part of her research internship at the University of Sheffield Medical School. All funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Altman DG, 2012, STAT MED, V31, P2985, DOI 10.1002/sim.5402; Bassler D, 2008, J CLIN EPIDEMIOL, V61, P241, DOI 10.1016/j.jclinepi.2007.07.016; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Camm CF, 2013, INT J CARDIOL, V168, P1393, DOI 10.1016/j.ijcard.2012.12.020; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chang M, 2006, J BIOPHARM STAT, V16, P299, DOI 10.1080/10543400600609718; Chew EY, 2014, OPHTHALMOLOGY, V121, P535, DOI 10.1016/j.ophtha.2013.10.027; Chow SC, 2014, ANNU REV MED, V65, P405, DOI 10.1146/annurev-med-092012-112310; Chow SC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-79; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Chuang-Stein C, 2010, J BIOPHARM STAT, V20, P1143, DOI 10.1080/10543406.2010.514456; Coffey CS, 2012, CLIN TRIALS, V9, P671, DOI 10.1177/1740774512461859; Detry MA, 2012, STANDARDS DESIGN CON; Dimairo M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0958-9; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Elsaesser A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-383; EMERSON SS, 1993, COMPUT BIOMED RES, V26, P68, DOI 10.1006/cbmr.1993.1004; EMERSON SS, 1990, BIOMETRIKA, V77, P875, DOI 10.2307/2337110; Emerson SS, 1997, BIOMETRICS, V53, P365, DOI 10.2307/2533122; *EQUATOR NETW, ENH QUALITY TRANSP H; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Freidlin B, 2009, CLIN TRIALS, V6, P119, DOI 10.1177/1740774509102310; Gaydos B, 2009, DRUG INF J, V43, P539, DOI 10.1177/009286150904300503; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hurst Dominic, 2011, Evid Based Dent, V12, P52, DOI 10.1038/sj.ebd.6400796; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Jennison C, 2000, FLEXIBLE MONITORING, P148; Kairalla JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-145; KIM K, 1989, BIOMETRICS, V45, P613, DOI 10.2307/2531502; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Liu AY, 1999, BIOMETRIKA, V86, P71, DOI 10.1093/biomet/86.1.71; Liu Q, 2010, J BIOPHARM STAT, V20, P1178, DOI 10.1080/10543406.2010.514462; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Middleton G, 2014, LANCET ONCOL, V15, P829, DOI 10.1016/S1470-2045(14)70236-0; Milanzi E, 2014, STAT BIOSCIENCES; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moore MJ, 2003, J CLIN ONCOL, V21, P3296, DOI 10.1200/JCO.2003.02.098; Morgan CC, 2014, THER INNOV REGUL SCI, V48, P473, DOI 10.1177/2168479014522468; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PAMPALLONA S, 1994, J STAT PLAN INFER, V42, P19, DOI 10.1016/0378-3758(94)90187-2; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Pritchett Y, 2011, CLIN TRIALS, V8, P165, DOI 10.1177/1740774511399128; Quinlan J, 2010, CLIN TRIALS, V7, P167, DOI 10.1177/1740774510361542; Quinlan JA, 2006, DRUG INF J, V40, P437, DOI 10.1177/216847900604000409; SAACTD Workshop Committee, 2009, CONN NONPR AD CLIN T; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sjogren P, 2002, BRIT DENT J, V192, P100, DOI 10.1038/sj.bdj.4801304; Stovold E, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-54; Thadhani R, 2012, VITAMIN D THERAPY CA, V02114; Todd S, 1996, BIOMETRIKA, V83, P453, DOI 10.1093/biomet/83.2.453; Todd S, 2007, STAT MED, V26, P237, DOI 10.1002/sim.2763; Troger W, 2013, EUR J CANCER, V49, P3788, DOI 10.1016/j.ejca.2013.06.043; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; US Food and Drug Administration, 2010, GUID IND AD DES CLIN; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Wears RL, 2015, ANN EMERG MED, V65, P214, DOI 10.1016/j.annemergmed.2014.12.020; Whitehead J, 1999, STAT MED, V18, P2271; WHITEHEAD J, 1986, BIOMETRIKA, V73, P573, DOI 10.1093/biomet/73.3.573; Wittes J, 2012, CLIN TRIALS, V9, P714, DOI 10.1177/1740774512454600; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; Yao AC, 2014, EYE, V28, P1341, DOI 10.1038/eye.2014.206; Zannad F, 2012, CIRC-HEART FAIL, V5, P294, DOI 10.1161/CIRCHEARTFAILURE.111.965707; Zhang JJ, 2012, CLIN CANCER RES, V18, P4872, DOI 10.1158/1078-0432.CCR-11-3118; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	77	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141104	10.1371/journal.pone.0141104	http://dx.doi.org/10.1371/journal.pone.0141104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528812	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000364032600017
J	Tu, XY; Kuang, ZC; Gong, X; Shi, Y; Yu, L; Shi, HJ; Wang, J; Sun, ZG				Tu, Xiaoyu; Kuang, Zhichao; Gong, Xia; Shi, Yan; Yu, Lin; Shi, Huijuan; Wang, Jian; Sun, Zhaogui			The Influence of LepR Tyrosine Site Mutations on Mouse Ovary Development and Related Gene Expression Changes	PLOS ONE			English	Article							LEPTIN RECEPTOR; C-KIT; CELL PROLIFERATION; MEDICAL PROGRESS; IDENTIFICATION; LOCALIZATION; PROTEIN; OBESITY; CLONING; TARGET	Leptin exerts many biological functions, such as in metabolism and reproduction, through binding to and activating the leptin receptor, LepRb, which is expressed in many regions of the brain. To better understand the roles of LepR downstream signaling pathways, Y123F mice, which expressed mutant leptin receptors with phenylalanine (F) substituted for three tyrosines (Y) (Tyr985, Tyr1077 and Tyr1138), were generated. The body weight and abdominal fat deposits of Y123F homozygous mice (HOM) were higher than those of wildtype mice (WT). HOM ovaries were atrophic and the follicles developed abnormally; however, the HOM ovaries did not exhibit polycystic phenotypes. Moreover, Y123F HOM adults had no estrous cycle and the blood estrogen concentration remained stable at a low level below detection limit of 5 pg/ml. LepR expression in HOM ovaries was higher than in WT ovaries. Using cDNA Microarrays, the mRNA expressions of 41 genes were increased, and 100 were decreased in HOM vs. WT ovaries, and many signaling pathways were evaluated to be involved significantly. The expressions of 19 genes were validated by real-time quantitative PCR, most of which were consistent with the microarray results. Thus, Y123F HOM mice were suggested as a new animal model of PCOS for research that mainly emphasizes metabolic disorders and anovulation, but not the polycystic phenotype. Meanwhile, using the model, we found that JAK-STAT and hormone biosynthesis pathways were involved in the follicular development and ovulation disorders caused by LepR deficiency in ovaries, although we could not exclude indirect actions from the brain.	[Tu, Xiaoyu; Kuang, Zhichao] Fudan Univ, Shanghai Med Coll, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Shi, Yan; Yu, Lin; Shi, Huijuan; Wang, Jian; Sun, Zhaogui] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China; [Gong, Xia] Shanghai Business Sch, Dept Food Sci, Shanghai, Peoples R China	Fudan University; Shanghai Business School	Sun, ZG (corresponding author), Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [81170569, 81370682]; Project from Science and Technology Commission of Shanghai Municipality [14140901301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project from Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (No. 81170569 and 81370682) and Project from Science and Technology Commission of Shanghai Municipality (14140901301). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 1997, GENOMICS, V39, P216, DOI 10.1006/geno.1996.4482; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Cirmanova V, 2008, PHYSIOL RES, V57, pS143, DOI 10.33549/physiolres.931499; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Elmquist JK, 2000, FRONT HORM RES, V26, P21; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARRIS DR, 1989, ANAT RECORD, V225, P310, DOI 10.1002/ar.1092250407; Ghizzoni L, 2001, HORM METAB RES, V33, P323, DOI 10.1055/s-2001-15419; Gorska E, 2010, EUR J MED RES, V15, P50; Guillemette C, 2004, BREAST CANCER RES, V6, P246, DOI 10.1186/bcr936; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Hiney JK, 1996, ENDOCRINOLOGY, V137, P3717, DOI 10.1210/en.137.9.3717; HORIE K, 1993, HUM REPROD, V8, P1955, DOI 10.1093/oxfordjournals.humrep.a137967; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Israel D, 2010, TRENDS ENDOCRIN MET, V21, P10, DOI 10.1016/j.tem.2009.07.004; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Kendall NR, 2004, REPRODUCTION, V128, P757, DOI 10.1530/rep.1.00256; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Moschos S, 2002, FERTIL STERIL, V77, P433, DOI 10.1016/S0015-0282(01)03010-2; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; Schedin P, 2000, J MAMMARY GLAND BIOL, V5, P211, DOI 10.1023/A:1026447506666; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Spicer LJ, 1997, ENDOCRINOLOGY, V138, P3374, DOI 10.1210/en.138.8.3374; Starlard-Davenport A, 2008, STEROIDS, V73, P139, DOI 10.1016/j.steroids.2007.09.007; Starlard-Davenport A, 2007, STEROIDS, V72, P85, DOI 10.1016/j.steroids.2006.11.016; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Swain JE, 2004, BIOL REPROD, V71, P1446, DOI 10.1095/biolreprod.104.033035; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Torn S, 2003, BIOCHEM BIOPH RES CO, V305, P37, DOI 10.1016/S0006-291X(03)00694-6; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wang N, 2014, METABOLISM, V63, P94, DOI 10.1016/j.metabol.2013.09.001; You J, 2010, MOL CELL BIOL, V30, P1650, DOI 10.1128/MCB.01307-09; Zabeau L, 2015, CELL MOL LIFE SCI, V72, P629, DOI 10.1007/s00018-014-1697-x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	45	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141800	10.1371/journal.pone.0141800	http://dx.doi.org/10.1371/journal.pone.0141800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529315	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600061
J	Le Trinh, T; Zhu, GZ; Xiao, XL; Puszyk, W; Sefah, K; Wu, QF; Tan, WH; Liu, C				Le Trinh, Thu; Zhu, Guizhi; Xiao, Xilin; Puszyk, William; Sefah, Kwame; Wu, Qunfeng; Tan, Weihong; Liu, Chen			A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy	PLOS ONE			English	Article							DOXORUBICIN-ELUTING BEADS; IN-VITRO; DELIVERY; NUCLEOLIN; NANOPARTICLES; CELLS; RNA; CYTOTOXICITY; LIPOPROTEINS; DISCOVERY	AS1411 (previously known as AGRO100) is a 26 nucleotide guanine-rich DNA aptamer which forms a guanine quadruplex structure. AS1411 has shown promising utility as a treatment for cancers in Phase I and Phase II clinical trials without causing major side-effects. AS1411 inhibits tumor cell growth by binding to nucleolin which is aberrantly expressed on the cell membrane of many tumors. In this study, we utilized a simple technique to conjugate a widely-used chemotherapeutic agent, doxorubicin (Dox), to AS1411 to form a synthetic Drug-DNA Adduct (DDA), termed as AS1411-Dox. We demonstrate the utility of AS1411-Dox in the treatment of hepatocellular carcinoma (HCC) by evaluating the targeted delivery of Dox to Huh7 cells in vitro and in a murine xenograft model of HCC.	[Le Trinh, Thu; Puszyk, William; Wu, Qunfeng; Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, Shands Canc Ctr, Ctr Res Bio Nano Interface, UF Genet Inst,Dept Chem, Gainesville, FL 32611 USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Tan, Weihong] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Mol Sci & Biomed Lab, Coll Biol, Changsha 410082, Hunan, Peoples R China; [Tan, Weihong] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Hunan University; Hunan University	Tan, WH (corresponding author), Univ Florida, Shands Canc Ctr, Ctr Res Bio Nano Interface, UF Genet Inst,Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu; liu@pathology.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Zhu, Guizhi/AAN-2888-2020	Tan, Weihong/0000-0002-8066-1524; Zhu, Guizhi/0000-0002-2945-7982	National Institute of Heath [R01 CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086, K24CA139570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	National Institute of Heath; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank the National Institute of Heath for awarding the funding for this project R01 CA133086 to (CL) and (WT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Chen H, 2013, J BIOTECHNOL, V168, P362, DOI 10.1016/j.jbiotec.2013.10.024; CHIN J H, 1986, Annals Academy of Medicine Singapore, V15, P162; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; DASHTI N, 1984, BIOCHIM BIOPHYS ACTA, V794, P373, DOI 10.1016/0005-2760(84)90003-1; DiPaola R.S., 2002, CLIN CANCER RES, V8, P3512; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Guo JW, 2011, BIOMATERIALS, V32, P8010, DOI 10.1016/j.biomaterials.2011.07.004; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P665, DOI 10.1038/nrd3270; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Lahoti TS, 2012, CURR NEUROVASC RES, V9, P282; LEVISCHAFFER F, 1982, CANCER TREAT REP, V66, P107; Li WM, 2014, ANAT REC, V297, P2280, DOI 10.1002/ar.22990; Lilienberg E, 2014, MOL PHARMACEUT, V11, P131, DOI 10.1021/mp4002574; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Pan X, 2010, TRANSPL P, V42, P1899, DOI 10.1016/j.transproceed.2009.11.043; Park Eun-sung, 2003, J Vet Sci, V4, P129; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Santra S, 2011, J AM CHEM SOC, V133, P16680, DOI 10.1021/ja207463b; Scharf A, 2013, ACS NANO, V7, P10695, DOI 10.1021/nn403443r; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shao RG, 2004, ACTA PHARMACOL SIN, V25, P756; Shieh YA, 2010, ACS NANO, V4, P1433, DOI 10.1021/nn901374b; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Vogl TJ, 2014, EXPERT OPIN PHARMACO, V15, P115, DOI 10.1517/14656566.2014.855719; Webb S, 2011, NAT BIOTECHNOL, V29, P297, DOI 10.1038/nbt0411-297; Xiong XL, 2013, ANGEW CHEM INT EDIT, V52, P1472, DOI 10.1002/anie.201207063; Yang L, 2011, ADV DRUG DELIVER REV, V63, P1361, DOI 10.1016/j.addr.2011.10.002; Yang M, 1998, BBA-GEN SUBJECTS, V1380, P329, DOI 10.1016/S0304-4165(97)00161-X; Yu DH, 2013, MACROMOL BIOSCI, V13, P1413, DOI 10.1002/mabi.201300165; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561; Zhang BL, 2014, J CONTROL RELEASE, V192, P192, DOI 10.1016/j.jconrel.2014.06.037; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8	51	40	43	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0136673	10.1371/journal.pone.0136673	http://dx.doi.org/10.1371/journal.pone.0136673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523833	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800001
J	Zeng, XF; Zhao, N; Sun, HW; Ye, L; Zhai, JQ				Zeng, Xiaofan; Zhao, Na; Sun, Huaiwei; Ye, Lei; Zhai, Jianqing			Changes and Relationships of Climatic and Hydrological Droughts in the Jialing River Basin, China	PLOS ONE			English	Article							TRENDS; INDEX; CIRCULATION; IRAN	The comprehensive assessment of climatic and hydrological droughts in terms of their temporal and spatial evolutions is very important for water resources management and social development in the basin scale. To study the spatial and temporal changes of climatic and hydrological droughts and the relationships between them, the SPEI and SDI are adopted to assess the changes and the correlations of climatic and hydrological droughts by selecting the Jialing River basin, China as the research area. The SPEI and SDI at different time scales are assessed both at the entire Jialing River basin and at the regional levels of the three sub basins. The results show that the SPEI and SDI are very suitable for assessing the changes and relationships of climatic and hydrological droughts in large basins. Based on the assessment, for the Jialing River basin, climatic and hydrological droughts have the increasing tendency during recent several decades, and the increasing trend of climatic droughts is significant or extremely significant in the western and northern basin, while hydrological drought has a less significant increasing trend. Additionally, climatic and hydrological droughts tend to increase in the next few years. The results also show that on short time scales, climatic droughts have one or two months lag impact on hydrological droughts in the north-west area of the basin, and have one month lag impact in south-east area of the basin. The assessment of climatic and hydrological droughts based on the SPEI and SDI could be very useful for water resources management and climate change adaptation at large basin scale.	[Zeng, Xiaofan; Zhao, Na] Inst Water Resources Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China; [Zeng, Xiaofan; Zhao, Na; Sun, Huaiwei; Ye, Lei] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China; [Zhai, Jianqing] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China	China Institute of Water Resources & Hydropower Research; Huazhong University of Science & Technology; China Meteorological Administration	Zhao, N (corresponding author), Inst Water Resources Hydropower Res, State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China.	na.zhao.2011@hust.edu.cn	Sun, Huaiwei/AAB-4063-2019	Sun, Huaiwei/0000-0003-4873-0697	National Natural Science Foundation of China [51309105, 51409109]; Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China [IWHR-SKL-201307, IWHR-SKL-201308]; Fundamental Research Funds for the Central Universities, HUST [2014QN233, 2014QN234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China; Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	Support was provided by: 1) National Natural Science Foundation of China (No. 51309105), to XFZ [http://www.nsfc.gov.cn/]; 2) National Natural Science Foundation of China (No. 51409109), to NZ [http://www.nsfc.gov.cn/]; 3) Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China (IWHR-SKL-201307), to XFZ [http://www.skl-wac.cn/sklsr/kfjj/A4505index_1.htm]; 4) Open Research Foundation of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin, China (IWHR-SKL-201308), to NZ [http://www.skl-wac.cn/sklsr/kfjj/A4505index_1.htm]; 5) Fundamental Research Funds for the Central Universities, HUST (No. 2014QN233), to XFZ; 6) Fundamental Research Funds for the Central Universities, HUST (No. 2014QN234), NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis KM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025711; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; [杜华明 Du Huaming], 2015, [自然资源学报, Journal of Natural Resources], V30, P836; [段文明 Duan Wenming], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P97; Fu GB, 2004, CLIMATIC CHANGE, V65, P149, DOI 10.1023/B:CLIM.0000037491.95395.bb; Gan TY, 1998, WATER RESOUR RES, V34, P3009, DOI 10.1029/98WR01265; IPCC, 2011, MAN RISKS EXTR EV DI; KENDALL M. G., 1948, Rank correlation methods.; Lopez-Moreno JI, 2013, J HYDROL, V477, P175, DOI 10.1016/j.jhydrol.2012.11.028; MCKEE TB, 1995, NINTH CONFERENCE ON APPLIED CLIMATOLOGY, P233; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Nalbantis I, 2009, WATER RESOUR MANAG, V23, P881, DOI 10.1007/s11269-008-9305-1; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Rodier JA, 1985, UNESCO WMO STUDIES R, P149; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Shafer B. A., 1982, P W SNOW C COL STAT, P164; SINGH VP, 1993, STOCH HYDROL HYDRAUL, V7, P163, DOI 10.1007/BF01585596; Sneyers R., 1991, Technical Note - World Meteorological Organization; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sterl A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034071; Tabari H, 2013, WATER RESOUR MANAG, V27, P137, DOI 10.1007/s11269-012-0173-3; Talaee PH, 2014, HYDROL PROCESS, V28, P764, DOI 10.1002/hyp.9586; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Tian D, 2012, J HYDROL, V475, P350, DOI 10.1016/j.jhydrol.2012.10.009; Tsakiris G, 2007, WATER RESOUR MANAG, V21, P821, DOI 10.1007/s11269-006-9105-4; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang HJ, 2001, ADV ATMOS SCI, V18, P376; Wilhite DA, 1992, ENCY EARTH SYSTEM SC, V2, P81, DOI DOI 10.4324/9781315298917-26; Wilhite DA, 2007, WATER RESOUR MANAG, V21, P763, DOI 10.1007/s11269-006-9076-5; [叶磊 Ye Lei], 2015, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V24, P943; Zhang Q., 2003, CHINA CLIMATE IMPACT, P12; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	33	16	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141648	10.1371/journal.pone.0141648	http://dx.doi.org/10.1371/journal.pone.0141648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544070	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700037
J	Castagnola, P; Zoppoli, G; Gandolfo, S; Monticone, M; Malacarne, D; Cirmena, G; Brown, D; Aiello, C; Maffei, M; Marino, R; Giaretti, W; Pentenero, M				Castagnola, Patrizio; Zoppoli, Gabriele; Gandolfo, Sergio; Monticone, Massimiliano; Malacarne, Davide; Cirmena, Gabriella; Brown, David; Aiello, Cinzia; Maffei, Massimo; Marino, Roberto; Giaretti, Walter; Pentenero, Monica			Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs	PLOS ONE			English	Article							POTENTIALLY MALIGNANT LESIONS; FALSE DISCOVERY RATE; CHROMOSOMAL INSTABILITY; EPITHELIAL DYSPLASIA; HIGH-RISK; PROGRESSION; HEAD; LEUKOPLAKIA; ALGORITHMS; EVOLUTION	Oral potentially malignant disorders (OPMDs) characterized by the presence of dysplasia and DNA copy number aberrations (CNAs), may reflect chromosomal instability (CIN) and predispose to oral squamous cell carcinoma (OSCC). Early detection of OPMDs with such characteristics may play a crucial role in OSCC prevention. The aim of this study was to explore the relationship between CNAs, histological diagnosis, oral subsite and aneuploidy in OPMDs/OSCCs. Samples from OPMDs and OSCCs were processed by high-resolution DNA flow cytometry (hr DNA-FCM) to determine the relative nuclear DNA content. Additionally, CNAs were obtained for a subset of these samples by genome-wide array comparative genomic hybridization (aCGH) using DNA extracted from either diploid or aneuploid nuclei suspension sorted by FCM. Our study shows that: i) aneuploidy, global genomic imbalance (measured as the total number of CNAs) and specific focal CNAs occur early in the development of oral cancer and become more frequent at later stages; ii) OPMDs limited to tongue (TNG) mucosa display a higher frequency of aneuploidy compared to OPMDs confined to buccal mucosa (BM) as measured by DNA-FCM; iii) TNG OPMDs/OSCCs show peculiar features of CIN compared to BM OPMDs/OSCCs given the preferential association with total broad and specific focal CNA gains. Follow-up studies are warranted to establish whether the presence of DNA aneuploidy and specific focal or broad CNAs may predict cancer development in non-dysplastic OPMDs.	[Castagnola, Patrizio; Zoppoli, Gabriele; Monticone, Massimiliano; Malacarne, Davide; Aiello, Cinzia; Giaretti, Walter] IRCCS AOU San Martino IST, Genoa, Italy; [Zoppoli, Gabriele; Cirmena, Gabriella; Maffei, Massimo] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Gandolfo, Sergio; Marino, Roberto; Pentenero, Monica] Univ Turin, Dept Oncol, Oral Med & Oral Oncol Unit, Turin, Italy; [Brown, David] Univ Libre Bruxelles, Inst Jules Bordet, JC Heuson Breast Canc Translat Res Lab, Brussels, Belgium	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Turin; Institut Jules Bordet; Universite Libre de Bruxelles	Castagnola, P (corresponding author), IRCCS AOU San Martino IST, Genoa, Italy.	patrizio.castagnola@hsanmartino.it	Castagnola, Patrizio/H-2029-2012; Maffei, Massimo/AAC-1669-2020; Zoppoli, Gabriele/B-6935-2016; Pentenero, Monica/F-8797-2013; Zoppoli, Gabriele/B-6935-2016	Castagnola, Patrizio/0000-0003-2008-9199; Maffei, Massimo/0000-0002-2453-9065; Zoppoli, Gabriele/0000-0003-3890-5588; Pentenero, Monica/0000-0003-3972-1203; Maffei, Massimo/0000-0001-6814-2353; Cirmena, Gabriella/0000-0002-5794-2766; Zoppoli, Gabriele/0000-0002-1619-1708	Compagnia di San Paolo [2011.0173]; AIRC [MFAG10570]; Ministero della Salute-Fondi Ministero della Salute	Compagnia di San Paolo(Compagnia di San Paolo); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute-Fondi Ministero della Salute	This work was supported by Compagnia di San Paolo-2011.0173- (http://www.compagniadisanpaolo.it), AIRC -MFAG10570- (http://www.airc.it), and Ministero della Salute-Fondi Ministero della Salute - 5 per mille 2011- (http://www.salute.gov.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Arduino PG, 2013, ORAL DIS, V19, P642, DOI 10.1111/odi.12065; Awan Kh, 2014, J Int Oral Health, V6, pi; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloebaum M, 2014, J CRANIO MAXILL SURG, V42, P1572, DOI 10.1016/j.jcms.2014.01.046; Borkosky SS, 2009, J CANCER RES CLIN, V135, P703, DOI 10.1007/s00432-008-0507-y; Bradley G, 2010, BRIT J CANCER, V103, P1432, DOI 10.1038/sj.bjc.6605905; Brennan M, 2007, ORAL SURG ORAL MED O, V103, pS19, DOI 10.1016/j.tripleo.2006.10.015; Buffart TE, 2007, CELL ONCOL, V29, P351; BUNDGAARD T, 1992, CANCER-AM CANCER SOC, V70, P1, DOI 10.1002/1097-0142(19920701)70:1<1::AID-CNCR2820700102>3.0.CO;2-S; Carlson JM HD, 2009, MICROSOFT RESEARCH T; Castagnola P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-445; Donadini A, 2010, CELL ONCOL, V32, P373, DOI 10.3233/CLO-2010-0525; Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2; Giaretti W, 2013, CANCER EPIDEM BIOMAR, V22, P1133, DOI 10.1158/1055-9965.EPI-13-0147; Giaretti W, 2012, FUTURE ONCOL, V8, P1257, DOI [10.2217/fon.12.116, 10.2217/FON.12.116]; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kresty LA, 2002, CANCER RES, V62, P5295; Ledet EM, 2013, PROSTATE, V73, P614, DOI 10.1002/pros.22602; Lee H, 2002, GENETICS, V161, P905; Lin M, 2006, ONCOGENE, V25, P1424, DOI 10.1038/sj.onc.1209166; Lippman SM, 2001, NEW ENGL J MED, V344, P1323, DOI 10.1056/NEJM200104263441710; Louhimo R, 2012, NAT METHODS, V9, P351, DOI [10.1038/NMETH.1893, 10.1038/nmeth.1893]; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nankivell P, 2013, OR SURG OR MED OR PA, V115, P87, DOI 10.1016/j.oooo.2012.10.015; Navone R, 2008, J ORAL PATHOL MED, V37, P358, DOI 10.1111/j.1600-0714.2008.00636.x; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; OTTO FJ, 1994, METHOD CELL BIOL, V41, P211; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Potapova TA, 2013, CANCER METAST REV, V32, P377, DOI 10.1007/s10555-013-9436-6; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; SAITO T, 1991, INT J ORAL MAX SURG, V20, P259, DOI 10.1016/S0901-5027(05)80148-1; SAITO T, 1995, INT J ORAL MAX SURG, V24, P44, DOI 10.1016/S0901-5027(05)80855-0; Salahshourifar I, 2014, ORAL ONCOL, V50, P404, DOI 10.1016/j.oraloncology.2014.02.005; SCULLY C, 1993, J ORAL PATHOL MED, V22, P246, DOI 10.1111/j.1600-0714.1993.tb01066.x; Scully C, 2014, ORAL DIS, V20, P1, DOI 10.1111/odi.12208; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sklenicka S, 2010, J ORAL MAXIL SURG, V68, P1270, DOI 10.1016/j.joms.2009.11.016; Smeets SJ, 2006, ONCOGENE, V25, P2558, DOI 10.1038/sj.onc.1209275; Sotillo R, 2009, CANCER CELL, V16, P451, DOI 10.1016/j.ccr.2009.11.014; Sperandio M, 2013, CANCER PREV RES, V6, P822, DOI 10.1158/1940-6207.CAPR-13-0001; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres-Rendon A, 2009, ORAL ONCOL, V45, P468, DOI 10.1016/j.oraloncology.2008.07.006; Towle R, 2014, CANCER MED-US, V3, P1170, DOI 10.1002/cam4.307; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; WALDRON CA, 1975, CANCER-AM CANCER SOC, V36, P1386, DOI 10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yong ZWE, 2014, SCI REP-UK, V4, DOI 10.1038/srep06073; Yoshioka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056165; Zhang LW, 2012, CANCER PREV RES, V5, P1081, DOI 10.1158/1940-6207.CAPR-12-0173	57	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142294	10.1371/journal.pone.0142294	http://dx.doi.org/10.1371/journal.pone.0142294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540282	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800076
J	Jackson, EE; Rendina-Ruedy, E; Smith, BJ; Lacombe, VA				Jackson, Ellen E.; Rendina-Ruedy, Elisabeth; Smith, Brenda J.; Lacombe, Veronique A.			Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; PROLONGED HYPERINSULINEMIA; SKELETAL-MUSCLE; TLR4 EXPRESSION; PLASMA-GLUCOSE; MICE; INFLAMMATION; TRANSPORTER; GLUT8; OBESITY	Diabetes is a chronic inflammatory disease that carries a high risk of cardiovascular disease. However, the pathophysiological link between these disorders is not well known. We hypothesize that TLR4 signaling mediates high fat diet (HFD)-induced peripheral and cardiac glucose metabolic derangements. Mice with a loss-of-function mutation in TLR4 (C3H/HeJ) and age-matched control (C57BL/6) mice were fed either a high-fat diet or normal diet for 16 weeks. Glucose tolerance and plasma insulin were measured. Protein expression of glucose transporters (GLUT), AKT (phosphorylated and total), and proinflammatory cytokines (IL-6, TNF-alpha and SOCS-3) were quantified in the heart usingWestern Blotting. Both groups fed a long-term HFD had increased body weight, blood glucose and insulin levels, as well as impaired glucose tolerance compared to mice fed a normal diet. TLR4-mutant mice were partially protected against long-term HFD-induced insulin resistance. In control mice, feeding a HFD decreased cardiac crude membrane GLUT4 protein content, which was partially rescued in TLR4-mutant mice. TLR4-mutant mice fed a HFD also had increased expression of GLUT8, a novel isoform, compared to mice fed a normal diet. GLUT8 content was positively correlated with SOCS-3 and IL-6 expression in the heart. No significant differences in cytokine expression were observed between groups, suggesting a lack of inflammation in the heart following a HFD. Loss of TLR4 function partially restored a healthy metabolic phenotype, suggesting that TLR4 signaling is a key mechanism in HFD-induced peripheral and cardiac insulin resistance. Our data further suggest that TLR4 exerts its detrimental metabolic effects in the myocardium through a cytokine-independent pathway.	[Jackson, Ellen E.; Lacombe, Veronique A.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Rendina-Ruedy, Elisabeth; Smith, Brenda J.] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA; [Lacombe, Veronique A.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lacombe, VA (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	veronique.lacombe@okstate.edu		Jackson, Ellen/0000-0001-6866-2105	NIH [T35OD011186]; American Veterinary Medical Foundation; Oklahoma State University Center for Veterinary Health Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Veterinary Medical Foundation; Oklahoma State University Center for Veterinary Health Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge funding from NIH grant T35OD011186, the American Veterinary Medical Foundation, and the Oklahoma State University Center for Veterinary Health Sciences.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; CDC National Diabetes Fact Sheet, 2014, NAT ENT DIS SURV LIS, P1, DOI [10.1002/ejoc.201200111, DOI 10.1002/EJOC.201200111]; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Laat MA, 2015, VET J, V205, P381, DOI 10.1016/j.tvjl.2015.05.018; de Laat MA, 2015, EQUINE VET J, V47, P494, DOI 10.1111/evj.12320; de Laat MA, 2014, VET IMMUNOL IMMUNOP, V157, P78, DOI 10.1016/j.vetimm.2013.10.010; de Laat MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00120; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; Dong BJ, 2012, AM J PHYSIOL-HEART C, V303, pH732, DOI 10.1152/ajpheart.00948.2011; Fuentes-Antras J, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/847827; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-77; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim J. J., 2010, GASTROENTEROL RES PR, V2010; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Ko HJ, 2009, DIABETES, V58, P2536, DOI 10.2337/db08-1361; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kowalski GM, 2015, BIOCHEM BIOPH RES CO, V463, P818, DOI 10.1016/j.bbrc.2015.06.019; Lacombe VA, 2003, AM J VET RES, V64, P1500, DOI 10.2460/ajvr.2003.64.1500; Lacombe Veronique A, 2014, ISRN Vet Sci, V2014, P409547, DOI 10.1155/2014/409547; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Lucas EA, 2011, BRIT J NUTR, V106, P1495, DOI 10.1017/S0007114511002066; Manolakis AC, 2011, EUR J ENDOCRINOL, V165, P261, DOI 10.1530/EJE-11-0280; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Razolli DS, 2015, ENDOCRINOLOGY, V156, P103, DOI 10.1210/en.2014-1552; Rendina-Ruedy E, 2015, J BONE MINER METAB; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Waller AP, 2012, VET IMMUNOL IMMUNOP, V149, P208, DOI 10.1016/j.vetimm.2012.07.003; Waller AP, 2011, J VET INTERN MED, V25, P315, DOI 10.1111/j.1939-1676.2010.0674.x; Waller AP, 2013, BBA-MOL BASIS DIS, V1832, P121, DOI 10.1016/j.bbadis.2012.09.013; Waller APK A., 2015, BIOCHIM BIOPHYS ACTA, V1852, P9	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142077	10.1371/journal.pone.0142077	http://dx.doi.org/10.1371/journal.pone.0142077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539824	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800050
J	Lin, DR; Chen, JJ; Lin, ZL; Li, XY; Wu, XH; Long, EP; Luo, LX; Zhang, B; Chen, H; Chen, W; Zhang, L; Lin, HT; Chen, WR; Liu, YZ				Lin, Duoru; Chen, Jingjing; Lin, Zhuoling; Li, Xiaoyan; Wu, Xiaohang; Long, Erping; Luo, Lixia; Zhang, Bo; Chen, Hui; Chen, Wan; Zhang, Li; Lin, Haotian; Chen, Weirong; Liu, Yizhi			10-Year Overview of the Hospital-Based Prevalence and Treatment of Congenital Cataracts: The CCPMOH Experience	PLOS ONE			English	Article							PEDIATRIC CATARACT; VISUAL IMPAIRMENT; DISEASES; CHILDREN; SURGERY	A review of 6 years of hospitalization charts from Zhongshan Ophthalmic Center (ZOC) revealed that congenital cataracts (CC) accounted for 2.39% of all cataract in-patient cases and that the age at surgery was decreasing before the establishment of the Childhood Cataract Program of the Chinese Ministry of Health (CCPMOH) in December 2010. We aimed to investigate data from the 4 years (January 2011 to December 2014) following the establishment of the CCPMOH, compared, and combined with data from the previous study period (January 2005 to December 2010) to generate a 10-year overview of the hospital-based prevalence and treatment of CC. In the 4-year period after CCPMOH establishment, the prevalence of CC was 2.01% in all hospitalizations, and was 2.78% in all cataract inpatients. Most of the eligible CC in-patients (71%) lived in south China. The ratio of boys to girls was 1.42:1. Nearly 2/3 of the patients underwent cataract extraction with primary intraocular lens (IOL) implantation at a mean age of 78.40 +/- 51.45 months, and cataract extraction surgeries without IOL implantation were performed in the remaining 1/3 of patients at a mean age of 10.03 +/- 15.92 months. After CCPMOH establishment, an increased incidence of CC was revealed, and the CC in-patients were younger than the patients in the previous period. The 10-year overview (2421 CC in-patients from 206630 hospitalizations) revealed upward trends in both the number and the prevalence of CC and a further reduction in age at surgery. In conclusion, the data from 4-year period after CCPMOH establishment and the 10-year overview showed upward trends in the hospital-based prevalence of CC cases and a further reduction in age at surgery, likely reflecting the effects of the CCPMOH establishment and providing useful information for further CC studies and a valuable foundation for the prevention and treatment of this cause of childhood blindness.	[Lin, Duoru; Chen, Jingjing; Lin, Zhuoling; Li, Xiaoyan; Wu, Xiaohang; Long, Erping; Luo, Lixia; Zhang, Bo; Chen, Hui; Chen, Wan; Zhang, Li; Lin, Haotian; Chen, Weirong; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lin, HT (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gddlht@aliyun.com; chenwr_q@aliyun.com; yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; Chen, Wei/GZK-7348-2022	Long, Erping/0000-0002-3502-5596	Ministry of Science and Technology of China [2015CB964600]; Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China [2014A030306030]; Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province [2014TQ01R573]; Cultivation Projects [12ykpy61]; Intensive Cultivation Projects [2015ykzd11]; Fundamental Research Funds for the Central Universities; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2015QN01]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China; Pearl River Science and Technology New Star Project of Guangzhou City; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China; Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province; Cultivation Projects; Intensive Cultivation Projects; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This clinical study was supported by the Ministry of Science and Technology of China Grants (973 program, 2015CB964600), the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010- 2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of the Ministry of Health), the Pearl River Science and Technology New Star (Grant No. 2014J2200060) Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China (Grant No. 2014A030306030), Youth Science and Technology Innovation Talents Funds in the Special Support Plan for High Level Talents in Guangdong Province (Grant No. 2014TQ01R573), the Cultivation Projects (12ykpy61) and Intensive Cultivation Projects (2015ykzd11) for Young Teaching Staff of Sun Yat-sen University, the Fundamental Research Funds for the Central Universities and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (Grant No. 2015QN01). The sponsors of the study played no role in the study protocol design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.	Bayoumi NHL, 2015, J PEDIAT OPHTH STRAB, V52, P214, DOI 10.3928/01913913-20150414-11; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Chen WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056540, 10.1371/journal.pone.0053985, 10.1371/journal.pone.0073764]; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Haargaard B, 2015, ACTA OPHTHALMOL, V93, P24, DOI 10.1111/aos.12445; He JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1312; Katibeh Marzieh, 2013, J Ophthalmic Vis Res, V8, P308; Lim Z, 2010, AM J OPHTHALMOL, V149, P887, DOI 10.1016/j.ajo.2010.01.012; Lin H.C., 2014, PLOS ONE, V9; Lin HT, 2012, INT J OPHTHALMOL-CHI, V5, P638, DOI 10.3980/j.issn.2222-3959.2012.05.19; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Sisk RA, 2010, OPHTHALMOLOGY, V117, P2178, DOI 10.1016/j.ophtha.2010.03.062; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; Umar MM, 2015, MIDDLE EAST AFR J OP, V22, P92, DOI 10.4103/0974-9233.148356; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014	18	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142298	10.1371/journal.pone.0142298	http://dx.doi.org/10.1371/journal.pone.0142298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540510	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800078
J	Song, YZ; Yang, HL; Peng, JH; Song, YR; Sun, Q; Li, Y				Song, Yong-Ze; Yang, Hong-Lei; Peng, Jun-Huan; Song, Yi-Rong; Sun, Qian; Li, Yuan			Estimating PM2.5 Concentrations in Xi'an City Using a Generalized Additive Model with Multi-Source Monitoring Data	PLOS ONE			English	Article							AEROSOL OPTICAL DEPTH; GROUND-LEVEL PM2.5; AIR-POLLUTANT CONCENTRATIONS; PARTICULATE MATTER PM2.5; UNITED-STATES; SOURCE APPORTIONMENT; EMPIRICAL RELATIONSHIP; SEASONAL-VARIATIONS; ELEMENTAL CARBON; THICKNESS	Particulate matter with an aerodynamic diameter <2.5 mu m (PM2.5) represents a severe environmental problem and is of negative impact on human health. Xi'an City, with a population of 6.5 million, is among the highest concentrations of PM2.5 in China. In 2013, in total, there were 191 days in Xi'an City on which PM2.5 concentrations were greater than 100 mu g/m(3). Recently, a few studies have explored the potential causes of high PM2.5 concentration using remote sensing data such as the MODIS aerosol optical thickness (AOT) product. Linear regression is a commonly used method to find statistical relationships among PM2.5 concentrations and other pollutants, including CO, NO2, SO2, and O-3, which can be indicative of emission sources. The relationships of these variables, however, are usually complicated and non-linear. Therefore, a generalized additive model (GAM) is used to estimate the statistical relationships between potential variables and PM2.5 concentrations. This model contains linear functions of SO2 and CO, univariate smoothing non-linear functions of NO2, O-3, AOT and temperature, and bivariate smoothing non-linear functions of location and wind variables. The model can explain 69.50% of PM2.5 concentrations, with R-2 = 0.691, which improves the result of a stepwise linear regression (R-2 = 0.582) by 18.73%. The two most significant variables, CO concentration and AOT, represent 20.65% and 19.54% of the deviance, respectively, while the three other gas-phase concentrations, SO2, NO2, and O-3 account for 10.88% of the total deviance. These results show that in Xi'an City, the traffic and other industrial emissions are the primary source of PM2.5. Temperature, location, and wind variables also non-linearly related with PM2.5.	[Song, Yong-Ze; Yang, Hong-Lei; Peng, Jun-Huan] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Song, Yi-Rong] Qinghai Univ, Dept Geol Engn, Xining, Qinghai, Peoples R China; [Sun, Qian] China Univ Geosci, Sch Water Resources & Environm, Beijing, Peoples R China; [Li, Yuan] China Univ Geosci, Sch Geophys & Informat Technol, Beijing, Peoples R China	China University of Geosciences; Qinghai University; China University of Geosciences; China University of Geosciences	Yang, HL (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	yanghonglei226@126.com	Song, Yongze/F-1940-2018	Song, Yongze/0000-0003-3420-9622	National Natural Science Foundation of China [41304012, 61427802, 41330634, 41374016]; National High-tech R&D Program of China [SS2012AA120804]; Doctoral Fund of Ministry of Education of China [20100022110008]; Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences [2010LDE002]; Fundamental Research Funds for the Central Universities [2652015180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the following research projects: the National Natural Science Foundation of China (41304012, 61427802, 41330634, 41374016); the National High-tech R&D Program of China (SS2012AA120804); the Doctoral Fund of Ministry of Education of China (20100022110008); the Open Research Fund of Key Laboratory of Digital Earth Science, Center for Earth Observation and Digital Earth, Chinese Academy of Sciences (2010LDE002); the Fundamental Research Funds for the Central Universities (2652015180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY DE, 1995, J EXPO ANAL ENV EPID, V5, P137; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Bhaskar BV, 2010, AEROSOL AIR QUAL RES, V10, P301, DOI 10.4209/aaqr.2009.10.0069; Bian HS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012781; Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Cao JJ, 2005, ATMOS CHEM PHYS, V5, P3127, DOI 10.5194/acp-5-3127-2005; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Chen LWA, 2001, GEOPHYS RES LETT, V28, P1711, DOI 10.1029/2000GL012354; Chi X, 2013, ATMOS CHEM PHYS, V13, P12271, DOI 10.5194/acp-13-12271-2013; Chu D.A., 2002, GEOPHYS RES LETT, V29, DOI [10.1029/2001GL013205, DOI 10.1029/2001GL013205]; Costabile F, 2006, JSME INT J B-FLUID T, V49, P35, DOI 10.1299/jsmeb.49.35; Deshmukh DK, 2011, AEROSOL AIR QUAL RES, V11, P696, DOI 10.4209/aaqr.2010.04.0025; Dogruparmak SC, 2011, CLEAN-SOIL AIR WATER, V39, P597, DOI 10.1002/clen.201000478; Edwards DP, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004727; Federal R, 1987, FED REG, V52; Federal R, 2013, FED REG, V78; Fumo Yang, 2002, Journal of Tsinghua University (Science and Technology), V42, P1605; Gao B, 2013, ENVIRON SCI POLLUT R, V20, P2398, DOI 10.1007/s11356-012-1129-0; Glantz P, 2009, ATMOS ENVIRON, V43, P5838, DOI 10.1016/j.atmosenv.2009.05.017; Glasser L, 2007, J CHEM EDUC, V84, P533, DOI 10.1021/ed084p533; Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139; Gupta P, 2006, ATMOS ENVIRON, V40, P5880, DOI 10.1016/j.atmosenv.2006.03.016; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Ho KF, 2014, ENVIRON MONIT ASSESS, V186, P2835, DOI 10.1007/s10661-013-3584-6; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Hu XF, 2014, REMOTE SENS ENVIRON, V140, P220, DOI 10.1016/j.rse.2013.08.032; Hu ZY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-27; Huang Y, 2014, ENVIRON SCI TECHNOL, V48, P13834, DOI 10.1021/es503696k; Khodeir M, 2012, ATMOS POLLUT RES, V3, P331, DOI 10.5094/APR.2012.037; Kim HS, 2014, ASIA-PAC J ATMOS SCI, V50, P191, DOI 10.1007/s13143-014-0007-8; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Kumar N, 2007, ATMOS ENVIRON, V41, P4492, DOI 10.1016/j.atmosenv.2007.01.046; Li Guo-xing, 2013, Zhonghua Yi Xue Za Zhi, V93, P2703; Li LF, 2013, ENVIRON SCI TECHNOL, V47, P9291, DOI 10.1021/es401281r; Li Z, 2010, ADV ATMOS SCI, V27, P777, DOI 10.1007/s00376-009-9052-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin CQ, 2015, REMOTE SENS ENVIRON, V156, P117, DOI 10.1016/j.rse.2014.09.015; Lin G, 2014, INT J ENV RES PUB HE, V11, P173, DOI 10.3390/ijerph110100173; Liousse C, 1996, J GEOPHYS RES-ATMOS, V101, P19411, DOI 10.1029/95JD03426; Liu Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI [10.1029/2004JD005025, 10.1029/2003JD003981]; Liu Y, 2007, REMOTE SENS ENVIRON, V107, P33, DOI 10.1016/j.rse.2006.05.022; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Lu YP DJ, 2006, J SHAANXI METEOROLOG, V01, P1; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Meng Z, 2007, FOOD CHEM TOXICOL, V45, P1368, DOI 10.1016/j.fct.2007.01.014; Moyeed RA, 2002, MATH GEOL, V34, P365, DOI 10.1023/A:1015085810154; Notario A, 2014, ATMOS RES, V145, P92, DOI 10.1016/j.atmosres.2014.03.021; Paciorek CJ, 2008, ENVIRON SCI TECHNOL, V42, P5800, DOI 10.1021/es703181j; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pui DYH, 2014, PARTICUOLOGY, V13, P1, DOI 10.1016/j.partic.2013.11.001; Saiz-Lopez A, 2009, WATER AIR SOIL POLL, V200, P277, DOI 10.1007/s11270-008-9912-8; Schaap M, 2009, ATMOS CHEM PHYS, V9, P909, DOI 10.5194/acp-9-909-2009; Schlesinger RB, 2007, INHAL TOXICOL, V19, P811, DOI 10.1080/08958370701402382; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; SEINFELD JH, 1989, SCIENCE, V243, P745, DOI 10.1126/science.243.4892.745; Shen ZX, 2009, ATMOS ENVIRON, V43, P2911, DOI 10.1016/j.atmosenv.2009.03.005; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; Sorek-Hamer M, 2013, ENVIRON POLLUT, V182, P417, DOI 10.1016/j.envpol.2013.08.002; Strawa A. W., 2011, ATMOSPHERIC CHEM PHY, P30563, DOI DOI 10.5194/ACPD-11-30563-2011; Sun YL, 2004, ATMOS ENVIRON, V38, P5991, DOI 10.1016/j.atmosenv.2004.07.009; Sun Z, 2013, ENVIRON SCI TECHNOL, V26, P75; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Tao J, 2009, PARTICUOLOGY, V7, P68, DOI 10.1016/j.partic.2008.11.002; Tao L, 2011, ENVIRON SCI TECHNOL, V24, P63; Tian J, 2010, REMOTE SENS ENVIRON, V114, P221, DOI 10.1016/j.rse.2009.09.011; Wang GengChen, 2014, Science & Technology Review, V32, P72; Wang J., 2003, GEOPHYS RES LETT, V30; Wang J, 2011, J ARID METEOROLOGY, V29, P174; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Wang YS, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015376; Wang ZF, 2010, REMOTE SENS ENVIRON, V114, P50, DOI 10.1016/j.rse.2009.08.009; Watson JG, 2008, J AIR WASTE MANAGE, V58, P265, DOI 10.3155/1047-3289.58.2.265; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xin JY, 2014, ATMOS RES, V138, P179, DOI 10.1016/j.atmosres.2013.11.001; Yan ZW, 2010, INT J CLIMATOL, V30, P1226, DOI 10.1002/joc.1971; Yang ChunXue, 2011, Journal of Environment and Health, V28, P735; [张承中 Zhang Chengzhong], 2013, [环境工程学报, Chinese Journal of Environmental Engineering], V7, P1477; Zhang K, 2010, ATMOS ENVIRON, V44, P1740, DOI 10.1016/j.atmosenv.2010.02.008; [张凯 ZHANG Kai], 2007, [环境科学学报, Acta Scientiae Circumstantiae], V27, P459	79	37	39	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142149	10.1371/journal.pone.0142149	http://dx.doi.org/10.1371/journal.pone.0142149			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540446	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800058
J	Perrin, JB; Durand, B; Gay, E; Ducrot, C; Hendrikx, P; Calavas, D; Henaux, V				Perrin, Jean-Baptiste; Durand, Benoit; Gay, Emilie; Ducrot, Christian; Hendrikx, Pascal; Calavas, Didier; Henaux, Viviane			Simulation-Based Evaluation of the Performances of an Algorithm for Detecting Abnormal Disease-Related Features in Cattle Mortality Records	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; BOVINE HERPESVIRUS-1; OUTBREAK DETECTION; MOUTH-DISEASE; TIME-SERIES; FRANCE; TRANSMISSION; EPIDEMIC; DAIRY	We performed a simulation study to evaluate the performances of an anomaly detection algorithm considered in the frame of an automated surveillance system of cattle mortality. The method consisted in a combination of temporal regression and spatial cluster detection which allows identifying, for a given week, clusters of spatial units showing an excess of deaths in comparison with their own historical fluctuations. First, we simulated 1,000 outbreaks of a disease causing extra deaths in the French cattle population (about 200,000 herds and 20 million cattle) according to a model mimicking the spreading patterns of an infectious disease and injected these disease-related extra deaths in an authentic mortality dataset, spanning from January 2005 to January 2010. Second, we applied our algorithm on each of the 1,000 semi-synthetic datasets to identify clusters of spatial units showing an excess of deaths considering their own historical fluctuations. Third, we verified if the clusters identified by the algorithm did contain simulated extra deaths in order to evaluate the ability of the algorithm to identify unusual mortality clusters caused by an outbreak. Among the 1,000 simulations, the median duration of simulated outbreaks was 8 weeks, with a median number of 5,627 simulated deaths and 441 infected herds. Within the 12-week trial period, 73% of the simulated outbreaks were detected, with a median timeliness of 1 week, and a mean of 1.4 weeks. The proportion of outbreak weeks flagged by an alarm was 61% (i.e. sensitivity) whereas one in three alarms was a true alarm (i.e. positive predictive value). The performances of the detection algorithm were evaluated for alternative combination of epidemiologic parameters. The results of our study confirmed that in certain conditions automated algorithms could help identifying abnormal cattle mortality increases possibly related to unidentified health events.	[Perrin, Jean-Baptiste; Gay, Emilie; Calavas, Didier; Henaux, Viviane] Agence Natl Secur Sanit Alimentat Environm & Trav, Lab Lyon, Unite Epidemiol, Lyon, France; [Durand, Benoit] Agence Natl Secur Sanit Alimentat Environm & Trav, Lab Sante Anim, Unite Epidemiol, Maisons Alfort, France; [Perrin, Jean-Baptiste; Ducrot, Christian] INRA, UR346, Unite Epidemiol Anim, F-63122 St Genes Champanelle, France; [Hendrikx, Pascal] Agence Natl Secur Sanit Alimentat Environm & Trav, Lab Lyon, Unite Coordinat & Appui Surveillance, Lyon, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon	Henaux, V (corresponding author), Agence Natl Secur Sanit Alimentat Environm & Trav, Lab Lyon, Unite Epidemiol, Lyon, France.	viviane.henaux@anses.fr	Durand, Benoit/GSE-2511-2022	Durand, Benoit/0000-0003-0669-1394	French Ministry of Agriculture	French Ministry of Agriculture	JBP received funding from the French Ministry of Agriculture for this research (FCPR Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AM, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-61; Alba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122547; [Anonymous], 2014, R LANG ENV STAT COMP; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buckeridge DL, 2006, EMERG INFECT DIS, V12, P1942; Buehler JW, 2004, FRAMEWORK EVALUATING; Carr D., 2011, HEXBIN HEXAGONAL BIN; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; Dupuy C, 2013, PREV VET MED, V111, P220, DOI 10.1016/j.prevetmed.2013.06.005; Farrington C.P., 2004, MONITORING HLTH POPU, P36; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Fried R, 2004, J NONPARAMETR STAT, V16, P313, DOI 10.1080/10485250410001656444; Fried R, 2012, ROBFILTER ROBUST TIM; Gergonne B, 2010, EUROMOMO WORK PACKAG; Groenewold MR, 2007, PUBLIC HEALTH REP, V122, P521, DOI 10.1177/003335490712200414; Hage JJ, 2003, EPIDEMIOL INFECT, V130, P541, DOI 10.1017/S0950268803008379; Hage JJ, 1996, VET MICROBIOL, V53, P169, DOI 10.1016/S0378-1135(96)01245-X; Hohle M, 2009, PREV VET MED, V91, P2, DOI 10.1016/j.prevetmed.2009.05.017; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Kanieff M, 2010, EUROSURVEILLANCE, V15, P14; Kulldorf M., 2009, SATSCAN V8 0 SOFTWAR; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Le Menach A, 2005, VET RES, V36, P699, DOI 10.1051/vetres:2005025; Mandl Kenneth D, 2004, MMWR Suppl, V53, P130; Marsot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086323; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Morignat E, 2015, ENVIRON RES, V140, P524, DOI 10.1016/j.envres.2015.05.001; Morignat E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093176; Nordin JD, 2005, EMERG INFECT DIS, V11, P1394, DOI 10.3201/eid1109.050223; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Perrin JB, 2012, PREV VET MED, V105, P244, DOI 10.1016/j.prevetmed.2011.12.015; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; Quest software Inc, 2011, TOAD MYSQL 6 0 1 172; Rautureau S, 2012, TRANSBOUND EMERG DIS, V59, P311, DOI 10.1111/j.1865-1682.2011.01271.x; Robertson C, 2010, SPAT SPATIO-TEMPORAL, V1, P105, DOI 10.1016/j.sste.2009.12.001; Siegrist David, 2004, MMWR Suppl, V53, P152; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Virasakdi C, 2012, EPICALC EPIDEMIOLOGI; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263	42	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141273	10.1371/journal.pone.0141273	http://dx.doi.org/10.1371/journal.pone.0141273			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536596	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400056
J	Provence, A; Hristov, KL; Parajuli, SP; Petkov, GV				Provence, Aaron; Hristov, Kiril L.; Parajuli, Shankar P.; Petkov, Georgi V.			Regulation of Guinea Pig Detrusor Smooth Muscle Excitability by 17 beta-Estradiol: The Role of the Large Conductance Voltage- and Ca2+-Activated K+ Channels	PLOS ONE			English	Article							LOWER URINARY-TRACT; BK CHANNEL; RELAXATION; ESTRADIOL; ESTROGENS; ACTIVATION; PROGESTERONE; MODULATION; PHYSIOLOGY; BINDING	Estrogen replacement therapies have been suggested to be beneficial in alleviating symptoms of overactive bladder. However, the precise regulatory mechanisms of estrogen in urinary bladder smooth muscle (UBSM) at the cellular level remain unknown. Large conductance voltage- and Ca2+-activated K+ (BK) channels, which are key regulators of UBSM function, are suggested to be non-genomic targets of estrogens. This study provides an electrophysiological investigation into the role of UBSM BK channels as direct targets for 17 beta-estradiol, the principle estrogen in human circulation. Single BK channel recordings on inside-out excised membrane patches and perforated whole cell patch-clamp were applied in combination with the BK channel selective inhibitor paxilline to elucidate the mechanism of regulation of BK channel activity by 17 beta-estradiol in freshly-isolated guinea pig UBSM cells. 17 beta-Estradiol (100 nM) significantly increased the amplitude of depolarization-induced whole cell steady-state BK currents and the frequency of spontaneous transient BK currents in freshly-isolated UBSM cells. The increase in whole cell BK currents by 17 beta-estradiol was eliminated upon blocking BK channels with paxilline. 17 beta-Estradiol (100 nM) significantly increased (similar to 3-fold) the single BK channel open probability, indicating direct 17 beta-estradiol-BK channel interactions. 17 beta-Estradiol (100 nM) caused a significant hyperpolarization of the membrane potential of UBSM cells, and this hyperpolarization was reversed by blocking the BK channels with paxilline. 17 beta-Estradiol (100 nM) had no effects on L-type voltage-gated Ca2+ channel currents recorded under perforated patch-clamp conditions. This study reveals a new regulatory mechanism in the urinary bladder whereby BK channels are directly activated by 17 beta-estradiol to reduce UBSM cell excitability.	[Provence, Aaron; Hristov, Kiril L.; Parajuli, Shankar P.; Petkov, Georgi V.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Petkov, GV (corresponding author), Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	petkov@cop.sc.edu			NIH [R01-DK084284, R01-DK106964]; National Institutes of Health [F31-DK104528]; SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106964, F31DK104528, R01DK084284] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the NIH R01-DK084284 and R01-DK106964 to Georgi V. Petkov. Aaron Provence was supported by National Institutes of Health pre-doctoral fellowship F31-DK104528 and a SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina.	Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Cairrao E, 2012, ACTA PHARMACOL SIN, V33, P615, DOI 10.1038/aps.2012.4; Cardozo L, 2004, ACTA OBSTET GYN SCAN, V83, P892, DOI 10.1111/j.0001-6349.2004.00581.x; Dambros M, 2004, PHARMACOLOGY, V72, P121, DOI 10.1159/000080184; De Wet H, 2006, MOL MEMBR BIOL, V23, P420, DOI 10.1080/09687860600802803; de Wet Heidi, 2008, V491, P177, DOI 10.1007/978-1-59745-526-8_14; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Game X, 2013, PROG UROL, V23, P502, DOI 10.1016/j.purol.2013.03.012; Hanna-Mitchell AT, 2014, NEUROUROL URODYNAM, V33, P611, DOI 10.1002/nau.22582; Hanna-Mitchell AT, 2015, NEUROUROL U IN PRESS; Kelly MJ, 1999, STEROIDS, V64, P64, DOI 10.1016/S0039-128X(98)00095-6; Koski Michelle E, 2011, Curr Urol Rep, V12, P345, DOI 10.1007/s11934-011-0208-y; Maher J, 2013, BRIT J PHARMACOL, V169, P1153, DOI 10.1111/bph.12211; Malysz J, 2014, AM J PHYSIOL-CELL PH, V306, pC45, DOI 10.1152/ajpcell.00047.2013; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Ogata R, 1996, BRIT J PHARMACOL, V117, P351, DOI 10.1111/j.1476-5381.1996.tb15198.x; Patra PB, 2009, UROLOGY, V74, P463, DOI 10.1016/j.urology.2008.12.046; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Robinson D, 2014, NEUROUROL URODYNAM, V33, P1086, DOI 10.1002/nau.22464; Robinson Dudley, 2013, Menopause Int, V19, P155, DOI 10.1177/1754045313511398; Rosenfeld CR, 2012, ENDOCRINOLOGY, V153, P6012, DOI 10.1210/en.2012-1717; SHELDON JH, 1995, J PHARMACOL EXP THER, V274, P723; Valeri A, 2009, EXP PHYSIOL, V94, P834, DOI 10.1113/expphysiol.2009.047118; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; YASAY GD, 1995, PHARMACOLOGY, V51, P273, DOI 10.1159/000139336	27	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141950	10.1371/journal.pone.0141950	http://dx.doi.org/10.1371/journal.pone.0141950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536038	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400105
J	Qhanya, LB; Matowane, G; Chen, WP; Sun, YX; Letsimo, EM; Parvez, M; Yu, JH; Mashele, SS; Syed, K				Qhanya, Lehlohonolo Benedict; Matowane, Godfrey; Chen, Wanping; Sun, Yuxin; Letsimo, Elizabeth Mpholoseng; Parvez, Mohammad; Yu, Jae-Hyuk; Mashele, Samson Sitheni; Syed, Khajamohiddin			Genome-Wide Annotation and Comparative Analysis of Cytochrome P450 Monooxygenases in Basidiomycete Biotrophic Plant Pathogens	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; FUNGAL; ACID; HYDROXYLASE; SEQUENCE; IDENTIFICATION; CHRYSOSPORIUM; MECHANISMS; EVOLUTION; FEATURES	Fungi are an exceptional source of diverse and novel cytochrome P450 monooxygenases (P450s), heme-thiolate proteins, with catalytic versatility. Agaricomycotina saprophytes have yielded most of the available information on basidiomycete P450s. This resulted in observing similar P450 family types in basidiomycetes with few differences in P450 families among Agaricomycotina saprophytes. The present study demonstrated the presence of unique P450 family patterns in basidiomycete biotrophic plant pathogens that could possibly have originated from the adaptation of these species to different ecological niches (host influence). Systematic analysis of P450s in basidiomycete biotrophic plant pathogens belonging to three different orders, Agaricomycotina (Armillaria mellea), Pucciniomycotina (Melampsora laricis-populina, M. lini, Mixia osmundae and Puccinia graminis) and Ustilaginomycotina (Ustilago maydis, Sporisorium reilianum and Tilletiaria anomala), revealed the presence of numerous putative P450s ranging from 267 (A. mellea) to 14 (M. osmundae). Analysis of P450 families revealed the presence of 41 new P450 families and 27 new P450 subfamilies in these biotrophic plant pathogens. Order-level comparison of P450 families between biotrophic plant pathogens revealed the presence of unique P450 family patterns in these organisms, possibly reflecting the characteristics of their order. Further comparison of P450 families with basidiomycete non-pathogens confirmed that biotrophic plant pathogens harbour the unique P450 families in their genomes. The CYP63, CYP5037, CYP5136, CYP5137 and CYP5341 P450 families were expanded in A. mellea when compared to other Agaricomycotina saprophytes and the CYP5221 and CYP5233 P450 families in P. graminis and M. laricis-populina. The present study revealed that expansion of these P450 families is due to paralogous evolution of member P450s. The presence of unique P450 families in these organisms serves as evidence of how a host/ecological niche can influence shaping the P450 content of an organism. The present study initiates our understanding of P450 family patterns in basidiomycete biotrophic plant pathogens.	[Qhanya, Lehlohonolo Benedict; Matowane, Godfrey; Letsimo, Elizabeth Mpholoseng; Parvez, Mohammad; Mashele, Samson Sitheni; Syed, Khajamohiddin] Cent Univ Technol, Unit Drug Discovery Res, Dept Hlth Sci, Fac Hlth & Environm Sci, ZA-9300 Bloemfontein, Free State, South Africa; [Chen, Wanping; Sun, Yuxin] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Hubei Province, Peoples R China; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Central University of Technology; Huazhong Agricultural University; University of Wisconsin System; University of Wisconsin Madison	Syed, K (corresponding author), Cent Univ Technol, Unit Drug Discovery Res, Dept Hlth Sci, Fac Hlth & Environm Sci, ZA-9300 Bloemfontein, Free State, South Africa.	khajamohiddinsyed@gmail.com	Syed, Khajamohiddin/L-8774-2013; Yu, Jae-Hyuk/A-2343-2008; Mashele, Samson Sitheni/AAC-4015-2020	Syed, Khajamohiddin/0000-0002-1497-3570; Mashele, Samson Sitheni/0000-0002-6339-4807; Qhanya, Lehlohonolo/0000-0001-7563-9704; Yu, Jae-Hyuk/0000-0002-6530-8407	University Research and Innovation Fund; Emerging Researcher Award; Department of Higher Education and Training (DHET); Technology Innovation Agency (TIA), South Africa	University Research and Innovation Fund; Emerging Researcher Award; Department of Higher Education and Training (DHET); Technology Innovation Agency (TIA), South Africa	KS and SSM express their sincere gratitude to the Central University of Technology (CUT), Bloemfontein, Free State, South Africa, for a grant from the University Research and Innovation Fund and Emerging Researcher Award (to KS). KS and SSM thank the Department of Higher Education and Training (DHET) and Technology Innovation Agency (TIA), South Africa for a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Collins C, 2013, J PROTEOME RES, V12, P2552, DOI 10.1021/pr301131t; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Durairaj P, 2015, ENZYME MICROB TECH, V70, P58, DOI 10.1016/j.enzmictec.2014.12.013; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Faber BW, 2001, ARCH BIOCHEM BIOPHYS, V394, P245, DOI 10.1006/abbi.2001.2534; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Ferrer-Sevillano F, 2007, EUKARYOT CELL, V6, P514, DOI 10.1128/EC.00226-06; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fraser JA, 2002, FUNGAL GENET BIOL, V35, P135, DOI 10.1006/fgbi.2001.1307; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; GOTOH O, 1992, J BIOL CHEM, V267, P83; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Hlavica P, 2013, BBA-PROTEINS PROTEOM, V1834, P205, DOI 10.1016/j.bbapap.2012.09.012; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Jawallapersand P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107209; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Kgosiemang IKR, 2014, J PURE APPL MICROBIO, V8, P291; Konishi M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00409-13; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Matsuzaki F, 2005, BIOCHEM BIOPH RES CO, V334, P1184, DOI 10.1016/j.bbrc.2005.07.013; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; Mingot JM, 1999, J BIOL CHEM, V274, P14545, DOI 10.1074/jbc.274.21.14545; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Morita T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00064-13; Mthakathi NT, 2015, ALGAE-SEOUL, V30, P233, DOI 10.4490/algae.2015.30.3.233; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Nelson D R, 1998, Methods Mol Biol, V107, P15; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nemri A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00098; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Sello MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11572; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Syed K, 2014, GENES GENOM, V36, P321, DOI 10.1007/s13258-013-0170-9; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095616; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086683; Syed K, 2013, MYCOLOGIA, V105, P1445, DOI 10.3852/13-002; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Toome Merje, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00539-14; Toome M, 2014, NEW PHYTOL, V202, P554, DOI 10.1111/nph.12653; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; WIGHTMAN F, 1982, PHYSIOL PLANTARUM, V55, P17, DOI 10.1111/j.1399-3054.1982.tb00278.x; Yamazaki H, 2014, 50 YEARS CYTOCHROME, DOI [10.1007/978-4-431-54992-5, DOI 10.1007/978-4-431-54992-5]; Zhu ZW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2112	68	34	35	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142100	10.1371/journal.pone.0142100	http://dx.doi.org/10.1371/journal.pone.0142100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536121	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400133
J	Roberts, AI; Roberts, SGB				Roberts, Anna Ilona; Roberts, Sam George Bradley			Gestural Communication and Mating Tactics in Wild Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; REPRODUCTIVE STRATEGIES; FEMALE CHIMPANZEES; PRIMATE; REPERTOIRE; COPULATION; EVOLUTION; PATERNITY; RESPONSES; COGNITION	The extent to which primates can flexibly adjust the production of gestural communication according to the presence and visual attention of the audience provides key insights into the social cognition underpinning gestural communication, such as an understanding of third party relationships. Gestures given in a mating context provide an ideal area for examining this flexibility, as frequently the interests of a male signaller, a female recipient and a rival male bystander conflict. Dominant chimpanzee males seek to monopolize matings, but subordinate males may use gestural communication flexibly to achieve matings despite their low rank. Here we show that the production of mating gestures in wild male East African chimpanzees (Pan troglodytes schweunfurthii) was influenced by a conflict of interest with females, which in turn was influenced by the presence and visual attention of rival males. When the conflict of interest was low (the rival male was present and looking away), chimpanzees used visual/tactile gestures over auditory gestures. However, when the conflict of interest was high (the rival male was absent, or was present and looking at the signaller) chimpanzees used auditory gestures over visual/tactile gestures. Further, the production of mating gestures was more common when the number of oestrous and non-oestrus females in the party increased, when the female was visually perceptive and when there was no wind. Females played an active role in mating behaviour, approaching for copulations more often when the number of oestrus females in the party increased and when the rival male was absent, or was present and looking away. Examining how social and ecological factors affect mating tactics in primates may thus contribute to understanding the previously unexplained reproductive success of subordinate male chimpanzees.	[Roberts, Anna Ilona; Roberts, Sam George Bradley] Univ Chester, Dept Psychol, Chester, Cheshire, England	University of Chester	Roberts, AI (corresponding author), Univ Chester, Dept Psychol, Parkgate Rd, Chester, Cheshire, England.	anna.roberts@chester.ac.uk		Roberts, Sam/0000-0003-3986-0254; Roberts, Anna/0000-0003-1185-7897	Economic and Social Research Council; University of Chester	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Chester	Economic and Social Research Council funded data collection. University of Chester funded write up and data analyses.; We would like to thank the BCFS, NSCT, UWA for permission to conduct this project. We thank Geresomu Muhumuza for providing excellent support in the field. The fieldwork for this study was funded by Economic and Social Research Council, UK. A. R., S. R. designed the study, analysed the data, wrote the manuscript. A. R. collected the data, coded the footage. We are grateful to two anonymous reviewers for making a valuable contribution to this paper.	Bard KA, 2014, AM J PRIMATOL, V76, P14, DOI 10.1002/ajp.22189; Barrett L, 2005, P ROY SOC B-BIOL SCI, V272, P1865, DOI 10.1098/rspb.2005.3200; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Blute M, 2006, GESTURE, V6, P177; Bryant Gregory A, 2013, Front Psychol, V4, P990, DOI 10.3389/fpsyg.2013.00990; Clark A, 1997, BEHAV BRAIN SCI, V20, P57, DOI 10.1017/S0140525X97000022; Connor R. C., 2009, SEXUAL COERCION PRIM; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; de Waal F., 1986, P221; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Feldblum JT, 2014, CURR BIOL, V24, P2855, DOI 10.1016/j.cub.2014.10.039; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hasegawa T., 1983, J ETHOL, V1, P75, DOI DOI 10.1007/BF02347833; HEWES GW, 1992, CURR ANTHROPOL, V33, P65, DOI 10.1086/204019; Heyes C, 2012, PHILOS T R SOC B, V367, P2091, DOI 10.1098/rstb.2012.0111; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; le Roux A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2468; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Matsumoto-Oda A, 1999, BEHAV ECOL SOCIOBIOL, V46, P258, DOI 10.1007/s002650050618; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MORLAND HS, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P193; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Muller Martin N., 2009, P184; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; NIEMEYER CL, 1983, ETHOL SOCIOBIOL, V4, P205, DOI 10.1016/0162-3095(83)90010-9; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Pawlowski B, 1998, BEHAVIOUR, V135, P357, DOI 10.1163/156853998793066285; Penn DC., 2013, AGENCY JOINT ATTENTI, P62, DOI [10.1093/acprof%3Aoso/9780199988341.003.0004, DOI 10.1093/ACPROF%3AOSO/9780199988341.003.0004, DOI 10.1093/ACPROF:OSO/9780199988341.001.0001]; Peters RA, 2007, CURR BIOL, V17, P1231, DOI 10.1016/j.cub.2007.06.035; Pika S, 2003, AM J PRIMATOL, V60, P95, DOI 10.1002/ajp.10097; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Reynolds V., 2005, CHIMPANZEES BUDONGO; Roberts AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4088; Roberts AI, 2014, ANIM COGN, V17, P317, DOI 10.1007/s10071-013-0664-5; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Roberts AI, 2012, EVOL HUM BEHAV, V33, P578, DOI 10.1016/j.evolhumbehav.2012.05.006; Roberts AI, 2012, ANIM BEHAV, V84, P459, DOI 10.1016/j.anbehav.2012.05.022; Shanker SG, 2002, BEHAV BRAIN SCI, V25, P646, DOI 10.1017/S0140525X02510116; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Tomasello M, 2002, COGNITIVE ANIMAL EMP; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; Tutin C.E.G., 1981, P239; TUTIN CEG, 1979, ANIM BEHAV, V27, P845, DOI 10.1016/0003-3472(79)90022-8; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; TUTIN CEG, 1973, FOLIA PRIMATOL, V19, P237, DOI 10.1159/000155542; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	58	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139683	10.1371/journal.pone.0139683	http://dx.doi.org/10.1371/journal.pone.0139683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536467	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000364298400010
J	Simpson, HM; Khan, RZ; Song, C; Sharma, D; Sadashivaiah, K; Furusawa, A; Liu, XY; Nagaraj, S; Sengamalay, N; Sadzewicz, L; Tallon, LJ; Chen, QC; Livak, F; Rapoport, AP; Kimball, A; Banerjee, A				Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Liu, Xinyue; Nagaraj, Sushma; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Chen, Qing C.; Livak, Ferenc; Rapoport, Aaron P.; Kimball, Amy; Banerjee, Arnob			Concurrent Mutations in ATM and Genes Associated with Common gamma Chain Signaling in Peripheral T Cell Lymphoma	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STAT5B N642H MUTATION; MISSENSE MUTATIONS; SOMATIC MUTATION; CANCER; REVEALS; KINASE; INACTIVATION; LANDSCAPE; ACTIVATION	Peripheral T cell lymphoma (PTCL) is a heterogeneous malignancy with poor response to current therapeutic strategies and incompletely characterized genetics. We conducted whole exome sequencing of matched PTCL and non-malignant samples from 12 patients, spanning 8 subtypes, to identify potential oncogenic mutations in PTCL. Analysis of the mutations identified using computational algorithms, CHASM, PolyPhen2, PROVEAN, and MutationAssessor to predict the impact of these mutations on protein function and PTCL tumorigenesis, revealed 104 somatic mutations that were selected as high impact by all four algorithms. Our analysis identified recurrent somatic missense or nonsense mutations in 70 genes, 9 of which contained mutations predicted significant by all 4 algorithms: ATM, RUNX1T1, WDR17, NTRK3, TP53, TRMT12, CACNA2D1, INTS8, and KCNH8. We observed somatic mutations in ATM (ataxia telangiectasia-mutated) in 5 out of the 12 samples and mutations in the common gamma chain (gamma(c)) signaling pathway (JAK3, IL2RG, STAT5B) in 3 samples, all of which also harbored mutations in ATM. Our findings contribute insights into the genetics of PTCL and suggest a relationship between gamma(c) signaling and ATM in T cell malignancy.	[Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Livak, Ferenc; Rapoport, Aaron P.; Kimball, Amy; Banerjee, Arnob] Univ Maryland, Sch Med, Dept Med, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Simpson, Haley M.; Khan, Rashid Z.; Song, Chang; Sharma, Deva; Sadashivaiah, Kavitha; Furusawa, Aki; Banerjee, Arnob] Univ Maryland, Sch Med, Ctr Stem Cell Res & Regenerat Med, Baltimore, MD 21201 USA; [Liu, Xinyue; Nagaraj, Sushma; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.] Univ Maryland, Sch Med, Inst Genome Sci, Genome Resource Ctr, Baltimore, MD 21201 USA; [Chen, Qing C.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Banerjee, A (corresponding author), Univ Maryland, Sch Med, Dept Med, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	abanerjee@som.umaryland.edu	Khan, Rashid/HHZ-3812-2022		National Institute of Health [P30CA134272, K08HL93207]; Gabrielle's Angel Foundation for Cancer Research; American Cancer Society; Marlene and Stewart Greenebaum Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093027] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; American Cancer Society(American Cancer Society); Marlene and Stewart Greenebaum Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institute of Health grants (P30CA134272, K08HL93207) (AB) (http://www.nih.gov/), the Gabrielle's Angel Foundation for Cancer Research (AB) (http://www.gabriellesangels.org/), the American Cancer Society (AB) (http://www.cancer.org/), and the Marlene and Stewart Greenebaum Cancer Center (http://umm.edu/programs/cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwal A, 2015, ONCOGENE, V34, P2991, DOI 10.1038/onc.2014.243; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; Babushok DV, 2015, CANC GENET; Bandapalli OR, 2014, HAEMATOLOGICA, V99, pE188, DOI 10.3324/haematol.2014.104992; Bergmann AK, 2014, GENE CHROMOSOME CANC, V53, P309, DOI 10.1002/gcc.22141; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bullrich F, 1999, CANCER RES, V59, P24; Camacho E, 2002, BLOOD, V99, P238, DOI 10.1182/blood.V99.1.238; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Degryse S, 2014, BLOOD, V124, P3092, DOI 10.1182/blood-2014-04-566687; Fang NY, 2003, P NATL ACAD SCI USA, V100, P5372, DOI 10.1073/pnas.0831102100; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Gandhi MK, 2015, BLOOD REV; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gronbaek K, 2002, BLOOD, V100, P1430, DOI 10.1182/blood-2002-02-0382; Hong S, 2013, J NANOMATER, V2013, DOI [10.1155/2013/246328, 10.1155/2013/790323]; Huang YL, 2013, BEST PRACT RES CL HA, V26, P57, DOI 10.1016/j.beha.2013.04.006; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kontro M, 2014, LEUKEMIA, V28, P1738, DOI 10.1038/leu.2014.89; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kucuk C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7025; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Ma XL, 2015, CANCER GENET-NY, V208, P52, DOI 10.1016/j.cancergen.2014.12.001; Manso R, 2015, HAEMATOLOGICA, V100, pE25, DOI 10.3324/haematol.2014.113696; Manso R, 2014, BLOOD, V123, P2893, DOI 10.1182/blood-2014-02-555946; Nakamoto-Matsubara R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109714; Navrkalova V, 2013, HAEMATOLOGICA, V98, P1124, DOI 10.3324/haematol.2012.081620; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nicolae A, 2014, LEUKEMIA, V28, P2244, DOI 10.1038/leu.2014.200; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Savage KJ, 2011, CURR HEMATOL MALIG R, V6, P222, DOI 10.1007/s11899-011-0100-3; Shimizu D, 2007, INT J HEMATOL, V85, P212, DOI 10.1532/IJH97.06165; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Skarbnik AP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00138; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Stilgenbauer S, 1997, NAT MED, V3, P1155, DOI 10.1038/nm1097-1155; Stoppa-Lyonnet D, 1998, BLOOD, V91, P3920, DOI 10.1182/blood.V91.10.3920.3920_3920_3926; Thoma G, 2014, BIOORG MED CHEM LETT, V24, P4617, DOI 10.1016/j.bmcl.2014.08.046; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; Vorechovsky I, 1997, NAT GENET, V17, P96, DOI 10.1038/ng0997-96; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Wang C, 2014, BIOINFORMATICS, V30, P2678, DOI 10.1093/bioinformatics/btu363; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Wong WC, 2011, BIOINFORMATICS, V27, P2147, DOI 10.1093/bioinformatics/btr357; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yuille MAR, 1998, ONCOGENE, V16, P789, DOI 10.1038/sj.onc.1201603; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	64	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141906	10.1371/journal.pone.0141906	http://dx.doi.org/10.1371/journal.pone.0141906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536348	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400099
J	Youngsteadt, E; Appler, RH; Lopez-Uribe, MM; Tarpy, DR; Frank, SD				Youngsteadt, Elsa; Appler, R. Holden; Lopez-Uribe, Margarita M.; Tarpy, David R.; Frank, Steven D.			Urbanization Increases Pathogen Pressure on Feral and Managed Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; NOSEMA-CERANAE; IMMUNE-RESPONSE; VARROA-JACOBSONI; N. CERANAE; INFECTION; COLONIES; BIODIVERSITY; PREVALENCE; PATTERNS	Given the role of infectious disease in global pollinator decline, there is a need to understand factors that shape pathogen susceptibility and transmission in bees. Here we ask how urbanization affects the immune response and pathogen load of feral and managed colonies of honey bees (Apis mellifera Linnaeus), the predominant economically important pollinator worldwide. Using quantitative real-time PCR, we measured expression of 4 immune genes and relative abundance of 10 honey bee pathogens. We also measured worker survival in a laboratory bioassay. We found that pathogen pressure on honey bees increased with urbanization and management, and the probability of worker survival declined 3-fold along our urbanization gradient. The effect of management on pathogens appears to be mediated by immunity, with feral bees expressing immune genes at nearly twice the levels of managed bees following an immune challenge. The effect of urbanization, however, was not linked with immunity; instead, urbanization may favor viability and transmission of some disease agents. Feral colonies, with lower disease burdens and stronger immune responses, may illuminate ways to improve honey bee management. The previously unexamined effects of urbanization on honey-bee disease are concerning, suggesting that urban areas may favor problematic diseases of pollinators.	[Youngsteadt, Elsa; Appler, R. Holden; Lopez-Uribe, Margarita M.; Tarpy, David R.; Frank, Steven D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lopez-Uribe, Margarita M.; Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Tarpy, DR (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	drtarpy@ncsu.edu		Youngsteadt, Elsa/0000-0003-2032-9674; Tarpy, David/0000-0001-8601-6094	Agriculture and Food Research Initiative Competitive [2013-02476]; United States Department of Agriculture National Institute of Food and Agriculture; North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant; North Carolina Department of Agriculture and Consumer Services; North Carolina State Beekeepers Association; North Carolina State University Department of Entomology; United States Geological Survey [G11AC20471, G13AC00405]	Agriculture and Food Research Initiative Competitive; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant; North Carolina Department of Agriculture and Consumer Services; North Carolina State Beekeepers Association; North Carolina State University Department of Entomology; United States Geological Survey(United States Geological Survey)	This research was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-02476 from the United States Department of Agriculture National Institute of Food and Agriculture to SDF and EY (http://nifa.usda.gov/); a North Carolina State University College of Agriculture and Life Sciences Dean's Enrichment Grant to DRT and SDF (http://harvest.cals.ncsu.edu/); the North Carolina Department of Agriculture and Consumer Services (DRT) (http://www.ncagr.gov/); a gift from the North Carolina State Beekeepers Association to RHA and DRT (http://www.ncbeekeepers.org/); support from the North Carolina State University Department of Entomology to RHA (http://www.cals.ncsu.edu/entomology/); and by Cooperative Agreement No. G11AC20471 and G13AC00405 from the United States Geological Survey to SDF (http://www.usgs.gov/). Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of the Interior Southeast Climate Science Center or the USGS. This manuscript is submitted for publication with the understanding that the United States Government is authorized to reproduce and distribute reprints for Governmental purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; [Anonymous], 2013, R LANG ENV STAT COMP; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borowska J, 2011, J INSECT PHYSIOL, V57, P760, DOI 10.1016/j.jinsphys.2011.02.012; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cassell DL, 2002, RANDOMIZATION TEST W; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Faeth SH, 2011, ANN NY ACAD SCI, V1223, P69, DOI 10.1111/j.1749-6632.2010.05925.x; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Giersch T, 2009, APIDOLOGIE, V40, P117, DOI 10.1051/apido/2008065; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; GILLIAM M, 1991, J INVERTEBR PATHOL, V58, P286, DOI 10.1016/0022-2011(91)90077-4; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2012, ECOL ENTOMOL, V37, P83, DOI 10.1111/j.1365-2311.2011.01334.x; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Kraus B, 1995, ENVIRON ENTOMOL, V24, P1473, DOI 10.1093/ee/24.6.1473; Kuhnholz S, 1997, BEHAV ECOL SOCIOBIOL, V41, P407, DOI 10.1007/s002650050402; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Lecocq A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132473; Lee KV, 2013, APIDOLOGIE IN PRESS; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leong M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086357; Lowe EC, 2011, AUST J ZOOL, V59, P73, DOI 10.1071/ZO11041; Magnus R, 2010, SOCIOBIOLOGY, V55, P285; Magnus RM, 2014, BIOCHEM GENET, V52, P245, DOI 10.1007/s10528-014-9644-y; Manning R, 2007, AUST J EXP AGR, V47, P883, DOI 10.1071/EA04222; Martin SJ, 2013, ENV MICROBIOL REP, V5, P506, DOI 10.1111/1758-2229.12052; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Natsopoulou ME, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1896; Oksanen J., **DATA OBJECT**; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Smith M. L., APIDOLOGIE IN PRESS; Sponsler DB, 2015, PEERJ, V3, DOI 10.7717/peerj.838; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stevenson M., EPIR TOOLS ANAL EPID; Szalanski AL, 2014, FLA ENTOMOL, V97, P585, DOI 10.1653/024.097.0233; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Thompson CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105164; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Xian G, 2011, PHOTOGRAMM ENG REM S, V77, P758	71	45	47	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142031	10.1371/journal.pone.0142031	http://dx.doi.org/10.1371/journal.pone.0142031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536606	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400119
J	Joseph, MA; Fraize, N; Ansoud-Lerouge, J; Sapin, E; Peyron, C; Arthaud, S; Libourel, PA; Parmentier, R; Salin, PA; Malleret, G				Joseph, Mickael Antoine; Fraize, Nicolas; Ansoud-Lerouge, Jennifer; Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael			Differential Involvement of the Dentate Gyrus in Adaptive Forgetting in the Rat	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; EARLY GENE ZIF268; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; PATTERN SEPARATION; HIPPOCAMPAL NEUROGENESIS; EXPRESSION; BRAIN; REORGANIZATION; TRANSCRIPTION	How does the brain discriminate essential information aimed to be stored permanently from information required only temporarily, and that needs to be cleared away for not saturating our precious memory space? Reference Memory (RM) refers to the long-term storage of invariable information whereas Working Memory (WM) depends on the short-term storage of trial-unique information. Previous work has revealed that WM tasks are very sensitive to proactive interference. In order to prevent such interference, irrelevant old memories must be forgotten to give new ones the opportunity to be stabilized. However, unlike memory, physiological processes underlying this adaptive form of forgetting are still poorly understood. Here, we precisely ask what specific brain structure(s) could be responsible for such process to occur. To answer this question, we trained rats in a radial maze using three paradigms, a RM task and two WM tasks involving or not the processing of interference but strictly identical in terms of locomotion or motivation. We showed that an inhibition of the expression of Zif268 and c-Fos, two indirect markers of neuronal activity and synaptic plasticity, was observed in the dentate gyrus of the dorsal hippocampus when processing such interfering previously stored information. Conversely, we showed that inactivating the dentate gyrus impairs both RM and WM, but improves the processing of interference. Altogether, these results strongly suggest for the first time that the dentate gyrus could be a key structure involved in adaptive forgetting.	[Joseph, Mickael Antoine; Fraize, Nicolas; Ansoud-Lerouge, Jennifer; Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] Univ Lyon 1, F-69365 Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] CNRS, Unite Mixte Rech 5292, Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] INSERM, U1028, F-69008 Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] Lyon Neurosci Res Ctr CRNL, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Malleret, G (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	gaelmalleret@gmail.com	JOSEPH, M A/GYJ-5320-2022; Peyron, Christelle/H-6223-2017; joseph, Mickael/AAY-2966-2021	JOSEPH, M A/0000-0001-8661-0042; Peyron, Christelle/0000-0002-9317-3546; joseph, Mickael/0000-0002-5008-0542; Salin, Paul/0000-0001-5221-9109; Libourel, Paul-Antoine/0000-0001-6726-5829; Arthaud, Sebastien/0000-0001-7271-5468	CNRS (ATIP program); Fondation pour la recherche sur le cerveau (FRC); Region Rhone-Alpes (CIBLE program); Fondation pour la recherche medicale [FRM-FDT20130928087]; Region Rhone-Alpes (ARC2 doctoral fellowship)	CNRS (ATIP program); Fondation pour la recherche sur le cerveau (FRC); Region Rhone-Alpes (CIBLE program)(Region Auvergne-Rhone-Alpes); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Region Rhone-Alpes (ARC2 doctoral fellowship)(Region Auvergne-Rhone-Alpes)	This work was supported by grants from CNRS (ATIP program), Fondation pour la recherche sur le cerveau (FRC), and Region Rhone-Alpes (CIBLE program). M.A.J and N.F. were also supported by Fondation pour la recherche medicale (FRM-FDT20130928087) and Region Rhone-Alpes (ARC2 doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Della Sala S., 2009, FORGETTING FORGETTIN; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; ELLEN P, 1968, PHYSIOL BEHAV, V3, P857, DOI 10.1016/0031-9384(68)90167-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Izquierdo I., 2015, ART FORGETTING; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Levy BJ, 2009, FUNCTIONNAL NEUROIMA, P135; MacLeod CM, 1999, PSYCHON B REV, V6, P123, DOI 10.3758/BF03210819; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; ROBERTS WA, 1981, LEARN MOTIV, V12, P261, DOI 10.1016/0023-9690(81)90009-6; Rosenzweig ES, 2002, NAT NEUROSCI, V5, P6, DOI 10.1038/nn0102-6; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; Wimber M, 2015, NAT NEUROSCI, V18, P582, DOI 10.1038/nn.3973; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; [No title captured]	43	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142065	10.1371/journal.pone.0142065	http://dx.doi.org/10.1371/journal.pone.0142065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528714	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600096
J	Karlas, T; Dietrich, A; Peter, V; Wittekind, C; Lichtinghagen, R; Garnov, N; Linder, N; Schaudinn, A; Busse, H; Prettin, C; Keim, V; Troltzsch, M; Schutz, T; Wiegand, J				Karlas, Thomas; Dietrich, Arne; Peter, Veronica; Wittekind, Christian; Lichtinghagen, Ralf; Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald; Prettin, Christiane; Keim, Volker; Troeltzsch, Michael; Schuetz, Tatjana; Wiegand, Johannes			Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients	PLOS ONE			English	Article							BARIATRIC SURGERY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE METHODS; HEPATIC-FIBROSIS; XL PROBE; DISEASE; METAANALYSIS; PERFORMANCE; BIOPSY	Background Liver fibrosis induced by non-alcoholic fatty liver disease causes peri-interventional complications in morbidly obese patients. We determined the performance of transient elastography (TE), acoustic radiation force impulse (ARFI) imaging, and enhanced liver fibrosis (ELF) score for fibrosis detection in bariatric patients. Patients and Methods 41 patients (median BMI 47 kg/m(2)) underwent 14-day low-energy diets to improve conditions prior to bariatric surgery (day 0). TE (M and XL probe), ARFI, and ELF score were performed on days -15 and -1 and compared with intraoperative liver biopsies (NAS staging). Results Valid TE and ARFI results at day -15 and -1 were obtained in 49%/88% and 51%/90% of cases, respectively. High skin-to-liver-capsule distances correlated with invalid TE measurements. Fibrosis of liver biopsies was staged as F1 and F3 in n = 40 and n = 1 individuals. However, variations (median/range at d-15/-1) of TE (4.6/2.6-75 and 6.7/2.9-21.3 kPa) and ARFI (2.1/0.7-3.7 and 2.0/0.7-3.8 m/s) were high and associated with overestimation of fibrosis. The ELF score correctly classified 87.5% of patients. Conclusion In bariatric patients, performance of TE and ARFI was poor and did not improve after weight loss. The ELF score correctly classified the majority of cases and should be further evaluated.	[Karlas, Thomas; Garnov, Nikita] Univ Leipzig, IFB AdiposityDis, D-04109 Leipzig, Germany; [Karlas, Thomas; Keim, Volker; Troeltzsch, Michael; Wiegand, Johannes] Univ Hosp Leipzig, Dept Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany; [Dietrich, Arne] Univ Hosp Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany; [Peter, Veronica; Schuetz, Tatjana] Univ Leipzig, Res Area Bariatr Surg, IFB AdiposityDis, D-04109 Leipzig, Germany; [Wittekind, Christian] Univ Hosp Leipzig, Inst Pathol, Leipzig, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Clin Chem, Hannover, Germany; [Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Prettin, Christiane] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Hannover Medical School; Leipzig University; Leipzig University	Wiegand, J (corresponding author), Univ Hosp Leipzig, Dept Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de	Karlas, Thomas/I-1782-2019; Schütz, Tatjana/B-3362-2014	Karlas, Thomas/0000-0002-8109-8526; 	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, K7-40]; German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing; Siemens Healthcare Diagnostics GmbH	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig within the program of Open Access Publishing; Siemens Healthcare Diagnostics GmbH	This work was supported by Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (Project No. K7-40), and by the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing. Siemens Healthcare Diagnostics GmbH provided technical and financial support for ELF score analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzigotti A, 2013, J HEPATOL, V59, P180, DOI 10.1016/j.jhep.2012.12.028; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Bota S, 2013, ULTRASOUND MED BIOL, V39, P407, DOI 10.1016/j.ultrasmedbio.2012.09.017; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; Dyson JK, 2013, J CLIN PATHOL, V66, P1033, DOI 10.1136/jclinpath-2013-201620; Edholm D, 2014, SURG OBES RELAT DIS; Fagan KJ, 2015, LIVER INT, V35, P1673, DOI 10.1111/liv.12760; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Guzman-Aroca F, 2012, EUR RADIOL, V22, P2525, DOI 10.1007/s00330-012-2505-3; Karlas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091987; Karlas T, 2013, BEST PRACT RES CL EN, V27, P195, DOI 10.1016/j.beem.2013.02.002; Karlas T, 2011, SCAND J GASTROENTERO, V46, P1458, DOI 10.3109/00365521.2011.610004; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lassailly G, 2013, J HEPATOL, V58, P1249, DOI 10.1016/j.jhep.2012.12.026; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Naveau S, 2014, OBES SURG, V24, P1693, DOI 10.1007/s11695-014-1235-9; Nierhoff J, 2013, EUR RADIOL, V23, P3040, DOI 10.1007/s00330-013-2927-6; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Potthoff A, 2013, EUR J RADIOL, V82, P1207, DOI 10.1016/j.ejrad.2013.02.011; Runkel N, 2011, INT J COLORECTAL DIS, V26, P397, DOI 10.1007/s00384-011-1136-5; Verna EC, 2014, SEMIN LIVER DIS, V34, P1, DOI 10.1055/s-0034-1371549; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Yoneda M, 2015, CLIN GASTROENTEROL H; Yoshioka K, 2015, HEPATOL RES, V45, P142, DOI 10.1111/hepr.12388	35	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141649	10.1371/journal.pone.0141649	http://dx.doi.org/10.1371/journal.pone.0141649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528818	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600047
J	Lai, HJ; Chiang, YW; Yang, CC; Hsieh, ST; Chao, CC; Lee, MJ; Kuo, CC				Lai, Hsing-Jung; Chiang, Ya-Wen; Yang, Chih-Chao; Hsieh, Sung-Tsang; Chao, Chi-Chao; Lee, Ming-Jen; Kuo, Chung-Chin			The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; AXONAL EXCITABILITY; CALCIUM INFLUX; TRANSTHYRETIN; NEUROPATHY; THERAPY; NEUROTOXICITY; SUPPRESSION; DYSFUNCTION; CHANNELS	Familial amyloid polyneuropathy (FAP) caused by a mutation in transthyretin (TTR) gene is an autosomal dominant inherited disorder. The aim of this study is to explore the pathophysiological mechanism of FAP. We prospectively recruited 12 pauci-symptomatic carriers, 18 patients who harbor a TTR mutation, p.A97S, and two-age matched control groups. Data of nerve excitability test (NET) from ulnar motor and sensory axons were collected.NET study of ulnar motor axons of patients shows increased threshold and rheobase, reduced threshold elevation during hyperpolarizing threshold electrotonus (TE), and increased refractoriness. In sensory nerve studies, there are increased threshold reduction in depolarizing TE, lower slope of recovery and delayed time to overshoot after hyperpolarizing TE, increased refractoriness and superexcitability in recovery cycle. NET profiles obtained from the ulnar nerve of carriers show the increase of threshold and rheobase, whereas no significant threshold changes in hyperpolarizing TE and superexcitability. The regression models demonstrate that the increase of refractoriness and prolonged relative refractory period are correlated to the disease progression from carriers to patients. The marked increase of refractoriness at short-width stimulus suggests a defect in sodium current which may represent an early, pre-symptomatic pathophysiological change in TTR-FAP. Focal disruption of basal lamina and myelin may further increase the internodal capacity, manifested by the lower slope of recovery and delayed time to overshoot after hyperpolarization TE as well as the increase of superexcitability. NET could therefore make a pragmatic tool for monitoring disease progress from the very early stage of TTR-FAP.	[Lai, Hsing-Jung; Chiang, Ya-Wen; Yang, Chih-Chao; Hsieh, Sung-Tsang; Chao, Chi-Chao; Lee, Ming-Jen; Kuo, Chung-Chin] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hsieh, Sung-Tsang] Natl Taiwan Univ, Coll Med, Inst Anat & Cell Biol, Taipei, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Kuo, Chung-Chin] Natl Taiwan Univ, Coll Med, Inst Physiol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	mjlee@ntu.edu.tw; cckuo@ntu.edu.tw	Hsieh, Sung-Tsang/J-5994-2019; Lai, Nathan/AAG-4470-2021	Hsieh, Sung-Tsang/0000-0002-3188-8482; Chao, Chi-Chao/0000-0001-6499-5789; Lai, Hsing Jung/0000-0003-4782-3349	Ministry of Science and Technology, Taiwan [103-2321-B-002 -037]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by a grant provided by the Ministry of Science and Technology, Taiwan (103-2321-B-002 -037) (https://www.most.gov.tw/). The grant was obtained by MJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495; Benson MD, 2006, MUSCLE NERVE, V33, P609, DOI 10.1002/mus.20503; BENSON MD, 1989, TRENDS NEUROSCI, V12, P88, DOI 10.1016/0166-2236(89)90162-8; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; BOSTOCK H, 1991, J PHYSIOL-LONDON, V441, P537, DOI 10.1113/jphysiol.1991.sp018766; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Bostock H, 2006, CLIN NEUROPHYSIOL, V117, pS85; Buxbaum JN, 2000, ANNU REV MED, V51, P543, DOI 10.1146/annurev.med.51.1.543; Cappelen-Smith C, 2001, BRAIN, V124, P2439, DOI 10.1093/brain/124.12.2439; Carvalho Md, 2014, CLIN NEUROPHYSIOL, V125, pS270; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Conceicao I, 2014, MUSCLE NERVE, V49, P181, DOI 10.1002/mus.23901; Conceicao IM, 2008, CLIN NEUROPHYSIOL, V119, P1082, DOI 10.1016/j.clinph.2008.01.006; Davies GR, 2003, MULT SCLER J, V9, P246, DOI 10.1191/1352458503ms911oa; DYCK PJ, 1980, ANN NEUROL, V8, P590, DOI 10.1002/ana.410080608; Faivre-Sarrailh C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00196; Gasperini RJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-19; Graham RC, 2006, J NEUROL NEUROSUR PS, V77, P973, DOI 10.1136/jnnp.2005.081547; Hafner J, 2015, MUSCLE NERVE, V51, P443, DOI 10.1002/mus.24508; Hellman U, 2008, AMYLOID, V15, P181, DOI 10.1080/13506120802193720; HOLMGREN G, 1991, CLIN GENET, V40, P242; Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Hund E, 2001, NEUROLOGY, V56, P431, DOI 10.1212/WNL.56.4.431; Hund E, 2012, APPL CLIN GENET, V5, P37, DOI 10.2147/TACG.S19903; Jankelowitz SK, 2007, J PHYSIOL-LONDON, V581, P927, DOI 10.1113/jphysiol.2006.123661; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Kiernan MC, 2002, BRAIN, V125, P664, DOI 10.1093/brain/awf041; Kollmer J, 2015, BRAIN, V138, P549, DOI 10.1093/brain/awu344; Kurosawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1012, DOI 10.1016/j.bbrc.2005.09.142; Lefaucheur JP, 2013, J NEUROL, V260, P1497, DOI 10.1007/s00415-012-6816-8; Lin CSY, 2011, ARCH NEUROL-CHICAGO, V68, P862, DOI 10.1001/archneurol.2011.137; MYERS RR, 1986, ANESTHESIOLOGY, V64, P29, DOI 10.1097/00000542-198601000-00006; Nodera H, 2004, BRAIN, V127, P203, DOI 10.1093/brain/awh020; Plante-Bordeneuve V, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e120; Plante-Bordeneuve V, 1998, NEUROLOGY, V51, P708, DOI 10.1212/WNL.51.3.708; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Reilly M, 2005, PERIPHERAL NEUROPATH, V2, P1921; Said G, 2003, AMYLOID, V10, P7; SAID G, 1984, NEUROLOGY, V34, P1025, DOI 10.1212/WNL.34.8.1025; Said G, 2009, J NEUROL SCI, V284, P149, DOI 10.1016/j.jns.2009.05.001; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sung JY, 2015, J NEUROL NEUROSUR PS, V86, P640, DOI 10.1136/jnnp-2014-308088; Sung JY, 2004, MUSCLE NERVE, V29, P28, DOI 10.1002/mus.10516; Tanaka K, 2001, J NEUROL SCI, V183, P79, DOI 10.1016/S0022-510X(00)00481-0; THOMAS PK, 1974, BRAIN, V97, P395, DOI 10.1093/brain/97.1.395; Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318; Yamashita T, 2012, NEUROLOGY, V78, P637, DOI 10.1212/WNL.0b013e318248df18; Yang NCC, 2010, NEUROLOGY, V75, P532, DOI 10.1212/WNL.0b013e3181ec7fda	53	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141935	10.1371/journal.pone.0141935	http://dx.doi.org/10.1371/journal.pone.0141935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529114	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600079
J	Morstedt, B; Corbisiero, S; Bitto, H; Stieglitz, RD				Moerstedt, Beatrice; Corbisiero, Salvatore; Bitto, Hannes; Stieglitz, Rolf-Dieter			Attention-Deficit/Hyperactivity Disorder (ADHD) in Adulthood: Concordance and Differences between Self- and Informant Perspectives on Symptoms and Functional Impairment	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; BORDERLINE PERSONALITY-DISORDER; GERMAN VALIDATION; COMORBIDITY; CHILDREN; RELIABILITY; CHILDHOOD; DIAGNOSIS; VALIDITY; RATINGS	Attention-deficit/hyperactivity disorder (ADHD) is a severe mental illness, associated with major impairment and a high comorbidity rate. Particularly undiagnosed ADHD in adulthood has serious consequences. Thus, a valid diagnosis is important. In adulthood, the diagnostic process for ADHD is complicated: symptoms may overlap with comorbid disorders, and the onset and progression of the disorder must be reconstructed retrospectively. Guidelines for the diagnostic process recommend the inclusion of additional informant ratings. Research into the relation between self-and informant ratings shows extremely heterogeneous results. The levels of agreement range from low to high. The focus of this study is the concordance and differences between self-and informant ratings on ADHD symptoms and impairments. In this regard, two possible influencing factors (gender and relationship type) are also examined. 114 people participated in this study, 77 with an ADHD diagnosis and 37 without a diagnosis. For all participants, either parents or partners also rated ADHD symptoms and impairments. Small to moderate concordance was found between self-and informant ratings, with females being slightlymore concordant than males, particularly for ratings of problems with self-concept. Examination of the consistency within a particular perspective showed that people with ADHD seemed to be unaware of the causal relation between ADHD symptoms and their impairments. A close investigation found almost no influence of gender and relationship type on differences within perspectives. Based on these results, the implications for the diagnostic process are that additional informant information is clearly necessary and helpful.	[Moerstedt, Beatrice; Bitto, Hannes; Stieglitz, Rolf-Dieter] Univ Basel, Dept Psychol, Div Clin Psychol & Psychiat, Basel, Switzerland; [Corbisiero, Salvatore; Stieglitz, Rolf-Dieter] Univ Basel, Psychiat Clin, Basel, Switzerland	University of Basel; University of Basel	Morstedt, B (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Psychiat, Basel, Switzerland.	bea.moerstedt@unibas.ch						Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Adler LA, 2008, J ATTEN DISORD, V11, P711, DOI 10.1177/1087054707308503; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bagwell CL, 2001, J AM ACAD CHILD PSY, V40, P1285, DOI 10.1097/00004583-200111000-00008; Barkley R. A., 2008, ADHD ADULTS WHAT SCI; Barkley R.A., 2011, BARKLEY FUNCTIONAL I; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Barkley RA, 2006, HDB DAIGNOSIS TREATM; Barkley RA, 2006, ATTENTION DEFICIT HY; Barkley RA, 2008, CNS SPECTRUMS, V13, P977, DOI 10.1017/S1092852900014036; Barkley RA, 2011, PSYCHOL ASSESSMENT, V23, P437, DOI 10.1037/a0022172; Biederman J, 2006, J CLIN PSYCHIAT, V67, P524, DOI 10.4088/JCP.v67n0403; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Canu W H, 2003, J Atten Disord, V6, P123, DOI 10.1177/108705470300600304; Carlson C. L., 2004, ADHD REPORT, P1, DOI DOI 10.1521/ADHD.12.2.1.30979; Christiansen H, 2012, EUR PSYCHIAT, V27, P321, DOI 10.1016/j.eurpsy.2010.12.010; Christiansen H, 2011, EUR PSYCHIAT, V26, P100, DOI 10.1016/j.eurpsy.2009.12.024; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Corbisiero S, 2013, ADHD-ATTEND DEFICIT, V5, P83, DOI 10.1007/s12402-012-0097-z; Danckaerts M, 1999, PSYCHOPATHOLOGY, V32, P81, DOI 10.1159/000029071; de Zwaan M, 2012, EUR ARCH PSY CLIN N, V262, P79, DOI 10.1007/s00406-011-0211-9; Eakin L, 2004, J Atten Disord, V8, P1, DOI 10.1177/108705470400800101; Edel MA, 2009, PHARMACOPSYCHIATRY, V42, P109, DOI 10.1055/s-0028-1112130; Fossati A, 2002, COMPR PSYCHIAT, V43, P369, DOI 10.1053/comp.2002.34634; Friedman SR, 2003, NEUROPSYCHOLOGY, V17, P50, DOI 10.1037/0894-4105.17.1.50; Glutting JJ, 2005, PSYCHOL ASSESSMENT, V17, P44, DOI 10.1037/1040-3590.17.1.44; Goodman David W, 2007, J Psychiatr Pract, V13, P318, DOI 10.1097/01.pra.0000290670.87236.18; Gordon Michael, 2006, J Atten Disord, V9, P465, DOI 10.1177/1087054705283881; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; HASE, 2008, HASE HOMBURGER ADHS; Hoza B, 2000, CHILD DEV, V71, P432, DOI 10.1111/1467-8624.00155; Jacobson NS, 2000, J CONSULT CLIN PSYCH, V68, P351, DOI 10.1037/0022-006X.68.2.351; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P1569, DOI 10.1097/00004583-199912000-00019; Kendall T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1239; Knouse Laura E, 2005, J Atten Disord, V8, P221, DOI 10.1177/1087054705280159; Knouse LE, 2008, J ATTEN DISORD, V11, P652, DOI 10.1177/1087054707299411; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Kooij JJS, 2012, J ATTEN DISORD, V16, p3S, DOI 10.1177/1087054711435361; Magnusson Pall, 2006, J Atten Disord, V9, P494, DOI 10.1177/1087054705283650; Miller TW, 2007, J ABNORM PSYCHOL, V116, P519, DOI 10.1037/0021-843X.116.3.519; Millstein R. B., 1997, J ATTEN DISORD, V2, P159, DOI [DOI 10.1177/108705479700200302, 10.1177/108705479700200302]; Minde K, 2003, J CHILD PSYCHOL PSYC, V44, P637, DOI 10.1111/1469-7610.00150; Moeller SJ, 2014, TRENDS COGN SCI, V18, P635, DOI 10.1016/j.tics.2014.09.003; Murphy P, 2000, AM J PSYCHIAT, V157, P1156, DOI 10.1176/appi.ajp.157.7.1156; Newark PE, 2010, ADHD-ATTEND DEFICIT, V2, P59, DOI 10.1007/s12402-010-0023-1; Nijmeijer JS, 2008, CLIN PSYCHOL REV, V28, P692, DOI 10.1016/j.cpr.2007.10.003; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Philipsen A, 2006, EUR ARCH PSY CLIN N, V256, P42, DOI 10.1007/s00406-006-1006-2; Prevatt F, 2012, J ATTEN DISORD, V16, P235, DOI 10.1177/1087054710392538; Ratey JJ, 1995, COMPREHENSIVE GUIDE, P218; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Rizzo P, 2012, Z PSYCHIATR PSYCH PS, V60, P131, DOI 10.1024/1661-4747/a000108; Robbins CA, 2005, J CLIN PSYCHOL, V61, P565, DOI 10.1002/jclp.20120; Robin A.L., 2002, ADHD REPORT, V10, P9, DOI DOI 10.1521/ADHD.10.3.9.20553; Saunders B, 1996, PSYCHOL SCHOOLS, V33, P333, DOI 10.1002/(SICI)1520-6807(199610)33:4<333::AID-PITS8>3.0.CO;2-N; Sobanski E, 2007, EUR ARCH PSY CLIN N, V257, P371, DOI 10.1007/s00406-007-0712-8; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Turgay A, 2012, J CLIN PSYCHIAT, V73, P192, DOI 10.4088/JCP.10m06628; Wasserstein J, 2005, J CLIN PSYCHOL, V61, P535, DOI 10.1002/jclp.20118; Wender P. H., 1995, ATTENTION DEFICIT HY; Wender PH, 2001, ANN NY ACAD SCI, V931, P1; Wender PH, 1998, PSYCHIAT CLIN N AM, V21, P761, DOI 10.1016/S0193-953X(05)70039-3; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Zucker M, 2002, PSYCHOL ASSESSMENT, V14, P379, DOI 10.1037//1040-3590.14.4.379	64	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141342	10.1371/journal.pone.0141342	http://dx.doi.org/10.1371/journal.pone.0141342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529403	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600022
J	Wettenschwiler, PD; Lorenzetti, S; Stampfli, R; Rossi, RM; Ferguson, SJ; Annaheim, S				Wettenschwiler, Patrick D.; Lorenzetti, Silvio; Staempfli, Rolf; Rossi, Rene M.; Ferguson, Stephen J.; Annaheim, Simon			Mechanical Predictors of Discomfort during Load Carriage	PLOS ONE			English	Article							BACK-PAIN; PRESSURE MEASUREMENTS; SHOULDER INTERFACE; RUCKSACK PARALYSIS; COMFORT; SCHOOLCHILDREN; ASSOCIATION; ADOLESCENTS; PERCEPTIONS; BACKPACKS	Discomfort during load carriage is a major issue for activities using backpacks (e.g. infantry maneuvers, children carrying school supplies, or outdoor sports). It is currently unclear which mechanical parameters are responsible for subjectively perceived discomfort. The aim of this study was to identify objectively measured mechanical predictors of discomfort during load carriage. We compared twelve different configurations of a typical load carriage system, a commercially available backpack with a hip belt. The pressure distribution under the hip belt and the shoulder strap, as well as the tensile force in the strap and the relative motion of the backpack were measured. Multiple linear regression analyses were conducted to investigate possible predictors of discomfort. The results demonstrate that static peak pressure, or alternatively, static strap force is a significant (p<0.001) predictor of discomfort during load carriage in the shoulder and hip region, accounting for 85% or more of the variation in discomfort. As an additional finding, we discovered that the regression coefficients of these predictors are significantly smaller for the hip than for the shoulder region. As static peak pressure is measured directly on the body, it is less dependent on the type of load carriage system than static strap force. Therefore, static peak pressure is well suited as a generally applicable, objective mechanical parameter for the optimization of load carriage system design. Alternatively, when limited to load carriage systems of the type backpack with hip belt, static strap force is the most valuable predictor of discomfort. The regionally differing regression coefficients of both predictors imply that the hip region is significantly more tolerant than the shoulder region. In order to minimize discomfort, users should be encouraged to shift load from the shoulders to the hip region wherever possible, at the same time likely decreasing the risk of low back pain or injury.	[Wettenschwiler, Patrick D.; Staempfli, Rolf; Rossi, Rene M.; Annaheim, Simon] Empa, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland; [Wettenschwiler, Patrick D.; Lorenzetti, Silvio; Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Wettenschwiler, PD (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland.	patrick.wettenschwiler@empa.ch	Ferguson, Stephen J./A-4118-2012; Lorenzetti, Silvio Rene/B-1188-2009; Annaheim, Simon/B-1389-2017; Rossi, Rene Michel/A-1507-2012	Ferguson, Stephen J./0000-0003-0650-5889; Lorenzetti, Silvio Rene/0000-0002-8339-8960; Annaheim, Simon/0000-0002-8192-1391; Rossi, Rene Michel/0000-0003-0946-682X				BESSEN RJ, 1987, MIL MED, V152, P372, DOI 10.1093/milmed/152.7.372; Cavallo Carla Maria, 2003, Work, V20, P137; DAUBE JR, 1969, J AMER MED ASSOC, V208, P2447, DOI 10.1001/jama.208.13.2447; de Looze MP, 2003, ERGONOMICS, V46, P985, DOI 10.1080/0014013031000121977; Doan JB., 2001, P RTO HUMAN FACTORS; Ebe K, 2000, ERGONOMICS, V43, P771, DOI 10.1080/001401300404742; Gutierrez JT, 2009, THESIS MARINE CORPS; Hadid A, 2012, J APPL PHYSIOL, V112, P597, DOI 10.1152/japplphysiol.00990.2011; Helander MG, 1997, ERGONOMICS, V40, P895, DOI 10.1080/001401397187739; HOLLOWAY GA, 1976, J APPL PHYSIOL, V40, P597, DOI 10.1152/jappl.1976.40.4.597; Jones GR, 2005, APPL ERGON, V36, P79, DOI 10.1016/j.apergo.2004.07.001; Kim JH, 2011, ERGONOMICS, V54, P626, DOI 10.1080/00140139.2011.583362; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Konitzer LN, 2008, J HAND THER, V21, P143, DOI 10.1197/j.jht.2007.10.017; Korovessis P, 2004, J SPINAL DISORD TECH, V17, P33, DOI 10.1097/00024720-200402000-00008; LaFiandra M, 2004, MED SCI SPORT EXER, V36, P460, DOI 10.1249/01.MSS.0000117113.77904.46; Mackie HW, 2005, APPL ERGON, V36, P199, DOI 10.1016/j.apergo.2004.10.007; Makela JP, 2006, CLIN ORTHOP RELAT R, P205, DOI 10.1097/01.blo.0000229338.29277.29; Martin J, 2000, MILITARY LOAD CARRIA; Maurya S, 2009, INDIAN J NEUROTRAUM, V6, P153, DOI 10.1016/S0973-0508(09)80013-0; Morrissey MP, 2013, TEXT PROG, V45, P145, DOI 10.1080/00405167.2013.845540; Negrini S, 2002, SPINE, V27, P187, DOI 10.1097/00007632-200201150-00014; Piscione J, 2006, EUR J APPL PHYSIOL, V97, P573, DOI 10.1007/s00421-006-0221-x; Psikuta A., 2009, THESIS DE MONFORT U; Richards L., 1980, HUMAN FACTORS TRANSP, P2; SANGEORZAN BJ, 1989, J ORTHOP RES, V7, P423, DOI 10.1002/jor.1100070315; Scribano F, 1970, DESIGN DEV FABRICATI; Sharpe SR, 2008, J BIOMECH, V41, P968, DOI 10.1016/j.jbiomech.2007.12.018; Sheir-Neiss GI, 2003, SPINE, V28, P922, DOI 10.1097/00007632-200305010-00015; Skaggs DL, 2006, J PEDIATR ORTHOPED, V26, P358, DOI 10.1097/01.bpo.0000217723.14631.6e; Stevenson JM, 1997, RES DEV ADV PERSONAL; Wettenschwiler PD, 2015, INT J IND ERGONOM, V49, P60, DOI 10.1016/j.ergon.2015.06.003; Zemp R, 2015, APPL ERGON, V48, P273, DOI 10.1016/j.apergo.2014.12.010; Zhang LJ, 1996, HUM FACTORS, V38, P377, DOI 10.1518/001872096778701962	34	12	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142004	10.1371/journal.pone.0142004	http://dx.doi.org/10.1371/journal.pone.0142004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529414	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600092
J	Wu, ZY; Milne, RI; Chen, CJ; Liu, J; Wang, H; Li, DZ				Wu, Zeng-Yuan; Milne, Richard I.; Chen, Chia-Jui; Liu, Jie; Wang, Hong; Li, De-Zhu			Ancestral State Reconstruction Reveals Rampant Homoplasy of Diagnostic Morphological Characters in Urticaceae, Conflicting with Current Classification Schemes	PLOS ONE			English	Article							ELATOSTEMA URTICACEAE; REPEATED EVOLUTION; NOV URTICACEAE; PHYLOGENY; FAMILY; DIVERSITY; RADIATION; ANATOMY	Urticaceae is a family with more than 2000 species, which contains remarkable morphological diversity. It has undergone many taxonomic reorganizations, and is currently the subject of further systematic studies. To gain more resolution in systematic studies and to better understand the general patterns of character evolution in Urticaceae, based on our previous phylogeny including 169 accessions comprising 122 species across 47 Urticaceae genera, we examined 19 diagnostic characters, and analysed these employing both maximum-parsimony and maximum-likelihood approaches. Our results revealed that 16 characters exhibited multiple state changes within the family, with ten exhibiting >eight changes and three exhibiting between 28 and 40. Morphological synapomorphies were identified for many clades, but the diagnostic value of these was often limited due to reversals within the clade and/or homoplasies elsewhere. Recognition of the four clades comprising the family at subfamily level can be supported by a small number carefully chosen defining traits for each. Several non-monophyletic genera appear to be defined only by characters that are plesiomorphic within their clades, and more detailed work would be valuable to find defining traits for monophyletic clades within these. Some character evolution may be attributed to adaptive evolution in Urticaceae due to shifts in habitat or vegetation type. This study demonstrated the value of using phylogeny to trace character evolution, and determine the relative importance of morphological traits for classification.	[Wu, Zeng-Yuan; Liu, Jie; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant & Biodivers East Asia, Kunming 650201, Yunnan, Peoples R China; [Wu, Zeng-Yuan; Liu, Jie; Wang, Hong; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China; [Milne, Richard I.] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Chen, Chia-Jui] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wu, Zeng-Yuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Edinburgh; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China.	wanghong@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Wu, Zeng-Yuan/ABD-4758-2021; Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; jie, liu/0000-0003-4356-1943; Wu, Zeng-Yuan/0000-0003-4652-0194	National Natural Science Foundation of China [40830209, 41571059]; National Key Basic Research Program of China [2014CB954100]; Ministry of Science and Technology, China [2013FY112600]; Applied Fundamental Research Foundation of Yunnan Province [2014GA003]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Applied Fundamental Research Foundation of Yunnan Province; China Scholarship Council(China Scholarship Council)	(1) National Natural Science Foundation of China (40830209), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is design, data collection. (2) The National Key Basic Research Program of China (2014CB954100), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is analysis. (3) Ministry of Science and Technology, China, Basic Research Project (No. 2013FY112600), http://www.most.gov.cn/, Hong Wang. The role of this sponsor is analysis. (4) National Natural Science Foundation of China (41571059), http://www.nsfc.gov.cn/, Jie Liu. The role of this sponsor is materials collection. (5) Applied Fundamental Research Foundation of Yunnan Province (2014GA003), http://www.nsfc.gov.cn/, De-Zhu Li. The role of this sponsor is decision to publish. (6) China Scholarship Council, http://www.csc.edu.cn/, Zeng-Yuan Wu. The role of this sponsor is preparation of the manuscript.	[Anonymous], 1989, EVOLUTION SYSTEMATIC; [Anonymous], 2003, FLORA CHINA; Banks H, 2014, TAXON, V63, P299, DOI 10.12705/632.37; Bechtel ARI, 1921, AM J BOT, V8, P386, DOI 10.2307/2435455; Beentje HJ, 2010, ROYAL BOT GARDENS, P147; BERG CC, 1978, TAXON, V27, P39, DOI 10.2307/1220477; Berg CC., 1989, EVOLUTION SYSTEMATIC, V2, P193; BIGALKE HILDEGARD, 1933, BEITR BIOL PFLANZEN, V21, P1; Chen C.J., 1985, ACTA PHYTOTAX SINICA, V23, P444; Chew W. L., 1963, Gardens' Bulletin, V20, P1; Conn Barry J., 2009, Kew Bulletin, V64, P349; Couvreur TLP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010473; Cunha AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117553; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; de Oliveira LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089701; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; FRIIS I, 1988, NORD J BOT, V8, P25, DOI 10.1111/j.1756-1051.1988.tb01705.x; Friis I., 1993, FAMILIES GENERA VASC, VII, P612, DOI DOI 10.2307/1222750; Gaudichaud C., 1830, VOYAGE AUTOUR MONDE, P111; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Givnish TJ, 2005, P ROY SOC B-BIOL SCI, V272, P1481, DOI 10.1098/rspb.2005.3067; Hadiah JT, 2009, BLUMEA BIODIVERS ECO, V54, P1; Hadiah Julisasi T., 2003, Telopea, V10, P235; Hadiah JT, 2008, AUST SYST BOT, V21, P375, DOI 10.1071/SB08041; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harris J.G., 1994, PLANT IDENTIFICATION; Horn JW, 2009, AM J BOT, V96, P1462, DOI 10.3732/ajb.0800396; Kato T, 2008, ECOL RES, V23, P339, DOI 10.1007/s11284-007-0387-7; Kim C, 2015, TAXON, V64, P65, DOI 10.12705/641.20; Kravtsova TI, 2009, COMP CARPOLOGY URTIC, P136; Lu L, 2010, BOT J LINN SOC, V162, P477, DOI 10.1111/j.1095-8339.2009.01024.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Nurk NM, 2013, MOL PHYLOGENET EVOL, V66, P1, DOI 10.1016/j.ympev.2012.08.022; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Robinson CB., 1910, PHILIPP J SCI, V5, P465; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Schaffer S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-246; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; Soltis DE, 2013, AM J BOT, V100, P916, DOI 10.3732/ajb.1300044; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Takhtajan A, 2009, FLOWERING PLANTS, P281; THURSTON EL, 1974, AM J BOT, V61, P809, DOI 10.2307/2441617; Thurston EL, 1969, BOT REV, V65, P393, DOI DOI 10.1007/BF02858878; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Wang W.T., 1995, FLORA REIPUBLICAE PO, V23, P187; [王文采 Wang Wentsai], 2010, [广西植物, Guihaia], V30, P571; Wang WT, 1980, B BOT LAB N E FOREST, V7, P1; Wang WT, 2012, PAPER COLLECTION WT; Wang WT, 1995, FLORA REIPUBLICAE PO, V23, P1; Wang WT, 1980, B BOT LAB N E FOREST, V6, P45; Webster NB, 2012, MOL PHYLOGENET EVOL, V63, P625, DOI 10.1016/j.ympev.2012.02.004; Weddell H.A., 1869, PRODROMUS SYSTEMATIS, V16, P32, DOI [10.5962/bhl.title.286, DOI 10.5962/BHL.TITLE.286]; Weddell HA, 1854, ANN SCI NAT BOT 4, V4, P173; Weddell HA., 1856, ARCH MUSEUM HIST NAT, V9, P1; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wilmot-Dear C. M., 2012, Edinburgh Journal of Botany, V69, P301, DOI 10.1017/S096042861200011X; Wilmot-Dear CM, 2004, NORD J BOT, V24, P5, DOI 10.1111/j.1756-1051.2004.tb00825.x; Wilmot-Dear C.M., 1996, OPERA BOT, V129, P1; Wu ZY, 2013, MOL PHYLOGENET EVOL, V69, P814, DOI 10.1016/j.ympev.2013.06.022; Wu ZY, 2013, ANN BOT FENN, V50, P75, DOI 10.5735/085.050.0113; Wu Zeng-Yuan, 2011, PhytoKeys, V7, P57, DOI 10.3897/phytokeys.7.2022; Wu ZY, 2011, NORD J BOT, V29, P227, DOI 10.1111/j.1756-1051.2011.01076.x	67	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141821	10.1371/journal.pone.0141821	http://dx.doi.org/10.1371/journal.pone.0141821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529598	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600064
J	Kibira, SPS; Muhumuza, C; Bukenya, JN; Atuyambe, LM				Kibira, Simon P. S.; Muhumuza, Christine; Bukenya, Justine N.; Atuyambe, Lynn M.			"I Spent a Full Month Bleeding, I Thought I Was Going to Die..." A Qualitative Study of Experiences of Women Using Modern Contraception in Wakiso District, Uganda	PLOS ONE			English	Article							HEALTH-SERVICES; PERCEPTIONS; BARRIERS; DISCONTINUATION; PLEASURE; REGION; USERS; MEN	Introduction There is high unmet need for family planning (FP) in Uganda as well as high contraceptive discontinuation rates. These contribute to the high fertility rates that in part are due to unplanned pregnancies. There are gaps in knowledge about experiences that couples go through while using contraceptives in their lives. This study explored women's experiences during the course of their contraceptive use. Methods We conducted a qualitative study involving 30 women who had used modern contraception for at least one year in Wakiso district, central Uganda. We used in-depth interviews to obtain their personal accounts. Index women were approached through health officers at four health centres in the district. All ethical approvals and informed consent were obtained. We used conventional content analysis; identifying codes through open coding, on which basis categories were developed and grouped into overarching themes. Results Women's accounts were summarised in the following themes: negative experiences with modern contraceptive use, motivation to continue using FP in spite of these negative experiences, the role of influential people, and discontinuation of use. Negative accounts dominated the experiences of most women but they expressed strong desire to continue using modern contraception even amidst all challenges. Health workers emerged as the most influential people that played a vital role in women's decisions. Conclusion Varied negative experiences with modern contraception and misperceptions exist amidst a determination to continue use. Partner engagement, health service strengthening to improve side effects management and health worker skills, and engaging older women that have successfully used contraception as community champions, are potential strategies to support women's contraceptive decisions.	[Kibira, Simon P. S.; Bukenya, Justine N.; Atuyambe, Lynn M.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Kibira, Simon P. S.] Univ Bergen, Fac Med & Dent, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Muhumuza, Christine] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; University of Bergen; Makerere University	Kibira, SPS (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda.	pskibira@gmail.com		Kibira, Simon Peter Sebina/0000-0002-7385-423X	Family Health Research and Development Centre at Makerere University School of Public Health; The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA	Family Health Research and Development Centre at Makerere University School of Public Health; The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA	The funds for data collection for this study were provided by the Family Health Research and Development Centre at Makerere University School of Public Health, and The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA. SPSK received the faculty grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayiasi MR, 2015, THE PAN AFRICAN MEDI, V21; Babigumira JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030735; Barden-O'Fallon J, 2009, HEALTH CARE WOMEN IN, V30, P475, DOI 10.1080/07399330902801187; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Cleary S, 2013, SOC SCI MED, V80, P37, DOI 10.1016/j.socscimed.2012.11.035; Davis AR, 2004, ANN REV SEX RES, V15, P297; Eskindir L, 2003, ETHIOP J HEALTH DEV, V18, P8; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hardon A, 1997, M WOM MENS PERSP FER; Higgins JA, 2008, SEX HEALTH, V5, P321, DOI 10.1071/SH08021; Higgins JA, 2008, AM J PUBLIC HEALTH, V98, P1803, DOI 10.2105/AJPH.2007.115790; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kasedde S., 2000, LONG TERM AND PERMAN; Khan MA, 2003, HEALTH POLICY PLANN, V18, P101, DOI 10.1093/heapol/18.1.101; Lopez LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001863.pub2; Machado JC, 2014, REV PANAM SALUD PUBL, V36, P134; Morse JE, 2014, INT J GYNECOL OBSTET, V124, P30, DOI 10.1016/j.ijgo.2013.07.014; Mosha I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-523; Mota K, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0209-y; Mugisha JF, 2008, J FAM PLAN REPROD H, V34, P37, DOI 10.1783/147118908783332230; Nalwadda G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027908; Nalwadda G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-220; Ochako R, 2015, BMC PUBLIC HEALTH, V15, P1483; Population Reference Bureau, 2013, WORLD POPULATION DAT; Rahnama P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-779; Reuter S, 2003, EUR J CONTRACEP REPR, V8, P27; Schaffir J, 2006, J SEX MARITAL THER, V32, P305, DOI 10.1080/00926230600666311; Sedgh G, 2007, OCCASIONAL REPORT; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Smit J, 2002, SOC SCI MED, V55, P1511, DOI 10.1016/S0277-9536(01)00284-2; Tolley E, 2005, INT FAM PLAN PERSPEC, V31, P15, DOI 10.1363/3101505; Uganda Bureau of Statistics, 2007, PROJECTIONS OF DEMOG; Uganda Bureau of Statistics (UBOS) and Macro International Inc, 2007, UGANDA DEMOGRAPHIC A; Uganda Bureau of Statistics (UBOS) & ICF International Inc, 2012, UGANDA DEMOGRAPHIC A; United Nations, 1995, INTERNATIONAL CONFER; United Nations, 2012, WORKING PAPER 2013; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) Knowledge for Health Project, 2011, FAMILY PLANNING A GL	40	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141998	10.1371/journal.pone.0141998	http://dx.doi.org/10.1371/journal.pone.0141998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524603	Green Submitted, Green Published, gold			2022-12-27	WOS:000364029800031
J	Ahmad, M; Asghar, A; Raman, AAA; Daud, WMAW				Ahmad, Mushtaq; Asghar, Anam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan			Enhancement of Treatment Efficiency of Recalcitrant Wastewater Containing Textile Dyes Using a Newly Developed Iron Zeolite Socony Mobil-5 Heterogeneous Catalyst	PLOS ONE			English	Article							WET PEROXIDE OXIDATION; FENTON OXIDATION; AZO-DYE; PHOTOCATALYTIC DEGRADATION; EXCHANGED ZEOLITE; AQUEOUS-SOLUTION; RHODAMINE 6G; DECOLORIZATION; OPTIMIZATION; EFFLUENT	Fenton oxidation, an advanced oxidation process, is an efficient method for the treatment of recalcitrant wastewaters. Unfortunately, it utilizes H2O2 and iron-based homogeneous catalysts, which lead to the formation of high volumes of sludge and secondary pollutants. To overcome these problems, an alternate option is the usage of heterogeneous catalyst. In this study, a heterogeneous catalyst was developed to provide an alternative solution for homogeneous Fenton oxidation. Iron Zeolite Socony Mobile-5 (Fe-ZSM-5) was synthesized using a new two-step process. Next, the catalyst was characterized by scanning electron microscopy, energy-dispersive X-ray spectroscopy, fourier transform infrared spectroscopy, and Brunauer-Emmett-Teller analysis and tested against a model wastewater containing the azo dye Acid Blue 113. Results showed that the loading of iron particles reduced the surface area of the catalyst from 293.59 to 243.93 m(2)/g; meanwhile, the average particle size of the loaded material was 12.29 nm. Furthermore, efficiency of the developed catalyst was evaluated by performing heterogeneous Fenton oxidation. Taguchi method was coupled with principal component analysis in order to assess and optimize mineralization efficiency. Experimental results showed that under optimized conditions, over 99.7% degradation and 77% mineralization was obtained, with a 90% reduction in the consumption of the developed catalyst. Furthermore, the developed catalyst was stable and reusable, with less than 2% leaching observed under optimized conditions. Thus, the present study proved that newly developed catalyst has enhanced the oxidation process and reduced the chemicals consumption.	[Ahmad, Mushtaq; Asghar, Anam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan] Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Raman, AAA (corresponding author), Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia.	azizraman@um.edu.my	DAUD, WAN MOHD ASHRI WAN/C-1022-2010; Asghar, Anam/K-7200-2016; ABDUL RAMAN, ABDUL AZIZ/B-8094-2010	Asghar, Anam/0000-0001-7099-4109; ABDUL RAMAN, ABDUL AZIZ/0000-0001-7586-1903	University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia [HIR-MOHE-D000038-16001]; University of Malaya Bright Sparks Unit	University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia; University of Malaya Bright Sparks Unit	We are thankful to the University of Malaya High Impact Research Grant (HIR-MOHE-D000038-16001) from the Ministry of Higher Education Malaysia and University of Malaya Bright Sparks Unit which financially supported this work.	Ahmad M, 2014, LOW TEMPERATURE SYNT, P20; Ahmad M, 2015, AUST J BASIC APPL SC, V9, P114; Ahmad M, 2015, POWDER TECHNOL, V280, P42, DOI 10.1016/j.powtec.2015.03.030; Ajeel MA, 2015, ELECTROCHIM ACTA, V153, P379, DOI 10.1016/j.electacta.2014.11.163; Akan J. C., 2009, Australian Journal of Basic and Applied Sciences, V3, P1933; Asghar A, 2014, SCI WORLD J, DOI 10.1155/2014/869120; Banerjee A, 2012, J MATER CHEM, V22, P19694, DOI 10.1039/c2jm33798c; Battiston AA, 2003, J CATAL, V213, P251, DOI 10.1016/S0021-9517(02)00051-9; Bolova E, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2852; Chang JH, 2009, SCI TOTAL ENVIRON, V407, P5914, DOI 10.1016/j.scitotenv.2009.07.041; Dantas TLP, 2006, CHEM ENG J, V118, P77, DOI 10.1016/j.cej.2006.01.016; Dong YC, 2010, SCI TOTAL ENVIRON, V408, P2245, DOI 10.1016/j.scitotenv.2010.01.020; Dubey AK, 2008, OPT LASER ENG, V46, P124, DOI 10.1016/j.optlaseng.2007.08.011; Dukkanci M, 2010, J HAZARD MATER, V181, P343, DOI 10.1016/j.jhazmat.2010.05.016; Dukkanci M, 2010, APPL CATAL B-ENVIRON, V95, P270, DOI 10.1016/j.apcatb.2010.01.004; Faryal R, 2005, PAK J BOT, V37, P1003; Gauri SK, 2009, INT J ADV MANUF TECH, V41, P741, DOI 10.1007/s00170-008-1529-y; Gomathi D L, 2009, JOURNAL OF HAZARDOUS, V164, P459, DOI DOI 10.1016/J.JHAZMAT.2008.08.017; Gu F, 2014, MATER DESIGN, V62, P189, DOI 10.1016/j.matdes.2014.05.013; de Souza SMDGU, 2010, J HAZARD MATER, V179, P35, DOI 10.1016/j.jhazmat.2010.02.053; Inoue M, 2006, ULTRASON SONOCHEM, V13, P313, DOI 10.1016/j.ultsonch.2005.05.003; Karthikeyan S, 2012, ENVIRON SCI POLLUT R, V19, P1828, DOI 10.1007/s11356-011-0691-1; Karthikeyan S, 2011, DESALINATION, V281, P438, DOI 10.1016/j.desal.2011.08.019; Kaur J, 2013, PHYSICA B, V416, P33, DOI 10.1016/j.physb.2013.02.005; Kiss E, 2006, REV ROUM CHIM, V51, P931; Korbahti BK, 2008, J HAZARD MATER, V151, P422, DOI 10.1016/j.jhazmat.2007.06.010; Kusic H, 2006, CHEMOSPHERE, V65, P65, DOI 10.1016/j.chemosphere.2006.02.053; Li YM, 2014, CHEMOSPHERE, V105, P24, DOI 10.1016/j.chemosphere.2013.10.043; Liao HC, 2004, COMPUT IND ENG, V46, P817, DOI 10.1016/j.cie.2004.05.012; Lucas MS, 2006, DYES PIGMENTS, V71, P236, DOI 10.1016/j.dyepig.2005.07.007; Matta R, 2007, SCI TOTAL ENVIRON, V385, P242, DOI 10.1016/j.scitotenv.2007.06.030; Meric S, 2003, J ENVIRON SCI HEAL A, V38, P2241, DOI 10.1081/ESE-120023371; Navalon S, 2010, APPL CATAL B-ENVIRON, V99, P1, DOI 10.1016/j.apcatb.2010.07.006; Nazir R, 2012, J THERM ANAL CALORIM, V110, P707, DOI 10.1007/s10973-011-1919-5; Neyens E, 2003, J HAZARD MATER, V98, P33, DOI 10.1016/S0304-3894(02)00282-0; Pirkanniemi K, 2002, CHEMOSPHERE, V48, P1047, DOI 10.1016/S0045-6535(02)00168-6; Prihod'ko R, 2011, APPL CATAL B-ENVIRON, V104, P201, DOI 10.1016/j.apcatb.2011.02.004; Qin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113282; Qiu ZM, 2005, CHEM ENG PROCESS, V44, P1013, DOI 10.1016/j.cep.2005.01.004; Queiros S, 2015, SEP PURIF TECHNOL, V141, P235, DOI 10.1016/j.seppur.2014.11.046; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Savin II, 2008, ENVIRON ENG MANAG J, V7, P859, DOI 10.30638/eemj.2008.113; Shu HY, 2010, J HAZARD MATER, V184, P499, DOI 10.1016/j.jhazmat.2010.08.064; Sun JH, 2007, DYES PIGMENTS, V74, P647, DOI 10.1016/j.dyepig.2006.04.006; SZOSTAK R, 1987, J CHEM SOC FARAD T 1, V83, P487, DOI 10.1039/f19878300487; Tantak NP, 2006, J HAZARD MATER, V136, P698, DOI 10.1016/j.jhazmat.2005.12.049; Tekbas M, 2008, MICROPOR MESOPOR MAT, V115, P594, DOI 10.1016/j.micromeso.2008.03.001; Tekin H, 2006, J HAZARD MATER, V136, P258, DOI 10.1016/j.jhazmat.2005.12.012; Turhan K, 2012, DYES PIGMENTS, V92, P897, DOI 10.1016/j.dyepig.2011.07.012; Uslu MO, 2009, SCI TOTAL ENVIRON, V407, P3450, DOI 10.1016/j.scitotenv.2009.01.045; Vinodgopal K, 2003, RES CHEM INTERMEDIAT, V29, P307, DOI 10.1163/156856703764929967; Yaman C, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0162-6; Yan Y, 2014, SEP PURIF TECHNOL, V133, P365, DOI 10.1016/j.seppur.2014.07.014; Yang SJ, 2011, J HAZARD MATER, V186, P376, DOI 10.1016/j.jhazmat.2010.11.019; Zayani G, 2008, J ENVIRON SCI HEAL A, V43, P202, DOI 10.1080/10934520701781608	55	40	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141348	10.1371/journal.pone.0141348	http://dx.doi.org/10.1371/journal.pone.0141348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517827	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800037
J	Chacoma, A; Zanette, DH				Chacoma, Andes; Zanette, Damian H.			Opinion Formation by Social Influence: From Experiments to Modeling	PLOS ONE			English	Article							CONVERGENCE; EVOLUTION; DECISION; DYNAMICS; PHYSICS	Predicting different forms of collective behavior in human populations, as the outcome of individual attitudes and their mutual influence, is a question of major interest in social sciences. In particular, processes of opinion formation have been theoretically modeled on the basis of a formal similarity with the dynamics of certain physical systems, giving rise to an extensive collection of mathematical models amenable to numerical simulation or even to exact solution. Empirical ground for these models is however largely missing, which confine them to the level of mere metaphors of the real phenomena they aim at explaining. In this paper we present results of an experiment which quantifies the change in the opinions given by a subject on a set of specific matters under the influence of others. The setup is a variant of a recently proposed experiment, where the subject's confidence on his or her opinion was evaluated as well. In our realization, which records the quantitative answers of 85 subjects to 20 questions before and after an influence event, the focus is put on characterizing the change in answers and confidence induced by such influence. Similarities and differences with the previous version of the experiment are highlighted. We find that confidence changes are to a large extent independent of any other recorded quantity, while opinion changes are strongly modulated by the original confidence. On the other hand, opinion changes are not influenced by the initial difference with the reference opinion. The typical time scales on which opinion varies are moreover substantially longer than those of confidence change. Experimental results are then used to estimate parameters for a dynamical agent-based model of opinion formation in a large population. In the context of the model, we study the convergence to full consensus and the effect of opinion leaders on the collective distribution of opinions.	[Zanette, Damian H.] Comis Nacl Energia Atom, Ctr Atom Bariloche, CONICET, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Comis Nacl Energia Atom, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Zanette, DH (corresponding author), Comis Nacl Energia Atom, Ctr Atom Bariloche, CONICET, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	zanette@cab.cnea.gov.ar		Zanette, Damian/0000-0003-0681-0592; Chacoma, Andres/0000-0002-9879-494X	Agencia Nacional de Investigaciones Cientificas y Tecnicas [PICT 2011-0545]	Agencia Nacional de Investigaciones Cientificas y Tecnicas	This work was supported by Agencia Nacional de Investigaciones Cientificas y Tecnicas, PICT 2011-0545, http://www.agencia.mincyt.gob.ar/, AC DHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albi G, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0138; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Boccara N, 2008, INT J MOD PHYS C, V19, P93, DOI 10.1142/S0129183108011954; Caruso F, 2005, INT J MOD PHYS C, V16, P1473, DOI 10.1142/S0129183105008059; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen P, 2005, J PHYS A-MATH GEN, V38, P7239, DOI 10.1088/0305-4470/38/33/003; Cohen GL, 2007, ENCY SOCIAL PSYCHOL; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Deffuant G, 2002, JASSS-J ARTIF SOC S, V5, P4; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Galam S, 1997, PHYSICA A, V238, P66, DOI 10.1016/S0378-4371(96)00456-6; Ghaderi J, 2014, AUTOMATICA, V50, P3209, DOI 10.1016/j.automatica.2014.10.034; Iniguez G, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0007-z; Kacperski K, 2000, PHYSICA A, V287, P631, DOI 10.1016/S0378-4371(00)00398-8; Knowles E.S., 2004, RESISTANCE PERSUASIO, DOI 10.4324/9781410609816; Laguna MF, 2004, COMPLEXITY, V9, P31, DOI 10.1002/cplx.20018; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mavrodiev P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01360; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Schweitzer F, 2000, EUR PHYS J B, V15, P723, DOI 10.1007/s100510051177; Silverman MP, 2014, CERTAIN UNCERTAINTY: NATURE'S RANDOM WAYS, P1, DOI 10.1017/CBO9781139507370; Sobkowicz P, 2009, JASSS-J ARTIF SOC S, V12; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Torok J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.088701; Toscani G, 2006, COMMUN MATH SCI, V4, P481; Weisbuch G., 2002, Complexity, V7, P55, DOI 10.1002/cplx.10031	31	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140406	10.1371/journal.pone.0140406	http://dx.doi.org/10.1371/journal.pone.0140406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517825	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800005
J	Ekins, S; Madrid, PB; Sarker, M; Li, SG; Mittal, N; Kumar, P; Wang, X; Stratton, TP; Zimmerman, M; Talcott, C; Bourbon, P; Travers, M; Yadav, M; Freundlich, JS				Ekins, Sean; Madrid, Peter B.; Sarker, Malabika; Li, Shao-Gang; Mittal, Nisha; Kumar, Pradeep; Wang, Xin; Stratton, Thomas P.; Zimmerman, Matthew; Talcott, Carolyn; Bourbon, Pauline; Travers, Mike; Yadav, Maneesh; Freundlich, Joel S.			Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery	PLOS ONE			English	Article							TB MOBILE; GENETIC REQUIREMENTS; DATA SETS; IN-VITRO; INHIBITORS; SURVIVAL; TARGET; MOLECULES; DERIVATIVES; CHEMISTRY	Integrated computational approaches for Mycobacterium tuberculosis (Mtb) are useful to identify new molecules that could lead to future tuberculosis (TB) drugs. Our approach uses information derived from the TBCyc pathway and genome database, the Collaborative Drug Discovery TB database combined with 3D pharmacophores and dual event Bayesian models of whole-cell activity and lack of cytotoxicity. We have prioritized a large number of molecules that may act as mimics of substrates and metabolites in the TB metabolome. We computationally searched over 200,000 commercial molecules using 66 pharmacophores based on substrates and metabolites from Mtb and further filtering with Bayesian models. We ultimately tested 110 compounds in vitro that resulted in two compounds of interest, BAS 04912643 and BAS 00623753 (MIC of 2.5 and 5 mu g/mL, respectively). These molecules were used as a starting point for hit-to-lead optimization. The most promising class proved to be the quinoxaline di-N-oxides, evidenced by transcriptional profiling to induce mRNA level perturbations most closely resembling known protonophores. One of these, SRI58 exhibited an MIC = 1.25 mu g/mL versus Mtb and a CC50 in Vero cells of >40 mu g/mL, while featuring fair Caco-2 A-B permeability (2.3 x 10(-6) cm/s), kinetic solubility (125 mu M at pH 7.4 in PBS) and mouse metabolic stability (63.6% remaining after 1 h incubation with mouse liver microsomes). Despite demonstration of how a combined bioinformatics/cheminformatics approach afforded a small molecule with promising in vitro profiles, we found that SRI58 did not exhibit quantifiable blood levels in mice.	[Ekins, Sean; Travers, Mike] Collaborat Drug Discovery Inc, Burlingame, CA 94010 USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC 27526 USA; [Madrid, Peter B.; Sarker, Malabika; Talcott, Carolyn; Bourbon, Pauline; Yadav, Maneesh] SRI Int, Menlo Pk, CA 94025 USA; [Li, Shao-Gang; Mittal, Nisha; Wang, Xin; Stratton, Thomas P.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Ctr Emerging & Reemerging Pathogens, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Li, Shao-Gang; Mittal, Nisha; Kumar, Pradeep; Wang, Xin; Stratton, Thomas P.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Ctr Emerging & Reemerging Pathogens, Dept Med, Newark, NJ 07103 USA; [Zimmerman, Matthew] Rutgers State Univ, Sch Med, Publ Hlth Res Inst, Newark, NJ 07103 USA	SRI International; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Ekins, S (corresponding author), Collaborat Drug Discovery Inc, 1633 Bayshore Highway,Suite 342, Burlingame, CA 94010 USA.	ekinssean@yahoo.com; peter.madrid@sri.com; freundjs@rutgers.edu	Li, Shao-Gang/O-4223-2019; Kumar, Pradeep/I-7989-2014	Kumar, Pradeep/0000-0003-0042-7525; Madrid, Peter/0000-0002-4895-5610; Wang, Xin/0000-0002-6930-3347	Bill and Melinda Gates Foundation [49852]; National Institutes of Health / National Institute of Allergy and Infectious Diseases [2R42AI088893-02]; Rutgers University-New Jersey Medical School; NIH/NIAID [R21 AI111647-01, CETR 1 U19 AI109713-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111647, R42AI088893, U19AI109713] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health / National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rutgers University-New Jersey Medical School; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The CDD TB database was made possible with funding from the Bill and Melinda Gates Foundation (Grant #49852 "Collaborative drug discovery for TB through a novel database of SAR data optimized to promote data archiving and sharing"). The project described was supported by Award Number 2R42AI088893-02 from the National Institutes of Health / National Institute of Allergy and Infectious Diseases. J.S.F. acknowledges additional start-up funding from Rutgers University-New Jersey Medical School. P.K was supported by NIH/NIAID R21 AI111647-01 and CETR 1 U19 AI109713-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chen FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100829; Chopra S, 2012, J MED CHEM, V55, P6047, DOI 10.1021/jm300123s; Clark AM, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0038-2; Clark AM, 2013, TB MOBILE 2013; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekins S, 2000, J PHARMACOL TOX MET, V44, P251, DOI 10.1016/S1056-8719(00)00109-X; Ekins S, 2000, J PHARMACOL TOX MET, V44, P313, DOI 10.1016/S1056-8719(00)00110-6; Ekins S, 2013, PHARM RES IN PRESS; Ekins S, 2013, MLSMR DUAL EVENT TB; Ekins S, 2013, KINASE TB DUAL EVENT; Ekins S, 2013, TUBERCULOSI IN PRESS; Ekins S, 2013, CB2 DUAL EVENT TUBER; Ekins S, 2010, MOL BIOSYST, V6, P2316, DOI 10.1039/c0mb00104j; Ekins S, 2014, J CHEM INF MODEL, V54, P2157, DOI 10.1021/ci500264r; Ekins S, 2014, J CHEM INF MODEL, V54, P1070, DOI 10.1021/ci500077v; Ekins S, 2014, TUBERCULOSIS, V94, P162, DOI 10.1016/j.tube.2013.12.001; Ekins S, 2014, PHARM RES-DORDR, V31, P414, DOI 10.1007/s11095-013-1172-7; Ekins S, 2013, J CHEM INF MODEL, V53, P3054, DOI 10.1021/ci400480s; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Ekins Sean, 2013, Methods Mol Biol, V993, P245, DOI 10.1007/978-1-62703-342-8_16; Ekins S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-13; Ekins S, 2013, CHEM BIOL, V20, P370, DOI 10.1016/j.chembiol.2013.01.011; Ekins S, 2011, PHARM RES-DORDR, V28, P1859, DOI 10.1007/s11095-011-0413-x; Ekins S, 2011, TRENDS MICROBIOL, V19, P65, DOI 10.1016/j.tim.2010.10.005; Ekins S, 2010, MEDCHEMCOMM, V1, P325, DOI 10.1039/c0md00129e; Ekins S, 2010, DRUG DISCOV TODAY, V15, P812, DOI 10.1016/j.drudis.2010.08.010; Ekins S, 2010, MOL BIOSYST, V6, P840, DOI 10.1039/b917766c; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Ganley B, 2001, BIOORGAN MED CHEM, V9, P2395, DOI 10.1016/S0968-0896(01)00163-8; Hohman M, 2009, DRUG DISCOV TODAY, V14, P261, DOI 10.1016/j.drudis.2008.11.015; Jain SK, 2007, J INFECT DIS, V195, P1634, DOI 10.1086/517526; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kushwaha SK, 2010, J THEOR BIOL, V262, P284, DOI 10.1016/j.jtbi.2009.09.029; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Li SG, 2015, TETRAHEDRON LETT, V56, P3246, DOI 10.1016/j.tetlet.2015.02.129; Manikandan K, 2011, PROTEINS, V79, P35, DOI 10.1002/prot.22856; Mugumbate G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121492; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; North EJ, 2014, CURR PHARM DESIGN, V20, P4357; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pauli I, 2013, J CHEM INF MODEL, V53, P2390, DOI 10.1021/ci400202t; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sarker M, 2012, PHARM RES-DORDR, V29, P2115, DOI 10.1007/s11095-012-0741-5; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Talcott C, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P568; Talcott C, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1656, DOI 10.1109/WSC.2006.322940; Tiwari A, 2007, LECT NOTES COMPUT SC, V4545, P155; Vicente E, 2008, ANTIMICROB AGENTS CH, V52, P3321, DOI 10.1128/AAC.00379-08; Vilcheze C, 2011, ANTIMICROB AGENTS CH, V55, P3889, DOI 10.1128/AAC.00266-11; Villar R, 2008, J ANTIMICROB CHEMOTH, V62, P547, DOI 10.1093/jac/dkn214; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; Wang D, 2013, J CHEM INF MODEL, V53, P343, DOI 10.1021/ci3004545; Warner DF, 2014, CURR TOP MICROBIOL, V374, P27, DOI 10.1007/82_2013_328; Wei JR, 2008, TUBERCULOSIS, V88, pS19, DOI 10.1016/S1472-9792(08)70033-7; Wilson R, 2013, NAT CHEM BIOL, V9, P499, DOI 10.1038/nchembio.1277; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zheng XW, 2009, MOL PHARMACEUT, V6, P1591, DOI 10.1021/mp900163d	70	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141076	10.1371/journal.pone.0141076	http://dx.doi.org/10.1371/journal.pone.0141076			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517557	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800019
J	Zhu, MZ; Lu, YP; Wang, JF; Li, S; Wang, XN				Zhu, Muzi; Lu, Yanping; Wang, Jufang; Li, Shuang; Wang, Xiaoning			Carbon Catabolite Repression and the Related Genes of ccpA, ptsH and hprK in Thermoanaerobacterium aotearoense	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MOLECULAR CHARACTERIZATION; PHOSPHOTRANSFERASE SYSTEM; DEPENDENT PHOSPHORYLATION; PHOSPHOCARRIER PROTEIN; HYDROGEN-PRODUCTION; 2-DEOXYGLUCOSE; EXPRESSION; PHOSPHOENOLPYRUVATE; RESISTANCE	The strictly anaerobic, Gram-positive bacterium, Thermoanaerobacterium aotearoense SCUT27, is capable of producing ethanol, hydrogen and lactic acid by directly fermenting glucan, xylan and various lignocellulosically derived sugars. By using non-metabolizable and metabolizable sugars as substrates, we found that cellobiose, galactose, arabinose and starch utilization was strongly inhibited by the existence of 2-deoxyglucose (2-DG). However, the xylose and mannose consumptions were not markedly affected by 2-DG at the concentration of one-tenth of the metabolizable sugar. Accordingly, T. aotearoense SCUT27 could consume xylose and mannose in the presence of glucose. The carbon catabolite repression (CCR) related genes, ccpA, ptsH and hprK were confirmed to exist in T. aotearoense SCUT27 through gene cloning and protein characterization. The highly purified Histidine-containing Protein (HPr) could be specifically phosphorylated at Serine 46 by HPr kinase/phosphatase (HPrK/P) with no need to add fructose-1,6-bisphosphate (FBP) or glucose-6-phosphate (Glc-6-P) in the reaction mixture. The specific protein-interaction of catabolite control protein A (CcpA) and phosphorylated HPr was proved via affinity chromatography in the absence of formaldehyde. The equilibrium binding constant (K-D) of CcpA and HPrSerP was determined as 2.22 +/- 0.36 nM by surface plasmon resonance (SPR) analysis, indicating the high affinity between these two proteins.	[Zhu, Muzi; Lu, Yanping; Wang, Jufang; Li, Shuang] S China Univ Technol, Sch Biosci & Bioengn, Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China; [Wang, Xiaoning] Chinese Peoples Liberat Army Gen Hosp, Inst Life Sci, State Key Lab Kidney, Beijing 100853, Peoples R China	South China University of Technology; Chinese People's Liberation Army General Hospital	Li, S (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China.	shuangli@scut.edu.cn	Wang, Jufang/AAH-8068-2019		National Natural Science Foundation of China [21276096]; International Cooperation Research Program of Guangdong, China [2014A050503024]; Natural Science Foundation of Guangdong, China [2014A030313258]; Fundamental Research Funds for the Central Universities, SCUT; Pearl River New-Star of Science Technology; Guangzhou City [2012J2200012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Research Program of Guangdong, China; Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Pearl River New-Star of Science Technology; Guangzhou City	This study was supported by research grants from the National Natural Science Foundation of China (21276096), International Cooperation Research Program of Guangdong, China (2014A050503024), the Natural Science Foundation of Guangdong, China (2014A030313258) and the Fundamental Research Funds for the Central Universities, SCUT. Shuang Li was funded by the Pearl River New-Star of Science & Technology supported by Guangzhou City (2012J2200012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma N, 2004, APPL ENVIRON MICROB, V70, P5244, DOI 10.1128/AEM.70.9.5244-5251.2004; Asanuma N, 2003, ARCH MICROBIOL, V179, P205, DOI 10.1007/s00203-003-0516-9; BARBAN S, 1961, J BIOL CHEM, V236, P1887; Colabardini AC, 2012, FUNGAL GENET BIOL, V49, P130, DOI 10.1016/j.fgb.2011.11.004; Dahl MK, 2002, J MOL MICROB BIOTECH, V4, P315; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; Filho SA, 1986, NAT BIOTECHNOL, V4, P311; Foudeh AM, 2014, BIOSENS BIOELECTRON, V52, P129, DOI 10.1016/j.bios.2013.08.032; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Jankovic I, 2002, J MOL MICROB BIOTECH, V4, P309; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; KORNBERG H, 1994, P NATL ACAD SCI USA, V91, P11080, DOI 10.1073/pnas.91.23.11080; KRAUS A, 1994, J BACTERIOL, V176, P1738, DOI 10.1128/jb.176.6.1738-1745.1994; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Lai ZC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0119-5; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li SA, 2010, BIORESOURCE TECHNOL, V101, P8718, DOI 10.1016/j.biortech.2010.06.111; Lin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002318; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; Ren C, 2010, METAB ENG, V12, P446, DOI 10.1016/j.ymben.2010.05.002; SANZ P, 1994, YEAST, V10, P1195, DOI 10.1002/yea.320100907; Schumacher MA, 2007, J MOL BIOL, V368, P1042, DOI 10.1016/j.jmb.2007.02.054; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2012, METAB ENG, V14, P528, DOI 10.1016/j.ymben.2012.06.004; Sun XS, 2011, PROTEOMICS, V11, P3288, DOI 10.1002/pmic.201000396; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THEVENOT T, 1995, J BACTERIOL, V177, P2751, DOI 10.1128/jb.177.10.2751-2759.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Tsakraklides V, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-85; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wunsche A, 2012, FEBS J, V279, P2201, DOI 10.1111/j.1742-4658.2012.08604.x; Yang XF, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-124; Ye JJ, 1996, J BACTERIOL, V178, P3557, DOI 10.1128/jb.178.12.3557-3563.1996; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhou Y, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-138	47	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142121	10.1371/journal.pone.0142121	http://dx.doi.org/10.1371/journal.pone.0142121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540271	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800056
J	Arsenault, D; Coulombe, K; Zhu, AJ; Gong, CY; Kil, KE; Choi, JK; Poutiainen, P; Brownell, AL				Arsenault, Dany; Coulombe, Katherine; Zhu, Aijun; Gong, Chunyu; Kil, Kun-Eek; Choi, Ji-Kyung; Poutiainen, Pekka; Brownell, Anna-Liisa			Loss of Metabotropic Glutamate Receptor 5 Function on Peripheral Benzodiazepine Receptor in Mice Prenatally Exposed to LPS	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATOR; MICROGLIAL ACTIVATION; MGLUR5 ANTAGONIST; RAT-BRAIN; PSYCHIATRIC-DISORDERS; MULTIPLE-SCLEROSIS; VIRAL-INFECTION; PROTEIN; SCHIZOPHRENIA; EXPRESSION	Parental microglial induced neuroinflammation, triggered by bacterial-or viral infections, can induce neuropsychiatric disorders like schizophrenia and autism to offspring in animal models. Recent investigations suggest that microglia, the resident immune cells of the brain, provides a link between neurotransmission, immune cell activation, brain inflammation and neuronal dysfunction seen with the offspring. Relatively little is known about how reduction of brain inflammation and restoration of glial function are associated with diminution of brain degeneration and behavioral deficits in offspring. Increased mGluR5 expression and the long-lasting excitotoxic effects of the neurotoxin during brain development are associated with the glial dysfunctions. We investigated the relationship of mGluR5 and PBR and how they regulate glial function and inflammatory processes in mice prenatally exposed to LPS (120 mu g/kg, between gestational days 15 and 17), an inflammatory model of a psychiatric disorder. Using PET imaging, we showed that pharmacological activation of mGluR5 during 5 weeks reduced expression of classic inflammation marker PBR in many brain areas and that this molecular association was not present in LPS-exposed offspring. The post-mortem analysis revealed that the down regulation of PBR was mediated through activation of mGluR5 in astrocytes. In addition, we demonstrated that this interaction is defective in a mouse model of the psychiatric deficit offering a novel insight of mGluR5 involvement to brain related disorders and PBR related imaging studies. In conclusion, mGluR5 driven glutamatergic activity regulates astrocytic functions associated with PBR (cholesterol transport, neurosteroidogenesis, glial phenotype) during maturation and could be associated with neuropsychiatric disorders in offspring.	[Arsenault, Dany; Zhu, Aijun; Gong, Chunyu; Kil, Kun-Eek; Choi, Ji-Kyung; Poutiainen, Pekka; Brownell, Anna-Liisa] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Med Sch, Charlestown, MA 02129 USA; [Coulombe, Katherine] Univ Laval, Ctr Rech, CHU Quebec, Axe Neurosci Fac Pharm, Quebec City, PQ, Canada	Harvard University; Massachusetts General Hospital; Laval University	Brownell, AL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Med Sch, Charlestown, MA 02129 USA.	abrownell@partners.org	Kil, Kun-Eek/ABD-7285-2020	Kil, Kun-Eek/0000-0002-1113-2469; Poutiainen, Pekka/0000-0001-8148-9909	National Institute of Mental Health [1R01MH091684]; Fonds de la Recherche en Sante du Quebec (FRSQ); Orion Farmos Research Foundation; Saastamoinen Foundation; Sigrid Juselius Foundation; Osk Huttunen Foundation; Kuopio University Foundation; National Center of Research Resources [S10RR029495, S10RR026666]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091684] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Orion Farmos Research Foundation; Saastamoinen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Osk Huttunen Foundation; Kuopio University Foundation; National Center of Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health [grant 1R01MH091684]. Dany Arsenault was supported by scholarship from Fonds de la Recherche en Sante du Quebec (FRSQ). The authors would like to express their appreciation of the financial support for PP from The Orion Farmos Research Foundation, Saastamoinen Foundation, Sigrid Juselius Foundation, Osk Huttunen Foundation and Kuopio University Foundation. The used instrumentation in the experiments was supported by the grants from the National Center of Research Resources (grants S10RR029495 and S10RR026666].	Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; Arsenault Dany, 2014, Open J Med Psychol, V3, P202; Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cagnin A, 2007, NEUROTHERAPEUTICS, V4, P443, DOI 10.1016/j.nurt.2007.04.006; CATANIA MV, 1994, NEUROSCIENCE, V61, P481, DOI 10.1016/0306-4522(94)90428-6; CATANIA MV, 1994, MOL PHARMACOL, V45, P626; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen MK, 2006, TOXICOL SCI, V91, P532, DOI 10.1093/toxsci/kfj172; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Debruyne JC, 2003, EUR J NEUROL, V10, P257, DOI 10.1046/j.1468-1331.2003.00571.x; Diaz-Cabiale Z, 2002, NEUROSCI LETT, V324, P154, DOI 10.1016/S0304-3940(02)00179-9; Dickerson JW, 2012, NEURODEGENER DIS MAN, V2, P221, DOI 10.2217/NMT.12.6; Drouin-Ouellet J, 2011, GLIA, V59, P188, DOI 10.1002/glia.21086; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fatemi SH, 2014, SCHIZOPHR RES, V158, P270, DOI 10.1016/j.schres.2014.06.029; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Golan H, 2006, NEUROSCIENCE, V141, P1909, DOI 10.1016/j.neuroscience.2006.05.045; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Guilarte TR, 2003, NEUROSCIENCE, V122, P499, DOI 10.1016/S0306-4522(03)00476-7; Haidan A, 2000, MOL CELL ENDOCRINOL, V165, P25, DOI 10.1016/S0303-7207(00)00267-7; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Higashimori H, 2013, HUM MOL GENET, V22, P2041, DOI 10.1093/hmg/ddt055; Hovelso N, 2012, CURR NEUROPHARMACOL, V10, P12, DOI 10.2174/157015912799362805; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Klodzinska A, 2004, NEUROPHARMACOLOGY, V47, P342, DOI 10.1016/j.neuropharm.2004.04.013; Kneeland RE, 2013, PROG NEURO-PSYCHOPH, V42, P35, DOI 10.1016/j.pnpbp.2012.02.001; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Lin CW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00087; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mikulecka A, 2009, BEHAV BRAIN RES, V204, P133, DOI 10.1016/j.bbr.2009.05.032; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; NOVAIS ARB, 2013, PEDIATR RES, V73, P750, DOI DOI 10.1038/PR.2013.40; O'Connor EC, 2010, NEUROPSYCHOPHARMACOL, V35, P1807, DOI 10.1038/npp.2010.48; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Palucha A, 2005, PHARMACOL BIOCHEM BE, V81, P901, DOI 10.1016/j.pbb.2005.06.015; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Papadopoulos V., 2003, Annales Pharmaceutiques Francaises, V61, P30; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Patel S, 2007, NUCL MED BIOL, V34, P1009, DOI 10.1016/j.nucmedbio.2007.07.009; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; PECKNOLD JC, 1982, J CLIN PSYCHOPHARM, V2, P129; Pellegrino D, 2007, J NUCL MED, V48, P1147, DOI 10.2967/jnumed.106.037796; Piers TM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00199; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rosenbrock H, 2010, EUR J PHARMACOL, V639, P40, DOI 10.1016/j.ejphar.2010.02.057; Rousset CI, 2013, DEV NEUROSCI-BASEL, V35, P172, DOI 10.1159/000346579; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Sullivan JM, 2013, J CEREBR BLOOD F MET, V33, P532, DOI 10.1038/jcbfm.2012.195; Versijpt JJ, 2003, EUR NEUROL, V50, P39, DOI 10.1159/000070857; Wei XH, 2013, J NEUROSCI, V33, P1540, DOI 10.1523/JNEUROSCI.0324-12.2013	76	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142093	10.1371/journal.pone.0142093	http://dx.doi.org/10.1371/journal.pone.0142093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536027	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400132
J	Van Zee, J; Piesman, JF; Hojgaard, A; Black, WC				Van Zee, Janice; Piesman, Joseph F.; Hojgaard, Andrias; Black, William Cormack			Nuclear Markers Reveal Predominantly North to South Gene Flow in Ixodes scapularis, the Tick Vector of the Lyme Disease Spirochete	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; RANGE EXPANSION; MOLECULAR CLOCK; DAMMINI ACARI; IXODIDAE; INFERENCE; SOFTWARE	Ixodes scapularis, the tick vector of the Lyme disease spirochete, is distributed over most of the eastern United States, but >80% of all Lyme disease cases occur in the northeast. The role that genetic differences between northern and southern tick populations play in explaining this disparate distribution of Lyme disease cases is unclear. The present study was conducted with 1,155 SNP markers in eight nuclear genes; the 16S mitochondrial gene was examined for comparison with earlier studies. We examined 350 I. scapularis from 7 states covering a representative area of the species. A demographic analysis using Bayesian Extended Skyline Analysis suggested that I. scapularis populations in Mississippi and Georgia began expanding 500,000 years ago, those in Florida and North Carolina 200,000 years ago and those from Maryland and New Jersey only during the past 50,000 years with an accompanying bottleneck. Wisconsin populations only began expanding in the last 20,000 years. Analysis of current migration patterns suggests large amounts of gene flow in northern collections and equally high rates of gene flow among southern collections. In contrast there is restricted and unidirectional gene flow between northern and southern collections, mostly occurring from northern into southern populations. Northern populations are characterized by nymphs that quest above the leaf litter, are easy to collect by flagging, frequently feed on mammals such as rodents and shrews, commonly attach to people, and about 25% of which are infected with B. burgdorferi. If there is a genetic basis for these behaviors, then the patterns detected in this study are of concern because they suggest that northern I. scapularis populations with a greater ability to vector B. burgdorferi to humans are expanding south.	[Van Zee, Janice; Piesman, Joseph F.; Hojgaard, Andrias] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Black, William Cormack] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Centers for Disease Control & Prevention - USA; Colorado State University	Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	wcb4@lamar.colostate.edu			American Society of Microbiology post doctorate fellowship program; Centers for Disease Control and Prevention	American Society of Microbiology post doctorate fellowship program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was financially supported by American Society of Microbiology post doctorate fellowship program and Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chas Apperson (North Carolina), Katherine Feldman (Maryland), Michael Levin (Florida and Georgia), Marc Dolan and Terry Schulze (New Jersey), Jerome Goddard (Mississippi) and Susan Paskewicz (Wisconsin) for providing us with ticks. This work was financially supported by American Society of Microbiology post doctorate fellowship program and Centers for Disease Control and Prevention.	Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; Brinkerhoff RJ, 2014, EMERG INFECT DIS, V20, P1661, DOI 10.3201/eid2010.130782; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dennis DT, 2005, CLIN INFECT DIS, V41, P966, DOI 10.1086/432958; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Kelly RR, 2014, INFECT GENET EVOL, V27, P543, DOI 10.1016/j.meegid.2014.05.022; Khatchikian CE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00134.1; Kingman JFC, 2000, GENETICS, V156, P1461; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCLAIN DK, 1995, HEREDITY, V75, P303, DOI 10.1038/hdy.1995.139; Norris DE, 1996, J MED ENTOMOL, V33, P78, DOI 10.1093/jmedent/33.1.78; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P3919, DOI 10.1128/AEM.00857-08; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; OLIVER JH, 1993, J MED ENTOMOL, V30, P54, DOI 10.1093/jmedent/30.1.54; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Piesman J., 2002, LYME BORRELIOSIS BIO; Pritchard JK, 2000, GENETICS, V155, P945; Qiu WG, 2002, GENETICS, V160, P833; RICH SM, 1995, P NATL ACAD SCI USA, V92, P6284, DOI 10.1073/pnas.92.14.6284; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sakamoto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101389; Schauber EM, 1998, J MED ENTOMOL, V35, P901, DOI 10.1093/jmedent/35.5.901; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; Van Zee J, 2013, TICKS TICK-BORNE DIS, V4, P63, DOI 10.1016/j.ttbdis.2012.07.005; WESSON DM, 1993, P NATL ACAD SCI USA, V90, P10221, DOI 10.1073/pnas.90.21.10221	50	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139630	10.1371/journal.pone.0139630	http://dx.doi.org/10.1371/journal.pone.0139630			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536360	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400009
J	Habota, T; McLennan, SN; Cameron, J; Ski, CF; Thompson, DR; Rendell, PG				Habota, Tina; McLennan, Skye N.; Cameron, Jan; Ski, Chantal F.; Thompson, David R.; Rendell, Peter G.			An Investigation of Emotion Recognition and Theory of Mind in People with Chronic Heart Failure	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; COGNITIVE TEST BATTERY; QUALITY-OF-LIFE; SOCIAL COGNITION; ASPERGER-SYNDROME; NORMAL ADULTS; BRAIN-INJURY; IMPAIRMENT; DEPRESSION; VOICE	Objectives Cognitive deficits are common in patients with chronic heart failure (CHF), but no study has investigated whether these deficits extend to social cognition. The present study provided the first empirical assessment of emotion recognition and theory of mind (ToM) in patients with CHF. In addition, it assessed whether each of these social cognitive constructs was associated with more general cognitive impairment. Methods A group comparison design was used, with 31 CHF patients compared to 38 demographically matched controls. The Ekman Faces test was used to assess emotion recognition, and the Mind in the Eyes test to measure ToM. Measures assessing global cognition, executive functions, and verbal memory were also administered. Results There were no differences between groups on emotion recognition or ToM. The CHF group's performance was poorer on some executive measures, but memory was relatively preserved. In the CHF group, both emotion recognition performance and ToM ability correlated moderately with global cognition (r = .38, p = .034; r = .49, p = .005, respectively), but not with executive function or verbal memory. Conclusion CHF patients with lower cognitive ability were more likely to have difficulty recognizing emotions and inferring the mental states of others. Clinical implications of these findings are discussed.	[Habota, Tina; McLennan, Skye N.; Rendell, Peter G.] Australian Catholic Univ, Cognit & Emot Res Ctr, Melbourne, Vic, Australia; [Cameron, Jan; Ski, Chantal F.; Thompson, David R.] Australian Catholic Univ, Ctr Heart & Mind, Melbourne, Vic, Australia	Australian Catholic University; Australian Catholic University	Habota, T (corresponding author), Australian Catholic Univ, Cognit & Emot Res Ctr, Melbourne, Vic, Australia.	tina.habota@acu.edu.au	Cameron, Jan/GPC-8933-2022; Cameron, Jan/AAE-4937-2019; Ski, Chantal/AAJ-6595-2020; Rendell, Peter/E-7539-2010; Thompson, David R/E-2431-2018	Cameron, Jan/0000-0002-3335-904X; Ski, Chantal/0000-0003-1324-2933; Rendell, Peter/0000-0002-4829-4322; Thompson, David R/0000-0001-8518-6307; Habota, Tina/0000-0002-5596-5139	Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd; Discovery Project Grant from the Australian Research Council; Australian Postgraduate Award scholarship	Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd; Discovery Project Grant from the Australian Research Council(Australian Research Council); Australian Postgraduate Award scholarship	The study was funded by a Mona Menzies Post-Doctoral Nursing Research Grant from the Nurses Board Victoria Legacy Ltd, Discovery Project Grant from the Australian Research Council, and an Australian Postgraduate Award scholarship.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Arestedt K, 2013, EUR J CARDIOVASC NUR, V12, P69, DOI 10.1177/1474515111432997; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; Bennett JA, 2002, HEART LUNG, V31, P262, DOI 10.1067/mhl.2002.124554; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cameron J, 2010, EUR J HEART FAIL, V12, P508, DOI 10.1093/eurjhf/hfq042; Cannon JA, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0106-5; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Edwards J, 2002, CLIN PSYCHOL REV, V22, P1267, DOI 10.1016/S0272-7358(02)00162-9; Ekman I, 2001, J Cardiovasc Nurs, V16, P47; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friedmann E, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.009; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Grossmann T, 2010, RESTOR NEUROL NEUROS, V28, P219, DOI 10.3233/RNN-2010-0499; Habota T, 2015, J INT NEUROPSYCH SOC, V21, P183, DOI 10.1017/S1355617715000119; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hawkins MAW, 2015, J CARDIOVASC NURS, V30, pE9, DOI 10.1097/JCN.0000000000000178; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Insel KC, 2002, J ADV NURS, V38, P360, DOI 10.1046/j.1365-2648.2002.02196.x; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Li YS, 2001, INT J GERIATR PSYCH, V16, P455, DOI 10.1002/gps.360; Luttik Marie Louise, 2005, J Cardiovasc Nurs, V20, P162; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Moser DK, 2008, J CARDIOVASC NURS, V23, P205, DOI 10.1097/01.JCN.0000305097.09710.a5; Murberg TA, 2004, INT J PSYCHIAT MED, V34, P207, DOI 10.2190/GKJ2-P8BD-V59X-MJNQ; Nelson HE., 1982, NATL ADULT READING T; O'Loughlin C, 2010, INT J CARDIOL, V139, P60, DOI 10.1016/j.ijcard.2008.09.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips LH, 2011, NEUROPSYCHOLOGY, V25, P131, DOI 10.1037/a0020752; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pottgen J, 2013, J NEUROL NEUROSUR PS, V84, P523, DOI 10.1136/jnnp-2012-304157; Pressler SJ, 2008, J CARDIOVASC NURS, V23, P239, DOI 10.1097/01.JCN.0000305096.09710.ec; Pressler SJ, 2010, NURS RES, V59, P127, DOI 10.1097/NNR.0b013e3181d1a747; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1958, EXAMEN CLIN PSYCHOL; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Vogels RLC, 2007, J AM GERIATR SOC, V55, P1764, DOI 10.1111/j.1532-5415.2007.01395.x; Vogels RLC, 2007, EUR J HEART FAIL, V9, P1003, DOI 10.1016/j.ejheart.2007.07.006; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Volz A, 2011, J BEHAV MED, V34, P13, DOI 10.1007/s10865-010-9282-8; Woo MA, 2003, J APPL PHYSIOL, V95, P677, DOI 10.1152/japplphysiol.00101.2003; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141607	10.1371/journal.pone.0141607	http://dx.doi.org/10.1371/journal.pone.0141607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529409	Green Published, gold			2022-12-27	WOS:000364032600042
J	Koudelkova, P; Weber, G; Mikulits, W				Koudelkova, Petra; Weber, Gerhard; Mikulits, Wolfgang			Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; EXPRESSION; CULTURE; PECAM-1	Liver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a rapid onset of stress-induced senescence a few days post isolation, which limits genetic and biochemical studies ex vivo. Here we show the establishment of LSECs isolated from p19(ARF-/-) mice which undergo more than 50 cell doublings in the absence of senescence. Isolated p19(ARF-/-) LSECs display a cobblestone-like morphology and show the ability of tube formation. Analysis of DNA content revealed a stable diploid phenotype after long-term passaging without a gain of aneuploidy. Notably, p19(ARF-/-) LSECs express the endothelial markers CD31, vascular endothelial growth factor receptor (VEGFR)-2, VE-cadherin, von Willebrand factor, stabilin-2 and CD146 suggesting that these cells harbor and maintain an endothelial phenotype. In line, treatment with small molecule inhibitors against VEGFR-2 caused cell death, demonstrating the sustained ability of p19(ARF-/-) LSECs to respond to anti-angiogenic therapeutics. From these data we conclude that loss of p19(ARF) overcomes senescence of LSECs, allowing immortalization of cells without losing endothelial characteristics. Thus, p19(ARF-/-) LSECs provide a novel cellular model to study endothelial cell biology.	[Koudelkova, Petra; Weber, Gerhard; Mikulits, Wolfgang] Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria	Medical University of Vienna	Mikulits, W (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria.	wolfgang.mikulits@meduniwien.ac.at	Mikulits, Wolfgang/AAH-4043-2021	Mikulits, Wolfgang/0000-0003-4612-7106	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7) under Research Executive Agency Grant [PITN-GA-2012-316549-(IT-LIVER)]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7) under Research Executive Agency Grant	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme, Spain (FP7/2007-2013) under Research Executive Agency Grant agreement no. PITN-GA-2012-316549-(IT-LIVER) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Angst BD, 2001, J CELL SCI, V114, P629; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bian Chang, 2005, J Zhejiang Univ Sci B, V6, P631, DOI 10.1631/jzus.2005.B0631; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Geraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262; Geraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618; Gotzmann J, 2002, J CELL SCI, V115, P1189; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Ponnuchamy B, 2008, CIRC RES, V102, P1139, DOI 10.1161/CIRCRESAHA.108.177394; Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009; QUELLE DE, 1995, CELL, V83, P993; Sano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089830; Schneider GP, 2002, CLIN CANCER RES, V8, P3955; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Siow RCM, 2012, METHODS MOL BIOL, V806, P265, DOI 10.1007/978-1-61779-367-7_18; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu WC, 2003, ONCOGENE, V22, P3361, DOI 10.1038/sj.onc.1206285; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142134	10.1371/journal.pone.0142134	http://dx.doi.org/10.1371/journal.pone.0142134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528722	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600106
J	Mohr, M; Nann, M; von Tscharner, V; Eskofier, B; Nigg, BM				Mohr, Maurice; Nann, Marius; von Tscharner, Vinzenz; Eskofier, Bjoern; Nigg, Benno Maurus			Task-Dependent Intermuscular Motor Unit Synchronization between Medial and Lateral Vastii Muscles during Dynamic and Isometric Squats	PLOS ONE			English	Article							SURFACE EMG; SIGNALS; CONTRACTIONS; STRATEGIES; COHERENCE; STRENGTH; WALKING; INPUTS; PAIN	Purpose Motor unit activity is coordinated between many synergistic muscle pairs but the functional role of this coordination for the motor output is unclear. The purpose of this study was to investigate the short-term modality of coordinated motor unit activity-the synchronized discharge of individual motor units across muscles within time intervals of 5ms-for the Vastus Medialis (VM) and Lateralis (VL). Furthermore, we studied the task-dependency of intermuscular motor unit synchronization between VM and VL during static and dynamic squatting tasks to provide insight into its functional role. Methods Sixteen healthy male and female participants completed four tasks: Bipedal squats, single-leg squats, an isometric squat, and single-leg balance. Monopolar surface electromyography (EMG) was used to record motor unit activity of VM and VL. For each task, intermuscular motor unit synchronization was determined using a coherence analysis between the raw EMG signals of VM and VL and compared to a reference coherence calculated from two desynchronized EMG signals. The time shift between VM and VL EMG signals was estimated according to the slope of the coherence phase angle spectrum. Results For all tasks, except for singe-leg balance, coherence between 15-80Hz significantly exceeded the reference. The corresponding time shift between VM and VL was estimated as 4ms. Coherence between 30-60Hz was highest for the bipedal squat, followed by the single-leg squat and the isometric squat. Conclusion There is substantial short-term motor unit synchronization between VM and VL. Intermuscular motor unit synchronization is enhanced for contractions during dynamic activities, possibly to facilitate a more accurate control of the joint torque, and reduced during single-leg tasks that require balance control and thus, a more independent muscle function. It is proposed that the central nervous system scales the degree of intermuscular motor unit synchronization according to the requirements of the movement task at hand.	[Mohr, Maurice; von Tscharner, Vinzenz; Nigg, Benno Maurus] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Mohr, Maurice; von Tscharner, Vinzenz; Nigg, Benno Maurus] Biomechanigg Sport & Hlth Res Inc, Calgary, AB, Canada; [Nann, Marius; Eskofier, Bjoern] Univ Erlangen Nurnberg, Digital Sports Grp, D-91054 Erlangen, Germany	University of Calgary; University of Erlangen Nuremberg	Mohr, M (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	mmaurice@ucalgary.ca	Mohr, Maurice/AAA-1436-2020; Eskofier, Bjoern/ABF-1284-2021	Mohr, Maurice/0000-0003-3726-730X; Eskofier, Bjoern/0000-0002-0417-0336	Biomechanigg Sport & Health Research Inc.; German Academic Exchange Service (DAAD)	Biomechanigg Sport & Health Research Inc.; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This project was supported by Biomechanigg Sport & Health Research Inc. The funder provided support in the form of salaries for authors [MM, VVT, BMN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MN was a visiting student from Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany, supervised by BE and was supported by the German Academic Exchange Service (DAAD).	Boonstra TW, 2008, J ELECTROMYOGR KINES, V18, P717, DOI 10.1016/j.jelekin.2007.03.005; Boonstra TW, 2009, EUR J NEUROSCI, V29, P613, DOI 10.1111/j.1460-9568.2008.06584.x; Croft JL, 2008, MOTOR CONTROL, V12, P283, DOI 10.1123/mcj.12.4.283; De Luca CJ, 2015, J NEUROPHYSIOL, V113, P1941, DOI 10.1152/jn.00555.2014; De Luca CJ, 2002, J NEUROPHYSIOL, V87, P2200, DOI 10.1152/jn.00793.2001; DE LUCA CJ, 1993, J NEUROPHYSIOL, V70, P2010, DOI 10.1152/jn.1993.70.5.2010; Enders H, 2015, MED SCI SPORT EXER, V47, P1450, DOI 10.1249/MSS.0000000000000564; Farina D, 2014, J APPL PHYSIOL, V117, P1215, DOI 10.1152/japplphysiol.00162.2014; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127, DOI 10.1113/jphysiol.1993.sp019851; GIBBS J, 1995, J PHYSIOL-LONDON, V485, P245, DOI 10.1113/jphysiol.1995.sp020727; Gibbs J, 1997, J PHYSIOL-LONDON, V499, P255, DOI 10.1113/jphysiol.1997.sp021924; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Halliday DM, 2003, J NEUROPHYSIOL, V89, P960, DOI 10.1152/jn.00844.2002; Hansen NL, 2001, J NEUROPHYSIOL, V86, P1266, DOI 10.1152/jn.2001.86.3.1266; Hermens JHF, 1999, SENIAM EUROPEAN RECO; LAGO P, 1977, MED BIOL ENG COMPUT, V15, P648, DOI 10.1007/BF02457923; Maurer C, 2013, J ELECTROMYOGR KINES, V23, P673, DOI 10.1016/j.jelekin.2013.01.007; Mellor R, 2006, J ORTHOP RES, V24, P1420, DOI 10.1002/jor.20161; Mellor R, 2005, J PAIN, V6, P550, DOI 10.1016/j.jpain.2005.03.006; Mellor R, 2005, CLIN NEUROPHYSIOL, V116, P1585, DOI 10.1016/j.clinph.2005.04.004; Neptune RR, 2000, CLIN BIOMECH, V15, P611, DOI 10.1016/S0268-0033(00)00028-0; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Semmler JG, 1998, EXP BRAIN RES, V119, P27, DOI 10.1007/s002210050316; Semmler JG, 2004, J NEUROPHYSIOL, V92, P3320, DOI 10.1152/jn.00316.2004; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V., 2014, J EXERC SPORTS ORTHO, V1, P1, DOI DOI 10.15226/2374-6904/1/1/00105; von Tscharner V, 2010, SPORTS ORTHOP TRAUMA, V26, P84, DOI DOI 10.1016/J.0RTHTR.2010.04.002; von Tscharner V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00223; von Tscharner V, 2013, J ELECTROMYOGR KINES, V23, P1044, DOI 10.1016/j.jelekin.2013.07.011; von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P1088, DOI 10.1016/j.jelekin.2010.06.004; WEYTJENS JLF, 1984, BIOL CYBERN, V51, P71, DOI 10.1007/BF00357919; Witvrouw E, 1996, J ORTHOP SPORT PHYS, V24, P160, DOI 10.2519/jospt.1996.24.3.160	34	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142048	10.1371/journal.pone.0142048	http://dx.doi.org/10.1371/journal.pone.0142048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529604	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600094
J	Polyakova, M; Schroeter, ML; Elzinga, BM; Holiga, S; Schoenknecht, P; de Kloet, ER; Molendijk, ML				Polyakova, M.; Schroeter, M. L.; Elzinga, B. M.; Holiga, S.; Schoenknecht, P.; de Kloet, E. R.; Molendijk, M. L.			Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature	PLOS ONE			English	Review							RESISTANT DEPRESSED-PATIENTS; GENE-EXPRESSION PROFILE; NERVE GROWTH-FACTOR; TRKB MESSENGER-RNA; BLOOD BDNF LEVELS; RAT-BRAIN; MAJOR DEPRESSION; MOOD DISORDERS; HIPPOCAMPAL BDNF; FACTOR PROTEIN	Emerging data suggest that Electro-Convulsive Treatment (ECT) may reduce depressive symptoms by increasing the expression of Brain-Derived Neurotrophic Factor (BDNF). Yet, conflicting findings have been reported. For this reason we performed a systematic review and meta-analysis of the preclinical and clinical literature on the association between ECT treatment (ECS in animals) and changes in BDNF concentrations and their effect on behavior. In addition, regional brain expression of BDNF in mouse and human brains were compared using Allen Brain Atlas. ECS, over sham, increased BDNF mRNA and protein in animal brain (effect size [Hedge's g]: 0.38-0.54; 258 effect-size estimates, N = 4,284) but not in serum (g = 0.06, 95% CI = -0.05-0.17). In humans, plasma but not serum BDNF increased following ECT (g = 0.72 vs. g = 0.14; 23 effect sizes, n = 281). The gradient of the BDNF increment in animal brains corresponded to the gradient of the BDNF gene expression according to the Allen brain atlas. Effect-size estimates were larger following more ECT sessions in animals (r = 0.37, P < .0001) and in humans (r = 0.55; P = 0.05). There were some indications that the increase in BDNF expression was associated with behavioral changes in rodents, but not in humans. We conclude that ECS in rodents and ECT in humans increase BDNF concentrations but this is not consistently associated with changes in behavior.	[Polyakova, M.; Schroeter, M. L.; Holiga, S.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Polyakova, M.; Schroeter, M. L.; Holiga, S.] Univ Hosp, Clin Cognit Neurol, Leipzig, Germany; [Elzinga, B. M.; Molendijk, M. L.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Elzinga, B. M.; Molendijk, M. L.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Polyakova, M.] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [de Kloet, E. R.] Leiden Univ, Med Ctr, Div Endocrinol, Div Med Pharmacol, Leiden, Netherlands; [de Kloet, E. R.] Leiden Univ, Med Ctr, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Max Planck Society; Leipzig University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leipzig University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Polyakova, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	polyakova@cbs.mpg.de; molendijkml@fsw.leidenuniv.nl	de Kloet, Edo Ronald/H-3278-2011	Polyakova, Maryna/0000-0003-0617-0097; de Kloet, Ron/0000-0001-9176-1830				Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; Angelucci F, 2003, NEUROPEPTIDES, V37, P51, DOI 10.1016/S0143-4179(03)00004-0; Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bilgen AE, 2014, BRAIN RES BULL, V104, P82, DOI 10.1016/j.brainresbull.2014.04.005; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Borenstein M, 2009, COMPREHENSIVE METAAN; Bouckaert F, 2014, J ECT, V30, P143, DOI 10.1097/YCT.0000000000000129; Brunoni AR, 2014, WORLD J BIOL PSYCHIA, V15, P411, DOI 10.3109/15622975.2014.892633; Bumb JM, 2015, EUR ARCH PSY CLIN N, V265, P227, DOI 10.1007/s00406-014-0543-3; Caputo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028656; Chen ACH, 2001, J ECT, V17, P27, DOI 10.1097/00124509-200103000-00006; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Cooper H, 2009, PSYCHOL METHODS, V14, P165, DOI 10.1037/a0015565; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Dierckx B, 2012, BIPOLAR DISORD, V14, P146, DOI 10.1111/j.1399-5618.2012.00997.x; Dukart J, 2014, P NATL ACAD SCI USA, V111, P1156, DOI 10.1073/pnas.1321399111; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Dyrvig M, 2014, GENE, V539, P8, DOI 10.1016/j.gene.2014.01.072; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elfving B, 2010, INT J NEUROPSYCHOPH, V13, P563, DOI 10.1017/S1461145709990721; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fernandes B, 2009, NEUROSCI LETT, V453, P195, DOI 10.1016/j.neulet.2009.02.032; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gedge Laura, 2012, Front Psychiatry, V3, P12, DOI 10.3389/fpsyt.2012.00012; Gersner R, 2010, BIOL PSYCHIAT, V67, P125, DOI 10.1016/j.biopsych.2009.09.015; Gronli O, 2009, WORLD J BIOL PSYCHIA, V10, P295, DOI 10.3109/15622970701586323; Guloksuz S, 2014, J ECT, V30, P132, DOI 10.1097/YCT.0000000000000127; Haghighi M, 2013, J PSYCHIATR RES, V47, P908, DOI 10.1016/j.jpsychires.2013.03.006; Harker LA, 2000, BLOOD, V95, P2514; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu YD, 2010, J ECT, V26, P121, DOI 10.1097/YCT.0b013e3181c18bbf; IBM Corp, 2012, SOFTW WIND REL 21 0; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kho KH, 2003, J ECT, V19, P139, DOI 10.1097/00124509-200309000-00005; Khundakar AA, 2006, BRAIN RES, V1106, P12, DOI 10.1016/j.brainres.2006.05.063; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kleimann A, 2015, J NEURAL TRANSM, V122, P925, DOI 10.1007/s00702-014-1336-6; Klein AB, 2010, J CEREBR BLOOD F MET, V30, pE1, DOI 10.1038/jcbfm.2010.114; Kyeremanteng C, 2014, PROG NEURO-PSYCHOPH, V54, P170, DOI 10.1016/j.pnpbp.2014.05.012; Kyeremanteng C, 2012, PHARMACOPSYCHIATRY, V45, P244, DOI 10.1055/s-0032-1306278; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Li B, 2006, EUR J PHARMACOL, V529, P114, DOI 10.1016/j.ejphar.2005.11.009; Li BJ, 2007, LIFE SCI, V80, P1539, DOI 10.1016/j.lfs.2007.01.032; Li N, 2010, ACTA PHARMACOL SIN, V31, P265, DOI 10.1038/aps.2010.3; Lin CH, 2013, NEUROPSYCHOBIOLOGY, V68, P110, DOI 10.1159/000352013; LINDEFORS N, 1995, NEUROSCIENCE, V65, P661, DOI 10.1016/0306-4522(94)00550-O; Luo J, 2012, PSYCHIAT RES, V198, P300, DOI 10.1016/j.psychres.2011.09.010; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Marano CM, 2007, J CLIN PSYCHIAT, V68, P512, DOI 10.4088/JCP.v68n0404; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Mueller K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.121; Newton SS, 2003, J NEUROSCI, V23, P10841; NIBUYA M, 1995, J NEUROSCI, V15, P7539; O'Donovan S, 2012, PROG NEURO-PSYCHOPH, V37, P147, DOI 10.1016/j.pnpbp.2011.12.012; Okamoto T, 2008, PROG NEURO-PSYCHOPH, V32, P1185, DOI 10.1016/j.pnpbp.2008.02.009; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Piccinni A, 2009, EUR NEUROPSYCHOPHARM, V19, P349, DOI 10.1016/j.euroneuro.2009.01.002; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Rotheneichner P, 2014, HIPPOCAMPAL NEUROGEN, V2014, DOI [10.1155/2014/723915, DOI 10.1155/2014/723915]; Ryan KM, 2013, NEUROSCI LETT, V549, P125, DOI 10.1016/j.neulet.2013.05.035; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sartorius A, 2009, PHARMACOPSYCHIATRY, V42, P270, DOI 10.1055/s-0029-1224162; Schloesser RJ, 2015, BRAIN STIMUL, V8, P862, DOI 10.1016/j.brs.2015.05.011; Segawa M, 2013, INT J NEUROPSYCHOPH, V16, P339, DOI 10.1017/S1461145712000053; Segi-Nishida E, 2013, NEUROPHARMACOLOGY, V71, P164, DOI 10.1016/j.neuropharm.2013.03.033; Stezhammer V, 2013, EUR NEUROPSYCHOPHARM, V23, P1199, DOI 10.1016/j.euroneuro.2012.10.012; Tongiorgi E, 2008, NEUROSCI RES, V61, P335, DOI 10.1016/j.neures.2008.04.013; Weiner Richard D, 2011, J Am Psychiatr Nurses Assoc, V17, P217, DOI 10.1177/1078390311408603; Wells G.A., NEWCASTLE OTTAWA SCA; Zetterstrom TSC, 1998, MOL BRAIN RES, V57, P106, DOI 10.1016/S0169-328X(98)00077-1	86	75	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141564	10.1371/journal.pone.0141564	http://dx.doi.org/10.1371/journal.pone.0141564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529101	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600039
J	Stillova, K; Jurak, P; Chladek, J; Chrastina, J; Halamek, J; Bockova, M; Goldemundova, S; Riha, I; Rektor, I				Stillova, Klara; Jurak, Pavel; Chladek, Jan; Chrastina, Jan; Halamek, Josef; Bockova, Martina; Goldemundova, Sabina; Riha, Ivo; Rektor, Ivan			The Role of Anterior Nuclei of the Thalamus: A Subcortical Gate in Memory Processing: An Intracerebral Recording Study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ELECTRICAL-STIMULATION; MAMMILLARY BODIES; SPATIAL MEMORY; CORTEX; CONNECTIVITY; HIPPOCAMPUS; AMNESIA; PET; PERFORMANCE	Objective To study the involvement of the anterior nuclei of the thalamus (ANT) as compared to the involvement of the hippocampus in the processes of encoding and recognition during visual and verbal memory tasks. Methods We studied intracerebral recordings in patients with pharmacoresistent epilepsy who underwent deep brain stimulation (DBS) of the ANT with depth electrodes implanted bilaterally in the ANT and compared the results with epilepsy surgery candidates with depth electrodes implanted bilaterally in the hippocampus. We recorded the event-related potentials (ERPs) elicited by the visual and verbal memory encoding and recognition tasks. Results P300-like potentials were recorded in the hippocampus by visual and verbal memory encoding and recognition tasks and in the ANT by the visual encoding and visual and verbal recognition tasks. No significant ERPs were recorded during the verbal encoding task in the ANT. In the visual and verbal recognition tasks, the P300-like potentials in the ANT preceded the P300-like potentials in the hippocampus. Conclusions The ANT is a structure in the memory pathway that processes memory information before the hippocampus. We suggest that the ANT has a specific role in memory processes, especially memory recognition, and that memory disturbance should be considered in patients with ANT-DBS and in patients with ANT lesions.	[Stillova, Klara; Chrastina, Jan; Bockova, Martina; Goldemundova, Sabina; Riha, Ivo; Rektor, Ivan] Cent European Inst Technol CEITEC, Brain & Mind Res Program, Brno, Czech Republic; [Stillova, Klara; Bockova, Martina; Goldemundova, Sabina; Rektor, Ivan] Masaryk Univ, St Annes Teaching Hosp, Dept Neurol, Sch Med, Brno, Czech Republic; [Chrastina, Jan; Riha, Ivo] Masaryk Univ, St Annes Teaching Hosp, Dept Neurosurg, Sch Med, Brno, Czech Republic; [Jurak, Pavel; Chladek, Jan; Halamek, Josef] Acad Sci Czech Republ, Inst Sci Instruments, CS-61264 Brno, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences	Rektor, I (corresponding author), Cent European Inst Technol CEITEC, Brain & Mind Res Program, Brno, Czech Republic.	irektor@med.muni.cz	Halamek, Josef/M-3836-2019; Chladek, Jan/AAK-2231-2021; Halamek, Josef/D-5110-2012; Jurak, Pavel/AAO-3084-2020; Jurák, Pavel/G-1466-2014; Chladek, Jan/B-2600-2009	Halamek, Josef/0000-0001-8986-796X; Chladek, Jan/0000-0002-9500-0657; Halamek, Josef/0000-0001-8986-796X; Jurak, Pavel/0000-0002-3793-5075; Jurák, Pavel/0000-0002-3793-5075; Chladek, Jan/0000-0002-9500-0657; Bockova, Martina/0000-0003-2691-9122	research project CEITEC MU-Central European Institute of Technology Masaryk University; "Research and Development for Innovations" Operational Programme the European Regional Development Fund; Application Laboratories of Advanced Microtechnologies and Nanotechnologies [CZ.1.05/2.1.00/01.0017];  [GACR P103/11/0933]	research project CEITEC MU-Central European Institute of Technology Masaryk University; "Research and Development for Innovations" Operational Programme the European Regional Development Fund; Application Laboratories of Advanced Microtechnologies and Nanotechnologies; 	This work was supported by the research project CEITEC MU-Central European Institute of Technology Masaryk University. The technical part of the study was also supported by the projects GA GACR P103/11/0933 and Application Laboratories of Advanced Microtechnologies and Nanotechnologies, CZ.1.05/2.1.00/01.0017, co-funded by the "Research and Development for Innovations" Operational Programme the European Regional Development Fund and the state budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Bockova M, 2014, BRAIN TOPOGRAPHY, P1; Cihak R, 1997, ANATOMIE; CLARKE S, 1994, J NEUROL NEUROSUR PS, V57, P27, DOI 10.1136/jnnp.57.1.27; FAZIO F, 1992, J CEREBR BLOOD F MET, V12, P353, DOI 10.1038/jcbfm.1992.52; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Garden DLF, 2009, BRAIN, V132, P1847, DOI 10.1093/brain/awp090; HALGREN E, 1978, ELECTROEN CLIN NEURO, V45, P585, DOI 10.1016/0013-4694(78)90159-1; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Hu R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0975; Jankowski MM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00045; JONESGOTMAN M, 1994, EPILEPSIA, V35, P61, DOI 10.1111/j.1528-1157.1994.tb02913.x; Kopelman MD, 2014, NEUROSCI BIOBEHAV RE; Kubota Y, 2013, CLIN NEUROPHYSIOL, V124, P1547, DOI 10.1016/j.clinph.2013.01.024; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; O'keefe J, 1978, HIPPOCAMPUS COGNITIV, V3, P483; Oedekoven CS, 2014, BRAIN IMAGING BEHAV, P1; Oh YS, 2012, SEIZURE-EUR J EPILEP, V21, P183, DOI 10.1016/j.seizure.2011.12.003; Parker A, 1997, NEUROPSYCHOLOGIA, V35, P1093, DOI 10.1016/S0028-3932(97)00042-0; Parvizi J, 2009, TRENDS COGN SCI, V13, P354, DOI 10.1016/j.tics.2009.04.008; Pergola G, 2013, NEUROIMAGE, V74, P195, DOI 10.1016/j.neuroimage.2013.02.017; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; Reed LJ, 2003, CORTEX, V39, P1027, DOI 10.1016/S0010-9452(08)70876-1; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stillova K, 2013, J NEURAL TRANSM, V120, P391, DOI 10.1007/s00702-012-0890-z; Talairach J, 1967, ATLAS ANATOMIE STERE; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vann SD, 2007, EUR J NEUROSCI, V26, P1575, DOI 10.1111/j.1460-9568.2007.05773.x; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Warburton EC, 2000, EUR J NEUROSCI, V12, P1714, DOI 10.1046/j.1460-9568.2000.00039.x; Wennberg R, 2006, CLIN NEUROPHYSIOL, V117, P474, DOI 10.1016/j.clinph.2005.09.020; Wennberg RA, 2003, CLIN NEUROPHYSIOL, V114, P1403, DOI 10.1016/S1388-2457(03)00152-4; Wolff M, 2006, J NEUROSCI, V26, P2907, DOI 10.1523/JNEUROSCI.5481-05.2006; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	43	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140778	10.1371/journal.pone.0140778	http://dx.doi.org/10.1371/journal.pone.0140778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529407	gold, Green Published			2022-12-27	WOS:000364032600012
J	Baerts, L; Waumans, Y; Brandt, I; Jungraithmayr, W; Van der Veken, P; Vanderheyden, M; De Meester, I				Baerts, Lesley; Waumans, Yannick; Brandt, Inger; Jungraithmayr, Wolfgang; Van der Veken, Pieter; Vanderheyden, Marc; De Meester, Ingrid			Circulating Stromal Cell-Derived Factor 1 alpha Levels in Heart Failure: A Matter of Proper Sampling	PLoS One			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; FACTOR-I; ADENOSINE-DEAMINASE; CXCR4; INHIBITION; CD26; FACTOR-1-ALPHA; RECRUITMENT; DYSFUNCTION	Background The chemokine Stromal cell-derived factor 1 alpha (SDF1 alpha, CXCL12) is currently under investigation as a biomarker for various cardiac diseases. The correct interpretation of SDF1 alpha levels is complicated by the occurrence of truncated forms that possess an altered biological activity. Methodology We studied the immunoreactivities of SDF1 alpha forms and evaluated the effect of adding a DPP4 inhibitor in sampling tubes on measured SDF1 alpha levels. Using optimized sampling, we measured DPP4 activity and SDF1 alpha levels in patients with varying degrees of heart failure. Results The immunoreactivities of SDF1 alpha and its degradation products were determined with three immunoassays. A one hour incubation of SDF1 alpha with DPP4 at 37 degrees C resulted in 2/3 loss of immunoreactivity in each of the assays. Incubation with serum gave a similar result. Using appropriate sampling, SDF1 alpha levels were found to be significantly higher in those heart failure patients with a severe loss of left ventricular function. DPP4 activity in serum was not altered in the heart failure population. However, the DPP4 activity was found to be significantly decreased in patients with high SDF1 alpha levels Conclusions We propose that all samples for SDF1 alpha analysis should be collected in the presence of at least a DPP4 inhibitor. In doing so, we found higher SDF1 alpha levels in subgroups of patients with heart failure. Our work supports the need for further research on the clinical relevance of SDF1 alpha levels in cardiac disease.	[Baerts, Lesley; Waumans, Yannick; De Meester, Ingrid] Univ Antwerp, Med Biochem Lab, B-2020 Antwerp, Belgium; [Brandt, Inger] OLV Hosp Aalst, Clin Chem Lab, Aalst, Belgium; [Jungraithmayr, Wolfgang] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Van der Veken, Pieter] Univ Antwerp, Med Chem Lab, B-2020 Antwerp, Belgium; [Vanderheyden, Marc] OLV Hosp Aalst, Cardiovasc Ctr, Aalst, Belgium	University of Antwerp; University of Zurich; University Zurich Hospital; University of Antwerp; Cardiovascular Center Aalst	De Meester, I (corresponding author), Univ Antwerp, Med Biochem Lab, B-2020 Antwerp, Belgium.	ingrid.demeester@uantwerpen.be	De Meester, Ingrid/A-6881-2017; Jungraithmayr, Wolfgang/F-3882-2015; Van der Veken, Pieter/P-5819-2016	De Meester, Ingrid/0000-0002-3421-0124; Jungraithmayr, Wolfgang/0000-0002-1442-4862; Van der Veken, Pieter/0000-0003-1208-3571	University of Antwerp Special research Fund (BOF) [FFB3551]; Flanders Research Foundation (FWO) [G0141.12]	University of Antwerp Special research Fund (BOF); Flanders Research Foundation (FWO)(FWO)	This work was supported by the University of Antwerp Special research Fund (BOF; Grant FFB3551, https://www.uantwerpen.be/nl/) and the Flanders Research Foundation (FWO; Grant G0141.12, http://www.fwo.be/en/).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aiuti BA, 1997, J EXP MED, V185, P111; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; DeMeester I, 1996, J IMMUNOL METHODS, V189, P99, DOI 10.1016/0022-1759(95)00239-1; dos Santos L, 2013, CIRC-HEART FAIL, V6, P1029, DOI 10.1161/CIRCHEARTFAILURE.112.000057; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Ghasemzadeh N, 2014, ATHEROSCLEROSIS; Heymes C, 1999, CIRCULATION, V99, P3009, DOI 10.1161/01.CIR.99.23.3009; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Jungraithmayr W, 2012, EUR J CARDIO-THORAC, V41, P1166, DOI 10.1093/ejcts/ezr180; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; LaRocca TJ, 2012, J MOL CELL CARDIOL, V53, P223, DOI 10.1016/j.yjmcc.2012.05.016; Lee BC, 2009, EUR J HEART FAIL, V11, P238, DOI 10.1093/eurjhf/hfn035; Matheeussen V, 2011, BIOL CHEM, V392, P189, DOI 10.1515/BC.2011.002; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Pala L, 2012, ACTA DIABETOL, V49, pS59, DOI 10.1007/s00592-010-0195-3; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; Subramanian S, 2014, ARTERIOSCL THROM VAS, V34, P2100, DOI 10.1161/ATVBAHA.114.303579; Theiss HD, 2013, INT J CARDIOL, V168, P3359, DOI 10.1016/j.ijcard.2013.04.121; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yang T, 2014, HEART LUNG, V43, P322, DOI 10.1016/j.hrtlng.2014.04.016; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141408	10.1371/journal.pone.0141408	http://dx.doi.org/10.1371/journal.pone.0141408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544044	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700021
J	Larmuseau, MHD; Vessi, A; Jobling, MA; Van Geystelen, A; Primativo, G; Biondi, G; Martinez-Labarga, C; Ottoni, C; Decorte, R; Rickards, O				Larmuseau, Maarten H. D.; Vessi, Andrea; Jobling, Mark A.; Van Geystelen, Anneleen; Primativo, Giuseppina; Biondi, Gianfranco; Martinez-Labarga, Cristina; Ottoni, Claudio; Decorte, Ronny; Rickards, Olga			The Paternal Landscape along the Bight of Benin - Testing Regional Representativeness of West-African Population Samples Using Y-Chromosomal Markers	PLOS ONE			English	Article							PHYLOGENETIC TREE; MITOCHONDRIAL-DNA; GENETIC-VARIATION; HAPLOGROUP TREE; DIVERSITY; POLYMORPHISMS; EXPANSION; SCALE; LINEAGES; PHYLOGEOGRAPHY	Patterns of genetic variation in human populations across the African continent are still not well studied in comparison with Eurasia and America, despite the high genetic and cultural diversity among African populations. In population and forensic genetic studies a single sample is often used to represent a complete African region. In such a scenario, inappropriate sampling strategies and/or the use of local, isolated populations may bias interpretations and pose questions of representativeness at a macrogeographic-scale. The non-recombining region of the Y-chromosome (NRY) has great potential to reveal the regional representation of a sample due to its powerful phylogeographic information content. An area poorly characterized for Y-chromosomal data is the West-African region along the Bight of Benin, despite its important history in the trans-Atlantic slave trade and its large number of ethnic groups, languages and lifestyles. In this study, Y-chromosomal haplotypes from four Beninese populations were determined and a global meta-analysis with available Y-SNP and YSTR data from populations along the Bight of Benin and surrounding areas was performed. A thorough methodology was developed allowing comparison of population samples using Y-chromosomal lineage data based on different Y-SNP panels and phylogenies. Geographic proximity turned out to be the best predictor of genetic affinity between populations along the Bight of Benin. Nevertheless, based on Y-chromosomal data from the literature two population samples differed strongly from others from the same or neighbouring areas and are not regionally representative within large-scale studies. Furthermore, the analysis of the HapMap sample YRI of a Yoruban population from South-western Nigeria based on Y-SNPs and Y-STR data showed for the first time its regional representativeness, a result which is important for standard population and forensic genetic applications using the YRI sample. Therefore, the uniquely and powerful geographical information carried by the Y-chromosome makes it an important locus to test the representativeness of a certain sample even in the genomic era, especially in poorly investigated areas like Africa.	[Larmuseau, Maarten H. D.; Vessi, Andrea; Ottoni, Claudio; Decorte, Ronny] Katholieke Univ Leuven, Forens Biomed Sci, Dept Imaging & Pathol, Leuven, Belgium; [Larmuseau, Maarten H. D.; Van Geystelen, Anneleen] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Dept Biol, Leuven, Belgium; [Larmuseau, Maarten H. D.; Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Vessi, Andrea; Primativo, Giuseppina; Martinez-Labarga, Cristina; Ottoni, Claudio; Rickards, Olga] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Biondi, Gianfranco] Univ Laquila, Dept Clin Med Publ Hlth Life & Environm, Laquila, Italy; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Archaeol Sci, Dept Earth & Environm Sci, Leuven, Belgium; [Decorte, Ronny] UZ Leuven, Lab Forens Genet & Mol Archaeol, Leuven, Belgium	KU Leuven; KU Leuven; University of Leicester; University of Rome Tor Vergata; University of L'Aquila; KU Leuven; KU Leuven; University Hospital Leuven	Larmuseau, MHD (corresponding author), Katholieke Univ Leuven, Forens Biomed Sci, Dept Imaging & Pathol, Leuven, Belgium.	maarten.larmuseau@bio.kuleuven.be	Decorte, Ronny/AAG-1365-2021; Ottoni, Claudio/AFM-1230-2022; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Larmuseau, Maarten/GSJ-0393-2022; Ottoni, Claudio/AFM-1348-2022; RICKARDS, OLGA/L-7878-2015	MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Ottoni, Claudio/0000-0001-8870-1589; RICKARDS, OLGA/0000-0003-2880-7466; Decorte, Ronny/0000-0002-0001-386X; Jobling, Mark/0000-0002-8061-1308; Larmuseau, Maarten H.D./0000-0002-5974-7235	Wellcome Trust [087576]; KU Leuven BOF Centre of Excellence [PF/2010/07]	Wellcome Trust(Wellcome TrustEuropean Commission); KU Leuven BOF Centre of Excellence	MHDL is a postdoctoral fellow of the FWO Vlaanderen (Research Foundation Flanders). MAJ was supported by a Wellcome Trust Senior Fellowship (grant no. 087576). This study was funded in the context of the KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' (Project number PF/2010/07) and on 'Centre for Archaeological Sciences 2 - New methods for research in demography and interregional exchange'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2011, R FDN STAT COMP R R; Argyle WJ, 1966, THE FON OF DAHOMEY A; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Batini C, 2011, MOL BIOL EVOL, V28, P2603, DOI 10.1093/molbev/msr089; Biondi G, 1996, AM J PHYS ANTHROPOL, V99, P519; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Brucato N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-314; Caratti S, 2009, INT J LEGAL MED, V123, P357, DOI 10.1007/s00414-009-0350-y; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Corbo RM, 1999, AM J HUM BIOL, V11, P297, DOI 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eltis D., 2010, ATLAS TRANSATLANTIC; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Heine B, 2000, AFRICAN LANGUAGES; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2014, FORENSIC DNA APPL IN; Klein Herbert S, 1999, ATLANTIC SLAVE TRADE; Larmuseau MHD, 2015, HEREDITY, V115, P3, DOI 10.1038/hdy.2015.5; Larmuseau MHD, 2014, FORENSIC SCI INT-GEN, V9, P179, DOI 10.1016/j.fsigen.2013.04.002; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; Larmuseau MHD, 2012, HEREDITY, V109, P90, DOI 10.1038/hdy.2012.17; Larmuseau MHD, 2015, FORENSIC SCI INT-GEN, V15, P39, DOI 10.1016/j.fsigen.2014.11.012; Larmuseau MHD, 2014, EUR J HUM GENET, V22, P681, DOI 10.1038/ejhg.2013.211; Larmuseau MHD, 2012, EUR J HUM GENET, V20, P434, DOI 10.1038/ejhg.2011.218; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; Law Robin, 2005, OUIDAH SOCIAL HIST W; MANTEL N, 1967, CANCER RES, V27, P209; Marks SJ, 2012, MOL ECOL, V21, P4958, DOI 10.1111/j.1365-294X.2012.05689.x; Mendez FL, 2013, AM J HUM GENET, V92, P637, DOI 10.1016/j.ajhg.2013.03.006; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Ottoni C, 2011, AM J PHYS ANTHROPOL, V145, P118, DOI 10.1002/ajpa.21473; Pour NA, 2013, EUR J HUM GENET, V21, P423, DOI 10.1038/ejhg.2012.176; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rickards O., 1994, CONTRIBUTIONS ANIMAL, P355; Sanchez-Faddeev H, 2013, EUR J HUM GENET, V21, P1134, DOI 10.1038/ejhg.2013.12; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Strassmann BI, 2012, P NATL ACAD SCI USA, V109, P9781, DOI 10.1073/pnas.1110442109; Trombetta B, 2015, GENOME BIOL EVOL, V7, P1940, DOI 10.1093/gbe/evv118; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Valverde L, EUROPEAN J IN PRESS; Van Geystelen A, 2013, FORENSIC SCI INT-GEN, V7, P573, DOI 10.1016/j.fsigen.2013.03.010; Van Geystelen A, 2014, ELECTROPHORESIS, V35, P3102, DOI 10.1002/elps.201300459; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; van Oven M, 2011, INT J LEGAL MED, V125, P879, DOI 10.1007/s00414-011-0605-2; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017	65	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141510	10.1371/journal.pone.0141510	http://dx.doi.org/10.1371/journal.pone.0141510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544036	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700029
J	Gatticchi, L; Bellezza, I; Del Sordo, R; Peirce, MJ; Sidoni, A; Roberti, R; Minelli, A				Gatticchi, Leonardo; Bellezza, Ilaria; Del Sordo, Rachele; Peirce, Matthew J.; Sidoni, Angelo; Roberti, Rita; Minelli, Alba			The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury	PLOS ONE			English	Article							TNF-ALPHA; PROXIMAL TUBULE; INDUCED LIPOTOXICITY; LIPID-METABOLISM; RENAL-FAILURE; FATTY-ACID; CHOLESTEROL; INFLAMMATION; AUTOPHAGY; CELLS	Cholesterol is essential for diverse cellular functions and cellular and whole-body cholesterol homeostasis is highly controlled. Cholesterol can also influence cellular susceptibility to injury. The connection between cholesterol metabolism and inflammation is exemplified by the Tm7sf2 gene, the absence of which reveals an essential role in cholesterol biosynthesis under stress conditions but also results in an inflammatory phenotype, i.e. NF-kappa B activation and TNF alpha up-regulation. Here, by using Tm7sf2(+/+) and Tm7sf2(-/-) mice, we investigated whether the Tm7sf2 gene, through its role in cholesterol biosynthesis under stress conditions, is involved in the renal failure induced by the administration of LPS. We found that the loss of Tm7sf2 gene results in significantly reduced blood urea nitrogen levels accompanied by decreased renal inflammatory response and neutral lipid accumulation. The increased expression of fatty acids catabolic enzymes reduces the need of the renal autophagy, a known crucial nutrient-sensing pathway in lipid metabolism. Moreover, we observed that the Tm7sf2 insufficiency is responsible for the inhibition of the NF-kappa B signalling thus dampening the inflammatory response and leading to a reduced renal damage. These results suggest a pivotal role for Tm7sf2 in renal inflammatory and lipotoxic response under endotoxemic conditions.	[Gatticchi, Leonardo; Bellezza, Ilaria; Del Sordo, Rachele; Peirce, Matthew J.; Sidoni, Angelo; Roberti, Rita; Minelli, Alba] Univ Perugia, Dept Expt Med, I-06124 Perugia, Italy	University of Perugia	Minelli, A (corresponding author), Univ Perugia, Dept Expt Med, Piazzale Gambuli, I-06124 Perugia, Italy.	alba.minelli@unipg.it	Peirce, Matthew/ABB-9577-2021; Gatticchi, Leonardo/AAX-2811-2020; BELLEZZA, ILARIA/AAA-8099-2022	Peirce, Matthew/0000-0003-3648-5639; BELLEZZA, ILARIA/0000-0002-8106-1600; Gatticchi, Leonardo/0000-0002-0098-7840	PRIN (Progetti di Ricerca di Interesse Nazionele) [20092BE97Y_005]; Fondazione Cassa di Risparmio di Perugia [2011.0184.021, 2011.0099.021]	PRIN (Progetti di Ricerca di Interesse Nazionele)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by PRIN (Progetti di Ricerca di Interesse Nazionele) (20092BE97Y_005), and Fondazione Cassa di Risparmio di Perugia (2011.0184.021 and 2011.0099.021) to RR and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba M, 2010, MITOCHONDRION, V10, P369, DOI 10.1016/j.mito.2010.03.004; BALABAN RS, 1988, AM J PHYSIOL, V254, pF407, DOI 10.1152/ajprenal.1988.254.3.F407; Bascands JL, 2009, BIOCHEM BIOPH RES CO, V386, P407, DOI 10.1016/j.bbrc.2009.06.063; Bellezza I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09471; Bellezza I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068017; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, CURR OPIN CLIN NUTR, V12, P110, DOI 10.1097/MCO.0b013e32832182ee; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; GULLANS SR, 1984, AM J PHYSIOL, V247, pF582, DOI 10.1152/ajprenal.1984.247.4.F582; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Heemskerk S, 2006, CLIN J AM SOC NEPHRO, V1, P853, DOI 10.2215/CJN.00490206; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huang LH, 2011, KIDNEY INT, V79, P613, DOI 10.1038/ki.2010.469; Hunter I, 2006, J BIOL CHEM, V281, P34705, DOI 10.1074/jbc.M605738200; Johnson ACM, 2005, KIDNEY INT, V67, P2196, DOI 10.1111/j.1523-1755.2005.00325.x; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; MACALA LJ, 1983, J LIPID RES, V24, P1243; Meldrum KK, 2002, AM J PHYSIOL-HEART C, V282, pH540, DOI 10.1152/ajpheart.00072.2001; MOORHEAD JF, 1982, LANCET, V2, P1309; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Shpilka T., 2015, EMBO J; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030134; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Vasko R, 2013, ANTIOXID REDOX SIGN, V19, P211, DOI 10.1089/ars.2012.4768; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang CW, 2014, J CELL BIOL, V206, P357, DOI 10.1083/jcb.201404115; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Xin W, 2015, BIOCHEM BIOPH RES CO, V463, P364, DOI 10.1016/j.bbrc.2015.05.070; Zager RA, 2007, KIDNEY INT, V71, P496, DOI 10.1038/sj.ki.5002092; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zager RA, 2002, AM J PATHOL, V161, P681, DOI 10.1016/S0002-9440(10)64224-1; Zager RA, 2001, AM J PATHOL, V159, P743, DOI 10.1016/S0002-9440(10)61745-2; Zager RA, 2000, KIDNEY INT, V58, P193, DOI 10.1046/j.1523-1755.2000.00154.x; Zager RA, 2000, AM J PATHOL, V157, P1007, DOI 10.1016/S0002-9440(10)64613-5; Zager RA, 1999, KIDNEY INT, V56, P1788, DOI 10.1046/j.1523-1755.1999.00745.x; Zager RA, 2006, KIDNEY INT, V67, P111; Zarbock A, 2014, CURR OPIN CRIT CARE, V20, P588, DOI 10.1097/MCC.0000000000000153	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141885	10.1371/journal.pone.0141885	http://dx.doi.org/10.1371/journal.pone.0141885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540160	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800033
J	Kang, HB; Ji, WJ; Qian, ZH; Li, YX; Jiang, CH; Wu, ZX; Wen, XL; Xu, WJ; Liu, AH				Kang, Huibin; Ji, Wenjun; Qian, Zenghui; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue; Wen, Xiaolong; Xu, Wenjuan; Liu, Aihua			Aneurysm Characteristics Associated with the Rupture Risk of Intracranial Aneurysms: A Self-Controlled Study	PLOS ONE			English	Article							UNRUPTURED CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; ASPECT RATIO; SACCULAR ANEURYSMS; BOTTLENECK FACTOR; SIZE; SHAPE; HEMODYNAMICS; POPULATION	This study analyzed the rupture risk of intracranial aneurysms (IAs) according to aneurysm characteristics by comparing the differences between two aneurysms in different locations within the same patient. We utilized this self-controlled model to exclude potential interference from all demographic factors to study the risk factors related to IA rupture. A total of 103 patients were diagnosed with IAs between January 2011 and April 2015 and were enrolled in this study. All enrolled patients had two IAs. One IA (the case) was ruptured, and the other (the control) was unruptured. Aneurysm characteristics, including the presence of a daughter sac, the aneurysm neck, the parent artery diameter, the maximum aneurysm height, the maximum aneurysm width, the location, the aspect ratio (AR, maximum perpendicular height/average neck diameter), the size ratio (SR, maximum aneurysm height/average parent diameter) and the width/height ratio (WH ratio, maximum aneurysm width/maximum aneurysm height), were collected and analyzed to evaluate the rupture risks of the two IAs within each patient and to identify the independent risk factors associated with IA rupture. Multivariate, conditional, backward, stepwise logistic regression analysis was performed to identify the independent risk factors associated with IA rupture. The multivariate analysis identified the presence of a daughter sac (odds ratio [OR], 13.80; 95% confidence interval [CI], 1.65-115.87), a maximum aneurysm height >= 7 mm (OR, 4.80; 95% CI, 1.21-18.98), location on the posterior communicating artery (PCOM) or anterior communicating artery (ACOM; OR, 3.09; 95% CI, 1.34-7.11) and SR (OR, 2.13; 95% CI, 1.16-3.91) as factors that were significantly associated with IA rupture. The presence of a daughter sac, the maximum aneurysm height, PCOM or ACOM locations and SR (>1.5 +/- 0.7) of unruptured IAs were significantly associated with IA rupture.	[Kang, Huibin; Ji, Wenjun; Qian, Zenghui; Li, Youxiang; Jiang, Chuhan; Wu, Zhongxue; Wen, Xiaolong; Xu, Wenjuan; Liu, Aihua] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University	Liu, AH (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	liuaihuadoctor@163.com			National Natural Science Foundation [81441038]; Natural Science Foundation of Beijing, China [7142032]; Specific Research Projects for Capital Health Development [2014-3-2044]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing, China(Beijing Natural Science Foundation); Specific Research Projects for Capital Health Development	This research was supported by the National Natural Science Foundation (81441038), Natural Science Foundation of Beijing, China (No. 7142032), and Specific Research Projects for Capital Health Development (2014-3-2044).	Anderson C, 2003, STROKE, V34, P1771, DOI 10.1161/01.STR.0000077015.90334.A7; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Beck J, 2003, ACTA NEUROCHIR, V145, P861, DOI 10.1007/s00701-003-0124-0; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Korja M, 2014, STROKE, V45, P1958, DOI 10.1161/STROKEAHA.114.005318; Laaksamo E, 2012, NEUROSURGERY, V70, P1565, DOI 10.1227/NEU.0b013e31824c057e; Lai H. P., 2009, Hong Kong Medical Journal, V15, P262; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Ma D, 2010, NEUROL RES, V32, P482, DOI 10.1179/016164109X12581096796558; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Muller TB, 2013, NEUROSURGERY, V73, P256, DOI 10.1227/01.neu.0000430295.23799.16; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Schnell S, 2014, J MAGN RESON IMAGING, V39, P120, DOI 10.1002/jmri.24110; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Tominari S, 2015, ANN NEUROL, V77, P1050, DOI 10.1002/ana.24400; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Vlak MHM, 2013, STROKE, V44, P1256, DOI 10.1161/STROKEAHA.111.000679; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Williams Lindsy N, 2013, Neurol Clin Pract, V3, P99; Yu SCH, 2004, AM J NEURORADIOL, V25, P307; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085668	40	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142330	10.1371/journal.pone.0142330	http://dx.doi.org/10.1371/journal.pone.0142330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540158	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800083
J	Poli, E; Zhang, J; Nwachukwu, C; Zheng, YL; Adedokun, B; Olopade, OI; Han, YJ				Poli, Elizabeth; Zhang, Jing; Nwachukwu, Chika; Zheng, Yonglan; Adedokun, Babatunde; Olopade, Olufunmilayo I.; Han, Yoo-Jeong			Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter	PLOS ONE			English	Article							DNA METHYLATION; TUMORS; MIR-29C; HYPERMETHYLATION; CARCINOMAS; PORTRAITS	Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.	[Poli, Elizabeth; Zhang, Jing; Nwachukwu, Chika; Zheng, Yonglan; Adedokun, Babatunde; Olopade, Olufunmilayo I.; Han, Yoo-Jeong] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Sect Hematol Oncol, Chicago, IL 60637 USA	University of Chicago	Han, YJ (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yjhan@medicine.bsd.uchicago.edu	Zheng, Yonglan/O-4112-2019	Zheng, Yonglan/0000-0001-6597-7072	Howard Hughes Medical Fellows Program; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; National Institute of Health-Specialized Program of Research Excellence in Breast Cancer [(P50 CA125183]; FOGARTY INTERNATIONAL CENTER [D43TW009112] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Howard Hughes Medical Fellows Program; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; National Institute of Health-Specialized Program of Research Excellence in Breast Cancer; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding to E. P. from Howard Hughes Medical Fellows Program, O. I. O. and Y.H from the Breast Cancer Research Foundation and the Ralph and Marion Falk Medical Research Trust. This research was also supported by the National Institute of Health-Specialized Program of Research Excellence in Breast Cancer (P50 CA125183 to OIO). OIO is American Cancer Society Clinical Research Professor.	American Cancer Society, 2013, BREAST CANC FACTS FI; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Barch MJ, 1997, AGT CYTOGENETICS LAB; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072287; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YW, 2014, GYNECOL ONCOL, V133, P340, DOI 10.1016/j.ygyno.2014.02.009; Jia HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088057; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nguyen T, 2011, EPIGENETICS-US, V6, P388, DOI 10.4161/epi.6.3.14056; Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Presneau N, 2013, BRIT J CANCER, V108, P964, DOI 10.1038/bjc.2012.518; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	40	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142224	10.1371/journal.pone.0142224	http://dx.doi.org/10.1371/journal.pone.0142224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539832	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800070
J	Sun, LJ; Wang, F; Liu, A; Xin, RL; Zhu, YX; Li, JW; Shao, Y; Ye, JZ; Chen, DQ; Li, ZC				Sun, Lijun; Wang, Fang; Liu, An; Xin, Ruolei; Zhu, Yunxia; Li, Jianwei; Shao, Ying; Ye, Jiangzhu; Chen, Danqing; Li, Zaicun			Natural Conception May Be an Acceptable Option in HIV-Serodiscordant Couples in Resource Limited Settings	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; ASSISTED REPRODUCTION; TRANSMISSION; CARE; INSEMINATION; CONCEIVE; DESIRE; KENYA; WOMEN	Many HIV serodiscordant couples have a strong desire to have their own biological children. Natural conception may be the only choice in some resource limited settings but data about natural conception is limited. Here, we reported our findings of natural conception in HIV serodiscordant couples. Between January 2008 and June 2014, we retrospectively collected data on 91 HIV serodiscordant couples presenting to Beijing Youan Hospital with childbearing desires. HIV counseling, effective ART on HIV infected partners, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) in negative female partners and timed intercourse were used to maximally reduce the risk of HIV transmission. Of the 91 HIV serodiscordant couples, 43 were positive in male partners and 48 were positive in female partners. There were 196 unprotected vaginal intercourses, 100 natural conception and 97 newborns. There were no cases of HIV seroconversion in uninfected sexual partners. Natural conception may be an acceptable option in HIV-serodiscordant couples in resource limited settings if HIV-positive individuals have undetectable viremia on HAART, combined with HIV counseling, PrEP, PEP and timed intercourse.	[Sun, Lijun; Liu, An; Li, Jianwei; Shao, Ying; Ye, Jiangzhu; Li, Zaicun] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing 100069, Peoples R China; [Wang, Fang] China CDC, Natl Ctr Women & Childrens Hlth, Beijing 100081, Peoples R China; [Xin, Ruolei] Beijing Ctr Prevent Med Res, Beijing 100013, Peoples R China; [Zhu, Yunxia] Capital Med Univ, Beijing Youan Hosp, Dept Gynecol, Beijing 100069, Peoples R China; [Chen, Danqing] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310006, Zhejiang, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Capital Medical University; Zhejiang University	Chen, DQ (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310006, Zhejiang, Peoples R China.	chendq@zju.edu.cn; cun521@vip.163.com	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of China [81273136]; Development and Application Research of Beijing AIDS Clinical Data and Sample Repository [D13110700530000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development and Application Research of Beijing AIDS Clinical Data and Sample Repository	This study was supported by the National Natural Science Foundation of China (81273136) and Development and Application Research of Beijing AIDS Clinical Data and Sample Repository (D13110700530000).	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bauni EK, 2000, STUD FAMILY PLANN, V31, P69, DOI 10.1111/j.1728-4465.2000.00069.x; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Louis B, 2007, EUR J OBSTET GYN R B, V135, P76, DOI 10.1016/j.ejogrb.2007.04.011; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gosselin JT, 2011, AIDS BEHAV, V15, P469, DOI 10.1007/s10461-010-9830-9; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Leggett Hadley, 2011, BETA, V23, P43; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Mandelbrot L, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61754-0; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; PoAGfAa A, 2013, GUIDELINES USE ANTIR; Transmission PoToH-IPWaPoP, 2014, REC US ANT DRUGS PRE; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127	23	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142085	10.1371/journal.pone.0142085	http://dx.doi.org/10.1371/journal.pone.0142085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540103	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800052
J	Telang, PR; Kalia, AK; Singh, MP				Telang, Pankaj R.; Kalia, Anup K.; Singh, Munindar P.			Modeling Healthcare Processes Using Commitments: An Empirical Evaluation	PLOS ONE			English	Article								The two primary objectives of this paper are: (a) to demonstrate how Comma, a business modeling methodology based on commitments, can be applied in healthcare process modeling, and (b) to evaluate the effectiveness of such an approach in producing healthcare process models. We apply the Comma approach on a breast cancer diagnosis process adapted from an HHS committee report, and presents the results of an empirical study that compares Comma with a traditional approach based on the HL7 Messaging Standard (Traditional-HL7). Our empirical study involved 47 subjects, and two phases. In the first phase, we partitioned the subjects into two approximately equal groups. We gave each group the same requirements based on a process scenario for breast cancer diagnosis. Members of one group first applied Traditional-HL7 and then Comma whereas members of the second group first applied Comma and then Traditional-HL7-each on the above-mentioned requirements. Thus, each subject produced two models, each model being a set of UML Sequence Diagrams. In the second phase, we repartitioned the subjects into two groups with approximately equal distributions from both original groups. We developed exemplar Traditional-HL7 and Comma models; we gave one repartitioned group our Traditional-HL7 model and the other repartitioned group our Comma model. We provided the same changed set of requirements to all subjects and asked them to modify the provided exemplar model to satisfy the new requirements. We assessed solutions produced by subjects in both phases with respect to measures of flexibility, time, difficulty, objective quality, and subjective quality. Our study found that Comma is superior to Traditional-HL7 in flexibility and objective quality as validated via Student's t-test to the 10% level of significance. Comma is a promising new approach for modeling healthcare processes. Further gains could be made through improved tooling and enhanced training of modeling personnel.	[Telang, Pankaj R.] Cisco Syst Inc, Durham, NC 27560 USA; [Kalia, Anup K.; Singh, Munindar P.] NC State Univ, Dept Comp Sci, Raleigh, NC USA	Cisco Systems Inc; University of North Carolina; North Carolina State University	Telang, PR (corresponding author), Cisco Syst Inc, Durham, NC 27560 USA.	ptelang@gmail.com	Singh, Munindar P/L-8500-2013	Singh, Munindar P/0000-0003-3599-3893	US Department of Defense through the NCSU Laboratory of Analytic Sciences; Cisco Systems Inc.	US Department of Defense through the NCSU Laboratory of Analytic Sciences; Cisco Systems Inc.	This research was partially supported by the US Department of Defense through the NCSU Laboratory of Analytic Sciences. There was no additional funding received for this study. Pankaj R. Telang (PRT) is employed by Cisco Systems Inc. Cisco Systems Inc. provided support in the form of salary for author PRT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Agrawal A, 2013, ARTIF INTELL MED, V58, P73, DOI 10.1016/j.artmed.2013.03.008; Andrighetto G., 2013, DAGSTUHL FOLLOW UPS, V4; [Anonymous], 2009, ISOHL7; [Anonymous], 2004, UML 2 0 SUPERSTRUCTU; ASPE, 2010, IMP RAD PATH COMM DI; Attie P. C., 1993, 19th International Conference on Very Large Data Bases Proceedings, P134; Baldoni M, 2014, AUTON AGENT MULTI-AG, V28, P519, DOI 10.1007/s10458-013-9233-1; Bresciani P, 2004, AUTON AGENT MULTI-AG, V8, P203, DOI 10.1023/B:AGNT.0000018806.20944.ef; Cass A. G., 2000, Proceedings of the 2000 International Conference on Software Engineering. ICSE 2000 the New Millennium, P754, DOI 10.1109/ICSE.2000.870488; Chen B, 2008, ICSE'08 PROCEEDINGS OF THE THIRTIETH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, P623, DOI 10.1145/1368088.1368175; Darimont R, 1997, PROC INT CONF SOFTW, P612, DOI 10.1145/253228.253499; Dignum V, 2004, MODEL ORG INTERACTIO; Fornara N., 2009, INT WORKSH DECL AG L, P101; Fornara Nicoletta, 2003, P 2 INT JOINT C AUT, P520, DOI DOI 10.1145/860575.860659; Fowler M, 2003, UML DISTILLED BRIEF; Fox J, 2004, STUD HEALTH TECHNOL, V101, P31; Grando A, 2010, J BIOMED INFORM, V43, P287, DOI 10.1016/j.jbi.2009.11.006; Grando MA, 2011, ARTIF INTELL MED, V53, P139, DOI 10.1016/j.artmed.2011.08.005; Hanachi C, 2012, LECT NOTES BUS INF P, V123, P63; Hinge K, 2010, INT J E-HEALTH MED C, V1, P24, DOI 10.4018/jehmc.2010040103; Hofreiter B, 2006, LECT NOTES COMPUT SC, V4231, P19; Juristo N, 2001, BASICS SOFTWARE ENG; Kalia Anup K., 2013, 2013 IEEE International Conference on Services Computing (SCC), P160, DOI 10.1109/SCC.2013.62; Kalia AK, 2012, P 11 INT C AUT AG MU, P1489; Lenz R, 2007, DATA KNOWL ENG, V61, P39, DOI 10.1016/j.datak.2006.04.007; Marengo Elisa, 2011, P 10 INT C AUT AG MU, V2, P467; Muller H, 2009, STUD HEALTH TECHNOL, V150, P210, DOI 10.3233/978-1-60750-044-5-210; OMG, 2011, BUS PROC MOD NOT BPM; Pesic M, 2007, LECT NOTES COMPUT SC, V4803, P77; Rovani M, 2014, BPM1411; Shakir AM, 2002, HLTH INFORMAT SER, P194; Singh M. P., 1999, Artificial Intelligence and Law, V7, P97, DOI 10.1023/A:1008319631231; Singh MP, 1996, PROC INT CONF DATA, P616, DOI 10.1109/ICDE.1996.492212; Singh MP, 2009, COMPUTER, V42, P72, DOI 10.1109/MC.2009.347; Singureanu I, 2008, HDF HL7 METHODOLOGY; Telang P.R., 2012, P 11 INT C AUT AG MU, V2, P1073; Telang PR, 2014, IEEE INTERNET COMPUT, V18, P46, DOI 10.1109/MIC.2013.86; Telang PR, 2012, IEEE T SERV COMPUT, V5, P305, DOI 10.1109/TSC.2011.4; Telang PR, 2015, LECT NOTES COMPUTER, P1; UMLSRReference Manual, 2009, UMLS REF MAN; van Riemsdijk MB, 2012, P PROGR SYST LANG AP, P119; Winikoff M, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY, PROCEEDINGS, P363, DOI 10.1109/IAT.2006.53; Zugal S, 2012, LECT NOTES BUS INF P, V107, P16	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141202	10.1371/journal.pone.0141202	http://dx.doi.org/10.1371/journal.pone.0141202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539985	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800011
J	Galetti, M; Camargo, H; Siqueira, T; Keuroghlian, A; Donatti, CI; Jorge, MLSP; Pedrosa, F; Kanda, CZ; Ribeiro, MC				Galetti, Mauro; Camargo, Hileia; Siqueira, Tadeu; Keuroghlian, Alexine; Donatti, Camila I.; Jorge, Maria Luisa S. P.; Pedrosa, Felipe; Kanda, Claudia Z.; Ribeiro, Milton C.			Diet Overlap and Foraging Activity between Feral Pigs and Native Peccaries in the Pantanal	PLOS ONE			English	Article							TAYASSU-TAJACU; FOREST; TERRESTRIAL; COMPETITION; BEHAVIOR; PECARI	Inter-specific competition is considered one of the main selective pressures affecting species distribution and coexistence. Different species vary in the way they forage in order to minimize encounters with their competitors and with their predators. However, it is still poorly known whether and how native species change their foraging behavior in the presence of exotic species, particularly in South America. Here we compare diet overlap of fruits and foraging activity period of two sympatric native ungulates (the white-lipped peccary, Tayassu pecari, and the collared peccary, Pecari tajacu) with the invasive feral pig (Sus scrofa) in the Brazilian Pantanal. We found high diet overlap between white-lipped peccaries and feral pigs, but low overlap between collared peccaries and feral pigs. Furthermore, we found that feral pigs may influence the foraging period of both native peccaries, but in different ways. In the absence of feral pigs, collared peccary activity peaks in the early evening, possibly allowing them to avoid white-lipped peccary activity peaks, which occur in the morning. In the presence of feral pigs, collared peccaries forage mostly in early morning, while white-lipped peccaries forage throughout the day. Our results indicate that collared peccaries may avoid foraging at the same time as white-lipped peccaries. However, they forage during the same periods as feral pigs, with whom they have lower diet overlap. Our study highlights how an exotic species may alter interactions between native species by interfering in their foraging periods.	[Galetti, Mauro; Camargo, Hileia; Siqueira, Tadeu; Ribeiro, Milton C.] Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil; [Keuroghlian, Alexine] Wildlife Conservat Soc, Campo Grande, MS, Brazil; [Donatti, Camila I.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Jorge, Maria Luisa S. P.] Vanderbilt Univ, Depatment Earth & Environm Sci, Nashville, TN 37235 USA; [Pedrosa, Felipe; Kanda, Claudia Z.] Univ Estadual Paulista, UNESP, Programa Posgrad Ecol & Biodiversidade, Sao Paulo, Brazil	Universidade Estadual Paulista; Conservation International; Vanderbilt University; Universidade Estadual Paulista	Galetti, M (corresponding author), Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Pedrosa, Felipe/N-7367-2019; Donatti, Camila/AAF-3605-2020; Siqueira, Tadeu/A-6978-2009; Kanda, Claudia Zukeran/O-4967-2016; Donatti, Camila I./AAV-2324-2020; Jorge, Maria Luisa/S-1164-2016; Galetti, Mauro/M-8751-2013	Siqueira, Tadeu/0000-0001-5069-2904; Kanda, Claudia Zukeran/0000-0003-1118-0759; Jorge, Maria Luisa/0000-0003-4264-5897; Galetti, Mauro/0000-0002-8187-8696	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/10154-7]; Earthwatch Institute volunteers; UNIDERP; Fundacao Manoel Barros; Conservation International -Brasil; York High School/Expedition Pantanal from Maine; Silicon Valley Community Foundation; Overbrook Foundation; WCS Brasil; CNPq; CAPES; Stanford University	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Earthwatch Institute volunteers; UNIDERP; Fundacao Manoel Barros; Conservation International -Brasil; York High School/Expedition Pantanal from Maine; Silicon Valley Community Foundation; Overbrook Foundation; WCS Brasil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Stanford University(Stanford University)	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant 2008/10154-7), Earthwatch Institute volunteers, UNIDERP, Fundacao Manoel Barros, Conservation International -Brasil, York High School/Expedition Pantanal from Maine, Silicon Valley Community Foundation, The Overbrook Foundation, and WCS Brasil for financial support.; We thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant 2008/10154-7), Earthwatch Institute volunteers, UNIDERP, Fundacao Manoel Barros, Conservation International - Brasil, York High School/Expedition Pantanal from Maine, Silicon Valley Community Foundation, The Overbrook Foundation, and WCS Brasil. Special thanks to Maria do Carmo A. Santos, Marion Marcondes, Ellen Wang, Ezidio (Baiano) and Celso Vicente for all their field assistance. We also thank Lucas Leuzinger, Marina Schweizer, Paulenir de Barros, Lourdes F. Gomes, Pedro Chaves, and Conservation International for allowing us to conduct our fieldwork at their farms. M. Galetti and M. Ribeiro receive a CNPq fellowship and H. Camargo received a PIBIC fellowship from CNPq. F. Pedrosa and C. Kandra receive a fellowship from CAPES and C. Donatti from Stanford University.	Agostinelli C., 2011, R PACKAGE CIRCULAR C; Alho CJR, 2011, BRAZ J BIOL, V71, P297, DOI 10.1590/S1519-69842011000200009; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; de Melo LFB, 2007, J ZOOL, V271, P27, DOI 10.1111/j.1469-7998.2006.00176.x; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; Chirichella R., 2014, BEHAV MANAGEMENT EUR, P110; da Silva CJ, 2001, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 2, P187; Desbiez ALJ, 2009, MAMMALIA, V73, P369, DOI 10.1515/MAMM.2009.049; Donatti C. I., 2007, Seed dispersal: theory and its application in a changing world, P104, DOI 10.1079/9781845931650.0104; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; FLEMING TH, 1979, AM ZOOL, V19, P1157; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fragoso JMV, 1999, J MAMMAL, V80, P993, DOI 10.2307/1383270; GALETTI M, 1993, BIOTROPICA, V25, P419, DOI 10.2307/2388865; Gotelli N.J., 1996, NULL MODELS ECOLOGY; ILSE LM, 1995, J MAMMAL, V76, P784, DOI 10.2307/1382747; Desbiez ALJ, 2011, ORYX, V45, P78, DOI 10.1017/S0030605310001304; Desbiez ALJ, 2009, J MAMMAL, V90, P119, DOI 10.1644/08-MAMM-A-038.1; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; Keuroghlian A, 2004, BIOL CONSERV, V120, P411, DOI 10.1016/j.biocon.2004.03.016; Keuroghlian A, 2008, BIOTROPICA, V40, P62, DOI 10.1111/j.1744-7429.2007.00351.x; Keuroghlian A, 2015, MAMMALIA, V79, P491, DOI 10.1515/mammalia-2014-0094; Keuroghlian Alexine, 2010, Suiform Soundings, V9, P24; Keuroghlian Alexine, 2009, Suiform Soundings, V8, P9; Keuroghlian A, 2009, BIODIVERS CONSERV, V18, P1733, DOI 10.1007/s10531-008-9554-6; KILTIE RA, 1982, BIOTROPICA, V14, P188, DOI 10.2307/2388025; LAWLOR LR, 1980, AM NAT, V116, P394, DOI 10.1086/283634; MITTERMEIER R A, 1990, Oryx, V24, P103; Nogueira SLG, 2009, BIODIVERS CONSERV, V18, P3677, DOI 10.1007/s10531-009-9680-9; Norris D, 2010, J MAMMAL, V91, P551, DOI 10.1644/09-MAMM-A-199.1; Oliveira-Santos LGR, 2011, J TROP ECOL, V27, P557, DOI 10.1017/S026646741100023X; Pedrosa F, 2015, NAT CONSERVACAO, V13, P84, DOI 10.1016/j.ncon.2015.04.005; Putman R. J., 1994, COMMUNITY ECOLOGY; Sicuro FL, 2002, J MAMMAL, V83, P207, DOI 10.1644/1545-1542(2002)083<0207:COPAFH>2.0.CO;2	35	35	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141459	10.1371/journal.pone.0141459	http://dx.doi.org/10.1371/journal.pone.0141459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536608	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400065
J	Arias-Palencia, NM; Solera-Martinez, M; Gracia-Marco, L; Silva, P; Martinez-Vizcaino, V; Canete-Garcia-Prieto, J; Sanchez-Lopez, M				Maria Arias-Palencia, Natalia; Solera-Martinez, Monserrat; Gracia-Marco, Luis; Silva, Pedro; Martinez-Vizcaino, Vicente; Canete-Garcia-Prieto, Jorge; Sanchez-Lopez, Mairena			Levels and Patterns of Objectively Assessed Physical Activity and Compliance with Different Public Health Guidelines in University Students	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; YOUNG-ADULTS; LIFE-STYLE; PREVALENCE; RECOMMENDATIONS; ADHERENCE; FITNESS; WEIGHT; ASSOCIATION; PREVENTION	Background Physical activity (PA) is associated with health enhancement. The aim of this study was to assess: 1) levels and patterns of PA in university students by using accelerometers; and 2) the percentage of fulfilment of PA recommendations for adults, according to different public health guidelines. Methods Observational cross-sectional study (Cuenca's Adults Study) involving 296 (206 women) healthy Spanish university students aged 18-25 years old. Participants wore the ActiGraph GT1M accelerometer for seven consecutive days. Total PA, steps and time spent in sedentary time, light, moderate, vigorous, and moderate to vigorous PA (MVPA) was assessed, and the prevalence of sufficient PA was calculated according to various public health guidelines. Results No sex differences in total PA were found. University students were more sedentary during weekend days than weekdays (p<0.05). Only 30.3% of participants accumulated 30 min/day at least five days a week of MVPA. A total of 5.4% of students met the recommendation of 150 min/week of MVPA or 75 min/week of vigorous PA, in PA bouts of at least 10 min. using the same definition, but on five or more days a week, only 0.5% students were found to meet the recommendation. In addition, only 0.5% of students met the recommendation of 30 min/day of MVPA, at least five days a week and in bouts of at least 10 min. Finally, 28.1% of the students met the recommendation of 10,000 steps/day. Conclusions Our study shows a high incidence of sedentary time in university students. The number of students meeting PA recommendations significantly differed depending on the recommendation proposed. Specific strategies to promote PA in this population are necessary as well as an agreement as to which PA guidelines should be used.	[Maria Arias-Palencia, Natalia; Solera-Martinez, Monserrat; Martinez-Vizcaino, Vicente; Canete-Garcia-Prieto, Jorge; Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Hlth & Social Res Ctr, Castilla La Mancha, Cuenca, Spain; [Maria Arias-Palencia, Natalia] Univ Castilla La Mancha, Fac Educ, Castilla La Mancha, Cuenca, Spain; [Solera-Martinez, Monserrat] Univ Castilla La Mancha, Fac Occupat Therapy Speech Therapy & Nursing, Castilla La Mancha, Cuenca, Spain; [Gracia-Marco, Luis] Univ Exeter, CHERC Sport & Hlth Sci, Exeter, Devon, England; [Gracia-Marco, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Silva, Pedro] Univ Porto, Fac Sport, Res Ctr Phys Act Hlth & Leisure, P-4100 Oporto, Portugal; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile; [Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Fac Educ, E-13071 Ciudad Real, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Exeter; University of Zaragoza; Universidade do Porto; Universidad Autonoma de Chile; Universidad de Castilla-La Mancha	Sanchez-Lopez, M (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Castilla La Mancha, Cuenca, Spain.	Mairena.Sanchez@uclm.es	Gracia-Marco, Luis/A-8845-2018; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Gracia-Marco, Luis/R-4899-2019; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; Palencia, Natalia María Arias/Q-5070-2017; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016	Gracia-Marco, Luis/0000-0002-4020-0256; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Gracia-Marco, Luis/0000-0002-4020-0256; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Palencia, Natalia María Arias/0000-0001-5004-3197; Sanchez Lopez, Mairena/0000-0002-0217-0623	Fundacion para la Investigacion Sanitaria (Health Research Foundation) in Castilla-La Mancha, Spain (FISCAM) [AN/2008/31]; Ministry of Health and Consumer Affairs, Instituto de Salud Carlos III, Red de Investigacion en Actividades Preventivas y de Promocion de Salud (Network for Research in Preventive Activities and Health Promotion) [RD12/0005/0009]	Fundacion para la Investigacion Sanitaria (Health Research Foundation) in Castilla-La Mancha, Spain (FISCAM); Ministry of Health and Consumer Affairs, Instituto de Salud Carlos III, Red de Investigacion en Actividades Preventivas y de Promocion de Salud (Network for Research in Preventive Activities and Health Promotion)	This study has been funded by the Fundacion para la Investigacion Sanitaria (Health Research Foundation) in Castilla-La Mancha, Spain (FISCAM; ref. AN/2008/31) and the Ministry of Health and Consumer Affairs, Instituto de Salud Carlos III, Red de Investigacion en Actividades Preventivas y de Promocion de Salud (Network for Research in Preventive Activities and Health Promotion) (ref. RD12/0005/0009).	Anderssen N, 1996, AM J EPIDEMIOL, V143, P351, DOI 10.1093/oxfordjournals.aje.a008749; Serrano-Sanchez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038693; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Bertrais S, 2004, AM J PUBLIC HEALTH, V94, P1560, DOI 10.2105/AJPH.94.9.1560; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Chastin SFM, 2009, EUR J APPL PHYSIOL, V106, P893, DOI 10.1007/s00421-009-1090-x; Colley RC, 2011, HLTH REP, V22, P7; Dinger MK, 2003, AM HLTH STUD, V18; Dyck DV, 2014, INT J OBES LOND; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garriguet D, 2012, HEALTH REP, V23, P27; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Irwin JD, 2004, PERCEPT MOTOR SKILL, V98, P927; JAKICIC JM, 1995, INT J OBESITY, V19, P893; Keating XFD, 2005, J AM COLL HEALTH, V54, P116, DOI 10.3200/JACH.54.2.116-126; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lee PH, 2013, PUBLIC HEALTH NUTR, V16, P1436, DOI 10.1017/S1368980012003631; Lopez-Martinez S, 2013, INT J SPORT NUTR EXE, V23, P312, DOI 10.1123/ijsnem.23.4.312; Loprinzi PD, 2013, AM J HEALTH PROMOT, V27, P143, DOI 10.4278/ajhp.110916-QUAN-348; Luke A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-397; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Meseguer CM, 2009, REV ESP CARDIOL, V62, P1125, DOI 10.1016/S0300-8932(09)72381-4; Molina-Garcia J, 2011, PSYCHOL REP, V109, P453, DOI 10.2466/06.10.13.PR0.109.5.453-460; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Ortiz-Galeano I, 2012, REV CLIN ESP, V212, P287, DOI 10.1016/j.rce.2012.03.008; Ortiz-Galeano I, 2012, REV ESP SALUD PUBLIC, V86, P523, DOI 10.4321/S1135-57272012000500006; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Peters TM, 2010, AM J PREV MED, V38, P583, DOI 10.1016/j.amepre.2010.02.012; Rissel C, 2013, INT J ENV RES PUB HE, V10, P3563, DOI 10.3390/ijerph10083563; Rodriguez-Romo G, 2011, REV ESP SALUD PUBLIC, V85, P351, DOI [10.1590/S1135-57272011000400004, 10.1590/s1135-57272011000400004]; Romaguera D, 2011, J SPORT SCI, V29, P989, DOI 10.1080/02640414.2011.578149; Scheers T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-136; Sisson SB, 2008, OBES REV, V9, P606, DOI 10.1111/j.1467-789X.2008.00506.x; Spring B, 2014, CIRCULATION, V130, P10, DOI 10.1161/CIRCULATIONAHA.113.005445; Strath Scott J, 2008, Prev Chronic Dis, V5, pA131; Telama R, 2000, MED SCI SPORT EXER, V32, P1617; Thompson D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004337; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Varela-Mato V, 2012, INT J ENV RES PUB HE, V9, P2728, DOI 10.3390/ijerph9082728; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	51	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141977	10.1371/journal.pone.0141977	http://dx.doi.org/10.1371/journal.pone.0141977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536605	gold, Green Published			2022-12-27	WOS:000364298400110
J	Ni, ZQ; Zhou, LX; Li, X; Zhang, J; Dong, SL				Ni, Zhongqiu; Zhou, Lanxia; Li, Xu; Zhang, Jing; Dong, Shouliang			Tetrazine-Containing Amino Acid for Peptide Modification and Live Cell Labeling	PLOS ONE			English	Article							DIELS-ALDER REACTIONS; SUBSTANCE-P; TRANS-CYCLOOCTENES; MAMMALIAN-CELLS; CANCER-CELLS; LIGATION; REACTIVITY; PROTEINS; CYCLOADDITIONS; DIENOPHILE	A novel amino acid derivative 3-(4-(1, 2, 4, 5-tetrazine-3-yl) phenyl)-2-aminopropanoic acid was synthesized in this study. The compound possessed better water-solubility and was synthesized more easily compared with the well-known and commercially available 3-(p-benzylamino)-1, 2, 4, 5-tetrazine. Tetrazine-containing amino acid showed excellent stability in biological media and might be used for cancer cell labeling. Moreover, the compound remained relatively stable in 50% TFA/DCM with little decomposition after prolonged exposure at room temperature. The compound could be utilized as phenylalanine or tyrosine analogue in peptide modification, and the tetrazine-containing peptide demonstrated more significant biological activity than that of the parent peptide. The combination of tetrazine group and amino acid offered broad development prospects of the bioorthogonal labeling and peptide synthesis.	[Ni, Zhongqiu; Li, Xu; Zhang, Jing; Dong, Shouliang] Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China; [Zhou, Lanxia] Lanzhou Univ, Affiliated Hosp 1, Core Lab, Lanzhou 730000, Peoples R China; [Zhou, Lanxia] Lanzhou Univ, Key Lab Gastrointestinal Dis, Lanzhou 730000, Peoples R China; [Dong, Shouliang] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Dong, SL (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China.	dongsl@lzu.edu.cn			Fundamental Research Funds for the Central Universities [lzujbky-2013-154]; Health Industry Research Project of Gansu Province [GWGL2014-54]; Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province [gswcky-2012-006]; National Natural Science Foundation of China [30870526]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Health Industry Research Project of Gansu Province; Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (lzujbky-2013-154), Health Industry Research Project of Gansu Province (GWGL2014-54), partially the Foundation of Key Laboratory for Gastrointestinal Diseases of Gansu Province (gswcky-2012-006), and the grant from National Natural Science Foundation of China (No. 30870526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAR J, 1983, TETRAHEDRON LETT, V24, P1481, DOI 10.1016/S0040-4039(00)81687-1; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Borrmann A, 2012, CHEMBIOCHEM, V13, P2094, DOI 10.1002/cbic.201200407; BURY RW, 1976, J MED CHEM, V19, P854, DOI 10.1021/jm00228a028; Canalle LA, 2010, CHEM SOC REV, V39, P329, DOI 10.1039/b807871h; COUTURE R, 1982, PHARMACOLOGY, V24, P1, DOI 10.1159/000137572; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233; Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446; INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X; Jiang JB, 2013, CHEM-EUR J, V19, P17679, DOI 10.1002/chem.201303290; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Li H, 2011, PROG CRYST GROWTH CH, V57, P117, DOI 10.1016/j.pcrysgrow.2011.10.006; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; LUNDBERG JM, 1984, ACTA PHYSIOL SCAND, V120, P217, DOI 10.1111/j.1748-1716.1984.tb00127.x; Niederwieser A, 2013, ANGEW CHEM INT EDIT, V52, P4265, DOI 10.1002/anie.201208991; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Park S, 2011, CARBON, V49, P3019, DOI 10.1016/j.carbon.2011.02.071; Pipkorn R, 2009, J PEPT SCI, V15, P235, DOI 10.1002/psc.1108; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sauer J, 1998, EUR J ORG CHEM, V1998, P2885; Schneider S, 2013, CHEMBIOCHEM, V14, P2114, DOI 10.1002/cbic.201300435; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Selvaraj R, 2013, CURR OPIN CHEM BIOL, V17, P753, DOI 10.1016/j.cbpa.2013.07.031; SIEBER P, 1987, TETRAHEDRON LETT, V28, P2107, DOI 10.1016/S0040-4039(00)96055-6; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Tucker MJ, 2010, ANGEW CHEM INT EDIT, V49, P3612, DOI 10.1002/anie.201000500; Vrabel M, 2013, CHEM-EUR J, V19, P13309, DOI 10.1002/chem.201301838; Zhang WH, 2013, CURR OPIN STRUC BIOL, V23, P581, DOI 10.1016/j.sbi.2013.06.009	36	14	14	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141918	10.1371/journal.pone.0141918	http://dx.doi.org/10.1371/journal.pone.0141918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536589	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400101
J	Coker, DJ; Hoey, AS; Wilson, SK; Depczynski, M; Graham, NAJ; Hobbs, JPA; Holmes, TH; Pratchett, MS				Coker, Darren J.; Hoey, Andrew S.; Wilson, Shaun K.; Depczynski, Martial; Graham, Nicholas A. J.; Hobbs, Jean-Paul A.; Holmes, Thomas H.; Pratchett, Morgan S.			Habitat Selectivity and Reliance on Live Corals for Indo-Pacific Hawkfishes (Family: Cirrhitidae)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SOCIAL-ORGANIZATION; REPRODUCTIVE-BEHAVIOR; FISHES; DEGRADATION; EVOLUTION; PREDATION; SPECIALIZATION; SUSCEPTIBILITY; DISTURBANCES	Hawkfishes (family: Cirrhitidae) are small conspicuous reef predators that commonly perch on, or shelter within, the branches of coral colonies. This study examined habitat associations of hawkfishes, and explicitly tested whether hawkfishes associate with specific types of live coral. Live coral use and habitat selectivity of hawkfishes was explored at six locations from Chagos in the central Indian Ocean extending east to Fiji in the Pacific Ocean. A total of 529 hawkfishes from seven species were recorded across all locations with 63% of individuals observed perching on, or sheltering within, live coral colonies. Five species (all except Cirrhitus pinnulatus and Cirrhitichthys oxycephalus) associated with live coral habitats. Cirrhitichthys falco selected for species of Pocillopora while Paracirrhites arcatus and P. forsteri selected for both Pocillopora and Acropora, revealing that these habitats are used disproportionately more than expected based on the local cover of these coral genera. Habitat selection was consistent across geographic locations, and species of Pocillopora were the most frequently used and most consistently selected even though this coral genus never comprised more than 6% of the total coral cover at any of the locations. Across locations, Paracirrhites arcatus and P. forsteri were the most abundant species and variation in their abundance corresponded with local patterns of live coral cover and abundance of Pocilloporid corals, respectively. These findings demonstrate the link between small predatory fishes and live coral habitats adding to the growing body of literature highlighting that live corals (especially erect branching corals) are critically important for sustaining high abundance and diversity of fishes on coral reefs.	[Coker, Darren J.; Hoey, Andrew S.; Graham, Nicholas A. J.; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Coker, Darren J.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Wilson, Shaun K.; Depczynski, Martial; Holmes, Thomas H.] Univ Western Australia, Oceans Inst, Crawley, Australia; [Wilson, Shaun K.; Holmes, Thomas H.] Dept Pk & Wildlife, Marine Sci Program, Perth, WA, Australia; [Depczynski, Martial] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, Australia; [Graham, Nicholas A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	James Cook University; King Abdullah University of Science & Technology; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Lancaster University; Curtin University	Coker, DJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Darren.coker@kaust.edu.sa	Hoey, Andrew S/B-5457-2015; Pratchett, Morgan/AAW-5179-2020; Graham, Nicholas AJ/C-8360-2014; Pratchett, Morgan S/A-9256-2010; Hobbs, Jean-Paul/I-8743-2012; depczynski, martial/B-7689-2008	Pratchett, Morgan/0000-0002-1862-8459; Graham, Nicholas AJ/0000-0002-0304-7467; Pratchett, Morgan S/0000-0002-1862-8459; Hobbs, Jean-Paul/0000-0003-0331-354X; depczynski, martial/0000-0001-8723-0076; Hoey, Andrew/0000-0002-4261-5594; Wilson, Shaun/0000-0002-4590-0948	ARC Centre of Excellence for Coral Reef Studies; Natural Environment Research Council [ceh010010] Funding Source: researchfish	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	THis work was supported by the ARC Centre of Excellence for Coral Reef Studies. MSP received the finds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2003, REEF FISH IDENTIFICA; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; COLES SL, 1980, MAR ECOL PROG SER, V2, P281, DOI 10.3354/meps002281; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 1996, COPEIA, P362, DOI 10.2307/1446852; DeMartini EE, 1996, B MAR SCI, V58, P826; DONALDSON TJ, 1990, JPN J ICHTHYOL, V36, P439, DOI 10.1007/BF02905464; DONALDSON TJ, 1989, ENVIRON BIOL FISH, V24, P295, DOI 10.1007/BF00001403; DONALDSON TJ, 1987, B MAR SCI, V41, P531; DONALDSON TJ, 1986, JPN J ICHTHYOL, V33, P329, DOI 10.1007/BF02904172; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FOWLER AJ, 1987, CORAL REEFS, V6, P49, DOI 10.1007/BF00302212; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hanski I, 1993, 3 EXPLANATIONS POSIT, P108; Hiatt R. H., 1960, Ecological Monographs, V30, P65, DOI 10.2307/1942181; HOBSON ES, 1974, FISH B-NOAA, V72, P915; HOBSON ES, 1994, ENVIRON BIOL FISH, V40, P49, DOI 10.1007/BF00002182; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kadota T, 2011, ENVIRON BIOL FISH, V92, P79, DOI 10.1007/s10641-011-9817-z; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Manly B.F.J., 2002, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Morin PJ, 2011, COMMUNITY ECOLOGY, 2ND EDITION, P1, DOI 10.1002/9781444341966; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, 2000, ENVIRON BIOL FISH, V58, P355, DOI 10.1023/A:1007689314926; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Myers RF, 1989, CORAL GRAPHICS GUAM; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; PIMM SL, 1981, OIKOS, V37, P1, DOI 10.2307/3544067; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; RCore Team, 2020, R LANG ENV STAT COMP; Rosenzweig ML, 1997, EVOL ECOL, V11, P733, DOI 10.1023/A:1018490419885; SADOVY Y, 1995, ENVIRON BIOL FISH, V42, P143, DOI 10.1007/BF00001992; SALE PF, 1971, COPEIA, P324; Schmitt RJ, 2009, ECOLOGY, V90, P2434, DOI 10.1890/08-1225.1; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; SMITH EP, 1982, ECOLOGY, V63, P1675, DOI 10.2307/1940109; Stella JS, 2010, CORAL REEFS, V29, P957, DOI 10.1007/s00338-010-0648-8; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185	62	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0138136	10.1371/journal.pone.0138136	http://dx.doi.org/10.1371/journal.pone.0138136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529406	Green Published, Green Accepted, gold			2022-12-27	WOS:000364032600002
J	Harris, C; Abubeker, S; Yu, MM; Leskey, T; Zhang, AJ				Harris, Christina; Abubeker, Sitra; Yu, Mengmeng; Leskey, Tracy; Zhang, Aijun			Semiochemical Production and Laboratory Behavior Response of the Brown Marmorated Stink Bug, Halyomorpha Halys	PLOS ONE			English	Article							SUBSTRATE-BORNE SIGNALS; SEX-PHEROMONE; HETEROPTERA-PENTATOMIDAE; AGGREGATION PHEROMONE; MOTH; IDENTIFICATION; COMMUNICATION; ATTRACTION; HEMIPTERA	Background The brown marmorated stink bug (BMSB) is an exotic insect pest that was first recognized in the United States in 2001. As of today, it has been found in more than 42 states. BMSB has a very broad host plant range and damage to crops in mid-Atlantic States has reached a critical level. A reliable and accurate tool for infestation detection and population monitoring is urgently needed to provide better and more timely interventions. Pheromones produced by male BMSB have been previously identified and are currently used in BMSB infestation detection. However, the conditions affecting BMSB production of these pheromones were unknown. Methodology/Principal Findings In this study, we collected headspace volatiles from male BMSB under laboratory conditions, measured the temporal patterns of release of these pheromones, and assayed the attractiveness to conspecifics. In addition to the pheromone components, tridecane (C13) and E-2-decenal (an alarm compound) were observed in headspace collections of males, as well as in females and nymphs. Exposure of pheromone-emitting adult males to synthetic C13 greatly reduced pheromone emission. Conclusions/Significance This information should lead to a better understanding of the biology, physiology, and chemical ecology of BMSB, which will help scientists and growers develop more efficient strategies based on natural products to manage BMSB population, therefore, reducing pesticide usage and protecting the crops from BMSB damage.	[Harris, Christina; Abubeker, Sitra; Yu, Mengmeng; Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD 20705 USA; [Harris, Christina] Virginia Tech Univ, Dept Entomol, Blacksburg, VA 24060 USA; [Leskey, Tracy] ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA	United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Zhang, AJ (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD 20705 USA.	aijun.zhang@ars.usda.gov			USDA	USDA(United States Department of Agriculture (USDA))	This research was fully funded by USDA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JR, 2009, FLA ENTOMOL, V92, P483, DOI 10.1653/024.092.0310; Aldrich JR, 2007, J CHEM ECOL, V33, P801, DOI 10.1007/s10886-007-9270-9; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; BAKER TC, 1979, J INSECT PHYSIOL, V25, P943, DOI 10.1016/0022-1910(79)90107-0; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; KAWADA H, 1983, APPL ENTOMOL ZOOL, V18, P234, DOI 10.1303/aez.18.234; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Krupke CH, 2006, ANN ENTOMOL SOC AM, V99, P169, DOI 10.1603/0013-8746(2006)099[0169:DPOECH]2.0.CO;2; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Leskey TC, 2012, J ENTOMOL SCI, V47, P76; Levi-Zada A, 2014, J CHEM ECOL, V40, P236, DOI 10.1007/s10886-014-0391-7; McBrien HL, 2001, J CHEM ECOL, V27, P1821, DOI 10.1023/A:1010460709535; MORIYA S, 1984, APPL ENTOMOL ZOOL, V19, P317, DOI 10.1303/aez.19.317; Nielsen AL, 2008, J ECON ENTOMOL, V101, P1439, DOI 10.1603/0022-0493(2008)101[1439:TOITHH]2.0.CO;2; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; PRESTWICH GD, 1990, J CHEM ECOL, V16, P1761, DOI 10.1007/BF01020493; Ryan MF., 2002, INSECT CHEMORECEPTIO, P113, DOI DOI 10.1007/0-306-47581-2; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; Zahn DK, 2008, J CHEM ECOL, V34, P238, DOI 10.1007/s10886-007-9415-x; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101; ZHANG AJ, 1994, J CHEM ECOL, V20, P2415, DOI 10.1007/BF02033210; Zunic A, 2008, ANN ENTOMOL SOC AM, V101, P1169, DOI 10.1603/0013-8746-101.6.1169	25	30	30	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140876	10.1371/journal.pone.0140876	http://dx.doi.org/10.1371/journal.pone.0140876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528717	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600016
J	Marchant, I; Boissel, JP; Nony, P; Gueyffier, F				Marchant, Ivanny; Boissel, Jean-Pierre; Nony, Patrice; Gueyffier, Francois			High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EUROPEAN GUIDELINES; CLINICAL-PRACTICE; HEALTH-CARE; FRAMINGHAM; SCORE; ENGINE; METAANALYSIS; POPULATION; VALIDATION	Objective To examine the performances of an alternative strategy to decide initiating BP-lowering drugs called Proportional Benefit (PB). It selects candidates addressing the inequity induced by the high-risk approach since it distributes the gains proportionally to the burden of disease by genders and ages. Study Design and Setting Mild hypertensives from a Realistic Virtual Population by genders and 10-year age classes (range 35-64 years) received simulated treatment over 10 years according to the PB strategy or the 2007 ESH/ESC guidelines (ESH/ESC). Primary outcomes were the relative lifeyear gain (life-years gained-to-years of potential life lost ratio) and the number needed to treat to gain a life-year. A sensitivity analysis was performed to assess the impact of changes introduced by the ESH/ESC guidelines appeared in 2013 on these outcomes. Results The 2007 ESH/ESC relative life-year gains by ages were 2%; 10%; 14% in men, and 0%; 2%; 11% in women, this gradient being abolished by the PB (relative gain in all categories = 10%), while preserving the same overall gain in life-years. The redistribution of benefits improved the profile of residual events in younger individuals compared to the 2007 ESH/ESC guidelines. The PB strategy was more efficient (NNT = 131) than the 2013 ESH/ESC guidelines, whatever the level of evidence of the scenario adopted (NNT = 139 and NNT = 179 with the evidence-based scenario and the opinion-based scenario, respectively), although the 2007 ESH/ESC guidelines remained the most efficient strategy (NNT = 114). Conclusion The Proportional Benefit strategy provides the first response ever proposed against the inequity of resource use when treating highest risk people. It occupies an intermediate position with regards to the efficiency expected from the application of historical and current ESH/ESC hypertension guidelines. Our approach allows adapting recommendations to the risk and resources of a particular country.	[Marchant, Ivanny] Univ Valparaiso, Escuela Med, Valparaiso, Chile; [Boissel, Jean-Pierre] NovaDiscovery, Biomodelling Dept, Lyon, France; [Nony, Patrice; Gueyffier, Francois] CNRS, Lab Biometrie & Biol Evolut, Serv Pharmacol Clin & Essais Therapeut, UMR 5558, Lyon, France; [Gueyffier, Francois] INSERM, EPICIME, CIC 201, F-69008 Lyon, France; [Gueyffier, Francois] CHU Lyon, Hop L Pradel, Lyon, France	Universidad de Valparaiso; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Marchant, I (corresponding author), Univ Valparaiso, Escuela Med, Valparaiso, Chile.	ivanny.marchant@uv.cl	Gueyffier, François/B-8545-2008	Gueyffier, François/0000-0002-9921-0977	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile [11110399]; Agence Nationale de la Recherche France [SYSCOMM 002]; NovaDiscovery	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Agence Nationale de la Recherche France(French National Research Agency (ANR)); NovaDiscovery	This study was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT Iniciacion a la investigacion at CONICYT Chile [11110399] (http://www.conicyt.cl/fondecyt/), and the Agence Nationale de la Recherche France [SYSCOMM 002] (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NovaDiscovery provided support in the form of a salary for author JPB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Almeda-Valdes P, 2010, CURR DIABETES REV, V6, P1, DOI 10.2174/157339910790442646; [Anonymous], 2010, INSEE POPULATION EVO; [Anonymous], WHO DEF OLD ELD PERS; Athanasakis K, 2012, J HYPERTENS, V30, P227, DOI 10.1097/HJH.0b013e32834d9f18; Boissel JP, 2011, PERS MED, V8, P581, DOI [10.2217/pme.11.54, 10.2217/PME.11.54]; Capewell S, 2009, AM J EPIDEMIOL, V170, P229, DOI 10.1093/aje/kwp150; Claxton K, 2011, HEALTH ECON, V20, P2, DOI 10.1002/hec.1612; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; Coleman RL, 2012, DIABETES, V61, pA103; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Earnshaw J, 2008, PHARMACOECONOMICS, V26, P725, DOI 10.2165/00019053-200826090-00002; Erhardt LR, 2006, ATHEROSCLEROSIS, V185, P12, DOI 10.1016/j.atherosclerosis.2005.10.001; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Granstrom O, 2012, CLINICOECONOMIC OUTC, V4, P313, DOI 10.2147/CEOR.S35824; Gravelle H, 2007, HEALTH ECON, V16, P307, DOI 10.1002/hec.1168; Gueyffier F, 1996, J HUM HYPERTENS, V10, P1; Guzder RN, 2005, DIABETIC MED, V22, P554, DOI 10.1111/j.1464-5491.2005.01494.x; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Kahn R, 2008, DIABETES CARE, V31, P1686, DOI 10.2337/dc08-9022; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Liew SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000728; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marchant I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017508; Marchant I, 2009, EUR J CARDIOV PREV R, V16, P609, DOI 10.1097/HJR.0b013e32832da006; Nord E, 2011, HEALTH ECON, V20, P16, DOI 10.1002/hec.1687; PAHO's Area of Health Analysis and Information Systems (AIS), 2003, Epidemiol Bull, V24, P1; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; R Core Team, 2021, R LANGUAGE ENV STAT; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sozou PD, 2009, P R SOC B, V276, P2955, DOI 10.1098/rspb.2009.0401; SPIEGELHALTER DJ, 1992, BRIT MED J, V305, P1205, DOI 10.1136/bmj.305.6863.1205; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Thomopoulos C, 2014, J HYPERTENS, V32, P2305, DOI 10.1097/HJH.0000000000000380; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Torgerson DJ, 1999, BRIT MED J, V319, P914, DOI 10.1136/bmj.319.7214.914; van der Heijden AAWA, 2009, DIABETES CARE, V32, P2094, DOI 10.2337/dc09-0745	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140793	10.1371/journal.pone.0140793	http://dx.doi.org/10.1371/journal.pone.0140793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529507	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600013
J	Richardson, MF; Sherman, CDH				Richardson, Mark F.; Sherman, Craig D. H.			De Novo Assembly and Characterization of the Invasive Northern Pacific Seastar Transcriptome	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; MUSSELS GENUS MYTILUS; TRANSPOSABLE ELEMENTS; RAPID TRANSCRIPTOME; POPULATION GENOMICS; ASTERIAS-AMURENSIS; ERROR-CORRECTION; HEAT-STRESS; RNA-SEQ; CD-HIT	Invasive species are a major threat to global biodiversity but can also serve as valuable model systems to examine important evolutionary processes. While the ecological aspects of invasions have been well documented, the genetic basis of adaptive change during the invasion process has been hampered by a lack of genomic resources for the majority of invasive species. Here we report the first larval transcriptomic resource for the Northern Pacific Seastar, Asterias amurensis, an invasive marine predator in Australia. Approximately 117.5 million 100 base-pair (bp) paired-end reads were sequenced from a single RNA-Seq library from a pooled set of full-sibling A. amurensis bipinnaria larvae. We evaluated the efficacy of a pre-assembly error correction pipeline on subsequent de novo assembly. Error correction resulted in small but important improvements to the final assembly in terms of mapping statistics and core eukaryotic genes representation. The error-corrected de novo assembly resulted in 115,654 contigs after redundancy clustering. 41,667 assembled contigs were homologous to sequences from NCBI's non-redundant protein and Uni-Prot databases. We assigned Gene Ontology, KEGG Orthology, Pfam protein domain terms and predicted protein-coding sequences to > 36,000 contigs. The final transcriptome dataset generated here provides functional information for 18,319 unique proteins, comprising at least 11,355 expressed genes. Furthermore, we identified 9,739 orthologs to P. miniata proteins, evaluated our annotation pipeline and generated a list of 150 candidate genes for responses to several environmental stressors that may be important for adaptation of A. amurensis in the invasive range. Our study has produced a large set of A. amurensis RNA contigs with functional annotations that can serve as a resource for future comparisons to other echinoderm transcriptomes and gene expression studies. Our data can be used to study the genetic basis of adaptive change and other important evolutionary processes during a successful invasion.	[Richardson, Mark F.] Deakin Univ, Geelong, Vic 3217, Australia; Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3220, Australia	Deakin University	Richardson, MF (corresponding author), Deakin Univ, Geelong, Vic 3217, Australia.	m.richardson@deakin.edu.au	Sherman, Craig/A-2484-2010	Sherman, Craig/0000-0003-2099-0462	Holsworth Wildlife Research Endowment Award [RM23514]; Centre for Integrative Ecology (Deakin University); Deakin University International Postgraduate Research Scholarship	Holsworth Wildlife Research Endowment Award; Centre for Integrative Ecology (Deakin University); Deakin University International Postgraduate Research Scholarship	Research was supported by a Holsworth Wildlife Research Endowment Award (RM23514) and funding from the Centre for Integrative Ecology (Deakin University). MFR is supported by a Deakin University International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhoff M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S1; Arthofer W, 2015, MOL ECOL RESOUR, V15, P228, DOI 10.1111/1755-0998.12340; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barron MG, 2014, ANNU REV GENET, V48, P561, DOI 10.1146/annurev-genet-120213-092359; Bock DG, 2014, MOL ECOL; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; BRUCE BD, 1995, LAB FIELD STUDIES LA; BYRNE M, 1992, MAR BIOL, V114, P297, DOI 10.1007/BF00349533; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chu JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-149; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gillard GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-45; Goggin LC., 1998, P M BIOL MAN INTR SE; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harms L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-789; Hou R., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021560, DOI 10.1371/J0URNAL.P0NE.0021560]; Ioannidis P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-738; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashenko SD., 2005, RUSS J MAR BIOL, V31, P294, DOI [10.1007/s11179-005-0091-9, DOI 10.1007/S11179-005-0091-9]; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolbe JJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P92, DOI 10.1086/672157; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Logan CA, 2011, AM J PHYSIOL-REG I, V300, pR1373, DOI 10.1152/ajpregu.00689.2010; MacManes MD, 2013, PEERJ, V1, DOI 10.7717/peerj.113; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mateo L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004560; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nourisson C, 2014, MOL ECOLOGY RESOURCE, DOI [10.5061/dryad, DOI 10.5061/DRYAD]; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Prentis P, 2008, TRENDS PLANT SCI, V13, P1360; Rollins LA, 2015, MOL ECOL, V24, P2264, DOI 10.1111/mec.13184; Rollins LA, 2013, ECOL EVOL, V3, P4501, DOI 10.1002/ece3.824; Ross DJ, 2006, ESTUAR COAST SHELF S, V67, P695, DOI 10.1016/j.ecss.2005.11.038; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaw TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048472; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stapley J, 2015, MOL ECOL, V24, P2241, DOI 10.1111/mec.13089; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tu Q, 2014, DEV BIOL, V385, P160, DOI 10.1016/j.ydbio.2013.11.019; Tulin S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-16; Vandepitte K, 2014, MOL ECOL, V23, P2157, DOI 10.1111/mec.12683; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	70	12	12	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142003	10.1371/journal.pone.0142003	http://dx.doi.org/10.1371/journal.pone.0142003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529321	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600091
J	Swartzwelder, HS; Acheson, SK; Miller, KM; Sexton, HG; Liu, W; Crews, FT; Risher, ML				Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Liu, Wen; Crews, Fulton T.; Risher, Mary-Louise			Adolescent Intermittent Alcohol Exposure: Deficits in Object Recognition Memory and Forebrain Cholinergic Markers	PLOS ONE			English	Article							ETHANOL EXPOSURE; HIPPOCAMPAL NEUROGENESIS; PERSISTENT LOSS; ADULT; RATS; CONSUMPTION; NEURONS; LESIONS; IMPACT; CORTEX	The long-term effects of intermittent ethanol exposure during adolescence (AIE) are of intensive interest and investigation. The effects of AIE on learning and memory and the neural functions that drive them are of particular interest as clinical findings suggest enduring deficits in those cognitive domains in humans after ethanol abuse during adolescence. Although studies of such deficits after AIE hold much promise for identifying mechanisms and therapeutic interventions, the findings are sparse and inconclusive. The present results identify a specific deficit in memory function after AIE and establish a possible neural mechanism of that deficit that may be of translational significance. Male rats (starting at PND-30) received exposure to AIE (5g/kg, i.g.) or vehicle and were allowed to mature into adulthood. At PND-71, one group of animals was assessed using the spatial-temporal object recognition (stOR) test to evaluate memory function. A separate group of animals was used to assess the density of cholinergic neurons in forebrain areas Ch1-4 using immunohistochemistry. AIE exposed animals manifested deficits in the temporal component of the stOR task relative to controls, and a significant decrease in the number of ChAT labeled neurons in forebrain areas Ch1-4. These findings add to the growing literature indicating long-lasting neural and behavioral effects of AIE that persist into adulthood and indicate that memory-related deficits after AIE depend upon the tasks employed, and possibly their degree of complexity. Finally, the parallel finding of diminished cholinergic neuron density suggests a possible mechanism underlying the effects of AIE on memory and hippocampal function as well as possible therapeutic or preventive strategies for AIE.	[Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Risher, Mary-Louise] Durham VA Med Ctr, Durham, NC 27705 USA; [Swartzwelder, H. Scott; Acheson, Shawn K.; Miller, Kelsey M.; Sexton, Hannah G.; Risher, Mary-Louise] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Swartzwelder, H. Scott] Duke Univ, Med Ctr Durham, Dept Psychol & Neurosci, Durham, NC 27705 USA; [Liu, Wen; Crews, Fulton T.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Swartzwelder, HS (corresponding author), Durham VA Med Ctr, Durham, NC 27705 USA.	hss@duke.edu	Crews, Fulton/T-1181-2019; Acheson, Shawn/A-3299-2016; Risher, Louise/AAP-2646-2020	Crews, Fulton/0000-0003-2393-4976; Risher, Louise/0000-0002-3139-4378	NIH/NIAAA NADIA [AA019925, AA020023, AA020024]; Department of Veterans Affairs Senior Research Career Scientist award; Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award [IK2BX001267, 1IK2BX002505]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925, U24AA020024, U01AA020023] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002505] Funding Source: NIH RePORTER	NIH/NIAAA NADIA; Department of Veterans Affairs Senior Research Career Scientist award(US Department of Veterans Affairs); Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the NIH/NIAAA NADIA AA019925 (to HSS), AA020023 and AA020024 (to FTC), a Department of Veterans Affairs Senior Research Career Scientist award (to HSS), a Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award IK2BX001267 (to SKA), and a Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award 1IK2BX002505 (to M-LR). The contents do not represent the views of the U.S. Department of Veteran Affairs or the United States Government.	Acheson SK, 2012, PLOS ONE, V8, P1; Boutros NN, 2014, INT J PSYCHIAT CLIN, V18, P2, DOI 10.3109/13651501.2013.873053; Broadwater M, 2013, BEHAV BRAIN RES, V256, P10, DOI 10.1016/j.bbr.2013.08.013; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Broadwater MA, 2014, DEV PSYCHOBIOL, V56, P1150, DOI 10.1002/dev.21186; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Clark RE, 2000, J NEUROSCI, V20, P8853; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Desikan A, 2014, PHARMACOL BIOCHEM BE, V122, P279, DOI 10.1016/j.pbb.2014.04.011; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kanju PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031073; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Lehmann O, 2003, EUR J NEUROSCI, V18, P651, DOI 10.1046/j.1460-9568.2003.02745.x; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2010, ALCOHOL, V44, P1, DOI 10.1016/j.alcohol.2009.10.018; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; RILEY JN, 1978, SCIENCE, V201, P646, DOI 10.1126/science.566953; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Silvers JM, 2006, ALCOHOL, V39, P151, DOI 10.1016/j.alcohol.2006.09.001; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Sircar R, 2005, ALCOHOL CLIN EXP RES, V29, P1402, DOI 10.1097/01.alc.0000175012.77756.d9; Spear LP, 2014, NEUROSCI BIOBEHAV R, V45, P1, DOI 10.1016/j.neubiorev.2014.04.012; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; Teles-Grilo Ruivo Leonor M, 2013, Front Synaptic Neurosci, V5, P2, DOI 10.3389/fnsyn.2013.00002; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Vetreno RP, 2015, ADDICT BIOL, P12232; Vetreno RP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00035; Vetreno RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113421; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; WALKER DW, 1978, NEUROPSYCHOLOGIA, V16, P545, DOI 10.1016/0028-3932(78)90082-9; WALKER DW, 1980, SCIENCE, V209, P711, DOI 10.1126/science.7394532; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026	44	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140042	10.1371/journal.pone.0140042	http://dx.doi.org/10.1371/journal.pone.0140042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529506	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600003
J	Yoon, HJ; Kim, HN; Yun, Y; Kim, Y; Ha, AN; Kim, HL; Kim, BS				Yoon, Hai-Jeon; Kim, Han-Na; Yun, Yeojun; Kim, Yemi; Ha, Ae-Na; Kim, Hyung-Lae; Kim, Bom Sahn			Background Intestinal F-18-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients	PLOS ONE			English	Article							GUT MICROBIOTA; GLUCOSE; METABOLISM; METFORMIN	Background This study investigated the relationships between background intestinal uptake on F-18-FDG PET and cardio-metabolic risk (CMR) factors. Methods A total of 326 female patients that underwent F-18-FDG PET to determine the initial stage of breast cancer were enrolled. None of the patients had history of diabetes or hypertension. The background intestinal uptake on PET was visually graded (low vs. high uptake group) and quantitatively measured using the maximal standardized uptake value (SUVmax). SUVmax of 7 bowel segments (duodenum, jejunum, ileum, cecum, hepatic flexure, splenic flexure, and descending colon-sigmoid junction) were averaged for the total bowel (TB SUVmax). Age, body mass index (BMI), fasting blood glucose level (BST), triglyceride (TG), cholesterol, high density lipoprotein (HDL), and low density lipoprotein (LDL) were the considered CMR factors. The relationships between background intestinal F-18-FDG uptake on PET and diverse CMR factors were analyzed. Results The visual grades based on background intestinal F-18-FDG uptake classified 100 (30.7%) patients into the low uptake group, while 226 (69.3%) were classified into the high uptake group. Among CMR factors, age (p = 0.004), BMI (p<0.001), and TG (p<0.001) were significantly different according to visual grade of background intestinal F-18-FDG uptake. Quantitative TB SUVmax showed significant positive correlation with age (r = 0.203, p<0.001), BMI (r = 0.373, p<0.001), TG (r = 0.338, p<0.001), cholesterol (r = 0.148, p = 0.008), and LDL (r = 0.143, p = 0.024) and significant negative correlation with HDL (r = -0.147, p = 0.022). Multivariate analysis indicated that BMI and TG were independent factors in both visually graded background intestinal F-18-FDG uptake (p = 0.027 and p = 0.023, respectively) and quantitatively measured TB SUVmax (p = 0.006 and p = 0.004, respectively). Conclusion Increased background intestinal 18F-FDG uptake on PET may suggest alteration of lipid metabolism and risk of cardio-metabolic disease in non-diabetic and non-hypertensive breast cancer patients.	[Yoon, Hai-Jeon; Kim, Bom Sahn] Ewha Womans Univ, Sch Med, Dept Nucl Med, Seoul, South Korea; [Kim, Han-Na; Yun, Yeojun; Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Kim, Yemi; Ha, Ae-Na; Kim, Bom Sahn] Ewha Womans Univ, Med Res Inst, Sch Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, HL (corresponding author), Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea.	hyung@ewha.ac.kr; kbomsahn@ewha.ac.kr			Ewha Womans University [1-2015-1057-001-1, 1-2014-1676-001-1]; National Research Foundation [2015R1C1A1A02037051, 2012M3A9B6055379, NRF-2014R1A2A2A04006291]	Ewha Womans University; National Research Foundation	This research was supported by grants from Ewha Womans University (1-2015-1057-001-1 and 1-2014-1676-001-1) and the National Research Foundation (2015R1C1A1A02037051, 2012M3A9B6055379, and NRF-2014R1A2A2A04006291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BAILEY CJ, 1994, BRIT J PHARMACOL, V112, P671, DOI 10.1111/j.1476-5381.1994.tb13128.x; Chatterjee A, 2012, CAN FAM PHYSICIAN, V58, P389; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook GJR, 2004, SEMIN NUCL MED, V34, P122, DOI 10.1053/j.semnuclmed.2003.12.003; Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Franquet E, 2014, NUCL MED COMMUN, V35, P1026, DOI 10.1097/MNM.0000000000000170; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; GORBACH SL, 1984, REV INFECT DIS, V6, pS85; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Kim Seok ki, 1999, Clin Positron Imaging, V2, P273, DOI 10.1016/S1095-0397(99)00030-8; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Oh JR, 2010, AM J ROENTGENOL, V195, P1404, DOI 10.2214/AJR.10.4663; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; Xu DB, 2014, GASTROENTEROLOGY, V146, P484, DOI 10.1053/j.gastro.2013.10.026; Yasuda Seiei, 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P241	24	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141473	10.1371/journal.pone.0141473	http://dx.doi.org/10.1371/journal.pone.0141473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523374	Green Published, gold			2022-12-27	WOS:000364029800010
J	Allenbach, Y; Guiguet, M; Rigolet, A; Marie, I; Hachulla, E; Drouot, L; Jouen, F; Jacquot, S; Mariampillai, K; Musset, L; Grenier, P; Devilliers, H; Hij, A; Boyer, O; Herson, S; Benveniste, O				Allenbach, Yves; Guiguet, Marguerite; Rigolet, Aude; Marie, Isabelle; Hachulla, Eric; Drouot, Laurent; Jouen, Fabienne; Jacquot, Serge; Mariampillai, Kuberaka; Musset, Lucile; Grenier, Philippe; Devilliers, Herve; Hij, Adrian; Boyer, Olivier; Herson, Serge; Benveniste, Olivier			Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti-Synthetase Auto-Antibodies: An Open-Label, Phase II Trial	PLOS ONE			English	Article							ANTISYNTHETASE SYNDROME; RHEUMATOID-ARTHRITIS; MYOSITIS; POLYMYOSITIS; DISEASE; ADULT; VALIDATION; PREDICTORS; MANAGEMENT; VASCULITIS	Objective Anti-synthetase syndrome (anti-SS) is frequently associated with myositis and interstitial lung disease (ILD). We evaluated prospectively, in a multicenter, open-label, phase II study, the efficacy of rituximab on muscle and lung outcomes. Methods Patients were enrolled if they were refractory to conventional treatments (prednisone and at least 2 immunosuppressants). They received 1 g of rituximab at D0, D15, and M6. The primary endpoint was muscular improvement based on manual muscular testing (MMT10, Kendall score in 10 muscles) at M12. Secondary endpoints were normalization of creatine kinase (CK) level, ILD improvement based on forced vital capacity and/or diffuse capacity for carbon monoxide, and number and/or doses of associated immunosuppressants. Results Twelve patients were enrolled, and 10 completed the study. Only 2 patients presented an improvement of at least 4 points on at least two muscle groups (primary end-point). Overall, seven patients had an increase of at least 4 points on MMT10. CK level decreased from 399 IU/L (range, 48-11,718) to 74.5 IU/L (range, 40-47,857). Corticosteroid doses decreased from 52.5 mg/d (range, 10-70) to 9 mg/d (range, 7- 65) and six patients had a decrease in the burden of their associated immunosuppressants. At baseline, all 10 patients presented with ILD. At M12, improvement of ILD was observed in 5 out of the 10 patients, stabilization in 4, and worsening in 1. Conclusions This pilot study of rituximab treatment in patients with refractory anti-SS provided data on evolution of muscular and pulmonary parameters. Rituximab should now be evaluated in a larger, controlled study for this homogenous group of patients.	[Allenbach, Yves; Rigolet, Aude; Mariampillai, Kuberaka; Herson, Serge; Benveniste, Olivier] UPMC, Hop La Pitie Salpetriere, APHP,INSERM,UMR 974,DHU i2B, Dept Med Interne & Immunol Clin,Ctr Reference Pat, Paris, France; [Guiguet, Marguerite] UPMC, INSERM, Dept Biostat, UMRS 943, Paris, France; [Marie, Isabelle] Hop Charles Nicole, Dept Med Interne, Rouen, France; [Hachulla, Eric] Univ Lille 2, Ctr Reference Malad Autoimmunes Syst Rares Sclero, Hop Claude Huriez, Lille, France; [Drouot, Laurent; Jouen, Fabienne; Jacquot, Serge; Boyer, Olivier] Univ Rouen Normandie, Dept Immunol, INSERM, U905,Hop Univ Rouen, Rouen, France; [Musset, Lucile] UPMC, Lab Immunochim, Hop La Pitie Salpetriere, APHP, Paris, France; [Grenier, Philippe] UPMC, Dept Radiol Gen, Hop La Pitie Salpetriere, APHP, Paris, France; [Devilliers, Herve] Hop Univ Dijon, Dept Med Interne, Dijon, France; [Hij, Adrian] Univ Paris 07, Hop St Louis, APHP, Dept Med Interne & Pathol Vasc, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Allenbach, Y (corresponding author), UPMC, Hop La Pitie Salpetriere, APHP,INSERM,UMR 974,DHU i2B, Dept Med Interne & Immunol Clin,Ctr Reference Pat, Paris, France.	yves.allenbach@aphp.fr	HACHULLA, ERIC/R-8488-2018; Devilliers, Hervé/I-5464-2016; Boyer, Olivier/N-6552-2013; Guiguet, Marguerite/L-8480-2018	HACHULLA, ERIC/0000-0001-7432-847X; Boyer, Olivier/0000-0002-7591-307X; Allenbach, Yves/0000-0002-3185-7993	French Ministry of Health (PHRC); Association Francaise contre les Myopathies (AFM)	French Ministry of Health (PHRC); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This study was supported by the French Ministry of Health (PHRC) and the Association Francaise contre les Myopathies (AFM). Rituximab was kindly provided by Roche. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2014, ARTHRITIS RHEUMATOL, V66, P740, DOI 10.1002/art.38270; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Ascherman Dana P, 2003, Curr Rheumatol Rep, V5, P425, DOI 10.1007/s11926-003-0052-2; Cartin-Ceba R, 2012, ARTHRITIS RHEUM-US, V64, P3770, DOI 10.1002/art.34584; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Hervier B, 2012, AUTOIMMUN REV, V12, P210, DOI 10.1016/j.autrev.2012.06.006; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427; Jones RB, 2009, ARTHRITIS RHEUM, V60, P2156, DOI 10.1002/art.24637; Katsumata Y, 2007, J AUTOIMMUN, V29, P174, DOI 10.1016/j.jaut.2007.07.005; Koenig M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2276; Lambotte O, 2005, J RHEUMATOL, V32, P1369; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mahler EAM, 2011, RHEUMATOLOGY, V50, P2206, DOI 10.1093/rheumatology/ker088; Mok CC, 2007, J RHEUMATOL, V34, P1864; Oddis CV, 2012, ARTHRITIS RHEUM; Provance PG, MUSCLES TESTING FUNC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035; Sem M, 2009, RHEUMATOLOGY, V48, P968, DOI 10.1093/rheumatology/kep157; Soejima M, 2011, ARTHRITIS RHEUM-US, V63, P479, DOI 10.1002/art.30113; Stanciu R, 2012, J RHEUMATOL, V39, P1835, DOI 10.3899/jrheum.111604; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Stone KB, 2007, ARTHRITIS RHEUM, V56, P3125, DOI 10.1002/art.22865; Vandenbroucke E, 2009, RHEUMATOL INT, V29, P1499, DOI 10.1007/s00296-009-0859-x; Vanhoutte EK, 2012, BRAIN, V135, P1639, DOI 10.1093/brain/awr318; Vital EM, 2010, ARTHRITIS RHEUM-US, V62, P1273, DOI 10.1002/art.27359; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005	29	60	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0133702	10.1371/journal.pone.0133702	http://dx.doi.org/10.1371/journal.pone.0133702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539981	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800001
J	Liu, J; Bai, J; Jiang, GQ; Li, XL; Wang, J; Wu, DC; Owusu, L; Zhang, ES; Li, WL				Liu, Jia; Bai, Jing; Jiang, Guoqiang; Li, Xinli; Wang, Jing; Wu, Dachang; Owusu, Lawrence; Zhang, Ershao; Li, Weiling			Anti-Tumor Effect of Pinus massoniana Bark Proanthocyanidins on Ovarian Cancer through Induction of Cell Apoptosis and Inhibition of Cell Migration	PLOS ONE			English	Article							KAPPA-B ACTIVATION; MMP-9 EXPRESSION; MAP KINASE; INVASION; PATHWAYS; EXTRACT; PROLIFERATION; MITOCHONDRIAL; PROGRESSION; METASTASIS	Pinus massoniana bark proanthocyanidins (PMBPs), an active component isolated from Pinus massoniana bark, has been reported to possess a wide range of biochemical properties. Here, we investigated the anti-tumor effect of PMBPs on ovarian cancer. The results indicated that PMBPs significantly reduced the growth of ovarian cancer cells and induced dose-dependent apoptosis. The underlying mechanisms involved were elucidated to include the loss of mitochondrial membrane potential, down-regulation of the anti-apoptotic protein Bcl-2 and the activation of Caspase 3/9, suggesting that PMBPs triggered apoptosis through activation of mitochondria-associated apoptotic pathway. In addition, wound healing and transwell chamber assays revealed that PMBPs could suppress migration and invasion of ovarian cancer cells. PMBPs dramatically inhibited MMP-9 activity and expression, blocked the activity of NF kappa B and the activation of ERK1/2 and p38 MAPK. Our findings suggest that PMBPs has the potential to be developed as an anti-tumor drug for ovarian cancer treatment and/or disease management.	[Liu, Jia; Bai, Jing; Jiang, Guoqiang; Li, Xinli; Wang, Jing; Wu, Dachang; Zhang, Ershao; Li, Weiling] Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China; [Owusu, Lawrence] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Owusu, Lawrence] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL USA	Dalian Medical University; Kwame Nkrumah University Science & Technology; State University System of Florida; University of South Florida	Li, WL (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China.	liweiling2006@hotmail.com		liu, jia/0000-0002-1021-9271; li, weiling/0000-0001-6681-9156	National Natural Science Foundation of China [81302282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81302282) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi H, 2014, TUMOR BIOL, V35, P11027, DOI 10.1007/s13277-014-2396-9; Akl H, 2014, BBA-MOL CELL RES, V1843, P2240, DOI 10.1016/j.bbamcr.2014.04.017; Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068808; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Chang C, 2013, INTEGR CANCER THER, V13, P249; Cui YY, 2005, WORLD J GASTROENTERO, V11, P5277, DOI 10.3748/wjg.v11.i34.5277; Cui YY, 2005, PHYTOTHER RES, V19, P34, DOI 10.1002/ptr.1619; Decker D G, 1972, Proc Natl Cancer Conf, V7, P223; Ebermann R, 1996, J PHOTOCH PHOTOBIO B, V36, P95, DOI 10.1016/S1011-1344(96)07353-8; Gatti L, 2014, J PHARMACOL EXP THER, V348, P360, DOI 10.1124/jpet.113.210054; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Im NK, 2014, J MED FOOD, V17, P855, DOI 10.1089/jmf.2013.3077; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kim JJ, 2014, BIOL PHARM BULL, V37, P158, DOI 10.1248/bpb.b13-00534; Kim YI, 2015, MOL MED REP, V12, P657, DOI 10.3892/mmr.2015.3460; Li L, 2014, ONCOL REP, V32, P1779, DOI 10.3892/or.2014.3422; Li YY, 2015, J PHARMACOL EXP THER, V353, P9, DOI 10.1124/jpet.114.220277; Lin F, 2014, J ORAL PATHOLOGY MED; Ma HL, 2010, INT J MOL MED, V25, P751, DOI 10.3892/ijmm_00000401; Ma HL, 2008, PHYTOTHER RES, V22, P1472, DOI 10.1002/ptr.2496; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Millimouno FM, 2014, CANCER PREV RES, V7, P1081, DOI 10.1158/1940-6207.CAPR-14-0136; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Noh EM, 2015, EUR J PHARMACOL, V764, P79, DOI 10.1016/j.ejphar.2015.06.038; Ooi KK, 2015, J BIOL INORG CHEM, V20, P855, DOI 10.1007/s00775-015-1271-5; Ozols RF, 2003, J CLIN ONCOL, V21, P2451, DOI 10.1200/JCO.2003.03.039; Pal HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086338; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Sak Katrin, 2012, Chemother Res Pract, V2012, P282570, DOI 10.1155/2012/282570; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh L, 2015, CLIN EXP OPHTHALMOL, V43, P259, DOI 10.1111/ceo.12397; Uchino R, 2010, BLOOD COAGUL FIBRIN, V21, P528, DOI 10.1097/MBC.0b013e32833a9b61; Wang XF, 2015, EXPERT OPIN THER TAR, V19, P577, DOI 10.1517/14728222.2015.1012156; Wei ZJ, 2015, INT J CLIN EXP PATHO, V8, P4481; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; [高晓文 XiaoWen Gao], 2008, [细胞生物学杂志, Chinese Journal of Cell Biology], V30, P642; Zhang JH, 2012, AM J CHINESE MED, V40, P861, DOI 10.1142/S0192415X12500644; Zhu L, 2012, J CELL PHYSIOL, V227, P1814, DOI 10.1002/jcp.22906	41	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142157	10.1371/journal.pone.0142157	http://dx.doi.org/10.1371/journal.pone.0142157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539720	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800059
J	Merkado, G; Titelboim, D; Hyams-Kaphzan, O; Holzmann, M; Pawlowski, J; Almogi-Labin, A; Abdu, U; Herut, B; Abramovich, S				Merkado, Gily; Titelboim, Danna; Hyams-Kaphzan, Orit; Holzmann, Maria; Pawlowski, Jan; Almogi-Labin, Ahuva; Abdu, Uri; Herut, Barak; Abramovich, Sigal			Molecular Phylogeny and Ecology of Textularia agglutinans d'Orbigny from the Mediterranean Coast of Israel: A Case of a Successful New Incumbent	PLOS ONE			English	Article							BENTHIC FORAMINIFERAL ASSEMBLAGES; MICROHABITAT SELECTION; SHELF; CHLOROPHYLL; DIVERSITY; TRANSECT; SEA	Textularia agglutinans d'Orbigny is a non-symbiont bearing and comparatively large benthic foraminiferal species with a widespread distribution across all oceans. In recent years, its populations have considerably expanded along the Israeli Mediterranean coast of the eastern Levantine basin. Despite its exceptionally widespread occurrence, no molecular data have yet been obtained. This study provides the first ribosomal DNA sequences of T. agglutinans complemented with morphological and ecological characterization, which are based on material collected during environmental monitoring of the hard bottom habitats along the Israeli Mediterranean coast, and from the Gulf of Elat (northern Red Sea). Our phylogenetic analyses reveal that all specimens from both provinces belong to the same genetic population, regardless their morphological variability. These results indicate that modern population of T. agglutinans found on the Mediterranean coast of Israel is probably Lessepsian. Our study also reveals that T. agglutinans has an epiphytic life mode, which probably enabled its successful colonization of the hard bottom habitats, at the Mediterranean coast of Israel, which consist of a diverse community of macroalgae. Our study further indicates that the species does not tolerate high SST (> 35 degrees C), which will probably prevent its future expansion in the easternmost Mediterranean in light of the expected rise in temperatures.	[Merkado, Gily; Titelboim, Danna; Abdu, Uri; Abramovich, Sigal] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Hyams-Kaphzan, Orit; Almogi-Labin, Ahuva] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Holzmann, Maria; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Herut, Barak] Israel Oceanog & Limnol Res, Natl Inst Oceanog, Haifa, Israel	Ben Gurion University; Geological Survey Israel; University of Geneva; Israel Oceanographic & Limnological Research Institute	Abramovich, S (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	sigalabr@bgu.ac.il	Pawlowski, Jan/AAO-3306-2021; Abramovich, Sigal/AAR-5034-2021	Pawlowski, Jan/0000-0003-2421-388X; Abramovich, Sigal/0000-0003-3124-1387; Herut, Barak/0000-0002-7093-8753; Almogi-Labin, Ahuva/0000-0002-4082-7120	Israel Science Foundation [587/2013]; BMBF-MOST German Israeli cooperation project [3-9054, 3-9055]; Swiss National Science Foundation [31003A_140766]; G. & A. Claraz Donation	Israel Science Foundation(Israel Science Foundation); BMBF-MOST German Israeli cooperation project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); G. & A. Claraz Donation	The research was supported by the Israel Science Foundation grant No. 587/2013, by BMBF-MOST German Israeli cooperation project 3-9054, 3-9055, by the Swiss National Science Foundation grant 31003A_140766, and by a G. & A. Claraz Donation (JP, MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani A.D., 1990, Memorie di Scienze Geologiche, V42, P271; Almagor G, 1984, GEOL SURV ISR B, V77, P31; Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Avital A, 2002, THESIS B GURION U NE; Avnaim-Katav S, 2015, J SEA RES, V99, P97, DOI 10.1016/j.seares.2015.02.006; Avnaim-Katav S, 2013, PALAEOGEOGR PALAEOCL, V386, P512, DOI 10.1016/j.palaeo.2013.06.019; BANNER F T, 1981, Journal of Foraminiferal Research, V11, P85; BARMAWIDJAJA DM, 1992, J FORAMIN RES, V22, P297, DOI 10.2113/gsjfr.22.4.297; Brady H.B., 1884, REPORTS SCI RESULTS, V9, P1; Buosi C, 2012, J FORAMIN RES, V42, P39; Coppa M. Grazia, 1995, Revista Espanola de Paleontologia, V10, P161; CULVER S J, 1980, Smithsonian Contributions to the Marine Sciences, P1; Culver SJ, 1987, DISTRIBUTION RECENT, P1, DOI [10.5479/si.01960768.30.1, DOI 10.5479/SI.01960768.30.1]; D'Orbigny A., 1839, HIT PHYS NATURELLE L, P144; d'Orbigny A.D., 1826, ANN SCI NATURELLES 1, V7, P245; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Debenay JP, 2012, GUIDE 1000 FORMINIFE; Defrance M, 1824, MOLLUSQUES VERS ZOOP, P32; Delage Y, 1896, TRAITE ZOOLOGIE CONC; Dorst S, 2013, J FORAMIN RES, V43, P238, DOI 10.2113/gsjfr.43.3.238; du Chatelet EA, 2013, MAR GEOL, V335, P114, DOI 10.1016/j.margeo.2012.10.013; Duchemin G, 2005, J FORAMIN RES, V35, P198, DOI 10.2113/35.3.198; Duijnstee I., 2001, THESIS UTRECHT U; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrenberg C, 1839, BILDING KREIDEFELSEN; Felder DL., 2009, GULF MEXICO ORIGIN W; Frontalini F, 2015, MAR BIODIVERS, V45, P549, DOI 10.1007/s12526-014-0238-z; Frontalini F, 2014, MICROPALEONTOLOGY, V60, P27; Gertman I, 2002, CIESM WORK SER, V16; Glazer A, 2010, MONITORING PROGRAM M; Goineau A, 2011, J SEA RES, V65, P58, DOI 10.1016/j.seares.2010.07.007; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Holzmann M, 2000, J MICROPALAEONTOL, V19, P85, DOI 10.1144/jm.19.1.85; Hottinger L., 1993, RECENT FORAMINIFERID; Hyams-Kaphzan O, 2014, GEOL SIRV ISR, P38; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; Jannink NT, 2001, THESIS UTECHT U; Javaux Emmanuelle J., 2003, Palaeontologia Electronica, V6, P1; Jorissen F, 1988, UTR MICROPALEONTOL B; JORISSEN FJ, 1987, MAR MICROPALEONTOL, V12, P21, DOI 10.1016/0377-8398(87)90012-0; Kucera M, 2002, PHILOS T ROY SOC A, V360, P695, DOI 10.1098/rsta.2001.0962; Langer M.R., 1991, MEDITERRANEAN FORAMI; Langer MR, 2013, NEUES JAHRB GEOL P-A, V267, P155, DOI 10.1127/0077-7749/2013/0302; LANGER MR, 1993, MAR MICROPALEONTOL, V20, P235, DOI 10.1016/0377-8398(93)90035-V; LANGER MR, 1993, J FORAMIN RES, V23, P40, DOI 10.2113/gsjfr.23.1.40; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Le Calvez Y, 1977, CAHIERS MICROPALEONT; Lecroq B, 2009, ZOOTAXA, P23, DOI 10.11646/zootaxa.2096.1.4; Loeblich A, 1994, FORAMINIFERA SAHUL S, P31; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; McCloskey B, 2009, THESIS U S FLORIDA; Meric E, 2007, J ASIAN EARTH SCI, V30, P353, DOI 10.1016/j.jseaes.2006.10.006; Milker Y, 2012, PALAEONTOL ELECTRON, V15; Mojtahid M, 2010, J FORAMIN RES, V40, P231, DOI 10.2113/gsjfr.40.3.231; Nomura R, 1981, MEM FAC ED SHIMANE U, V15, P31; Nomura R., 1997, MEM FAC EDU NAT SCI, V31, P1; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Pawlowski J, 2008, BIODIVERS CONSERV, V17, P317, DOI 10.1007/s10531-007-9253-8; Pawlowski J, 2013, MAR MICROPALEONTOL, V100, P1, DOI 10.1016/j.marmicro.2013.04.002; Reiss Z, 1961, GEOLOGICAL SURVEY IS, V32, P10; Richardson Susan L., 2003, Micronesica, V35-36, P38; Rilov G, 2014, H322014 IOLR, V2014, pH32; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Sgarrella Franca, 1993, Bollettino della Societa Paleontologica Italiana, V32, P145; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapiero I, 2002, HIGH RESOLUTION PALE	70	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142263	10.1371/journal.pone.0142263	http://dx.doi.org/10.1371/journal.pone.0142263			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539992	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800071
J	Ross, CT				Ross, Cody T.			A Multi-Level Bayesian Analysis of Racial Bias in Police Shootings at the County-Level in the United States, 2011-2014	PLoS One			English	Article							DEADLY FORCE; THREAT; DETERMINANTS; PERCEPTION; HOMICIDE; DECISION; VIOLENCE; NORMS; BLACK	A geographically-resolved, multi-level Bayesian model is used to analyze the data presented in the U.S. Police-Shooting Database (USPSD) in order to investigate the extent of racial bias in the shooting of American civilians by police officers in recent years. In contrast to previous work that relied on the FBI's Supplemental Homicide Reports that were constructed from self-reported cases of police-involved homicide, this data set is less likely to be biased by police reporting practices. County-specific relative risk outcomes of being shot by police are estimated as a function of the interaction of: 1) whether suspects/civilians were armed or unarmed, and 2) the race/ethnicity of the suspects/civilians. The results provide evidence of a significant bias in the killing of unarmed black Americans relative to unarmed white Americans, in that the probability of being {black, unarmed, and shot by police} is about 3.49 times the probability of being {white, unarmed, and shot by police} on average. Furthermore, the results of multi-level modeling show that there exists significant heterogeneity across counties in the extent of racial bias in police shootings, with some counties showing relative risk ratios of 20 to 1 or more. Finally, analysis of police shooting data as a function of county-level predictors suggests that racial bias in police shootings is most likely to emerge in police departments in larger metropolitan counties with low median incomes and a sizable portion of black residents, especially when there is high financial inequality in that county. There is no relationship between county-level racial bias in police shootings and crime rates (even race-specific crime rates), meaning that the racial bias observed in police shootings in this data set is not explainable as a response to local-level crime rates.	Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA	University of California System; University of California Davis	Ross, CT (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	ctross@ucdavis.edu						Alejandro R., 2014, BATON ROUGE POLICE O; [Anonymous], 2015, WASHINGTON POST; [Anonymous], 2015, GUARDIAN; Antony MG, 2010, THIS IS CITIZEN JOUR; Bankoff C., 2014, 2 STLOUIS AREA COPS; BERGESEN A, 1982, J BLACK STUD, V12, P261, DOI 10.1177/002193478201200302; Blascovich J, 2001, J PERS SOC PSYCHOL, V80, P253, DOI 10.1037//0022-3514.80.2.253; Burghart D., 2020, FATAL ENCOUNTERS STE; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; Doane Jr Ashley W., 2006, CRITICAL SOCIOLOGY, V32, P255, DOI DOI 10.1163/156916306777835303; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Ezekiel RS, 2002, AM BEHAV SCI, V46, P51, DOI 10.1177/0002764202046001005; Freedman D.A., 1999, INT ENCY SOCIAL BEHA, V6, P4027; FYFE JJ, 1980, J RES CRIME DELINQ, V17, P101, DOI 10.1177/002242788001700107; Gabrielson R, 2014, PROPUBLICA; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Goldkamp JS., 1976, JUSTICE SYST J, P169; Harring S, 1977, CRIME SOC JUSTICE, V8, P34; Hensley N., 2014, NEW YORK DAILY NEWS; Hijmans R.J., 2010, GADM DATABASE GLOBAL; Holmes MD, 2000, CRIMINOLOGY, V38, P343, DOI 10.1111/j.1745-9125.2000.tb00893.x; Hudson R, 2014, WASHINGTON POST; JACOBS D, 1979, SOC PROBL, V26, P403, DOI 10.1525/sp.1979.26.4.03a00050; Jacobs D, 1998, AM J SOCIOL, V103, P837, DOI 10.1086/231291; Klinger DA, 2012, HOMICIDE STUD, V16, P78, DOI 10.1177/1088767911430861; Lind Dara, 2014, NOT SHOOT CIVILIANS; MACDONALD JM, 1999, J CRIME JUSTICE, V0022; MacDonald JM, 2001, CRIME DELINQUENCY, V47, P155, DOI 10.1177/0011128701047002001; Martinot Steve, 2003, SOC IDENT, V9, P169, DOI DOI 10.1080/1350463032000101542; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; Murphy D, 2013, NEW YORK DAILY NEWS; Nesdale D, 2005, CHILD DEV, V76, P652, DOI 10.1111/j.1467-8624.2005.00869.x; Plant EA, 2005, J EXP SOC PSYCHOL, V41, P141, DOI 10.1016/j.jesp.2004.07.004; Post Huffington, 2013, HUFFINGTON POST; Ross C, 2015, SOCIOLOGICA IN PRESS; Ross CT, 2015, AM J HUMAN BIOL, DOI 10.1002/ajhb.22757; Sidanius J., 2001, SOCIAL DOMINANCE INT; Smith BW, 2004, POLICING, V27, P539, DOI 10.1108/13639510410566262; Smith BW, 2003, POLICY STUD J, V31, P147, DOI 10.1111/1541-0072.t01-1-00009; SORENSEN JR, 1993, JUSTICE Q, V0010; Stahl J, 2008, HUFFINGTON POST; Stan Development Team, 2014, STAN C LIB PROB SAMP; Stephens-Davidowitz S, 2014, J PUBLIC ECON, V118, P26, DOI 10.1016/j.jpubeco.2014.04.010; Swaine J, 2014, THE GAURDIAN; The Centers for Disease Control and Prevention, 2014, NAT VIT STAT SYST; U S Department of Justice, 2014, FED BUR INV S; United Nations Committee Against Torture, 2014, CONCL OBS 3 5 PER RE; United States Department of Justice Office of Justice Programs Federal Bureau of Investigation, 2014, UN CRIM REP PROGR DA; Wagner K., 2014, US POLICE SHOOTINGS; Warren P, 2006, CRIMINOLOGY, V44, P709, DOI 10.1111/j.1745-9125.2006.00061.x; Weitzer R, 2015, SOCIETY, V52, P475, DOI 10.1007/s12115-015-9931-1; Whaley N, 2013, 2 BLACK COPS WRITE S	53	78	78	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141854	10.1371/journal.pone.0141854	http://dx.doi.org/10.1371/journal.pone.0141854			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540108	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800032
J	Sharma, NK; Kumar, A; Kumari, A; Tokar, EJ; Waalkes, MP; Bortner, CD; Williams, J; Ehrenshaft, M; Mason, RP; Sinha, BK				Sharma, Nilesh K.; Kumar, Ashutosh; Kumari, Amrita; Tokar, Erik J.; Waalkes, Michael P.; Bortner, Carl D.; Williams, Jason; Ehrenshaft, Marilyn; Mason, Ronald P.; Sinha, Birandra K.			Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; S-NITROSYLATION; ANTICANCER ACTIVITY; MELANOMA-CELLS; P53 FUNCTION; DNA-DAMAGE; WILD-TYPE; CANCER; PROTEIN; SENSITIVITY	Camptothecin (CPT), a topoisomerase I poison, is an important drug for the treatment of solid tumors in the clinic. Nitric oxide ((NO)-N-center dot), a physiological signaling molecule, is involved in many cellular functions, including cell proliferation, survival and death. We have previously shown that (NO)-N-center dot plays a significant role in the detoxification of etoposide (VP-16), a topoisomerase II poison in vitro and in human melanoma cells. (NO)-N-center dot/(NO)-N-center dot-derived species are reported to modulate activity of several important cellular proteins. As topoisomerases contain a number of free sulfhydryl groups which may be targets of (NO)-N-center dot/(NO)-N-center dot-derived species, we have investigated the roles of (NO)-N-center dot/(NO)-N-center dot-derived species in the stability and activity of topo I. Here we show that (NO)-N-center dot/(NO)-N-center dot-derived species induces a significant down-regulation of topoisomerase I protein via the ubiquitin/26S proteasome pathway in human colon (HT29) and breast (MCF-7) cancer cell lines. Importantly, (NO)-N-center dot treatment induced a significant resistance to CPT only in MCF-7 cells. This resistance to CPT did not result from loss of topoisomerase I activity as there were no differences in topoisomerase I-induced DNA cleavage in vitro or in tumor cells, but resulted from the stabilization/induction of bcl2 protein. This up-regulation of bcl2 protein in MCF-7 cells was wtp53 dependent as pifithrine-alpha, a small molecule inhibitor of wtp53 function, completely reversed CPT resistance, suggesting that wtp53 and bcl2 proteins played important roles in CPT resistance. Because tumors in vivo are heterogeneous and contaminated by infiltrating macrophages, (NO)-N-center dot-induced down-regulation of topoisomerase I protein combined with bcl2 protein stabilization could render certain tumors highly resistant to CPT and drugs derived from it in the clinic.	[Sharma, Nilesh K.; Kumar, Ashutosh; Kumari, Amrita; Ehrenshaft, Marilyn; Mason, Ronald P.; Sinha, Birandra K.] NIEHS, Immun Inflammat & Dis Lab, NIH, Durham, NC 27713 USA; [Tokar, Erik J.; Waalkes, Michael P.] NIEHS, Natl Toxicol Program, NIH, Durham, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, NIH, Durham, NC USA; [Williams, Jason] NIEHS, Struct Biol Lab, NIH, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sinha, BK (corresponding author), NIEHS, Immun Inflammat & Dis Lab, NIH, Durham, NC 27713 USA.	sinha1@niehs.nih.gov	Sharma, Prof. Nilesh Kumar/ABA-5959-2020; Mason, Ronald P/G-5967-2019	Sharma, Prof. Nilesh Kumar/0000-0002-8774-3020; Mason, Ronald P/0000-0002-1859-9109	National Institute of Environmental Health Sciences, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102925, ZICES102488, ZIAES050139] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported [in part] by the intramural research program of the National Institute of Environmental Health Sciences, NIH.	BEIDLER DR, 1995, MOL PHARMACOL, V47, P907; Calmels S, 1997, CANCER RES, V57, P3365; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chazotte-Aubert L, 2000, BIOCHEM BIOPH RES CO, V267, P609, DOI 10.1006/bbrc.1999.2003; Chazotte-Aubert L, 2001, BIOCHEM BIOPH RES CO, V281, P766, DOI 10.1006/bbrc.2001.4423; Chowdhury R, 2012, CHEM RES TOXICOL, V25, P2194, DOI 10.1021/tx300274a; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Davis PL, 1998, ANTICANCER RES, V18, P2919; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; FAN SJ, 1995, CANCER RES, V55, P1649; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Gobert C, 1999, P NATL ACAD SCI USA, V96, P10355, DOI 10.1073/pnas.96.18.10355; Gobert C, 1996, BIOCHEMISTRY-US, V35, P5778, DOI 10.1021/bi952327w; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; Goldwasser F, 1996, CANCER RES, V56, P4430; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hasinoff BB, 2005, MOL PHARMACOL, V67, P937, DOI 10.1124/mol.104.004416; Hawkins DS, 1996, CANCER RES, V56, P892; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Jaiswal M, 2000, CANCER RES, V60, P184; Jaiswal M, 2001, CANCER RES, V61, P6388; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; LIU LF, 1983, J BIOL CHEM, V258, P5365; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; POMMIER Y, 1994, CANCER INVEST, V12, P530, DOI 10.3109/07357909409021413; Ridnour LA, 2006, ANTIOXID REDOX SIGN, V8, P1329, DOI 10.1089/ars.2006.8.1329; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Shih JY, 2006, J CANC MOL, V2, P101; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sinha BK, 2013, J PHARMACOL EXP THER, V347, P607, DOI 10.1124/jpet.113.207928; Sinha BK, 2013, CHEM RES TOXICOL, V26, P379, DOI 10.1021/tx300480q; SINHA BK, 1995, DRUGS, V49, P11, DOI 10.2165/00003495-199549010-00002; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Tokar EJ, 2013, CHEM RES TOXICOL, V26, P96, DOI 10.1021/tx3004054; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YT, 2014, ACS CHEM BIOL, V9, P821, DOI 10.1021/cb400547u; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; Zhou H, 2005, TOXICOLOGY, V208, P223, DOI 10.1016/j.tox.2004.11.021; Zhou J, 2004, CURR MOL MED, V4, P741, DOI 10.2174/1566524043359926	53	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141897	10.1371/journal.pone.0141897	http://dx.doi.org/10.1371/journal.pone.0141897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540186	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800034
J	Dong, JL; Sun, BN; Ma, FJ; Wang, QJ; Jin, PH; Wang, WJ; Deng, P; Yang, Y; Li, XJ				Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing			Paliurus Fruits from the Oligocene of South China and Their Phytogeographic Implications	PLOS ONE			English	Article							MORPHOLOGY; BIOGEOGRAPHY; GUANGXI	Paliurus favonii Unger is recognized and described based on fruits from the Oligocene Ningming flora of Guangxi, South China. Characteristics of the present specimens include circular winged fruits that are 10.0-11.5 mm in diameter with a central endocarp at 3.0 to 4.0 mm in diameter. The specimens fall into the morphological range of the fossil species P. favonii, which has been observed in other Cenozoic sites in the Northern Hemisphere. The present discovery represents the lowest latitude distribution of P. favonii in the world, and we are presenting the first P. favonii fossil described with detailed cuticular characteristics from China. Further, this finding demonstrates that the genus existed in the Oligocene Ningming region, South China, and provides new information for understanding the fossil history. The dispersal mode for winged fossils demonstrates that wind dispersal is well-represented in the Oligocene Ningming flora.	[Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing] Lanzhou Univ, Sch Earth Sci, Lanzhou 730000, Peoples R China; [Dong, Jun-Ling; Sun, Bai-Nian; Ma, Fu-Jun; Wang, Qiu-Jun; Jin, Pei-Hong; Wang, Wen-Jia; Deng, Peng; Yang, Yi; Li, Xiao-Jing] Lanzhou Univ, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China; [Dong, Jun-Ling; Sun, Bai-Nian] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences	Sun, BN (corresponding author), Lanzhou Univ, Sch Earth Sci, Lanzhou 730000, Peoples R China.	bnsun@lzu.edu.cn			National Natural Science Foundation of China [41172022]; National Basic Research Program of China (973 Program) [2012CB822003]; Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS [Y421140303]; Fundamental Research Funds for the Central Universities [lzujbky-2014-285]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by the National Natural Science Foundation of China, grant 41172022 (http://www.nsfc.gov.cn/). This work was also supported by the National Basic Research Program of China (973 Program, number 2012CB822003), the Funds of Key Laboratory of Economic Stratigraphy and Palaeogeography, Nanjing Institute of Geology and Palaeontology, CAS (No. Y421140303), and the Fundamental Research Funds for the Central Universities (No. lzujbky-2014-285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airy Shaw H. K., 1951, KEW B, V51, P327, DOI [10.2307/4118000, DOI 10.2307/4118000]; AUGSPURGER CK, 1988, NEW PHYTOL, V108, P357, DOI 10.1111/j.1469-8137.1988.tb04174.x; AUGSPURGER CK, 1986, AM J BOT, V73, P353, DOI 10.2307/2444078; Burge DO, 2008, INT J PLANT SCI, V169, P1066, DOI 10.1086/590453; Chen Geng-Jiao, 2004, Vertebrata Palasiatica, V42, P81; Chen GJ, 2011, SCI CHINA EARTH SCI, V54, P481, DOI 10.1007/s11430-011-4182-5; Chen GJ, 2005, J VERTEBR PALEONTOL, V25, P492, DOI 10.1671/0272-4634(2005)025[0492:ANCCRT]2.0.CO;2; Chen YF, 2005, BOT J LINN SOC, V147, P437, DOI 10.1111/j.1095-8339.2005.00373.x; Chen YF., 2014, INT J LATEST RES SCI, V3, P13; CONOVER MV, 1991, BOT J LINN SOC, V107, P295, DOI 10.1111/j.1095-8339.1991.tb00225b.x; Correa E, 2010, AM J BOT, V97, P71, DOI 10.3732/ajb.0900093; de Potascheff CD, 2014, BRITTONIA, V66, P191, DOI 10.1007/s12228-013-9314-0; Harris JG, 2001, PLANT IDENTIFICATION; Huzioka K., 1970, J MINING COLL AKITA, V4, P1; Kovar-Eder Johanna, 2004, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V105A, P45; [李浩敏 Li Haomin], 2003, [古生物学报, Acta Palaeontologica Sinica], V42, P537; Li XC, 2014, ACTA GEOL SIN-ENGL, V88, P1364, DOI 10.1111/1755-6724.12304; Ma FJ, 2015, MYCOLOGIA, DOI [10.3852/38143270, DOI 10.3852/3814-3270]; Mai DH, 1991, ABH STAATL MUS MIN G, V38, P1; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 1987, MONOGRAPHS SYSTEMATI, V21, P91; Manchester SR, 2010, BOT REV, V76, P1, DOI 10.1007/s12229-010-9041-0; MIKI SHlGERU, 1933, BOT MAG [TOKYO], V47, P619; Morton CM, 1997, AM J BOT, V84, P530, DOI 10.2307/2446029; Pigg K. B., 2002, WASHINGTON GEOL, V30, P3; PRANCE GT, 1978, BRITTONIA, V30, P21, DOI 10.2307/2806452; Richardson J. E., 2000, Kew Bulletin, V55, P311, DOI 10.2307/4115645; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Schirarend C, 1996, GRANA, V35, P347, DOI 10.1080/00173139609429093; Schirarend C., 2007, FLORA CHINA HIPPOCAS, V12, P115; Schirarend Carsten, 1994, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V116, P333; Shi GL, 2014, PALAEOWORLD, V23, P336, DOI 10.1016/j.palwor.2014.08.001; Shi GL, 2012, AM J BOT, V99, P108, DOI 10.3732/ajb.1100331; Shi GL, 2011, REV PALAEOBOT PALYNO, V166, P325, DOI 10.1016/j.revpalbo.2011.06.005; Shi GL, 2010, REV PALAEOBOT PALYNO, V161, P179, DOI 10.1016/j.revpalbo.2010.04.002; [宋柱秋 Song Zhuqiu], 2014, [古生物学报, Acta Palaeontologica Sinica], V53, P191; Sprague TA, 1916, DIONCOPHYLLUM B MISC, V4, P89; Unger F., 1847, CHLORIS PROTOGAEA, DOI [10.5962/bhl.title.141709, DOI 10.5962/BHL.TITLE.141709]; Wang Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-88; Wang QJ, 2015, CR PALEVOL, DOI [10.1016/j.crpv.2015.1003.1005, DOI 10.1016/J.CRPV.2015.1003.1005]; [王伟铭 Wang Weiming], 2003, [地层学杂志, Journal of Stratigraphy], V27, P324; Wilde V, 1998, REV PALAEOBOT PALYNO, V101, P7, DOI 10.1016/S0034-6667(97)00067-5; Wilde V, 2010, REV PALAEOBOT PALYNO, V159, P143, DOI 10.1016/j.revpalbo.2009.11.010; Work Group of 'Cenozoic Plant from China' (WGCPC), 1978, CENOZ PLANTS CHIN FO; Zhang Zhicheng, 1980, PALEONTOLOGICAL AT 2, P308	46	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140653	10.1371/journal.pone.0140653	http://dx.doi.org/10.1371/journal.pone.0140653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536607	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400029
J	Guimaraes, ML; Marques, BCL; Bertoni, N; Teixeira, SLM; Morgado, MG; Bastos, FI				Guimaraes, Monick Lindenmeyer; Leires Marques, Bianca Cristina; Bertoni, Neilane; Maia Teixeira, Sylvia Lopes; Morgado, Mariza Goncalves; Bastos, Francisco Inacio		Brazilian Multicity Study Grp Drug	Assessing the HIV-1 Epidemic in Brazilian Drug Users: A Molecular Epidemiology Approach	PLOS ONE			English	Article							RIO-DE-JANEIRO; SUBTYPE-C; RESISTANCE SURVEILLANCE; SAO-PAULO; STATE; PREVALENCE; INJECTION; INFECTION; POPULATION; DIVERSITY	Person who inject illicit substances have an important role in HIV-1 blood and sexual transmission and together with person who uses heavy non-injecting drugs may have less than optimal adherence to anti-retroviral treatment and eventually could transmit resistant HIV variants. Unfortunately, molecular biology data on such key population remain fragmentary in most low and middle-income countries. The aim of the present study was to assess HIV infection rates, evaluate HIV-1 genetic diversity, drug resistance, and to identify HIV transmission clusters in heavy drug users (DUs). For this purpose, DUs were recruited in the context of a Respondent-Driven Sampling (RDS) study in different Brazilian cities during 2009. Overall, 2,812 individuals were tested for HIV, and 168 (6%) of them were positive, of which 19 (11.3%) were classified as recent seroconverters, corresponding to an estimated incidence rate of 1.58%/year (95% CI 0.92-2.43%). Neighbor joining phylogenetic trees from env and pol regions and bootscan analyses were employed to subtype the virus from132 HIV-1-infected individuals. HIV-1 subtype B was prevalent in most of the cities under analysis, followed by BF recombinants (9%-35%). HIV-1 subtype C was the most prevalent in Curitiba (46%) and Itajai (86%) and was also detected in Brasilia (9%) and Campo Grande (20%). Pure HIV-1F infections were detected in Rio de Janeiro (9%), Recife (6%), Salvador (6%) and Brasilia (9%). Clusters of HIV transmission were assessed by Maximum likelihood analyses and were cross-compared with the RDS network structure. Drug resistance mutations were verified in 12.2% of DUs. Our findings reinforce the importance of the permanent HIV-1 surveillance in distinct Brazilian cities due to viral resistance and increasing subtype heterogeneity all over Brazil, with relevant implications in terms of treatment monitoring, prophylaxis and vaccine development.	[Guimaraes, Monick Lindenmeyer; Leires Marques, Bianca Cristina; Maia Teixeira, Sylvia Lopes; Morgado, Mariza Goncalves] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Bertoni, Neilane; Bastos, Francisco Inacio] Fiocruz MS, Inst Comunicacao & Informacao Cient & Tecnol Saud, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Guimaraes, ML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	monicklg@ioc.fiocruz.br	Bertoni, Neilane/F-4026-2014		Brazilian Ministry of Health	Brazilian Ministry of Health	This study was funded by the Brazilian Ministry of Health.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Argentinean Ministry of Hlealth, 2014, B VIH SID ARG; Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Bastos Francisco I, 2008, Rev. Saúde Pública, V42, P109, DOI 10.1590/S0034-89102008000800013; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; Bastos FI, 2012, SUBST USE MISUSE, V47, P1603, DOI 10.3109/10826084.2012.705678; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bermudez-Aza EH, 2011, JAIDS-J ACQ IMM DEF, V57, pS186, DOI 10.1097/QAI.0b013e31821e9c36; Brazilian Ministry of Health, 2013, B EP HIV AIDS; Brazilian Ministry of Health, 2014, B EP HIV AIDS; Brigido LFM, 2011, AIDS RES HUM RETROV, V27, P339, DOI 10.1089/aid.2010.0157; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Caiaffa Waleska Teixeira, 2006, Cad. Saúde Pública, V22, P771, DOI 10.1590/S0102-311X2006000400016; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Cunha LKH, 2012, BRAZ J MED BIOL RES, V45, P104, DOI 10.1590/S0100-879X2012007500003; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; De Boni R, 2005, CAD SAUDE PUBLICA, V32, P5; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Espinosa A, 2004, JAIDS-J ACQ IMM DEF, V36, P630, DOI 10.1097/00126334-200405010-00012; Fischer B, 2013, INT J DRUG POLICY, V24, P631, DOI 10.1016/j.drugpo.2013.09.003; Frentz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094495; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guimaraes ML, 2001, J CLIN VIROL, V21, P143, DOI 10.1016/S1386-6532(01)00158-5; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hacker MA, 2005, SUBST USE MISUSE, V40, P99, DOI 10.1081/JA-200030511; Hicks PL, 2007, AIDS CARE, V19, P1134, DOI 10.1080/09540120701351888; Inciardi JA, 2006, J PSYCHOACTIVE DRUGS, V38, P305, DOI 10.1080/02791072.2006.10399856; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Malta M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-317; Mesquita F, 2001, J ACQ IMMUN DEF SYND, V28, P298, DOI 10.1097/00042560-200111010-00016; Nogueira M, 2013, INCREASING HETEROSEX, V404, P396; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAY S, 2009, SIMPLOT V3 5 1; Ristic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017485; Rossini MAA, 2001, BRAZ J MED BIOL RES, V34, P45, DOI 10.1590/S0100-879X2001000100005; Shoptaw S, 2013, JAIDS-J ACQ IMM DEF, V63, pS174, DOI 10.1097/QAI.0b013e3182987028; Soares CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102676; Sosa-Estani S, 2003, CLIN INFECT DIS, V37, pS338, DOI 10.1086/377556; Teixeira SLM, 2006, J MED VIROL, V78, P764, DOI 10.1002/jmv.20621; Teixeira SLM, 2004, J CLIN VIROL, V31, P221, DOI 10.1016/j.jcv.2004.03.016; Telles-Dias PR, 2007, REV SAUDE PUBL, V41, DOI 10.1590/S0034-89102007000900015; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo L, 2011, JAIDS-J ACQ IMM DEF, V57, pS136, DOI 10.1097/QAI.0b013e31821e9981; UNAIDS, 2013, METH UND HIV EST; Cardoso LPV, 2010, J MED VIROL, V82, P351, DOI 10.1002/jmv.21722; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Werb D, 2010, LANCET INFECT DIS, V10, P464, DOI 10.1016/S1473-3099(10)70097-9; Wood E, 2003, CAN MED ASSOC J, V169, P656; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed	54	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141372	10.1371/journal.pone.0141372	http://dx.doi.org/10.1371/journal.pone.0141372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536040	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400060
J	Rath, S; Salinas, M; Villegas, AG; Ramaswamy, S				Rath, Sasmita; Salinas, Manuel; Villegas, Ana G.; Ramaswamy, Sharan			Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype	PLOS ONE			English	Article							FLUID SHEAR-STRESS; CONGENITAL AORTIC-STENOSIS; TRILEAFLET HEART-VALVES; TIME RT-PCR; PULSATILE BIOREACTOR; ENDOTHELIAL-CELLS; TISSUE; DESIGN; IDENTIFICATION; REPLACEMENT	For treatment of critical heart valve diseases, prosthetic valves perform fairly well in most adults; however, for pediatric patients, there is the added requirement that the replacement valve grows with the child, thus extremely limiting current treatment options. Tissue engineered heart valves (TEHV), such as those derived from autologous bone marrow stem cells (BMSCs), have the potential to recapitulate native valve architecture and accommodate somatic growth. However, a fundamental pre-cursor in promoting directed integration with native tissues rather than random, uncontrolled growth requires an understanding of BMSC mechanobiological responses to valve-relevant mechanical environments. Here, we report on the responses of human BMSC-seeded polymer constructs to the valve-relevant stress states of: (i) steady flow alone, (ii) cyclic flexure alone, and (iii) the combination of cyclic flexure and steady flow (flex-flow). BMSCs were seeded onto a PGA: PLLA polymer scaffold and cultured in static culture for 8 days. Subsequently, the aforementioned mechanical conditions, (groups consisting of steady flow alone-850ml/min, cyclic flexure alone-1 Hz, and flex-flow-850ml/min and 1 Hz) were applied for an additional two weeks. We found samples from the flex-flow group exhibited a valve-like distribution of cells that expressed endothelial (preference to the surfaces) and myofibroblast (preference to the intermediate region) phenotypes. We interpret that this was likely due to the presence of both appreciable fluid-induced shear stress magnitudes and oscillatory shear stresses, which were concomitantly imparted onto the samples. These results indicate that flex-flow mechanical environments support directed in vitro differentiation of BMSCs uniquely towards a heart valve phenotype, as evident by cellular distribution and expression of specific gene markers. A priori guidance of BMSC-derived, engineered tissue growth under flex-flow conditions may serve to subsequently promote controlled, engineered to native tissue integration processes in vivo necessary for successful long-term valve remodeling.	[Rath, Sasmita; Salinas, Manuel; Villegas, Ana G.; Ramaswamy, Sharan] Florida Int Univ, Dept Biomed Engn, Miami, FL 33174 USA	State University System of Florida; Florida International University	Ramaswamy, S (corresponding author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33174 USA.	sramaswa@fiu.edu	Sharan, Ramaswamy/H-4469-2019	Ramaswamy, Sharan/0000-0003-4108-7141	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Sasmita Rath, provided by the university graduate school at FIU, is gratefully acknowledged.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Alfonso AR, 2013, ACTA BIOMATER, V9, P8149, DOI 10.1016/j.actbio.2013.06.009; [Anonymous], KEY OP TRAIN KIT POW; Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723; Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260; Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367; Brand NJ, 2006, INT J BIOCHEM CELL B, V38, P30, DOI 10.1016/j.biocel.2005.06.018; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Dumont K, 2002, ARTIF ORGANS, V26, P710, DOI 10.1046/j.1525-1594.2002.06931_3.x; Engelmayr GC, 2008, ANN BIOMED ENG, V36, P700, DOI 10.1007/s10439-008-9447-6; Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012; Flanagan Thomas C., 2003, European Cells & Materials, V6, P28; Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hildebrand DK, 2004, ANN BIOMED ENG, V32, P1039, DOI 10.1114/B:ABME.0000036640.11387.4b; Hoerstrup SP, 2000, CIRCULATION, V102, P44; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57; Justo RN, 1996, AM J CARDIOL, V77, P1332, DOI 10.1016/S0002-9149(96)00201-9; Kadner A, 2002, ANN THORAC SURG, V74, pS1422; KONNO S, 1975, J THORAC CARDIOV SUR, V70, P909; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Martinez C, 2013, MOL IMAGING, V12; Martinez C, 2013, TISSUE ENG PT A, V19, P458, DOI [10.1089/ten.tea.2012.0149, 10.1089/ten.TEA.2012.0149]; Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Ramaswamy S, NOVEL BIOREACT UNPUB; Ramaswamy S BS, 2014, J BIOMECHANICAL ENG; Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019; Rath S, 2015, J LONG-TERM EFF MED, V25; REYNOLDS JL, 1960, NEW ENGL J MED, V262, P276, DOI 10.1056/NEJM196002112620603; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Salinas M, 2014, J BIOMECH, V47, P3517, DOI 10.1016/j.jbiomech.2014.08.028; Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002; Schmidt D, 2007, CIRCULATION, V116, pI64, DOI 10.1161/CIRCULATIONAHA.106.6806637; Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040; Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Steinhoff G, 2000, CIRCULATION, V102, P50; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Yap CH, 2012, BIOMECH MODEL MECHAN, V11, P171, DOI 10.1007/s10237-011-0301-7; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	56	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141802	10.1371/journal.pone.0141802	http://dx.doi.org/10.1371/journal.pone.0141802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536240	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400089
J	Salilew-Wondim, D; Fournier, E; Hoelker, M; Saeed-Zidane, M; Tholen, E; Looft, C; Neuhoff, C; Besenfelder, U; Havlicek, V; Rings, F; Gagne, D; Sirard, MA; Robert, C; Saadi, HAS; Gad, A; Schellander, K; Tesfaye, D				Salilew-Wondim, Dessie; Fournier, Eric; Hoelker, Michael; Saeed-Zidane, Mohammed; Tholen, Ernst; Looft, Christian; Neuhoff, Christiane; Besenfelder, Urban; Havlicek, Vita; Rings, Franca; Gagne, Dominic; Sirard, Marc-Andre; Robert, Claude; Saadi, Habib A. Shojaei; Gad, Ahmed; Schellander, Karl; Tesfaye, Dawit			Genome-Wide DNA Methylation Patterns of Bovine Blastocysts Developed In Vivo from Embryos Completed Different Stages of Development In Vitro	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; CPG-ISLANDS; BODY METHYLATION; MESSENGER-RNA; TRANSCRIPTOME; OOCYTES; TISSUE; DEMETHYLATION; EPIGENETICS; ERRORS	Early embryonic loss and altered gene expression in in vitro produced blastocysts are believed to be partly caused by aberrant DNA methylation. However, specific embryonic stage which is sensitive to in vitro culture conditions to alter the DNA methylation profile of the resulting blastocysts remained unclear. Therefore, the aim of this study was to investigate the stage specific effect of in vitro culture environment on the DNA methylation response of the resulting blastocysts. For this, embryos cultured in vitro until zygote (ZY), 4-cell (4C) or 16-cell (16C) were transferred to recipients and the blastocysts were recovery at day 7 of the estrous cycle. Another embryo group was cultured in vitro until blastocyst stage (IVP). Genome-wide DNA methylation profiles of ZY, 4C, 16C and IVP blastocyst groups were then determined with reference to blastocysts developed completely under in vivo condition (VO) using EmbryoGENE DNA Methylation Array. To assess the contribution of methylation changes on gene expression patterns, the DNA methylation data was superimposed to the transcriptome profile data. The degree of DNA methylation dysregulation in the promoter and/or gene body regions of the resulting blastocysts was correlated with successive stages of development the embryos advanced under in vitro culture before transfer to the in vivo condition. Genomic enrichment analysis revealed that in 4C and 16C blastocyst groups, hypermethylated loci were outpacing the hypomethylated ones in intronic, exonic, promoter and proximal promoter regions, whereas the reverse was observed in ZY blastocyst group. However, in the IVP group, as much hypermethylated as hypomethylated probes were detected in gene body and promoter regions. In addition, gene ontology analysis indicated that differentially methylated regions were found to affected several biological functions including ATP binding in the ZY group, programmed cell death in the 4C, glycolysis in 16C and genetic imprinting and chromosome segregation in IVP blastocyst groups. Furthermore, 1.6, 3.4, 3.9 and 9.4% of the differentially methylated regions that were overlapped to the transcriptome profile data were negatively correlated with the gene expression patterns in ZY, 4C, 16C and IVP blastocyst groups, respectively. Therefore, this finding indicated that suboptimal culture condition during preimplantation embryo development induced changes in the DNA methylation landscape of the resulting blastocysts in a stage dependent manner and the altered DNA methylation pattern was only partly explained the observed aberrant gene expression patterns of the blastocysts.	[Salilew-Wondim, Dessie; Hoelker, Michael; Saeed-Zidane, Mohammed; Tholen, Ernst; Looft, Christian; Neuhoff, Christiane; Rings, Franca; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, D-53115 Bonn, Germany; [Fournier, Eric; Gagne, Dominic; Sirard, Marc-Andre; Robert, Claude; Saadi, Habib A. Shojaei] Univ Laval Quebec, Fac Sci Agr & Alimentat, Ctr Rech Biol Reprod, INAF, Laval, PQ G1V 0A6, Canada; [Besenfelder, Urban; Havlicek, Vita] Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria; [Gad, Ahmed] Cairo Univ, Fac Agr, Dept Anim Prod, Giza 12613, Egypt	University of Bonn; Istituto Nazionale Astrofisica (INAF); Laval University; University of Veterinary Medicine Vienna; Egyptian Knowledge Bank (EKB); Cairo University	Salilew-Wondim, D (corresponding author), Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, D-53115 Bonn, Germany.	dsal@itw.uni-bonn.de	Sirard, Marc/A-9112-2011; Saadi, Habib A. Shojaei/U-6878-2019; Gad, Ahmed/M-7273-2013	Gad, Ahmed/0000-0001-9741-2105; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865	EmbryoGENE Research Network, Canada	EmbryoGENE Research Network, Canada	Funding: This research was funded by EmbryoGENE Research Network, Canada.	Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BARNES FL, 1991, MOL REPROD DEV, V29, P117, DOI 10.1002/mrd.1080290205; Betsha S, 2013, MOL REPROD DEV, V80, P315, DOI 10.1002/mrd.22165; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bogliotti YS, 2015, ANIM REPROD, V12, P52; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Clemente M, 2011, BIOL REPROD, V85, P285, DOI 10.1095/biolreprod.111.091587; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dessie SW, 2007, REPRODUCTION, V133, P931, DOI 10.1530/REP-06-0277; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Elango N, 2011, GENETICS, V187, P1077, DOI 10.1534/genetics.110.126094; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; FREI RE, 1989, J REPROD FERTIL, V86, P637, DOI 10.1530/jrf.0.0860637; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Han L, 2007, CANCER BIOL THER, V6, P1284; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; Hou J, 2007, SCI CHINA SER C, V50, P56, DOI 10.1007/s11427-007-0003-7; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mamrut S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056869; Memili E, 1998, MOL REPROD DEV, V51, P36, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;36::AID-MRD4&gt;3.0.CO;2-X; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Michels KB, 2013, NAT METHODS, V10, P949, DOI 10.1038/nmeth.2632; PARK JG, 1994, MOL CELL BIOL, V14, P7975, DOI 10.1128/MCB.14.12.7975; Park JS, 2007, DEV DYNAM, V236, P2523, DOI 10.1002/dvdy.21278; Silva ARRE, 2012, EPIGENETICS-US, V7, P440, DOI 10.4161/epi.19563; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Saadi HAS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-451; Salilew-Wondim D, 2013, PHYSIOL GENOMICS, V45, P28, DOI 10.1152/physiolgenomics.00076.2012; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Shen J, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/230642; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-12; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tesfaye D, 2004, REPROD DOMEST ANIM, V39, P396, DOI 10.1111/j.1439-0531.2004.00531.x; Tesfaye D, 2003, MOL REPROD DEV, V66, P105, DOI 10.1002/mrd.10338; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Viuff D, 1996, MOL REPROD DEV, V43, P171, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;171::AID-MRD6&gt;3.0.CO;2-O; Wrenzycki Christine, 2003, Reprod Biomed Online, V7, P649; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Young LE, 2004, ANIM REPROD SCI, V82-3, P61, DOI 10.1016/j.anireprosci.2004.05.020	61	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140467	10.1371/journal.pone.0140467	http://dx.doi.org/10.1371/journal.pone.0140467			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536655	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400021
J	Winiecka-Klimek, M; Smolarz, M; Walczak, MP; Zieba, J; Hulas-Bigoszewska, K; Kmieciak, B; Piaskowski, S; Rieske, P; Grzela, DP; Stoczynska-Fidelus, E				Winiecka-Klimek, Marta; Smolarz, Maciej; Walczak, Maciej P.; Zieba, Jolanta; Hulas-Bigoszewska, Krystyna; Kmieciak, Blazej; Piaskowski, Sylwester; Rieske, Piotr; Grzela, Dawid P.; Stoczynska-Fidelus, Ewelina			SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence	PLOS ONE			English	Article							DIRECT CONVERSION; MOUSE FIBROBLASTS; DEFINED FACTORS; SOMATIC-CELLS; DOPAMINERGIC-NEURONS; PROGENITOR CELLS; PRECURSOR CELLS; DIFFERENTIATION; EXPRESSION; BRAIN	Tumorigenic potential of induced pluripotent stem cells (iPSCs) infiltrating population of induced neural stem cells (iNSCs) generated from iPSCs may limit their medical applications. To overcome such a difficulty, direct reprogramming of adult somatic cells into iNSCs was proposed. The aim of this study was the systematic comparison of induced neural cells (iNc) obtained with different methods-direct reprogramming of human adult fibroblasts with either SOX2 (SiNSc-like) or SOX2 and c-MYC (SMiNSc-like) and induced pluripotent stem cells differentiation to ebiNSc-in terms of gene expression profile, differentiation potential as well as proliferation properties. Immunocytochemistry and real-time PCR analyses were used to evaluate gene expression profile and differentiation potential of various iNc types. Bromodeoxyuridine (BrdU) incorporation and senescence-associated beta-galactosidase (SA-beta-gal) assays were used to estimate proliferation potential. All three types of iNc were capable of neuronal differentiation; however, astrocytic differentiation was possible only in case of ebiNSc. Contrary to ebiNSc generation, the direct reprogramming was rarely a propitious process, despite 100% transduction efficiency. The potency of direct iNSCs-like cells generation was lower as compared to iNSCs obtained by iPSCs differentiation, and only slightly improved when c-MYC was added. Directly reprogrammed iNSCs-like cells were lacking the ability to differentiate into astrocytic cells and characterized by poor efficiency of neuronal cells formation. Such features indicated that these cells could not be fully reprogrammed, as confirmed mainly with senescence detection. Importantly, SiNSc-like and SMiNSc-like cells were unable to achieve the long-term survival and became senescent, which limits their possible therapeutic applicability. Our results suggest that iNSCs-like cells, generated in the direct reprogramming attempts, were either not fully reprogrammed or reprogrammed only into neuronal progenitors, mainly because of the inaccuracies of currently available protocols.	[Winiecka-Klimek, Marta; Smolarz, Maciej; Walczak, Maciej P.; Zieba, Jolanta; Hulas-Bigoszewska, Krystyna; Piaskowski, Sylwester; Rieske, Piotr; Grzela, Dawid P.; Stoczynska-Fidelus, Ewelina] Celther Polska, Dept Res & Dev, Lodz, Poland; [Winiecka-Klimek, Marta; Smolarz, Maciej; Zieba, Jolanta; Piaskowski, Sylwester; Rieske, Piotr; Stoczynska-Fidelus, Ewelina] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Kmieciak, Blazej] Med Univ Lodz, Chair Human Sci, Dept Med Law, Lodz, Poland	Medical University Lodz; Medical University Lodz	Winiecka-Klimek, M (corresponding author), Celther Polska, Dept Res & Dev, Lodz, Poland.	marta.winiecka-klimek@celther.com	Rieske, Piotr/M-4821-2015; Grzela, Dawid P/G-6395-2015; Stoczynska-Fidelus, Ewelina/S-9948-2016; Stoczynska-Fidelus, Ewelina/M-4871-2015	Rieske, Piotr/0000-0002-2970-0970; Grzela, Dawid P/0000-0002-0667-6488; Kmieciak, Blazej/0000-0002-6347-1796; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075	Polish Agency for Enterprise Development [POIG.01.04.00-10-011/11]	Polish Agency for Enterprise Development	This study was sponsored by Polish Agency for Enterprise Development, Grant No. POIG.01.04.00-10-011/11. ESF, PR, and SP participated in acquisition of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1998, EXP HEMATOL, V26, P143; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Beguin PC, 2012, J CELL PHYSIOL, V227, P813, DOI 10.1002/jcp.22794; Bi D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-46; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Glettig DL, 2013, BIORESEARCH OPEN ACC, V2, P179, DOI 10.1089/biores.2013.0006; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hemmer K, 2014, STEM CELL REP, V3, P423, DOI 10.1016/j.stemcr.2014.06.017; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Kerosuo L, 2010, DIFFERENTIATION, V80, P68, DOI 10.1016/j.diff.2010.04.003; KILPATRICK TJ, 1993, J NEUROSCI RES, V35, P147, DOI 10.1002/jnr.490350205; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Kishaba Y, 2010, PATHOL INT, V60, P378, DOI 10.1111/j.1440-1827.2010.02532.x; Kodama S, 2001, RADIAT RES, V155, P254, DOI 10.1667/0033-7587(2001)155[0254:CCDSLG]2.0.CO;2; Kumar A, 2012, J MOL CELL BIOL, V4, P252, DOI 10.1093/jmcb/mjs015; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Maucksch C, 2012, J STEM CELLS REGEN, V8, pP162; Oh J, 2010, J NEUROSCI RES, V88, P2798, DOI 10.1002/jnr.22447; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park TIH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037742; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Polouliakh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00007; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rieske P, 2009, EXP CELL RES, V315, P462, DOI 10.1016/j.yexcr.2008.11.004; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rosser AE, 1997, DEV BRAIN RES, V98, P291, DOI 10.1016/S0165-3806(96)00189-7; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sun CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5112; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKANASHI H, 1994, IN VITRO CELL DEV-AN, V30A, P384, DOI 10.1007/BF02634359; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224	57	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141688	10.1371/journal.pone.0141688	http://dx.doi.org/10.1371/journal.pone.0141688			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535892	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400077
J	Jang, H; Lee, JH; Braatz, RD				Jang, Hong; Lee, Jay H.; Braatz, Richard D.			State Estimation of the Time-Varying and Spatially Localized Concentration of Signal Molecules from the Stochastic Adsorption Dynamics on the Carbon Nanotube-Based Sensors and Its Application to Tumor Cell Detection	PLOS ONE			English	Article							NITRIC-OXIDE; FLUORESCENT-PROBES; HYDROGEN-PEROXIDE; PARTICLE FILTERS; SMOOTH-MUSCLE; GROWTH; ROLES; PROLIFERATION; DEATH; ASSAY	This paper addresses a problem of estimating time-varying, local concentrations of signal molecules with a carbon-nanotube (CNT)-based sensor array system, which sends signals triggered by monomolecular adsorption/desorption events of proximate molecules on the surfaces of the sensors. Such sensors work on nano-scale phenomena and show inherently stochastic non-Gaussian behavior, which is best represented by the chemical master equation (CME) describing the time evolution of the probabilities for all the possible number of adsorbed molecules. In the CME, the adsorption rate on each sensor is linearly proportional to the local concentration in the bulk phase. State estimators are proposed for these types of sensors that fully address their stochastic nature. For CNT-based sensors motivated by tumor cell detection, the particle filter, which is nonparametric and can handle non-Gaussian distributions, is compared to a Kalman filter that approximates the underlying distributions by Gaussians. In addition, the second-order generalized pseudo Bayesian estimation (GPB2) algorithm and the Markov chain Monte Carlo (MCMC) algorithm are incorporated into KF and PF respectively, for detecting latent drift in the concentration affected by different states of a cell.	[Jang, Hong; Lee, Jay H.] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea; [Braatz, Richard D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea.	jayhlee@kaist.ac.kr	Lee, Jay Hyung/C-1808-2011; Braatz, Richard D/I-6725-2015	Lee, Jay Hyung/0000-0001-6134-6118; Braatz, Richard D/0000-0003-4304-3484	Advanced Biomass R&D Center(ABC) of Global Frontier Project - Ministry of Science, ICT and Future Planning [ABC-2011-0031354]	Advanced Biomass R&D Center(ABC) of Global Frontier Project - Ministry of Science, ICT and Future Planning	This work was supported by the Advanced Biomass R&D Center(ABC) of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning (ABC-2011-0031354). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Bar-Shalom Y, 1993, ESTIMATION TRACKING; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Boghossian AA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3606496; Bracewell RN., 1986, FOURIER TRANSFORM IT; Casanova D, 2009, NAT NANOTECHNOL, V4, P581, DOI [10.1038/nnano.2009.200, 10.1038/NNANO.2009.200]; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Czubryt MR, 2003, PROG EXP CARDIOL, V7, P249; Doucet A, 2001, IEEE T SIGNAL PROCES, V49, P613, DOI 10.1109/78.905890; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Garipcan B, 2011, ADV ENG MATER, V13, pB54, DOI 10.1002/adem.201080076; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Hayter AJ., 2012, CENGAGE LEARNING; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jahnke T, 2007, J MATH BIOL, V54, P1, DOI 10.1007/s00285-006-0034-x; Jang H., 2015, P 2015 52 ACM EDAC I, P1, DOI DOI 10.1109/FCV.2015.7103755; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jin H, 2010, NAT NANOTECHNOL, V5, P302, DOI [10.1038/nnano.2010.24, 10.1038/NNANO.2010.24]; Jin H, 2008, NANO LETT, V8, P4299, DOI 10.1021/nl802010z; Jones MK, 2004, BIOCHEM BIOPH RES CO, V318, P520, DOI 10.1016/j.bbrc.2004.04.055; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kim J.H., 2010, ANGEW CHEM, V122, P1498; Kim JH, 2009, NAT CHEM, V1, P473, DOI [10.1038/NCHEM.332, 10.1038/nchem.332]; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Li PF, 1997, CIRCULATION, V96, P3602; Lim MH, 2007, ACCOUNTS CHEM RES, V40, P41, DOI 10.1021/ar950149t; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Morbidelli L, 2004, CANC TREAT, V117, P155; Moses MA, 1995, INT REV CYTOL, V161, P1; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Robinson JK, 1999, ANAL CHEM, V71, P5131, DOI 10.1021/ac990646d; Saito S, 2008, CONT CONCEPT CONDENS, P1; Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Staniek K, 1999, BBA-BIOENERGETICS, V1413, P70, DOI 10.1016/S0005-2728(99)00083-3; Truskey G., 2009, TRANSPORT PHENOMENA; Ulissi ZW, 2013, COMPUT CHEM ENG, V51, P149, DOI 10.1016/j.compchemeng.2012.07.004; Ulissi ZW, 2011, J PHYS CHEM LETT, V2, P1690, DOI 10.1021/jz200572b; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wong WC, 2010, IND ENG CHEM RES, V49, P7901, DOI 10.1021/ie9020655; Wong WC, 2009, J PROCESS CONTR, V19, P1438, DOI 10.1016/j.jprocont.2009.04.014; Zhang JQ, 2011, J AM CHEM SOC, V133, P567, DOI 10.1021/ja1084942	49	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141930	10.1371/journal.pone.0141930	http://dx.doi.org/10.1371/journal.pone.0141930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528927	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600078
J	Nakatsuji, M; Inoue, H; Kohno, M; Saito, M; Tsuge, S; Shimizu, S; Ishida, A; Ishibashi, O; Inui, T				Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishida, Atsuko; Ishibashi, Osamu; Inui, Takashi			Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38	PLOS ONE			English	Article							LIPOPHILIC LIGANDS; POLYMERIC MICELLES; CANCER; CPT-11; SN38; MODEL; TUMOR; CAMPTOTHECIN; IRINOTECAN; BINDING	Lipocalin-type prostaglandin D synthase (L-PGDS) is a member of the lipocalin superfamily, which is composed of secretory transporter proteins, and binds a wide variety of small hydrophobic molecules. Using this function, we have reported the feasibility of using L-PGDS as a novel drug delivery vehicle for poorly water-soluble drugs. In this study, we show the development of a drug delivery system using L-PGDS, one that enables the direct clinical use of 7-ethyl-10-hydroxy-camptothecin (SN-38), a poorly water-soluble anti-cancer drug. In the presence of 2 mM L-PGDS, the concentration of SN-38 in PBS increased 1,130-fold as compared with that in PBS. Calorimetric experiments revealed that L-PGDS bound SN-38 at a molecular ratio of 1: 3 with a dissociation constant value of 60 mu M. The results of an in vitro growth inhibition assay revealed that the SN-38/L-PGDS complexes showed high anti-tumor activity against 3 human cancer cell lines, i.e., Colo201, MDA-MB-231, and PC-3 with a potency similar to that of SN-38 used alone. The intravenous administration of SN-38/L-PGDS complexes to mice bearing Colo201 tumors showed a pronounced anti-tumor effect. Intestinal mucositis, which is one of the side effects of this drug, was not observed in mice administered SN-38/L-PGDS complexes. Taken together, L-PGDS enables the direct usage of SN-38 with reduced side effects.	[Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishida, Atsuko; Ishibashi, Osamu; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Osaka Metropolitan University	Inui, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	inuit@bioinfo.osakafu-u.ac.jp	Ishibashi, Osamu/J-8413-2019; Inui, Takashi/G-1069-2011	Ishibashi, Osamu/0000-0003-4698-460X; 	Japan Society for the Promotion of Science [25242046, 21200076]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants 25242046 (to TI), and 21200076 (to TI) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/).	Abu Lila AS, 2013, J CONTROL RELEASE, V172, P38, DOI 10.1016/j.jconrel.2013.07.026; Al-Jamal WT, 2011, ACCOUNTS CHEM RES, V44, P1094, DOI 10.1021/ar200105p; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bala V, 2013, J CONTROL RELEASE, V172, P48, DOI 10.1016/j.jconrel.2013.07.022; Cavadas M, 2011, NANOMED-NANOTECHNOL, V7, P730, DOI 10.1016/j.nano.2011.04.006; Chadha R, 2008, J SCI IND RES INDIA, V67, P185; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Ebrahimnejad P, 2011, INT J PHARMACEUT, V406, P122, DOI 10.1016/j.ijpharm.2010.12.022; Fukuhara A, 2012, J CONTROL RELEASE, V159, P143, DOI 10.1016/j.jconrel.2011.12.020; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; FUKUOKA M, 1992, J CLIN ONCOL, V10, P16, DOI 10.1200/JCO.1992.10.1.16; Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641; Gong J, 2012, J CONTROL RELEASE, V159, P312, DOI 10.1016/j.jconrel.2011.12.012; Guichard S, 1999, BRIT J CANCER, V80, P364, DOI 10.1038/sj.bjc.6690364; Guo Q, 2012, COLLOID SURFACE B, V100, P138, DOI 10.1016/j.colsurfb.2012.04.041; Inoue K, 2009, J BIOCHEM, V145, P169, DOI 10.1093/jb/mvn154; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Inui T, 2014, J CEREBR BLOOD F MET, V34, P1558, DOI 10.1038/jcbfm.2014.127; Jiskoot W, 2009, PHARM RES-DORDR, V26, P1303, DOI 10.1007/s11095-009-9855-9; Koizumi F, 2006, CANCER RES, V66, P10048, DOI 10.1158/0008-5472.CAN-06-1605; Kume S, 2012, BIOCHEM J, V446, P279, DOI 10.1042/BJ20120324; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Meyer-Losic F, 2008, CLIN CANCER RES, V14, P2145, DOI 10.1158/1078-0432.CCR-07-4580; Miyamoto Y, 2010, J STRUCT BIOL, V169, P209, DOI 10.1016/j.jsb.2009.10.005; Mizoguchi M, 2015, EUR J PHARM SCI, V74, P77, DOI 10.1016/j.ejps.2015.04.012; Peng CL, 2009, BIOMATERIALS, V30, P3614, DOI 10.1016/j.biomaterials.2009.03.048; ROTHENBERG ML, 1993, J CLIN ONCOL, V11, P2194, DOI 10.1200/JCO.1993.11.11.2194; Rothenberg ML, 1997, ANN ONCOL, V8, P837, DOI 10.1023/A:1008270717294; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Sepehri N, 2014, INT J PHARMACEUT, V471, P485, DOI 10.1016/j.ijpharm.2014.05.046; Shimamoto S, 2007, J BIOL CHEM, V282, P31373, DOI 10.1074/jbc.M700123200; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Slatter JG, 2000, DRUG METAB DISPOS, V28, P423; Svenson S, 2009, EUR J PHARM BIOPHARM, V71, P445, DOI 10.1016/j.ejpb.2008.09.023; Takasuna K, 1996, CANCER RES, V56, P3752; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vangara KK, 2014, AAPS PHARMSCITECH, V15, P472, DOI 10.1208/s12249-013-0068-5; Verhoef JJF, 2013, DRUG DELIV TRANSL RE, V3, P499, DOI 10.1007/s13346-013-0176-5; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s; Zhou YY, 2010, FASEB J, V24, P4668, DOI 10.1096/fj.10-164863	44	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142206	10.1371/journal.pone.0142206	http://dx.doi.org/10.1371/journal.pone.0142206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529243	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600110
J	Alkooranee, JT; Yin, YT; Aledan, TR; Jiang, YF; Lu, GY; Wu, JS; Li, MT				Alkooranee, Jawadayn Talib; Yin, Yongtai; Aledan, Tamarah Raad; Jiang, Yingfen; Lu, Guangyuan; Wu, Jiangsheng; Li, Maoteng			Systemic Resistance to Powdery Mildew in Brassica napus (AACC) and Raphanus alboglabra (RRCC) by Trichoderma harzianum TH12	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ERYSIPHE-CRUCIFERARUM; ACQUIRED-RESISTANCE; DISEASE RESISTANCE; DEFENSE RESPONSES; JUNCEA CHITINASE; PLANT-RESPONSES; SATIVUS L.; CELL-WALL; GENE	Trichoderma harzianum TH12 is a microbial pesticide for certain rapeseed diseases. The mechanism of systemic resistance induced by TH12 or its cell-free culture filtrate (CF) in Brassica napus (AACC) and Raphanus alboglabra (RRCC) to powdery mildew disease caused by ascomycete Erysiphe cruciferarum was investigated. In this study, we conducted the first large-scale global study on the cellular and molecular aspects of B. napus and R. alboglabra infected with E. cruciferarum. The histological study showed the resistance of R. alboglabra to powdery mildew disease. The growth of fungal colonies was not observed on R. alboglabra leaves at 1, 2, 4, 6, 8, and 10 days post-inoculation (dpi), whereas this was clearly observed on B. napus leaves after 6 dpi. In addition, the gene expression of six plant defense-related genes, namely, PR-1, PR-2 (a marker for SA signaling), PR-3, PDF 1.2 (a marker for JA/ET signaling), CHI620, and CHI570, for both genotypes were analyzed in the leaves of B. napus and R. alboglabra after treatment with TH12 or CF and compared with the non-treated ones. The qRT-PCR results showed that the PR-1 and PR-2 expression levels increased in E. cruciferarum-infected leaves, but decreased in the TH12-treated leaves compared with leaves treated with CF. The expression levels of PR-3 and PDF1.2 decreased in plants infected by E. cruciferarum. However, expression levels increased when the leaves were treated with TH12. For the first time, we disclosed the nature of gene expression in B. napus and R. alboglabra to explore the resistance pathways in the leaves of both genotypes infected and non-infected by powdery mildew and inoculated or non-inoculated with elicitor factors. Results suggested that R. alboglabra exhibited resistance to powdery mildew disease, and the application of T. harzianum and its CF are a useful tool to facilitate new protection methods for resist or susceptible plants.	[Alkooranee, Jawadayn Talib; Yin, Yongtai; Aledan, Tamarah Raad; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Peoples R China; [Alkooranee, Jawadayn Talib] Univ Basrah, Dept Plant Protect, Coll Agr, Basrah, Iraq; [Alkooranee, Jawadayn Talib; Li, Maoteng] Huanggang Normal Univ, Hubei Collaborat Innovat Ctr Characterist Resourc, Huanggang, Peoples R China; [Jiang, Yingfen] Anhui Acad Agr Sci, Crops Inst, Hefei, Anhui, Peoples R China; [Lu, Guangyuan] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Wu, Jiangsheng] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong University of Science & Technology; University of Basrah; Huanggang Normal University; Anhui Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Huazhong Agricultural University	Lu, GY (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	luwiz@oilcrops.cn; limaoteng426@mail.hust.edu.cn	Alkooranee, Jawadayn Talib/ABG-4193-2020	Alkooranee, Jawadayn Talib/0000-0003-2997-4637	National Natural Science Foundation of China [31201267]; National 863 projects of China [2011AA10A104, 2009AA101105]; scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains [2015TD03]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 projects of China(National High Technology Research and Development Program of China); scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains; New Century Talents Support Program of the Ministry of Education of China	The work was supported by the National Natural Science Foundation of China (31201267), the National 863 projects of China (2011AA10A104, 2009AA101105), the scientific research project of Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains (2015TD03), and New Century Talents Support Program of the Ministry of Education of China (NCET110172).	Adam L, 1999, MOL PLANT MICROBE IN, V12, P1031, DOI 10.1094/MPMI.1999.12.12.1031; Ahmed NU, 2012, MOL BIOL REP, V39, P3649, DOI 10.1007/s11033-011-1139-x; Alkooranee J. T., 2015, American Journal of Plant Sciences, V6, P1662, DOI 10.4236/ajps.2015.610166; Alkooranee JT, 2015, PLANT DIS; Barilli E, 2014, EUPHYTICA, V198, P13, DOI 10.1007/s10681-014-1062-z; Chen HG, 2008, GENET RESOUR CROP EV, V55, P143, DOI 10.1007/s10722-007-9223-8; Cheng YL, 2015, PROTOPLASMA, V252, P1167, DOI 10.1007/s00709-014-0750-9; Choi HW, 2009, PLANT PATHOLOGY J, V25, P86, DOI 10.5423/PPJ.2009.25.1.086; De Meyer G, 1998, EUR J PLANT PATHOL, V104, P279, DOI 10.1023/A:1008628806616; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Enright SM, 2007, AM J BOT, V94, P1813, DOI 10.3732/ajb.94.11.1813; Fondevilla S, 2011, PLANT BREEDING, V130, P281, DOI 10.1111/j.1439-0523.2010.01769.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez K.A., 1984, STAT PROCEDURES AGR, P13; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Guan Y, 2008, PLANT SIGNAL BEHAV, V3, P1103, DOI 10.4161/psb.3.12.7006; Guan Y, 2008, J EXP BOT, V59, P3475, DOI 10.1093/jxb/ern197; Gurjar SG, 2012, AM J PLANT SCI, V3, P190; Gus-Mayer S, 1998, P NATL ACAD SCI USA, V95, P8398, DOI 10.1073/pnas.95.14.8398; Hafez YM, 2011, EGYPTIAN J PHYTOPATH, V39, P180; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Harel YM, 2014, PHYTOPATHOLOGY, V104, P150, DOI 10.1094/PHYTO-02-13-0043-R; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hossain MM, 2008, PLANT SOIL, V304, P227, DOI 10.1007/s11104-008-9542-3; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Iglesias-Garcia R, 2015, EUPHYTICA, V201, P381, DOI 10.1007/s10681-014-1221-2; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; Karossi AT, 2009, TEKNOLOGI INDONESIA, V32, P91; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Khan AM, 1972, PL480; Khanal P, 2014, J CLIN DIAGN RES, V8, P112, DOI 10.7860/JCDR/2014/6788.3956; KOCH E, 1990, BOT HELV, V100, P257; Kokina A., 2008, Agronomijas Vestis, P77; Korolev N, 2008, BIOCONTROL, V53, P667, DOI 10.1007/s10526-007-9103-3; Kumar Sudheer, 2002, Journal of Mycology and Plant Pathology, V32, P184; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Long H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117198; Maksimov IV, 2011, APPL BIOCHEM MICRO+, V47, P333, DOI 10.1134/S0003683811040090; Martinez-Medina A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00206; Meena PD, 2013, CROP PROT, V53, P169, DOI 10.1016/j.cropro.2013.07.006; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Mora-Aviles M. A., 2004, Revista Chapingo. Serie Horticultura, V10, P141; Narusaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115864; Penaud A, 1999, P 10 INT RAP C REG I; Perazzolli M, 2008, BIOL CONTROL, V47, P228, DOI 10.1016/j.biocontrol.2008.08.008; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Pombo MA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0492-1; Potlakayala SD, 2007, PHYTOPATHOLOGY, V97, P794, DOI 10.1094/PHYTO-97-7-0794; Sasek V, 2012, MOL PLANT MICROBE IN, V25, P1238, DOI 10.1094/MPMI-02-12-0033-R; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Sharma Pratibha, 2004, Journal of Biological Control, V18, P21; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Sisti M, 2003, FITOTERAPIA, V74, P453, DOI 10.1016/S0367-326X(03)00108-4; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang XL, 2014, EUPHYTICA, V198, P289, DOI 10.1007/s10681-014-1105-5; Wang Z, 2009, MOL PLANT MICROBE IN, V22, P235, DOI 10.1094/MPMI-22-3-0235; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; WILLIAMSON CJ, 1986, J AGR SCI, V107, P385, DOI 10.1017/S0021859600087190; Xiao SY, 1997, PLANT J, V12, P757, DOI 10.1046/j.1365-313X.1997.12040757.x; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220; Yu X, 2013, THEOR APPL GENET, V126, P2553, DOI 10.1007/s00122-013-2154-1; Zhan HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113455; Zhu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053901	75	19	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142177	10.1371/journal.pone.0142177	http://dx.doi.org/10.1371/journal.pone.0142177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540161	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800063
J	Li, GW; Du, J; Li, YP; Wu, JX				Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang			Identification of Putative Olfactory Genes from the Oriental Fruit Moth Grapholita molesta via an Antennal Transcriptome Analysis	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; SEX-PHEROMONE; HELICOVERPA-ARMIGERA; CYDIA-MOLESTA; HOST PLANTS; HONEY-BEE; EXPRESSION; RECEPTORS; GENOME; LEPIDOPTERA	Background The oriental fruit moth, Grapholita molesta, is an extremely important oligophagous pest species of stone and pome fruits throughout the world. As a host-switching species, adult moths, especially females, depend on olfactory cues to a large extent in locating host plants, finding mates, and selecting oviposition sites. The identification of olfactory genes can facilitate investigation on mechanisms for chemical communications. Methodology/Principal Finding We generated transcriptome of female antennae of G. molesta using the next-generation sequencing technique, and assembled transcripts from RNA-seq reads using Trinity, SOAPdenovo-trans and Abyss-trans assemblers. We identified 124 putative olfactory genes. Among the identified olfactory genes, 118 were novel to this species, including 28 transcripts encoding for odorant binding proteins, 17 chemosensory proteins, 48 odorant receptors, four gustatory receptors, 24 ionotropic receptors, two sensory neuron membrane proteins, and one odor degrading enzyme. The identified genes were further confirmed through semi-quantitative reverse transcription PCR for transcripts coding for 26 OBPs and 17 CSPs. OBP transcripts showed an obvious antenna bias, whereas CSP transcripts were detected in different tissues. Conclusion Antennal transcriptome data derived from the oriental fruit moth constituted an abundant molecular resource for the identification of genes potentially involved in the olfaction process of the species. This study provides a foundation for future research on the molecules involved in olfactory recognition of this insect pest, and in particular, the feasibility of using semiochemicals to control this pest.	[Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China; [Li, Guangwei; Du, Juan; Li, Yiping; Wu, Junxiang] Northwest A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wu, JX (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.	junxw@nwsuaf.edu.cn			National Natural Science Foundation of China [31272043]; Public Welfare Project from Ministry of Agriculture of the People's Republic of China [201103024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Project from Ministry of Agriculture of the People's Republic of China	This work was supported by National Natural Science Foundation of China (Grant No. 31272043) and Public Welfare Project from Ministry of Agriculture of the People's Republic of China (Grant No. 201103024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; CARDE AM, 1979, J CHEM ECOL, V5, P423, DOI 10.1007/BF00987927; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Dorn Silvia, 2001, IOBC-WPRS Bulletin, V24, P133; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Galindo K, 2001, GENETICS, V159, P1059; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Garczynski SF, 2013, INSECT SCI, V20, P559, DOI 10.1111/j.1744-7917.2012.01560.x; Garczynski SF, 2012, INSECT SCI, V19, P64, DOI 10.1111/j.1744-7917.2011.01423.x; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Il'ichev AL, 2009, J PLANT INTERACT, V4, P289, DOI 10.1080/17429140903267814; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Najar-Rodriguez A, 2013, J CHEM ECOL, V39, P418, DOI 10.1007/s10886-013-0262-7; Najar-Rodriguez AJ, 2011, J EXP BIOL, V214, P162, DOI 10.1242/jeb.054262; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Natale D, 2004, J APPL ENTOMOL, V128, P22, DOI 10.1046/j.1439-0418.2003.00802.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; NOMURA A, 1992, INT J DEV BIOL, V36, P391; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Pinero JC, 2008, J INSECT PHYSIOL, V54, P333, DOI 10.1016/j.jinsphys.2007.10.002; Pinero JC, 2009, ENTOMOL EXP APPL, V131, P67, DOI 10.1111/j.1570-7458.2009.00832.x; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RICE RE, 1972, J ECON ENTOMOL, V65, P1212, DOI 10.1093/jee/65.4.1212; Sato K., 2009, RESULTS PROBL CELL D, P203; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Song YQ, 2014, J INTEGR AGR, V13, P2709, DOI 10.1016/S2095-3119(13)60686-3; STEINER L. F., 1933, JOUR ECON ENT, V26, P774, DOI 10.1093/jee/26.4.774; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Varela N, 2009, CELL TISSUE RES, V337, P513, DOI 10.1007/s00441-009-0839-1; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang TT, 2012, J INSECT PHYSIOL, V58, P941, DOI 10.1016/j.jinsphys.2012.04.010; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao Z. R., 1989, Insect Knowledge, V26, P17; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930	70	29	48	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142193	10.1371/journal.pone.0142193	http://dx.doi.org/10.1371/journal.pone.0142193			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540284	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800066
J	Cornu, A; Farruggia, A; Leppik, E; Pinier, C; Fournier, F; Genoud, D; Frerot, B				Cornu, Agnes; Farruggia, Anne; Leppik, Ene; Pinier, Centina; Fournier, Florence; Genoud, David; Frerot, Brigitte			Trapping the Pasture Odorscape Using Open-Air Solid-Phase Micro Extraction, a Tool to Assess Grassland Value	PLOS ONE			English	Article							GRAZING INTENSITY; PLANTS; DIVERSITY; MICROEXTRACTION; VOLATILES; EMISSIONS; RESPONSES; INSECTS	Besides supporting cattle feeding, grasslands are home to a diversity of plants and insects that interact with each other by emitting volatile compounds. The aim of this work was to develop a method to determine permanent grassland odorscape and relate it to flower-visiting insects. Two grasslands were chosen for their contrasting levels of botanical diversity, resulting from differing grazing managements. Measurements were made over two periods of three consecutive days at the beginning of grazing, and just after the cows had left the plots. Volatile compounds were trapped using solid-phase microextraction (SPME) fibers exposed eight hours a day in three exclosures per plot, and then analyzed by gas-chromatography-mass spectrometry (GC-MS). Insects were trapped using pan traps and a net, sorted and counted. The open air SPME method yielded volatile compound profiles that were richer than maize field profiles, comprising the common green leaf volatiles (GLV) and more specific ones. Differences between the odorscapes of the two grasslands were found, but they were not as marked as expected from their botanical composition. By contrast, there were sharp differences between the two periods, resulting from the combined effects of changes in weather conditions, plant phenological stage and grazing progress. Several correlations between insect counts and volatile compounds were found. Although their correlation coefficients were low, some of them were confirmed when tested by Spearman rank correlation, and could be logically explained. This method of grassland odorscape deserves to be developed because it can provide information on many aspects of grassland function and on the stresses that grassland plants undergo.	[Cornu, Agnes; Farruggia, Anne] Clermont Univ, VetAgro Sup, INRA, Herbivores UMR1213, St Genes Champanelle, France; [Leppik, Ene; Pinier, Centina; Frerot, Brigitte] INRA, Inst Ecol & Sci Environm Paris, UMR1392, F-78026 Versailles, France; [Fournier, Florence] INRA, Unite Expt Monts Auvergne UE1296, Laqueuille, France; [Genoud, David] Diagnost Gest Environm, Arzens, France; [Genoud, David] Observ Abeilles, Arzens, France	INRAE; VetAgro Sup; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE	Cornu, A (corresponding author), Clermont Univ, VetAgro Sup, INRA, Herbivores UMR1213, St Genes Champanelle, France.	agnes.cornu@clermont.inra.fr	Cornu, Agnès/ABA-6876-2021	Cornu, Agnès/0000-0001-5954-8896; GENOUD, David/0000-0001-8564-040X	INRA; Diagnostic Gestion Environnement and Observatoire des Abeilles	INRA; Diagnostic Gestion Environnement and Observatoire des Abeilles	Funding: This work was funded by INRA. David Genoud is affiliated with Diagnostic Gestion Environnement and Observatoire des Abeilles. Diagnostic Gestion Environnement and Observatoire des Abeilles provided support in the form of salary to David Genoud, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Cornu A, 2001, J AGR FOOD CHEM, V49, P203, DOI 10.1021/jf0008341; Davis TS, 2013, J CHEM ECOL, V39, P840, DOI 10.1007/s10886-013-0306-z; Dellicour S, 2013, J SEP SCI, V36, P3206, DOI 10.1002/jssc.201300388; Dumont B, 2009, GRASS FORAGE SCI, V64, P92, DOI 10.1111/j.1365-2494.2008.00674.x; Feng L, 2008, J CHROMATOGR SCI, V46, P577, DOI 10.1093/chromsci/46.7.577; Hales KE, 2012, ATMOS ENVIRON, V60, P292, DOI 10.1016/j.atmosenv.2012.06.080; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Leppik E., 2014, American Journal of Plant Sciences, V5, P811, DOI 10.4236/ajps.2014.56095; Leppik E, 2014, CHEMOECOLOGY, V24, P221, DOI 10.1007/s00049-014-0165-2; Lu M, 2007, IDENTIFICATION ODOR; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Scala A, 2013, INT J MOL SCI, V14, P17781, DOI 10.3390/ijms140917781; Sharkey TD, 1996, TRENDS PLANT SCI, V1, P78, DOI 10.1016/S1360-1385(96)80038-0; Sjodin NE, 2007, BIODIVERS CONSERV, V16, P2103, DOI 10.1007/s10531-006-9103-0; Thomas D.B., 2010, SUBTROP PLANT SCI, V62, P34; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1	18	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140600	10.1371/journal.pone.0140600	http://dx.doi.org/10.1371/journal.pone.0140600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536369	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400027
J	Fairbridge, NA; Southall, TM; Ayre, DC; Komatsu, Y; Raquet, PI; Brown, RJ; Randell, E; Kovacs, CS; Christian, SL				Fairbridge, Nicholas A.; Southall, Thomas M.; Ayre, D. Craig; Komatsu, Yumiko; Raquet, Paula I.; Brown, Robert J.; Randell, Edward; Kovacs, Christopher S.; Christian, Sherri L.			Loss of CD24 in Mice Leads to Metabolic Dysfunctions and a Reduction in White Adipocyte Tissue	PLOS ONE			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; IN-VIVO; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; GENE-EXPRESSION; CELLS; DIFFERENTIATION; PROTEIN	CD24 is a glycophosphatidylinositol (GPI)-linked cell surface receptor that is involved in regulating the survival or differentiation of several different cell types. CD24 has been used to identify pre-adipocytes that are able to reconstitute white adipose tissue (WAT) in vivo. Moreover, we recently found that the dynamic upregulation of CD24 in vitro during early phases of adipogenesis is necessary for mature adipocyte development. To determine the role of CD24 in adipocyte development in vivo, we evaluated the development of the inguinal and interscapular subcutaneous WAT and the epididymal visceral WAT in mice with a homozygous deletion of CD24 (CD24KO). We observed a significant decrease in WAT mass of 40% to 74% in WAT mass from both visceral and subcutaneous depots in male mice, with no significant effect in female mice, compared to wild-type (WT) sex-and age-matched controls. We also found that CD24KO mice had increased fasting glucose and free fatty acids, decreased fasting insulin, and plasma leptin. No major differences were observed in the sensitivity to insulin or glucose, or in circulating triglycerides, total cholesterol, HDL-cholesterol, or LDL-cholesterol levels between WT and CD24KO mice. Challenging the CD24KO mice with either high sucrose (35%) or high fat (45%) diets that promote increased adiposity, increased WAT mass and fasting insulin, adiponectin and leptin levels, as well as reduced the sensitivity to insulin and glucose, to the levels of WT mice on the same diets. The CD24-mediated reduction in fat pad size was due to a reduction in adipocyte cell size in all depots with no significant reduction pre-adipocyte or adipocyte cell number. Thus, we have clearly demonstrated that the global absence of CD24 affects adipocyte cell size in vivo in a sex-and diet-dependent manner, as well as causing metabolic disturbances in glucose homeostasis and free fatty acid levels.	[Fairbridge, Nicholas A.; Southall, Thomas M.; Ayre, D. Craig; Raquet, Paula I.; Brown, Robert J.; Christian, Sherri L.] Mem Univ Newfoundland, Dept Biochem, Fac Sci, St John, NF, Canada; [Komatsu, Yumiko] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Fac Med, Dept Lab Med, St John, NF, Canada; [Kovacs, Christopher S.] Mem Univ Newfoundland, Fac Med, Div Med Endocrinol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland	Christian, SL (corresponding author), Mem Univ Newfoundland, Dept Biochem, Fac Sci, St John, NF, Canada.	sherri.christian@mun.ca		Ayre, D. Craig/0000-0003-0345-4764; Brown, Robert/0000-0002-1875-1537; Christian, Sherri/0000-0002-4289-4386	Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes [126614, 126754]; Research and Development Corporation of Newfoundland [5404.1090.103]; Beatrice Hunter Cancer Research Institute; Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland	Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Research and Development Corporation of Newfoundland; Beatrice Hunter Cancer Research Institute; Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland	This study was funded by the Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes (www.cihr-irsc.gc.ca, grant no. 126614 and 126754) and the Research and Development Corporation of Newfoundland (www.rdc.org, grant no. 5404.1090.103). DCA is supported by a trainee award from the Beatrice Hunter Cancer Research Institute, with funds provided by The Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR and Memorial University of Newfoundland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Ayre DC, 2015, IMMUNOLOGY; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Byrne MF, 2002, CAN J GASTROENTEROL, V16, P849, DOI 10.1155/2002/836012; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chaput JP, 2012, OBES REV, V13, P681, DOI 10.1111/j.1467-789X.2012.00992.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cram DS, 1999, DIFFERENTIATION, V64, P237, DOI 10.1046/j.1432-0436.1999.6440237.x; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Fernandes AB, 2011, J NEUROENDOCRINOL, V23, P1288, DOI 10.1111/j.1365-2826.2011.02226.x; Forest C, 2003, BIOCHEM SOC T, V31, P1125; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Heinrichsen ET, 2014, MOL METAB, V3, P42, DOI 10.1016/j.molmet.2013.10.003; HERZBERG GR, 1982, CAN J PHYSIOL PHARM, V60, P912, DOI 10.1139/y82-128; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kaipparettu BA, 2008, INT J CANCER, V123, P66, DOI 10.1002/ijc.23480; Kim JI, 2015, MOL CELL BIOL, V35, P1686, DOI 10.1128/MCB.01321-14; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Lisiansky V, 2014, INT J BIOL MARKER, V29, pE62, DOI 10.5301/jbm.5000072; Martin S, 2013, HORM MOL BIOL CLIN I, V15, P11, DOI 10.1515/hmbci-2013-0035; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Parks EJ, 2002, P NUTR SOC, V61, P281, DOI 10.1079/PNS2002148; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; RCore Team, 2020, R LANG ENV STAT COMP; Rochford JJ, 2014, CURR TOP DEV BIOL, V109, P53, DOI 10.1016/B978-0-12-397920-9.00005-6; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rungaldier S, 2013, BBA-BIOMEMBRANES, V1828, P956, DOI 10.1016/j.bbamem.2012.11.030; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith NC, 2015, ADIPOCYTE, V4, P89, DOI 10.4161/21623945.2014.985015; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Team RC, 2014, NLME LINEAR NONLINEA; Temple KA, 2007, FEBS LETT, V581, P469, DOI 10.1016/j.febslet.2007.01.007; Wang LZ, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030049; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou QM, 2003, P NATL ACAD SCI USA, V100, P15041, DOI 10.1073/pnas.2533866100	65	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141966	10.1371/journal.pone.0141966	http://dx.doi.org/10.1371/journal.pone.0141966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536476	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400109
J	Fortunato, CS; Crump, BC				Fortunato, Caroline S.; Crump, Byron C.			Microbial Gene Abundance and Expression Patterns across a River to Ocean Salinity Gradient	PLOS ONE			English	Article							LIVING BACTERIAL COMMUNITIES; ANOXYGENIC PHOTOTROPHIC BACTERIA; COLUMBIA RIVER; MARINE-BACTERIA; ESTUARY; DIVERSITY; ASSEMBLAGES; VARIABILITY; DELAWARE; SEQUENCE	Microbial communities mediate the biogeochemical cycles that drive ecosystems, and it is important to understand how these communities are affected by changing environmental conditions, especially in complex coastal zones. As fresh and marine waters mix in estuaries and river plumes, the salinity, temperature, and nutrient gradients that are generated strongly influence bacterioplankton community structure, yet, a parallel change in functional diversity has not been described. Metagenomic and metatranscriptomic analyses were conducted on five water samples spanning the salinity gradient of the Columbia River coastal margin, including river, estuary, plume, and ocean, in August 2010. Samples were pre-filtered through 3 mu m filters and collected on 0.2 mu m filters, thus results were focused on changes among free-living microbial communities. Results from metagenomic 16S rRNA sequences showed taxonomically distinct bacterial communities in river, estuary, and coastal ocean. Despite the strong salinity gradient observed over sampling locations (0 to 33), the functional gene profiles in the metagenomes were very similar from river to ocean with an average similarity of 82%. The metatranscriptomes, however, had an average similarity of 31%. Although differences were few among the metagenomes, we observed a change from river to ocean in the abundance of genes encoding for catabolic pathways, osmoregulators, and metal transporters. Additionally, genes specifying both bacterial oxygenic and anoxygenic photosynthesis were abundant and expressed in the estuary and plume. Denitrification genes were found throughout the Columbia River coastal margin, and most highly expressed in the estuary. Across a river to ocean gradient, the free-living microbial community followed three different patterns of diversity: 1) the taxonomy of the community changed strongly with salinity, 2) metabolic potential was highly similar across samples, with few differences in functional gene abundance from river to ocean, and 3) gene expression was highly variable and generally was independent of changes in salinity.	[Fortunato, Caroline S.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Crump, Byron C.] Oregon State Univ, Coll Earth Oceans & Atmospher Sci, Corvallis, OR 97331 USA	Marine Biological Laboratory - Woods Hole; Oregon State University	Fortunato, CS (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA.	cfortunato@mbl.edu	Crump, Byron/ABF-3711-2020	Crump, Byron/0000-0001-7062-1273	National Science Foundation [OCE-0424602]	National Science Foundation(National Science Foundation (NSF))	Funding: This study was carried out within the context of the Science and Technology Center for Coastal Margin Observation & Prediction (CMOP) supported by the National Science Foundation, grant number OCE-0424602 to Antonio Baptista (http://www.stccmop.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bernhard AE, 2005, ENVIRON MICROBIOL, V7, P1289, DOI 10.1111/j.1462-2920.2005.00808.x; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brauer SL, 2013, ESTUAR COAST, V36, P1073, DOI 10.1007/s12237-013-9603-6; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Crump BC, 1998, AQUAT MICROB ECOL, V14, P7, DOI 10.3354/ame014007; Dupont CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089549; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fortunato CS, 2013, ISME J, V7, P1899, DOI 10.1038/ismej.2013.79; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Green RT, 2013, ISME J, V7, P581, DOI 10.1038/ismej.2012.140; Grote J, 2011, STAND GENOMIC SCI, V5, P269, DOI 10.4056/sigs.1854551; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; Hewson I, 2014, APPL ENVIRON MICROB, V80, P328, DOI 10.1128/AEM.02680-13; Hickey BM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005452; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Mou XZ, 2007, ENVIRON MICROBIOL, V9, P2025, DOI 10.1111/j.1462-2920.2007.01318.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oh HM, 2010, J BACTERIOL, V192, P3240, DOI 10.1128/JB.00347-10; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; PORETSKY RS, 2009, JOVE-J VIS EXP, DOI DOI 10.3791/1086; Prahl FG, 1998, HYDROBIOLOGIA, V361, P37; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Selje N, 2003, AQUAT MICROB ECOL, V30, P221, DOI 10.3354/ame030221; SIMENSTAD CA, 1990, PROG OCEANOGR, V25, P1, DOI 10.1016/0079-6611(90)90002-J; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; SMALL LF, 1990, PROG OCEANOGR, V25, P175, DOI 10.1016/0079-6611(90)90007-O; Smith MW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00120; Smith MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013312; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Waidner LA, 2005, ENVIRON MICROBIOL, V7, P1896, DOI 10.1111/j.1462-2920.2005.00883.x; Waidner LA, 2007, APPL ENVIRON MICROB, V73, P3936, DOI 10.1128/AEM.00592-07; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	57	48	50	8	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140578	10.1371/journal.pone.0140578	http://dx.doi.org/10.1371/journal.pone.0140578			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536246	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400026
J	Heinrichs, J; Scheben, A; Lee, GE; Vana, J; Schafer-Verwimp, A; Krings, M; Schmidt, AR				Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee; Vana, Jiri; Schaefer-Verwimp, Alfons; Krings, Michael; Schmidt, Alexander R.			Molecular and Morphological Evidence Challenges the Records of the Extant Liverwort Ptilidium pulcherrimum in Eocene Baltic Amber	PLOS ONE			English	Article							LAND PLANTS; MARCHANTIOPHYTA; ORIGIN; FOSSIL; DIVERSIFICATION; PHYLOGENY; EVOLUTION; JUNGERMANNIOPSIDA; CLASSIFICATION; DISJUNCTIONS	Preservation of liverworts in amber, a fossilized tree resin, is often exquisite. Twenty-three fossil species of liverworts have been described to date from Eocene (35-50 Ma) Baltic amber. In addition, two inclusions have been assigned to the extant species Ptilidium pulcherrimum (Ptilidiales or Porellales). However, the presence of the boreal P. pulcherrimum in the subtropical or warm-temperate Baltic amber forest challenges the phytogeographical interpretation of the Eocene flora. A re-investigation of one of the fossils believed to be P. pulcherrimum reveals that this specimen in fact represents the first fossil evidence of the genus Tetralophozia, and thus is re-described here as Tetralophozia groehnii sp. nov. A second fossil initially assigned to P. pulcherrimum is apparently lost, and can be reassessed only based on the original description and illustrations. This fossil is morphologically similar to the extant North Pacific endemic Ptilidium californicum, rather than P. pulcherrimum. Divergence time estimates based on chloroplast DNA sequences provide evidence of a Miocene origin of P. pulcherrimum, and thus also argue against the presence of this taxon in the Eocene. Ptilidium californicum originated 25-43 Ma ago. As a result, we cannot rule out that the Eocene fossil belongs to P. californicum. Alternatively, the fossil might represent a stem lineage element of Ptilidium or an early crown group species with morphological similarities to P. californicum.	[Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee] Univ Munich LMU, Dept Biol, Munich, Germany; [Heinrichs, Jochen; Scheben, Armin; Lee, Gaik Ee] Univ Munich LMU, Geobioctr, Munich, Germany; [Vana, Jiri] Charles Univ Prague, Dept Bot, Prague, Czech Republic; [Krings, Michael] Univ Munich LMU, Dept Earth & Environm Sci, Munich, Germany; [Krings, Michael] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Schmidt, Alexander R.] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany	University of Munich; University of Munich; Charles University Prague; University of Munich; University of Gottingen	Heinrichs, J (corresponding author), Univ Munich LMU, Dept Biol, Munich, Germany.	jheinrichs@lmu.de; alexander.schmidt@geo.uni-goettingen.de	Lee, Gaik Ee G/W-3683-2018; Krings, Michael/AAM-6436-2020; Váňa, Jiří/I-5979-2016; Lee, Gaik Ee/O-8353-2019; Scheben, Armin/AAS-2136-2020	Lee, Gaik Ee G/0000-0001-5161-6196; Váňa, Jiří/0000-0001-5532-3286; Lee, Gaik Ee/0000-0001-5161-6196; Scheben, Armin/0000-0002-2230-2013	Alexander von Humboldt foundation; German Research Foundation (DFG); University of Gottingen	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Gottingen	Funding: This work was supported by the Alexander von Humboldt foundation (fellowship to GEL): The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen: The publication fee in an open access publication will be covered by the funders.	Berendt GC, 1845, BERNSTEIN IHM BEFIND; Botting RS, 2006, CAN J BOT, V84, P120, DOI [10.1139/B05-146, 10.1139/b05-146]; Caspary R., 1907, ABHANDLUNGEN KONIGLI, V4, P11; Caspary R., 1887, SCHRIFTEN KONIGLICHE, V27, P1; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Conwentz H., 1890, MONOGRAPHIE BALTISCH; Cooper ED, 2012, BIOL J LINN SOC, V107, P425, DOI 10.1111/j.1095-8312.2012.01946.x; Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Crandall-Stotler B., 2009, Edinburgh Journal of Botany, V66, P155, DOI 10.1017/S0960428609005393; Doyle William T., 2006, Madrono, V53, P89, DOI 10.3120/0024-9637(2006)53[89:CTABOC]2.0.CO;2; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Feldberg K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05974; Feldberg K, 2013, PLANT SYST EVOL, V299, P585, DOI 10.1007/s00606-012-0745-y; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Frahm J.-P., 2013, ARCH BRYOLOGY, V175, P1; Frahm J-P., 2010, LAUBMOOSFLORA BALTIS; Garrett RM, 1909, PRECIOUS STONES OLD; Goremykin VV, 2005, PLANT SYST EVOL, V254, P93, DOI 10.1007/s00606-005-0337-1; GROLLE R, 1980, Feddes Repertorium, V91, P183; Grolle R., 1993, J HATTORI BOT LAB, V74, P71; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; GUSTAFSSON L, 1995, J APPL ECOL, V32, P412, DOI 10.2307/2405107; Hall T.A., 1999, SYMPOSIUM, V41, P95; Hartmann FA, 2006, INT J PLANT SCI, V167, P1205, DOI 10.1086/508023; Heinrichs J, 2005, CRYPTOGAMIE BRYOL, V26, P131; Heinrichs J, 2007, TAXON, V56, P31, DOI 10.2307/25065733; Heinrichs J, 2015, REV PALAEOBOT PALYNO, V221, P59, DOI 10.1016/j.revpalbo.2015.05.007; Heinrichs J, 2015, REV PALAEOBOT PALYNO, V217, P39, DOI 10.1016/j.revpalbo.2015.02.006; Heinrichs J, 2014, REV PALAEOBOT PALYNO, V203, P48, DOI 10.1016/j.revpalbo.2014.01.004; J-P Frahm, 2006, LIMPRICHTIA, V29, P119; Katagiri T., 2015, NOVA HEDWIGIA, DOI [10.1127/novaHedwigia/2015/0276, DOI 10.1127/NOVAHEDWIGIA/2015/0276]; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Kiraly I, 2013, BIODIVERS CONSERV, V22, P209, DOI 10.1007/s10531-012-0415-y; Krassilov VA, 1984, NEW MANUAL BRYOLOGY, VII, P1172; Kreier HP, 2010, MOL PHYLOGENET EVOL, V57, P1260, DOI 10.1016/j.ympev.2010.10.002; Kuusinen M, 1999, ECOGRAPHY, V22, P729, DOI 10.1111/j.1600-0587.1999.tb00522.x; Laenen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6134; Liu Y, 2008, ANN MO BOT GARD, V95, P459, DOI 10.3417/2006071; Loriga J, 2014, AM J BOT, V101, P1466, DOI 10.3732/ajb.1400262; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Meister, 2004, LIVERWORTS BALTIC BI; Nascimbene J, 2009, CAN J FOREST RES, V39, P785, DOI 10.1139/X09-013; Nishiyama T, 2004, MOL BIOL EVOL, V21, P1813, DOI 10.1093/molbev/msh203; Oostendorp C., 1987, BRYOPHYTORUM BIBLIOT, V34, P5; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Paton J. A., 1999, LIVERWORT FLORA BRIT; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Penney D., 2010, BIODIVERSITY FOSSILS; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Rambaut A, 2014, FIGTREE V 1 4 2; Rambaut A., 2014, TRACER V1 6; Renner MAM, 2015, BOT J LINN SOC, V178, P222, DOI 10.1111/boj.12279; Schneider H, 2015, ORG DIVERS EVOL, V15, P277, DOI 10.1007/s13127-015-0200-3; Schofield W. B., 2002, FIELD GUIDE LIVERWOR; SCHUSTER RM, 1989, REV PALAEOBOT PALYNO, V57, P277, DOI 10.1016/0034-6667(89)90025-0; Schuster RM, 2002, NOVA HEDWIGIA, V74, P465, DOI 10.1127/0029-5035/2002/0074-0465; Schuster RM., 1966, HEPATICAE ANTHOCEROT; Schuwirth Rainer, 2002, NOVA HEDWIGIA S, P1; Sendel N., 1742, HIST SUCCINORUM CORP; Soderstrom L, 2010, PHYTOTAXA, V3, P47; Standke G., 2008, EXKURSIONSF HRER VER, V236, P11; Standke G., 1998, SCHRIFTENREIHE F R G, V7, P93; Sun Y, 2014, MOL PHYLOGENET EVOL, V76, P189, DOI 10.1016/j.ympev.2014.03.018; Taylor T. N., 2009, BIOL EVOLUTION FOSSI; URMI E, 1983, J BRYOL, V12, P393, DOI 10.1179/jbr.1983.12.3.393; Vana J., 1993, TROP BRYOL, V8, P99, DOI [10.11646/bde.8.1.12, DOI 10.11646/BDE.8.1.12]; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Weitschat Wolfgang, 2010, P80; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; WILLMANN R, 1985, ART RAUM Z; Wilson R, 2007, BIOLOGY LETT, V3, P566, DOI 10.1098/rsbl.2007.0287; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wolfe AP, 2009, P R SOC B, V276, P3403, DOI 10.1098/rspb.2009.0806	76	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140977	10.1371/journal.pone.0140977	http://dx.doi.org/10.1371/journal.pone.0140977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536603	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400047
J	Kunert, R; Willems, RM; Casasanto, D; Patel, AD; Hagoort, P				Kunert, Richard; Willems, Roel M.; Casasanto, Daniel; Patel, Aniruddh D.; Hagoort, Peter			Music and Language Syntax Interact in Broca's Area: An fMRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BRAIN RESOURCES; ATTENTION; SUBJECT; REPRESENTATION; COMPREHENSION; ORGANIZATION; ACTIVATIONS; VARIABILITY; SENSITIVITY	Instrumental music and language are both syntactic systems, employing complex, hierar-chically-structured sequences built using implicit structural norms. This organization allows listeners to understand the role of individual words or tones in the context of an unfolding sentence or melody. Previous studies suggest that the brain mechanisms of syntactic processing may be partly shared between music and language. However, functional neuro-imaging evidence for anatomical overlap of brain activity involved in linguistic and musical syntactic processing has been lacking. In the present study we used functional magnetic resonance imaging (fMRI) in conjunction with an interference paradigm based on sung sentences. We show that the processing demands of musical syntax (harmony) and language syntax interact in Broca's area in the left inferior frontal gyrus (without leading to music and language main effects). A language main effect in Broca's area only emerged in the complex music harmony condition, suggesting that (with our stimuli and tasks) a language effect only becomes visible under conditions of increased demands on shared neural resources. In contrast to previous studies, our design allows us to rule out that the observed neural interaction is due to: (1) general attention mechanisms, as a psychoacoustic auditory anomaly behaved unlike the harmonic manipulation, (2) error processing, as the language and the music stimuli contained no structural errors. The current results thus suggest that two different cognitive domains-music and language-might draw on the same high level syntactic integration resources in Broca's area.	[Kunert, Richard; Willems, Roel M.; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kunert, Richard; Willems, Roel M.; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Casasanto, Daniel] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Patel, Aniruddh D.] Tufts Univ, Medford, MA 02155 USA	Max Planck Society; Radboud University Nijmegen; University of Chicago; Tufts University	Kunert, R (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	r.kunert@donders.ru.nl	Hagoort, Peter/B-7417-2012	Willems, Roel/0000-0002-4963-5387	Dutch science organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Max Planck Society	Dutch science organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); Max Planck Society(Max Planck Society)	This study was financially supported by a Dutch science organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek: www.nwo.nl/) Spinoza Prize awarded to PH and a PhD grant from the Max Planck Society (www.mpg.de) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2011, CEREB CORTEX, V21, P1507, DOI 10.1093/cercor/bhq198; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brett M., 2002, 8 INT C FUNCT MAPP H; Carrus E, 2013, CORTEX, V49, P2186, DOI 10.1016/j.cortex.2012.08.024; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Drai D, 2006, BRAIN LANG, V96, P117, DOI 10.1016/j.bandl.2004.10.016; Eerola Tuomas, 2006, PSYCHOL MUSIC, V34, P337, DOI DOI 10.1177/0305735606064842; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Fedorenko E, 2012, J NEUROPHYSIOL, V108, P3289, DOI 10.1152/jn.00209.2012; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Fedorenko E, 2009, MEM COGNITION, V37, P1, DOI 10.3758/MC.37.1.1; Fitzroy AB, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00603; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; Gaser C, 2003, J NEUROSCI, V23, P9240; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 2013, FRONT PSYCHOL, P4, DOI DOI 10.3389/; Hoch L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00112; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; James CE, 2014, BRAIN STRUCT FUNCT, V219, P353, DOI 10.1007/s00429-013-0504-z; Jentschke S, 2009, NEUROIMAGE, V47, P735, DOI 10.1016/j.neuroimage.2009.04.090; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; KRUMHANSL CL, 1979, COGNITIVE PSYCHOL, V11, P346, DOI 10.1016/0010-0285(79)90016-1; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; Kunert R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00330; Lerdahl F., 2001, TONAL PITCH SPACE; Lerdahl F., 2013, MUSICAL IMPLICATIONS, P255; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Maidhof C, 2011, J COGNITIVE NEUROSCI, V23, P2252, DOI 10.1162/jocn.2010.21542; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Musso M, 2015, NEUROIMAGE, V117, P267, DOI 10.1016/j.neuroimage.2015.05.020; Nieto-Castanon A, 2012, NEUROIMAGE, V63, P1646, DOI 10.1016/j.neuroimage.2012.06.065; Okada BM, 2014, PSYCHON B REV, P1, DOI [10.3758/s13423-014-0712-4, DOI 10.3758/S13423-014-0712-4]; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2013, STRUNGMANN FORUM REP, P329; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Perruchet P, 2013, PSYCHON B REV, V20, P310, DOI 10.3758/s13423-012-0344-5; Rogalsky C, 2011, J NEUROSCI, V31, P3843, DOI 10.1523/JNEUROSCI.4515-10.2011; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Segaert K, 2012, CEREB CORTEX, V22, P1662, DOI 10.1093/cercor/bhr249; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Xiong JH, 2000, NEUROIMAGE, V12, P326, DOI 10.1006/nimg.2000.0621	60	54	54	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141069	10.1371/journal.pone.0141069	http://dx.doi.org/10.1371/journal.pone.0141069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536026	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400051
J	Magris, RA; Heron, SF; Pressey, RL				Magris, Rafael A.; Heron, Scott F.; Pressey, Robert L.			Conservation Planning for Coral Reefs Accounting for Climate Warming Disturbances	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; EL-NINO; OCEAN ACIDIFICATION; GLOBAL TREND; RESILIENCE; MANAGEMENT; FUTURE; IMPACTS; STRESS; VULNERABILITY	Incorporating warming disturbances into the design of marine protected areas (MPAs) is fundamental to developing appropriate conservation actions that confer coral reef resilience. We propose an MPA design approach that includes spatially-and temporally-varying sea-surface temperature (SST) data, integrating both observed (1985-2009) and projected (2010-2099) time-series. We derived indices of acute (time under reduced ecosystem function following short-term events) and chronic thermal stress (rate of warming) and combined them to delineate thermal-stress regimes. Coral reefs located on the Brazilian coast were used as a case study because they are considered a conservation priority in the southwestern Atlantic Ocean. We show that all coral reef areas in Brazil have experienced and are projected to continue to experience chronic warming, while acute events are expected to increase in frequency and intensity. We formulated quantitative conservation objectives for regimes of thermal stress. Based on these objectives, we then evaluated if/how they are achieved in existing Brazilian MPAs and identified priority areas where additional protection would reinforce resilience. Our results show that, although the current system of MPAs incorporates locations within some of our thermal-stress regimes, historical and future thermal refugia along the central coast are completely unprotected. Our approach is applicable to other marine ecosystems and adds to previous marine planning for climate change in two ways: (i) by demonstrating how to spatially configure MPAs that meet conservation objectives for warming disturbance using spatially-and temporally-explicit data; and (ii) by strategically allocating different forms of spatial management (MPA types) intended to mitigate warming impacts and also enhance future resistance to climate warming.	[Magris, Rafael A.; Pressey, Robert L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Heron, Scott F.] Natl Ocean & Atmospher Adm Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Dept Phys, Marine Geophys Lab, Coll Sci Technol & Engn, Townsville, Qld 4811, Australia	James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University	Magris, RA (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	Rafael.magris@my.jcu.edu.au	Heron, Scott F/E-7928-2011; /AAL-3738-2021	Heron, Scott/0000-0001-5262-6978	Australian Research Council; NOAA Coral Reef Conservation Program; Brazilian Ministry of Environment; CNPq-Brazil	Australian Research Council(Australian Research Council); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Brazilian Ministry of Environment; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: RAM and RLP are supported by Australian Research Council; SFH is supported by NOAA Coral Reef Conservation Program. RAM is also supported by Brazilian Ministry of Environment. RAM thanks CNPq-Brazil for financial support.	Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allison GW, 2003, ECOL APPL, V13, pS8; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Amaral Fernanda D., 2006, Arquivos de Ciencias do Mar, V39, P138; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Chollett I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110634; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Donner Simon D., 2009, V205, P159; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Ferreira BP, 2013, CORAL REEFS, V32, P441, DOI 10.1007/s00338-012-0992-y; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gerhardinger LC, 2011, ENVIRON MANAGE, V47, P630, DOI 10.1007/s00267-010-9554-7; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Good SA, 2007, J CLIMATE, V20, P1255, DOI 10.1175/JCLI4049.1; Hallock P, 2005, SEDIMENT GEOL, V175, P19, DOI 10.1016/j.sedgeo.2004.12.027; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen L, 2010, CONSERV BIOL, V24, P63, DOI 10.1111/j.1523-1739.2009.01404.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Heron Scott F., 2013, P285; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hobday AJ, 2011, MAR ECOL-EVOL PERSP, V32, P392, DOI 10.1111/j.1439-0485.2011.00459.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Klein CJ, 2014, CONSERV LETT, DOI [10.1111/econl.12147, DOI 10.1111/C0NL.12147]; Krug LA, 2013, ENVIRON MODELL SOFTW, V42, P157, DOI 10.1016/j.envsoft.2013.01.003; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; Leão Zelinda Margarida Andrade Nery, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300006; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Liu G, 2006, 10 INT COR REEF S OK; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Magris RA, 2013, NAT CONSERVACAO, V11, P81, DOI 10.4322/natcon.2013.013; Magris RA, 2016, ECOGRAPHY, V39, P649, DOI 10.1111/ecog.01507; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Makino A, 2014, DIVERS DISTRIB, V20, P859, DOI 10.1111/ddi.12184; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McAvaney BJ, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P471; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McLeod E, 2012, COAST MANAGE, V40, P651, DOI 10.1080/08920753.2012.728123; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miranda RJ, 2013, LAT AM J AQUAT RES, V41, P351, DOI 10.3856/vol41-issue2-fulltext-14; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mumby PJ, 2014, CONSERV LETT, V7, P176, DOI 10.1111/conl.12047; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Penaflor EL, 2009, CORAL REEFS, V28, P841, DOI 10.1007/s00338-009-0522-8; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Salm R.V., 2006, CORAL REEFS CLIMATE, DOI 10.1029/61CE12; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Spillman CM, 2011, B AM METEOROL SOC, V92, P1581, DOI 10.1175/BAMS-D-11-00009.1; Strange N, 2011, BIOL CONSERV, V144, P2968, DOI 10.1016/j.biocon.2011.08.022; van Hooidonk R, 2012, CORAL REEFS, V31, P121, DOI 10.1007/s00338-011-0825-4; van Hooidonk R, 2015, GLOBAL CHANGE BIOL, V21, P3389, DOI 10.1111/gcb.12901; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wu Q, 2008, GEOPHYS RES LETT, V35; Yang JS, 2012, HYDROL EARTH SYST SC, V16, P801, DOI 10.5194/hess-16-801-2012; Zhang J, 2010, ATMOS CHEM PHYS, V10, P10949, DOI 10.5194/acp-10-10949-2010	105	28	31	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140828	10.1371/journal.pone.0140828	http://dx.doi.org/10.1371/journal.pone.0140828			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535586	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000364298400040
J	Nigorikawa, K; Hazeki, K; Sasaki, J; Omori, Y; Miyake, M; Morioka, S; Guo, Y; Sasaki, T; Hazeki, O				Nigorikawa, Kiyomi; Hazeki, Kaoru; Sasaki, Junko; Omori, Yumio; Miyake, Mikiko; Morioka, Shin; Guo, Ying; Sasaki, Takehiko; Hazeki, Osamu			Inositol Polyphosphate-4-Phosphatase Type I Negatively Regulates Phagocytosis via Dephosphorylation of Phagosomal PtdIns (3,4)P-2	PLOS ONE			English	Article							MYOSIN-X; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOINOSITIDE 3-KINASE; ROLES; MEMBRANE; RAB5; MACROPINOCYTOSIS; PHOSPHATASES; ENDOCYTOSIS; ACTIVATION	Phagocytosis is a highly conserved process whereby phagocytic cells engulf pathogens and apoptotic bodies. The present study focused on the role of inositol polyphosphate-4-phosphatase type I (Inpp4a) in phagocytosis. Raw264.7 cells that express shRNA against Inpp4a (shInpp4a cells) showed significantly increased phagocytic activity. The introduction of shRNA-resistant human Inpp4a abolished this increase. Macrophages from Inpp4a knockout mice showed similar increases in the phagocytic activity. Inpp4a was recruited to the phagosome membrane by a mechanism other than the direct interaction with Rab5. PtdIns(3,4)P-2 increased on the phagosome of shInpp4a cells, while PtdIns(3) P significantly decreased. The results indicate that Inpp4a negatively regulates the phagocytic activity of macrophages as a member of the sequential dephosphorylation system that metabolizes phagosomal PtdIns(3,4,5)P-3 to PtdIns(3)P.	[Nigorikawa, Kiyomi; Hazeki, Kaoru; Omori, Yumio; Miyake, Mikiko; Morioka, Shin; Guo, Ying; Hazeki, Osamu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Dept Pathol & Immunol, Sch Med, Akita 0108543, Japan	Hiroshima University; Akita University	Hazeki, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 7348553, Japan.	khazeki@hiroshima-u.ac.jp		Sasaki, Takehiko/0000-0003-1837-3748				Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Billcliff PG, 2014, BIOCHEM J, V461, P159, DOI 10.1042/BJ20140361; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bohdanowicz M, 2012, MOL BIOL CELL, V23, P176, DOI 10.1091/mbc.E11-06-0489; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hazeki K, 2012, FEBS LETT, V586, P4010, DOI 10.1016/j.febslet.2012.09.043; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Maekawa M, 2014, P NATL ACAD SCI USA, V111, pE978, DOI 10.1073/pnas.1311029111; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Segawa T, 2014, BIOCHEM J, V464, P365, DOI 10.1042/BJ20140916; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Tamura N, 2009, BIOCHEM J, V423, P99, DOI 10.1042/BJ20090687; Thi EP, 2012, J LEUKOCYTE BIOL, V92, P553, DOI 10.1189/jlb.0212053; Tsukamoto K, 2008, J IMMUNOL, V180, P2054, DOI 10.4049/jimmunol.180.4.2054; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069	28	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142091	10.1371/journal.pone.0142091	http://dx.doi.org/10.1371/journal.pone.0142091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535897	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400131
J	Qureshi, R; Yildirim, O; Gasser, A; Basmadjian, C; Zhao, Q; Wilmet, JP; Desaubry, L; Nebigil, CG				Qureshi, Rehana; Yildirim, Onur; Gasser, Adeline; Basmadjian, Christine; Zhao, Qian; Wilmet, Jean-Philippe; Desaubry, Laurent; Nebigil, Canan G.			FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity	PLOS ONE			English	Article							POTENT ANTICANCER; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; CARDIAC FIBROSIS; TRANSCRIPTION 3; HEART-FAILURE; PATHWAY; CELLS; SURVIVAL; INHIBITION	Aims The clinical use of doxorubicin for the treatment of cancer is limited by its cardiotoxicity. Flavaglines are natural products that have both potent anticancer and cardioprotective properties. A synthetic analog of flavaglines, FL3, efficiently protectsmice from the cardiotoxicity of doxorubicin. The mechanism underlying this cardioprotective effect has yet to be elucidated. Methods and Results Here, we show that FL3 binds to the scaffold proteins prohibitins (PHBs) and thus promotes their translocation to mitochondria in the H9c2 cardiomyocytes. FL3 induces heterodimerization of PHB1 with STAT3, thereby ensuring cardioprotection from doxorubicin toxicity. This interaction is associated with phosphorylation of STAT3. A JAK2 inhibitor, WP1066, suppresses both the phosphorylation of STAT3 and the protective effect of FL3 in cardiomyocytes. The involvement of PHBs in the FL3-mediated cardioprotection was confirmed by means of small interfering RNAs (siRNAs) targeting PHB1 and PHB2. The siRNA knockdown of PHBs inhibits both phosphorylation of STAT3 and the cardioprotective effect of FL3. Conclusion Activation of mitochondrial STAT3/PHB1 complex by PHB ligands may be a new strategy against doxorubicin-induced cardiotoxicity and possibly other cardiac problems.	[Qureshi, Rehana; Yildirim, Onur; Gasser, Adeline; Wilmet, Jean-Philippe; Nebigil, Canan G.] Univ Strasbourg, CNRS, GPCRs Cardiobiol & Metab Team, UMR 7242,LabEx Medalis,Strasbourg Sch Biotechnol, Illkirch Graffenstaden, France; [Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent] Univ Strasbourg, CNRS, Lab Therapeut Innovat, UMR 7200,Fac Pharm, Illkirch Graffenstaden, France; [Desaubry, Laurent] Tianjin Univ Sci & Technol, Coll Biotechnol, Sino French Joint Lab Food Nutr Safety & Med Chem, Tianjin 300457, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tianjin University Science & Technology	Desaubry, L (corresponding author), Univ Strasbourg, CNRS, Lab Therapeut Innovat, UMR 7200,Fac Pharm, Illkirch Graffenstaden, France.	desaubry@unistra.fr; nebigil@unistra.fr	YILDIRIM, Onur Gokhan/AAA-9156-2022; Nebigil, Canan/AAK-7162-2021; Desaubry, Laurent G/R-5446-2017; YILDIRIM, ONUR GOKHAN/ABF-4347-2021	Nebigil, Canan/0000-0002-2035-5795; Desaubry, Laurent G/0000-0002-1192-2970; YILDIRIM, ONUR GOKHAN/0000-0003-0090-7369; GASSER, Adeline/0000-0003-2678-327X	"Association pour la Recherche sur le Cancer" (ARC) [3940, SFI20111204054, PJA 20141201909]; "Agence National la Recherche" (ANR) [ANR-11-EMMA-021]; French government; AAREC Filia Research; Association Nationale de la Recherche et de la Technologie; Erasmus fellowship; Centre National de la Recherche Scientifique; Universite de Strasbourg	"Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Agence National la Recherche" (ANR)(French National Research Agency (ANR)); French government; AAREC Filia Research; Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Erasmus fellowship; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	This work was supported by the "Association pour la Recherche sur le Cancer" (ARC, grant numbers 3940, SFI20111204054 and PJA 20141201909) and the "Agence National la Recherche" (ANR, grant number ANR-11-EMMA-021). This work has also been published within the LABEX ANR-10-LABX-0034_Medalis and received a financial support from the French government managed by Agence Nationale de la recherche under Programme d'investissement d'avenir. Christine Basmadjian and Qian Zhao were supported by AAREC Filia Research and the Association Nationale de la Recherche et de la Technologie. Onur Yildirim received an Erasmus fellowship. This work was supported by grants from Centre National de la Recherche Scientifique, and Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Becker MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.528; Bernard Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025302; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Chowdhury I, 2011, LIFE SCI, V89, P295, DOI 10.1016/j.lfs.2011.06.022; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Gratia S, 2012, J PROTEOMICS, V75, P4705, DOI 10.1016/j.jprot.2012.02.004; Han J, 2014, CELL SIGNAL, V26, P2086, DOI 10.1016/j.cellsig.2014.06.006; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hoch M, 2011, CELL STEM CELL, V9, P131, DOI 10.1016/j.stem.2011.07.001; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jia YH, 2012, CELL BIOCHEM FUNCT, V30, P426, DOI 10.1002/cbf.2820; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lee JH, 2010, FEBS J, V277, P488, DOI 10.1111/j.1742-4658.2009.07505.x; Liu XH, 2004, PROTEOMICS, V4, P3167, DOI 10.1002/pmic.200300845; Liu XH, 2009, CELL STRESS CHAPERON, V14, P311, DOI 10.1007/s12192-008-0086-5; Liu YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/605154; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Ribeiro N, 2012, J MED CHEM, V55, P10064, DOI 10.1021/jm301201z; Song W, 2014, FEBS LETT, V588, P422, DOI 10.1016/j.febslet.2013.12.021; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Wang K, 2015, CELL DEATH DIFFER, V22, P1058, DOI 10.1038/cdd.2014.200; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Zhu WQ, 2014, CARDIOVASC RES, V103, P81, DOI 10.1093/cvr/cvu118	38	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141826	10.1371/journal.pone.0141826	http://dx.doi.org/10.1371/journal.pone.0141826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536361	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400090
J	Scarlet, D; Ertl, R; Aurich, C; Steinborn, R				Scarlet, Dragos; Ertl, Reinhard; Aurich, Christine; Steinborn, Ralf			The Orthology Clause in the Next Generation Sequencing Era: Novel Reference Genes Identified by RNA-seq in Humans Improve Normalization of Neonatal Equine Ovary RT-qPCR Data	PLOS ONE			English	Article							REAL-TIME PCR; RELIABLE REFERENCE GENES; HOUSEKEEPING GENES; EXPRESSION ANALYSIS; MESSENGER-RNA; COEXPRESSION; TISSUES; INFORMATION; VALIDATION; PREDICTION	Background Vertebrate evolution is accompanied by a substantial conservation of transcriptional programs with more than a third of unique orthologous genes showing constrained levels of expression. Moreover, there are genes and exons exhibiting excellent expression stability according to RNA-seq data across a panel of eighteen tissues including the ovary (Human Body Map 2.0). Results We hypothesized that orthologs of these exons would also be highly uniformly expressed across neonatal ovaries of the horse, which would render them appropriate reference genes (RGs) for normalization of reverse transcription quantitative PCR (RT-qPCR) data in this context. The expression stability of eleven novel RGs (C1orf43, CHMP2A, EMC7, GPI, PSMB2, PSMB4, RAB7A, REEP5, SNRPD3, VCP and VPS29) was assessed by RT-qPCR in ovaries of seven neonatal fillies and compared to that of the expressed repetitive element ERE-B, two universal (OAZ1 and RPS29) and four traditional RGs (ACTB, GAPDH, UBB and B2M). Expression stability analyzed with the software tool RefFinder top ranked the normalization factor constituted of the genes SNRPD3 and VCP, a gene pair that is not co-expressed according to COEXPRESdb and GeneMANIA. The traditional RGs GAPDH, B2M, ACTB and UBB were only ranked 3rd and 12th to 14th, respectively. Conclusions The functional diversity of the novel RGs likely facilitates expression studies over a wide range of physiological and pathological contexts related to the neonatal equine ovary. In addition, this study augments the potential for RT-qPCR-based profiling of human samples by introducing seven new human RG assays (C1orf43, CHMP2A, EMC7, GPI, RAB7A, VPS29 and UBB).	[Scarlet, Dragos; Aurich, Christine] Univ Vet Med, Ctr Artificial Inseminat & Embryo Transfer, Vienna, Austria; [Ertl, Reinhard; Steinborn, Ralf] Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Scarlet, D (corresponding author), Univ Vet Med, Ctr Artificial Inseminat & Embryo Transfer, Vienna, Austria.	dragos.scarlet@vetmeduni.ac.at	Scarlet, Dragos/AAU-5766-2021	Scarlet, Dragos/0000-0002-9599-0830; Ertl, Reinhard/0000-0001-7485-3661				Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Beekman L, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-5; BHATIA P, 1994, ANAL BIOCHEM, V216, P223, DOI 10.1006/abio.1994.1028; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095974; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; De Keyser E, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-13; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; GOLDSWORTHY SM, 1993, CELL PROLIFERAT, V26, P511, DOI 10.1111/j.1365-2184.1993.tb00029.x; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Herrera-Luna CV, 2012, REPROD DOMEST ANIM, V47, P928, DOI 10.1111/j.1439-0531.2012.01993.x; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Laurell H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1259; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Meyer FRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063125; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Omondi BA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0862-x; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pervouchine DD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6903; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Saint-Marcoux D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118678; Savonet V, 1997, ANAL BIOCHEM, V247, P165, DOI 10.1006/abio.1997.2055; Scarlet D, 2015, REPROD FERTILITY DEV; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassetzky NS, 2013, NUCLEIC ACIDS RES, V41, pD83, DOI 10.1093/nar/gks1263; Walt M L, 1979, J Reprod Fertil Suppl, P471; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142122	10.1371/journal.pone.0142122	http://dx.doi.org/10.1371/journal.pone.0142122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536597	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400137
J	Nilsson, M; Szczepankiewicz, F; van Westen, D; Hansson, O				Nilsson, Markus; Szczepankiewicz, Filip; van Westen, Danielle; Hansson, Oskar			Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson's Disease Dementia	PLOS ONE			English	Article							DIFFUSIONAL KURTOSIS; WATER DIFFUSION; ORIENTATION DISPERSION; IMAGE REGISTRATION; IN-VIVO; BRAIN; MICROSTRUCTURE; DISTORTION; QUANTIFICATION; ELIMINATION	Purpose Conventional motion and eddy-current correction, where each diffusion-weighted volume is registered to a non diffusion-weighted reference, suffers from poor accuracy for high b-value data. An alternative approach is to extrapolate reference volumes from low b-value data. We aim to compare the performance of conventional and extrapolation-based correction of diffusional kurtosis imaging (DKI) data, and to demonstrate the impact of the correction approach on group comparison studies. Methods DKI was performed in patients with Parkinson's disease dementia (PDD), and healthy age-matched controls, using b-values of up to 2750 s/mm(2). The accuracy of conventional and extrapolation-based correction methods was investigated. Parameters from DTI and DKI were compared between patients and controls in the cingulum and the anterior thalamic projection tract. Results Conventional correction resulted in systematic registration errors for high b-value data. The extrapolation-based methods did not exhibit such errors, yielding more accurate tractography and up to 50% lower standard deviation in DKI metrics. Statistically significant differences were found between patients and controls when using the extrapolation-based motion correction that were not detected when using the conventional method. Conclusion We recommend that conventional motion and eddy-current correction should be abandoned for high b-value data in favour of more accurate methods using extrapolation-based references.	[Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Szczepankiewicz, Filip] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [van Westen, Danielle] Lund Univ, Dept Radiol, Lund, Sweden; [van Westen, Danielle] Skane Univ Hosp, Imaging & Physiol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Nilsson, M (corresponding author), Lund Univ, Bioimaging Ctr, Lund, Sweden.	markus.nilsson@med.lu.se	Szczepankiewicz, Filip/AAV-9958-2021; Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Szczepankiewicz, Filip/0000-0002-5251-587X; Hansson, Oskar/0000-0001-8467-7286; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874	European Research Council; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society [CAN 2009/1076]; Swedish Foundation for Strategic Research [AM13-0090]; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, The Parkinson Foundation of Sweden, the Swedish Brain Foundation, the Swedish Cancer Society (grant no. CAN 2009/1076), the Swedish Foundation for Strategic Research (AM13-0090), and the Swedish Federal Government under the ALF Agreement. The funding sources had no role in the design and conduct of the study; in the collection, analysis, interpretation of the data; or in the preparation, review, or approval of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bai Y, 2008, BIOMEDICAL IMAGING N, DOI [10.1109/ISBI.2008.4541154, DOI 10.1109/ISBI.2008.4541154]; Bastin ME, 2001, MAGN RESON IMAGING, V19, P937, DOI 10.1016/S0730-725X(01)00427-1; Ben-Amitay S, 2012, MAGN RESON MED, V67, P1694, DOI 10.1002/mrm.23186; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Bracht T, 2015, J AFFECT DISORDERS, V170, P143, DOI 10.1016/j.jad.2014.08.031; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Child ND, 2013, NEUROLOGY, V81, P1869, DOI 10.1212/01.wnl.0000436078.95856.56; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Crum WR, 2003, NEUROIMAGE, V20, P1425, DOI 10.1016/j.neuroimage.2003.07.014; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2010, P INT SOC MAG RESON, P3972; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liptrot MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096247; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mohammadi S, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00427; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Nam H, 2011, NEUROIMAGE, V57, P968, DOI 10.1016/j.neuroimage.2011.05.018; Nielsen JF, 2004, MAGN RESON IMAGING, V22, P1319, DOI 10.1016/j.mri.2004.08.024; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Nilsson M, 2013, MAGN RESON MED, V69, P1572, DOI 10.1002/mrm.24395; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Theilmann RJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00037; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Westin CF, 2014, LECT NOTES COMPUT SC, V8675, P209, DOI 10.1007/978-3-319-10443-0_27; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	59	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141825	10.1371/journal.pone.0141825	http://dx.doi.org/10.1371/journal.pone.0141825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528541	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600065
J	Zilelidou, EA; Rychli, K; Manthou, E; Ciolacu, L; Wagner, M; Skandamis, PN				Zilelidou, Evangelia A.; Rychli, Kathrin; Manthou, Evanthia; Ciolacu, Luminita; Wagner, Martin; Skandamis, Panagiotis N.			Highly Invasive Listeria monocytogenes Strains Have Growth and Invasion Advantages in Strain Competition	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-FLUORESCENS; STRESS-ADAPTATION; BIOFILM FORMATION; SEROTYPE 1/2A; 4B STRAINS; BACTERIA; FOOD; ENRICHMENT; INHIBITION	Multiple Listeria monocytogenes strains can be present in the same food sample; moreover, infection with more than one L. monocytogenes strain can also occur. In this study we investigated the impact of strain competition on the growth and in vitro virulence potential of L. monocytogenes. We identified two strong competitor strains, whose growth was not (or only slightly) influenced by the presence of other strains and two weak competitor strains, which were outcompeted by other strains. Cell contact was essential for growth inhibition. In vitro virulence assays using human intestinal epithelial Caco2 cells showed a correlation between the invasion efficiency and growth inhibition: the strong growth competitor strains showed high invasiveness. Moreover, invasion efficiency of the highly invasive strain was further increased in certain combinations by the presence of a low invasive strain. In all tested combinations, the less invasive strain was outcompeted by the higher invasive strain. Studying the effect of cell contact on in vitro virulence competition revealed a complex pattern in which the observed effects depended only partially on cell-contact suggesting that competition occurs at two different levels: i) during co-cultivation prior to infection, which might influence the expression of virulence factors, and ii) during infection, when bacterial cells compete for the host cell. In conclusion, we show that growth of L. monocytogenes can be inhibited by strains of the same species leading potentially to biased recovery during enrichment procedures. Furthermore, the presence of more than one L. monocytogenes strain in food can lead to increased infection rates due to synergistic effects on the virulence potential.	[Zilelidou, Evangelia A.; Manthou, Evanthia; Skandamis, Panagiotis N.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, GR-11855 Athens, Greece; [Rychli, Kathrin; Ciolacu, Luminita; Wagner, Martin] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Ciolacu, Luminita] Dunarea de Jos Univ Galati, Galati, Romania	Agricultural University of Athens; University of Veterinary Medicine Vienna; Dunarea De Jos University Galati	Rychli, K (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.	Kathrin.rychli@vetmeduni.ac.at	Nychas, George/B-2734-2009	Nychas, George/0000-0002-2673-6425; Ciolacu, Luminita/0000-0003-4123-7859; Kober-Rychli, Kathrin/0000-0001-6147-577X	European Union: 7th Framework Programme projects PROMISE [265877]; University of Veterinary Medicine Vienna, Austria [PL4]	European Union: 7th Framework Programme projects PROMISE; University of Veterinary Medicine Vienna, Austria	Support was provided by the European Union: 7th Framework Programme projects PROMISE, project number 265877 (to MW and PNS), and by an internal start-up project from the University of Veterinary Medicine Vienna, Austria; PL4 (to KR).	Al-Zeyara SA, 2011, INT J FOOD MICROBIOL, V145, P98, DOI 10.1016/j.ijfoodmicro.2010.11.036; Amezquita A, 2002, J FOOD PROTECT, V65, P316, DOI 10.4315/0362-028X-65.2.316; Andritsos ND, 2013, FOOD MICROBIOL, V36, P395, DOI 10.1016/j.fm.2013.06.020; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Besse NG, 2005, INT J FOOD MICROBIOL, V104, P123, DOI 10.1016/j.ijfoodmicro.2005.01.012; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; Buchanan RL, 1999, FOOD MICROBIOL, V16, P523, DOI 10.1006/fmic.1998.0264; Carvalheira A, 2010, FOOD CONTROL, V21, P1492, DOI 10.1016/j.foodcont.2010.04.021; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI 10.1016/0378-1097(93)90119-M; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Cornu M, 2002, INT J FOOD MICROBIOL, V73, P261, DOI 10.1016/S0168-1605(01)00658-4; Dailey RC, 2014, FOOD MICROBIOL, V44, P173, DOI 10.1016/j.fm.2014.05.004; De Blackburn WC, 1994, INT J FOOD MICROBIOL, V24, P125, DOI [10.1016/0168-1605(94)90112-0, DOI 10.1016/0168-1605(94)90112-0]; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Fleet GH, 1999, INT J FOOD MICROBIOL, V50, P101, DOI 10.1016/S0168-1605(99)00080-X; Fox E, 2009, J FOOD PROTECT, V72, P1450, DOI 10.4315/0362-028X-72.7.1450; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; Galvez A, 2010, CURR OPIN BIOTECH, V21, P142, DOI 10.1016/j.copbio.2010.01.005; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Giaouris E, 2014, MEAT SCI, V97, P298, DOI 10.1016/j.meatsci.2013.05.023; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Gnanou Besse N., 2010, International Journal of Food Microbiology, V136, P345; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Gueimonde M, 2006, FOOD RES INT, V39, P467, DOI 10.1016/j.foodres.2005.10.003; Haruta S, 2009, ENVIRON MICROBIOL, V11, P2963, DOI 10.1111/j.1462-2920.2009.01956.x; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Leverentz B, 2006, APPL ENVIRON MICROB, V72, P1135, DOI 10.1128/AEM.72.2.1135-1140.2006; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Moroni O, 2006, APPL ENVIRON MICROB, V72, P6894, DOI 10.1128/AEM.00928-06; Nadell Carey D, 2008, J Biol, V7, P27, DOI 10.1186/jbiol87; O'Byrne CP, 2008, ADV APPL MICROBIOL, V65, P115, DOI 10.1016/S0065-2164(08)00605-9; Oliveira M, 2012, FOOD CONTROL, V25, P678, DOI 10.1016/j.foodcont.2011.12.002; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Pricope-Ciolacu L, 2013, INT J FOOD MICROBIOL, V166, P59, DOI 10.1016/j.ijfoodmicro.2013.05.027; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Ruhe ZC, 2013, MBIO, P4; Rychli K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089964; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Schvartzman MS, 2011, J FOOD PROTECT, V74, P1805, DOI 10.4315/0362-028X.JFP-11-102; Simos M, 2008, INT J FOOD MICROBIOL, V128, P309, DOI 10.1016/j.ijfoodmicro.2008.09.003; Soni KA, 2011, FOODBORNE PATHOG DIS, V8, P843, DOI 10.1089/fpd.2010.0746; Tan QL, 2012, BIOSCI BIOTECH BIOCH, V76, P699, DOI 10.1271/bbb.110832; Tham W, 2002, EPIDEMIOL INFECT, V128, P105, DOI 10.1017/S0950268801006379; Thomas LV, 1996, INT J FOOD MICROBIOL, V29, P361, DOI 10.1016/0168-1605(95)00077-1; Vivant AL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00160; Xayarath B, 2012, FUTURE MICROBIOL, V7, P839, DOI [10.2217/fmb.12.57, 10.2217/FMB.12.57]; Zitz U, 2011, J FOOD PROTECT, V74, P1282, DOI 10.4315/0362-028X.JFP-11-045	62	21	21	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141617	10.1371/journal.pone.0141617	http://dx.doi.org/10.1371/journal.pone.0141617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529510	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600043
J	Sbragaglia, V; Lamanna, F; Mat, AM; Rotllant, G; Joly, S; Ketmaier, V; de la Iglesia, HO; Aguzzi, J				Sbragaglia, Valerio; Lamanna, Francesco; Mat, Audrey M.; Rotllant, Guiomar; Joly, Silvia; Ketmaier, Valerio; de la Iglesia, Horacio O.; Aguzzi, Jacopo			Identification, Characterization, and Diel Pattern of Expression of Canonical Clock Genes in Nephrops norvegicus (Crustacea: Decapoda) Eyestalk	PLOS ONE			English	Article							LONG-TERM-MEMORY; RNA-SEQ DATA; NORWAY LOBSTER; RHYTHMS; GENERATION; SMART; TOOL	The Norway lobster, Nephrops norvegicus, is a burrowing decapod with a rhythmic burrow emergence (24 h) governed by the circadian system. It is an important resource for European fisheries and its behavior deeply affects its availability. The current knowledge of Nephrops circadian biology is phenomenological as it is currently the case for almost all crustaceans. In attempt to elucidate the putative molecular mechanisms underlying circadian gene regulation in Nephrops, we used a transcriptomics approach on cDNA extracted from the eyestalk, a structure playing a crucial role in controlling behavior of decapods. We studied 14 male lobsters under 12-12 light-darkness blue light cycle. We used the Hiseq 2000 Illumina platform to sequence two eyestalk libraries (under light and darkness conditions) obtaining about 90 millions 100-bp paired-end reads. Trinity was used for the de novo reconstruction of transcriptomes; the size at which half of all assembled bases reside in contigs (N50) was equal to 1796 (light) and 2055 (darkness). We found a list of candidate clock genes and focused our attention on canonical ones: timeless, period, clock and bmal1. The cloning of assembled fragments validated Trinity outputs. The putative Nephrops clock genes showed high levels of identity (blastx on NCBI) with known crustacean clock gene homologs such as Eurydice pulchra (period: 47%, timeless: 59%, bmal1: 79%) and Macrobrachium rosenbergii (clock: 100%). We also found a vertebrate-like cryptochrome 2. RT-qPCR showed that only timeless had a robust diel pattern of expression. Our data are in accordance with the current knowledge of the crustacean circadian clock, reinforcing the idea that the molecular clockwork of this group shows some differences with the established model in Drosophila melanogaster.	[Sbragaglia, Valerio; Rotllant, Guiomar; Joly, Silvia; Aguzzi, Jacopo] ICM CSIC, Inst Marine Sci, Barcelona, Spain; [Lamanna, Francesco] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Mat, Audrey M.; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Ketmaier, Valerio] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Potsdam; University of Washington; University of Washington Seattle; Sapienza University Rome	Sbragaglia, V (corresponding author), ICM CSIC, Inst Marine Sci, Barcelona, Spain.	Sbragaglia@icm.csic.es	sbragaglia, valerio/AAB-1507-2019; Joly, Silvia/ABG-9801-2020; Mat, Audrey M/GVS-6454-2022; sbragaglia, valerio/ABA-7409-2020; Rotllant, Guiomar/I-1838-2013; Aguzzi, Jacopo/D-6574-2012	Joly, Silvia/0000-0003-0106-1895; sbragaglia, valerio/0000-0002-4775-7049; Rotllant, Guiomar/0000-0002-6692-9678; Aguzzi, Jacopo/0000-0002-1484-8219; Lamanna, Francesco/0000-0002-0447-759X; , Audrey/0000-0003-2930-6268	FPI grant by the Spanish Ministry of Research Science and Technology [CTM2010-16274]; Belgian American Educational Foundation; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Potsdam	FPI grant by the Spanish Ministry of Research Science and Technology; Belgian American Educational Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam	VS was supported by a FPI grant by the Spanish Ministry of Research Science and Technology in the frame of the project RITFIM (CTM2010-16274); AM was supported by a Fellowship of the Belgian American Educational Foundation. We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam.	Aguzzi J, 2003, MAR ECOL PROG SER, V258, P201, DOI 10.3354/meps258201; Aguzzi J, 2008, J NEUROSCI METH, V173, P215, DOI 10.1016/j.jneumeth.2008.06.009; Aguzzi J, 2008, REV FISH BIOL FISHER, V18, P235, DOI 10.1007/s11160-007-9071-9; Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arechiga H, 2002, CRUSTACEAN NERVOUS SYSTEM, P113; Arechiga H., 1985, P361; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell Mike C., 2006, P412, DOI 10.1002/9780470995969.ch13; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bocking D, 2002, CRUSTACEAN NERVOUS SYSTEM, P84; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; De Pitta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068652; Escamilla-Chimal EG, 2010, J EXP BIOL, V213, P3723, DOI 10.1242/jeb.047548; Escamllla-Chimal EG, 2001, J EXP BIOL, V204, P1073; Farmer A. S. D., 1975, FAO FISHERIES SYNOPS, V112, P1; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GARFIAS A, 1995, J EXP BIOL, V198, P1447; GATEN E, 1990, J MAR BIOL ASSOC UK, V70, P343, DOI 10.1017/S0025315400035451; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Johnson M. L., 2013, ADVANCES IN MARINE B, V64, P325; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P277, DOI 10.1177/0748730410376159; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Le Trionnaire G, 2013, PHYSIOL ENTOMOL, V38, P117, DOI 10.1111/phen.12021; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin C. M., 2012, J BIOMEDICAL SCI, V19, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Main J., 1985, DEP AGR FISHERIES SC, V34, P1; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazzotta GM, 2010, CHRONOBIOL INT, V27, P425, DOI 10.3109/07420521003697494; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NEWLAND PL, 1989, FISH RES, V8, P63, DOI 10.1016/0165-7836(89)90041-6; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Rao KR, 2001, AM ZOOL, V41, P364, DOI 10.1668/0003-1569(2001)041[0364:CPEHCA]2.0.CO;2; Refinetti R, 2006, CIRCADIAN PHYSIOLOGY, P688; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sarda F., 1995, ICES Marine Science Symposia, V199, P78; Sarda F, 2012, REV FISH BIOL FISHER, V22, P409, DOI 10.1007/s11160-011-9242-6; Sbragaglia V, 2013, J EXP MAR BIOL ECOL, V446, P177, DOI 10.1016/j.jembe.2013.05.018; Sbragaglia V, 2013, SCI MAR, V77, P641, DOI 10.3989/scimar.03902.28C; Scheuermann TH, 2007, METHOD ENZYMOL, V435, P3, DOI 10.1016/S0076-6879(07)35001-5; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Teschke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026090; Winbush A, 2012, G3-GENES GENOM GENET, V2, P1437, DOI 10.1534/g3.112.004119; Yang JS, 2006, BRAIN RES, V1067, P13, DOI 10.1016/j.brainres.2005.10.003; Zhang L, 2013, CURR BIOL, V23, P1863, DOI 10.1016/j.cub.2013.08.038; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	61	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141893	10.1371/journal.pone.0141893	http://dx.doi.org/10.1371/journal.pone.0141893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524198	gold, Green Published, Green Submitted			2022-12-27	WOS:000364029800028
J	Kumazaki, M; Usuku, S				Kumazaki, Makoto; Usuku, Shuzo			Genetic Analysis of Norovirus GII.4 Variant Strains Detected in Outbreaks of Gastroenteritis in Yokohama, Japan, from the 2006-2007 to the 2013-2014 Seasons	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SPORADIC GASTROENTERITIS; EMERGENCE; EVOLUTION; CHILDREN; GENOTYPES; IMMUNITY; ESCAPE	Noroviruses (NoVs) are the leading cause of acute gastroenteritis, both in sporadic cases and outbreaks. Since the 1990s, the emergence of several GII.4 variants has been reported worldwide. To investigate the epidemic status of NoV, 6,724 stool samples collected from outbreaks in Yokohama, Japan, from the 2006-2007 to 2013-2014 seasons were assessed for NoVs. We genotyped one specimen from each GII outbreak and conducted a sequence analysis of the VP1 gene for several GII.4 strains. Of the 947 NoV outbreaks during our study, GII was detected in 835, and GII.4 was the predominant genotype of GII. Five different GII.4 variants, Yerseke 2006a, Den Haag 2006b (2006b), Apeldoorn 2007, New Orleans 2009, and Sydney 2012, were detected. During this study period, the most prevalent variant of GII.4 was 2006b, and in each individual season, either 2006b or Sydney 2012 was the predominant variant. Out of the 16 detected 2006b strains, 12 had some amino acid substitutions in their blockade epitope, and these substitutions were concentrated in three residues. Two of the 2006b strains detected in the 2012-2013 season had a S368E substitution, which is consistent with the amino acid residues at same site of NSW0514 (Sydney 2012 prototype). Among the 16 detected strains of Sydney 2012, a phylogenetic analysis showed that all five strains detected in Yokohama during the 2011-2012 season clustered away from the other Sydney 2012 strains that were detected in the 2012-2013 and 2013-2014 seasons. These five strains and other Sydney 2012 strains in Yokohama had a few amino acid differences in the blockade epitopes compared with NSW0514. The amino acid substitutions observed in this study provide informative data about the evolution of a novel GII.4 variant.	[Kumazaki, Makoto; Usuku, Shuzo] Yokohama City Inst Publ Hlth, Microbiol Testing & Res Div, Yokohama, Kanagawa, Japan		Kumazaki, M (corresponding author), Yokohama City Inst Publ Hlth, Microbiol Testing & Res Div, Yokohama, Kanagawa, Japan.	ma00-kumazaki@city.yokohama.jp						Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chan-It W, 2012, J MED VIROL, V84, P1089, DOI 10.1002/jmv.23309; Cho HG, 2014, J CLIN VIROL, V61, P340, DOI 10.1016/j.jcv.2014.08.018; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Giammanco GM, 2014, VIROLOGY, V450, P355, DOI 10.1016/j.virol.2013.12.007; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green K., 2013, FIELDS VIROLOGY, V1, P583; Hasing ME, 2014, INFECT GENET EVOL, V27, P181, DOI 10.1016/j.meegid.2014.07.016; Hasing ME, 2013, J CLIN MICROBIOL, V51, P2204, DOI 10.1128/JCM.00663-13; Hoehne M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-69; Huhti L, 2011, J INFECT DIS, V203, P1442, DOI 10.1093/infdis/jir039; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kumazaki M, 2014, ARCH VIROL, V159, P761, DOI 10.1007/s00705-013-1894-1; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Okada M, 2005, J CLIN MICROBIOL, V43, P4391, DOI 10.1128/JCM.43.9.4391-4401.2005; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Simmons K, 2013, EMERG INFECT DIS, V19, P1260, DOI 10.3201/eid1908.130472; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Yu YX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196169; Zhirakovskaia EV, 2015, J MED VIROL, V87, P740, DOI 10.1002/jmv.24068	37	18	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142568	10.1371/journal.pone.0142568	http://dx.doi.org/10.1371/journal.pone.0142568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544040	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700157
J	Sun, X; Ban, JH; Sha, XJ; Wang, WG; Jiao, Y; Wang, WS; Yang, YW; Wei, JJ; Shen, LJ; Chen, JH				Sun, Xiang; Ban, Jinghao; Sha, Xinjia; Wang, Weiguo; Jiao, Yang; Wang, Wanshan; Yang, Yanwei; Wei, Jingjing; Shen, Lijuan; Chen, Jihua			Effect of Er,Cr:YSGG Laser at Different Output Powers on the Micromorphology and the Bond Property of Non-Carious Sclerotic Dentin to Resin Composites	PLOS ONE			English	Article							SELF-ETCH ADHESIVES; SURFACE-ROUGHNESS; BOVINE DENTIN; HYBRID LAYER; STRENGTH; ENAMEL; ERBIUM; PERFORMANCE; CEMENTS; SYSTEMS	Background The objective of this study was to investigate the influence of Er, Cr:YSGG laser irradiated at different powers on the micromorphology and the bonding property of non-carious sclerotic dentin to resin composites. Methods Two hundred bovine incisors characterized by non-carious sclerotic dentin were selected, and the seventy-two teeth of which for surface morphological analysis were divided into nine groups according to various treatments (A: the control group, B: only treated with the adhesive Adper Easy One, C: diamond bur polishing followed by Adper Easy One, D-I: Er, Cr: YSGG laser irradiating at 1W, 2W, 3W, 4W, 5W, 6W output power, respectively, followed by Adper Easy One). The surface roughness values were measured by the non-contact three-dimensional morphology scanner, then the surface micromorphologies of surfaces in all groups were assessed by scanning electron microscopy (SEM); meanwhile, Image Pro-Plus 6.0 software was used to measure the relative percentage of open tubules on SEM images. The rest, one hundred twenty-eight teeth for bond strength test, were divided into eight groups according to the different treatments (A: only treated with the adhesive Adper Easy One, B: diamond bur polishing followed by the above adhesive, C-H: Er, Cr: YSGG laser irradiating at 1W, 2 W, 3W, 4 W, 5W, 6W output power, respectively, followed by the above adhesive), and each group was subsequently divided into two subgroups according to whether aging is performed (immediately tested and after thermocycling). Micro-shear bond strength test was used to evaluate the bond strength. Results The 4W laser group showed the highest roughness value (30.84 +/- 1.93 mu m), which was statistically higher than the control group and the diamond bur groups (p<0.05). The mean percentages ((27.8 +/- 1.8)%, (28.0 +/- 2.2)%, (30.0 +/- 1.9)%) of open tubules area in the 4W, 5W, 6W group were higher than other groups (p<0.05). The 4W laser group showed the highest micro-shear bond strength not only in immediately tested (17.60 +/- 2.55 PMa) but after thermocycling (14.35 +/- 2.08MPa). Conclusion The Er,Cr:YSGG laser at 4W power can effectively improve the bonding property between non-carious sclerotic dentin and resin composites by increasing the roughness and mean percentage area of open tubules.	[Sun, Xiang; Sha, Xinjia] Fourth Mil Med Univ, Sch Stomatol, Dept VIP Dent Care, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Ban, Jinghao] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prevent Dent, Sch Stomatol, Xian 710032, Peoples R China; [Wang, Weiguo] PLA, Hosp 117, Dept Stomatol, Hangzhou, Zhejiang, Peoples R China; [Jiao, Yang; Wei, Jingjing; Shen, Lijuan; Chen, Jihua] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China; [Jiao, Yang; Wei, Jingjing; Shen, Lijuan; Chen, Jihua] Shaanxi Key Lab Stomatol, Xian, Peoples R China; [Wang, Wanshan] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Dent Mat, Sch Stomatol, Xian 710032, Peoples R China; [Yang, Yanwei] PLA, Lanzhou Gen Hosp, Lanzhou Command, Dept Stomatol, Lanzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn	wei, jing/GXA-1455-2022	Chen, Ji-hua/0000-0002-1151-0693	National Natural Science Foundation of China [81130078, 81371187]; program for Changjiang Scholars and Innovative Research Team in University [IRT13051]; Specialized Research Project for Military health care [14BJZ56]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Specialized Research Project for Military health care	This work was financially supported by grants from the National Natural Science Foundation of China (No. 81130078 and No. 81371187), by the program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051) and by the Specialized Research Project for Military health care (No. 14BJZ56).	Amaral RC, 2010, OPER DENT, V35, P211, DOI 10.2341/09-198-L; Ansari ZJ, 2012, LASER MED SCI, V27, P761, DOI 10.1007/s10103-011-0961-7; ARCORIA CJ, 1993, J ORAL REHABIL, V20, P213, DOI 10.1111/j.1365-2842.1993.tb01603.x; Bahrololoomi Zahra, 2014, J Dent (Tehran), V11, P172; Baygin O, 2012, LASER MED SCI, V27, P153, DOI 10.1007/s10103-011-0918-x; Botta SB, 2011, PHOTOMED LASER SURG, V29, P261, DOI 10.1089/pho.2010.2812; Camargo MA, 2008, J DENT, V36, P922, DOI 10.1016/j.jdent.2008.07.009; Camargo MA, 2008, ARCH ORAL BIOL, V53, P105, DOI 10.1016/j.archoralbio.2007.09.005; De Munck J, 2002, EUR J ORAL SCI, V110, P322, DOI 10.1034/j.1600-0722.2002.21281.x; Ding M, 2014, J ADV PROSTHODONT, V6, P165, DOI 10.4047/jap.2014.6.3.165; Eckert GJ, 2007, DENT MATER, V23, P385, DOI 10.1016/j.dental.2006.02.007; Eliguzeloglu E, 2008, OPER DENT, V33, P338, DOI 10.2341/07-96; Eversole LR, 1997, J AM DENT ASSOC, V128, P1099, DOI 10.14219/jada.archive.1997.0367; Giray FE, 2014, PHOTOMED LASER SURG, V32, P413, DOI 10.1089/pho.2013.3701; Gisler G, 2014, LASER MED SCI, V29, P77, DOI 10.1007/s10103-012-1243-8; HEYMANN HO, 1993, J AM DENT ASSOC, V124, P27; Hoshing Upendra A, 2014, J Conserv Dent, V17, P320, DOI 10.4103/0972-0707.136438; Hossain M, 2001, J CLIN LASER MED SUR, V19, P297, DOI 10.1089/104454701753342749; Jordehi AY, 2007, PHOTOMED LASER SURG, V25, P402, DOI 10.1089/pho.2006.2074; Kenshima S, 2006, J DENT, V34, P775, DOI 10.1016/j.jdent.2006.03.001; Koase K, 2004, J ADHES DENT, V6, P97; Kuscer L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.108002; Kusunoki M, 2002, J DENT, V30, P91, DOI 10.1016/S0300-5712(02)00003-9; Loguercio AD, 2005, DENT MATER, V21, P224, DOI 10.1016/j.dental.2004.03.012; Loguercio AD, 2011, J DENT, V39, P578, DOI 10.1016/j.jdent.2011.06.005; Luque-Martinez IV, 2013, OPER DENT, V38, P39, DOI 10.2341/11-390-L; McDonough WG, 2001, DENT MATER, V17, P492, DOI 10.1016/S0109-5641(01)00008-2; Mena-Serrano AP, 2013, J APPL ORAL SCI, V21, P196, DOI 10.1590/1678-7757201302136; Nishiyama N, 2006, J DENT RES, V85, P422, DOI 10.1177/154405910608500505; Rizoiu loana M, 1995, JCDA, V12, P41; Shahabi S, 2013, LASER MED SCI, V28, P139, DOI 10.1007/s10103-012-1086-3; Sudsangiam S, 1999, J Adhes Dent, V1, P57; Tsai YL, 2011, DENT MATER J, V30, P941, DOI 10.4012/dmj.2011-111; Turkmen C, 2010, QUINTESSENCE INT, V41, pE119; Uekusa Satoshi, 2007, J Oral Sci, V49, P183; van Dijken JWV, 2004, AM J DENT, V17, P27; Visuri SR, 1996, J DENT RES, V75, P599, DOI 10.1177/00220345960750011401; Wegehaupt F, 2008, J ORAL REHABIL, V35, P390, DOI 10.1111/j.1365-2842.2007.01843.x; Xie C, 2010, OPER DENT, V35, P547, DOI 10.2341/10-025-L	39	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142311	10.1371/journal.pone.0142311	http://dx.doi.org/10.1371/journal.pone.0142311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544034	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700109
J	Henzi, T; Schwaller, B				Henzi, Thomas; Schwaller, Beat			Antagonistic Regulation of Parvalbumin Expression and Mitochondrial Calcium Handling Capacity in Renal Epithelial Cells	PLOS ONE			English	Article							FAST-TWITCH MUSCLES; CA2+ UPTAKE; COTRANSPORTER NCC; SKELETAL-MUSCLE; MOUSE MODEL; DEFICIENCY; PROTEIN; REABSORPTION; ABSORPTION; GENES	Parvalbumin (PV) is a cytosolic Ca2+-binding protein acting as a slow-onset Ca2+ buffer modulating the shape of Ca2+ transients in fast-twitch muscles and a subpopulation of neurons. PV is also expressed in non-excitable cells including distal convoluted tubule (DCT) cells of the kidney, where it might act as an intracellular Ca2+ shuttle facilitating transcellular Ca2+ resorption. In excitable cells, upregulation of mitochondria in "PV-ergic" cells in PV-/- mice appears to be a general hallmark, evidenced in fast-twitch muscles and cerebellar Purkinje cells. Using Gene Chip Arrays and qRT-PCR, we identified differentially expressed genes in the DCT of PV-/- mice. With a focus on genes implicated in mitochondrial Ca2+ transport and membrane potential, uncoupling protein 2 (Ucp2), mitocalcin (Efhd1), mitochondrial calcium uptake 1 (Micu1), mitochondrial calcium uniporter (Mcu), mitochondrial calcium uniporter regulator 1 (Mcur1), cytochrome c oxidase subunit 1 (COX1), and ATP synthase subunit beta (Atp5b) were found to be up-upregulated. At the protein level, COX1 was increased by 31 +/- 7%, while ATP-synthase subunit beta was unchanged. This suggested that these mitochondria were better suited to uphold the electrochemical potential across the mitochondrial membrane, necessary for mitochondrial Ca2+ uptake. Ectopic expression of PV in PV-negative Madin-Darby canine kidney (MDCK) cells decreased COX1 and concomitantly mitochondrial volume, while ATP synthase subunit beta levels remained unaffected. Suppression of PV by shRNA in PV-expressing MDCK cells led subsequently to an increase in COX1 expression. The collapsing of the mitochondrial membrane potential by the uncoupler CCCP occurred at lower concentrations in PV-expressing MDCK cells than in control cells. In support, a reduction of the relative mitochondrial mass was observed in PV-expressing MDCK cells. Deregulation of the cytoplasmic Ca2+ buffer PV in kidney cells was counterbalanced in vivo and in vitro by adjusting the relative mitochondrial volume and modifying the mitochondrial protein composition conceivably to increase their Ca2+-buffering/sequestration capacity.	[Henzi, Thomas; Schwaller, Beat] Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Schwaller, B (corresponding author), Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch		Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation (SNSF) [130680, 10A22]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by funding from the Swiss National Science Foundation (SNSF grant #130680 to B.S.) and a Novartis grant #10A22 to B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Belge H, 2007, P NATL ACAD SCI USA, V104, P14849, DOI 10.1073/pnas.0702810104; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Bianchi K, 2006, CELL DEATH DIFFER, V13, P586, DOI 10.1038/sj.cdd.4401784; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Calvo AC, 2008, PROTEOMICS, V8, P4338, DOI 10.1002/pmic.200701091; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Chen G, 2006, NEUROSCIENCE, V142, P97, DOI 10.1016/j.neuroscience.2006.06.008; Chen GP, 2001, AM J PHYSIOL-CELL PH, V281, pC114, DOI 10.1152/ajpcell.2001.281.1.C114; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Ducreux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044837; Gailly P, 2014, PFLUG ARCH EUR J PHY, V466, P2035, DOI 10.1007/s00424-013-1438-2; Gustavsson N, 2006, BIOCHEM BIOPH RES CO, V340, P1119, DOI 10.1016/j.bbrc.2005.12.119; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hsu YJ, 2015, J BONE MINER RES, V30, P116, DOI 10.1002/jbmr.2306; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; LANG F, 1995, KIDNEY INT, V48, P1200, DOI 10.1038/ki.1995.403; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RL, 2006, AM J PHYSIOL-RENAL, V291, pF236, DOI 10.1152/ajprenal.00273.2005; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nicolet-Barousse L, 2005, J BONE MINER RES, V20, P799, DOI 10.1359/JBMR.041238; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Olinger E, 2012, NEPHROL DIAL TRANSPL, V27, P3988, DOI 10.1093/ndt/gfs457; Orduz D, 2013, J PHYSIOL-LONDON, V591, P3215, DOI 10.1113/jphysiol.2012.250795; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Racay P, 2006, FEBS J, V273, P96, DOI 10.1111/j.1742-4658.2005.05046.x; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P2983, DOI 10.1093/ndt/gft358; Vecellio M, 2000, EUR J NEUROSCI, V12, P945, DOI 10.1046/j.1460-9568.2000.00986.x; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wohr M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.19; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Xi Q, 2009, PFLUG ARCH EUR J PHY, V458, P89, DOI 10.1007/s00424-008-0601-7	48	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142005	10.1371/journal.pone.0142005	http://dx.doi.org/10.1371/journal.pone.0142005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540196	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800044
J	Miramontes, R; Hill, AN; Woodruff, RSY; Lambert, LA; Navin, TR; Castro, KG; LoBue, PA				Miramontes, Roque; Hill, Andrew N.; Woodruff, Rachel S. Yelk; Lambert, Lauren A.; Navin, Thomas R.; Castro, Kenneth G.; LoBue, Philip A.			Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SKIN-TEST; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; TB; IMPLEMENTATION; TRANSMISSION; GUIDELINES; HOMELESS	Background Reexamining the prevalence of persons infected with tuberculosis (TB) is important to determine trends over time. In 2011-2012 a TB component was included in the National Health and Nutrition Examination Survey (NHANES) to estimate the reservoir of persons infected with TB. Methods Civilian, noninstitutionalized U.S. population survey participants aged 6 years and older were interviewed regarding their TB history and eligibility for the tuberculin skin test (TST) and interferon gamma release assay (IGRA) blood test. Once eligibility was confirmed, both tests were conducted. Prevalence and numbers of TST positive (10 mm or greater), IGRA positive, and both TST and IGRA positive were calculated by adjusting for the complex survey design after applying corrections for item nonresponse and digit preference in TST induration measurements. To examine TST positivity over time, data from NHANES 1999-2000 were reanalyzed using the same statistical methods. The TST was performed using Tubersol, a commercially available purified protein derivative (PPD), rather than PPD-S, which was the antigen used in NHANES 1999-2000. Prior patient history of TB vaccination was not collected in this study nor were patients examined for the presence of a Bacillus of Calmette and Guerin (BCG) vaccine scar. Results For NHANES 2011-2012, TST and IGRA results were available for 6,128 (78.4%) and 7,107 (90.9%) eligible participants, respectively. There was no significant difference between the percentage of the U.S. population that was TST positive in 2011-2012 (4.7% [95% CI 3.4-6.3]; 13,276,000 persons) compared with 1999-2000 (4.3%; 3.5-5.3). In 2011-2012 the percentage that was IGRA positive was 5.0% (4.2-5.8) and double TST and IGRA positivity was 2.1% (1.5-2.8). The point estimate of IGRA positivity prevalence in foreign-born persons (15.9%; 13.5-18.7) was lower than for TST (20.5%; 16.1-25.8) in 2011-2012. The point estimate of IGRA positivity prevalence in U.S.-born persons (2.8%; 2.0-3.8) was higher than for TST (1.5%; 0.9-2.6). Conclusions No statistically significant decline in the overall estimated prevalence of TST positivity was detected from 1999-2000 to 2011-2012. The prevalence of TB infection, whether measured by TST or IGRA, remains lower among persons born in the United States compared with foreign-born persons.	[Miramontes, Roque; Hill, Andrew N.; Woodruff, Rachel S. Yelk; Lambert, Lauren A.; Navin, Thomas R.; Castro, Kenneth G.; LoBue, Philip A.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Miramontes, R (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	rmiramontes@cdc.gov	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354; Miramontes, Roque/0000-0001-9535-460X				Affronti L F, 1969, Am Rev Respir Dis, V99, P460; Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; [Anonymous], 1995, MMWR Recomm Rep, V44, P19; [Anonymous], 2013, TUB PUR PROT DER; [Anonymous], 2013, REP TUB US; [Anonymous], 2010, MMWR-MORBID MORTAL W; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1974, WHO TECHN REP SER, V552, P16; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Baillargeon J, 2000, ANN EPIDEMIOL, V10, P74, DOI 10.1016/S1047-2797(99)00033-2; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Bennett RJ, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301637; Brown A, 2012, STAT PORTRAIT FOREIG; Cain KP, 2012, AM J RESP CRIT CARE, V186, P273, DOI 10.1164/rccm.201111-2076OC; Camarda CG, 2008, STAT MODEL, V8, P385, DOI 10.1177/1471082X0800800404; Centers for Disease Control and Prevention, 2015, NHANES 1999 2000 PUB; Centers for Disease Control and Prevention, 2014, NHANES 2011 2012 OV; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Choi JC, 2008, CHEST, V133, P1415, DOI 10.1378/chest.07-2193; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Eilers RHC, 2004, INT J TUBERC LUNG D, V8, P232; Engel A, 1977, Vital Health Stat 11, P1; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Goodwin DJ, 2014, MIL MED, V179, P333, DOI 10.7205/MILMED-D-13-00364; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kimerling Michael E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Kong PM, 2002, EMERG INFECT DIS, V8, P1280; Lashley M, 2007, PUBLIC HEALTH NURS, V24, P34, DOI 10.1111/j.1525-1446.2006.00605.x; Lee D P R, 2009, MMWR REP, V62, P1; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Mirel L.B., 2013, VITAL HLTH STAT, V2; Onozaki I, 2010, RESPIROLOGY, V15, P32, DOI 10.1111/j.1440-1843.2009.01673.x; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WHO, 2014, GLOB TUB REP 2014; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206; Woodruff RSY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065276; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, 2013, 13 M WHO STRAT TECHN; Zhao XR, 2009, AM J CLIN PATHOL, V132, P678, DOI 10.1309/AJCPUHC34NBDGKKL	48	107	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140881	10.1371/journal.pone.0140881	http://dx.doi.org/10.1371/journal.pone.0140881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536035	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400042
J	Nishijima, T; Hayashida, T; Kurosawa, T; Tanaka, N; Oka, S; Gatanaga, H				Nishijima, Takeshi; Hayashida, Tsunefusa; Kurosawa, Takuma; Tanaka, Noriko; Oka, Shinichi; Gatanaga, Hiroyuki			Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TENOFOVIR DISOPROXIL FUMARATE; KIDNEY TUBULAR DYSFUNCTION; FUNCTION DECLINE; IMPAIRMENT; DISEASE; REGIMEN; SAFETY; ADULTS; ABCC2	Objective To investigate whether single nucleotide polymorphisms (SNP) of drug transporter proteins for TDF is a risk factor for TDF-related renal function decrement. Methods This study investigated the association between 3 SNPs (ABCC2-24, 1249, and ABCB1 2677), which are shown to be associated with TDF-induced tubulopathy, and clinically important renal outcomes (>10ml/min/1.73m(2) decrement in eGFR relative to baseline, >25% decrement in eGFR, and eGFR <60ml/min/1.73m(2)) in 703 HIV-1-infected Japanese patients who initiated TDF-containing antiretroviral therapy (ART). Genotyping was performed by allelic discrimination using TaqMan 5'-nuclease assays. Results 95% of the study patients were males and 66% were treatment-naive, with median CD4 count of 249/mu l, median baseline eGFR of 96ml/min/1.73m(2) (IQR 84.6-109.2), and median exposure to TDF of 3.66 years (IQR 1.93-5.59). The frequencies of genotypes at -24, 1249 of ABCC2, and 2677 of ABCB1 were neither different between patients with decrement in eGFR of >10ml/min/1.73m(2) and those without such decrement (ABCC2: -24, p = 0.53, 1249, p = 0.68; ABCB1: 2677, p = 0.74), nor between those without and with the other two renal outcomes (>25% decrement: ABCC2: -24, p = 0.83, 1249, p = 0.97, ABCB1: 2677, p = 0.40; eGFR <60ml/min/1.73m(2): ABCC2: -24, p = 0.51, 1249, p = 0.81, ABCB1: 2677, p = 0.94). Logistic regression analysis showed that the risk genotype of the three SNPs were not associated with any of the three renal outcomes, respectively. Logistic regression model that applied either dominant, recessive, or additive model yielded the same results. Conclusions SNPs of the drug transporters for TDF are not associated with clinically important renal outcomes in patients who initiated TDF-containing ART.	[Nishijima, Takeshi; Hayashida, Tsunefusa; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Kurosawa, Takuma] Tokyo Univ Sci, Grad Sch Sci, Dept Math Sci Informat Sci, Tokyo 162, Japan; [Kurosawa, Takuma; Tanaka, Noriko] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res & Informat, Biostat Sect, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University; Tokyo University of Science; National Center for Global Health & Medicine - Japan	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Tanaka, Noriko/AAP-8984-2021; Tanaka, Noriko/J-7811-2018	Tanaka, Noriko/0000-0003-3025-1591; Tanaka, Noriko/0000-0003-3025-1591	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]; Grant for National Center for Global Health and Medicine [25-106, 27-6001]; IMAI MEMORIAL TRUST FOR AIDS RESEARCH	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grant for National Center for Global Health and Medicine; IMAI MEMORIAL TRUST FOR AIDS RESEARCH	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001), The Grant for National Center for Global Health and Medicine (25-106 and 27-6001), and a grants-in-aid of The IMAI MEMORIAL TRUST FOR AIDS RESEARCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PREEXP PROPH PREV HI; [Anonymous], GUIDELINES USE ANTIR; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Choi AI, 2007, KIDNEY INT, V72, P1380, DOI 10.1038/sj.ki.5002541; Fung S, 2013, GASTROENTEROLOGY; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Horio M, 2013, CLIN EXP NEPHROL, V17, P352, DOI 10.1007/s10157-012-0704-5; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Kiser JJ, 2008, JAIDS-J ACQ IMM DEF, V47, P298, DOI 10.1097/QAI.0b013e31815e7478; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Kurata Y, 2002, CLIN PHARMACOL THER, V72, P209, DOI 10.1067/mcp.2002.126177; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucas GM, 2014, CLIN INFECT DIS; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Manosuthi W, 2014, J ANTIMICROB CHEMOTH, V69, P2195, DOI 10.1093/jac/dku129; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Moss DM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00248; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Neumanova Z, 2014, AIDS, V28, P9, DOI 10.1097/QAD.0000000000000112; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2012, CLIN INFECT DIS, V55, P1558, DOI 10.1093/cid/cis772; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Poizot-Martin I, 2013, JAIDS-J ACQ IMM DEF, V62, P375, DOI 10.1097/QAI.0b013e31827ce4ee; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Rodriguez-Novoa S, 2009, PHARMACOGENOMICS, V10, P1675, DOI 10.2217/PGS.09.115; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sirirungsi W, 2015, JAIDS-J ACQ IMM DEF, V68, pE56, DOI 10.1097/QAI.0000000000000504; Verhelst D, 2002, AM J KIDNEY DIS, V40, P1331, DOI 10.1053/ajkd.2002.36924; World Health Organization, CONS GUID US ANT DRU; World Health Organization, 2014, POL BRIEF CONS GUID	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141931	10.1371/journal.pone.0141931	http://dx.doi.org/10.1371/journal.pone.0141931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535588	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400103
J	Ponnusamy, D; Clinkenbeard, KD				Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.			Role of Tellurite Resistance Operon in Filamentous Growth of Yersinia pestis in Macrophages	PLOS ONE			English	Article							ESCHERICHIA-COLI; SURVIVAL; REPLICATION; VIRULENCE; PLASMID; REGION; GENES; PERSISTENCE; DIVISION; STRESS	Background Yersinia pestis initiates infection by parasitism of host macrophages. In response to macrophage infections, intracellular Y. pestis can assume a filamentous cellular morphology which may mediate resistance to host cell innate immune responses. We previously observed the expression of Y. pestis tellurite resistance proteins TerD and TerE from the terZABCDE operon during macrophage infections. Others have observed a filamentous response associated with expression of tellurite resistance operon in Escherichia coli exposed to tellurite. Therefore, in this study we examine the potential role of Y. pestis tellurite resistance operon in filamentous cellular morphology during macrophage infections. Principal Findings In vitro treatment of Y. pestis culture with sodium tellurite (Na2TeO3) caused the bacterial cells to assume a filamentous phenotype similar to the filamentous phenotype observed during macrophage infections. A deletion mutant for genes terZAB abolished the filamentous morphologic response to tellurite exposure or intracellular parasitism, but without affecting tellurite resistance. However, a terZABCDE deletion mutant abolished both filamentous morphologic response and tellurite resistance. Complementation of the terZABCDE deletion mutant with terCDE, but not terZAB, partially restored tellurite resistance. When the terZABCDE deletion mutant was complemented with terZAB or terCDE, Y. pestis exhibited filamentous morphology during macrophage infections as well as while these complemented genes were being expressed under an in vitro condition. Further in E. coli, expression of Y. pestis terZAB, but not terCDE, conferred a filamentous phenotype. Conclusions These findings support the role of Y. pestis terZAB mediation of the filamentous response phenotype; whereas, terCDE confers tellurite resistance. Although the beneficial role of filamentous morphological responses by Y. pestis during macrophage infections is yet to be fully defined, it may be a bacterial adaptive strategy to macrophage associated stresses.	[Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Clinkenbeard, KD (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	ken.clinkenbeard@okstate.edu			Center for Veterinary Heath Sciences, Oklahoma State University	Center for Veterinary Heath Sciences, Oklahoma State University	The study was funded by the Center for Veterinary Heath Sciences, Oklahoma State University.	Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Aradska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078010; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; BRUBAKER RR, 1964, J INFECT DIS, V114, P13, DOI 10.1093/infdis/114.1.13; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Comer JE, 2010, INFECT IMMUN, V78, P5086, DOI 10.1128/IAI.00256-10; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Franks SE, 2014, INFECT IMMUN, V82, P1132, DOI 10.1128/IAI.01614-13; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; HALL PJ, 1974, INFECT IMMUN, V9, P1105, DOI 10.1128/IAI.9.6.1105-1113.1974; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Liu MF, 1999, FEMS MICROBIOL LETT, V174, P385; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211; Ponnusamy D, 2011, THESIS; Ponnusamy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042211; Ponnusamy D, 2011, VET MICROBIOL, V150, P146, DOI 10.1016/j.vetmic.2010.12.025; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; SLATER M, 1974, BACTERIOL REV, V38, P199, DOI 10.1128/MMBR.38.2.199-221.1974; Spinner JL, 2014, J LEUKOCYTE BIOL, V95, P389, DOI 10.1189/jlb.1112551; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Toptchieva A, 2003, MICROBIOL-SGM, V149, P1285, DOI 10.1099/mic.0.25981-0; Tremaroli V, 2009, APPL ENVIRON MICROB, V75, P719, DOI 10.1128/AEM.01771-08; Trutko SM, 2000, ARCH MICROBIOL, V173, P178, DOI 10.1007/s002039900123; Valkova D, 2007, CENT EUR J BIOL, V2, P182, DOI 10.2478/s11535-007-0019-9; Valkovicova L, 2013, ANTON LEEUW INT J G, V104, P899, DOI 10.1007/s10482-013-0009-z; Vavrova S, 2006, BIOMETALS, V19, P453, DOI 10.1007/s10534-005-4862-8; WALTER EG, 1991, J BACTERIOL, V173, P1111, DOI 10.1128/jb.173.3.1111-1119.1991; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Whelan KF, 1997, J BACTERIOL, V179, P63, DOI 10.1128/jb.179.1.63-71.1997; Wimsatt J, 2009, J VECTOR DIS, V46, P85; Zannoni D, 2008, ADV MICROB PHYSIOL, V53, P1, DOI 10.1016/S0065-2911(07)53001-8; Zhou DS, 2006, MICROBES INFECT, V8, P2669, DOI 10.1016/j.micinf.2006.07.015	44	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141984	10.1371/journal.pone.0141984	http://dx.doi.org/10.1371/journal.pone.0141984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536670	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400111
J	Tian, M; Miao, HM; Shen, Y; Gao, J; Mo, XF; Zhou, XT				Tian, Mi; Miao, Huamao; Shen, Yang; Gao, Jian; Mo, Xiaofen; Zhou, Xingtao			Intra- and Intersession Repeatability of an Optical Quality and Intraocular Scattering Measurement System in Children	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; RETINAL IMAGE QUALITY; CLINICAL-EVALUATION; GRADING NUCLEAR; PENTACAM; ABERRATIONS; OPACITY; EYES	Purpose To evaluate intra-and intersession repeatability of objective optical quality and intraocular scattering measurements with a double-pass system in children. Methods Forty-two eyes of 42 children were included in the study. An optical quality analysis system (OQAS) was used to measure optical quality parameters, including modulation transfer function cutoff frequency (MTFcutoff), Strehl ratio (SR), OQAS values (OV) at 3 different contrasts and objective scatter index (OSI). Three measurement sessions with 10-min intervals were operated by the same technician, and in each session four consecutive measurements were obtained. Results Mean values for MTFcutoff, SR and OSI were 46.85 +/- 7.45cpd, 0.27 +/- 0.06 and 0.34 +/- 0.22 respectively. 1) The intraclass correlation coefficients were ranged from 0.89 to 0.97 and coefficients of variation from 0.06 to 0.16 for all the parameters in the first session; the relative repeatability were 11.1% (MTFcutoff), 22.5% (SR), 10.9% (OV100%), 16.6% (OV2%), 22.4% (OV9%) and 56.3% (OSI). Similar results were found in the second and third sessions. 2) Bland-Altman analysis showed that narrow 95% confidence intervals (compared between the first and second sessions) ranged from -5.42 to 5.28 (MTFcutoff), -0.05 to 0.07 (SR), -0.18 to 0.18 (OV100%), -0.26 to 0.29 (OV20%), -0.33 to 0.39 (OV9%) and -0.11 to 0.09 (OSI); the comparison between any two of the three sessions showed similar results. Conclusion Measurements of optical quality and intraocular scattering in children by the double-pass system showed good intra- and intersession repeatability. Retinal image quality is high and intraocular scattering is low in children.	[Tian, Mi; Miao, Huamao; Shen, Yang; Mo, Xiaofen; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Gao, Jian] Fudan Univ, Ctr Clin Epidemiol & Evidence Based Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Mo, XF (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	xfmo@fudan.edu.cn; xingtaozhou@163.com	Shen, Yang/R-3539-2016; zhou, xt/GWZ-9212-2022	Shen, Yang/0000-0002-5859-0790; 	Key Project of Science and Technology of Shanghai [11JC1402000]; Shanghai Municipal Education Comission [12SG04]	Key Project of Science and Technology of Shanghai; Shanghai Municipal Education Comission(Shanghai Municipal Education Commission (SHMEC))	This work was funded by the Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000) and the Shanghai Municipal Education Comission (Grant No. 12SG04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldebasi HI, 2013, SAUDI J OPHTHALMOL, V27, P253, DOI 10.1016/j.sjopt.2013.07.007; Anera RG, 2011, J REFRACT SURG, V27, P597, DOI 10.3928/1081597X-20110303-01; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cabot F, 2013, AM J OPHTHALMOL, V155, P629, DOI 10.1016/j.ajo.2012.11.005; Chen D, 2009, CLIN EXP OPTOM, V92, P110, DOI 10.1111/j.1444-0938.2008.00336.x; de Juan V, 2014, CONTACT LENS ANTERIO, V37, P278, DOI 10.1016/j.clae.2014.02.003; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Gispets J, 2002, OPHTHAL PHYSL OPT, V22, P221, DOI 10.1046/j.1475-1313.2002.00021.x; Gobbe M, 2002, J REFRACT SURG, V18, pS567; Guell JL, 2004, J CATARACT REFR SURG, V30, P1598, DOI 10.1016/j.jcrs.2004.04.031; He JC, 2002, VISION RES, V42, P1063, DOI 10.1016/S0042-6989(02)00035-4; Kamiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066846; Kamiya K, 2012, CURR EYE RES, V37, P884, DOI 10.3109/02713683.2012.688164; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P892, DOI 10.1097/01.opx.0000180817.46312.0a; Li T, 2012, CLIN EXP OPTOM, V95, P399, DOI 10.1111/j.1444-0938.2012.00739.x; Martinez-Roda JA, 2011, CLIN EXP OPTOM, V94, P223, DOI 10.1111/j.1444-0938.2010.00535.x; Miao HM, 2014, J REFRACT SURG, V30, P296, DOI 10.3928/1081597X-20140415-02; Ondategui JC, 2012, J CATARACT REFR SURG, V38, P16, DOI 10.1016/j.jcrs.2011.07.037; Ortiz D, 2008, J CATARACT REFR SURG, V34, P1345, DOI 10.1016/j.jcrs.2008.04.022; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tomas J, 2012, CLIN EXP OPTOM, V95, P60, DOI 10.1111/j.1444-0938.2011.00660.x; Torrents A, 1997, OPHTHAL PHYSL OPT, V17, P357, DOI 10.1111/j.1475-1313.1997.tb00067.x; Vilaseca M, 2012, BRIT J OPHTHALMOL, V96, P1204, DOI 10.1136/bjophthalmol-2011-301055; Vilaseca M, 2010, J CATARACT REFR SURG, V36, P1945, DOI 10.1016/j.jcrs.2010.05.029; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142189	10.1371/journal.pone.0142189	http://dx.doi.org/10.1371/journal.pone.0142189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536120	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400142
J	Collinson, S; Khan, K; Heffernan, JM				Collinson, Shannon; Khan, Kamran; Heffernan, Jane M.			The Effects of Media Reports on Disease Spread and Important Public Health Measurements	PLOS ONE			English	Article							EPIDEMIC; TRANSMISSION; MODEL; DESENSITIZATION; COMMUNICATION; VACCINATION; VIOLENCE	Controlling the spread of influenza to reduce the effects of infection on a population is an important mandate of public health. Mass media reports on an epidemic or pandemic can provide important information to the public, and in turn, can induce positive healthy behaviour practices (i.e., handwashing, social distancing) in the individuals, that will reduce the probability of contracting the disease. Mass media fatigue, however, can dampen these effects. Mathematical models can be used to study the effects of mass media reports on epidemic/pandemic outcomes. In this study we employ a stochastic agent based model to provide a quantification of mass media reports on the variability in important public health measurements. We also include mass media report data compiled by the Global Public Health Intelligence Network, to study the effects of mass media reports in the 2009 H1N1 pandemic. We find that the report rate and the rate at which individuals relax their healthy behaviours (media fatigue) greatly affect the variability in important public health measurements. When the mass media reporting data is included in the model, two peaks of infection result.	[Collinson, Shannon; Heffernan, Jane M.] York Univ, Ctr Dis Modelling, Modelling Infect & Immun Lab, Toronto, ON M3J 2R7, Canada; [Collinson, Shannon; Heffernan, Jane M.] York Univ, Math & Stat, Toronto, ON M3J 2R7, Canada; [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada	York University - Canada; York University - Canada; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Heffernan, JM (corresponding author), York Univ, Ctr Dis Modelling, Modelling Infect & Immun Lab, Toronto, ON M3J 2R7, Canada.	jmheffer@yorku.ca			Natural Science and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; Mitacs	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Mitacs	This study was supported by the Natural Science and Engineering Research Council of Canada, the Ontario Ministry of Research and Innovation, and Mitacs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; [Anonymous], 2006, HIGHLIGHTS CANADIAN; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Breban R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028300; Catalan-Matamoros D., 2011, HLTH MANAGEMENT DIFF, P296; Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; Fanti KA, 2009, AGGRESSIVE BEHAV, V35, P179, DOI 10.1002/ab.20295; Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; GRIFFITHS MD, 1989, NEW IDEAS PSYCHOL, V7, P85, DOI 10.1016/0732-118X(89)90039-1; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hornik R.C., 2002, PUBLIC HLTH COMMUNIC; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Jung M, 2013, VACCINE, V31, P4860, DOI 10.1016/j.vaccine.2013.07.068; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kerho S, 2010, MACROSOCIAL DETERMIN; Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777; Kinnick KN, 1996, JOURNALISM MASS COMM, V73, P687, DOI 10.1177/107769909607300314; Laskowski M., 2015, BIOMAT 2014 P; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Li YF, 2008, ROCKY MT J MATH, V38, P1437, DOI 10.1216/RMJ-2008-38-5-1437; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; Majumder Maimuna S, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.e6659013c1d7f11bdab6a20705d1e865; McBurney DH, 1997, PHYSIOL BEHAV, V61, P181, DOI 10.1016/S0031-9384(96)00366-6; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Misra AK, 2011, MATH COMPUT MODEL, V53, P1221, DOI 10.1016/j.mcm.2010.12.005; Mostaco-Guidolin LC, 2011, CANADIAN APPL MATH Q, P19; National Advisory Committee on Immunization (NACI), 2011, STAT SEAS INFL VACC; Pang JH, 2009, ICIC 2009: SECOND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTING SCIENCE, VOL 3, PROCEEDINGS, P116, DOI 10.1109/ICIC.2009.235; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Public Health Agency of Canada (PHAC), FLUWATCH REP; Roth D., 2011, SOCIAL DISTANCING PA; Samanta S, 2013, APPL MATH COMPUT, V219, P6965, DOI 10.1016/j.amc.2013.01.009; Schabas R, 2009, THE GLOBE AND MAIL; Schweitzer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001458; Smith KC, 2013, INFLUENZA OTHER RESP, V7, P847, DOI 10.1111/irv.12073; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wang Q, 2015, DISCRETE CONT DYN-B, V20, P215, DOI 10.3934/dcdsb.2015.20.215; Weaver LR, 2003, CHINA SARS NUMBERS P; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Xiao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07838; Yuan XP, 2013, CHAOS SOLITON FRACT, V48, P1, DOI 10.1016/j.chaos.2012.12.001	49	68	73	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141423	10.1371/journal.pone.0141423	http://dx.doi.org/10.1371/journal.pone.0141423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26528909	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600028
J	Duran, BOD; Fernandez, GJ; Mareco, EA; Moraes, LN; Salomao, RAS; de Paula, TG; Santos, VB; Carvalho, RF; Dal-Pai-Silvca, M				da Silva Duran, Bruno Oliveira; Fernandez, Geysson Javier; Mareco, Edson Assuncao; Moraes, Leonardo Nazario; Simoes Salomao, Rondinelle Artur; de Paula, Tassiana Gutierrez; Santos, Vander Bruno; Carvalho, Robson Francisco; Dal-Pai-Silvca, Maeli			Differential microRNA Expression in Fast- and Slow-Twitch Skeletal Muscle of Piaractus mesopotamicus during Growth	PLOS ONE			English	Article							QUANTITATIVE EXPRESSION; GENE-EXPRESSION; PROLIFERATION; PAX7; PREDICTION; MYOGENIN; CELLS; MYOD; ACT	Pacu (Piaractus mesopotamicus) is a Brazilian fish with a high economic value in pisciculture due to its rusticity and fast growth. Postnatal growth of skeletal muscle in fish occurs by hyperplasia and/or hypertrophy, processes that are dependent on the proliferation and differentiation of myoblasts. A class of small noncoding RNAs, known as microRNAs (miRNAs), represses the expression of target mRNAs, and many studies have demonstrated that miR-1, miR-133, miR-206 and miR-499 regulate different processes in skeletal muscle through the mRNA silencing of hdac4 (histone deacetylase 4), srf (serum response factor), pax7 (paired box 7) and sox6 ((sex determining region Y)-box 6), respectively. The aim of our work was to evaluate the expression of these miRNAs and their putative target mRNAs in fast-and slow-twitch skeletal muscle of pacu during growth. We used pacus in three different development stages: larval (aged 30 days), juvenile (aged 90 days and 150 days) and adult (aged 2 years). To complement our study, we also performed a pacu myoblast cell culture, which allowed us to investigate miRNA expression in the progression from myoblast proliferation to differentiation. Our results revealed an inverse correlation between the expression of the miRNAs and their target mRNAs, and there was evidence that miR-1 and miR-206 may regulate the differentiation of myoblasts, whereas miR-133 may regulate the proliferation of these cells. miR-499 was highly expressed in slow-twitch muscle, which suggests its involvement in the specification of the slow phenotype in muscle fibers. The expression of these miRNAs exhibited variations between different development stages and between distinct muscle twitch phenotypes. This work provides the first identification of miRNA expression profiles in pacu skeletal muscle and suggests an important role of these molecules in muscle growth and in the maintenance of the muscle phenotype.	[da Silva Duran, Bruno Oliveira; Fernandez, Geysson Javier; Mareco, Edson Assuncao; Moraes, Leonardo Nazario; de Paula, Tassiana Gutierrez; Carvalho, Robson Francisco; Dal-Pai-Silvca, Maeli] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil; [Simoes Salomao, Rondinelle Artur] Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil; [Santos, Vander Bruno] Sao Paulo Agcy Agribusiness Technol, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Dal-Pai-Silvca, M (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil.	maeli@ibb.unesp.br	de Paula, Tassiana Gutierrez/L-2867-2017; de Moraes, Leonardo Nazario/F-8621-2012; Dal-Pai-Silva, Maeli/GLR-1413-2022; Fernandez, geysson javier/O-2783-2017; Carvalho, Robson Francisco/AAE-4134-2020; Fernandez, Geysson/AAT-9495-2021; Duran, Bruno/AAA-9977-2020	Fernandez, geysson javier/0000-0002-7982-9940; Carvalho, Robson Francisco/0000-0002-4901-7714; Duran, Bruno/0000-0002-7920-8175; Santos, Vander Bruno/0000-0003-1816-169X; Mareco, Edson/0000-0002-3504-6936; Dal Pai, Maeli/0000-0001-7269-9197; Fernandez, Geysson Javier/0000-0002-8493-1587; Moraes, Leonardo/0000-0003-4515-4137	Sao Paulo Research Foundation [2013/01892-2, 2013/10196-0]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Sao Paulo Research Foundation (Process no 2013/01892-2 and Process no 2013/10196-0), http://www.fapesp.br/, to BOSD and MDPS.	Aguiar DH, 2008, AQUAC RES, V39, P1673, DOI 10.1111/j.1365-2109.2008.02042.x; de Almeida FLA, 2010, MICRON, V41, P997, DOI 10.1016/j.micron.2010.06.012; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Castagnolli N, 1986, PISCICULTURA NOS TRO; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Froehlich JM, 2013, IN VITRO CELL DEV-AN, V49, P371, DOI 10.1007/s11626-013-9616-2; Gabillard JC, 2010, CELL TISSUE RES, V342, P471, DOI 10.1007/s00441-010-1071-8; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hitachi Keisuke, 2013, Front Physiol, V4, P408, DOI 10.3389/fphys.2013.00408; Johansen KA, 2005, MAR BIOTECHNOL, V7, P576, DOI 10.1007/s10126-004-5133-3; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nachtigall PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119804; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rowlerson A., 2001, Fish Physiology, V18, P103; Saenger A.M., 2001, Fish Physiology, V18, P187; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Soulez M, 1996, MOL CELL BIOL, V16, P6065; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Urbinati E.C., 2005, ESPECIES NATIVAS PIS, P225; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XG, 2011, DEVELOPMENT, V138, P4399, DOI 10.1242/dev.070516; Yan B, 2012, AQUACULTURE, V364, P240, DOI 10.1016/j.aquaculture.2012.08.018; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	42	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141967	10.1371/journal.pone.0141967	http://dx.doi.org/10.1371/journal.pone.0141967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529415	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600082
J	de Oliveira, RR; Melo, EC; Falavina, LP; Mathias, TAD				de Oliveira, Rosana Rosseto; Melo, Emiliana Cristina; Falavina, Larissa Pereira; de Freitas Mathias, Thais Aidar			The Growing Trend of Moderate Preterm Births: An Ecological Study in One Region of Brazil	PLOS ONE			English	Article							EPIDEMIOLOGY; RATES; STATE; RISK	Background Preterm birth is a serious public health problem, as it is linked to high rates of neonatal and child morbidity and mortality, with Brazil listed among the countries with the ten highest numbers of premature births. Nonetheless, knowledge is scarce regarding prematurity and associated factors in mid-sized cities. The objective of this study was to analyze the trend of preterm births and associated factors in a municipality located in the state of Parana, Brazil. Methods This was an ecological time series study of births recorded into the Live Birth Information System for residents of Maringa, Parana, Brazil, between 2000 and 2013. The polynomial regression model was used for trend analysis of preterm birth, characteristics of the mother, gestation and delivery, and newborn. The association with preterm birth was analyzed using odds ratio (OR). Results A total of 61,634 live births were analyzed, of which 5,632 were preterm births. Prematurity increased from 7.9% in 2000 to 11.2% in 2013-an average increase of 0.54% per year (r(2) = 0.93)-with a growing share of moderate preterm births (32 to < 37 weeks), which rose from 7.0% in 2000 to 9.7% in 2013. Between 2011 and 2013, multiple pregnancy (OR = 16.64; CI = 13.24-20.92), inadequate number of prenatal visits (OR = 2.81; CI = 2.51-3.15), Apgar score below 7 at 1 (OR = 4.07; CI = 3.55-4.67) and 5 minutes (OR = 10.88; CI = 7.71-15.36), low birth weight (OR = 38.75; CI = 33.72-44.55) and congenital malformations (OR = 3.18; CI = 2.14-4.74) were associated with preterm birth. A growing trend was observed for multiple pregnancies, with an average annual increase of 0.32% (r(2) = 0.90), as well as for C-section birth (2.38% yearly increase). Of all newborn characteristics, Apgar score below 7 at 5 minutes (-0.19% per year) and low birth weight (-1.43%) decreased, whereas congenital malformations rose (0.20% per year). Conclusions Efforts are required to prevent premature delivery, particularly during the moderate period, as well as greater care during the prenatal period towards expectant mothers bearing multiple pregnancies, birth defects, in addition to reducing C-section birth as it may be linked to preterm birth.	[de Oliveira, Rosana Rosseto] Univ Estadual Maringa, Grad Nursing Program, Dept Nursing, Maringa, Parana, Brazil; [Melo, Emiliana Cristina] Northern Parana State Univ, Dept Nursing, Bandeirantes, Parana, Brazil; [Falavina, Larissa Pereira] Univ Estadual Maringa, Sch Nursing, Nursing Program, Maringa, Parana, Brazil; [de Freitas Mathias, Thais Aidar] Univ Estadual Maringa, Dept Nursing, Publ Hlth, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Oliveira, RR (corresponding author), Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil.	rosanarosseto@gmail.com	Falavina, Larissa Pereira/AAS-8519-2021; Oliveira, Rosana Rosseto/E-6193-2017	Falavina, Larissa Pereira/0000-0001-9158-6673; Oliveira, Rosana Rosseto/0000-0003-3373-1654	National Council for Scientific and Technological Development (CNPq) [473708/2012-4]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financed by the National Council for Scientific and Technological Development (CNPq), call 14/2012, process 473708/2012-4. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, LANCET, V2, P436; Brito VRS, 2010, REV RENE, V11, P27; Cheong JLY, 2012, J PAEDIATR CHILD H, V48, P784, DOI 10.1111/j.1440-1754.2012.02536.x; da Saude Ministerio, 2006, PRENATAL PUERPERIO A; da Saude Misterio, 2011, SECR VIG SAUD MAN IN; da Silva Gisele Ferreira, 2011, Rev Esc Enferm USP, V45, P79; Fujimori E, 2013, CAD SAUDE PUBLICA, V29, P145, DOI 10.1590/S0102-311X2013000100017; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Howson C, 2012, BORN TOO SOON GLOBAL; Instituto Paranaense de Desenvolvimento Economico e Social, 2014, PAR EM NUM; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Lantos JD, 2011, ARAMBAM MAIMONIDES M, V2, pe0065; Lee SH, 2010, INT J NURS STUD, V47, P1159, DOI 10.1016/j.ijnurstu.2010.02.006; Moreira MEL, 2014, CIENC SAUDE COLETIVA, V19, P1981, DOI 10.1590/1413-81232014194.10182012; Lopez PO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-26; Mcnally LZ, 2011, PERINATAL STAT SERIE, V25; Melo EC, 2013, CIENC CUID SAUDE, V12, P415; Ministerio da Saude, 2012, EST VIT NASC VIV; Vasconcelos AMN, 2012, EPIDEMIOL SERV SAUDE, V21, P539, DOI 10.5123/S1679-49742012000400003; Oliveira RR, REV PESQ CU IN PRESS; Ramos Helena Ângela de Camargo, 2009, Esc. Anna Nery, V13, P297; Silva AMR, 2009, CAD SAUDE PUBLICA, V25, P2125, DOI 10.1590/S0102-311X2009001000004; Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007; Silveira Mariângela F, 2008, Rev. Saúde Pública, V42, P957, DOI 10.1590/S0034-89102008000500023; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141852	10.1371/journal.pone.0141852	http://dx.doi.org/10.1371/journal.pone.0141852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529097	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600069
J	Liu, TC; Li, H; Ding, GH; Wang, Z; Chen, YQ; Liu, L; Li, YY; Li, YX				Liu, Tiancheng; Li, Hong; Ding, Guohui; Wang, Zhen; Chen, Yunqin; Liu, Lei; Li, Yuanyuan; Li, Yixue			Comparative Genome of GK and Wistar Rats Reveals Genetic Basis of Type 2 Diabetes	PLOS ONE			English	Article							COPY-NUMBER VARIATION; IMPAIRED GLUCOSE-TOLERANCE; WIDE ASSOCIATION; RISK LOCI; BETA-CELL; DIPEPTIDYL PEPTIDASE-4; INSULIN-RESISTANCE; SUSCEPTIBILITY; NEPHROPATHY; SEQUENCE	The Goto-Kakizaki (GK) rat, which has been developed by repeated inbreeding of glucose-intolerant Wistar rats, is the most widely studied rat model for Type 2 diabetes (T2D). However, the detailed genetic background of T2D phenotype in GK rats is still largely unknown. We report a survey of T2D susceptible variations based on high-quality whole genome sequencing of GK and Wistar rats, which have generated a list of GK-specific variations (228 structural variations, 2660 CNV amplification and 2834 CNV deletion, 1796 protein affecting SNVs or indels) by comparative genome analysis and identified 192 potential T2D-associated genes. The genes with variants are further refined with prior knowledge and public resource including variant polymorphism of rat strains, protein-protein interactions and differential gene expression. Finally we have identified 15 genetic mutant genes which include seven known T2D related genes (Tnfrsf1b, Scg5, Fgb, Sell, Dpp4, Icam1, and Pkd2l1) and eight high-confidence new candidate genes (Ldlr, Ccl2, Erbb3, Akr1b1, Pik3c2a, Cd5, Eef2k, and Cpd). Our result reveals that the T2D phenotype may be caused by the accumulation of multiple variations in GK rat, and that the mutated genes may affect biological functions including adipocytokine signaling, glycerolipid metabolism, PPAR signaling, T cell receptor signaling and insulin signaling pathways. We present the genomic difference between two closely related rat strains (GK and Wistar) and narrow down the scope of susceptible loci. It also requires further experimental study to understand and validate the relationship between our candidate variants and T2D phenotype. Our findings highlight the importance of sequenced-based comparative genomics for investigating disease susceptibility loci in inbreeding animal models.	[Liu, Tiancheng; Li, Hong; Ding, Guohui; Wang, Zhen; Liu, Lei; Li, Yixue] Chinese Acad Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ding, Guohui; Chen, Yunqin; Li, Yuanyuan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Li, YX (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	yyli@scbit.org; yxli@sibs.ac.cn			National Basic Research Program of China [2011CB910204, 2011CB510102, 2010CB529200]; National Key Technology Support Program [2013BAI101B09]; National Key Scientific Instrument and Equipment Development Project [2012YQ03026108]; SIBS Knowledge Innovation Program [2014KIP215]; SA-SIBS Scholarship Program	National Basic Research Program of China(National Basic Research Program of China); National Key Technology Support Program(National Key Technology R&D Program); National Key Scientific Instrument and Equipment Development Project; SIBS Knowledge Innovation Program; SA-SIBS Scholarship Program	This work was supported by National Basic Research Program of China (2011CB910204, 2011CB510102, 2010CB529200), National Key Technology Support Program (2013BAI101B09), National Key Scientific Instrument and Equipment Development Project (2012YQ03026108), SIBS Knowledge Innovation Program (2014KIP215) and SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Benjafield AV, 2001, DIABETES CARE, V24, P753, DOI 10.2337/diacare.24.4.753; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bouatia-Naji N, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-44; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Chu KY, 2011, ISLETS, V3, P155, DOI 10.4161/isl.3.4.15767; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Engelbertsen D, 2012, EXP DIABETES RES, DOI 10.1155/2012/176162; Fernandez-Real JM, 2006, CLIN IMMUNOL, V121, P236, DOI 10.1016/j.clim.2006.07.011; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Guest PC, 2002, J ENDOCRINOL, V175, P637, DOI 10.1677/joe.0.1750637; Hanson RL, 2014, DIABETES, V63, P369, DOI 10.2337/db13-0416; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200; Kamiuchi K, 2002, J DIABETES COMPLICAT, V16, P333, DOI 10.1016/S1056-8727(01)00226-4; Karadayi K, 2003, OCUL IMMUNOL INFLAMM, V11, P123, DOI 10.1076/ocii.11.2.123.15920; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kvasnicka J, 1996, Cas Lek Cesk, V135, P174; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Makiishi T, 2003, AM J KIDNEY DIS, V42, P943, DOI 10.1016/j.ajkd.2003.06.003; Mancusi S, 2013, J NEPHROL, V26, P207, DOI 10.5301/jn.5000126; Marfella R, 2012, EXP DIABETES RES, DOI 10.1155/2012/892706; Mastej K, 2008, ACTA DIABETOL, V45, P183, DOI 10.1007/s00592-008-0040-0; Maumus S, 2007, ATHEROSCLEROSIS, V191, P369, DOI 10.1016/j.atherosclerosis.2006.04.003; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Movassat J, 2007, DIABETES OBES METAB, V9, P187, DOI 10.1111/j.1463-1326.2007.00786.x; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pala L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/590456; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Prasad P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-52; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Ravassa S, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-143; Rensing KL, 2014, CARDIOVASC RES, V101, P277, DOI 10.1093/cvr/cvt252; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Shah P, 2013, J CLIN ENDOCR METAB, V98, pE1163, DOI 10.1210/jc.2013-1029; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sun X, 2014, INT J CLIN EXP PATHO, V7, P4136; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Twigger S, 2002, NUCLEIC ACIDS RES, V30, P125, DOI 10.1093/nar/30.1.125; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Wu S H, 1993, Zhonghua Yi Xue Za Zhi, V73, P10; Wu SH, 1993, ZHONGHUA YI XUE ZA Z, V73, P60; Xi RB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-O10; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Ye ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014077; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103794; Zheng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105681; Zhou DL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/569435	94	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141859	10.1371/journal.pone.0141859	http://dx.doi.org/10.1371/journal.pone.0141859			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529237	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600070
J	Lu, JF; Li, JE; Liu, YL; Ren, S; Cao, ZH; Jin, Y; Ma, LN; Shen, CL; Chen, XY				Lu, Junfeng; Li, Jin'e; Liu, Yali; Ren, Shan; Cao, Zhenhuan; Jin, Yi; Ma, Lina; Shen, Chengli; Chen, Xinyue			Study on Post-Treatment Relapse in HBeAg Positive CHB Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; E-ANTIGEN SEROCONVERSION; PEGINTERFERON ALPHA-2A; OFF-TREATMENT; VIRUS DNA; LAMIVUDINE; DURABILITY; THERAPY; COMBINATION	Background Many factors are associated with post-treatment relapse in CHB patients, and there are no effective factors to predict relapse. In this study, we investigate the influence factors associated with post-treatment relapse and their predictive value in HBeAg positive CHB (eP-CHB). Methods The factors associated with post-treatment relapse were analyzed firstly by a retrospective study in eP-CHB. Variables included age, sex, regimen, baseline HBeAg and HBV DNA level, total course of treatment as well as duration of consolidation therapy after HBeAg seroconversion. The predictive effects of the influence factors were evaluated in an eP-CHB prospective cohort. Results 89 patients were enrolled in the retrospective study, 42(47.2%) relapsed after discontinuation of treatment. Factors related to post-treatment relapse were total course of treatment, duration of consolidation therapy and baseline HBV DNA level. Relapse rates in patients with total course >36 months, consolidation duration >12 months and baseline HBV DNA level < 1.0E+5IU/ml were lower than those of total course <24 months (P = 0.002), consolidation duration <= 1 = 0.01) respectively. Patients with HBV DNA >= 1.0E+ 7IU/ml plus HBeAg<200COI at baseline had the highest relapse rate and cumulative relapse rate than the other three arms (P = 0.048 and 0.008 respectively). Logistic regression analysis demonstrated that baseline HBV DNA level, duration of consolidation therapy and combination of baseline HBV DNA and HBeAg (Ig(DNA)/Ig(HBeAg)) were independent factors to predict post-treatment relapse. The model based on baseline Ig(DNA)/Ig(HBeAg) and consolidation duration worked well in predicting post-treatment relapse in the prospective study and the accuracy, specificity, sensitivity, PPV and NPV for prediction were 80.3%, 81.1%, 79.2%, 73.1% and 85.7% respectively. Conclusions Virological factors including baseline HBV DNA, HBeAg and treatment course were major influence factors associated with post-treatment relapse in eP-CHB. Patients with higher HBV DNA and lower HBeAg levels at baseline, shorter total course as well as consolidation therapy were more likely to develop relapse after discontinuation of therapy. The antiviral therapy in eP-CHB patients should be individually managed at different levels. It is better to treat those with higher viral load and lower HBeAg levels at baseline for a longer course, especially longer consolidation duration so as to decrease the relapse rate.	[Lu, Junfeng; Li, Jin'e; Liu, Yali; Ren, Shan; Cao, Zhenhuan; Jin, Yi; Ma, Lina; Chen, Xinyue] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Shen, Chengli] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, XY (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China.	chenxydoc@163.com	chen, xinyue/HHR-9308-2022		Beijing Youan Hospital hepatic Disease HIV Fund [20150205];  [PXM2015 014226 000058];  [2013ZX1000 2002-006];  [Z151100004015181]	Beijing Youan Hospital hepatic Disease HIV Fund; ; ; 	This work was supported by The capital characteristic clinical application research and extension of achievements, Z151100004015181(XC), Beijing Youan Hospital hepatic Disease & HIV Fund 20150205 (XC), Collaborative innovation project, PXM2015 014226 000058 (XC), and The twelfth Five-Year major science and technology projects, 2013ZX1000 2002-006 (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao ZH, 2013, J DIGEST DIS, V14, P446, DOI 10.1111/1751-2980.12065; Chaung KT, 2012, J CLIN GASTROENTEROL, V46, P865, DOI 10.1097/MCG.0b013e31825ceed9; Chien RN, 2003, HEPATOLOGY, V38, P1267, DOI 10.1053/jhep.2003.50458; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Flink HJ, 2007, GUT, V56, P1485, DOI 10.1136/gut.2007.125633; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Lee HW, 2010, HEPATOLOGY, V51, P415, DOI 10.1002/hep.23323; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Pan XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068568; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Sohn HR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-439; Song BC, 2000, HEPATOLOGY, V32, P803, DOI 10.1053/jhep.2000.16665; Song MJ, 2012, WORLD J GASTROENTERO, V18, P6277, DOI 10.3748/wjg.v18.i43.6277; van Nunen AB, 2003, GUT, V52, P420, DOI 10.1136/gut.52.3.420; Wang L, 2010, J VIRAL HEPATITIS, V17, P298, DOI 10.1111/j.1365-2893.2009.01178.x; Xie Dong-ying, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P341; Yeh CT, 2009, J CLIN VIROL, V45, P114, DOI 10.1016/j.jcv.2009.04.006	18	0	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141072	10.1371/journal.pone.0141072	http://dx.doi.org/10.1371/journal.pone.0141072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524467	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000364029800006
J	Nakata, PA				Nakata, Paul A.			An Assessment of Engineered Calcium Oxalate Crystal Formation on Plant Growth and Development as a Step toward Evaluating Its Use to Enhance Plant Defense	PLOS ONE			English	Article							OXALYL-COA SYNTHETASE; BROWN PLANTHOPPER; FINE-STRUCTURE; ARABIDOPSIS; RICE; ACID; DELPHACIDAE; HOMOPTERA; RAPHIDES; INSECTS	The establishment of new approaches to control chewing insects has been sought not only for direct use in reducing crop loss but also in managing resistance to the pesticides already in use. Engineered formation of calcium oxalate crystals is a potential strategy that could be developed to fulfill both these needs. As a step toward this development, this study investigates the effects of transforming a non-calcium oxalate crystal accumulating plant, Arabidopsis thaliana, into a crystal accumulating plant. Calcium oxalate crystal accumulating A. thaliana lines were generated by ectopic expression of a single bacterial gene encoding an oxalic acid biosynthetic enzyme. Biochemical and cellular studies suggested that the engineered A. thaliana lines formed crystals of calcium oxalate in a manner similar to naturally occurring crystal accumulating plants. The amount of calcium oxalate accumulated in leaves also reached levels similar to those measured in the leaves of Medicago truncatula in which the crystals are known to play a defensive role. Visual inspection of the different engineered lines, however, suggested a phenotypic consequence on plant growth and development with higher calcium oxalate concentrations. The restoration of a near wildtype plant phenotype through an enzymatic reduction of tissue oxalate supported this observation. Overall, this study is a first to provide initial insight into the potential consequences of engineering calcium oxalate crystal formation in non-crystal accumulating plants.	Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med,Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med,Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	U.S. Department of Agriculture, Agricultural Research Service, 58-3092-5-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; Howe GA, 2015, CURR OPIN INSECT SCI; James LF, 1999, J NAT TOXINS, V8, P395; Julian CG, 1997, CONTACT DERMATITIS, V37, P259, DOI 10.1111/j.1600-0536.1997.tb02461.x; Konno K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091341; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; Koul O, 2008, CRIT REV PLANT SCI, V27, P1, DOI 10.1080/07352680802053908; MASSONIE G, 1980, ANN NUTR ALIMENT, V34, P139; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nakata PA, 2000, PLANT PHYSIOL, V124, P1097, DOI 10.1104/pp.124.3.1097; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Nakata PA, 2012, PLANT CELL PHYSIOL, V53, P1275, DOI 10.1093/pcp/pcs071; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Park SH, 2009, ENTOMOL EXP APPL, V131, P208, DOI 10.1111/j.1570-7458.2009.00846.x; Salinas ML, 2001, CONTACT DERMATITIS, V44, P94, DOI 10.1034/j.1600-0536.2001.440208.x; THURSTON EL, 1976, AM J BOT, V63, P710, DOI 10.2307/2442029; Wang YC, 2008, ENTOMOL EXP APPL, V129, P295, DOI 10.1111/j.1570-7458.2008.00785.x; YOSHIHARA T, 1979, ENTOMOL EXP APPL, V26, P314, DOI 10.1111/j.1570-7458.1979.tb02932.x; YOSHIHARA T, 1980, ENTOMOL EXP APPL, V27, P149, DOI 10.1007/BF00573889	27	17	18	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141982	10.1371/journal.pone.0141982	http://dx.doi.org/10.1371/journal.pone.0141982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517544	gold, Green Submitted, Green Published			2022-12-27	WOS:000363920800099
J	Chatterjee, T; Sheikh, IA; Chakravarty, D; Chakrabarti, P; Sarkar, P; Saha, T; Chakrabarti, MK; Hoque, KM				Chatterjee, Tanaya; Sheikh, Irshad Ali; Chakravarty, Devlina; Chakrabarti, Pinak; Sarkar, Paramita; Saha, Tultul; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			Effects of Small Molecule Calcium-Activated Chloride Channel Inhibitors on Structure and Function of Accessory Cholera Enterotoxin (Ace) of Vibrio cholerae	PLOS ONE			English	Article							SECRETION; DEGRADATION; TOXIN	Cholera pathogenesis occurs due to synergistic pro-secretory effects of several toxins, such as cholera toxin (CTX) and Accessory cholera enterotoxin (Ace) secreted by Vibrio cholerae strains. Ace activates chloride channels stimulating chloride/bicarbonate transport that augments fluid secretion resulting in diarrhea. These channels have been targeted for drug development. However, lesser attention has been paid to the interaction of chloride channel modulators with bacterial toxins. Here we report the modulation of the structure/function of recombinant Ace by small molecule calcium-activated chloride channel (CaCC) inhibitors, namely CaCCinh-A01, digallic acid (DGA) and tannic acid. Biophysical studies indicate that the unfolding (induced by urea) free energy increases upon binding CaCCinh-A01 and DGA, compared to native Ace, whereas binding of tannic acid destabilizes the protein. Far-UV CD experiments revealed that the alpha-helical content of Ace-CaCCinh-A01 and Ace-DGA complexes increased relative to Ace. In contrast, binding to tannic acid had the opposite effect, indicating the loss of protein secondary structure. The modulation of Ace structure induced by CaCC inhibitors was also analyzed using docking and molecular dynamics (MD) simulation. Functional studies, performed using mouse ileal loops and Ussing chamber experiments, corroborate biophysical data, all pointing to the fact that tannic acid destabilizes Ace, inhibiting its function, whereas DGA stabilizes the toxin with enhanced fluid accumulation in mouse ileal loop. The efficacy of tannic acid in mouse model suggests that the targeted modulation of Ace structure may be of therapeutic benefit for gastrointestinal disorders.	[Chatterjee, Tanaya; Chakravarty, Devlina; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata 700054, India; [Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, Kolkata 700010, India	Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chatterjee, T (corresponding author), Bose Inst, Dept Biochem, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	tanaya_chatterjee@yahoo.com	Sheikh, Irshad/AAD-6196-2022; Kazi, Mirajul Hoque/AAR-5291-2021; CHAKRAVARTY, DEVLINA/E-2676-2018	CHAKRAVARTY, DEVLINA/0000-0002-7499-9553; Saha, Tultul/0000-0002-7913-9640	Department of Science and Technology, India [SR/WOS-A/LS-390/2011]; JC Bose National Fellowship [SR/S2/JCB-12/2006]; Department of Biotechnology [BT/HRD/35/02/07/2009]; Indian Council of Medical Research [3/1/3/JRF-2010/HRD-58(42194), 3/1/3/JRF-2013/HRD-045(4025)]	Department of Science and Technology, India(Department of Science & Technology (India)); JC Bose National Fellowship; Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	TC is supported by a DST Woman Scientist Grant from the Department of Science and Technology, India [SR/WOS-A/LS-390/2011] and PC by the JC Bose National Fellowship [SR/S2/JCB-12/2006]. KMH gratefully acknowledges financial support by Department of Biotechnology as a Ramalingaswami Fellow [BT/HRD/35/02/07/2009]. IAS thanka Indian Council of Medical Research for their funding [3/1/3/JRF-2010/HRD-58(42194), No. 3/1/3/JRF-2013/HRD-045(4025)].	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Ai-Awqati Q, 2002, J CLIN INVEST, V110, P1599, DOI 10.1172/JCI200217301; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; De SN, 2010, B WORLD HEALTH ORGAN, V88, P239, DOI 10.1002/path.1700660228; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Karaolis DK, 1988, P NATL ACAD SCI USA, V95, P3134; Li Y, 2006, BIOORGAN MED CHEM, V14, P1431, DOI 10.1016/j.bmc.2005.09.066; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; McDonald I, 1993, HBPLUS COMPUTER PROG; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Ren AX, 2012, DIGEST DIS SCI, V57, P99, DOI 10.1007/s10620-011-1821-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shahlaei M, 2011, BBA-BIOMEMBRANES, V1808, P802, DOI 10.1016/j.bbamem.2010.12.004; Sheikh IA, 2013, J BIOL CHEM, V288, P20404, DOI 10.1074/jbc.M113.467860; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Trucksis M, 2000, AM J PHYSIOL-CELL PH, V279, pC567, DOI 10.1152/ajpcell.2000.279.3.C567; Trucksis M., 2009, US Patent, Patent No. [US 7, 582, 424 B2, 7582424]; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wachsmuth K., 1994, VIBRIO CHOLERAE CHOL; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	35	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141283	10.1371/journal.pone.0141283	http://dx.doi.org/10.1371/journal.pone.0141283			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540279	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800015
J	Chen, YX; Zhou, T; Zhang, CC; Wang, K; Liu, J; Lu, JY; Xu, KW				Chen, Yuanxue; Zhou, Tao; Zhang, Chaochun; Wang, Ke; Liu, Jing; Lu, Junyu; Xu, Kaiwei			Rational Phosphorus Application Facilitates the Sustainability of the Wheat/Maize/Soybean Relay Strip Intercropping System	PLOS ONE			English	Article							INTERSPECIFIC INTERACTIONS; YIELD ADVANTAGE; MAIZE; WHEAT; PRODUCTIVITY; MANAGEMENT; ROTATIONS; RECOVERY; QUALITY; GROWTH	Wheat (Triticum aestivum L.)/maize (Zea mays L.)/soybean (Glycine max L.) relay strip intercropping (W/M/S) system is commonly used by the smallholders in the Southwest of China. However, little known is how to manage phosphorus (P) to enhance P use efficiency of the W/M/S system and to mitigate P leaching that is a major source of pollution. Field experiments were carried out in 2011, 2012, and 2013 to test the impact of five P application rates on yield and P use efficiency of the W/M/S system. The study measured grain yield, shoot P uptake, apparent P recovery efficiency (PRE) and soil P content. A linear-plateau model was used to determine the critical P rate that maximizes gains in the indexes of system productivity. The results show that increase in P application rates aggrandized shoot P uptake and crops yields at threshold rates of 70 and 71.5 kg P ha(-1) respectively. With P application rates increasing, the W/M/S system decreased the PRE from 35.9% to 12.3% averaged over the three years. A rational P application rate, 72 kg P ha(-1), or an appropriate soil Olsen-P level, 19.1 mg kg(-1), drives the W/M/S system to maximize total grain yield while minimizing P surplus, as a result of the PRE up to 28.0%. We conclude that rational P application is an important approach for relay intercropping to produce high yield while mitigating P pollution and the rational P application-based integrated P fertilizer management is vital for sustainable intensification of agriculture in the Southwest of China.	[Chen, Yuanxue; Zhou, Tao; Wang, Ke; Liu, Jing; Xu, Kaiwei] Sichuan Agr Univ, Coll Resource Sci, Dept Plant Nutr & Microbiol, Chengdu, Peoples R China; [Zhang, Chaochun] China Agr Univ, Dept Plant Nutr, Coll Resource & Environm Sci, Beijing 100094, Peoples R China; [Lu, Junyu] Yaan Agr Bur, Yaan, Peoples R China	Sichuan Agricultural University; China Agricultural University	Chen, YX (corresponding author), Sichuan Agr Univ, Coll Resource Sci, Dept Plant Nutr & Microbiol, Chengdu, Peoples R China.	cyxue2002@aliyun.com; xkwei@126.com			National Natural Science Foundation of China [31210103906]; National Maize Production System in China [CARS-02-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Maize Production System in China	This work was supported by the National Natural Science Foundation of China (31210103906) and the National Maize Production System in China (CARS-02-24).	Aulakh MS, 2003, FIELD CROP RES, V80, P99, DOI 10.1016/S0378-4290(02)00172-7; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; [陈晓辉 Chen Xiaohui], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P1127; Chen YuanXue, 2014, Acta Prataculturae Sinica, V23, P73; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Erisman JW, 2008, ATMOS ENVIRON, V42, P3209, DOI 10.1016/j.atmosenv.2007.04.004; FAO, 2011, FAOSTAT DAT AGR PROD; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Kihara J, 2010, EXP AGR, V46, P35, DOI 10.1017/S0014479709990810; Le C, 2010, ENVIRON MANAGE, V45, P662, DOI 10.1007/s00267-010-9440-3; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Li HG, 2010, BIOL FERT SOILS, V46, P79, DOI 10.1007/s00374-009-0411-x; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li L, 2011, SOIL SCI PLANT NUTR, V57, P61, DOI 10.1080/00380768.2010.548307; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Ma L, 2010, J ENVIRON QUAL, V39, P1279, DOI 10.2134/jeq2009.0403; Ma WQ, 2011, CHEMOSPHERE, V84, P814, DOI 10.1016/j.chemosphere.2011.04.055; Mao LL, 2012, FIELD CROP RES, V138, P11, DOI 10.1016/j.fcr.2012.09.019; Mei PP, 2012, FIELD CROP RES, V130, P19, DOI 10.1016/j.fcr.2012.02.007; Motta SR, 2013, EUR J AGRON, V45, P59, DOI 10.1016/j.eja.2012.10.007; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Tang X, 2009, PLANT SOIL, V323, P143, DOI 10.1007/s11104-009-9919-y; Vandamme E, 2014, NUTR CYCL AGROECOSYS, V98, P187, DOI 10.1007/s10705-014-9605-1; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Xu JZ, 2013, SOIL TILL RES, V126, P169, DOI 10.1016/j.still.2012.07.005; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Yong TW, 2009, THESIS SICHUAN AGR U; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang HM, 2010, NUTR CYCL AGROECOSYS, V88, P341, DOI 10.1007/s10705-010-9359-3; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang WF, 2008, NUTR CYCL AGROECOSYS, V80, P131, DOI 10.1007/s10705-007-9126-2; Zhang XB, 2004, CHINESE SCI BULL, V49, P1953, DOI 10.1360/04wd0106; [钟晓英 Zhong Xiaoying], 2004, [生态学报, Acta Ecologica Sinica], V24, P2275; Zingore S, 2008, NUTR CYCL AGROECOSYS, V80, P1, DOI 10.1007/s10705-007-9117-3	40	13	13	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141725	10.1371/journal.pone.0141725	http://dx.doi.org/10.1371/journal.pone.0141725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540207	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800024
J	Jin, J; Kim, J				Jin, Junghwan; Kim, Jinsoo			Forecasting Natural Gas Prices Using Wavelets, Time Series, and Artificial Neural Networks	PLOS ONE			English	Article							CRUDE-OIL PRICE; TRANSFORM; ARIMA; MODEL; DECOMPOSITION; PERFORMANCE; PREDICTION	Following the unconventional gas revolution, the forecasting of natural gas prices has become increasingly important because the association of these prices with those of crude oil has weakened. With this as motivation, we propose some modified hybrid models in which various combinations of the wavelet approximation, detail components, autoregressive integrated moving average, generalized autoregressive conditional heteroskedasticity, and artificial neural network models are employed to predict natural gas prices. We also emphasize the boundary problem in wavelet decomposition, and compare results that consider the boundary problem case with those that do not. The empirical results show that our suggested approach can handle the boundary problem, such that it facilitates the extraction of the appropriate forecasting results. The performance of the wavelet-hybrid approach was superior in all cases, whereas the application of detail components in the forecasting was only able to yield a small improvement in forecasting performance. Therefore, forecasting with only an approximation component would be acceptable, in consideration of forecasting efficiency.	[Jin, Junghwan; Kim, Jinsoo] Hanyang Univ, Dept Nat Resources & Environm Engn, Seoul 133791, South Korea	Hanyang University	Kim, J (corresponding author), Hanyang Univ, Dept Nat Resources & Environm Engn, Seoul 133791, South Korea.	jinsookim@hanyang.ac.kr	Kim, Jinsoo/P-9559-2015	Kim, Jinsoo/0000-0001-6496-1714	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [20152510101880]	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20152510101880).	Ahmad S, WAVELET BASED MULTIR; Amjady N, 2009, ENERGY, V34, P46, DOI 10.1016/j.energy.2008.09.020; [Anonymous], 2010, GARCH MODELS; Barucci E., 2001, J INT FINANC MARK I, V12, P183, DOI DOI 10.1016/S1042-4431(02); Cao JC, 2006, ENERGY, V31, P3435, DOI 10.1016/j.energy.2006.04.001; Chen KY, 2011, EXPERT SYST APPL, V38, P10368, DOI 10.1016/j.eswa.2011.02.049; Ching-Lai H, 2006, PROB METH APPL POW S; Conejo AJ, 2005, IEEE T POWER SYST, V20, P1035, DOI 10.1109/TPWRS.2005.846054; Cooper JCB, 1999, J APPL STAT, V26, P909, DOI 10.1080/02664769921927; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Garcia RC, 2005, IEEE T POWER SYST, V20, P867, DOI 10.1109/TPWRS.2005.846044; Giovanni Petris SP, 2009, DYNAMIC LINEAR MODEL; Hamzacebi C, 2008, INFORM SCIENCES, V178, P4550, DOI 10.1016/j.ins.2008.07.024; Hartley P, THE FUTURE OF LONG T; Hong C, 2001, POWER ENGINEERING SO; Hwang Y, 2012, JOURNAL OF KOREA TRA, V37, P217; IEA, 2013, GAS MEDIUM TERM MARK; IEA, 2013, DEVELOPING A NATURAL; IEA, 2012, WORLD EN OUTL 2012; IHS, 2013, AMERICAS NEW ENERGY, V3; International Energy Agency (IEA), 2011, WORLD ENERGY OUTLOOK; Jakasa T, 2011, 2011 8TH INTERNATION; 황광수, 2012, [Journal of the Korean Society of Mineral and Energy Resources Engineers, 한국자원공학회지], V49, P338; Kandil N, 2006, INT J ELEC POWER, V28, P525, DOI 10.1016/j.ijepes.2006.02.014; Kim D, 2005, NEURAL NETWORKS THEO; Lee D, THE EFFIECT OF OIL P, V12; Liu H, 2013, APPL ENERG, V107, P191, DOI 10.1016/j.apenergy.2013.02.002; Malik F, 2006, J ECON BUS, V58, P168, DOI 10.1016/j.jeconbus.2005.09.004; MathWorks, 2005, GARCH TOOLB US MATLA; Mazighi AEH, 2005, OPEC ENERGY REV, V29, P219, DOI 10.1111/j.0277-0180.2005.00152.x; Mellit A, 2006, APPL ENERG, V83, P705, DOI 10.1016/j.apenergy.2005.06.003; Meulenkamp F, 1999, INT J ROCK MECH MIN, V36, P29, DOI 10.1016/S0148-9062(98)00173-9; Moazzami M, 2013, APPL ENERG, V101, P489, DOI 10.1016/j.apenergy.2012.06.009; Nguyen HT, 2010, ENERGY, V35, P3674, DOI 10.1016/j.energy.2010.05.013; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Ramberg DJ, 2012, ENERG J, V33, P13, DOI 10.5547/01956574.33.2.2; Reboredo JC, 2013, ECON MODEL, V32, P42, DOI 10.1016/j.econmod.2012.12.028; Secretariat EC, 2007, PUTTING A PRICE ON E; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; SHENSA MJ, 1992, IEEE T SIGNAL PROCES, V40, P2464, DOI 10.1109/78.157290; Shumway H-R, 2010, TIME SERIES ANAL ITS; Soltani S, 2002, NEUROCOMPUTING, V48, P267, DOI 10.1016/S0925-2312(01)00648-8; Suseelatha A, 2013, J ENG; Tan ZF, 2010, APPL ENERG, V87, P3606, DOI 10.1016/j.apenergy.2010.05.012; Terui N, 2002, INT J FORECASTING, V18, P421, DOI 10.1016/S0169-2070(01)00120-0; Tseng FM, 2001, FUZZY SET SYST, V118, P9, DOI 10.1016/S0165-0114(98)00286-3; vanderVoort M, 1996, TRANSPORT RES C-EMER, V4, P307, DOI 10.1016/S0968-090X(97)82903-8; Wilhelmsson A, 2006, J FORECASTING, V25, P561, DOI 10.1002/for.1009; Yao SJ, 2000, ENERG CONVERS MANAGE, V41, P1975, DOI 10.1016/S0196-8904(00)00035-2; Yousefi S, 2005, CHAOS SOLITON FRACT, V25, P265, DOI 10.1016/j.chaos.2004.11.015; Yu LA, 2008, ENERG ECON, V30, P2623, DOI 10.1016/j.eneco.2008.05.003; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7	52	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142064	10.1371/journal.pone.0142064	http://dx.doi.org/10.1371/journal.pone.0142064			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539722	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800049
J	Peng, YC; Yu, K; Zhang, YJ; Islam, S; Sun, DF; Ma, WJ				Peng, Yanchun; Yu, Kan; Zhang, Yujuan; Islam, Shahidul; Sun, Dongfa; Ma, Wujun			Two Novel Y-Type High Molecular Weight Glutenin Genes in Chinese Wheat Landraces of the Yangtze-River Region	PLOS ONE			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; BREAD-MAKING QUALITY; SUBUNIT GENE; HETEROLOGOUS EXPRESSION; ALLELIC VARIATION; STORAGE PROTEINS; SDS-PAGE; PERFORMANCE; SEQUENCE; GENOME	High molecular weight glutenin subunits (HMW-GSs) are key determinants for the end-use quality of wheat. Chinese wheat landraces are an important resource for exploring novel HMW-GS genes to improve the wheat baking quality. Two novel Glu-1Dy HMW-GSs (designated as 1Dy12.6 and 1Dy12.7) were identified and cloned from two Chinese wheat landraces Huazhong830 and Luosimai. The 1Dy12.6 and 1Dy12.7 subunits were deposited as the NCBInr Acc. No KR262518, and KR262519, respectively. The full open reading frames (ORFs) of 1Dy12.6 and 1Dy12.7 were 2022 bp and 1977 bp, encoding for proteins of 673 and 658 amino acid residues, respectively. Each contains four typical primary regions of HMW-GSs (a signal peptide, N-and C-terminal regions, and a central repetitive region). Their deduced molecular masses (70,165 Da and 68,400 Da) were strikingly consistent with those identified by MALDI-TOF-MS (69,985Da and 68,407 Da). The 1Dy12.6 is the largest 1Dy glutenin subunits cloned in common wheat up to date, containing longer repetitive central domains than other 1Dy encoded proteins. In comparison with the most similar active 1Dy alleles previously reported, the newly discovered alleles contained a total of 20 SNPs and 3 indels. The secondary structure prediction indicated that 1Dy12.6 and 1Dy12.7 have similar proportion of alpha-helix, beta-turn, and beta-bend to those of 1Dy10 (X12929). The phylogenetic analysis illustrated that the x-and y-type subunits of glutenins were well separated, but both 1Dy12.6 and 1Dy12.7 were clustered with the other Glu-1Dy alleles. Our results revealed that the 1Dy12.6 and 1Dy12.7 subunit have potential to strengthen gluten polymer interactions, and are valuable genetic resources for wheat quality improvement.	[Peng, Yanchun; Yu, Kan; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Peng, Yanchun; Zhang, Yujuan; Islam, Shahidul; Ma, Wujun] Murdoch Univ, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia; [Peng, Yanchun; Zhang, Yujuan; Islam, Shahidul; Ma, Wujun] AEGIC, Perth, WA 6150, Australia; [Sun, Dongfa] Grain Ind, Hubei Collaborat Innovat Ctr, Jingzhou 434025, Peoples R China	Huazhong Agricultural University; Murdoch University	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.	sundongfa1@mail.hzau.edu.cn; w.ma@murdoch.edu.au	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X; Islam, Shahidul/0000-0001-5994-0521; Zhang, Yujuan/0000-0002-3243-1644	"863" China High-Tech Research Program [2011AA10A106]	"863" China High-Tech Research Program(National High Technology Research and Development Program of China)	Funded by the "863" China High-Tech Research Program grant #2011AA10A106 DFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; ANDERSON OD, 1989, THEOR APPL GENET, V77, P689, DOI 10.1007/BF00261246; ANDERSON OD, 1989, NUCLEIC ACIDS RES, V17, P461, DOI 10.1093/nar/17.1.461; Belton PS, 1998, SPECTROCHIM ACTA A, V54, P955, DOI 10.1016/S1386-1425(98)00025-0; BELTON PS, 1995, INT J BIOL MACROMOL, V17, P74, DOI 10.1016/0141-8130(95)93520-8; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; Butow BJ, 2003, THEOR APPL GENET, V107, P1524, DOI 10.1007/s00122-003-1396-8; Chen J, 2007, RAPID COMMUN MASS SP, V21, P2913, DOI 10.1002/rcm.3151; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; Cunsolo V, 2004, J MASS SPECTROM, V39, P66, DOI 10.1002/jms.558; Cunsolo V, 2003, RAPID COMMUN MASS SP, V17, P442, DOI 10.1002/rcm.938; D'Ovidio R, 1997, PLANT BREEDING, V116, P525, DOI 10.1111/j.1439-0523.1997.tb02184.x; DOVIDIO R, 1995, THEOR APPL GENET, V91, P189, DOI 10.1007/BF00220876; DOvidio R, 1996, THEOR APPL GENET, V93, P1048, DOI 10.1007/BF00230123; DOVIDIO R, 1995, CEREAL CHEM, V72, P443; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gianibelli MC, 2001, J CEREAL SCI, V33, P39, DOI 10.1006/jcrs.2000.0328; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; Gilbert SM, 2000, BBA-PROTEIN STRUCT M, V1479, P135, DOI 10.1016/S0167-4838(00)00059-5; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; Kohler P, 1994, WHEAT KERNEL PROTEIN, P45; Kussmann M, 1997, J MASS SPECTROM, V32, P593; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; LAWRENCE GJ, 1981, THEOR APPL GENET, V59, P25, DOI 10.1007/BF00275771; Lei ZS, 2006, J CEREAL SCI, V43, P94, DOI 10.1016/j.jcs.2005.08.003; Li X, 2007, GENOME, V50, P1130, DOI 10.1139/G07-089; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; LUKOW O M, 1992, Journal of Genetics and Breeding, V46, P187; LUKOW OM, 1989, J SCI FOOD AGR, V46, P451, DOI 10.1002/jsfa.2740460407; Ma W, 2003, EUPHYTICA, V134, P51, DOI 10.1023/A:1026191918704; MARCHYLO BA, 1992, J CEREAL SCI, V15, P29, DOI 10.1016/S0733-5210(09)80054-4; Masci S, 2000, THEOR APPL GENET, V100, P396, DOI 10.1007/s001220050052; Mihalik D, 2013, FOOD SCI BIOTECHNOL, V22, P33, DOI 10.1007/s10068-013-0045-5; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; Pandey R, 2008, MOL BIOL REP, V35, P153, DOI 10.1007/s11033-007-9065-7; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Pierucci VRM, 2009, J AGR FOOD CHEM, V57, P6318, DOI 10.1021/jf900629s; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; Shewry PR, 2003, THEOR APPL GENET, V106, P744, DOI 10.1007/s00122-002-1135-6; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SHEWRY PR, 1992, J CEREAL SCI, V15, P105, DOI 10.1016/S0733-5210(09)80062-3; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Subburaj S, 2014, J APPL GENET, V55, P27, DOI 10.1007/s13353-013-0187-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATHAM AS, 1990, J CEREAL SCI, V11, P189, DOI 10.1016/S0733-5210(09)80163-X; TATHAM AS, 1985, CEREAL CHEM, V62, P405; Wang JR, 2007, BIOCHEM SYST ECOL, V35, P421, DOI 10.1016/j.bse.2006.12.002; Wang K, 2012, HEREDITAS, V149, P41, DOI 10.1111/j.1601-5223.2011.02215.x; Wrigley CW, 1996, NATURE, V381, P738, DOI 10.1038/381738a0; Yan YM, 2009, J CEREAL SCI, V50, P398, DOI 10.1016/j.jcs.2009.08.004; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Zhao XL, 2006, THEOR APPL GENET, V113, P1247, DOI 10.1007/s00122-006-0379-y; Zheng W, 2011, J CEREAL SCI, V54, P401, DOI 10.1016/j.jcs.2011.08.004	58	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142348	10.1371/journal.pone.0142348	http://dx.doi.org/10.1371/journal.pone.0142348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540300	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800087
J	Renga, B; Cipriani, S; Carino, A; Simonetti, M; Zampella, A; Fiorucci, S				Renga, Barbara; Cipriani, Sabrina; Carino, Adriana; Simonetti, Michele; Zampella, Angela; Fiorucci, Stefano			Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1	PLoS One			English	Article							FARNESOID-X-RECEPTOR; HEPATIC STELLATE CELLS; NORMAL RAT-LIVER; NITRIC-OXIDE; HYDROGEN-SULFIDE; MOLECULAR TARGETS; BILE-ACIDS; CIRRHOSIS; MICROCIRCULATION; HOMOCYSTEINE	Background GPBAR1 is a bile acids activated receptor expressed in entero-hepatic tissues. In the liver expression of GPBAR1 is restricted to sinusoidal and Kuppfer cells. In the systemic circulation vasodilation caused by GPBAR1 agonists is abrogated by inhibition of cystathione-gamma-liase (CSE), an enzyme essential to the generation of hydrogen sulfide (H2S), a vasodilatory agent. Portal BAR501 is a semisynthetic bile acid derivative endowed with a potent and selective agonistic activity toward GPBAR1. Methods Cirrhosis was induced in mice by carbon tetrachloride (CCL4) administration for 9 weeks. Liver endothelial dysfunction was induced by feeding wild type and Gpbar1(-/-) mice with methionine for 4 weeks. In both models, mice were administered BAR501, 15 mg/kg/day. Results By transactivation assay we demonstrate that BAR501 is a selective GPBAR1 agonist devoid of any FXR agonistic activity. In naive rats, BAR501 effectively reduced hepatic perfusion pressure and counteracted the vasoconstriction activity of norepinephrine. In the CCl4 model, 9 weeks treatment with BAR501 effectively protected against development of endothelial dysfunction by increasing liver CSE expression and activity and by reducing endothelin (ET)-1 gene expression. In mice feed methionine, treatment with BAR501 attenuated endothelial dysfunction and caused a GPBAR1-dependent regulation of CSE. Using mediated by both genomic (recruitment of CREB to CRE in the CSE promoter) and non-genomic effects, involving a Akt-dependent phosporylation of CSE and endothelial nitric oxide (NO) synthase (eNOS). BAR501, phosphorylates FOXO1 and inhibits ET-1 transcription in liver sinusoidal cells. Conclusions BAR501, a UDCA-like GPBAR1 agonist, rescues from endothelial dysfunction in rodent models of portal hypertension by exerting genomic and non-genomic effects on CSE, eNOS and ET-1 in liver sinusoidal cells.	[Renga, Barbara; Carino, Adriana; Simonetti, Michele; Fiorucci, Stefano] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Cipriani, Sabrina] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Perugia; University of Perugia; University of Naples Federico II	Fiorucci, S (corresponding author), Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy.	Stefano.Fiorucci@unipg.it		Carino, Adriana/0000-0003-2341-9528	BAR Pharmaceuticals; Department of Surgery and Biomedical Sciences	BAR Pharmaceuticals; Department of Surgery and Biomedical Sciences	This study was partially supported by a grant by BAR Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funds were intramural from Department of Surgery and Biomedical Sciences.	Bolognesi M, 2014, WORLD J GASTROENTERO, V20, P2555, DOI 10.3748/wjg.v20.i10.2555; Bosy-Westphal A, 2001, HEPATOL RES, V20, P28, DOI 10.1016/S1386-6346(00)00119-4; Carbajo-Pescador S, 2014, CURR MED CHEM, V21, P1231, DOI 10.2174/0929867321666131228205703; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Gracia-Sancho J, 2015, HEPATOL INT, V9, P183, DOI 10.1007/s12072-015-9613-5; GROSSMAN HJ, 1995, HEPATOLOGY, V21, P162; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Hendrickson H, 2003, AM J PHYSIOL-GASTR L, V285, pG652, DOI 10.1152/ajpgi.00143.2003; HOROWITZ JH, 1981, GASTROENTEROLOGY, V81, P668; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Leon J, 2014, J PINEAL RES, V56, P415, DOI 10.1111/jpi.12131; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Martin-Duce A, 1988, HEPATOLOGY, V8, P65; MITTAL MK, 1994, AM J PHYSIOL, V267, pG416, DOI 10.1152/ajpgi.1994.267.3.G416; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Renga B, 2012, FASEB J, V26, P3021, DOI 10.1096/fj.11-195701; Renga B, 2009, WORLD J GASTROENTERO, V15, P2097, DOI 10.3748/wjg.15.2097; Rockey DC, 2000, GASTROENTEROLOGY, V118, P1261, DOI 10.1016/S0016-5085(00)70379-9; Shah V, 2001, AM J PHYSIOL-GASTR L, V280, pG1209, DOI 10.1152/ajpgi.2001.280.6.G1209; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shah V, 1997, J CLIN INVEST, V100, P2923, DOI 10.1172/JCI119842; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923	37	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141082	10.1371/journal.pone.0141082	http://dx.doi.org/10.1371/journal.pone.0141082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539823	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800010
J	Rutkowski, R; Krofel, M; Giannatos, G; Cirovic, D; Mannil, P; Volokh, AM; Lanszki, J; Heltai, M; Szabo, L; Banea, OC; Yavruyan, E; Hayrapetyan, V; Kopaliani, N; Miliou, A; Tryfonopoulos, GA; Lymberakis, P; Penezic, A; Pakeltyte, G; Suchecka, E; Bogdanowicz, W				Rutkowski, Robert; Krofel, Miha; Giannatos, Giorgos; Cirovic, Dusko; Maennil, Peep; Volokh, Anatoliy M.; Lanszki, Jozsef; Heltai, Miklos; Szabo, Laszlo; Banea, Ovidiu C.; Yavruyan, Eduard; Hayrapetyan, Vahram; Kopaliani, Natia; Miliou, Anastasia; Tryfonopoulos, George A.; Lymberakis, Petros; Penezic, Aleksandra; Pakeltyte, Giedre; Suchecka, Ewa; Bogdanowicz, Wieslaw			A European Concern? Genetic Structure and Expansion of Golden Jackals (Canis aureus) in Europe and the Caucasus	PLOS ONE			English	Article							RAPID RANGE EXPANSION; BEAR URSUS-ARCTOS; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; WOLF POPULATION; CONSERVATION GENETICS; DIET COMPOSITION; VULPES-VULPES; RED FOX; DIVERSITY	In the first continent-wide study of the golden jackal (Canis aureus), we characterised its population genetic structure and attempted to identify the origin of European populations. This provided a unique insight into genetic characteristics of a native carnivore population with rapid large-scale expansion. We analysed 15 microsatellite markers and a 406 basepair fragment of the mitochondrial control region. Bayesian-based and principal components methods were applied to evaluate whether the geographical grouping of samples corresponded with genetic groups. Our analysis revealed low levels of genetic diversity, reflecting the unique history of the golden jackal among Europe's native carnivores. The results suggest ongoing gene flow between south-eastern Europe and the Caucasus, with both contributing to the Baltic population, which appeared only recently. The population from the Peloponnese Peninsula in southern Greece forms a common genetic cluster with samples from south-eastern Europe (Delta K approach in STRUCTURE, Principal Components Analysis [PCA]), although the results based on BAPS and the estimated likelihood in STRUCTURE indicate that Peloponnesian jackals may represent a distinct population. Moreover, analyses of population structure also suggest either genetic distinctiveness of the island population from Samos near the coast of Asia Minor (BAPS, most STRUCTURE, PCA), or possibly its connection with the Caucasus population (one analysis in STRUCTURE). We speculate from our results that ancient Mediterranean jackal populations have persisted to the present day, and have merged with jackals colonising from Asia. These data also suggest that new populations of the golden jackal may be founded by long-distance dispersal, and thus should not be treated as an invasive alien species, i.e. an organism that is "non-native to an ecosystem, and which may cause economic or environmental harm or adversely affect human health". These insights into the genetic structure and ancestry of Baltic jackals have important implications for management and conservation of jackals in Europe. The golden jackal is listed as an Annex V species in the EU Habitats Directive and as such, considering also the results presented here, should be legally protected in all EU member states.	[Rutkowski, Robert; Suchecka, Ewa; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Krofel, Miha] Univ Ljubljana, Wildlife Ecol Res Grp, Dept Forestry, Biotech Fac, Ljubljana, Slovenia; [Giannatos, Giorgos] Univ Athens, Sch Biol, Dept Zool Marine Biol, Athens, Greece; [Cirovic, Dusko; Penezic, Aleksandra] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia; [Maennil, Peep] Estonian Environm Agcy, Tartu, Estonia; [Volokh, Anatoliy M.] Tauride Agrotechnol State Univ, Melitopol, Ukraine; [Lanszki, Jozsef] Univ Kaposvar, Nat Conservat Dept, Kaposvar, Hungary; [Heltai, Miklos; Szabo, Laszlo] Szent Istvan Univ, Inst Wildlife Conservat, Godollo, Hungary; [Banea, Ovidiu C.] Ecol Dept Crispus NGO Sibiu, Sibiu, Romania; [Yavruyan, Eduard] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Hayrapetyan, Vahram] Armenian Natl Agrarian Univ, Stepanakert Branch, Stepanakert, Armenia; [Kopaliani, Natia] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Miliou, Anastasia] Archipelagos Inst Marine Conservat, Pythagorio, Samos, Greece; [Tryfonopoulos, George A.] Management Body Mt Parnon & Moustos Wetland, Arkadia, Astros, Greece; [Lymberakis, Petros] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece; [Pakeltyte, Giedre] Kaunas T Ivanauskas Zool Museum, Kaunas, Lithuania	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Ljubljana; National & Kapodistrian University of Athens; University of Belgrade; Ministry of Education & Science of Ukraine; Dmytro Motornyi Tavria State Agrotechnological University; Kaposvar University; Hungarian University of Agriculture & Life Sciences; National Academy of Sciences of Armenia; Ilia State University; University of Crete	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland.	wieslawb@miiz.waw.pl	Krofel, Miha/I-4495-2019; BANEA, Ovidiu/AAE-3234-2021; Cirovic, Dusko/AAM-6303-2020; Lanszki, Jozsef/AAN-1013-2020	Krofel, Miha/0000-0002-2010-5219; Cirovic, Dusko/0000-0001-9468-0948; Penezic, Aleksandra/0000-0002-3033-1658; Rutkowski, Robert/0000-0003-0265-7455; Lanszki, Jozsef/0000-0002-2067-6601; Lymberakis, Petros/0000-0002-5067-9600; Banea, Ovidiu Constantin/0000-0002-0074-7011; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education, Poland [N N303 566339]; Slovenian Research Agency [P4-0059]; Ministry of Education and Science and Technological Development, Serbia [TR 31009]; Research Centre of Excellence [9878/2015/FEKUT]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Education and Science and Technological Development, Serbia; Research Centre of Excellence	This study was supported by the Ministry of Science and Higher Education, Poland (grant no. N N303 566339 to WB); the Slovenian Research Agency (grant no. P4-0059 to MK); the Ministry of Education and Science and Technological Development, Serbia (grant no. TR 31009 to DC); and the Research Centre of Excellence (grant no. 9878/2015/FEKUT to MH and LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Andersen LW, 2015, MAMMAL RES, V60, P163, DOI 10.1007/s13364-015-0220-6; [Anonymous], 2012, KORA NEWS       0908; Arnold J, 2012, MAMMAL REV, V42, P1, DOI 10.1111/j.1365-2907.2011.00185.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banea O, 2013, GOJAGE BLOG     0301; Banks SC, 2010, MOL ECOL, V19, P2011, DOI 10.1111/j.1365-294X.2010.04627.x; Boskovic Ivica, 2013, Agriculturae Conspectus Scientificus, V78, P245; Brelih S., 1955, BIOL VESTNIK, V4, P56; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Buckley J, 2012, MOL ECOL, V21, P267, DOI 10.1111/j.1365-294X.2011.05388.x; Carty J, 2009, J CONSERV BIOL, V1, P38; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cirovic D, 2015, J HELMINTHOL, V89, P28, DOI 10.1017/S0022149X13000552; Cirovic D, 2015, ACTA VET HUNG, V63, P189, DOI 10.1556/AVet.2015.016; Cirovic D, 2014, ACTA VET HUNG, V62, P481, DOI 10.1556/AVet.2014.021; Cirovic D, 2014, MAMM BIOL, V79, P132, DOI 10.1016/j.mambio.2013.11.003; Cohen TM, 2013, CONSERV GENET, V14, P55, DOI 10.1007/s10592-012-0423-1; Convention on Biological Diversity, 2015, WHAT AR INV AL SPEC; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DEMETER A., 1993, HDB SAUGETIERE EUROP, P107; Djan M, 2014, MAMM BIOL, V79, P277, DOI 10.1016/j.mambio.2014.03.001; Dolf G, 2000, GENET SEL EVOL, V32, P533, DOI 10.1051/gse:2000135; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards CJ, 2012, QUATERNARY SCI REV, V57, P95, DOI 10.1016/j.quascirev.2012.10.010; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Galov A, 2014, MAMM BIOL, V79, P77, DOI 10.1016/j.mambio.2013.10.003; Garroway CJ, 2011, GLOBAL CHANGE BIOL, V17, P1760, DOI 10.1111/j.1365-2486.2010.02384.x; Giannatos G, 2005, BELG J ZOOL, V135, P145; Giannatos G., 2004, POPULATION STATUS CO; Gompert Z, 2012, MOL ECOL, V21, P1542, DOI 10.1111/j.1365-294X.2012.05471.x; Goudet J., 2001, FSTAT V2 9 3 PROGRAM; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Heltai M., 2012, INT S HUNT MOD ASP S, P13; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Jhala Y, 2015, CANIS AUREUS IUCN RE; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kocijan I, 2011, MAMM BIOL, V76, P615, DOI 10.1016/j.mambio.2010.12.003; Koepfli KP, 2015, CURR BIOL, V25, P2158, DOI 10.1016/j.cub.2015.06.060; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Koskinen MT, 2004, HEREDITAS, V141, P61, DOI 10.1111/j.1601-5223.2004.01804.x; Kowalczyk R, 2015, MAMMAL RES, V60, P411, DOI 10.1007/s13364-015-0238-9; Krehenwinkel H, 2013, MOL ECOL, V22, P2232, DOI 10.1111/mec.12223; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Krystufek B., 1990, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V91, P7; Kuhn W., 1935, Zeitschrift fuer Saugietierkunde, V10, P144; Lanszki J, 2015, ANN ZOOL FENN, V52, P243, DOI 10.5735/086.052.0403; Levickait R, 2015, LIETUVOJE SUMEDZIOTA; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnell J., 2008, GUIDELINES POPULATIO; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Mackel R., 2000, SAUGETIERKUNDLICHE I, V4, P477; Malez V., 1984, 9 YUG SPEL C C P, P617; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Mehora M., 1953, LOVEC, V36, P470; Mihelic Miha, 2012, Natura Sloveniae, V14, P51; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Murtskhvaladze M, 2010, MOL ECOL, V19, P1829, DOI 10.1111/j.1365-294X.2010.04610.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PEAKALL R, 2001, GENAIEX V5 GENETIC A; Penezic A, 2014, PARASITOL RES, V113, P3281, DOI 10.1007/s00436-014-3991-9; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pritchard JK, 2000, GENETICS, V155, P945; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozenko Nikolaj, 2010, Beitraege zur Jagd- und Wildforschung, V35, P237; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Salek M, 2014, EUR J WILDLIFE RES, V60, P193, DOI 10.1007/s10344-013-0765-0; Sarre SD, 2009, WILDLIFE RES, V36, P70, DOI 10.1071/WR08066; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Spassov N., 1989, Historia Naturalis Bulgarica, V1, P44; Stoyanov S., 2012, INT S HUNT MOD ASP S, V1, P48; Stratford Jos, 2015, Zoology and Ecology, V25, P277, DOI 10.1080/21658005.2015.1073894; STV, 2012, ZIT IZ DER TOM BREST; Swaegers J, 2013, HEREDITY, V111, P422, DOI 10.1038/hdy.2013.64; Szabo L, 2009, MAMMALIA, V73, P307, DOI 10.1515/MAMM.2009.048; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Thibault I, 2009, DIVERS DISTRIB, V15, P1060, DOI 10.1111/j.1472-4642.2009.00606.x; Toom M, 2014, THESIS ESTONIAN U LI; Toth T, 2009, NORTH-WEST J ZOOL, V5, P386; Trouwborst A, 2015, BIODIVERS CONSERV, V24, P1567, DOI 10.1007/s10531-015-0894-8; Vuletic-Vukasovic V, 1908, CAGALJ NA KORCULI; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Wang SP, 2014, MOL ECOL, V23, P637, DOI 10.1111/mec.12634; Watts PC, 2010, BIOL INVASIONS, V12, P3887, DOI 10.1007/s10530-010-9779-7; Weingarth Kirsten, 2012, Saeugetierkundliche Informationen, V8, P443; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yom-Tov Y., 1995, ISR BIOL CONS, V73, P19, DOI DOI 10.1016/0006-3207(95)90051-9; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y; Zila S., 2014, SAKAL UKRAINI STRATI	144	55	58	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141236	10.1371/journal.pone.0141236	http://dx.doi.org/10.1371/journal.pone.0141236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540195	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800014
J	Sharma, M; Damlin, A; Pathak, A; Lundborg, CS				Sharma, Megha; Damlin, Anna; Pathak, Ashish; Lundborg, Cecilia Stalsby			Antibiotic Prescribing among Pediatric Inpatients with Potential Infections in Two Private Sector Hospitals in Central India	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; NEW-DELHI; MANAGEMENT; ASSOCIATION; CHALLENGES; GUIDELINES; CHILDREN; UJJAIN	Introduction Infectious diseases are one of the major causes of child mortality in India. Pediatric patients are commonly prescribed antibiotics for non-bacterial infections. Monitoring of local antibiotic prescribing with respect to the diagnosis is necessary to improve the prescribing practices. The aim of the study was to describe antibiotic prescribing for potential infections among patients admitted in pediatric departments in two private sector hospitals; one teaching (TH) and one non-teaching (NTH) in Central India. Methods Data from all patients admitted at the pediatric departments of both study hospitals was collected manually, for 3 years (2008-2011) using a customized form. Data from inpatients aged 0-18 years, diagnosed with; acute gastroenteritis (AGE), respiratory tract infections, enteric fever, viral fever or unspecified fever were focused for analysis. Antibiotic prescriptions were analysed using the WHO Anatomical Therapeutic Chemical (ATC) classification system and defined daily doses (DDDs). Adherence to the Indian Academy of Pediatrics list of essential medicines (IAP-LEM) was investigated. P-values <0.05 were considered significant. Results Oftotal6, 825 inpatients admitted at two pediatric departments, 510 patients from the TH and 2,479from the NTH were selected based on the assigned potential infectious diagnoses. Of these, 224 patients (44%) at the TH and 2,088 (84%) at the NTH were prescribed at least one antibiotic during hospital stay (odds ratio-0.69, 95% confidence interval-0.52 to 0.93; p<0.001). Patients with AGE, viral-and enteric fever were frequently prescribed antibiotics at both hospitals, yet higher proportion were prescribed antibiotics at the NTH compared to the TH. Broad-spectrum antibiotics were the most commonly prescribed antibiotic class in both hospitals, namely third generation cephalosporins, J01DD (69%) at the TH, and new fixed dose combinations of antibiotics J01R (FDCs, 42%) at the NTH. At the TH, 37% of the antibiotic prescriptions were comprised of antibiotics listed in the IAP-LEM, compared to 24% at the NTH (p<0.05). Conclusions Broad-spectrum antibiotics were prescribed frequently in both hospitals also for the un-indicated conditions such as viral fever and enteric fever. At the NTH, new FDCs were more frequently prescribed and adherence to the IAP-LEM was substantially lower at the NTH compared to the TH. The results demonstrate need to develop diagnosis-specific prescribing guidelines to facilitate rational use of antibiotics and implement antibiotic stewardship program.	[Sharma, Megha] Ruxmaniben Deepchand Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India; [Sharma, Megha; Damlin, Anna; Pathak, Ashish; Lundborg, Cecilia Stalsby] Karolinska Inst, Global Hlth Hlth Syst & Policy HSP Med Focusing A, Dept Publ Hlth Sci, S-17177 Stockholm, Sweden; [Pathak, Ashish] Ruxmaniben Deepchand Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] Uppsala Univ, Dept Women & Childrens Hlth, Int Maternal & Child Hlth Unit, SE-75185 Uppsala, Sweden	Karolinska Institutet; Uppsala University	Sharma, M (corresponding author), Ruxmaniben Deepchand Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India.	meghasharma27@rediffmail.com	Pathak, Ashish/Y-1821-2019; Sharma, Megha/AAJ-1119-2021; Pathak, Ashish/N-2303-2019	Pathak, Ashish/0000-0002-7576-895X; Sharma, Megha/0000-0001-9165-9393; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Swedish Research Council [K2007-70X-20514-01-3]; Asia Link [348-2006-6633]; Erasmus Mundus External Cooperation Window Lot-15, India; Karolinska Institutet, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Asia Link; Erasmus Mundus External Cooperation Window Lot-15, India; Karolinska Institutet, Sweden(Karolinska Institutet)	This study was funded by the Swedish Research Council (K2007-70X-20514-01-3) and Asia Link (348-2006-6633). MS is a recipient of a scholarship from Erasmus Mundus External Cooperation Window Lot-15, India. AD is a recipient of a scholarship for medical science research from Karolinska Institutet, Sweden.	[Anonymous], 2011, LIST ESS MED CHILDR; Arora NK, 2010, INDIAN PEDIATR, V47, P11, DOI 10.1007/s13312-010-0015-4; Austad KE, 2014, JAMA INTERN MED, V174, P1283, DOI 10.1001/jamainternmed.2014.2202; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bergman U, 2000, SETTING USING DU90 T, P155; Bhatnagar S, 2007, INDIAN PEDIATR, V44, P380; Bjorkman I, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-1; Cabral C, 2014, PATIENT EDUC COUNS, V95, P248, DOI 10.1016/j.pec.2014.01.010; Chandy SJ, 2013, J ANTIMICROB CHEMOTH, V68, P229, DOI 10.1093/jac/dks355; Cheng VCC, 2009, EUR J CLIN MICROBIOL, V28, P1447, DOI 10.1007/s10096-009-0803-8; Chiappini E, 2014, PAEDIATR RESPIR REV, V15, P231, DOI 10.1016/j.prrv.2013.11.011; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gravatt LAH, 2013, CURR INFECT DIS REP, V15, P559, DOI 10.1007/s11908-013-0374-9; Karande Sunil, 2005, Indian Journal of Pediatrics, V72, P117, DOI 10.1007/BF02760693; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2012, VALUE HEALTH, V15, pS116, DOI 10.1016/j.jval.2011.11.008; Kotwani A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-99; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Kumar R, 2008, J CLIN PHARM THER, V33, P625, DOI 10.1111/j.1365-2710.2008.00960.x; Kundu R, 2006, INDIAN PEDIATR, V43, P884; Pathak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038641; Pathak D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-32; Pitaknetinan K, 1999, HEALTH POLICY, V46, P179, DOI 10.1016/S0168-8510(98)00066-9; Sharma MM, 2015, INT CONF COMM SYST, P1, DOI 10.1109/CSNT.2015.92; Sharma M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-155; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; WHO, 2002, WHO POLICY PERSPECTI; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; WHO. World Health Organization, 2010, MED RAT US MED; World Health Organization, 2003, INTRO DRUG UTILIZATI	30	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142317	10.1371/journal.pone.0142317	http://dx.doi.org/10.1371/journal.pone.0142317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540104	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800082
J	Stoffers, D; Diaz, BA; Chen, G; den Braber, A; van 't Ent, D; Boomsma, DI; Mansvelder, HD; de Geus, E; Van Someren, EJW; Linkenkaer-Hansen, K				Stoffers, Diederick; Diaz, B. Alexander; Chen, Gang; den Braber, Anouk; van 't Ent, Dennis; Boomsma, Dorret I.; Mansvelder, Huibert D.; de Geus, Eco; Van Someren, Eus J. W.; Linkenkaer-Hansen, Klaus			Resting-State fMRI Functional Connectivity Is Associated with Sleepiness, Imagery, and Discontinuity of Mind	PLOS ONE			English	Article							DEFAULT-MODE; CORRELATED FLUCTUATIONS; WANDERING MINDS; BRAIN ACTIVITY; VISUAL-CORTEX; BASE-LINE; NETWORK; DYNAMICS; PATTERNS; NEUROSCIENCE	Resting-state functional magnetic resonance imaging (rs-fMRI) is widely used to investigate the functional architecture of the healthy human brain and how it is affected by learning, life-long development, brain disorders or pharmacological intervention. Non-sensory experiences are prevalent during rest and must arise from ongoing brain activity, yet little is known about this relationship. Here, we used two runs of rs-fMRI both immediately followed by the Amsterdam Resting-State Questionnaire (ARSQ) to investigate the relationship between functional connectivity within ten large-scale functional brain networks and ten dimensions of thoughts and feelings experienced during the scan in 106 healthy participants. We identified 11 positive associations between brain-network functional connectivity and ARSQ dimensions. 'Sleepiness' exhibited significant associations with functional connectivity within Visual, Sensorimotor and Default Mode networks. Similar associations were observed for 'Visual Thought' and 'Discontinuity of Mind', which may relate to variation in imagery and thought control mediated by arousal fluctuations. Our findings show that selfreports of thoughts and feelings experienced during a rs-fMRI scan help understand the functional significance of variations in functional connectivity, which should be of special relevance to clinical studies.	[Stoffers, Diederick; Diaz, B. Alexander; Mansvelder, Huibert D.; Van Someren, Eus J. W.; Linkenkaer-Hansen, Klaus] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands; [Stoffers, Diederick; Van Someren, Eus J. W.] Netherlands Inst Neurosci, Dept Sleep & Cognit, Amsterdam, Netherlands; [Chen, Gang] NIMH, Sci & Stat Comp Core, Bethesda, MD 20892 USA; [den Braber, Anouk; van 't Ent, Dennis; Boomsma, Dorret I.; de Geus, Eco] Vrije Univ Amsterdam, Fac Psychol & Educ, Dept Biol Psychol, Amsterdam, Netherlands; [Van Someren, Eus J. W.] Vrije Univ Amsterdam, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Linkenkaer-Hansen, K (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands.	klaus.linkenkaer@cncr.vu.nl	Van Someren, Eus/AAA-6789-2020; Mansvelder, Huibert/N-6138-2018; Boomsma, Dorret I/AAX-4470-2020; Linkenkaer-Hansen, Klaus/A-6757-2009; de Geus, Eco J.C./M-9318-2015	Mansvelder, Huibert/0000-0003-1365-5340; Linkenkaer-Hansen, Klaus/0000-0003-2140-9780; de Geus, Eco J.C./0000-0001-6022-2666; van 't Ent, Dennis/0000-0003-2001-1375; den Braber, A./0000-0002-3377-2627	Netherlands Organization for Scientific Research [400-07-080, 433-08-121]; Neuroscience Campus Amsterdam [AC-2009-F2-3]; VU University Amsterdam (VU-CvB Financial Incentive Scheme)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Neuroscience Campus Amsterdam; VU University Amsterdam (VU-CvB Financial Incentive Scheme)	This work was supported by the Netherlands Organization for Scientific Research (MaGW-nr: 400-07-080 and 433-08-121), the Neuroscience Campus Amsterdam (AC-2009-F2-3), and VU University Amsterdam (VU-CvB Financial Incentive Scheme to KL-H).	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Chang C, 2013, NEUROIMAGE, V72, P227, DOI 10.1016/j.neuroimage.2013.01.049; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Diaz BA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00271; Diaz B Alexander, 2013, Front Hum Neurosci, V7, P446, DOI 10.3389/fnhum.2013.00446; Donner TH, 2013, J NEUROSCI, V33, P2188, DOI 10.1523/JNEUROSCI.3388-12.2013; Doucet G, 2012, NEUROIMAGE, V59, P3194, DOI 10.1016/j.neuroimage.2011.11.059; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Fell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00409; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Gruberger M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00056; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jenkinson M., 2000, TR00MJ3 U OXF DEP CL; Khalili-Mahani N, 2012, HUM BRAIN MAPP, V33, P1003, DOI 10.1002/hbm.21265; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klumpers LE, 2012, NEUROIMAGE, V63, P1701, DOI 10.1016/j.neuroimage.2012.07.051; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird Angela R, 2011, BMC Res Notes, V4, P349, DOI 10.1186/1756-0500-4-349; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Locke DEC, 2009, DEMENT GERIATR COGN, V27, P260, DOI 10.1159/000203890; Lowe MJ, 2012, NEUROIMAGE, V62, P1146, DOI 10.1016/j.neuroimage.2012.01.014; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley William W., 2009, V24, P160, DOI 10.1159/000197895; Singer W, 2013, TRENDS COGN SCI, V17, P616, DOI 10.1016/j.tics.2013.09.006; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tusche A, 2014, NEUROIMAGE, V97, P107, DOI 10.1016/j.neuroimage.2014.03.076; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Yang CM, 2010, CONSCIOUS COGN, V19, P1084, DOI 10.1016/j.concog.2009.12.017; Yarkoni T, 2010, TRENDS COGN SCI, V14, P489, DOI 10.1016/j.tics.2010.08.004; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	74	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142014	10.1371/journal.pone.0142014	http://dx.doi.org/10.1371/journal.pone.0142014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540239	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800045
J	Cruz, M; Gomez, D; Cruz-Orive, LM				Cruz, Marcos; Gomez, Domingo; Cruz-Orive, Luis M.			Efficient and Unbiased Estimation of Population Size	PLOS ONE			English	Article							VARIANCE PREDICTION; STEREOLOGY; PRECISION	Population sizing from still aerial pictures is of wide applicability in ecological and social sciences. The problem is long standing because current automatic detection and counting algorithms are known to fail in most cases, and exhaustive manual counting is tedious, slow, difficult to verify and unfeasible for large populations. An alternative is to multiply population density with some reference area but, unfortunately, sampling details, handling of edge effects, etc., are seldom described. For the first time we address the problem using principles of geometric sampling. These principles are old and solid, but largely unknown outside the areas of three dimensional microscopy and stereology. Here we adapt them to estimate the size of any population of individuals lying on an essentially planar area, e.g. people, animals, trees on a savanna, etc. The proposed design is unbiased irrespective of population size, pattern, perspective artifacts, etc. The implementation is very simple-it is based on the random superimposition of coarse quadrat grids. Also, an objective error assessment is often lacking. For the latter purpose the quadrat counts are often assumed to be independent. We demonstrate that this approach can perform very poorly, and we propose (and check via Monte Carlo resampling) a new theoretical error prediction formula. As far as efficiency, counting about 50 (100) individuals in 20 quadrats, can yield relative standard errors of about 8% (5%) in typical cases. This fact effectively breaks the barrier hitherto imposed by the current lack of automatic face detection algorithms, because semiautomatic sampling and manual counting becomes an attractive option.	[Cruz, Marcos; Gomez, Domingo; Cruz-Orive, Luis M.] Univ Cantabria, Dept Math Stat & Comp Sci, E-39005 Santander, Spain	Universidad de Cantabria	Cruz, M (corresponding author), Univ Cantabria, Dept Math Stat & Comp Sci, Ave Los Castros S-N, E-39005 Santander, Spain.	marcos.cruz@unican.es	Cruz, Marcos/N-3429-2014; Gomez-perez, Domingo/S-2121-2018; Gomez-Perez, Domingo/AAD-5884-2020; Cruz-Orive, Luis M/Q-9519-2016	Cruz, Marcos/0000-0002-4767-530X; Gomez-perez, Domingo/0000-0002-5780-2165; Gomez-Perez, Domingo/0000-0002-5780-2165; Cruz-Orive, Luis M/0000-0002-9355-0911				Ancel A, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100404, DOI 10.1371/J0URNAL.P0NE.0100404]; Arnau XG, 1998, ADV APPL PROBAB, V30, P889, DOI 10.1239/aap/1035228198; Baddeley A., 2005, STEREOLOGY STAT; Baddeley AJ, 1999, MG STAT PRO, V80, P37; Botta F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150162; Cancio R, 2010, SIMPLEMENTE PERIODIS; Cruz-Orive LM, 2006, J MICROSC-OXFORD, V222, P158, DOI 10.1111/j.1365-2818.2006.01535.x; Cruz-Orive LM, 2004, J AEROSOL MED, V17, P197, DOI 10.1089/jam.2004.17.197; Cruz-Orive LM, 2004, J MICROSC-OXFORD, V213, P205, DOI 10.1111/j.1365-2818.2004.01291.x; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Garcia-Finana M, 2004, STATISTICS-ABINGDON, V38, P243, DOI 10.1080/0233188032000158826; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HOWARD CV, 2005, 3 DIMENSIONAL MEASUR; Idrees H, 2013, PROC CVPR IEEE, P2547, DOI 10.1109/CVPR.2013.329; Kieu K, 1999, J STAT PLAN INFER, V77, P263, DOI 10.1016/S0378-3758(98)00193-1; Liao S., 2012, MSUCSE1215; Matheron G., 1971, THEORY REGIONALIZED, V5; Miles R., 1974, STOCHASTIC GEOMETRY, V10, P228; MILES RE, 1978, J MICROSC-OXFORD, V113, P257, DOI 10.1111/j.1365-2818.1978.tb00104.x; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Watson R., 2011, SIGNIFICANCE, V8, P104, DOI DOI 10.1111/J.1740-9713.2011.00502.X	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141868	10.1371/journal.pone.0141868	http://dx.doi.org/10.1371/journal.pone.0141868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535587	Green Published, gold			2022-12-27	WOS:000364298400094
J	Delcher, A; Hily, S; Boureau, AS; Chapelet, G; Berrut, G; de Decker, L				Delcher, Anne; Hily, Sylvie; Boureau, Anne Sophie; Chapelet, Guillaume; Berrut, Gilles; de Decker, Laure			Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients	PLOS ONE			English	Article							ACID-SUPPRESSIVE THERAPY; OVERUSE; DISCHARGE; RISK	Objectives To determine whether there is an association between overprescription of proton pump inhibitors (PPIs) and multimorbidities in older patients. Design Multicenter prospective study. Setting Acute geriatric medicine at the University Hospital of Nantes and the Hospital of Saint-Nazaire. Participants Older patients aged 75 and over hospitalized in acute geriatric medicine. Measurements Older patients in acute geriatric medicine who received proton pump inhibitors. Variables studied were individual multimorbidities, the burden of multimorbidity evaluated by the Cumulative Illness Rating Scale, age, sex, type of residence (living in nursing home or not), functional abilities (Lawton and Katz scales), nutritional status (Body Mass Index), and the type of concomitant medications (antiaggregant, corticosteroids', or anticoagulants). Results Overprescription of proton pump inhibitors was found in 73.9% older patients. In the full model, cardiac diseases (odds ratio [OR] = 4.17, p = 0.010), metabolic diseases (OR = 2.14, p = 0.042) and corticosteroids (OR = 5.39, p = 0.028) were significantly associated with overprescription of proton pump inhibitors. Esogastric diseases (OR = 0.49, p = 0.033) were negatively associated with overprescription of proton pump inhibitors. Conclusion Cardiac diseases and metabolic diseases were significantly associated with overprescription of proton pump inhibitors.	[Delcher, Anne; Hily, Sylvie] St Nazaire Hosp, Dept Geriatr, St Nazaire, France; [Boureau, Anne Sophie; Chapelet, Guillaume; Berrut, Gilles; de Decker, Laure] Nantes Univ Hosp, Dept Geriatr, Nantes, France	Nantes Universite; CHU de Nantes	Delcher, A (corresponding author), St Nazaire Hosp, Dept Geriatr, St Nazaire, France.	a.delcher@ch-saintnazaire.fr		boureau, annesophie/0000-0002-2224-2014				Ahrens D, 2010, EUR J CLIN PHARMACOL, V66, P1265, DOI 10.1007/s00228-010-0871-9; Bouchoucha M, 2011, DIABETES METAB, V37, P90, DOI 10.1016/j.diabet.2010.11.002; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; De Decker L, 2009, ANN GERONTOL, V2, P1; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; George CJ, 2008, AM J GERIATR PHARMAC, V6, P249, DOI 10.1016/j.amjopharm.2008.12.001; Hamzat H, 2012, DRUG AGING, V29, P681, DOI 10.2165/11632700-000000000-00000; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; Heidelbaugh JJ, 2012, THER ADV GASTROENTER, V5, P219, DOI 10.1177/1756283X12437358; Huang C, 2009, ENDOCR PRACT, V15, P653, DOI 10.4158/EP.15.6.653; Jarchow-MacDonald AA, 2013, GERIATR GERONTOL INT, V13, P1002, DOI 10.1111/ggi.12047; Masclee GMC, 2014, DRUG AGING, V31, P263, DOI 10.1007/s40266-014-0166-4; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Mullins PM, 2013, ACAD EMERG MED, V20, P479, DOI 10.1111/acem.12134; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Niklasson A, 2003, RESP MED, V97, P1143, DOI 10.1016/S0954-6111(03)00187-2; Palkovic Lindsay B, 2009, Int J Pharm Pract, V17, P73; Pasina L, 2011, EUR J INTERN MED, V22, P205, DOI 10.1016/j.ejim.2010.11.009; Ramirez E, 2010, CURR CLIN PHARMACOL, V5, P288, DOI 10.2174/157488410793352067; Seite F, 2009, J AM GERIATR SOC, V57, P2169, DOI 10.1111/j.1532-5415.2009.02540.x; Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323; Wang XB, 2008, WORLD J GASTROENTERO, V14, P709, DOI 10.3748/wjg.14.709; Wolfe MM, 2000, GASTROENTEROLOGY, V118, pS9, DOI 10.1016/S0016-5085(00)70004-7; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	27	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141779	10.1371/journal.pone.0141779	http://dx.doi.org/10.1371/journal.pone.0141779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535585	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400085
J	Deliens, G; Stercq, F; Mary, A; Slama, H; Cleeremans, A; Peigneux, P; Kissine, M				Deliens, Gaetane; Stercq, Fanny; Mary, Alison; Slama, Hichem; Cleeremans, Axel; Peigneux, Philippe; Kissine, Mikhail			Impact of Acute Sleep Deprivation on Sarcasm Detection	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; PERSPECTIVE-TAKING; VERBAL IRONY; INDIVIDUAL-DIFFERENCES; HEALTHY-ADULTS; WORKING-MEMORY; REACTION-TIME; ONE NIGHT; TASK; STROOP	There is growing evidence that sleep plays a pivotal role on health, cognition and emotional regulation. However, the interplay between sleep and social cognition remains an uncharted research area. In particular, little is known about the impact of sleep deprivation on sarcasm detection, an ability which, once altered, may hamper everyday social interactions. The aim of this study is to determine whether sleep-deprived participants are as able as sleep-rested participants to adopt another perspective in gauging sarcastic statements. At 9am, after a whole night of sleep (n = 15) or a sleep deprivation night (n = 15), participants had to read the description of an event happening to a group of friends. An ambiguous voicemail message left by one of the friends on another's phone was then presented, and participants had to decide whether the recipient would perceive the message as sincere or as sarcastic. Messages were uttered with a neutral intonation and were either: (1) sarcastic from both the participant's and the addressee's perspectives (i.e. both had access to the relevant background knowledge to gauge the message as sarcastic), (2) sarcastic from the participant's but not from the addressee's perspective (i.e. the addressee lacked context knowledge to detect sarcasm) or (3) sincere. A fourth category consisted in messages sarcastic from both the participant's and from the addressee's perspective, uttered with a sarcastic tone. Although sleep-deprived participants were as accurate as sleep-rested participants in interpreting the voice message, they were also slower. Blunted reaction time was not fully explained by generalized cognitive slowing after sleep deprivation; rather, it could reflect a compensatory mechanism supporting normative accuracy level in sarcasm understanding. Introducing prosodic cues compensated for increased processing difficulties in sarcasm detection after sleep deprivation. Our findings support the hypothesis that sleep deprivation might damage the flow of social interactions by slowing perspective-taking processes.	[Deliens, Gaetane; Cleeremans, Axel] Univ Libre Bruxelles, CRCN, CO3, Brussels, Belgium; [Deliens, Gaetane; Mary, Alison; Slama, Hichem; Cleeremans, Axel; Peigneux, Philippe] Univ Libre Bruxelles, UNI ULB Neurosci Inst, Brussels, Belgium; [Deliens, Gaetane; Mary, Alison; Slama, Hichem; Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Grp UR2NF, CRCN, Brussels, Belgium; [Deliens, Gaetane; Stercq, Fanny; Kissine, Mikhail] Univ Libre Bruxelles, ACTE, LaDisco Ctr Res Linguist, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Deliens, G (corresponding author), Univ Libre Bruxelles, CRCN, CO3, Brussels, Belgium.	Gaetane.Deliens@ulb.ac.be	Slama, Hichem/HGA-3213-2022; Kissine, Mikhail/AAE-9184-2020	Slama, Hichem/0000-0003-3856-4488; Kissine, Mikhail/0000-0001-6693-9772; Mary, Alison/0000-0002-4298-1922; Peigneux, Philippe/0000-0003-4745-1434	Departement du developpement technologique", Region Wallonne (Belgium) [DGO6]; FNRSCC [1.5.184.10.F]; FRSM [3.4.594.08.F]; MIS grant F.R.S.-FNRS [F.4502.15]	Departement du developpement technologique", Region Wallonne (Belgium); FNRSCC(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); MIS grant F.R.S.-FNRS	Funding: GD is a postdoctoral researcher supported by a "Greentic" grant from the "Departement du developpement technologique" (DGO6), Region Wallonne (Belgium). FS and AM are Research Fellows at the Belgian Fond National de la Recherche Scientifique (FNRS). AC is a Research Director with the same institution. PP is Francqui Research Professor 2013-2016. This study has been conducted with support of FNRSCC grant 1.5.184.10.F, FRSM grant 3.4.594.08.F and MIS grant F.4502.15 F.R.S.-FNRS.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akimoto Y, 2012, METAPHOR SYMBOL, V27, P217, DOI 10.1080/10926488.2012.691750; Axelsson J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6614; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Basner M., 2015, J SLEEP RES; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bazydlo R, 2001, PSYCHOSOM MED, V63, P56, DOI 10.1097/00006842-200101000-00007; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berger RH, 2012, J SLEEP RES, V21, P235, DOI 10.1111/j.1365-2869.2011.00962.x; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Bryant GA, 2002, METAPHOR SYMBOL, V17, P99, DOI 10.1207/S15327868MS1702_2; Bryant GA, 2010, DISCOURSE PROCESS, V47, P545, DOI 10.1080/01638530903531972; Butt M, 2015, SLEEP BREATH, V19, P255, DOI 10.1007/s11325-014-1005-x; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; Cain SW, 2011, BRAIN COGNITION, V76, P37, DOI 10.1016/j.bandc.2011.03.005; Cheang HS, 2011, PRAGMAT COGN, V19, P203, DOI 10.1075/pc.19.2.02che; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deliens G, 2015, RJAD, P1; Deliens G, 2014, EXP BRAIN RES, V232, P1403, DOI 10.1007/s00221-014-3832-1; Deltour JJ, 1993, MANUEL ET ANNEXES; DEWS S, 1995, METAPHOR SYMB ACT, V10, P3, DOI 10.1207/s15327868ms1001_2; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Dress ML, 2008, J LANG SOC PSYCHOL, V27, P71, DOI 10.1177/0261927X07309512; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Engle-Friedman M, 2003, J SLEEP RES, V12, P113, DOI 10.1046/j.1365-2869.2003.00351.x; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Gibbs R.W., 2000, METAPHOR SYMBOL, V15, P5, DOI [DOI 10.1080/10926488.2000.9678862, 10.1207/S15327868MS1512_2, DOI 10.1207/S15327868MS1512_2]; Griffin AM, 2006, SOC COGNITION, V24, P187, DOI 10.1521/soco.2006.24.2.187; Harrison Y, 2000, Q J EXP PSYCHOL-A, V53, P271, DOI 10.1080/027249800390772; Hayes AF., 2003, INTRO MEDIATION MODE; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kahn-Greene ET, 2006, PERS INDIV DIFFER, V41, P1433, DOI 10.1016/j.paid.2006.06.002; KEYSAR B, 1994, COGNITIVE PSYCHOL, V26, P165, DOI 10.1006/cogp.1994.1006; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Killgore WDS, 2007, PERCEPT MOTOR SKILL, V105, P276; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kreuz RJ, 1999, J PRAGMATICS, V31, P1685, DOI 10.1016/S0378-2166(99)00010-7; Laval V, 2005, J SPEECH LANG HEAR R, V48, P610, DOI 10.1044/1092-4388(2005/042); Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; LINGENFELSER T, 1994, MED EDUC, V28, P566, DOI 10.1111/j.1365-2923.1994.tb02737.x; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mary A, 2015, CHILD NEUROPSYCHOL, V12, P1; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Morris Charles W., 1934, MIND SELF SOC STANDP, V18, P1972; National Sleep Foundation, 2013, INT BEDR POLL SUMM F; Nichols Shaun, 2003, MINDREADING INTEGRAT; Nickerson RS, 1999, PSYCHOL BULL, V125, P737, DOI 10.1037/0033-2909.125.6.737; Pallesen S, 2004, PERCEPT MOTOR SKILL, V98, P1305, DOI 10.2466/PMS.98.3.1305-1314; Pexman PM, 2004, METAPHOR SYMBOL, V19, P143, DOI 10.1207/s15327868ms1902_3; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Russell J., 1997, AUTISM EXECUTIVE DIS, P256, DOI DOI 10.1093/MED:PSYCH/9780198523499.003.0008; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Sagaspe P, 2003, CAN J EXP PSYCHOL, V57, P265, DOI 10.1037/h0087430; Schwarz JFA, 2013, BIOL PSYCHOL, V93, P41, DOI 10.1016/j.biopsycho.2013.01.008; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Toplak M, 2000, J PRAGMATICS, V32, P1467, DOI 10.1016/S0378-2166(99)00101-0; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vriend JL, 2013, J PEDIAT PSYCHOL; Wardlow L, 2013, PSYCHON B REV, V20, P766, DOI 10.3758/s13423-013-0396-1; Wilcox R. R., 1987, NEW STAT PROCEDURES; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Woodland J, 2011, METAPHOR SYMBOL, V26, P227, DOI 10.1080/10926488.2011.583197; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	78	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140527	10.1371/journal.pone.0140527	http://dx.doi.org/10.1371/journal.pone.0140527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535906	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400023
J	Kojima, W				Kojima, Wataru			Attraction to Carbon Dioxide from Feeding Resources and Conspecific Neighbours in Larvae of the Rhinoceros Beetle Trypoxylus dichotomus	PLOS ONE			English	Article							HOST-PLANT LOCATION; MICROBIAL ACTIVITY; COLEOPTERA; PHYSIOLOGY; SIZE; AGGREGATION; PLASTICITY; RECEPTORS; EVOLUTION; RESPONSES	Saprophagous (feeding on decaying matter) insects often use carbon dioxide (CO2) as a cue for finding food. Humus-feeding larvae of the giant rhinoceros beetle Trypoxylus dichotomus exhibit a clumped distribution in natural microhabitats, but the mechanisms driving the distribution were unknown. Herein, I examined whether larvae use CO2 as a cue for fermented humus and aggregate in the vicinity of the food. I found that (i) larvae of T. dichotomus are strongly attracted to CO2, (ii) larvae orient toward highly fermented humus when given a choice between highly and poorly fermented humus, (iii) the highly fermented humus emits more CO2 than the poorly fermented humus, and (iv) larvae grow larger when fed highly fermented humus rather than poorly fermented humus. The clumped distribution of larvae is probably formed along the concentration gradient of CO2 induced by heterogeneity of fermented organic materials in soil. My laboratory experiments also revealed that larvae are chemically attracted to each other. Moreover, CO2 concentrations in soil were increased by the larval respiration, and small amounts of CO2 (much less than emitted during respiration by a single larva) were sufficient for larval attraction. These results suggest that not only response to fermented food resources, but also respiratory CO2 from conspecifics may lead to aggregation. Enhanced densities resulted in reduced weight gain under experimental conditions. However, exploiting a high-value resource at enhanced densities still led to greater body weight compared to individually exploiting a low-value resource. This demonstrates the adaptive value of the response to CO2 sources in this species.	Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Kojima, W (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	koj.wataru@gmail.com			Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [13J08975] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; AVERILL AL, 1987, ECOLOGY, V68, P878, DOI 10.2307/1938359; Barrozo RB, 2004, CHEM SENSES, V29, P319, DOI 10.1093/chemse/bjh035; Bernklau EJ, 2005, J ECON ENTOMOL, V98, P476, DOI 10.1603/0022-0493-98.2.476; Bernklau EJ, 1998, J ECON ENTOMOL, V91, P444, DOI 10.1093/jee/91.2.444; Binet F, 1998, BIOL FERT SOILS, V27, P79, DOI 10.1007/s003740050403; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; Denno RF, 1997, ECOL ENTOMOL, V22, P133, DOI 10.1046/j.1365-2311.1997.t01-1-00063.x; DOANE JF, 1975, CAN ENTOMOL, V107, P1233, DOI 10.4039/Ent1071233-12; Eilers EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041357; Erb M, 2013, ADV INSECT PHYSIOL, V45, P53, DOI 10.1016/B978-0-12-417165-7.00002-7; Fordyce JA, 2003, OECOLOGIA, V135, P250, DOI 10.1007/s00442-003-1177-8; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; Hongo Y, 2007, BEHAV ECOL SOCIOBIOL, V62, P245, DOI 10.1007/s00265-007-0459-2; Johnson SN, 2006, B ENTOMOL RES, V96, P361, DOI 10.1079/BER2006436; Johnson SN, 2012, J CHEM ECOL, V38, P604, DOI 10.1007/s10886-012-0106-x; Johnson SN, 2006, PHYSIOL ENTOMOL, V31, P1, DOI 10.1111/j.1365-3032.2005.00487.x; JONES OT, 1978, ENTOMOL EXP APPL, V24, P472, DOI 10.1007/BF02385099; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kojima W, 2015, ECOL ENTOMOL, V40, P420, DOI 10.1111/een.12205; Kojima W, 2014, NATURWISSENSCHAFTEN, V101, P687, DOI 10.1007/s00114-014-1199-6; Krause J, 2002, LIVING GROUPS; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogers CD, 2013, B ENTOMOL RES, V103, P675, DOI 10.1017/S0007485313000382; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Tsurumaki H, 1987, SAISHU TO SHIIKU, V49, P254; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329	34	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141733	10.1371/journal.pone.0141733	http://dx.doi.org/10.1371/journal.pone.0141733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536591	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400083
J	Liu, LF; Zhang, JL; Lu, Y; Fang, CF; Li, SL; Lin, JS				Liu, Lifeng; Zhang, Jinliang; Lu, Yan; Fang, Chunfang; Li, Senlin; Lin, Jusheng			Correlations between ASCC3 Gene Polymorphisms and Chronic Hepatitis B in a Chinese Han Population	PLOS ONE			English	Article							CHRONIC HBV INFECTION; ORGAN-SPECIFIC EXPRESSION; GENOME-WIDE ASSOCIATION; CELL-SURFACE TARGET; VIRUS-INFECTION; DISEASE PROGRESSION; COLORECTAL-CANCER; ANTIGEN A33; TRANSMISSION; TRANSCRIPTION	We have previously identified 8 SNPs in Han Chinese HBV carriers that are associated with disease progression. Although not well studied, genetic factors may also play a significant role in developing chronic HBV disease after exposure. We extend the effect of these eight SNPs on persistent HBV infection in this study. A total of 875 unrelated Han Chinese, 493 chronic hepatitis B subjects (CHB) and 382 HBV clearance individuals (Clear), were recruited from Hubei Province from September 2007 to March 2010. SNPs were verified by using TaqMan 7900HT Sequence Detection System. By using multiple logistic regression analysis, each of the 8 SNP associations was tested using 3 different genetic models (Dominant, Recessive and Additive model), in 4 types of analyses (full sample, men, women, age stratified). A Bonferroni correction was used to account for multiple statistical tests for each SNP association (P<0.05/8 = 0.0063). A significant correlation was observed at SNP rs10485138 located in ASCC3 gene in female patients (OR, 0.445; 95% CI, 0.253-0.784; P = 0.005). Females bearing C allele infected by HBV had an increased susceptibility to CHB compared with those T allele carriers. Our results indicated that SNP rs10485138 located in ASCC3 gene was associated with persistent HBV infection in Han Chinese.	[Liu, Lifeng; Lu, Yan; Fang, Chunfang; Li, Senlin] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng Peoples Hosp, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China; [Zhang, Jinliang] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng Peoples Hosp, Dept Hepatobiliary Surg, Liaocheng, Shandong, Peoples R China; [Lin, Jusheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Liver Dis, Wuhan 430074, Hubei, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Huazhong University of Science & Technology	Liu, LF (corresponding author), Taishan Med Univ, Liaocheng Clin Sch, Liaocheng Peoples Hosp, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China.	llf2006tj@163.com			medical and health technology development program in Shandong province [2013WS0094]; Shandong Provincial Natural Science [ZR2014HL019]	medical and health technology development program in Shandong province; Shandong Provincial Natural Science	This study was supported by the Projects of medical and health technology development program in Shandong province (2013WS0094) and Shandong Provincial Natural Science (ZR2014HL019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOG Y, 1992, ANTIVIR RES, V19, P285, DOI 10.1016/0166-3542(92)90010-3; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; BOSCH J, 1973, LANCET, V2, P457; Carrasquillo JA, 2011, J NUCL MED, V52, P1173, DOI 10.2967/jnumed.110.086165; Carrilho FJ, 2005, BRAZ J MED BIOL RES, V38, P1399, DOI 10.1590/S0100-879X2005000900015; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; GarinChesa P, 1996, INT J ONCOL, V9, P465; Hall AJ, 1997, BRIT MED BULL, V53, P10; He XX, 2010, VIRAL IMMUNOL, V23, P251, DOI 10.1089/vim.2009.0102; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Johnstone CN, 2002, J BIOL CHEM, V277, P34531, DOI 10.1074/jbc.M204865200; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lei RX, 2009, HEPATOLOGY, V50, P763, DOI 10.1002/hep.23062; Li DL, 2009, HEPATOLOGY, V50, P735, DOI 10.1002/hep.23047; Li J., 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00385-13; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Liu LF, 2011, VIRAL IMMUNOL, V24, P397, DOI 10.1089/vim.2011.0027; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; O'Donoghue JA, 2011, J NUCL MED, V52, P1878, DOI 10.2967/jnumed.111.095596; OHBAYASHI A, 1972, GASTROENTEROLOGY, V62, P618; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Sakamoto J, 2000, CANCER CHEMOTH PHARM, V46, pS27, DOI 10.1007/PL00014045; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Sun C, 2011, HUM GENET, V130, P767, DOI 10.1007/s00439-011-1025-6; Tran TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121632; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Turner SJ, 2015, NEUROLOGY, V84, P586, DOI 10.1212/WNL.0000000000001228; Wang JS, 2002, CHINESE MED J-PEKING, V115, P1510; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Winham SJ, 2014, GENET EPIDEMIOL, V38, P457, DOI 10.1002/gepi.21815; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamada-Fowler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099294; Zhuang Hui, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P241, DOI 10.3760/cma.j.issn.1007-3418.2010.04.001	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141861	10.1371/journal.pone.0141861	http://dx.doi.org/10.1371/journal.pone.0141861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536629	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400093
J	Skovdahl, HK; Granlund, AVB; Ostvik, AE; Bruland, T; Bakke, I; Torp, SH; Damas, JK; Sandvik, AK				Skovdahl, Helene Kolstad; Granlund, Atle Van Beelen; Ostvik, Ann Elisabet; Bruland, Torunn; Bakke, Ingunn; Torp, Sverre Helge; Damas, Jan Kristian; Sandvik, Arne Kristian			Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTOR-3; INTESTINAL EPITHELIUM; PROTEIN 3-ALPHA; IMMUNITY; ACTIVATION; INNATE; PROTEIN-3-ALPHA/CCL20; RESPONSIVENESS; RECRUITMENT	Background The chemokine CCL20 and its receptor CCR6 are putative drug targets in inflammatory bowel disease, and CCL20 is a novel IBD predilection gene. Previous findings on the CCL20 response in these diseases are divergent. This study was undertaken to examine CCL20 and CCR6 during active and inactive disease, and mechanisms for CCL20 regulation by the innate immune system. As TLR3 has recently emerged as a possible mediator of CCL20 production, we hypothesised that this TLR plays an important role in enterocytic CCL20 production. Methods A large microarray study on colonic pinch biopsies from active and inactive ulcerative colitis and Crohn's disease provided background information. CCL20 and CCR6 were localized and their expression levels assessed in biopsies using in situ hybridization and immunohistochemistry. Regulation of CCL20 was studied in the HT29 cell line using a panel of pattern recognition receptor ligands followed by a TLR3 siRNA assay. Results CCL20 and CCR6 mRNA abundances were increased during active inflammation (CCL20 5.4-fold in ulcerative colitis and 4.2-fold in Crohn's disease; CCR6 1.8 and 2.0, respectively). CCL20 and CCR6 mRNA positive immune cells in lamina propria were more numerous, and CCL20 immunoreactivity increased massively in the epithelial cells during active inflammation for both diseases. TLR3 stimulation potently induced upregulation and release of CCL20 from HT29 cells, and TLR3 silencing reduced CCL20 mRNA and protein levels. Conclusions The CCL20-CCR6 axis is involved during active inflammation in both ulcerative colitis and Crohn's disease. The epithelial cells seem particularly involved in the CCL20 response, and results from this study strongly suggest that the innate immune system is important for activation of the epithelium, especially through TLR3.	[Skovdahl, Helene Kolstad; Granlund, Atle Van Beelen; Ostvik, Ann Elisabet; Damas, Jan Kristian; Sandvik, Arne Kristian] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Skovdahl, Helene Kolstad; Granlund, Atle Van Beelen; Ostvik, Ann Elisabet; Bruland, Torunn; Bakke, Ingunn; Damas, Jan Kristian; Sandvik, Arne Kristian] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Torp, Sverre Helge] Norwegian Univ Sci & Technol, Children & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Ostvik, Ann Elisabet; Sandvik, Arne Kristian] St Olavs Univ Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Torp, Sverre Helge] St Olavs Univ Hosp, Dept Pathol & Med Genet, Trondheim, Norway; [Damas, Jan Kristian] St Olavs Univ Hosp, Dept Infect Dis, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Sandvik, AK (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway.	arne.sandvik@ntnu.no	Torp, Sverre Helge/AAN-4229-2020; Bluland, Torunn/AAT-5730-2021	Torp, Sverre Helge/0000-0001-8345-6852; Bakke, Ingunn/0000-0003-0356-6184; Bruland, Torunn/0000-0002-1568-2476; Granlund, Atle van Beelen/0000-0001-8117-2637	Liaison Committee; Faculty of Medicine at the Norwegian University of Science and Technology; Central Norway Regional Health Authority	Liaison Committee; Faculty of Medicine at the Norwegian University of Science and Technology; Central Norway Regional Health Authority	This study was supported by grants from the Liaison Committee between the Central Norway Regional Health Authority (AEO, AvBG) and the Norwegian University of Science and Technology (https://www.ntnu.no/dmf/rad/samorg), and this work has also received funding from a research grant from The Liaison Committee between St. Olav's University Hospital and the Faculty of Medicine (http://www.ntnu.no/dmf/ffu-og-fuu). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.; The microarray service was provided by the Genomics Core Facility (GCF), Norwegian University of Science and Technology (NTNU). GCF is funded by the Faculty of Medicine at the Norwegian University of Science and Technology and the Central Norway Regional Health Authority. Bjorn Munkvold provided excellent technical assistance. Conference presentation: Part of this work was presented at the 2014 ECCO conference, Copenhagen, Denmark.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Bogaert S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-61; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Davies JM, 2015, SCAND J GASTROENTERO, V50, P24, DOI 10.3109/00365521.2014.966321; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Granlund AV, 2011, SCAND J GASTROENTERO, V46, P1316, DOI 10.3109/00365521.2011.605463; Hedrick MN, 2010, EXPERT OPIN THER TAR, V14, P911, DOI 10.1517/14728222.2010.504716; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hosokawa Y, 2013, CELL IMMUNOL, V283, P8, DOI 10.1016/j.cellimm.2013.05.005; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Lee AYS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00194; Liao F, 1999, J IMMUNOL, V162, P186; Liu JZ, 2015, NAT GENET; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Ostvik AE, 2013, CLIN EXP IMMUNOL, V173, P502, DOI 10.1111/cei.12136; Ostvik AE, 2013, INFLAMM BOWEL DIS, V19, P265, DOI 10.1002/ibd.23034; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sugiura Y, 2013, MUCOSAL IMMUNOLOGY, V6, P9; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; Wehkamp J, 2009, GASTROEN CLIN BIOL, V33, pS137, DOI 10.1016/S0399-8320(09)73149-5; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	40	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141710	10.1371/journal.pone.0141710	http://dx.doi.org/10.1371/journal.pone.0141710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536229	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400080
J	Taciak, M; Barszcz, M; Tusnio, A; Pastuszewska, B				Taciak, Marcin; Barszcz, Marcin; Tusnio, Anna; Pastuszewska, Barbara			Interactive Effects of Indigestible Carbohydrates, Protein Type, and Protein Level on Biomarkers of Large Intestine Health in Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE ACTIVITY; COLONIC DNA-DAMAGE; RESISTANT STARCH; DIETARY FIBER; POTATO FIBER; BACTERIAL METABOLITES; CECAL FERMENTATION; ACID; MORPHOLOGY; CASEIN	The effects of indigestible carbohydrates, protein type, and protein level on large intestine health were examined in rats. For 21 days, 12 groups of six 12-week-old male Wistar rats were fed diets with casein (CAS), or potato protein concentrate (PPC), providing 14%(lower protein level; LP), or 20%(higher protein level; HP) protein, and containing cellulose, resistant potato starch, or pectin. Fermentation end-products, pH, and beta-glucuronidase levels in cecal digesta, and ammonia levels in colonic digesta were determined. Cecal digesta, tissue weights, cecal and colon morphology, and colonocyte DNA damage were also analyzed. Digesta pH was lower, whereas relative mass of cecal tissue and digesta were higher in rats fed pectin diets than in those fed cellulose. Cecal parameters were greater in rats fed PPC and HP diets than in those fed CAS and LP diets, respectively. Short-chain fatty acid (SCFA) concentrations were unaffected by protein or carbohydrate type. Total SCFA, acetic acid, and propionic acid concentrations were greater in rats fed LP diets than in those fed HP. Cecal pool of isobutyric and isovaleric acids was greater in rats fed PPC than in those fed CAS diets. PPC diets decreased phenol concentration and increased ammonia concentration in cecal and colonic digesta, respectively. Cecal crypt depth was greater in rats fed PPC and HP diets, and was unaffected by carbohydrates; whereas colonic crypt depth was greater in rats fed cellulose. Myenteron thickness in the cecum was unaffected by nutrition, but was greater in the colon of rats fed cellulose. Colonocyte DNA damage was greater in rats fed LP diets than in those fed HP diets, and was unaffected by carbohydrate or protein type. It was found that nutritional factors decreasing cecal digesta weight contribute to greater phenol production, increased DNA damage, and reduced ammonia concentration in the colon.	[Taciak, Marcin; Barszcz, Marcin; Tusnio, Anna; Pastuszewska, Barbara] Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland	Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences	Taciak, M (corresponding author), Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland.	m.taciak@ifzz.pl	Taciak, Marcin/J-9425-2013; Tuśnio, Anna/AAI-1430-2019; Barszcz, Marcin/AAL-4761-2021; Taciak, Marcin/H-3751-2017	Taciak, Marcin/0000-0002-8963-9745; Barszcz, Marcin/0000-0002-3428-9805; Taciak, Marcin/0000-0002-8963-9745; Tusnio, Anna/0000-0001-7480-3592	Ministry of Science and Higher Education of Poland [N N311 046634]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	This study was financially supported by the Ministry of Science and Higher Education of Poland, Grant No. N N311 046634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x; An C, 2014, APPL MICROBIOL BIOT, V98, P2779, DOI 10.1007/s00253-013-5271-5; Barszcz M, 2011, J ANIM FEED SCI, V20, P613, DOI 10.22358/jafs/66219/2011; Barszcz M, 2011, J ANIM FEED SCI, V20, P3, DOI 10.22358/jafs/66152/2011; Barth SW, 2005, CARCINOGENESIS, V26, P1414, DOI 10.1093/carcin/bgi082; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Buraczewska L, 2007, LIVEST SCI, V109, P53, DOI 10.1016/j.livsci.2007.01.058; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Henningsson AM, 2002, J NUTR, V132, P3098, DOI 10.1093/jn/131.10.3098; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Juskiewicz J, 2009, J ANIM FEED SCI, V18, P709; Khattak M. M. A. K., 2002, Pakistan Journal of Nutrition, V1, P161; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; LUPTON JR, 1989, J NUTR, V119, P235, DOI 10.1093/jn/119.2.235; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Metzler BU, 2008, ASIAN AUSTRAL J ANIM, V21, P603, DOI 10.5713/ajas.2008.r.03; Morita T, 1998, J NUTR, V128, P1156, DOI 10.1093/jn/128.7.1156; Mouille B, 2004, AM J PHYSIOL-GASTR L, V287, pG344, DOI 10.1152/ajpgi.00445.2003; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oberreuther-Moschner DL, 2005, TOXICOL LETT, V159, P212, DOI 10.1016/j.toxlet.2005.05.008; Pastuszewska B, 2010, ARCH ANIM NUTR, V64, P155, DOI 10.1080/17450390903478885; Paturi G, 2012, J FOOD SCI, V77, pH216, DOI 10.1111/j.1750-3841.2012.02911.x; Propst EL, 2003, J ANIM SCI, V81, P3057; SHIAU SY, 1983, J NUTR, V113, P138, DOI 10.1093/jn/113.1.138; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Toden S, 2007, BRIT J NUTR, V97, P535, DOI 10.1017/S0007114507336817; Toden S, 2006, CANCER BIOL THER, V5, P267, DOI 10.4161/cbt.5.3.2382; Tusnio A, 2011, J ANIM FEED SCI, V20, P361, DOI 10.22358/jafs/66192/2011; Williams BA, 2001, NUTR RES REV, V14, P207, DOI 10.1079/NRR200127; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542	39	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142176	10.1371/journal.pone.0142176	http://dx.doi.org/10.1371/journal.pone.0142176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536028	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400141
J	Tateno, C; Kawase, Y; Tobita, Y; Hamamura, S; Ohshita, H; Yokomichi, H; Sanada, H; Kakuni, M; Shiota, A; Kojima, Y; Ishida, Y; Shitara, H; Wada, NA; Tateishi, H; Sudoh, M; Nagatsuka, S; Jishage, K; Kohara, M				Tateno, Chise; Kawase, Yosuke; Tobita, Yoshimi; Hamamura, Satoko; Ohshita, Hiroki; Yokomichi, Hiroshi; Sanada, Harumi; Kakuni, Masakazu; Shiota, Akira; Kojima, Yuha; Ishida, Yuji; Shitara, Hiroshi; Wada, Naoko A.; Tateishi, Hiromi; Sudoh, Masayuki; Nagatsuka, Shin-ichiro; Jishage, Kou-ichi; Kohara, Michinori			Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR TRANSGENE; MESSENGER-RNA EXPRESSION; HUMAN HEPATOCYTES; IN-VIVO; CYTOCHROME-P450; ENZYMES; INDUCTION; INFECTION; MOUSE; MODEL	We have used homozygous albumin enhancer/promoter-driven urokinase-type plasminogen activator/severe combined immunodeficient (uPA/SCID) mice as hosts for chimeric mice with humanized livers. However, uPA/SCID mice show four disadvantages: the human hepatocytes (h-heps) replacement index in mouse liver is decreased due to deletion of uPA transgene by homologous recombination, kidney disorders are likely to develop, body size is small, and hemizygotes cannot be used as hosts as more frequent homologous recombination than homozygotes. To solve these disadvantages, we have established a novel host strain that has a transgene containing albumin promoter/enhancer and urokinase-type plasminogen activator cDNA and has a SCID background (cDNA-uPA/SCID). We applied the embryonic stem cell technique to simultaneously generate a number of transgenic lines, and found the line with the most appropriate levels of uPA expression-not detrimental but with a sufficiently damaged liver. We transplanted h-heps into homozygous and hemizygous cDNA-uPA/SCID mice via the spleen, and monitored their human albumin (h-alb) levels and body weight. Blood h-alb levels and body weight gradually increased in the hemizygous cDNA-uPA/SCID mice and were maintained until they were approximately 30 weeks old. By contrast, blood h-alb levels and body weight in uPA/SCID chimeric mice decreased from 16 weeks of age onwards. A similar decrease in body weight was observed in the homozygous cDNA-uPA/SCID genotype, but h-alb levels were maintained until they were approximately 30 weeks old. Microarray analyses revealed identical h-heps gene expression profiles in homozygous and hemizygous cDNA-uPA/SCID mice were identical to that observed in the uPA/SCID mice. Furthermore, like uPA/SCID chimeric mice, homozygous and hemizygous cDNA-uPA/SCID chimeric mice were successfully infected with hepatitis B virus and C virus. These results indicate that hemizygous cDNA-uPA/SCID mice may be novel and useful hosts for producing chimeric mice for use in future long-term studies, including hepatitis virus infection analysis or drug toxicity studies.	[Tateno, Chise; Hamamura, Satoko; Ohshita, Hiroki; Yokomichi, Hiroshi; Sanada, Harumi; Kakuni, Masakazu; Shiota, Akira; Kojima, Yuha; Ishida, Yuji] PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan; [Tateno, Chise; Ishida, Yuji] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Kawase, Yosuke; Wada, Naoko A.; Tateishi, Hiromi] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Tobita, Yoshimi; Shitara, Hiroshi; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Sudoh, Masayuki; Jishage, Kou-ichi] Chugai Pharmaceut Co Ltd, Shizuoka, Japan; [Nagatsuka, Shin-ichiro] Sekisui Med Co Ltd, Tokyo, Japan	PHOENIXBIO CO. LTD.; Hiroshima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Tokyo Metropolitan Institute of Medical Science; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Sekisui Chemical Co Ltd	Tateno, C (corresponding author), PhoenixBio Co Ltd, Higashihiroshima, Hiroshima, Japan.	chise.mukaidani@phoenixbio.co.jp; kohara-mc@igakuken.or.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	PhoenixBio, Co., Ltd.; Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd.; Sekisui Medical Co., Ltd.; Grants-in-Aid for Scientific Research [15H01272] Funding Source: KAKEN	PhoenixBio, Co., Ltd.; Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd.; Sekisui Medical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by PhoenixBio, Co., Ltd., Chugai Research Institute for Medical Science, Chugai Pharmaceutical Co., Ltd., and Sekisui Medical Co., Ltd., which provided support in the form of salaries for authors [CT, Y. Kawase, SH, HO, HY, H. Sanada, M. Kakuni, AS, Y. Kojima, YI, NAW, HT, MS, SN, KJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Coleman MD, 2005, FACTORS AFFECTING DR; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kakuni M, 2014, INT J MOL SCI, V15, P58, DOI 10.3390/ijms15010058; Katoh M, 2005, DRUG METAB DISPOS, V33, P1333, DOI 10.1124/dmd.105.005157; Katoh M, 2005, DRUG METAB DISPOS, V33, P754, DOI 10.1124/dmd.104.002600; Katoh M, 2004, DRUG METAB DISPOS, V32, P1402, DOI 10.1124/dmd.104.001347; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Nishimura M, 2006, DRUG METAB PHARMACOK, V21, P357, DOI 10.2133/dmpk.21.357; Okumura H, 2007, TOXICOL SCI, V97, P533, DOI 10.1093/toxsci/kfm041; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SANDGREN EP, 1992, P NATL ACAD SCI USA, V89, P11523, DOI 10.1073/pnas.89.23.11523; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tanaka T, 2004, J MED VIROL, V72, P223, DOI 10.1002/jmv.10566; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Yoshizato K, 2013, EXPERT OPIN DRUG MET, V9, P1419, DOI 10.1517/17425255.2013.826649	23	82	83	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142145	10.1371/journal.pone.0142145	http://dx.doi.org/10.1371/journal.pone.0142145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536627	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400138
J	Van Dam, NT; Brown, A; Mole, TB; Davis, JH; Britton, WB; Brewer, JA				Van Dam, Nicholas T.; Brown, Anna; Mole, Tom B.; Davis, Jake H.; Britton, Willoughby B.; Brewer, Judson A.			Development and Validation of the Behavioral Tendencies Questionnaire	PLOS ONE			English	Article							FORCED-CHOICE QUESTIONNAIRES; BIG 5; PERSONALITY PSYCHOLOGY; IPSATIVE DATA; MODEL; ACTIVATION; SCALES; TEMPERAMENT; ORIENTATION; INHIBITION	At a fundamental level, taxonomy of behavior and behavioral tendencies can be described in terms of approach, avoid, or equivocate (i.e., neither approach nor avoid). While there are numerous theories of personality, temperament, and character, few seem to take advantage of parsimonious taxonomy. The present study sought to implement this taxonomy by creating a questionnaire based on a categorization of behavioral temperaments/tendencies first identified in Buddhist accounts over fifteen hundred years ago. Items were developed using historical and contemporary texts of the behavioral temperaments, described as "Greedy/Faithful", "Aversive/Discerning", and "Deluded/Speculative". To both maintain this categorical typology and benefit from the advantageous properties of forced-choice response format (e.g., reduction of response biases), binary pairwise preferences for items were modeled using Latent Class Analysis (LCA). One sample (n(1) = 394) was used to estimate the item parameters, and the second sample (n(2) = 504) was used to classify the participants using the established parameters and cross-validate the classification against multiple other measures. The cross-validated measure exhibited good nomothetic span (construct-consistent relationships with related measures) that seemed to corroborate the ideas present in the original Buddhist source documents. The final 13-block questionnaire created from the best performing items (the Behavioral Tendencies Questionnaire or BTQ) is a psychometrically valid questionnaire that is historically consistent, based in behavioral tendencies, and promises practical and clinical utility particularly in settings that teach and study meditation practices such as Mindfulness Based Stress Reduction (MBSR).	[Van Dam, Nicholas T.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Van Dam, Nicholas T.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Brown, Anna] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Mole, Tom B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Davis, Jake H.] CUNY, Grad Ctr, New York, NY USA; [Britton, Willoughby B.] Brown Univ, Sch Med, Dept Behav & Social Sci, Providence, RI 02912 USA; [Brewer, Judson A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Brewer, Judson A.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Brewer, Judson A.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Icahn School of Medicine at Mount Sinai; Nathan Kline Institute for Psychiatric Research; University of Kent; University of Cambridge; City University of New York (CUNY) System; Brown University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Brewer, JA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.	judson.brewer@umassmed.edu	/V-3995-2019; Brewer, Judson/K-2283-2019; Van Dam, Nicholas Thomas/G-2799-2010	Van Dam, Nicholas Thomas/0000-0002-1131-0739; Brown, Anna/0000-0002-5612-2627	Kent Albert research fund at Yale University; National Center for Complementary & Integrative Health [K23AT006328, UH2AT009145] Funding Source: NIH RePORTER	Kent Albert research fund at Yale University; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This research was supported by the Kent Albert research fund at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Bartram D, 2007, INT J SELECT ASSESS, V15, P263, DOI 10.1111/j.1468-2389.2007.00386.x; Brown A, 2013, PSYCHOL METHODS, V18, P36, DOI 10.1037/a0030641; Brown A, 2012, BEHAV RES METHODS, V44, P1135, DOI 10.3758/s13428-012-0217-x; Brown A, 2011, EDUC PSYCHOL MEAS, V71, P460, DOI 10.1177/0013164410375112; Buddhaghosa B., PATH PURIFICATION VI; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Busia K, 2007, IYENGAR YOGA MASTER; BUSS DM, 1991, ANNU REV PSYCHOL, V42, P459, DOI 10.1146/annurev.ps.42.020191.002331; Campbell-Sills L, 2004, PSYCHOL ASSESSMENT, V16, P244, DOI 10.1037/1040-3590.16.3.244; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chan W, 1998, PSYCHOMETRIKA, V63, P369, DOI 10.1007/BF02294861; Chan W., 2003, BEHAVIORMETRIKA, V30, P99, DOI [10.2333/bhmk.30.99, DOI 10.2333/BHMK.30.99]; Cheung MWL, 2002, STRUCT EQU MODELING, V9, P55, DOI 10.1207/S15328007SEM0901_4; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Corr PJ, 2010, EUR J PERSONALITY, V24, P376, DOI 10.1002/per.779; Couch LL, 1996, J PERS ASSESS, V67, P305, DOI 10.1207/s15327752jpa6702_7; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Evans DE, 2009, PERS INDIV DIFFER, V47, P565, DOI 10.1016/j.paid.2009.05.010; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Frawley D, 2008, INT J YOGA THERAPY, V18, P21; Gethin Rupert., 1998, FDN BUDDHISM; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Haddock CK, 1998, PSYCHOL METHODS, V3, P339, DOI 10.1037/1082-989X.3.3.339; JACKSON DJ, 1980, SOCIOL METHOD RES, V9, P218, DOI 10.1177/004912418000900206; Janis I.L., 1977, DECISION MAKING PSYC; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Kabat-Zinn J, 1990, FULL CATASTROPHE LIV; Kornfield Jack, 2008, WISE HEART GUIDE UNI; Mann L, 1997, J BEHAV DECIS MAKING, V10, P1, DOI 10.1002/(SICI)1099-0771(199703)10:1<1::AID-BDM242>3.0.CO;2-X; Mann R, 1992, BUDDHIST CHARACTER A; Maydeu-Olivares A, 2010, MULTIVAR BEHAV RES, V45, P935, DOI 10.1080/00273171.2010.531231; McAdams DP, 2006, AM PSYCHOL, V61, P204, DOI 10.1037/0003-066X.61.3.204; Moos R.H., 1993, COPING RESPONSES INV; MOOS RH, 1990, PSYCHOL AGING, V5, P31, DOI 10.1037/0882-7974.5.1.31; Muthen B., 2010, MPLUS USERS GUIDE; Norcross JC, 2011, J CLIN PSYCHOL, V67, P127, DOI 10.1002/jclp.20764; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Smits IAM, 2011, J PERS SOC PSYCHOL, V100, P1124, DOI 10.1037/a0022874; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Thomas A., 1977, TEMPERAMENT DEV; van Herk H, 2004, J CROSS CULT PSYCHOL, V35, P346, DOI 10.1177/0022022104264126	52	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140867	10.1371/journal.pone.0140867	http://dx.doi.org/10.1371/journal.pone.0140867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535904	Green Published, Green Accepted, gold			2022-12-27	WOS:000364298400041
J	Lindholm, AK; Sandkam, B; Pohl, K; Breden, F				Lindholm, Anna K.; Sandkam, Ben; Pohl, Kristina; Breden, Felix			Poecilia picta, a Close Relative to the Guppy, Exhibits Red Male Coloration Polymorphism: A System for Phylogenetic Comparisons	PLOS ONE			English	Article							MATING PREFERENCES; RETICULATA PISCES; SEXUAL SELECTION; MATE PREFERENCE; RARE MALES; POPULATIONS; EVOLUTION; CHOICE; CYPRINODONTIFORMES; MAINTENANCE	Studies on the evolution of female preference and male color polymorphism frequently focus on single species since traits and preferences are thought to co-evolve. The guppy, Poecilia reticulata, has long been a premier model for such studies because female preferences and orange coloration are well known to covary, especially in upstream/downstream pairs of populations. However, focused single species studies lack the explanatory power of the comparative method, which requires detailed knowledge of multiple species with known evolutionary relationships. Here we describe a red color polymorphism in Poecilia picta, a close relative to guppies. We show that this polymorphism is restricted to males and is maintained in natural populations of mainland South America. Using tests of female preference we show female P. picta are not more attracted to red males, despite preferences for red/orange in closely related species, such as P. reticulata and P. parae. Male color patterns in these closely related species are different from P. picta in that they occur in discrete patches and are frequently Y chromosome-linked. P. reticulata have an almost infinite number of male patterns, while P. parae males occur in discrete morphs. We show the red male polymorphism in P. picta extends continuously throughout the body and is not a Y-linked trait despite the theoretical prediction that sexually-selected characters should often be linked to the heterogametic sex chromosome. The presence/absence of red male coloration of P. picta described here makes this an ideal system for phylogenetic comparisons that could reveal the evolutionary forces maintaining mate choice and color polymorphisms in this speciose group.	[Lindholm, Anna K.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Sandkam, Ben; Pohl, Kristina; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of Zurich; Simon Fraser University	Lindholm, AK (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	anna.lindholm@ieu.uzh.ch	Sandkam, Ben/A-1989-2013; Lindholm, Anna K/E-5207-2012	Sandkam, Ben/0000-0002-5043-9295; Lindholm, Anna K/0000-0001-8460-9769; Breden, Felix/0000-0001-9762-6314	Natural Sciences and Engineering Council of Canada; University of New South Wales; Field Museum of Natural History; National Geographic Society;  [163318]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of New South Wales; Field Museum of Natural History; National Geographic Society(National Geographic Society); 	The Natural Sciences and Engineering Council of Canada (www.nserc-crsng.gc.ca) provided funding through a postdoctoral fellowship to AL, and an operating grant to FB (#163318). Additional funding was provided by the University of New South Wales through a Vice-Chancellor's Postdoctoral Fellowship (AL; https://research.unsw.edu.au/unsw-internal-funding-opportunities#VC_Postdoc_Anchor), The Field Museum of Natural History (FB; www.fieldmuseum.org) and the National Geographic Society (FB; www.nationalgeographic.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; Andersson Malte, 1994; BERRY AJ, 1986, ECOL ENTOMOL, V11, P251, DOI 10.1111/j.1365-2311.1986.tb00301.x; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Breden F, 1999, ENVIRON BIOL FISH, V55, P449, DOI 10.1023/A:1007591926457; Breden F, 2011, ECOLOGY EVOLUTION PO; Dargent F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056789; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; FARR JA, 1976, EVOLUTION, V30, P707, DOI 10.1111/j.1558-5646.1976.tb00951.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Ford E.B., 1965, GENETIC POLYMORPHISM; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Hamilton A, 2001, MOL PHYLOGENET EVOL, V19, P277, DOI 10.1006/mpev.2000.0919; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; HASKINS CP, 1949, EVOLUTION, V3, P160, DOI 10.2307/2405550; HAZEL WN, 1990, HEREDITY, V65, P449, DOI 10.1038/hdy.1990.116; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; Hurtado-Gonzales JL, 2010, J EVOLUTION BIOL, V23, P1293, DOI 10.1111/j.1420-9101.2010.01995.x; Hurtado-Gonzales JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101497; Hurtado-Gonzales JL, 2009, ANIM BEHAV, V77, P1187, DOI 10.1016/j.anbehav.2008.12.032; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; KANESHIRO KY, 1976, EVOLUTION, V30, P740, DOI 10.1111/j.1558-5646.1976.tb00954.x; KANESHIRO KY, 1980, EVOLUTION, V34, P437, DOI 10.1111/j.1558-5646.1980.tb04833.x; Keith P, 2000, PATRIMOINES NATURELS, V43, P1; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Liley N. R., 1966, Behaviour Suppl, V13, P1; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; Lindholm AK, 2014, J EVOLUTION BIOL, V27, P437, DOI 10.1111/jeb.12313; Lindholm AK, 2004, HEREDITY, V92, P156, DOI 10.1038/sj.hdy.6800386; Lucinda Paulo Henrique Franco, 2005, Neotrop. ichthyol., V3, P1, DOI 10.1590/S1679-62252005000100001; Magurran AE, 2005, CURR BIOL, V15, pR867, DOI 10.1016/j.cub.2005.10.034; Magurran AE, 2004, ANIM BEHAV, V67, P1077, DOI 10.1016/j.anbehav.2003.10.010; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Meyer Manfred K., 1993, Zoologische Abhandlungen (Dresden), V47, P121; Morlon H, 2014, ECOL LETT, V17, P508, DOI 10.1111/ele.12251; R Development Core Team, 2014, R LANG ENV STAT COMP; Ravigne V, 2004, EVOL ECOL RES, V6, P125; REZNICK DN, 1992, COPEIA, P782, DOI 10.2307/1446155; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; Sandkam B, 2015, MOL ECOL, V24, P596, DOI 10.1111/mec.13058; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Torres-Dowdall J, 2013, BIOL J LINN SOC, V108, P790, DOI 10.1111/bij.12031; WINEMILLER KO, 1990, ENVIRON BIOL FISH, V29, P179, DOI 10.1007/BF00002218	55	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142089	10.1371/journal.pone.0142089	http://dx.doi.org/10.1371/journal.pone.0142089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529081	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000364032600099
J	Monnig, MA; Yeo, RA; Tonigan, JS; McCrady, BS; Thoma, RJ; Sabbineni, A; Hutchison, KE				Monnig, Mollie A.; Yeo, Ronald A.; Tonigan, J. Scott; McCrady, Barbara S.; Thoma, Robert J.; Sabbineni, Amithrupa; Hutchison, Kent E.			Associations of White Matter Microstructure with Clinical and Demographic Characteristics in Heavy Drinkers	PLOS ONE			English	Article							CHRONIC CIGARETTE-SMOKING; ALCOHOL-USE DISORDERS; CORPUS-CALLOSUM; MAGNETIC-RESONANCE; SPATIAL STATISTICS; GENDER-DIFFERENCES; HUMAN BRAIN; DIFFUSION; DEPENDENCE; INTEGRITY	Damage to the brain's white matter is a signature injury of alcohol use disorders (AUDs), yet understanding of risks associated with clinical and demographic characteristics is incomplete. This study investigated alcohol problem severity, recent drinking behavior, and demographic factors in relation to white matter microstructure in heavy drinkers. Magnetic resonance imaging (MRI) scans, including diffusion tensor imaging (DTI), were collected from 324 participants (mean age = 30.9 +/- 9.1 years; 30% female) who reported five or more heavy drinking episodes in the past 30 days. Drinking history and alcohol problem severity were assessed. A common white matter factor was created from fractional anisotropy (FA) values of five white matter tracts: body of corpus callosum, fornix, external capsule, superior longitudinal fasciculus, and cingulate gyrus. Previous research has implicated these tracts in heavy drinking. Structural equation modeling (SEM) analyses tested the hypothesis that, after controlling for duration of alcohol exposure, clinical and behavioral measures of alcohol use severity would be associated with lower white matter factor scores. Potential interactions with smoking status, gender, age, treatment-seeking status, and depression or anxiety symptoms also were tested. Controlling for number of years drinking, greater alcohol problem severity and recent drinking frequency were significantly associated with lower white matter factor scores. The effect of drinking frequency differed significantly for men and women, such that higher drinking frequency was linked to lower white matter factor scores in women but not in men. In conclusion, alcohol problem severity was a significant predictor of lower white matter FA in heavy drinkers, after controlling for duration of alcohol exposure. In addition, more frequent drinking contributed to lower FA in women but not men, suggesting gender-specific vulnerability to alcohol neurotoxicity.	[Monnig, Mollie A.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Yeo, Ronald A.; McCrady, Barbara S.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Tonigan, J. Scott; McCrady, Barbara S.] Ctr Alcoholism Subst Abuse & Addict, Albuquerque, NM USA; [Thoma, Robert J.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Sabbineni, Amithrupa; Hutchison, Kent E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Brown University; University of New Mexico; University of New Mexico; University of Colorado System; University of Colorado Boulder	Monnig, MA (corresponding author), Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA.	mollie_monnig@brown.edu; kent.hutchison@colorado.edu			NIAAA [F31AA021631, T32AA018108, 5T32AA007459, 5R01AA012238, 5R01AA014886]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA021631, T32AA018108, T32AA007459, R01AA014886, R01AA012238] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support for this project was provided by NIAAA individual predoctoral fellowship F31AA021631 (PI: Monnig) and institutional training grants T32AA018108 (PI: McCrady) and 5T32AA007459 (PI: Monti). Data were collected under NIAAA grants 5R01AA012238 and 5R01AA014886 (PI: Hutchison). The NIAAA website can be accessed at www.niaaa.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck A., 1993, BECK ANXIETY INVENTO; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Dawson DA, 2011, ALCOHOL RES HEALTH, V34, P144; Durazzo TC, 2014, ADDICT BIOL, V19, P132, DOI 10.1111/j.1369-1600.2012.00492.x; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gazdzinski S, 2008, ALCOHOL, V42, P67, DOI 10.1016/j.alcohol.2008.01.002; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; HEATHER N, 1993, J STUD ALCOHOL, V54, P700, DOI 10.15288/jsa.1993.54.700; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HOYLE RH, 1994, J CONSULT CLIN PSYCH, V62, P429, DOI 10.1037/0022-006X.62.3.429; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudkins M, 2012, PSYCHOPHARMACOLOGY, V221, P285, DOI 10.1007/s00213-011-2621-9; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kline TA, 2006, CONFIRMATORY FACTOR; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lin FC, 2013, DRUG ALCOHOL DEPEN, V129, P82, DOI 10.1016/j.drugalcdep.2012.09.013; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mann K, 2005, ALCOHOL CLIN EXP RES, V29, P896, DOI 10.1097/01.ALC.0000164376.69978.6B; Monnig MA, 2014, BRAIN BEHAV, V4, P158, DOI 10.1002/brb3.204; Monnig MA, 2013, PSYCHOL ADDICT BEHAV, V27, P455, DOI 10.1037/a0027168; Monnig MA, 2013, ADDICT BIOL, V18, P581, DOI 10.1111/j.1369-1600.2012.00441.x; Muthen, 2020, MPLUS DISCUSSION LAT; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Pfefferbaum A, 2001, AM J PSYCHIAT, V158, P188, DOI 10.1176/appi.ajp.158.2.188; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; ROSS HE, 1990, J STUD ALCOHOL, V51, P506, DOI 10.15288/jsa.1990.51.506; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Skinner H.A., 1984, ALCOHOL DEPENDENCE S; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sobell LC, 1992, ASSESSING ALCOHOL PR, P55; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Umene-Nakano W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087890; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012	54	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142042	10.1371/journal.pone.0142042	http://dx.doi.org/10.1371/journal.pone.0142042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529515	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600093
J	Patten, ML; Welchman, AE				Patten, Matthew L.; Welchman, Andrew E.			fMRI Activity in Posterior Parietal Cortex Relates to the Perceptual Use of Binocular Disparity for Both Signal-In-Noise and Feature Difference Tasks	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; STEREOSCOPIC DEPTH-PERCEPTION; ANTERIOR INTRAPARIETAL AREA; MIDDLE TEMPORAL AREA; HUMAN BRAIN; SURFACE-ORIENTATION; 3-DIMENSIONAL SHAPE; OBJECT SHAPE; 3D SHAPE; MOTION	Visually guided action and interaction depends on the brain's ability to (a) extract and (b) discriminate meaningful targets from complex retinal inputs. Binocular disparity is known to facilitate this process, and it is an open question how activity in different parts of the visual cortex relates to these fundamental visual abilities. Here we examined fMRI responses related to performance on two different tasks (signal-in-noise "coarse" and feature difference "fine" tasks) that have been widely used in previous work, and are believed to differentially target the visual processes of signal extraction and feature discrimination. We used multi-voxel pattern analysis to decode depth positions (near vs. far) from the fMRI activity evoked while participants were engaged in these tasks. To look for similarities between perceptual judgments and brain activity, we constructed 'fMR-metric' functions that described decoding performance as a function of signal magnitude. Thereafter we compared fMRmetric and psychometric functions, and report an association between judged depth and fMRI responses in the posterior parietal cortex during performance on both tasks. This highlights common stages of processing during perceptual performance on these tasks.	[Patten, Matthew L.; Welchman, Andrew E.] Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England; [Patten, Matthew L.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia; [Welchman, Andrew E.] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England	University of Birmingham; University of New South Wales Sydney; University of Cambridge	Welchman, AE (corresponding author), Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England.	aew69@cam.ac.uk		Welchman, Andrew/0000-0002-7559-3299	European Community [PITN-GA-2008-214728, PIIF-GA-2011-299610]; Wellcome Trust [095183/Z/10/Z]	European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The research leading to these results received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (grant agreements PITN-GA-2008-214728 and PIIF-GA-2011-299610) and the Wellcome Trust (095183/Z/10/Z).	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Ban H, 2015, J NEUROSCI, V35, P9823, DOI 10.1523/JNEUROSCI.1255-15.2015; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chang DHF, 2014, CURR BIOL, V24, P2445, DOI 10.1016/j.cub.2014.08.058; Chang DHF, 2013, J NEUROSCI, V33, P10962, DOI 10.1523/JNEUROSCI.0101-13.2013; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Cottereau BR, 2012, J NEUROSCI, V32, P826, DOI 10.1523/JNEUROSCI.2709-11.2012; Cottereau BR, 2011, J NEUROSCI, V31, P954, DOI 10.1523/JNEUROSCI.3795-10.2011; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 2005, P NATL ACAD SCI USA, V102, P5286, DOI 10.1073/pnas.0500492102; Dosher BA, 2013, P NATL ACAD SCI USA, V110, P13678, DOI 10.1073/pnas.1312552110; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Joachims T., 1999, ADV KERNEL METHODS S; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Minini L, 2010, J NEUROPHYSIOL, V104, P169, DOI 10.1152/jn.00790.2009; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NORCIA AM, 1985, VISION RES, V25, P1603, DOI 10.1016/0042-6989(85)90130-0; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2006, NEUROPSYCHOLOGIA, V44, P2647, DOI 10.1016/j.neuropsychologia.2005.11.001; Palanca BJA, 2003, J NEUROSCI, V23, P7647; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Popple AV, 1998, VISION RES, V38, P319, DOI 10.1016/S0042-6989(97)00166-1; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Shiozaki HM, 2012, J NEUROSCI, V32, P3830, DOI 10.1523/JNEUROSCI.5083-11.2012; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Theys T, 2012, J NEUROPHYSIOL, V107, P995, DOI 10.1152/jn.00248.2011; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; TYLER CW, 1990, VISION RES, V30, P1877, DOI 10.1016/0042-6989(90)90165-H; Tyler CW, 2005, CURR MED IMAGING REV, V1, P319, DOI 10.2174/157340505774574772; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189	68	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140696	10.1371/journal.pone.0140696	http://dx.doi.org/10.1371/journal.pone.0140696			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529314	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600011
J	Willemsen, I; Oome, S; Verhulst, C; Pettersson, A; Verduin, K; Kluytmans, J				Willemsen, Ina; Oome, Stijn; Verhulst, Carlo; Pettersson, Annika; Verduin, Kees; Kluytmans, Jan			Trends in Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae and ESBL Genes in a Dutch Teaching Hospital, Measured in 5 Yearly Point Prevalence Surveys (2010-2014)	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHICKEN MEAT; CTX-M; CARRIAGE; STRAINS; SPREAD; HUMANS	This paper describes the trends in prevalence of ESBL producing Enterobacteriaceae (ESBL-E) and ESBL genes, measured in five consecutive yearly Point Prevalence Surveys (PPS). All patients present in the hospital and in a day-care clinic (including patients on dialysis) on the day of the survey, were screened for perianal ESBL-E carriage. Perianal swabs were taken and cultured using an enrichment broth and a selective agar plate. Both phenotypic and genotypic methods were used to detect the production of ESBL, presence of ESBL-genes and clonal relatedness. Out of 2,695 patients, 135 (5.0%) were tested ESBL-E positive. The overall ESBL-E prevalence was stable over the years. Overall 5.2% of all ESBL-E were acquired by nosocomial transmission. A relative decrease of CTX-M-1-1-like ESBL genes (from 44 to 25%, p = 0.026) was observed, possibly related to the strong (>60%) decrease in antibiotic use in livestock in our country during the same period.	[Willemsen, Ina; Oome, Stijn; Verhulst, Carlo; Verduin, Kees; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Pettersson, Annika; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Amphia Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Willemsen, I (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	iwillemsen@amphia.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408				[Anonymous], 2014, MORT CANC HLTH GLANC, DOI 10.1787/health_glance_eur-2014-en; Bernards AT, 2012, NVMM GUIDELINE LAB D; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Kaier K, 2009, J ANTIMICROB CHEMOTH, V63, P609, DOI 10.1093/jac/dkn534; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; MARAN, 2014, MON ANT RES ANT US A; Mohammadi T, 2005, BRIT J HAEMATOL, V131, P403, DOI 10.1111/j.1365-2141.2005.05771.x; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Shitrit P, 2013, J HOSP INFECT, V85, P230, DOI 10.1016/j.jhin.2013.07.014; van Mansfeld R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158106; Willemsen I, 2008, INFECT CONT HOSP EP, V29, P1110, DOI 10.1086/592408; Willemsen I, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-26	15	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141765	10.1371/journal.pone.0141765	http://dx.doi.org/10.1371/journal.pone.0141765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528549	Green Published, gold			2022-12-27	WOS:000364032600055
J	Yu, D; Makkar, G; Dong, T; Strickland, DK; Sarkar, R; Monahan, TS				Yu, Dan; Makkar, George; Dong, Tuo; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey			MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27(kip1)-Dependent Mechanism	PLOS ONE			English	Article							UBIQUITIN-MEDIATED DEGRADATION; NEOINTIMAL HYPERPLASIA; INDIVIDUAL PROPENSITY; GENE-EXPRESSION; CDK INHIBITORS; SAPHENOUS-VEIN; CANCER CELLS; P27(KIP1); KINASE; GROWTH	Background Overexpression of the myristolated alanine-rich C kinase substrate (MARCKS) occurs in vascular proliferative diseases such as restenosis after bypass surgery. MARCKS knockdown results in arrest of vascular smooth muscle cell (VSMC) proliferation with little effect on endothelial cell (EC) proliferation. We sought to identify the mechanism of differential regulation by MARCKS of VSMC and EC proliferation in vitro and in vivo. Methods and Results siRNA-mediated MARCKS knockdown in VSMCs inhibited proliferation and prevented progression from phase G(0)/G(1) to S. Protein expression of the cyclin-dependent kinase inhibitor p27(kip1), but not p21(cip1) was increased by MARCKS knockdown. MARCKS knockdown did not affect proliferation in VSMCs derived from p27(kip1)-/- mice indicating that the effect of MARCKS is p27(kip1)-dependent. MARCKS knockdown resulted in decreased phosphorylation of p27(kip1) at threonine 187 and serine 10 as well as, kinase interacting with stathmin (KIS), cyclin D1, and Skp2 expression. Phosphorylation of p27(kip1) at serine 10 by KIS is required for nuclear export and degradation of p27(kip1). MARCKS knockdown caused nuclear trapping of p27(kip1). Both p27(kip1) nuclear trapping and cell cycle arrest were released by overexpression of KIS, but not catalytically inactive KIS. In ECs, MARCKS knockdown paradoxically increased KIS expression and cell proliferation. MARCKS knockdown in a murine aortic injury model resulted in decreased VSMC proliferation determined by bromodeoxyuridine (BrdU) integration assay, and inhibition of vascular wall thickening. MARCKS knockdown increased the rate of re-endothelialization. Conclusions MARCKS knockdown arrested VSMC cell cycle by decreasing KIS expression. Decreased KIS expression resulted in nuclear trapping of p27(kip1) in VSMCs. MARCKS knockdown paradoxically increased KIS expression in ECs resulting in increased EC proliferation. MARCKS knockdown significantly attenuated the VSMC proliferative response to vascular injury, but accelerated reestablishment of an intact endothelium. MARCKS is a novel translational target with beneficial cell type-specific effects on both ECs and VSMCs.	[Yu, Dan; Dong, Tuo; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Baltimore Vet Affairs Med Ctr, Dept Surg, Baltimore, MD 21201 USA; [Makkar, George; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Strickland, Dudley K.; Sarkar, Rajabrata] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Yu, Dan; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monahan, TS (corresponding author), Baltimore Vet Affairs Med Ctr, Dept Surg, Baltimore, MD 21201 USA.	tmonahan@smail.umaryland.edu			Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration [1IK2BX001553-01]; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells; Veterans Affairs [IK2BX001553] Funding Source: NIH RePORTER	Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells; Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration, (1IK2BX001553-01) TSM; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells, TSM.	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Brooks G, 1996, CARCINOGENESIS, V17, P683, DOI 10.1093/carcin/17.4.683; Browne BC, 2013, FEBS J, V280, P5237, DOI 10.1111/febs.12441; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castronuovo JJ, 2002, J VASC SURG, V35, P146, DOI 10.1067/mva.2002.119230; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Conte MS, 2013, J VASC SURG, V57, P1179, DOI 10.1016/j.jvs.2012.11.040; Disatnik MH, 2002, J CELL SCI, V115, P2151; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gardner-Thorpe J, 2002, BIOCHEM BIOPH RES CO, V293, P391, DOI 10.1016/S0006-291X(02)00237-1; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hayashi S, 2009, AM J PATHOL, V175, P2226, DOI 10.2353/ajpath.2009.090152; Hirai A, 1997, J BIOL CHEM, V272, P13; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Kalish JA, 2004, J VASC SURG, V39, P645, DOI 10.1016/j.jvs.2003.10.049; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lim Y, 2010, ATHEROSCLEROSIS, V210, P372, DOI 10.1016/j.atherosclerosis.2009.11.037; Manceau V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043946; Masaki T, 2005, INT J ONCOL, V26, P661; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173; Ohmitsu M, 1999, J BIOL CHEM, V274, P408, DOI 10.1074/jbc.274.1.408; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PANETTA TF, 1992, J VASC SURG, V16, P867; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Schonwasser DC, 1996, FEBS LETT, V395, P1; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Techasen A, 2010, CANCER SCI, V101, P658, DOI 10.1111/j.1349-7006.2009.01427.x; Tsui LV, 2001, CIRC RES, V89, P323, DOI 10.1161/hh1601.094482; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239; Wang XW, 2006, MED SCI MONITOR, V12, pRA177; Willis DJ, 2004, J SURG RES, V120, P27, DOI 10.1016/j.jss.2003.12.014; Wysokinski W, 2008, THROMB RES, V122, P390, DOI 10.1016/j.thromres.2007.10.010; Wysokinski WE, 1999, ARTERIOSCL THROM VAS, V19, P883, DOI 10.1161/01.ATV.19.4.883; Ye WZ, 2007, HISTOCHEM CELL BIOL, V127, P195, DOI 10.1007/s00418-006-0238-6; Yu D, 2012, ONCOGENE, V31, P3561, DOI 10.1038/onc.2011.509	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141397	10.1371/journal.pone.0141397	http://dx.doi.org/10.1371/journal.pone.0141397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528715	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600026
J	den Heijer, AE; Groen, Y; Fuermaier, ABM; van Heuvelen, MJG; van der Zee, EA; Tucha, L; Tucha, O				den Heijer, Anne E.; Groen, Yvonne; Fuermaier, Anselm B. M.; van Heuvelen, Marieke J. G.; van der Zee, Eddy A.; Tucha, Lara; Tucha, Oliver			Acute Effects of Whole Body Vibration on Inhibition in Healthy Children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DOPAMINE; EXERCISE; ADHD; THERAPY; SLEEP	Objectives Whole Body Vibration (WBV) is a passive exercise method known to have beneficial effects on various physical measures. Studies on adults furthermore demonstrated beneficial effects of WBV treatment on cognition (e.g. inhibition). The present study replicated these findings in healthy children and examined acute effects of WBV treatment on inhibition. Methods Fifty-five healthy children (aged 8-13) participated in this within-subject design study. WBV treatment was applied by having the children sit on a chair mounted to a vibrating platform. After each condition (vibration vs. non-vibration), inhibition was measured by using the Stroop Color-Word Interference Test. Repeated measures analyses were applied in order to explore the effects of WBV treatment on inhibition, and correlations were computed between the treatment effect and participant characteristics in order to explore individual differences in treatment sensitivity. Results Three-minute WBV treatments had significant beneficial effects on inhibition in this sample of healthy children. Especially the repeated application (three times) of WBV treatment appeared beneficial for cognition. Stronger WBV treatment effects were correlated with higher intelligence and younger age, but not with symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Conclusions This study demonstrates that especially repeated WBV treatment improves inhibition in healthy children. As this cognitive function is often impaired in children with developmental disorders (e.g. ADHD), future studies should further explore the effects, working mechanism and potential applicability of WBV treatment for this target group.	[den Heijer, Anne E.; Groen, Yvonne; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver] Univ Groningen, Clin & Dev Neuropsychol, Groningen, Netherlands; [van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	den Heijer, AE (corresponding author), Univ Groningen, Clin & Dev Neuropsychol, Groningen, Netherlands.	a.e.den.heijer@rug.nl	Tucha, Oliver/AAD-1403-2019; van der Zee, Eddy/AAZ-2120-2020	Groen, Yvonne/0000-0002-7242-0317; Fuermaier, Anselm/0000-0002-2331-0840				Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; APA, 1994, DIAGN STAT MAN MENT; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Bishop DVM, 2007, J PAEDIATR CHILD H, V43, P653, DOI 10.1111/j.1440-1754.2007.01225.x; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Buitelaar J, 2010, EUR CHILD ADOLES PSY, V19, P325, DOI 10.1007/s00787-009-0056-1; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; Chang YK, 2012, ARCH CLIN NEUROPSYCH, V27, P225, DOI 10.1093/arclin/acr094; Cochrane DI, 2008, ARCH PHYS MED REHAB, V89, P815, DOI 10.1016/j.apmr.2007.09.055; Cohen J., 1988, AM EDUC; Da Cunha Sa-Caputo D., 2014, PUBLIC HLTH RES, V4, P136; dela Pena I, 2013, ARCH PHARM RES, V36, P400, DOI 10.1007/s12272-013-0037-2; Duan X., 2010, PSYCHOL TEST ASSESSM, V52, P419, DOI DOI 10.1044/2F2016_JSLHR-L-15-0310; Dunn W., 1999, SENSORY PROFILES USE; Fuermaier A.B.M., 2014, WHOLE BODY VIBRATION; Fuermaier ABM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090747; Geissler J, 2011, EXPERT REV NEUROTHER, V11, P1467, DOI [10.1586/ERN.11.136, 10.1586/ern.11.136]; Groen Y., UNPUB; Halperin JM, 2012, NEUROTHERAPEUTICS, V9, P531, DOI 10.1007/s13311-012-0123-z; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Huang CLC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095014; Ishihara S., 1917, TESTS COLOR BLINDNES; Keijser N., 2011, 9 DUTCH END ENP M, P125; Kim H, 2011, NEUROSCI LETT, V504, P35, DOI 10.1016/j.neulet.2011.08.052; Lahr M. M. H., 2009, 8 DUTCH END M; Lam FMH, 2012, MATURITAS, V72, P206, DOI 10.1016/j.maturitas.2012.04.009; Matute-Llorente A, 2014, J ADOLESCENT HEALTH, V54, P385, DOI 10.1016/j.jadohealth.2013.11.001; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Myers KA, 2014, PEDIATR NEUROL, V51, P126, DOI 10.1016/j.pediatrneurol.2014.03.005; Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549; Pesce C, 2009, EXERCISE COGNITIVE F, P211, DOI [DOI 10.1002/9780470740668.CH11, 10.1002/9780470740668.ch11]; Pinto N, 2010, J MED MED SCI, V2; Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506; Santos Filho S. D., 2014, British Journal of Medicine and Medical Research, V4, P1539; Scholte E. M., 1998, HANDLEIDING VRAGENLI; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Soderpalm AC, 2013, J MUSCULOSKEL NEURON, V13, P13; Sonuga-Barke EJS, 2009, J CHILD ADOL PSYCHOP, V19, P683, DOI 10.1089/cap.2009.0024; Stein MA, 2003, PEDIATRICS, V112, pE404, DOI 10.1542/peds.112.5.e404; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Timmer M, 2006, FEDERATION EUROPEAN; Van der Heijden KB, 2006, J SLEEP RES, V15, P55; Van der Zee E. A., 2010, FEDERATION EUROPEAN; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	57	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140665	10.1371/journal.pone.0140665	http://dx.doi.org/10.1371/journal.pone.0140665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524188	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800004
J	Canfran-Duque, A; Pastor, O; Reina, M; Lerma, M; Cruz-Jentoft, AJ; Lasuncion, MA; Busto, R				Canfran-Duque, Alberto; Pastor, Oscar; Reina, Manuel; Lerma, Milagros; Cruz-Jentoft, Alfonso J.; Lasuncion, Miguel A.; Busto, Rebeca			Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In Vitro	PLOS ONE			English	Article							LIPOGENIC GENE-EXPRESSION; INDUCED ACTIVATION; LDL RECEPTOR; CHOLESTEROL; MECHANISM; HALOPERIDOL; TRAFFICKING; DRUGS; INHIBITION; SECRETION	Scope First-and second-generation antipsychotics (FGAs and SGAs, respectively), both inhibit cholesterol biosynthesis and impair the intracellular cholesterol trafficking, leading to lipid accumulation in the late endosome/lysosome compartment. In this study we examined if curcumin, a plant polyphenol that stimulates exosome release, can alleviate antipsychoticinduced intracellular lipid accumulation. Methods HepG2 hepatocarcinoma cells were treated with antipsychotics or placebo and DiI-labelled LDL for 18 h and then exposed to curcumin for the last 2 h. Cells and media were collected separately and used for biochemical analyses, electron microscopy and immunocytochemistry. Exosomes were isolated from the incubation medium by ultracentrifugation. Results Curcumin treatment reduced the number of heterolysosomes and shifted their subcellular localization to the periphery, as revealed by electron microscopy, and stimulated the release of lysosomal beta-hexosaminidase and exosome markers flotillin-2 and CD63 into the media. The presence of DiI in exosomes released by cells preloaded with DiI-LDL demonstrated the endolysosomal origin of the microvesicles. Furthermore, curcumin increased the secretion of cholesterol as well as LDL-derived DiI and [H-3]-cholesterol, in association with a decrease of intracellular lipids. Thus, the disruption of lipid trafficking induced by FGAs or SGAs can be relieved by curcumin treatment. This polyphenol, however, did not mitigate the reduction of cholesterol esterification induced by antipsychotics. Conclusion Curcumin stimulates exosome release to remove cholesterol (and presumably other lipids) accumulated within the endolysosomal compartment, thereby normalizing intracellular lipid homeostasis. This action may help minimize the adverse metabolic effects of antipsychotic treatment, which should now be evaluated in clinical trials.	[Canfran-Duque, Alberto; Lerma, Milagros; Lasuncion, Miguel A.; Busto, Rebeca] Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Invest, Madrid, Spain; [Pastor, Oscar] Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Clin, Madrid, Spain; [Reina, Manuel] Univ Barcelona, Dept Cell Biol, Celltec UB, Barcelona, Spain; [Cruz-Jentoft, Alfonso J.] Hosp Univ Ramon & Cajal, IRyCIS, Unidad Geriatria, Madrid, Spain; [Lasuncion, Miguel A.; Busto, Rebeca] Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; University of Barcelona; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Lasuncion, MA (corresponding author), Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Invest, Madrid, Spain.	miguel.a.lasuncion@hrc.es; rebeca.busto@hrc.es	PASTOR, OSCAR/ABD-6831-2020; Lasunción, Miguel A./K-6167-2014; Cruz-Jentoft, Alfonso J/G-2675-2015; Reina, Manuel/D-4655-2014	PASTOR, OSCAR/0000-0002-4368-433X; Lasunción, Miguel A./0000-0003-0299-9391; Cruz-Jentoft, Alfonso J/0000-0001-7628-4861; Reina, Manuel/0000-0002-0701-200X; Busto, Rebeca/0000-0001-9869-4087	Ministerio de Ciencia e Innovacion, Spain [SAF2011-29951]; Comunidad de Madrid, Madrid, Spain [ALIBIRD S2013/ABI-2728]; Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA Investigacion Basica), Spain; Instituto de Salud Carlos III (CIBERobn), Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid, Madrid, Spain(Comunidad de Madrid); Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA Investigacion Basica), Spain; Instituto de Salud Carlos III (CIBERobn), Spain	This work was funded by Ministerio de Ciencia e Innovacion (SAF2011-29951), (http://www.mineco.gob.es/portal/site/mineco/), Spain, to MAL; Comunidad de Madrid (Program ALIBIRD S2013/ABI-2728), (http://www.madrid.org/; http://www.alibird.org/), Madrid, Spain, to MAL; Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA 2014 Investigacion Basica), (http://www.searteriosclerosis.org/), Spain, to RB; Instituto de Salud Carlos III (CIBERobn, http://www.ciberobn.es/), (http://www.isciii.es/), Spain, to MAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Baum L, 2007, PHARMACOL RES, V56, P509, DOI 10.1016/j.phrs.2007.09.013; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Bishnoi M, 2008, PHARMACOL BIOCHEM BE, V88, P511, DOI 10.1016/j.pbb.2007.10.009; Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4; Calvo D, 1998, J LIPID RES, V39, P777; Canfran-Duque A, 2014, MOL NUTR FOOD RES, V58, P687, DOI 10.1002/mnfr.201300350; Canfran-Duque A, 2013, J LIPID RES, V54, P310, DOI 10.1194/jlr.M026948; Chamorro L, 2013, CLIN CHIM ACTA, V421, P132, DOI 10.1016/j.cca.2013.02.007; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Dong SZ, 2011, MOL CELL BIOCHEM, V358, P281, DOI 10.1007/s11010-011-0978-z; Fan CL, 2006, PHARMACOL REP, V58, P577; Ferno J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-69; Ferno J, 2011, FRONT BIOSCI-LANDMRK, V16, P49, DOI 10.2741/3675; Ghislat G, 2013, CURR PROTEIN PEPT SC, V14, P97, DOI 10.2174/13892037112139990033; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guenette MD, 2014, DRUG AGING, V31, P159, DOI 10.1007/s40266-014-0152-x; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kang QH, 2009, BRIT J PHARMACOL, V157, P1354, DOI 10.1111/j.1476-5381.2009.00261.x; Kristiana I, 2010, PHARMACOGENOMICS J, V10, P396, DOI 10.1038/tpj.2009.62; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Sanchez-Wandelmer J, 2010, NEUROSCIENCE, V167, P143, DOI 10.1016/j.neuroscience.2010.01.051; Sanchez-Wandelmer J, 2009, J NEUROCHEM, V110, P631, DOI 10.1111/j.1471-4159.2009.06159.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shakor ABA, 2014, BBA-MOL CELL BIOL L, V1841, P1672, DOI 10.1016/j.bbalip.2014.09.006; Shin SK, 2011, MOL NUTR FOOD RES, V55, P1829, DOI 10.1002/mnfr.201100440; Singla N, 2012, NEUROTOX RES, V22, P115, DOI 10.1007/s12640-011-9307-2; Skrede S, 2013, J LIPID RES, V54, P307, DOI 10.1194/jlr.E034736; Sookram C, 2011, SYNAPSE, V65, P788, DOI 10.1002/syn.20905; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Suarez Y, 2004, CARDIOVASC RES, V64, P346, DOI 10.1016/j.cardiores.2004.06.024; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Um MY, 2013, BASIC CLIN PHARMACOL, V113, P152, DOI 10.1111/bcpt.12076; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; XU QB, 1992, BIOCHEM J, V285, P105, DOI 10.1042/bj2850105; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	49	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141829	10.1371/journal.pone.0141829	http://dx.doi.org/10.1371/journal.pone.0141829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517556	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800083
J	Chauhan, A; Weiss, H; Koch, F; Ibrahim, SM; Vera, J; Wolkenhauer, O; Tiedge, M				Chauhan, Anuradha; Weiss, Heike; Koch, Franziska; Ibrahim, Saleh M.; Vera, Julio; Wolkenhauer, Olaf; Tiedge, Markus			Dissecting Long-Term Glucose Metabolism Identifies New Susceptibility Period for Metabolic Dysfunction in Aged Mice	PLoS One			English	Article							INSULIN REGULATORY SYSTEM; BODY-WEIGHT; ENERGY-BALANCE; MATHEMATICAL-MODELS; ADIPOSE-TISSUE; PLASMA LEPTIN; SECRETION; OBESITY; ACCUMULATION; HOMEOSTASIS	Metabolic disorders, like diabetes and obesity, are pathogenic outcomes of imbalance in glucose metabolism. Nutrient excess and mitochondrial imbalance are implicated in dysfunctional glucose metabolism with age. We used conplastic mouse strains with defined mitochondrial DNA (mtDNA) mutations on a common nuclear genomic background, and administered a high-fat diet up to 18 months of age. The conplastic mouse strain B6-mt(FVB), with a mutation in the mt-Atp8 gene, conferred beta-cell dysfunction and impaired glucose tolerance after high-fat diet. To our surprise, despite of this functional deficit, blood glucose levels adapted to perturbations with age. Blood glucose levels were particularly sensitive to perturbations at the early age of 3 to 6 months. Overall the dynamics consisted of a peak between 3-6 months followed by adaptation by 12 months of age. With the help of mathematical modeling we delineate how body weight, insulin and leptin regulate this non-linear blood glucose dynamics. The model predicted a second rise in glucose between 15 and 21 months, which could be experimentally confirmed as a secondary peak. We therefore hypothesize that these two peaks correspond to two sensitive periods of life, where perturbations to the basal metabolism can mark the system for vulnerability to pathologies at later age. Further mathematical modeling may perspectively allow the design of targeted periods for therapeutic interventions and could predict effects on weight loss and insulin levels under conditions of pre-diabetic obesity.	[Chauhan, Anuradha; Vera, Julio; Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, Inst Comp Sci, D-18055 Rostock, Germany; [Chauhan, Anuradha; Vera, Julio; Wolkenhauer, Olaf] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Weiss, Heike; Koch, Franziska; Tiedge, Markus] Univ Rostock, Dept Med Biochem & Mol Biol, D-18055 Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Inst Expt Dermatol, D-23538 Lubeck, Germany	University of Rostock; Stellenbosch University; University of Rostock; University of Lubeck	Tiedge, M (corresponding author), Univ Rostock, Dept Med Biochem & Mol Biol, D-18055 Rostock, Germany.	markus.tiedge@med.uni-rostock.de	Koch, Franziska/AAF-2159-2021; Ibrahim, Saleh/AAO-9541-2020; Vera, Julio/O-4134-2015	Ibrahim, Saleh/0000-0001-7827-2290; Koch, Franziska/0000-0002-1798-5374; Vera, Julio/0000-0002-3076-5122	Bundesministerium fur Bildung und Forschung [0315892A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Support was provided by Bundesministerium fur Bildung und Forschung (Grant number: 0315892A) to JV and OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, METABOLISM, V46, P1477, DOI 10.1016/S0026-0495(97)90152-9; ALPERT SS, 1990, AM J CLIN NUTR, V52, P784, DOI 10.1093/ajcn/52.5.784; ANTONETTI VW, 1973, AM J CLIN NUTR, V26, P64, DOI 10.1093/ajcn/26.1.64; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Boutayeb A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-43; BROCK N, 1961, ARZNEIMITTELFORSCH, V11, P1071; Cammisotto PG, 2002, AM J PHYSIOL-CELL PH, V283, pC244, DOI 10.1152/ajpcell.00033.2002; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Cobelli Claudio, 2009, IEEE Rev Biomed Eng, V2, P54, DOI 10.1109/RBME.2009.2036073; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Johannesson B, 2015, EMBO J; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Kozusko FP, 2001, B MATH BIOL, V63, P393, DOI 10.1006/bulm.2001.0229; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Livingston EH, 2001, J SURG RES, V101, P216, DOI 10.1006/jsre.2001.6286; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Malmstrom R, 1996, DIABETOLOGIA, V39, P993; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pattaranit R, 2008, J R SOC INTERFACE, V5, P1119, DOI 10.1098/rsif.2008.0216; PAYNE PR, 1977, ANN HUM BIOL, V4, P525, DOI 10.1080/03014467700002521; Sainsbury A, 1996, DIABETOLOGIA, V39, P353; Scheen AJ, 2005, DIABETES METAB, V31, pS27; SCHRAER WD, 1999, BIOL STUDY LIFE; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sethumadhavan S, 2012, J BIOL CHEM, V287, P22174, DOI 10.1074/jbc.M111.327866; Shimizu H, 1997, PEPTIDES, V18, P1263, DOI 10.1016/S0196-9781(97)00137-X; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Thorens B, 2008, INT J OBESITY, V32, pA62, DOI 10.1038/ijo.2008.208; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; WOLFF SP, 1992, NATURE, V356, P375, DOI 10.1038/356375a0; Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108; Zhou B, 2012, P NATL ACAD SCI USA, V109, pE1201, DOI 10.1073/pnas.1119304109	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140858	10.1371/journal.pone.0140858	http://dx.doi.org/10.1371/journal.pone.0140858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540285	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800006
J	Huet, S; Gorre, H; Perrocheau, A; Picot, J; Cinier, M				Huet, Simon; Gorre, Harmony; Perrocheau, Anaelle; Picot, Justine; Cinier, Mathieu			Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion Tag	PLOS ONE			English	Article							DNA-BINDING PROTEIN; RIBOSOME DISPLAY; SYSTEM; SAC7D; SELECTION; PCR; POLYMERASES; EXPRESSION; ANTIBODIES; EVOLUTION	With the continuous diversification of recombinant DNA technologies, the possibilities for new tailor-made protein engineering have extended on an on-going basis. Among these strategies, the use of the green fluorescent protein (GFP) as a fusion domain has been widely adopted for cellular imaging and protein localization. Following the lead of the direct head-to-tail fusion of GFP, we proposed to provide additional features to recombinant proteins by genetic fusion of artificially derived binders. Thus, we reported a GFP-ready fusion tag consisting of a small and robust fusion-friendly anti-GFP Nanofitin binding domain as a proof-of-concept. While limiting steric effects on the carrier, the GFP-ready tag allows the capture of GFP or its blue (BFP), cyan (CFP) and yellow (YFP) alternatives. Here, we described the generation of the GFP-ready tag from the selection of a Nanofitin variant binding to the GFP and its spectral variants with a nanomolar affinity, while displaying a remarkable folding stability, as demonstrated by its full resistance upon thermal sterilization process or the full chemical synthesis of Nanofitins. To illustrate the potential of the Nanofitin-based tag as a fusion partner, we compared the expression level in Escherichia coli and activity profile of recombinant human tumor necrosis factor alpha (TNF alpha) constructs, fused to a SUMO or GFP-ready tag. Very similar expression levels were found with the two fusion technologies. Both domains of the GFP-ready tagged TNFa were proved fully active in ELISA and interferometry binding assays, allowing the simultaneous capture by an antiTNFa antibody and binding to the GFP, and its spectral mutants. The GFP-ready tag was also shown inert in a L929 cell based assay, demonstrating the potent TNFa mediated apoptosis induction by the GFP-ready tagged TNFa. Eventually, we proposed the GFP-ready tag as a versatile capture and labeling system in addition to expected applications of antiGFP Nanofitins (as illustrated with previously described state-of-the-art anti-GFP binders applied to living cells and in vitro applications). Through a single fusion domain, the GFPready tagged proteins benefit from subsequent customization within a wide range of fluorescence spectra upon indirect binding of a chosen GFP variant.	[Huet, Simon; Gorre, Harmony; Perrocheau, Anaelle; Picot, Justine; Cinier, Mathieu] Affilogic SAS, Nantes, France		Cinier, M (corresponding author), Affilogic SAS, Nantes, France.	mathieu@affilogic.com	Homolka, Miloslav/F-9649-2014	Homolka, Miloslav/0000-0001-9650-1288	Affilogic SAS, Nantes, France	Affilogic SAS, Nantes, France	Affilogic SAS, Nantes, France, provided financial support in the form of salaries for authors SH HG AP JP MC, and participated in study design, conducted the study, and provided data collection, management and interpretation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The specific roles of the authors are articulated in the 'author contributions' section. Funder's website: http://www.affilogic.com/.	Behar G, 2013, PROTEIN ENG DES SEL, P1; Behar G, 2014, J BIOTECHNOL, V192, P123, DOI 10.1016/j.jbiotec.2014.10.006; Brauchle M, 2014, BIOL OPEN, V3, P1252, DOI 10.1242/bio.201410041; Buddelmeijer N, 2009, J BACTERIOL, V191, P161, DOI 10.1128/JB.01138-08; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chevrel A, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150080; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cinier M, 2012, J BIOL INORG CHEM, V17, P399, DOI 10.1007/s00775-011-0863-y; Cinier M, 2009, BIOCONJUGATE CHEM, V20, P2270, DOI 10.1021/bc9002597; Correa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097438; Ekblad T, 2009, BIOPOLYMERS, V92, P116, DOI 10.1002/bip.21142; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; GELLERT M, 1967, P NATL ACAD SCI USA, V57, P148, DOI 10.1073/pnas.57.1.148; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Herce HD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3660; Hoffmann A, 2010, PROTEIN EXPRES PURIF, V72, P238, DOI 10.1016/j.pep.2010.03.022; Hussain M, 2013, BIOTECHNOL PROGR, V29, P237, DOI 10.1002/btpr.1655; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Krehenbrink M, 2008, J MOL BIOL, V383, P1058, DOI 10.1016/j.jmb.2008.09.016; Lee JI, 2010, ENZYME MICROB TECH, V47, P147, DOI 10.1016/j.enzmictec.2010.06.003; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105078; MCAFEE JG, 1995, BIOCHEMISTRY-US, V34, P10063, DOI 10.1021/bi00031a031; Miranda FF, 2011, BIOSENS BIOELECTRON, V26, P4184, DOI 10.1016/j.bios.2011.04.030; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Mouratou B, 2012, METHODS MOL BIOL, V805, P315, DOI 10.1007/978-1-61779-379-0_18; Pacheco S, 2014, PROTEIN ENG DES SEL, V27, P431, DOI 10.1093/protein/gzu042; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Ppyun H, 2013, J BIOTECHNOL, V164, P363, DOI 10.1016/j.jbiotec.2013.01.022; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Schaffitzel C, 2001, PROTEINPROTEIN INTER, P535; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Skrlec K, 2015, TRENDS BIOTECHNOL, V33, P408, DOI 10.1016/j.tibtech.2015.03.012; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Varga I, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-569; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; WEISS B, 1967, P NATL ACAD SCI USA, V57, P1021, DOI 10.1073/pnas.57.4.1021; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu SW, 2005, PROTEINS, V60, P617, DOI 10.1002/prot.20524; Yang JM, 2004, J BIOMOL STRUCT DYN, V21, P513, DOI 10.1080/07391102.2004.10506945	51	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142304	10.1371/journal.pone.0142304	http://dx.doi.org/10.1371/journal.pone.0142304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539718	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800079
J	Song, YJ; Lim, J; Park, WS; Sohn, H; Lee, MS; Shin, DH; Kim, CB; Kim, H; Oh, GJ; Ki, M				Song, Yeong-Jun; Lim, Jiseun; Park, Woong-Sub; Sohn, Haesook; Lee, Moo-Sik; Shin, Dong-Hoon; Kim, Chun-Bae; Kim, Hwasung; Oh, Gyung-Jae; Ki, Moran			Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus	PLOS ONE			English	Article							ANTIBODY-RESPONSE; IMMUNOGENICITY; VIROSOME; BOOSTER; EPAXAL(R); VACCINES; SAFETY; FEVER	We previously observed 80.7% seropositivity and a significant interaction between gender and hepatitis A virus (HAV) vaccine type (Havrix vs. Epaxal) on the seropositivity approximately 11 months after single-dose HAV vaccinations in Korean young adults. Our objective was to evaluate seropositivity approximately 2 years after a single-dose HAV vaccination and the influence of demographic characteristics on seropositivity, including the interaction between gender and vaccine type. Seronegative medical school students were randomly vaccinated with Havrix or Epaxal. Based on a total serum anti-HAV antibody titer cutoff of 20 IU/ mL, 338 participants (76.0%) of the 445 vaccinees were seropositive 20-25 months after a single-dose HAV vaccination. The seropositive rates were similar after vaccination with Havrix (77.0%) and Epaxal (74.9%). Univariate analysis indicated that female (p = 0.052) and less obese (p < 0.001) participants had a higher seropositive rate, whereas other characteristics such as age, alcohol use, smoking history, vaccine type, and follow-up duration were not associated with seropositivity. Multivariate analysis indicated that women (p = 0.026) and participants with moderate alcohol use (p < 0.001) showed significantly higher seropositive rates than men and participants with no or low alcohol use, respectively. The seropositive rates after vaccination with Havrix and Epaxal were 70.9% and 67.5% in men and 87.7% and 91.3% in women, respectively (p for interaction = 0.304). Compared with the seropositive rate approximately 11 months after vaccination, the seropositive rate decreased substantially only in men in the Havrix group (11.0% points), and consequently, the interaction between gender and vaccine type disappeared while seropositivity remained high (87.7% and 91.3% in Havrix and Epaxal groups, respectively) among women approximately 2 years after vaccination. Further studies are needed to assess whether the seropositive rate would be maintained in all groups more than 2 years after a single-dose HAV vaccination.	[Song, Yeong-Jun; Lim, Jiseun] Eulji Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Park, Woong-Sub] Kwandong Univ, Dept Prevent Med & Publ Hlth, Coll Med, Kangnung, South Korea; [Sohn, Haesook] Inje Univ, Sch Med, Dept Prevent Med, Busan, South Korea; [Lee, Moo-Sik] Konyang Univ, Dept Prevent Med, Coll Med, Daejeon, South Korea; [Shin, Dong-Hoon] Keimyung Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Kim, Chun-Bae] Yonsei Univ, Wonju Coll Med, Inst Poverty Alleviat & Int Dev, Dept Prevent Med, Wonju, South Korea; [Kim, Hwasung] Soonchunhyang Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Oh, Gyung-Jae] Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan, South Korea; [Ki, Moran] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea	Eulji University; Catholic Kwandong University; Inje University; Konyang University; Konyang University Hospital; Keimyung University; Yonsei University; Soonchunhyang University; Wonkwang University; National Cancer Center - Korea (NCC)	Ki, M (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, South Korea.	moranki@naver.com	Ki, Moran/R-6600-2019	Ki, Moran/0000-0002-8892-7104	National Research Foundation of Korea (KR) [2010-0022066]	National Research Foundation of Korea (KR)	This work was funded by National Research Foundation of Korea (KR) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none), grant number 2010-0022066, to MK.	Ambrosch F, 2004, INFECTION, V32, P149, DOI 10.1007/s15010-004-3147-4; Baber TF H-BJ, 2001, ALCOHOL USE DISORDER; Beck BR, 2003, CLIN INFECT DIS, V37, pE126, DOI 10.1086/378890; Bovier PA, 1999, J TRAVEL MED, V6, P228, DOI 10.1111/j.1708-8305.1999.tb00523.x; Chun Sung-Soo, 2005, J Prev Med Public Health, V38, P307; D'Acremont V, 2006, J TRAVEL MED, V13, P78, DOI 10.1111/j.1708-8305.2006.00001.x; Hatz C, 2011, CLIN VACCINE IMMUNOL, V18, P885, DOI 10.1128/CVI.00358-10; Holzer BR, 1996, VACCINE, V14, P982, DOI 10.1016/0264-410X(96)00042-4; Kim SS, 2008, ARCH PSYCHIAT NURS, V22, P190, DOI 10.1016/j.apnu.2007.07.005; Landry P, 2000, VACCINE, V19, P399, DOI 10.1016/S0264-410X(00)00188-2; Lim J, 2014, YONSEI MED J, V55, P126, DOI 10.3349/ymj.2014.55.1.126; Maiwald H, 1997, VACCINE, V15, P346, DOI 10.1016/S0264-410X(97)00211-9; Ott JJ, 2013, INT J INFECT DIS, V17, pE939, DOI 10.1016/j.ijid.2013.04.012; Overbosch D, 2005, J TRAVEL MED, V12, P319, DOI 10.2310/7060.2005.12604; Park SH, 2012, SUBST ABUS, V33, P327, DOI 10.1080/08897077.2012.662209; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC	16	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142297	10.1371/journal.pone.0142297	http://dx.doi.org/10.1371/journal.pone.0142297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540392	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800077
J	Goh, S; Han, K; Ryu, J; Kim, S; Choi, M				Goh, Segun; Han, Kyungreem; Ryu, Jehkwang; Kim, Seonjin; Choi, MooYoung			Failure of Arm Movement Control in Stroke Patients, Characterized by Loss of Complexity	PLOS ONE			English	Article							PHYSIOLOGICAL TIME-SERIES; THEORETICAL-MODEL; POSTURAL TREMOR; ENTROPY; NETWORK; NONLINEARITY; TRANSITIONS; DYNAMICS	We study the mechanism of human arm-posture control by means of nonlinear dynamics and quantitative time series analysis methods. Utilizing linear and nonlinear measures in combination, we find that pathological tremors emerge in patient dynamics and serve as a main feature discriminating between normal and patient groups. The deterministic structure accompanied with loss of complexity inherent in the tremor dynamics is also revealed. To probe the underlying mechanism of the arm-posture dynamics, we further analyze the coupling patterns between joints and components, and discuss their roles in breaking of the organization structure. As a result, we elucidate the mechanisms in the arm-posture dynamics of normal subjects responding to the gravitational force and for the reduction of the dynamic degrees of freedom in the patient dynamics. This study provides an integrated framework for the origin of the loss of complexity in the dynamics of patients as well as the coupling structure in the arm-posture dynamics.	[Goh, Segun; Han, Kyungreem; Choi, MooYoung] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Goh, Segun; Han, Kyungreem; Choi, MooYoung] Seoul Natl Univ, Ctr Theoret Phys, Seoul 151747, South Korea; [Ryu, Jehkwang] Seoul Natl Univ, Coll Humanities, Inst Cognit Sci, Seoul 151742, South Korea; [Kim, Seonjin] Seoul Natl Univ, Dept Phys Educ, Seoul 151748, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, M (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea.	mychoi@snu.ac.kr	Goh, Segun/E-5471-2018	Goh, Segun/0000-0003-3027-8815; Choi, MooYoung/0000-0001-8070-7716	National Research Foundation of Korea [2012R1A2A4A01004419, 2011-0012331, 2014R1A6A3A01059467, 2010-0021103]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea, through grants 2012R1A2A4A01004419 and 2011-0012331 (MYC), 2014R1A6A3A01059467 (SG), and 2010-0021103 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; BOCK O, 1990, BEHAV BRAIN RES, V41, P167, DOI 10.1016/0166-4328(90)90106-O; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Cantu H, 2014, HUM MOVEMENT SCI, V35, P1, DOI 10.1016/j.humov.2014.02.003; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HARWELL R C, 1983, Microsurgery, V4, P187, DOI 10.1002/micr.1920040310; Hirose A, 2008, NEURAL INFORM PROCES; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; James EG, 2013, HUM MOVEMENT SCI, V32, P147, DOI 10.1016/j.humov.2012.11.003; Kantz H., 2005, NONLINEAR TIME SERIE, V2nd; Lakie M, 2010, EXP PHYSIOL, V95, P441, DOI 10.1113/expphysiol.2009.047555; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Morrison S, 2008, PARKINSONISM RELAT D, V14, P298, DOI 10.1016/j.parkreldis.2007.09.004; Patzelt F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238103; Pellegrini B, 2004, J NEUROSCI METH, V139, P185, DOI 10.1016/j.jneumeth.2004.04.025; Renyi A., 1961, MEASURES ENTROPY INF; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ryu J, 2011, J SPORT EXERCISE PSY, V33, pS106; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shen Y, 2003, CLIN NEUROPHYSIOL, V114, P199, DOI 10.1016/S1388-2457(02)00338-3; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Takens F, 1981, DYNAMICAL SYSTEMS TU; TASS P, 1995, J BIOL PHYS, V21, P83, DOI 10.1007/BF00705593; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yao W, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021902	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141996	10.1371/journal.pone.0141996	http://dx.doi.org/10.1371/journal.pone.0141996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536132	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400115
J	Stowe, C; Pizzey, A; Kalber, T; Badar, A; Lythgoe, M; Pule, M				Stowe, Cassandra; Pizzey, Arnold; Kalber, Tammy; Badar, Adam; Lythgoe, Mark; Pule, Martin			Flow-Based Single Cell Deposition for High-Throughput Screening of Protein Libraries	PLOS ONE			English	Article							RED-FLUORESCENT PROTEINS; LUCIFERASE MUTANTS; IMAGE-ANALYSIS; SELECTION; REPORTER; DESIGN	The identification and engineering of proteins having refined or novel characteristics is an important area of research in many scientific fields. Protein modelling has enabled the rational design of unique proteins, but high-throughput screening of large libraries is still required to identify proteins with potentially valuable properties. Here we report on the development and evaluation of a novel fluorescent activated cell sorting based screening platform. Single bacterial cells, expressing a protein library to be screened, are electronically sorted and deposited onto plates containing solid nutrient growth media in a dense matrix format of between 44 and 195 colonies/cm(2). We show that this matrix format is readily applicable to machine interrogation (<30 seconds per plate) and subsequent bioinformatic analysis (similar to 60 seconds per plate) thus enabling the high-throughput screening of the protein library. We evaluate this platform and show that bacteria containing a bioluminescent protein can be spectrally analysed using an optical imager, and a rare clone (0.5% population) can successfully be identified, picked and further characterised. To further enhance this screening platform, we have developed a prototype electronic sort stream multiplexer, that when integrated into a commercial flow cytometric sorter, increases the rate of colony deposition by 89.2% to 24 colonies per second. We believe that the screening platform described here is potentially the foundation of a new generation of high-throughput screening technologies for proteins.	[Stowe, Cassandra; Pizzey, Arnold; Pule, Martin] UCL, Dept Haematol, Inst Canc, Div Med, London, England; [Stowe, Cassandra; Kalber, Tammy; Badar, Adam; Lythgoe, Mark] UCL, Div Med, Ctr Adv Biomed Imaging, London, England	University of London; University College London; University of London; University College London	Pizzey, A (corresponding author), UCL, Dept Haematol, Inst Canc, Div Med, London, England.	a.pizzey@cancer.ucl.ac.uk		Lythgoe, Mark/0000-0002-4945-0171; Pule, Martin/0000-0002-8347-9867; Kalber, Tammy/0000-0002-3378-3748	EPSCR [EP/L006472/1]; King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK; MRC; DoH (England); Medical Research Council [MR/J013110/1]; National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub [MRC: MR/K026739/1]; Eli Lilly and Company; EPSRC;  [BB/J012955/1]; Biotechnology and Biological Sciences Research Council [1331513] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L006472/1] Funding Source: researchfish; Medical Research Council [MR/K026739/1] Funding Source: researchfish; EPSRC [EP/L006472/1] Funding Source: UKRI; MRC [MR/J013110/1, MR/K026739/1] Funding Source: UKRI	EPSCR; King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DoH (England); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); UK Regenerative Medicine Platform Safety Hub; Eli Lilly and Company(Eli Lilly); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: TK is funded by an EPSCR Early Career Fellowship (EP/L006472/1). AB and ML receives funding from the King's College London and UCL Comprehensive Cancer Imaging Centre CR-UK & EPSRC, in association with the MRC and DoH (England): ML also receives funding from Medical Research Council (MR/J013110/1); the National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub (MRC: MR/K026739/1); Eli Lilly and Company. Funding was provided by BB/J012955/1 (http://www.bbsrc.ac.uk/); Biospace Laboratories provide the PhotonIMAGER (TM) Optima Optical imaging system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2014, CURR OPIN CHEM BIOL, V20, P92, DOI 10.1016/j.cbpa.2014.05.016; Bean GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085177; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Branchini BR, 2005, ANAL BIOCHEM, V345, P140, DOI 10.1016/j.ab.2005.07.015; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Dean KM, 2015, INTEGR BIOL-UK, V7, P263, DOI 10.1039/c4ib00251b; Hellinga HW, 1998, NAT STRUCT BIOL, V5, P525, DOI 10.1038/776; Kennedy D, 2011, APPL ENVIRON MICROB, V77, P4657, DOI 10.1128/AEM.00323-11; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Olsen M, 2000, CURR OPIN BIOTECH, V11, P331, DOI 10.1016/S0958-1669(00)00108-7; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shapiro E, 2005, PROTEIN ENG DES SEL, V18, P581, DOI 10.1093/protein/gzi066; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	25	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140730	10.1371/journal.pone.0140730	http://dx.doi.org/10.1371/journal.pone.0140730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536118	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400034
J	Kreitler, J; Schloss, CA; Soong, O; Hannah, L; Davis, FW				Kreitler, Jason; Schloss, Carrie A.; Soong, Oliver; Hannah, Lee; Davis, Frank W.			Conservation Planning for Offsetting the Impacts of Development: A Case Study of Biodiversity and Renewable Energy in the Mojave Desert	PLOS ONE			English	Article							NO NET LOSS; ENVIRONMENTAL IMPACTS; DISTRIBUTION MODELS; LAND; SCALE	Balancing society's competing needs of development and conservation requires careful consideration of tradeoffs. Renewable energy development and biodiversity conservation are often considered beneficial environmental goals. The direct footprint and disturbance of renewable energy, however, can displace species' habitat and negatively impact populations and natural communities if sited without ecological consideration. Offsets have emerged as a potentially useful tool to mitigate residual impacts after trying to avoid, minimize, or restore affected sites. Yet the problem of efficiently designing a set of offset sites becomes increasingly complex where many species or many sites are involved. Spatial conservation prioritization tools are designed to handle this problem, but have seen little application to offset siting and analysis. To address this need we designed an offset siting support tool for the Desert Renewable Energy Conservation Plan (DRECP) of California, and present a case study of hypothetical impacts from solar development in the Western Mojave subsection. We compare two offset scenarios designed to mitigate a hypothetical 15,331 ha derived from proposed utility-scale solar energy development (USSED) projects. The first scenario prioritizes offsets based precisely on impacted features, while the second scenario offsets impacts to maximize biodiversity conservation gains in the region. The two methods only agree on 28% of their prioritized sites and differ in meeting species-specific offset goals. Differences between the two scenarios highlight the importance of clearly specifying choices and priorities for offset siting and mitigation in general. Similarly, the effects of background climate and land use change may lessen the durability or effectiveness of offsets if not considered. Our offset siting support tool was designed specifically for the DRECP area, but with minor code modification could work well in other offset analyses, and could provide continuing support for a potentially innovative mitigation solution to environmental impacts.	[Kreitler, Jason; Schloss, Carrie A.] US Geol Survey, Western Geog Sci Ctr, Boise, ID 83702 USA; [Soong, Oliver; Hannah, Lee; Davis, Frank W.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Hannah, Lee] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Conservation International	Kreitler, J (corresponding author), US Geol Survey, Western Geog Sci Ctr, Boise, ID 83702 USA.	jkreitler@usgs.gov	Davis, Frank W./B-7010-2009	Davis, Frank W./0000-0002-4643-5718	California Energy Commission [500-10-021]; U.S. Geological Survey Land Change Science program	California Energy Commission; U.S. Geological Survey Land Change Science program	This project was funded under California Energy Commission Contract#500-10-021 (http://www.energy.ca.gov/) and through the U.S. Geological Survey Land Change Science program (http://www.usgs.gov/climate_landuse/lcs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SA, 2000, APPL ENERG, V65, P121, DOI 10.1016/S0306-2619(99)00077-X; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; BBOP (Business and Biodiversity Offsets Programme), 2012, NO NET LOSS LOSS GAI; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bull JW, 2014, CONSERV BIOL, V28, P799, DOI 10.1111/cobi.12243; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Cameron DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038437; Davis FW, 2006, ECOL SOC, V11; Davis FW, 2015, CEC5002015062; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; Gordon A, 2011, ENVIRON MODELL SOFTW, V26, P1481, DOI 10.1016/j.envsoft.2011.07.021; Goudey C.B., 1994, ECOLOGICAL UNITS CAL; Habib TJ, 2013, CONSERV BIOL, V27, P1313, DOI 10.1111/cobi.12098; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Heller NE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00313.1; Hernandez RR, 2014, RENEW SUST ENERG REV, V29, P766, DOI 10.1016/j.rser.2013.08.041; Hernandez RR, 2015, NAT CLIM CHANGE, V5, P353, DOI 10.1038/nclimate2556; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kreitler J, 2015, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.ks5dr, DOI 10.5061/DRYAD.KS5DR]; Laitila J, 2014, METHODS ECOL EVOL, V5, P1247, DOI 10.1111/2041-210X.12287; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Madsen B., 2010, STATE BIODIVERSITY M; Maron M, 2013, CONSERV LETT, V6, P359, DOI 10.1111/conl.12007; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2013, WILDLIFE RES, V40, P153, DOI 10.1071/WR12083; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Quetier F, 2014, ENVIRON SCI POLICY, V38, P120, DOI 10.1016/j.envsci.2013.11.009; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; R Core Team, 2012, R LANG ENV STAT COMP; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Spencer W, 2014, RECOMMENDATIONS INDE; Stoms DM, 2013, RENEW ENERG, V57, P289, DOI 10.1016/j.renene.2013.01.055; ten Kate K., 2004, BIODIVERSITY OFFSETS; Underwood JG, 2011, ENVIRON MANAGE, V47, P121, DOI 10.1007/s00267-010-9589-9; van Teeffelen AJA, 2014, LANDSCAPE URBAN PLAN, V130, P64, DOI 10.1016/j.landurbplan.2014.06.004; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Webb RH, 2009, MOJAVE DESERT, P343	51	14	14	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140226	10.1371/journal.pone.0140226	http://dx.doi.org/10.1371/journal.pone.0140226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529595	Green Published, gold			2022-12-27	WOS:000364032600004
J	Jalin, AMAA; Rajasekaran, M; Prather, PL; Kwon, JS; Gajulapati, V; Choi, Y; Kim, C; Pahk, K; Ju, C; Kim, WK				Jalin, Angela M. A. Anthony; Rajasekaran, Maheswari; Prather, Paul L.; Kwon, Jin Sun; Gajulapati, Veeraswamy; Choi, Yongseok; Kim, Chunsook; Pahk, Kisoo; Ju, Chung; Kim, Won-Ki			Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENERGY-METABOLISM; OXIDATIVE STRESS; CELL-MIGRATION; INJURY; AGONIST; ENDOCANNABINOIDS; NEUROPROTECTION; ANTIOXIDANT; CHEMOTAXIS	Growing evidence suggests that therapeutic strategies to modulate the post-ischemic inflammatory responses are promising approaches to improve stroke outcome. Although the endocannabinoid system has been emerged as an endogenous therapeutic target to regulate inflammation after stroke insult, the downstream mechanisms and their potentials for therapeutic intervention remain controversial. Here we identified trans-and cis-hinokiresinols as novel non-selective antagonists for two G-protein-coupled cannabinoid receptors, cannabinoid receptor type 1 and type 2. The Electric Cell-substrate Impedance Sensing and Boyden chamber migration assays using primary microglial cultures revealed that both hinokiresinols significantly inhibited an endocannabinoid, 2-arachidonoylglycerol-induced migration. Hinokiresinols modulated 2-arachidonoylglycerol-induced mitochondrial bioenergetics in microglia as evidenced by inhibition of ATP turnover and reduction in respiratory capacity, thereby resulting in impaired migration activity. In rats subjected to transient middle cerebral artery occlusion (1.5-h) followed by 24-h reperfusion, post-ischemic treatment with hinokiresinols (2 and 7-h after the onset of ischemia, 10 mg/kg) significantly reduced cerebral infarct and infiltration of ED1-positive microglial/macrophage cells into cerebral ischemic lesions in vivo. Co-administration of exogenous 2-AG (1 mg/kg, i.v., single dose at 2 h after starting MCAO) abolished the protective effect of trans-hinokiresionol. These results suggest that hinokiresinols may serve as stroke treatment by targeting the endocannabinoid system. Alteration of mitochondrial bioenergetics and consequent inhibition of inflammatory cells migration may be a novel mechanism underlying anti-ischemic effects conferred by cannabinoid receptor antagonists.	[Jalin, Angela M. A. Anthony; Pahk, Kisoo; Ju, Chung; Kim, Won-Ki] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea; [Rajasekaran, Maheswari; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Kwon, Jin Sun; Gajulapati, Veeraswamy; Choi, Yongseok] Korea Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Kim, Chunsook] Kyungdong Univ, Dept Nursing, Wonju, Kangwon Do, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Arkansas System; University of Arkansas Medical Sciences; Korea University; Kyungdong University	Ju, C (corresponding author), Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea.	cj2013@korea.ac.kr; wonki@korea.ac.kr	Choi, Yongseok/F-8375-2012; Pahk, Kisoo/AAD-5965-2020	Choi, Yongseok/0000-0002-3622-3439; Anthony Jalin, Angela Melinda/0000-0002-2831-7996; Pahk, Kisoo/0000-0003-2971-4202	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea [2015R1A2A2A01004202, 2014R1A1A1037088]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea	This study was supported by grants from Basic Science Research Program (#NRF-2015R1A2A2A01004202 to W-KK) and Basic Science Research Program (#NRF-2014R1A1A1037088 to CJ) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso de Lecinana Maria, 2006, Cerebrovasc Dis, V21 Suppl 2, P48; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Chiurchiu V, 2015, J NEUROIMMUNE PHARM, V10, P268, DOI 10.1007/s11481-015-9584-2; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Fisar Z, 2014, TOXICOL LETT, V231, P62, DOI 10.1016/j.toxlet.2014.09.002; Gertsch J, 2010, BRIT J PHARMACOL, V160, P523, DOI 10.1111/j.1476-5381.2010.00745.x; Hadjout N, 2007, J IMMUNOL METHODS, V320, P70, DOI 10.1016/j.jim.2006.12.005; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Ju C, 2013, NEUROPHARMACOLOGY, V67, P465, DOI 10.1016/j.neuropharm.2012.12.006; Lassen PR, 2005, J NAT PROD, V68, P1603, DOI 10.1021/np0502995; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Ma YL, 2010, AM J PHYSIOL-REG I, V299, pR871, DOI 10.1152/ajpregu.00031.2010; Mounsey RB, 2015, EXP NEUROL, V273, P36, DOI 10.1016/j.expneurol.2015.07.024; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	30	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141600	10.1371/journal.pone.0141600	http://dx.doi.org/10.1371/journal.pone.0141600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517721	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800060
J	Lima, SIVC; Diniz, RS; Egito, EST; Azevedo, PRM; Oliveira, AG; Araujo, IB				Lima, Sara I. V. C.; Diniz, Rodrigo S.; Egito, Eryvaldo S. T.; Azevedo, Paulo R. M.; Oliveira, Antonio G.; Araujo, Ivonete B.			Rationality of Antimicrobial Prescriptions in Community Pharmacy Users	PLOS ONE			English	Article							ANTIBIOTICS; COMPLETENESS; HANDWRITTEN; LEGIBILITY; QUALITY; MISUSE; CITY	Background Although there is a conflict between the treatment benefits for a single individual and society, restrictions on antibiotic use are needed to reduce the prevalence of resistance to these drugs, which is the main result of irrational use. Brazil, cataloged as a pharmemerging market, has implemented restrictive measures for the consumption of antibiotics. The objective of this study was to investigate the quality of antimicrobial prescriptions and user knowledge of their treatment with these drugs. Methods and Findings A two-stage cross-sectional, combined and stratified survey of pharmacy users holding an antimicrobial prescription was conducted in the community between May and November 2014. A pharmacist analyzed each prescription for legibility and completeness, and applied a structured questionnaire to the users or their caregivers on their knowledge regarding treatment and user sociodemographic data. An estimated 29.3% of prescriptions had one or more illegible items, 91.3% had one or more missing items, and 29.0% had both illegible and missing items. Dosing schedule and patient identification were the most commonly unreadable items in prescriptions, 18.81% and 12.14%, respectively. The lack of complete patient identification occurred in 90.53% of the prescriptions. It is estimated that 40.3% of users have used antimicrobials without prescription and that 46.49% did not receive any guidance on the administration of the drug. Conclusions Despite the measures taken by health authorities to restrict the misuse of antimicrobials, it was observed that prescribers still do not follow the criteria of current legislation, particularly relating to items needed for completion of the prescription. Moreover, users receive little information about their antimicrobial treatment.	[Lima, Sara I. V. C.; Diniz, Rodrigo S.; Egito, Eryvaldo S. T.; Oliveira, Antonio G.; Araujo, Ivonete B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil; [Diniz, Rodrigo S.] Univ Fed Campina Grande, Ctr Educ Saude, Dept Farmacia, Cuite, PB, Brazil; [Egito, Eryvaldo S. T.; Araujo, Ivonete B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farmacia, BR-59072970 Natal, RN, Brazil; [Azevedo, Paulo R. M.] Univ Fed Rio Grande do Norte, Ctr Ciencias Exatas Terra, Dept Estat, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Campina Grande; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Lima, SIVC (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil.	sivclima@gmail.com	ST Egito, Socrates/O-1813-2014	ST Egito, Socrates/0000-0002-2180-3991				Abrantes PD, 2008, CIENC SAUDE COLETIVA, V13, P711, DOI 10.1590/S1413-81232008000700021; Agencia Nacional de Vigilancia Sanitiria-ANVISA, 2010, RDC 44 OCTOBER 26 20; Agencia Nacional de Vigilancia Sanitiria-ANVISA, 2011, RDC 20 MAY 5 2011; Albarrak AI, 2014, SAUDI PHARM J, V22, P522, DOI 10.1016/j.jsps.2014.02.013; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; BRASIL, 2013, DEFINIDA NOVA DATA P; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Calligaris Laura, 2009, BMC Clin Pharmacol, V9, P9, DOI 10.1186/1472-6904-9-9; Cisneros Jose Miguel, 2010, Enferm Infecc Microbiol Clin, V28 Suppl 4, P28, DOI 10.1016/S0213-005X(10)70039-2; de Vries TPGM, 1994, GUIDE GOOD PRESCRIBI; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; IBGE, 2010, DIRETORIA PESQISAS C; IMS Health, PHARMERGING MARKETS; Nicolini P, 2008, CIENC SAUDE COLETIVA, V13, P689, DOI 10.1590/S1413-81232008000700018; Porco TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046505; Rosa Mário Borges, 2009, Rev. Saúde Pública, V43, P490, DOI 10.1590/S0034-89102009005000028; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075550; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Silverio MS, 2010, REV ASSOC MED BRAS, V56, P675, DOI 10.1590/S0104-42302010000600016; Tripathi N, 2012, CLIN PERINATOL, V39, P61, DOI 10.1016/j.clp.2011.12.003; Waltham MA, 2015, CIPROFLOXACIN SYSTEM; WHO, 2001, WHO GLOB STRAT CONT; Wilf-Miron R, 2012, J MANAGE CARE PHARM, V18, P324, DOI 10.18553/jmcp.2012.18.4.324; Winslow EH, 1997, HEART LUNG, V26, P158, DOI 10.1016/S0147-9563(97)90076-5	25	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141615	10.1371/journal.pone.0141615	http://dx.doi.org/10.1371/journal.pone.0141615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517874	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800062
J	Al-Temaimi, RA; Al-Enezi, A; Al-Serri, A; Al-Roughani, R; Al-Mulla, F				Al-Temaimi, Rabeah Abbas; Al-Enezi, Anwar; Al-Serri, Ahmad; Al-Roughani, Raed; Al-Mulla, Fahd			The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait	PLOS ONE			English	Article							GENE POLYMORPHISMS; RISK; METAANALYSIS	Vitamin D deficiency is associated with several diseases including multiple sclerosis (MS). Several factors influence vitamin D levels and its optimal multi-function maintenance. Our objective was to assess quantifiable variables influencing vitamin D level and metabolism in MS patients from Kuwait. In a case-control study involving 50 MS patients, and 50 healthy control individuals for which plasma vitamin D levels, supplement use, vitamin D receptor (VDR) variants, and skin pigmentation indices were ascertained; we found overall vitamin D levels to be deficient in both groups, and supplement use to be common practice. VDR variants TaqI and BsmI associated with MS risk, and ApaI associated with low disease progression. VDR variant FokI associated with higher vitamin D levels in both groups. We conclude that several quantifiable variables related to vitamin D associate with MS suggesting a possible clinical immuno-modulatory application of vitamin D for MS patients in Kuwait.	[Al-Temaimi, Rabeah Abbas; Al-Serri, Ahmad] Kuwait Univ, Dept Pathol, Human Genet Unit, Fac Med, Jabriya, Kuwait; [Al-Enezi, Anwar] Kuwait Univ, Dept Pathol, Pathol Masters Program, Fac Med, Jabriya, Kuwait; [Al-Roughani, Raed] Amiri Hosp, Div Neurol, Dept Med, Kuwait, Kuwait; [Al-Roughani, Raed] Dasman Diabet Inst, Dept Med, Neurol Clin, Kuwait, Kuwait; [Al-Mulla, Fahd] Kuwait Univ, Fac Med, Dept Pathol, Mol Pathol Unit, Jabriya, Kuwait	Kuwait University; Kuwait University; Amiri Hospital; Kuwait University	Al-Temaimi, RA (corresponding author), Kuwait Univ, Dept Pathol, Human Genet Unit, Fac Med, Jabriya, Kuwait.	rabeah@hsc.edu.kw	Altemaimi, Rabeah/AAE-4726-2020; Al-Mulla, Fahd/E-2068-2015	Altemaimi, Rabeah/0000-0002-5662-7684; Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University College [212126150]; Kuwait Foundation [2012-1302-02]	Kuwait University College; Kuwait Foundation	This project was funded by the Kuwait University College of Graduate Studies grant no. 212126150, which was awarded to AAE, and in part by the Kuwait Foundation for the Advancement of Science (http://www.kfas.org/) grant no. 2012-1302-02 awarded to RAT.	Agliardi C, 2011, BRAIN BEHAV IMMUN, V25, P1460, DOI 10.1016/j.bbi.2011.05.015; Al-Temaimi R, 2015, J NEUROIMMUNOL, V285, P57, DOI 10.1016/j.jneuroim.2015.05.021; ALDIN ASN, 1990, J NEUROL SCI, V100, P137, DOI 10.1016/0022-510X(90)90024-H; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Alroughani R, 2014, MULT SCLER J, V20, P543, DOI 10.1177/1352458513504328; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Asani FF, 2013, PLOS ONE, V8; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Ben-Selma W, 2015, INT J IMMUNOGENET; Christensen MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056019; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Fields Jessica, 2011, Curr Osteoporos Rep, V9, P243, DOI 10.1007/s11914-011-0071-2; Fukazawa T, 1999, J NEUROL SCI, V166, P47, DOI 10.1016/S0022-510X(99)00112-4; Garcia-Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065487; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang J, 2012, J NEUROL SCI, V313, P79, DOI 10.1016/j.jns.2011.09.024; Laaser U, 1985, PRIMARY HLTH CARE MA, Vxxiv; Lang PO, 2015, NUTRIENTS, V7, P2044, DOI 10.3390/nu7032044; Martinelli V, 2014, MULT SCLER J, V20, P147, DOI 10.1177/1352458513494959; Munger KL, 2014, ANN CLIN TRANSL NEUR, V1, P605, DOI 10.1002/acn3.91; Narooie-Nejad M, 2015, J MOL NEUROSCI; Narooie-Nejad M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/427519; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; Sioka C, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-3; Smolders J, 2009, ANN NY ACAD SCI, V1173, P515, DOI 10.1111/j.1749-6632.2009.04656.x; Smolders J, 2009, J NEUROIMMUNOL, V207, P117, DOI 10.1016/j.jneuroim.2008.12.011; Stocklin E, 2013, INT J VITAM NUTR RES, V83, P92, DOI 10.1024/0300-9831/a000151; Tajouri L, 2005, J NEUROGENET, V19, P25, DOI 10.1080/01677060590949692; Tizaoui K, 2015, CELL MOL IMMUNOL, V12, P243, DOI 10.1038/cmi.2014.47; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; VanAmerongen BM, 2004, EUR J CLIN NUTR, V58, P1095, DOI 10.1038/sj.ejcn.1601952; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145	39	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142265	10.1371/journal.pone.0142265	http://dx.doi.org/10.1371/journal.pone.0142265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540116	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800072
J	Laine, N; Vaara, M; Anttila, VJ; Hoppu, K; Laaksonen, R; Airaksinen, M; Saxen, H				Laine, Niina; Vaara, Martti; Anttila, Veli-Jukka; Hoppu, Kalle; Laaksonen, Raisa; Airaksinen, Marja; Saxen, Harri			Evaluation of Antimicrobial Therapy of Blood Culture Positive Healthcare-Associated Infections in Children	PLoS One			English	Article							REPEATED PREVALENCE SURVEYS; FOR-DISEASE-CONTROL; NOSOCOMIAL INFECTIONS; STREAM INFECTIONS; APPROPRIATENESS; RESISTANCE; SURVIVAL; UNIT	Aim Knowledge of the quality of antimicrobial therapy (AMT) used for invasive healthcare-associated infections (HAIs) in paediatrics is scarce. Influence of the final information about the isolated pathogen on the subsequent targeted AMT was investigated in our study. Methods Data on 149 children (0-17 years) with blood culture positive HAIs were collected. The causative microbes under investigation were Staphylococcus aureus, Staphylococcus epidermidis, streptococci, Gram negative rods, and mixed infections were likewise included. For adjusting the antimicrobial regimen, an expert panel evaluated the quality of the targeted AMT and the delay of 72 hours after final microbiology results. AMT was regarded as inappropriate if the pathogen was totally resistant to the used antimicrobials (i) or if the chosen therapy was of not optimal efficacy against the pathogen (ii). Results 17% of the patients received inappropriate AMT. Half of these infections 13/26 (50%) were treated with an antimicrobial to which the isolate was resistant. Three (3/13, 23%) of these patients received antimicrobials which were totally ineffective according to in vitro data. Suboptimal or too broad spectrum AMT was administered to 13/26 (50%) patients. The most common causes of inappropriate use were the use of beta-lactams in oxacillin-resistant Staphylococcus epidermidis infections and vancomycin given in oxacillin-sensitive Staphylococcus aureus infections. Conclusion Approximately 17% of the selected cohort received inappropriate AMT. More attention should be paid to the appropriate use of antimicrobials, and training of prescribers should be urgently provided.	[Laine, Niina; Saxen, Harri] HUCH, Childrens Hosp, Helsinki, Finland; [Laine, Niina; Laaksonen, Raisa; Airaksinen, Marja] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Fac Pharm, Helsinki, Finland; [Vaara, Martti] Helsinki Univ Cent HUCH Hosp, Div Clin Microbiol, HUSLAB, Helsinki, Finland; [Anttila, Veli-Jukka] HUCH, Dept Infect Dis, Helsinki, Finland; [Hoppu, Kalle] HUCH, Poison Informat Ctr, Helsinki, Finland	University of Helsinki	Laine, N (corresponding author), HUCH, Childrens Hosp, Helsinki, Finland.	niina.laine@helsinki.fi	Hoppu, Kalle/A-2811-2009	Hoppu, Kalle/0000-0001-6775-0453	University Pharmacy of Finland; Foundation of Paivikki ja Sakari Sohlberg; University of Helsinki, Finland	University Pharmacy of Finland; Foundation of Paivikki ja Sakari Sohlberg; University of Helsinki, Finland	The work was supported by The University Pharmacy of Finland (www.yliopistonapteekki.fi), The Foundation of Paivikki ja Sakari Sohlberg (www.psssaatio.fi) and The University of Helsinki, Finland. The funding was salary for PhD student Niina Laine. It was not used on other purposes besides working (i.e., no materials/computers etc.).	Balaban I, 2012, JPN J INFECT DIS, V65, P318, DOI 10.7883/yoken.65.318; Bartlett JM, 2014, AM J HEALTH-SYST PH, V71, P943, DOI 10.2146/ajhp130602; Burgner D, 1996, J HOSP INFECT, V34, P163, DOI 10.1016/S0195-6701(96)90062-6; Buyle FM, 2014, ACTA CLIN BELG; Cosgrove SE, 2007, INFECT CONT HOSP EP, V28, P641, DOI 10.1086/518345; Davey PG, 2008, CLIN MICROBIOL INFEC, V14, P15, DOI 10.1111/j.1469-0691.2008.01959.x; Erbay A, 2009, INT J ANTIMICROB AG, V34, P575, DOI 10.1016/j.ijantimicag.2009.07.006; Frank M, 2005, SCAND J INFECT DIS, V37, P177, DOI 10.1080/00365540410020956; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Levy ER, 2012, INFECT CONT HOSP EP, V33, P346, DOI 10.1086/664761; Muhlemann K, 2004, INFECT CONT HOSP EP, V25, P765, DOI 10.1086/502474; Patel SJ, 2009, PEDIATR INFECT DIS J, V28, P1047, DOI 10.1097/INF.0b013e3181b12484; Raineri E, 2008, AM J INFECT CONTROL, V36, P283, DOI 10.1016/j.ajic.2007.06.009; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Sarvikivi E, 2008, CLIN MICROBIOL INFEC, V14, P1072, DOI 10.1111/j.1469-0691.2008.02079.x; Shah PJ, 2014, J PHARM PRACT; Suppli M, 2011, CLIN MICROBIOL INFEC, V17, P1078, DOI 10.1111/j.1469-0691.2010.03394.x; WelshKerry J, 2010, J CLIN MICROBIOL, V48, P894, DOI [10.1128/JCM.01949-09, DOI 10.1128/JCM.01949-09]; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Yu K, 2014, AM J HEALTH-SYST PH, V71, P1019, DOI 10.2146/ajhp130612; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141555	10.1371/journal.pone.0141555	http://dx.doi.org/10.1371/journal.pone.0141555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539831	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800020
J	Ostrovski, I; Lovblom, LE; Farooqi, MA; Scarr, D; Boulet, G; Hertz, P; Wu, T; Halpern, EM; Ngo, M; Ng, E; Orszag, A; Bril, V; Perkins, BA				Ostrovski, Ilia; Lovblom, Leif E.; Farooqi, Mohammed A.; Scarr, Daniel; Boulet, Genevieve; Hertz, Paul; Wu, Tong; Halpern, Elise M.; Ngo, Mylan; Ng, Eduardo; Orszag, Andrej; Bril, Vera; Perkins, Bruce A.			Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy	PLOS ONE			English	Article							DISTAL SYMMETRIC POLYNEUROPATHY; PRACTICE PARAMETER EVALUATION; SUBBASAL NERVE PLEXUS; PERIPHERAL NEUROPATHY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; FIBER DAMAGE; INDIVIDUALS; NEUROLOGY	Objective In vivo Corneal Confocal Microscopy (IVCCM) is a validated, non-invasive test for diabetic sensorimotor polyneuropathy (DSP) detection, but its utility is limited by the image analysis time and expertise required. We aimed to determine the inter-and intra-observer reproducibility of a novel automated analysis program compared to manual analysis. Methods In a cross-sectional diagnostic study, 20 non-diabetes controls (mean age 41.4 +/- 17.3y, HbA1c 5.5 +/- 0.4%) and 26 participants with type 1 diabetes (42.8 +/- 16.9y, 8.0 +/- 1.9%) underwent two separate IVCCM examinations by one observer and a third by an independent observer. Along with nerve density and branch density, corneal nerve fibre length (CNFL) was obtained by manual analysis (CNFLMANUAL), a protocol in which images were manually selected for automated analysis (CNFLSEMI-AUTOMATED), and one in which selection and analysis were performed electronically (CNFLFULLY-AUTOMATED). Reproducibility of each protocol was determined using intraclass correlation coefficients (ICC) and, as a secondary objective, the method of Bland and Altman was used to explore agreement between protocols. Results Mean CNFLManual was 16.7 +/- 4.0, 13.9 +/- 4.2 mm/mm(2) for non-diabetes controls and diabetes participants, while CNFLSemi-Automated was 10.2 +/- 3.3, 8.6 +/- 3.0 mm/mm(2) and CNFLFully-Automated was 12.5 +/- 2.8, 10.9 +/- 2.9 mm/mm(2). Inter-observer ICC and 95% confidence intervals (95%CI) were 0.73(0.56, 0.84), 0.75(0.59, 0.85), and 0.78(0.63, 0.87), respectively (p = NS for all comparisons). Intra-observer ICC and 95%CI were 0.72(0.55, 0.83), 0.74(0.57, 0.85), and 0.84(0.73, 0.91), respectively (p<0.05 for CNFLFully-Automated compared to others). The other IVCCM parameters had substantially lower ICC compared to those for CNFL. CNFLSemi-Automated and CNFL Fully-Automated underestimated CNFLManual by mean and 95%CI of 35.1(-4.5, 67.5)% and 21.0(-21.6, 46.1)%, respectively. Conclusions Despite an apparent measurement (underestimation) bias in comparison to the manual strategy of image analysis, fully-automated analysis preserves CNFL reproducibility. Future work must determine the diagnostic thresholds specific to the fully-automated measure of CNFL.	[Ostrovski, Ilia; Lovblom, Leif E.; Farooqi, Mohammed A.; Scarr, Daniel; Boulet, Genevieve; Hertz, Paul; Wu, Tong; Halpern, Elise M.; Orszag, Andrej; Perkins, Bruce A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Ngo, Mylan; Ng, Eduardo; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Perkins, BA (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	bperkins@mtsinai.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Lovblom, Leif Erik/0000-0002-6774-8924; Farooqi, Mohammed/0000-0001-5282-4034; Orszag, Andrej/0000-0002-0027-1607	JDRF Operating Grant [17-2008-715]; Harvey and Annice Frisch Family Fund	JDRF Operating Grant; Harvey and Annice Frisch Family Fund	The study was funded by the JDRF Operating Grant No. 17-2008-715, website: http://www.jdrf.ca/ (Juvenile Diabetes Research Foundation). The authors wish to acknowledge the generous support of Randy and Jenny Frisch and The Harvey and Annice Frisch Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Chen X, 2015, DIABETES CARE, V38, P1138, DOI 10.2337/dc14-2422; Dabbah MA, 2011, MED IMAGE ANAL, V15, P738, DOI 10.1016/j.media.2011.05.016; Dabbah MA, 2010, LECT NOTES COMPUT SC, V6361, P300; Dehghani C, 2014, INVEST OPHTH VIS SCI, V55, P7982, DOI 10.1167/iovs.14-15605; Dehghani C, 2014, CORNEA, V33, P696, DOI 10.1097/ICO.0000000000000152; Dehghani C, 2014, INVEST OPHTH VIS SCI, V55, P3195, DOI 10.1167/iovs.14-13959; Edwards K, 2012, CLIN EXP OPTOM, V95, P348, DOI 10.1111/j.1444-0938.2012.00740.x; Efron N, 2010, EYE CONTACT LENS, V36, P245, DOI 10.1097/ICL.0b013e3181eea915; England J. D., 2005, Neurology, V64, P199; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Halpern EM, 2013, J DIABETES COMPLICAT, V27, P240, DOI 10.1016/j.jdiacomp.2012.10.011; Hertz P, 2011, DIABETIC MED, V28, P1253, DOI 10.1111/j.1464-5491.2011.03299.x; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Hume DA, 2012, DIABETES RES CLIN PR, V97, pE37, DOI 10.1016/j.diabres.2012.04.010; Jiang MS, 2016, BRIT J OPHTHALMOL, V100, P9, DOI 10.1136/bjophthalmol-2014-306038; Kim G, 2013, CORNEA, V32, P1331, DOI 10.1097/ICO.0b013e31829dd7f8; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Oh SJ, 2002, CLIN ELECTROMYOGRAPH, P86; Oremus M, 2012, BMJ OPEN, V4, P2, DOI DOI 10.1136/BMJ0PEN-2012-001368; Perkins BA, 2002, MUSCLE NERVE, V25, P212, DOI 10.1002/mus.10044; Petropoulos IN, 2015, INVEST OPHTH VIS SCI, V56, P2498, DOI 10.1167/iovs.14-15919; Petropoulos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123517; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Pritchard N, 2015, DIABETES CARE, V38, P671, DOI 10.2337/dc14-2114; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Ruggeri Alfredo, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4739; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sivaskandarajah GA, 2013, DIABETES CARE, V36, P2748, DOI 10.2337/dc12-2075; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2012, CLIN EXP OPTOM, V95, P338, DOI 10.1111/j.1444-0938.2012.00743.x; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tavakoli M, 2008, CLIN OPHTHALMOL, V2, P435; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Wu T, 2012, DIABETIC MED, V29, pE297, DOI 10.1111/j.1464-5491.2012.03678.x; Ziegler D, 2002, INT REV NEUROBIOL, V50, P431	45	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142309	10.1371/journal.pone.0142309	http://dx.doi.org/10.1371/journal.pone.0142309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539984	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800081
J	Shahbazi, S; Studnicki, J; Warner-Hillard, CW				Shahbazi, Sara; Studnicki, James; Warner-Hillard, Charles Wayne			A Cross-Sectional Retrospective Analysis of the Racial and Geographic Variations in Cataract Surgery	PLOS ONE			English	Article							HEALTH DISPARITIES; CARE; MORTALITY; BARRIERS	Background Cataract surgery is the most common surgery performed on beneficiaries of Medicare, accounting for more than $3.4 billion in annual expenditures. The purpose of this study is to examine racial and geographic variations in cataract surgery rates and determine the association between the racial composition of the community population and the racial disparity in the likelihood of receiving necessary cataract surgery. Methods Using the national prevalence rates from the National Institute of Eye Health and the 2010 Healthcare Cost and Utilization Project-Florida State Ambulatory Surgery Database, we determined the estimated cases of cataract and the actual number of cataract procedures performed, on four race/gender determined groups aged 65 and over in the state of Florida in 2010. The utilization rates and disparity ratios were also calculated for each Florida county. The counties were segmented into groups based on their racial composition. The association between racial composition and disparity ratios in receiving necessary cataract surgery was examined. The Geographic Information System was used to display county-level geospatial relationships. Results African-Americans have a lower gender-specific cataract prevalence (African-American male = 0.246, African-American female = 0.392, white male = 0.368, and white female = 0.457), but they are also less likely than whites to receive necessary cataract surgery (utilization rate: African-American male = 7.92%, African-American female = 6.17%, white male = 12.08%, and white female = 10.54%). The statistical results show no overall differences between the disparity ratios and the racial composition of the communities. However, our geospatial analyses revealed a concentration of high racial disparity/high white population counties largely along the West Coast and South Central portion of the state. Conclusions There are racial differences in the likelihood of receiving necessary cataract surgery. However, there is no significant statewide association between the racial composition of the community population and the racial disparity in the likelihood of receiving necessary cataract surgery. Geospatial techniques did, however, identify subpopulations of interest which were not otherwise identifiable with typical statistical approaches, nor consistent with their conclusions.	[Shahbazi, Sara] Univ N Carolina, Coll Hlth & Human Serv, Dept Hlth Serv Res, Charlotte, NC 28223 USA; [Studnicki, James; Warner-Hillard, Charles Wayne] Univ N Carolina, Coll Hlth & Human Serv, Dept Publ Hlth Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Shahbazi, S (corresponding author), Univ N Carolina, Coll Hlth & Human Serv, Dept Hlth Serv Res, Charlotte, NC 28223 USA.	sshahbaz@uncc.edu						Baicker K, 2005, PERSPECT BIOL MED, V48, pS42; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Bhatt B. M., 2012, National Journal of Community Medicine, V3, P259; Broman AT, 2005, ARCH OPHTHALMOL-CHIC, V123, P1231, DOI 10.1001/archopht.123.9.1231; Centers for Disease Control and Prevention, VIS HLTH IN VHI COMM; Centers for Disease Control and Prevention, 1993, MMWR, V42; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Cooper GS, 1997, J GEN INTERN MED, V12, P485, DOI 10.1046/j.1525-1497.1997.00087.x; Cooper RA, 2012, J URBAN HEALTH, V89, P828, DOI 10.1007/s11524-012-9689-3; Flood M, 14 OFR; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; French DD, 2012, MIL MED, V177, P752, DOI 10.7205/MILMED-D-12-00046; Graves BA, 2009, ONLINE J RURAL NURS, V9; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584; Hayanga AJ, 2009, J AM COLL SURGEONS, V208, P1017, DOI 10.1016/j.jamcollsurg.2009.01.047; Healthcare Cost and Utilization Project, HCUP DAT US AGR TRAI; Healthcare Cost and Utilization Project, INTR HCUP STAT AMB S; JAVITT JC, 1995, MED CARE, V33, P90, DOI 10.1097/00005650-199501000-00008; Johnson JG, 1998, TROP DOCT, V28, P218, DOI 10.1177/004947559802800410; Keeffe JE, 2002, BRIT J OPHTHALMOL, V86, P24, DOI 10.1136/bjo.86.1.24; Klein BEK, 1997, OPHTHALMOLOGY, V104, P573, DOI 10.1016/S0161-6420(97)30267-X; Kohnen T, 2009, DTSCH ARZTEBL INT, V106, P695, DOI 10.3238/arztebl.2009.0695; Lewallen S, 2000, Community Eye Health, V13, P20; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Martin P., 2013, EFFECT CATARACT SURG; Ntsoane MD, 2010, AFR VIS EYE HEALTH J, V69, P182; Ocampo VVD, 2002, CATARACT SENILE EMED; Ortman J. M., 2014, AGING NATION OLDER P, P25; Prevent Blindness America, 2012, PREV AD VIS IMP AG R; Roberts D, 2012, CAMB Q HEALTHC ETHIC, V21, P332, DOI 10.1017/S0963180112000059; United States Census Bureau, 2010, 2010 CENSUS BRIEFS; Wang F, 1997, Ophthalmic Epidemiol, V4, P89; West SK, 1998, AM J EPIDEMIOL, V148, P1033; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Women's Eye Health Task Force: Schepens Eye Research Institute Inc., 2003, EYE; Younan C, 2002, CLIN EXP OPHTHALMOL, V30, P163, DOI 10.1046/j.1442-9071.2002.00523.x; Zhang XZ, 2012, AM J OPHTHALMOL, V154, pS53, DOI 10.1016/j.ajo.2011.08.045	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142459	10.1371/journal.pone.0142459	http://dx.doi.org/10.1371/journal.pone.0142459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540168	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800093
J	Aug, A; Altraja, S; Kilk, K; Porosk, R; Soomets, U; Altraja, A				Aug, Argo; Altraja, Siiri; Kilk, Kalle; Porosk, Rando; Soomets, Ursel; Altraja, Alan			E-Cigarette Affects the Metabolome of Primary Normal Human Bronchial Epithelial Cells	PLOS ONE			English	Article							SMOKE; IMPACT	E-cigarettes are widely believed to be safer than conventional cigarettes and have been even suggested as aids for smoking cessation. However, while reasonable with some regards, this judgment is not yet supported by adequate biomedical research data. Since bronchial epithelial cells are the immediate target of inhaled toxicants, we hypothesized that exposure to e-cigarettes may affect the metabolome of human bronchial epithelial cells (HBEC) and that the changes are, at least in part, induced by oxidant-driven mechanisms. Therefore, we evaluated the effect of e-cigarette liquid (ECL) on the metabolome of HBEC and examined the potency of antioxidants to protect the cells. We assessed the changes of the intracellular metabolome upon treatment with ECL in comparison of the effect of cigarette smoke condensate (CSC) with mass spectrometry and principal component analysis on air-liquid interface model of normal HBEC. Thereafter, we evaluated the capability of the novel antioxidant tetrapeptide O-methyl-L-tyrosinyl-.-L-glutamyl-L-cysteinylglycine (UPF1) to attenuate the effect of ECL. ECL caused a significant shift in the metabolome that gradually gained its maximum by the 5th hour and receded by the 7th hour. A second alteration followed at the 13th hour. Treatment with CSC caused a significant initial shift already by the 1st hour. ECL, but not CSC, significantly increased the concentrations of arginine, histidine, and xanthine. ECL, in parallel with CSC, increased the content of adenosine diphosphate and decreased that of three lipid species from the phosphatidylcholine family. UPF1 partially counteracted the ECL-induced deviations, UPF1's maximum effect occurred at the 5th hour. The data support our hypothesis that ECL profoundly alters the metabolome of HBEC in a manner, which is comparable and partially overlapping with the effect of CSC. Hence, our results do not support the concept of harmlessness of e-cigarettes.	[Aug, Argo; Kilk, Kalle; Porosk, Rando; Soomets, Ursel] Univ Tartu, Inst Biomed & Translat Med, Dept Biochem, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Altraja, Siiri] Univ Tartu, Dept Biomed, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Altraja, Alan] Univ Tartu, Dept Pulm Med, EE-50090 Tartu, Estonia; [Altraja, Alan] Tartu Univ Hosp, Lung Clin, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Altraja, A (corresponding author), Univ Tartu, Dept Pulm Med, Ulikooli 18, EE-50090 Tartu, Estonia.	alan@kliinikum.ee	Soomets, Ursel/H-5919-2015	Soomets, Ursel/0000-0002-3681-188X	Estonian Science Foundation [9043, 9103]; Institutional Research Support Project [IUT 20-42]; European Union through the European Social Fund	Estonian Science Foundation; Institutional Research Support Project; European Union through the European Social Fund	This work was supported by The Estonian Science Foundation (http://www.etag.ee/en/estonian-research-council/) grants No. 9043 (AlA) and 9103 (SA), by the Institutional Research Support Project IUT 20-42 (http://www.etag.ee/en/estonian-researchcouncil/), and by the European Union through the European Social Fund (http://www.doktorikool.ut.ee/kmdk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2008, ANAL CHEM, V80, P9171, DOI 10.1021/ac801215c; Altraja S, 2013, EXP TOXICOL PATHOL, V65, P711, DOI 10.1016/j.etp.2012.09.005; Aug A, 2014, AM J RESP CELL MOL, V51, P586, DOI 10.1165/rcmb.2013-0377OC; Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Choi K, 2014, AM J PREV MED, V46, P175, DOI 10.1016/j.amepre.2013.10.007; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Harrell PT, 2015, NICOTINE TOB RES, V17, P193, DOI 10.1093/ntr/ntu149; Pokhrel P, 2013, AM J PUBLIC HEALTH, V103, pE57, DOI 10.2105/AJPH.2013.301453; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Rahman I, 1996, FEBS LETT, V396, P21, DOI 10.1016/0014-5793(96)01027-7; Somborac-Bacura A, 2013, EXP PHYSIOL, V98, P316, DOI 10.1113/expphysiol.2012.067249; Soomets Ursel, 2005, V298, P241; Sutfin EL, 2013, DRUG ALCOHOL DEPEN, V131, P214, DOI 10.1016/j.drugalcdep.2013.05.001; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Vulimiri SV, 2009, CHEM RES TOXICOL, V22, P492, DOI 10.1021/tx8003246; World Health Organization, 2016, C PART WHO FRAM CONV; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	20	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142053	10.1371/journal.pone.0142053	http://dx.doi.org/10.1371/journal.pone.0142053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536230	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400125
J	Bhatia, U; Kumar, D; Kodra, E; Ganguly, AR				Bhatia, Udit; Kumar, Devashish; Kodra, Evan; Ganguly, Auroop R.			Network Science Based Quantification of Resilience Demonstrated on the Indian Railways Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SYSTEM RESILIENCE; RESTORATION; PERCOLATION; ROBUSTNESS; FRAMEWORK; ECOLOGY	The structure, interdependence, and fragility of systems ranging from power-grids and transportation to ecology, climate, biology and even human communities and the Internet have been examined through network science. While response to perturbations has been quantified, recovery strategies for perturbed networks have usually been either discussed conceptually or through anecdotal case studies. Here we develop a network science based quantitative framework for measuring, comparing and interpreting hazard responses as well as recovery strategies. The framework, motivated by the recently proposed temporal resilience paradigm, is demonstrated with the Indian Railways Network. Simulations inspired by the 2004 Indian Ocean Tsunami and the 2012 North Indian blackout as well as a cyber-physical attack scenario illustrate hazard responses and effectiveness of proposed recovery strategies. Multiple metrics are used to generate various recovery strategies, which are simply sequences in which system components should be recovered after a disruption. Quantitative evaluation of these strategies suggests that faster and more efficient recovery is possible through network centrality measures. Optimal recovery strategies may be different per hazard, per community within a network, and for different measures of partial recovery. In addition, topological characterization provides a means for interpreting the comparative performance of proposed recovery strategies. The methods can be directly extended to other Large-Scale Critical Lifeline Infrastructure Networks including transportation, water, energy and communications systems that are threatened by natural or human-induced hazards, including cascading failures. Furthermore, the quantitative framework developed here can generalize across natural, engineered and human systems, offering an actionable and generalizable approach for emergency management in particular as well as for network resilience in general.	[Bhatia, Udit; Kumar, Devashish; Kodra, Evan; Ganguly, Auroop R.] Northeastern Univ, Dept Civil & Environm Engn, Sustainabil & Data Sci Lab, Boston, MA 02115 USA	Northeastern University	Ganguly, AR (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Sustainabil & Data Sci Lab, Boston, MA 02115 USA.	a.ganguly@neu.edu	Ganguly, Auroop/AAJ-5591-2020		Northeastern University; US National Science Foundation's (NSF) Expeditions Computing Award [1029711]; National Science Foundation (NSF) BIGDATA award [1447587]; Direct For Computer & Info Scie & Enginr [1029711] Funding Source: National Science Foundation	Northeastern University; US National Science Foundation's (NSF) Expeditions Computing Award(National Science Foundation (NSF)); National Science Foundation (NSF) BIGDATA award(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Funding was provided by Northeastern University (UB, DK, EK, ARG), the US National Science Foundation's (NSF) Expeditions Computing Award #1029711 (UB, DK, EK, ARG), and National Science Foundation (NSF) BIGDATA award # 1447587 (ARG).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barker K, 2013, RELIAB ENG SYST SAFE, V117, P89, DOI 10.1016/j.ress.2013.03.012; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Berche B, 2009, EUR PHYS J B, V71, P125, DOI 10.1140/epjb/e2009-00291-3; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bocchini P, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000177; Borgatti S. P, 2006, COMPUT MATH ORGAN TH, V12, P21, DOI DOI 10.1007/S10588-006-7084-X; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cimellaro GP, 2010, ENG STRUCT, V32, P3639, DOI 10.1016/j.engstruct.2010.08.008; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Filippini R, 2014, RELIAB ENG SYST SAFE, V125, P82, DOI 10.1016/j.ress.2013.09.010; Fisher L, 2015, NATURE, V518, P35, DOI 10.1038/518035a; Francis R, 2014, RELIAB ENG SYST SAFE, V121, P90, DOI 10.1016/j.ress.2013.07.004; Ganin AA, 2015, ARXIV150801230; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hamilton KE, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.208701; Henry D, 2012, RELIAB ENG SYST SAFE, V99, P114, DOI 10.1016/j.ress.2011.09.002; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Ip WH, 2011, IEEE SYST J, V5, P189, DOI 10.1109/JSYST.2010.2096670; Jiang XF, 2013, PHYSICA A, V392, P5369, DOI 10.1016/j.physa.2013.07.006; JORGENSEN SE, 1992, ECOL MODEL, V62, P1, DOI 10.1016/0304-3800(92)90080-X; Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227; Massaro E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052817; Miller-Hooks E, 2012, COMPUT OPER RES, V39, P1633, DOI 10.1016/j.cor.2011.09.017; Monechi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125546; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ouyang M, 2015, RELIAB ENG SYST SAFE, V141, P74, DOI 10.1016/j.ress.2015.03.011; Ouyang M, 2012, STRUCT SAF, V36-37, P23, DOI 10.1016/j.strusafe.2011.12.004; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Quattrociocchi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087986; Radicchi F, 2015, NAT PHYS, V11, P597, DOI 10.1038/NPHYS3374; Raghu S, 2010, CYBER SECURITY CYBER; Raghuraman R., 2014, INDIAN RAILWAYS PIVO, V58; ROMERO JJ, 2012, IEEE SPECTRUM, V49, P11, DOI DOI 10.1109/MSPEC.2012.6309237; Satumtira G, 2010, SUSTAINABLE AND RESILIENT CRITICAL INFRASTRUCTURE SYSTEMS: SIMULATION, MODELING, AND INTELLIGENT ENGINEERING, P1, DOI 10.1007/978-3-642-11405-2_1; Sheridan TB, 2008, HUM FACTORS, V50, P418, DOI 10.1518/001872008X250773; Sheth A, 2006, EARTHQ SPECTRA, V22, pS435, DOI 10.1193/1.2208562; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Steinhaeuser K, 2012, CLIM DYNAM, V39, P889, DOI 10.1007/s00382-011-1135-9; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Sun X, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P4000, DOI 10.1109/ICECC.2011.6068022	47	48	50	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141890	10.1371/journal.pone.0141890	http://dx.doi.org/10.1371/journal.pone.0141890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536227	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400098
J	Kasparova, E; Van de Putte, AP; Marshall, C; Janko, K				Kasparova, Eva; Van de Putte, Anton P.; Marshall, Craig; Janko, Karel			Lifestyle and Ice: The Relationship between Ecological Specialization and Response to Pleistocene Climate Change	PLOS ONE			English	Article							ESTIMATING DEMOGRAPHIC HISTORY; HUMAN MITOCHONDRIAL-DNA; LAST GLACIAL MAXIMUM; SOUTHERN-OCEAN; POPULATION-GROWTH; NOTOTHENIOID FISHES; MOLECULAR VARIANCE; STATISTICAL-METHOD; GENETIC-STRUCTURE; ANTARCTIC FISHES	Major climatic changes in the Pleistocene had significant effects on marine organisms and the environments in which they lived. The presence of divergent patterns of demographic history even among phylogenetically closely-related species sharing climatic changes raises questions as to the respective influence of species-specific traits on population structure. In this work we tested whether the lifestyle of Antarctic notothenioid benthic and pelagic fish species from the Southern Ocean influenced the concerted population response to Pleistocene climatic fluctuations. This was done by a comparative analysis of sequence variation at the cyt b and S7 loci in nine newly sequenced and four re-analysed species. We found that all species underwent more or less intensive changes in population size but we also found consistent differences between demographic histories of pelagic and benthic species. Contemporary pelagic populations are significantly more genetically diverse and bear traces of older demographic expansions than less diverse benthic species that show evidence of more recent population expansions. Our findings suggest that the lifestyles of different species have strong influences on their responses to the same environmental events. Our data, in conjunction with previous studies showing a constant diversification tempo of these species during the Pleistocene, support the hypothesis that Pleistocene glaciations had a smaller effect on pelagic species than on benthic species whose survival may have relied upon ephemeral refugia in shallow shelf waters. These findings suggest that the interaction between lifestyle and environmental changes should be considered in genetic analyses.	[Kasparova, Eva; Janko, Karel] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov 27721, Czech Republic; [Kasparova, Eva; Janko, Karel] Acad Sci Czech Republic, Inst Vertebrate Biol, CS-60365 Brno, Czech Republic; [Van de Putte, Anton P.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, B-3000 Leuven, Belgium; [Marshall, Craig] Univ Otago, Dept Biochem & Genet Otago, Dunedin, New Zealand; [Janko, Karel] Univ South Bohemia Ceske Budejovice, Ctr Polar Ecol, Ceske Budejovice 37005, Czech Republic; [Janko, Karel] Univ Ostrava, Fac Nat Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; KU Leuven; University of Otago; University of South Bohemia Ceske Budejovice; University of Ostrava	Kasparova, E (corresponding author), Acad Sci Czech Republic, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov 27721, Czech Republic.	kasparova@iapg.cas.cz; janko@iapg.cas.cz	Marshall, Craig J./C-6668-2009; Van de Putte, Anton/S-3729-2019	Marshall, Craig J./0000-0003-4186-0368; Van de Putte, Anton/0000-0003-1336-5554; Stefkova Kasparova, Eva/0000-0003-4321-8213	Royal Belgian Institute for Natural Sciences, OD Nature, Brussels, Belgium [Vautierstraat 29, B-1000]; Grant Agency of Czech Academy of Sciences [KJB600450903]; European Centre of Ichtyoparasitology [P505/12/G112]; Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice) [LM2010009, CZ.1.07/2.2.00/28.0190]; Belgian Science Policy (BELSPO) [BR/132/A1/vERSO]; Institute of Animal Physiology and Genetics [RVO: 67985904]	Royal Belgian Institute for Natural Sciences, OD Nature, Brussels, Belgium; Grant Agency of Czech Academy of Sciences; European Centre of Ichtyoparasitology; Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice); Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office); Institute of Animal Physiology and Genetics	This work has been supported by the Royal Belgian Institute for Natural Sciences, OD Nature, Vautierstraat 29, B-1000 Brussels, Belgium. Grant Agency of the Czech Academy of Sciences (GA AS CR) (No. KJB600450903), European Centre of Ichtyoparasitology. (No. P505/12/G112), Ministry of Education, Youth and Sport of Czech Republic (Centre for Polar Ecology University of South Bohemia in Ceske Budejovice) (LM2010009, CZ.1.07/2.2.00/28.0190) and the Belgian Science Policy (BELSPO contract no BR/132/A1/vERSO). The authors' team receives continuous support from the Institute of Animal Physiology and Genetics (RVO: 67985904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barnes DKA, 2001, J BIOGEOGR, V28, P359, DOI 10.1046/j.1365-2699.2001.00562.x; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dambach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046283; Damerau M, 2012, POLAR BIOL, V35, P1073, DOI 10.1007/s00300-012-1155-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eastman J.T., 1985, P430; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Eastman JT, 2000, J FISH BIOL, V57, P84, DOI 10.1111/j.1095-8649.2000.tb02246.x; Ehrich D, 2008, J BIOGEOGR, V35, P801, DOI 10.1111/j.1365-2699.2007.01864.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2010, EVOLUTION, V64, P3380, DOI 10.1111/j.1558-5646.2010.01071.x; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Heemstra Gon, 1990, FISHES SO OCEAN; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Hey J, 1997, GENETICS, V145, P833; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Janko K, 2011, MOL PHYLOGENET EVOL, V60, P305, DOI 10.1016/j.ympev.2011.03.008; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kock KH, 2006, ANTARCT SCI, V18, P223, DOI 10.1017/S0954102006000265; Krosby M, 2009, P ROY SOC B-BIOL SCI, V276, P615, DOI 10.1098/rspb.2008.1310; Kuhner MK, 1998, GENETICS, V149, P429; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marino IAM, 2013, MOL ECOL, V22, P5148, DOI 10.1111/mec.12458; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGaughran A, 2010, J BIOGEOGR, V37, P103, DOI 10.1111/j.1365-2699.2009.02178.x; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Near TJ, 2004, ANTARCT SCI, V16, P37, DOI 10.1017/S0954102004001798; Papetti C, 2007, POLAR BIOL, V30, P1605, DOI 10.1007/s00300-007-0325-8; Papetti C, 2012, J BIOGEOGR, V39, P1361, DOI 10.1111/j.1365-2699.2011.02682.x; Patarnello T, 2011, BIOESSAYS, V33, P260, DOI 10.1002/bies.201000124; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; RAFFI S, 1986, PALAEOGEOGR PALAEOCL, V52, P267, DOI 10.1016/0031-0182(86)90051-9; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rogers Alex D., 2012, P417; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rutschmann S, 2011, MOL ECOL, V20, P4707, DOI 10.1111/j.1365-294X.2011.05279.x; Sabovljevic M, 2011, BIOLOGIA, V66, P42, DOI 10.2478/s11756-010-0129-0; Schneider S, 1999, GENETICS, V152, P1079; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; TAJIMA F, 1989, GENETICS, V123, P585; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Van de Putte AP, 2012, MAR GENOM, V8, P23, DOI 10.1016/j.margen.2012.05.002; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x	74	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0138766	10.1371/journal.pone.0138766	http://dx.doi.org/10.1371/journal.pone.0138766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535569	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400004
J	Kumalija, CJ; Perera, S; Masanja, H; Rubona, J; Ipuge, Y; Mboera, L; Hosseinpoor, AR; Boerma, T				Kumalija, Claud J.; Perera, Sriyanjit; Masanja, Honorati; Rubona, Josibert; Ipuge, Yahya; Mboera, Leonard; Hosseinpoor, Ahmad R.; Boerma, Ties			Regional Differences in Intervention Coverage and Health System Strength in Tanzania	PLOS ONE			English	Article							INFANT-MORTALITY	Background Assessments of subnational progress and performance coverage within countries should be an integral part of health sector reviews, using recent data from multiple sources on health system strength and coverage. Method As part of the midterm review of the national health sector strategic plan of Tanzania mainland, summary measures of health system strength and coverage of interventions were developed for all 21 regions, focusing on the priority indicators of the national plan. Household surveys, health facility data and administrative databases were used to compute the regional scores. Findings Regional Millennium Development Goal (MDG) intervention coverage, based on 19 indicators, ranged from 47% in Shinyanga in the northwest to 71% in Dar es Salaam region. Regions in the eastern half of the country have higher coverage than in the western half of mainland. The MDG coverage score is strongly positively correlated with health systems strength (r = 0.84). Controlling for socioeconomic status in a multivariate analysis has no impact on the association between the MDG coverage score and health system strength. During 1991-2010 intervention coverage improved considerably in all regions, but the absolute gap between the regions did not change during the past two decades, with a gap of 22% between the top and bottom three regions. Interpretation The assessment of regional progress and performance in 21 regions of mainland Tanzania showed considerable inequalities in coverage and health system strength and allowed the identification of high and low-performing regions. Using summary measures derived from administrative, health facility and survey data, a subnational picture of progress and performance can be obtained for use in regular health sector reviews.	[Kumalija, Claud J.; Rubona, Josibert] Minist Hlth & Social Welf, Dept Policy & Planning, Dar Es Salaam, Tanzania; [Perera, Sriyanjit] Ctr Dis Control & Prevent, CTS Global, Dar Es Salaam, Tanzania; [Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ipuge, Yahya] World Bank, Dar Es Salaam, Tanzania; [Mboera, Leonard] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Hosseinpoor, Ahmad R.; Boerma, Ties] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland	Ifakara Health Institute; The World Bank; National Institute of Medical Research; World Health Organization	Boerma, T (corresponding author), World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland.	boermat@who.int	Hosseinpoor, Ahmad Reza/AFP-8422-2022	Hosseinpoor, Ahmad Reza/0000-0001-7322-672X	Global Alliance for Vaccines and Immunization (GAVI); Global Fund against AIDS, TB and Malaria	Global Alliance for Vaccines and Immunization (GAVI); Global Fund against AIDS, TB and Malaria	The Global Alliance for Vaccines and Immunization (GAVI) and the Global Fund against AIDS, TB and Malaria provided financial support to the analysis workshops.	[Anonymous], 2013, ANN HLTH SECT PERF R; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Boerma JT, 2014, PLOS MED, V11, DOI [10.1371/journal.pmed.1001731, DOI 10.1371/J0URNAL.PMED.1001731]; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Fernandes QF, 2014, LANCET GLOB HEALTH, V2, pE468, DOI 10.1016/S2214-109X(14)70276-1; Heywood P, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-3; Ifakara Health Institute, 2012, INT MEASL ROUT IMM P; Macinko J, 2007, SOC SCI MED, V65, P2070, DOI 10.1016/j.socscimed.2007.06.028; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Massyn N, 2013, S HLTH BAROMETER 201; Ministry of Health and Social Welfare, 2012, ANN HLTH SECT PERF P; Ministry of Health and Social Welfare, 2009, NAT HLTH SECT STRAT; Ministry of Health and Social Welfare, 2012, ANN HLTH SECT PERF P; [Ministry of Health and Social Welfare WHO Ifakara Health Institute National Institute of Medical Research], 2013, MIDT AN REV PERF HLT; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; National Bureau of Statistics, 2013, POP HOUS CENS 2012 P, V1; National Bureau of Statistics Dar es Salaam Tanzania, 2005, TANZ DEM HLTH SURV 2; [National Bureau of Statistics (NBS) Macro International Inc], 1992, TANZ DEM HLTH SURV 1; [National Bureau of Statistics (NBS) Macro International Inc], 1997, TANZ DEM HLTH SURV 1; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS) [Tanzania] & ORC Macro, 2005, TANZ HIV AIDS IND SU; UNICEF, 2020, LEV TRENDS CHILD MOR; World Health Organization, 2011, MON EV REV NAT HLTH	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142066	10.1371/journal.pone.0142066	http://dx.doi.org/10.1371/journal.pone.0142066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536351	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400126
J	Omarova, EO; Nazarov, PA; Firsov, AM; Strakhovskaya, MG; Arkhipova, AY; Moisenovich, MM; Agapov, II; Ol'shevskaya, VA; Zaitsev, AV; Kalinin, VN; Kotova, EA; Antonenko, YN				Omarova, Elena O.; Nazarov, Pavel A.; Firsov, Alexander M.; Strakhovskaya, Marina G.; Arkhipova, Anastasia Yu.; Moisenovich, Mikhail M.; Agapov, Igor I.; Ol'shevskaya, Valentina A.; Zaitsev, Andrey V.; Kalinin, Valery N.; Kotova, Elena A.; Antonenko, Yuri N.			Carboranyl-Chlorin e(6) as a Potent Antimicrobial Photosensitizer	PLOS ONE			English	Article							NEUTRON-CAPTURE THERAPY; PHOTODYNAMIC INACTIVATION; ESCHERICHIA-COLI; MEMBRANE PERMEABILIZATION; BORON; BINDING; PHOTOINACTIVATION; DERIVATIVES; CHEMISTRY; PHTHALOCYANINES	Antimicrobial photodynamic inactivation is currently being widely considered as alternative to antibiotic chemotherapy of infective diseases, attracting much attention to design of novel effective photosensitizers. Carboranyl-chlorin-e(6) (the conjugate of chlorin e(6) with carborane), applied here for the first time for antimicrobial photodynamic inactivation, appeared to be much stronger than chlorin e(6) against Gram-positive bacteria, such as Bacillus subtilis, Staphyllococcus aureus and Mycobacterium sp. Confocal fluorescence spectroscopy and membrane leakage experiments indicated that bacteria cell death upon photodynamic treatment with carboranyl-chlorin-e(6) is caused by loss of cell membrane integrity. The enhanced photobactericidal activity was attributed to the increased accumulation of the conjugate by bacterial cells, as evaluated both by centrifugation and fluorescence correlation spectroscopy. Gram-negative bacteria were rather resistant to antimicrobial photodynamic inactivation mediated by carboranyl-chlorin-e(6). Unlike chlorin e(6), the conjugate showed higher (compared to the wild-type strain) dark toxicity with Escherichia coli Delta tolC mutant, deficient in TolC-requiring multidrug efflux transporters.	[Omarova, Elena O.; Nazarov, Pavel A.; Firsov, Alexander M.; Kotova, Elena A.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Strakhovskaya, Marina G.; Arkhipova, Anastasia Yu.; Moisenovich, Mikhail M.; Agapov, Igor I.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Strakhovskaya, Marina G.] FMBA, Fed Sci & Clin Ctr Specialized Med Serv & Med Tec, Moscow, Russia; [Agapov, Igor I.] Shumakov Res Ctr Transplantol & Artificial Organs, Moscow, Russia; [Ol'shevskaya, Valentina A.; Zaitsev, Andrey V.; Kalinin, Valery N.] Russian Acad Sci, Nesmeyanov Inst Organoelement Cpds, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds	Kotova, EA (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	kotova@genebee.msu.ru	Nazarov, Pavel A/G-7885-2018; Moisenovich, Michael/D-9428-2014; Zaitsev, Andrei/R-4081-2016; Strakhovskaya, Marina/I-5529-2012; Agapov, Igor/D-9450-2014; Arkhipova, Anastasiya Yur'evna/D-9432-2014; Ol'shevskaya, Valentina/ABA-9045-2020; Firsov, Alexander/AAD-1859-2019	Nazarov, Pavel A/0000-0003-1857-323X; Strakhovskaya, Marina/0000-0002-4571-0431; Agapov, Igor/0000-0002-0273-4601; Arkhipova, Anastasiya Yur'evna/0000-0001-6940-0406; Zaitsev, Andrei/0000-0001-6448-2561; Firsov, Alexander/0000-0001-5265-1348; Zaitsev, Artem/0000-0002-2314-0482	Russian Science Foundation [14-50-00029]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was financially supported by the Russian Science Foundation (No. 14-50-00029).	Alves E, 2014, FUTURE MED CHEM, V6, P141, DOI 10.4155/fmc.13.211; Antonenko YN, 2014, BBA-BIOMEMBRANES, V1838, P793, DOI 10.1016/j.bbamem.2013.11.012; Asano R, 2014, J PHOTOCH PHOTOBIO B, V140, P140, DOI 10.1016/j.jphotobiol.2014.07.008; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELLIN JS, 1969, ARCH BIOCHEM BIOPHYS, V132, P157, DOI 10.1016/0003-9861(69)90348-8; BERTOLONI G, 1990, FEMS MICROBIOL LETT, V71, P149; BERTOLONI G, 1985, J GEN MICROBIOL, V131, P2217; Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005; Denisov SS, 2014, CHEM COMMUN, V50, P15366, DOI 10.1039/c4cc04996a; Efremenko AV, 2014, PHOTOCH PHOTOBIO SCI, V13, P92, DOI 10.1039/c3pp50226k; Efremenko AV, 2012, PHOTOCH PHOTOBIO SCI, V11, P645, DOI 10.1039/c2pp05237g; Embleton ML, 2005, ANTIMICROB AGENTS CH, V49, P3690, DOI 10.1128/AAC.49.9.3690-3696.2005; Endo Y, 2001, CHEM BIOL, V8, P341, DOI 10.1016/S1074-5521(01)00016-3; Fanfrlik J, 2006, CHEMPHYSCHEM, V7, P1100, DOI 10.1002/cphc.200500648; Fomichev A Iu, 1991, Mikrobiologiia, V60, P507; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; FUJITA H, 1970, Journal of Radiation Research, V11, P9, DOI 10.1269/jrr.11.9; Gad F, 2004, ANTIMICROB AGENTS CH, V48, P2173, DOI 10.1128/AAC.48.6.2173-2178.2004; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; HAMBLIN MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI DOI 10.1039/B311900A; Hao E, 2008, ORG BIOMOL CHEM, V6, P3732, DOI 10.1039/b807836j; HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501; Horiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108642; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Issa F, 2011, CHEM REV, V111, P5701, DOI 10.1021/cr2000866; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; Kato H, 2012, PHOTOCHEM PHOTOBIOL, V88, P423, DOI 10.1111/j.1751-1097.2012.01080.x; Kishen A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1343, DOI 10.1111/j.1751-1097.2010.00792.x; Komagoe K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1181, DOI 10.1039/c0pp00376j; Korbe S, 2006, CHEM REV, V106, P5208, DOI 10.1021/cr050548u; Kotova EA, 2011, BBA-BIOMEMBRANES, V1808, P2252, DOI 10.1016/j.bbamem.2011.05.018; Krishnamoorthy G, 2013, MOL MICROBIOL, V87, P982, DOI 10.1111/mmi.12143; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; LIBERMAN EA, 1970, BIOCHIM BIOPHYS ACTA, V196, P221, DOI 10.1016/0005-2736(70)90010-6; Lopes D, 2014, J PHOTOCH PHOTOBIO B, V141, P145, DOI 10.1016/j.jphotobiol.2014.08.024; Luguya R, 2006, BIOORGAN MED CHEM, V14, P5890, DOI 10.1016/j.bmc.2006.05.026; MALIK Z, 1990, J PHOTOCH PHOTOBIO B, V5, P281, DOI 10.1016/1011-1344(90)85044-W; Mikula P, 2014, J PHOTOCH PHOTOBIO B, V138, P230, DOI 10.1016/j.jphotobiol.2014.04.014; Minnock A, 1996, J PHOTOCH PHOTOBIO B, V32, P159, DOI 10.1016/1011-1344(95)07148-2; Moisenovich MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012717; Mojzisova H, 2009, PHOTOCH PHOTOBIO SCI, V8, P778, DOI 10.1039/b822269j; Nitzan Y, 2001, CURR MICROBIOL, V42, P408, DOI 10.1007/s002840010238; O'Riordan K, 2005, PHOTODIAGN PHOTODYN, V2, P247, DOI 10.1016/S1572-1000(05)00099-2; Ol'shevskaya VA, 2009, BIOORGAN MED CHEM, V17, P1297, DOI 10.1016/j.bmc.2008.12.016; Oros G, 1999, AMINO ACIDS, V17, P357, DOI 10.1007/BF01361661; Pashkovskaya A, 2010, LANGMUIR, V26, P5726, DOI 10.1021/la903867a; Pereira MA, 2014, PHOTOCH PHOTOBIO SCI, V13, P680, DOI 10.1039/c3pp50408e; Perevoshchikova IV, 2008, BBA-BIOMEMBRANES, V1778, P2182, DOI 10.1016/j.bbamem.2008.04.008; Pudziuvyte B, 2011, PHOTOCH PHOTOBIO SCI, V10, P1046, DOI 10.1039/c1pp05028a; Ratajski Michal, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P159, DOI 10.2174/187152006776119126; Rokitskaya TI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P975, DOI 10.1134/S0006297912090039; Rokitskaya TI, 2014, FEBS LETT, V588, P1590, DOI 10.1016/j.febslet.2014.02.046; Schafer M, 1998, INT J RADIAT BIOL, V74, P249, DOI 10.1080/095530098141636; Simon C, 2014, J PHOTOCH PHOTOBIO B, V141, P113, DOI 10.1016/j.jphotobiol.2014.09.015; Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595; Spesia MB, 2009, PHOTODIAGN PHOTODYN, V6, P52, DOI 10.1016/j.pdpdt.2009.01.003; Strakhovskaya MG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1305, DOI 10.1134/S0006297909120025; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; TOTANI T, 1981, J MED CHEM, V24, P1492, DOI 10.1021/jm00144a024; Uliana MP, 2014, PHOTOCH PHOTOBIO SCI, V13, P1137, DOI 10.1039/c3pp50376c; Valduga G, 1999, BIOCHEM BIOPH RES CO, V256, P84, DOI 10.1006/bbrc.1999.0190; Valliant JF, 2002, COORDIN CHEM REV, V232, P173, DOI 10.1016/S0010-8545(02)00087-5; Verma S, 2009, PHOTOCHEM PHOTOBIOL, V85, P111, DOI 10.1111/j.1751-1097.2008.00403.x; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13	65	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141990	10.1371/journal.pone.0141990	http://dx.doi.org/10.1371/journal.pone.0141990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535905	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400113
J	Sengupta, A; McConkey, KR; Radhakrishna, S				Sengupta, Asmita; McConkey, Kim R.; Radhakrishna, Sindhu			Primates, Provisioning and Plants: Impacts of Human Cultural Behaviours on Primate Ecological Functions	PLOS ONE			English	Article							SEED DISPERSAL; FOOD; FOREST; MACAQUES; STRATEGIES; MONKEYS	Human provisioning of wildlife with food is a widespread global practice that occurs in multiple socio-cultural circumstances. Provisioning may indirectly alter ecosystem functioning through changes in the eco-ethology of animals, but few studies have quantified this aspect. Provisioning of primates by humans is known to impact their activity budgets, diets and ranging patterns. Primates are also keystone species in tropical forests through their role as seed dispersers; yet there is no information on how provisioning might affect primate ecological functions. The rhesus macaque is a major human-commensal species but is also an important seed disperser in the wild. In this study, we investigated the potential impacts of provisioning on the role of rhesus macaques as seed dispersers in the Buxa Tiger Reserve, India. We studied a troop of macaques which were provisioned for a part of the year and were dependent on natural resources for the rest. We observed feeding behaviour, seed handling techniques and ranging patterns of the macaques and monitored availability of wild fruits. Irrespective of fruit availability, frugivory and seed dispersal activities decreased when the macaques were provisioned. Provisioned macaques also had shortened daily ranges implying shorter dispersal distances. Finally, during provisioning periods, seeds were deposited on tarmac roads that were unconducive for germination. Provisioning promotes human-primate conflict, as commensal primates are often involved in aggressive encounters with humans over resources, leading to negative consequences for both parties involved. Preventing or curbing provisioning is not an easy task as feeding wild animals is a socio-cultural tradition across much of South and South-East Asia, including India. We recommend the initiation of literacy programmes that educate lay citizens about the ill-effects of provisioning and strongly caution them against the practice.	[Sengupta, Asmita; McConkey, Kim R.; Radhakrishna, Sindhu] Natl Inst Adv Studies, Sch Nat Sci & Engn, Bangalore, Karnataka, India		Sengupta, A (corresponding author), Natl Inst Adv Studies, Sch Nat Sci & Engn, Indian Inst Sci Campus, Bangalore, Karnataka, India.	asmita.sengupta@gmail.com	McConkey, Kim/AAP-5609-2021	McConkey, Kim/0000-0002-3793-7732	Department of Science and Technology, Government of India [SB/SO/AS-128/2012]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	Funding: This study was supported by the Department of Science and Technology, Government of India [http://www.dst.gov.in/]: contract grant number SB/SO/AS-128/2012 awarded to SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 2013, INT J PRIMATOL, V34, P170, DOI 10.1007/s10764-012-9649-5; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Asaba N., 1984, ARASHIYAMA JAPANESE, V3, P55; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Becker DJ, 2015, ECOL LETT, V18, P483, DOI 10.1111/ele.12428; Becker DJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0309; Berman CM, 2007, INT J PRIMATOL, V28, P1123, DOI 10.1007/s10764-007-9199-4; Berman CM, 2002, INT J PRIMATOL, V23, P383, DOI 10.1023/A:1013891730061; BOUG A, 1994, REV ECOL-TERRE VIE, V49, P307; BRENNAN EJ, 1985, AFR J ECOL, V23, P35, DOI 10.1111/j.1365-2028.1985.tb00710.x; Chapman C.A., 2007, PRIMATES PERSPECTIVE, P510; Duncan RS, 2000, BIOTROPICA, V32, P33, DOI 10.1111/j.1744-7429.2000.tb00445.x; El Alami A, 2012, AM J PRIMATOL, V74, P210, DOI 10.1002/ajp.21989; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; Fuentes A, 2007, HUMANS MONKEYS ROCK; Garber PA, 1998, AM J PRIMATOL, V45, P3, DOI 10.1002/(SICI)1098-2345(1998)45:1<3::AID-AJP2>3.0.CO;2-#; Goldberg JL, 2001, BEHAV ECOL, V12, P490, DOI 10.1093/beheco/12.4.490; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hemery Gwenael, 2005, Western Indian Ocean Journal of Marine Science, V4, P123; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jefferies RL, 2004, INTEGR COMP BIOL, V44, P130, DOI 10.1093/icb/44.2.130; Julliot C, 1996, INT J PRIMATOL, V17, P239, DOI 10.1007/BF02735451; Kunz BK, 2008, J TROP ECOL, V24, P235, DOI 10.1017/S0266467408005014; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McConkey KR, 2015, TRENDS ECOL EVOL, V30, P182, DOI 10.1016/j.tree.2015.01.006; McConkey KR, 2000, AM J PRIMATOL, V52, P13, DOI 10.1002/1098-2345(200009)52:1&lt;13::AID-AJP2&gt;3.0.CO;2-Y; McKinney T., 2010, AM J PRIMATOL, V71, P1; Medhi Rekha, 2007, Primate Conservation, V22, P135, DOI 10.1896/052.022.0114; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; PRISTON N.E.C, 2013, MACAQUE CONNECTION, V43, P225; R Core Team, 2014, LANG ENV STAT COMP; Radhakrishna S, INT J PRIMA IN PRESS; Ram S, 2003, CURR SCI INDIA, V84, P780; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sekercioglu CH, 2010, CONSERVATION BIOLOGY FOR ALL, P45, DOI 10.1093/acprof:oso/9780199554232.003.0004; Sengupta A, 2014, AM J PRIMATOL, V76, P1175, DOI 10.1002/ajp.22302; Sinha A, 2005, CURR SCI INDIA, V89, P1166; Sivakumar S., 2006, Forktail, V22, P128; Sukumar R., 2003, STUDY ELEPHANT UNPUB; Tsuji Y, 2011, MAMM BIOL, V76, P525, DOI 10.1016/j.mambio.2011.01.001; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Zar JH., 2010, BIOSTAT ANAL, V5th	47	30	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140961	10.1371/journal.pone.0140961	http://dx.doi.org/10.1371/journal.pone.0140961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536365	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000364298400045
J	Ando, K; Carr, KM; Colle, M; Mansfeld, BN; Grumet, R				Ando, Kaori; Carr, Kevin M.; Colle, Marivi; Mansfeld, Ben N.; Grumet, Rebecca			Exocarp Properties and Transcriptomic Analysis of Cucumber (Cucumis sativus) Fruit Expressing Age-Related Resistance to Phytophthora capsici	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; GLUTATHIONE S-TRANSFERASES; SALICYLIC-ACID; CELL-DEATH; ONTOGENIC RESISTANCE; DEFENSE RESPONSES; POWDERY MILDEW; ARABIDOPSIS; PLANTS; ACCUMULATION	Very young cucumber (Cucumis sativus) fruit are highly susceptible to infection by the oomycete pathogen, Phytophthora capsici. As the fruit complete exponential growth, at approximately 10-12 days post pollination (dpp), they transition to resistance. The development of age-related resistance (ARR) is increasingly recognized as an important defense against pathogens, however, underlying mechanisms are largely unknown. Peel sections from cucumber fruit harvested at 8 dpp (susceptible) and 16 dpp (resistant) showed equivalent responses to inoculation as did whole fruit, indicating that the fruit surface plays an important role in defense against P. capsici. Exocarp from 16 dpp fruit had thicker cuticles, and methanolic extracts of peel tissue inhibited growth of P. capsici in vitro, suggesting physical or chemical components to the ARR. Transcripts specifically expressed in the peel vs. pericarp showed functional differentiation. Transcripts predominantly expressed in the peel were consistent with fruit surface associated functions including photosynthesis, cuticle production, response to the environment, and defense. Peel-specific transcripts that exhibited increased expression in 16 dpp fruit relative to 8 dpp fruit, were highly enriched (P<0.0001) for response to stress, signal transduction, and extracellular and transport functions. Specific transcripts included genes associated with potential physical barriers (i.e., cuticle), chemical defenses (flavonoid biosynthesis), oxidative stress, penetration defense, and molecular pattern (MAMP)-triggered or effector-triggered (R-gene mediated) pathways. The developmentally regulated changes in gene expression between peels from susceptible-and resistant-age fruits suggest programming for increased defense as the organ reaches full size.	[Ando, Kaori; Colle, Marivi; Mansfeld, Ben N.; Grumet, Rebecca] Michigan State Univ, Program Plant Breeding Genet & Biotechnol, E Lansing, MI 48824 USA; [Carr, Kevin M.] Michigan State Univ, Res Technol Support Facil, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Grumet, R (corresponding author), Michigan State Univ, Program Plant Breeding Genet & Biotechnol, E Lansing, MI 48824 USA.	grumet@msu.edu			USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative) [2011-51181-30661]; Pickle Packers International - Agriculture Research Fund	USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative); Pickle Packers International - Agriculture Research Fund	This work was supported by USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative) 2011-51181-30661, http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri, to RG and Pickle Packers International - Agriculture Research Fund, https://www.ilovepickles.org/, to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon BG, 1996, J HERED, V87, P219, DOI 10.1093/oxfordjournals.jhered.a022988; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Alcazar R, 2011, CURR OPIN PLANT BIOL, V14, P378, DOI 10.1016/j.pbi.2011.04.001; Ando K., 2009, THESIS MICHIGAN STAT; Ando K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-518; Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Ando K, 2009, J AM SOC HORTIC SCI, V134, P176, DOI 10.21273/JASHS.134.2.176; Asalf B, 2014, PHYTOPATHOLOGY, V104, P954, DOI 10.1094/PHYTO-12-13-0345-R; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Colle M, 2012, CUCURBITACEAE 2012: PROCEEDINGS OF THE XTH EUCARPIA MEETING ON GENETICS AND BREEDING OF CUCURBITACEAE, P585; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Dominguez E, 2015, TRENDS PLANT SCI, V20, P551, DOI 10.1016/j.tplants.2015.05.009; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Dunn AR, 2013, AUSTRALAS PLANT PATH, V42, P583, DOI 10.1007/s13313-013-0222-2; Fofana B, 2005, PHYTOPATHOLOGY, V95, P114, DOI 10.1094/PHYTO-95-0114; Fu FQ, 2008, J EXP BOT, V59, P2299, DOI 10.1093/jxb/ern093; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Ge YH, 2014, J PHYTOPATHOL, V162, P48, DOI 10.1111/jph.12158; Gee CT, 2008, PLANT DIS, V92, P1067, DOI 10.1094/PDIS-92-7-1067; Gevens AJ, 2006, PLANT DIS, V90, P1276, DOI 10.1094/PD-90-1276; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hugot K, 2004, PLANT PHYSIOL, V134, P858, DOI 10.1104/pp.103.034173; Humphry M, 2010, P NATL ACAD SCI USA, V107, P21896, DOI 10.1073/pnas.1003619107; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Kuzniak E, 2015, J PLANT PHYSIOL, V181, P9, DOI 10.1016/j.jplph.2015.03.017; Lin TC, 2009, J PHYTOPATHOL, V157, P40, DOI 10.1111/j.1439-0434.2008.01448.x; MARCELIS LFM, 1993, J HORTIC SCI, V68, P665, DOI 10.1080/00221589.1993.11516398; McNally DJ, 2003, PHYSIOL MOL PLANT P, V63, P293, DOI 10.1016/j.pmpp.2004.03.005; Meyer MD, 2013, PLANT DIS, V97, P446, DOI 10.1094/PDIS-01-12-0082-RE; Noutoshi Y, 2006, PLANT MOL BIOL, V62, P29, DOI 10.1007/s11103-006-9001-6; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Ongena M, 2000, PLANT PATHOL, V49, P523, DOI 10.1046/j.1365-3059.2000.00468.x; Oztetik E, 2008, BOT REV, V74, P419, DOI 10.1007/s12229-008-9013-9; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Pel MJC, 2013, J EXP BOT, V64, P1237, DOI 10.1093/jxb/ers262; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rusterucci C, 2005, PHYSIOL MOL PLANT P, V66, P222, DOI 10.1016/j.pmpp.2005.08.004; Sanogo S, 2012, CAN J PLANT PATHOL, V34, P479, DOI 10.1080/07060661.2012.732117; Sappl PG, 2004, PLANT MOL BIOL, V54, P205, DOI 10.1023/B:PLAN.0000028786.57439.b3; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106; Straus MR, 2010, PLANT J, V62, P628, DOI 10.1111/j.1365-313X.2010.04178.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Underwood W, 2008, J EXP BOT, V59, P3501, DOI 10.1093/jxb/ern205; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; Wilson DC, 2013, PLANT MOL BIOL, V83, P235, DOI 10.1007/s11103-013-0083-7; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yang XY, 2013, J EXP BOT, V64, P4541, DOI 10.1093/jxb/ert269; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006	62	14	14	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142133	10.1371/journal.pone.0142133	http://dx.doi.org/10.1371/journal.pone.0142133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528543	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600105
J	Kitsak, M; Elmokashfi, A; Havlin, S; Krioukov, D				Kitsak, Maksim; Elmokashfi, Ahmed; Havlin, Shlomo; Krioukov, Dmitri			Long-Range Correlations and Memory in the Dynamics of Internet Interdomain Routing	PLOS ONE			English	Article							PERSISTENCE; EVOLUTION; INSIGHTS	Data transfer is one of the main functions of the Internet. The Internet consists of a large number of interconnected subnetworks or domains, known as Autonomous Systems (ASes). Due to privacy and other reasons the information about what route to use to reach devices within other ASes is not readily available to any given AS. The Border Gateway Protocol (BGP) is responsible for discovering and distributing this reachability information to all ASes. Since the topology of the Internet is highly dynamic, all ASes constantly exchange and update this reachability information in small chunks, known as routing control packets or BGP updates. In the view of the quick growth of the Internet there are significant concerns with the scalability of the BGP updates and the efficiency of the BGP routing in general. Motivated by these issues we conduct a systematic time series analysis of BGP update rates. We find that BGP update time series are extremely volatile, exhibit long-term correlations and memory effects, similar to seismic time series, or temperature and stock market price fluctuations. The presented statistical characterization of BGP update dynamics could serve as a basis for validation of existing and developing better models of Internet interdomain routing.	[Kitsak, Maksim; Krioukov, Dmitri] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Elmokashfi, Ahmed] Simula Res Lab, Oslo, Norway; [Havlin, Shlomo] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Krioukov, Dmitri] Northeastern Univ, Dept Math, Boston, MA 02115 USA; [Krioukov, Dmitri] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA	Northeastern University; Bar Ilan University; Northeastern University; Northeastern University	Kitsak, M (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	m.kitsak@neu.edu	Krioukov, Dmitri/K-7035-2017; Havlin, Shlomo/ABF-1527-2020	Krioukov, Dmitri/0000-0001-9478-8182; Kitsak, Maksim/0000-0002-6862-6021	NSF [CNS-1344289, CNS-1442999, CNS-0964236, CNS-1441828, CNS-1039646]; DARPA grant [HR001112-10012]; Norwegian Research Council [240850/O70]; Cisco Systems	NSF(National Science Foundation (NSF)); DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Cisco Systems	This work was supported in part by NSF grants nos. CNS-1344289, CNS-1442999, CNS-0964236, CNS-1441828, and CNS-1039646; DARPA grant no. HR001112-10012; Norwegian Research Council grant no. 240850/O70; and Cisco Systems.	Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Beran J., 1994, STAT LONG MEMORY PRO, V61; Boguna M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1063; Bunde A., 2002, SCI DISASTERS CLIMAT, V2; Caesar M, 2003, UCBCSD041302; Cittadini L, 2010, IEEE J SEL AREA COMM, V28, P1238, DOI 10.1109/JSAC.2010.101002; Eichner JF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011128; Eichner JF, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046133; Elmokashfi A, 2011, IEEE ACM T NETWORKIN; Elmokashfi A, 2012, IEEE ACM T NETWORK, V20, P571, DOI 10.1109/TNET.2011.2168610; Farinacci D, 2012, LOCATOR ID SEPARATIO; Feldmann A, 2004, ACM SIGCOMM COMP COM, V34, P205, DOI 10.1145/1030194.1015491; Francois Pierre, 2007, IEEE Transactions on Network and Service Management, V4, P1, DOI 10.1109/TNSM.2007.021102; Gao JB, 2012, J R SOC INTERFACE, V9, P1956, DOI 10.1098/rsif.2011.0846; Hawkinson John, 1996, RFC1930; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Koscielny-Bunde E, 1998, PHYS REV LETT, V81, P729, DOI 10.1103/PhysRevLett.81.729; Labovitz C, 2000, ACM SIGCOMM COMP COM, V30, P175, DOI 10.1145/347057.347428; Lan W, 2002, IMW 2002: PROCEEDINGS OF THE SECOND INTERNET MEASUREMENT WORKSHOP, P183, DOI 10.1145/637201.637231; Lennartz S, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/69001; Meyer D., 2007, IAB WORKSH ROUT ADDR; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Petersen Alexander M., 2012, SCI REPORTS, V2; Preis T., 2012, SCI REPORTS, V2; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Rekhter Y., 2006, RFC4271; Valler N. C., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P900, DOI 10.1109/INFCOMW.2011.5928940; Varghese G., 2004, NETWORK ALGORITHMICS; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102	31	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141481	10.1371/journal.pone.0141481	http://dx.doi.org/10.1371/journal.pone.0141481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529312	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600031
J	Mchitarjan, I; Reisenzein, R				Mchitarjan, Irina; Reisenzein, Rainer			The Culture-Transmission Motive in Immigrants: A World-Wide Internet Survey	PLOS ONE			English	Article							IDENTITY; 2ND-GENERATION; ADOLESCENTS; ACCULTURATION; BICULTURALISM; GERMANY; CONTEXT	A world-wide internet survey was conducted to test central assumptions of a recent theory of cultural transmission in minorities proposed by the authors. 844 1(st) to 2(nd) generation immigrants from a wide variety of countries recruited on a microjob platform completed a questionnaire designed to test eight hypotheses derived from the theory. Support was obtained for all hypotheses. In particular, evidence was obtained for the continued presence, in the immigrants, of the culture-transmission motive postulated by the theory: the desire to maintain the culture of origin and transmit it to the next generation. Support was also obtained for the hypothesized anchoring of the culture-transmission motive in more basic motives fulfilled by cultural groups, the relative intra- and intergenerational stability of the culture-transmission motive, and its motivating effects for action tendencies and desires that support cultural transmission under the difficult conditions of migration. Furthermore, the findings suggest that the assumption that people have a culture-transmission motive belongs to the folk psychology of sociocultural groups, and that immigrants regard the fulfillment of this desire as a moral right.	[Mchitarjan, Irina] Univ Greifswald, Inst Sci Educ, D-17487 Greifswald, Germany; [Reisenzein, Rainer] Univ Greifswald, Inst Psychol, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Mchitarjan, I (corresponding author), Univ Greifswald, Inst Sci Educ, D-17487 Greifswald, Germany.	irina.mchitarjan@uni-greifswald.de						Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Alba Richard D., 1990, ETHNIC IDENTITY TRAN; Barni D, 2013, INTERGENERATIONAL RELATIONS: EUROPEAN PERSPECTIVES ON FAMILY AND SOCIETY, P101; Batista GEAPA., 2002, SER FRONT ARTIF INTE, V87, P48; Berry JW, 2006, APPL PSYCHOL-INT REV, V55, P303, DOI 10.1111/j.1464-0597.2006.00256.x; Birman D, 1994, FOCUS, V8, P9; Bisin A., 2011, HDB SOCIAL EC, V1A, P339; Boos-Nunning U, 2006, VIELE WELTEN LEBEN L; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Brewer MB., 2000, HDB RES METHODS SOCI, P2; Conte R., 1995, COGNITIVE SOCIAL ACT; Deutsche Gesellschaft fur Psychologie (DGPs), 2004, ETH RICHTL DGPS BDP; Drasgow F, 2005, ADAPTING ED PSYCHOL, P294; Esser H., 1999, ALLGEMEINE GRUNDLAGE; Esser Hartmut, 1980, ASPEKTE WANDERUNGSSO; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Feidel-Mertz H, 2004, SHOFAR, V23, P71; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hirth M., 2011, 2011 5 INT C INN MOB, P322, DOI [10.1109/IMIS.2011.89, DOI 10.1109/IMIS.2011.89]; Huynh QL, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P827, DOI 10.1007/978-1-4419-7988-9_35; KALISH RA, 1972, J MARRIAGE FAM, V34, P49, DOI 10.2307/349629; Kaufmann Nicolas, 2011, P 17 AM C INF SYST A; Klein T, 2001, J COMP FAM STUD, V32, P325, DOI 10.3138/jcfs.32.3.325; Klinger E., 2004, HDB MOTIVATIONAL COU, P3, DOI DOI 10.1002/9780470713129.CH1; Knafo A, 2001, J CROSS CULT PSYCHOL, V32, P213, DOI 10.1177/0022022101032002008; Knafo a, 2009, CULTURAL TRANSMISSIO, P240, DOI DOI 10.1017/CB09780511804670.012; Krosnick JA, 2010, SURV RES METHODS-GER, V4, P61, DOI [10.18148/srm/2010.v4i1.2682, DOI 10.18148/SRM/2010.V4I1.2682, DOI 10.18148/SRM/2010]; Layton-Henry Z., 2001, INT ENCY SOCIAL BEHA, V14, P9894; Leiner DJ., 2019, SOSCI SURVEY VERSION; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; May S, 2005, LANGUAGE MINORITY RI; Mchitarjan I., 2014, INTERCULTURE J, V13, P25; Mchitarjan I., 2014, INTERDISCIPLINES J H, V5, P1; Mchitarjan I, 2013, ISRN INT SCHOLARLY R, V2013; Mchitarjan I, 2014, MIGRATION FAMILIE GE, P131; Mchitarjan I, 2006, Z PADAGOGIK, V52, P732; Mchitarjan I, 2014, ETHNICITIES, V14, P181, DOI 10.1177/1468796813505553; Mchitarjan I, 2010, Z SOZIOL ERZIEH SOZI, V30, P421; Modood T, 2007, MULTICULTURALISM CIV; Nguyen AMD, 2007, SOC PERSONAL PSYCHOL, V1, P101, DOI 10.1111/j.1751-9004.2007.00029.x; Osborne J. W., 2011, BEST PRACTICES QUANT; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Park RE, 1950, RACE CULTURE, P81; PHINNEY JS, 1990, PSYCHOL BULL, V108, P499, DOI 10.1037/0033-2909.108.3.499; Polm R, 1995, ETHNISCHE MINDERHEIT, P340; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; R Core Team, 2021, R LANGUAGE ENV STAT; Rakic T, 2011, J PERS SOC PSYCHOL, V100, P16, DOI 10.1037/a0021522; Reisenzein R, 2006, HDB PSYCHOL, P239; Reisenzein R, 2015, INT J PSYCHOL, V50, P308, DOI 10.1002/ijop.12153; Reiss S, 2004, ZYGON, V39, P303, DOI 10.1111/j.1467-9744.2004.00575.x; Revelle W., 2020, PSYCH PROCEDURES PER; Richerson PJ., 2005, NOT GENES ALONE CULT; Rokeach M., 1973, NATURE HUMAN VALUES, DOI DOI 10.1111/J.1540-4560.1968.TB01466.X; Rumbaut RG, 2004, INT MIGR REV, V38, P1160; Sabatier C, 2008, J ADOLESCENCE, V31, P185, DOI 10.1016/j.adolescence.2007.08.001; SCHILLER NG, 1992, ANN NY ACAD SCI, V645, P1; Schonpflug U, 2001, J CROSS CULT PSYCHOL, V32, P174, DOI 10.1177/0022022101032002005; Schonpflug U, 2009, CULTURAL TRANSMISSIO; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Schwartz SJ, 2010, HUM DEV, V53, P26, DOI 10.1159/000268137; Sheldon KM, 2001, J PERS SOC PSYCHOL, V80, P325, DOI 10.1037/0022-3514.80.2.325; Simon B, 2008, J PERS SOC PSYCHOL, V95, P1354, DOI 10.1037/a0012630; Sober E, 1998, EVOLUTION PSYCHOL UN; Templ M, 2013, VIM VISUALIZATION IM; Thompson B., 2004, EXPLORATORY CONFIRMA, DOI [10.1037/10694-000, DOI 10.1037/10694-000]; Tukey JW, 1977, EXPLORATORY DATA ANA; Umana-Taylor AJ, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P791, DOI 10.1007/978-1-4419-7988-9_33; Verkuyten Maykel, 2005, SOCIAL PSYCHOL ETHNI; Wilson David Sloan, 2002, DARWINS CATHEDRAL EV	70	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141625	10.1371/journal.pone.0141625	http://dx.doi.org/10.1371/journal.pone.0141625			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529599	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600044
J	Quan, JH; Chu, JQ; Kwon, J; Choi, IW; Ismail, HAHA; Zhou, W; Cha, GH; Zhou, Y; Yuk, JM; Jo, EK; Lee, YH				Quan, Juan-Hua; Chu, Jia-Qi; Kwon, Jaeyul; Choi, In-Wook; Ismail, Hassan Ahmed Hassan Ahmed; Zhou, Wei; Cha, Guang-Ho; Zhou, Yu; Yuk, Jae-Min; Jo, Eun-Kyeong; Lee, Young-Ha			Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; INFECTION; RESISTANCE; ACTIVATION; EXPRESSION; CYTOKINE; PROTEIN; INNATE; MICE	Interleukin (IL)-23 and IL-12 are closely related in structure, and these cytokines regulate both innate and adaptive immunity. However, the precise signaling networks that regulate the production of each in Toxoplasma gondii-infected THP-1 monocytic cells, particularly the PI3K/AKT and MAPK signaling pathways, remain unknown. In the present study, T. gondii infection upregulated the expression of IL-23 and IL-12 in THP-1 cells, and both cytokines increased with parasite dose. IL-23 secretion was strongly inhibited by TLR2 monoclonal antibody (mAb) treatment in a dose-dependent manner and by TLR2 siRNA transfection, whereas IL-12 secretion was strongly inhibited by TLR4 mAb treatment dose-dependently and by TLR4 siRNA transfection. IL-23 production was dose-dependently inhibited by the PI3K inhibitors LY294002 and wortmannin, whereas IL-12 production increased dose-dependently. THP- 1 cells exposed to live T. gondii tachyzoites underwent rapid p38 MAPK, ERK1/2 and JNK activation. IL-23 production was significantly upregulated by the p38 MAPK inhibitor SB203580 dose-dependently, whereas pretreatment with 10 mu M SB203580 significantly downregulated IL-12 production. ERK1/2 inhibition by PD98059 was significantly downregulated IL-23 production but upregulated IL-12 production. JNK inhibition by SP600125 upregulated IL-23 production, but IL-12 production was significantly downregulated dose-dependently. T. gondii infection resulted in AKT activation, and AKT phosphorylation was inhibited dose-dependently after pretreatment with PI3K inhibitors. In T. gondii-infected THP- 1 cells, ERK1/2 activation was regulated by PI3K; however, the phosphorylation of p38 MAPK and JNK was negatively modulated by the PI3K signaling pathway. Collectively, these results indicate that IL-23 production in T. gondii-infected THP-1 cells was regulated mainly by TLR2 and then by PI3K and ERK1/2; however, IL-12 production was mainly regulated by TLR4 and then by p38 MAPK and JNK. Our findings provide new insight concerning the intracellular networks of the PI3K/AKT and MAPK signaling cascades for regulating T. gondii- induced IL-23 and IL-12 secretion in human monocytic cells.	[Quan, Juan-Hua; Zhou, Yu] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang 524001, Guangdong, Peoples R China; [Chu, Jia-Qi] Guangdong Med Coll, Affiliated Hosp, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang 524001, Peoples R China; [Kwon, Jaeyul] Chungnam Natl Univ, Sch Med, Dept Med Educ, Taejon 301131, South Korea; [Choi, In-Wook; Ismail, Hassan Ahmed Hassan Ahmed; Zhou, Wei; Cha, Guang-Ho; Yuk, Jae-Min; Lee, Young-Ha] Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon 301131, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301131, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon 301131, South Korea	Guangdong Medical University; Guangdong Medical University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University	Lee, YH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Infect Biol, Taejon 301131, South Korea.	yhalee@cnu.ac.kr		Kwon, Jaeyul/0000-0002-2452-4111; Yuk, Jae-Min/0000-0002-0630-9194; Cha, Guang-Ho/0000-0003-2639-1727; Eun-Kyeong, Jo/0000-0001-7191-0587; Ismail, Hassan Ahmed Hassan Ahmed/0000-0001-6554-9596	National Research Foundation of Korea (NRF) - Korean government (MSIP) [20070054932]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2057655]; National Natural Science Foundation of China [81300368, 81301449]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (No. 20070054932), and supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2014R1A1A2057655). This study was also supported by grants from the National Natural Science Foundation of China (Grant No. 81300368 to Juan-Hua Quan and Grant No. 81301449 to Jia-Qi Chu).	Aldebert D, 2007, CYTOKINE, V37, P206, DOI 10.1016/j.cyto.2007.03.012; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Del Rio L, 2004, J IMMUNOL, V172, P6954, DOI 10.4049/jimmunol.172.11.6954; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Quan JH, 2013, KOREAN J PARASITOL, V51, P85, DOI 10.3347/kjp.2013.51.1.85; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Sher A, 2003, IMMUNOL RES, V27, P521, DOI 10.1385/IR:27:2-3:521; Sukhumayasi W, 2010, EXP PARASITOL, V126, P415, DOI 10.1016/j.exppara.2010.01.019; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Valere A, 2003, PARASITE, V10, P59, DOI 10.1051/parasite/2003101p59; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	35	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141550	10.1371/journal.pone.0141550	http://dx.doi.org/10.1371/journal.pone.0141550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528819	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600037
J	Shin, YS; Chang, WD; Park, J; Im, CH; Lee, SI; Kim, IY; Jang, DP				Shin, Young Seok; Chang, Won-du; Park, Jinsick; Im, Chang-Hwan; Lee, Sang In; Kim, In Young; Jang, Dong Pyo			Correlation between Inter-Blink Interval and Episodic Encoding during Movie Watching	PLOS ONE			English	Article							SHORT-TERM-MEMORY; VISUAL SUPPRESSION; PARKINSONS-DISEASE; EYEBLINK ACTIVITY; EYE BLINKING; ATTENTION; MOVEMENTS; HYPEREXCITABILITY; EXPLANATION; SACCADES	Human eye blinking is cognitively suppressed to minimize loss of visual information for important real-world events. Despite the relationship between eye blinking and cognitive state, the effect of eye blinks on cognition in real-world environments has received limited research attention. In this study, we focused on the temporal pattern of inter-eye blink interval (IEBI) during movie watching and investigated its relationship with episodic memory. As a control condition, 24 healthy subjects watched a nature documentary that lacked a specific story line while electroencephalography was performed. Immediately after viewing the movie, the subjects were asked to report its most memorable scene. Four weeks later, subjects were asked to score 32 randomly selected scenes from the movie, based on how much they were able to remember and describe. The results showed that the average IEBI was significantly longer during the movie than in the control condition. In addition, the significant increase in IEBI when watching a movie coincided with the most memorable scenes of the movie. The results suggested that the interesting episodic narrative of the movie attracted the subjects' visual attention relative to the documentary clip that did not have a story line. In the episodic memory test executed four weeks later, memory performance was significantly positively correlated with IEBI (p<0.001). In summary, IEBI may be a reliable bio-marker of the degree of concentration on naturalistic content that requires visual attention, such as a movie.	[Shin, Young Seok; Chang, Won-du; Park, Jinsick; Im, Chang-Hwan; Kim, In Young; Jang, Dong Pyo] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Sang In] Hanyang Univ, Dept Theater & Film, Seoul 133791, South Korea	Hanyang University; Hanyang University	Jang, DP (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.	dongpjang@hanyang.ac.kr	Im, Chang-Hwan/ABB-4391-2021	Im, Chang-Hwan/0000-0003-3795-3318; Chang, Won-Du/0000-0002-7437-4211	ICT R&D program of Ministry of Science, ICT and future Planning (MSIP)/Institute for Information and Communications Technology Promotion (IITP) [KI10045461]	ICT R&D program of Ministry of Science, ICT and future Planning (MSIP)/Institute for Information and Communications Technology Promotion (IITP)	This work was supported by ICT R&D program of Ministry of Science, ICT and future Planning (MSIP)/Institute for Information and Communications Technology Promotion (IITP) [KI10045461, Development of cultural contents evaluation technology based on real-time bio-signal of multiple subjects]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Anund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064782; Bacher LF, 2004, DEV PSYCHOBIOL, V44, P95, DOI 10.1002/dev.10162; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Bodis-Wollner I, 1999, NEUROLOGY, V53, P1800, DOI 10.1212/WNL.53.8.1800; Bristow D, 2005, CURR BIOL, V15, P1296, DOI 10.1016/j.cub.2005.06.025; Cardona G, 2014, CURR EYE RES, V39, P239, DOI 10.3109/02713683.2013.841256; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Chang WD, 2014, J APPL MATH, DOI 10.1155/2014/528071; Chun MM, 2011, NEURON, V72, P520, DOI 10.1016/j.neuron.2011.10.026; Doughty MJ, 2002, OPTOMETRY VISION SCI, V79, P439, DOI 10.1097/00006324-200207000-00013; Drew GC, 1951, Q J EXP PSYCHOL, V3, P73, DOI 10.1080/17470215108416776; EISENSTEIN S, 1947, FILM SENSE; FOGARTY C, 1989, INT J PSYCHOPHYSIOL, V8, P35, DOI 10.1016/0167-8760(89)90017-2; FUKUDA K, 1994, PERCEPT MOTOR SKILL, V79, P1599, DOI 10.2466/pms.1994.79.3f.1599; HALL A, 1945, BRIT J OPHTHALMOL, V29, P445, DOI 10.1136/bjo.29.9.445; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Higgins JS, 2009, ATTEN PERCEPT PSYCHO, V71, P1607, DOI 10.3758/APP.71.7.1607; HOLLAND MK, 1975, PERCEPT MOTOR SKILL, V41, P403, DOI 10.2466/pms.1975.41.2.403; Irwin DE, 2014, MEMORY, V22, P898, DOI 10.1080/09658211.2013.847959; Irwin DE, 2011, ATTEN PERCEPT PSYCHO, V73, P1374, DOI 10.3758/s13414-011-0111-0; Irwin DE, 2011, TUTORIALS VISUAL COG; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; MANNING KA, 1983, PERCEPT PSYCHOPHYS, V34, P250, DOI 10.3758/BF03202953; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; ORCHARD L N, 1991, Integrative Physiological and Behavioral Science, V26, P108, DOI 10.1007/BF02691032; PONDER ERIC, 1927, QUART JOUR EXP PHYSIOL, V18, P89; POSNER MI, 1984, J NEUROSCI, V4, P1863; SHIBUTANI H, 1984, EXP BRAIN RES, V55, P1; showbox.co.kr [internet]. SHOWBOX, 2007, THE CHAS; Shultz S, 2011, P NATL ACAD SCI USA, V108, P21270, DOI 10.1073/pnas.1109304108; STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; Turk-Browne NB, 2013, NEUROIMAGE, V66, P553, DOI 10.1016/j.neuroimage.2012.10.053; VanderWerf F, 2003, J NEUROPHYSIOL, V89, P2784, DOI 10.1152/jn.00557.2002; VOLKMANN FC, 1980, SCIENCE, V207, P900, DOI 10.1126/science.7355270; VOLKMANN FC, 1986, VISION RES, V26, P1401, DOI 10.1016/0042-6989(86)90164-1	40	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141242	10.1371/journal.pone.0141242	http://dx.doi.org/10.1371/journal.pone.0141242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529091	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600019
J	Tansley, G; Schuurman, N; Amram, O; Yanchar, N				Tansley, Gavin; Schuurman, Nadine; Amram, Ofer; Yanchar, Natalie			Spatial Access to Emergency Services in Low- and Middle-Income Countries: A GIS-Based Analysis	PLOS ONE			English	Article							TRAUMA MORTALITY PATTERNS; PREHOSPITAL TIME; SYSTEMS; CARE; SURVIVAL	Injury is a leading cause of the global disease burden, accounting for 10 percent of all deaths worldwide. Despite 90 percent of these deaths occurring in low and middle-income countries (LMICs), the majority of trauma research and infrastructure development has taken place in high-income settings. Furthermore, although accessible services are of central importance to a mature trauma system, there remains a paucity of literature describing the spatial accessibility of emergency services in LMICs. Using data from the Service Provision Assessment component of the Demographic and Health Surveys of Namibia and Haiti we defined the capabilities of healthcare facilities in each country in terms of their preparedness to provide emergency services. A Geographic Information System-based network analysis method was used to define 5- 10- and 50-kilometer catchment areas for all facilities capable of providing 24-hour care, higher-level resuscitative services or tertiary care. The proportion of a country's population with access to each level of service was obtained by amalgamating the catchment areas with a population layer. A significant proportion of the population of both countries had poor spatial access to lower level services with 25% of the population of Haiti and 51% of the population of Namibia living further than 50 kilometers from a facility capable of providing 24-hour care. Spatial access to tertiary care was considerably lower with 51% of Haitians and 72% of Namibians having no access to these higher-level services within 50 kilometers. These results demonstrate a significant disparity in potential spatial access to emergency services in two LMICs compared to analogous estimates from high-income settings, and suggest that strengthening the capabilities of existing facilities may improve the equity of emergency services in these countries. Routine collection of georeferenced patient and facility data in LMICs will be important to understanding how spatial access to services influences outcomes.	[Tansley, Gavin; Yanchar, Natalie] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS, Canada; [Schuurman, Nadine; Amram, Ofer] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada	Dalhousie University; Simon Fraser University	Schuurman, N (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	nadine@sfu.ca		amram, ofer/0000-0002-8835-3104				Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Central Intelligene Agency, WORLD FACTB ROADW; Deckelbaum DL, 2012, LANCET, V380, P713, DOI 10.1016/S0140-6736(11)61090-8; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Hsia RY, 2012, HEALTH POLICY PLANN, V27, P234, DOI 10.1093/heapol/czr023; Institut Haitien de l'Enfance II, 2013, EV PREST SERV SOINS; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mathers C, 2004, GLOB BURD DIS 2004 U; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Ministry of Health and Social Services, 2009, NAM HLTH FAC CENS HF; Mitchell AD, 2007, CAN J SURG, V50, P129; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Namibia Statistics Agency, 2011, POP CENS IND; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nations United Department of Economic and Social Affairs SD, 2014, WORLD STAT POCK; Nesbitt RC, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-25; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Whedon James M, 2013, J Emerg Trauma Shock, V6, P259, DOI 10.4103/0974-2700.120368; World Health Assembly 60, 2007, HLTH SYST EM CAR SYS; World Health Organization, INT MAN EM ESS SURG	31	32	32	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141113	10.1371/journal.pone.0141113	http://dx.doi.org/10.1371/journal.pone.0141113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528911	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600018
J	Wu, CJ; Lin, HJ; Weng, SF; Hsu, CC; Wang, JJ; Su, SB; Huang, CC; Guo, HR				Wu, Chia-Jung; Lin, Hung-Jung; Weng, Shih-Feng; Hsu, Chien-Chin; Wang, Jhi-Joung; Su, Shih-Bin; Huang, Chien-Cheng; Guo, How-Ran			Acute Myocardial Infarction Risk in Patients with Coronary Artery Disease Doubled after Upper Gastrointestinal Tract Bleeding: A Nationwide Nested Case-Control Study	PLOS ONE			English	Article							MANAGEMENT; HEMORRHAGE; ASPIRIN; TAIWAN; ANEMIA	Prior studies of upper gastrointestinal bleeding (UGIB) and acute myocardial infarction (AMI) are small, and long-term effects of UGIB on AMI have not been delineated. We investigated whether UGIB in patients diagnosed with coronary artery disease (CAD) increased their risk of subsequent AMI. This was a population-based, nested case-control study using Taiwan's National Health Insurance Research Database. After propensity-score matching for age, gender, comorbidities, CAD date, and follow-up duration, we identified 1,677 new-onset CAD patients with AMI (AMI([+])) between 2001 and 2006 as the case group and 10,062 new-onset CAD patients without (AMI([-])) as the control group. Conditional logistic regression was used to examine the association between UGIB and AMI. Compared with UGIB([-]) patients, UGIB([+]) patients had twice the risk for subsequent AMI (adjusted odds ratio [AOR] = 2.08; 95% confidence interval [CI], 1.72-2.50). In the subgroup analysis for gender and age, UGIB([+]) women (AOR = 2.70; 95% CI, 2.03-3.57) and patients < 65 years old (AOR = 2.23; 95% CI, 1.56-3.18) had higher odds of an AMI. UGIB([+]) AMI([+]) patients used nonsignificantly less aspirin than did UGIB([-]) AMI([+]) patients (27.69% vs. 35.61%, respectively). UGIB increased the risk of subsequent AMI in CAD patients, especially in women and patients < 65. This suggests that physicians need to use earlier and more aggressive intervention to detect UGIB and prevent AMI in CAD patients.	[Wu, Chia-Jung; Lin, Hung-Jung; Hsu, Chien-Chin; Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Lin, Hung-Jung] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan; [Lin, Hung-Jung; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Weng, Shih-Feng; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Su, Shih-Bin; Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Chien-Cheng; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Geriatr & Geronotol, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chi Mei Hospital; Taipei Medical University; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Kaohsiung Medical University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Huang, CC (corresponding author), Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan.	chienchenghuang@yahoo.com.tw; hrguo@mail.ncku.edu.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446; Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10440]	Chi-Mei Medical Center	This study was supported by grants CMFHR10440 from the Chi-Mei Medical Center. http://www.chimei.org.tw/.	Albeldawi M, 2010, CLEV CLIN J MED, V77, P131, DOI 10.3949/ccjm.77a.09035; Bellotto F, 2005, AM J MED, V118, P548, DOI 10.1016/j.amjmed.2005.01.026; Bhatti N, 1998, CHEST, V114, P1137, DOI 10.1378/chest.114.4.1137; CAPPELL MS, 1995, AM J GASTROENTEROL, V90, P1444; Cappell MS, 2000, GASTROENTEROL CLIN N, V29, P423, DOI 10.1016/S0889-8553(05)70121-7; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Chou P., 2003, VALIDATION COMORBIDI; Emenike E, 1999, MAYO CLIN PROC, V74, P235, DOI 10.4065/74.3.235; Feinstein LB, 2010, EMERG INFECT DIS, V16, P1410, DOI 10.3201/eid1609.091126; GOSTOUT CJ, 1992, J CLIN GASTROENTEROL, V14, P260, DOI 10.1097/00004836-199204000-00014; Holster IL, 2012, WORLD J GASTROENTERO, V18, P1202, DOI 10.3748/wjg.v18.i11.1202; Kaplan RC, 2001, J AM GERIATR SOC, V49, P126, DOI 10.1046/j.1532-5415.2001.49032.x; Lai H.-T., 1998, CHINESE J PUBLIC HLT, V17, P337; Lee CY, 2013, EUR J PREV CARDIOL, V20, P930, DOI 10.1177/2047487312451252; Lewis JD, 2002, AM J GASTROENTEROL, V97, P2540; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Viviane A, 2008, VALUE HEALTH, V11, P1, DOI 10.1111/j.1524-4733.2007.00208.x; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; YAVORSKI RT, 1995, AM J GASTROENTEROL, V90, P568; Zeidman A, 2004, ISR MED ASSOC J, V6, P16	21	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142000	10.1371/journal.pone.0142000	http://dx.doi.org/10.1371/journal.pone.0142000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529110	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600089
J	Liu, Y; Lv, HB; Jiang, XD; Hu, XD; Zhang, MZ; Li, XM				Liu, Yan; Lv, Huibin; Jiang, Xiaodan; Hu, Xiaodan; Zhang, Mingzhou; Li, Xuemin			Intraocular Pressure Changes during Accommodation in Progressing Myopes, Stable Myopes and Emmetropes	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETER; AXIAL LENGTH; REBOUND TONOMETRY; REFRACTIVE ERROR; ICARE TONOMETER; GLAUCOMA; BIOMECHANICS; BIOMETRICS; THICKNESS; SUBGROUP	Purpose To investigate the changes of intraocular pressure (IOP) induced by 3-diopter (3 D) accommodation in progressing myopes, stable myopes and emmetropes. Design Cross-sectional study. Participants 318 subjects including 270 myopes and 48 emmetropes. Methods 195 progressing myopes, 75 stable myopes and 48 emmetropes participated in this study. All subjects had their IOP measured using iCare rebound tonometer while accommodative stimuli of 0 D and 3 D were presented. Main Outcome Measures IOP values without accommodation and with 3 D accommodation were measured in all subjects. Baseline IOPs and IOP changes were compared within and between groups. Results There was no significant difference in IOPs between progressing myopes, stable myopes and emmetropes when no accommodation was induced (17.47 +/- 3.46, 16.62 +/- 2.98 and 16.80 +/- 3.62 respectively, p > 0.05). IOP experienced an insignificantly slight decrease after 3 D accommodation in three groups (mean change -0.19 +/- 2.16, -0.03 +/- 1.68 and -0.39 +/- 2.65 respectively, p > 0.05). Subgroup analysis showed in progressing myopic group, IOP of children (<18 years old) declined with accommodation while IOP of adults (>= 18 years) increased, and the difference was statistically significant (p = 0.008). However, after excluding the age factor, accommodation induced IOP changes of high progressing myopes (<=- 6 D), low, moderate and non- myopes (>-6 D) was not significantly different after Bonferroni correction (p = 0.838). Conclusions Although no difference was detected between the baseline IOPs and accommodation induced IOP changes in progressing myopes, stable myopes and emmetropes, this study found accommodation could cause transient IOP elevation in adult progressing myopes.	[Liu, Yan; Lv, Huibin; Jiang, Xiaodan; Hu, Xiaodan; Zhang, Mingzhou; Li, Xuemin] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China	Peking University	Li, XM (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	lxmlxm66@sina.com.cn		Li, Xuemin/0000-0002-4018-9974; Li, Xuemin/0000-0001-7822-4694				ARMALY MF, 1962, INVEST OPHTH VISUAL, V1, P480; Au Eong K G, 1993, Singapore Med J, V34, P29; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Brusini P, 2006, J GLAUCOMA, V15, P213, DOI 10.1097/01.ijg.0000212208.87523.66; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Drexler W, 1998, INVEST OPHTH VIS SCI, V39, P2140; Faria-Ribeiro M, 2013, OPTOMETRY VISION SCI, V90, P9, DOI 10.1097/OPX.0b013e318278153c; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; GOSS DA, 1985, AM J OPTOM PHYS OPT, V62, P470; GREENE PR, 1980, AM J OPTOM PHYS OPT, V57, P902; Hartwig A, 2011, VISION RES, V51, P1712, DOI 10.1016/j.visres.2011.05.014; JENSEN H, 1992, DOC OPHTHALMOL, V82, P249, DOI 10.1007/BF00160772; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Loh KL, 2015, AM J OPHTHALMOL, V159, P945, DOI 10.1016/j.ajo.2015.01.029; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Manny RE, 2008, OPTOMETRY VISION SCI, V85, P97, DOI 10.1097/OPX.0b013e3181622633; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Moghimi Sasan, 2014, J Ophthalmic Vis Res, V9, P439, DOI 10.4103/2008-322X.150812; Muttuvelu DV, 2012, ACTA OPHTHALMOL, V90, P322, DOI 10.1111/j.1755-3768.2010.01987.x; Nomura H, 2004, OPHTHAL PHYSL OPT, V24, P41, DOI 10.1046/j.1475-1313.2003.00158.x; Pruett R C, 1988, Acta Ophthalmol Suppl, V185, P117; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Read SA, 2010, OPTOMETRY VISION SCI, V87, P656, DOI 10.1097/OPX.0b013e3181e87dd3; Read SA, 2010, BRIT J OPHTHALMOL, V94, P332, DOI 10.1136/bjo.2009.166355; Schreiber W, 2007, OPHTHALMOLOGE, V104, P299, DOI 10.1007/s00347-007-1487-z; TOMLINSON A, 1970, BRIT J OPHTHALMOL, V54, P548, DOI 10.1136/bjo.54.8.548; Vandewalle E, 2009, EUR J OPHTHALMOL, V19, P783, DOI 10.1177/112067210901900516; Vera-Diaz FA, 2002, CURR EYE RES, V24, P289, DOI 10.1076/ceyr.24.4.289.8418; Yan L, 2014, EYE, V28, P1334, DOI 10.1038/eye.2014.208; Yeo ACH, 2006, ANN ACAD MED SINGAP, V35, P868	32	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141839	10.1371/journal.pone.0141839	http://dx.doi.org/10.1371/journal.pone.0141839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517725	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800084
J	Mehra, T; Muller, CTB; Volbracht, J; Seifert, B; Moos, R				Mehra, Tarun; Mueller, Christian Thomas Benedikt; Volbracht, Joerk; Seifert, Burkhardt; Moos, Rudolf			Predictors of High Profit and High Deficit Outliers under SwissDRG of a Tertiary Care Center	PLOS ONE			English	Article								Principles Case weights of Diagnosis Related Groups (DRGs) are determined by the average cost of cases from a previous billing period. However, a significant amount of cases are largely over-or underfunded. We therefore decided to analyze earning outliers of our hospital as to search for predictors enabling a better grouping under SwissDRG. Methods 28,893 inpatient cases without additional private insurance discharged from our hospital in 2012 were included in our analysis. Outliers were defined by the interquartile range method. Predictors for deficit and profit outliers were determined with logistic regressions. Predictors were shortlisted with the LASSO regularized logistic regression method and compared to results of Random forest analysis. 10 of these parameters were selected for quantile regression analysis as to quantify their impact on earnings. Results Psychiatric diagnosis and admission as an emergency case were significant predictors for higher deficit with negative regression coefficients for all analyzed quantiles (p<0.001). Admission from an external health care provider was a significant predictor for a higher deficit in all but the 90% quantile (p<0.001 for Q10, Q20, Q50, Q80 and p = 0.0017 for Q90). Burns predicted higher earnings for cases which were favorably remunerated (p<0.001 for the 90% quantile). Osteoporosis predicted a higher deficit in the most underfunded cases, but did not predict differences in earnings for balanced or profitable cases (Q10 and Q20: p<0.00, Q50: p = 0.10, Q80: p = 0.88 and Q90: p = 0.52). ICU stay, mechanical and patient clinical complexity level score (PCCL) predicted higher losses at the 10% quantile but also higher profits at the 90% quantile (p<0.001). Conclusion We suggest considering psychiatric diagnosis, admission as an emergencay case and admission from an external health care provider as DRG split criteria as they predict large, consistent and significant losses.	[Mehra, Tarun; Volbracht, Joerk; Moos, Rudolf] Univ Zurich Hosp, Med Directorate, CH-8091 Zurich, Switzerland; [Mueller, Christian Thomas Benedikt; Seifert, Burkhardt] Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Mehra, T (corresponding author), Univ Zurich Hosp, Med Directorate, CH-8091 Zurich, Switzerland.	tarun.mehra@usz.ch						[Anonymous], 2015, FALLPAUSCHALWENKATAL; [Anonymous], 2011, SWISSDEG 1 0 ABRECHU; [Anonymous], 2014, PACKAGE QUANTERG; [Anonymous], 2015, STELLUNGNAHME FMH SW; [Anonymous], 2014, HDB BETR RECHH SPIT; Bekelis K, 2016, J NEUROINTERV SURG, V8, P316, DOI 10.1136/neurintsurg-2014-011575; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Busse R, 2011, DIAGNOSIS RELATED GR; Carter G, 1994, COST ESTIMATES COST; Centers for Medicare and Medicaid Services (CMS) H, 2003, FED REGISTER, P34494; Cots F, 2004, HEALTH POLICY, V68, P159, DOI 10.1016/j.healthpol.2003.09.004; Dasgupta A, 2011, GENET EPIDEMIOL, V35, pS5, DOI 10.1002/gepi.20642; Fehst K, 2011, SCHWEIZERISCHE OPERA; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gesundheitsdirektion KZ, 2014, GESUNDHEISVERSORGUNG; Graubner B, 2011, ICD10GM 2012; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Innasimuthu AL, 2009, CAN J CARDIOL, V25, P369, DOI 10.1016/S0828-282X(09)70109-6; JENCKS SF, 1987, NEW ENGL J MED, V317, P679, DOI 10.1056/NEJM198709103171106; Koenker R, 2005, QUANTILE REGRESSION, DOI [10.1017/CBO9780511754098, DOI 10.1017/CBO9780511754098]; Lee TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089700; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Omachonu V K, 2004, Health Serv Manage Res, V17, P1, DOI 10.1258/095148404322772688; Pirson M, 2006, HEALTH POLICY, V76, P13, DOI 10.1016/j.healthpol.2005.04.008; R Core Team, 2021, R LANGUAGE ENV STAT; Ricci C, 2012, KODIERUNGSHANDUCH OF; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Tape, INTERPRETING DIAGNOS; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140874	10.1371/journal.pone.0140874	http://dx.doi.org/10.1371/journal.pone.0140874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517545	Green Published, gold			2022-12-27	WOS:000363920800011
J	Kigen, G; Busakhala, N; Ogaro, F; Chesire, E; Saat, N; Too, R; Nyandiko, W				Kigen, Gabriel; Busakhala, Naftali; Ogaro, Francis; Chesire, Emily; Saat, Nathan; Too, Robert; Nyandiko, Winstone			A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?	PLOS ONE			English	Review							COLD MEDICATIONS; DIPHENHYDRAMINE MONOINTOXICATION; ADULT LITERATURE; PEDIATRIC COUGH; MEDICINE ABUSE; ADVERSE EVENTS; CHILDREN; ANTIHISTAMINES; PROMETHAZINE; WARNINGS	Background Cough syrups are widely used in the developing world, but safety of their use in infants and children less than two years has not been well documented. Some syrups contain multiple combinations of such drugs as promethazine, diphenhydramine and ephedrine; which are individually now contraindicated in children less than two years. Despite this, the syrups are available as over the counter drugs and may be dispensed to mothers who are unaware of the potentially hazardous effects to their infants. A descriptive cross-sectional study was used to investigate suitability of cough syrups sold within Eldoret municipality for use in children less than two years of age based on their formulations and available literature. Methods Two semi-structured questionnaires were administered to pharmacy attendants and mothers attending sick child clinic at a referral hospital to establish whether cough syrups containing more than one active ingredient of compounds, now contraindicated in children are administered to infants, and awareness of potential serious adverse effects. Data from labeled contents of cough syrups from retail pharmacies was recorded and corroborated with information from literature to determine those deemed to contain the ingredients. The second questionnaire was administered to mothers with children less than two years to ascertain whether they had used the identified syrups. A total of 260 mothers and 55 pharmacy attendants were interviewed. Results There was widespread use of the syrups in children, including infants, with 192 (74%) of the respondents having used identified syrups and over 90% of these on children less than 2 years including those less than three months. 146 (76%) mothers had administered the syrup at double the recommended dose. Conclusion The regulatory authorities should make concerted efforts to discourage use of cough syrups containing ingredients that pose adverse events to infants, including campaigns to educate pharmacy workers and mothers.	[Kigen, Gabriel; Busakhala, Naftali] Moi Univ, Dept Pharmacol & Toxicol, Sch Med, Eldoret, Kenya; [Ogaro, Francis; Chesire, Emily] Moi Teaching & Referral Hosp, Dept Paediat, Eldoret, Kenya; [Saat, Nathan] Moi Univ, Dept Pharm, Hlth Serv, Eldoret, Kenya; [Too, Robert] Moi Univ, Sch Publ Hlth, Dept Epidemiol & Nutr, Eldoret, Kenya; [Nyandiko, Winstone] Moi Univ, Sch Med, Dept Child Hlth & Pediat, Eldoret, Kenya	Moi University; Moi University; Moi University; Moi University	Kigen, G (corresponding author), Moi Univ, Dept Pharmacol & Toxicol, Sch Med, Eldoret, Kenya.	gkigen@mu.ac.ke	Kigen, Gabriel K/C-8494-2018	Kigen, Gabriel K/0000-0002-5047-4066				ACCP, 2006, PAT INF PAR CHILD CO; American Academy of Pediatrics, 2021, AAP AACAP CHA DECL N; [Anonymous], 1995, Pediatrics, V95, P598; Ashkin E, 2013, J FAM PRACTICE, V62, P145; Avois L, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2006.027557; Baker AM, 2003, J FORENSIC SCI, V48, P425; BENADRYL, 2013, BENADRYL DIPH HYDR I; Berg Ansgar, 2010, Tidsskr Nor Laegeforen, V130, P2474, DOI 10.4045/tidsskr.10.0503; Braude D, 2008, ACAD EMERG MED, V15, P209, DOI 10.1111/j.1553-2712.2008.00060.x; BRONCHODILATE, 2012, BRONCHO DILATE EPH H; BRONCHOLATE, 2007, BRONCHOLATE SYRUP PR; BRONKAID Bayer Corporation, BRONK EPH SULF 25 MG; Buck ML, 2010, MONTHLY NEWSLETTER H, V16; Chang CC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006088.pub4; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Cooper R, 2013, HEALTH SOC CARE COMM, V21, P254, DOI 10.1111/hsc.12012; Cooper RJ, 2013, J SUBST USE, V18, P82, DOI 10.3109/14659891.2011.615002; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Davila I, 2013, J INVEST ALLERG CLIN, V23, P1; del Cuvillo A, 2007, J INVEST ALLERG CLIN, V17, P28; Duggal HS, 2001, AUST NZ J PSYCHIAT, V35, P250; FDA, 2006, INF HEALTHC PROF PRO; Goldman RD, 2011, PAED CHILD HEALT-CAN, V16, P564, DOI 10.1093/pch/16.9.564; Isbister GK, 2012, J PAEDIATR CHILD H, V48, P91, DOI 10.1111/j.1440-1754.2010.01780.x; Knol K, 2000, ALLERGY, V55, P31, DOI 10.1034/j.1398-9995.2000.00005.x; Kuffner E, 2010, AM J FOREN MED PATH, V31, P106, DOI 10.1097/PAF.0b013e3181c2159c; Lazarus SG, 2013, CLIN PEDIATR, V52, P534, DOI 10.1177/0009922813482761; Lokker N, 2009, PEDIATRICS, V123, P1464, DOI 10.1542/peds.2008-0854; Maglione M, 2005, AM J PSYCHIAT, V162, P189, DOI 10.1176/appi.ajp.162.1.189; Morin CM, 2005, SLEEP, V28, P1465, DOI 10.1093/sleep/28.11.1465; Nine JS, 2006, AM J FOREN MED PATH, V27, P36, DOI 10.1097/01.paf.0000188093.45675.ee; Ostroff C, 2011, CHEST, V140, P295, DOI 10.1378/chest.11-0981; PHENERGAN, 2010, PHENERGAN PROM HYDR; PPB, 2014, CHILDR OV THE COUNT; Rimsza ME, 2008, PEDIATRICS, V122, pE318, DOI 10.1542/peds.2007-3813; Ryan Teresa, 2008, Pediatr Nurs, V34, P174; Salocks C, 2003, OFFICE ENV HLTH HAZA; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Sen EF, 2011, BRIT J CLIN PHARMACO, V71, P943, DOI 10.1111/j.1365-2125.2010.03860.x; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; Shefrin AE, 2009, CAN FAM PHYSICIAN, V55, P1081; Simons FER, 2007, ARCH PEDIAT ADOL MED, V161, P105, DOI 10.1001/archpedi.161.1.105-a; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4; Standardmedia, 2014, WHY HON NOT COUGH SY; Starke PR, 2005, NEW ENGL J MED, V352, P2653, DOI 10.1056/NEJM200506233522522; Vassilev ZP, 2010, EXPERT OPIN DRUG SAF, V9, P233, DOI 10.1517/14740330903496410; Vernacchio L, 2008, PEDIATRICS, V122, pE323, DOI 10.1542/peds.2008-0498; Waris A, 2014, E AFRICAN MED J, V91	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142092	10.1371/journal.pone.0142092	http://dx.doi.org/10.1371/journal.pone.0142092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540251	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800055
J	Zhai, YM; Yang, Q; Hou, MM				Zhai, Yaming; Yang, Qian; Hou, Maomao			The Effects of Saline Water Drip Irrigation on Tomato Yield, Quality, and Blossom-End Rot Incidence-A 3a Case Study in the South of China	PLOS ONE			English	Article							ROOT-ZONE; DEFICIT IRRIGATION; FRUIT-QUALITY; SOIL; GROWTH; CALCIUM; CULTIVARS; PRODUCTIVITY; HOMEOSTASIS; TOLERANCE	Saline water resources are abundant in the coastal areas of south China. Most of these resources still have not been effectively utilized. A 3-year study on the effects of saline water irrigation on tomato yield, quality and blossom-end rot (BER) was conducted at different lower limits of soil matric potential (-10 kPa, -20 kPa, -30 kPa, -40 kPa and -50 kPa). Saline water differing in electrical conductivity (EC) (3 dS/m, 4 dS/m, 4.5 dS/m, 5 dS/m and 5.5 dS/m) was supplied to the plant after the seedling establishment. In all three years, irrigation water with 5.5 dS/m salinity reduced the maximum leaf area index (LAIm) and chlorophyll content the most significantly when compared with other salinity treatments. However, compared with the control treatment (CK), a slight increase in LAIm and chlorophyll content was observed with 3 similar to 4 dS/m salinity. Saline water improved tomato quality, including fruit density, soluble solid, total acid, vitamin C and the sugar-acid ratio. There was a positive relationship between the overall tomato quality and salinity of irrigation water, as analyzed by principal component analysis (PCA). The tomato yield decreased with increased salinity. The 5.5 dS/m treatment reduced the tomato yield (Y-t) by 22.4 similar to 31.1%, 12.6 similar to 28.0% and 11.7 similar to 27.3%, respectively in 2012, 2013 and 2014, compared with CK. Moreover, a significant (P <= 0.01) coupling effect of salinity and soil matric potential on Yt was detected. Saline water caused Yt to increase more markedly when the lower limit of soil matric potential was controlled at a relatively lower level. The critical salinity level that produced significant increases in the BERi was 3 dS/m similar to 4 dS/m. Following the increase in BERi under saline water irrigation, marketable tomato yield (Y-m) decreased by 8.9%similar to 33.8% in 2012, 5.1% similar to 30.4% in 2013 and 10.1%similar to 32.3% in 2014 compared with CK. In terms of maintaining the Yt and Ym, the salinity of irrigation water should be controlled under 4 dS/m, and the lower limit of soil matric potential should be greater than -20 kPa.	[Zhai, Yaming; Hou, Maomao] Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhai, Yaming] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Yang, Qian] Henan Vocat Coll Agr, Dept Gardening, Zhengzhou, Peoples R China; [Hou, Maomao] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China	Hohai University; Hohai University; Fujian Agriculture & Forestry University	Hou, MM (corresponding author), Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Minist Educ, Nanjing, Jiangsu, Peoples R China.	njhoumaomao@126.com			Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China [E2015002]; Natural Science Foundation of Jiangsu province [BK20130838]; Natural Science Foundation of China [E090203]; basic research funds of Hohai University [2012B00914, 2014B04814]	Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); basic research funds of Hohai University	This work was financed by Open-up Fund of Key Laboratory of Efficient Irrigation-Drainage and Agricultural Soil-Water Environment in Southern China (E2015002), Natural Science Foundation of Jiangsu province (BK20130838), Natural Science Foundation of China (E090203) and the basic research funds of Hohai University (2012B00914, 2014B04814).	Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; ALARCON JJ, 1994, PLANT SOIL, V166, P75, DOI 10.1007/BF02185483; Beckles DM, 2012, POSTHARVEST BIOL TEC, V63, P129, DOI 10.1016/j.postharvbio.2011.05.016; Ben Ahmed C, 2012, J ENVIRON MANAGE, V113, P538, DOI 10.1016/j.jenvman.2012.03.016; Chen LJ, 2014, AGR WATER MANAGE, V146, P24, DOI 10.1016/j.agwat.2014.07.021; Chen WP, 2010, AGR WATER MANAGE, V97, P2001, DOI 10.1016/j.agwat.2010.03.008; Cramer MD, 2001, SCI HORTIC-AMSTERDAM, V89, P269, DOI 10.1016/S0304-4238(00)00243-0; Cuartero J, 1999, SCI HORTIC-AMSTERDAM, V78, P83, DOI 10.1016/S0304-4238(98)00191-5; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Dorais M., 2001, Horticultural Reviews, V26, P239; EHRET DL, 1986, ANN BOT-LONDON, V58, P679, DOI 10.1093/oxfordjournals.aob.a087230; Gawad GA, 2005, AGR WATER MANAGE, V78, P39, DOI 10.1016/j.agwat.2005.04.024; Hong-yun H, 2004, J EC WATER RESOURCES, V22, P54; Hou M. M., 2013, RES CROP, V14, P1232; Hou MM, 2014, SCI WORLD J, DOI 10.1155/2014/953675; Huang CH, 2012, EUR J AGRON, V43, P68, DOI 10.1016/j.eja.2012.05.008; Huang Z, 2010, AGR SCI CHINA, V9, P1150, DOI 10.1016/S1671-2927(09)60202-9; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Kamaluldeen J, 2014, AGR WATER MANAGE, V146, P95, DOI 10.1016/j.agwat.2014.07.027; Karin, 1997, NEW PHYTOL, V135, P213; Karlberg L, 2007, AGR WATER MANAGE, V89, P59, DOI 10.1016/j.agwat.2006.12.011; Katerji N, 1998, AGR WATER MANAGE, V38, P59, DOI 10.1016/S0378-3774(98)00051-1; Kumar P, 2015, AGR WATER MANAGE, V148, P72, DOI 10.1016/j.agwat.2014.09.014; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li XB, 2015, SOIL TILL RES, V146, P159, DOI 10.1016/j.still.2014.10.005; Li YL, 2002, SCI HORTIC-AMSTERDAM, V93, P267, DOI 10.1016/S0304-4238(01)00329-6; Liu J, 2004, JIANGXI COTTON, V26, p19~22; [刘友兆 Liu Youzhao], 2004, [地理与地理信息科学, Geography and geo-information science], V20, P57; Lu ShaoWei, 2012, China Vegetables, P56; Manai J, 2014, J PLANT PHYSIOL, V171, P1028, DOI 10.1016/j.jplph.2014.03.012; McGovern HJ, 2001, SOIL BIOL BIOCHEM, V33, P689, DOI 10.1016/S0038-0717(00)00185-1; Mestre TC, 2012, J PLANT PHYSIOL, V169, P1719, DOI 10.1016/j.jplph.2012.07.013; Nebauer SG, 2013, PLANT PHYSIOL BIOCH, V63, P61, DOI 10.1016/j.plaphy.2012.11.006; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Savic S, 2008, SCI HORTIC-AMSTERDAM, V117, P15, DOI 10.1016/j.scienta.2008.03.009; Setia R, 2013, EUR J SOIL BIOL, V56, P95, DOI 10.1016/j.ejsobi.2013.02.003; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; Shao GC, 2014, EUR J AGRON, V53, P1, DOI 10.1016/j.eja.2013.10.005; Shao X, 2013, RES CROP, V14, P1159; Shao XH, 2012, ENRGY PROCED, V16, P747, DOI 10.1016/j.egypro.2012.01.120; SPURR ARTHUR R., 1959, HILGARDIA, V28, P269; Tabatabaie SJ, 2004, PLANT SOIL, V258, P169, DOI 10.1023/B:PLSO.0000016548.84566.62; TACHIBANA S, 1991, SCI HORTIC-AMSTERDAM, V45, P235, DOI 10.1016/0304-4238(91)90068-A; Taylor MD, 2004, HORTSCIENCE, V39, P1110, DOI 10.21273/HORTSCI.39.5.1110; Tuna AL, 2007, ENVIRON EXP BOT, V59, P173, DOI 10.1016/j.envexpbot.2005.12.007; Wan SQ, 2007, AGR WATER MANAGE, V90, P63, DOI 10.1016/j.agwat.2007.02.011; Wan ShuQin, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P30; Wang FX, 2007, AGR WATER MANAGE, V88, P34, DOI 10.1016/j.agwat.2006.08.006; Wang W, 2014, J HOHAI U NATURAL SC, V42, P373; Zhang Z, 1999, J IRRIGATION DRAINAG, V18, P18; Zhao A, 1998, ACTA AGR U JIANGXIEN, V20, P523; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; Zushi K, 2011, SCI HORTIC-AMSTERDAM, V129, P18, DOI 10.1016/j.scienta.2011.02.011	54	44	48	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142204	10.1371/journal.pone.0142204	http://dx.doi.org/10.1371/journal.pone.0142204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540394	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800067
J	Bundela, S; Sharma, A; Bisen, PS				Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.			Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NATURAL-PRODUCTS; DRUG DISCOVERY; CELL INVASION; SUPPRESSION; INHIBITION; APOPTOSIS; CURCUMIN; EXPRESSION; DELIVERY	Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries. There are very limited treatment options available for oral cancer. Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities. We mined the large pool of compounds from the publicly available compound databases, to identify potential therapeutic compounds for oral cancer. Over 84 million compounds were screened for the possible anti-cancer activity by custom build SVM classifier. The molecular targets of the predicted anti-cancer compounds were mined from reliable sources like experimental bioassays studies associated with the compound, and from protein-compound interaction databases. Therapeutic compounds from DrugBank, and a list of natural anti-cancer compounds derived from literature mining of published studies, were used for building partial least squares regression model. The regression model thus built, was used for the estimation of oral cancer specific weights based on the molecular targets. These weights were used to compute scores for screening the predicted anti-cancer compounds for their potential to treat oral cancer. The list of potential compounds was annotated with corresponding physicochemical properties, cancer specific bioactivity evidences, and literature evidences. In all, 288 compounds with the potential to treat oral cancer were identified in the current study. The majority of the compounds in this list are natural products, which are well-tolerated and have minimal side-effects compared to the synthetic counterparts. Some of the potential therapeutic compounds identified in the current study are resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, berberine, pterostilbene, deguelin, andrographolide, and colchicine.	[Bundela, Saurabh; Bisen, Prakash S.] Govt India, Minist Def, Def Res Dev Org, Def Res Dev Estab, Gwalior, Madhya Pradesh, India; [Bundela, Saurabh; Sharma, Anjana] Rani Durgavati Univ, Dept Postgrad Studies & Res Biol Sci, Jabalpur 482001, Madhya Pradesh, India; [Bisen, Prakash S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Jiwaji University Gwalior	Bisen, PS (corresponding author), Govt India, Minist Def, Def Res Dev Org, Def Res Dev Estab, Gwalior, Madhya Pradesh, India.	psbisen@gmail.com	Bisen, Prakash S/H-3392-2019	Bisen, Prakash S/0000-0002-2818-7829				Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bisen P.S., 2012, J CANC SCI THER, V4, P23, DOI [DOI 10.4172/1948-5956.1000106, 10.4172/1948-5956.1000106]; Bisen PS, 2013, BIOL ORAL CANCER KEY; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Bundela S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102610; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Chang CM, 2012, ONCOL REP, V28, P1799, DOI 10.3892/or.2012.1991; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HJ, 2013, INT J ONCOL, V43, P629, DOI 10.3892/ijo.2013.1977; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen YY, 2010, ANTICANCER RES, V30, P945; Cheng YH, 2012, TOXICOL APPL PHARM, V263, P360, DOI 10.1016/j.taap.2012.07.010; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng YT, 2011, ORAL ONCOL, V47, P256, DOI 10.1016/j.oraloncology.2011.01.005; Dudas J, 2013, EXP CELL RES, V319, P800, DOI 10.1016/j.yexcr.2012.12.001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Ho YT, 2009, ANTICANCER RES, V29, P4063; Huang CY, 2013, J NUTR BIOCHEM, V24, P1596, DOI 10.1016/j.jnutbio.2013.01.010; Jaccard P., 1907, REV G N RALE SCI PUR, V18, P961; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Krishnamoorthy Bhuvana, 2013, Dent Res J (Isfahan), V10, P527; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Li GH, 2012, BIOINFORMATICS, V28, P3334, DOI 10.1093/bioinformatics/bts625; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lin CW, 2014, EXPERT OPIN THER TAR, V18, P1109, DOI 10.1517/14728222.2014.947962; Lin HT, 2003, STUDY SIGMOID KERNEL, V3, P1, DOI DOI 10.1111/J.1945-1474.2005.TB00541.X; Lin HY, 2012, INT J NANOMED, V7, P941, DOI 10.2147/IJN.S28510; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu YP, 2016, HEAD NECK-J SCI SPEC, V38, pE524, DOI 10.1002/hed.24034; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Nagumo T, 2009, ORAL ONCOL, V45, P766, DOI 10.1016/j.oraloncology.2008.11.009; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Priyadarsini RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034628; ROSENBERG B, 1973, NATURWISSENSCHAFTEN, V60, P399, DOI 10.1007/BF00623551; Sarkar J, 2009, ORAL ONCOL, V45, P974, DOI 10.1016/j.oraloncology.2009.04.009; Schomburg K, 2010, J CHEM INF MODEL, V50, P1529, DOI 10.1021/ci100209a; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Tamatani T, 2013, INT J ONCOL, V42, P935, DOI 10.3892/ijo.2013.1786; Wang LJ, 2011, J DENT RES, V90, P1246, DOI 10.1177/0022034511418341; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; WOOD P H N, 1990, World Health Statistics Quarterly, V43, P263; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Zhou GL, 2010, CANCER PREV RES, V3, P1493, DOI 10.1158/1940-6207.CAPR-10-0135; Zhou S, 2014, J CANCER RES CLIN, V140, P371, DOI 10.1007/s00432-013-1575-1	56	29	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141719	10.1371/journal.pone.0141719	http://dx.doi.org/10.1371/journal.pone.0141719			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536350	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400081
J	Darbani, B; Noeparvar, S; Borg, S				Darbani, Behrooz; Noeparvar, Shahin; Borg, Soren			Deciphering Mineral Homeostasis in Barley Seed Transfer Cells at Transcriptional Level	PLOS ONE			English	Article							TRANSPORTER 1 IRT1; PROTEIN 5 FBXL5; ARABIDOPSIS-THALIANA; IRON-DEFICIENCY; GENE-EXPRESSION; F-BOX; REPEAT PROTEIN; INTRACELLULAR TRAFFICKING; SALMONELLA-TYPHIMURIUM; CONJUGATE SENSITIVITY	In addition to the micronutrient inadequacy of staple crops for optimal human nutrition, a global downtrend in crop-quality has emerged from intensive breeding for yield. This trend will be aggravated by elevated levels of the greenhouse gas carbon dioxide. Therefore, crop bio-fortification is inevitable to ensure a sustainable supply of minerals to the large part of human population who is dietary dependent on staple crops. This requires a thorough understanding of plant-mineral interactions due to the complexity of mineral homeostasis. Employing RNA sequencing, we here communicate transfer cell specific effects of excess iron and zinc during grain filling in our model crop plant barley. Responding to alterations inmineral contents, we found a long range of different genes and transcripts. Among them, it is worth to highlight the auxin and ethylene signaling factors Arfs, Abcbs, Cand1, Hps4, Hac1, Ecr1, and Ctr1, diurnal fluctuation components Sdg2, Imb1, Lip1, and PhyC, retroelements, sulfur homeostasis components Amp1, Hmt3, Eil3, and Vip1, mineral trafficking components Med16, Cnnm4, Aha2, Clpc1, and Pcbps, and vacuole organization factors Ymr155W, RabG3F, Vps4, and Cbl3. Our analysis introduces new interactors and signifies a broad spectrum of regulatory levels from chromatin remodeling to intracellular protein sorting mechanisms active in the plant mineral homeostasis. The results highlight the importance of storage proteins in metal ion toxicity-resistance and chelation. Interestingly, the protein sorting and recycling factors Exoc7, Cdc1, Sec23A, and Rab11A contributed to the response as well as the polar distributors of metal-transporters ensuring the directional flow of minerals. Alternative isoform switching was found important for plant adaptation and occurred among transcripts coding for identical proteins as well as transcripts coding for protein isoforms. We also identified differences in the alternative-isoform preference between the treatments, indicating metal-affinity shifts among isoforms of metal transporters. Most important, we found the zinc treatment to impair both photosynthesis and respiration. A wide range of transcriptional changes including stress-related genes and negative feedback loops emphasize the importance to withhold mineral contents below certain cellular levels which otherwise might lead to agronomical impeding side-effects. By illustrating new mechanisms, genes, and transcripts, this report provides a solid platform towards understanding the complex network of plant mineral homeostasis.	[Darbani, Behrooz; Noeparvar, Shahin; Borg, Soren] Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark; [Darbani, Behrooz] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Aarhus University; University of Copenhagen	Darbani, B (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark.	behroozdarbani@gmail.com; soren.borg@mbg.au.dk	darbani, behrooz/AAM-1641-2020	Darbani, Behrooz/0000-0003-0289-6392	Aarhus University; HarvestPlus	Aarhus University; HarvestPlus	This work was financially supported by Aarhus University and HarvestPlus.	Abadia J, 2011, PLANT PHYSIOL BIOCH, V49, P471, DOI 10.1016/j.plaphy.2011.01.026; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Atwood SE, 2014, PLANT CELL ENVIRON, V37, P213, DOI 10.1111/pce.12147; Bagley DC, 2012, J BIOL CHEM, V287, P25577, DOI 10.1074/jbc.M112.354043; Bamdad F, 2013, MOL NUTR FOOD RES, V57, P493, DOI 10.1002/mnfr.201200252; Barberon M, 2014, P NATL ACAD SCI USA, V111, P8293, DOI 10.1073/pnas.1402262111; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cakmak I, 1996, PLANT SOIL, V180, P165, DOI 10.1007/BF00015299; Carbone R, 1997, CANCER RES, V57, P5498; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chen CC, 2011, PLANT PHYSIOL, V156, P2225, DOI 10.1104/pp.111.178996; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Cho M, 2012, PLANT PHYSIOL, V159, P642, DOI 10.1104/pp.112.196139; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; Cui Y, 2014, PLANT CELL, V26, P2080, DOI 10.1105/tpc.114.123141; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Darbani B, 2014, J BIOTECHNOL, V188, P100, DOI 10.1016/j.jbiotec.2014.08.012; Darbani B, 2014, J BIOL RES-THESSALON, V21, DOI 10.1186/2241-5793-21-3; Darbani B, 2013, BIOTECHNOL ADV, V31, P1292, DOI 10.1016/j.biotechadv.2013.05.003; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Deng FL, 2013, PLANT PHYSIOL, V163, P1353, DOI 10.1104/pp.113.226225; Doskocilova A, 2011, PLANTA, V234, P459, DOI 10.1007/s00425-011-1419-7; Drdova EJ, 2013, PLANT J, V73, P709, DOI 10.1111/tpj.12074; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Ezaki B, 2007, J EXP BOT, V58, P497, DOI 10.1093/jxb/erl221; Fan HJ, 2014, PLANT J, V77, P209, DOI 10.1111/tpj.12380; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Fujimoto M, 2015, PLANT CELL PHYSIOL, V56, P287, DOI 10.1093/pcp/pcu195; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Gaillard S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-22; Garcia MJ, 2010, J EXP BOT, V61, P3885, DOI 10.1093/jxb/erq203; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Gollhofer J, 2011, PLANT PHYSIOL BIOCH, V49, P557, DOI 10.1016/j.plaphy.2011.02.011; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Kanter U, 2010, J EXP BOT, V61, P3995, DOI 10.1093/jxb/erq213; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lasswell J, 2000, PLANT CELL, V12, P2395, DOI 10.1105/tpc.12.12.2395; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Li C, 2014, PLANT CELL PHYSIOL, V55, P426, DOI 10.1093/pcp/pct180; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WZ, 2013, P NATL ACAD SCI USA, V110, P1548, DOI 10.1073/pnas.1213235110; Loladze I, 2014, ELIFE, V3, DOI 10.7554/eLife.02245; Lubkowitz M, 2011, MOL PLANT, V4, P407, DOI 10.1093/mp/ssr004; Magidin M, 2003, PLANT J, V35, P523, DOI 10.1046/j.1365-313X.2003.01826.x; Malapeira J, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24079; McCreedy RA, 2009, NUTR REV, V67, P607, DOI 10.1111/j.1753-4887.2009.00233.x; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Penalver E, 1999, J BACTERIOL, V181, P2555; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Rampey RA, 2013, G3-GENES GENOM GENET, V3, P131, DOI 10.1534/g3.112.004655; Rangan P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239621; Ranocha P, 2001, PLANT J, V25, P575, DOI 10.1046/j.1365-313x.2001.00988.x; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Cazorla E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004983; Rodriguez-Celma J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00276; Ruiz JC, 2013, J BIOL CHEM, V288, P552, DOI 10.1074/jbc.M112.426171; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sauter M, 2013, BIOCHEM J, V451, P145, DOI 10.1042/BJ20121744; Schmidt W, 2000, PLANT PHYSIOL, V122, P1109, DOI 10.1104/pp.122.4.1109; Shahriari M, 2010, PLANT J, V64, P71, DOI 10.1111/j.1365-313X.2010.04310.x; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Smith MR, 2013, APPL ENVIRON MICROB, V79, P728, DOI 10.1128/AEM.01737-12; SMITH RL, 1993, J BIOL CHEM, V268, P14071; Song WY, 2014, PLANT CELL ENVIRON, V37, P1192, DOI 10.1111/pce.12227; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; Sunkar R, 2000, PLANT J, V24, P533, DOI 10.1046/j.1365-313x.2000.00901.x; Tang RJ, 2015, P NATL ACAD SCI USA, V112, P3134, DOI 10.1073/pnas.1420944112; Tang SN, 2013, NUCLEIC ACIDS RES, V41, pW441, DOI 10.1093/nar/gkt428; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; Tiong J, 2014, NEW PHYTOL, V201, P131, DOI 10.1111/nph.12468; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033; Wang HY, 1997, GENE DEV, V11, P799, DOI 10.1101/gad.11.6.799; Waters BM, 2014, NEW PHYTOL, V203, P1128, DOI 10.1111/nph.12911; Wu HL, 2010, ANN BOT-LONDON, V105, P823, DOI 10.1093/aob/mcq051; Wu Y, 2010, J EXP BOT, V61, P3407, DOI 10.1093/jxb/erq161; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yu HL, 2012, J EXP BOT, V63, P4527, DOI 10.1093/jxb/ers131; Zargar SM, 2015, PLANT CELL REP, V34, P157, DOI 10.1007/s00299-014-1696-2; Zhang Y, 2014, NEW PHYTOL, V203, P770, DOI 10.1111/nph.12860; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820; Zientara K, 2009, J BIOTECHNOL, V139, P258, DOI 10.1016/j.jbiotec.2008.12.001; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	128	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141398	10.1371/journal.pone.0141398	http://dx.doi.org/10.1371/journal.pone.0141398			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536247	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400062
J	Dobay, A; Pilo, P; Lindholm, AK; Origgi, F; Bagheri, HC; Konig, B				Dobay, Akos; Pilo, Paola; Lindholm, Anna K.; Origgi, Francesco; Bagheri, Homayoun C.; Koenig, Barbara			Dynamics of a Tularemia Outbreak in a Closely Monitored Free-Roaming Population of Wild House Mice	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; DISEASES; MODELS	Infectious disease outbreaks can be devastating because of their sudden occurrence, as well as the complexity of monitoring and controlling them. Outbreaks in wildlife are even more challenging to observe and describe, especially when small animals or secretive species are involved. Modeling such infectious disease events is relevant to investigating their dynamics and is critical for decision makers to accomplish outbreak management. Tularemia, caused by the bacterium Francisella tularensis, is a potentially lethal zoonosis. Of the few animal outbreaks that have been reported in the literature, only those affecting zoo animals have been closely monitored. Here, we report the first estimation of the basic reproduction number R-0 of an outbreak in wildlife caused by F. tularensis using quantitative modeling based on a susceptible-infected-recovered framework. We applied that model to data collected during an extensive investigation of an outbreak of tularemia caused by F. tularensis subsp. holarctica (also designated as type B) in a closely monitored, free-roaming house mouse (Mus musculus domesticus) population in Switzerland. Based on our model and assumptions, the best estimated basic reproduction number R-0 of the current outbreak is 1.33. Our results suggest that tularemia can cause severe outbreaks in small rodents. We also concluded that the outbreak self-exhausted in approximately three months without administrating antibiotics.	[Dobay, Akos; Lindholm, Anna K.; Bagheri, Homayoun C.; Koenig, Barbara] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pilo, Paola; Origgi, Francesco] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Origgi, Francesco] Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland	University of Zurich; University of Bern	Dobay, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	Akos.Dobay@uzh.ch	Dobay, Akos/N-3655-2019; Lindholm, Anna K/E-5207-2012	Dobay, Akos/0000-0001-6492-9298; Lindholm, Anna K/0000-0001-8460-9769; Bagheri, Homayoun/0000-0002-2495-7785; Konig, Barbara/0000-0001-7696-4736	canton of Zurich; Swiss Federal Office for the Environment [12.0003.KP/L121-0964]; Swiss Expert Committee for Biosafety [04.1240.PZ/L064-7521]; Swiss National Science Foundation [310030M-138389]	canton of Zurich; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the canton of Zurich (to HB, BK and AL) and by the Swiss Federal Office for the Environment (grant number 12.0003.KP/L121-0964, http://www.bafu.admin.ch, to PP), by the Swiss Expert Committee for Biosafety (grant number 04.1240.PZ/L064-7521, http://www.efbs.admin.ch, to PP) and the Swiss National Science Foundation (grant number 310030M-138389, http://www.snf.ch, to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin H, 2009, INT J INFECT DIS, V13, P547, DOI 10.1016/j.ijid.2008.09.020; Anda P, 2001, EMERG INFECT DIS, V7, P575; Attie O, 2013, J DATA MINING GENOMI, V4, P2153, DOI [10.4172/2153-0602.1000125, DOI 10.4172/2153-0602.1000125]; Auclair Y, 2014, BEHAV ECOL, V25, P1467, DOI 10.1093/beheco/aru143; Decors A, 2011, EUROSURVEILLANCE, V16; Desvars A, 2015, EMERG INFECT DIS, V21, P32, DOI 10.3201/eid2101.140916; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Ferrecchia CE, 2012, COMPARATIVE MED, V62, P316; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Gee K-F, 2012, TRANSWORLD RES NETWO, V37, P23; Gillard JJ, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00169; Helvaci S, 2000, EUR J EPIDEMIOL, V16, P271, DOI 10.1023/A:1007610724801; Hyman JM, 2000, MATH BIOSCI, V167, P65, DOI 10.1016/S0025-5564(00)00025-0; Jones R.M., 2005, APPL BIOSAF, V10, P227, DOI DOI 10.1177/153567600501000405; Kantardjiev T, 2006, EMERG INFECT DIS, V12, P678, DOI 10.3201/eid1204.050709; Kaysser P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-157; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Konig B., 2012, EVOLUTION HOUSE MOUS, P114, DOI [DOI 10.1017/CBO9781139044547.007, 10.1017/CBO9781139044547.007]; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leander R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002757; Matz-Rensing K, 2007, VET PATHOL, V44, P327, DOI 10.1354/vp.44-3-327; Marchette JN, 1960, THESIS; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Moreau GB, 2013, VIRULENCE, V4, P826, DOI 10.4161/viru.25629; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Morrison M.L., 2008, WILDLIFE STUDY DESIG; Origgi FC, 2015, EMERG INFECT DIS, V21, P133, DOI 10.3201/eid2101.140906; Runfola JK, 2015, MMWR-MORBID MORTAL W, V64, P429; Ryden P, 2012, J INFECT DIS, V205, P297, DOI 10.1093/infdis/jir732; Splettstoesser WD, 2007, EPIDEMIOL INFECT, V135, P1256, DOI 10.1017/S0950268807008035; Stundick MV, 2013, VET PATHOL, V50, P877, DOI 10.1177/0300985813486812; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Weidt A, 2014, NATURWISSENSCHAFTEN, V101, P73, DOI 10.1007/s00114-013-1130-6	37	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141103	10.1371/journal.pone.0141103	http://dx.doi.org/10.1371/journal.pone.0141103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536232	Green Accepted, Green Published, gold			2022-12-27	WOS:000364298400053
J	Haas, WR; Klink, CJ; Maggard, GJ; Aldenderfer, MS				Haas, W. Randall, Jr.; Klink, Cynthia J.; Maggard, Greg J.; Aldenderfer, Mark S.			Settlement-Size Scaling among Prehistoric Hunter-Gatherer Settlement Systems in the New World	PLOS ONE			English	Article							DISTRIBUTIONS; PATTERNS; SHAPE	Settlement size predicts extreme variation in the rates and magnitudes of many social and ecological processes in human societies. Yet, the factors that drive human settlement-size variation remain poorly understood. Size variation among economically integrated settlements tends to be heavy tailed such that the smallest settlements are extremely common and the largest settlements extremely large and rare. The upper tail of this size distribution is often formalized mathematically as a power-law function. Explanations for this scaling structure in human settlement systems tend to emphasize complex socioeconomic processes including agriculture, manufacturing, and warfare-behaviors that tend to differentially nucleate and disperse populations hierarchically among settlements. But, the degree to which heavy-tailed settlement-size variation requires such complex behaviors remains unclear. By examining the settlement patterns of eight prehistoric New World hunter-gatherer settlement systems spanning three distinct environmental contexts, this analysis explores the degree to which heavy-tailed settlement-size scaling depends on the aforementioned socioeconomic complexities. Surprisingly, the analysis finds that power-law models offer plausible and parsimonious statistical descriptions of prehistoric hunter-gatherer settlement-size variation. This finding reveals that incipient forms of hierarchical settlement structure may have preceded socioeconomic complexity in human societies and points to a need for additional research to explicate how mobile foragers came to exhibit settlement patterns that are more commonly associated with hierarchical organization. We propose that hunter-gatherer mobility with preferential attachment to previously occupied locations may account for the observed structure in site-size variation.	[Haas, W. Randall, Jr.] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Klink, Cynthia J.] SUNY Coll Oneonta, Dept Anthropol, Oneonta, NY 13820 USA; [Maggard, Greg J.] Univ Kentucky, Dept Anthropol, Lexington, KY 40506 USA; [Aldenderfer, Mark S.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95343 USA	University System of Maryland; University of Maryland College Park; State University of New York (SUNY) System; University of Kentucky; University of California System; University of California Merced	Haas, WR (corresponding author), Univ Maryland, Dept Anthropol, 1111 Woods Hall, College Pk, MD 20742 USA.	wrhaas@umd.edu		Haas, Randall/0000-0002-7742-2127	National Science Foundation [BCS-0331992, BCS-9816313]; American Philosophical Society Lewis and Clark Fund; Wenner Gren Foundation [6174]	National Science Foundation(National Science Foundation (NSF)); American Philosophical Society Lewis and Clark Fund; Wenner Gren Foundation	Funding: This study was supported by the National Science Foundation BCS-0331992 awarded to Haas, American Philosophical Society Lewis and Clark Fund awarded to Haas, National Science Foundation BCS-9816313 awarded to Aldenderfer, Wenner Gren Foundation 6174 awarded to Klink, and National Science Foundation BCS-0331992 awarded to Maggard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Alberti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091510; Aldenderfer M.S., 1998, MONTANE FORAGERS ASA; Aldenderfer MS, 2011, CHUNGARA, V43, P531, DOI 10.4067/S0717-73562011000300011; Aldenderfer MS, 2005, ADV TITICACA BASIN A, P25; Aldenderfer MS., 2005, ADV TITICACA BASIN A, P13; Bandy MS, 2006, ANDEAN ARCHAEOLOGY III: NORTH AND SOUTH, P210, DOI 10.1007/0-387-28940-2_10; Bandy MS, 2004, AM ANTHROPOL, V106, P322, DOI 10.1525/aa.2004.106.2.322; Basso K., 1996, WISDOM SITS PLACES L; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bentley RA, 2008, HDB ARCHAEOLOGICAL T, P487; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Briceno J., 2004, DESARROLLO ARQUEOLOG, P29; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Brown CT, 2005, J ARCHAEOL METHOD TH, V12, P37, DOI 10.1007/s10816-005-2396-6; Brown CT, 2003, J ARCHAEOL SCI, V30, P1619, DOI 10.1016/S0305-4403(03)00063-3; Carneiro RL, 2000, P NATL ACAD SCI USA, V97, P12926, DOI 10.1073/pnas.240462397; Chauchat C., 2006, PREHISTORIA COSTA NO; Christaller W., 1933, CENTRAL PLACES SO GE; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crema ER, 2014, J ARCHAEOL METHOD TH, V21, P385, DOI 10.1007/s10816-013-9185-4; Decker EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000934; Dillehay TD, 2003, QUATERN INT, V109, P3, DOI 10.1016/S1040-6182(02)00198-2; Dillehay TD, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P29, DOI 10.1007/978-0-387-74907-5_2; Drennan RD, 2004, J ARCHAEOL SCI, V31, P533, DOI 10.1016/j.jas.2003.10.002; Dunnell R., 1992, SPACE TIME ARCHAEOLO, P21; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Flannery KV., 1998, ARCHAIC STATES, P15; Fujita M., 1999, SPATIAL EC CITIES RE; Gershenson C, 2012, COMPLEXITY, V18, P29, DOI 10.1002/cplx.21424; Gillespie C. S., 2013, FITTING HEAVY TAILED; Griffin AF, 2007, STRUCTURE DYNAMICS, V2, P1; Grove M, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P83, DOI 10.1007/978-1-4419-6861-6_5; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hodder I., 1982, RANKING RESOURCE EXC, P150; Inomata Takeshi, 1996, LAT AM ANTIQ, V7, P291, DOI DOI 10.2307/972261; JOHNSON GA, 1980, ECON GEOGR, V56, P234, DOI 10.2307/142715; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Krugman P., 1996, SELF ORG EC; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Loendorf CR, 2012, HOHOKAM AKIMEL OODHA; Maggard GJ, 2011, B ARQUEOL PUCP, V15, P1; Mitzenmacher Michael, 2001, P ANN ALL C COMM CON, V39, P182; Moseley M. E., 1974, MARITIME FDN ANDEAN; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Paynter RW., 1982, MODELS SPATIAL INEQU; Peterson CE, 2005, AM ANTIQUITY, V70, P5, DOI 10.2307/40035266; Phillips S.J., 2000, NATURAL HIST SONORAN; Rice G, 2004, PROJECTILE POINT TYP; RICHARDSON HW, 1973, REG STUD, V7, P239, DOI 10.1080/09595237300185241; Schiffer M. B., 1975, PLAINS ANTHROPOL, V20, P253; Schlanger S.H., 1992, SPACE TIME ARCHAEOLO, P91, DOI DOI 10.1007/978-1-4899-2450-6_5; Shennan S, 2000, CURR ANTHROPOL, V41, P811, DOI 10.1086/317403; Stanish C, 2003, ANCIENT TITICACA: THE EVOLUTION OF COMPLEX SOCIETY IN SOUTHERN PERU AND NORTHERN BOLIVIA, P1, DOI 10.1525/california/9780520232457.001.0001; STOCKLI R., 2005, BLUE MARBLE NEXT GEN; The R Foundation, 2009, R STAT COMP LANG; Venables WN., 2002, MODERN APPL STAT S 4; Wearmouth VJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2997; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Winterhalder B, 1978, GEOECOLOGY SO HIGHLA; WOBST HM, 1978, AM ANTIQUITY, V43, P303, DOI 10.2307/279256; WRIGHT HT, 1977, ANNU REV ANTHROPOL, V6, P379, DOI 10.1146/annurev.an.06.100177.002115; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	69	12	12	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140127	10.1371/journal.pone.0140127	http://dx.doi.org/10.1371/journal.pone.0140127			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536241	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400017
J	Sato, C; Sekiguchi, A; Kawai, M; Kotozaki, Y; Nouchi, R; Tada, H; Takeuchi, H; Ishida, T; Taki, Y; Kawashima, R; Ohuchi, N				Sato, Chiho; Sekiguchi, Atsushi; Kawai, Masaaki; Kotozaki, Yuka; Nouchi, Rui; Tada, Hiroshi; Takeuchi, Hikaru; Ishida, Takanori; Taki, Yasuyuki; Kawashima, Ryuta; Ohuchi, Noriaki			Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; PREFRONTAL CORTEX; NEUROCOGNITIVE FUNCTION; GENERAL-ANESTHESIA; ATTENTION; SURGERY; SEVOFLURANE; NEUROINFLAMMATION; CHEMOTHERAPY; MECHANISMS	Objective The primary purpose of this study was to clarify the influence of the early response to surgery on brain structure and cognitive function in patients with breast cancer. It was hypothesized that the structure of the thalamus would change during the early response after surgery due to the effects of anesthesia and would represent one aspect of an intermediate phenotype of postoperative cognitive dysfunction (POCD). Methods We examined 32 postmenopausal females with breast cancer and 20 age-matched controls. We assessed their cognitive function (attention, memory, and executive function), and performed brain structural MRI 1.5 +/- 0.5 days before and 5.6 +/- 1.2 days after surgery. Results We found a significant interaction between regional grey matter volume (rGMV) in the thalamus (P < 0.05, familywise error (FWE), small volume correction (SVC)) and one attention domain subtest (P = 0.001, Bonferroni correction) after surgery in the patient group compared with the control group. Furthermore, the changes in attention were significantly associated with sevoflurane anesthetic dose (r(2) = 0.247, beta = -0.471, P = 0.032) and marginally associated with rGMV changes in the thalamus (P = 0.07, FWE, SVC) in the Pt group. Conclusion Our findings suggest that alterations in brain structure, particularly in the thalamus, may occur shortly after surgery and may be associated with attentional dysfunction. This early postoperative response to anesthesia may represent an intermediate phenotype of POCD. It was assumed that patients experiencing other risk factors of POCD, such as the severity of surgery, the occurrence of complications, and pre-existing cognitive impairments, would develop clinical POCD with broad and multiple types of cognitive dysfunction.	[Sato, Chiho; Sekiguchi, Atsushi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sato, Chiho; Tada, Hiroshi; Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Div Surg Oncol, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan; [Kawai, Masaaki] Miyagi Canc Ctr Hosp, Dept Breast Oncol, Natori, Miyagi, Japan; [Kotozaki, Yuka] Fukushima Med Univ, Sch Med, Med Ind Translat Res Ctr, Div Clin Res, Fukushima, Japan; [Nouchi, Rui] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Creat Interdisciplinary Res Div, Sendai, Miyagi 980, Japan; [Nouchi, Rui; Kawashima, Ryuta] Tohoku Univ, Dept Adv Brain Sci, Smart Ageing Int Res Ctr, IDAC, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, IDAC, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; National Center for Neurology & Psychiatry - Japan; Miyagi Cancer Center; Fukushima Medical University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Sekiguchi, A (corresponding author), Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	asekiguchi@ncnp.go.jp	Kotozaki, Yuka/ABA-2922-2020; Tada, Hiroshi/G-2551-2014; Nouchi, Rui/GQH-1608-2022; Kotozaki, Yuka/ABA-2267-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Tada, Hiroshi/0000-0003-2670-8982; xing zhi, shi zhi/0000-0003-3289-5681; Takeuchi, Hikaru/0000-0002-8022-9694; Nouchi, Rui/0000-0002-2078-9518	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology in Japan [KAKENHI 24790653]	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: Financial support for this study was provided by a Grant for Special Project Research from the International Research Institute of Disaster Science, a Grant-in-Aid for Young Scientists (B) (KAKENHI 24790653) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Ahles TA, 2005, J CLIN ONCOL, V23, P4399, DOI 10.1200/JCO.2005.03.343; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen MH, 2013, J ANESTH, V27, P487, DOI 10.1007/s00540-012-1548-6; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Correa DD, 2008, CANCER J, V14, P396, DOI 10.1097/PPO.0b013e31818d8769; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidalgo AR, 2011, NEUROSCIENCE, V190, P194, DOI 10.1016/j.neuroscience.2011.05.073; Fiset P, 1999, J NEUROSCI, V19, P5506; Fougnie D, 2008, RELATIONSHIP ATTENTI; Franks NP, 2011, CAN J ANESTH, V58, P139, DOI 10.1007/s12630-010-9420-3; Gaster C, 2011, VBM TOOLBOX SPM8; Guay J, 2011, INDIAN J ANAESTH, V55, P358, DOI 10.4103/0019-5049.84850; Hakoda Y, 1990, KYOIKUSHINRIGAKUKENK, P389; Hatta T, 2004, APPL NEUROPSYCHOL, V11, P153, DOI 10.1207/s15324826an1103_3; Hedayati E, 2011, ACTA ONCOL, V50, P1027, DOI 10.3109/0284186X.2011.572911; Hermelink K, 2007, CANCER, V109, P1905, DOI 10.1002/cncr.22610; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; HOLE A, 1980, ACTA ANAESTH SCAND, V24, P279, DOI 10.1111/j.1399-6576.1980.tb01549.x; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ketz NA, 2015, TRENDS NEUROSCI, V38, P3, DOI 10.1016/j.tins.2014.09.007; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nakane Y, 1997, WHOQOL 26 INFORM; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Omura K, 2004, J CLIN EXP NEUROPSYC, V26, P645, DOI 10.1080/13803390490504272; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Schlunzen L, 2004, ACTA ANAESTH SCAND, V48, P1268, DOI 10.1111/j.1399-6576.2004.00505.x; Schlunzen L, 2010, ACTA ANAESTH SCAND, V54, P603, DOI 10.1111/j.1399-6576.2010.02208.x; Sherman S.M., 2009, EXPLORING THALAMUS I, V2nd Edn; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugishita M, 2001, WECHSLER MEMORY SCAL; Tashiro M, 2005, BREAST CANC, V12; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D, 1987, WMS R WECHSLER MEMOR; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Yoshizaki K, 2006, D CAT MANUAL SCREENI; Zehnder Antoinette E, 2007, Am J Alzheimers Dis Other Demen, V22, P416, DOI 10.1177/1533317507302448	64	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140655	10.1371/journal.pone.0140655	http://dx.doi.org/10.1371/journal.pone.0140655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536672	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400030
J	Chung, YG; Seth, A; Doyle, C; Franck, D; Kim, D; Cristofaro, V; Benowitz, LI; Tu, DD; Estrada, CR; Mauney, JR; Sullivan, MP; Adam, RM				Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Franck, Debra; Kim, Daniel; Cristofaro, Vivian; Benowitz, Larry I.; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Sullivan, Maryrose P.; Adam, Rosalyn M.			Inosine Improves Neurogenic Detrusor Overactivity following Spinal Cord Injury	PLOS ONE			English	Article							PURINE-SENSITIVE MECHANISM; ADENOSINE RECEPTORS; PROMOTES RECOVERY; AFFERENT ACTIVITY; BLADDER; CELLS; MODEL; REGENERATION; OUTGROWTH; SUPPORT	Neurogenic detrusor overactivity and the associated loss of bladder control are among the most challenging complications of spinal cord injury (SCI). Anticholinergic agents are the mainstay for medical treatment of detrusor overactivity. However, their use is limited by significant side effects such that a search for new treatments is warranted. Inosine is a naturally occurring purine nucleoside with neuroprotective, neurotrophic and antioxidant effects that is known to improve motor function in preclinical models of SCI. However, its effect on lower urinary tract function has not been determined. The objectives of this study were to determine the effect of systemic administration of inosine on voiding function following SCI and to delineate potential mechanisms of action. Sprague-Dawley rats underwent complete spinal cord transection, or cord compression by application of an aneurysm clip at T8 for 30 sec. Inosine (225 mg/kg) or vehicle was administered daily via intraperitoneal injection either immediately after injury or after a delay of 8 wk. At the end of treatment, voiding behavior was assessed by cystometry. Levels of synaptophysin (SYP), neurofilament 200 (NF200) and TRPV1 in bladder tissues were measured by immunofluorescence imaging. Inosine administration decreased overactivity in both SCI models, with a significant decrease in the frequency of spontaneous non-voiding contractions during filling, compared to vehicle-treated SCI rats (p<0.05), including under conditions of delayed treatment. Immunofluorescence staining demonstrated increased levels of the pan-neuronal marker SYP and the Adelta fiber marker NF200, but decreased staining for the C-fiber marker, TRPV1 in bladder tissues from inosine-treated rats compared to those from vehicle-treated animals, including after delayed treatment. These findings demonstrate that inosine prevents the development of detrusor overactivity and attenuates existing overactivity following SCI, and may achieve its effects through modulation of sensory neurotransmission.	[Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Franck, Debra; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Adam, Rosalyn M.] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA USA; [Chung, Yeun Goo; Seth, Abhishek; Doyle, Claire; Kim, Daniel; Cristofaro, Vivian; Benowitz, Larry I.; Tu, Duong D.; Estrada, Carlos R.; Mauney, Joshua R.; Sullivan, Maryrose P.; Adam, Rosalyn M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Daniel; Benowitz, Larry I.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Cristofaro, Vivian; Sullivan, Maryrose P.] VA Boston Healthcare Syst, Div Urol, West Roxbury, MA USA; [Cristofaro, Vivian; Sullivan, Maryrose P.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Sullivan, MP (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	msullivan@rics.bwh.harvard.edu; rosalyn.adam@childrens.harvard.edu		Benowitz, Larry/0000-0002-0277-7222	Children's Urological Foundation; National Institutes of Health [R01 DK077195, P50 DK65298]; PVA Research Foundation [2909]; Department of Veterans Affairs Medical Research Service [BX001790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077195, T32DK060442, P50DK065298] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001790] Funding Source: NIH RePORTER	Children's Urological Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PVA Research Foundation; Department of Veterans Affairs Medical Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors acknowledge financial support from the Children's Urological Foundation, the National Institutes of Health (R01 DK077195, P50 DK65298, to R.M.A), the PVA Research Foundation (Grant 2909 to R.M.A) and Department of Veterans Affairs Medical Research Service, (BX001790 to M.P.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz LI, 2002, PROG BRAIN RES, V137, P389; Benowitz LI, 2001, RESTOR NEUROL NEUROS, V19, P41; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Benowitz LI, 1998, J BIOL CHEM, V273, P29626, DOI 10.1074/jbc.273.45.29626; Bocklinger K, 2004, EUR J CELL BIOL, V83, P51, DOI 10.1078/0171-9335-00362; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chung YG, 2014, BIOMATERIALS, V35, P7452, DOI 10.1016/j.biomaterials.2014.05.044; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; del Popolo G, 2012, SPINAL CORD, V50, P8, DOI 10.1038/sc.2011.110; Gomez G, 2003, BLOOD, V102, P4472, DOI 10.1182/blood-2002-11-3624; Gopalakrishnan SM, 2002, J PHARMACOL EXP THER, V300, P910, DOI 10.1124/jpet.300.3.910; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hou B, 2004, INVEST OPHTH VIS SCI, V45, P662, DOI 10.1167/iovs.03-0281; Juszczak K, 2009, J PHYSIOL PHARMACOL, V60, P85; Kim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081948; Komiyama I, 1999, J UROLOGY, V161, P314, DOI 10.1016/S0022-5347(01)62138-4; Kuricova M, 2014, NEUROL SCI, V35, P1785, DOI 10.1007/s10072-014-1840-3; Liu F, 2006, SPINAL CORD, V44, P421, DOI 10.1038/sj.sc.3101878; Macedo SJ, 2013, PURINERG SIGNAL, V9, P51, DOI 10.1007/s11302-012-9327-2; Nascimento FP, 2010, J PHARMACOL EXP THER, V334, P590, DOI 10.1124/jpet.110.166058; Petrausch B, 2000, J NEUROSCI, V20, P8031; Schwarzschild MA, 2014, JAMA NEUROL, V71, P141, DOI 10.1001/jamaneurol.2013.5528; Seth A, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-24; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Shi M, 2002, NEUROREPORT, V13, P477, DOI 10.1097/00001756-200203250-00024; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009	28	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141492	10.1371/journal.pone.0141492	http://dx.doi.org/10.1371/journal.pone.0141492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529505	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600033
J	Davenport, ER; Cusanovich, DA; Michelini, K; Barreiro, LB; Ober, C; Gilad, Y				Davenport, Emily R.; Cusanovich, Darren A.; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav			Genome-Wide Association Studies of the Human Gut Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; 3,000 SHARED CONTROLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; GASTROINTESTINAL-TRACT; FECAL MICROBIOTA; PHOSPHOLIPASE-D; HOST GENETICS; FAECALIBACTERIUM-PRAUSNITZII; COMMON DISEASES	The bacterial composition of the human fecal microbiome is influenced by many lifestyle factors, notably diet. It is less clear, however, what role host genetics plays in dictating the composition of bacteria living in the gut. In this study, we examined the association of similar to 200K host genotypes with the relative abundance of fecal bacterial taxa in a founder population, the Hutterites, during two seasons (n = 91 summer, n = 93 winter, n = 57 individuals collected in both). These individuals live and eat communally, minimizing variation due to environmental exposures, including diet, which could potentially mask small genetic effects. Using a GWAS approach that takes into account the relatedness between subjects, we identified at least 8 bacterial taxa whose abundances were associated with single nucleotide polymorphisms in the host genome in each season (at genome-wide FDR of 20%). For example, we identified an association between a taxon known to affect obesity )genus Akkermansia) and a variant near PLD1, a gene previously associated with body mass index. Moreover, we replicate a previously reported association from a quantitative trait locus (QTL) mapping study of fecal microbiome abundance in mice (genus Lactococcus, rs3747113, P = 3.13 x 10(-7)). Finally, based on the significance distribution of the associated microbiome QTLs in our study with respect to chromatin accessibility profiles, we identified tissues in which host genetic variation may be acting to influence bacterial abundance in the gut.	[Davenport, Emily R.; Cusanovich, Darren A.; Michelini, Katelyn; Ober, Carole; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Barreiro, Luis B.] St Justine Hosp Res Ctr, Dept Pediat, Montreal, PQ, Canada	University of Chicago; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu; gilad@uchicago.edu	Barreiro, Luis/I-7772-2015	Davenport, Emily R./0000-0002-6938-4933; Cusanovich, Darren/0000-0001-6889-0095; Barreiro, Luis/0000-0001-9456-367X; Ober, Carole/0000-0003-4626-9809	National Institutes of Health (NIH) [HG006123, HL085197, U19 AI095230]; University of Chicago Digestive Disease Research Core Center [P30-DK42086]; NIH [T32 GM007197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Digestive Disease Research Core Center(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH, http://www.nih.gov/) grants HG006123 to YG, HL085197 to CO, U19 AI095230 to CO, and the University of Chicago Digestive Disease Research Core Center (http://www.uchicagoddrcc. org/) grant P30-DK42086 (through a P&F grant to YG). DAC was partially supported by NIH grant T32 GM007197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Collins SM, 2009, DIGEST LIVER DIS, V41, P850, DOI 10.1016/j.dld.2009.07.023; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dominguez-Pumar M., 2010, P SPIE C DSS 2010 OR, V7679, P1; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Gomez-Cambronero J, 1998, CELL SIGNAL, V10, P387, DOI 10.1016/S0898-6568(97)00197-6; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han LD, 2013, EUR J HUM GENET, V21, P205, DOI 10.1038/ejhg.2012.148; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiersche M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071775; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hostetler J, 1974, HUTTERITE SOC; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Macfarlane S, 2005, BRIT J NUTR, V93, pS67, DOI 10.1079/BJN20041347; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Ng MCY, 2012, OBESITY, V20, P622, DOI 10.1038/oby.2011.154; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Ouwehand AC, 1999, FEMS MICROBIOL LETT, V172, P61, DOI [10.1016/S0378-1097(99)00013-0, 10.1111/j.1574-6968.1999.tb13450.x]; Ouwerkerk JP, 2013, BEST PRACT RES CL GA, V27, P25, DOI 10.1016/j.bpg.2013.03.001; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RDCT, 2011, R LANG ENV STAT COMP; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Samartin S, 2001, NUTR RES, V21, P243, DOI 10.1016/S0271-5317(00)00255-4; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Beek JHDA, 2015, EUR J HUM GENET, V23, P1223, DOI 10.1038/ejhg.2014.259; Vogler C, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.81; Wang M, 2007, DIGEST DIS SCI, V52, P620, DOI 10.1007/s10620-006-9461-1; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zoetendal E.G., 2001, MICROBIAL ECOLOGY HL, V13	81	149	157	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140301	10.1371/journal.pone.0140301	http://dx.doi.org/10.1371/journal.pone.0140301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528553	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600005
J	Gaidos, G; Panaitiu, AE; Guo, BQ; Pellegrini, M; Mierke, DF				Gaidos, Gabriel; Panaitiu, Alexandra E.; Guo, Bingqian; Pellegrini, Maria; Mierke, Dale F.			Identification and Characterization of the Interaction Site between cFLIP(L) and Calmodulin	PLOS ONE			English	Article							CANCER CELL-DEATH; C-FLIP; CHOLANGIOCARCINOMA CELLS; MOLECULAR-DYNAMICS; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; LUNG-CANCER; BINDING; TARGET	Overexpression of the cellular FLICE-like inhibitory protein (cFLIP) has been reported in a number of tumor types. As an inactive procaspase-8 homologue, cFLIP is recruited to the intracellular assembly known as the Death Inducing Signaling Complex (DISC) where it inhibits apoptosis, leading to cancer cell proliferation. Here we characterize the molecular details of the interaction between cFLIP(L) and calmodulin, a ubiquitous calcium sensing protein. By expressing the individual domains of cFLIP(L), we demonstrate that the interaction with calmodulin is mediated by the N-terminal death effector domain (DED1) of cFLIP(L). Additionally, we mapped the interaction to a specific region of the C-terminus of DED1, referred to as DED1 R4. By designing DED1/DED2 chimeric constructs in which the homologous R4 regions of the two domains were swapped, calmodulin binding properties were transferred to DED2 and removed from DED1. Furthermore, we show that the isolated DED1 R4 peptide binds to calmodulin and solve the structure of the peptide-protein complex using NMR and computational refinement. Finally, we demonstrate an interaction between cFLIP(L) and calmodulin in cancer cell lysates. In summary, our data implicate calmodulin as a potential player in DISC-mediated apoptosis and provide evidence for a specific interaction with the DED1 of cFLIP(L).	[Gaidos, Gabriel; Panaitiu, Alexandra E.; Guo, Bingqian; Pellegrini, Maria; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College	Mierke, DF (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	Dale.F.Mierke@dartmouth.edu	Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412	National Institute of General Medical Sciences of the National Institutes of Health [P30GM106394]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30GM106394 (to MP) (http://www.nigms.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, TRENDS BIOCHEM SCI, V17, P438, DOI 10.1016/0968-0004(92)90016-3; Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Bagnoli M, 2009, ENDOCR-RELAT CANCER, V16, P443, DOI 10.1677/ERC-08-0218; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; Carlomagno T, 2005, ANNU REV BIOPH BIOM, V34, P245, DOI 10.1146/annurev.biophys.34.040204.144419; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Coggins BE, 2003, J BIOMOL NMR, V26, P93, DOI 10.1023/A:1023589029301; Egger Denise, 1994, Molecular Biotechnology, V1, P289, DOI 10.1007/BF02921696; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Havel T.F., 2002, ENCY COMPUTATIONAL C; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang MK, 2009, BIOCHEM CELL BIOL, V87, P919, DOI [10.1139/O09-058, 10.1139/o09-058]; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITO H, 1991, ANTICANCER RES, V11, P249; Kaminskyy VO, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.51; Kaufmann M, 2002, FEBS LETT, V527, P250, DOI 10.1016/S0014-5793(02)03146-0; Keller Rochus L. J., 1966, COMPUTER AIDED RESON; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Menyhard DK, 2009, CURR COMPUT-AID DRUG, V5, P264, DOI 10.2174/157340909789577874; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Pan G, 1999, AM J PATHOL, V155, P193, DOI 10.1016/S0002-9440(10)65113-9; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Rogers KMA, 2007, MOL CANCER THER, V6, P1544, DOI 10.1158/1535-7163.MCT-06-0673; Safa A. R., 2012, Experimental Oncology, V34, P176; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Tian F, 2012, CLIN EXP DERMATOL, V37, P259, DOI 10.1111/j.1365-2230.2011.04238.x; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wu XJ, 2005, J BIOL CHEM, V280, P29964, DOI 10.1074/jbc.M500710200; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	62	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141692	10.1371/journal.pone.0141692	http://dx.doi.org/10.1371/journal.pone.0141692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529318	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600051
J	Mela, CA; Patterson, C; Thompson, WK; Papay, F; Liu, Y				Mela, Christopher A.; Patterson, Carrie; Thompson, William K.; Papay, Francis; Liu, Yang			Stereoscopic Integrated Imaging Goggles for Multimodal Intraoperative Image Guidance	PLOS ONE			English	Article							NEAR-INFRARED FLUORESCENCE; INDOCYANINE GREEN; GUIDED SURGERY; CANCER; SYSTEM; RESOLUTION; CONTRAST; ULTRASOUND; AGENT; MRI	We have developed novel stereoscopic wearable multimodal intraoperative imaging and display systems entitled Integrated Imaging Goggles for guiding surgeries. The prototype systems offer real time stereoscopic fluorescence imaging and color reflectance imaging capacity, along with in vivo handheld microscopy and ultrasound imaging. With the Integrated Imaging Goggle, both wide-field fluorescence imaging and in vivo microscopy are provided. The real time ultrasound images can also be presented in the goggle display. Furthermore, real time goggle-to-goggle stereoscopic video sharing is demonstrated, which can greatly facilitate telemedicine. In this paper, the prototype systems are described, characterized and tested in surgeries in biological tissues ex vivo. We have found that the system can detect fluorescent targets with as low as 60 nM indocyanine green and can resolve structures down to 0.25 mm with large FOV stereoscopic imaging. The system has successfully guided simulated cancer surgeries in chicken. The Integrated Imaging Goggle is novel in 4 aspects: it is (a) the first wearable stereoscopic wide-field intraoperative fluorescence imaging and display system, (b) the first wearable system offering both large FOV and microscopic imaging simultaneously, (c) the first wearable system that offers both ultrasound imaging and fluorescence imaging capacities, and (d) the first demonstration of goggle- to-goggle communication to share stereoscopic views for medical guidance.	[Mela, Christopher A.; Patterson, Carrie; Liu, Yang] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Thompson, William K.] John H Glenn Res Ctr, Cleveland, OH USA; [Papay, Francis] Cleveland Clin, Dermatol & Plast Surg Inst, Cleveland, OH 44106 USA	University System of Ohio; University of Akron; Cleveland Clinic Foundation	Papay, F (corresponding author), Cleveland Clin, Dermatol & Plast Surg Inst, Cleveland, OH 44106 USA.	papayf@ccf.org; yliu@uakron.edu			Ohio Department of Development Third Frontier Grant [TVSF 15-0123]; LEAP Award [F14-10-LIU-WEB]; National Aeronautics and Space Administration (NASA Space Technology Research Fellowship) [NNX14AL37H]; University of Akron Startup Funds	Ohio Department of Development Third Frontier Grant; LEAP Award; National Aeronautics and Space Administration (NASA Space Technology Research Fellowship); University of Akron Startup Funds	This study was supported in part by grants from the Ohio Department of Development Third Frontier Grant (TVSF 15-0123), the LEAP Award (F14-10-LIU-WEB), the National Aeronautics and Space Administration (NASA Space Technology Research Fellowship NNX14AL37H), and the University of Akron Startup Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhr E, 2003, PHYS MED IMAGING MED; Cinotti E, 2015, AM J OPHTHALMOL, V159, P324, DOI 10.1016/j.ajo.2014.10.031; Dumas D, 2012, OPT LETT, V37, P653, DOI 10.1364/OL.37.000653; Getty DJ, 2007, J SOC INF DISPLAY, V15, P377, DOI 10.1889/1.2749323; Gill R., 2012, PHYS TECHNOLOGY DIAG; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Held RT, 2011, ACAD RADIOL, V18, P1035, DOI 10.1016/j.acra.2011.04.005; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hughes OR, 2010, HEAD NECK-J SCI SPEC, V32, P1544, DOI 10.1002/hed.21321; Kelderhouse LE, 2013, BIOCONJUGATE CHEM, V24, P1075, DOI 10.1021/bc400131a; Keller MD, 2010, LASER SURG MED, V42, P15, DOI 10.1002/lsm.20865; Kingham TP, 2013, J GASTROINTEST SURG, V17, P1274, DOI 10.1007/s11605-013-2214-5; Kingham TP, 2012, HPB, V14, P594, DOI 10.1111/j.1477-2574.2012.00487.x; Kubben PL, 2011, LANCET ONCOL, V12, P1062, DOI 10.1016/S1470-2045(11)70130-9; Lam D.L., 2012, BJR, V85, P1293; Liao HE, 2011, HANDBOOK OF AUGMENTED REALITY, P589, DOI 10.1007/978-1-4614-0064-6_27; Liu Y, 2013, TRANSL RES, V162, P324, DOI 10.1016/j.trsl.2013.05.002; Liu Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101303; Liu Y, 2011, SURGERY, V149, P689, DOI 10.1016/j.surg.2011.02.007; Marshall MV, 2012, OPEN SURG ONCOL J, V2, P12, DOI DOI 10.2174/1876504101002010012.NEAR-INFRARED; Martirosyan NL, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13486; Mela CA, 2015, P SPIE; Mela CA, 2015, METHODS MOL IN PRESS; Mieog JSD, 2010, MOL IMAGING, V9, P223, DOI 10.2310/7290.2010.00014; Nam WH, 2012, PHYS MED BIOL, V57, P69, DOI 10.1088/0031-9155/57/1/69; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Pallone MJ, 2014, ANN SURG ONCOL, V21, P2203, DOI 10.1245/s10434-014-3598-5; Pamir MN, 2011, INTRAOPERATIVE IMAGI; Peloso A, 2013, HPB, V15, P928, DOI 10.1111/hpb.12057; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Stelzer EHK, 1998, J MICROSC-OXFORD, V189, P15, DOI 10.1046/j.1365-2818.1998.00290.x; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; van Beurden MHPH, 2012, 3D RES, V3, DOI 10.1007/3DRes.01(2012)3; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Wang S, 2004, P 4 INT C MICR MILL, P18; Wang XH, 2010, JDI, V24, P478; Wang XH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3378128; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Zhou SA, 2010, RADIAT PROT DOSIM, V139, P334, DOI 10.1093/rpd/ncq012	43	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141956	10.1371/journal.pone.0141956	http://dx.doi.org/10.1371/journal.pone.0141956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529249	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600080
J	Moon, BI; Kim, TH; Seoh, JY				Moon, Byung-In; Kim, Tae Hun; Seoh, Ju-Young			Functional Modulation of Regulatory T Cells by IL-2	PLOS ONE			English	Article							LOW-DOSE INTERLEUKIN-2; IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; AUTOIMMUNE-DISEASE; CUTTING EDGE; INDUCTION; THERAPY; IMMUNITY; SUPPRESSION; ACTIVATION	The suppressive function of regulatory T cells (Tregs) is critical to the maintenance of immune homeostasis in vivo and yet, the specific identification of Tregs by phenotypic markers is not perfect. Tregs were originally identified in the CD4(+)CD25(+) fraction of T cells, but FoxP3 expression was later included as an additional marker of Tregs as FoxP3 expression was identified as being critical to the development and function of these cells. Intracellular expression of FoxP3 makes it difficult in using to isolate live and not permeabilized cells for functional assays. As such CD4(+)CD25(+) fraction is still frequently used for functional assays of Tregs. Although, the CD4(+)CD25(+) fraction substantially overlaps with the FoxP3(+) fraction, the minor mismatch between CD4(+)CD25(+) and FoxP3(+) fractions may confound the functional characteristics of Tregs. In this study, we isolated CD4(+)FoxP3(+) as well as CD4(+)CD25(+) fractions from Foxp3 knock-in mice, and compared their proliferative and suppressive activity in the presence or absence of various concentrations of IL-2. Our results showed comparable patterns of proliferative and suppressive responses for both fractions, except that contrary to the CD4(+)CD25(+) fraction the FoxP3+ fraction did not proliferate in an autocrine fashion even in response to a strong stimulation. In presence of exogenous IL-2, both CD4(+)CD25(+) and CD4(+)FoxP3(+) fractions were more sensitive than the CD4(+)CD25(-) responder cells in proliferative responsiveness. In addition, a low dose IL-2 enhanced whereas a high dose abrogated the suppressive activities of the CD4(+)CD25(+) and CD4(+)FoxP3(+) fractions. These results may provide an additional understanding of the characteristics of the various fractions of isolated Tregs based on phenotype and function and the role of varying levels of exogenous IL-2 on the suppressive activity of these cells.	[Moon, Byung-In] Ewha Womans Univ, Dept Surg, Grad Sch Med, Seoul, South Korea; [Kim, Tae Hun] Ewha Womans Univ, Dept Internal Med, Grad Sch Med, Seoul, South Korea; [Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Seoh, JY (corresponding author), Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea.	jyseoh@ewha.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project (https://www.htdream.kr/), Ministry of Health & Welfare, Republic of Korea (HI12C0050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00125; Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Berntsen A, 2010, J IMMUNOTHER, V33, P425, DOI 10.1097/CJI.0b013e3181cd870f; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dooms H, 2010, EUR J IMMUNOL, V40, P1538, DOI 10.1002/eji.201040617; Givan AL, 1999, J IMMUNOL METHODS, V230, P99, DOI 10.1016/S0022-1759(99)00136-2; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; GUTIERREZRAMOS JC, 1992, EUR J IMMUNOL, V22, P2867, DOI 10.1002/eji.1830221117; He H, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-24; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; Jang MH, 2011, REGULATORY T CELLS, P201; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091146; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KOLB H, 1986, EUR J IMMUNOL, V16, P209, DOI 10.1002/eji.1830160218; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Margolin KA, 2000, SEMIN ONCOL, V27, P194; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Oliveira V, 2006, TRANSPL IMMUNOL, V17, P7, DOI 10.1016/j.trim.2006.09.028; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; RIZZO LV, 1994, J CLIN INVEST, V94, P1668, DOI 10.1172/JCI117511; Rosenzwajg M, 2015, J AUTOIMMUN, V58, P48, DOI 10.1016/j.jaut.2015.01.001; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shaker MA, 2009, J PHARM SCI-US, V98, P2268, DOI 10.1002/jps.21596; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Waldmann T, 2002, ARTHRITIS RES THER, V4, pS161, DOI 10.1186/ar584; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Webster AC, 2007, NEPHROLOGY, V12, pS75, DOI 10.1111/j.1440-1797.2006.00732.x; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	57	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141864	10.1371/journal.pone.0141864	http://dx.doi.org/10.1371/journal.pone.0141864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529512	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600073
J	Dold, S; Richter, S; Kollmar, O; von Heesen, M; Scheuer, C; Laschke, MW; Vollmar, B; Schilling, MK; Menger, MD				Dold, Stefan; Richter, Sven; Kollmar, Otto; von Heesen, Maximilian; Scheuer, Claudia; Laschke, Matthias W.; Vollmar, Brigitte; Schilling, Martin K.; Menger, Michael D.			Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation	PLOS ONE			English	Article							BLOOD-FLOW; NITRIC-OXIDE; LIVER-TRANSPLANTATION; TISSUE OXYGENATION; SHEAR-STRESS; RAT; REGENERATION; HYPOXIA; VEIN; FLUORESCENCE	Background & Aims Portal hyperperfusion after extended hepatectomy or small-for-size liver transplantation may induce organ dysfunction and failure. The underlying mechanisms, however, are still not completely understood. Herein, we analysed whether hepatectomy-associated portal hyperperfusion induces a hepatic arterial buffer response, i.e., an adaptive hepatic arterial constriction, which may cause hepatocellular hypoxia and organ dysfunction. Methods Sprague-Dawley rats underwent 30%, 70% and 90% hepatectomy. Baseline measurements before hepatectomy served as controls. Hepatic arterial and portal venous flows were analysed by ultrasonic flow measurement. Microvascular blood flow and mitochondrial redox state were determined by intravital fluorescence microscopy. Hepatic tissue pO2 was analysed by polarographic techniques. Hepatic function and integrity were studied by bromosulfophthalein bile excretion and liver histology. Results Portal blood flow was 2- to 4-fold increased after 70% and 90% hepatectomy. This, however, did not provoke a hepatic arterial buffer response. Nonetheless, portal hyperperfusion and constant hepatic arterial blood flow were associated with a reduced mitochondrial redox state and a decreased hepatic tissue pO2 after 70% and 90% hepatectomy. Microvascular blood flow increased significantly after hepatectomy and functional sinusoidal density was found only slightly reduced. Major hepatectomy further induced a 2- to 3-fold increase of bile flow. This was associated with a 2-fold increase of bromosulfophthalein excretion. Conclusions Portal hyperperfusion after extended hepatectomy does not induce a hepatic arterial buffer response but reduces mitochondrial redox state and hepatocellular oxygenation. This is not due to a deterioration of microvascular perfusion, but rather due to a relative hypermetabolism of the remnant liver after major resection.	[Dold, Stefan; Richter, Sven; Kollmar, Otto; von Heesen, Maximilian; Schilling, Martin K.] Univ Saarland, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany; [Scheuer, Claudia; Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany; [Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany	Saarland University; Saarland University; University of Rostock	von Heesen, M (corresponding author), Univ Saarland, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany.	maximilian.von.heesen@uniklinik-saarland.de			HOMFOR grant of the University of Saarland	HOMFOR grant of the University of Saarland	This study was supported by a HOMFOR grant of the University of Saarland.	Boermeester MA, 1999, J HEPATOL, V31, P905, DOI 10.1016/S0168-8278(99)80293-1; Cantre D, 2008, BRIT J SURG, V95, P785, DOI 10.1002/bjs.6139; Carnovale CE, 2012, ANN HEPATOL, V11, P636, DOI 10.1016/S1665-2681(19)31436-X; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chouker A, 2008, MOL MED, V14, P116, DOI 10.2119/2007-00075.Chouker; Cray SH, 2001, BRIT J ANAESTH, V86, P425, DOI 10.1093/bja/86.3.425; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045; Eipel C, 2005, ANN SURG, V241, P477, DOI 10.1097/01.sla.0000154264.41201.51; Eipel C, 2010, TRANSPL INT, V23, P998, DOI 10.1111/j.1432-2277.2010.01079.x; EZZAT WR, 1987, AM J PHYSIOL, V252, pH836, DOI 10.1152/ajpheart.1987.252.4.H836; Gaucher C, 2007, CLIN HEMORHEOL MICRO, V37, P99; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Hayashi H, 2009, HEPATOL RES, V39, P78, DOI 10.1111/j.1872-034X.2008.00404.x; HICKMAN R, 1995, DIGEST DIS SCI, V40, P1246, DOI 10.1007/BF02065532; HOSHINO M, 1995, BIOCHEM J, V305, P367, DOI 10.1042/bj3050367; Knopp J, 1997, ANN NY ACAD SCI, V827, P489, DOI 10.1111/j.1749-6632.1997.tb51859.x; Kostopanagiotou G, 2007, J SURG RES, V141, P257, DOI 10.1016/j.jss.2006.11.005; Lautt WW, 2007, HEPATOL RES, V37, P891, DOI 10.1111/j.1872-034X.2007.00148.x; LAUTT WW, 1990, GASTROENTEROLOGY, V98, P1024, DOI 10.1016/0016-5085(90)90029-Z; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Macedo MP, 1998, AM J PHYSIOL-GASTR L, V274, pG253, DOI 10.1152/ajpgi.1998.274.2.G253; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Asencio JM, 2014, J HEPATO-BIL-PAN SCI, V21, P399, DOI 10.1002/jhbp.97; Marcos A, 2000, TRANSPLANTATION, V70, P1697, DOI 10.1097/00007890-200012270-00006; Martin-Sanz P, 2002, METAB BRAIN DIS, V17, P325, DOI 10.1023/A:1021909902310; MENGER MD, 1991, EUR SURG RES, V23, P158, DOI 10.1159/000129148; Mucke I, 2000, INT J COLORECTAL DIS, V15, P335, DOI 10.1007/s003840000247; Palmes D, 2004, TRANSPL INT, V17, P862, DOI 10.1111/j.1432-2277.2004.tb00522.x; Richter S, 2001, J PHYSIOL-LONDON, V531, P193, DOI 10.1111/j.1469-7793.2001.0193j.x; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com; Serenari M, 2013, WORLD J GASTROENTERO, V19, P7922, DOI 10.3748/wjg.v19.i44.7922; Smyrniotis V, 2002, TRANSPL INT, V15, P355, DOI 10.1111/j.1432-2277.2002.tb00178.x; Tazuma S, 2001, DIGEST DIS SCI, V46, P1285, DOI 10.1023/A:1010623631456; Vollmar B, 1997, MICROVASC RES, V54, P164, DOI 10.1006/mvre.1997.2028; VOLLMAR B, 1994, AM J PATHOL, V145, P1421	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141877	10.1371/journal.pone.0141877	http://dx.doi.org/10.1371/journal.pone.0141877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523932	gold, Green Submitted, Green Published			2022-12-27	WOS:000364029800026
J	Liu, F; Guo, QL; Xie, GQ; Zhang, H; Wu, YX; Yang, LX				Liu, Feng; Guo, Qinglong; Xie, Guoqiang; Zhang, Han; Wu, Yaxi; Yang, Lixia			Percutaneous Coronary Intervention after Fibrinolysis for ST-Segment Elevation Myocardial Infarction Patients: An Updated Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MULTICENTER RANDOMIZED-TRIAL; ABCIXIMAB RETEPLASE STENT; LEFT-VENTRICULAR FUNCTION; PRIMARY ANGIOPLASTY; PLASMINOGEN-ACTIVATOR; ROUTINE ANGIOPLASTY; FOLLOW-UP; IMMEDIATE THROMBOLYSIS; ENHANCE REPERFUSION; INVASIVE STRATEGY	Background Percutaneous coronary intervention (PCI), fibrinolysis and the combination of both methods are current therapeutic options for patients with ST-segment elevation myocardial infarction (STEMI). Methods We searched PubMed, EMBASE, Google scholar and Cochrane Controlled Trials Register for randomized controlled trials (RCTs) evaluating the efficacy and safety of PCI after fibrinolysis within 24 hours, which was compared with primary PCI alone and ischemia-guided or delayed PCI. Meta-analysis was conducted using Review Manager 5.30 following the methods described by the Cochrane library. Results A total of 16 studies including 10,034 patients were enrolled. As compared with primary PCI alone group, the short-term mortality (5.8% vs 4.5%, RR 1.29, 95% confidence interval [CI] 1.00-1.65) and re-infarction rate (4.1% vs 2.7%, RR 1.46, 95% CI 1.05-2.03) were higher in the immediate PCI group (median/mean time <= 2 h after fibrinolysis). However, the short-term mortality and re-infarction rate showed no statistically significant differences in the early PCI group (2-24 hours after fibrinolysis). The rate of major bleeding events was higher both in the immediate PCI (6.3% vs 4.4%, RR 1.43, 95% CI 1.11-1.85) and the early PCI group (6.4% vs 4.4%, RR 1.46, 95% CI 1.03-2.06) as compared with primary PCI alone group. As compared with ischemia-guided or delayed PCI, early PCI was associated with significantly reduced re-infarction (2.4% vs 4.0%, RR 0.61, 95% CI 0.41-0.92) and recurrent ischemia (1.5% vs 5.3%, RR 0.29, 95% CI 0.12-0.70) at short-term. And the reduced reinfarction rate was also observed at long-term. Conclusions Early PCI after fibrinolysis, with a relatively broader time for PCI preparation, can bring the similar effects with primary PCI alone and is better than ischemia-guided or delayed PCI in STEMI patients with symptom onset < 12 h who cannot receive timely PCI. However, immediate PCI after fibrinolysis is detrimental.	[Liu, Feng] Third Mil Med Univ, Dept Postgrad, Chongqing, Peoples R China; [Liu, Feng; Guo, Qinglong; Xie, Guoqiang; Zhang, Han] Second Mil Med Univ, Dept Postgrad, Shanghai, Peoples R China; [Wu, Yaxi; Yang, Lixia] Kunming Gen Hosp, Dept Cardiol, Chengdu Mil Area, Yunnan, Peoples R China; [Wu, Yaxi] Kunming Med Univ, Dept Postgrad, Yunnan, Peoples R China	Army Medical University; Naval Medical University; Kunming General Hospital; Kunming Medical University	Yang, LX (corresponding author), Kunming Gen Hosp, Dept Cardiol, Chengdu Mil Area, Yunnan, Peoples R China.	doctorylixia@aliyun.com						Agati L, 2007, AM HEART J, V154, P151, DOI 10.1016/j.ahj.2007.03.028; Al Shammeri O, 2013, INT J HEALTH SCI-IJH, V7, P91, DOI 10.12816/0006026; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Armstrong PW, 2010, AM HEART J, V160, P30, DOI 10.1016/j.ahj.2010.04.007; Bagai A, 2013, AM HEART J, V165, P630, DOI 10.1016/j.ahj.2012.12.016; Bednar F, 2003, CAN J CARDIOL, V19, P1133; BELENKIE I, 1991, AM HEART J, V121, P407, DOI 10.1016/0002-8703(91)90706-N; Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; Cantor WJ, 2008, AM HEART J, V155, P19, DOI 10.1016/j.ahj.2007.08.025; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Clever YP, 2011, CIRC-CARDIOVASC INTE, V4, P342, DOI 10.1161/CIRCINTERVENTIONS.111.962316; Collet JP, 2006, J AM COLL CARDIOL, V48, P1326, DOI 10.1016/j.jacc.2006.03.064; D'Souza SP, 2011, EUR HEART J, V32, P972, DOI 10.1093/eurheartj/ehq398; Danchin N, 2014, CIRCULATION, V129, P1629, DOI 10.1161/CIRCULATIONAHA.113.005874; Desch S, 2010, HEART, V96, P1695, DOI 10.1136/hrt.2010.193862; Di Mario C, 2004, AM HEART J, V148, P378, DOI 10.1016/j.ahj.2004.03.038; Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8; Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816; Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P909, DOI 10.1016/j.jcin.2009.07.009; Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1; Fernandez-Aviles F, 2007, EUR HEART J, V28, P949, DOI 10.1093/eurheartj/ehl461; Geng W, 2013, CORONARY ARTERY DIS, V24, P238, DOI 10.1097/MCA.0b013e32835e5c67; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Kanakakis J, 2009, CATHETER CARDIO INTE, V74, P398, DOI 10.1002/ccd.22009; Le May MR, 2005, J AM COLL CARDIOL, V46, P417, DOI 10.1016/j.jacc.2005.04.042; Li DB, 2011, AFR J BIOTECHNOL, V10, P15801, DOI 10.5897/AJB11.975; O'Gara PT, 2013, CATHETER CARDIO INTE, V82, pE1, DOI 10.1002/ccd.24776; ONEILL WW, 1992, CIRCULATION, V86, P1710, DOI 10.1161/01.CIR.86.6.1710; ROGERS WJ, 1991, J AM COLL CARDIOL, V17, P1007, DOI 10.1016/0735-1097(91)90823-R; Ross AM, 1999, J AM COLL CARDIOL, V34, P1954, DOI 10.1016/S0735-1097(99)00444-1; Scheller B, 2003, J AM COLL CARDIOL, V42, P634, DOI 10.1016/S0735-1097(03)00763-0; Sinnaeve PR, 2014, CIRCULATION, V130, P1139, DOI 10.1161/CIRCULATIONAHA.114.009570; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thiele H, 2005, EUR HEART J, V26, P1956, DOI 10.1093/eurheartj/ehi432; Thiele H, 2011, JACC-CARDIOVASC INTE, V4, P605, DOI 10.1016/j.jcin.2011.01.013; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1987, NEW ENGL J MED, V317, P581, DOI 10.1056/NEJM198709033171001; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Vora AN, 2015, JAMA INTERN MED, V175, P207, DOI 10.1001/jamainternmed.2014.6573; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993	42	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141855	10.1371/journal.pone.0141855	http://dx.doi.org/10.1371/journal.pone.0141855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523834	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800025
J	Li, LB; Leung, DYM; Goleva, E				Li, Ling-bo; Leung, Donald Y. M.; Goleva, Elena			Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; CORTICOSTEROID INSENSITIVITY; ALVEOLAR MACROPHAGES; INHIBITION; PATHWAYS; CELLS; INFLAMMATION; MECHANISMS; DISEASE	Steroid resistance is a significant problem in management of chronic inflammatory diseases, including asthma. Accessible biomarkers are needed to identify steroid resistant patients to optimize their treatment. This study examined corticosteroid resistance in severe asthma. 24 asthmatics with forced expiratory volume in one second of less then 80% predicted were classified as steroid resistant or steroid sensitive based on changes in their lung function following a week of treatment with oral prednisone. Heparinised blood was collected from patients prior to oral prednisone administration. Phosphorylated mitogen activated kinases (MAPK) (extracellular regulated kinase (ERK), p38 and jun kinase (JNK)) were analyzed in whole blood samples using flow cytometry. Activation of phospho-p38 MAPK and phospho-mitogen-and stress-activated protein kinase 1 (MSK1) in asthmatics' peripheral blood mononuclear cells (PBMC) were confirmed by Western blot. Dexamethasone suppression of the LPS-induced IL-8 mRNA production by steroid resistant asthmatics PBMC in the presence of p38 and ERK inhibitors was evaluated by real time PCR. Flow cytometry analysis identified significantly stronger p38 phosphorylation in CD14(+) monocytes from steroid resistant than steroid sensitive asthmatics (p = 0.014), whereas no difference was found in phosphorylation of ERK or JNK in CD14(+) cells from these two groups of asthmatics. No difference in phosphorylated p38, ERK, JNK was detected in CD4(+), CD8(+) T cells, B cells and NK cells from steroid resistant vs. steroid sensitive asthmatics. P38 MAPK pathway activation was confirmed by Western blot, as significantly higher phospho-p38 and phospho-MSK1 levels were detected in the PBMC lysates from steroid resistant asthmatics. P38 inhibitor significantly enhanced DEX suppression of LPS-induced IL-8 mRNA by PBMC of steroid resistant asthmatics. This is the first report demonstrating selective p38 MAPK pathway activation in blood monocytes of steroid resistant asthmatics, suggesting that p38 and MSK1 phosphorylation can serve as blood biomarkers of steroid resistance.	[Li, Ling-bo; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	GolevaE@njhealth.org			National Institutes of Health [AI070140, HL036577]; National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070140, R01AI070140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI070140 (DL), HL036577 (DL) and National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute grant UL1 TR001082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 1999, J ASTHMA, V36, P257, DOI 10.3109/02770909909075409; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Beck IME, 2009, BIOCHEM PHARMACOL, V77, P1194, DOI 10.1016/j.bcp.2008.12.008; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Gallelli L, 2010, INT J IMMUNOPATH PH, V23, P471, DOI 10.1177/039463201002300209; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Khorasani N, 2015, INT J CHRONIC OBSTR, V10, P283, DOI 10.2147/COPD.S72403; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lea S, 2015, BRIT J CLIN PHARMACO, V79, P756, DOI 10.1111/bcp.12536; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Liu WM, 2010, MOL CELL BIOL, V30, P1783, DOI 10.1128/MCB.01003-09; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; McManus R, 2003, J ENDOCRINOL, V178, P1, DOI 10.1677/joe.0.1780001; Mercado N, 2011, MOL PHARMACOL, V80, P1128, DOI 10.1124/mol.111.071993; Mercado N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041582; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rawadi G, 1999, J IMMUNOL, V162, P2193; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468	36	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141909	10.1371/journal.pone.0141909	http://dx.doi.org/10.1371/journal.pone.0141909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517722	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800092
J	Nishimura, W; Kapoor, A; El Khattabi, I; Jin, WZ; Yasuda, K; Bonner-Weir, S; Sharma, A				Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Yasuda, Kazuki; Bonner-Weir, Susan; Sharma, Arun			Compensatory Response by Late Embryonic Tubular Epithelium to the Reduction in Pancreatic Progenitors	PLoS One			English	Article							ENDOCRINE CELL-TYPES; BETA-CELLS; EXOCRINE PANCREAS; MOUSE PANCREAS; DUCTAL CELLS; DIFFERENTIATION; BIRTH; REGENERATION; EXPRESSION; NEOGENESIS	Early in pancreatic development, epithelial cells of pancreatic buds function as primary multipotent progenitor cells (1 degrees MPC) that specify all three pancreatic cell lineages, i.e., endocrine, acinar and duct. Bipotent "Trunk" progenitors derived from 1 degrees MPC are implicated in directly regulating the specification of endocrine progenitors. It is unclear if this specification process is initiated in the 1 degrees MPC where some 1 degrees MPC become competent for later specification of endocrine progenitors. Previously we reported that in Pdx1(tTA/+); tetO(MafA) (bigenic) mice inducing expression of transcription factor MafA in Pdx1-expressing (Pdx1(+)) cells throughout embryonic development inhibited the proliferation and differentiation of 1 degrees MPC cells, resulting in reduced pancreatic mass and endocrine cells by embryonic day (E) 17.5. Induction of the transgene only until E12.5 in Pdx1(+) 1 degrees MPC was sufficient for this inhibition of endocrine cells and pancreatic mass at E17.5. However, by birth (P0), as we now report, such bigenic pups had significantly increased pancreatic and endocrine volumes with endocrine clusters containing all pancreatic endocrine cell types. The increase in endocrine cells resulted from a higher proliferation of tubular epithelial cells expressing the progenitor marker Glut2 in E17.5 bigenic embryos and increased number of Neurog3-expressing cells at E19.5. A BrdU-labeling study demonstrated that inhibiting proliferation of 1 degrees MPC by forced MafA-expression did not lead to retention of those progenitors in E17.5 tubular epithelium. Our data suggest that the forced MafA expression in the 1 degrees MPC inhibits their competency to specify endocrine progenitors only until E17.5, and after that compensatory proliferation of tubular epithelium gives rise to a distinct pool of endocrine progenitors. Thus, these bigenic mice provide a novel way to characterize the competency of 1 degrees MPC for their ability to specify endocrine progenitors, a critical limitation in our understanding of endocrine differentiation.	[Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Bonner-Weir, Susan; Sharma, Arun] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Nishimura, Wataru; Kapoor, Archana; El Khattabi, Ilham; Jin, Wanzhu; Bonner-Weir, Susan; Sharma, Arun] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Nishimura, Wataru; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Nishimura, Wataru] Jichi Univ, Div Anat Bioimaging & Neurocell Sci, Shimotsuke, Tochigi, Japan	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; National Center for Global Health & Medicine - Japan	Sharma, A (corresponding author), MedImmune, Cardiovasc & Metab Dis, Gaithersburg, MD 20878 USA.	arun.sharma@joslin.harvard.edu	Nishimura, Wataru/R-9215-2019	Nishimura, Wataru/0000-0002-8068-1277; Bonner-Weir, Susan/0000-0003-4682-0656	NIH [RO1 DK060127]; Juvenile Diabetes Research Foundation (JDRF); American Diabetes Association [1-12-BS-187]; Herbert Graetz Fund; Shirley and William Fleisher Family Foundation; Alexander and Margaret Stewart Trust; JDRF; JSPS [22591022]; Takeda Science Foundation; National Center for Global Health and Medicine; Okinaka Memorial Institute for Medical Research; Japan Diabetes Foundation; Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH) [DK-36836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060127, P30DK036836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Herbert Graetz Fund; Shirley and William Fleisher Family Foundation; Alexander and Margaret Stewart Trust; JDRF(Juvenile Diabetes Research Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Okinaka Memorial Institute for Medical Research; Japan Diabetes Foundation; Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by research grants from NIH (RO1 DK060127), Juvenile Diabetes Research Foundation (JDRF), American Diabetes Association grant 1-12-BS-187, the Herbert Graetz Fund, Shirley and William Fleisher Family Foundation, and the Alexander and Margaret Stewart Trust to AS; JDRF postdoctoral fellowship, Mary K. Iacocca Fellowship, and grants from JSPS KAKENHI (22591022), Takeda Science Foundation, National Center for Global Health and Medicine, the Okinaka Memorial Institute for Medical Research and Japan Diabetes Foundation to WN; and Media and Advanced Microscopy Cores of Joslin Diabetes Endocrinology Research Center (NIH DK-36836); and an important group of private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Beucher A, 2012, DEV BIOL, V361, P277, DOI 10.1016/j.ydbio.2011.10.025; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gouzi M, 2011, DEV DYNAM, V240, P589, DOI 10.1002/dvdy.22544; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; He KH, 2014, DEV BIOL, V385, P2, DOI 10.1016/j.ydbio.2013.10.024; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Magenheim J, 2011, DEV BIOL, V359, P26, DOI 10.1016/j.ydbio.2011.08.006; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142286	10.1371/journal.pone.0142286	http://dx.doi.org/10.1371/journal.pone.0142286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540252	Green Published, gold			2022-12-27	WOS:000364303800075
J	Yu, XJ; Chen, SH; Hu, ZH; Liu, M; Chen, YM; Shi, PC; Liu, HF				Yu, Xingjian; Chen, Shuhang; Hu, Zhenghui; Liu, Meng; Chen, Yunmei; Shi, Pengcheng; Liu, Huafeng			Sparse/Low Rank Constrained Reconstruction for Dynamic PET Imaging	PLOS ONE			English	Article							TIME-OF-FLIGHT; POSITRON-EMISSION-TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; LEAST-SQUARES ALGORITHM; MAXIMUM-LIKELIHOOD; SCANNER	In dynamic Positron Emission Tomography (PET), an estimate of the radio activity concentration is obtained from a series of frames of sinogramdata taken at ranging in duration from 10 seconds tominutes under some criteria. So far, all the well-known reconstruction algorithms require known data statistical properties. It limits the speed of data acquisition, besides, it is unable to afford the separated information about the structure and the variation of shape and rate of metabolism which play a major role in improving the visualization of contrast for some requirement of the diagnosing in application. This paper presents a novel low rank-based activity map reconstruction scheme from emission sinograms of dynamic PET, termed as SLCR representing Sparse/Low Rank Constrained Reconstruction for Dynamic PET Imaging. In this method, the stationary background is formulated as a low rank component while variations between successive frames are abstracted to the sparse. The resulting nuclear norm and l1 norm relatedminimization problem can also be efficiently solved by many recently developed numerical methods. In this paper, the linearized alternating direction method is applied. The effectiveness of the proposed scheme is illustrated on three data sets.	[Yu, Xingjian; Chen, Shuhang; Hu, Zhenghui; Liu, Huafeng] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Coll Opt Sci & Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Meng; Chen, Yunmei] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Shi, Pengcheng] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY 14623 USA	Zhejiang University; State University System of Florida; University of Florida; Rochester Institute of Technology	Liu, HF (corresponding author), Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Coll Opt Sci & Engn, Hangzhou 310003, Zhejiang, Peoples R China.	liuhf@zju.edu.cn			National Natural Science Foundation of China [61427807, 61271083, 61525106]; Shenzhen Innovation Funding [SGLH20131010110119871, GJHZ20140415152115754]; Natural Science Foundation of Zhejiang [LR12F03001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Innovation Funding; Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province)	This work is supported in part by the National Natural Science Foundation of China (No: 61427807, 61271083, 61525106), by the Shenzhen Innovation Funding (SGLH20131010110119871 and GJHZ20140415152115754), and by Natural Science Foundation of Zhejiang (No: LR12F03001).	Alenius S, 1997, EUR J NUCL MED, V24, P258, DOI 10.1007/s002590050050; Bendriem B., 2013, THEORY PRACTICE 3D P, V32; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Conti M, 2005, PHYS MED BIOL, V50, P4507, DOI 10.1088/0031-9155/50/19/006; De Pierro AR, 2001, IEEE T MED IMAGING, V20, P280, DOI 10.1109/42.921477; Fessler JA, 1996, IEEE T IMAGE PROCESS, V5, P1346, DOI 10.1109/83.535846; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; FESSLER JA, 1995, IEEE T IMAGE PROCESS, V4, P1417, DOI 10.1109/83.465106; Gaitanis A, 2010, COMPUT MED IMAG GRAP, V34, P131, DOI 10.1016/j.compmedimag.2009.07.006; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Karp JS, 2008, J NUCL MED, V49, P462, DOI 10.2967/jnumed.107.044834; KAUFMAN L, 1993, IEEE T MED IMAGING, V12, P200, DOI 10.1109/42.232249; LAINE A, 1995, IEEE ENG MED BIOL, V14, P536, DOI 10.1109/51.464770; LEVITAN E, 1987, IEEE T MED IMAGING, V6, P185, DOI 10.1109/TMI.1987.4307826; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; Nichols TE, 2002, IEEE T MED IMAGING, V21, P396, DOI 10.1109/TMI.2002.1000263; Nuyts J, 1999, IEEE T MED IMAGING, V18, P393, DOI 10.1109/42.774167; Otazo R., 2014, MAGNETIC RESONANCE M; Qi JY, 2006, PHYS MED BIOL, V51, P4017, DOI 10.1088/0031-9155/51/16/009; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rahmim A, 2009, MED PHYS, V36, P3654, DOI 10.1118/1.3160108; Reader AJ, 2002, IEEE T NUCL SCI, V49, P693, DOI 10.1109/TNS.2002.1039550; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Vandenberghe S, 2006, PHYS MED BIOL, V51, P1603, DOI 10.1088/0031-9155/51/6/017; Vandenberghe S, 2001, COMPUT MED IMAG GRAP, V25, P105, DOI 10.1016/S0895-6111(00)00060-4; Verhaeghe J, 2008, IEEE T MED IMAGING, V27, P943, DOI 10.1109/TMI.2008.923698; Verhaeghe J, 2007, IEEE T NUCL SCI, V54, P80, DOI 10.1109/TNS.2006.888814; Wernick MN, 1999, IEEE T MED IMAGING, V18, P185, DOI 10.1109/42.764885; Wright J., 2009, P ADV NEURAL INFORM, V22, DOI DOI 10.5555/2984093.2984326; Xing L, 2006, MED DOSIM, V31, P91, DOI 10.1016/j.meddos.2005.12.004; Yang JF, 2013, MATH COMPUT, V82, P301; Zeng GL, 2001, COMPUT MED IMAG GRAP, V25, P97, DOI 10.1016/S0895-6111(00)00059-8; Zhou J, 2006, DIGIT SIGNAL PROCESS, V16, P735, DOI 10.1016/j.dsp.2006.08.006; Zhou J, 2008, COMPUT MED IMAG GRAP, V32, P710, DOI 10.1016/j.compmedimag.2008.08.008	35	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142019	10.1371/journal.pone.0142019	http://dx.doi.org/10.1371/journal.pone.0142019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540274	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800046
J	Akhtar, S; Chandrasekhar, B; Attur, S; Dhaunsi, GS; Yousif, MHM; Benter, IF				Akhtar, Saghir; Chandrasekhar, Bindu; Attur, Sreeja; Dhaunsi, Gursev S.; Yousif, Mariam H. M.; Benter, Ibrahim F.			Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; VASCULAR DYSFUNCTION; DIABETIC COMPLICATIONS; DEPENDENT PATHWAY; PATHOPHYSIOLOGY; MECHANISMS; SYSTEM; CANCER; EGFR; RATS	Transactivation of the epidermal growth factor receptor (EGFR or ErbB) family members, namely EGFR and ErbB2, appears important in the development of diabetes-induced vascular dysfunction. Angiotensin-(1-7) [Ang-(1-7)] can prevent the development of hyperglycemia-induced vascular complications partly through inhibiting EGFR transactivation. Here, we investigated whether Ang-(1-7) can inhibit transactivation of ErbB2 as well as other ErbB receptors in vivo and in vitro. Streptozotocin-induced diabetic rats were chronically treated with Ang-(1-7) or AG825, a selective ErbB2 inhibitor, for 4 weeks and mechanistic studies performed in the isolated mesenteric vasculature bed as well as in cultured vascular smooth muscle cells (VSMCs). Ang-(1-7) or AG825 treatment inhibited diabetes-induced phosphorylation of ErbB2 receptor at tyrosine residues Y1221/22, Y1248, Y877, as well as downstream signaling via ERK1/2, p38 MAPK, ROCK, eNOS and IkB-alpha in the mesenteric vascular bed. In VSMCs cultured in high glucose (25 mM), Ang-(1-7) inhibited src-dependent ErbB2 transactivation that was opposed by the selective Mas receptor antagonist, D-Pro(7)-Ang-(1-7). Ang-(1-7) via Mas receptor also inhibited both Angiotensin II- and noradrenaline/norephinephrine-induced transactivation of ErbB2 and/or EGFR receptors. Further, hyperglycemia-induced transactivation of ErbB3 and ErbB4 receptors could be attenuated by Ang-(1-7) that could be prevented by D-Pro(7)-Ang-(1-7) in VSMC. These data suggest that Ang-(1-7) via its Mas receptor acts as a pan-ErbB inhibitor and might represent a novel general mechanism by which Ang-(1-7) exerts its beneficial effects in many disease states including diabetes-induced vascular complications.	[Akhtar, Saghir; Chandrasekhar, Bindu; Attur, Sreeja; Yousif, Mariam H. M.; Benter, Ibrahim F.] Kuwait Univ, Dept Pharmacol & Toxicol, Fac Med, Safat 13110, Kuwait; [Dhaunsi, Gursev S.] Kuwait Univ, Dept Pediat, Fac Med, Safat 13110, Kuwait	Kuwait University; Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Dept Pharmacol & Toxicol, Fac Med, Safat 13110, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University Research Sector/Administration [MR 05/09]; OMICS Research Unit/RCF; General Facility Grant [SRUL02/13]	Kuwait University Research Sector/Administration; OMICS Research Unit/RCF; General Facility Grant	This study was supported by a grant from Kuwait University Research Sector/Administration (Project number MR 05/09). The authors also acknowledge support from the OMICS Research Unit/RCF and the General Facility Grant (SRUL02/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067813; Akhtar S, 2013, BIOIMPACTS, V3, P5, DOI 10.5681/bi.2013.008; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Beltowski J, 2014, CURR PHARM DESIGN, V20, P616, DOI 10.2174/138161282004140213155050; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2015, J DRUG TARGET, V23, P506, DOI 10.3109/1061186X.2015.1057150; Benter IF, 2011, J CARDIOVASC PHARM, V57, P559, DOI 10.1097/FJC.0b013e31821324b6; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BENTER IF, 1993, PEPTIDES, V14, P679, DOI 10.1016/0196-9781(93)90097-Z; Cabello-Verrugio C, 2015, MED RES REV, V35, P437, DOI 10.1002/med.21343; Cao X, 2014, MOL CELL ENDOCRINOL, V393, P30, DOI 10.1016/j.mce.2014.05.024; Chappell M. C., 2014, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FEND0.2013.00201; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Costa A, 2014, NITRIC OXIDE-BIOL CH, V37, P11, DOI 10.1016/j.niox.2013.12.007; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; El-Hashim AZ, 2012, BRIT J PHARMACOL, V166, P1964, DOI [10.1111/i.1476-5381.2012.01905.x, DOI 10.1111/J.1476-5381.2012.01905.X]; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fu Z, 2014, HYPERTENSION, V63, P1219, DOI 10.1161/HYPERTENSIONAHA.113.03025; Galan M, 2012, HYPERTENSION, V60, P71, DOI 10.1161/HYPERTENSIONAHA.112.192500; Gallagher PE, 2014, CURR MED CHEM, V21, P2417, DOI 10.2174/0929867321666140205133357; Garcia-Foncillas J, 2015, ORAL ONCOL, DOI [10.1016/j.oraloncology.2015.02.092, DOI 10.1016/J.0RAL0NC0L0GY.2015.02.092]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gray SP, 2014, J MOL MED, V92, P441, DOI 10.1007/s00109-014-1146-1; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Jiang T, 2014, BRIT J PHARMACOL, V171, P4222, DOI 10.1111/bph.12770; Li YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08209; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Matrougui K, 2010, DIABETES-METAB RES, V26, P13, DOI 10.1002/dmrr.1050; McKinney CA, 2014, CLIN SCI, V126, P815, DOI 10.1042/CS20130436; Patel VB, 2014, CLIN SCI, V126, P471, DOI 10.1042/CS20130344; Pernomian L, 2014, VASA, V43, P404, DOI 10.1024/0301-1526/a000387; Price KAR, 2015, ORAL ONCOL, V51, P399, DOI 10.1016/j.oraloncology.2015.01.018; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Souza LL, 2012, J CELL PHYSIOL, V227, P2117, DOI 10.1002/jcp.22940; Sur S, 2014, CURR VASC PHARMACOL, V12, P190, DOI 10.2174/1570161112666140226123745; Tao XL, 2014, BIOL CELL, V106, P182, DOI 10.1111/boc.201400015; te Riet L, 2015, CIRC RES, V116, P960, DOI 10.1161/CIRCRESAHA.116.303587; Ulu N, 2010, BRIT J PHARMACOL, V161, P1301, DOI 10.1111/j.1476-5381.2010.00829.x; Wang XC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00002; Yousif M. H. M., 2005, Autonomic & Autacoid Pharmacology, V25, P69, DOI 10.1111/j.1474-8673.2004.00333.x; Yousif MH, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/142154	48	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141657	10.1371/journal.pone.0141657	http://dx.doi.org/10.1371/journal.pone.0141657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536590	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400074
J	Danish, LM; Heistermann, M; Agil, M; Engelhardt, A				Danish, Lisa Michelle; Heistermann, Michael; Agil, Muhammad; Engelhardt, Antje			Validation of a Novel Collection Device for Non-Invasive Urine Sampling from Free-Ranging Animals	PLOS ONE			English	Article							C-PEPTIDE; WILD; DOMINANCE; EXCRETION; CORTISOL; ZOO	Recent advances in non-invasively collected samples have opened up new and exciting opportunities for wildlife research. Different types of samples, however, involve different limitations and certain physiological markers (e.g., C-peptide, oxytocin) can only be reliably measured from urine. Common collection methods for urine to date work best for arboreal animals and large volumes of urine. Sufficient recovery of urine is thus still difficult for wildlife biologists, particularly for terrestrial and small bodied animals. We tested three collection devices (two commercially available saliva swabs, Salivette synthetic and cotton, and cotton First aid swabs) against a control to permit the collection of small volumes of urine from the ground. We collected urine samples from captive and wild macaques, and humans, measured volume recovery, and analyzed concentrates of selected physiological markers (creatinine, C-peptide, and neopterin). The Salivette synthetic device was superior to the two alternative devices. Concentrations of creatinine, absolute C-peptide, C-peptide per creatinine, absolute neopterin, and neopterin per creatinine measured in samples collected with this device did not differ significantly from the control and were also strongly correlated to it. Fluid recovery was also best for this device. The least suitable device is the First aid collection device; we found that while absolute C-peptide and C-peptide per creatinine concentrations did not differ significantly from the control, creatinine concentrations were significantly lower than the control. In addition, these concentrations were either not or weakly correlated to the control. The Salivette cotton device provided intermediate results, although these concentrations were strongly correlated to the control. Salivette synthetic swabs seem to be useful devices for the collection of small amounts of urine from the ground destined for the assessment of physiological parameters. They thus provide new opportunities for field studies to incorporate physiological markers, particularly on smaller bodied and terrestrial animals and where urine collection is difficult.	[Danish, Lisa Michelle; Engelhardt, Antje] German Primate Ctr, Jr Res Grp Sexual Select, Gottingen, Germany; [Heistermann, Michael] German Primate Ctr, Endocrinol Lab, Gottingen, Germany; [Agil, Muhammad] Bogor Agr Univ, Fac Vet Med, Bogor, Indonesia	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Bogor Agricultural University	Danish, LM (corresponding author), German Primate Ctr, Jr Res Grp Sexual Select, Gottingen, Germany.	ldanish@dpz.eu	Agil, Muhammad/GPP-6160-2022; Engelhardt, Antje/A-2660-2013	Engelhardt, Antje/0000-0003-2704-7493	Leibniz-DAAD	Leibniz-DAAD	LMD was funded by Leibniz-DAAD (https://www.daad.org/leibnizdaad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manWucript.	Apps P, 2014, BIOCHEM SYST ECOL, V53, P17, DOI 10.1016/j.bse.2013.12.013; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; DELGIUDICE GD, 1988, WILDLIFE SOC B, V16, P324; Furtbauer I, 2015, J FISH BIOL, V86, P1644, DOI 10.1111/jfb.12662; Girard-Buttoz C, 2014, BEHAV ECOL SOCIOBIOL; Girard-Buttoz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018042; Hamerlinck FFV, 1999, EXP DERMATOL, V8, P167, DOI 10.1111/j.1600-0625.1999.tb00367.x; Higham JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022398; Higham JP, 2011, ANIM BEHAV, V81, P1001, DOI 10.1016/j.anbehav.2011.02.001; Higham JP, AM J PHYS ANT UNPUB; Hodges JK, 2011, FIELD LAB METHODS PR, P282; HOOGWERF BJ, 1986, AM J CLIN NUTR, V43, P350, DOI 10.1093/ajcn/43.3.350; Kersey DC, 2014, GEN COMP ENDOCR, V203, P296, DOI 10.1016/j.ygcen.2014.04.022; Kirkpatrick JF, 1996, CAN J ZOOL, V74, P8, DOI 10.1139/z96-002; KIRKPATRICK JF, 1990, CAN J ZOOL, V68, P2576, DOI 10.1139/z90-359; Knott Cheryl D., 1997, Tropical Biodiversity, V4, P95; MECH LD, 1987, J WILDLIFE MANAGE, V51, P10, DOI 10.2307/3801620; Monfort SL, 2003, CONSERV BIOL SER, V8, P147; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; OBrien TG, 1997, INT J PRIMATOL, V18, P321, DOI 10.1023/A:1026330332061; R Development Core Team, 2010, COMP RFFS; Rajagopal T, 2010, BEHAV PROCESS, V85, P58, DOI 10.1016/j.beproc.2010.06.007; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shirtcliff EA, 2001, PSYCHONEUROENDOCRINO, V26, P165, DOI 10.1016/S0306-4530(00)00042-1; Thompson ME, 2009, HORM BEHAV, V55, P299, DOI 10.1016/j.yhbeh.2008.11.005; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1, DOI 10.1002/(SICI)1096-8644(1998)107:27+<1::AID-AJPA2>3.0.CO;2-H; Widner Bernhard, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P251	30	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142051	10.1371/journal.pone.0142051	http://dx.doi.org/10.1371/journal.pone.0142051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536024	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000364298400123
J	Helmy, MM; Helmy, MW; El-Mas, MM				Helmy, Mai M.; Helmy, Maged W.; El-Mas, Mahmoud M.			Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE-RENAL-FAILURE; GAMMA AGONIST; IN-VITRO; ALPHA; EXPRESSION; PROTECTS; INJURY; CELL; CYCLOSPORINE	Nephrotoxicity is a major side effect for the antineoplastic drug cisplatin. Here, we employed pharmacological, biochemical, and molecular studies to investigate the role of peroxisome proliferator-activated receptors (PPARs) in cisplatin nephrotoxicity. Rats were treated with a single i.p. dose of cisplatin (5 mg/kg) alone or combined with pioglitazone (PPAR gamma agonist), fenofibrate (PPAR alpha agonist), pioglitazone plus fenofibrate, or thalidomide (Tumor necrosis factor-a inhibitor; TNF-alpha). Cisplatin nephrotoxicity was evidenced by rises in renal indices of functional (blood urea nitrogen, BUN, and creatinine), inflammatory (TNF-alpha, interleukin 6, IL-6), oxidative (increased malondialdehyde, MDA, and decreased superoxide dismutase, SOD and nitric oxide metabolites, NOx), apoptotic (caspase 3), and histological (glomerular atrophy, acute tubular necrosis and vacuolation) profiles. Cisplatin effects were partly abolished upon concurrent exposure to pioglitazone, fenofibrate, or thalidomide; more renoprotection was observed in rats treated with pioglitazaone plus fenofibrate. Immunostaining showed that renal expressions of PPAR alpha and PPAR gamma were reduced by cisplatin and restored to vehicle-treated values after simultaneous treatment with pioglitazone or fenofibrate. Fenofibrate or pioglitazone renoprotection remained unaltered after concurrent blockade of PPAR alpha (GW6471) and PPAR gamma (GW9662), respectively. To complement the rat studies, we also report that in human embryonic kidney cells (HEK293 cells), increases caused by cisplatin in inflammatory, apoptotic, and oxidative biomarkers were (i) partly improved after exposure to pioglitazone, fenofibrate, or thalidomide, and (ii) completely disappeared in cells treated with a combination of all three drugs. These data establish that the combined use of pioglitazone and fenofibrate additively improved manifestations of cisplatin nephrotoxicity through perhaps GW6471/GW9662-insensitive mechanisms.	[Helmy, Mai M.; El-Mas, Mahmoud M.] Univ Alexandria, Pharmacol & Toxicol, Fac Pharm, Alexandria, Egypt; [Helmy, Maged W.] Damanhour Univ, Pharmacol & Toxicol, Fac Pharm, Damanhour, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Damanhour University	El-Mas, MM (corresponding author), Univ Alexandria, Pharmacol & Toxicol, Fac Pharm, Alexandria, Egypt.	mahelm@hotmail.com	El-Mas, Mahmoud M./B-9047-2009; Helmy, Maged/AFU-2420-2022	El-Mas, Mahmoud M./0000-0001-8855-7070; Helmy, Maged/0000-0003-0375-6762				Ahmed LA, 2014, SCI WORLD J, DOI 10.1155/2014/273870; Amirshahrokhi K, 2015, INFLAMMATION, V38, P476, DOI 10.1007/s10753-014-9953-7; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; Brautigam K, 2011, J CANCER RES CLIN, V137, P875, DOI 10.1007/s00432-010-0952-2; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Cheng Ching-Feng, 2010, PPAR Res, V2010, P345098, DOI 10.1155/2010/345098; Choi JI, 2010, KOREAN J PAIN, V23, P172, DOI 10.3344/kjp.2010.23.3.172; Chung BH, 2005, NEPHROLOGY, V10, pS40, DOI 10.1111/j.1440-1797.2005.00456.x; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; El-Gowelli HM, 2014, TOXICOL APPL PHARM, V275, P88, DOI 10.1016/j.taap.2014.01.008; El-Gowelli HM, 2011, J CARDIOVASC PHARM, V58, P173, DOI 10.1097/FJC.0b013e31821ed803; El-Mas MM, 2008, J PHARMACOL EXP THER, V324, P368, DOI 10.1124/jpet.107.127498; El-Mas MM, 2015, TOXICOL APPL PHARM, V284, P1, DOI 10.1016/j.taap.2015.01.018; El-Mas MM, 2011, BIOCHEM PHARMACOL, V81, P526, DOI 10.1016/j.bcp.2010.11.013; El-Mas MM, 2009, ALCOHOL CLIN EXP RES, V33, P1158, DOI 10.1111/j.1530-0277.2009.00939.x; Fram Robert J., 1992, Current Opinion in Oncology, V4, P1073, DOI 10.1097/00001622-199212000-00012; Ghavimi H, 2015, DRUG RES, V65, P113, DOI 10.1055/s-0033-1364035; Glineur C, 2013, ARTERIOSCL THROM VAS, V33, P621, DOI 10.1161/ATVBAHA.112.300665; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Helmy MW, 2014, J PHYSIOL PHARMACOL, V65, P393; Helmy MM, 2014, EUR J PHARMACOL, V730, P133, DOI 10.1016/j.ejphar.2014.03.002; Helmy MM, 2012, EUR J PHARMACOL, V683, P294, DOI 10.1016/j.ejphar.2012.03.018; Helmy MW, 2015, BR J PHARM IN PRESS; Ibrahim MA, 2014, IMMUNOPHARM IMMUNOT, V36, P130, DOI 10.3109/08923973.2014.884135; Israili ZH, 2011, AM J THER, V18, P117, DOI 10.1097/MJT.0b013e3181afbf51; Jesse CR, 2014, J APPL TOXICOL, V34, P25, DOI 10.1002/jat.2818; Johnson SA, 2015, AM J PHYSIOL-RENAL, V309, pE807, DOI 10.1152/ajprenal.00266.2015; Kadian S, 2013, EUR J PHARMACOL, V698, P388, DOI 10.1016/j.ejphar.2012.10.012; Kapoor A, 2010, SHOCK, V34, P117, DOI 10.1097/SHK.0b013e3181cd86d6; Kim CS, 2012, REGUL PEPTIDES, V174, P65, DOI 10.1016/j.regpep.2011.12.001; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Kuru Karabas Munire, 2013, ISRN Endocrinol, V2013, P858690, DOI 10.1155/2013/858690; Li LY, 2010, EXP BIOL MED, V235, P383, DOI 10.1258/ebm.2009.009218; Li SY, 2004, AM J PHYSIOL-RENAL, V287, pF990, DOI 10.1152/ajprenal.00206.2004; Mahmoud MF, 2013, FOOD CHEM TOXICOL, V51, P114, DOI 10.1016/j.fct.2012.09.006; Mao ZG, 2009, NEPHRON CLIN PRACT, V112, pC230, DOI 10.1159/000224789; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McKinnon B, 2012, FERTIL STERIL, V97, P657, DOI 10.1016/j.fertnstert.2011.12.001; Mulay V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062667; Nasr MA, 2010, VASC PHARMACOL, V53, P53, DOI 10.1016/j.vph.2010.03.006; Oliveira ACP, 2007, EUR J PHARMACOL, V561, P194, DOI 10.1016/j.ejphar.2006.12.026; Orasanu G, 2008, J AM COLL CARDIOL, V52, P869, DOI 10.1016/j.jacc.2008.04.055; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Ramesh G, 2004, KIDNEY INT, V65, P490, DOI 10.1111/j.1523-1755.2004.00413.x; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ray DM, 2006, BIODRUGS, V20, P231, DOI 10.2165/00063030-200620040-00004; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Roca H, 2009, NEOPLASIA, V11, P1309, DOI 10.1593/neo.09936; Saad SY, 2002, CHEMOTHERAPY, V48, P309, DOI 10.1159/000069714; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Saleh S, 2005, BASIC CLIN PHARMACOL, V97, P91, DOI 10.1111/j.1742-7843.2005.pto_114.x; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sato K, 2004, HYPERTENS RES, V27, P417, DOI 10.1291/hypres.27.417; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Shafique E, 2015, FASEB J, V29; Sohn SH, 2010, BRIT J CLIN PHARMACO, V70, P547, DOI 10.1111/j.1365-2125.2010.03724.x; Ueki M, 2013, J BIOSCI BIOENG, V115, P547, DOI 10.1016/j.jbiosc.2012.11.007; Vasvari GP, 2007, INT J CANCER, V121, P1697, DOI 10.1002/ijc.22867; Yamasaki D, 2011, EUR J CELL BIOL, V90, P657, DOI 10.1016/j.ejcb.2011.02.005; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e	63	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142303	10.1371/journal.pone.0142303	http://dx.doi.org/10.1371/journal.pone.0142303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536032	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400150
J	Mario, JT; Fujioka, K; Ikenaka, Y; Nakayama, SMM; Mizukawa, H; Aoyama, Y; Ishizuka, M; Taira, K				Mario, Jemima Tiwaa; Fujioka, Kazutoshi; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Mizukawa, Hazuki; Aoyama, Yoshiko; Ishizuka, Mayumi; Taira, Kumiko			Relationship between Urinary N-Desmethyl-Acetamiprid and Typical Symptoms including Neurological Findings: A Prevalence Case-Control Study	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CHRONIC KIDNEY-DISEASE; NEONICOTINOID INSECTICIDES; MYASTHENIA-GRAVIS; CLOTHIANIDIN; EXPOSURE; THIAMETHOXAM; EXPRESSION; UNIQUE	Neonicotinoid insecticides are nicotinic acetylcholine receptor agonists used worldwide. Their environmental health effects including neurotoxicity are of concern. We previously determined a metabolite of acetamiprid, N-desmethyl-acetamiprid in the urine of a patient, who exhibited some typical symptoms including neurological findings. We sought to investigate the association between urinary N-desmethyl-acetamiprid and the symptoms by a prevalence case-control study. Spot urine samples were collected from 35 symptomatic patients of unknown origin and 50 non-symptomatic volunteers (non-symptomatic group, NSG, 4-87 year-old). Patients with recent memory loss, finger tremor, and more than five of six symptoms (headache, general fatigue, palpitation/chest pain, abdominal pain, muscle pain/weakness/spasm, and cough) were in the typical symptomatic group (TSG, n = 19, 5-69 year-old); the rest were in the atypical symptomatic group (ASG, n = 16, 5-78 year-old). N-desmethyl-acetamiprid and six neonicotinoids in the urine were quantified by liquid chromatography-tandem mass spectrometry. The detection of N-desmethyl-acetamiprid was the most frequent and highest in TSG (47.4%, 6.0 ppb (frequency, maximum)), followed by in ASG (12.5%, 4.4 ppb) and in NSG (6.0%, 2.2 ppb), however acetamiprid was not detected. Thiamethoxam was detected in TSG (31.6%, 1.4 ppb), in ASG (6.3%, 1.9 ppb), but not in NSG. Nitenpyram was detected in TSG (10.5%, 1.2 ppb), in ASG (6.3%, not quantified) and in NSG (2.0%, not quantified). Clothianidin was only detected in ASG (6.3%, not quantified), and in NSG (2.0%, 1.6 ppb). Thiacloprid was detected in ASG (6.3%, 0.1 ppb). The cases in TSG with detection of N-desmethyl-acetamiprid and thiamethoxam were aged 5 to 62 years and 13 to 62 years, respectively. Detection of N-desmethyl-acetamiprid was associated with increased prevalence of the symptoms (odds ratio: 14, 95% confidence interval: 3.5-57). Urinary N-desmethyl-acetamiprid can be used as a biomarker for environmental exposure to acetamiprid. Further multi-centered clinical research in larger patients groups with more metabolites analysis is needed.	[Mario, Jemima Tiwaa; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Fac Vet Med, Sapporo, Hokkaido 060, Japan; [Fujioka, Kazutoshi] Hawaii Inst Mol Educ, Honolulu, HI USA; [Ikenaka, Yoshinori] North West Univ, Sch Environm Sci & Dev, Water Res Grp, Potchefstroom, South Africa; [Mizukawa, Hazuki] Hokkaido Univ, Fac Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido 060, Japan; [Aoyama, Yoshiko] Aoyama Allergy Clin, Gunma, Japan; [Taira, Kumiko] Tokyo Womens Med Univ Med Ctr East, Dept Anesthesiol, Tokyo, Japan	Hokkaido University; North West University - South Africa; Hokkaido University	Taira, K (corresponding author), Tokyo Womens Med Univ Med Ctr East, Dept Anesthesiol, Tokyo, Japan.	VFG03077@nifty.com	IKENAKA, Yoshinori/F-8529-2012	Ikenaka, Yoshinori/0000-0002-6633-6637	Japan Endocrine-disruptor Preventive Action; Yamada Research Grant [182]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26304043, 15K00559]	Japan Endocrine-disruptor Preventive Action; Yamada Research Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is partially supported by the Japan Endocrine-disruptor Preventive Action awarded to Dr. K. Taira, Yamada Research Grant awarded to Dr. K. Taira (No. 182), and Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) awarded to Dr. Y. Ikenaka (No. 26304043) and Dr. K. Taira (No. 15K00559). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agha A, 2012, SAUDI J KIDNEY DIS T, V23, P1300, DOI 10.4103/1319-2442.103584; Akiyama Y, 2011, J PESTIC SCI, V36, P66, DOI 10.1584/jpestics.G10-63; [Anonymous], 2002, FACTSH AC, P4; Bednarska AJ, 2013, ECOTOXICOLOGY, V22, P548, DOI 10.1007/s10646-013-1047-z; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Brunet JL, 2008, J ENVIRON SCI HEAL B, V43, P261, DOI 10.1080/03601230701771446; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Dempsey DA, 2013, CLIN PHARMACOL THER, V94, P400, DOI 10.1038/clpt.2013.114; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Ding F, 2015, J PHOTOCH PHOTOBIO B, V147, P24, DOI 10.1016/j.jphotobiol.2015.03.010; Ford KA, 2006, CHEM RES TOXICOL, V19, P1549, DOI 10.1021/tx0601859; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Grando SA, 2007, LIFE SCI, V80, P2181, DOI 10.1016/j.lfs.2007.03.015; Intrenational Programme on Chemical Safety, 1994, ENV HLTH CRIT; IUPAC, 1976, PURE APPL CHEM, V45, P99, DOI DOI 10.1351/PAC197645020099; Jayasumana C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-6; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432; Li P, 2011, J NEUROSCI RES, V89, P1295, DOI 10.1002/jnr.22644; Lips KS, 2005, PLACENTA, V26, P735, DOI 10.1016/j.placenta.2004.10.009; MacGregor DA, 2000, ANESTHESIOLOGY, V92, P338, DOI 10.1097/00000542-200002000-00013; Matsui N, 2009, J NEUROL NEUROSUR PS, V80, P1168, DOI 10.1136/jnnp.2008.152637; Mesnage R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179691; Metruccio F, 2010, CLOTHIANIDIN, P20; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; MUSHA M, 1993, TOHOKU J EXP MED, V169, P335, DOI 10.1620/tjem.169.335; Nakane S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118312; Nakanishi R, 2013, ANN REP KYOTO PREFEC, V58, P29; National Pesticide Information Center, IM TECHN FACT SHEET; Phua DH, 2009, CLIN TOXICOL, V47, P336, DOI 10.1080/15563650802644533; [Plant Products Safety Division & Plant Protection Division Food Safety and Consumer Affairs Bureau Ministry of Agriculture Firestry and Fisheries], 2013, NOYAK YOR 2012; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Rezonzew G, 2012, AM J PHYSIOL-RENAL, V303, pF304, DOI 10.1152/ajprenal.00661.2011; Rueter LE, 2004, CNS DRUG REV, V10, P167; Shi XY, 2009, J AGR FOOD CHEM, V57, P4861, DOI 10.1021/jf900250f; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Taira K, 2011, JPN CHUDOKU KENKYU, V24, P222; Taira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080332; Todani Masaki, 2008, Chudoku Kenkyu, V21, P387; Tomizawa M, 2000, TOXICOL APPL PHARM, V169, P114, DOI 10.1006/taap.2000.9057; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; Uchida K, 2002, CLIN CHIM ACTA, V323, P121, DOI 10.1016/S0009-8981(02)00177-8; Ueyama J, 2014, J OCCUP HLTH; US Environmental Protection Agency (USEPA) Factsheet-clothianidin, 2003, FACTSH CLOTH, P12; US Environmental Protection Agency (USEPA) Factsheet-dinotefuran, 2004, FACTSH DIN, P2; US Environmental Protection Agency (USEPA) Factsheet-thiacloprid, 2003, FACTSH THIACL, P7; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; Yamamoto A, 2012, J ENVIRON MONITOR, V14, P2189, DOI 10.1039/c2em30296a	49	53	56	10	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142172	10.1371/journal.pone.0142172	http://dx.doi.org/10.1371/journal.pone.0142172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535579	Green Submitted, gold, Green Published			2022-12-27	WOS:000364298400139
J	Sekimura, T; Venkataraman, C; Madzvamuse, A				Sekimura, Toshio; Venkataraman, Chandrasekhar; Madzvamuse, Anotida			A Model for Selection of Eyespots on Butterfly Wings	PLOS ONE			English	Article							BIOLOGICAL PATTERN-FORMATION; TURING SYSTEMS; EVOLUTION; GENES	Unsolved Problem The development of eyespots on the wing surface of butterflies of the family Nympalidae is one of the most studied examples of biological pattern formation. However, little is known about the mechanism that determines the number and precise locations of eyespots on the wing. Eyespots develop around signaling centers, called foci, that are located equidistant from wing veins along the midline of a wing cell (an area bounded by veins). A fundamental question that remains unsolved is, why a certain wing cell develops an eyespot, while other wing cells do not. Key Idea and Model We illustrate that the key to understanding focus point selection may be in the venation system of the wing disc. Our main hypothesis is that changes in morphogen concentration along the proximal boundary veins of wing cells govern focus point selection. Based on previous studies, we focus on a spatially two-dimensional reaction-diffusion system model posed in the interior of each wing cell that describes the formation of focus points. Using finite element based numerical simulations, we demonstrate that variation in the proximal boundary condition is sufficient to robustly select whether an eyespot focus point forms in otherwise identical wing cells. We also illustrate that this behavior is robust to small perturbations in the parameters and geometry and moderate levels of noise. Hence, we suggest that an anterior-posterior pattern of morphogen concentration along the proximal vein may be the main determinant of the distribution of focus points on the wing surface. In order to complete our model, we propose a two stage reaction-diffusion system model, in which an one-dimensional surface reaction-diffusion system, posed on the proximal vein, generates the morphogen concentrations that act as non-homogeneous Dirichlet (i.e., fixed) boundary conditions for the two-dimensional reaction-diffusion model posed in the wing cells. The two-stage model appears capable of generating focus point distributions observed in nature. Result We therefore conclude that changes in the proximal boundary conditions are sufficient to explain the empirically observed distribution of eyespot focus points on the entire wing surface. The model predicts, subject to experimental verification, that the source strength of the activator at the proximal boundary should be lower in wing cells in which focus points form than in those that lack focus points. The model suggests that the number and locations of eyespot foci on the wing disc could be largely controlled by two kinds of gradients along two different directions, that is, the first one is the gradient in spatially varying parameters such as the reaction rate along the anterior-posterior direction on the proximal boundary of the wing cells, and the second one is the gradient in source values of the activator along the veins in the proximal-distal direction of the wing cell.	[Sekimura, Toshio] Chubu Univ, Grad Sch Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan; [Venkataraman, Chandrasekhar] Univ St Andrews, Sch Math & Stat, St Andrews KY16 9SS, Fife, Scotland; [Madzvamuse, Anotida] Univ Sussex, Dept Math, Falmer BN1 9QH, England	Chubu University; University of St Andrews; University of Sussex	Sekimura, T (corresponding author), Chubu Univ, Grad Sch Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan.	sekimura@isc.chubu.ac.jp; cv28@st-andrews.ac.uk	Venkataraman, Chandrasekhar/O-3368-2015; Madzvamuse, Anotida/F-9270-2012	Venkataraman, Chandrasekhar/0000-0003-4039-2056; Madzvamuse, Anotida/0000-0002-9511-8903	EPSRC [EP/J016780/1]; Leverhulme Trust [RPG-2014-149]; European Union [642866]; Simons Foundation	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); European Union(European Commission); Simons Foundation	The authors acknowledge financial support from the EPSRC grant EP/J016780/1. AM and CV acknowledge financial support from the Leverhulme Trust Research Project Grant (RPG-2014-149). This research was started while CV was visiting Japan as a 2013 Japanese Society for the Promotion of Science (JSPS) Summer Fellow (http://www.jsps.go.jp/). This research was finalized whilst TS, CV and AM were participants in the Isaac Newton Institute Program, Coupling Geometric PDEs with Physics for Cell Morphology, Motility and Pattern Formation. This work (AM) has received funding from the European Union Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642866. AM was partially supported by a grant from the Simons Foundation.	Aragon JL, 1998, FORMA, V13, P145; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Benson DL, 1998, J MATH BIOL, V37, P381, DOI 10.1007/s002850050135; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Dilao R, 2004, P ROY SOC B-BIOL SCI, V271, P1565, DOI 10.1098/rspb.2004.2761; DILLON R, 1994, J MATH BIOL, V32, P345, DOI 10.1007/BF00160165; Evans TM, 2006, EVOL DEV, V8, P273, DOI 10.1111/j.1525-142X.2006.00098.x; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Lakkis O, 2013, SIAM J NUMER ANAL, V51, P2309, DOI 10.1137/120880112; MEINHARDT H, 1989, DEVELOPMENT, V107, P169; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Murray J. D., 2001, MATH BIOL, V18; Nijhout HF, 2003, CR BIOL, V326, P717, DOI 10.1016/j.crvi.2003.08.004; NIJHOUT HF, 1994, SCIENCE, V265, P44, DOI 10.1126/science.7912450; NIJHOUT HF, 1990, PROC R SOC SER B-BIO, V239, P81, DOI 10.1098/rspb.1990.0009; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Page K, 2003, PHYSICA D, V181, P80, DOI 10.1016/S0167-2789(03)00068-X; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Reed RD, 2007, EVOL DEV, V9, P2, DOI 10.1111/j.1525-142X.2006.00133.x; SCHNAKENBERG J, 1979, J THEOR BIOL, V81, P389, DOI 10.1016/0022-5193(79)90042-0; Sekimura Toshio, 1998, Comments on Theoretical Biology, V5, P69; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; Shirota Y, KAMEN SEI NO SHINKA, V37; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810	29	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141434	10.1371/journal.pone.0141434	http://dx.doi.org/10.1371/journal.pone.0141434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536487	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000364298400064
J	Shanmuganathan, B; Malar, DS; Sathya, S; Devi, KP				Shanmuganathan, Balakrishnan; Malar, Dicson Sheeja; Sathya, Sethuraman; Devi, Kasi Pandima			Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide(25-35) and Cholinesterase Inhibitory Property of Its Bioactive Compounds	PLOS ONE			English	Article							PRECURSOR PROTEIN; IN-VITRO; BUTYRYLCHOLINESTERASE; AGGREGATION; EXTRACTS; DISEASE	Inhibition of beta-amyloid (A beta) aggregation in the cerebral cortex of the brain is a promising therapeutic and defensive strategy in identification of disease modifying agents for Alzheimer's disease (AD). Since natural products are considered as the current alternative trend for the discovery of AD drugs, the present study aims at the evaluation of anti-amyloidogenic potential of the marine seaweed Padina gymnospora. Prevention of aggregation and disaggregation of the mature fibril formation of A beta(25-35) by acetone extracts of P. gymnospora (ACTPG) was evaluated in two phases by Thioflavin T assay. The results were further confirmed by confocal laser scanning microscopy (CLSM) analysis and Fourier transform infrared (FTIR) spectroscopic analysis. The results of antiaggregation and disaggregation assay showed that the increase in fluorescence intensity of aggregated A beta and the co-treatment of ACTPG (250 mu g/ml) with A beta(25-35), an extensive decrease in the fluorescence intensity was observed in both phases, which suggests that ACTPG prevents the oligomers formation and disaggregation of mature fibrils. In addition, ACTPG was subjected to column chromatography and the bioactivity was screened based on the cholinesterase inhibitory activity. Finally, the active fraction was subjected to LC-MS/MS analysis for the identification of bioactive compounds. Overall, the results suggest that the bioactive compound alpha bisabolol present in the alga might be responsible for the observed cholinesterase inhibition with the IC50 value < 10 mu g/ml for both AChE and BuChE when compared to standard drug donepezil (IC50 value < 6 mu g/ml) and support its use for the treatment of neurological disorders.	[Shanmuganathan, Balakrishnan; Malar, Dicson Sheeja; Sathya, Sethuraman; Devi, Kasi Pandima] Alagappa Univ, Dept Biotechnol, Karaikkudi 630004, Tamil Nadu, India	Alagappa University	Devi, KP (corresponding author), Alagappa Univ, Dept Biotechnol, Sci Campus, Karaikkudi 630004, Tamil Nadu, India.	devikasi@yahoo.com	Devi, Kasi Pandima/J-9172-2012; Devi, Kasi Pandima/U-9565-2019	Devi, Kasi Pandima/0000-0002-6175-8961; Devi, Kasi Pandima/0000-0002-6175-8961; Sethuraman, Sathya/0000-0002-1819-2798; , Dicson Sheeja Malar/0000-0003-4253-9496	Department of Science and Technology, Government of India (DST) [SR/S0/AS-22/2012]; Bioinformatics Infrastructure Facility, Alagappa University - Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/BI/25/015/2012]; DST	Department of Science and Technology, Government of India (DST)(Department of Science & Technology (India)); Bioinformatics Infrastructure Facility, Alagappa University - Department of Biotechnology, Ministry of Science and Technology, Government of India; DST(Department of Science & Technology (India))	This work was supported by Department of Science and Technology, Government of India through Major Research Grant (DST No: SR/S0/AS-22/2012, http://www.dst.gov.in/), Bioinformatics Infrastructure Facility, Alagappa University funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India (No. BT/BI/25/015/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KPD wishes to thank DST, India, for offering Major Research Grant (DST No: SR/S0/AS-22/2012). BS wishes to thank DST for providing fellowship in the form of project fellow. The authors also gratefully acknowledge the use of the Bioinformatics Infrastructure Facility, Alagappa University funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India (No. BT/BI/25/015/2012).	Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249; Chander M. P., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P364; Choi EY, 2009, FOOD CHEM TOXICOL, V47, P134, DOI 10.1016/j.fct.2008.10.026; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fujiwara H, 2009, J NEUROCHEM, V109, P1648, DOI 10.1111/j.1471-4159.2009.06069.x; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Ghahremanitamadon F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/798535; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Joshi NVM., 2012, INT J BIO PHAR RES, V3, P956; Kamatou GPP, 2010, J AM OIL CHEM SOC, V87, P1, DOI 10.1007/s11746-009-1483-3; Kayalvizhi K., 2012, INT J PHARM APPL, V3, P306; Krishnamurthy V, 1970, CHECK LIST INDIAN MA, P1; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Mathew M, 2014, INDIAN J EXP BIOL, V52, P606; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Munoz-Ruiz P, 2005, J MED CHEM, V48, P7223, DOI 10.1021/jm0503289; Murugan K, 2014, INDIAN J PHARM SCI, V76, P548; Nielson KA, 1996, BRAIN RES, V741, P284, DOI 10.1016/S0006-8993(96)00983-3; Oza RM, 2003, REVISED CHECKLIST IN, P1; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Pryor NE, 2012, INT J MOL SCI, V13, P3038, DOI 10.3390/ijms13033038; Ramesh BN, 2010, NEUROSCI LETT, V475, P110, DOI 10.1016/j.neulet.2010.03.062; RATNASOORIYA WD, 1994, CONTRACEPTION, V50, P291, DOI 10.1016/0010-7824(94)90074-4; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Reid GA, 2015, NEUROSCIENCE, V298, P424, DOI 10.1016/j.neuroscience.2015.04.039; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sun YD, 2008, BIOORGAN MED CHEM, V16, P7177, DOI 10.1016/j.bmc.2008.06.045; Szabo Z, 1999, BIOCHEM BIOPH RES CO, V265, P297, DOI 10.1006/bbrc.1999.1667; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Vauzour D, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/914273; Wu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109438; Zubia M, 2007, J APPL PHYCOL, V19, P449, DOI 10.1007/s10811-006-9152-5	36	32	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141708	10.1371/journal.pone.0141708	http://dx.doi.org/10.1371/journal.pone.0141708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536106	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400079
J	Siah, A; Morrison, DB; Fringuelli, E; Savage, P; Richmond, Z; Johns, R; Purcell, MK; Johnson, SC; Saksida, SM				Siah, Ahmed; Morrison, Diane B.; Fringuelli, Elena; Savage, Paul; Richmond, Zina; Johns, Robert; Purcell, Maureen K.; Johnson, Stewart C.; Saksida, Sonja M.			Piscine Reovirus: Genomic and Molecular Phylogenetic Analysis from Farmed and Wild Salmonids Collected on the Canada/US Pacific Coast	PLOS ONE			English	Article							HEMORRHAGIC-SEPTICEMIA-VIRUS; SKELETAL-MUSCLE INFLAMMATION; HEMATOPOIETIC NECROSIS VIRUS; ATLANTIC SALMON; SOFTWARE PACKAGE; SALAR L.; PRV; BIOLOGY; HEART; SEQUENCES	Piscine reovirus (PRV) is a double stranded non-enveloped RNA virus detected in farmed and wild salmonids. This study examined the phylogenetic relationships among different PRV sequence types present in samples from salmonids in Western Canada and the US, including Alaska (US), British Columbia (Canada) and Washington State (US). Tissues testing positive for PRV were partially sequenced for segment S1, producing 71 sequences that grouped into 10 unique sequence types. Sequence analysis revealed no identifiable geographical or temporal variation among the sequence types. Identical sequence types were found in fish sampled in 2001, 2005 and 2014. In addition, PRV positive samples from fish derived from Alaska, British Columbia and Washington State share identical sequence types. Comparative analysis of the phylogenetic tree indicated that Canada/US Pacific Northwest sequences formed a subgroup with some Norwegian sequence types (group II), distinct from other Norwegian and Chilean sequences (groups I, III and IV). Representative PRV positive samples from farmed and wild fish in British Columbia and Washington State were subjected to genome sequencing using next generation sequencing methods. Individual analysis of each of the 10 partial segments indicated that the Canadian and US PRV sequence types clustered separately from available whole genome sequences of some Norwegian and Chilean sequences for all segments except the segment S4. In summary, PRV was genetically homogenous over a large geographic distance (Alaska to Washington State), and the sequence types were relatively stable over a 13 year period.	[Siah, Ahmed; Richmond, Zina; Johns, Robert; Saksida, Sonja M.] British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada; [Morrison, Diane B.] Marine Harvest Canada, Campbell River, BC, Canada; [Fringuelli, Elena; Savage, Paul] AFBI Stormont, Vet Sci Div, Belfast, Antrim, North Ireland; [Purcell, Maureen K.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Johnson, Stewart C.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	Agri-Food & Biosciences Institute; United States Department of the Interior; United States Geological Survey; Fisheries & Oceans Canada	Siah, A (corresponding author), British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada.	ahmed.siah@cahs-bc.ca	siah, ahmed/P-9359-2015	siah, ahmed/0000-0002-1961-7022; Purcell, Maureen/0000-0003-0154-8433	Marine Harvest Canada	Marine Harvest Canada	This study was funded by Marine Harvest Canada. The funder provided support in the form of salaries for authors (DBM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Batts WN, 2008, J AQUAT ANIM HEALTH, V20, P215, DOI 10.1577/H07-050.1; Enzmann PJ, 2005, DIS AQUAT ORGAN, V66, P187, DOI 10.3354/dao066187; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garseth AH, 2013, PREV VET MED, V112, P138, DOI 10.1016/j.prevetmed.2013.06.007; Garver KA, 2013, DIS AQUAT ORGAN, V104, P93, DOI 10.3354/dao02588; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P211, DOI 10.3354/dao055211; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kurath G, 2003, J GEN VIROL, V84, P803, DOI 10.1099/vir.0.18771-0; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sano T, 1977, Journal Tokyo Univ Fish, V63, P81; Solomon DJ, 1979, COHO SALMON N W EURO, V49; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; Wessel O, 2015, VIRUS RES, V198, P22, DOI 10.1016/j.virusres.2015.01.001; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	28	38	41	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141475	10.1371/journal.pone.0141475	http://dx.doi.org/10.1371/journal.pone.0141475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536673	Green Published, gold			2022-12-27	WOS:000364298400066
J	Topolovec-Vranic, J; Zhang, S; Wong, H; Lam, E; Jing, RW; Russell, K; Cusimano, MD				Topolovec-Vranic, Jane; Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Russell, Kelly; Cusimano, Michael D.		Canadian Brain Injury Violence Res	Recognizing the Symptoms of Mental Illness following Concussions in the Sports Community: A Need for Improvement	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PUBLIC KNOWLEDGE; FOOTBALL PLAYERS; SEX-DIFFERENCES; HEAD-INJURY; POPULATION; PROFESSIONALS; ADOLESCENTS; ENGLAND; RISK	Objective To evaluate the awareness of concussion-related symptoms amongst members of the sports community in Canada. Methods A cross-sectional national electronic survey was conducted. Youth athletes, parents, coaches and medical professionals across Canada were recruited through mailing lists from sports-related opt-in marketing databases. Participants were asked to identify, from a list of options, the symptoms of a concussion. The proportion of identified symptoms (categorized as physical, cognitive, mental health-related and overall) as well as participant factors associated with symptom recognition were analyzed. Results The survey elicited 6,937 responses. Most of the respondents (92.1%) completed the English language survey, were male (57.7%), 35-54 years of age (61.7%), with post-secondary education (58.2%), or high reported yearly household income (>$80,000; 53.0%). There were respondents from all provinces and territories with the majority of respondents from Ontario (35.2%) or British Columbia (19.1%). While participants identified most of the physical (mean = 84.2% of symptoms) and cognitive (mean = 91.2% of symptoms), they on average only identified 53.5% of the mental health-related symptoms of concussions. Respondents who were older, with higher education and household income, or resided in the Northwest Territories or Alberta identified significantly more of the mental health-related symptoms listed. Interpretation While Canadian youth athletes, parents, coaches and medical professionals are able to identify most of the physical and cognitive symptoms associated with concussion, identification of mental health-related symptoms of concussion is still lagging.	[Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Zhang, Stanley; Wong, Hatty; Lam, Emily; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Manitoba; University of Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019; Meijer, Anna/K-5118-2016; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]; Ontario Neurotrauma Foundation; Public Health Agency of Canada	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Public Health Agency of Canada	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation, and Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Author, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058868, DOI 10.1371/J0URNAL.P0NE.0058868]; Babul S, 2014, IOC WORLD C PREV INJ, P563, DOI [10.1136/bjsports-2014-093494.11, DOI 10.1136/BJSP0RTS-2014-093494.11]; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Blake T, 2014, BRIT J SPORT MED, V48, P570, DOI [10.1136/bjsports-2014-093494.28, DOI 10.1136/BJSP0RTS-2014-093494.28]; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Craig A. T., 2005, INTRO MATH STAT; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun C, 2014, BRIT J SPORT MED, V48, P623, DOI [10.1136/bjsports-2014-093494.171, DOI 10.1136/BJSP0RTS-2014-093494.171]; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitaker S, 2012, FAM PRACT, V29, P168, DOI 10.1093/fampra/cmr079; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	40	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141699	10.1371/journal.pone.0141699	http://dx.doi.org/10.1371/journal.pone.0141699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536016	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400078
J	Huang, FF; Li, X; Wang, C; Xu, Q; Wang, W; Luo, YX; Tao, LX; Gao, Q; Guo, J; Chen, SP; Cao, K; Liu, L; Gao, N; Liu, XT; Yang, K; Yan, AS; Guo, XH				Huang, Fangfang; Li, Xia; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Yan, Aoshuang; Guo, Xiuhua			PM2.5 Spatiotemporal Variations and the Relationship with Meteorological Factors during 2013-2014 in Beijing, China	PLOS ONE			English	Article							FINE PARTICULATE MATTER; PARTICLE NUMBER CONCENTRATIONS; EMERGENCY-ROOM VISITS; YANGTZE-RIVER DELTA; AIR-POLLUTION; AMBIENT AIR; TEMPORAL VARIATIONS; GASEOUS-POLLUTANTS; PM10; TEMPERATURE	Objective Limited information is available regarding spatiotemporal variations of particles with median aerodynamic diameter < 2.5 mu m (PM2.5) at high resolutions, and their relationships with meteorological factors in Beijing, China. This study aimed to detect spatiotemporal change patterns of PM2.5 from August 2013 to July 2014 in Beijing, and to assess the relationship between PM2.5 and meteorological factors. Methods Daily and hourly PM2.5 data from the Beijing Environmental Protection Bureau (BJEPB) were analyzed separately. Ordinary kriging (OK) interpolation, time-series graphs, Spearman correlation coefficient and coefficient of divergence (COD) were used to describe the spatiotemporal variations of PM2.5. The Kruskal-Wallis H test, Bonferroni correction, and Mann-Whitney U test were used to assess differences in PM2.5 levels associated with spatial and temporal factors including season, region, daytime and day of week. Relationships between daily PM2.5 and meteorological variables were analyzed using the generalized additive mixed model (GAMM). Results Annual mean and median of PM2.5 concentrations were 88.07 mu g/m(3) and 71.00 mu g/m(3), respectively, from August 2013 to July 2014. PM2.5 concentration was significantly higher in winter (P < 0.0083) and in the southern part of the city (P < 0.0167). Day to day variation of PM2.5 showed a long-term trend of fluctuations, with 2-6 peaks each month. PM2.5 concentration was significantly higher in the night than day (P < 0.0167). Meteorological factors were associated with daily PM2.5 concentration using the GAMM model (R-2 = 0.59, AIC = 7373.84). Conclusion PM2.5 pollution in Beijing shows strong spatiotemporal variations. Meteorological factors influence the PM2.5 concentration with certain patterns. Generally, prior day wind speed, sunlight hours and precipitation are negatively correlated with PM2.5, whereas relative humidity and air pressure three days earlier are positively correlated with PM2.5.	[Huang, Fangfang; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Yan, Aoshuang; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Huang, Fangfang; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Yan, Aoshuang] Beijing Municipal Sci & Technol Commiss, Beijing, Peoples R China	Capital Medical University; University of Limerick; Edith Cowan University; Beijing Municipal Science & Technology Commission	Yan, AS (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	hnlg0771@hotmail.com; guoxiuh@ccmu.edu.cn	TAO, Li/HIR-4254-2022; Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536	Natural Science Fund of China [81302516]; National S&T Major Project Grant [2014ZX10004005-001]; National "12th Five-Year" Plan for Science and Technology Support, China [2012BAI37B03]; Edith Cowan University Strategic Funding (SRF); Edith Cowan University Industry Collaboration Scheme [G1001368]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project Grant; National "12th Five-Year" Plan for Science and Technology Support, China; Edith Cowan University Strategic Funding (SRF); Edith Cowan University Industry Collaboration Scheme; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	This work was supported by grants from the Natural Science Fund of China Grant (81302516), National S&T Major Project Grant (2014ZX10004005-001), National "12th Five-Year" Plan for Science and Technology Support, China (2012BAI37B03), Edith Cowan University Strategic Funding (SRF 2015-2016), and Edith Cowan University Industry Collaboration Scheme-2013 (G1001368). WW is supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions. The funders had no role in study design,	Ailshire JA, 2014, AM J EPIDEMIOL, V180, P359, DOI 10.1093/aje/kwu155; Akyuz M, 2009, J HAZARD MATER, V170, P13, DOI 10.1016/j.jhazmat.2009.05.029; Beijing Municipal Bureau of Statistics, 2014, BEIJ STAT YB; Blanchard CL, 2006, J AIR WASTE MANAGE, V56, P271, DOI 10.1080/10473289.2006.10464455; Bravo MA, 2011, J AIR WASTE MANAGE, V61, P69, DOI 10.3155/1047-3289.61.1.69; Chai FH, 2014, J ENVIRON SCI, V26, P75, DOI 10.1016/S1001-0742(13)60383-6; Clifford S, 2011, ATMOS ENVIRON, V45, P5934, DOI 10.1016/j.atmosenv.2011.05.004; Coull B A, 2001, Biostatistics, V2, P337, DOI 10.1093/biostatistics/2.3.337; Cyrys J, 2008, SCI TOTAL ENVIRON, V401, P168, DOI 10.1016/j.scitotenv.2008.03.043; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Giakoumi A, 2009, ENVIRON MONIT ASSESS, V152, P83, DOI 10.1007/s10661-008-0298-2; Guinot B, 2006, ATMOS ENVIRON, V40, P5167, DOI 10.1016/j.atmosenv.2006.03.051; Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139; Guo YM, 2009, SCI TOTAL ENVIRON, V407, P4826, DOI 10.1016/j.scitotenv.2009.05.022; Hu JL, 2014, ATMOS ENVIRON, V95, P598, DOI 10.1016/j.atmosenv.2014.07.019; Huang P, 2015, INT J ENV RES PUB HE, V12, P6608, DOI 10.3390/ijerph120606608; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Ji DS, 2012, ATMOS ENVIRON, V50, P338, DOI 10.1016/j.atmosenv.2011.11.053; Lee BJ, 2014, TOXICOL RES-GER, V30, P71, DOI [10.5487/TR.2014.30.2.71, 10.5487/TR.2014.30.2.071]; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Li F, 2013, ZHONG GUO HUAN JING, V29, P22; Li L, 2014, ENVIRON POLLUT, V190, P75, DOI 10.1016/j.envpol.2014.03.020; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Liang RJ, 2014, J HYPERTENS, V32, P2130, DOI 10.1097/HJH.0000000000000342; Liu J., 2015, ENVIRON SCI POLLUT R, DOI DOI 10.1007/S11356-015-5252-6; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Liu ZH, 2015, ENVIRON SCI POLLUT R, V22, P4753, DOI [10.1007/s11356-014-3347-0, 10.1007/s11356-014-3981-6]; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Miao SG, 2009, J APPL METEOROL CLIM, V48, P484, DOI 10.1175/2008JAMC1909.1; Motallebi N, 2003, J AIR WASTE MANAGE, V53, P876, DOI 10.1080/10473289.2003.10466229; Olivares G, 2007, ATMOS ENVIRON, V41, P2145, DOI 10.1016/j.atmosenv.2006.10.068; Pal S, 2014, SCI TOTAL ENVIRON, V496, P424, DOI 10.1016/j.scitotenv.2014.07.067; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; Shen GF, 2014, J ENVIRON SCI HEAL A, V49, P171, DOI 10.1080/10934529.2013.838851; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Song C, 2015, INT J ENV RES PUB HE, V12, P1099, DOI 10.3390/ijerph120201099; State Forestry Administration of the People's Republic of China, 2013, CHIN FOR DEV REP; Trivedi DK, 2014, SCI TOTAL ENVIRON, V478, P175, DOI 10.1016/j.scitotenv.2014.01.101; Turner MC, 2011, AM J RESP CRIT CARE, V184, P1374, DOI 10.1164/rccm.201106-1011OC; Vassilakos C, 2005, SCI TOTAL ENVIRON, V349, P223, DOI 10.1016/j.scitotenv.2005.01.012; Wallace J, 2009, SCI TOTAL ENVIRON, V407, P5085, DOI 10.1016/j.scitotenv.2009.05.050; Wang G, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4288-x; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wang YG, 2014, ENVIRON INT, V73, P413, DOI 10.1016/j.envint.2014.08.016; Wilson JG, 2006, SCI TOTAL ENVIRON, V367, P559, DOI 10.1016/j.scitotenv.2005.08.045; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wu SW, 2014, CHEMOSPHERE, V108, P168, DOI 10.1016/j.chemosphere.2014.01.032; Xiao QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117311; Xu MM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-109; Yanosky JD, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-63; Yu Y, 2011, J ENVIRON MONITOR, V13, P334, DOI 10.1039/c0em00467g; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang HL, 2015, ENVIRON RES, V140, P242, DOI 10.1016/j.envres.2015.04.004; Zhang Q, 2015, SCI TOTAL ENVIRON, V502, P578, DOI 10.1016/j.scitotenv.2014.09.079; Zhang YQ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2187-3	57	111	119	8	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141642	10.1371/journal.pone.0141642	http://dx.doi.org/10.1371/journal.pone.0141642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528542	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600045
J	Zach, F; Mueller, A; Gessner, A				Zach, Frank; Mueller, Alexandra; Gessner, Andre			Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells	PLOS ONE			English	Article							IN-VITRO; RECEPTOR ACTIVATOR; DEFICIENT MICE; BONE; PROTEIN; CANCER; LIGAND; OSTEOIMMUNOLOGY; ORGANIZATION; STIMULATION	In vitro differentiation into functional osteoclasts is routinely achieved by incubation of embryonic stem cells, induced pluripotent stem cells, or primary as well as cryopreserved spleen and bone marrow-derived cells with soluble receptor activator of nuclear factor kappa-B ligand and macrophage colony-stimulating factor. Additionally, osteoclasts can be derived from co-cultures with osteoblasts or by direct administration of soluble receptor activator of nuclear factor kappa-B ligand to RAW 264.7 macrophage lineage cells. However, despite their benefits for osteoclast-associated research, these different methods have several drawbacks with respect to differentiation yields, time and animal consumption, storage life of progenitor cells or the limited potential for genetic manipulation of osteoclast precursors. In the present study, we therefore established a novel protocol for the differentiation of osteoclasts from murine ER-Hoxb8-immortalized myeloid stem cells. We isolated and immortalized bone marrow cells from wild type and genetically manipulated mouse lines, optimized protocols for osteoclast differentiation and compared these cells to osteoclasts derived from conventional sources. In vitro generated ER-Hoxb8 osteoclasts displayed typical osteoclast characteristics such as multi-nucleation, tartrate-resistant acid phosphatase staining of supernatants and cells, F-actin ring formation and bone resorption activity. Furthermore, the osteoclast differentiation time course was traced on a gene expression level. Increased expression of osteoclast-specific genes and decreased expression of stem cell marker genes during differentiation of osteoclasts from ER-Hoxb8-immortalized myeloid progenitor cells were detected by gene array and confirmed by semi-quantitative and quantitative RT-PCR approaches. In summary, we established a novel method for the quantitative production of murine bona fide osteoclasts from ER-Hoxb8 stem cells generated from wild type or genetically manipulated mouse lines. These cells represent a standardized and theoretically unlimited source for osteoclast-associated research projects.	[Zach, Frank; Mueller, Alexandra; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany	University of Regensburg	Gessner, A (corresponding author), Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany.	andre.gessner@ukr.de		Zach, Frank/0000-0003-1168-8106	Bayerische Forschungsstiftung [AZ 1070-13]; Deutsche Forschungsgemeinschaft [1656, GE671/14-1]	Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Bayerische Forschungsstiftung (www.forschungsstiftung.de/; AZ 1070-13 to AG) and the Deutsche Forschungsgemeinschaft (www.dfg.de/; 1656, Ref. No. GE671/14-1 to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Baek JM, 2014, MOLECULES, V19, P11628, DOI 10.3390/molecules190811628; Bohuslavova R, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-11; Boraschi-Diaz I, 2014, CYTOTECHNOLOGY; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappariello A, 2014, ARCH BIOCHEM BIOPHYS, V561, P13, DOI 10.1016/j.abb.2014.08.009; Charles JF, 2014, TRENDS MOL MED, V20, P449, DOI 10.1016/j.molmed.2014.06.001; Chen H, 2011, J BONE MINER RES, V26, P2537, DOI 10.1002/jbmr.456; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Li RF, 2014, J HISTOCHEM CYTOCHEM, V62, P879, DOI 10.1369/0022155414551367; Li XD, 2000, ENDOCRINOLOGY, V141, P2054, DOI 10.1210/en.141.6.2054; Maria SM, 2014, J BIOMED MATER RES B, V102, P903, DOI 10.1002/jbm.b.33071; Mohrs M, 1999, J IMMUNOL, V162, P7302; Nishikawa K, 2014, J BONE MINER METAB, V32, P331, DOI 10.1007/s00774-013-0547-5; Park SJ, 2013, J MOL HISTOL, V44, P65, DOI 10.1007/s10735-012-9465-4; Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Teti Anna, 2013, Bonekey Rep, V2, P449, DOI 10.1038/bonekey.2013.183; Tevlin R, 2014, JOVE-J VIS EXP, DOI 10.3791/52056; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yamada A, 2007, IMMUNOLOGY, V120, P573, DOI 10.1111/j.1365-2567.2006.02538.x; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoneda T, 1998, EUR J CANCER, V34, P240, DOI 10.1016/S0959-8049(97)10132-0; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Youn BU, SLAT NEGATIVELY REGU	44	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142211	10.1371/journal.pone.0142211	http://dx.doi.org/10.1371/journal.pone.0142211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529319	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600111
J	Ghosh, B; Mitra, J; Chakraborty, S; Bhattacharyya, J; Chakraborty, A; Sen, SK; Neerathilingam, M				Ghosh, Bidisha; Mitra, Joy; Chakraborty, Saikat; Bhattacharyya, Jagannath; Chakraborty, Anirban; Sen, Soumitra Kumar; Neerathilingam, Muniasamy			Simple Detection Methods for Antinutritive Factor beta-ODAP Present in Lathyrus sativus L. by High Pressure Liquid Chromatography and Thin Layer Chromatography	PLOS ONE			English	Article							NONPROTEIN AMINO-ACIDS; BETA-N-OXALYL-L-ALPHA,BETA-DIAMINOPROPIONIC ACID; GRASS-PEA; PRECOLUMN DERIVATIZATION; ALPHA-ISOMER; NEUROTOXIN; REACTOR; ASSAY	Lathyrus sativus L. (Grass pea) is the source for cheap and nutritious food choice in drought and famine susceptible zones in greater part of North India and Africa. The non-protein amino acid beta-N-oxalyl-L-alpha, beta-diaminopropionic acid (beta-ODAP) has been known for decades for its potent neurotoxic effect, causing irreversible neurodegenerative disease "neurolathyrism", present in both seed and leaf of Lathyrus sativus L. and other species in varying proportions. It is crucial to establish a rapid as well as reliable detection methodology for beta-ODAP content in various Lathyrus plants. Currently available HPLC based methods involve multi-step derivatization of the sample. To overcome this, we have developed beta-ODAP analysis method by HPLC without any prior derivatization. This method is statistically significant in the range of 2 to 100 mu g/ml and exhibited linear response with r(2) > 0.99. Limit of detection and quantitation of the later method was determined to be 5.56 mu g/ml and 16.86 mu g/ml, respectively. In addition to this, a TLC based method has also been developed. The limit of detection of beta-ODAP is 0.6 mu g and for its substrate, L-1,2-diaminopropionic acid is 5 mu g. Both HPLC and TLC methods were validated by conducting in-vitro bioconversion test to detect the presence of biocatalyst in plant extract. This method is economical, rapid and simple.	[Ghosh, Bidisha; Neerathilingam, Muniasamy] NCBS TIFR, Ctr Cellular & Mol Platforms, Prot Technol Core, Bangalore, Karnataka, India; [Mitra, Joy; Chakraborty, Saikat; Bhattacharyya, Jagannath; Chakraborty, Anirban; Sen, Soumitra Kumar] Indian Inst Technol, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Neerathilingam, M (corresponding author), NCBS TIFR, Ctr Cellular & Mol Platforms, Prot Technol Core, Bangalore, Karnataka, India.	munish@ccamp.res.in	Mitra, Joy/AAH-5977-2020; CHAKRABORTY, ANIRBAN/ABC-6552-2020; /AAO-4852-2020	Mitra, Joy/0000-0002-5985-0582; 	Department of Biotechnology, India; Centre for Cellular and Molecular Platforms	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Centre for Cellular and Molecular Platforms	This work was supported by the Department of Biotechnology, India and Centre for Cellular and Molecular Platforms.	ADDIS G, 1994, ANN BOT-LONDON, V74, P209, DOI 10.1006/anbo.1994.1111; Alizadeh K., 2013, DEV FEED LEGUMES SUI; Astha AN, 1996, INT PLANT GENETIC RE, P144; Bhowmick M.K., 2015, LIV DEV SUST AGR 9 A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen X, 2000, J AGR FOOD CHEM, V48, P3383, DOI 10.1021/jf000033y; Fikre A, 2008, FOOD CHEM, V110, P422, DOI 10.1016/j.foodchem.2008.02.019; Fuchs B, 2011, J CHROMATOGR A, V1218, P2754, DOI 10.1016/j.chroma.2010.11.066; Getahun H, 2003, LANCET, V362, P1808, DOI 10.1016/S0140-6736(03)14902-1; Gulla V, 2008, CHROMATOGRAPHIA, V68, P663, DOI 10.1365/s10337-008-0783-3; Hanbury CD, 2000, ANIM FEED SCI TECH, V87, P1, DOI 10.1016/S0377-8401(00)00186-3; Jiao CJ, 2011, FOOD CHEM TOXICOL, V49, P543, DOI 10.1016/j.fct.2010.04.050; KHAN JK, 1993, ANAL BIOCHEM, V208, P237, DOI 10.1006/abio.1993.1038; Kumar S, 2011, FOOD CHEM TOXICOL, V49, P589, DOI 10.1016/j.fct.2010.06.051; Long YC, 2000, INT J PEPT PROT RES, V47, P42; MALATHI K, 1970, PHYTOCHEMISTRY, V9, P1603, DOI 10.1016/S0031-9422(00)85283-8; MOGES G, 1994, ANAL CHEM, V66, P3834, DOI 10.1021/ac00093a046; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paleacu D, 1999, PARKINSONISM RELAT D, V5, P55, DOI 10.1016/S1353-8020(99)00016-4; Paradkar MM, 2003, J SCI FOOD AGR, V83, P727, DOI 10.1002/jsfa.1361; Pati S, 2007, ANAL CHIM ACTA, V594, P234, DOI 10.1016/j.aca.2007.05.026; Rosenthal G.A., 1982, PLANT NONPROTEIN AMI; Salazar C, 2012, METABOLITES, V2, P398, DOI 10.3390/metabo2030398; Santiago M, 2013, METHOD ENZYMOL, V533, P303, DOI 10.1016/B978-0-12-420067-8.00024-6; SHAH AJ, 1992, PHYTOCHEM ANALYSIS, V3, P20, DOI 10.1002/pca.2800030104; Tarade KM, 2007, FOOD CHEM, V104, P643, DOI 10.1016/j.foodchem.2006.12.018; Thippeswamy R, 2007, FOOD CHEM, V101, P1290, DOI 10.1016/j.foodchem.2005.12.024; Truei YH, 1992, ADV BIOCHEM ENG BIOT, V47, P1; Wang F, 2000, J CHROMATOGR A, V883, P113, DOI 10.1016/S0021-9673(00)00264-8; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145; Woldeamanuel YW, 2012, J NEUROL, V259, P1263, DOI 10.1007/s00415-011-6306-4; Yan ZY, 2006, PHYTOCHEMISTRY, V67, P107, DOI 10.1016/j.phytochem.2005.10.022; Yan ZY, 2005, CHINESE CHEM LETT, V16, P627; Zhao L, 1999, J CHROMATOGR A, V857, P295, DOI 10.1016/S0021-9673(99)00788-8	34	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140649	10.1371/journal.pone.0140649	http://dx.doi.org/10.1371/journal.pone.0140649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524073	gold, Green Published, Green Submitted			2022-12-27	WOS:000364029800003
J	Yu, JB; Shi, J; Zhang, Y; Gong, LR; Dong, SA; Cao, XS; Wu, LL; Wu, LN				Yu, Jian-bo; Shi, Jia; Zhang, Yuan; Gong, Li-rong; Dong, Shu-an; Cao, Xin-shun; Wu, Li-li; Wu, Li-na			Electroacupuncture Ameliorates Acute Renal Injury in Lipopolysaccharide-Stimulated Rabbits via Induction of HO-1 through the PI3K/Akt/Nrf2 Pathways	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; HEME OXYGENASE-1; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; LIVER-INJURY; FAILURE; SEPSIS; RATS; CELLS	Electroacupuncture at select acupoints have been verified to protect against organ dysfunctions during endotoxic shock. And, heme oxygenase (HO)-1 as a phase II enzyme and antioxidant contributed to the protection of kidney in septic shock rats. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway mediated the activation of NF-E2 related factor-2 (Nrf2), which was involved in HO-1 induction. To understand the efficacy of electroacupuncture stimulation in ameliorating acute kidney injury (AKI) through the PI3K/Akt/Nrf2 pathway and subsequent HO-1 upregulation, a dose of LPS 5mg/kg was administered intravenously to replicate the rabbit model of AKI induced by endotoxic shock. Electroacupuncture pretreatment was handled bilaterally at Zusanli and Neiguan acupoints for five consecutive days while sham electroacupuncture at non-acupoints as control. Results displayed that electroacupuncture stimulation significantly alleviated the morphologic renal damage, attenuated renal tubular apoptosis, suppressed the elevated biochemical indicators of AKI caused by LPS, enhanced the expressions of phospho-Akt, HO-1protein, Nrf2 total and nucleoprotein, and highlighted the proportions of Nrf2 nucleoprotein as a parallel. Furthermore, partial protective effects of elecroacupuncture were counteracted by preconditioning with wortmannin ( the selective PI3K inhibitor), indicating a direct involvement of PI3K/Akt pathway. Inconsistently, wortmannin pretreatment made little difference to the expressions of HO-1, Nrf2 nucleoprotein and total protein, which indicated that PI3K/Akt may be not the only pathway responsible for electroacupuncture-afforded protection against LPS-induced AKI. These findings provide new insights into the potential future clinical applications of electroacupuncture for AKI induced by endotoxic shock instead of traditional remedies.	[Yu, Jian-bo; Shi, Jia; Zhang, Yuan; Gong, Li-rong; Dong, Shu-an; Cao, Xin-shun; Wu, Li-li; Wu, Li-na] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Yu, JB (corresponding author), Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China.	yujianbo11@126.com			National Natural Science Foundation of China, Beijing, China [81372096]; Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China [12ZCZDSY013300]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China	Financial support for this research was provided by grant No. 81372096 from the National Natural Science Foundation of China, Beijing, China, and grant No. 12ZCZDSY013300 from the Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Chen XJ, 2013, RESP PHYSIOL NEUROBI, V188, P214, DOI 10.1016/j.resp.2013.04.014; Chiari PC, 2005, ANESTHESIOLOGY, V102, P102, DOI 10.1097/00000542-200501000-00018; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Fenhammar J, 2011, ANESTHESIOLOGY, V114, P1130, DOI 10.1097/ALN.0b013e31820b8b44; Ferenbach DA, 2010, MOL THER, V18, P1706, DOI 10.1038/mt.2010.100; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Huang CL, 2007, ANESTH ANALG, V104, P646, DOI 10.1213/01.ane.0000255288.68199.eb; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Langenberg C, 2014, CRIT CARE MED, V42, pE58, DOI 10.1097/CCM.0b013e3182a639da; Liu HW, 2011, ACUPUNCT MED, V29, P284, DOI 10.1136/aim.2010.003525; LOEWENBERG J. R., 1967, ANAL BIOCHEM, V19, P95, DOI 10.1016/0003-2697(67)90138-8; Lu CY, 2014, BIOCHEM PHARMACOL, V91, P40, DOI 10.1016/j.bcp.2014.06.024; MISRA HP, 1971, J BIOL CHEM, V246, P6886; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2014, CURR OPIN NEPHROL HY, V23, P17, DOI 10.1097/01.mnh.0000437613.88158.d3; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozyurt H, 2004, J APPL TOXICOL, V24, P269, DOI 10.1002/jat.983; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schiffl H, 2012, MOL DIAGN THER, V16, P199, DOI 10.2165/11634310-000000000-00000; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Siu FKW, 2004, NEUROSCI LETT, V354, P158, DOI 10.1016/j.neulet.2003.10.009; Song JG, 2012, ANESTHESIOLOGY, V116, P406, DOI 10.1097/ALN.0b013e3182426ebd; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsai PS, 2006, ANESTHESIOLOGY, V105, P1201, DOI 10.1097/00000542-200612000-00020; Tsao CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108455; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wang K, 2009, ANESTH ANALG, V109, P1666, DOI 10.1213/ANE.0b013e3181b5a234; Wang W, 2007, AM J PHYSIOL-RENAL, V293, pF1131, DOI 10.1152/ajprenal.00212.2007; WELLWOOD JM, 1975, BRIT MED J, V3, P408, DOI 10.1136/bmj.3.5980.408; Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449; Wulfert FM, 2012, ANESTHESIOLOGY, V117, P126, DOI 10.1097/ALN.0b013e31825b57c9; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b; Yu JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104924; Yu JB, 2009, TRANSL RES, V153, P283, DOI 10.1016/j.trsl.2009.01.002; Yu JB, 2013, EXP BIOL MED, V238, P705, DOI 10.1177/1535370213489487; Yu JB, 2013, ANESTH ANALG, V116, P239, DOI 10.1213/ANE.0b013e31826f0a4a; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhang RX, 2014, ANESTHESIOLOGY, V120, P482, DOI 10.1097/ALN.0000000000000101; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002	47	22	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141622	10.1371/journal.pone.0141622	http://dx.doi.org/10.1371/journal.pone.0141622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524181	Green Submitted, Green Published, gold			2022-12-27	WOS:000364029800016
J	Zhang, M; Chen, YX; Xie, LZ; Li, YH; Jiang, H; Du, MQ				Zhang, Meng; Chen, Yongxing; Xie, Lingzhi; Li, Yuhong; Jiang, Han; Du, Minquan			Pyrosequencing of Plaque Microflora In Twin Children with Discordant Caries Phenotypes	PLOS ONE			English	Article							DENTAL-CARIES; MOLECULAR ANALYSIS; ORAL MICROBIOTA; BACTERIAL-FLORA; CLONAL ANALYSIS; HEALTH; HERITABILITY	Despite recent successes in the control of dental caries, the mechanism of caries development remains unclear. To investigate the causes of dental decay, especially in early childhood caries, the supragingival microflora composition of 20 twins with discordant caries phenotypes were analyzed using high-throughput pyrosequencing. In addition, the parents completed a lifestyle questionnaire. A total of 228,789 sequencing reads revealed 10 phyla, 84 genera, and 155 species of microflora, the relative abundances of these strains varied dramatically among the children, Comparative analysis between groups revealed that Veillonella, Corynebacterium and Actinomyces were presumed to be caries-related genera, Fusobacterium, Kingella and Leptotrichia were presumed to be healthy-related genus, yet this six genera were not statistically significant (P>0.05). Moreover, a cluster analysis revealed that the microbial composition of samples in the same group was often dissimilar but that the microbial composition observed in twins was usually similar. Although the genetic and environmental factors that strongly influence the microbial composition of dental caries remains unknown, we speculate that genetic factors primarily influence the individual's susceptibility to dental caries and that environmental factors primarily regulate the microbial composition of the dental plaque and the progression to caries. By using improved twins models and increased sample sizes, our study can be extended to analyze the specific genetic and environmental factors that affect the development of caries.	[Zhang, Meng; Chen, Yongxing; Xie, Lingzhi; Li, Yuhong; Jiang, Han; Du, Minquan] Wuhan Univ, Sch & Hosp Stomatol, MOST KLOS & KLOBM, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Du, MQ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, MOST KLOS & KLOBM, Luoyu Rd 237, Wuhan 430072, Hubei, Peoples R China.	duminquan@whu.edu.cn	Du, Min Quan/V-7359-2018; li, Yu/HCI-9086-2022	Du, Min Quan/0000-0002-5043-9981; 	National Natural Science Foundation of China [81170954, 81371130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. Grants No: 81170954 and 81371130 to MQD. http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Arif N, 2008, J DENT RES, V87, P278, DOI 10.1177/154405910808700308; Bachrach FH, 1927, BR DENT J, V48, P1293; Bastos João Luiz Dornelles, 2007, Ciênc. saúde coletiva, V12, P1611, DOI 10.1590/S1413-81232007000600022; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bretz WA, 2005, CARIES RES, V39, P168, DOI 10.1159/000084793; Bretz WA, 2006, ARCH ORAL BIOL, V51, P1156, DOI 10.1016/j.archoralbio.2006.06.003; Chalmers NI, 2008, J BACTERIOL, V190, P8145, DOI 10.1128/JB.00983-08; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Corby PM, 2007, TWIN RES HUM GENET, V10, P821, DOI 10.1375/twin.10.6.821; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Fejerskov O, 2004, CARIES RES, V38, P182, DOI 10.1159/000077753; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Hu DY, 2011, INT J ORAL SCI, V3, P7, DOI 10.4248/IJOS11006; International Caries Detection and Assessment System (ICDAS) Coordinating Committee, 2011, RAT EV INT CAR DET A; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; KEYES PH, 1960, ARCH ORAL BIOL, V1, P304, DOI 10.1016/0003-9969(60)90091-1; LEHNER T, 1981, NATURE, V292, P770, DOI 10.1038/292770a0; LENCH NJ, 1994, HUM MOL GENET, V3, P827, DOI 10.1093/hmg/3.5.827; Leone C W, 2001, J Dent Educ, V65, P1054; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Marsh P D, 1994, Adv Dent Res, V8, P263; Nariyama M, 2004, CARIES RES, V38, P79, DOI 10.1159/000075929; Papapostolou A, 2011, J CLIN PERIODONTOL, V38, P517, DOI 10.1111/j.1600-051X.2011.01718.x; Parahitiyawa NB, 2010, ORAL DIS, V16, P136, DOI 10.1111/j.1601-0825.2009.01607.x; Petronis A, 2008, TRENDS GENET, V22, P347; Reed DR, 1997, BEHAV GENET, V27, P373, DOI 10.1023/A:1025692031673; SAXEN L, 1989, SCAND J DENT RES, V97, P150; Schulze-Schweifing K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00164; Sheiham A, 2006, BRIT DENT J, V201, P625, DOI 10.1038/sj.bdj.4814259; Takeshita T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang X, 2010, CARIES RES, V44, P277, DOI 10.1159/000314676; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Xu H, 2013, PLOS ONE, V9; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	42	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141310	10.1371/journal.pone.0141310	http://dx.doi.org/10.1371/journal.pone.0141310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524687	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800008
J	Mohamed, R; Degac, J; Helms, V				Mohamed, Ruzianisra; Degac, Jennifer; Helms, Volkhard			Composition of Overlapping Protein-Protein and Protein-Ligand Interfaces	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; BINDING MOAD; CD-HIT; SITES; DATABASE	Protein-protein interactions (PPIs) play a major role in many biological processes and they represent an important class of targets for therapeutic intervention. However, targeting PPIs is challenging because often no convenient natural substrates are available as starting point for small-molecule design. Here, we explored the characteristics of protein interfaces in five non-redundant datasets of 174 protein-protein (PP) complexes, and 161 protein-ligand (PL) complexes from the ABC database, 436 PP complexes, and 196 PL complexes from the PIBASE database and a dataset of 89 PL complexes from the Timbal database. In all cases, the small molecule ligands must bind at the respective PP interface. We observed similar amino acid frequencies in all three datasets. Remarkably, also the characteristics of PP contacts and overlapping PL contacts are highly similar.	[Mohamed, Ruzianisra; Degac, Jennifer; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-66041 Saarbrucken, Germany; [Mohamed, Ruzianisra] Univ Teknol MARA UiTM, Fac Pharm, Dept Pharmaceut Life Sci, Puncak Alam 42300, Selangor, Malaysia	Saarland University; Universiti Teknologi MARA	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, Bldg E2 1,POB 151150, D-66041 Saarbrucken, Germany.	volkhard.helms@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154	Universiti Teknologi MARA	Universiti Teknologi MARA	RM thanks Universiti Teknologi MARA for a predoctoral scholarship.	Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004473; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hakulinen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049216; Higueruelo AP, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat039; Higueruelo AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051742; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubbard S, 1996, V2 1 1; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Koes DR, 2012, BIOINFORMATICS, V28, P784, DOI 10.1093/bioinformatics/btr717; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Walter P, 2007, J INTEGR BIOINFORMAT, V4; Walter P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058583; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x	38	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140965	10.1371/journal.pone.0140965	http://dx.doi.org/10.1371/journal.pone.0140965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517868	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800014
J	Otto, MCD; Padhye, NS; Bertoni, AG; Jacobs, DR; Mozaffarian, D				Otto, Marcia C. de Oliveira; Padhye, Nikhil S.; Bertoni, Alain G.; Jacobs, David R., Jr.; Mozaffarian, Dariush			Everything in Moderation - Dietary Diversity and Quality, Central Obesity and Risk of Diabetes	PLOS ONE			English	Article							HEALTHY FOOD DIVERSITY; CORONARY-HEART-DISEASE; ASSOCIATION; VARIETY; INDEX; SCORE; ATHEROSCLEROSIS; ADIPOSITY; MORTALITY; PATTERNS	Diet guidelines recommend increasing dietary diversity. Yet, metrics for dietary diversity have neither been well-defined nor evaluated for impact on metabolic health. Also, whether diversity has effects independent of diet quality is unknown. We characterized and evaluated associations of diet diversity and quality with abdominal obesity and type II diabetes (T2D) in the Multi-Ethnic Study of Atherosclerosis. At baseline (2000-02), diet was assessed among 5,160 Whites, Hispanic, Blacks, and Chinese age 45-84 y and free of T2D, using a validated questionnaire. Three different aspects of diet diversity were characterized including count (number of different food items eaten more than once/week, a broad measure of diversity), evenness (Berry index, a measure of the spread of the diversity), and dissimilarity (Jaccard distance, a measure of the diversity of the attributes of the foods consumed). Diet quality was characterized using aHEI, DASH, and a priori pattern. Count and evenness were weakly positively correlated with diet quality (r with AHEI: 0.20, 0.04), while dissimilarity was moderately inversely correlated (r = -0.34). In multivariate models, neither count nor evenness was associated with change in waist circumference (WC) or incident T2D. Greater food dissimilarity was associated with higher gain in WC (p-trend<0.01), with 120% higher gain in participants in the highest quintile of dissimilarity scores. Diet diversity was not associated with incident T2D. Also, none of the diversity metrics were associated with change in WC or incident T2D when restricted to only healthier or less healthy foods. Higher diet quality was associated with lower risk of T2D. Our findings provide little evidence for benefits of diet diversity for either abdominal obesity or diabetes. Greater dissimilarity among foods was actually associated with gain in WC. These results do not support the notion that "eating everything in moderation" leads to greater diet quality or better metabolic health.	[Otto, Marcia C. de Oliveira] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Padhye, Nikhil S.] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Ctr Nursing Res, Houston, TX 77030 USA; [Bertoni, Alain G.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Tufts University	Otto, MCD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	marcia.c.otto@uth.tmc.edu	Mozaffarian, Dariush/ABC-2822-2020	Jacobs, David/0000-0002-7232-0543; Padhye, Nikhil/0000-0001-5738-7486	National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL085710]; Bunge LLC; Swiss Re; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bunge LLC; Swiss Re; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Otto was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL085710 and by unrestricted educational grants from Bunge LLC and from Swiss Re, which had no role in the study design, data collection and analysis, or data interpretation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Drescher LS, 2007, J NUTR, V137, P647, DOI 10.1093/jn/137.3.647; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2007, DIABETES CARE, V30, P1753, DOI 10.2337/DC06-2581; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2005, AM J CLIN NUTR, V82, P163; German Nutrition Society (DGE), 2005, 10 GUIDELINES OF THE; Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kastorini CM, 2009, CURR DIABETES REV, V5, P221, DOI 10.2174/157339909789804341; Katanoda K, 2006, NUTRITION, V22, P283, DOI 10.1016/j.nut.2005.06.014; Kroger J, 2014, DIABETOLOGIA, V57, P321, DOI 10.1007/s00125-013-3092-9; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; McCrory MA, 1999, AM J CLIN NUTR, V69, P440; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Nettleton JA, 2009, BRIT J NUTR, V102, P1220, DOI 10.1017/S0007114509382161; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Rhee JJ, 2015, DIABETES CARE, V38, P596, DOI 10.2337/dc14-1986; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Sijtsma FPC, 2012, AM J CLIN NUTR, V95, P580, DOI 10.3945/ajcn.111.020719; South African Department of Health, 2004, SOUTH AFRICAN GUIDEL; U. S. Department of Agriculture and U. S. Department of Health and Human Services, 2010, CONTRACT NO REPORT; U. S. Department of Agriculture CfNPaP, 1992, THE FOOD GUIDE PYRAM; Vadiveloo M, 2015, J NUTR, V145, P555, DOI 10.3945/jn.114.199067; Vadiveloo M, 2014, BRIT J NUTR, V112, P1562, DOI 10.1017/S0007114514002049; World Health Organization Food and Agriculture Organization of the United Nations (FAO), 1996, CONTRACT NO REPORT	33	54	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141341	10.1371/journal.pone.0141341	http://dx.doi.org/10.1371/journal.pone.0141341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517708	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800036
J	Zhang, YJ; Kong, WJ; Gao, Y; Liu, XY; Gao, K; Xie, H; Wu, Y; Zhang, YH; Wang, JM; Gao, F; Wu, XR; Jiang, YW				Zhang, Yujia; Kong, Weijing; Gao, Yang; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Gao, Feng; Wu, Xiru; Jiang, Yuwu			Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/Developmental Disabilities	PLoS One			English	Article							MIGRATING PARTIAL SEIZURES; CHILDHOOD-ONSET EPILEPSY; BETA-SUBUNIT; K+ CHANNELS; POTASSIUM; INACTIVATION; INFANCY; ENCEPHALOPATHY; PRODUCT; KCNA1B	Objective Epilepsy and intellectual/developmental disabilities (ID/DD) have a high rate of co-occurrence. Here, we investigated gene mutations in Chinese children with unexplained epilepsy and ID/DD. Methods We used targeted next-generation sequencing to detect mutations within 300 genes related to epilepsy and ID/DD in 253 Chinese children with unexplained epilepsy and ID/DD. A series of filtering criteria was used to find the possible pathogenic variations. Validation and parental origin analyses were performed by Sanger sequencing. We reviewed the phenotypes of patients with each mutated gene. Results We identified 32 novel and 16 reported mutations within 24 genes in 46 patients. The detection rate was 18% (46/253) in the whole group and 26% (17/65) in the early-onset (before three months after birth) epilepsy group. To our knowledge, we are the first to report KCNAB1 is a disease-causing gene of epilepsy by identifying a novel de novo mutation (c. 1062dupCA p.Leu355HisfsTer5) within this gene in one patient with early infantile epileptic encephalopathy (EIEE). Patients with an SCN1A mutation accounted for the largest proportion, 17% (8/46). A total of 38% (9/24) of the mutated genes re-occurred at least 2 times and 63% (15/24) occurred only one time. Ion channel genes are the most common (8/24) and genes related to synapse are the next most common to occur (5/24). Significance We have established genetic diagnosis for 46 patients of our cohort. Early-onset epilepsy had the highest detection rate. KCNAB1 mutation was first identified in EIEE patient. We expanded the phenotype and mutation spectrum of the genes we identified. The mutated genes in this cohort are mostly isolated. This suggests that epilepsy and ID/ DD phenotypes occur as a consequence of brain dysfunction caused by a highly diverse population of mutated genes. Ion channel genes and genes related to synapse were more common mutated in this patient cohort.	[Zhang, Yujia; Kong, Weijing; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhang, Yujia; Kong, Weijing; Liu, Xiaoyan; Gao, Kai; Xie, Han; Wu, Ye; Zhang, Yuehua; Wang, Jingmin; Wu, Xiru; Jiang, Yuwu] Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing 100871, Peoples R China; [Zhang, Yujia; Jiang, Yuwu] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China; [Gao, Yang] Dalian Med Univ, Hosp 2, Dept Neurosurg, Dalian, Peoples R China; [Gao, Feng] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Peking University; Peking University; Dalian Medical University; Zhejiang University	Jiang, YW (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	jiangyuwu@bjmu.edu.cn	han, xie/AAO-9359-2021; jiang, yu/HGU-0029-2022	Zhang, Yuehua/0000-0003-1432-5423	National Key Research Project [2012CB944602]; Beijing Institute for Brain Disorders, the National Key Research Project [2012CB944602]; Beijing Institute for Brain Disorders Foundation [BIBDPXM2014_014226_000016]; grant for Beijing Key Laboratory of Pediatric Genetic Disease; Key Project of Beijing Natural Science Foundation [7151010]	National Key Research Project; Beijing Institute for Brain Disorders, the National Key Research Project; Beijing Institute for Brain Disorders Foundation; grant for Beijing Key Laboratory of Pediatric Genetic Disease; Key Project of Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Key Research Project (2012CB944602) and Beijing Institute for Brain Disorders, the National Key Research Project (2012CB944602), and the Beijing Institute for Brain Disorders Foundation (BIBDPXM2014_014226_000016), grant for Beijing Key Laboratory of Pediatric Genetic Disease and Key Project of Beijing Natural Science Foundation (7151010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 2011, EPILEPSIA, V52, P7, DOI 10.1111/j.1528-1167.2010.02905.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Busolin G, 2011, EPILEPSY RES, V94, P110, DOI 10.1016/j.eplepsyres.2011.01.010; Camfield C, 2007, PEDIATRICS, V120, pE52, DOI 10.1542/peds.2006-3290; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chahine L, 2013, EPILEPSY RES, V106, P338, DOI 10.1016/j.eplepsyres.2013.07.007; Diani E, 2008, EPILEPSY RES, V80, P1, DOI 10.1016/j.eplepsyres.2008.03.001; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; Freilich ER, 2011, ARCH NEUROL-CHICAGO, V68, P665, DOI 10.1001/archneurol.2011.98; Geerts A, 2011, EPILEPSIA, V52, P2192, DOI 10.1111/j.1528-1167.2011.03294.x; Giese KP, 1998, LEARN MEMORY, V5, P257; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jefferys JGR, 2010, SEIZURE-EUR J EPILEP, V19, P638, DOI 10.1016/j.seizure.2010.10.026; Kong WJ, 2015, EPILEPSIA, V56, P431, DOI 10.1111/epi.12925; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Numis AL, 2014, NEUROLOGY, V82, P368, DOI 10.1212/WNL.0000000000000060; Pan YP, 2008, NAT CHEM BIOL, V4, P708, DOI 10.1038/nchembio.114; Pandolfo M, 2013, CURR OPIN NEUROL, V26, P137, DOI 10.1097/WCO.0b013e32835f19da; Pandolfo M, 2011, SEMIN NEUROL, V31, P506, DOI 10.1055/s-0031-1299789; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rojo DC, 2011, NEUROLOGY, V77, P380, DOI 10.1212/WNL.0b013e318227046d; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Schultz D, 1996, GENOMICS, V31, P389, DOI 10.1006/geno.1996.0065; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239	42	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141782	10.1371/journal.pone.0141782	http://dx.doi.org/10.1371/journal.pone.0141782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544041	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700045
J	Nanson, JD; Forwood, JK				Nanson, Jeffrey D.; Forwood, Jade K.			Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis	PLOS ONE			English	Article							BETA-KETOACYL REDUCTASE; ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; DEHYDROGENASE; INFORMATION; METABOLISM; INTERFACE; DISCOVERY	Ketoacyl-acyl carrier protein reductases (FabG) are ubiquitously expressed enzymes that catalyse the reduction of acyl carrier protein (ACP) linked thioesters within the bacterial type II fatty acid synthesis (FASII) pathway. The products of these enzymes, saturated and unsaturated fatty acids, are essential components of the bacterial cell envelope. The FASII reductase enoyl-ACP reductase (FabI) has been the focus of numerous drug discovery efforts, some of which have led to clinical trials, yet few studies have focused on FabG. Like FabI, FabG appears to be essential for survival in many bacteria, similarly indicating the potential of this enzyme as a drug target. FabG enzymes are members of the short-chain alcohol dehydrogenase/reductase (SDR) family, and like other SDRs, exhibit highly conserved secondary and tertiary structures, and contain a number of conserved sequence motifs. Here we describe the crystal structures of FabG from Yersinia pestis (YpFabG), the causative agent of bubonic, pneumonic, and septicaemic plague, and three human pandemics. Y. pestis remains endemic in many parts of North America, South America, Southeast Asia, and Africa, and a threat to human health. YpFabG shares a high degree of structural similarity with bacterial homologues, and the ketoreductase domain of the mammalian fatty acid synthase from both Homo sapiens and Sus scrofa. Structural characterisation of YpFabG, and comparison with other bacterial FabGs and the mammalian fatty acid synthase, provides a strong platform for virtual screening of potential inhibitors, rational drug design, and the development of new antimicrobial agents to combat Y. pestis infections.	[Nanson, Jeffrey D.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Forwood, Jade K.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia	Charles Sturt University; Charles Sturt University	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Nanson, Jeffrey D/E-6313-2017	Nanson, Jeffrey D/0000-0003-1306-1948; Forwood, Jade/0000-0003-3267-9997				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Banerjee DR, 2014, ORG BIOMOL CHEM, V12, P73, DOI 10.1039/c3ob41676c; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Caceres O, 2013, GENOME ANNOUNCEMENTS, V1; Cukier CD, 2013, ACS CHEM BIOL, V8, P2518, DOI 10.1021/cb4005063; Di Tommaso P., 2011, NUCLEIC ACIDS RES; Duax WL, 2005, ANN NY ACAD SCI, V1061, P135, DOI 10.1196/annals.1336.015; Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107; Dutta D, 2011, J STRUCT BIOL, V174, P147, DOI 10.1016/j.jsb.2010.11.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ge PF, 2015, INT J INFECT DIS, V33, P67, DOI 10.1016/j.ijid.2014.12.044; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Janssen HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-7; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064984; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Martinez MA, 2010, MICROBIOL-SGM, V156, P484, DOI 10.1099/mic.0.033316-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nanson JD, 2014, ACTA CRYSTALLOGR F, V70, P101, DOI 10.1107/S2053230X13033402; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pillai S, 2003, BIOCHEM BIOPH RES CO, V303, P387, DOI 10.1016/S0006-291X(03)00321-8; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Richard V, 2015, EMERG INFECT DIS, V21, P8, DOI 10.3201/eid2101.131828; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Sohn MJ, 2008, J ANTIBIOT, V61, P687, DOI 10.1038/ja.2008.98; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wickramasinghe SR, 2006, BIOCHEM J, V393, P447, DOI 10.1042/BJ20050832; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	45	10	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141543	10.1371/journal.pone.0141543	http://dx.doi.org/10.1371/journal.pone.0141543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539719	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800019
J	Chung, MJY; Friesen, AL; Fox, D; Meltzoff, AN; Rao, RPN				Chung, Michael Jae-Yoon; Friesen, Abram L.; Fox, Dieter; Meltzoff, Andrew N.; Rao, Rajesh P. N.			A Bayesian Developmental Approach to Robotic Goal-Based Imitation Learning	PLOS ONE			English	Article							OTHERS; BEHAVIOR; DESIGN	A fundamental challenge in robotics today is building robots that can learn new skills by observing humans and imitating human actions. We propose a new Bayesian approach to robotic learning by imitation inspired by the developmental hypothesis that children use self-experience to bootstrap the process of intention recognition and goal-based imitation. Our approach allows an autonomous agent to: (i) learn probabilistic models of actions through self-discovery and experience, (ii) utilize these learned models for inferring the goals of human actions, and (iii) perform goal-based imitation for robotic learning and human-robot collaboration. Such an approach allows a robot to leverage its increasing repertoire of learned behaviors to interpret increasingly complex human actions and use the inferred goals for imitation, even when the robot has very different actuators from humans. We demonstrate our approach using two different scenarios: (i) a simulated robot that learns human-like gaze following behavior, and (ii) a robot that learns to imitate human actions in a tabletop organization task. In both cases, the agent learns a probabilistic model of its own actions, and uses this model for goal inference and goal-based imitation. We also show that the robotic agent can use its probabilistic model to seek human assistance when it recognizes that its inferred actions are too uncertain, risky, or impossible to perform, thereby opening the door to human-robot collaboration.	[Chung, Michael Jae-Yoon; Friesen, Abram L.; Fox, Dieter; Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu	Meltzoff, Andrew N/GPC-8807-2022	Meltzoff, Andrew N/0000-0001-8683-0547; Rao, Rajesh P. N./0000-0003-0682-8952	Office of Naval Research (ONR) Science of Autonomy [N000141310817]; Office of Naval Research (ONR) Cognitive Science program [N000140910097]; National Science Foundation (NSF) [SMA-1540619, IIS-1318733]; Intel Science and Technology Center (ISTC), Seattle; NSERC; Direct For Computer & Info Scie & Enginr [1318733] Funding Source: National Science Foundation	Office of Naval Research (ONR) Science of Autonomy(Office of Naval Research); Office of Naval Research (ONR) Cognitive Science program(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); Intel Science and Technology Center (ISTC), Seattle; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by Office of Naval Research (ONR) Science of Autonomy, grant no. N000141310817, http://www.onr.navy.mil/; Office of Naval Research (ONR) Cognitive Science program, grant no. N000140910097, http://www.onr.navy.mil/; National Science Foundation (NSF), NSF grant no. SMA-1540619 and NSF grant no. IIS-1318733, http://www.nsf.gov/; Intel Science and Technology Center (ISTC), Seattle; and (NSERC) fellowship to A. Friesen, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2003, VISUAL NEUROSCIENCES, P1324; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Billard A., 2000, Proceedings of the Fourth International Conference on Autonomous Agents, P373, DOI 10.1145/336595.337544; Billard A., 2008, SPRINGER HDB ROBOTIC, P1371, DOI DOI 10.1007/978-3-540-30301-5_60; Botvinick Matthew, 2009, Adv Neural Inf Process Syst, V21, P169; Breazeal C, 2005, ARTIF LIFE, V11, P31, DOI 10.1162/1064546053278955; Breazeal C, 2002, FROM ANIM ANIMAT, P363; Cangelosi A., 2015, DEV ROBOTICS BABIES; Churchland P., 1989, PHILOS PERSPECT, V3, P225, DOI [10.2307/2214269, DOI 10.2307/2214269]; Copete JL, 2014, DEV LEARNING EPIGENE, P334, DOI DOI 10.1109/DEVLRN.2014.6983005; Davies M., 1995, FOLK PSYCHOL; Deisenroth M., 2011, P 28 INT C MACH LEAR, P465; Ek C. H., 2010, 2010 10th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2010), P548, DOI 10.1109/ICHR.2010.5686348; Gopnik A., 1997, WORDS THOUGHTS THEOR; Grimes D., 2006, P ROB SCI SYST; Grimes DB, 2009, LECT NOTES ARTIF INT, V5436, P103, DOI 10.1007/978-3-642-00616-6_7; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Kaipa KN, 2010, NEURAL NETWORKS, V23, P1113, DOI 10.1016/j.neunet.2010.07.009; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kroemer O, 2015, IEEE INT CONF ROBOT, P1503, DOI 10.1109/ICRA.2015.7139389; Kwon WY, 2012, IEEE INT CONF ROBOT, P3685, DOI 10.1109/ICRA.2012.6224673; Lungarella M, 2003, CONNECT SCI, V15, P151, DOI 10.1080/09540090310001655110; Mataric MJ, 1998, TRENDS COGN SCI, V2, P82, DOI 10.1016/S1364-6613(98)01141-3; Matuszek Cynthia, 2011, IEEE International Conference on Robotics and Automation, P4291; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2008, DEV PSYCHOL, V44, P1257, DOI 10.1037/a0012888; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Meltzoff AN, 2010, NEURAL NETWORKS, V23, P966, DOI 10.1016/j.neunet.2010.09.005; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Metta G, 1999, NEURAL NETWORKS, V12, P1413, DOI 10.1016/S0893-6080(99)00070-2; Montemerlo Michael, 2002, AAAI IAAI, DOI DOI 10.1007/S00244-005-7058-X; Patel M, 2013, IEEE INT CONF ROBOT, P4997, DOI 10.1109/ICRA.2013.6631291; Rao RPN, 2007, IMITATION AND SOCIAL LEARNING IN ROBOTS, HUMANS AND ANIMALS: BEHAVIOURAL, SOCIAL AND COMMUNICATIVE DIMENSIONS, P217, DOI 10.1017/CBO9780511489808.016; Rasmussen C., 2003, ADV NEURAL INFORM PR, P489; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Sauser EL, 2005, NEUROCOMPUTING, V64, P5, DOI 10.1016/j.neucom.2004.11.019; Sauser EL, 2007, LECT NOTES COMPUT SC, V4669, P768; Scassellati B., 1999, Computation for metaphors, analogy, and agents, P176; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Shon AP, 2007, INT J HUM ROBOT, V4, P387, DOI 10.1142/S0219843607001059; Song D., 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P1579, DOI 10.1109/IROS.2010.5649406; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thrun S., 2005, PROBABILISTIC ROBOTI; Toussaint Marc, 2006, INT C MACH LEARN ICM, P945; Ugur E, 2015, IEEE T AUTON MENT DE, V7, P119, DOI 10.1109/TAMD.2015.2426192; Verma D., 2006, ADV NEURAL INFORM PR, P1393; Verma D, 2007, LECT NOTES ARTIF INT, V4701, P757; Verma D, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P2382, DOI 10.1109/IROS.2006.281675; Waismeyer A, 2015, DEVELOPMENTAL SCI, V18, P175, DOI 10.1111/desc.12208; Wang ZK, 2013, INT J ROBOT RES, V32, P841, DOI 10.1177/0278364913478447	54	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141965	10.1371/journal.pone.0141965	http://dx.doi.org/10.1371/journal.pone.0141965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536366	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400108
J	Li, X; Lu, M; Tang, DQ; Shi, YM				Li, Xin; Lu, Min; Tang, Dongqin; Shi, Yimin			Composition of Carotenoids and Flavonoids in Narcissus Cultivars and their Relationship with Flower Color	PLOS ONE			English	Article							HPLC; ANTHOCYANINS; QUANTIFICATION; IDENTIFICATION; ANTIOXIDANT; EXTRACTS; PETALS; MS/MS; NAPUS	Narcissus is widely used for cut flowers and potted plants, and is one of the most important commercial bulbous flowers in the floricultural industry. In this study, ten carotenoid and eighteen flavonoid compounds from the perianths and coronas of fifteen narcissus cultivars were measured by HPLC-APCI-MS/MS and UPLC-Q-TOF-MS/MS. Among these, six carotenoids, a total of seventeen flavonols and chlorogenic acid were identified in narcissus for the first time. A multivariate analysis was used to explore the relationship between flower color and pigment composition. We found that all-trans-violaxanthin and total carotenoid content were the main factors that affected flower color. These investigations could provide a global view of flower color formation and a theoretical basis for hybridization breeding in narcissus.	[Li, Xin; Lu, Min; Tang, Dongqin; Shi, Yimin] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shi, YM (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	shiyimin@sjtu.edu.cn			Shanghai Chongming Project [13391912504]	Shanghai Chongming Project	This work was supported by Shanghai Chongming Project (Grant 13391912504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger B, 2010, J AGR FOOD CHEM, V58, P6246, DOI 10.1021/jf903619v; Bako E, 2002, J BIOCHEM BIOPH METH, V53, P241, DOI 10.1016/S0165-022X(02)00112-4; Chiste RC, 2012, J AGR FOOD CHEM, V60, P5884, DOI 10.1021/jf301904f; de Faria AF, 2009, PLANT FOOD HUM NUTR, V64, P108, DOI 10.1007/s11130-009-0111-6; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; Ertas A, 2014, J AGR FOOD CHEM, V62, P4601, DOI 10.1021/jf500067q; Fromm M, 2012, J AGR FOOD CHEM, V60, P10733, DOI 10.1021/jf3028446; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; He QL, 2011, PLOS ONE, V6, P1; Jia N, 2008, SCI HORTIC-AMSTERDAM, V117, P167, DOI 10.1016/j.scienta.2008.03.016; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; Kishimoto S, 2004, PHYTOCHEMISTRY, V65, P2781, DOI 10.1016/j.phytochem.2004.08.038; Li CH, 2009, J AGR FOOD CHEM, V57, P8496, DOI 10.1021/jf902103b; Li L, 2013, ARCH BIOCHEM BIOPHYS, V539, P102, DOI 10.1016/j.abb.2013.07.002; Lin LZ, 2011, J AGR FOOD CHEM, V59, P12059, DOI 10.1021/jf202556p; MA YL, 2001, PHYTOCHEM ANALYSIS, V12, P159; Melendez-Martinez AJ, 2009, J SEP SCI, V32, P1838, DOI 10.1002/jssc.200800717; Ohmiya A, 2011, JARQ-JPN AGR RES Q, V45, P163, DOI 10.6090/jarq.45.163; Olsen H, 2009, J AGR FOOD CHEM, V57, P2816, DOI 10.1021/jf803693t; de Andrade JP, 2012, J PHARMACEUT BIOMED, V70, P13, DOI 10.1016/j.jpba.2012.05.009; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Santos-Gally R, 2012, J BIOGEOGR, V39, P782, DOI 10.1111/j.1365-2699.2011.02526.x; Schmitzer V, 2012, SCI HORTIC-AMSTERDAM, V146, P14, DOI 10.1016/j.scienta.2012.07.035; Shao YL, 2014, J AGR FOOD CHEM, V62, P2935, DOI 10.1021/jf404826u; Suzuki S, 2007, PLANT CELL REP, V26, P951, DOI 10.1007/s00299-006-0302-7; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; VALADON LRG, 1968, BIOCHEM J, V106, P479, DOI 10.1042/bj1060479; Vera de Rosso V, 2007, J AGR FOOD CHEM, V55, P9135, DOI 10.1021/jf071316u; Wang LJ, 2014, FOOD CHEM, V160, P357, DOI 10.1016/j.foodchem.2014.03.081; Wang X, 2005, J CHROMATOGR A, V1075, P127, DOI 10.1016/j.chroma.2005.04.017; Whent M, 2012, J AGR FOOD CHEM, V60, P2129, DOI 10.1021/jf203807w; Xie ZH, 2011, J AGR FOOD CHEM, V59, P9877, DOI 10.1021/jf202069g; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; Yun Z, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-44; Zhu CF, 2010, ARCH BIOCHEM BIOPHYS, V504, P132, DOI 10.1016/j.abb.2010.07.028; Zsila F, 2001, PLANTA, V213, P937, DOI 10.1007/s004250100569	37	28	30	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142074	10.1371/journal.pone.0142074	http://dx.doi.org/10.1371/journal.pone.0142074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536625	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400129
J	Smithson, P; Florey, L; Salgado, SR; Hershey, CL; Masanja, H; Bhattarai, A; Mwita, A; McElroy, PD				Smithson, Paul; Florey, Lia; Salgado, S. Rene; Hershey, Christine L.; Masanja, Honorati; Bhattarai, Achuyt; Mwita, Alex; McElroy, Peter D.		Tanzania Malaria Impact Evaluation	Impact of Malaria Control on Mortality and Anemia among Tanzanian Children Less than Five Years of Age, 1999-2010	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SUB-SAHARAN AFRICA; SULFADOXINE-PYRIMETHAMINE; TREATMENT POLICY; PUBLIC-HEALTH; PROTECTIVE EFFICACY; SYSTEMATIC ANALYSIS; MATERNAL EDUCATION; NEONATAL-MORTALITY; ATTRIBUTABLE RISK	Background Mainland Tanzania scaled up multiple malaria control interventions between 1999 and 2010. We evaluated whether, and to what extent, reductions in all-cause under-five child mortality (U5CM) tracked with malaria control intensification during this period. Methods Four nationally representative household surveys permitted trend analysis for malaria intervention coverage, severe anemia (hemoglobin <8 g/dL) prevalence (SAP) among children 6-59 months, and U5CM rates stratified by background characteristics, age, and malaria endemicity. Prevalence of contextual factors (e.g., vaccination, nutrition) likely to influence U5CM were also assessed. Population attributable risk percentage (PAR%) estimates for malaria interventions and contextual factors that changed over time were used to estimate magnitude of impact on U5CM. Results Household ownership of insecticide-treated nets (ITNs) rose from near zero in 1999 to 64% (95% CI, 61.7-65.2) in 2010. Intermittent preventive treatment of malaria in pregnancy reached 26% (95% CI, 23.6-28.0) by 2010. Sulfadoxine-pyrimethamine replaced chloroquine in 2002 and artemisinin-based combination therapy was introduced in 2007. SAP among children 6-59 months declined 50% between 2005 (11.1%; 95% CI, 10.0-12.3%) and 2010 (5.5%; 95% CI, 4.7-6.4%) and U5CM declined by 45% between baseline (1995-9) and endpoint (2005-9), from 148 to 81 deaths/1000 live births, respectively. Mortality declined 55% among children 1-23 months of age in higher malaria endemicity areas. A large reduction in U5CM was attributable to ITNs (PAR%=11) with other malaria interventions adding further gains. Multiple contextual factors also contributed to survival gains. Conclusion Marked declines in U5CM occurred in Tanzania between 1999 and 2010 with high impact from ITNs and ACTs. High-risk children (1-24 months of age in high malaria endemicity) experienced the greatest declines in mortality and SAP. Malaria control should remain a policy priority to sustain and further accelerate progress in child survival.	[Smithson, Paul; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Florey, Lia] ICF Int, Rockville, MD USA; [Salgado, S. Rene; Hershey, Christine L.] US Agcy Int Dev, US Presidents Malaria Initiat, Washington, DC 20523 USA; [Bhattarai, Achuyt; McElroy, Peter D.] Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Atlanta, GA USA; [Mwita, Alex] Minist Hlth & Social Welf, Natl Malaria Control Programme, Dar Es Salaam, Tanzania	Ifakara Health Institute; United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA	Smithson, P (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.	psmithson@ihi.or.tz	Bhattarai, Achuyt/B-8760-2008	Bhattarai, Achuyt/0000-0002-0514-4850	United Republic of Tanzania Ministry of Health and Social Welfare; U. S. Agency for International Development; United Nations Children's Fund; Global Fund; Department for International Development; United Nations Population Fund; World Food Programme; United Nations Development Programme; Irish Aid	United Republic of Tanzania Ministry of Health and Social Welfare; U. S. Agency for International Development(United States Agency for International Development (USAID)); United Nations Children's Fund; Global Fund; Department for International Development; United Nations Population Fund; World Food Programme; United Nations Development Programme; Irish Aid(CGIAR)	The household surveys included in this analysis were funded in part by the United Republic of Tanzania Ministry of Health and Social Welfare, U. S. Agency for International Development, United Nations Children's Fund, The Global Fund, Department for International Development, United Nations Population Fund, World Food Programme, United Nations Development Programme, and Irish Aid. The authors received no specific funding for this work.	Abdalla SHPG, 2011, TROPICAL INFECT DIS, P1024; Abdullah S, 2007, AM J TROP MED HYG, V77, P99; Alba S, 2014, INT J EPIDEMIOL, V43, P204, DOI 10.1093/ije/dyt231; [Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], HLTH PEOPL AFR REG H; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Boerma J T, 1993, World Health Stat Q, V46, P222; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Cuadros DF, 2011, INT J EPIDEMIOL, V40, P931, DOI 10.1093/ije/dyq256; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Farnert A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-459; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Govender T, 2014, J INFECTION, V68, pS57, DOI 10.1016/j.jinf.2013.09.015; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hanson K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-205; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill GB, 1996, AM J PUBLIC HEALTH, V86, P1483, DOI 10.2105/AJPH.86.10.1483-a; [ICF International MEASURE DHS], 2006, GUIDE DHS STAT; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Inc. NBoSaMI, 1993, TANZ DEM HLTH SURV 1; Inc. NBoSaMI, 1997, TANZ DEM HLTH SURV 1; International Monetary Fund, 2012, ECONSTATS WORLD EC O; International Monetary Fund Staff, 2011, REG EC OUTL OCT 2011; International Research Institute, 2013, WEIGHT AN STAND PREC; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Joseph D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-60; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; KELSEY JL, 1986, METHODS OBSERVATIONA; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Korenromp EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-94; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1; Macro NBoSNal, 2011, MICR RES 2010 TANZ D; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; McCurdy RJ, 2011, ACTA OBSTET GYN SCAN, V90, P779, DOI 10.1111/j.1600-0412.2011.01133.x; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Mugittu K, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-55; Mugittu K, 2004, AM J TROP MED HYG, V71, P696, DOI 10.4269/ajtmh.2004.71.696; Mushi AK, 2003, HEALTH POLICY PLANN, V18, P163, DOI 10.1093/heapol/czg021; Namusoke F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-310; [National Bureau of Statistics ORC Macro], 2005, TANZ DEM HLTH SURV 2; [National Bureau of Statistics Macro International], 2000, TANZ REPR CHILD HLTH; National Malaria Control Programme, 2008, TANZ MAL MED TERM ST; National Malaria Control Programme, 2003, TANZ MAL MED TERM ST; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Obonyo CO, 2007, AM J TROP MED HYG, V77, P23; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roll Back Malaria Partnership, 2011, DEC PARTN RES; Roll Back Malaria Partnership, 2009, GUID COR POP BAS IND; Rowe AK, 2007, AM J TROP MED HYG, V77, P48, DOI 10.4269/ajtmh.2007.77.48; Ruton H, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-4; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Stresman GH, 2010, ACTA TROP, V116, P167, DOI 10.1016/j.actatropica.2010.08.005; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS) [Tanzania] & ORC Macro, 2005, TANZ HIV AIDS IND SU; The Global Fund to Fight AIDS TaM, 2010, IMPR VAL MON GLOB FU; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; UNAIDS, 2011, GLOB REP UNAIDS REP; UNAIDS, 1999, AIDS EPIDEMIC UPDATE; [UNFPA World Bank WHO U], 2012, TRENDS MAT MORT 1990; UNICEF, 2015, COMMITTING CHILD SUR; United Nations Inter-agency Group for Child Mortality Estimation, 2013, LEV TRENDS CHILD MOR; United Nations Inter-agency Group for Child Mortality Estimation, 2011, LEV TRENDS CHILD MOR; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2009, GLOB PREV VIAT A DEF; World Bank, 2013, GDP PER CAP CURR US; Yazbeck AS, 2007, LANCET, V370, P1291, DOI 10.1016/S0140-6736(07)61553-0	110	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141112	10.1371/journal.pone.0141112	http://dx.doi.org/10.1371/journal.pone.0141112			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536354	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400054
J	Brokordt, KB; Gonzalez, RC; Farias, WJ; Winkler, FM				Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.			Potential Response to Selection of HSP70 as a Component of Innate Immunity in the Abalone Haliotis rufescens	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SPOT SYNDROME VIRUS; GENE-EXPRESSION; BODY-SIZE; VIBRIO-SPLENDIDUS; PENAEUS-MONODON; TRADE-OFFS; HERITABILITY; RESISTANCE; SYSTEM	Assessing components of the immune system may reflect disease resistance. In some invertebrates, heat shock proteins (HSPs) are immune effectors and have been described as potent activators of the innate immune response. Several diseases have become a threat to abalone farming worldwide; therefore, increasing disease resistance is considered to be a long-term goal for breeding programs. A trait will respond to selection only if it is determined partially by additive genetic variation. The aim of this study was to estimate the heritability (h(2)) and the additive genetic coefficient of variation (CVA) of HSP70 as a component of innate immunity of the abalone Haliotis rufescens, in order to assess its potential response to selection. These genetic components were estimated for the variations in the intracellular (in haemocytes) and extracellular (serum) protein levels of HSP70 in response to an immunostimulant agent in 60 full-sib families of H. rufescens. Levels of HSP70 were measured twice in the same individuals, first when they were young and again when they were pre-harvest adults, to estimate the repeatability (R), the h(2) and the potential response to selection of these traits at these life stages. High HSP70 levels were observed in abalones subjected to immunostimulation in both the intracellular and extracellular haemolymph fractions. This is the first time that changes in serum levels of HSP70 have been reported in response to an immune challenge in molluscs. HSP70 levels in both fractions and at both ages showed low h(2) and R, with values that were not significantly different from zero. However, HSP70 induced levels had a CVA of 13.3-16.2% in young adults and of 2.7-8.1% in pre-harvest adults. Thus, despite its low h(2), HSP70 synthesis in response to an immune challenge in red abalone has the potential to evolve through selection because of its large phenotypic variation and the presence of additive genetic variance, especially in young animals.	[Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.] Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Brokordt, Katherina B.; Gonzalez, Roxana C.; Farias, William J.; Winkler, Federico M.] Univ Catolica Norte, Dept Biol Marina, Fac Ciencias Mar, Coquimbo, Chile	Universidad Catolica del Norte	Brokordt, KB (corresponding author), Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile.	kbrokord@ucn.cl			Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1140849]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D05I-10013]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF)	This study was financed by Fondo Nacional de Ciencia y Tecnologia (FONDECYT) Grant No. 1140849 (http://www.conicyt.cl/fondecyt/) to KB; and Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) Grant No. D05I-10013 (http://www.conicyt.cl/fondef/) to FW.	Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Beardmore JA, 1998, J APPL ICHTHYOL, V14, P167, DOI 10.1111/j.1439-0426.1998.tb00637.x; Bech C, 1999, P ROY SOC B-BIOL SCI, V266, P2161, DOI 10.1098/rspb.1999.0903; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Brown T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067246; Calderwood SK, 2007, METHODS, V43, P199, DOI 10.1016/j.ymeth.2007.06.008; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Campalans M, 2009, REV BIOL MAR OCEANOG, V44, P561; Cellura C, 2007, FISH SHELLFISH IMMUN, V22, P340, DOI 10.1016/j.fsi.2006.06.007; Cellura C, 2006, DEV COMP IMMUNOL, V30, P984, DOI 10.1016/j.dci.2005.12.009; Cheng PZ, 2007, FISH SHELLFISH IMMUN, V22, P77, DOI 10.1016/j.fsi.2006.03.014; Christe P, 2000, HEREDITY, V85, P75, DOI 10.1046/j.1365-2540.2000.00732.x; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Cotter SC, 2002, HEREDITY, V88, P229, DOI 10.1038/sj.hdy.6800031; Crane MS, 2013, J SHELLFISH RES, V32, P67, DOI 10.2983/035.032.0112; Crosson LM, 2014, DIS AQUAT ORGAN, V108, P261, DOI 10.3354/dao02713; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; Decanini LI, 2007, J HERED, V98, P195, DOI 10.1093/jhered/esm008; Diggles B, 2005, DIS ASIAN AQUACULTUR, P275; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dohm MR, 2002, FUNCT ECOL, V16, P273; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; Flores-Aguilar RA, 2007, J SHELLFISH RES, V26, P705, DOI 10.2983/0730-8000(2007)26[705:DACSOA]2.0.CO;2; Gestal C, 2007, GENE, V406, P134, DOI 10.1016/j.gene.2007.07.030; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gilmour A, 2009, ASREML USER GUIDE; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Gordon HR, 2001, J SHELLFISH RES, V20, P567; Hill BJ, 2005, DEV BIOLOGICALS, V121, P3; HOULE D, 1992, GENETICS, V130, P195; Huang F, 1999, B ENTOMOL RES, V89, P449, DOI 10.1017/S0007485399000589; Institute SAS, 1999, SAS SYST WIND REL 8; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lacoste A, 2001, DIS AQUAT ORGAN, V46, P139, DOI 10.3354/dao046139; Langand J, 1998, J PARASITOL, V84, P739, DOI 10.2307/3284580; Lenth R., 2014, LEAST SQUARES MEANS; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynch M., 1998, GENETIC ANAL QUANTIT; Yanez JM, 2013, AQUACULTURE, V414, P155, DOI 10.1016/j.aquaculture.2013.08.009; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Mgaya YD, 2000, RE ADV MAR BIOTECHNO, V4, P59; Morse D, 2000, SCIENCE, V196, P298; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Rungrassamee W, 2010, DEV COMP IMMUNOL, V34, P1082, DOI 10.1016/j.dci.2010.05.012; Ryder JJ, 2001, J EVOLUTION BIOL, V14, P646, DOI 10.1046/j.1420-9101.2001.00302.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Senar J.C., 1999, Etologuia, V17, P53; Snedecor G.W., 1989, AMES IOWA STATE U PR; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stirling DG, 2002, J EVOLUTION BIOL, V15, P277, DOI 10.1046/j.1420-9101.2002.00389.x; Sung Y.Y., 2011, J AQUAC RES DEV, V3, P1, DOI 10.4172/2155-9546.S2-006; Tan JM, 2008, J VIROL METHODS, V149, P338, DOI 10.1016/j.jviromet.2007.12.019; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wakelin D, 1996, IMMUNITY PARASITES; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Zhou J, 2010, J INVERTEBR PATHOL, V103, P170, DOI 10.1016/j.jip.2009.12.006	70	13	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141959	10.1371/journal.pone.0141959	http://dx.doi.org/10.1371/journal.pone.0141959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529324	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600081
J	Feketa, VV; Marrelli, SP				Feketa, Viktor V.; Marrelli, Sean P.			Systemic Administration of the TRPV3 Ion Channel Agonist Carvacrol Induces Hypothermia in Conscious Rodents	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; ISCHEMIC-STROKE; CAPSAICIN; HEAT	Therapeutic hypothermia is a promising new strategy for neuroprotection. However, the methods for safe and effective hypothermia induction in conscious patients are lacking. The current study explored the Transient Receptor Potential Vanilloid 3 (TRPV3) channel activation by the agonist carvacrol as a potential hypothermic strategy. It was found that carvacrol lowers core temperature after intraperitoneal and intravenous administration in mice and rats. However, the hypothermic effect at safe doses was modest, while higher intravenous doses of carvacrol induced a pronounced drop in blood pressure and substantial toxicity. Experiments on the mechanism of the hypothermic effect in mice revealed that it was associated with a decrease in whole-body heat generation, but not with a change in cold-seeking behaviors. In addition, the hypothermic effect was lost at cold ambient temperature. Our findings suggest that although TRPV3 agonism induces hypothermia in rodents, it may have a limited potential as a novel pharmacological method for induction of hypothermia in conscious patients due to suboptimal effectiveness and high toxicity.	[Feketa, Viktor V.; Marrelli, Sean P.] Baylor Coll Med, Dept Mol Physiol & Biophys, Grad Program, Cardiovasc Sci Track, Houston, TX 77030 USA; [Marrelli, Sean P.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Marrelli, SP (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Grad Program, Cardiovasc Sci Track, Houston, TX 77030 USA.	marrelli@bcm.edu			National Institute of Neurological Diseases and Stroke [NS077413, NS090129]; National Heart, Lung, and Blood Institute [HL088435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS090129, R21NS077413] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institute of Neurological Diseases and Stroke (www.ninds.nih.gov; Grant Numbers NS077413 and NS090129) and the National Heart, Lung, and Blood Institute (www.nhlbi.nih.gov; Grant Number HL088435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cao ZJ, 2014, AM J PHYSIOL-REG I, V306, pR149, DOI 10.1152/ajpregu.00329.2013; Feketa Viktor V, 2015, Temperature (Austin), V2, P244, DOI 10.1080/23328940.2015.1024383; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-51; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; GORDON CJ, 1988, TOXICOLOGY, V53, P161, DOI 10.1016/0300-483X(88)90211-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; HORI T, 1984, PHARMACOL THERAPEUT, V26, P389, DOI 10.1016/0163-7258(84)90041-X; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Muzzi M, 2013, J CEREBR BLOOD F MET, V33, P171, DOI 10.1038/jcbfm.2012.181; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	22	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141994	10.1371/journal.pone.0141994	http://dx.doi.org/10.1371/journal.pone.0141994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528923	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600088
J	Ge, MW; Fang, L; Tian, D				Ge, Mingwei; Fang, Le; Tian, De			Influence of Reynolds Number on Multi-Objective Aerodynamic Design of a Wind Turbine Blade	PLOS ONE			English	Article								At present, the radius of wind turbine rotors ranges from several meters to one hundred meters, or even more, which extends Reynolds number of the airfoil profile from the order of 105 to 10(7). Taking the blade for 3MW wind turbines as an example, the influence of Reynolds number on the aerodynamic design of a wind turbine blade is studied. To make the study more general, two kinds of multi-objective optimization are involved: one is based on the maximum power coefficient (C-Popt) and the ultimate load, and the other is based on the ultimate load and the annual energy production (AEP). It is found that under the same configuration, the optimal design has a larger C-Popt or AEP (C-Popt//AEP) for the same ultimate load, or a smaller load for the same C-Popt//AEP at higher Reynolds number. At a certain tip-speed ratio or ultimate load, the blade operating at higher Reynolds number should have a larger chord length and twist angle for the maximum C-popt//AEP. If a wind turbine blade is designed by using an airfoil database with a mismatched Reynolds number from the actual one, both the load and C-popt//AEP will be incorrectly estimated to some extent. In some cases, the assessment error attributed to Reynolds number is quite significant, which may bring unexpected risks to the earnings and safety of a wind power project.	[Ge, Mingwei; Tian, De] North China Elect Power Univ, State Key Lab Alternate Elect Power Syst Renewabl, Beijing, Peoples R China; [Fang, Le] Beihang Univ, Sinofrench Engn Sch, Beijing 100191, Peoples R China	North China Electric Power University; Beihang University	Ge, MW (corresponding author), North China Elect Power Univ, State Key Lab Alternate Elect Power Syst Renewabl, Beijing, Peoples R China.	gmwncepu@163.com			National Natural Science Foundation of China [11402088, 51376062]; State Key Laboratory of Alternate Electrical Power System with Renewable Energy Sources [LAPS15005]; Fundamental Research Funds for the Central Universities [2014MS33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Alternate Electrical Power System with Renewable Energy Sources; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work is supported by The National Natural Science Foundation of China (Grant No. 11402088 and Grant No. 51376062), State Key Laboratory of Alternate Electrical Power System with Renewable Energy Sources (Grant No. LAPS15005) and the Fundamental Research Funds for the Central Universities (Grant No. 2014MS33).	Abbott I. H., 1945, NACATR824; Bak C, 2007, J PHYS CONF SER, V75, P12008, DOI 10.1088/1742-6596/75/1/012008; Benini E, 2002, J SOL ENERG-T ASME, V124, P357, DOI 10.1115/1.1510868; Bjoork A, 1990, 199015 FFA TN; Brondsted P, 2013, WOODHEAD PUBL SER EN, P1; Buhl ML, 2005, NEW EMPIRICAL RELATI; Ceyhan O, 2012, 50 AIAA ASM C NASHV; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Drela M., C LOW REYN NUMB AIRF; Fuglsang P, 2004, WIND ENERGY, V7, P145, DOI 10.1002/we.117; Fuglsang P, 1999, J WIND ENG IND AEROD, V80, P191, DOI 10.1016/S0167-6105(98)00191-3; Ge MW, 2016, J ENERG ENG, V142, DOI 10.1061/(ASCE)EY.1943-7897.0000254; Hameed Z, 2012, ENRGY PROCED, V24, P263, DOI 10.1016/j.egypro.2012.06.108; He J, 2013, SYSTEMS MAN CYBERN A, V24; Johansen J, 2009, WIND ENERGY, V12, P261, DOI 10.1002/we.292; Jonkman J., 2009, DEFINITION 5 MW REFE; Lanzafame R, 2007, RENEW ENERG, V32, P2291, DOI 10.1016/j.renene.2006.12.010; Lanzafame R, 2012, RENEW ENERG, V39, P440, DOI 10.1016/j.renene.2011.08.008; Martinez J, 2005, WIND ENERGY, V8, P385, DOI 10.1002/we.147; Peeringa J., 2011, ECNE11017; Vaz JRP, 2011, RENEW ENERG, V36, P1734, DOI 10.1016/j.renene.2010.11.018; Ronold KO, 2000, ENG STRUCT, V22, P565, DOI 10.1016/S0141-0296(99)00014-0; Schubel PJ, 2012, ENERGIES, V5, P3425, DOI 10.3390/en5093425; Steele A, 2013, 20130914 AIAA; Tangler J.L., 1995, NREL AIRFOIL FAMILIE; Terao Y, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2177628; Timmer WA, 2003, J SOL ENERG-T ASME, V125, P488, DOI 10.1115/1.1626129; Timmer WA, 2009, 2009268 AIAA; Tony Burton, 2001, WIND ENERGY HDB, P41; van Rooij R, 1996, IW96087R TU DELFT; Veers PS, 2001, AIAA20010044; Viterna L.A., 1982, DOE NASA WORKSH LARG, P69	32	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141848	10.1371/journal.pone.0141848	http://dx.doi.org/10.1371/journal.pone.0141848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528815	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600067
J	Harrington, A; Hammond-Tooke, GD				Harrington, Allanah; Hammond-Tooke, Graeme David			Theta Burst Stimulation of the Cerebellum Modifies the TMS-Evoked N100 Potential, a Marker of GABA Inhibition	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; CORTICAL EXCITABILITY; BRAIN-STIMULATION; PHYSIOLOGICAL-BASIS; COMBINED EEG; RTMS; EPILEPSY; INSIGHTS; HUMANS	Theta burst stimulation (TBS) of the cerebellum, a potential therapy for neurological disease, can modulate corticospinal excitability via the dentato-thalamo-cortical pathway, but it is uncertain whether its effects are mediated via inhibitory or facilitatory networks. The aim of this study was to investigate the effects of 30Hz cerebellar TBS on the N100 waveform of the TMS-evoked potential (TEP), a marker of intracortical GABAB-mediated inhibition. 16 healthy participants (aged 18-30 years; 13 right handed and 3 left handed) received 30Hz intermittent TBS (iTBS), continuous TBS (cTBS) or sham stimulation over the right cerebellum, in three separate sessions. The first 8 participants received TBS at a stimulus intensity of 80% of active motor threshold (AMT), while the remainder received 90% of AMT. Motor evoked potentials (MEP) and TEP were recorded before and after each treatment, by stimulating the first dorsal interosseus area of the left motor cortex. Analysis of the 13 right handed participants showed that iTBS at 90% of AMT increased the N100 amplitude compared to sham and cTBS, without significantly altering MEP amplitude. cTBS at 80% of active motor threshold decreased the N100 amplitude and cTBS overall reduced resting MEP amplitude. The study demonstrates effects of 30Hz cerebellar TBS on inhibitory cortical networks that may be useful for treatment of neurological conditions associated with dysfunctional intracortical inhibition.	[Harrington, Allanah; Hammond-Tooke, Graeme David] Univ Otago, Dept Med, Dunedin, New Zealand; [Hammond-Tooke, Graeme David] Dunedin Publ Hosp, Dept Neurol, Dunedin, New Zealand	University of Otago; Dunedin Public Hospital	Hammond-Tooke, GD (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	graeme.hammond-tooke@southerndhb.govt.nz			University of Otago	University of Otago	This work was funded by University of Otago (www.otago.ac.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawy RAB, 2012, FUNCT NEUROL, V27, P131; Bikmullina R, 2009, EXP BRAIN RES, V194, P517, DOI 10.1007/s00221-009-1723-7; Brighina F, 2006, NEUROSCI LETT, V397, P229, DOI 10.1016/j.neulet.2005.12.050; Bruckmann S, 2012, BRAIN, V135, P2215, DOI 10.1093/brain/aws071; Carrillo F, 2013, BRAIN STIMUL, V6, P582, DOI 10.1016/j.brs.2012.12.004; Casula EP, 2014, NEUROIMAGE, V98, P225, DOI 10.1016/j.neuroimage.2014.04.065; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Delorme A., J NEUROSCI METHODS, V134, P9; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Di Lorenzo F, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00002; Farzan F, 2013, NEUROIMAGE, V83, P120, DOI 10.1016/j.neuroimage.2013.06.059; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Galea JM, 2009, J NEUROSCI, V29, P9115, DOI 10.1523/JNEUROSCI.2184-09.2009; Gerschlager W, 2002, CLIN NEUROPHYSIOL, V113, P1435, DOI 10.1016/S1388-2457(02)00156-6; Goldsworthy MR, 2012, CLIN NEUROPHYSIOL, V123, P2256, DOI 10.1016/j.clinph.2012.05.001; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hardwick RM, 2014, BRAIN STIMUL, V7, P643, DOI 10.1016/j.brs.2014.04.009; Helfrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050073; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iwata NK, 2005, CEREBELLUM, V4, P218, DOI 10.1080/14734220500277007; Jacobs MF, 2014, BRAIN STIMUL, V7, P269, DOI 10.1016/j.brs.2013.12.009; Joseph Classen, 2013, Handb Clin Neurol, V116, P525, DOI 10.1016/B978-0-444-53497-2.00041-3; Julkunen P, 2008, J NEUROSCI METH, V172, P270, DOI 10.1016/j.jneumeth.2008.04.021; Julkunen P, 2013, EPILEPSY RES, V106, P103, DOI 10.1016/j.eplepsyres.2013.04.001; Kahkonen S, 2007, J NEUROSCI METH, V166, P104, DOI 10.1016/j.jneumeth.2007.06.030; Kimiskidis VK, 2014, CURR OPIN NEUROL, V27, P236, DOI 10.1097/WCO.0000000000000071; Koch G, 2009, NEUROLOGY, V73, P113, DOI 10.1212/WNL.0b013e3181ad5387; Koch G, 2014, BRAIN STIMUL, V7, P564, DOI 10.1016/j.brs.2014.05.002; Koch G, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00180; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Middleton FA, 1997, INT REV NEUROBIOL, V41, P61, DOI 10.1016/S0074-7742(08)60347-5; Nikulin VV, 2003, EUR J NEUROSCI, V18, P1206, DOI 10.1046/j.1460-9568.2003.02858.x; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; Platz T, 2010, RESTOR NEUROL NEUROS, V28, P387, DOI 10.3233/RNN-2010-0570; Popa T, 2010, BRAIN STIMUL, V3, P161, DOI 10.1016/j.brs.2009.10.001; Premoli I, 2014, NEUROIMAGE, V103, P152, DOI 10.1016/j.neuroimage.2014.09.028; Premoli I, 2014, J NEUROSCI, V34, P5603, DOI 10.1523/JNEUROSCI.5089-13.2014; Quartarone Angelo, 2013, Handb Clin Neurol, V116, P543, DOI 10.1016/B978-0-444-53497-2.00043-7; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Spieser L, 2010, NEUROIMAGE, V52, P316, DOI 10.1016/j.neuroimage.2010.04.020; Theodore WH, 2007, ACTA NEUROCHIR SUPPL, V97, P261; Todd G, 2010, CLIN NEUROPHYSIOL, V121, P441, DOI 10.1016/j.clinph.2009.11.089; UGAWA Y, 1991, J PHYSIOL-LONDON, V441, P57, DOI 10.1113/jphysiol.1991.sp018738; Williams JA, 2009, J REHABIL MED, V41, P305, DOI 10.2340/16501977-0356; Wu SW, 2012, J NEUROSCI METH, V208, P161, DOI 10.1016/j.jneumeth.2012.05.014	50	34	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141284	10.1371/journal.pone.0141284	http://dx.doi.org/10.1371/journal.pone.0141284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529225	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600020
J	Jiang, W; Zhuang, Y; Wang, SZ; Fang, BS				Jiang, Wei; Zhuang, Yuan; Wang, Shizhen; Fang, Baishan			Directed Evolution and Resolution Mechanism of 1, 3-Propanediol Oxidoreductase from Klebsiella pneumoniae toward Higher Activity by Error-Prone PCR and Bioinformatics	PLOS ONE			English	Article							1,3-PROPANEDIOL DEHYDROGENASE; MICROBIAL-PRODUCTION; ESCHERICHIA-COLI; GLYCEROL; EXPRESSION; PURIFICATION; MUTAGENESIS; GENE; CONVERSION; XYLANASE	1, 3-propanediol oxidoreductase (PDOR) is a key enzyme in glycerol bioconversion to 1,3-propanediol (1, 3-PD) which is a valuable chemical and one of the six new petrochemical products. We used error-prone PCR and activity screening to identify mutants of Klebsiella pneumoniae (K. pneumoniae) PDOR with improved activity. The activity of one of the identified mutants, PDOR'-24, which includes a single mutation, A199S, was 48 U/mg, 4.9 times that of the wild-type enzyme. Molecular docking was performed to analyze the identified mutants; and amino acids S103, H271, N366, D106, N262 and D364 were predicted to bond with NADH. The origins of the improved activity of PDOR'-24, as well as three other mutants were analyzed by simulating the interaction mechanism of the mutants with the substrate and coenzyme, respectively. This research provides useful information about the use of safranine O plate screening for the directed evolution of oxidoreductases, identifies interesting sites for improving PDOR activity, and demonstrates the utility of using molecular docking to analyze the interaction mechanism of the mutants with the substrate and coenzyme, respectively.	[Jiang, Wei; Wang, Shizhen; Fang, Baishan] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen 361005, Fujian, Peoples R China; [Jiang, Wei; Wang, Shizhen; Fang, Baishan] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen 361005, Fujian, Peoples R China; [Zhuang, Yuan] Hua Qiao Univ, Key Lab Ind Biotechnol Fujian Higher Educ, Xiamen, Fujian, Peoples R China; [Fang, Baishan] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University; Huaqiao University; Xiamen University	Fang, BS (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen 361005, Fujian, Peoples R China.	fbs@xmu.edu.cn			National Natural Science Foundation of China [41176111, 41306124]; State Key Program of National Natural Science Foundation of China [21336009]; Fundamental Research Funds for the Central Universities [2013121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 41176111, No. 41306124), the State Key Program of National Natural Science Foundation of China (No. 21336009), and the Fundamental Research Funds for the Central Universities (No. 2013121029).	Ahrens K, 1998, BIOTECHNOL BIOENG, V59, P544, DOI 10.1002/(SICI)1097-0290(19980905)59:5<544::AID-BIT3>3.0.CO;2-A; Allen K. D., 1998, US, DOI 10.1097/00001503-199804000-00005, Patent No. [US 5 777 182, 5777182]; Barbirato F, 1997, ARCH MICROBIOL, V168, P160, DOI 10.1007/s002030050482; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Cao Y, 2006, J CHEM TECHNOL BIOT, V81, P109, DOI 10.1002/jctb.1360; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; Chen KQ, 1991, NAT BIOTECHNOL, V9, P1073; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Hongwen C., 2005, BIOCH ENG J, V25, P47, DOI DOI 10.1016/j.bej.2005.03.011; Johannes TW, 2006, CURR OPIN MICROBIOL, V9, P261, DOI 10.1016/j.mib.2006.03.003; JOHNSON EA, 1987, J BACTERIOL, V169, P2050, DOI 10.1128/jb.169.5.2050-2054.1987; Leisola M, 2007, APPL MICROBIOL BIOT, V75, P1225, DOI 10.1007/s00253-007-0964-2; Li Wei, 2011, Electron. J. Biotechnol., V14, P7; Lin L, 2009, APPL MICROBIOL BIOT, V82, P671, DOI 10.1007/s00253-008-1789-3; Luers F, 1997, FEMS MICROBIOL LETT, V154, P337, DOI 10.1016/S0378-1097(97)00351-0; Malaoui H, 2000, ENZYME MICROB TECH, V27, P399, DOI 10.1016/S0141-0229(00)00219-2; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stephens DE, 2009, FEMS MICROBIOL LETT, V293, P42, DOI 10.1111/j.1574-6968.2009.01519.x; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P1195, DOI 10.1128/AEM.56.4.1195-1197.1990; van Loo B, 2004, CHEM BIOL, V11, P981, DOI 10.1016/j.chembiol.2004.04.019; VEIGADACUNHA M, 1992, APPL ENVIRON MICROB, V58, P2005, DOI 10.1128/AEM.58.6.2005-2010.1992; WITT U, 1994, MACROMOL CHEM PHYSIC, V195, P793, DOI 10.1002/macp.1994.021950235; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Zhang ZG, 2010, BIORESOURCE TECHNOL, V101, P9272, DOI 10.1016/j.biortech.2010.07.060; Zhao L, 2009, J CHEM TECHNOL BIOT, V84, P626, DOI 10.1002/jctb.2092; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0; [No title captured], DOI DOI 10.1038/NBT0795-658	29	2	2	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141837	10.1371/journal.pone.0141837	http://dx.doi.org/10.1371/journal.pone.0141837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528716	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600066
J	Miller, JRC; Trager, U; Andre, R; Tabrizi, SJ				Miller, James R. C.; Traeger, Ulrike; Andre, Ralph; Tabrizi, Sarah J.			Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; PROLIFERATION; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; ONSET	Huntington's disease is a fatal neurodegenerative condition caused by a CAG repeat expansion in the huntingtin gene. The peripheral innate immune system is dysregulated in Huntington's disease and may contribute to its pathogenesis. However, it is not clear whether or to what extent the adaptive immune system is also involved. Here, we carry out the first comprehensive investigation of human ex vivo T lymphocytes in Huntington's disease, focusing on the frequency of a range of T lymphocyte subsets, as well as analysis of proliferation, cytokine production and gene transcription. In contrast to the innate immune system, the intrinsic phenotype of T lymphocytes does not appear to be affected by the presence of mutant huntingtin, with Huntington's disease T lymphocytes exhibiting no significant functional differences compared to control cells. The transcriptional profile of T lymphocytes also does not appear to be significantly affected, suggesting that peripheral immune dysfunction in Huntington's disease is likely to be mediated primarily by the innate rather than the adaptive immune system. This study increases our understanding of the effects of Huntington's disease on peripheral tissues, while further demonstrating the differential effects of the mutant protein on different but related cell types. Finally, this study suggests that the potential use of novel therapeutics aimed at modulating the Huntington's disease innate immune system should not be extended to include the adaptive immune system.	[Miller, James R. C.; Traeger, Ulrike; Andre, Ralph; Tabrizi, Sarah J.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England	University of London; University College London	Tabrizi, SJ (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	s.tabrizi@ucl.ac.uk		Tabrizi, Sarah/0000-0003-2716-2045; Trager, Ulrike/0000-0002-4493-1136; Miller, James/0000-0003-2067-4136	CHDI Foundation [A-9412]; Rosetrees Trust [JS16/M220]; Medical Research Council [MR/L02053X/1]; National Institute for Health Research University College London Hospitals Biomedical Research Centre [BRC54/NS/RA, BRC230/NS/RA/101410]; Medical Research Council [1354752, MR/J003832/1, G0700877] Funding Source: researchfish; Rosetrees Trust [M220] Funding Source: researchfish; MRC [MR/L02053X/1, MR/J003832/1, G0700877] Funding Source: UKRI	CHDI Foundation; Rosetrees Trust(Rosetrees Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported financially by the following: CHDI Foundation (SJT), Grant number: A-9412, http://chdifoundation.org/; Rosetrees Trust (JRCM), Grant number: JS16/M220, http://www.rosetreestrust.co.uk/; Medical Research Council (JRCM, RA, SJT), Grant number: MR/L02053X/1, http://www.mrc.ac.uk/; and National Institute for Health Research University College London Hospitals Biomedical Research Centre (SJT, UT, RA), Grant numbers: BRC54/NS/RA, BRC230/NS/RA/101410, http://www.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS CURR; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Shanker A, 2010, IMMUNOL LETT, V131, P107, DOI 10.1016/j.imlet.2010.04.002; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trager U, 2013, PLOS CURR, V5; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141793	10.1371/journal.pone.0141793	http://dx.doi.org/10.1371/journal.pone.0141793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529236	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600060
J	Amer, S; Abd El Wahab, T; Metwaly, A; Feng, YY; Xiao, LH				Amer, Said; Abd El Wahab, Taher; Metwaly, Abd El Naby; Feng, Yaoyu; Xiao, Lihua			Morphologic and Genotypic Characterization of Psoroptes Mites from Water Buffaloes in Egypt	PLOS ONE			English	Article							MANGE MITES; SHEEP SCAB; OVIS INFESTATION; BUBALUS-BUBALIS; GREAT-BRITAIN; RESPONSES; CUNICULI; RABBITS; ACARI; POPULATIONS	Species delimitation of Psoroptes spp. and identity of the parasite in water buffaloes remain poorly defined. In this study, Psoroptes infestation on three water buffalo farms in Egypt was examined based on morphometric characteristics, especially the opisthosomal setae of adult male mites. Clinical investigations showed that 28% (196/700) of the sampled animals had mange infestation. Microscopic examinations of 80 skin scrapings indicated the occurrence of Psoroptes mites in 17 (21.3%) samples, Sarcoptes mites in 27 (33.7%) samples, and the concurrence of both in 36 (45.0%) samples. Morphologically, the Psoroptes parasite was identified as Psoroptes natalensis. DNA sequence analysis of the second internal transcribed spacer (ITS2) in 11 representative samples confirmed the diagnosis and suggested the presence of a distinct variety of Psoroptes natalensis in Egypt.	[Amer, Said; Xiao, Lihua] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Amer, Said] Kafr El sheikh Univ, Fac Sci, Dept Zool, Kafr Al Sheikh, Egypt; [Abd El Wahab, Taher; Metwaly, Abd El Naby] Anim Hlth Res Inst, Kafr El Sheikh Provis Lab, Kafr Al Sheikh, Egypt; [Feng, Yaoyu] E China Univ Sci & Technol, Sch Resources & Environm Engn, State Environm Protect Key Lab Environm Risk Asse, Shanghai 200237, Peoples R China	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Animal Health Research Institute (AHRI); East China University of Science & Technology	Feng, YY (corresponding author), E China Univ Sci & Technol, Sch Resources & Environm Engn, State Environm Protect Key Lab Environm Risk Asse, Shanghai 200237, Peoples R China.	yyfeng@ecust.edu.cn; lxiao@cdc.gov	Feng, Yaoyu/B-3076-2014; Xiao, Lihua/B-1704-2013; Feng, Yaoyu/S-1979-2019	Feng, Yaoyu/0000-0002-8380-1246; Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246	Arab Fund for Economic & Social Development "Zamalat Program"; National Natural Science Foundation of China [31110103901]	Arab Fund for Economic & Social Development "Zamalat Program"(Arab Fund for Economic and Social Development); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Arab Fund for Economic & Social Development "Zamalat Program" and the National Natural Science Foundation of China (Project No. 31110103901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094705; [Anonymous], 1934, BUFFALOES IN EGYPT, P6; Bates PG, 1999, VET PARASITOL, V83, P201, DOI 10.1016/S0304-4017(99)00058-8; Bisdorff B, 2006, VET REC, V158, P749, DOI 10.1136/vr.158.22.749; Bisdorff B, 2008, VET PARASITOL, V155, P120, DOI 10.1016/j.vetpar.2008.04.002; Bochkov A. V., 2010, Acarina, V18, P99; Bochkov AV, 2014, PARASITOL RES, V113, P2603, DOI 10.1007/s00436-014-3914-9; Boyce WM, 2005, J WILDLIFE DIS, V41, P525, DOI 10.7589/0090-3558-41.3.525; Corke MJ, 1999, VET PARASITOL, V83, P291, DOI 10.1016/S0304-4017(99)00065-5; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; El-Khodery SA, 2010, TROP ANIM HEALTH PRO, V42, P275, DOI 10.1007/s11250-009-9417-5; El-Khodery SA, 2009, TROP ANIM HEALTH PRO, V41, P1505, DOI 10.1007/s11250-009-9340-9; Fukunaga M, 2000, J PARASITOL, V86, P38, DOI 10.1645/0022-3395(2000)086[0038:MPAOIT]2.0.CO;2; GRIFFITHS DA, 1990, J ZOOL, V220, P1, DOI 10.1111/j.1469-7998.1990.tb04291.x; Hallal-Calleros C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-361; Ismail A. A., 1976, Assiut Veterinary Medical Journal, V3, P199; Jones A, 2014, VET REC, V174, P509, DOI 10.1136/vr.g3292; Kazmi Syed Asad Irshad, 2009, J Parasit Dis, V33, P54, DOI 10.1007/s12639-009-0009-0; Kotb S, 2011, ASSUIT U B ENV RES, V14, P9; Liebisch A, 1980, VET MED NACHR, V1, P3; Losson BJ, 2012, VET PARASITOL, V189, P39, DOI 10.1016/j.vetpar.2012.03.030; Mathieson BRF, 1996, VET REC, V138, P210, DOI 10.1136/vr.138.9.210; MCLAIN DK, 1995, J MED ENTOMOL, V32, P353, DOI 10.1093/jmedent/32.3.353; Mitchell ES, 2012, VET REC, V170, DOI 10.1136/vr.100565; Ochs H, 1999, PARASITOLOGY, V119, P419, DOI 10.1017/S003118209900476X; Osman SA, 2006, VET PARASITOL, V141, P191, DOI 10.1016/j.vetpar.2006.04.039; Panyarachun B, 2010, EXP PARASITOL, V125, P95, DOI 10.1016/j.exppara.2009.12.020; Pegler KR, 2005, MED VET ENTOMOL, V19, P392, DOI 10.1111/j.1365-2915.2005.00586.x; RAFFERTY DE, 1987, J PARASITOL, V73, P901, DOI 10.2307/3282508; Ramey RR, 2000, J MED ENTOMOL, V37, P791, DOI 10.1603/0022-2585-37.6.791; Ramprabhu Rajah Arunachalam, 2001, Veterinarski Arhiv, V71, P53; Randhawa CS, 1997, TROP ANIM HEALTH PRO, V29, P253, DOI 10.1007/BF02632318; Rose H, 2009, VET PARASITOL, V165, P112, DOI 10.1016/j.vetpar.2009.06.037; Sanders A, 2000, MED VET ENTOMOL, V14, P131, DOI 10.1046/j.1365-2915.2000.00223.x; Shang XF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-124; Shastri U. V., 1974, Indian Veterinary Journal, V51, P274; STROMBERG PC, 1986, AM J VET RES, V47, P1326; SWEATMAN GORDON K., 1958, CANADIAN JOUR ZOOL, V36, P905, DOI 10.1139/z58-078; van den Broek AH, 2003, J COMP PATHOL, V128, P79, DOI 10.1053/jcpa.2002.0627; Wall R, 2006, EXP APPL ACAROL, V39, P159, DOI 10.1007/s10493-006-9000-y; Wang S, 2012, VET PARASITOL, V184, P392, DOI 10.1016/j.vetpar.2011.09.011; Wells B, 2012, MOL CELL PROBE, V26, P47, DOI 10.1016/j.mcp.2011.07.002; WRIGHT FC, 1983, J PARASITOL, V69, P696, DOI 10.2307/3281144; Yassin Mohammad K., 2011, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V41, P55; Zahler M, 2000, EXP APPL ACAROL, V24, P213, DOI 10.1023/A:1006443722815; Zahler M, 1998, INT J PARASITOL, V28, P1713, DOI 10.1016/S0020-7519(98)00145-3; Zayed A, 1985, THESIS CAIRO U EGYPT	47	4	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141554	10.1371/journal.pone.0141554	http://dx.doi.org/10.1371/journal.pone.0141554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517834	gold, Green Published			2022-12-27	WOS:000363920800053
J	Choe, AS; Jones, CK; Joel, SE; Muschelli, J; Belegu, V; Caffo, BS; Lindquist, MA; van Zijl, PCM; Pekar, JJ				Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; Muschelli, John; Belegu, Visar; Caffo, Brian S.; Lindquist, Martin A.; van Zijl, Peter C. M.; Pekar, James J.			Reproducibility and Temporal Structure in Weekly Resting-State fMRI over a Period of 3.5 Years	PLOS ONE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; SPINAL-CORD-INJURY; RESONANCE-IMAGING DATA; FUNCTIONAL MRI DATA; ALZHEIMERS-DISEASE; HUMAN BRAIN; PARKINSONS-DISEASE; RETEST RELIABILITY	Resting-state functional MRI (rs-fMRI) permits study of the brain's functional networks without requiring participants to perform tasks. Robust changes in such resting state networks (RSNs) have been observed in neurologic disorders, and rs-fMRI outcome measures are candidate biomarkers for monitoring clinical trials, including trials of extended therapeutic interventions for rehabilitation of patients with chronic conditions. In this study, we aim to present a unique longitudinal dataset reporting on a healthy adult subject scanned weekly over 3.5 years and identify rs-fMRI outcome measures appropriate for clinical trials. Accordingly, we assessed the reproducibility, and characterized the temporal structure of, rs-fMRI outcome measures derived using independent component analysis (ICA). Data was compared to a 21-person dataset acquired on the same scanner in order to confirm that the values of the single-subject RSN measures were within the expected range as assessed from the multi-participant dataset. Fourteen RSNs were identified, and the inter-session reproducibility of outcome measures-network spatial map, temporal signal fluctuation magnitude, and between-network connectivity (BNC)-was high, with executive RSNs showing the highest reproducibility. Analysis of the weekly outcome measures also showed that many rs-fMRI outcome measures had a significant linear trend, annual periodicity, and persistence. Such temporal structure was most prominent in spatial map similarity, and least prominent in BNC. High reproducibility supports the candidacy of rs-fMRI outcome measures as biomarkers, but the presence of significant temporal structure needs to be taken into account when such outcome measures are considered as biomarkers for rehabilitation-style therapeutic interventions in chronic conditions.	[Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; van Zijl, Peter C. M.; Pekar, James J.] Johns Hopkins Univ Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; van Zijl, Peter C. M.; Pekar, James J.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA; [Choe, Ann S.; Belegu, Visar] Kennedy Krieger Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA; [Caffo, Brian S.; Lindquist, Martin A.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Belegu, Visar] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Kennedy Krieger Institute; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Choe, AS (corresponding author), Johns Hopkins Univ Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	annschoe@gmail.com	Van Zijl, Peter C/ABF-3732-2020; AS, Choe/I-2637-2019	AS, Choe/0000-0001-7352-1489; Belegu, Visar/0000-0002-1361-4517; Jones, Craig/0000-0002-0629-3006; Pekar, James/0000-0002-9830-0655	National Institute of Health [P41 EB015909, RO1 EB012547]; U.S. Department of Defense [W81XWH-08-1-0192]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016061, R01EB012547, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, T32AG000247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by grant support from the National Institute of Health (www.nih.gov; P41 EB015909 (PvZ), RO1 EB012547 (BC)) and U.S. Department of Defense (www.defense.gov; W81XWH-08-1-0192 (VB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amann M, 2009, MAGN RESON IMAGING, V27, P1347, DOI 10.1016/j.mri.2009.05.016; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Anderson JAE, 2014, PSYCHOL AGING, V29, P648, DOI 10.1037/a0037243; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blautzik J, 2014, CHRONOBIOL INT, P1; Blautzik J, 2013, NEUROIMAGE, V71, P298, DOI 10.1016/j.neuroimage.2012.08.010; Broersen PMT, 2006, DIGIT SIGNAL PROCESS, V16, P754, DOI 10.1016/j.dsp.2006.01.001; Broersen PMT, 2004, AUTOMATICA, V40, P1495, DOI 10.1016/j.automatica.2004.04.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Choe AS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00290; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Damiano DL, 2006, PHYS THER, V86, P1534, DOI 10.2522/ptj.20050397; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Egolf AE., 2004, NEUROIMAGE, V22, P14; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Geerligs L, 2014, CEREB CORTEX; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hjelmervik H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103492; Hodkinson DJ, 2014, J CEREBR BLOOD F MET, V34, P1493, DOI 10.1038/jcbfm.2014.109; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Jones CK, 2014, 22 SCI M EXH INT SOC, P1775; Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kent BA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00234; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Krmpotich TD, 2013, DRUG ALCOHOL DEPEN, V129, P1, DOI 10.1016/j.drugalcdep.2013.01.021; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Lorenz DJ, 2012, ARCH PHYS MED REHAB, V93, P1541, DOI 10.1016/j.apmr.2012.01.027; Martin JH, 2011, DEV MED CHILD NEUROL, V53, P9, DOI 10.1111/j.1469-8749.2011.04055.x; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Merrow M, 2005, EMBO REP, V6, P930, DOI 10.1038/sj.embor.7400541; Miller MI, 2005, P NATL ACAD SCI USA, V102, P9685, DOI 10.1073/pnas.0503892102; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Paredes SD, 2009, J GERONTOL A-BIOL, V64, P340, DOI 10.1093/gerona/gln054; Pesonen AK, 2013, NEUROBIOL AGING, V34, P1674, DOI 10.1016/j.neurobiolaging.2012.12.012; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Sandler RA, 2014, J COMPUT NEUROSCI; Sato JR, 2014, J PSYCHIATR RES, V58, P89, DOI 10.1016/j.jpsychires.2014.07.004; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segall JM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00010; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Stanculescu I, 2014, IEEE J BIOMED HEALTH, V18, P1560, DOI 10.1109/JBHI.2013.2294692; STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Weiland B. J., 2014, HUM BRAIN MAPP; Wisner KM, 2013, NEUROIMAGE, V76, P236, DOI 10.1016/j.neuroimage.2013.02.066; Yamada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027493; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	89	71	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140134	10.1371/journal.pone.0140134	http://dx.doi.org/10.1371/journal.pone.0140134			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517540	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800003
J	Iqbal, S; Hoque, MT				Iqbal, Sumaiya; Hoque, Md Tamjidul			DisPredict: A Predictor of Disordered Protein Using Optimized RBF Kernel	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEINS; SEQUENCE-BASED PREDICTION; BACKBONE TORSION ANGLES; ACCESSIBLE SURFACE-AREA; INTRINSIC DISORDER; UNSTRUCTURED REGIONS; ACCURATE PREDICTION; SERVER; RECOGNITION; DATABASE	Intrinsically disordered proteins or, regions perform important biological functions through their dynamic conformations during binding. Thus accurate identification of these disordered regions have significant implications in proper annotation of function, induced fold prediction and drug design to combat critical diseases. We introduce DisPredict, a disorder predictor that employs a single support vector machine with RBF kernel and novel features for reliable characterization of protein structure. DisPredict yields effective performance. In addition to 10-fold cross validation, training and testing of DisPredict was conducted with independent test datasets. The results were consistent with both the training and test error minimal. The use of multiple data sources, makes the predictor generic. The datasets used in developing the model include disordered regions of various length which are categorized as short and long having different compositions, different types of disorder, ranging from fully to partially disordered regions as well as completely ordered regions. Through comparison with other state of the art approaches and case studies, DisPredict is found to be a useful tool with competitive performance.	[Iqbal, Sumaiya; Hoque, Md Tamjidul] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Hoque, MT (corresponding author), Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA.	thoque@uno.edu		Iqbal, Sumaiya/0000-0001-7700-4374	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF [(2013-16)-RD-A-19]	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF	SI and MTH gratefully acknowledge the Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF (2013-16)-RD-A-19.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baens M, 1996, GENOME RES, V6, P404, DOI 10.1101/gr.6.5.404; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Di Domenico T, 2012, BIOINFORMATICS, V28, P2080, DOI 10.1093/bioinformatics/bts327; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Fukuchi S, 2014, NUCLEIC ACIDS RES, V42, pD320, DOI 10.1093/nar/gkt1010; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Iqbal S, 2014, TECH REPORT, P1; Iqbal S, 2015, J THEOR BIOL, V380, P380, DOI 10.1016/j.jtbi.2015.06.012; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Kulkarni P, 2011, J CELL BIOCHEM, V112, P1949, DOI 10.1002/jcb.23115; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; McCoy M, 1997, EMBO J, V16, P6230, DOI 10.1093/emboj/16.20.6230; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Mizianty Marcin J, 2013, Intrinsically Disord Proteins, V1, pe24428, DOI 10.4161/idp.24428; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radivojac P, 2004, PROTEIN SCI, V13, P71, DOI 10.1110/ps.03128904; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089890; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Su CT, 2007, NUCLEIC ACIDS RES, V35, pW465, DOI 10.1093/nar/gkm353; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097982; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vendruscolo M, 2000, LETTERS TO NATURE, V409, P641, DOI [10.1038/35054591, DOI 10.1038/35054591]; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whitford PC, 2013, P NATL ACAD SCI USA, V110, P7114, DOI 10.1073/pnas.1305236110; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2012, J BIOMOL STRUCT DYN, V29, P843, DOI 10.1080/073911012010525024; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang JY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S8; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2010, PROTEINS, V78, P3353, DOI 10.1002/prot.22842	82	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141551	10.1371/journal.pone.0141551	http://dx.doi.org/10.1371/journal.pone.0141551			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517719	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800052
J	Wu, PY; Yang, SH; Wong, TC; Chen, TW; Chen, HH; Chen, TH; Chen, YT				Wu, Pei-Yu; Yang, Shwu-Huey; Wong, Te-Chih; Chen, Tzen-Wen; Chen, His-Hsien; Chen, Tso-Hsiao; Chen, Yu-Tong			Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; ARTERY CALCIFICATION; DIETARY ASSESSMENT; SODIUM-INTAKE; ENERGY-INTAKE; ALL-CAUSE; MORTALITY	In this cross-sectional study, we hypothesized that hemodialysis patients consuming greater processed meat is associated with hypertension risk, which can be partly explained by the high sodium content in processed meat. From September 2013 to May 2014, one hundred and four patients requiring chronic hemodialysis treatment were recruited from hemodialysis centers. Data on systolic blood pressure and diastolic blood pressure before receiving dialysis, and 3-day dietary records of the recruited patients were collected. HD patients with systolic and diastolic blood pressures greater than 140 mmHg and higher than 90 mmHg, respectively, were considered hypertension risk. Protein foods were divided into 4 categories: red meat, white meat, soybeans, and processed meat (e.g., sausage and ham). In a model adjusted for energy intake and hypertension history, additional servings of processed meats was positively associated to systolic blood pressure >140 mmHg (odds ratio [95% confidence interval]: 2.1 [1.0-4.3]), and diastolic blood pressure > 90 mmHg (odds ratio: 2.5 [1.2-5.5]). After adjustment for dietary sodium contents or body mass index (BMI), most associations were substantially attenuated and were no longer significant. In systolic blood pressure greater than140 mmHg, one serving per day of red meats (beta = -1.22, P < .05) and white meats (beta = -0. 75, P = .05) was associated with a reduced risk compared with one serving per day of processed meats. Similarly, compared with one serving per day of processed meat, a reduced risk of diastolic blood pressure higher than 90 mmHg was associated with one serving per day of red meat (beta = -1. 59, P < .05), white meat (beta = -0. 62, P < .05). Thus, in these hemodialysis patients, intake of processed meat is significantly positively associated with higher blood pressure risk, and both sodium contents in processed meat and BMI significantly contributes to this association.	[Wu, Pei-Yu; Yang, Shwu-Huey; Wong, Te-Chih; Chen, Yu-Tong] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Chen, Tzen-Wen; Chen, His-Hsien] Taipei Med Univ Hosp, Dept Nephrol, Taipei, Taiwan; [Chen, Tso-Hsiao] Wan Fang Med Ctr, Dept Nephrol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Municipal WanFang Hospital	Yang, SH (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	sherry@tmu.edu.tw	Wong, Te-Chih/AAH-7667-2020	Wong, Te-Chih/0000-0002-5798-1060	Ministry of Science and Technology (Taiwan);  [NSC-102-2320-B-038-026]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); 	This study was funded by Ministry of Science and Technology (Taiwan), and the website is http://www.most.gov.tw/mp.aspx. The grant number is: NSC-102-2320-B-038-026. PYW, SHY, TCW, and YTC have received the funding.	Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; [Anonymous], 2014, USRDS 2014 ANN DAT R; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Bross R, 2010, SEMIN DIALYSIS, V23, P359, DOI 10.1111/j.1525-139X.2010.00743.x; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Caro P, 2010, DIALYSIS TRANSPLANT, V39, P27, DOI 10.1002/dat.20399; Chang TY, 2007, CURR MED RES OPIN, V23, P1879, DOI 10.1185/030079907X218077; Chazot C, 2007, NEPHROL THER, V3, pS137, DOI 10.1016/S1769-7255(07)80022-8; Chen HS, 2014, HEMODIAL INT, V18, P799, DOI 10.1111/hdi.12165; Chen KH, 2008, KIDNEY BLOOD PRESS R, V31, P143, DOI 10.1159/000127388; Chiu YF, 2014, J RENAL NUTR, V24, P163, DOI 10.1053/j.jrn.2013.12.006; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Fogarty AW, 2009, AM J CLIN NUTR, V89, P1901, DOI 10.3945/ajcn.2008.27006; Gallardo JM, 2007, ARCH MED RES, V38, P34, DOI 10.1016/j.arcmed.2006.08.010; Grossman C, 2013, AM J HYPERTENS, V26, P13, DOI 10.1093/ajh/hps028; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Hecking M, 2014, AM J HYPERTENS, V27, P1160, DOI 10.1093/ajh/hpu040; Heidari B, 2013, CASP J INTERN MED, V4, P611; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Ikizler TA, 1996, KIDNEY INT, V50, P343, DOI 10.1038/ki.1996.323; Kalantar-Zadeh K, 2010, CLIN J AM SOC NEPHRO, V5, P519, DOI 10.2215/CJN.06080809; Kaluza J, 2014, CIRC-HEART FAIL, V7, P552, DOI 10.1161/CIRCHEARTFAILURE.113.000921; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P347; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Lajous M, 2014, AM J CLIN NUTR, V100, P948, DOI 10.3945/ajcn.113.080598; Larsson SC, 2011, STROKE, V42, P324, DOI 10.1161/STROKEAHA.110.596510; Levin NW, 2010, KIDNEY INT, V77, P273, DOI 10.1038/ki.2009.469; Ley SH, 2014, AM J CLIN NUTR, V99, P352, DOI 10.3945/ajcn.113.075663; Lin HS, 2014, KAOHSIUNG J MED SCI, V30, P206, DOI 10.1016/j.kjms.2013.12.002; Luhrmann PM, 1999, EUR J NUTR, V38, P235, DOI 10.1007/s003940050066; Mafra D, 2012, J RENAL NUTR, V22, P578, DOI 10.1053/j.jrn.2011.10.037; Malluche HH, 2015, J AM SOC NEPHROL; Martinez-Maldonado M, 1998, KIDNEY INT, V54, pS67, DOI 10.1046/j.1523-1755.1998.06816.x; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Moriya H, 2008, CLIN J AM SOC NEPHRO, V3, P416, DOI 10.2215/CJN.03490807; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Noori N, 2011, AM J NEPHROL, V33, P157, DOI 10.1159/000323972; Ortega RM, 2015, NUTR HOSP, V31, P38, DOI 10.3305/nh.2015.31.sup3.8749; Potter SM, 1998, NUTR REV, V56, P231, DOI 10.1111/j.1753-4887.1998.tb01754.x; Ravel VA, 2013, J NUTR, V143, P1084, DOI 10.3945/jn.112.169722; Renal Data System U.S, 2014, AM J KIDNEY DIS, V63, pe215; Ribeiro S, 1998, NEPHROL DIAL TRANSPL, V13, P2037, DOI 10.1093/ndt/13.8.2037; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rouhani MH, 2014, OBES REV, V15, P740, DOI 10.1111/obr.12172; Ruusunen M, 2005, MEAT SCI, V70, P531, DOI 10.1016/j.meatsci.2004.07.016; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Shapiro BB, 2015, J RENAL NUTR, V25, P357, DOI 10.1053/j.jrn.2014.12.004; Shinaberger CS, 2006, AM J KIDNEY DIS, V48, P37, DOI 10.1053/j.ajkd.2006.03.049; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Takeda A, 2005, AM J KIDNEY DIS, V45, P112, DOI 10.1053/j.ajkd.2004.08.045; TERMAN DS, 1971, AM J MED, V50, P744, DOI 10.1016/0002-9343(71)90182-3; Therrien M, 2014, J RENAL NUTR, V24, P72, DOI 10.1053/j.jrn.2013.09.005; THOMPSON GR, 1994, LANCET, V343, P670, DOI 10.1016/S0140-6736(94)92664-6; Uribarri J, 2009, CLIN J AM SOC NEPHRO, V4, P1290, DOI 10.2215/CJN.03950609; Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45; Wanner C, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_8.29; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104; Wu PY, 2014, NEPHROLOGY, V19, P98; Wu SJ, 2011, ASIA PAC J CLIN NUTR, V20, P251; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	70	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141917	10.1371/journal.pone.0141917	http://dx.doi.org/10.1371/journal.pone.0141917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517837	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800093
J	Pless, E; Queirolo, J; Pinter-Wollman, N; Crow, S; Allen, K; Mathur, MB; Gordon, DM				Pless, Evlyn; Queirolo, Jovel; Pinter-Wollman, Noa; Crow, Sam; Allen, Kelsey; Mathur, Maya B.; Gordon, Deborah M.			Interactions Increase Forager Availability and Activity in Harvester Ants	PLOS ONE			English	Article							DIVISION-OF-LABOR; COLLECTIVE REGULATION; ORGANIZATION; HYMENOPTERA; INFORMATION; ACTIVATION; DECISIONS; NETWORKS; MASS	Social insect colonies use interactions among workers to regulate collective behavior. Harvester ant foragers interact in a chamber just inside the nest entrance, here called the 'entrance chamber'. Previous studies of the activation of foragers in red harvester ants show that an outgoing forager inside the nest experiences an increase in brief antennal contacts before it leaves the nest to forage. Here we compare the interaction rate experienced by foragers that left the nest and ants that did not. We found that ants in the entrance chamber that leave the nest to forage experienced more interactions than ants that descend to the deeper nest without foraging. Additionally, we found that the availability of foragers in the entrance chamber is associated with the rate of forager return. An increase in the rate of forager return leads to an increase in the rate at which ants descend to the deeper nest, which then stimulates more ants to ascend into the entrance chamber. Thus a higher rate of forager return leads to more available foragers in the entrance chamber. The highest density of interactions occurs near the nest entrance and the entrances of the tunnels from the entrance chamber to the deeper nest. Local interactions with returning foragers regulate both the activation of waiting foragers and the number of foragers available to be activated.	[Pless, Evlyn; Queirolo, Jovel; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pinter-Wollman, Noa] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Crow, Sam] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Allen, Kelsey] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mathur, Maya B.] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Stanford University	Pless, E (corresponding author), Yale Univ, Dept Ecol & Evolut, New Haven, CT 06520 USA.	evlyn.pless@yale.edu			Stanford UAR Student Small Grant; Stanford UAR Student Major Grant; National Institutes of Health [R01GM105024]	Stanford UAR Student Small Grant; Stanford UAR Student Major Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Field work for EP in 2012 was funded by a Stanford UAR Student Small Grant, and field work for JQ in 2013 was funded by a Stanford UAR Student Major Grant (https://undergrad.stanford.edu/opportunities/research/get-funded/apply-studentgrants/grant-types). Other expenses were funded by the grant DMG received from the National Institutes of Health (grant number R01GM105024, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1992, AM NAT, V140, P373, DOI 10.1086/285418; Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Biesmeijer JC, 1998, BEHAV ECOL SOCIOBIOL, V42, P107, DOI 10.1007/s002650050418; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Burd M, 2010, ECOL ENTOMOL, V35, P464, DOI 10.1111/j.1365-2311.2010.01202.x; Camazine S, 1999, INSECT SOC, V46, P348, DOI 10.1007/s000400050156; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; Czaczkes TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1009; Dussutour A, 2007, INSECT SOC, V54, P158, DOI 10.1007/s00040-007-0926-9; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Farji-Brener AG, 2010, ANIM BEHAV, V79, P343, DOI 10.1016/j.anbehav.2009.11.009; Fernandez PC, 2003, BEHAV ECOL SOCIOBIOL, V54, P80, DOI 10.1007/s00265-003-0607-2; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; GORDON DM, 1986, ANIM BEHAV, V34, P1402, DOI 10.1016/S0003-3472(86)80211-1; GORDON DM, 1995, ANIM BEHAV, V50, P995, DOI 10.1016/0003-3472(95)80100-6; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; GORDON DM, 1988, BEHAVIOUR, V104, P162, DOI 10.1163/156853988X00656; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; Gordon DM., 2010, ANT ENCOUNTERS; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Kietzman PM, 2015, FRONT ECOL EVOL, V3, P1, DOI DOI 10.3389/FEV0.2015.00014/ABSTRACT; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Mailleux AC, 2010, ANIM BEHAV, V79, P31, DOI 10.1016/j.anbehav.2009.09.027; Navlakha S, 2015, COMMUN ACM, V58, P94, DOI 10.1145/2678280; O'Donnell S, 2001, BEHAV ECOL, V12, P353, DOI 10.1093/beheco/12.3.353; Pinter-Wollman N, 2015, BIOL LETT IN PRESS; Pinter-Wollman N, 2013, ANIM BEHAV, V86, P197, DOI 10.1016/j.anbehav.2013.05.012; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; R Core Team, 2021, R LANGUAGE ENV STAT; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; Sonnentag PJ, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1101; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	46	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141971	10.1371/journal.pone.0141971	http://dx.doi.org/10.1371/journal.pone.0141971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539724	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800039
J	Zhang, TY; Ji, S; Bozovic, D				Zhang, Tracy-Ying; Ji, Seung; Bozovic, Dolores			Synchronization of Spontaneous Active Motility of Hair Cell Bundles	PLoS One			English	Article							SPONTANEOUS OTOACOUSTIC EMISSIONS; OTOLITHIC-MEMBRANE; COCHLEAR AMPLIFIER; MECHANICAL STIMULATION; BULLFROGS SACCULUS; ADAPTATION; AMPLIFICATION; HEARING; MECHANOTRANSDUCTION; SENSITIVITY	Hair cells of the inner ear exhibit an active process, believed to be crucial for achieving the sensitivity of auditory and vestibular detection. One of the manifestations of the active process is the occurrence of spontaneous hair bundle oscillations in vitro. Hair bundles are coupled by overlying membranes in vivo; hence, explaining the potential role of innate bundle motility in the generation of otoacoustic emissions requires an understanding of the effects of coupling on the active bundle dynamics. We used microbeads to connect small groups of hair cell bundles, using in vitro preparations that maintain their innate oscillations. Our experiments demonstrate robust synchronization of spontaneous oscillations, with either 1:1 or multi-mode phase-locking. The frequency of synchronized oscillation was found to be near the mean of the innate frequencies of individual bundles. Coupling also led to an improved regularity of entrained oscillations, demonstrated by an increase in the quality factor.	[Zhang, Tracy-Ying; Bozovic, Dolores] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bozovic, Dolores] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ji, Seung] Los Angeles Mission Coll, Dept Phys Sci, Sylmar, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bozovic, D (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	bozovic@physics.ucla.edu		Ji, Seung Keun/0000-0003-1249-5330	National Science Foundation [CMMI-1131842]	National Science Foundation(National Science Foundation (NSF))	Funding is provided by National Science Foundation (http://www.nsf.gov/), with grant number CMMI-1131842. Author D.B. and T.Z. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0525; Anishchenko V.S., 2007, NONLINEAR DYNAMICS C; Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Ashmore J, 2000, CURR BIOL, V10, pR325, DOI 10.1016/S0960-9822(00)00457-7; Barral J, 2010, P NATL ACAD SCI USA, V107, P10765, DOI 10.1073/pnas.1005833107; Benser ME, 1996, J NEUROSCI, V16, P5629; BENSER ME, 1993, HEARING RES, V68, P243, DOI 10.1016/0378-5955(93)90128-N; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dierkes K, 2008, P NATL ACAD SCI USA, V105, P18669, DOI 10.1073/pnas.0805752105; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; KACHAR B, 1990, HEARING RES, V45, P179, DOI 10.1016/0378-5955(90)90119-A; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Kao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058143; KEMP DT, 1979, SCAND AUDIOL, P35; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14380, DOI 10.1073/pnas.251530598; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Meenderink SWF, 2015, J NEUROSCI IN PRESS; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Smotherman MS, 2000, J EXP BIOL, V203, P2237; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Strimbu CE, 2010, HEARING RES, V265, P38, DOI 10.1016/j.heares.2010.03.001; Strimbu CE, 2009, HEARING RES, V256, P58, DOI 10.1016/j.heares.2009.06.015; Strimbu CE, 2011, MECH HEARING; van der Heijden M, 2014, P NATL ACAD SCI USA, V111, P14548, DOI 10.1073/pnas.1412412111; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Vilfan A, 2008, BIOPHYS J, V95, P4622, DOI 10.1529/biophysj.108.130286; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141764	10.1371/journal.pone.0141764	http://dx.doi.org/10.1371/journal.pone.0141764			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540409	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800027
J	Bora, JK; Saikia, N				Bora, Jayanta Kumar; Saikia, Nandita			Gender Differentials in Self-Rated Health and Self-Reported Disability among Adults in India	PLOS ONE			English	Article							SEX-DIFFERENCES; LIFE EXPECTANCY; PHYSICAL-DISABILITY; CARE UTILIZATION; OLDER-ADULTS; MORTALITY; POPULATION; WOMEN; MEN; DETERMINANTS	Background The extant literature on gender differentials in health in developed countries suggests that women outlive men at all ages, but women report poorer health than men. It is well established that Indian women live longer than men, but few studies have been conducted to understand the gender dimension in self-rated health and self-reported disability. The present study investigates gender differentials in self-rated health (SRH) and self-reported disability (SRD) among adults in India, using a nationally representative data. Methods Using data on 10,736 respondents aged 18 and older in the 2007 WHO Study on Global Ageing and Adult Health in India, prevalence estimates of SRH are calculated separately for men and women by socio-economic and demographic characteristics. The association of SRH with gender is tested using a multinomial logistic regression method. SRD is assessed using 20 activities of daily living (ADL). Further, gender differences in total life expectancy (TLE), disability life expectancy (DLE) and the proportion of life spent with a disability at various adult ages are measured. Results The relative risk of reporting poor health by women was significantly higher than men (relative risk ratio: 1.660; 95% confidence Interval (CI): 1.430-1.927) after adjusting for socioeconomic and demographic characteristics. Women reported higher prevalence of severe and extreme disability than men in 14 measures out of a total20 ADL measures. Women aged less than 60 years reported two times more than men in SRD >= 5 ADLs. Finally, both DLE and proportion of life spent with a disability were substantially higher for women irrespective of their ages. Conclusion Indian women live longer but report poorer health than men. A substantial gender differential is found in self-reported disability. This makes for an urgent call to health researchers and policy makers for gender-sensitive programs.	[Bora, Jayanta Kumar] Publ Hlth Fdn India, Gurgaon, India; [Saikia, Nandita] Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi 110067, India	Public Health Foundation of India; Jawaharlal Nehru University, New Delhi	Saikia, N (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi 110067, India.	nanditasts@gmail.com	Bora, Jayanta/AAK-9419-2020	Bora, Jayanta/0000-0002-9735-3042	Max Planck Society	Max Planck Society(Max Planck Society)	This study was conceived when Dr. Nandita Saikia was a Max Planck India fellow at Max Planck Institute for Demographic Research (MPIDR), Germany. Dr. Saikia is grateful to Max Planck Society for providing fellowship during her stay at MPIDR, Germany; website: (http://www.demogr.mpg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2010, J APPL GERONTOL, V29, P155, DOI 10.1177/0733464809339622; Al Snih S, 2005, J GERONTOL A-BIOL, V60, P1152, DOI 10.1093/gerona/60.9.1152; Alkema L, 2014, LANCET GLOB HEALTH, V2, pE521, DOI 10.1016/S2214-109X(14)70280-3; Arber S, 1999, SOC SCI MED, V48, P61, DOI 10.1016/S0277-9536(98)00289-5; Arokiasamy P, 2004, POPULATION, V59, P949, DOI 10.2307/3654939; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; BASU AM, 1993, ECON POLIT WEEKLY, V28, P2356; Benson TM, 2014, INDIAN J GERONTOL, V28, P321; Blazer DG, 2008, GERONTOLOGIST, V48, P415, DOI 10.1093/geront/48.4.415; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Chakrabarty D, 2010, Ghana Med J, V44, P150; Chen B, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-30; Crimmins EM, 2010, EUR J PUBLIC HEALTH; Dhak B, 2009, J BIOSOC SCI, V41, P625, DOI 10.1017/S002193200999006X; Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Fayers PM, 2002, LANCET, V359, P187, DOI 10.1016/S0140-6736(02)07466-4; FRIEDMAN HS, 1995, AM PSYCHOL, V50, P69, DOI 10.1037/0003-066X.50.2.69; Gupta Priti, 2014, Indian J Public Health, V58, P11, DOI 10.4103/0019-557X.128155; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hirve S, 2012, INT J EPIDEMIOL, V41, P1719, DOI 10.1093/ije/dys163; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kalben BB, 2000, N AM ACTUAR J, V4, P83; KANDRACK MA, 1991, SOC SCI MED, V32, P579, DOI 10.1016/0277-9536(91)90293-L; KISHOR S, 1993, AM SOCIOL REV, V58, P247, DOI 10.2307/2095969; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Ladusingh L, 2013, J APPL GERONTOLOGY; Lhungdim, 2013, STUDY GLOBAL AGEING; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lundberg O, 1996, SCAND J SOC MED, V24, P218, DOI 10.1177/140349489602400314; Luy M, 2014, HEALTH REP, V25, P12; MCCALLUM J, 1994, AM J PUBLIC HEALTH, V84, P1100, DOI 10.2105/AJPH.84.7.1100; Mencher J., 1988, WOMENS WORK POVERTY; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Mohammad MA, 2013, J INT WOMENS STUDIES, V11, P162; Moser KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086043; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Murthi M, 1995, POPUL DEV REV, V21, P745, DOI 10.2307/2137773; Mutharayappa R, 2009, GENDER DIFFERENTIAL; NATHANSON CA, 1984, ANNU REV SOCIOL, V10, P191, DOI 10.1146/annurev.so.10.080184.001203; Nummela O, 2009, INT J BEHAV MED, V16, P189, DOI 10.1007/s12529-008-9027-z; Oksuzyan A, 2009, ANN EPIDEMIOL, V19, P504, DOI 10.1016/j.annepidem.2009.03.014; Oman D, 1999, AM J EPIDEMIOL, V150, P834; Pampel FC, 2005, AM J PUBLIC HEALTH, V95, P1009, DOI 10.2105/AJPH.2004.056895; RGI, 2012, SAMPL REG SYST STAT; Rieker PP, 2005, J GERONTOL B-PSYCHOL, V60, P40; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Rosenbloom T, 2011, SOC BEHAV PERSONAL, V39, P1263, DOI 10.2224/sbp.2011.39.9.1263; Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015; Saikia N, 2011, POP STUD-J DEMOG, V65, P73, DOI 10.1080/00324728.2010.534642; Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538; Singh Abhishek, 2007, Genus, V63, P55; Singh L, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013487914; Srinivasan K, 2010, INDIAN J MED RES, V131, P515; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; VERBRUGGE LM, 1987, WOMEN HEALTH, V12, P103, DOI 10.1300/J013v12n02_07; VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; WALDRON I, 1976, SOC SCI MED, V10, P349, DOI 10.1016/0037-7856(76)90090-1; Waldron I., 1998, TOO YOUNG GENES GEND, P64; Waldron I, 2005, DEMOGR RES, V13, P415, DOI 10.4054/DemRes.2005.13.17; Wray LA, 2001, GERONTOLOGIST, V41, P499, DOI 10.1093/geront/41.4.499; Zunzunegui MV, 2009, SOC SCI MED, V68, P235, DOI 10.1016/j.socscimed.2008.10.031	67	42	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141953	10.1371/journal.pone.0141953	http://dx.doi.org/10.1371/journal.pone.0141953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536133	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400106
J	Park, BY; Seo, J; Yi, J; Park, H				Park, Bo-yong; Seo, Jongbum; Yi, Juneho; Park, Hyunjin			Structural and Functional Brain Connectivity of People with Obesity and Prediction of Body Mass Index Using Connectivity	PLOS ONE			English	Article							CORTICAL NETWORKS; REWARD; BMI; MRI; ACTIVATION; PATTERNS; GHRELIN; DISEASE; LEPTIN; VOLUME	Obesity is a medical condition affecting billions of people. Various neuroimaging methods including magnetic resonance imaging (MRI) have been used to obtain information about obesity. We adopted a multi-modal approach combining diffusion tensor imaging (DTI) and resting state functional MRI (rs-fMRI) to incorporate complementary information and thus better investigate the brains of non-healthy weight subjects. The objective of this study was to explore multi-modal neuroimaging and use it to predict a practical clinical score, body mass index (BMI). Connectivity analysis was applied to DTI and rs-fMRI. Significant regions and associated imaging features were identified based on group-wise differences between healthy weight and non-healthy weight subjects. Six DTI-driven connections and 10 rs-fMRI-driven connectivities were identified. DTI-driven connections better reflected group-wise differences than did rs-fMRI-driven connectivity. We predicted BMI values using multimodal imaging features in a partial least-square regression framework (percent error 15.0%). Our study identified brain regions and imaging features that can adequately explain BMI. We identified potentially good imaging biomarker candidates for obesity-related diseases.	[Park, Bo-yong] Sungkyunkwan Univ, Dept Elect Elect & Comp Engn, Suwon, South Korea; [Seo, Jongbum] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea; [Yi, Juneho; Park, Hyunjin] Sungkyunkwan Univ, Sch Elect Elect Engn, Suwon, South Korea; [Park, Hyunjin] Inst Basic Sci, CNIR, Suwon, South Korea	Sungkyunkwan University (SKKU); Yonsei University; Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS)	Park, H (corresponding author), Sungkyunkwan Univ, Sch Elect Elect Engn, Suwon, South Korea.	hyunjinp@skku.edu	Park, Hyunjin/A-1164-2007; Park, Bo-yong/AAM-8094-2020	Park, Hyunjin/0000-0001-5681-8918; Park, Bo-yong/0000-0001-7096-337X	Basic Science Research Program through the National Research Foundation of Korea [20100023233]; Institute for Basic Science [IBS-R015-D1]; Human Connectome Project, WU-Minn Consortium [NIH 1U54MH091657]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Institute for Basic Science; Human Connectome Project, WU-Minn Consortium; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study (H.P.) was supported by the Basic Science Research Program through the National Research Foundation of Korea (grant number 20100023233, http://www.nrf.re.kr/nrf_eng_cms/). This study (H.P.) was also supported in part by the Institute for Basic Science (grant number IBS-R015-D1, http://www.ibs.re.kr/). Data were provided by the Human Connectome Project, WU-Minn Consortium (NIH 1U54MH091657, http://www.humanconnectome.org/). There were no other sources of funding than those listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Bolzenius JD, 2015, BEHAV BRAIN RES, V278, P342, DOI 10.1016/j.bbr.2014.10.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burger KS, 2014, PHYSIOL BEHAV, V136, P121, DOI 10.1016/j.physbeh.2014.04.025; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Englander ZA, 2013, NEUROIMAGE-CLIN, V2, P440, DOI 10.1016/j.nicl.2013.03.006; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Garcia-Garcia I, 2013, HUM BRAIN MAPP, V34, P2786, DOI 10.1002/hbm.22104; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hart J, 2013, BRAIN LANG, V126, P89, DOI 10.1016/j.bandl.2012.08.002; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Lee SH, 2014, NEUROREPORT, V25, P1393, DOI 10.1097/WNR.0000000000000279; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Marques-Iturria I, 2013, PSYCHIAT RES-NEUROIM, V214, P109, DOI 10.1016/j.pscychresns.2013.06.004; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Monteleone P, 2013, PSYCHONEUROENDOCRINO, V38, P312, DOI 10.1016/j.psyneuen.2012.10.021; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Musen G, 2012, DIABETES, V61, P2375, DOI 10.2337/db11-1669; Opel N, 2015, HUM BRAIN MAPP, V36, P2330, DOI 10.1002/hbm.22773; Opel N, 2015, PSYCHONEUROENDOCRINO, V51, P219, DOI 10.1016/j.psyneuen.2014.10.001; Park H, 2014, COMPUT BIOL MED, V47, P139, DOI 10.1016/j.compbiomed.2014.02.003; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shott ME, 2015, INT J OBESITY, V39, P214, DOI 10.1038/ijo.2014.121; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Stam Cornelius J., 2007, NONLINEAR BIOMEDICAL, V1, P1, DOI DOI 10.1186/1753-4631-1-3; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stice E, 2009, PHYSIOL BEHAV, V97, P551, DOI 10.1016/j.physbeh.2009.03.020; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Torgerson CM, 2013, BRAIN IMAGING BEHAV, V7, P129, DOI 10.1007/s11682-012-9202-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; World Health Organization,, 2015, OB OV; Xia SG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00162; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	55	23	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141376	10.1371/journal.pone.0141376	http://dx.doi.org/10.1371/journal.pone.0141376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536135	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400061
J	Tong, XM; Chen, JH; Miao, HY; Li, TT; Zhang, L				Tong, Xuming; Chen, Jinghang; Miao, Hongyu; Li, Tingting; Zhang, Le			Development of an Agent-Based Model (ABM) to Simulate the Immune System and Integration of a Regression Method to Estimate the Key ABM Parameters by Fitting the Experimental Data	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION	Agent-based models (ABM) and differential equations (DE) are two commonly used methods for immune system simulation. However, it is difficult for ABM to estimate key parameters of the model by incorporating experimental data, whereas the differential equation model is incapable of describing the complicated immune system in detail. To overcome these problems, we developed an integrated ABM regression model (IABMR). It can combine the advantages of ABM and DE by employing ABM to mimic the multi-scale immune system with various phenotypes and types of cells as well as using the input and output of ABM to build up the Loess regression for key parameter estimation. Next, we employed the greedy algorithm to estimate the key parameters of the ABM with respect to the same experimental data set and used ABM to describe a 3D immune system similar to previous studies that employed the DE model. These results indicate that IABMR not only has the potential to simulate the immune system at various scales, phenotypes and cell types, but can also accurately infer the key parameters like DE model. Therefore, this study innovatively developed a complex system development mechanism that could simulate the complicated immune system in detail like ABM and validate the reliability and efficiency of model like DE by fitting the experimental data.	[Tong, Xuming; Chen, Jinghang; Zhang, Le] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Zhang, Le] Univ Rochester, Ctr Biodef Immune Modeling, Dept Biostat & Computat Biol, New York, NY USA; [Miao, Hongyu] Univ Texas Houston, Sch Publ Hlth, Dept Biostat, Houston, TX USA; [Li, Tingting] Southwest Univ, Sch Math & Stat, Chongqing, Peoples R China	Southwest University - China; University of Rochester; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Southwest University - China	Chen, JH (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China.	jinghang_chen@outlook.com; tinalee@swu.edu.cn; zhanglcq@swu.edu.cn	Zhang, Le/AAD-9104-2019	Zhang, Le/0000-0002-3708-1727	Natural Science Foundation of China [61372138]; USA National Institutes of Health [U01 CA166886-01, P30AI078498, HHSN272201000055C]; Chongqing excellent youth award; Chinese Recruitment Program of Global Youth Experts; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chongqing excellent youth award; Chinese Recruitment Program of Global Youth Experts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following sources of funding: 1. Natural Science Foundation of China No. 61372138 (http://www.nsfc.gov.cn/); 2. USA National Institutes of Health grants U01 CA166886-01, P30AI078498, and HHSN272201000055C (http://grants.nih.gov/grants/oer.htm); 3. Chongqing excellent youth award (http://www.ctin.ac.cn/); and 4. Chinese Recruitment Program of Global Youth Experts (http://www.1000plan.org/).	Bang-Jensen J., 2004, DISCRETE OPTIM, V1, P121, DOI [DOI 10.1016/j.disopt.2004.03.007, 10.1016/j.disopt.2004.03.007]; Bendall G, 2006, DISCRETE OPTIM, V3, P288, DOI 10.1016/j.disopt.2006.03.001; Chan AL-F, 2011, MATH PROBLEMS ENG 20, V2011, P14; Charles MM, 2006, TUTORIAL AGENT BAS 2, P73; Chiacchio F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907171; Clerc M., 2012, ARXIV; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cormen T., 2001, INTRO ALGORITHMS, V2; Cormen Thomas H., 2009, INTRO ALGORITHMS; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Fachada N., 2007, AGENT BASED MODELLIN; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Halling-Brown M, 2010, PHILOS T R SOC A, V368, P2799, DOI 10.1098/rsta.2010.0067; Heiss F, 2008, J ECONOMETRICS, V144, P62, DOI 10.1016/j.jeconom.2007.12.004; Jacob C, 2004, LECT NOTES COMPUT SC, V3239, P400; Jones DS, 2011, DIFFERENTIAL EQUATIO; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Kennedy J., 2010, ENCY MACHINE LEARNIN, P760, DOI DOI 10.1007/978-0-387-30164-8_630; Mansury Y, 2006, J THEOR BIOL, V238, P146, DOI 10.1016/j.jtbi.2005.05.027; Miao HY, 2014, J AM STAT ASSOC, V109, P1672, DOI 10.1080/01621459.2014.957287; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Nobile F, 2008, SIAM J NUMER ANAL, V46, P2309, DOI 10.1137/060663660; Nocedal J., 2006, LEAST SQUARES PROBLE; Oksendal B, 2003, STOCHASTIC DIFFERENT; Pedersen MEH, 2010, APPL SOFT COMPUT, V10, P618, DOI 10.1016/j.asoc.2009.08.029; Poli R., 2008, J ARTIF EVOL APPL, V2008, P3; Poli R, 2007, ANAL PUBLICATIONS PA; Shyu, 1992, STAT MODELS; Siddiqa A, 2009, NEW HYBRID AGENT BAS, P134; Weisstein E.W., 2002, CRC CONCISE ENCY MAT; Xie Xiao-feng, 2003, Control and Decision, V18, P129; Ypma J, 2013, INTRO SPARSEGRID; Yserentant H, 2005, NUMER MATH, V101, P381, DOI 10.1007/s00211-005-0581-x; Zhang L, 2009, J MATH BIOL, V58, P545, DOI 10.1007/s00285-008-0211-1	39	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141295	10.1371/journal.pone.0141295	http://dx.doi.org/10.1371/journal.pone.0141295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535589	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400058
J	Williams, VL; Loveridge, AJ; Newton, DJ; Macdonald, DW				Williams, Vivienne L.; Loveridge, Andrew J.; Newton, David J.; Macdonald, David W.			'Skullduggery': Lions Align and Their Mandibles Rock!	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; TIGERS	South Africa has legally exported substantial quantities of lion bones to Southeast Asia and China since 2008, apparently as part of the multinational trade substituting bones and body parts of other large cats for those of the tiger in wine and other health tonics. The legal sale of lion bones may mask an illegal trade, the size of which is only partially known. An observed component of the illegal trade is that quantities of skeletons are sometimes declared falsely/fraudulently on CITES export permits. Furthermore, there are emerging concerns that bones from tigers reared in captivity in South Africa and elsewhere are being laundered as lion bones using CITES Appendix II permits. There is therefore a need for tools to monitor the trade in lion body parts and to distinguish between lions and tigers. Our research indicates that it is possible to use skeletons, skulls and cranial sutures to detect misdeclarations in the lion bone trade. It is also possible to use the average mass of a lion skeleton to corroborate the numbers of skeletons declared on CITES permits, relative to the weight of the consolidated consignments stated on the air waybills. When the mass of consolidated consignments of skeletons destined for export was regressed against the number of skeletons in that consignment, there was a strong correlation between the variables (r(2) = 0.992) that can be used as a predictor of the accuracy of a declaration on a CITES permit. Additionally, the skulls of lions and tigers differ: two cranial sutures of lions align and their mandibles rock when placed on a flat surface, whereas the cranial sutures of tigers are not aligned and their mandibles rest naturally on two contact points. These two morphological differences between the skulls of tigers and lions are easy to observe at a glance and provide a method for distinguishing between the species if illegal trade in the bones is suspected and the skulls are present. These identifications should ideally be confirmed by a DNA test to provide rigorous evidence to prosecute offenders violating CITES regulations.	[Williams, Vivienne L.; Newton, David J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [Newton, David J.] TRAFFIC, East Southern Africa Reg Off, Pretoria, South Africa	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivwill@netdial.co.za	Williams, Vivienne Linda/M-1453-2019	Williams, Vivienne Linda/0000-0003-0698-6512	Robertson Foundation; Mackenzie Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa); University of Witwatersrand	Robertson Foundation; Mackenzie Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Witwatersrand	DWM and AJL acknowledge funding support from the Robertson Foundation, the Mackenzie Foundation, and the Recanati-Kaplan Foundation. VLW acknowledges financial support from National Research Foundation (South Africa) and the University of the Witwatersrand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanford W.T., 1888, FAUNA BRIT INDIA INC; Callister D, 1995, TIGER TREATMENTS RHI; Christiansen P, 2008, MAMM BIOL, V73, P451, DOI 10.1016/j.mambio.2007.08.001; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Haken J., 2011, GLOB FINANC INTEGR, V32, P11; Henry L, TALE 2 CITIES COMP S, P2; Jackson P., 1996, BIOL CONSERVATION; Johnson RN, 2014, FORENSIC SCI INT-GEN, V10, P1, DOI 10.1016/j.fsigen.2013.12.007; Kirberger RM, 2005, J ZOO WILDLIFE MED, V36, P21, DOI 10.1638/03-012; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Loveridge Andrew J., 2010, P161; Merriam J. C., 1932, FELIDAE RANCHO LA BR; Mills J. A., 1997, RHINOCEROS HORN TIGE; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nowell K., 2007, TAMING TIGER TRADE C; Nowell K., 2000, FAR CURE TIGER TRADE; Pocock R. I., 1930, Journal of the Bombay Natural History Society, V34, P638; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Pocock R. I., 1939, FAUNA BRIT INDIA INC, V1; Raja S, 2009, J THERM ANAL CALORIM, V98, P173, DOI 10.1007/s10973-009-0124-2; Raptors Nest, 2008, DIFFERENCE LION TIGE; Williams VL., 2015, BONES CONTENTION ASS; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P149, DOI 10.1007/s12024-010-9179-4	23	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0135144	10.1371/journal.pone.0135144	http://dx.doi.org/10.1371/journal.pone.0135144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536601	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400002
J	Wynendaele, E; Verbeke, F; Stalmans, S; Gevaert, B; Janssens, Y; Van De Wiele, C; Peremans, K; Burvenich, C; De Spiegeleer, B				Wynendaele, Evelien; Verbeke, Frederick; Stalmans, Sofie; Gevaert, Bert; Janssens, Yorick; Van De Wiele, Christophe; Peremans, Kathelijne; Burvenich, Christian; De Spiegeleer, Bart			Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier	PLOS ONE			English	Article							GUT-BRAIN; MICROBIOME; TRANSPORT; COMMUNICATION; ANXIETY; CROSS; QUANTIFICATION; TRANSCRIPTION; PATHOGENS; SYSTEMS	Bacteria communicate with each other by the use of signaling molecules, a process called 'quorum sensing'. One group of quorum sensing molecules includes the oligopeptides, which are mainly produced by Gram-positive bacteria. Recently, these quorum sensing peptides were found to biologically influence mammalian cells, promoting i.a. metastasis of cancer cells. Moreover, it was found that bacteria can influence different central nervous system related disorders as well, e.g. anxiety, depression and autism. Research currently focuses on the role of bacterial metabolites in this bacteria-brain interaction, with the role of the quorum sensing peptides not yet known. Here, three chemically diverse quorum sensing peptides were investigated for their brain influx (multiple time regression technique) and efflux properties in an in vivo mouse model (ICR-CD-1) to determine blood-brain transfer properties: PhrCACET1 demonstrated comparatively a very high initial influx into the mouse brain (K-in = 20.87 mu l/(gxmin)), while brain penetrabilities of BIP-2 and PhrANTH2 were found to be low (K-in = 2.68 mu l/(gxmin)) and very low (K-in = 0.18 mu l/(gxmin)), respectively. All three quorum sensing peptides were metabolically stable in plasma (in vitro) during the experimental time frame and no significant brain efflux was observed. Initial tissue distribution data showed remarkably high liver accumulation of BIP-2 as well. Our results thus support the potential role of some quorum sensing peptides in different neurological disorders, thereby enlarging our knowledge about the microbiome-brain axis.	[Wynendaele, Evelien; Verbeke, Frederick; Stalmans, Sofie; Gevaert, Bert; Janssens, Yorick; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Van De Wiele, Christophe] Ghent Univ Hosp, Dept Radiol & Nucl Med, Fac Med & Hlth Sci, Ghent, Belgium; [Peremans, Kathelijne] Univ Ghent, Fac Vet Med, Dept Med Imaging Med & Clin Biol Small Anim, Merelbeke, Belgium; [Burvenich, Christian] Univ Ghent, Fac Vet Med, Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108	Special Research Fund of Ghent University [BOF 01J22510, BOF 01D38811]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [121512, 131356]	Special Research Fund of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund of Ghent University (www.ugent.be, Grant numbers BOF 01J22510 to BDS and EW, and BOF 01D38811 to SS) and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, www.iwt.be, Grant numbers 121512 to BG and 131356 to FV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey G., 2002, PROTEIN PROTOCOLS HD, P963; Bailey Graham S., 1996, P673, DOI 10.1007/978-1-60327-259-9_115; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; BANKS WA, 1989, METHOD ENZYMOL, V168, P652; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cryan JF, 2014, ADV EXPT MED BIOL MI; De Spiegeleer B, 2015, PLOS ONE, DOI [10.1371/journal,pone-.0119471, DOI 10.1371/J0URNAL.P0NE.0119471]; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dinan TG, 2015, J PSYCHIATR RES, V63, P1, DOI 10.1016/j.jpsychires.2015.02.021; Durre P, 2004, ANAEROBE, V10, P69, DOI 10.1016/j.anaerobe.2003.11.001; Egleton Richard D, 2005, NeuroRx, V2, P44, DOI 10.1007/BF03206641; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; GJEDDE A, 1981, J NEUROCHEM, V36, P1463, DOI 10.1111/j.1471-4159.1981.tb00587.x; GJEDDE A, 1982, BRAIN RES REV, V4, P237, DOI 10.1016/0165-0173(82)90018-2; Gjedde A, 2011, NEUROKINETICS DYNAMI, DOI [10.1007/978-1-4419-7409-9, DOI 10.1007/978-1-4419-7409-9]; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Henriques-Normark B, 2010, EXP CELL RES, V316, P1408, DOI 10.1016/j.yexcr.2010.03.003; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Knutsen E, 2004, J BACTERIOL, V186, P3078, DOI 10.1128/JB.186.10.3078-3085.2004; Kumar S, 2013, MBIO, V4, DOI 10.1128/mBio.00314-13; Kumari A, 2008, ANAL BIOANAL CHEM, V391, P1619, DOI 10.1007/s00216-008-2002-3; Kurihara A, 1999, CANCER RES, V59, P6159; Luna RA, 2015, CURR OPIN BIOTECH, V32, P35, DOI 10.1016/j.copbio.2014.10.007; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Schmidt C, 2015, NATURE, V518, pS12, DOI 10.1038/518S13a; Stalmans S, 2015, PROTEIN PEPTIDE LETT, V22, P768, DOI 10.2174/0929866522666150622101223; Stalmans S, 2014, PROTEIN PEPTIDE LETT, V21, P399, DOI 10.2174/09298665113206660110; Sternini C, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00553.x; Sudo N, 2012, CHEM IMMUNOL ALLERGY, V98, P163, DOI 10.1159/000336510; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Van Dorpe S, 2012, BRAIN STRUCT FUNCT, V217, P687, DOI 10.1007/s00429-011-0375-0; Van Dorpe S, 2010, PEPTIDES, V31, P1390, DOI 10.1016/j.peptides.2010.03.029; Verbeke F, 2015, J PHARM ANAL, DOI [10.1016/j.pha.2014.12.002, DOI 10.1016/J.PHA.2014.12.002]; Verbeken M, 2015, PEPTIDES, V63, P10, DOI 10.1016/j.peptides.2014.10.010; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; WONG DF, 1986, J CEREBR BLOOD F MET, V6, P137, DOI 10.1038/jcbfm.1986.27; Wynendaele E, 2015, BIOPOLYMERS, V104, P544, DOI 10.1002/bip.22649; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Wynendaele E, 2014, CURR PHARM DESIGN, V20, P2250, DOI 10.2174/13816128113196660663; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137	61	31	31	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142071	10.1371/journal.pone.0142071	http://dx.doi.org/10.1371/journal.pone.0142071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536593	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400128
J	Zhu, C; Nigam, KB; Date, RC; Bush, KT; Springer, SA; Saier, MH; Wu, W; Nigam, SK				Zhu, Christopher; Nigam, Kabir B.; Date, Rishabh C.; Bush, Kevin T.; Springer, Stevan A.; Saier, Milton H., Jr.; Wu, Wei; Nigam, Sanjay K.			Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; CATION TRANSPORTER; GENOME DUPLICATION; MOLECULAR-CLONING; CHOROID-PLEXUS; FAMILY; IDENTIFICATION; DRUG; AFFINITY; POLYMORPHISMS	The SLC22 family includes organic anion transporters (OATs), organic cation transporters (OCTs) and organic carnitine and zwitterion transporters (OCTNs). These are often referred to as drug transporters even though they interact with many endogenous metabolites and signaling molecules (Nigam, S.K., Nature Reviews Drug Discovery, 14: 29-44, 2015). Phylogenetic analysis of SLC22 supports the view that these transporters may have evolved over 450 million years ago. Many OAT members were found to appear after a major expansion of the SLC22 family in mammals, suggesting a physiological and/or toxicological role during the mammalian radiation. Putative SLC22 orthologs exist in worms, sea urchins, flies, and ciona. At least six groups of SLC22 exist. OATs and OCTs form two Major clades of SLC22, within which (apart from Oat and Oct subclades), there are also clear Oat-like, Octn, and Oct-related subclades, as well as a distantly related group we term "Oat-related" (which may have different functions). Based on available data, it is arguable whether SLC22A18, which is related to bacterial drug-proton antiporters, should be assigned to SLC22. Disease-causing mutations, single nucleotide polymorphisms (SNPs) and other functionally analyzed mutations in OAT1, OAT3, URAT1, OCT1, OCT2, OCTN1, and OCTN2 map to the first extracellular domain, the large central intracellular domain, and transmembrane domains 9 and 10. These regions are highly conserved within subclades, but not between subclades, and may be necessary for SLC22 transporter function and functional diversification. Our results not only link function to evolutionarily conserved motifs but indicate the need for a revised sub-classification of SLC22.	[Zhu, Christopher; Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Kabir B.; Date, Rishabh C.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Springer, Stevan A.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular Med, La Jolla, CA 92093 USA; [Springer, Stevan A.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Mol Med, La Jolla, CA 92093 USA; [Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wu, W (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	weiwu@ucsd.edu; snigam@ucsd.edu		Saier, Milton/0000-0001-5530-0017	National Institute of General Medical Sciences (US) [R01GM104098, R01GM098449, R01GM077402]; Nancy Kaehr Chair in Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098, R01GM077402] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (US); Nancy Kaehr Chair in Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was funded by 1. National Institute of General Medical Sciences (US), Award Number: R01GM104098, Recipient: Sanjay K. Nigam; 2. National Institute of General Medical Sciences (US), Award Number: R01GM098449, Recipient: Sanjay K. Nigam; 3. National Institute of General Medical Sciences (US), Award Number: R01GM077402, Recipient: Milton H. Saier Jr. Dr. Nigam is also funded by the Nancy Kaehr Chair in Research.	Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Astorga B, 2011, AM J PHYSIOL-RENAL, V301, pF378, DOI 10.1152/ajprenal.00735.2010; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Bailey TL, 1997, J STEROID BIOCHEM, V62, P29, DOI 10.1016/S0960-0760(97)00013-7; Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bleasby K, 2005, J PHARMACOL EXP THER, V314, P923, DOI 10.1124/jpet.105.084301; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Canestro C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-208; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chu SH, 2014, CANCER GENE THER, V21, P103, DOI 10.1038/cgt.2014.4; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2003, BIOCHEM BIOPH RES CO, V300, P333, DOI 10.1016/S0006-291X(02)02853-X; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nies AT, 2011, HANDB EXP PHARMACOL, P105; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Perry JL, 2006, J BIOL CHEM, V281, P38071, DOI 10.1074/jbc.M608834200; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schnabolk GW, 2006, AM J PHYSIOL-RENAL, V291, pF314, DOI 10.1152/ajprenal.00497.2005; SIMONSON GD, 1994, J CELL SCI, V107, P1065; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tsigelny IF, 2011, CELL BIOCHEM BIOPHYS, V61, P251, DOI 10.1007/s12013-011-9191-7; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; Xu G, 2005, KIDNEY INT, V68, P1491, DOI 10.1111/j.1523-1755.2005.00612.x	56	52	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140569	10.1371/journal.pone.0140569	http://dx.doi.org/10.1371/journal.pone.0140569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536134	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400025
J	Gazestani, VH; Salavati, R				Gazestani, Vahid H.; Salavati, Reza			Deciphering RNA Regulatory Elements Involved in the Developmental and Environmental Gene Regulation of Trypanosoma brucei	PLOS ONE			English	Article							LIFE-CYCLE STAGES; GENOME-WIDE; BINDING PROTEINS; MESSENGER-RNAS; COMPUTATIONAL IDENTIFICATION; EXPRESSION; RECOGNITION; REVEALS; STABILITY; DISCOVERY	Trypanosoma brucei is a vector-borne parasite with intricate life cycle that can cause serious diseases in humans and animals. This pathogen relies on fine regulation of gene expression to respond and adapt to variable environments, with implications in transmission and infectivity. However, the involved regulatory elements and their mechanisms of actions are largely unknown. Here, benefiting from a new graph-based approach for finding functional regulatory elements in RNA (GRAFFER), we have predicted 88 new RNA regulatory elements that are potentially involved in the gene regulatory network of T. brucei. We show that many of these newly predicted elements are responsive to both transcriptomic and proteomic changes during the life cycle of the parasite. Moreover, we found that 11 of predicted elements strikingly resemble previously identified regulatory elements for the parasite. Additionally, comparison with previously predicted motifs on T. brucei suggested the superior performance of our approach based on the current limited knowledge of regulatory elements in T. brucei.	[Gazestani, Vahid H.; Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ, Canada; [Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Salavati, R (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Montreal, PQ, Canada.	reza.salavati@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [328186]; CIHR Systems Biology Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Systems Biology Fellowship(Canadian Institutes of Health Research (CIHR))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant #328186 to RS. VHG is supported by a CIHR Systems Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Das A, 2012, RNA, V18, P1968, DOI 10.1261/rna.033829.112; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fernandez-Moya SM, 2014, NUCLEIC ACIDS RES, V42, P7201, DOI 10.1093/nar/gku358; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Gazestani VH, 2014, TRENDS PARASITOL, V30, P234, DOI 10.1016/j.pt.2014.02.008; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hotz HR, 1998, MOL BIOCHEM PARASIT, V91, P131, DOI 10.1016/S0166-6851(97)00196-5; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jha BA, 2015, FEBS LETT, V589, P1966, DOI 10.1016/j.febslet.2015.05.036; Khosravi P, 2014, COMPUT BIOL MED, V54, P24, DOI 10.1016/j.compbiomed.2014.08.020; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Li X, 2014, WIRES RNA, V5, P111, DOI 10.1002/wrna.1201; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Mao Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-355; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Monk SL, 2013, J CELL SCI, V126, P2294, DOI 10.1242/jcs.126011; Najafabadi HS, 2013, NUCLEIC ACIDS RES, V41, P8591, DOI 10.1093/nar/gkt647; Najafabadi HS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000810; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142342	10.1371/journal.pone.0142342	http://dx.doi.org/10.1371/journal.pone.0142342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529602	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600114
J	Wisting, L; Bang, L; Skrivarhaug, T; Dahl-Jorgensen, K; Ro, O				Wisting, Line; Bang, Lasse; Skrivarhaug, Torild; Dahl-Jorgensen, Knut; Ro, Oyvind			Adolescents with Type 1 Diabetes - The Impact of Gender, Age, and Health-Related Functioning on Eating Disorder Psychopathology	PLOS ONE			English	Article							ILLNESS PERCEPTIONS; ONSET; GIRLS; MORTALITY; BEHAVIOR; BELIEFS; FEMALES; INSULIN; QUESTIONNAIRE; PREVALENCE	Objective To investigate correlates of eating disorder psychopathology in adolescent males and females with type 1 diabetes. Method A total of 105 adolescents with type 1 diabetes (42% males), aged 12-20 years, were recruited from the Norwegian Childhood Diabetes Registry in this population-based study. All participants were interviewed with the Child Eating Disorder Examination. Additionally, the Brief Illness Perception Questionnaire, the Adolescent Coping Orientation for Problem Experiences and the Beliefs about Medicines Questionnaire were administered to assess health-related functioning. Clinical data were obtained from the Norwegian Childhood Diabetes Registry. Results Significant gender differences were demonstrated in the pattern of correlates of eating disorder pathology. Among females, eating disorder psychopathology was significantly associated with body mass index adjusted for age and gender, age, insulin restriction, coping, illness perceptions, and perceptions of insulin concern. In a regression model, age, illness perceptions, and insulin restriction remained significantly associated with eating disorder psychopathology, explaining 48% of the variance. None of the variables were associated with eating disorder psychopathology among males. Discussion Greater clinical awareness of illness perceptions, attitudes toward insulin, and insulin restriction may potentially decrease the risk of developing eating disorders among female adolescents with type 1 diabetes, and the subsequent increased morbidity and mortality associated with comorbid type 1 diabetes and eating disorders.	[Wisting, Line; Bang, Lasse; Ro, Oyvind] Oslo Univ Hosp, Div Mental Hlth & Addict, Reg Dept Eating Disorders, Oslo, Norway; [Skrivarhaug, Torild] Oslo Univ Hosp, Dept Pediat Med, Norwegian Childhood Diabet Registry, Oslo, Norway; [Skrivarhaug, Torild; Dahl-Jorgensen, Knut] Oslo Univ Hosp, Dept Pediat Med, Oslo, Norway; [Skrivarhaug, Torild; Dahl-Jorgensen, Knut] Univ Oslo, Fac Med, Oslo, Norway; [Wisting, Line; Skrivarhaug, Torild; Dahl-Jorgensen, Knut] Oslo Diabet Res Ctr, Oslo, Oslo, Norway; [Ro, Oyvind] Univ Oslo, Inst Clin Med, Div Mental Hlth & Addict, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Wisting, L (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Reg Dept Eating Disorders, Oslo, Norway.	line.wisting@oslo-universitetssykehus.no	Bang, Lasse/I-9524-2019	Bang, Lasse/0000-0002-3548-5234	Research Council of Norway; Health Region South-East	Research Council of Norway(Research Council of Norway); Health Region South-East	The work was supported by Research Council of Norway, www.forskningsradet.no. The Norwegian Childhood Diabetes Registry is fully funded by the Health Region South-East.	[Anonymous], 2011, ANN REPORT 2011; Baines T, 2013, J CLIN PSYCHOL MED S, V20, P263, DOI 10.1007/s10880-012-9337-9; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Bryant-Waugh R, 2007, CA CH AD PS, P111; BryantWaugh RJ, 1996, INT J EAT DISORDER, V19, P391, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;391::AID-EAT6&gt;3.0.CO;2-G; Brytek-Matera A, 2013, PSYCHIAT DANUB, V25, P359; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colton PA, 2007, DIABETES CARE, V30, P2861, DOI 10.2337/dc07-1057; DeJong H, 2012, J HEALTH PSYCHOL, V17, P399, DOI 10.1177/1359105311416874; Domargard A, 1999, ACTA PAEDIATR, V88, P1223, DOI 10.1080/080352599750030329; Fortenberry KT, 2014, J PEDIATR PSYCHOL, V39, P687, DOI 10.1093/jpepsy/jsu043; Frampton I, 2011, SCAND J PSYCHOL, V52, P196, DOI 10.1111/j.1467-9450.2010.00833.x; Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026; Griva K, 2000, PSYCHOL HEALTH, V15, P733, DOI 10.1080/08870440008405578; Holliday J, 2005, INT J EAT DISORDER, V37, P50, DOI 10.1002/eat.20056; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563; Jongenelis MI, 2014, PSYCHOL ASSESSMENT, V26, P267, DOI 10.1037/a0034803; Jonsdottir H, 2009, ACTA PSYCHIAT SCAND, V119, P78, DOI 10.1111/j.1600-0447.2008.01279.x; Kuczmarski RJ., 2000, ADV DATA, P1; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nielsen S, 2002, EUR EAT DISORD REV, V10, P241, DOI 10.1002/erv.474; Nielsen S, 2002, DIABETES CARE, V25, P309, DOI 10.2337/diacare.25.2.309; Olmsted MP, 2008, DIABETES CARE, V31, P1978, DOI 10.2337/dc08-0333; Patterson J, 1991, A COPE ADOLESCENT CO; Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84; Rewers MJ, 2014, PEDIATR DIABETES, V15, P102, DOI 10.1111/pedi.12190; RODIN GM, 1992, DIABETES CARE, V15, P1402, DOI 10.2337/diacare.15.10.1402; Skre I, 2007, TIDSSKRIFT NORSK PSY, V3, P236; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P2281, DOI 10.1007/s00125-006-0364-7; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Skrivarhaug T, 2006, PEDIATR DIABETES, V7, P239, DOI 10.1111/j.1399-5448.2006.00204.x; Swarr AE, 1996, DEV PSYCHOL, V32, P636, DOI 10.1037/0012-1649.32.4.636; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wisting L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3486094; Wisting L, 2013, DIABETES CARE, V36, P3382, DOI 10.2337/dc13-0431; Young V, 2012, DIABETMED	37	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141386	10.1371/journal.pone.0141386	http://dx.doi.org/10.1371/journal.pone.0141386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529593	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600024
J	Nakano, R; Edamura, K; Nakayama, T; Narita, T; Okabayashi, K; Sugiya, H				Nakano, Rei; Edamura, Kazuya; Nakayama, Tomohiro; Narita, Takanori; Okabayashi, Ken; Sugiya, Hiroshi			Fibroblast Growth Factor Receptor-2 Contributes to the Basic Fibroblast Growth Factor-Induced Neuronal Differentiation in Canine Bone Marrow Stromal Cells via Phosphoinositide 3-Kinase/Akt Signaling Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO DIFFERENTIATION; NEURITE OUTGROWTH; SPINAL-CORD; NEURAL DIFFERENTIATION; EXPRESSION; SURVIVAL; ACTIVATION; RAT; AKT	Bone marrow stromal cells (BMSCs) are considered as candidates for regenerative therapy and a useful model for studying neuronal differentiation. The role of basic fibroblast growth factor (bFGF) in neuronal differentiation has been previously studied; however, the signaling pathway involved in this process remains poorly understood. In this study, we investigated the signaling pathway in the bFGF-induced neuronal differentiation of canine BMSCs. bFGF induced the mRNA expression of the neuron marker, microtubule associated protein-2 (MAP2) and the neuron-like morphological change in canine BMSCs. In the presence of inhibitors of fibroblast growth factor receptors (FGFR), phosphatidylinositol 3-kinase (PI3K) and Akt, i.e., SU5402, LY294002, and MK2206, respectively, bFGF failed to induce the MAP2 mRNA expression and the neuron-like morphological change. bFGF induced Akt phosphorylation, but it was attenuated by the FGFR inhibitor SU5402 and the PI3K inhibitor LY294002. In canine BMSCs, expression of FGFR-1 and FGFR-2 was confirmed, but only FGFR-2 activation was detected by cross-linking and immunoprecipitation analysis. Small interfering RNA-mediated knockdown of FGFR-2 in canine BMSCs resulted in the attenuation of bFGF-induced Akt phosphorylation. These results suggest that the FGFR-2/PI3K/Akt signaling pathway is involved in the bFGF-induced neuronal differentiation of canine BMSCs.	[Nakano, Rei; Edamura, Kazuya] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Surg, Fujisawa, Kanagawa, Japan; [Nakano, Rei; Narita, Takanori; Okabayashi, Ken; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, Fujisawa, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Radiol, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022; Narita, Takanori/F-1092-2011	Okabayashi, Ken/0000-0003-2525-9265; Nakano, Rei/0000-0003-0255-6347; Narita, Takanori/0000-0003-0295-5014	Ministry of Education, Science, Sports and Culture of Japan [24580465, 24580433]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research [#24580465 (KE) and #24580433 (HS)] from the Ministry of Education, Science, Sports and Culture of Japan (https://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Chen XH, 2004, CELL BIOL INT, V28, P791, DOI 10.1016/j.cellbi.2004.07.009; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; Cosker KE, 2007, BIOCHEM SOC T, V35, P207, DOI 10.1042/BST0350207; Dastjerdi FV, 2012, CELL BIOL INT, V36, P967, DOI 10.1042/CBI20110541; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Edamura K, 2012, J VET MED SCI, V74, P923, DOI 10.1292/jvms.11-0388; Edamura K, 2012, J VET MED SCI, V74, P817, DOI 10.1292/jvms.11-0367; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Gong Y, 2015, MOL MED REP, V11, P367, DOI 10.3892/mmr.2014.2727; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kaka GR, 2012, INT J NEUROSCI, V122, P237, DOI 10.3109/00207454.2011.642037; Khonsari RH, 2012, AM J MED GENET A, V158A, P2797, DOI 10.1002/ajmg.a.35598; Li L, 2015, CELL MOL BIOL LETT, V20, P385, DOI 10.1515/cmble-2015-0023; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Middlemas DS, 1999, J BIOL CHEM, V274, P16451, DOI 10.1074/jbc.274.23.16451; Mruthyunjaya S, 2011, FEBS LETT, V585, P1915, DOI 10.1016/j.febslet.2011.04.072; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Nakano R, 2013, AM J VET RES, V74, P1311, DOI 10.2460/ajvr.74.10.1311; Nandy SB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0083-1; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Niidome T, 2009, BIOCHEM BIOPH RES CO, V390, P1018, DOI 10.1016/j.bbrc.2009.10.100; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Park JH, 2012, BMB REP, V45, P521, DOI 10.5483/BMBRep.2012.45.9.114; Park SS, 2011, J CELL PHYSIOL, V226, P3251, DOI 10.1002/jcp.22686; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Terada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093223; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Tsai HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104937; Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Weiss S, 1996, J NEUROSCI, V16, P7599; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Yu Q, 2013, BIOCHEM BIOPH RES CO, V439, P297, DOI 10.1016/j.bbrc.2013.08.030; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zeng X, 2015, BIOMATERIALS, V53, P184, DOI 10.1016/j.biomaterials.2015.02.073; Zhang F, 2002, NEUROSCIENCE, V114, P837, DOI 10.1016/S0306-4522(02)00321-4; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang ZY, 2012, J CELL MOL MED, V16, P2708, DOI 10.1111/j.1582-4934.2012.01591.x; Zurashvili T, 2013, MOL CELL BIOL, V33, P1027, DOI 10.1128/MCB.01052-12	70	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141581	10.1371/journal.pone.0141581	http://dx.doi.org/10.1371/journal.pone.0141581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523832	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800013
J	van Giesen, RI; Fischer, ARH; van Dijk, H; van Trijp, HCM				van Giesen, Roxanne I.; Fischer, Arnout R. H.; van Dijk, Heleen; van Trijp, Hans C. M.			Affect and Cognition in Attitude Formation toward Familiar and Unfamiliar Attitude Objects	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; INDIVIDUAL-DIFFERENCES; NEED; TECHNOLOGIES; EXPOSURE; THINKING; MODEL	At large attitudes are built on earlier experience with the attitude object. If earlier experiences are not available, as is the case for unfamiliar attitude objects such as new technologies, no stored evaluations exist. Yet, people are still somehow able to construct attitudes on the spot. Depending on the familiarity of the attitude object, attitudes may find their basis more in affect or cognition. The current paper investigates differences in reliance on affect or cognition in attitude formation toward familiar and unfamiliar realistic attitude objects. In addition, individual differences in reliance on affect (high faith in intuition) or cognition (high need for cognition) are taken into account. In an experimental survey among Dutch consumers (N = 1870), we show that, for unfamiliar realistic attitude objects, people rely more on affect than cognition. For familiar attitude objects where both affective and cognitive evaluations are available, high need for cognition leads to more reliance on cognition, and high faith in intuition leads to more reliance on affect, reflecting the influence of individually preferred thinking style. For people with high need for cognition, cognition has a higher influence on overall attitude for both familiar and unfamiliar realistic attitude objects. On the other hand, affect is important for people with high faith in intuition for both familiar and unfamiliar attitude objects and for people with low faith in intuition for unfamiliar attitude objects; this shows that preferred thinking style is less influential for unfamiliar objects. By comparing attitude formation for familiar and unfamiliar realistic attitude objects, this research contributes to understanding situations in which affect or cognition is the better predictor of overall attitudes.	[van Giesen, Roxanne I.; Fischer, Arnout R. H.; van Dijk, Heleen; van Trijp, Hans C. M.] Wageningen Univ, Mkt & Consumer Behav Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van Giesen, RI (corresponding author), Tilburg Univ, CentERdata, NL-5000 LE Tilburg, Netherlands.	R.I.vanGiesen@uvt.nl	Fischer, Arnout R.H/B-9589-2009; van trijp, hans/F-6643-2013	Fischer, Arnout R.H/0000-0003-0474-5336; van trijp, hans/0000-0003-2323-4064; van Giesen, Roxanne/0000-0001-6819-8808	NanoNextNL; micro and nanotechnology consortium of the Government of the Netherlands	NanoNextNL; micro and nanotechnology consortium of the Government of the Netherlands	This work was supported by NanoNextNL to RVG AF HVD HVT, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. More information on www.nanonextnl.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Borisenko VE, 2012, HDB NANOSCIENCE NANO; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; BRECKLER SJ, 1989, J EXP SOC PSYCHOL, V25, P253, DOI 10.1016/0022-1031(89)90022-X; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Chaiken S, 1999, PSYCHOL INQ, V10, P118, DOI 10.1207/S15327965PL100204; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Clore GL, 2005, HANDBOOK OF ATTITUDES, P437; CRITES SL, 1994, PERS SOC PSYCHOL B, V20, P619, DOI 10.1177/0146167294206001; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; Desmet P., 2003, FUNOLOGY ENJOYMENT, P111, DOI [DOI 10.1007/1-4020-2967-5_12, 10.1007/1-4020-2967-5_12]; Dudo A, 2013, SCI COMMUN, V35, P476, DOI 10.1177/1075547012460845; Eagly AH, 2007, SOC COGNITION, V25, P582, DOI 10.1521/soco.2007.25.5.582; EDWARDS K, 1990, J PERS SOC PSYCHOL, V59, P202, DOI 10.1037/0022-3514.59.2.202; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Epstein S, 2010, PSYCHOL INQ, V21, P295, DOI 10.1080/1047840X.2010.523875; Fazio RH, 2004, J PERS SOC PSYCHOL, V87, P293, DOI 10.1037/0022-3514.87.3.293; Fazio RH, 2007, SOC COGNITION, V25, P603, DOI 10.1521/soco.2007.25.5.603; Frewer LJ, 2011, TRENDS FOOD SCI TECH, V22, P442, DOI 10.1016/j.tifs.2011.05.005; Giner-Sorolla R, 2004, EUR J SOC PSYCHOL, V34, P761, DOI 10.1002/ejsp.229; Glockner A., 2008, 200842 MPI; Glockner A., 2010, FDN TRACING INTUITIO; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Haddock G, 2008, PERS SOC PSYCHOL B, V34, P769, DOI 10.1177/0146167208314871; Hansen J, 2009, SOC COGNITION, V27, P161, DOI 10.1521/soco.2009.27.2.161; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Huskinson TLH, 2004, J EXP SOC PSYCHOL, V40, P82, DOI 10.1016/S0022-1031(03)00060-X; Keller J, 2009, EUR J SOC PSYCHOL, V39, P467, DOI 10.1002/ejsp.586; Kline RB, 2005, PRINCIPLES PRACTICE; Lattin J., 2003, ANAL MULTIVARIATE DA; Lee CJ, 2005, SCI COMMUN, V27, P240, DOI 10.1177/1075547005281474; Loken B, 2006, ANNU REV PSYCHOL, V57, P453, DOI 10.1146/annurev.psych.57.102904.190136; Midden CJH, 2009, RISK ANAL, V29, P743, DOI 10.1111/j.1539-6924.2009.01201.x; Mukherjee A, 2001, J CONSUM RES, V28, P462, DOI 10.1086/323733; Neys WD, 2006, PSYCHOL SCI, V17, P428, DOI [10.1111/j.1467-9280.2006.01723.x, DOI 10.1111/J.1467-9280.2006.01723.X]; NWO EC/TKI, 2012, ROADM NAN TOP SECT; Plessner H, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P251; Pretz JE, 2007, PERS INDIV DIFFER, V43, P1247, DOI 10.1016/j.paid.2007.03.015; Rossiter JR, 2002, INT J RES MARK, V19, P305, DOI 10.1016/S0167-8116(02)00097-6; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scheufele DA, 2005, J NANOPART RES, V7, P659, DOI 10.1007/s11051-005-7526-2; Schwarz N, 2007, SOC COGNITION, V25, P638, DOI 10.1521/soco.2007.25.5.638; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P, 2002, MISS LAW REV, V69, P971; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; STERN PC, 1995, J APPL SOC PSYCHOL, V25, P1611, DOI 10.1111/j.1559-1816.1995.tb02636.x; Stijnen DAJM, 2011, 12282011 WAG UR FOOD; Van Overwalle F, 2005, PERS SOC PSYCHOL REV, V9, P231, DOI 10.1207/s15327957pspr0903_3; Verplanken B, 1998, EUR J SOC PSYCHOL, V28, P23, DOI 10.1002/(SICI)1099-0992(199801/02)28:1<23::AID-EJSP843>3.0.CO;2-Z; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	56	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141790	10.1371/journal.pone.0141790	http://dx.doi.org/10.1371/journal.pone.0141790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517876	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800078
J	Hamatani, Y; Yamashita, Y; Esato, M; Chun, YH; Tsuji, H; Wada, H; Hasegawa, K; Abe, M; Lip, GYH; Akao, M				Hamatani, Yasuhiro; Yamashita, Yugo; Esato, Masahiro; Chun, Yeong-Hwa; Tsuji, Hikari; Wada, Hiromichi; Hasegawa, Koji; Abe, Mitsuru; Lip, Gregory Y. H.; Akao, Masaharu			Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry	PLOS ONE			English	Article							RISK-FACTORS; ORAL ANTICOAGULANTS; FOLLOW-UP; OUTCOMES; EVENTS; ANEMIA; IMPACT; THROMBOEMBOLISM; IMPAIRMENT; VALIDATION	Background Atrial fibrillation (AF) increases the risk of stroke and death. Data on the predictors for stroke and death in 'real-world' AF patients are limited, especially from large prospective Asian cohorts. Methods The Fushimi AF Registry is a community-based prospective survey designed to enroll all AF patients who visited the participating medical institutions in Fushimi-ku, Kyoto, Japan. Follow-up data were available for 3,304 patients (median follow-up period 741 days). We explored the predictors for 'death, stroke, and systemic embolism (SE)' during follow-up in 1,541 patients not receiving oral anticoagulants (OAC) at baseline. Results The mean age was 73.1 +/- 12.5 years, and 673 (44%) patients were female. The mean CHADS2 and CHA2DS2-VASc scores were 1.76 and 3.08, respectively. Cumulative events were as follows: stroke/SE in 61 (4%) and death in 230 (15%), respectively. On multivariate analysis, advanced age (hazard ratio (HR): 1.68, 95% confidence interval (CI): 1.24-2.29), underweight (body mass index <18.5 kg/m(2)) (HR: 1.71, 95% CI: 1.25-2.32), previous stroke/SE/transient ischemic attack (HR: 1.70, 95% CI: 1.25-2.30), heart failure (HR: 1.59, 95% CI: 1.17-2.15), chronic kidney disease (HR: 1.53, 95% CI: 1.16-2.02), and anemia (HR: 2.41, 95% CI: 1.78-3.28) were independent predictors for death/stroke/SE. Cumulative numbers of these 6 risk predictors could stratify the incidence of death/stroke/SE in patients without OAC, as well as those with OAC in our registry. Conclusions Advanced age, underweight, previous stroke/SE/transient ischemic attack, heart failure, chronic kidney disease, and anemia were independently associated with the risk of death/stroke/SE in non-anticoagulated Japanese AF patients.	[Hamatani, Yasuhiro; Yamashita, Yugo; Abe, Mitsuru; Akao, Masaharu] Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Esato, Masahiro; Chun, Yeong-Hwa] Ijinkai Takeda Gen Hosp, Dept Arrhythmia, Kyoto, Japan; [Tsuji, Hikari] Tsuji Clin, Kyoto, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto, Japan; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	University of Birmingham; Aalborg University	Akao, M (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan.	akao@kuhp.kyoto-u.ac.jp	Yamashita, Yugo/S-7190-2019	Wada, Hiromichi/0000-0002-8980-224X	Boehringer Ingelheim; Bayer Healthcare; Pfizer; Bristol-Myers Squibb; Astellas Pharma; AstraZeneca; Daiichi-Sankyo; Novartis Pharma; MSD; Sanofi-Aventis; Takeda Pharmaceutical	Boehringer Ingelheim(Boehringer Ingelheim); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Astellas Pharma(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Novartis Pharma; MSD; Sanofi-Aventis(Sanofi-Aventis); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd)	The Fushimi AF Registry is supported by research funding from Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi-Sankyo, Novartis Pharma, MSD, Sanofi-Aventis and Takeda Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Banerjee A, 2013, J AM COLL CARDIOL, V61, P2079, DOI 10.1016/j.jacc.2013.02.035; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guo YT, 2013, INT J CARDIOL, V168, P1502, DOI 10.1016/j.ijcard.2012.12.099; Hamatani Y, 2015, CIRC J, V79, P1009, DOI 10.1253/circj.CJ-14-1245; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Inoue H, 2014, AM J CARDIOL, V113, P957, DOI 10.1016/j.amjcard.2013.11.057; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Lip GYH, 2007, EUR HEART J, V28, P752, DOI 10.1093/eurheartj/ehl504; Lip GYH, 2014, EUR HEART J, V35, P3365, DOI 10.1093/eurheartj/ehu374; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Muzzarelli S, 2006, AM HEART J, V152, P991, DOI 10.1016/j.ahj.2006.06.014; Nakagawa K, 2011, AM J CARDIOL, V107, P912, DOI 10.1016/j.amjcard.2010.10.074; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; PETERSEN P, 1990, ARCH INTERN MED, V150, P819, DOI 10.1001/archinte.150.4.819; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Puurunen M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004700; Sharma S, 2009, AM HEART J, V157, P1057, DOI 10.1016/j.ahj.2009.03.009; Vaglio J, 2005, AM J CARDIOL, V96, P496, DOI 10.1016/j.amjcard.2005.04.008; Wang J, 2014, CLIN RES CARDIOL, V103, P533, DOI 10.1007/s00392-014-0681-7; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang YM, 2014, INT J CARDIOL, V173, P242, DOI 10.1016/j.ijcard.2014.02.040; Zeng WT, 2015, STROKE, V46, P157, DOI 10.1161/STROKEAHA.114.006881	38	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142394	10.1371/journal.pone.0142394	http://dx.doi.org/10.1371/journal.pone.0142394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540107	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800092
J	Kremer, PHC; Jolink, WMT; Kappelle, LJ; Algra, A; Klijn, CJM				Kremer, Philip H. C.; Jolink, Wilmar M. T.; Kappelle, L. Jaap; Algra, Ale; Klijn, Catharina J. M.		SMART ESPRIT Study Grp	Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease	PLOS ONE			English	Article							ISCHEMIC-STROKE; GENERAL-POPULATION; CEREBRAL-ISCHEMIA; ARTERIAL ORIGIN; DEEP; HISPANICS; ETIOLOGY; BLACKS; DESIGN; ESPRIT	Introduction Lobar and non-lobar non-traumatic intracerebral hemorrhage (ICH) are presumably caused by different types of small vessel diseases. The aim of this study was to assess risk factors for ICH according to location. Methods In two large prospective studies, SMART (n = 9088) and ESPRIT (n = 2625), including patients with manifest cardiovascular, cerebrovascular or peripheral artery disease or with vascular risk factors, we investigated potential risk factors for ICH during follow-up according to lobar or non-lobar location by Cox proportional hazards analyses. Results During 65,156 patient years of follow up 19 patients had lobar ICH (incidence rate 29, 95% CI 19-42 per 100,000 person-years) and 24 non-lobar ICH (incidence rate 37, 95% CI 2651 per 100,000 person-years). Age significantly increased the risk of lobar ICH (HR per 10 years increase 1.90; 95% CI 1.17-3.10) in the multivariable analysis, but not of non-lobar hemorrhage. Anticoagulant medication (HR 3.49; 95% CI 1.20-10.2) and male sex (HR 3.79; 95% CI 1.13-12.8) increased the risk of non-lobar but not lobar ICH. Conclusion This study shows an elevated risk of future ICH in patients with manifestations of, or risk factors for, cardiovascular, cerebrovascular or peripheral artery disease. Our data suggest that risk factors for ICH vary according to location, supporting the hypothesis of a differential pathophysiology of lobar and non-lobar ICH.	[Kremer, Philip H. C.; Jolink, Wilmar M. T.; Kappelle, L. Jaap; Algra, Ale; Klijn, Catharina J. M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Klijn, Catharina J. M.] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behav,Dept Neurol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Klijn, CJM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	Karin.Klijn@Radboudumc.nl	Klijn, C.J.M./E-1700-2016	Klijn, C.J.M./0000-0002-8495-4578; Visseren, Frank/0000-0003-3951-5223	Dutch Brain Foundation [BG 201302]; Dutch Heart Foundation [2012 T077, 2007B48]; ASPASIA grant from ZonMw [015008048]	Dutch Brain Foundation; Dutch Heart Foundation(Netherlands Heart Foundation); ASPASIA grant from ZonMw	The study was supported by a grant from the Dutch Brain Foundation (grant number BG 201302) to Prof. dr. L.J. Kappelle. Prof dr. C.J.M. Klijn is supported by a clinical established investigator grant of the Dutch Heart Foundation (grant number 2012 T077) and an ASPASIA grant from ZonMw (grant number 015008048). Dr. Jolink was supported by a grant from the Dutch Heart Foundation (Grant Number 2007B48).	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Bejot Y, 2013, BRAIN, V136, P658, DOI 10.1093/brain/aws349; Biffi A, 2011, STROKE, V42, P2526, DOI 10.1161/STROKEAHA.111.617225; Biffi A, 2010, ANN NEUROL, V68, P934, DOI 10.1002/ana.22134; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Dequatre-Ponchelle N, 2013, STROKE, V44, P350, DOI 10.1161/STROKEAHA.112.672303; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferket BS, 2014, NEUROLOGY, V82, P1804, DOI 10.1212/WNL.0000000000000427; Flaherty ML, 2006, NEUROLOGY, V66, P956, DOI 10.1212/01.wnl.0000218670.19577.4c; Garcia-Rodriguez LA, 2013, NEUROLOGY, V81, P566, DOI 10.1212/WNL.0b013e31829e6ffa; Halkes PHA, 2006, LANCET, V367, P1665; Howard G, 2013, STROKE, V44, P1282, DOI 10.1161/STROKEAHA.111.000529; Jackson CA, 2006, J NEUROL NEUROSUR PS, V77, P1244, DOI 10.1136/jnnp.2006.089292; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Maas MB, 2013, NEUROCRIT CARE, V18, P166, DOI 10.1007/s12028-012-9814-x; Martini SR, 2012, NEUROLOGY, V79, P2275, DOI 10.1212/WNL.0b013e318276896f; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pezzini A, 2014, NEUROLOGY, V82, P529, DOI 10.1212/WNL.0000000000000108; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van de Woestijne AP, 2014, EUR J CLIN INVEST, V44, P184, DOI 10.1111/eci.12206; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Zia E, 2006, CEREBROVASC DIS, V21, P18, DOI 10.1159/000089589	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142338	10.1371/journal.pone.0142338	http://dx.doi.org/10.1371/journal.pone.0142338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540190	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800084
J	Caron, JM; Caron, JM				Caron, Joan McIntyre; Caron, Jane McIntyre			Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells	PLOS ONE			English	Article							MOUSE MAMMARY-TUMOR; MANIFESTS ANTICANCER ACTIVITY; INDUCIBLE FACTOR; POSTTRANSLATIONAL MODIFICATION; TRANSFERRIN RECEPTOR; TUBULIN SYNTHESIS; IRON HOMEOSTASIS; GENE-EXPRESSION; IN-VIVO; PALMITOYLATION	Metastatic cancer causes 90% of cancer deaths. Unlike many primary tumors, metastatic tumors cannot be cured by surgery alone. Metastatic cancer requires chemotherapy. However, metastatic cells are not easily killed by chemotherapy. These problems with chemotherapy are caused in part by the metastatic cell niche: hypoxia. Here we show that the molecule, methyl sulfone, normalized metastatic metabolism of hypoxic breast cancer and melanoma cells by altering several metabolic functions of the cells. Under hypoxia, methyl sulfone decreased expression of the master regulator of hypoxia, HIF-1 alpha, and reduced levels of the glycolytic enzymes, PKM2, LDHA, GLUT1, the pro-angiogenic protein, VEGF, and the iron-sulfur metabolism molecules, miR-210 and transferrin, all of which promote metastasis. Conversely, methyl sulfone increased levels of ISCU1/2 and ferroportin, proteins associated with iron-sulfur cluster biogenesis and iron homeostasis in normal cells. These data identify methyl sulfone as a multi-targeting molecule that blocks the survival/proliferative effect of hypoxia on metastatic cells and brings normality back to cellular metabolism.	[Caron, Joan McIntyre; Caron, Jane McIntyre] JMCaron LLC, Thomaston, CT 06787 USA		Caron, JM (corresponding author), JMCaron LLC, Thomaston, CT 06787 USA.	JoanCaron@JMCaronllc.com			Methyl Sulfone Research Fund; University of Connecticut Foundation, Storrs, CT	Methyl Sulfone Research Fund; University of Connecticut Foundation, Storrs, CT	This work was supported by the Methyl Sulfone Research Fund (JoMC); this fund was managed by the University of Connecticut Foundation, Storrs, CT. Donors to this fund are Connecticut State Residents whose identity remains anonymous to JoMC. The University of Connecticut Foundation had no input into any part of this research, including study design, data collection and analysis, decision to publish, or preparation of this manuscript. The company, JMCaron, LLC, provided no funding for this study. JMCaron, LLC, has no assets, nor has the company ever had any assets. JoMC has a patent pending for the use of methyl sulfone in the treatment of metastatic cancer. JoMC's affiliation with JMCaron, LLC, does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. JoMC obtained funding through donations to the Methyl Sulfone Research Fund, an account established by the University of Connecticut Foundation for Dr. Caron. This sole source of funding covered salary, indirect costs and lab supplies for JoMC. Neither the company (JMCaron, LLC) nor the University of Connecticut Foundation (including donors) played a role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific contributions of the authors to this study are articulated in the "Author Contribution Section".	Airley R, 2001, CLIN CANCER RES, V7, P928; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Behrooz A, 1997, J BIOL CHEM, V272, P5555, DOI 10.1074/jbc.272.9.5555; Bureau USC, 2014, ANN EST RES POP; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; CARON JM, 1989, J CELL PHYSIOL, V138, P603, DOI 10.1002/jcp.1041380322; Caron JM, 2001, MOL BIOL CELL, V12, P2672, DOI 10.1091/mbc.12.9.2672; CARON JM, 1985, NATURE, V317, P648, DOI 10.1038/317648a0; Caron JM, 2007, CHEMOTHERAPY, V53, P51, DOI 10.1159/000098419; Caron JM, 2013, CHEMOTHERAPY, V59, P24, DOI 10.1159/000351099; Caron JM, 2013, CHEMOTHERAPY, V59, P14, DOI 10.1159/000351100; Caron JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011788; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; DEXTER DL, 1978, CANCER RES, V38, P3174; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Faber M. P JLR, 1990, EVOLUTION TIME PRODU; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Filipp Fabian V, 2013, J Carcinog, V12, P14, DOI 10.4103/1477-3163.115423; Gosselin RE, 1984, CLIN TOXICOLOGY COMM; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; HAGER JC, 1981, CANCER RES, V41, P1720; He M, 2012, J BIOL CHEM, V287, P43995, DOI 10.1074/jbc.M112.417501; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jian JL, 2011, FREE RADICAL BIO MED, V50, P841, DOI 10.1016/j.freeradbiomed.2010.12.028; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kaplan J, 2011, INT J HEMATOL, V93, P14, DOI 10.1007/s12185-010-0760-0; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Krutilina R, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3693; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Macedo Maria F., 2008, Inflammation & Allergy Drug Targets, V7, P41, DOI 10.2174/187152808784165162; Magnuson BA, 2007, J AGR FOOD CHEM, V55, P1033, DOI 10.1021/jf0621469; Ozols J, 1997, MOL BIOL CELL, V8, P637, DOI 10.1091/mbc.8.4.637; Piwowarczyk K, 2015, EXPERT OPIN THER TAR, V19, P163, DOI 10.1517/14728222.2014.981153; Qin Q, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-50; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; SACKETT DL, 1994, BIOCHEMISTRY-US, V33, P12868, DOI 10.1021/bi00209a019; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen GM, 2013, ACTA PHARMACOL SIN, V34, P336, DOI 10.1038/aps.2012.195; Sinkevicius KW, 2014, P NATL ACAD SCI USA, V111, P10299, DOI 10.1073/pnas.1404399111; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10851; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Wu XN, 2014, EUR J CANCER PREV, V23, P122, DOI 10.1097/CEJ.0b013e3283627f14; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu L, 2013, GYNECOL ONCOL, V128, P391, DOI 10.1016/j.ygyno.2012.11.002	68	10	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141565	10.1371/journal.pone.0141565	http://dx.doi.org/10.1371/journal.pone.0141565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536104	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400070
J	Chanson-Rolle, A; Aubin, F; Braesco, V; Hamasaki, T; Kitakaze, M				Chanson-Rolle, Aurelie; Aubin, Francois; Braesco, Veronique; Hamasaki, Toshimitsu; Kitakaze, Masafumi			Influence of the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CASEIN HYDROLYSATE; SOUR MILK; ANTIHYPERTENSIVE PEPTIDES; HYPERTENSION; INHIBITORS; BLIND	Background The lactotripeptides isoleucine-proline-proline (IPP) and valine-proline-proline (VPP)have been shown to decrease systolic blood pressure (SBP) in several populations, but the size of the effect varies among studies. We performed a meta-analysis including all published studies to evaluate the SBP-lowering effect of IPP/VPP in Japanese subjects more comprehensively. Methods and Findings Eligible randomized controlled trials were searched for within four bibliographic databases, including two Japanese ones. Eighteen studies (including a total of 1194 subjects) were included in the meta-analysis. A random effect model using the restricted maximum likelihood (REML) estimator was used for the analysis. The analysis showed that consumption of IPP/VPP induced a significant reduction in SBP as compared with placebo in Japanese subjects, with an estimated effect of -5.63 mm Hg (95% CI, -6.87 to -4.39, P<0.0001) and no evidence of publication bias. A significant heterogeneity between series was evident, which could be explained by a significant influence of the baseline blood pressure status of the subjects, the effect of IPP/VPP on SBP being stronger in hypertensive subjects (-8.35 mm Hg, P< 0.0001) than in non-hypertensive subjects (-3.42mm Hg, P<0.0001). Furthermore, the effect of IPP/VPP on SBP remained significant when limiting the analysis to series that tested the usual doses of IPP/VPP consumed daily (below 5 mg/d), with estimated effects of -6.01 mm Hg in the overall population and -3.32 mm Hg in non-hypertensive subjects. Conclusions Results from this meta-analysis show that IPP/VPP lactotripeptides can significantly reduce office SBP in Japanese subjects with or without overt hypertension, and for doses that can potentially be consumed as an everyday supplement. This suggests that these peptides could play a role in controlling blood pressure in Japanese subjects. The systematic review protocol was published on the PROSPERO register (CRD42014014322).	[Chanson-Rolle, Aurelie; Braesco, Veronique] VAB Nutr, Clermont Ferrand, France; [Aubin, Francois] Venn Life Sci, Paris, France; [Hamasaki, Toshimitsu] Natl Cerebral & Cardiovasc Ctr, Dept Adv Med Technol, Osaka, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Chanson-Rolle, A (corresponding author), VAB Nutr, Clermont Ferrand, France.	aurelie.chanson-rolle@vab-nutrition.com	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160	Calpis Co., Ltd., Japan; VAB-nutrition; Venn Life Sciences	Calpis Co., Ltd., Japan; VAB-nutrition; Venn Life Sciences	This work was sponsored by Calpis Co., Ltd. (a subsidiary of Asahi Group Holdings, Ltd), 1110, 5-chome, Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252-0206, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ACR and VB are employed by VAB-nutrition. FA is employed by Venn Life Sciences. VAB-nutrition and Venn Life Sciences provided support in the form of salaries for authors ACR, VB and FA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aihara K, 2005, J AM COLL NUTR, V24, P257, DOI 10.1080/07315724.2005.10719473; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cicero AFG, 2011, J HUM HYPERTENS, V25, P425, DOI 10.1038/jhh.2010.85; Cicero AFG, 2013, AM J HYPERTENS, V26, P442, DOI 10.1093/ajh/hps044; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Fekete AA, 2015, NUTRIENTS, V7, P659, DOI 10.3390/nu7010659; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Hirata H., 2002, J NEW REM CLIN, V51, P61; Hirota T, 2011, HEART VESSELS, V26, P549, DOI 10.1007/s00380-010-0096-y; Ishida Y., 2007, J PHARM THER, V35, P1249; Ishida Y., 2006, J PHARM THER, V34, P1107; Ishida Y, 2011, BIOSCI BIOTECH BIOCH, V75, P427, DOI 10.1271/bbb.100560; Itakura H., 2001, J JPN SOC CLIN NUTR, V23, P26; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jurgens G, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004022.pub2, DOI 10.1002/14651858.CD004022.PUB2]; Kajimoto O., 2001, Journal of Japanese Society of Nutrition and Food Science, V54, P347; Kajimoto O., 2001, J NUTR FOOD, V4, P51; Kajimoto O., 2002, J NUTR FOOD, V5, P55; Kajimoto O, 2007, J NEW REM CLIN, V56, P129; Kajimoto O., 2001, J NUTR FOOD, V4, P37; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Masuda O, 1996, J NUTR, V126, P3063, DOI 10.1093/jn/126.12.3063; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Mizuno S, 2005, BRIT J NUTR, V94, P84, DOI 10.1079/BJN20051422; Mizushima S, 2004, AM J HYPERTENS, V17, P701, DOI 10.1016/j.amjhyper.2004.03.674; Murakami Y, 2008, HYPERTENSION, V51, P1483, DOI 10.1161/HYPERTENSIONAHA.107.102459; Nakamura K, 2014, WORLD J CARDIOL, V6, P531, DOI 10.4330/wjc.v6.i7.531; Nakamura T, 2011, ATHEROSCLEROSIS, V219, P298, DOI 10.1016/j.atherosclerosis.2011.06.007; NAKAMURA Y, 1995, J DAIRY SCI, V78, P1253, DOI 10.3168/jds.S0022-0302(95)76745-5; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Nakamura Y., 2004, J NUTR FOOD, V7, P123; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Pripp Are Hugo, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1641; Sano J, 2005, J MED FOOD, V8, P423, DOI 10.1089/jmf.2005.8.423; Sano J, 2004, J NUTR FOOD, V7, P17; Sutton A.J., 2000, METHODS METAANALYSIS; UESHIMA H, 1987, J HUM HYPERTENS, V1, P113; Usinger L, 2010, CLIN PHYSIOL FUNCT I, V30, P162, DOI 10.1111/j.1475-097X.2009.00921.x; van der Zander K, 2008, AM J CLIN NUTR, V88, P1697, DOI 10.3945/ajcn.2008.26003; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Xu JY, 2008, NUTRITION, V24, P933, DOI 10.1016/j.nut.2008.04.004; Yamaguchi N, 2009, EUR J PHARMACOL, V620, P71, DOI 10.1016/j.ejphar.2009.08.005; Yoshizawa M, 2010, AM J HYPERTENS, V23, P368, DOI 10.1038/ajh.2009.270	46	15	15	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142235	10.1371/journal.pone.0142235	http://dx.doi.org/10.1371/journal.pone.0142235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536628	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400147
J	Galetti, M; Petronini, PG; Fumarola, C; Cretella, D; La Monica, S; Bonelli, M; Cavazzoni, A; Saccani, F; Caffarra, C; Andreoli, R; Mutti, A; Tiseo, M; Ardizzoni, A; Alfieri, RR				Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Tiseo, Marcello; Ardizzoni, Andrea; Alfieri, Roberta R.			Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CANCER RESISTANCE PROTEIN; BINDING CASSETTE TRANSPORTERS; MULTIDRUG TRANSPORTERS; CHEMORESISTANCE; MECHANISMS; MODULATORS; SUBSTRATE; FAMILY; ZD1839	Background BCRP/ABCG2 emerged as an important multidrug resistance protein, because it confers resistance to several classes of cancer chemotherapeutic agents and to a number of novel molecularly-targeted therapeutics such as tyrosine kinase inhibitors. Gefitinib is an orally active, selective EGFR tyrosine kinase inhibitor used in the treatment of patients with advanced non small cell lung cancer (NSCLC) carrying activating EGFR mutations. Membrane transporters may affect the distribution and accumulation of gefitinib in tumour cells; in particular a reduced intracellular level of the drug may result from poor uptake, enhanced efflux or increased metabolism. Aim The present study, performed in a panel of NSCLC cell lines expressing different ABCG2 plasma membrane levels, was designed to investigate the effect of the efflux transporter ABCG2 on intracellular gefitinib accumulation, by dissecting the contribution of uptake and efflux processes. Methods and Results Our findings indicate that gefitinib, in lung cancer cells, inhibits ABCG2 activity, as previously reported. In addition, we suggest that ABCG2 silencing or overexpression affects intracellular gefitinib content by modulating the uptake rather than the efflux. Similarly, overexpression of ABCG2 affected the expression of a number of drug transporters, altering the functional activities of nutrient and drug transport systems, in particular inhibiting MPP, glucose and glutamine uptake. Conclusions Therefore, we conclude that gefitinib is an inhibitor but not a substrate for ABCG2 and that ABCG2 overexpression may modulate the expression and activity of other transporters involved in the uptake of different substrates into the cells.	[Galetti, Maricla; Petronini, Pier Giorgio; Fumarola, Claudia; Cretella, Daniele; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Saccani, Francesca; Caffarra, Cristina; Andreoli, Roberta; Mutti, Antonio; Alfieri, Roberta R.] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Galetti, Maricla; Mutti, Antonio] Univ Parma, Res Ctr, Italian Workers Compensat Author INAIL, I-43100 Parma, Italy; [Tiseo, Marcello] Univ Hosp Parma, Div Med Oncol, Parma, Italy; [Ardizzoni, Andrea] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy	University of Parma; University Hospital of Parma; University of Parma; University of Parma; University Hospital of Parma; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Petronini, PG (corresponding author), Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy.	piergiorgio.petronini@unipr.it	Tiseo, Marcello/K-6119-2016; caffarra, cristina/I-2361-2018; Mutti, Antonio/C-1095-2011; Mutti, Antonio/ABE-3833-2021; ardizzoni, andrea/AAC-4337-2021; Cavazzoni, Andrea/J-8079-2019; Alfieri, Roberta R/G-6350-2012; Mutti, Antonio/AAB-9037-2020; Galetti, Maricla/AAJ-8927-2020; Cretella, Daniele/AAB-2482-2019; Galetti, Maricla/CAG-4178-2022	Tiseo, Marcello/0000-0002-9553-8465; caffarra, cristina/0000-0003-4582-353X; Mutti, Antonio/0000-0003-2189-3808; ardizzoni, andrea/0000-0003-2678-0714; Cavazzoni, Andrea/0000-0002-3752-1868; Mutti, Antonio/0000-0003-2189-3808; Galetti, Maricla/0000-0002-8061-8649; Galetti, Maricla/0000-0002-8061-8649; La Monica, Silvia/0000-0003-3578-3917	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, A.VO.PRO.RI.T., Parma [IG 8856]; Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, A.VO.PRO.RI.T., Parma(Fondazione AIRC per la ricerca sul cancro); Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, grant IG 8856. A.VO.PRO.RI.T., Parma; Associazione Augusto per la Vita (Novellara, RE); Associazione Davide Rodella, Montichiari.	Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Alfieri RR, 2006, J PHYSIOL-LONDON, V576, P391, DOI 10.1113/jphysiol.2006.115006; Alfieri RR, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-143; Anreddy N, 2014, MOLECULES, V19, P13848, DOI 10.3390/molecules190913848; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brozik A, 2011, EXPERT OPIN DRUG MET, V7, P623, DOI 10.1517/17425255.2011.562892; Cavazzoni A, 2008, MOL CANCER THER, V7, P361, DOI 10.1158/1535-7163.MCT-07-0477; Cavazzoni A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-91; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Galetti M, 2010, BIOCHEM PHARMACOL, V80, P179, DOI 10.1016/j.bcp.2010.03.033; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hegedus C, 2009, CURR CANCER DRUG TAR, V9, P252; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Kim M, 2002, CLIN CANCER RES, V8, P22; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Li J, 2007, CANCER BIOL THER, V6, P432, DOI 10.4161/cbt.6.3.3763; Li XH, 2009, CHEM RES TOXICOL, V22, P1736, DOI 10.1021/tx900256y; Maliepaard M, 2001, CANCER RES, V61, P3458; Miyake K, 1999, CANCER RES, V59, P8; Nagashima S, 2006, CANCER CHEMOTH PHARM, V58, P594, DOI 10.1007/s00280-006-0212-y; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Pan GY, 2010, MOL PHARMACEUT, V7, P138, DOI 10.1021/mp900177r; Petronini PG, 2000, AM J PHYSIOL-REG I, V279, pR1580, DOI 10.1152/ajpregu.2000.279.5.R1580; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shukla S, 2012, DRUG RESIST UPDATE, V15, P70, DOI 10.1016/j.drup.2012.01.005; Stam RW, 2004, LEUKEMIA, V18, P78, DOI 10.1038/sj.leu.2403168; Stewart CF, 2004, CANCER RES, V64, P7491, DOI 10.1158/0008-5472.CAN-04-0096; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wang XK, 2010, CURR DRUG METAB, V11, P618; Wang YJ, 2014, CANCERS, V6, P1925, DOI 10.3390/cancers6041925; Wang ZY, 2013, INT J PHARMACEUT, V441, P40, DOI 10.1016/j.ijpharm.2012.12.011; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yanase K, 2004, MOL CANCER THER, V3, P1119; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang K, 2015, CRIT REV ONCOL HEMAT, V93, P277, DOI 10.1016/j.critrevonc.2014.11.001; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	45	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141795	10.1371/journal.pone.0141795	http://dx.doi.org/10.1371/journal.pone.0141795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536031	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400087
J	Haxaire, C; Tromeur, C; Couturaud, F; Leroyer, C				Haxaire, Claudie; Tromeur, Cecile; Couturaud, Francis; Leroyer, Christophe			A Qualitative Study to Appraise Patients and Family Members Perceptions, Knowledge, and Attitudes towards Venous Thromboembolism Risk	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; OF-LIFE; PULMONARY-EMBOLISM; PREDICT RISK; THROMBOSIS; THROMBOPHILIA; ADHERENCE; DISEASE; ASSOCIATION; MUTATION	Objective This study aimed to examine perception, knowledge and concerns developed by patients and their family as regards venous thromboembolism (VTE) risk. Methods We conducted a qualitative study. Participants were: (1) patients with unprovoked VTE with either factor V Leiden mutation or G20210A prothrombin gene mutation or not; and (2) their first-degree relatives. Interviews took place mostly at Brest University Hospital. Participants produced narratives of the patient's illness, stressing their perception of the disorder, its mechanisms, etiology, circumstances and risk factors. Interviews were audiotaped and transcribed verbatim. On an ongoing basis, central themes were identified and data from narratives were categorized by these themes. Results A total of ten patients and 25 first-degree relatives were interviewed. Analyses of patient's narratives suggested 4 main themes: (1) concerns about initial symptoms and suspicion of VTE. The longer the duration of the initial phase, the more likely anxiety took place and persisted after diagnosis; (2) underestimation of potential life-threatening episode once being managed in emergency; (3) possible biographical disruption with inability to cope with the event; and (4) secondary prevention attitudes motivated by remains of the episode and favoring general prevention attitudes. Analyses of the first-degree relatives narratives suggested 3 main themes: (1) common interpretation of the VTE episode shared within the family; (2) diverse and sometimes confusing interpretation of the genetic status; and, (3) interpretation of clinical signs linked to VTE transmission within the family. Conclusions Construction of the risk of VTE is based on patient's initial experience and shared within the family. Collection of narratives illustrates the gap between these perceptions and current medical knowledge. These results support the need to collect the perceptions of the VTE episode and its consequences, as a prerequisite to any health education process.	[Haxaire, Claudie] Univ Brest, Univ Europeenne Bretagne, LABERS, EA 3149, Brest, France; [Haxaire, Claudie] Univ Paris 05, CNRS UMR 8211, INSERM, EHESS,CERMES3,U988, Paris, France; [Tromeur, Cecile; Couturaud, Francis; Leroyer, Christophe] Univ Brest, Univ Europeenne Bretagne, IFR148,EA3878, Hop La Cavale Blanche Dept Med Interne & Pneumol, Brest, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bretagne Occidentale	Leroyer, C (corresponding author), Univ Brest, Univ Europeenne Bretagne, IFR148,EA3878, Hop La Cavale Blanche Dept Med Interne & Pneumol, Brest, France.	christophe.leroyer@chu-brest.fr	Couturaud, Francis/Q-1366-2019	Couturaud, Francis/0000-0002-1855-8032; tromeur, cecile/0000-0001-9161-7521; leroyer, christophe/0000-0002-7601-1692	Groupe de Recherche de Bretagne Occidentale (GETBO); la Maison des Sciences de l'Homme de Bretagne	Groupe de Recherche de Bretagne Occidentale (GETBO); la Maison des Sciences de l'Homme de Bretagne	This study was partially funded by The Groupe de Recherche de Bretagne Occidentale (GETBO) AND la Maison des Sciences de l'Homme de Bretagne.	Anderson M A, 1991, ABNF J, V2, P28; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Cohn DM, 2008, J THROMB HAEMOST, V6, P1099, DOI 10.1111/j.1538-7836.2008.03005.x; Couturaud F, 2005, THROMB HAEMOSTASIS, V93, P605, DOI 10.1160/TH04-11-0741; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Heidbuchel H, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0046-0; Jones CJ, 2014, HEALTH PSYCHOL REV, V8, P253, DOI 10.1080/17437199.2013.802623; Kahn SR, 2004, J THROMB HAEMOST, V2, P2146, DOI 10.1111/j.1538-7836.2004.00957.x; Kaptein AA, 2007, HEALTH PSYCHOL, V26, P807, DOI 10.1037/0278-6133.26.6.807; Liu CP, 2011, CHINESE MED J-PEKING, V124, P2438, DOI 10.3760/cma.j.issn.0366-6999.2011.16.007; Lukas PS, 2009, THROMB HAEMOSTASIS, V102, P1219, DOI 10.1160/TH09-05-0316; Mattingly CGL, 1994, SOC SCI MED, V38, P4; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Noack F, 2015, VASC HEALTH RISK MAN, V11, P397, DOI 10.2147/VHRM.S81411; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Staniute M, 2014, EUR J CARDIOVASC NUR, V13, P338, DOI 10.1177/1474515113496942; Turner Victor, 1990, MEANS PERFORMANCE, P1; van Es J, 2013, THROMB RES, V132, P500, DOI 10.1016/j.thromres.2013.06.016; van Geffen ME, 2015, J REHABIL MED, V47, P569, DOI 10.2340/16501977-1967; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Wang Y, 2014, THROMB RES, V133, P550, DOI 10.1016/j.thromres.2014.01.002; Wilkinson L, 2004, RISK SOC 2004, V8, P8; Zempleni A, 1985, ETHNOGRAPHIE, V96-97, P31	26	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142070	10.1371/journal.pone.0142070	http://dx.doi.org/10.1371/journal.pone.0142070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536460	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400127
J	Wang, YZ; Wu, JH; Ma, X; Liu, B; Su, R; Jiang, Y; Wang, W; Dong, Y				Wang, Yangzi; Wu, Jianghong; Ma, Xiao; Liu, Bin; Su, Rui; Jiang, Yu; Wang, Wen; Dong, Yang			Single Base-Resolution Methylome of the Dizygotic Sheep	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; CPG ISLAND METHYLATION; DNA METHYLATION; REVEALS; MEMORY	Sheep is an important livestock in the world for meat, dairy and wool production. The third version of sheep reference genome has been recently assembled, but sheep DNA methylome has not been profiled yet. In this study, we report the comprehensive sheep methylome with 94.38% cytosine coverage at single base resolution by sequencing DNA samples from Longissimus dorsi of dizygotic Sunit sheep, which were bred in different habitats. We also compared methylomes between the twin sheep. DNA methylation status at genome-scale differentially methylated regions (DMRs), functional genomic regions and 248 DMR-containing genes were identified between the twin sheep. Gene ontology (GO) and KEGG annotations of these genes were performed to discover computationally predicted function. Lipid metabolism, sexual maturity and tumor-associated categories were observed to significantly enrich DMR-containing genes. These findings could be used to illustrate the relationship between phenotypic variations and gene methylation patterns.	[Wang, Yangzi] Kunming Univ Sci & Technol, Chenggong Dist, Kunming, Peoples R China; [Wu, Jianghong; Liu, Bin; Su, Rui; Jiang, Yu; Wang, Wen; Dong, Yang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wu, Jianghong; Liu, Bin] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China; [Wu, Jianghong] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China; [Ma, Xiao] Yunnan Agr Univ, Kunming, Peoples R China; [Su, Rui] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China; [Jiang, Yu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Yunnan Agricultural University; Inner Mongolia Agricultural University; Northwest A&F University - China	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wwang@mail.kiz.ac.cn; dongyang@dongyang-lab.org	Wang, Wen/AAP-9873-2020; wu, Jianghong/E-7587-2015; Jiang, Yu/O-5114-2015	wu, Jianghong/0000-0003-4027-2345; Jiang, Yu/0000-0003-4821-3585; MA, Xiao/0000-0003-0044-531X	Chinese 863 program [2013AA102506]; National Natural Science Foundations of China [31201773, 31560623]; State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF13-02]; China Postdoctoral Science Foundation [2014M562351]	Chinese 863 program(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Chinese 863 program (2013AA102506), the National Natural Science Foundations of China (31201773 and 31560623), the open project of the State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences (GREKF13-02) to JW, and the China Postdoctoral Science Foundation (2014M562351) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2015, GENOME BIOL, P16; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Baylin SB, 1998, ADV CANCER RES, V72, P141; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Couldrey C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101853; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Johnson MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004813; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Khatib H, 2012, LIVESTOCK EPIGENETICS, P1, DOI 10.1002/9781119949930; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-598; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lockett GA, 2010, NEUROREPORT, V21, P909, DOI 10.1097/WNR.0b013e32833e9288; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; NAKAMURA K, 1995, MICROBIOL-SGM, V141, P2965, DOI 10.1099/13500872-141-11-2965; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132866; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	47	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142034	10.1371/journal.pone.0142034	http://dx.doi.org/10.1371/journal.pone.0142034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536671	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400120
J	Rodriguez-Lima, O; Garcia-Gutierrez, P; Jimenez, L; Zarain-Herzberg, A; Lazzarini, R; Landa, A				Rodriguez-Lima, Oscar; Garcia-Gutierrez, Ponciano; Jimenez, Lucia; Zarain-Herzberg, Angel; Lazzarini, Roberto; Landa, Abraham			Molecular Cloning of a cDNA Encoding for Taenia solium TATA-Box Binding Protein 1 (TsTBP1) and Study of Its Interactions with the TATA-Box of Actin 5 and Typical 2-Cys Peroxiredoxin Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; TRANSCRIPTION; TBP; COMPLEX; DNA; CYSTICERCOSIS; RECOGNIZES; PATTERNS; CESTODA	TATA-box binding protein (TBP) is an essential regulatory transcription factor for the TATA-box and TATA-box-less gene promoters. We report the cloning and characterization of a full-length cDNA that encodes a Taenia solium TATA-box binding protein 1 (TsTBP1). Deduced amino acid composition from its nucleotide sequence revealed that encodes a protein of 238 residues with a predicted molecular weight of 26.7 kDa, and a theoretical pI of 10.6. The NH2-terminal domain shows no conservation when compared with to pig and human TBP1s. However, it shows high conservation in size and amino acid identity with taeniids TBP1s. In contrast, the TsTBP1 COOH-terminal domain is highly conserved among organisms, and contains the amino acids involved in interactions with the TATA-box, as well as with TFIIA and TFIIB. In silico TsTBP1 modeling reveals that the COOH-terminal domain forms the classical saddle structure of the TBP family, with one a-helix at the end, not present in pig and human. Native TsTBP1 was detected in T. solium cysticerci's nuclear extract by western blot using rabbit antibodies generated against two synthetic peptides located in the NH2 and COOH-terminal domains of TsTBP1. These antibodies, through immunofluorescence technique, identified the TBP1 in the nucleus of cells that form the bladder wall of cysticerci of Taenia crassiceps, an organism close related to T. solium. Electrophoretic mobility shift assays using nuclear extracts from T. solium cysticerci and antibodies against the NH2-terminal domain of TsTBP1 showed the interaction of native TsTBP1 with the TATA-box present in T. solium actin 5 (pAT5) and 2-Cys peroxiredoxin (Ts2-CysPrx) gene promoters; in contrast, when antibodies against the anti-COOH-terminal domain of TsTBP1 were used, they inhibited the binding of TsTBP1 to the TATA-box of the pAT5 promoter gene.	[Rodriguez-Lima, Oscar; Jimenez, Lucia; Landa, Abraham] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Garcia-Gutierrez, Ponciano] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico; [Zarain-Herzberg, Angel] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Lazzarini, Roberto] Univ Autonoma Metropolitana Iztapalapa, Dept Biol Expt, Mexico City 09340, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico	Landa, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.	landap@unam.mx		Garcia-Gutierrez, Ponciano/0000-0001-6178-3828; Lazzarini, Roberto/0000-0003-3537-1576; Rodriguez Lima, Oscar/0000-0002-2778-3872	Direccion General de Asuntos del Personal Academico [DGAPA-PAPIIT IN215714-3]; Consejo Nacional de Ciencia y Tecnologia [CONACyT-176925]; CONACyT [240037]	Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Direccion General de Asuntos del Personal Academico (DGAPA-PAPIIT IN215714-3); Consejo Nacional de Ciencia y Tecnologia (CONACyT-176925). ORL was supported by a scholarship (240037) from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; Almeida CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-35; Anandapadamanaban M, 2013, NAT STRUCT MOL BIOL, V20, P1008, DOI 10.1038/nsmb.2611; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Burley SK, 1996, PHILOS T ROY SOC B, V351, P483, DOI 10.1098/rstb.1996.0046; CAMPOS A, 1990, MOL BIOCHEM PARASIT, V40, P87, DOI 10.1016/0166-6851(90)90082-W; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; CHONG MS, 1991, POSTGRAD MED J, V67, P577, DOI 10.1136/pgmj.67.788.577; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Correa M, 1994, ENFERMEDADES TROPICA, V8, P335; Esquivel-Velazquez M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/516042; Everhart ME, 2004, J PARASITOL, V90, P79, DOI 10.1645/GE-3255; Fleury A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000805; Garcia HH, 2011, CURR OPIN INFECT DIS, V24, P423, DOI 10.1097/QCO.0b013e32834a1b20; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; HARN DA, 1992, J IMMUNOL, V148, P562; Hasan Md Shariful, 2011, Surg Neurol Int, V2, P177, DOI 10.4103/2152-7806.90698; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Jimenez L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/453469; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; LI SY, 1993, MOL BIOCHEM PARASIT, V61, P321, DOI 10.1016/0166-6851(93)90078-C; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Masson C, 1996, EXP CELL RES, V226, P114, DOI 10.1006/excr.1996.0209; Molina-Lopez J, 2006, J PARASITOL, V92, P796, DOI 10.1645/GE-754R.1; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Reichlen MJ, 2010, J BACTERIOL, V192, P1511, DOI 10.1128/JB.01165-09; Reyes-Juarez JL, 2007, J BIOL CHEM, V282, P35554; Ricardo PU, 2012, EXP PARASITOL, V130, P32, DOI 10.1016/j.exppara.2011.10.002; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; Sanabria-Ayala V, 2015, PARASITOL RES, V114, P55, DOI 10.1007/s00436-014-4159-3; SCHMIDT EE, 1995, DEVELOPMENT, V121, P2373; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SOTELO J, 1990, J NEUROL, V237, P69, DOI 10.1007/BF00314663; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Vaca-Paniagua F, 2009, PARASITOL RES, V105, P781, DOI 10.1007/s00436-009-1461-6; Victor SA, 2013, EXP PARASITOL, V134, P495, DOI 10.1016/j.exppara.2013.05.010; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045830; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283	51	1	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141818	10.1371/journal.pone.0141818	http://dx.doi.org/10.1371/journal.pone.0141818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529408	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600062
J	Sareila, O; Hagert, C; Rantakari, P; Poutanen, M; Holmdahl, R				Sareila, Outi; Hagert, Cecilia; Rantakari, Pia; Poutanen, Matti; Holmdahl, Rikard			Direct Comparison of a Natural Loss-Of-Function Single Nucleotide Polymorphism with a Targeted Deletion in the Ncf1 Gene Reveals Different Phenotypes	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; FEMALE SEX-HORMONES; DBA/1 MICE; SEVERITY; ENCEPHALOMYELITIS; IDENTIFICATION; SUPPRESSION; ANTIBODIES; MUTATION; DISEASE	The genetic targeting of mouse models has given insight into complex processes. However, phenotypes of genetically targeted mice are susceptible to artifacts due to gene manipulation, which may lead to misinterpretation of the observations. To directly address these issues, we have compared the immunological phenotypes of Ncf1 knockout mice with Ncf1(m1J) mice possessing a naturally occurring intronic loss-of-function SNP in their Ncf1 gene. Neutrophil cytosolic factor 1 NCF1) is the key regulatory component of the phagocytic NADPH oxidase 2 NOX2) complex. Defects in NCF1 lead to lower production of reactive oxygen species ROS) associated with autoimmune diseases in humans. In mice, collagen induced arthritis CIA) and psoriatic arthritis are autoimmune disorders known to be regulated by Ncf1, and they were utilized in the present study to compare the Ncf1 knockout with Ncf1m1J mice. Targeted Ncf1 knockout mice were generated on a pure C57BL/6N genetic background, and thereafter crossed with B10.Q.Ncf1(m1J) mice. The targeting silenced the Ncf1 gene as intended, and both the B6N; B10.Q.Ncf1(m1J) mice as well as the knockout littermates had reduced ROS production compared to wild type mice. Both also exhibited enhanced STAT1 signal transducer and activator of transcription 1) protein expression as an indicator of pronounced interferon signature reported recently for Ncf1 deficient mice. Surprisingly, female Ncf1 knockout mice were protected from CIA whereas the Ncf1(m1J) females developed severe disease. Ovariectomization retrieved the susceptibility of Ncf1 knockout females pointing to a sex hormone regulated protection against CIA in these mice. The data partly explains the discrepancy of the phenotypes reported earlier utilizing the Ncf1(m1J) mice or Ncf1 knockout mice. These observations indicate that even a targeted knockout mutation may lead to a different biological outcome in comparison to the natural loss-of-function mutation of the same gene.	[Sareila, Outi; Hagert, Cecilia; Rantakari, Pia; Holmdahl, Rikard] Univ Turku, Med Res Lab, Turku, Finland; [Hagert, Cecilia] Natl Doctoral Programme Informat & Struct Biol, Turku, Finland; [Rantakari, Pia; Poutanen, Matti] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Rantakari, Pia; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Holmdahl, Rikard] Karolinska Inst, Med Inflammat Res, Stockholm, Sweden	University of Turku; University of Turku; University of Turku; Karolinska Institutet	Holmdahl, R (corresponding author), Univ Turku, Med Res Lab, Turku, Finland.	rikard.holmdahl@ki.se	Fahlquist-Hagert, Cecilia/M-6248-2019; Holmdahl, Rikard/AAI-7682-2020; Poutanen, Matti/I-1700-2018	Fahlquist-Hagert, Cecilia/0000-0003-3850-4848; Poutanen, Matti/0000-0002-8953-1734; Sareila, Outi/0000-0001-5644-8216; Rantakari, Pia/0000-0003-1638-5075	Academy of Finland; Sigrid Juselius Foundation; Swedish Foundation for Strategic Research; National Doctoral Programme in Informational and Structural Biology; Turku University Foundation; Knut and Alice Wallenberg foundation; King Gustav V 80-years foundation; EU Innovative Medicine initiative BeTheCure grant; Swedish Research Council; European Union [Health-F2-2011-278611]; Finnish Cultural Foundation, Varsinais-Suomi Regional fund	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Doctoral Programme in Informational and Structural Biology; Turku University Foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); King Gustav V 80-years foundation; EU Innovative Medicine initiative BeTheCure grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Finnish Cultural Foundation, Varsinais-Suomi Regional fund(Finnish Cultural Foundation)	This study was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/) to RH, Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) to OS and RH, The Swedish Foundation for Strategic Research (http://www.stratresearch.se/en/) to RH, The National Doctoral Programme in Informational and Structural Biology (http://web.abo.fi/isb/) to CH, Turku University Foundation (https://www.utu.fi/fi/yksikot/yliopistosaatio/en/Sivut/home.aspx) to OS and CH, Knut and Alice Wallenberg foundation (https://www.wallenberg.com/kaw/en) to RH, King Gustav V 80-years foundation (http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond/english.4.67e94750148caf4ad27d21.html) to RH, The EU Innovative Medicine initiative BeTheCure grant (http://www.imi.europa.eu/content/btcure) to RH, The Swedish Research Council (http://www.vr.se) to RH, The European Union's Seventh Framework Programme (FP7) under grant agreements Neurinox (Health-F2-2011-278611; http://www.neurinox.eu/) to RH, Finnish Cultural Foundation, Varsinais-Suomi Regional fund (http://skr.fi/en) to CH. The funding sources were not involved in study design, interpretation of the data nor in the submission process.	Bengtsson AA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4575; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DINAUER MC, 1992, ANNU REV MED, V43, P117, DOI 10.1146/annurev.med.43.1.117; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P1501, DOI 10.1002/art.1780291212; HOLMDAHL R, 1987, CLIN EXP IMMUNOL, V70, P372; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; Holmdahl R, 2012, EUR J IMMUNOL, V42, P45, DOI 10.1002/eji.201142048; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2011, ANTIOXID REDOX SIGN, V14, P2373, DOI 10.1089/ars.2010.3440; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jansson L, 2001, ARTHRITIS RHEUM, V44, P2168, DOI 10.1002/1529-0131(200109)44:9<2168::AID-ART370>3.0.CO;2-2; Jochems C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-284; Kelkka T, 2014, ANTIOXID REDOX SIGNA; Khmaladze I, 2014, P NATL ACAD SCI USA, V111, pE3669, DOI 10.1073/pnas.1405798111; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mossberg N, 2007, J NEUROIMMUNOL, V192, P186, DOI 10.1016/j.jneuroim.2007.09.020; Nandakumar KS, 2005, J IMMUNOL METHODS, V304, P126, DOI 10.1016/j.jim.2005.06.017; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Olsson LM, 2011, ANTIOXID REDOX SIGNA; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Salvarrey-Strati A, 2008, ILAR J, V49, pE23; Sareila O, 2013, J LEUKOCYTE BIOL, V93, P427, DOI 10.1189/jlb.1211588; Stagi S, 2014, BMC MED GENET, V15; Tse HM, 2010, J IMMUNOL, V185, P5247, DOI 10.4049/jimmunol.1001472; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Wilson-Gerwing TD, 2013, COMPARATIVE MED, V63, P498	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141974	10.1371/journal.pone.0141974	http://dx.doi.org/10.1371/journal.pone.0141974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528554	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600085
J	Wiff, R; Roa-Ureta, RH; Borchers, DL; Milessi, AC; Barrientos, MA				Wiff, Rodrigo; Roa-Ureta, Ruben H.; Borchers, David L.; Milessi, Andres C.; Barrientos, Mauricio A.			Estimating Consumption to Biomass Ratio in Non-Stationary Harvested Fish Populations	PLOS ONE			English	Article							FOOD-CONSUMPTION; GROWTH-FUNCTION; TEMPERATURE; AGE; MODEL; MORTALITY; RATES; SIZE	The food consumption to biomass ratio (C) is one of the most important population parameters in ecosystem modelling because its quantifies the interactions between predator and prey. Existing models for estimating C in fish populations are per-recruit cohort models or empirical models, valid only for stationary populations. Moreover, empirical models lack theoretical support. Here we develop a theory and derive a general modelling framework to estimate C in fish populations, based on length frequency data and the generalised von Bertalanffy growth function, in which models for stationary populations with a stable-age distributions are special cases. Estimates using our method are compared with estimates from per-recruit cohort models for C using simulated harvested fish populations of different lifespans. The models proposed here are also applied to three fish populations that are targets of commercial fisheries in southern Chile. Uncertainty in the estimation of C was evaluated using a resampling approach. Simulations showed that stationary and non-stationary population models produce different estimates for C and those differences depend on the lifespan, fishing mortality and recruitment variations. Estimates of C using the new model exhibited smoother inter-annual variation in comparison with a per-recruit model estimates and they were also smaller than C predicted by the empirical equations in all population assessed.	[Wiff, Rodrigo] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Roa-Ureta, Ruben H.] King Fahd Univ Petr & Minerals, Ctr Environm & Water, Dhahran 31261, Saudi Arabia; [Borchers, David L.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, Sch Math & Stat, St Andrews KY16 9LZ, Fife, Scotland; [Milessi, Andres C.] Comis Invest Cient Prov BsAS CIC, RA-1900 La Plata, Argentina; [Milessi, Andres C.] Inst Nacl Invest & Desarrollo Pesquero INIDEP, RA-7600 Mar Del Plata, Argentina; [Barrientos, Mauricio A.] Pontificia Univ Catolica Valparaiso, Inst Matemat, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; King Fahd University of Petroleum & Minerals; University of St Andrews; Comision de Investigaciones Cientificas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Fisheries Research & Development Institute (INIDEP); Pontificia Universidad Catolica de Valparaiso	Wiff, R (corresponding author), Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Av Alameda 340, Santiago, Chile.	rodrigo.wiff@gmail.com	Roa-Ureta, Ruben/B-6045-2015	Roa-Ureta, Ruben/0000-0002-9620-5224; Borchers, David/0000-0002-3944-0754	CONICYT (Chile); CONICYT/FONDECYT [3130425]; CAPES Project Conicyt [FB 0002]	CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CAPES Project Conicyt	Rodrigo Wiff was funded by CONICYT (Chile) scholarship for postgraduate studies abroad ("Beca Presidente de la Republica para Estudios de Postgrado en el Extranjero"), CONICYT/FONDECYT post-doctoral project number 3130425 and by CAPES Project Conicyt FB 0002 (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NG, 2003, J FISH BIOL, V62, P395, DOI 10.1046/j.1095-8649.2003.00030.x; Aydin KY, 2004, AFR J MAR SCI, V26, P289, DOI 10.2989/18142320409504062; Beverton R.J.H., 1957, FISHERIES INVESTME 2, V19; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Charnov EL, 2004, INTEGR COMP BIOL, V44, P494, DOI 10.1093/icb/44.6.494; Charnov Eric L., 1993, P1; CONDREY RE, 1982, CAN J FISH AQUAT SCI, V39, P1585, DOI 10.1139/f82-214; DAWES BEN, 1931, JOUR MARINE BIOL ASSOC UNIT KINGDOM, V17, P949; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Essington TE, 2001, CAN J FISH AQUAT SCI, V58, P2129, DOI 10.1139/cjfas-58-11-2129; Finstad AG, 2005, J FISH BIOL, V66, P33, DOI 10.1111/j.0022-1112.2005.00577.x; France R.L., 2011, INT J ENV SCI, V1, P1379; Grant SM, 1999, J FISH BIOL, V54, P396, DOI 10.1111/j.1095-8649.1999.tb00838.x; Hewitt DA, 2005, FISH B-NOAA, V103, P433; Hidalgo M, 2014, ECOL APPL, V24, P1101, DOI 10.1890/12-1777.1; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; JOBLING M, 1980, J FISH BIOL, V17, P187, DOI 10.1111/j.1095-8649.1980.tb02752.x; Ojeda C. V., 1986, Investigacion Pesquera (Santiago), V33, P47; PALOHEIMO JE, 1965, J FISH RES BOARD CAN, V22, P521, DOI 10.1139/f65-048; Palomares MLD, 1998, MAR FRESHWATER RES, V49, P447, DOI 10.1071/MF98015; PAULY D, 1986, FISH B-NOAA, V84, P827; PAULY D, 1981, MEERESFORSCHUNG, V28, P251; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Pauly D, 1990, ICES COUNC M 1990 G; Pool H., 1997, 9432 FIP; Prajneshu, 1999, CAN J FISH AQUAT SCI, V56, P1026, DOI 10.1139/cjfas-56-6-1026; Quiroz JC, 2007, BIP2007; Richter H, 2004, ECOL MODEL, V171, P381, DOI 10.1016/j.ecolmodel.2003.07.005; Roa-Ureta RH, 2010, J AGR BIOL ENVIR ST, V15, P416, DOI 10.1007/s13253-009-0009-7; Silverstein JT, 1999, J FISH BIOL, V54, P607, DOI 10.1111/j.1095-8649.1999.tb00639.x; Temming A., 1994, NAGA ICLARM Q, V17, P41; Temming A, 2009, CAN J FISH AQUAT SCI, V66, P683, DOI 10.1139/F09-028; VANSTRAALEN NM, 1985, J THEOR BIOL, V113, P331, DOI 10.1016/S0022-5193(85)80231-9; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Wiff R, 2007, J APPL ICHTHYOL, V23, P270, DOI 10.1111/j.1439-0426.2007.00854.x; Wiff R, 2006, BIP2006; Wiff R, 2008, MAR FRESHWATER RES, V59, P912, DOI 10.1071/MF08053; Wiff R, 2015, J THEOR BIOL, V365, P67, DOI 10.1016/j.jtbi.2014.10.004; Xiao YS, 2000, FISH B-NOAA, V98, P835; Xiao YS, 1999, FISH B-NOAA, V97, P690	40	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141538	10.1371/journal.pone.0141538	http://dx.doi.org/10.1371/journal.pone.0141538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528721	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600036
J	Lange, A; Jost, S; Heider, D; Bock, C; Budeus, B; Schilling, E; Strittmatter, A; Boenigk, J; Hoffmann, D				Lange, Anja; Jost, Steffen; Heider, Dominik; Bock, Christina; Budeus, Bettina; Schilling, Elmar; Strittmatter, Axel; Boenigk, Jens; Hoffmann, Daniel			AmpliconDuo: A Split-Sample Filtering Protocol for High-Throughput Amplicon Sequencing of Microbial Communities	PLOS ONE			English	Article							RARE BIOSPHERE; DIVERSITY; DNA; WRINKLES	High throughput sequencing (HTSeq) of small ribosomal subunit amplicons has the potential for a comprehensive characterization of microbial community compositions, down to rare species. However, the error-prone nature of the multi-step experimental process requires that the resulting raw sequences are subjected to quality control procedures. These procedures often involve an abundance cutoff for rare sequences or clustering of sequences, both of which limit genetic resolution. Here we propose a simple experimental protocol that retains the high genetic resolution granted by HTSeq methods while effectively removing many low abundance sequences that are likely due to PCR and sequencing errors. According to this protocol, we split samples and submit both halves to independent PCR and sequencing runs. The resulting sequence data is graphically and quantitatively characterized by the discordance between the two experimental branches, allowing for a quick identification of problematic samples. Further, we discard sequences that are not found in both branches ("AmpliconDuo filter"). We show that the majority of sequences removed in this way, mostly low abundance but also some higher abundance sequences, show features expected from random modifications of true sequences as introduced by PCR and sequencing errors. On the other hand, the filter retains many low abundance sequences observed in both branches and thus provides a more reliable census of the rare biosphere. We find that the AmpliconDuo filter increases biological resolution as it increases apparent community similarity between biologically similar communities, while it does not affect apparent community similarities between biologically dissimilar communities. The filter does not distort overall apparent community compositions. Finally, we quantitatively explain the effect of the AmpliconDuo filter by a simple mathematical model.	[Lange, Anja; Heider, Dominik; Budeus, Bettina; Hoffmann, Daniel] Univ Duisburg Essen, Fac Biol, Res Grp Bioinformat, Essen, Germany; [Jost, Steffen; Bock, Christina; Boenigk, Jens] Univ Duisburg Essen, Fac Biol, Dept Biodivers, Essen, Germany; [Schilling, Elmar; Strittmatter, Axel] Eurofins Genom, Ebersberg, Germany	University of Duisburg Essen; University of Duisburg Essen	Boenigk, J (corresponding author), Univ Duisburg Essen, Fac Biol, Dept Biodivers, Essen, Germany.	Jens.Boenigk@uni-due.de; Daniel.Hoffmann@uni-due.de	Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018; Bock, Christina/S-5649-2017; Heider, Dominik/F-8545-2010	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Bock, Christina/0000-0002-6509-3768; Budeus, Bettina/0000-0002-9313-8636; Heider, Dominik/0000-0002-3108-8311	Deutsche Forschungsgemeinschaft (DFG) [TRR60/B1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	D. Hoffmann gratefully acknowledges funding by Deutsche Forschungsgemeinschaft (DFG), project TRR60/B1 (http://www.dfg.de). DFG had no role in study design, collection, analysis, and interpretation of data, writing of the paper, or decision to submit for publication.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bass D., 2010, BIOGEOGRAPHY MICROOR, P88; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boenigk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095340; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Bruls T, 2011, HUM MOL GENET, V20, pR142, DOI 10.1093/hmg/ddr353; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Karnati SKR, 2003, J ANIM SCI, V81, P812; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Oksanen J., **DATA OBJECT**; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torchiano M., 2015, **DATA OBJECT**; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407	40	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141590	10.1371/journal.pone.0141590	http://dx.doi.org/10.1371/journal.pone.0141590			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523925	Green Submitted, Green Published, gold			2022-12-27	WOS:000364029800014
J	Li, QF; Wang, JH; Pulkkinen, P; Kong, LS				Li, Q. F.; Wang, J. H.; Pulkkinen, P.; Kong, L. S.			Changes in the Metabolome of Picea balfouriana Embryogenic Tissues That Were Linked to Different Levels of 6-BAP by Gas Chromatography-Mass Spectrometry Approach	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; LOBLOLLY-PINE; POTATO-TUBER; INITIATION; REVEALS; ACID; IDENTIFICATION; SYLVESTRIS; PINASTER; CULTURES	Embryogenic cultures of Picea balfouriana, which is an important commercial species for reforestation in Southern China, easily lose their embryogenic ability during long-term culture. Embryogenic tissue that proliferated at lower concentrations (3.6 mu M and 2.5 mu M) of 6-benzylaminopurine (6-BAP) were more productive, and generated 113 +/- 6 and 89 +/- 3 mature embryos per 100 mg embryogenic tissue, respectively. A metabolomic approach was used to study the changes in metabolites linked to embryogenic competence related to three different 6-BAP concentrations (2.5 mu M, 3.6 mu M, and 5 mu M). A total of 309 compounds were obtained, among which 123 metabolites mapped to Kyoto Encyclopedia of Genes and genomes (KEGG) pathways. The levels of 35 metabolites were significantly differentially regulated among the three 6-BAP treatments, and 32 metabolites differed between the 2.5 mu M and 5 mu M treatments. A total of 17 metabolites appeared only once among the three comparisons. The combination of a score plot and a loading plot showed that in the samples with higher embryogenic ability (3.6 mu M and 2.5 mu M), up-regulated metabolites were mostly amino acids and down-regulated metabolites were mostly primary carbohydrates (especially sugars). These results suggested that 6-BAP may influence embryogenic competence by nitrogen metabolism, which could cause an increase in amino acid levels and higher amounts of aspartate, isoleucine, and leucine in tissues with higher embryogenic ability. Furthermore, we speculated that 6-BAP may affect the amount of tryptophan in tissues, which would change the indole-3-acetic acid levels and influence the embryogenic ability.	[Li, Q. F.; Wang, J. H.] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China; [Li, Q. F.] GuangXi Zhuang Autonomous Reg Forestry Res Ins, Guangxi Key Lab Special Non Wood Forest Cultivat, Nanning, Peoples R China; [Pulkkinen, P.] Finnish Forest Res Inst, Haapastensyrja, Finland; [Kong, L. S.] Univ Victoria, Dept Biol, Unit Ctr Forest Biol, Victoria, BC, Canada	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Natural Resources Institute Finland (Luke); University of Victoria	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China.	wangjh@caf.ac.cn			Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species [2012BAD01B01]	Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species	This research was funded by the Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species (2012BAD01B01).	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Alexandra L, 2005, J BIOL CHEM, V280, P24723, DOI [10.1074/jbc.M502285200, DOI 10.1074/JBC.M502285200]; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Argueso CT, 2010, CURR OPIN PLANT BIOL, V13, P533, DOI 10.1016/j.pbi.2010.08.006; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Businge E, 2012, TREE PHYSIOL, V32, P232, DOI 10.1093/treephys/tpr142; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Chen YZ, 2012, MOL PLANT, V5, P1138, DOI 10.1093/mp/sss034; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; GLEDDIE S, 1983, CAN J BOT, V61, P656, DOI 10.1139/b83-074; Gupta Pramod K., 2005, V77, P573; Gupta S, 2012, PLANT CELL REP, V31, P801, DOI 10.1007/s00299-012-1233-0; Hochberg U, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-184; Hosp J, 2007, PLANT MOL BIOL, V63, P137, DOI 10.1007/s11103-006-9078-y; Ikram-ul-Haq, 2004, African Journal of Biotechnology, V3, P319; Joy RW, 1996, PHYSIOL PLANTARUM, V97, P149, DOI 10.1111/j.1399-3054.1996.tb00491.x; Kim S, 2006, J PLANT BIOTECHNOL, V4, P83; Klimaszewska K, 2001, IN VITRO CELL DEV-PL, V37, P392, DOI 10.1007/s11627-001-0069-z; Lelu-Walter MA, 2008, PLANT CELL TISS ORG, V92, P31, DOI 10.1007/s11240-007-9300-x; Lelu-Walter MA, 2006, PLANT CELL REP, V25, P767, DOI 10.1007/s00299-006-0115-8; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; Li QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-553; Lipavska H, 2004, IN VITRO CELL DEV-PL, V40, P23, DOI 10.1079/IVP2003482; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Litvay JD, 114 IPC; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luedemann Alexander, 2012, Methods Mol Biol, V860, P255, DOI 10.1007/978-1-61779-594-7_16; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; MacKay JJ, 2006, TREE GENET GENOMES, V2, P1, DOI 10.1007/s11295-005-0020-2; Madsen A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055001; Menke-Milczarek I, 2001, ACTA PHYSIOL PLANT, V23, P37, DOI 10.1007/s11738-001-0020-2; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muraro D, 2013, J THEOR BIOL, V317, P71, DOI 10.1016/j.jtbi.2012.08.032; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Park YS, 2006, PLANT CELL TISS ORG, V86, P87, DOI 10.1007/s11240-006-9101-7; Pullman GS, 2009, TREE PHYSIOL, V29, P147, DOI 10.1093/treephys/tpn013; Pullman GS, 2003, PLANT CELL REP, V22, P85, DOI 10.1007/s00299-003-0673-y; Robinson AR, 2009, PLANT BIOTECHNOL J, V7, P952, DOI 10.1111/j.1467-7652.2009.00456.x; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Roessner U, 2001, PLANT PHYSIOL, V127, P749, DOI [10.1104/pp.010316, 10.1104/pp.127.3.749]; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Srivastava V., 2009, THESIS SWEDISH U AGR; Stasolla C, 2003, PLANT CELL TISS ORG, V74, P15, DOI 10.1023/A:1023345803336; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vales T, 2007, PLANT CELL REP, V26, P133, DOI 10.1007/s00299-006-0221-7; Wang JH, 2012, Patent No. [ZL 201210274334.9, 201210274334]; Wang JunHui, 2005, Journal of Zhejiang Forestry College, V22, P350; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weigelt K, 2008, PLANT J, V55, P909, DOI 10.1111/j.1365-313X.2008.03560.x; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]	60	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141841	10.1371/journal.pone.0141841	http://dx.doi.org/10.1371/journal.pone.0141841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517840	Green Published, gold			2022-12-27	WOS:000363920800085
J	Prince, TL; Kijima, T; Tatokoro, M; Lee, S; Tsutsumi, S; Yim, K; Rivas, C; Alarcon, S; Schwartz, H; Khamit-Kush, K; Scroggins, BT; Beebe, K; Trepel, JB; Neckers, L				Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Lee, Sunmin; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Alarcon, Sylvia; Schwartz, Harvey; Khamit-Kush, Kofi; Scroggins, Bradley T.; Beebe, Kristin; Trepel, Jane B.; Neckers, Len			Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants	PLOS ONE			English	Article							HEAT-SHOCK; ATP BINDING; CHAPERONE; ACTIVATION; MECHANISM; REVEALS; COMPLEX; KINASE; HSF1; GELDANAMYCIN	The two cytosolic/nuclear isoforms of the molecular chaperone HSP90, stress-inducible HSP90 alpha and constitutively expressed HSP90 beta, fold, assemble and maintain the three-dimensional structure of numerous client proteins. Because many HSP90 clients are important in cancer, several HSP90 inhibitors have been evaluated in the clinic. However, little is known concerning possible unique isoform or conformational preferences of either individual HSP90 clients or inhibitors. In this report, we compare the relative interaction strength of both HSP90 alpha and HSP90 beta with the transcription factors HSF1 and HIF1 alpha, the kinases ERBB2 and MET, the E3-ubiquitin ligases KEAP1 and RHOBTB2, and the HSP90 inhibitors geldanamycin and ganetespib. We observed unexpected differences in relative client and drug preferences for the two HSP90 isoforms, with HSP90 alpha binding each client protein with greater apparent affinity compared to HSP90 beta, while HSP90 beta bound each inhibitor with greater relative interaction strength compared to HSP90 alpha. Stable HSP90 interaction was associated with reduced client activity. Using a defined set of HSP90 conformational mutants, we found that some clients interact strongly with a single, ATP-stabilized HSP90 conformation, only transiently populated during the dynamic HSP90 chaperone cycle, while other clients interact equally with multiple HSP90 conformations. These data suggest different functional requirements among HSP90 clientele that, for some clients, are likely to be ATP-independent. Lastly, the two inhibitors examined, although sharing the same binding site, were differentially able to access distinct HSP90 conformational states.	[Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Schwartz, Harvey; Khamit-Kush, Kofi; Beebe, Kristin; Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lee, Sunmin; Alarcon, Sylvia; Trepel, Jane B.] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Scroggins, Bradley T.] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prince, TL (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	thomas.prince@nih.gov; neckers@nih.gov	Kijima, Toshiki/AAF-8264-2020	Kijima, Toshiki/0000-0002-4380-9294	Intramural Research Program, NCI [Z01 BC011032-01, Z01 SC010074-12]; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE [Z01BC011032, ZIABC011032, ZIASC010074, Z01SC010074] Funding Source: NIH RePORTER	Intramural Research Program, NCI; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds to L.N. from the Intramural Research Program, NCI (project #s Z01 BC011032-01 and Z01 SC010074-12). Biotinylated ganetespib (STA-7346) was provided by Weiwen Ying (Synta Pharmaceuticals, Lexington, MA). T.K. is supported by a JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Blagosklonny MV, 2001, LEUKEMIA, V15, P1537, DOI 10.1038/sj.leu.2402257; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2004, CELL CYCLE, V3, P51; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]; Cunningham CN, 2012, PROTEIN SCI, V21, P1162, DOI 10.1002/pro.2103; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Eiseman JL, 2005, CANCER CHEMOTH PHARM, V55, P21, DOI 10.1007/s00280-004-0865-3; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; HEISEY RM, 1986, J NAT PROD, V49, P859, DOI 10.1021/np50047a016; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Leinonen HM, 2014, ADV CANCER RES, V122, P281, DOI 10.1016/B978-0-12-420117-0.00008-6; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Manjarrez JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090054; McKinnon CM, 2008, ONCOGENE, V27, P6856, DOI 10.1038/onc.2008.317; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; Mishra P, 2014, MOL CELL, V53, P344, DOI 10.1016/j.molcel.2013.12.024; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Niture SK, 2010, J BIOL CHEM, V285, P36865, DOI 10.1074/jbc.M110.175802; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Pursell NW, 2012, EUKARYOT CELL, V11, P1033, DOI 10.1128/EC.00099-12; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Taherian A, 2008, BIOCHEM CELL BIOL, V86, P37, DOI [10.1139/O07-154, 10.1139/o07-154]; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; ULLRICH SJ, 1989, J BIOL CHEM, V264, P6810; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037; Zhao C, 2002, EXP CELL RES, V275, P200, DOI 10.1006/excr.2002.5501; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuehlke AD, 2015, GENE	55	37	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141786	10.1371/journal.pone.0141786	http://dx.doi.org/10.1371/journal.pone.0141786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517842	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800077
J	Zheng, MH; Long, H; Zhao, Y; Li, L; Xu, DL; Zhang, HL; Liu, F; Deng, GB; Pan, ZF; Yu, MQ				Zheng, Minghui; Long, Hai; Zhao, Yun; Li, Lin; Xu, Delin; Zhang, Haili; Liu, Feng; Deng, Guangbing; Pan, Zhifen; Yu, Maoqun			RNA-Seq Based Identification of Candidate Parasitism Genes of Cereal Cyst Nematode (Heterodera avenae) during Incompatible Infection to Aegilops variabilis	PLOS ONE			English	Article							UBIQUITIN-MEDIATED PROTEOLYSIS; FUNCTIONAL GENOMICS; GLOBODERA-PALLIDA; ESOPHAGEAL GLAND; BINDING PROTEIN; RESISTANCE; EXPRESSION; WHEAT; TOOL; TRANSCRIPTOMES	One of the reasons for the progressive yield decline observed in cereals production is the rapid build-up of populations of the cereal cyst nematode (CCN, Heterodera avenae). These nematodes secrete so-call effectors into their host plant to suppress the plant defense responses, alter plant signaling pathways and then induce the formation of syncytium after infection. However, little is known about its molecular mechanism and parasitism during incompatible infection. To gain insight into its repertoire of parasitism genes, we investigated the transcriptome of the early parasitic second-stage (30 hours, 3 days and 9 days post infection) juveniles of the CCN as well as the CCN infected tissue of the host Aegilops variabilis by Illumina sequencing. Among all assembled unigenes, 681 putative genes of parasitic nematode were found, in which 56 putative effectors were identified, including novel pioneer genes and genes corresponding to previously reported effectors. All the 681 CCN unigenes were mapped to 229 GO terms and 200 KEGG pathways, including growth, development and several stimulus-related signaling pathways. Sixteen clusters were involved in the CCN unigene expression atlas at the early stages during infection process, and three of which were significantly gene-enriched. Besides, the protein-protein interaction network analysis revealed 35 node unigenes which may play an important role in the plantCCN interaction. Moreover, in a comparison of differentially expressed genes between the pre-parasitic juveniles and the early parasitic juveniles, we found that hydrolase activity was up-regulated in pre J2s whereas binding activity was upregulated in infective J2s. RT-qPCR analysis on some selected genes showed detectable expression, indicating possible secretion of the proteins and putative role in infection. This study provided better insights into the incompatible interaction between H. avenae and the host plant Ae. varabilis. Moreover, RNAi targets with potential lethality were screened out and primarily validated, which provide candidates for engineering-based control of cereal cyst nematode in crops breeding.	[Zheng, Minghui; Long, Hai; Li, Lin; Zhang, Haili; Deng, Guangbing; Pan, Zhifen; Yu, Maoqun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zheng, Minghui; Li, Lin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zheng, Minghui; Zhao, Yun] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Xu, Delin] Zunyi Med Univ, Zunyi, Peoples R China; [Liu, Feng] Shandong Agr Univ, Plant Protect Coll, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; Zunyi Medical University; Shandong Agricultural University	Yu, MQ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	yumaoqun@cib.ac.cn	zhao, yun/AAJ-4105-2020	Zhang, Haili/0000-0002-7839-4420	Ministry of Science and Technology of the People's Republic of China [2013CB127502]; National Natural Science Foundation of China [31470097]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: No. 2013CB127502, Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn), HL; and 31470097, National Natural Science Foundation of China (www.nsfc.gov.cn), MQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad P, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P103, DOI 10.1007/978-94-007-0434-3_6; Aditya J, 2015, NEW PHYTOL; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Andres MF, 2001, NEW PHYTOL, V152, P343, DOI 10.1111/j.0028-646X.2001.00258.x; ASIEDU R, 1990, THEOR APPL GENET, V79, P331, DOI 10.1007/BF01186075; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Barloy D, 2007, MOL BREEDING, V20, P31, DOI 10.1007/s11032-006-9070-x; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benjamini Y, 2001, ANN STAT, V29, P1165; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blaxter M, 2012, PARASITE IMMUNOL, V34, P108, DOI 10.1111/j.1365-3024.2011.01342.x; Chen P, 1989, SCI AGR SINICA, V24, P89; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coriton O, 2009, GENOME, V52, P338, DOI [10.1139/G09-011, 10.1139/g09-011]; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-480; Deliang P, 2009, CURRENT KNOWLEDGE CE, P29; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Huang W-K, 2011, J HUAZHONG AGR U, V30; Iberkleid I, 2014, PHYTOPATHOLOGY, V104, P484, DOI 10.1094/PHYTO-07-13-0181-R; Jahier J, 2001, PLANT BREEDING, V120, P125, DOI 10.1046/j.1439-0523.2001.00585.x; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jones D, 2004, CUTIS, V74, P17; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones M, 1972, J CELL SCI, V10, P1; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kondorosi E, 2005, PLANT PHYSIOL, V137, P1197, DOI 10.1104/pp.105.060004; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maizels RM, 2000, INT J PARASITOL, V30, P495, DOI 10.1016/S0020-7519(00)00022-9; Mazarei M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/s00122-011-1659-8; Mitreva M, 2004, GENOME RES, V14, P209, DOI 10.1101/gr.1524804; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Peng D, 2013, PLANT DIS, V97, P1288; Peng D L, 2012, NEMATOLOGY RES CHINA, V4, P162; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069579; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso M-N., 2012, EFFECTORS PLANT MICR; Seah S, 2000, NEW PHYTOL, V146, P527, DOI 10.1046/j.1469-8137.2000.00654.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simonetti E, 2010, PLANT CELL REP, V29, P1169, DOI 10.1007/s00299-010-0903-z; SLOOTMAKER LA, 1974, EUPHYTICA, V23, P497, DOI 10.1007/BF00022470; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091591; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Williamson VM, 1996, PLANT CELL, V8, P1735, DOI 10.1105/tpc.8.10.1735; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	72	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141095	10.1371/journal.pone.0141095	http://dx.doi.org/10.1371/journal.pone.0141095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517841	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800021
J	Ryu, J; Lee, H; Suh, J; Yang, M; Kang, W; Kim, E				Ryu, JiHyeon; Lee, HeeYoung; Suh, JinUk; Yang, MyungSuk; Kang, Wonku; Kim, EunYoung			Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; CAUSALITY ASSESSMENT; EVENTS; PROBABILITY; COSTS	Objective We analyzed differences between spontaneously reported drug-induced (not including contrast media) and contrast media-induced adverse reactions. Methods Adverse drug reactions reported by an in-hospital pharmacovigilance center (St. Mary's teaching hospital, Daejeon, Korea) from 2010-2012 were classified as drug-induced or contrast media-induced. Clinical patterns, frequency, causality, severity, Schumock and Thornton's preventability, and type A/B reactions were recorded. The trends among causality tools measuring drug and contrast-induced adverse reactions were analyzed. Results Of 1,335 reports, 636 drug-induced and contrast media-induced adverse reactions were identified. The prevalence of spontaneously reported adverse drug reaction-related admissions revealed a suspected adverse drug reaction-reporting rate of 20.9/100,000 (inpatient, 0.021%) and 3.9/100,000 (outpatients, 0.004%). The most common adverse drug reaction-associated drug classes included nervous system agents and anti-infectives. Dermatological and gastrointestinal adverse drug reactions were most frequently and similarly reported between drug and contrast media-induced adverse reactions. Compared to contrast mediainduced adverse reactions, drug-induced adverse reactions were milder, more likely to be preventable (9.8% vs. 1.1%, p < 0.001), and more likely to be type A reactions (73.5% vs. 18.8%, p < 0.001). Females were over-represented among drug-induced adverse reactions (68.1%, p < 0.001) but not among contrast media-induced adverse reactions (56.6%, p = 0.066). Causality patterns differed between the two adverse reaction classes. The World Health Organization-Uppsala Monitoring Centre causality evaluation and Naranjo algorithm results significantly differed from those of the Korean algorithm version II (p < 0.001). Conclusions We found differences in sex, preventability, severity, and type A/B reactions between spontaneously reported drug and contrast media-induced adverse reactions. The World Health Organization-Uppsala Monitoring Centre and Naranjo algorithm causality evaluation afforded similar results.	[Ryu, JiHyeon; Lee, HeeYoung; Kim, EunYoung] Chung Ang Univ, Coll Pharm, Dept Clin Pharm & Pharmaceut Care, Evidence Based Res Lab, Seoul 156756, South Korea; [Ryu, JiHyeon] St Marys Hosp, Div Pharmacovigilance, Dept Pharm, Daejeon, South Korea; [Suh, JinUk; Yang, MyungSuk; Kim, EunYoung] Chung Ang Univ, Dept Pharmaceut Ind, Seoul 156756, South Korea; [Kang, Wonku; Kim, EunYoung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University; Chung Ang University; Chung Ang University	Kang, W (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	wkang@cau.ac.kr; eykimjcb777@cau.ac.kr	Lee, Heeyoung/ABC-4942-2021	Lee, Heeyoung/0000-0001-8099-5025; Kim, EunYoung/0000-0003-3525-8805	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF2015R1A5A1008958]; Korea Food and Drug Administration [15172KFDA101]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF2015R1A5A1008958) and by a grant from the Korea Food and Drug Administration for 2015 [15172KFDA101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID DET REP ADV DRU; [Anonymous], 2012, UPPS REP, P59; [Anonymous], 2012, US WHO UPPS MON CTR; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Belhekar MN, 2014, INDIAN J PHARMACOL, V46, P117, DOI 10.4103/0253-7613.125192; Bettmann MA, 1997, RADIOLOGY, V203, P611, DOI 10.1148/radiology.203.3.9169677; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Cutroneo P, 2007, PHARMACOL RES, V56, P35, DOI 10.1016/j.phrs.2007.03.003; D'Incau P, 2014, FUND CLIN PHARMACOL, V28, P342, DOI 10.1111/fcp.12032; Garcia-Cortes M, 2004, ANN PHARMACOTHER, V38, P1540, DOI 10.1345/aph.1E007; HARTWIG SC, 1991, AM J HOSP PHARM, V48, P2611, DOI 10.1093/ajhp/48.12.2611; Kane-Gill SL, 2012, DRUG SAFETY, V35, P645, DOI 10.2165/11599730-000000000-00000; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; KFDA, 2013, WHO ART; KIM Yoon, 2006, Biomolecules & Therapeutics, V14, P56; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Kyung EJ, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130418; LANG DM, 1995, J ALLERGY CLIN IMMUN, V95, P813, DOI 10.1016/S0091-6749(95)70123-0; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Montastruc JL, 2002, FUND CLIN PHARMACOL, V16, P343, DOI 10.1046/j.1472-8206.2002.00100.x; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Park S, 2013, EUR J CLIN PHARMACOL, V69, P119, DOI 10.1007/s00228-012-1318-2; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rademaker M, 2001, Am J Clin Dermatol, V2, P349, DOI 10.2165/00128071-200102060-00001; RAWLINS MD, 1981, BRIT MED J, V282, P974, DOI 10.1136/bmj.282.6268.974; Schumock G T, 1992, Hosp Pharm, V27, P538; Sharif-Askari FS, 2014, PLOS ONE, V22, DOI 10:483-486.1371/journal.pone.0095991; Slotboom A, 1996, STAT WORDS; Theophile H, 2010, DRUG SAFETY, V33, P1045, DOI 10.2165/11537780-000000000-00000; Truven Health Analytics, 2012, MICR HEALTHC SER, V2012-2015; WHO, 2012, ATC DDD METH; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6; 홍경섭, 2002, Translational and Clinical Pharmacology, V10, P129	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142418	10.1371/journal.pone.0142418	http://dx.doi.org/10.1371/journal.pone.0142418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544039	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700133
J	Biswas, A; Rahman, F; Eriksson, C; Halim, A; Dalal, K				Biswas, Animesh; Rahman, Fazlur; Eriksson, Charli; Halim, Abdul; Dalal, Koustuv			Facility Death Review of Maternal and Neonatal Deaths in Bangladesh	PLOS ONE			English	Review							LOW-RESOURCE SETTINGS; MORTALITY; AUDIT; IMPLEMENTATION; DISTRICTS; ACHIEVE; SENEGAL; HEALTH; CARE	Objectives To explore the experiences, acceptance, and effects of conducting facility death review (FDR) of maternal and neonatal deaths and stillbirths at or below the district level in Bangladesh. Methods This was a qualitative study with healthcare providers involved in FDRs. Two districts were studied: Thakurgaon district (a pilot district) and Jamalpur district (randomly selected from three follow-on study districts). Data were collected between January and November 2011. Data were collected from focus group discussions, in-depth interviews, and document review. Hospital administrators, obstetrics and gynecology consultants, and pediatric consultants and nurses employed in the same departments of the respective facilities participated in the study. Content and thematic analyses were performed. Results FDR for maternal and neonatal deaths and stillbirths can be performed in upazila health complexes at sub-district and district hospital levels. Senior staff nurses took responsibility for notifying each death and conducting death reviews with the support of doctors. Doctors reviewed the FDRs to assign causes of death. Review meetings with doctors, nurses, and health managers at the upazila and district levels supported the preparation of remedial action plans based on FDR findings, and interventions were planned accordingly. There were excellent examples of improved quality of care at facilities as a result of FDR. FDR also identified gaps and challenges to overcome in the near future to improve maternal and newborn health. Discussion FDR of maternal and neonatal deaths is feasible in district and upazila health facilities. FDR not only identifies the medical causes of a maternal or neonatal death but also explores remediable gaps and challenges in the facility. FDR creates an enabled environment in the facility to explore medical causes of deaths, including the gaps and challenges that influence mortality. FDRs mobilize health managers at upazila and district levels to forward plan and improve healthcare delivery.	[Biswas, Animesh; Eriksson, Charli; Dalal, Koustuv] Univ Orebro, Dept Publ Hlth Sci, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Biswas, Animesh; Rahman, Fazlur; Halim, Abdul] Bangladesh CIPRB, Ctr Injury Prevent & Res, Dhaka, Bangladesh	Orebro University	Biswas, A (corresponding author), Univ Orebro, Dept Publ Hlth Sci, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.	animesh@ciprb.org	Dalal, Koustuv/O-6737-2017; Biswas, Animesh/D-7011-2015	Dalal, Koustuv/0000-0001-7393-796X; 	UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development); Department for International Development (DFID) & European Commission (EC)	UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development); Department for International Development (DFID) & European Commission (EC)	Funded by UNICEF, Bangladesh through Canadian CIDA (Department of Foreign Affairs, Trade and Development) and Department for International Development (DFID) & European Commission (EC) to initiate the piloting.	Animesh Biswas, 2015, Healthmed, V9, P329; Armstrong CE, 2014, TROP MED INT HEALTH, V19, P1087, DOI 10.1111/tmi.12353; Biswas A., 2014, Health, V6, P1669, DOI 10.4236/health.2014.614198; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bryce J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-225; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Dumont A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-61; Gebrehiwot Y, 2014, INT J GYNECOL OBSTET, V127, pS29, DOI 10.1016/j.ijgo.2014.08.003; Goswami D, 2013, J OBSTET GYNAECOL RE, V39, P1569, DOI 10.1111/jog.12099; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Halim A, 2014, BJOG-INT J OBSTET GY, V121, P86, DOI 10.1111/1471-0528.13010; Hofman JJ, 2014, INT J GYNECOL OBSTET, V126, P111, DOI [10.1016/j.ijgo.2014.02.014, 10.1016/]; Kalter HD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-41; Khanam R. A., 2009, J OBSTET GYNAECOLOGY, V24, P18; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Kongnyuy Eugene J, 2008, BMC Pregnancy Childbirth, V8, P42, DOI 10.1186/1471-2393-8-42; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lewis G, 2014, INT J GYNECOL OBSTET, V127, pS17, DOI 10.1016/j.ijgo.2014.07.007; Management Information System Directorate General of Health Services, 2014, HLTH B; ManceyJones M, 1997, HEALTH POLICY PLANN, V12, P183, DOI 10.1093/heapol/12.3.183; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2015, BANDL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) UNC-CH ICDDR B ME, 2011, BANGL MAT MORT HLTH; Okonta PI, J OBSTET GYNAECOL, V22, P626; Osman H, 2009, ACTA OBSTET GYN SCAN, V88, P1338, DOI 10.3109/00016340903318014; Pearson L, 2009, INT J GYNECOL OBSTET, V106, P89, DOI 10.1016/j.ijgo.2009.04.009; Richard F, 2009, BJOG-INT J OBSTET GY, V116, P38, DOI 10.1111/j.1471-0528.2008.01741.x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sridhar RP, 2015, INT J MAT CHILD HLTH, V3, P31; Supratikto G, 2002, B WORLD HEALTH ORGAN, V80, P228; Tanzin D, 2013, J OBSTET GYN INDIA, V63, P101, DOI 10.1007/s13224-012-0264-3; Unicef, 2013, CHILD MORT REP, P1; WHO, 2004, BR MED B, V67; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2007, STRENGTHENING CAPACI, P10; World Health Organization, 2013, B WORLD HEAL, P128	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141902	10.1371/journal.pone.0141902	http://dx.doi.org/10.1371/journal.pone.0141902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540233	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800035
J	Zill, JM; Scholl, I; Harter, M; Dirmaier, J				Zill, Joerdis M.; Scholl, Isabelle; Haerter, Martin; Dirmaier, Joerg			Which Dimensions of Patient-Centeredness Matter? - Results of a Web-Based Expert Delphi Survey	PLOS ONE			English	Article							CARE; COMMUNICATION; CONSULTATIONS; OUTCOMES	Background Present models and definitions of patient-centeredness revealed a lack of conceptual clarity. Based on a prior systematic literature review, we developed an integrative model with 15 dimensions of patient-centeredness. The aims of this study were to 1) validate, and 2) prioritize these dimensions. Method A two-round web-based Delphi study was conducted. 297 international experts were invited to participate. In round one they were asked to 1) give an individual rating on a nine-pointscale on relevance and clarity of the dimensions, 2) add missing dimensions, and 3) prioritize the dimensions. In round two, experts received feedback about the results of round one and were asked to reflect and re-rate their own results. The cut-off for the validation of a dimension was a median < 7 on one of the criteria. Results 105 experts participated in round one and 71 in round two. In round one, one new dimension was suggested and included for discussion in round two. In round two, this dimension did not reach sufficient ratings to be included in the model. Eleven dimensions reached a median >= 7 on both criteria (relevance and clarity). Four dimensions had a median < 7 on one or both criteria. The five dimensions rated as most important were: patient as a unique person, patient involvement in care, patient information, clinician-patient communication and patient empowerment. Discussion 11 out of the 15 dimensions have been validated through experts' ratings. Further research on the four dimensions that received insufficient ratings is recommended. The priority order of the dimensions can help researchers and clinicians to focus on the most important dimensions of patient-centeredness. Overall, the model provides a useful framework that can be used in the development of measures, interventions, and medical education curricula, as well as the adoption of a new perspective in health policy.	[Zill, Joerdis M.; Scholl, Isabelle; Haerter, Martin; Dirmaier, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Zill, JM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	j.zill@uke.de	Scholl, Isabelle/AAN-9450-2020	Scholl, Isabelle/0000-0002-7639-0880; Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Education and Research [01GX1043]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project is funded by the German Federal Ministry of Education and Research (project number: 01GX1043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Commission on Safety and Quality in Health Care (ACSQHC), PAT CTR CAR IMPR QUA; Barr PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126553; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Chipchase LS, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-112; Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Epstein RM, 2005, SOC SCI MED, V61, P1516, DOI 10.1016/j.socscimed.2005.02.001; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Gerteis M., 1993, PATIENTS EYES; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Health Canada, 2004, INT ED COLL PAT CTR; Hobbs JL, 2009, NURS RES, V58, P52, DOI 10.1097/NNR.0b013e31818c3e79; Institute TP, 2004, PAT CTR CAR 2015 SCE; Lawrence M, 2012, HEALTH EXPECT, V15, P295, DOI 10.1111/j.1369-7625.2011.00683.x; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Mansfield A, 2011, PSYCHOL SOCIAL NEEDS; Mdege ND, 2014, J EVAL CLIN PRACT, V20, P100, DOI 10.1111/jep.12092; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mead N, 2000, PATIENT EDUC COUNS, V39, P71, DOI 10.1016/S0738-3991(99)00092-0; Mead N, 2002, PATIENT EDUC COUNS, V48, P51, DOI 10.1016/S0738-3991(02)00099-X; Michie S, 2003, PATIENT EDUC COUNS, V51, P197, DOI 10.1016/S0738-3991(02)00194-5; Muller E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106844; Rathert C, 2013, MED CARE RES REV, V70, P351, DOI 10.1177/1077558712465774; Reavley NJ, 2013, PEER J, V26; Scholl I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107828; Scholl I, 2014, PATIENT PREFER ADHER, V8, P1153, DOI 10.2147/PPA.S64051; Scholl I, 2011, Z EVIDENZ FORTBILD Q, V105, P313, DOI 10.1016/j.zefq.2011.04.012; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444; Stewart M, 2003, PATIENT CENTERED MED; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Uphoff EPMM, 2012, CANCER NURS, V35, P29, DOI 10.1097/NCC.0b013e318210e3a2; van Dulmen S, 2003, PATIENT EDUC COUNS, V51, P195, DOI 10.1016/S0738-3991(03)00039-9; Zill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112637; Zill JM, 2013, PATIENT PREFER ADHER, V7, P345, DOI 10.2147/PPA.S42759	34	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141978	10.1371/journal.pone.0141978	http://dx.doi.org/10.1371/journal.pone.0141978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539990	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800041
J	Al Kazzi, ES; Lau, B; Li, TJ; Schneider, EB; Makary, MA; Hutfless, S				Al Kazzi, Elie S.; Lau, Brandyn; Li, Tianjing; Schneider, Eric B.; Makary, Martin A.; Hutfless, Susan			Differences in the Prevalence of Obesity, Smoking and Alcohol in the United States Nationwide Inpatient Sample and the Behavioral Risk Factor Surveillance System	PLOS ONE			English	Article							HEALTH; OUTCOMES; QUALITY; VALIDITY; RECORD	Background The lack of adequate and standardized recording of leading risk factors for morbidity and mortality in medical records have downstream effects on research based on administrative databases. The measurement of healthcare is increasingly based on risk-adjusted outcomes derived from coded comorbidities in these databases. However inaccurate or haphazard assessment of risk factors for morbidity and mortality in medical record codes can have tremendous implications for quality improvement and healthcare reform. Objective We aimed to compare the prevalence of obesity, overweight, tobacco use and alcohol abuse of a large administrative database with a direct data collection survey. Materials and Methods We used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for four leading risk factors in the United States Nationwide Inpatient Sample (NIS) to compare them with a direct survey in the Behavioral Risk Factor Surveillance System (BRFSS) in 2011. After confirming normality of the risk factors, we calculated the national and state estimates and Pearson's correlation coefficient for obesity, overweight, tobacco use and alcohol abuse between NIS and BRFSS. Results Compared with direct participant questioning in BRFSS, NIS reported substantially lower prevalence of obesity (p<0.01), overweight (p<0.01), and alcohol abuse (p<0.01), but not tobacco use (p = 0.18). The correlation between NIS and BRFSS was 0.27 for obesity (p = 0.06), 0.09 for overweight (p = 0.55), 0.62 for tobacco use (p<0.01) and 0.40 for alcohol abuse (p<0.01). Conclusions The prevalence of obesity, overweight, tobacco smoking and alcohol abuse based on codes is not consistent with prevalence based on direct questioning. The accuracy of these important measures of health and morbidity in databases is critical for healthcare reform policies.	[Al Kazzi, Elie S.; Hutfless, Susan] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Lau, Brandyn; Schneider, Eric B.; Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Lau, Brandyn] Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD USA; [Lau, Brandyn] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Li, Tianjing; Hutfless, Susan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Makary, Martin A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hutfless, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA.	shutfle1@jhmi.edu	Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Al Kazzi, Elie/0000-0002-9285-9108; Li, Tianjing/0000-0001-5371-4558	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001079] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adler-Milstein J, 2013, AM J MANAG CARE, V19, pE273; Agency for Healthcare Research and Quality, CREAT COM VAR COM VE; Agency for Healthcare Research and Quality, 2014, 2011 NIS SAS LOAD PR; Agency for Healthcare Research and Quality, 2012, PAT SAF IND PSI RISK; Agency for Healthcare Research and Quality, PAT SAF IND OV; Agency for Healthcare Research and Quality, INTR HCUP NAT INP SA; Agency for Healthcare Research and Quality, OV NAT INP SAMPL NIS; [Anonymous], 2011, COMM PUBL HLTH STRAT; [Anonymous], 2013, PCORI METH REP; Balasubramaniyam N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.03.021; Belletti D, 2010, PATIENT-RELAT OUTCOM, V1, P29; Berthelsen C L, 2000, Top Health Inf Manage, V21, P10; Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Bordowitz R, 2007, FAM MED, V39, P274; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; CDC, 2011, OV BRFSS 2011; CDC, 2014, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2014, 2011 BRFSS SAS LOAD; Centers for Disease Control and Prevention (CDC), 2011, 2011 BRFSS SAS FORM; Centers for Disease Control and Prevention (CDC), 2011, COMP DAT BRFSS; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P53967; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coles J, 2010, PROMS RISK ADJ METH; CORN RF, 1980, MED CARE, V18, P416, DOI 10.1097/00005650-198004000-00006; Courtney PK, 2011, CANCER J, V17, P219, DOI 10.1097/PPO.0b013e3182270c83; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; DEMLO LK, 1978, MED CARE, V16, P995, DOI 10.1097/00005650-197812000-00003; Dixon BE, 2013, STUD HEALTH TECHNOL, V192, P884, DOI 10.3233/978-1-61499-289-9-884; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Golinvaux NS, 2014, SPINE J, V14, P2923, DOI 10.1016/j.spinee.2014.04.025; Gologorsky Y, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1459; Gupta T, 2014, AM J CARDIOL, V114, P169, DOI 10.1016/j.amjcard.2014.04.021; Hertzer NR, 2012, J VASC SURG, V55, P263, DOI 10.1016/j.jvs.2011.08.059; [HHS Centers for Medicare & Medicaid Services (CMS)], 2015, CMS ANN ENT INN ACC; [HHS Centers for Medicare & Medicaid Services (CMS)], 2013, OUTC MEAS; Hogan R W, 1993, HMO Pract, V7, P54; Hu SS, 2011, PREV CHRONIC DIS, V8; Iezzoni LI, 2004, AM J PHYS MED REHAB, V83, P316, DOI 10.1097/01.PHM.0000118041.17739.BB; James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Li TJ, 2014, J CLIN EPIDEMIOL, V67, P15, DOI 10.1016/j.jclinepi.2013.08.013; Lindenmayer DB, 2013, NATURE, V499, P284, DOI 10.1038/499284d; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52; ROMANO PS, 1994, MED CARE, V32, P81, DOI 10.1097/00005650-199401000-00006; Tai B, 2012, SUBST ABUSE REHABIL, V3, P1, DOI 10.2147/SAR.S22575; Trust for America's Health and Robert Wood Johnson Foundation, 2012, F FAT OB THREAT AM F; Zeng Xiaoming, 2011, Perspect Health Inf Manag, V8, p1b	54	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140165	10.1371/journal.pone.0140165	http://dx.doi.org/10.1371/journal.pone.0140165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536469	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400019
J	Ebersole, B; Petko, J; Woll, M; Murakami, S; Sokolina, K; Wong, V; Stagljar, I; Luscher, B; Levenson, R				Ebersole, Brittany; Petko, Jessica; Woll, Matthew; Murakami, Shoko; Sokolina, Kate; Wong, Victoria; Stagljar, Igor; Luescher, Bernhard; Levenson, Robert			Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability	PLOS ONE			English	Article							22Q11 DELETION SYNDROME; PROTEIN PALMITOYLATION; DIFFERENTIAL REGULATION; GABA(A) RECEPTORS; MAMMALIAN-CELLS; FATTY-ACYLATION; SPLIT-UBIQUITIN; MOUSE MODEL; SCHIZOPHRENIA; LOCALIZATION	We have used bioorthogonal click chemistry (BCC), a sensitive non-isotopic labeling method, to analyze the palmitoylation status of the D2 dopamine receptor (D2R), a G protein-coupled receptor (GPCR) crucial for regulation of processes such as mood, reward, and motor control. By analyzing a series of D2R constructs containing mutations in cysteine residues, we found that palmitoylation of the D2R most likely occurs on the C-terminal cysteine residue (C443) of the polypeptide. D2Rs in which C443 was deleted showed significantly reduced palmitoylation levels, plasma membrane expression, and protein stability compared to wild-type D2Rs. Rather, the C443 deletion mutant appeared to accumulate in the Golgi, indicating that palmitoylation of the D2R is important for cell surface expression of the receptor. Using the full-length D2R as bait in a membrane yeast two-hybrid (MYTH) screen, we identified the palmitoyl acyltransferase (PAT) zDHHC4 as a D2R interacting protein. Co-immunoprecipitation analysis revealed that several other PATs, including zDHHC3 and zDHHC8, also interacted with the D2R and that each of the three PATs was capable of affecting the palmitoylation status of the D2R. Finally, biochemical analyses using D2R mutants and the palmitoylation blocker, 2-bromopalmitate indicate that palmitoylation of the receptor plays a role in stability of the D2R.	[Ebersole, Brittany; Petko, Jessica; Woll, Matthew; Levenson, Robert] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Murakami, Shoko; Luescher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Sokolina, Kate; Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Luescher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Luescher, Bernhard] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Levenson, R (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	rlevenson@hmc.psu.edu	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906; Levenson, Robert/0000-0002-0936-8421	National Institute on Drug Abuse (NIDA) [DA035608]; CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; National Institutes of Health (NIH) [MH62391]; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH062391, R01MH099851, R01MH062391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA035608] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was supported by a grant from the National Institute on Drug Abuse (NIDA, DA035608) to R.L., a CURE grant to R.L. from the Pennsylvania Department of Health using Tobacco Settlement Funds and a grant from the National Institutes of Health (NIH, MH62391) to B.L. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; Citrome L, 2014, J CLIN PSYCHIAT, V75, P21, DOI 10.4088/JCP.13049su1c.04; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; Dalva MB, 2009, J CELL BIOL, V186, P7, DOI 10.1083/jcb.200906101; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ebersole B, 2014, ANAL BIOCHEM, V451, P25, DOI 10.1016/j.ab.2014.01.008; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Grunewald S, 1996, BIOCHEMISTRY-US, V35, P15149, DOI 10.1021/bi9607564; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hines RM, 2010, J BIOL CHEM, V285, P4621, DOI 10.1074/jbc.M109.069849; Huang K, 2010, NEUROBIOL DIS, V40, P207, DOI 10.1016/j.nbd.2010.05.027; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lin R, 2005, USE YEAST 2 HYBRID S; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; NG GYK, 1994, J NEUROCHEM, V63, P1589; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Sensoy O, 2015, BBA-BIOMEMBRANES, V1848, P976, DOI 10.1016/j.bbamem.2014.12.002; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Thaminy S, 2003, GENOME RES, V13, P1744, DOI 10.1101/gr.1276503; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tobin Andrew B, 2004, Methods Mol Biol, V259, P275; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	70	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140661	10.1371/journal.pone.0140661	http://dx.doi.org/10.1371/journal.pone.0140661			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535572	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400031
J	Feng, HS; Chai, NL; Dong, WH				Feng, Huashan; Chai, Ningli; Dong, Wenhao			Experimental Investigation on the Morphology and Adhesion Mechanism of Leech Posterior Suckers	PLOS ONE			English	Article							HIRUDO-MEDICINALIS; ARRAYS; KNEE	The posterior sucker of a leech represents a fascinating natural system that allows the leech to adhere to different terrains and substrates. However, the mechanism of adhesion and desorption has not yet to be elucidated. In order to better understand how the adhesion is performed, we analyzed the surface structure, adsorption movements, the muscles' distribution, physical characteristics, and the adsorption force of the leech posterior suckers by experimental investigation. Three conclusions can be drawn based on the obtained experimental results. First, the adhesion by the posterior sucker is wet adhesion, because the surface of the posterior sucker is smooth and the sealing can only be achieved on wet surfaces. Second, the deformation texture, consisting of soft collagen tissues and highly ductile epidermal tissues, plays a key role in adhering to rough surfaces. Finally, the adhesion and desorption is achieved by the synergetic operation of six muscle fibers working in different directions. Concrete saying, directional deformation of the collagen/epithermal interface driven by spatially-distributed muscle fibers facilitates the excretion of fluids in the sucker venter, thus allowing liquid sealing. Furthermore, we found that the adhesion strength is directly related to the size of the contact surface which is generated and affected by the sucker deformation. Such an underlying physical mechanism offers potential cues for developing innovative bio-inspired artificial adhesion systems.	[Feng, Huashan; Dong, Wenhao] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Peoples R China; [Chai, Ningli] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Northwestern Polytechnical University; Chinese People's Liberation Army General Hospital	Chai, NL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	csxlily@163.com			National Natural Science Foundation of China [81270564]; Northwestern Polytechnical University [Z2014008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwestern Polytechnical University	Funding: This project was supported by the National Natural Science Foundation of China (Grant No. 81270564) and graduate starting seed funding from Northwestern Polytechnical University (Z2014008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksak B, 2007, LANGMUIR, V23, P3322, DOI 10.1021/la062697t; Amend JR, 2012, IEEE T ROBOT, V28, P341, DOI 10.1109/TRO.2011.2171093; Asbeck AT, 2006, INT J ROBOT RES, V25, P1165, DOI 10.1177/0278364906072511; Busaba P, 2013, J VET SCI, V14, P425; Fie L., 2003, J CHINESE ELECT MICR, V22, P669; He B, 2013, OSTEOARTHR CARTILAGE, V21, P237, DOI 10.1016/j.joca.2012.10.008; Menciassi A, 2003, PHILOS T R SOC A, V361, P2287, DOI 10.1098/rsta.2003.1255; Michalsen A, 2002, ALTERN THER HEALTH M, V8, P84; Orevi M, 2000, J ZOOL, V250, P121, DOI 10.1111/j.1469-7998.2000.tb00583.x; Peter Z, 2001, U TORONTO MED J, V79, P65; Qiao N, 2015, SICHUAN J ZOOLOGY, V32, P526; Schliemann Harald, 2011, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P313; STERNTOMLINSON W, 1986, J COMP PHYSIOL A, V158, P593, DOI 10.1007/BF00603803; Takashi M., 2013, THESIS, P1120; Tang X-M, 2001, J CHIN ELECT MICROSC, V20, P217; Teut M, 2008, FORSCH KOMPLEMENTMED, V15, P269, DOI 10.1159/000158875; Tian JH, 2007, J COMP PHYSIOL A, V193, P1205, DOI 10.1007/s00359-007-0278-y; Tramacere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065074; Yang T, 2001, B BIOL FR BELG, V36, P8	19	12	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140776	10.1371/journal.pone.0140776	http://dx.doi.org/10.1371/journal.pone.0140776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536352	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400036
J	Fernandez-Guizan, A; Lopez-Soto, A; Acebes-Huerta, A; Huergo-Zapico, L; Villa-Alvarez, M; Nunez, LE; Moris, F; Gonzalez, S				Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Acebes-Huerta, Andrea; Huergo-Zapico, Leticia; Villa-Alvarez, Monica; Nunez, Luz-Elena; Moris, Francisco; Gonzalez, Segundo			Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-beta-D-Digitoxosyl-Mithramycin SK (EC-8042)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; HUMAN GASTRIC-CANCER; TUMOR ANGIOGENESIS; COMBINATORIAL BIOSYNTHESIS; ANTIANGIOGENIC THERAPY; MITHRAMYCIN ANALOG; PANCREATIC-CANCER; FACTOR EXPRESSION; VEGF EXPRESSION; DOWN-REGULATION	Demycarosyl-3D-beta-D-digitoxosyl-mithramycin SK (DIG-MSK) is a recently isolated analogue of mithramycin A (MTA) that showed differences with MTA in the DNA binding strength and selectivity. These differences correlated with a better therapeutic index and less toxicity in animal studies. Herein, we show that DIG-MSK displays a potent anti-tumor activity against different types of cancer cell lines, ovarian tumor cells being particularly sensitive to this drug. Of relevance, DIG-MSK exerts low toxicity on fibroblasts and peripheral blood mononuclear cells, this toxicity being significantly lower than that of MTA. In correlation with its antitumor activity, DIG-MSK strongly inhibited Sp1-mediated transcription and endogenous Sp1 mRNA expression, which correlated with the inhibition of the expression of key Sp1-regulated genes involved in tumorigenesis, including VEGFA, BCL2L1 (Bcl-XL), hTERT, BRCA2, MYC and SRC in several ovarian cells. Significantly, DIG-MSK was a stronger inhibitor of VEGFA expression than MTA. Accordingly, DIG-MSK also exhibited potent anti-angiogenic activity on microvascular endothelial cells. Likewise, it significantly inhibited the gene expression of VEGFR1, VEGFR2, FGFR, PDGFB and PDGFRA and, additionally, it induced the expression of the anti-angiogenic factors angiostatin and tunstatin. These effects correlated with a pro-apoptotic effect on proliferating microvascular endothelial cells and the inhibition of the formation of endothelial capillary structures. Overall, the pleiotropic activity of DIG-MSK in inhibiting key oncogenic and angiogenic pathways, together with its low toxicity profile, highlight the therapeutic potential of this new drug.	[Fernandez-Guizan, Azahara; Lopez-Soto, Alejandro; Acebes-Huerta, Andrea; Huergo-Zapico, Leticia; Villa-Alvarez, Monica; Gonzalez, Segundo] Univ Oviedo, Dept Funct Biol, IUOPA, Oviedo, Spain; [Lopez-Soto, Alejandro] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Nunez, Luz-Elena; Moris, Francisco] EntreChem SL, Oviedo 33006, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias	Gonzalez, S (corresponding author), Univ Oviedo, Dept Funct Biol, IUOPA, Oviedo, Spain.	segundog@uniovi.es	Acebes-Huerta, Andrea/AAA-8004-2020; Gonzalez, Segundo/AAK-8719-2021; López-Soto, Alejandro/A-9779-2018; Huergo-Zapico, Leticia/S-5863-2018	Acebes-Huerta, Andrea/0000-0002-7106-3063; Gonzalez, Segundo/0000-0003-4631-9255; López-Soto, Alejandro/0000-0002-6360-5205; Huergo-Zapico, Leticia/0000-0001-9942-1144	Instituto de Salud Carlos III [PI12/01280]; FEDER program of the European Community; Principado de Asturias Government through PCTI funds; FEDER Operative Program of the Principado de Asturias [FC-11-PC-10-31]; Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER program of the European Community(European Commission); Principado de Asturias Government through PCTI funds; FEDER Operative Program of the Principado de Asturias; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding: This work has been funded by the grant PI12/01280 from the Instituto de Salud Carlos III and the FEDER program of the European Community. It was also supported by the Principado de Asturias Government through PCTI funds 2006-2009, co-financed with the FEDER Operative Program of the Principado de Asturias 2007-2013 (project FC-11-PC-10-31). A.L.S. holds a Sara Borrell fellowship from the Instituto de Salud Carlos III. The drugs MTA and DIG-MSK were provided by the company EntreChem (http://entrechem.com/es/about_us/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EntreChem provided support in the form of salaries for authors LEN and FM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Beishline K, 2014, FEBS J; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Deacon K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397042; DeVita V. T., 2005, CANC PRINCIPLES PRAC; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Fernandez-Guizan A, 2014, CHEM-BIOL INTERACT, V219, P123, DOI 10.1016/j.cbi.2014.05.019; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; Lou Z, 2005, CANCER RES, V65, P1007; Mendez C, 2015, PLANTA MED IN PRESS; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t; Otjacques E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062818; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Safe S, 2014, EXPERT OPIN THER TAR, V18, P759, DOI 10.1517/14728222.2014.914173; Schwarzmayr L, 2008, INT J BIOCHEM CELL B, V40, P2845, DOI 10.1016/j.biocel.2008.06.001; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang HW, 2010, LIFE SCI, V86, P185, DOI 10.1016/j.lfs.2009.11.023; Wang LW, 2008, INT J ONCOL, V33, P161; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140786	10.1371/journal.pone.0140786	http://dx.doi.org/10.1371/journal.pone.0140786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536461	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400037
J	Fujita, S; Ushio, S; Ozawa, N; Masuguchi, K; Kawashiri, T; Oishi, R; Egashira, N				Fujita, Shunsuke; Ushio, Soichiro; Ozawa, Nana; Masuguchi, Ken; Kawashiri, Takehiro; Oishi, Ryozo; Egashira, Nobuaki			Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ROOT GANGLION NEURONS; INDUCED MECHANICAL ALLODYNIA; DOPAMINERGIC-NEURONS; RECEPTOR AGONIST; ANIMAL-MODEL; EXENDIN-4; NEUROPROTECTION; INVOLVEMENT; ACTIVATION	Background Oxaliplatin has widely been used as a key drug in the treatment of colorectal cancer; however, it causes peripheral neuropathy. Exenatide, a glucagon-like peptide-1 (GLP-1) agonist, is an incretin mimetic secreted from ileal L cells, which is clinically used to treat type 2 diabetes mellitus. GLP-1 receptor agonists have been reported to exhibit neuroprotective effects on the central and peripheral nervous systems. In this study, we investigated the effects of exenatide on oxaliplatin-induced neuropathy in rats and cultured cells. Methods Oxaliplatin (4 mg/kg) was administered intravenously twice per week for 4 weeks, and mechanical allodynia was evaluated using the von Frey test in rats. Axonal degeneration was assessed by toluidine blue staining of sciatic nerves. Results Repeated administration of oxaliplatin caused mechanical allodynia from day 14 to 49. Although the co-administration of extended-release exenatide (100 mu g/kg) could not inhibit the incidence of oxaliplatin-induced mechanical allodynia, it facilitated recovery from the oxaliplatin-induced neuropathy with reparation of axonal degeneration. Inhibition of neurite outgrowth was evaluated in cultured pheochromocytoma 12 (PC12) cells. Exenatide inhibited oxaliplatin-induced neurite degeneration, but did not affect oxaliplatin-induced cell injury in cultured PC12 cells. Additionally, extended-release exenatide had no effect on the anti-tumor activity of oxaliplatin in cultured murine colon adenocarcinoma 26 (C-26) cells or C-26 cell-implanted mice. Conclusion These results suggest that exenatide may be useful for treating peripheral neuropathy induced by oxaliplatin in colorectal cancer patients with type 2 diabetes.	[Fujita, Shunsuke; Ushio, Soichiro; Ozawa, Nana; Masuguchi, Ken; Kawashiri, Takehiro; Oishi, Ryozo; Egashira, Nobuaki] Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan	Kyushu University	Egashira, N (corresponding author), Kyushu Univ Hosp, Dept Pharm, Fukuoka 812, Japan.	n-egashi@pharm.med.kyushu-u.ac.jp	Egashira, Nobuaki/AAT-4183-2021	Kawashiri, Takehiro/0000-0002-7708-2855; Ushio, Soichiro/0000-0003-4365-7857	JSPS KAKENHI [25460335, 25870496]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 25460335 and 25870496 (https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Benoit E, 2006, GEN PHYSIOL BIOPHYS, V25, P263; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2208, DOI 10.1210/en.2011-1795; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Fu Z, 2012, PEPTIDES, V37, P25, DOI 10.1016/j.peptides.2012.06.006; Gong N, 2014, J NEUROSCI, V34, P5322, DOI 10.1523/JNEUROSCI.4703-13.2014; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Grothey Axel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS38, DOI 10.3816/CCC.2005.s.006; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Kagiava A, 2008, NEUROTOXICOLOGY, V29, P1100, DOI 10.1016/j.neuro.2008.09.005; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Kawashiri T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-7; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Land SR, 2007, J CLIN ONCOL, V25, P2205, DOI 10.1200/JCO.2006.08.6652; Li HT, 2015, INT J CLIN EXP PATHO, V8, P4837; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liu WJ, 2011, BRIT J PHARMACOL, V164, P1410, DOI 10.1111/j.1476-5381.2011.01272.x; Lolignier S, 2015, CELL REP, V11, P1067, DOI 10.1016/j.celrep.2015.04.027; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Mannelli LD, 2014, EXP NEUROL, V261, P22, DOI 10.1016/j.expneurol.2014.06.016; Mannelli LD, 2014, NEUROPHARMACOLOGY, V79, P37, DOI 10.1016/j.neuropharm.2013.10.034; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Ramanathan RK, 2010, ANN ONCOL, V21, P754, DOI 10.1093/annonc/mdp509; Robinson CR, 2014, NEUROSCIENCE, V274, P308, DOI 10.1016/j.neuroscience.2014.05.051; Saif M Wasif, 2005, Ther Clin Risk Manag, V1, P249; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Scuteri A, 2009, NEUROTOXICOLOGY, V30, P312, DOI 10.1016/j.neuro.2009.01.003; Shirahama M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-26; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tsukamoto M, 2015, HISTOCHEM CELL BIOL, V144, P249, DOI 10.1007/s00418-015-1333-3; Tsutsumi K, 2014, NEUROSCI RES, V80, P86, DOI 10.1016/j.neures.2014.02.004; Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Vincenzi B, 2013, SUPPORT CARE CANCER, V21, P1313, DOI 10.1007/s00520-012-1667-5; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Xiong H, 2013, J ALZHEIMERS DIS, V37, P623, DOI 10.3233/JAD-130584; Yamamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/315848; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	51	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141921	10.1371/journal.pone.0141921	http://dx.doi.org/10.1371/journal.pone.0141921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536615	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400102
J	Kong, XZ; Liu, ZG; Huang, LJ; Wang, X; Yang, ZT; Zhou, GF; Zhen, ZL; Liu, J				Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei; Liu, Jia			Mapping Individual Brain Networks Using Statistical Similarity in Regional Morphology from MRI	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GRAPH-THEORETICAL ANALYSIS; VOXEL-BASED MORPHOMETRY; HUMAN CORTICAL NETWORKS; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; RESTING-STATE; FUNCTIONAL CONNECTIVITY; MODULAR ORGANIZATION; TOPOLOGICAL PATTERNS	Representing brain morphology as a network has the advantage that the regional morphology of 'isolated' structures can be described statistically based on graph theory. However, very few studies have investigated brain morphology from the holistic perspective of complex networks, particularly in individual brains. We proposed a new network framework for individual brain morphology. Technically, in the new network, nodes are defined as regions based on a brain atlas, and edges are estimated using our newly-developed inter-regional relation measure based on regional morphological distributions. This implementation allows nodes in the brain network to be functionally/anatomically homogeneous but different with respect to shape and size. We first demonstrated the new network framework in a healthy sample. Thereafter, we studied the graph-theoretical properties of the networks obtained and compared the results with previous morphological, anatomical, and functional networks. The robustness of the method was assessed via measurement of the reliability of the network metrics using a test-retest dataset. Finally, to illustrate potential applications, the networks were used to measure age-related changes in commonly used network metrics. Results suggest that the proposed method could provide a concise description of brain organization at a network level and be used to investigate interindividual variability in brain morphology from the perspective of complex networks. Furthermore, the method could open a new window into modeling the complexly distributed brain and facilitate the emerging field of human connectomics.	[Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Liu, Zhaoguo; Huang, Lijie; Wang, Xu; Yang, Zetian; Zhou, Guangfu; Zhen, Zonglei; Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Zhen, ZL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhenzonglei@bnu.edu.cn; liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Liu, Jia/0000-0003-0383-0934; Kong, Xiangzhen/0000-0002-0805-1350	National Natural Science Foundation of China [31230031, 31221003, 31470055]; National Basic Research Program of China [2014CB846101]; Changjiang Scholars Programme of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Changjiang Scholars Programme of China	This study was funded by the National Natural Science Foundation of China (31230031, 31221003, and 31470055), the National Basic Research Program of China (2014CB846101), and Changjiang Scholars Programme of China.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Batalle D, 2013, NEUROIMAGE, V83, P901, DOI 10.1016/j.neuroimage.2013.07.045; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bowman AW, 1997, APPL SMOOTHING TECHN; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Dai D, 2013, MACH VISION APPL, V24, P1445, DOI 10.1007/s00138-012-0462-0; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Epstein JN, 2007, PSYCHIAT RES-NEUROIM, V155, P75, DOI 10.1016/j.pscychresns.2006.12.009; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068192; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kong XZ, 2014, J NEUROSCI METH, V237, P103, DOI 10.1016/j.jneumeth.2014.09.003; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Mesulam M., 2000, PRINCIPLES BEHAV COG; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Raj A, 2010, NEUROIMAGE, V52, P1302, DOI 10.1016/j.neuroimage.2010.05.045; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, CURR OPIN PSYCHIATR, V24, P219, DOI 10.1097/YCO.0b013e32834591f8; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang LJ, 2014, EUR J RADIOL, V83, P1890, DOI 10.1016/j.ejrad.2014.06.019; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	84	44	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141840	10.1371/journal.pone.0141840	http://dx.doi.org/10.1371/journal.pone.0141840			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536598	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400092
J	Serafy, JE; Shideler, GS; Araujo, RJ; Nagelkerken, I				Serafy, Joseph E.; Shideler, Geoffrey S.; Araujo, Rafael J.; Nagelkerken, Ivan			Mangroves Enhance Reef Fish Abundance at the Caribbean Regional Scale	PLOS ONE			English	Article							SEAGRASS BEDS; QUANTILE REGRESSION; CONNECTIVITY; COMMUNITIES; NURSERIES; MODELS	Several studies conducted at the scale of islands, or small sections of continental coastlines, have suggested that mangrove habitats serve to enhance fish abundances on coral reefs, mainly by providing nursery grounds for several ontogenetically-migrating species. However, evidence of such enhancement at a regional scale has not been reported, and recently, some researchers have questioned the mangrove-reef subsidy effect. In the present study, using two different regression approaches, we pursued two questions related to mangrove-reef connectivity at the Caribbean regional scale: (1) Are reef fish abundances limited by mangrove forest area?; and (2) Are mean reef fish abundances proportional to mangrove forest area after taking human population density and latitude into account? Specifically, we tested for Caribbean-wide mangrove forest area effects on the abundances of 12 reef fishes that have been previously characterized as "mangrove-dependent". Analyzed were data from an ongoing, long-term (20-year) citizen-scientist fish monitoring program; coastal human population censuses; and several wetland forest information sources. Quantile regression results supported the notion that mangrove forest area limits the abundance of eight of the 12 fishes examined. Linear mixed-effects regression results, which considered potential human (fishing and habitat degradation) and latitudinal influences, suggested that average reef fish densities of at least six of the 12 focal fishes were directly proportional to mangrove forest area. Recent work questioning the mangrove-reef fish subsidy effect likely reflects a failure to: (1) focus analyses on species that use mangroves as nurseries, (2) consider more than the mean fish abundance response to mangrove forest extent; and/or (3) quantitatively account for potentially confounding human impacts, such as fishing pressure and habitat degradation. Our study is the first to demonstrate at a large regional scale (i.e., the Wider Caribbean) that greater mangrove forest size generally functions to increase the densities on neighboring reefs of those fishes that use these shallow, vegetated habitats as nurseries.	[Serafy, Joseph E.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA; [Serafy, Joseph E.; Shideler, Geoffrey S.; Araujo, Rafael J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Nagelkerken, Ivan] Univ Adelaide, Sch Biol Sci, Southern Seas Ecol Labs, Adelaide, SA, Australia; [Nagelkerken, Ivan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami; University of Adelaide; University of Adelaide	Serafy, JE (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA.	joe.serafy@noaa.gov	Nagelkerken, Ivan/E-1093-2011; Shideler, Geoffrey/GVS-9403-2022	Nagelkerken, Ivan/0000-0003-4499-3940; Shideler, Geoffrey/0000-0002-0160-2973; Araujo, Rafael J./0000-0003-3781-2857				[Anonymous], [No title captured]; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bell C. D., 2009, Tourism in Marine Environments, V5, P245, DOI 10.3727/154427308788714768; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Conover WJ, 2012, WIRES COMPUT STAT, V4, P432, DOI 10.1002/wics.1216; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; FAO, 2007, 140 FAO; FAO, 2007, 138 FAO; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Green E.P., 2003, WORLD ATLAS SEAGRASS; Grol MGG, 2014, MAR ECOL PROG SER, V502, P229, DOI 10.3354/meps10682; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2004, MAR ECOL PROG SER, V272, P93, DOI 10.3354/meps272093; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Hyndes GA, 2014, BIOL REV, V89, P232, DOI 10.1111/brv.12055; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; KOENKER R., 2013, QUANTREG QUANTILE RE; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; LIN GH, 1991, AQUAT BOT, V40, P333, DOI 10.1016/0304-3770(91)90079-K; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; Pattengill-Semmens CV, 2003, ENVIRON MONIT ASSESS, V81, P43, DOI 10.1023/A:1021300302208; Pinheiro J., 2019, NLME LINEAR NONLINEA; Planque B, 2008, MAR ECOL PROG SER, V357, P213, DOI 10.3354/meps07274; Schmitt EF, 1996, B MAR SCI, V59, P404; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Terrell JW, 1996, T AM FISH SOC, V125, P104, DOI 10.1577/1548-8659(1996)125<0104:MSFHLF>2.3.CO;2; Thomson JD, 1996, ECOLOGY, V77, P1698, DOI 10.2307/2265776; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Vianna GMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095565; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Wolfe JR, 2013, CAL COOP OCEAN FISH, V54, P127	43	40	40	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142022	10.1371/journal.pone.0142022	http://dx.doi.org/10.1371/journal.pone.0142022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536478	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400118
J	Massenet, D; Yvon, JF; Couteaux, C; Goarant, C				Massenet, Denis; Yvon, Jean-Francois; Couteaux, Clement; Goarant, Cyrille			An Unprecedented High Incidence of Leptospirosis in Futuna, South Pacific, 2004-2014, Evidenced by Retrospective Analysis of Surveillance Data	PLOS ONE			English	Article							RISK-FACTORS	Futuna is a small Polynesian island in the South Pacific with a population of 3,612 in 2013. The first human leptospirosis case was confirmed in 1997. Active surveillance started in 2004. Cases were confirmed by PCR or real time PCR, or by serology using MAT or a combination of IgM-ELISA and MAT. A retrospective analysis of surveillance data shows that the disease was endemic with a mean annual incidence of 844 cases per 100,000 over an 11-year period from 2004 to 2014. An epidemic peak as high as 1,945 cases per 100,000 occurred in 2008. Serogroup Australis was predominant until 2007, Icterohaemorrhagiae was dominant afterwards. Cluster analysis revealed different hot spots over time. Lifestyle habits, such as walking barefoot in irrigated taro fields or pig pens probably contributed to contamination from the swine and rodent reservoirs to humans. Severe forms were rare, and the case fatality rate was 0.5%. The medical community and general population were aware of leptospirosis and rapid treatment with amoxycillin was the main treatment, probably contributing to this low fatality rate.	[Massenet, Denis; Yvon, Jean-Francois; Couteaux, Clement] Agence Sante Iles Wallis & Futuna, Hop SIA, Med Biol Lab, Matautu 98600, Wallis & Futuna, France; [Yvon, Jean-Francois] Lab Ducos, Noumea 98846, New Caledonia; [Goarant, Cyrille] Inst Pasteur New Caledonia, Inst Pasteur Int Network, Leptospirosis Res & Expertise Unit, Noumea 98845, New Caledonia		Goarant, C (corresponding author), Inst Pasteur New Caledonia, Inst Pasteur Int Network, Leptospirosis Res & Expertise Unit, 9-11 Ave Paul Doumer,BP 61, Noumea 98845, New Caledonia.	cgoarant@pasteur.nc	Goarant, Cyrille/D-4267-2018	Goarant, Cyrille/0000-0002-0690-9464	French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique [1134, 1161, 1277]; French Ministry for Research	French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique; French Ministry for Research(Ministry of Research, France)	This study was funded by grant numbers 1134, 1161 and 1277 from the French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique and the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], 2003, HUM LEPT GUID DIAGN; Berlioz-Arthaud A, 2007, T ROY SOC TROP MED H, V101, P714, DOI 10.1016/j.trstmh.2007.02.022; Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583; Coudert C, 2007, Med Trop (Mars), V67, P137; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x; Guimaraes RM, 2014, CIENC SAUDE COLETIVA, V19, P3683, DOI 10.1590/1413-81232014199.06432014; Hirschauer C., 2009, Bulletin Epidemiologique Hebdomadaire, P508; Katz AR, 2011, EMERG INFECT DIS, V17, P221, DOI 10.3201/eid1702.101109; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lau CL, 2012, AM J TROP MED HYG, V86, P309, DOI 10.4269/ajtmh.2012.11-0398; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lhomme V, 1996, MED MALADIES INFECT, V26, P94, DOI 10.1016/S0399-077X(96)80161-2; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Perez J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-325; SASAKI DM, 1993, AM J TROP MED HYG, V48, P35, DOI 10.4269/ajtmh.1993.48.35; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Theuerkauf J, 2013, NATURWISSENSCHAFTEN, V100, P385, DOI 10.1007/s00114-013-1033-6; Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798	26	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142063	10.1371/journal.pone.0142063	http://dx.doi.org/10.1371/journal.pone.0142063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528546	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600095
J	Passos, CLA; Ferreira, C; Soares, DC; Saraiva, EM				Alves Passos, Carlos Luan; Ferreira, Christian; Soares, Deivid Costa; Saraiva, Elvira Maria			Leishmanicidal Effect of Synthetic trans-Resveratrol Analogs	PLOS ONE			English	Article							IN-VITRO; PICEATANNOL; OXYRESVERATROL; PTEROSTILBENE; MILTEFOSINE; DERIVATIVES; APOPTOSIS; ASSAY	Background Stilbene-based compounds show antitumoral, antioxidant, antihistaminic, anti-inflammatory and antimicrobial activities. Here, we evaluated the effect of the trans-resveratrol analogs, pterostilbene, piceatannol, polydatin and oxyresveratrol, against Leishmania amazonensis. Methodology/Principal Findings Our results demonstrated a low murine macrophage cytotoxicity of all four analogs. Moreover, pterostilbene, piceatannol, polydatin and oxyresveratrol showed an anti-L. amazonensis activity with IC50 values of 18 mu M, 65 mu M, 95 mu M and 65 mu M for promastigotes, respectively. For intracellular amastigotes, the IC50 values of the analogs were 33.2 mu M, 45 mu M, 29 mu M and 30.5 mu M, respectively. Among the analogs assayed only piceatannol altered the cell cycle of the parasite, increasing 5-fold the cells in the Sub-G0 phase and decreasing 1.7-fold the cells in the G0-G1 phase. Piceatannol also changed the parasite mitochondrial membrane potential (Delta psi m) and increased the number of annexin-V positive promastigotes, which suggests incidental death. Conclusion/Significance Among the analogs tested, piceatannol, which is a metabolite of resveratrol, was the more promising candidate for future studies regarding treatment of leishmaniasis.	[Alves Passos, Carlos Luan; Ferreira, Christian; Soares, Deivid Costa; Saraiva, Elvira Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941 Rio De Janeiro, RJ, Brazil.	esaraiva@micro.ufrj.br	Saraiva, Elvira M/L-2864-2017; Ferreira, Christian/P-7358-2015	Saraiva, Elvira M/0000-0002-6388-5286; Ferreira, Christian/0000-0003-0504-0354	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [404245/2012-9, 308236]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E26/203638/2014, E26/102271/2010]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br, 404245/2012-9, 308236 to EMS; and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, http://www.faperj.br, E26/203638/2014 to EMS and E26/102271/2010 to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Chung KO, 2003, J PHARM PHARMACOL, V55, P1695, DOI 10.1211/0022357022313; Croft SL, 2006, INDIAN J MED RES, V123, P399; Delorenzi JC, 2002, ANTIMICROB AGENTS CH, V46, P2111, DOI 10.1128/AAC.46.7.2111-2115.2002; Duarte N, 2008, PHYTOTHER RES, V22, P455, DOI 10.1002/ptr.2334; Fabris S, 2008, BIOPHYS CHEM, V135, P76, DOI 10.1016/j.bpc.2008.03.005; Ferreira C, 2011, PHYTOCHEMISTRY, V72, P2155, DOI 10.1016/j.phytochem.2011.08.006; Ferreira C, 2014, ANTIMICROB AGENTS CH, V58, P6197, DOI 10.1128/AAC.00093-14; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Hsu CL, 2013, J AGR FOOD CHEM, V61, P602, DOI 10.1021/jf304487v; Jang DS, 1999, BIOCHEM PHARMACOL, V57, P705, DOI 10.1016/S0006-2952(98)00350-5; Kadam R. U., 2007, Indian Journal of Pharmaceutical Sciences, V69, P609; Kim HJ, 2008, J NUTR BIOCHEM, V19, P459, DOI 10.1016/j.jnutbio.2007.06.001; Kita Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672416; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu LT, 2012, CHIN J INTEGR MED, V18, P714, DOI 10.1007/s11655-012-1060-8; Lorenz P, 2003, NITRIC OXIDE-BIOL CH, V9, P64, DOI 10.1016/j.niox.2003.09.005; Marchal J, 2013, ANN NY ACAD SCI, V1290, P67, DOI 10.1111/nyas.12214; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Perecko T, 2008, NEUROENDOCRINOL LETT, V29, P802; Pinheiro LCS, 2012, J MICROBIOL ANTIMICR, V41, P32; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Piver B, 2004, BIOCHEM PHARMACOL, V68, P773, DOI 10.1016/j.bcp.2004.05.008; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Qureshi AA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-76; Ravagnan G, 2013, INFLAMMATION, V36, P26, DOI 10.1007/s10753-012-9516-8; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sanchez-Canete MP, 2009, ANTIMICROB AGENTS CH, V53, P1305, DOI 10.1128/AAC.01694-08; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sindermann H, 2006, T ROY SOC TROP MED H, V100, pS17, DOI 10.1016/j.trstmh.2006.02.010; Soares DC, 2010, PARASITOL INT, V59, P173, DOI 10.1016/j.parint.2010.01.002; Tolomeo M, 2013, EXP PARASITOL, V133, P37, DOI 10.1016/j.exppara.2012.10.006	39	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141778	10.1371/journal.pone.0141778	http://dx.doi.org/10.1371/journal.pone.0141778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517558	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800075
J	Haines, S; Gautheron, S; Nasser, W; Renauld-Mongenie, G				Haines, Sara; Gautheron, Sylviane; Nasser, William; Renauld-Mongenie, Genevieve			Identification of Novel Components Influencing Colonization Factor Antigen I Expression in Enterotoxigenic Escherichia coli	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; INTESTINAL EPITHELIAL-CELLS; REGULATORY PROTEIN; CATABOLITE REPRESSION; GENE-EXPRESSION; CFA/I FIMBRIAE; INDUCED GROWTH; CHOLERA-TOXIN; MUCIN; VIRULENCE	Colonization factors (CFs) mediate early adhesion of Enterotoxigenic Escherichia coli (ETEC) in the small intestine. Environmental signals including bile, glucose, and contact with epithelial cells have previously been shown to modulate CF expression in a strain dependent manner. To identify novel components modulating CF surface expression, 20 components relevant to the intestinal environment were selected for evaluation. These included mucin, bicarbonate, norepinephrine, lincomycin, carbon sources, and cations. Effects of individual components on surface expression of the archetype CF, CFA/I, were screened using a fractional factorial Hadamard matrix incorporating 24 growth conditions. As most CFs agglutinate erythrocytes, surface expression was evaluated by mannose resistant hemagglutination. Seven components, including porcine gastric mucin, lincomycin, glutamine, and glucose were found to induce CFA/I surface expression in vitro in a minimal media while five others were inhibitory, including leucine and 1,10-phenanthroline. To further explore the effect of components positively influencing CFA/I surface expression, a response surface methodology (RSM) was designed incorporating 36 growth conditions. The optimum concentration for each component was identified, thereby generating a novel culture media, SP1, for CFA/I expression. CFs closely related to CFA/I, including CS4 and CS14 were similarly induced in SP1 media. Other epidemiologically relevant CFs were also induced when compared to the level obtained in minimal media. These results indicate that although CF surface expression is complex and highly variable among strains, the CF response can be predicted for closely related strains. A novel culture media inducing CFs in the CF5a group was successfully identified. In addition, mucin was found to positively influence CF expression in strains expressing either CFA/I or CS1 and CS3, and may function as a common environmental cue.	[Haines, Sara; Gautheron, Sylviane; Renauld-Mongenie, Genevieve] Sanofi Pasteur, Res Dept, Marcy Letoile, France; [Nasser, William] Univ Lyon 1, CNRS INSA UCB UMR5240, F-69622 Villeurbanne, France; [Nasser, William] INSA Lyon, Villeurbanne, France	Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Renauld-Mongenie, G (corresponding author), Sanofi Pasteur, Res Dept, Marcy Letoile, France.	genevieve.renauld@sanofipasteur.com	NASSER, William/C-9611-2019	NASSER, William/0000-0001-9848-3597; Haines, Sara/0000-0002-4454-1584	Sanofi Pasteur; EZUS	Sanofi Pasteur; EZUS	Sanofi Pasteur provided support in the form of salaries for SG, SH and GR-M, and a research grant for SH through EZUS, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The decision to publish was validated by the Sanofi Pasteur legal team and senior management of the Research department, and was limited solely to the verification that the manuscript did not contravene company policy concerning the release of proprietary information.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Baker KK, 2009, CELL MICROBIOL, V11, P742, DOI 10.1111/j.1462-5822.2009.01287.x; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; BRAATEN BA, 1992, P NATL ACAD SCI USA, V89, P4250, DOI 10.1073/pnas.89.10.4250; CHOPRA I, 1986, J ANTIMICROB CHEMOTH, V18, P441, DOI 10.1093/jac/18.4.441; Crane JK, 2007, INFECT IMMUN, V75, P5974, DOI 10.1128/IAI.00750-07; Crane JK, 2011, INFECT IMMUN, V79, P1696, DOI 10.1128/IAI.01099-10; Crost C, 2003, J BACTERIOL, V185, P1886, DOI 10.1128/JB.185.6.1886-1894.2003; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Edwards RA, 1997, MOL MICROBIOL, V25, P797, DOI 10.1046/j.1365-2958.1997.5161875.x; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; EVANS DG, 1991, CURR MICROBIOL, V23, P71, DOI 10.1007/BF02092252; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; GHOSH AR, 1993, J CLIN MICROBIOL, V31, P2163, DOI 10.1128/JCM.31.8.2163-2166.1993; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; Gonzales L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074069; GOTHEFORS L, 1985, J INFECT DIS, V152, P1128, DOI 10.1093/infdis/152.6.1128; Grewal HMS, 1997, INFECT IMMUN, V65, P507, DOI 10.1128/IAI.65.2.507-513.1997; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; JORDI BJAM, 1992, EMBO J, V11, P2627, DOI 10.1002/j.1460-2075.1992.tb05328.x; Kansal R, 2013, INFECT IMMUN, V81, P259, DOI 10.1128/IAI.00919-12; KARJALAINEN TK, 1991, MICROB PATHOGENESIS, V11, P317, DOI 10.1016/0882-4010(91)90017-5; KARJALAINEN TK, 1991, CURR MICROBIOL, V23, P307, DOI 10.1007/BF02104131; Kim JC, 2012, BIOCHEM BIOPH RES CO, V423, P789, DOI 10.1016/j.bbrc.2012.06.041; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; KRISTIANSEN BE, 1983, ANTIMICROB AGENTS CH, V24, P731, DOI 10.1128/AAC.24.5.731; Kumar P, 2014, INFECT IMMUN, V82, P500, DOI 10.1128/IAI.01078-13; KUNIN CM, 1994, INFECT IMMUN, V62, P2178, DOI 10.1128/IAI.62.6.2178-2186.1994; LEVNER M, 1977, INFECT IMMUN, V15, P132, DOI 10.1128/IAI.15.1.132-137.1977; LEVNER MH, 1980, J BACTERIOL, V143, P441, DOI 10.1128/JB.143.1.441-447.1980; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Lyte M, 1997, ADV EXP MED BIOL, V412, P331; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Nicklasson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035827; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Steffen R, 2005, J TRAVEL MED, V12, P102; STROMBECK DR, 1974, INFECT IMMUN, V10, P1266, DOI 10.1128/IAI.10.6.1266-1272.1974; SUGARMAN B, 1984, J MED MICROBIOL, V18, P393, DOI 10.1099/00222615-18-3-393; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; THOMAS LV, 1985, J GEN MICROBIOL, V131, P2319; Torres OR, 2014, EPIDEMIOL INFECT, P1; Trachman JD, 2004, CURR MICROBIOL, V49, P353, DOI 10.1007/s00284-004-4282-y; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Vidya K C, 2005, Indian J Med Microbiol, V23, P102; von Mentzer A, 2014, NAT GENET; Wang B, 2014, AMINO ACIDS; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Yele VU, 2014, APPL BIOCH BIOTECHNO; Zamani M, 2014, MOL BIOTECHNOL; Zhou CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070303	61	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141469	10.1371/journal.pone.0141469	http://dx.doi.org/10.1371/journal.pone.0141469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517723	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800044
J	Rashid, MU; Muzaffar, M; Khan, FA; Kabisch, M; Muhammad, N; Faiz, S; Loya, A; Hamann, U				Rashid, Muhammad Usman; Muzaffar, Merium; Khan, Faiz Ali; Kabisch, Maria; Muhammad, Noor; Faiz, Sabeen; Loya, Asif; Hamann, Ute			Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study	PLOS ONE			English	Article							UK CAUCASIAN POPULATION; AFRICAN-AMERICAN WOMEN; BONE-MINERAL DENSITY; D PATHWAY; COMPREHENSIVE METAANALYSIS; TRANSCRIPTIONAL ACTIVATION; CONSANGUINEOUS MARRIAGE; POSTMENOPAUSAL WOMEN; OVARIAN-CANCER; MUTATIONS	Background Vitamin D is postulated to decrease the risk of breast cancer by inhibiting cell proliferation via the vitamin D receptor (VDR). Two common single nucleotide polymorphisms (SNPs) in the VDR gene, rs1544410 (BsmI) and rs2228570 (FokI), are inconsistently associated with breast cancer risk in Caucasian populations, while data for Asians are scarce. Here, we investigated the possible contribution of these SNPs to breast cancer risk in Pakistani breast cancer patients and in controls participating in a hospital-based breast cancer case-control study (PAK-BCCC). Methods Genotyping of the BsmI and FokI SNPs was performed by PCR-based restriction fragment length polymorphism (RFLP) analysis of 463 genetically enriched female breast cancer cases with known BRCA1/2 status and in 1,012 controls from Pakistan. The association between SNP genotypes and breast cancer risk was investigated by logistic regression adjusted for potential breast cancer risk factors and stratified by BRCA1/2 status and family history. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported. Results The b allele of the BsmI was associated with an increased breast cancer risk (per b allele OR 1.28, 95% CI 1.09-1.49, P = 0.003). Subgroup analysis revealed that this effect was restricted to BRCA1/2 non-carriers (per b allele OR 1.33, 95% CI 1.11-1.59, P = 0.002) and was stronger in those who reported a positive family history of breast and/or ovarian cancer (per b allele OR 1.64, 95% CI 1.20-2.22, P = 0.002). No association with breast cancer risk was detected for the FokI SNP. Conclusions The BsmI polymorphism in the VDR gene may be associated with an increased breast cancer risk in Pakistani women negative for BRCA1/2 germline mutations.	[Rashid, Muhammad Usman; Muzaffar, Merium; Khan, Faiz Ali; Muhammad, Noor; Faiz, Sabeen] SKMCH & RC, Dept Basic Sci Res, Lahore, Pakistan; [Rashid, Muhammad Usman] Univ Hlth Sci, Dept Human Genet & Mol Biol, Lahore, Pakistan; [Rashid, Muhammad Usman; Kabisch, Maria; Hamann, Ute] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Muzaffar, Merium] Univ Hlth Sci, Dept Physiol, Lahore, Pakistan; [Loya, Asif] SKMCH & RC, Dept Pathol, Lahore, Pakistan	Shaukat Khanum Memorial Cancer Hospital & Research Centre; University of Health Science - Pakistan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Health Science - Pakistan; Shaukat Khanum Memorial Cancer Hospital & Research Centre	Hamann, U (corresponding author), German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany.	hamann@dkfz-heidelberg.de	Muhammad, Noor/GYD-7914-2022; Muhammad, Noor/B-3611-2017	Muhammad, Noor/0000-0001-6811-5064; Rashid, Muhammad Usman/0000-0002-7684-3122	Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; German Cancer Research Center, Heidelberg, Germany	Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; German Cancer Research Center, Heidelberg, Germany	The study was supported by the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan and the German Cancer Research Center, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bhopal RS, 2014, EUR J PUBLIC HEALTH, V24, P862, DOI 10.1093/eurpub/ckt166; Bretherton-Watt D, 2001, BRIT J CANCER, V85, P171, DOI 10.1054/bjoc.2001.1864; Chen HK, 2013, BIOCHEM BIOPH RES CO, V430, P370, DOI 10.1016/j.bbrc.2012.11.003; Colston KW, 2008, BEST PRACT RES CL EN, V22, P587, DOI 10.1016/j.beem.2008.08.002; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6&lt;723::AID-IJC4&gt;3.0.CO;2-3; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dorjgochoo T, 2011, CANCER EPIDEM BIOMAR, V20, P2313, DOI 10.1158/1055-9965.EPI-11-0704; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fuhrman BJ, 2013, ANTICANCER RES, V33, P543; Gnagnarella P, 2014, CARCINOGENESIS, V35, P1913, DOI 10.1093/carcin/bgu150; Gross C, 1996, J BONE MINER RES, V11, P1850; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Holvik K, 2005, EUR J CLIN NUTR, V59, P57, DOI 10.1038/sj.ejcn.1602033; Huang Y, 2012, J MED RES, V41, P89; Imtiaz Saba, 2012, Indian J Endocrinol Metab, V16, P409, DOI 10.4103/2230-8210.95684; Ingles SA, 2000, CANCER CAUSE CONTROL, V11, P25, DOI 10.1023/A:1008979417618; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Iqbal R, 2013, JCPSP-J COLL PHYSICI, V23, P604, DOI 08.2013/JCPSP.604606; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Khan AA, 2009, AN INTERNATIONAL JOU, V24, P296; Kommagani R, 2007, J BIOL CHEM, V282, P29847, DOI 10.1074/jbc.M703641200; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Lowe NM, 2010, BRIT J NUTR, V103, P1706, DOI 10.1017/S0007114509993850; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Mauss D, 2015, INT J MED SCI, V12, P362, DOI 10.7150/ijms.10540; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mishra DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057967; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; National Institute of Population Studies (NIPS) [Pakistan] and ICF International, 2013, PAKISTAN DEMOGRAPHIC; Nezbedova P, 2004, Endocr Regul, V38, P29; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Raimondi S, 2014, MUTAT RES-FUND MOL M, V769, P17, DOI 10.1016/j.mrfmmm.2014.06.001; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; Rashid MU, 2014, BREAST CANCER RES TR, V145, P775, DOI 10.1007/s10549-014-2972-0; Rashid MU, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-312; Rashid MU, 2012, FAM CANCER, V11, P307, DOI 10.1007/s10689-012-9509-7; Shahbazi S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0393-7; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Sthanadar AA, 2014, J BIOSOC SCI, V46, P698, DOI 10.1017/S0021932013000552; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Wang J, 2013, TUMOR BIOL, V34, P3823, DOI 10.1007/s13277-013-0967-9; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	55	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141562	10.1371/journal.pone.0141562	http://dx.doi.org/10.1371/journal.pone.0141562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517870	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800054
J	Fencl, JS; Mather, ME; Costigan, KH; Daniels, MD				Fencl, Jane S.; Mather, Martha E.; Costigan, Katie H.; Daniels, Melinda D.			How Big of an Effect Do Small Dams Have? Using Geomorphological Footprints to Quantify Spatial Impact of Low-Head Dams and Identify Patterns of Across-Dam Variation	PLOS ONE			English	Article							OF-RIVER DAMS; COMMUNITY STRUCTURE; FISH ASSEMBLAGES; UNITED-STATES; NEOSHO RIVER; REMOVAL; DOWNSTREAM; STREAM; BIODIVERSITY; THRESHOLDS	Longitudinal connectivity is a fundamental characteristic of rivers that can be disrupted by natural and anthropogenic processes. Dams are significant disruptions to streams. Over 2,000,000 low-head dams (<7.6 m high) fragment United States rivers. Despite potential adverse impacts of these ubiquitous disturbances, the spatial impacts of low-head dams on geomorphology and ecology are largely untested. Progress for research and conservation is impaired by not knowing the magnitude of low-head dam impacts. Based on the geomorphic literature, we refined a methodology that allowed us to quantify the spatial extent of low-head dam impacts (herein dam footprint), assessed variation in dam footprints across low-head dams within a river network, and identified select aspects of the context of this variation. Wetted width, depth, and substrate size distributions upstream and downstream of six low-head dams within the Upper Neosho River, Kansas, United States of America were measured. Total dam footprints averaged 7.9 km (3.0-15.3 km) or 287 wetted widths (136437 wetted widths). Estimates included both upstream (mean: 6.7 km or 243 wetted widths) and downstream footprints (mean: 1.2 km or 44 wetted widths). Altogether the six low-head dams impacted 47.3 km (about 17%) of the mainstem in the river network. Despite differences in age, size, location, and primary function, the sizes of geomorphic footprints of individual low-head dams in the Upper Neosho river network were relatively similar. The number of upstream dams and distance to upstream dams, but not dam height, affected the spatial extent of dam footprints. In summary, ubiquitous low-head dams individually and cumulatively altered lotic ecosystems. Both characteristics of individual dams and the context of neighboring dams affected low-head dam impacts within the river network. For these reasons, low-head dams require a different, more integrative, approach for research and management than the individualistic approach that has been applied to larger dams.	[Fencl, Jane S.; Costigan, Katie H.] Kansas State Univ, Div Biol, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS 66506 USA; [Mather, Martha E.] Kansas State Univ, Div Biol, US Geol Survey, Kansas Cooperat Fish & Wildlife Res Unit, Manhattan, KS 66506 USA; [Daniels, Melinda D.] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; United States Department of the Interior; United States Geological Survey; Kansas State University	Fencl, JS (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jfencl@uw.edu	Rogosch, Jane S./AAJ-9314-2020	Rogosch, Jane S./0000-0002-1748-4991	Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife [002505]	Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife	This work was funded by Kansas Department of Wildlife Parks and Tourism, Ecological Services State Wildlife Grant 002505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ARCGIS VERS 10 2; [Anonymous], 2014, R LANG ENV STAT COMP; Bluck B. J., 1982, GRAVEL BED RIVERS, P339; BRANSON BA, 1967, AM MIDL NAT, V78, P126, DOI 10.2307/2423375; Burroughs BA, 2009, GEOMORPHOLOGY, V110, P96, DOI 10.1016/j.geomorph.2009.03.019; Carswell WJ, 1985, 854003 US GEOL SURV; City of Emporia, 2011, VIS MEN; City of Emporia, 2011, UTILITIES; Costigan KH, 2012, J HYDROL, V444, P90, DOI 10.1016/j.jhydrol.2012.04.008; Cross FB, 1952, T KANSAS ACAD SCI 19, V71, P350; Csiki S, 2010, PROG PHYS GEOG, V34, P755, DOI 10.1177/0309133310369435; Csiki SJC, 2014, GEOMORPHOLOGY, V206, P215, DOI 10.1016/j.geomorph.2013.10.009; Daniels MD, 2010, GEOMORPHOLOGY, V115, P194, DOI 10.1016/j.geomorph.2009.09.038; Dean Joseph, 2002, Transactions of the Kansas Academy of Science, V105, P232, DOI 10.1660/0022-8443(2002)105[0232:EOLDOF]2.0.CO;2; Dodds WK, 2010, J N AM BENTHOL SOC, V29, P988, DOI 10.1899/09-148.1; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; French LM., 2009, HIST EMPORIA LYON CO; Gillette DP, 2005, COPEIA, P539, DOI 10.1643/CE-04-135R2; Graf W.L., 1993, SUSTAINING OUR WATER, P11; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Hack J.T., 1957, STUDIES LONGITUDINAL, V294, P45; Hart DD, 2002, BIOSCIENCE, V52, P669, DOI 10.1641/0006-3568(2002)052[0669:DRCAOF]2.0.CO;2; Helms BS, 2011, J N AM BENTHOL SOC, V30, P1095, DOI 10.1899/10-093.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Juracek KE, 2000, J AM WATER RESOUR AS, V36, P633, DOI 10.1111/j.1752-1688.2000.tb04293.x; Juracek KE, 1999, 994147 US GEOL SURV; Kansas Biological Survey, DAT KANS APPL REM SE; Knighton AD., 1984, FLUVIAL FORMS PROCES; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Marren PM, 2014, SCI WORLD J, DOI 10.1155/2014/309673; National Inventory of Dams (NID) Data Team, 2013, CORPS MAP NAT INV DA; Obermeyer BK, 1997, J FRESHWATER ECOL, V12, P445, DOI 10.1080/02705060.1997.9663555; Pearson AJ, 2015, GEOMORPHOLOGY, V248, P382, DOI 10.1016/j.geomorph.2015.07.025; Perkin JS, 2015, AQUAT CONSERV, V25, P639, DOI 10.1002/aqc.2501; Perkin JS, 2011, FISHERIES, V36, P371, DOI 10.1080/03632415.2011.597666; PIZZUTO JE, 1995, WATER RESOUR RES, V31, P753, DOI 10.1029/94WR02532; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; SCHLOSSER IJ, 1982, ECOL MONOGR, V52, P395, DOI 10.2307/2937352; Schoewe WH, 1949, KANS ACAD SCI T, V52, P261; Schwab Eaton, 2012, SERV PROJ; Skalak K, 2009, J AM WATER RESOUR AS, V45, P97, DOI 10.1111/j.1752-1688.2008.00263.x; Stanley EH, 2002, J N AM BENTHOL SOC, V21, P172, DOI 10.2307/1468307; Stokes K, 2010, KANSAS TRAVEL TOURIS; Surian N, 2002, GEOMORPHOLOGY, V43, P137, DOI 10.1016/S0169-555X(01)00127-1; Tiemann JS, 2005, J FRESHWATER ECOL, V20, P519, DOI 10.1080/02705060.2005.9664767; Tullos DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108091; US Department of Transportation, 1995, VIS DAT TRANSP ENH C; US Geological Survey (USGS). National Hydrography Dataset, NAT HYDR DAT NAT MAP; USGS, NAT WAT INF SYST WEB; Williams G.P., 1984, REGUL RIVER, V1, P83; Wilson B., 2003, 200355E KGS OFR; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; Wolock D.M, 2003, 03263 US GEOL SURV; Yan YZ, 2013, ENVIRON BIOL FISH, V96, P495, DOI 10.1007/s10641-012-0035-0	62	61	64	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141210	10.1371/journal.pone.0141210	http://dx.doi.org/10.1371/journal.pone.0141210			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540105	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800012
J	McClurkin, MA; Yingling, LR; Ayers, C; Cooper-McCann, R; Suresh, V; Nothwehr, A; Barrington, DS; Powell-Wiley, TM				McClurkin, Michael A.; Yingling, Leah Rae; Ayers, Colby; Cooper-McCann, Rebecca; Suresh, Visakha; Nothwehr, Ann; Barrington, Debbie S.; Powell-Wiley, Tiffany M.			Health Insurance Status as a Barrier to Ideal Cardiovascular Health for US Adults: Data from the National Health and Nutrition Examination Survey (NHANES)	PLOS ONE			English	Article							SCIENTIFIC STATEMENT; PHYSICAL-ACTIVITY; MORTALITY; COVERAGE; RISK; CARE; HYPERTENSION; DEATH; ASSOCIATIONS; MEDICAID	Background Little is known about the association between cardiovascular (CV) health and health insurance status. We hypothesized that U.S. adults without health insurance coverage would have a lower likelihood of ideal cardiovascular health. Methods and Results Using National Health and Nutrition Examination Survey (NHANES) data from 2007-2010, we examined the relationship between health insurance status and ideal CV health in U.S. adults aged >= 19 years and <65 (N = 3304). Ideal CV health was defined by the American Heart Association (AHA) as the absence of clinically manifested CV disease and the simultaneous presence of 6-7 "ideal" CV health factors and behaviors. Logistic regression modeling was used to determine the relationship between health insurance status and the odds of ideal CV health. Of the U.S. adult population, 5.4% attained ideal CV health, and 23.5% were without health insurance coverage. Those without health insurance coverage were more likely to be young (p<0.0001), male (p<0.0001), non-white (p<0.0001), with less than a high school degree (p<0.0001), have a poverty-to-income ratio less than 1 (p<0.0001) and unemployed (p<0.0001) compared to those with coverage. Lack of health insurance coverage was associated with a lower likelihood of ideal CV health; however, this relationship was attenuated by socioeconomic status. Conclusions U.S. adults without health insurance coverage are less likely to have ideal CV health. Population-based strategies and interventions directed at the community-level may be one way to improve overall CV health and reach this at-risk group.	[McClurkin, Michael A.; Yingling, Leah Rae; Cooper-McCann, Rebecca; Suresh, Visakha; Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Ayers, Colby] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Nothwehr, Ann] Univ Maryland, College Pk, MD 20742 USA; [Barrington, Debbie S.] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD)	Powell-Wiley, TM (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	tiffany.powell-wiley@nih.gov		Suresh, Visakha/0000-0002-0950-2272; Yingling, Leah/0000-0002-7851-690X	Division of Intramural Research of NHLBI at NIH [HHSN268201300173P]; National Institutes of Health (NIH) Medical Research Scholars Program; NIH; NIH from Pfizer Inc; Doris Duke Charitable Foundation; Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006168] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [K22MD006133] Funding Source: NIH RePORTER	Division of Intramural Research of NHLBI at NIH; National Institutes of Health (NIH) Medical Research Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from Pfizer Inc; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for Colby Ayers is provided through a professional services contract (contract #HHSN268201300173P) through the Division of Intramural Research of NHLBI at NIH. Funding for Rebecca Cooper-McCann is provided through the National Institutes of Health (NIH) Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer Inc, The Doris Duke Charitable Foundation, The Alexandria Real Estate Equities, Inc., Mr. and Mrs. Joel S. Marcus, and the Howard Hughes Medical Institute, as well as other private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Regarding the private donors, none of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company. The identity of the private donors is not considered relevant to editors or reviewers' assessment of the validity of the work. The authors are not aware of any competing interests.	[Anonymous], 2009, NAT HLTH NUTR EX SUR; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BLACKBURN H, 1989, ANN MED, V21, P157, DOI 10.3109/07853898909149926; Blackwell D.L., 2014, VITAL HEALTH STAT 10, V260, P1; Bowman SA, 2015, FOOD PATTERNS EQUIVA; Brook RH, 2006, HLTH INSURANCE EXPT; Brooks EL, 2010, AM J MED, V123, P741, DOI 10.1016/j.amjmed.2010.02.013; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Davidoff A., 2005, UNINSURED AM CHRONIC; DeNavas-Walt C., 2014, INCOME POVERTY US 20; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Duru OK, 2007, AM J HYPERTENS, V20, P348, DOI 10.1016/j.amjhyper.2006.11.007; Fiore MC, 2008, RESP CARE, V53, P1217; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fowler-Brown A, 2007, J GEN INTERN MED, V22, P502, DOI 10.1007/s11606-007-0127-2; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gross CP, 2000, ARCH INTERN MED, V160, P3209, DOI 10.1001/archinte.160.21.3209; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012; Kontos EZ, 2010, J HEALTH COMMUN, V15, P216, DOI 10.1080/10810730.2010.522689; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lee JS, 2010, PUBLIC HEALTH REP, V125, P596, DOI 10.1177/003335491012500415; Levy J, 2015, US UNINSURED RATE DI; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; Medalia C., 2014, CURRENT POPULATION R, P60; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pleis JR, 2010, VITAL HLTH STAT, V249, P1; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; Schober SE, 2011, NCHS DATA BRIEF, V57, P1; Singleterry J, 2014, MMWR-MORBID MORTAL W, V63, P264; Sloane DC, 2003, J GEN INTERN MED, V18, P568, DOI 10.1046/j.1525-1497.2003.21022.x; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010; US Department of Agriculture, USDA FOOD NUTR DAT D; US Department of Agriculture Agricultural Research Service Food Surveys Research Group, 2010, FOOD NUTR DAT DIET S; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Wilper AP, 2009, HEALTH AFFAIR, V28, pW1151, DOI 10.1377/hlthaff.28.6.w1151; Yancey Antronette K, 2004, Prev Chronic Dis, V1, pA09; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	56	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141534	10.1371/journal.pone.0141534	http://dx.doi.org/10.1371/journal.pone.0141534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535890	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400068
J	Tong, J; Xie, JY; Ren, H; Liu, J; Zhang, WJ; Wei, CG; Xu, J; Zhang, W; Li, X; Wang, WM; Lv, DF; He, JC; Chen, N				Tong, Jun; Xie, Jingyuan; Ren, Hong; Liu, Jian; Zhang, Weijia; Wei, Chengguo; Xu, Jing; Zhang, Wen; Li, Xiao; Wang, Weiming; Lv, Danfeng; He, John Cijiang; Chen, Nan			Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DIABETIC-NEPHROPATHY; NEUTRAL ENDOPEPTIDASE; MICROARRAY ANALYSIS; MUTATIONS; ALLOIMMUNIZATION; MOLECULES; KIDNEY; CELLS	Objective To search for biomarkers to differentiate primary focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). Methods We isolated glomeruli from kidney biopsies of 6 patients with adult-onset steroid sensitiveFSGS and 5 patients with MCD, and compared the profiles of glomerular transcriptomes between the two groups of patients using microarray analysis. Results Analysis of differential expressed genes (DEGs) revealed that up-regulated DEGs in FSGS patients compared with MCD patients were primarily involved in spermatogenesis, gamete generation, regulation of muscle contraction, response to unfolded protein, cell proliferation and skeletal system development. The down-regulated DEGs were primarily related to metabolic process, intracellular transport, oxidation/reduction and establishment of intracellular localization. We validated the expression of the top 6 up-regulated and top 6 down-regulated DEGs using real-time PCR. Membrane metallo-endopeptidase (MME) is a down-regulated gene that was previously identified as a key gene for kidney development. Immunostaining confirmed that the protein expression of MME decreased significantly in FSGS kidneys compared with MCD kidneys. Conclusions This report was the first study to examine transcriptomes in Chinese patients with various glomerular diseases. Expressions of MME both in RNA and protein level decreased significantly in glomeruli of FSGS kidneys compared with MCD kidneys. Our data suggested that MME might play a role in the normal physiological function of podocytes and a decrease in MME expression might be related to podocyte injury. We also identified genes and pathways specific for FSGS versus MCD, and our data could help identify potential new biomarkers for the differential diagnosis between these two diseases.	[Tong, Jun; Xie, Jingyuan; Ren, Hong; Liu, Jian; Xu, Jing; Zhang, Wen; Li, Xiao; Wang, Weiming; Chen, Nan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Nephrol, Shanghai 200030, Peoples R China; [Xie, Jingyuan; Wang, Weiming; He, John Cijiang; Chen, Nan] Shanghai Jiao Tong Univ, Inst Nephrol, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Weijia; Wei, Chengguo; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Lv, Danfeng] Chinese Acad Sci, Natl Ctr Gene Res, Shanghai, Peoples R China; [Lv, Danfeng] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	He, JC (corresponding author), Shanghai Jiao Tong Univ, Inst Nephrol, Sch Med, Shanghai 200030, Peoples R China.	cijiang.he@mssm.edu; cnrj100@126.com	xie, jing/GRY-1689-2022; Xie, Jingyuan/AAX-2708-2021		National Basic Research Program of China [2012CB517600 (2012CB517604)]; National Natural Science Foundation of China [81570598, 81370015]; International Cooperation and Exchange Projects of Shanghai Science and Technology Commettee [14430721000]; Chinese Medical Association clinical research special fund [13030280413]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchange Projects of Shanghai Science and Technology Commettee; Chinese Medical Association clinical research special fund	Funding: This work was supported by grants from the National Basic Research Program of China973, grant No. 2012CB517600 (No. 2012CB517604), the National Natural Science Foundation of China (No. 81570598, 81370015), the International Cooperation and Exchange Projects of Shanghai Science and Technology Commettee (No. 14430721000), and the Chinese Medical Association clinical research special fund (No. 13030280413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozaykut P, 2013, J PROTEOMICS, V89, P238, DOI 10.1016/j.jprot.2013.06.025; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099645; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; CONLON PJ, 1995, AM J KIDNEY DIS, V26, P34, DOI 10.1016/0272-6386(95)90150-7; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Fan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093019; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Li XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092003; Liu J, 2015, PEDIAT RES; LIU LT, 1993, KIDNEY INT, V44, P322, DOI 10.1038/ki.1993.247; Luo HM, 2015, LAB INVEST, V95, P320, DOI 10.1038/labinvest.2014.158; Mak SK, 1996, NEPHROL DIAL TRANSPL, V11, P2192, DOI 10.1093/oxfordjournals.ndt.a027136; Maric C, 2006, NEPHRON PHYSIOL, V103, P149, DOI 10.1159/000092457; Miyoshi K, 2009, ACTA HISTOCHEM CYTOC, V42, P55, DOI 10.1267/ahc.08012; Muangman P, 2003, SHOCK, V19, P508, DOI 10.1097/01.shk.0000055815.40894.16; Noordmans GA, 2013, J AM SOC NEPHROL, V24, P1995, DOI 10.1681/ASN.2012080838; Pereira NL, 2010, J MOL CELL CARDIOL, V49, P864, DOI 10.1016/j.yjmcc.2010.07.020; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronco P, 2006, NAT CLIN PRACT NEPHR, V2, P388, DOI 10.1038/ncpneph0198; Rood IM, 2012, NEPHROL DIAL TRANSPL, V27, P882, DOI 10.1093/ndt/gfr771; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; Suvakov S, 2013, NEPHROL DIAL TRANSPL, V28, P202, DOI 10.1093/ndt/gfs369; Valach M, 2014, NUCLEIC ACIDS RES, V42, P13764, DOI 10.1093/nar/gku1266; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Xie JY, 2015, KIDNEY INT, V88, P593, DOI 10.1038/ki.2015.106; Xie JY, 2014, J MOL CELL BIOL, V6, P498, DOI 10.1093/jmcb/mju040; Yoshida R, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P289, DOI 10.1109/CSB.2005.32; Zhang DY, 2011, AM J NEPHROL, V34, P483, DOI 10.1159/000333006	36	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140453	10.1371/journal.pone.0140453	http://dx.doi.org/10.1371/journal.pone.0140453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536600	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400020
J	Berens, EM; Reder, M; Razum, O; Kolip, P; Spallek, J				Berens, Eva-Maria; Reder, Maren; Razum, Oliver; Kolip, Petra; Spallek, Jacob			Informed Choice in the German Mammography Screening Program by Education and Migrant Status: Survey among First-Time Invitees	PLOS ONE			English	Article							NON-ATTENDANCE; CANCER; BREAST; WOMEN; PARTICIPATION; PREDICTORS; KNOWLEDGE	Breast cancer is the most prevalent cancer among women and mammography screening programs are seen as a key strategy to reduce breast cancer mortality. In Germany, women are invited to the population-based mammography screening program between ages 50 to 69. It is still discussed whether the benefits of mammography screening outweigh its harms. Therefore, the concept of informed choice comprising knowledge, attitude and intention has gained importance. The objective of this observational study was to assess the proportion of informed choices among women invited to the German mammography screening program for the first time. A representative sample of 17,349 women aged 50 years from a subregion of North Rhine Westphalia was invited to participate in a postal survey. Turkish immigrant women were oversampled. The effects of education level and migration status on informed choice and its components were assessed. 5,847 (33.7%) women responded to the postal questionnaire of which 4,113 were used for analyses. 31.5% of the women had sufficient knowledge. The proportion of sufficient knowledge was lower among immigrants and among women with low education levels. The proportion of women making informed choices was low (27.1%), with similar associations with education level and migration status. Women of low (OR 2.75; 95% CI 2.18-3.46) and medium education level (OR 1.49; 95% CI 1.27-1.75) were more likely to make an uninformed choice than women of high education level. Turkish immigrant women had the greatest odds for making an uninformed choice (OR 5.30, 95% CI 1.92-14.66) compared to non-immigrant women. Other immigrant women only had slightly greater odds for making an uninformed choice than non-immigrant women. As immigrant populations and women with low education level have been shown to have poor knowledge, they need special attention in measures to increase knowledge and thus informed choices.	[Berens, Eva-Maria; Razum, Oliver; Spallek, Jacob] Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33615 Bielefeld, North Rhine Wes, Germany; [Berens, Eva-Maria] Univ Bielefeld, Sch Publ Hlth, Dept Hlth Serv Res & Nursing Sci, D-33615 Bielefeld, North Rhine Wes, Germany; [Reder, Maren; Kolip, Petra] Univ Bielefeld, Sch Publ Hlth, Dept Prevent & Hlth Promot, D-33615 Bielefeld, North Rhine Wes, Germany; [Spallek, Jacob] Brandenburg Univ Technol Cottbus Senftenberg, Dept Publ Hlth, Brandenburg, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Berens, EM (corresponding author), Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33615 Bielefeld, North Rhine Wes, Germany.	eva-maria.berens@uni-bielefeld.de	Reder, Maren/GXZ-5864-2022; Spallek, Jacob/G-6200-2016; Berens, Eva-Maria/GSJ-4113-2022	Berens, Eva-Maria/0000-0001-9181-2706; Kolip, Petra/0000-0002-1052-5869; Razum, Oliver/0000-0002-1244-7649	German Federal Ministry of Health [NKP-332-028]	German Federal Ministry of Health	This work was supported by the German Federal Ministry of Health within Research for the National Cancer Plan, grant number NKP-332-028. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens EM, 2016, EUR J CANCER CARE, V25, P38, DOI 10.1111/ecc.12334; Berens EM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006145; Berens EM, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-24; Bulliard JL, 2004, BREAST, V13, P284, DOI 10.1016/j.breast.2004.03.001; Dierks M-L., 2014, GESUNDHEITSMONITOR, P55; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Fontana M, 2008, SWISS MED WKLY, V138, P752, DOI 2008/49/smw-12328; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gummersbach E, 2015, DTSCH ARZTEBL INT, V112, P61, DOI 10.3238/arztebl.2015.0061; Haug S., 2008, SPRACHLICHE INTEGRAT; Helou A, 2014, BUNDESGESUNDHEITSBLA, V57, P288, DOI 10.1007/s00103-013-1902-3; Klug SJ, 2005, EUR J PUBLIC HEALTH, V15, P70, DOI 10.1093/eurpub/cki118; Kooperationsgemeinschaft Mammographie, 2012, EV 2008 2009 ERG MAM; Kristiansen M, 2012, ACTA ONCOL, V51, P28, DOI 10.3109/0284186X.2011.626447; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Nass-Griegoleit I, 2009, FRAUENARZT, V50, P494; Perry N., 2006, EUROPEAN GUIDELINES; Puddu M, 2009, INT J PUBLIC HEALTH, V54, P61, DOI 10.1007/s00038-009-8105-6; Razum O, 2001, TROP MED INT HEALTH, V6, P654, DOI 10.1046/j.1365-3156.2001.00760.x; Renshaw C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-157; van Agt H, 2012, PATIENT EDUC COUNS, V89, P353, DOI 10.1016/j.pec.2012.08.003; Vermeer B, 2010, EUR J CANCER PREV, V19, P195, DOI 10.1097/CEJ.0b013e328337214c; Visser O, 2005, EUR J CANCER PREV, V14, P251, DOI 10.1097/00008469-200506000-00009; Worbs S, 2013, 20 BUD MIGR FLUCHTL; Zackrisson S, 2007, SCAND J PUBLIC HEALT, V35, P548, DOI 10.1080/14034940701291716	29	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142316	10.1371/journal.pone.0142316	http://dx.doi.org/10.1371/journal.pone.0142316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529513	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600113
J	Bohr, S; Patel, SJ; Vasko, R; Shen, KY; Golberg, A; Berthiaume, F; Yarmush, ML				Bohr, Stefan; Patel, Suraj J.; Vasko, Radovan; Shen, Keyue; Golberg, Alexander; Berthiaume, Francois; Yarmush, Martin L.			The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model	PLOS ONE			English	Article							COLONIC EPITHELIAL-CELLS; CHITIN-BINDING PROTEINS; INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; SERUM YKL-40; INTESTINAL INFLAMMATION; RHEUMATOID-ARTHRITIS; BACTERIAL ADHESION	In severe burn injury the unique setting of a depleted, dysfunctional immune system along with a loss of barrier function commonly results in opportunistic infections that eventually proof fatal. Unfortunately, the dynamic sequence of bacterial contamination, colonization and eventually septic invasion with bacteria such as Pseudomonas species is still poorly understood although a limiting factor in clinical decision making. Increasing evidence supports the notion that inhibition of bacterial translocation into the wound site may be an effective alternative to prevent infection. In this context we investigated the role of the mammalian Chitinase-3-Like-1 (CHI3L1) non-enyzmatic protein predominately expressed on epithelial as well as innate immune cells as a potential bacterial-translocation-mediating factor. We show a strong trend that a modulation of chitinase expression is likely to be effective in reducing mortality rates in a mouse model of burn injury with superinfection with the opportunistic PA14 Pseudomonas strain, thus demonstrating possible clinical leverage.	[Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Sch Med, Shriners Hosp Children, Ctr Engn Med, Boston, MA 02138 USA; [Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Vasko, Radovan] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Berthiaume, Francois; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, New Brunswick, NJ USA; [Bohr, Stefan] Rhein Westfal TH Aachen, UKA Univ Clin, Dept Plast & Hand Surg, Burn Ctr, D-52062 Aachen, Germany; [Vasko, Radovan] UMG Univ Clin, Dept Nephrol & Rheumatol, Gottingen, Germany; [Golberg, Alexander] Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College; Rutgers State University New Brunswick; RWTH Aachen University; RWTH Aachen University Hospital; Tel Aviv University	Bohr, S (corresponding author), Harvard Univ, Sch Med, Shriners Hosp Children, Ctr Engn Med, Boston, MA 02138 USA.	sbohr@ukaachen.de	Golberg, Alexander/M-9563-2017; Berthiaume, Francois/ABD-2139-2020	Golberg, Alexander/0000-0001-8782-8879; Yarmush, Martin/0000-0003-4986-8444	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award [GZ:BO3468/2-1]	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award	This work was funded by the Shriners Hospitals for Children, https://www.shrinershospitalsforchildren.org/locations/boston. SB is a receipt of a Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award (GZ:BO3468/2-1), http://www.dfg.de/en/.	Adrangi S, 2013, BIOTECHNOL ADV, V31, P1786, DOI 10.1016/j.biotechadv.2013.09.012; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Azzopardi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095042; Baeten D, 2000, ANN RHEUM DIS, V59, P945, DOI 10.1136/ard.59.12.945; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; Duan XB, 2008, J LEUKOCYTE BIOL, V83, P305, DOI 10.1189/jlb.0407228; Duru S, 2013, TUBERK TORAK, V61, P71, DOI 10.5578/tt.3773; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Erol S, 2004, BURNS, V30, P357, DOI 10.1016/j.burns.2003.12.013; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; FUCHS RL, 1986, APPL ENVIRON MICROB, V51, P504, DOI 10.1128/AEM.51.3.504-509.1986; Holder IA, 2001, J BURN CARE REHABIL, V22, P311, DOI 10.1097/00004630-200109000-00004; Holmes CJ, 2015, ADV WOUND CARE, V4, P24, DOI 10.1089/wound.2014.0546; Jeon SJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092723, 10.1109/CICC.2014.6946008]; Johansen JS, 1997, SCAND J GASTROENTERO, V32, P582, DOI 10.3109/00365529709025104; Johansen JS, 2015, CANCER EPIDEM BIOMAR, V24, P621, DOI 10.1158/1055-9965.EPI-13-1281; Kamba A, 2013, CURR MOL MED, V13, P1110; Karavolos MH, 2014, ADV EXP MED BIOL, V817, P241, DOI 10.1007/978-1-4939-0897-4_11; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Libreros S, 2012, INT J CANCER, V131, P377, DOI 10.1002/ijc.26379; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Liu XM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0085-6; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090494; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Malaguarnera L, 2005, J CLIN LAB ANAL, V19, P128, DOI 10.1002/jcla.20063; Manafi A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-23; Manjeet K, 2013, MICROBIOL RES, V168, P461, DOI 10.1016/j.micres.2013.01.006; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; MANSON WL, 1992, J HOSP INFECT, V22, P55, DOI 10.1016/0195-6701(92)90130-E; MANSON WL, 1992, BURNS, V18, P98, DOI 10.1016/0305-4179(92)90002-C; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Ridker PM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000897; Rojas Y, 2012, EXPERT OPIN PHARMACO, V13, P2485, DOI 10.1517/14656566.2012.738195; Shen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050238; Shimizu Kentaro, 2015, Burns, V41, pe28, DOI 10.1016/j.burns.2014.10.019; Smyth D, 2012, CELL MICROBIOL, V14, P1257, DOI 10.1111/j.1462-5822.2012.01796.x; Swartjes JJ, 2014, CURR MED CHEM; Thompson CM, 2014, CRIT CARE MED, V42, P1397, DOI 10.1097/CCM.0000000000000218; Tran A, 2000, EUR J GASTROEN HEPAT, V12, P989, DOI 10.1097/00042737-200012090-00004; Tran HT, 2011, HISTOL HISTOPATHOL, V26, P1453, DOI 10.14670/HH-26.1453; Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60; Vind I, 2003, SCAND J GASTROENTERO, V38, P599, DOI 10.1080/00365520310000537; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wong VW, 2013, PLAST RECONSTR SURG, V132, p854E, DOI 10.1097/PRS.0b013e3182a3c11e	67	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140440	10.1371/journal.pone.0140440	http://dx.doi.org/10.1371/journal.pone.0140440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528713	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600006
J	Odhiambo, C; Zeh, C; Ondoa, P; Omolo, P; Akoth, B; Lwamba, H; Lando, R; Williamson, J; Otieno, J; Masaba, R; Weidle, P; Thomas, T				Odhiambo, Collins; Zeh, Clement; Ondoa, Pascale; Omolo, Paul; Akoth, Benta; Lwamba, Humphrey; Lando, Richard; Williamson, John; Otieno, Juliana; Masaba, Rose; Weidle, Paul; Thomas, Timothy		KiBS Study Team	Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANTIRETROVIRAL THERAPY; CHILDREN; TRANSMISSION; ZIDOVUDINE; MALARIA; PROPHYLAXIS; PARAMETERS; LAMIVUDINE; MALAWIAN	Background Anemia results in increased morbidity and mortality, underscoring the need to better understand its pathophysiology amongst HIV-exposed and infected children in sub-Saharan Africa, the region where most infant HIV exposure and infections occur. Methods This analysis used samples obtained from children in the Kisumu Breastfeeding Study (KiBS). KiBS was a longitudinal phase IIB, open-label, one-arm clinical trial, designed to investigate the safety, tolerability and effectiveness of a maternal triple-antiretroviral (ARV) regimen for prevention of mother-to-child transmission (PMTCT) of HIV, during late pregnancy and early infancy while breastfeeding. Blood samples from 482 children were obtained at birth, 2, 6, 10 and 14 weeks and 6, 9, 12, 18 and 24 months. Severity of anemia was graded using the NIH Division of AIDS (DAIDS) toxicity tables. We describe the proportion of children with anemia and anomalies in red blood cell parameters at various time points over 24 months and compare rates of anemia between HIV-infected and HIV-uninfected children and by mothers' ARV regimen and infant malaria infection. Results The proportion of children with anemia significantly increased after the breastfeeding period in both HIV-infected and HIV-uninfected children with higher proportion among HIV-infected children compared to HIV-uninfected children (RR: 1.72; CI: 1.22-2.44, p = 0.002). Maternal triple-antiretroviral regimen was not associated with infant anemia ( p = 0.11). There was no significant difference in mean hemoglobin between HIV-uninfected children with and without malaria at each time point except at 24 months. Conclusion A relatively lower proportion of children with severe anemia during the breastfeeding period suggest that exposure to mother's triple antiretroviral combinations through breast milk, posed minimal risk of hematologic toxicity.	[Odhiambo, Collins; Omolo, Paul; Akoth, Benta; Lwamba, Humphrey; Lando, Richard] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Zeh, Clement; Williamson, John; Thomas, Timothy] US Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Kisumu, Kenya; [Ondoa, Pascale] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Ctr Poverty Related Communicable Dis, Dept Internal Med,Ctr Infect & Immun, Amsterdam, Netherlands; [Otieno, Juliana] Jaramogi Oginga Odinga Teaching & Referral Hosp, Kisumu, Kenya; [Masaba, Rose] Family Hlth Int, Nairobi, Kenya; [Weidle, Paul] CDC, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Kenya Medical Research Institute; University of Amsterdam; Centers for Disease Control & Prevention - USA	Odhiambo, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	coodhiambo@kemricdc.org; czeh@ke.cdc.gov		odhiambo, collins/0000-0002-5534-8720	Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA	Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA	This study received funding from the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; Bain B J, 1999, Curr Opin Hematol, V6, P89, DOI 10.1097/00062752-199903000-00006; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; Calis JCJ, 2008, AIDS, V22, P1099, DOI 10.1097/QAD.0b013e3282fa759f; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V56, P428, DOI 10.1097/QAI.0b013e31820bd2b6; El Beitune P, 2006, EUR J OBSTET GYN R B, V128, P59, DOI 10.1016/j.ejogrb.2006.01.013; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Galli L, 1995, PEDIATR AIDS HIV INF, V6, P340; Hardin JW, 2012, GEN ESTIMATING EQUAT; Heinig M J, 1998, J Hum Lact, V14, P2, DOI 10.1177/089033449801400102; Heinig MJ, 2002, PEDIATRICS, V110, P1033, DOI 10.1542/peds.110.5.1033; Hoffmann CJ, 2008, AIDS, V22, P67, DOI 10.1097/QAD.0b013e3282f2306e; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP REP GLOB HI; Kiragga AN, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-42; Komba AN, 2009, CLIN INFECT DIS, V49, P216, DOI 10.1086/599834; Lubega IR, 2010, JAIDS-J ACQ IMM DEF, V55, P58, DOI 10.1097/QAI.0b013e3181db059d; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Miller MF, 2006, AM J CLIN NUTR, V84, P212; Miller MF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-1; Mirochnick M, 2009, ANTIMICROB AGENTS CH, V53, P1170, DOI 10.1128/AAC.01117-08; Mishra LC, 2010, AM J TROP MED HYG, V82, P148, DOI 10.4269/ajtmh.2010.09-0427; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; MUELLER BU, 1994, PEDIATRIC AIDS CHALL, P591; National Institutes of Health, 1994, DIV AIDS TABL GRAD S; Nommsen-Rivers L, 1997, J Hum Lact, V13, P179, DOI 10.1177/089033449701300301; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Semba RD, 2005, ARCH INTERN MED, V165, P2229, DOI 10.1001/archinte.165.19.2229; Semba RD, 2001, HAEMATOLOGICA, V86, P1221; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Taha TE, 2002, AIDS, V16, P851, DOI 10.1097/00002030-200204120-00004; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; United Nations Children's Fund, 2005, UN CHILDR UN AIDS CA; van Eijk AM, 2002, AM J TROP MED HYG, V67, P44, DOI 10.4269/ajtmh.2002.67.44; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; WHO, 2000, TECHN CONS BEH UNFPA; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2003, SCAL ANT THER RES LT	43	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141599	10.1371/journal.pone.0141599	http://dx.doi.org/10.1371/journal.pone.0141599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529316	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600041
J	Sharma, AM; Baraff, B; Hutchins, JT; Wong, MK; Blaisdell, GK; Cooper, ML; Daane, KM; Almeida, RPP				Sharma, Abhineet M.; Baraff, Breanna; Hutchins, John T.; Wong, Michelle K.; Blaisdell, G. Kai; Cooper, Monica L.; Daane, Kent M.; Almeida, Rodrigo P. P.			Relative Prevalence of Grapevine Leafroll-Associated Virus Species in Wine Grape-Growing Regions of California	PLOS ONE			English	Article							PSEUDOCOCCUS-LONGISPINUS; PLANOCOCCUS-FICUS; TRANSMISSION; GLRAV-3; GRAPEVINE-LEAFROLL-ASSOCIATED-VIRUS-3; INFECTION; HEMIPTERA; ECOLOGY	Some diseases manifest as one characteristic set of symptoms to the host, but can be caused by multiple pathogens. Control treatments based on plant symptoms can make it difficult to effectively manage such diseases, as the biology of the underlying pathogens can vary. Grapevine leafroll disease affects grapes worldwide, and is associated with several viral species in the family Closteroviridae. Whereas some of the viruses associated with this disease are transmitted by insect vectors, others are only graft-transmissible. In three regions of California, we surveyed vineyards containing diseased vines and screened symptomatic plants for all known viral species associated with grapevine leafroll disease. Relative incidence of each virus species differed among the three regions regions, particularly in relation to species with known vectors compared with those only known to be graft-transmitted. In one region, the pathogen population was dominated by species not known to have an insect vector. In contrast, populations in the other surveyed regions were dominated by virus species that are vector-transmissible. Our survey did not detect viruses associated with grapevine leafroll disease at some sites with characteristic disease symptoms. This could be explained either by undescribed genetic diversity among these viruses that prevented detection with available molecular tools at the time the survey was performed, or a misidentification of visual symptoms that may have had other underlying causes. Based on the differences in relative prevalence of each virus species among regions and among vineyards within regions, we expect that region and site-specific management strategies are needed for effective disease control.	[Sharma, Abhineet M.; Baraff, Breanna; Hutchins, John T.; Wong, Michelle K.; Blaisdell, G. Kai; Daane, Kent M.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Cooper, Monica L.] Univ Calif Cooperat Extens, Napa, CA 94559 USA	University of California System; University of California Berkeley; University of California System	Almeida, RPP (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo/0000-0003-2888-9617	United States Department of Agriculture NIFA-SCRI [2009-51181-06027]; California Agricultural Experiment Station; American Vineyard Foundation	United States Department of Agriculture NIFA-SCRI; California Agricultural Experiment Station; American Vineyard Foundation	This research was supported by an award from the United States Department of Agriculture NIFA-SCRI (award no. 2009-51181-06027), the California Agricultural Experiment Station, and grants to MLC, KMD and RPPA from the American Vineyard Foundation.	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Al Rwahnih M, 2013, PHYTOPATHOLOGY, V103, P1069, DOI 10.1094/PHYTO-10-12-0253-R; Al Rwahnih M, 2012, VIRUS RES, V163, P302, DOI 10.1016/j.virusres.2011.10.018; Almeida RPP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00094; Bell VA, 2015, INTEGRATED STRATEGY; Ben Salem-Fnayou A, 2006, J PHYTOPATHOL, V154, P528, DOI 10.1111/j.1439-0434.2006.01142.x; Bertazzon N, 2010, EUR J PLANT PATHOL, V127, P185, DOI 10.1007/s10658-010-9583-3; Bester R, 2012, ARCH VIROL, V157, P1815, DOI 10.1007/s00705-012-1333-8; Blaisdell GK, 2015, J ECON ENTOMOL, V108, P1531, DOI 10.1093/jee/tov153; Cabaleiro C, 1999, AM J ENOL VITICULT, V50, P40; Cabaleiro C, 1997, PLANT DIS, V81, P283, DOI 10.1094/PDIS.1997.81.3.283; Cabaleiro C, 1997, EUR J PLANT PATHOL, V103, P373, DOI 10.1023/A:1008619523666; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Douglas N, 2008, EUR J PLANT PATHOL, V122, P207, DOI 10.1007/s10658-008-9269-2; du Preez J, 2011, ARCH VIROL, V156, P1495, DOI 10.1007/s00705-011-1071-3; ENGELBRECHT D J, 1990, Phytophylactica, V22, P341; Golino DA, 2008, CALIF AGR, V62, P156, DOI 10.3733/ca.v062n04p156; HABILI N, 1995, PHYTOPATHOLOGY, V85, P1418, DOI 10.1094/Phyto-85-1418; Jooste AEC, 2011, EUR J PLANT PATHOL, V131, P371, DOI 10.1007/s10658-011-9814-2; Klaassen VA, 2011, PLANT DIS, V95, P657, DOI 10.1094/PDIS-09-10-0621; Kovacs LG, 2001, AM J ENOL VITICULT, V52, P254; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Le Maguet J, 2012, PHYTOPATHOLOGY, V102, P717, DOI 10.1094/PHYTO-10-11-0289; Mahfoudhi N, 2009, PLANT DIS, V93, P999, DOI 10.1094/PDIS-93-10-0999; Maree HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126819; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Petersen CL, 1997, PLANT PATHOL, V46, P509, DOI 10.1046/j.1365-3059.1997.d01-44.x; Reynard JS, 2015, PHYTOPATHOLOGY, V105, P1262, DOI 10.1094/PHYTO-12-14-0386-R; Sandanayaka WRM, 2013, ARTHROPOD-PLANT INTE, V7, P137, DOI 10.1007/s11829-012-9238-8; Seah YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-235; Sether DM, 2002, PHYTOPATHOLOGY, V92, P928, DOI 10.1094/PHYTO.2002.92.9.928; Sharma AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026227; Tsai CW, 2008, PHYTOPATHOLOGY, V98, P1093, DOI 10.1094/PHYTO-98-10-1093; Tsai CW, 2012, PLANT PATHOL, V61, P977, DOI 10.1111/j.1365-3059.2011.02571.x; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Velasco L, 2014, PLANT DIS, V98, P395, DOI 10.1094/PDIS-04-13-0433-RE; Volpe RJ, 2010, CALIF AGR, V64, P42, DOI 10.3733/ca.v064n01p42	38	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142120	10.1371/journal.pone.0142120	http://dx.doi.org/10.1371/journal.pone.0142120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529503	Green Published, gold			2022-12-27	WOS:000364032600103
J	Tiira, K; Lohi, H				Tiira, Katriina; Lohi, Hannes			Early Life Experiences and Exercise Associate with Canine Anxieties	PLOS ONE			English	Article							SEPARATION ANXIETY; MATERNAL-BEHAVIOR; GENETIC-ANALYSIS; GUIDE-DOGS; STRESS; PERSONALITY; FEAR; TEMPERAMENT; SUITABILITY; PREVALENCE	Personality and anxiety disorders across species are affected by genetic and environmental factors. Shyness-boldness personality continuum exists across species, including the domestic dog, with a large within-and across-breed variation. Domestic dogs are also diagnosed for several anxiety-related behavioral conditions, such as generalized anxiety disorders, phobias, and separation anxiety. Genetic and environmental factors contributing to personality and anxiety are largely unknown. We collected questionnaire data from a Finnish family dog population (N = 3264) in order to study the associating environmental factors for canine fearfulness, noise sensitivity, and separation anxiety. Early life experiences and exercise were found to associate with anxiety prevalence. We found that fearful dogs had less socialization experiences (p = 0.002) and lower quality of maternal care (p < 0.0001) during puppyhood. Surprisingly, the largest environmental factor associating with noise sensitivity (p < 0.0001) and separation anxiety (p = 0.007) was the amount of daily exercise; dogs with noise sensitivity and separation anxiety had less daily exercise. Our findings suggest that dogs share many of the same environmental factors that contribute to anxiety in other species as well, such as humans and rodents. Our study highlights the importance of early life experiences, especially the quality of maternal care and daily exercise for the welfare and management of the dogs, and reveals important confounding factors to be considered in the genetic characterization of canine anxiety.	[Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00014 Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; University of Helsinki; Folkhalsan Research Center	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, POB 63, FIN-00014 Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Tiira, Katriina/U-4035-2018	Lohi, Hannes/0000-0003-1087-5532; Tiira, Katriina/0000-0002-2253-8755	ERC [260997]; Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Cultural Foundation; Finnish Kennel Club	ERC(European Research Council (ERC)European Commission); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Kennel Club	This work was supported by ERC Starting Grant 260997 (http://erc.europa.eu/starting-grants) to HL, Jane and Aatos Erkko Foundation (http://www.jaes.fi/en/) to HL, the Academy of Finland (http://www.aka.fi/en) to HL, Finnish Cultural Foundation (https://skr.fi/en) to KT and The Finnish Kennel Club (http://www.kennelliitto.fi/en) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Arvelius P, 2014, J ANIM SCI, V92, P4843, DOI 10.2527/jas.2014-8169; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Carere C., 2013, ANIMAL PERSONALITIES; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Dale AR, 2010, NEW ZEAL VET J, V58, P286, DOI 10.1080/00480169.2010.69403; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dias BG, 2013, CURR OPIN NEUROBIOL, V23, P346, DOI 10.1016/j.conb.2013.01.013; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Dwyer CM, 2004, HORM BEHAV, V46, P529, DOI 10.1016/j.yhbeh.2004.05.011; Epstein S., 1972, ANXIETY CURR TRENDS, V2, P291, DOI 10.1016/B978-0-12-657402-9.50007-7; Feng XL, 2011, P NATL ACAD SCI USA, V108, P14312, DOI 10.1073/pnas.1010943108; Foyer P, 2013, APPL ANIM BEHAV SCI, V146, P79, DOI 10.1016/j.applanim.2013.03.013; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1983, APPL ANIM ETHOL, V9, P299, DOI 10.1016/0304-3762(83)90010-X; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Leckman JF, 2002, BIOL PSYCHIAT, V51, P27, DOI 10.1016/S0006-3223(01)01277-X; Levine ED, 2009, BSAVA MANUAL CANINE, V2nd, P159, DOI [10.22233/9781905319879.15, DOI 10.22233/9781905319879.15]; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mills D, 2005, IN PRACTICE, V27, P248; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Ohman A, 2008, HDB EMOTIONS, P709; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Overall KL, 2013, MANUAL CLIN BEHAV ME, V1st; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Pluijmakers JJTM, 2010, APPL ANIM BEHAV SCI, V126, P51, DOI 10.1016/j.applanim.2010.05.006; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Riva J, 2008, APPL ANIM BEHAV SCI, V114, P168, DOI 10.1016/j.applanim.2008.01.020; Roth TL, 2012, DEV PSYCHOBIOL, V54, P590, DOI 10.1002/dev.20550; Ruscio MG, 2007, HORM BEHAV, V51, P54, DOI 10.1016/j.yhbeh.2006.08.004; Saeki Y., 1979, Japanese Poultry Science, V16, P121; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; SCOTT JP, 1950, J GENET PSYCHOL, V77, P25; Scott JP, 1997, GENETICS SOCIAL BEHA; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P380, DOI 10.2460/javma.2004.224.380; Stamatakis A, 2008, STRESS, V11, P148, DOI 10.1080/10253890701653039; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Starling MJ, 2013, BEHAV PROCESS, V97, P53, DOI 10.1016/j.beproc.2013.04.008; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P182, DOI 10.1079/9781845931872.0182; Tami G, 2008, J VET BEHAV, V3, P59, DOI 10.1016/j.jveb.2007.09.002; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Tiira K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041684; van der Waaij EH, 2008, J ANIM SCI, V86, P2853, DOI 10.2527/jas.2007-0616; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wipfli B, 2011, SCAND J MED SCI SPOR, V21, P474, DOI 10.1111/j.1600-0838.2009.01049.x; YOUNG PT, 1959, PSYCHOL REV, V66, P104, DOI 10.1037/h0045997	64	64	64	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141907	10.1371/journal.pone.0141907	http://dx.doi.org/10.1371/journal.pone.0141907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528555	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600075
J	Calado, GP; Lopes, AJO; Costa, LM; Lima, FDA; Silva, LA; Pereira, WS; do Amaral, FMM; Garcia, JBS; Cartagenes, MDD; Nascimento, FRF				Calado, Gustavo P.; Lopes, Alberto Jorge O.; Costa Junior, Livio M.; Lima, Francisco das Chagas A.; Silva, Lucilene A.; Pereira, Wanderson S.; do Amaral, Flavia M. M.; Garcia, Joao Batista S.; Cartagenes, Maria do Socorro de S.; Nascimento, Flavia R. F.			Chenopodium ambrosioides L. Reduces Synovial Inflammation and Pain in Experimental Osteoarthritis	PLOS ONE			English	Article							RAT MODEL; DOCKING	The chronicity of osteoarthritis (OA), characterized by pain and inflammation in the joints, is linked to a glutamate receptor, N-methyl-D-aspartate (NMDA). The use of plant species such as Chenopodium ambrosioides L. (Amaranthaceae) as NMDA antagonists offers a promising perspective. This work aims to analyze the antinociceptive and anti-inflammatory responses of the crude hydroalcoholic extract (HCE) of C. ambrosioides leaves in an experimental OA model. Wistar rats were separated into six groups (n = 24): clean (C), negative control (CTL-), positive control (CTL+), HCE0.5, HCE5 and HCE50. The first group received no intervention. The other groups received an intra-articular injection of sodium monoiodoacetate (MIA) (8 mg/kg) on day 0. After six hours, they were orally treated with saline, Maxicam plus (meloxicam + chondroitin sulfate) and HCE at doses of 0.5 mg/kg, 5 mg/kg and 50 mg/kg, respectively. After three, seven and ten days, clinical evaluations were performed (knee diameter, mechanical allodynia, mechanical hyperalgesia and motor activity). On the tenth day, after euthanasia, synovial fluid and draining lymph node were collected for cellular quantification, and cartilage was collected for histopathological analysis. Finally, molecular docking was performed to evaluate the compatibility of ascaridole, a monoterpene found in HCE, with the NMDA receptor. After the third day, HCE reduced knee edema. HCE5 showed less cellular infiltrate in the cartilage and synovium and lower intensities of allodynia from the third day and of hyperalgesia from the seventh day up to the last treatment day. The HCE5 and HCE50 groups improved in forced walking. In relation to molecular docking, ascaridole showed NMDA receptor binding affinity. C. ambrosioides HCE was effective in the treatment of OA because it reduced synovial inflammation and behavioral changes due to pain. This effect may be related to the antagonistic effect of ascaridole on the NMDA receptor.	[Calado, Gustavo P.; Lopes, Alberto Jorge O.; Costa Junior, Livio M.; Silva, Lucilene A.; Pereira, Wanderson S.; do Amaral, Flavia M. M.; Garcia, Joao Batista S.; Cartagenes, Maria do Socorro de S.; Nascimento, Flavia R. F.] Univ Fed Maranhao, Biol & Hlth Sci Ctr, Hlth Sci Grad Program, BR-6508580 Sao Luis, MA, Brazil; [Lima, Francisco das Chagas A.] Univ Estadual Piaui, Dept Chem, Quantum Chem Computat Grp, Chem Grad Program, BR-64002150 Teresina, PI, Brazil	Universidade Federal do Maranhao; Universidade Estadual do Piaui (UESPI)	Nascimento, FRF (corresponding author), Univ Fed Maranhao, Biol & Hlth Sci Ctr, Hlth Sci Grad Program, Av Portugueses 1966, BR-6508580 Sao Luis, MA, Brazil.	nascimentofrf@yahoo.com.br	Lima, Francisco das Chagas das Chagas Alves/D-8730-2017; LOPES, ALBERTO JORGE OLIVEIRA/AAS-9995-2020; Costa-Junior, Livio M/H-7530-2012; Nascimento, Flavia/F-8173-2016	Lima, Francisco das Chagas das Chagas Alves/0000-0002-0447-4911; LOPES, ALBERTO JORGE OLIVEIRA/0000-0001-5267-9500; Costa-Junior, Livio M/0000-0002-1475-049X; Nascimento, Flavia/0000-0001-9328-1806	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento em Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento em Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento em Pesquisa (CNPq).	Castro RR, 2008, OSTEOARTHRIITIS CART, V14, P769; Dembitsky V, 2008, BIOMED PAP, V152, P209, DOI 10.5507/bp.2008.032; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Goh JZ, 2015, INT J NANOMED, V10, P297, DOI 10.2147/IJN.S75545; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Ibironke G. F., 2007, IJP - International Journal of Pharmacology, V3, P111; Ishizuka Pedro, 2007, Rev. Bras. Anestesiol., V57, P19, DOI 10.1590/S0034-70942007000100003; Kiselycznyk C, 2015, BEHAV BRAIN RES, V287, P89, DOI 10.1016/j.bbr.2015.03.023; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kumar R, 2007, INT J FOOD MICROBIOL, V115, P159, DOI 10.1016/j.ijfoodmicro.2006.10.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee CH, 2009, OSTEOARTHR CARTILAGE, V17, P1485, DOI 10.1016/j.joca.2009.05.006; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Lorenzi H., 2002, PLANTAS MED BRASIL N; Mannelli LD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-228; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matos F.J.A., 1997, INTRO FITOQUIMICA EX, V2a; Moller KA, 1998, J NEUROSCI METH, V84, P41, DOI 10.1016/S0165-0270(98)00083-1; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nascimento FRF, 2006, LIFE SCI, V78, P2650, DOI 10.1016/j.lfs.2005.10.006; Neiva VS, 2011, REV CIENCIAS SAUDE, V13, P155; Olajide O. A., 1997, Fitoterapia, V68, P529; Pastor J, 2015, ACTA TROP, V145, P31, DOI 10.1016/j.actatropica.2015.02.002; Patricio FJ, 2008, J ETHNOPHARMACOL, V115, P313, DOI 10.1016/j.jep.2007.10.009; Pereira WS, 2010, J ETHNOPHARMACOL, V127, P602, DOI 10.1016/j.jep.2009.12.018; PINHEIRO VF, 2005, J BRASILEIRO FITOMED, V3, P62; Rahman W, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0509-x; Ramos RM, 2012, J MOL MODEL, V18, P4013, DOI 10.1007/s00894-012-1383-6; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rocha FAC, 2003, REV BRAS REUMATOL, V43, P206; Sousa LHA, 2012, REV CIENC SAUDE, V14; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; TrivellatoGrassi L, 2013, J ETHNOPHARMACOL, V145, P127, DOI 10.1016/j.jep.2012.10.040; Yassin NZ, 2015, DRUG DES DEV THER, V9, P1491, DOI 10.2147/DDDT.S79957; Ye H, 2015, WORLD J GASTROENTERO, V21, P4178, DOI 10.3748/wjg.v21.i14.4178	35	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141886	10.1371/journal.pone.0141886	http://dx.doi.org/10.1371/journal.pone.0141886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524084	Green Submitted, gold, Green Published			2022-12-27	WOS:000364029800027
J	Schoeman, DS; Schlacher, TA; Jones, AR; Murray, A; Huijbers, CM; Olds, AD; Connolly, RM				Schoeman, David S.; Schlacher, Thomas A.; Jones, Alan R.; Murray, Anna; Huijbers, Chantal M.; Olds, Andrew D.; Connolly, Rod M.			Edging along a Warming Coast: A Range Extension for a Common Sandy Beach Crab	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; GHOST CRABS; DECAPODA BRACHYURA; MARINE LIFE; OCYPODE; CONSERVATION; SHIFTS; BIODIVERSITY; SYSTEMS; LIMITS	Determining the position of range edges is the first step in developing an understanding of the ecological and evolutionary dynamics in play as species' ranges shift in response to climate change. Here, we study the leading (poleward) range edge of Ocypode cordimanus, a ghost crab that is common along the central to northern east coast of Australia. Our study establishes the poleward range edge of adults of this species to be at Merimbula (36.90 degrees S, 149.93 degrees E), 270 km (along the coast) south of the previous southernmost museum record. We also establish that dispersal of pelagic larvae results in recruitment to beaches 248 km (along the coast; 0.9 degrees of latitude) beyond the adult range edge we have documented here. Although we cannot conclusively demonstrate that the leading range edge for this species has moved polewards in response to climate change, this range edge does fall within a "hotspot" of ocean warming, where surface isotherms are moving southwards along the coast at 20-50 km. decade(-1); coastal air temperatures in the region are also warming. If these patterns persist, future range extensions could be anticipated. On the basis of their ecology, allied with their occupancy of ocean beaches, which are home to taxa that are particularly amenable to climate-change studies, we propose that ghost crabs like O. cordimanus represent ideal model organisms with which to study ecological and evolutionary processes associated with climate change. The fact that "hotspots" of ocean warming on four other continents correspond with poleward range edges of ghost crab species suggests that results of hypothesis tests could be generalized, yielding excellent opportunities to rapidly progress knowledge in this field.	[Schoeman, David S.; Schlacher, Thomas A.; Huijbers, Chantal M.; Olds, Andrew D.] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore DC, Sippy Downs, Qld 4558, Australia; [Jones, Alan R.; Murray, Anna] Australian Museum Res Inst, Sydney, NSW 2010, Australia; [Huijbers, Chantal M.; Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Gold Coast, Qld 4222, Australia; [Huijbers, Chantal M.; Connolly, Rod M.] Griffith Univ, Sch Environm, Gold Coast, Qld 4222, Australia	University of the Sunshine Coast; Australian Museum; Griffith University; Griffith University	Schoeman, DS (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Maroochydore DC, Sippy Downs, Qld 4558, Australia.	dschoema@usc.edu.au	Huijbers, Chantal/J-5176-2014; Schlacher, Thomas/J-4614-2016; Connolly, Rod M/C-4094-2008	Huijbers, Chantal/0000-0001-5206-3415; Schlacher, Thomas/0000-0003-2184-9217; Connolly, Rod M/0000-0001-6223-1291; Murray, Anna/0000-0002-1765-1286; Schoeman, David/0000-0003-1258-0885; Olds, Andrew/0000-0002-8027-3599	Australian Commonwealth Government's Collaborative Research Network (CRN) Program; University of the Sunshine [USC/CRN2012/01]	Australian Commonwealth Government's Collaborative Research Network (CRN) Program; University of the Sunshine	This work was funded through the Australian Commonwealth Government's Collaborative Research Network (CRN) Program and the University of the Sunshine Coast Collaborative Research Networks Seed Funding Grant USC/CRN2012/01 to Assoc Prof Schoeman, Prof Thomas Schlacher, and Prof Rod Connolly. The funders had no role in the design, analysis or interpretation of this work.	Bates AE, 2015, DIVERS DISTRIB, V21, P13, DOI 10.1111/ddi.12263; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Davey K, 1998, PHOTOGRAPHIC GUIDE S, P1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elton CS, 1930, ANIMAL ECOLOGY AND E; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geber MA, 2011, AM NAT, V178, pS1, DOI 10.1086/661899; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Harris L, 2014, DIVERS DISTRIB, V20, P1120, DOI 10.1111/ddi.12226; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Huang JF, 1998, CRUSTACEANA, V71, P942, DOI 10.1163/156854098X00941; Jones DS, 2012, INTEGR COMP BIOL, V52, P366, DOI 10.1093/icb/ics100; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Ling SD, 2012, ECOL APPL, V22, P1232, DOI 10.1890/11-1587.1; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Lucrezi S, 2014, OCEANOGR MAR BIOL, V52, P201; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; McDermott JJ, 2013, NORTHEAST NAT, V20, P578, DOI 10.1656/045.020.0407; MCLACHLAN A, 1980, S AFR J ZOOL, V15, P57; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moss D, 2006, COAST MANAGE, V34, P133, DOI 10.1080/08920750500379383; O'Connor MI, 2015, GLOBAL ECOL BIOGEOGR, V24, P64, DOI 10.1111/geb.12218; PALMER JD, 1971, AM MIDL NAT, V85, P97, DOI 10.2307/2423915; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reisinger A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1371; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Sakai Katsushi, 2013, Memoirs of the Queensland Museum, V56, P665; Schlacher TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068221; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schoeman DS, 2014, GLOBAL CHANGE BIOL, V20, P2383, DOI 10.1111/gcb.12505; Short AD, 2006, J COASTAL RES, V22, P11, DOI 10.2112/05A-0002.1; Short AD, 2010, J COASTAL RES, V26, P395, DOI 10.2112/08-1120.1; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Waters JM, 2010, AUSTRAL ECOL, V35, P988, DOI 10.1111/j.1442-9993.2010.02114.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021	61	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141976	10.1371/journal.pone.0141976	http://dx.doi.org/10.1371/journal.pone.0141976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524471	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800030
J	Tsai, CC; Shih, HC; Wang, HV; Lin, YS; Chang, CH; Chiang, YC; Chou, CH				Tsai, Chi-Chu; Shih, Huei-Chuan; Wang, Hao-Ven; Lin, Yu-Shium; Chang, Chia-Hung; Chiang, Yu-Chung; Chou, Chang-Hung			RNA-Seq SSRs of Moth Orchid and Screening for Molecular Markers across Genus Phalaenopsis (Orchidaceae)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; POLYMORPHIC MICROSATELLITE MARKERS; CROSS-SPECIES AMPLIFICATION; EXPLOITING EST DATABASES; TRANSCRIPTOME CHARACTERIZATION; PCR AMPLIFICATION; GENETIC DIVERSITY; DNA-POLYMERASE; GENOME; GENERATION	Background The moth orchid (Phalaenopsis species) is an ornamental crop that is highly commercialized worldwide. Over 30,000 cultivars of moth orchids have been registered at the Royal Horticultural Society (RHS). These cultivars were obtained by artificial pollination of interspecific hybridization. Therefore, the identification of different cultivars is highly important in the worldwide market. Methods/Results We used Illumina sequencing technology to analyze an important species for breeding, Phalaenopsis aphrodite subsp. formosana and develop the expressed sequence tag (EST)simple sequence repeat (SSR) markers. After de novo assembly, the obtained sequence covered 29.1 Mb, approximately 2.2% of the P. aphrodite subsp. formosana genome (1,300 Mb), and a total of 1,439 EST-SSR loci were detected. SSR occurs in the exon region, including the 5' untranslated region (UTR), coding region (CDS), and 3'UTR, on average every 20.22 kb. The di- and tri-nucleotide motifs (51.49% and 35.23%, respectively) were the two most frequent motifs in the P. aphrodite subsp. formosana. To validate the developed EST-SSR loci and to evaluate the transferability to the genus Phalaenopsis, thirty trinucleotide motifs of the EST-SSR loci were randomly selected to design EST-SSR primers and to evaluate the polymorphism and transferability across 22 native Phalaenopsis species that are usually used as parents for moth orchid breeding. Of the 30 EST-SSR loci, ten polymorphic and transferable SSR loci across the 22 native taxa can be obtained. The validated EST-SSR markers were further proven to discriminate 12 closely related Phalaenopsis cultivars. The results show that it is not difficult to obtain universal SSR markers by transcriptome deep sequencing in Phalaenopsis species. Conclusions This study supported that transcriptome analysis based on deep sequencing is a powerful tool to develop SSR loci in non-model species. A large number of EST-SSR loci can be isolated, and about 33.33% EST-SSR loci are universal markers across the Phalaenopsis breeding germplasm after preliminary validation. The potential universal EST-SSR markers are highly valuable for identifying all of Phalaenopsis cultivars.	[Tsai, Chi-Chu; Lin, Yu-Shium; Chang, Chia-Hung] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan; [Shih, Huei-Chuan] Meiho Univ, Dept Nursing, Pingtung 912, Taiwan; [Wang, Hao-Ven] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Chiang, Yu-Chung] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan	National Pingtung University Science & Technology; National Cheng Kung University; National Sun Yat Sen University; Kaohsiung Medical University; China Medical University Taiwan	Tsai, CC (corresponding author), Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan.	tsaicc@mail.kdais.gov.tw; yuchung@mail.nsysu.edu.tw; choumasa@mail.cmu.edu.tw	Chiang, Yu-Chung/E-9143-2011	Wang, Hao-Ven/0000-0001-7523-087X	Ministry of Science and Technology, Taiwan [MOST 103-2321-B-067E-001, MOST 103-2621-B-110 -001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by funding from the Ministry of Science and Technology, Taiwan, MOST 103-2321-B-067E-001 to CCT and partial from MOST 103-2621-B-110 -001 to YCC.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Berube Y, 2007, TREE GENET GENOMES, V3, P251, DOI 10.1007/s11295-006-0061-1; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chen WH, 2013, SCI HORTIC-AMSTERDAM, V161, P70, DOI 10.1016/j.scienta.2013.06.045; Chiou CY, 2012, AM J BOT, V99, pE199, DOI 10.3732/ajb.1100500; Christenson EA, 2001, PHALAENOPSIS; Chuang HT, 2002, THESIS NATL CHIAYI U; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Cregan PB, 1994, PLANT GENOME ANAL, P43; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Diwan N, 2000, THEOR APPL GENET, V101, P165, DOI 10.1007/s001220051465; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fu Y. M., 1997, Report of the Taiwan Sugar Research Institute, P27; Gao LF, 2003, MOL BREEDING, V12, P245, DOI 10.1023/A:1026346121217; Garcia RAV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-41; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ge XJ, 2015, PLANT MOL BIOL REP, V33, P264, DOI 10.1007/s11105-014-0742-0; Ge XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043717; Goh MWK, 2005, EUPHYTICA, V141, P11, DOI 10.1007/s10681-005-4814-y; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRIESBACH RJ, 1985, J HERED, V76, P74, DOI 10.1093/oxfordjournals.jhered.a110029; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Han SY, 2005, THESIS NATL C KUNG U; HENTSCHEL CC, 1982, NATURE, V295, P714, DOI 10.1038/295714a0; Hite JM, 1996, NUCLEIC ACIDS RES, V24, P2429, DOI 10.1093/nar/24.12.2429; Ho Chin-Shang, 2014, BMC Res Notes, V7, P255, DOI 10.1186/1756-0500-7-255; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Hsu TW, 2013, INT J MOL SCI, V14, P20414, DOI 10.3390/ijms141020414; Huang CL, 2014, PLANT J, V80, P834, DOI 10.1111/tpj.12676; Hulzink RJM, 2002, PLANT PHYSIOL, V129, P342, DOI 10.1104/pp.001701; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Liao PC, 2012, INT J MOL SCI, V13, P6469, DOI 10.3390/ijms13056469; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Metzgar D, 2000, GENOME RES, V10, P72; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Neysa M, 1984, AM J BOT, V71, P309; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sweet HR, 1980, THE GENUS PHALAENOPS; Tanaka R, 1984, ORCHID BIOL REV PERS; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tsai CC, 2006, J HORTIC SCI BIOTECH, V81, P691, DOI 10.1080/14620316.2006.11512125; Tsai CC, 2010, PLANT SYST EVOL, V288, P77, DOI 10.1007/s00606-010-0314-1; Tsai CC, 2005, PLANT SYST EVOL, V256, P1, DOI 10.1007/s00606-005-0356-y; Tsai CC, 2010, J PLANT BIOL, V53, P453, DOI 10.1007/s12374-010-9136-5; Tsai CC, 2014, BOT STUD, V55, DOI 10.1186/s40529-014-0072-4; Tsai CC, 2013, SCI HORTIC-AMSTERDAM, V164, P196, DOI 10.1016/j.scienta.2013.09.037; Tsai CC, 2009, BIOCHEM SYST ECOL, V37, P633, DOI 10.1016/j.bse.2009.09.004; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young L G, 2004, THESIS CENTRAL POLIC; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; [张水明 Zhang Shuiming], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P560; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005; Zhu H, 2012, THEOR APPL GENET, V124, P87, DOI 10.1007/s00122-011-1689-2	87	10	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141761	10.1371/journal.pone.0141761	http://dx.doi.org/10.1371/journal.pone.0141761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523377	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800022
J	Hossain, F; Arnold, J; Beighley, E; Brown, C; Burian, S; Chen, J; Mitra, A; Niyogi, D; Pielke, R; Tidwell, V; Wegner, D				Hossain, Faisal; Arnold, Jeffrey; Beighley, Ed; Brown, Casey; Burian, Steve; Chen, Ji; Mitra, Anindita; Niyogi, Dev; Pielke, Roger, Sr.; Tidwell, Vincent; Wegner, Dave			What Do Experienced Water Managers Think of Water Resources of Our Nation and Its Management Infrastructure?	PLOS ONE			English	Article								This article represents the second report by an ASCE Task Committee "Infrastructure Impacts of Landscape-drivenWeather Change" under the ASCE Watershed Management Technical Committee and the ASCE Hydroclimate Technical Committee. Herein, the 'infrastructure impacts" are referred to as infrastructure-sensitive changes in weather and climate patterns (extremes and non-extremes) that are modulated, among other factors, by changes in landscape, land use and land cover change. In this first report, the article argued for explicitly considering the well-established feedbacks triggered by infrastructure systems to the land-atmosphere system via landscape change. In this report by the ASCE Task Committee (TC), we present the results of this ASCE TC's survey of a cross section of experienced water managers using a set of carefully crafted questions. These questions covered water resources management, infrastructure resiliency and recommendations for inclusion in education and curriculum. We describe here the specifics of the survey and the results obtained in the formof statistical averages on the 'perception' of thesemanagers. Finally, we discuss what these 'perception' averages may indicate to the ASCE TC and community as a whole for stewardship of the civil engineering profession. The survey and the responses gathered are not exhaustive nor do they represent the ASCE-endorsed viewpoint. However, the survey provides a critical first step to developing the framework of a research and education plan for ASCE. Given the Water Resources Reform and Development Act passed in 2014, we must now take into account the perceived concerns of the water management community.	[Hossain, Faisal] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Arnold, Jeffrey] US Army Corps Engineers, Inst Water Resources, Seattle, WA USA; [Beighley, Ed] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Brown, Casey] Univ Massachusetts Amherst, Dept Civil & Environm Engn, Amherst, MA 01003 USA; [Burian, Steve] Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA; [Chen, Ji] Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China; [Mitra, Anindita] CREA Affiliates, Seattle, WA 98103 USA; [Niyogi, Dev] Purdue Univ, Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Pielke, Roger, Sr.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Tidwell, Vincent] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Wegner, Dave] US House Representatives, Washington, DC 20515 USA	University of Washington; University of Washington Seattle; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; Northeastern University; University of Massachusetts System; University of Massachusetts Amherst; Utah System of Higher Education; University of Utah; University of Hong Kong; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Sandia National Laboratories	Hossain, F (corresponding author), Univ Washington, Dept Civil & Environm Engn, More Hall 201, Seattle, WA 98195 USA.	fhossain@uw.edu	Niyogi, Dev/ABE-7554-2020; Niyogi, Dev/H-6326-2013; Chen, Ji/C-1795-2009	Niyogi, Dev/0000-0002-1848-5080; Niyogi, Dev/0000-0002-1848-5080; Burian, Steven/0000-0003-0523-4968; Beighley, Edward/0000-0003-1139-6226	ASCE Headquarters; ASCE Environment and Water Institute (EWRI)	ASCE Headquarters; ASCE Environment and Water Institute (EWRI)	The authors acknowledge the support received from the ASCE Headquarters for conducting the survey using surveymonkey subscription. In particular, Gabrielle Dunkley at ASCE headquarters in Reston, Virginia is gratefully appreciated in setting up the survey. The Watershed Management Technical Council (WMTC) under the auspices of ASCE Environment and Water Institute (EWRI) is also acknowledged for approving the survey.	Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Hossain F, 2015, J HYDROL ENG, DOI [http://dx.doi.org/10.1061/(ASCE)HE.1943-5584.0001210, DOI 10.1061/(ASCE)HE.1943-5584.0001210)]; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Vorosmarty CJ, 2010, UNESCO WORLD WATER D, P10; Zarfl C, 2014, AQUATIC SCI	5	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142073	10.1371/journal.pone.0142073	http://dx.doi.org/10.1371/journal.pone.0142073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544045	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700077
J	Kim, SH; Huh, K; Won, S; Lee, KW; Park, MJ				Kim, Shin Hye; Huh, Kyoung; Won, Sungho; Lee, Kuk-Wha; Park, Mi-Jung			A Significant Increase in the Incidence of Central Precocious Puberty among Korean Girls from 2004 to 2010	PLOS ONE			English	Article							PREVALENCE; CHILDREN; BREAST; AGE	Background Few studies have explored the trends in central precocious puberty (CPP) in Asian populations. This study assessed the prevalence and annual incidence of CPP among Korean children. Methods Using data from the Korean Health Insurance Review Agency from 2004 to 2010, we reviewed the records of 21,351 children, including those registered with a diagnosis of CPP for the first time and those diagnosed with CPP who were treated with gonadotropin-releasing hormone analogs. Results The prevalence of CPP was 55.9 per 100,000 girls and 1.7 per 100,000 boys, respectively. The overall incidence of CPP was 15.3 per 100,000 girls, and 0.6 per 100,000 boys. The annual incidence of CPP in girls significantly increased from 3.3 to 50.4 per 100,000 girls; whereas in boys, it gradually increased from 0.3 to 1.2 per 100,000 boys. The annual incidence of CPP in girls consistently increased at all ages year by year, with greater increases at older ages (>= 6 years of age), and smaller increases in girls aged < 6 years. In contrast, the annual incidence remained relatively constant in boys aged < 8 years, while a small increase was observed only in boys aged 8 years. The increase of annual incidence showed significant differences depending on age and gender (P < 0.0001). Conclusions The annual incidence of CPP has substantially increased among Korean girls over the past 7 years. Continued monitoring of CPP trends among Korean children will be informative.	[Kim, Shin Hye; Park, Mi-Jung] Inje Univ, Sanggye Paik Hosp, Dept Pediat, Coll Med, Seoul, South Korea; [Huh, Kyoung] Kium Pediat Clin, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Lee, Kuk-Wha] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Endocrinol, Mattel Childrens Hosp, Los Angeles, CA 90095 USA	Inje University; Seoul National University (SNU); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Park, MJ (corresponding author), Inje Univ, Sanggye Paik Hosp, Dept Pediat, Coll Med, Seoul, South Korea.	PMJ@paik.ac.kr						Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Herman-Giddens ME, 2006, INT J ANDROL, V29, P241, DOI 10.1111/j.1365-2605.2005.00575.x; Hong CH, 1994, KOREAN J PEDIAT, V37, P193; Kim JY, 2010, J KOREAN MED SCI, V25, P1405, DOI 10.3346/jkms.2010.25.10.1405; Klein KO, 1999, J CLIN ENDOCR METAB, V84, P411, DOI 10.1210/jc.84.2.411; Korean Statistical Information Service, 2015, VIT STAT KOR, V6, P20; Ma HM, 2011, INT J ANDROL, V34, pE435, DOI 10.1111/j.1365-2605.2011.01173.x; Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638; Oh Chang-Mo, 2012, J Prev Med Public Health, V45, P227, DOI 10.3961/jpmph.2012.45.4.227; Soriano-Guillen L, 2010, J CLIN ENDOCR METAB, V95, P4305, DOI 10.1210/jc.2010-1025; Styne DM, 2011, WILLIAMS TXB ENDOCRI, P1087; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; 오경원, 2008, Clinical and Experimental Pediatrics, V51, P950; 박미정, 2006, Clinical and Experimental Pediatrics, V49, P610	17	56	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141844	10.1371/journal.pone.0141844	http://dx.doi.org/10.1371/journal.pone.0141844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539988	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800031
J	Kraut, B; Maier, HJ; Kokai, E; Fiedler, K; Boettger, T; Illing, A; Kostin, S; Walther, P; Braun, T; Wirth, T				Kraut, Baerbel; Maier, Harald J.; Kokai, Enikoe; Fiedler, Katja; Boettger, Thomas; Illing, Annett; Kostin, Sawa; Walther, Paul; Braun, Thomas; Wirth, Thomas			Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality	PLoS One			English	Article							NF-KAPPA-B; LIVER DEGENERATION; MICE; MYOCARDITIS; EXPRESSION; CARDIOMYOPATHY; APOPTOSIS; RECEPTOR; STAT1	The transcription factor NF-kappa B has been associated with a range of pathological conditions of the heart, mainly based on its function as a master regulator of inflammation and pro-survival factor. Here, we addressed the question what effects activation of NF-kappa B can have during murine heart development. We expressed a constitutively active (CA) mutant of IKK2, the kinase activating canonical NF-kappa B signaling, specifically in cardiomyocytes under the control of the alpha-myosin heavy chain promoter. Expression of IKK2-CA resulted in embryonic lethality around E13. Embryos showed defects in compact zone formation and the contractile apparatus, and overall were characterized by widespread inflammation with infiltration of myeloid cells. Gene expression analysis suggested an interferon type I signature, with increased expression of interferon regulatory factors. While apoptosis of cardiomyocytes was only increased at later stages, their proliferation was decreased early on, providing an explanation for the disturbed compact zone formation. Mechanistically, this could be explained by activation of the JAK/STAT axis and increased expression of the cell cycle inhibitor p21. A rescue experiment with an I kappa B alpha superrepressor demonstrated that the phenotype was dependent on NF-kappa B. We conclude that activation of NF-kappa B is detrimental during normal heart development due to excessive activation of pro-inflammatory pathways.	[Kraut, Baerbel; Maier, Harald J.; Kokai, Enikoe; Fiedler, Katja; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany; [Boettger, Thomas; Kostin, Sawa; Braun, Thomas] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Illing, Annett] Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany; [Walther, Paul] Univ Ulm, Core Facil Electron Microscopy, D-89069 Ulm, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University	Wirth, T (corresponding author), Univ Ulm, Inst Physiol Chem, D-89069 Ulm, Germany.	thomas.wirth@uni-ulm.de	Braun, Thomas/B-2310-2008; Wirth, Thomas/X-7172-2019; Boettger, Thomas/E-3406-2012	Boettger, Thomas/0000-0003-4280-8449; Braun, Thomas/0000-0002-6165-4804				Alter P, 2006, BIOCHEM BIOPH RES CO, V339, P180, DOI 10.1016/j.bbrc.2005.10.195; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Clowes C, 2014, GENESIS, V52, P713, DOI 10.1002/dvg.22794; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hirata H, 2006, CELLS TISSUES ORGANS, V184, P172, DOI 10.1159/000099624; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; O'Donnell SM, 2005, J CLIN INVEST, V115, P2341, DOI 10.1172/JCI22428; Ruppert V, 2008, CARDIOVASC PATHOL, V17, P81, DOI 10.1016/j.carpath.2007.07.004; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; Yamamoto K, 2003, J AM COLL CARDIOL, V42, P2000, DOI 10.1016/j.jacc.2003.07.021; Yokoseki O, 2001, CIRC RES, V89, P899, DOI 10.1161/hh2201.099373; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141591	10.1371/journal.pone.0141591	http://dx.doi.org/10.1371/journal.pone.0141591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539991	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800021
J	Pirson, M; Debrulle, S; Clippe, A; Clotman, F; Knoops, B				Pirson, Marc; Debrulle, Stephanie; Clippe, Andre; Clotman, Frederic; Knoops, Bernard			Thioredoxin-2 Modulates Neuronal Programmed Cell Death in the Embryonic Chick Spinal Cord in Basal and Target-Deprived Conditions	PLOS ONE			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL THIOREDOXIN; DEPENDENT ACTIVATION; PC12 CELLS; LIFE-SPAN; APOPTOSIS; GLUTATHIONE; REDUCTASE; SYSTEM; MOTONEURONS	Thioredoxin-2 (Trx2) is a mitochondrial protein using a dithiol active site to reduce protein disulfides. In addition to the cytoprotective function of this enzyme, several studies have highlighted the implication of Trx2 in cellular signaling events. In particular, growing evidence points to such roles of redox enzymes in developmental processes taking place in the central nervous system. Here, we investigate the potential implication of Trx2 in embryonic development of chick spinal cord. To this end, we first studied the distribution of the enzyme in this tissue and report strong expression of Trx2 in chick embryo post-mitotic neurons at E4.5 and in motor neurons at E6.5. Using in ovo electroporation, we go on to highlight a cytoprotective effect of Trx2 on the programmed cell death (PCD) of neurons during spinal cord development and in a novel cultured spinal cord explant model. These findings suggest an implication of Trx2 in the modulation of developmental PCD of neurons during embryonic development of the spinal cord, possibly through redox regulation mechanisms.	[Pirson, Marc; Debrulle, Stephanie; Clippe, Andre; Knoops, Bernard] Catholic Univ Louvain, ISV, Grp Anim Mol & Cellular Biol, B-1348 Louvain La Neuve, Belgium; [Clotman, Frederic] Catholic Univ Louvain, Grp Neural Differentiat, Inst Neurosci IONS, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Knoops, B (corresponding author), Catholic Univ Louvain, ISV, Grp Anim Mol & Cellular Biol, B-1348 Louvain La Neuve, Belgium.	bernard.knoops@uclouvain.be		Pirson, Magali/0000-0001-8468-3184; Pirson, Marc/0000-0001-5018-5072	Communaute francaise de Belgique-Actions de Recherche Concertees (ARC) [10/15-026]; DIANE research program of the Walloon region [816844]	Communaute francaise de Belgique-Actions de Recherche Concertees (ARC); DIANE research program of the Walloon region	This work was supported by Communaute francaise de Belgique-Actions de Recherche Concertees (ARC)" #10/15-026 of the "Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique - Direction de la Recherche scientifique - Communaute francaise de Belgique" and granted by the "Academie universitaire 'Louvain"' and the DIANE research program of the Walloon region, Grant number : 816844. Marc Pirson is holder of a FRIA fellowship (FRS-FNRS, Belgium). F.C. is a Research Associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Caldero J, 1998, J NEUROSCI, V18, P356; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Chen Y, 2006, TOXICOL APPL PHARM, V216, P256, DOI 10.1016/j.taap.2006.05.006; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; Ferretti P, 2008, CELL MOL LIFE SCI, V65, P45, DOI 10.1007/s00018-007-7430-2; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Halliwell B, 2007, FREE RADICALS IN BIO; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Hansen JM, 2015, BBA-GEN SUBJECTS, V1850, P1527, DOI 10.1016/j.bbagen.2014.12.001; Hellfritsch J, 2015, ANTIOXID REDOX SIGN, V22, P938, DOI 10.1089/ars.2014.5889; Horstkorte R, 2010, BIOCHEM BIOPH RES CO, V395, P296, DOI 10.1016/j.bbrc.2010.03.113; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kamata H, 2005, ARCH BIOCHEM BIOPHYS, V434, P16, DOI 10.1016/j.abb.2004.07.036; Kim SU, 2014, STEM CELLS, V32, P998, DOI 10.1002/stem.1593; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Lawson SJ, 1997, EUR J NEUROSCI, V9, P794, DOI 10.1111/j.1460-9568.1997.tb01428.x; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; MCKAY SE, 1991, J NEUROBIOL, V22, P721, DOI 10.1002/neu.480220707; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; Ostrakhovitch EA, 2013, ARCH BIOCHEM BIOPHYS, V534, P44, DOI 10.1016/j.abb.2012.08.002; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; Pirson M, 2015, J COMP NEUROL, V523, P2599, DOI 10.1002/cne.23807; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Sanchez-Carbente MR, 2005, CELL DEATH DIFFER, V12, P279, DOI 10.1038/sj.cdd.4401560; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Taylor AR, 2007, J NEUROSCI, V27, P634, DOI 10.1523/JNEUROSCI.4947-06.2007; Timme-Laragy AR, 2013, FREE RADICAL BIO MED, V65, P89, DOI 10.1016/j.freeradbiomed.2013.06.011; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang DM, 2006, J BIOL CHEM, V281, P7384, DOI 10.1074/jbc.M509876200; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142280	10.1371/journal.pone.0142280	http://dx.doi.org/10.1371/journal.pone.0142280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540198	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800074
J	Sachdev, PS; Lipnicki, DM; Kochan, NA; Crawford, JD; Thalamuthu, A; Andrews, G; Brayne, C; Matthews, FE; Stephan, BCM; Lipton, RB; Katz, MJ; Ritchie, K; Carriere, I; Ancelin, ML; Lam, LCW; Wong, CHY; Fung, AWT; Guaita, A; Vaccaro, R; Davin, A; Ganguli, M; Dodge, H; Hughes, T; Anstey, KJ; Cherbuin, N; Butterworth, P; Ng, TP; Gao, Q; Reppermund, S; Brodaty, H; Schupf, N; Manly, J; Stern, Y; Lobo, A; Lopez-Anton, R; Santabarbara, J				Sachdev, Perminder S.; Lipnicki, Darren M.; Kochan, Nicole A.; Crawford, John D.; Thalamuthu, Anbupalam; Andrews, Gavin; Brayne, Carol; Matthews, Fiona E.; Stephan, Blossom C. M.; Lipton, Richard B.; Katz, Mindy J.; Ritchie, Karen; Carriere, Isabelle; Ancelin, Marie-Laure; Lam, Linda C. W.; Wong, Candy H. Y.; Fung, Ada W. T.; Guaita, Antonio; Vaccaro, Roberta; Davin, Annalisa; Ganguli, Mary; Dodge, Hiroko; Hughes, Tiffany; Anstey, Kaarin J.; Cherbuin, Nicolas; Butterworth, Peter; Ng, Tze Pin; Gao, Qi; Reppermund, Simone; Brodaty, Henry; Schupf, Nicole; Manly, Jennifer; Stern, Yaakov; Lobo, Antonio; Lopez-Anton, Raul; Santabarbara, Javier		Cohort Studies Memory Internationa	The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RISK-FACTORS; COMMUNITY POPULATION; COHORT PROFILE; DEMENTIA; CRITERIA; IMPACT; MEMORY; ASSOCIATION; PROGRESSION	Background Changes in criteria and differences in populations studied and methodology have produced a wide range of prevalence estimates for mild cognitive impairment (MCI). Methods Uniform criteria were applied to harmonized data from 11 studies from USA, Europe, Asia and Australia, and MCI prevalence estimates determined using three separate definitions of cognitive impairment. Results The published range of MCI prevalence estimates was 5.0%-36.7%. This was reduced with all cognitive impairment definitions: performance in the bottom 6.681% (3.2%-10.8%); Clinical Dementia Rating of 0.5 (1.8%-14.9%); Mini-Mental State Examination score of 24-27 (2.1%-20.7%). Prevalences using the first definition were 5.9% overall, and increased with age (P < .001) but were unaffected by sex or the main races/ethnicities investigated (Whites and Chinese). Not completing high school increased the likelihood of MCI (P <= .01). Conclusion Applying uniform criteria to harmonized data greatly reduced the variation in MCI prevalence internationally.	[Sachdev, Perminder S.; Lipnicki, Darren M.; Kochan, Nicole A.; Crawford, John D.; Thalamuthu, Anbupalam; Andrews, Gavin; Reppermund, Simone; Brodaty, Henry] Univ New S Wales, Ctr Healthy Brain Ageing, Sydney, NSW, Australia; [Sachdev, Perminder S.; Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Matthews, Fiona E.] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Matthews, Fiona E.; Stephan, Blossom C. M.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lipton, Richard B.; Katz, Mindy J.] Yeshiva Univ, Albert Einstein Coll Med, Saul B Korey Dept Neurol, New York, NY 10033 USA; [Lipton, Richard B.] Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY 10033 USA; [Ritchie, Karen; Carriere, Isabelle; Ancelin, Marie-Laure] La Colombiere Hosp, INSERM, U1061, Nervous Syst Pathol Epidemiol & Clin Res, Montpellier 5, France; [Carriere, Isabelle; Ancelin, Marie-Laure] Univ Montpellier I, Montpellier, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, St Marks Hosp, Fac Med, London, England; [Lam, Linda C. W.; Fung, Ada W. T.] Chinese Univ Hong Kong, Hong Kong Special Adm Reg, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Wong, Candy H. Y.] Tai Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Guaita, Antonio; Vaccaro, Roberta; Davin, Annalisa] GolgiCenci Fdn, Milan, Italy; [Ganguli, Mary; Hughes, Tiffany] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ganguli, Mary] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ganguli, Mary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Dodge, Hiroko] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Dodge, Hiroko] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Anstey, Kaarin J.; Cherbuin, Nicolas; Butterworth, Peter] Australian Natl Univ, Coll Med Biol & Environm, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia; [Ng, Tze Pin; Gao, Qi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Gerontol Res Programme, Singapore 117548, Singapore; [Schupf, Nicole; Manly, Jennifer; Stern, Yaakov] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Schupf, Nicole; Manly, Jennifer; Stern, Yaakov] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Schupf, Nicole] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Div Epidemiol, New York, NY 10027 USA; [Manly, Jennifer; Stern, Yaakov] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Lobo, Antonio; Lopez-Anton, Raul; Santabarbara, Javier] Minist Sci & Innovat, CIBERSAM, Madrid, Spain; [Lobo, Antonio] Univ Zaragoza, Dept Med & Psychiat, Zaragoza, Spain; [Lopez-Anton, Raul] Spanish Minist Econ & Competitiveness, CIBERSAM, Madrid, Spain; [Santabarbara, Javier] Univ Zaragoza, Dept Microbiol Prevent Med & Publ Hlth, Zaragoza, Spain	University of New South Wales Sydney; University of New South Wales Sydney; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Newcastle University - UK; Yeshiva University; Yeshiva University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Imperial College London; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; University of Michigan System; University of Michigan; Australian National University; National University of Singapore; Columbia University; Columbia University; Columbia University; Columbia University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Spanish Ministry of Economy & Competitiveness; University of Zaragoza	Sachdev, PS (corresponding author), Univ New S Wales, Ctr Healthy Brain Ageing, Sydney, NSW, Australia.	p.sachdev@unsw.edu.au	Davin, Annalisa/AAB-8602-2022; Lipton, Richard B/B-5060-2011; Matthews, Fiona/O-6932-2015; Sachdev, Perminder/ABC-1137-2020; Carrière, Isabelle/W-8728-2019; FUNG, Ada Wai-Tung/K-7383-2019; Ancelin, Marie-Laure/L-1198-2019; Antón, Raul López/AAD-9198-2021; Butterworth, Peter/AFK-2636-2022; Guaita, Antonio/Q-1787-2019; Brayne, Carol/AAA-4285-2020; Cherbuin, Nicolas/A-8515-2008; Ritchie, Karen/G-3571-2013; Ancelin, Marie-Laure/F-3079-2013; Forloni, Gianluigi/AAB-2115-2020; Lopez-Anton, Raul/H-9890-2017; Anstey, Kaarin/A-3852-2008; Thalamuthu, Anbupalam/Z-5545-2019; Lipton, Richard Bruce/AAY-2818-2021; Vaccaro, Roberta/AAK-8117-2020; Schofield, Peter/C-9669-2011; Thompson, Claire/H-5181-2011	Davin, Annalisa/0000-0002-5597-7586; Matthews, Fiona/0000-0002-1728-2388; Sachdev, Perminder/0000-0002-9595-3220; FUNG, Ada Wai-Tung/0000-0001-7439-3503; Ancelin, Marie-Laure/0000-0002-1149-4320; Antón, Raul López/0000-0002-3360-7015; Guaita, Antonio/0000-0003-3954-5932; Brayne, Carol/0000-0001-5307-663X; Cherbuin, Nicolas/0000-0001-6481-0748; Ritchie, Karen/0000-0002-0688-8982; Ancelin, Marie-Laure/0000-0002-1149-4320; Forloni, Gianluigi/0000-0001-5374-3914; Lopez-Anton, Raul/0000-0002-3360-7015; Anstey, Kaarin/0000-0002-9706-9316; Thalamuthu, Anbupalam/0000-0002-7114-1260; Schofield, Peter/0000-0003-2967-9662; SANTABARBARA, JAVIER/0000-0002-7297-6104; Carriere, Isabelle/0000-0002-3617-0752; Butterworth, Peter/0000-0002-1531-3881; Abbondanza, Simona/0000-0002-6042-7298; Luchsinger, Jose/0000-0002-5886-3648; Christensen, Helen/0000-0003-0435-2065; Zaccaria, Daniele/0000-0002-9715-3796; Lobo Escolar, Elena/0000-0002-1252-2397; Stern, Yaakov/0000-0001-7542-3241; Thompson, Claire/0000-0001-9538-3371	National Health and Medical Research Council of Australia Program Grant [568969]; UK Medical Research Council; Department of Health; National Institute on Health/National Institute on Aging [5P01 AG003949, 1R03 AG045474]; Novartis; Eisai; Fondazione Golgi Cenci and Federazione Alzheimer Italia; National Institute on Aging, National Institutes of Health, United States Department of Health and Human Services [R01AG07562]; National Health and Medical Research Council of Australia [973302, 179805, 157125, 1002160]; Biomedical Research Council, Agency for Science, Technology and Research (A*STAR) in Singapore [03/121/17/214, 08/1/21/19/567]; National Health & Medical Research Council of Australia Program Grant [350833]; National Institute of Health/National Institute on Aging [R01 AG037212, P01 AG07232]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Health, Madrid, Spain [94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128]; Pfizer Foundation, Madrid; MRC [MC_U105292687, G9901400] Funding Source: UKRI; Medical Research Council [G9901400, MC_U105292687] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG003949, R03AG045474] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute on Health/National Institute on Aging; Novartis(Novartis); Eisai(Eisai Co Ltd); Fondazione Golgi Cenci and Federazione Alzheimer Italia; National Institute on Aging, National Institutes of Health, United States Department of Health and Human Services; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biomedical Research Council, Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR)); National Health & Medical Research Council of Australia Program Grant; National Institute of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Health, Madrid, Spain; Pfizer Foundation, Madrid; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Health and Medical Research Council of Australia Program Grant (ID 568969; PSS). For the contributing studies: Major awards from the UK Medical Research Council and the Department of Health (CB, FEM, BCMS); National Institute on Health/National Institute on Aging grants (5P01 AG003949, 1R03 AG045474; RBL, MJK); Novartis (KR, MLA, IC); Mr. Lai Seung Hung & Mrs. Lai Chan Pui Ngong Dementia in Hong Kong Research Fund, and an educational fund from Eisai (LCWL, CHYW, AWTF); Fondazione Golgi Cenci and Federazione Alzheimer Italia (AG, RV, AD); National Institute on Aging, National Institutes of Health, United States Department of Health and Human Services (Grant # R01AG07562; MG, HD, TH); National Health and Medical Research Council of Australia (Grants 973302, 179805, 157125 and 1002160; KJA, NC, PB); Research grants (No. 03/121/17/214 and No. 08/1/21/19/567) from the Biomedical Research Council, Agency for Science, Technology and Research (A*STAR) in Singapore (TPN, QG); National Health & Medical Research Council of Australia Program Grant (ID 350833; PSS, DML, NAK, JDC, AT, GA, SR, HB); National Institute of Health/National Institute on Aging (Grants # R01 AG037212, P01 AG07232; NS, JM, YS); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Health, Madrid, Spain (Grants 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, and G03/128) and Pfizer Foundation, Madrid (AL, RLA, JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Anstey KJ, 2013, ALZHEIMERS DEMENT, V9, P640, DOI 10.1016/j.jalz.2012.11.013; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Aretouli E, 2011, J INT NEUROPSYCH SOC, V17, P277, DOI 10.1017/S1355617710001621; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bondi MW, 2014, J INT NEUROPSYCH SOC, V20, P129, DOI 10.1017/S1355617714000010; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; Brodaty H, 2013, ALZHEIMERS DEMENT, V9, P310, DOI 10.1016/j.jalz.2011.11.010; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Feng L, 2010, J NUTR HEALTH AGING, V14, P433; Feng L, 2013, J ALZHEIMERS DIS, V34, P649, DOI 10.3233/JAD-121885; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Ganguli M, 2000, NEUROLOGY, V54, P1109, DOI 10.1212/WNL.54.5.1109; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Graham C, 1998, Int Psychogeriatr, V10, P183, DOI 10.1017/S1041610298005298; Guaita A, 2012, J NUTR HEALTH AGING, V16, P827; Guaita A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-98; Gussekloo J, 1997, BRIT MED J, V315, P1053, DOI 10.1136/bmj.315.7115.1053; Hayden KM, 2014, ALZHEIMERS DEMENT, V10, P760, DOI 10.1016/j.jalz.2014.02.008; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Kochan NA, 2010, AM J GERIAT PSYCHIAT, V18, P711, DOI 10.1097/JGP.0b013e3181d6b6a9; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lobo A, 2005, EUR J PSYCHIAT, V19, P40; Lopez-Anton R, 2015, ACTA PSYCHIAT SCAND, V131, P29, DOI 10.1111/acps.12297; Luck T, 2010, ACTA PSYCHIAT SCAND, V121, P260, DOI 10.1111/j.1600-0447.2009.01481.x; Luck T, 2010, J AM GERIATR SOC, V58, P1903, DOI 10.1111/j.1532-5415.2010.03066.x; Manly JJ, 2005, ARCH NEUROL-CHICAGO, V62, P1739, DOI 10.1001/archneur.62.11.1739; Miller SL, 2008, J NEUROL NEUROSUR PS, V79, P630, DOI 10.1136/jnnp.2007.124149; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Moustafa AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046496; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nikula S, 2003, AGING CLIN EXP RES, V15, P451, DOI 10.1007/BF03327367; O'Bryant SE, 2013, ALZHEIMERS DEMENT, V9, P622, DOI 10.1016/j.jalz.2012.12.007; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reppermund S, 2013, PSYCHOL MED, V43, P2437, DOI 10.1017/S003329171200308X; Riedel-Heller SG, 2000, NEUROEPIDEMIOLOGY, V19, P130, DOI 10.1159/000026248; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sachdev PS, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-165; Sachdev PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059649; Sosa AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001170; Stephan BCM, 2007, J AM GERIATR SOC, V55, P1534, DOI 10.1111/j.1532-5415.2007.01386.x; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Teng E, 2009, DEMENT GERIATR COGN, V28, P168, DOI 10.1159/000235732; THAL LJ, 1986, NEUROLOGY, V36, P262, DOI 10.1212/WNL.36.2.262; Vellas B, 2007, LANCET NEUROL, V6, P56, DOI 10.1016/S1474-4422(06)70677-9; Wang W, 2008, J ALZHEIMERS DIS, V13, P31; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wong CHY, 2013, INT PSYCHOGERIATR, V25, P1125, DOI 10.1017/S1041610213000161	67	164	174	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142388	10.1371/journal.pone.0142388	http://dx.doi.org/10.1371/journal.pone.0142388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539987	Green Published, Green Accepted, gold			2022-12-27	WOS:000364303800091
J	Davidson, AD; Hewitt, CL; Kashian, DR				Davidson, Alisha D.; Hewitt, Chad L.; Kashian, Donna R.			Understanding Acceptable Level of Risk: Incorporating the Economic Cost of Under-Managing Invasive Species	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; DREISSENA-POLYMORPHA; BALLAST WATER; MANAGEMENT; PREVENTION; TRANSPORT; BENEFITS; SYSTEMS; POLICY; SPREAD	Management of nonindigenous species includes prevention, early detection and rapid response and control. Early detection and rapid response depend on prioritizing and monitoring sites at risk for arrival or secondary spread of nonindigenous species. Such monitoring efforts require sufficient biosecurity budgets to be effective and meet management or policy directives for reduced risk of introduction. Such consideration of risk reduction is rarely considered, however. Here, we review the concepts of acceptable level of risk (ALOR) and associated costs with respect to nonindigenous species and present a framework for aligning risk reduction priorities with available biosecurity resources. We conclude that available biosecurity resources may be insufficient to attain stated and desired risk reduction. This outcome highlights the need to consider policy and management directives when beginning a biosecurity program to determine the feasibility of risk reduction goals, given available resources.	[Davidson, Alisha D.; Kashian, Donna R.] Wayne State Univ, Detroit, MI 48202 USA; [Hewitt, Chad L.] Univ Waikato, Hamilton 3240, New Zealand	Wayne State University; University of Waikato	Davidson, AD (corresponding author), Wayne State Univ, 5047 Gullen Mall, Detroit, MI 48202 USA.	alisha.dahlstrom@gmail.com	Hewitt, Chad L/J-2105-2019	Hewitt, Chad L/0000-0002-6859-6512; Kashian, Donna/0000-0002-4287-9338	U.S. Environmental Protection Agency [GLOOE01152-0]; Cooperative Institute for Limnology and Ecosystem Research; Wayne State University	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Cooperative Institute for Limnology and Ecosystem Research; Wayne State University	Funding for this work was provided by the U.S. Environmental Protection Agency (www.epa.gov) grant GLOOE01152-0, the Cooperative Institute for Limnology and Ecosystem Research and Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANS Task Force, 2013, STOP AQ HITCHH; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Beale R., 2008, ONE BIOSECURITY WORK; CBD Secretariat, 2002, 6 C PART CONV BIOL D; DAFF, 2009, IMP RISK AN HDB 2007; Dahlstrom A, 2012, AQUAT INVASIONS, V7, P567, DOI 10.3391/ai.2012.7.4.013; Davidson AD, 2015, ENVIRON MANAGE, V56, P54, DOI 10.1007/s00267-015-0484-2; Davidson AD, 2014, BIOL INVASIONS, V16, P1165, DOI 10.1007/s10530-013-0570-4; Domenech E, 2016, FOOD CONTROL, V59, P669, DOI 10.1016/j.foodcont.2015.05.042; Ferrari B, 2004, ENVIRON TOXICOL CHEM, V23, P1344, DOI 10.1897/03-246; Finnoff D, 2007, ECOL ECON, V62, P216, DOI 10.1016/j.ecolecon.2006.03.025; Glosten Associates, 2006, BALL TREAT SYST; Gollasch S, 2007, HARMFUL ALGAE, V6, P585, DOI 10.1016/j.hal.2006.12.009; Great Lakes Interagency Task Force, 2010, FY2010 FY2014 GREAT; Haight RG, 2010, RESOUR ENERGY ECON, V32, P519, DOI 10.1016/j.reseneeco.2010.04.005; Harlow SD, 2004, RISK ANAL, V24, P443, DOI 10.1111/j.0272-4332.2004.00446.x; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Horsch EJ, 2009, LAND ECON, V85, P391; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Keller RP, 2008, CONSERV BIOL, V22, P80, DOI 10.1111/j.1523-1739.2007.00811.x; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lovell S. J., 2006, Agricultural and Resource Economics Review, V35, P195; MAPSTONE BD, 1995, ECOL APPL, V5, P401, DOI 10.2307/1942031; Morse JT, 2009, BIOFOULING, V25, P605, DOI 10.1080/08927010902989245; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Ojaveer H, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002130; Oreska MPJ, 2011, BIOL INVASIONS, V13, P305, DOI 10.1007/s10530-010-9807-7; Otsuki T, 2001, FOOD POLICY, V26, P495, DOI 10.1016/S0306-9192(01)00018-5; Padilla DK, 1996, GLOBAL ECOL BIOGEOGR, V5, P353, DOI 10.2307/2997590; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; PETERMAN RM, 1990, ECOLOGY, V71, P2024, DOI 10.2307/1937612; ROSEN S, 1974, J POLIT ECON, V82, P34, DOI 10.1086/260169; Rothlisberger JD, 2012, ECOSYSTEMS, V15, P462, DOI 10.1007/s10021-012-9522-6; Rothlisberger JD, 2010, FISHERIES, V35, P121, DOI 10.1577/1548-8446-35.3.121; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Simonsen S., 2012, ACCEPTABLE RISK BIOM; Sims C, 2013, RESOUR ENERGY ECON, V35, P235, DOI 10.1016/j.reseneeco.2013.02.001; Tobin P. C., 2007, SLOW SPREAD NATL PRO; Underwood AJ, 2003, J EXP MAR BIOL ECOL, V296, P49, DOI 10.1016/S0022-0981(03)00304-6; United States Coast Guard, 2011, NAT RECR BOAT SURV; Van Nes EH, 1999, HYDROBIOLOGIA, V415, P335, DOI 10.1023/A:1003821314662; Vander Zanden MJ, 2010, J GREAT LAKES RES, V36, P199, DOI 10.1016/j.jglr.2009.11.002; Water Resources Division, 2012, MICH AQ INV SPEC STA; Wotton DM, 2004, NEW ZEAL J MAR FRESH, V38, P553, DOI 10.1080/00288330.2004.9517260; Zhang FZ, 1999, MAR ECOL PROG SER, V176, P243, DOI 10.3354/meps176243	48	11	11	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141958	10.1371/journal.pone.0141958	http://dx.doi.org/10.1371/journal.pone.0141958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536244	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400107
J	Dwyer, T; Pezic, A; Sun, C; Cochrane, J; Venn, A; Srikanth, V; Jones, G; Shook, R; Sui, XM; Ortaglia, A; Blair, S; Ponsonby, AL				Dwyer, Terence; Pezic, Angela; Sun, Cong; Cochrane, Jenny; Venn, Alison; Srikanth, Velandai; Jones, Graeme; Shook, Robin; Sui, Xuemei; Ortaglia, Andrew; Blair, Steven; Ponsonby, Anne-Louise			Objectively Measured Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; LIFE-STYLE; RISK; METAANALYSIS; PEDOMETER; ASSOCIATION; RELIABILITY; VALIDITY; DISEASE; FITNESS	Background Self-reported physical activity has been inversely associated with mortality but the effect of objectively measured step activity on mortality has never been evaluated. The objective is to determine the prospective association of daily step activity on mortality among free-living adults. Methods and Findings Cohort study of free-living adults residing in Tasmania, Australia between 2000 and 2005 who participated in one of three cohort studies (n = 2 576 total participants). Daily step activity by pedometer at baseline at a mean of 58.8 years of age, and for a subset, repeated monitoring was available 3.7 (SD 1.3) years later (n = 1 679). All-cause mortality (n = 219 deaths) was ascertained by record-linkage to the Australian National Death Index; 90% of participants were followed-up over ten years, until June 2011. Higher daily step count at baseline was linearly associated with lower all-cause mortality (adjusted hazard ratio AHR, 0.94; 95% CI, 0.90 to 0.98 per 1 000 steps; P = 0.004). Risk was altered little by removing deaths occurring in the first two years. Increasing baseline daily steps from sedentary to 10 000 steps a day was associated with a 46% (95% CI, 18% to 65%; P = 0.004) lower risk of mortality in the decade of follow-up. In addition, those who increased their daily steps over the monitoring period had a substantial reduction in mortality risk, after adjusting for baseline daily step count (AHR, 0.39; 95% CI, 0.22 to 0.72; P = 0.002), or other factors (AHR, 0.38; 95% CI, 0.21-0.70; P = 0.002). Conclusions Higher daily step count was linearly associated with subsequent long term mortality among free living adults. These data are the first to quantify mortality reductions using an objective measure of physical activity in a free living population. They strongly underscore the importance of physical inactivity as a major public health problem.	[Dwyer, Terence] George Inst Global Hlth, Oxford, England; [Dwyer, Terence; Cochrane, Jenny; Venn, Alison; Jones, Graeme; Ponsonby, Anne-Louise] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Dwyer, Terence; Pezic, Angela; Sun, Cong; Ponsonby, Anne-Louise] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sun, Cong; Ponsonby, Anne-Louise] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Srikanth, Velandai] Monash Univ, Sch Clin Sci, Med, Stroke & Ageing Res Grp, Melbourne, Vic 3004, Australia; [Shook, Robin; Sui, Xuemei; Ortaglia, Andrew; Blair, Steven] Iowa State Univ Sci & Technol, Ames, IA 50011 USA; [Sui, Xuemei; Blair, Steven] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Ortaglia, Andrew; Blair, Steven] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of Tasmania; Menzies Institute for Medical Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; Iowa State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ponsonby, AL (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	anne-louise.ponsonby@mcri.edu.au	Ponsonby, Anne-Louise/AAE-4351-2019; Venn, Alison J/J-2803-2013	Srikanth, Velandai/0000-0002-8442-8981; Ponsonby, Anne-Louise/0000-0002-6581-3657	National Health and Medical Research Council of Australia; Commonwealth Department of Health and Aged Care; Abbott Australasia; Alphapharm; Aventis Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly (Australia); GlaxoSmithKline; Janssen-Cilag (Australia); Merck Lipha; Merck Sharp and Dohme (Australia); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical; Pharmacia and Upjohn; Pfizer; Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; Hitech Pathology; Australian Kidney Foundation; Diabetes Australia; Tasmanian Department of Health and Human Services; Physiotherapy Research Foundation; Perpetual Trustees; Brain Foundation; Royal Hobart Hospital Research Foundation; ANZ Charitable Trust; Tasmanian Community Fund; Arthritis Foundation of Australia; Masonic Centenary Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Department of Health and Aged Care; Abbott Australasia(Abbott Laboratories); Alphapharm; Aventis Pharmaceutical; AstraZeneca(AstraZeneca); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly (Australia)(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag (Australia)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Lipha; Merck Sharp and Dohme (Australia)(Merck & Company); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical(Novo Nordisk); Pharmacia and Upjohn; Pfizer(Pfizer); Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; Hitech Pathology; Australian Kidney Foundation; Diabetes Australia; Tasmanian Department of Health and Human Services; Physiotherapy Research Foundation; Perpetual Trustees; Brain Foundation; Royal Hobart Hospital Research Foundation; ANZ Charitable Trust; Tasmanian Community Fund; Arthritis Foundation of Australia; Masonic Centenary Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	The study received financial support from the National Health and Medical Research Council of Australia, the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp and Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, Hitech Pathology, the Australian Kidney Foundation, Diabetes Australia, Tasmanian Department of Health and Human Services, the Physiotherapy Research Foundation, Perpetual Trustees, Brain Foundation, Royal Hobart Hospital Research Foundation, ANZ Charitable Trust, Tasmanian Community Fund; Arthritis Foundation of Australia and Masonic Centenary Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Amanda Hawker for cohort data management and Helen Raschella and Rianna Chapman for manuscript preparation. We thank Andrew Kemp for literature review. This work was supported by the Victorian Government's Operational Infrastructure Support Program.	Armitage P., 2001, STAT METHODS MED RES; Australian Institute of Health and Welfare, 2012, NAT DEATH IND CANB; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Callisaya ML, 2012, GAIT POSTURE, V36, P510, DOI 10.1016/j.gaitpost.2012.05.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dore D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3689; Dore D, 2009, J BONE MINER RES, V24, P2007, DOI [10.1359/JBMR.090532, 10.1359/jbmr.090532]; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Dwyer T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7249; Ekelund U, 2007, DIABETES CARE, V30, P2101, DOI 10.2337/dc07-0719; Gebel K, 2015, JAMA INT MED; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hatano Y, 1993, INT COUNC HLTH PHYS, V29, P4; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Kelley GA, 2006, ATHEROSCLEROSIS, V184, P207, DOI 10.1016/j.atherosclerosis.2005.04.005; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Ponsonby AL, 2011, DIABETES CARE, V34, P1497, DOI 10.2337/dc10-2386; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schmidt MD, 2009, AM J PREV MED, V37, P278, DOI 10.1016/j.amepre.2009.05.020; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Tudor-Locke C, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-59; Warnecke RB, 1997, ANN EPIDEMIOL, V7, P334, DOI 10.1016/S1047-2797(97)00030-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9	42	78	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141274	10.1371/journal.pone.0141274	http://dx.doi.org/10.1371/journal.pone.0141274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536618	Green Published, gold			2022-12-27	WOS:000364298400057
J	Klenova, AV				Klenova, Anna V.			Chick Begging Calls Reflect Degree of Hunger in Three Auk Species (Charadriiformes: Alcidae)	PLOS ONE			English	Article							PARENT-OFFSPRING RECOGNITION; PRIONS PACHYPTILA-BELCHERI; NESTLING TREE SWALLOWS; WILSONS STORM-PETRELS; INDIVIDUAL RECOGNITION; OCEANITES-OCEANICUS; ACOUSTIC PARAMETERS; MANX SHEARWATERS; SEX-DIFFERENCES; BODY CONDITION	Begging behaviour is an important element in the parent-offspring conflict; it has been studied in many avian species. However, the majority of the studies have been entirely based on the call counts, and they agreed that vocal activity was a good indicator of chick's nutritional need and/or condition. Fewer researches were dedicated to the temporal-frequency variables of the begging calls themselves and they showed contrary results. Here begging behaviour in three burrow nested, uniparous species of auks (Alcidae) was studied. These objects provide an opportunity to study the signalling value of begging calls in the absence of important confounding factors such as nestling competition and predation pressure. I recorded calls of individual chicks in two conditions: during natural feeding and after experimental four-hour food deprivation. I found that almost all measured acoustic variables contain information about the chick's state in all studied species. The hungry chicks produced calls higher in fundamental frequency and power variables and at higher calling rate compared to naturally feeding chicks. The effect of food deprivation on most acoustic variables exceeded both the effects of individuality and species. In all studied species, the frequency variables were stronger affected by hunger than the calling rate and call durations. I suppose that such strong change of acoustic variables after food deprivation can be explained by absence of vocal individual identification in these birds. As parents do not need to check individuality of the chick in the burrow, which they find visually during the day time, the chicks could use all of the acoustic variables to communicate about their nutritional needs.	Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Moscow 119234, Russia	Lomonosov Moscow State University	Klenova, AV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Vorobievy Gory 1-12, Moscow 119234, Russia.	anna.v.klenova@gmail.com			Russian Scientific Foundation [14-14-00237]; Russian Science Foundation [14-14-00237] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	Funding: To conduct this study AVK was funded by the Russian Scientific Foundation (grant 14-14-00237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev AV, 2010, B NESC FEB RAS, V2, P30; Bakhturina DS, 2014, B NESC FEB RAS, V3, P83; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; Duckworth A, 2009, ACTA ORNITHOL, V44, P127, DOI 10.3161/000164509X482704; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Frommolt Karl-Heinz, 1999, Bioacoustics, V10, P219; Gaston A.J., 1998, THE AUKS; Gladbach A, 2009, J ETHOL, V27, P267, DOI 10.1007/s10164-008-0115-y; Hamer KC, 1999, ANIM BEHAV, V57, P627, DOI 10.1006/anbe.1998.0994; Insley SJ, 2003, J EXP BIOL, V206, P25, DOI 10.1242/jeb.00072; Jones IL, 1993, BIRDS N AM ONLINE, DOI [10.2173/bna.70;1993, DOI 10.2173/BNA.70;]; Jones IL, BIRDS N AM ONLINE, DOI [10.2I73/bna.594, DOI 10.2173/BNA.594;]; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Klenova AV, 2012, ZOOL ZH, V91, P869; Klenova AV, 2013, J ORNITHOL, V154, P705, DOI 10.1007/s10336-013-0935-6; Klenova AV, 2012, ACTA ETHOL, V15, P141, DOI 10.1007/s10211-011-0120-y; Klenova AV, 2009, ACTA ETHOL, V12, P29, DOI 10.1007/s10211-009-0053-x; Kolesnikova YA, 2011, P 8 C EUR ORN UN RIG, P199; Lefevre K, 1998, ANIM BEHAV, V55, P925, DOI 10.1006/anbe.1997.0626; Leger S. A., 2015, COMMUNICATION; Leonard ML, 2006, ETHOLOGY, V112, P1020, DOI 10.1111/j.1439-0310.2006.01259.x; Leonard ML, 2005, P ROY SOC B-BIOL SCI, V272, P651, DOI 10.1098/rspb.2004.3021; Leonard ML, 2001, ANIM BEHAV, V61, P87, DOI 10.1006/anbe.2000.1575; Marques PAM, 2009, ZOOL STUD, V48, P587; Marques PAM, 2008, BIOACOUSTICS, V18, P133, DOI 10.1080/09524622.2008.9753596; Mathevon N, 2003, CR BIOL, V326, P329, DOI 10.1016/S1631-0691(03)00072-6; MONDLOCH CJ, 1995, ANIM BEHAV, V49, P601; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Piatt J.F., 2002, BIRDS N AM, DOI [10.2173/bna.603., DOI 10.2173/BNA.603]; Quillfeldt P, 2004, ANIM BEHAV, V68, P613, DOI 10.1016/j.anbehav.2003.12.002; Quillfeldt P, 2002, ANIM BEHAV, V64, P579, DOI 10.1006/anbe.2002.3090; Quillfeldt P, 2007, BEHAV ECOL SOCIOBIOL, V61, P793, DOI 10.1007/s00265-006-0310-1; Quillfeldt Petra, 2004, Acta Ethologica, V7, P73, DOI 10.1007/s10211-004-0100-6; Quillfeldt P, 2010, ACTA ETHOL, V13, P1, DOI 10.1007/s10211-009-0066-5; Quillfeldt P, 2009, GEN COMP ENDOCR, V161, P171, DOI 10.1016/j.ygcen.2008.12.006; Rector ME, 2014, BEHAV ECOL, V25, P496, DOI 10.1093/beheco/aru009; Reers Hendrik, 2011, BMC Ecology, V11, P3, DOI 10.1186/1472-6785-11-3; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Sacchi R, 2002, BEHAV ECOL, V13, P268, DOI 10.1093/beheco/13.2.268; Searby A, 2004, ANIM BEHAV, V67, P615, DOI 10.1016/j.anbehav.2003.03.012; Smith NA, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.91.709; Trager I, 2006, WATERBIRDS, V29, P315, DOI 10.1675/1524-4695(2006)29[315:DAPOBC]2.0.CO;2; WELHAM CVJ, 1993, ANIM BEHAV, V45, P827, DOI 10.1006/anbe.1993.1099; Wilden I., 1998, Bioacoustics, V9, P171; Zollinger SA, 2008, J EXP BIOL, V211, P1978, DOI 10.1242/jeb.014092	49	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140151	10.1371/journal.pone.0140151	http://dx.doi.org/10.1371/journal.pone.0140151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536362	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400018
J	Mohammad, H; Cushman, M; Seleem, MN				Mohammad, Haroon; Cushman, Mark; Seleem, Mohamed N.			Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; MUPIROCIN RESISTANCE; PRACTICE GUIDELINES; DISEASES SOCIETY; VANCOMYCIN; ANTIBIOTICS; COMBINATION; EPIDEMIOLOGY; CLINDAMYCIN; AMOXICILLIN	The emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA), including strains resistant to current antibiotics, has contributed to an increase in the number of skin infections reported in humans in recent years. New therapeutic options are needed to counter this public health challenge. The aim of the present study was to examine the potential of thiazole compounds synthesized by our research group to be used topically to treat MRSA skin and wound infections. The broth microdilution method confirmed that the lead thiazole compound and four analogues are capable of inhibiting MRSA growth at concentrations as low as 1.3 mu g/mL. Additionally, three compounds exhibited a synergistic relationship when combined with the topical antibiotic mupirocin against MRSA in vitro via the checkerboard assay. Thus the thiazole compounds have potential to be used alone or in combination with mupirocin against MRSA. When tested against human keratinocytes, four derivatives of the lead compound demonstrated an improved toxicity profile (were found to be non-toxic up to a concentration of 20 mu g/mL). Utilizing a murine skin infection model, we confirmed that the lead compound and three analogues exhibited potent antimicrobial activity in vivo, with similar capability as the antibiotic mupirocin, as they reduced the burden of MRSA present in skin wounds by more than 90%. Taken altogether, the present study provides important evidence that these thiazole compounds warrant further investigation for development as novel topical antimicrobials to treat MRSA skin infections.	[Mohammad, Haroon; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Ctr Canc Res, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018	Seleem, Mohamed/0000-0003-0939-0458; Mohammad, Haroon/0000-0002-8843-8933	Showalter Research Trust [205994]; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH [HHSN272200700055C]	Showalter Research Trust; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH	This work was supported by the Showalter Research Trust (Grant 205994). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract # HHSN272200700055C for providing the MRSA strains used in this study.	Alou L, 2004, INT J ANTIMICROB AG, V23, P513, DOI 10.1016/j.ijantimicag.2003.09.030; Bassani August S, 2008, Int J Pharm Compd, V12, P270; Boyce Steven T., 1995, Journal of Burn Care and Rehabilitation, V16, P97, DOI 10.1097/00004630-199503000-00002; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DAMOUR O, 1992, BURNS, V18, P479, DOI 10.1016/0305-4179(92)90180-3; dosSantos KRN, 1996, INFECT CONT HOSP EP, V17, P813; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Giordano Philip, 2007, Ther Clin Risk Manag, V3, P309, DOI 10.2147/tcrm.2007.3.2.309; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Guthrie HC, 2014, INJURY, V45, P1171, DOI 10.1016/j.injury.2014.05.007; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Institute CaLS, 2012, M07A9 I CALS; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Lio PA, 2004, INFECT DIS CLIN N AM, V18, P717, DOI 10.1016/j.idc.2004.04.008; Lio PA, 2011, MED CLIN N AM, V95, P703, DOI 10.1016/j.mcna.2011.03.008; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mayhoub AS, 2011, BIOORGAN MED CHEM, V19, P3845, DOI 10.1016/j.bmc.2011.04.041; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller MA, 1996, INFECT CONT HOSP EP, V17, P811; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Mohammad H, 2015, EUR J MED CHEM, V94, P306, DOI 10.1016/j.ejmech.2015.03.015; Mohammad H, 2014, J MED CHEM, V57, P1609, DOI 10.1021/jm401905m; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mulvey MR, 2005, EMERG INFECT DIS, V11, P844, DOI 10.3201/eid1106.041146; Nagao M, 2010, AM J INFECT CONTROL, V38, pE37, DOI 10.1016/j.ajic.2010.04.214; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Simor AE, 2007, ANTIMICROB AGENTS CH, V51, P3880, DOI 10.1128/AAC.00846-07; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296; Suzuki M, 2011, EMERG INFECT DIS, V17, P1917, DOI 10.3201/eid1710.101365; WEBER DJ, 1984, PHARMACOTHERAPY, V4, P122	39	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142321	10.1371/journal.pone.0142321	http://dx.doi.org/10.1371/journal.pone.0142321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536129	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400151
J	Park, J; Chung, H; Bang, SH; Han, AR; Seo, EK; Chang, SE; Kang, DH; Oh, ES				Park, Jisu; Chung, Heesung; Bang, Seung Hyun; Han, Ah-Reum; Seo, Eun-Kyoung; Chang, Sung Eun; Kang, Duk-Hee; Oh, Eok-Soo			(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression	PLOS ONE			English	Article							MURINE MELANOMA-CELLS; ACTIVATED PROTEIN-KINASE; ZINGIBER-CASSUMUNAR; TRANSCRIPTION FACTOR; INHIBITS MELANOGENESIS; DOWN-REGULATION; PHENYLBUTENOID DIMER; SIGNALING PATHWAY; MITF DEGRADATION; GENE-EXPRESSION	We investigated the potential melanogenic effect of compounds from Zingiber cassumunar Roxb. Our data revealed that chloroform-soluble extract of Z. cassumunar enhanced melanin synthesis in B16F10 melanoma cells. Among the components of the chloroform extract, (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol (DMPB) increased melanogenesis in both B16F10 cells and human primary melanocytes. In B16F10 cells, DMPB enhanced the activation of ERK and p38, and the level of tyrosinase. Although the level of microphthalmia-associated transcription factor was unchanged in DMPB-treated B16F10 cells, DMPB increased levels and nuclear localization of upstream stimulating factor-1 (USF1). Consistently, DMPB-mediated melanin synthesis was diminished in USF1-knockdown cells. Furthermore, DMPB induced hyperpigmentation in brown guinea pigs in vivo. Together, these data suggest that DMPB may promote melanin synthesis via USF1 dependent fashion and could be used as a clinical therapeutic agent against hypopigmentation-associated diseases.	[Park, Jisu; Chung, Heesung; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul, South Korea; [Bang, Seung Hyun; Chang, Sung Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Dermatol, Seoul, South Korea; [Han, Ah-Reum; Seo, Eun-Kyoung] Ewha Womans Univ, Coll Pharm, Global Res Program Top5, Seoul, South Korea; [Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea	Ewha Womans University; University of Ulsan; Asan Medical Center; Ewha Womans University; Ewha Womans University	Kang, DH (corresponding author), Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea.	dhkang@ewha.ac.kr; OhES@ewha.ac.kr	bang, sunghyun/AAH-1201-2020; chang, sungeun/AAH-1247-2020	Bang, Seunghyun/0000-0002-3211-7209	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A5A1048236]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]; Ministry of Science, ICT and Future Planning [NRF2012M3A9C4048761]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	The work was supported by the following: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP), grant number: 2012R1A5A1048236 (URL: www.nrf.re.kr); the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, grant number: HI12C0050 (URL: http://www.mw.go.kr); and the Ministry of Science, ICT and Future Planning (NRF2012M3A9C4048761). The funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, ARCH DERMATOL RES, V300, P325, DOI 10.1007/s00403-008-0863-0; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; ALBERT DM, 1979, OPHTHALMOLOGY, V86, P1145; Baron Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002470; Bruneton J. N., 1999, PHARMACOGNOSY PHYTOC; Chang MS, 2010, PHYTOTHER RES, V24, P1359, DOI 10.1002/ptr.3123; Chao HC, 2013, EXP DERMATOL, V22, P131, DOI 10.1111/exd.12089; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chung H, 2014, J BIOL CHEM, V289, P21751, DOI 10.1074/jbc.M113.541177; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Gaggioli C, 2003, PIGM CELL RES, V16, P374, DOI 10.1034/j.1600-0749.2003.00057.x; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Han AR, 2005, CHEM PHARM BULL, V53, P1466, DOI 10.1248/cpb.53.1466; Han AR, 2004, PLANTA MED, V70, P1095, DOI 10.1055/s-2004-832656; Horbach T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00003; Huang HC, 2013, BIOCHEM BIOPH RES CO, V438, P375, DOI 10.1016/j.bbrc.2013.07.079; Huang YC, 2011, PHYTOMEDICINE, V18, P1244, DOI 10.1016/j.phymed.2011.06.028; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Jang JY, 2012, J ETHNOPHARMACOL, V141, P338, DOI 10.1016/j.jep.2012.02.043; Jang JY, 2009, EXP DERMATOL, V18, P232, DOI 10.1111/j.1600-0625.2008.00794.x; Jung H, 2014, PIGM CELL MELANOMA R, V27, P387, DOI 10.1111/pcmr.12223; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim HE, 2012, BMB REP, V45, P724, DOI 10.5483/BMBRep.2012.45.12.039; Kumar CM, 2011, BIOCHIMIE, V93, P562, DOI 10.1016/j.biochi.2010.11.014; Lee CS, 2013, J INVEST DERMATOL, V133, P1063, DOI 10.1038/jid.2012.409; Lee JW, 2007, BIOL PHARM BULL, V30, P1561, DOI 10.1248/bpb.30.1561; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Lu YB, 2005, J CHROMATOGR A, V1089, P258, DOI 10.1016/j.chroma.2005.06.073; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsuda H, 2006, BIOL PHARM BULL, V29, P834, DOI 10.1248/bpb.29.834; Matsuda H, 2005, BIOL PHARM BULL, V28, P1229, DOI 10.1248/bpb.28.1229; Matsuda H, 2011, CHEM PHARM BULL, V59, P365, DOI 10.1248/cpb.59.365; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nagano T, 1997, JPN J PHARMACOL, V75, P363, DOI 10.1254/jjp.75.363; Nakamura S, 2009, CHEM PHARM BULL, V57, P1267, DOI 10.1248/cpb.57.1267; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Shin SH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.20; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Wang CQF, 2013, J INVEST DERMATOL, V133, P2741, DOI 10.1038/jid.2013.237; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141988	10.1371/journal.pone.0141988	http://dx.doi.org/10.1371/journal.pone.0141988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535571	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400112
J	Rosenblatt, SD; Crane, BT				Rosenblatt, Steven David; Crane, Benjamin Thomas			Influence of Visual Motion, Suggestion, and Illusory Motion on Self-Motion Perception in the Horizontal Plane	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; PERIPHERAL-VISION; VESTIBULAR CUES; YAW ROTATION; TRANSLATION; VECTION; MAGNITUDE; ACCELERATION; ASYMMETRIES; THRESHOLDS	A moving visual field can induce the feeling of self-motion or vection. Illusory motion from static repeated asymmetric patterns creates a compelling visual motion stimulus, but it is unclear if such illusory motion can induce a feeling of self-motion or alter self-motion perception. In these experiments, human subjects reported the perceived direction of self-motion for sway translation and yaw rotation at the end of a period of viewing set visual stimuli coordinated with varying inertial stimuli. This tested the hypothesis that illusory visual motion would influence self-motion perception in the horizontal plane. Trials were arranged into 5 blocks based on stimulus type: moving star field with yaw rotation, moving star field with sway translation, illusory motion with yaw, illusory motion with sway, and static arrows with sway. Static arrows were used to evaluate the effect of cognitive suggestion on self-motion perception. Each trial had a control condition; the illusory motion controls were altered versions of the experimental image, which removed the illusory motion effect. For the moving visual stimulus, controls were carried out in a dark room. With the arrow visual stimulus, controls were a gray screen. In blocks containing a visual stimulus there was an 8s viewing interval with the inertial stimulus occurring over the final 1s. This allowed measurement of the visual illusion perception using objective methods. When no visual stimulus was present, only the 1s motion stimulus was presented. Eight women and five men (mean age 37) participated. To assess for a shift in self-motion perception, the effect of each visual stimulus on the self-motion stimulus (cm/s) at which subjects were equally likely to report motion in either direction was measured. Significant effects were seen for moving star fields for both translation (p = 0.001) and rotation (p<0.001), and arrows (p = 0.02). For the visual motion stimuli, inertial motion perception was shifted in the direction consistent with the visual stimulus. Arrows had a small effect on self-motion perception driven by a minority of subjects. There was no significant effect of illusory motion on self-motion perception for either translation or rotation (p>0.1 for both). Thus, although a true moving visual field can induce self-motion, results of this study show that illusory motion does not.	[Rosenblatt, Steven David; Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14618 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14618 USA.	craneb@gmail.com			NIDCD [K23 DC011298, R01 DC0135480]; Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298, R01DC013580] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Society Career Scientist Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIDCD K23 DC011298 and R01 DC0135480. A Triological Society Career Scientist Award provided some salary support for BTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2005, J VISION, V5, P1055, DOI 10.1167/5.11.10; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; Chi MT, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360661; Coniglio AJ, 2014, JARO-J ASSOC RES OTO, V15, P305, DOI 10.1007/s10162-013-0438-4; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; Crane BT, 2014, EXP BRAIN RES, V232, P3897, DOI 10.1007/s00221-014-4060-4; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Crane BT, 2012, EXP BRAIN RES, V223, P89, DOI 10.1007/s00221-012-3243-0; Crane BT, 2012, EXP BRAIN RES, V219, P477, DOI 10.1007/s00221-012-3105-9; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; Garcia-Perez MA, 2013, Q J EXP PSYCHOL, V66, P319, DOI 10.1080/17470218.2012.708761; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Gibson JJ, 1950, PERCEPTION VISUAL WO; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Kitaoka A, 2007, PERCEPTION, V36, P1019, DOI 10.1068/p5362; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Roditi RE, 2011, 34 ANN M BALT MD, P1006; Seno T, 2013, PERCEPTION, V42, P1001, DOI 10.1068/p7511; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Seno T, 2009, VISION RES, V49, P2973, DOI 10.1016/j.visres.2009.09.017; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; TELFORD L, 1993, PERCEPT PSYCHOPHYS, V53, P682, DOI 10.3758/BF03211744; WARREN R, 1976, J EXP PSYCHOL HUMAN, V2, P448, DOI 10.1037/0096-1523.2.3.448; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	49	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142109	10.1371/journal.pone.0142109	http://dx.doi.org/10.1371/journal.pone.0142109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536235	Green Submitted, gold, Green Published			2022-12-27	WOS:000364298400134
J	Wang, HW; Milstein, JN				Wang, Haowei; Milstein, Joshua N.			Simulation Assisted Analysis of the Intrinsic Stiffness for Short DNA Molecules Imaged with Scanning Atomic Force Microscopy	PLOS ONE			English	Article							H-NS PROTEIN; CONFORMATIONAL STATISTICS; STRETCHING DNA; FOREIGN DNA; FLEXIBILITY; ELASTICITY; LENGTH; MICA; AFM; RECOGNITION	Studying the mechanical properties of short segments of dsDNA can provide insight into various biophysical phenomena, from DNA looping to the organization of nucleosomes. Scanning atomic force microscopy (AFM) is able to acquire images of single DNA molecules with near-basepair resolution. From many images, one may use equilibrium statistical mechanics to quantify the intrinsic stiffness (or persistence length) of the DNA. However, this approach is highly dependent upon both the correct microscopic polymer model and a correct image analysis of DNA contours. These complications have led to significant debate over the flexibility of dsDNA at short length scales. We first show how to extract accurate measures of DNA contour lengths by calibrating to DNA traces of simulated AFM data. After this calibration, we show that DNA adsorbed on an aminopropyl-mica surface behaves as a worm-like chain (WLC) for contour lengths as small as similar to 20 nm. We also show that a DNA binding protein can modify the mechanics of the DNA from that of a WLC.	[Wang, Haowei] Univ Sci & Technol China, Dept Opt & Opt Engn, Hefei, Anhui, Peoples R China; [Wang, Haowei] Heifi Natl Lab Phys Sci Microscale, Heifi, Anhui, Peoples R China; [Wang, Haowei; Milstein, Joshua N.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [Milstein, Joshua N.] Univ Toronto, Dept Phys, Toronto, ON, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toronto; University Toronto Mississauga; University of Toronto	Milstein, JN (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	josh.milstein@utoronto.ca		Wang, Haowei/0000-0001-9197-8730	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [RGPIN 418251]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	HW and JNM were supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN 418251, http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BRUGAL G, 1977, HISTOCHEMISTRY, V52, P241, DOI 10.1007/BF00495860; BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005; Chen YF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.020903; Cognet JAH, 1999, J MOL BIOL, V285, P997, DOI 10.1006/jmbi.1998.2322; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; de Pablo Pedro J, 2014, Cold Spring Harb Protoc, V2014, P167, DOI 10.1101/pdb.top080473; Ficarra E, 2005, IEEE T INF TECHNOL B, V9, P508, DOI 10.1109/TITB.2005.855546; Halford SE, 2004, ANNU REV BIOPH BIOM, V33, P1, DOI 10.1146/annurev.biophys.33.110502.132711; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Mantelli S, 2011, SOFT MATTER, V7, P3412, DOI 10.1039/c0sm01160f; Marilley M, 2005, MOL GENET GENOMICS, V274, P658, DOI 10.1007/s00438-005-0058-8; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mazur AK, 2014, NUCLEIC ACIDS RES, V42, P14006, DOI 10.1093/nar/gku1192; Mazur AK, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.068104; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rivetti C, 2001, ULTRAMICROSCOPY, V87, P55, DOI 10.1016/S0304-3991(00)00064-4; Sanchez-Sevilla A, 2002, ULTRAMICROSCOPY, V92, P151, DOI 10.1016/S0304-3991(02)00128-6; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Vologodskii A, 2013, NUCLEIC ACIDS RES, V41, P6785, DOI 10.1093/nar/gkt396; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wolfe KC, 2012, J PHYS CHEM B, V116, P8556, DOI 10.1021/jp2126015; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yuan CL, 2006, NUCLEIC ACIDS RES, V34, P4554, DOI 10.1093/nar/gkl394; Zhou Y, 2006, MACROMOLECULES, V39, P1950, DOI 10.1021/ma0512556; Zhou Y, 2003, J CHEM PHYS, V119, P4962, DOI 10.1063/1.1596911	36	3	3	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142277	10.1371/journal.pone.0142277	http://dx.doi.org/10.1371/journal.pone.0142277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535902	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400149
J	Zhang, ZF; Feng, J; Wu, CW; Lu, Q; Pan, ZH				Zhang, Zhifei; Feng, Jie; Wu, Chaowen; Lu, Qi; Pan, Zhuo-Hua			Targeted Expression of Channelrhodopsin-2 to the Axon Initial Segment Alters the Temporal Firing Properties of Retinal Ganglion Cells	PLOS ONE			English	Article							ACTION-POTENTIAL GENERATION; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; SODIUM-CHANNELS; RESPONSES; RESTORATION; DENDRITES; RESTORES; NEURONS; MOTIF	The axon initial segment (AIS) is essential for initiating action potentials and maintaining neuronal excitability in axon-bearing neurons in the CNS. There is increasing interest in the targeting of optogenetic tools to subcellular compartments, including the AIS, to gain precise control of neuronal activity for basic research and clinical applications. In particular, targeted expression of optogenetic tools in retinal ganglion cells (RGCs) has been explored as an approach for restoring vision after photoreceptor degeneration. Thus, understanding the effects of such targeting on spiking abilities and/or patterns is important. Here, we examined the effects of recombinant adeno-associated virus (rAAV)-mediated targeted expression of channelrhodopsin-2 (ChR2)-GFP with a NaV channel motif in mouse RGCs. We found that this targeted expression disrupted NaV channel clustering at the AIS and converted the spike firing patterns of RGCs from sustained to transient. Our results suggest that the clustering of membrane channels, including NaV channels, at the AIS is important for the ability of RGCs to generate sustained spike firing. Additionally, the targeting of optogenetic tools to the AIS with the NaV channel motif may offer a way to create transient light responses in RGCs for vision restoration.	[Zhang, Zhifei; Feng, Jie; Wu, Chaowen; Lu, Qi; Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Feng, Jie] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Hlth Sci Ctr, Xian 710049, Peoples R China; [Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Xi'an Jiaotong University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	zhpan@med.wayne.edu			National Institutes of Health (NIH) [EY17130]; Department of Anatomy and Cell Biology at Wayne State University [EY04068]; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness to Department of Ophthalmology at Wayne State University; NATIONAL EYE INSTITUTE [P30EY004068, R01EY017130] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anatomy and Cell Biology at Wayne State University; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness to Department of Ophthalmology at Wayne State University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grant EY17130, core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, Dryer Foundation, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grubb MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013761; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066332; Wu CW, 2011, J NEUROSCI, V31, P14654, DOI 10.1523/JNEUROSCI.1861-11.2011; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	26	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142052	10.1371/journal.pone.0142052	http://dx.doi.org/10.1371/journal.pone.0142052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536117	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400124
J	Benzekri, NA; Sambou, J; Diaw, B; Sall, EI; Sall, F; Niang, A; Ba, S; Gueye, NFN; Diallo, MB; Hawes, SE; Seydi, M; Gottlieb, GS				Benzekri, Noelle A.; Sambou, Jacques; Diaw, Binetou; Sall, El Hadji Ibrahima; Sall, Fatima; Niang, Alassane; Ba, Selly; Gueye, Ndeye Fatou Ngom; Diallo, Mouhamadou Baila; Hawes, Stephen E.; Seydi, Moussa; Gottlieb, Geoffrey S.			High Prevalence of Severe Food Insecurity and Malnutrition among HIV-Infected Adults in Senegal, West Africa	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; SOCIAL DETERMINANTS; NUTRITIONAL-STATUS; EARLY MORTALITY; RURAL DISTRICT; ADHERENCE; HIV/AIDS; IMPACT; SURVIVAL; HEALTH	Background Malnutrition and food insecurity are associated with increased mortality and poor clinical outcomes among people living with HIV/AIDS; however, the prevalence of malnutrition and food insecurity among people living with HIV/AIDS in Senegal, West Africa is unknown. The objective of this study was to determine the prevalence and severity of food insecurity and malnutrition among HIV-infected adults in Senegal, and to identify associations between food insecurity, malnutrition, and HIV outcomes. Methods We conducted a cross-sectional study at outpatient clinics in Dakar and Ziguinchor, Senegal. Data were collected using participant interviews, anthropometry, the Household Food Insecurity Access Scale, the Individual Dietary Diversity Scale, and chart review. Results One hundred and nine HIV-1 and/or HIV-2 participants were enrolled. The prevalence of food insecurity was 84.6% in Dakar and 89.5% in Ziguinchor. The prevalence of severe food insecurity was 59.6% in Dakar and 75.4% in Ziguinchor. The prevalence of malnutrition (BMI <18.5) was 19.2% in Dakar and 26.3% in Ziguinchor. Severe food insecurity was associated with missing clinic appointments (p = 0.01) and not taking antiretroviral therapy due to hunger (p = 0.02). Malnutrition was associated with lower CD4 cell counts (p = 0.01). Conclusions Severe food insecurity and malnutrition are highly prevalent among HIV-infected adults in both Dakar and Ziguinchor, and are associated with poor HIV outcomes. Our findings warrant further studies to determine the root causes of malnutrition and food insecurity in Senegal, and the short- and long-term impacts of malnutrition and food insecurity on HIV care. Urgent interventions are needed to address the unacceptably high rates of malnutrition and food insecurity in this population.	[Benzekri, Noelle A.; Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Sambou, Jacques; Sall, El Hadji Ibrahima; Niang, Alassane] Ctr Sante Ziguinchor, Ziguinchor, Senegal; [Diaw, Binetou; Sall, Fatima; Ba, Selly; Gueye, Ndeye Fatou Ngom; Diallo, Mouhamadou Baila; Seydi, Moussa] Ctr Hosp Univ Fann, Dakar, Senegal; [Hawes, Stephen E.; Gottlieb, Geoffrey S.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hawes, Stephen E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Benzekri, NA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	benzekri@uw.edu		Gottlieb, Geoffrey/0000-0002-5749-481X	University of Washington Center for AIDS Research, International Pilot Grant; NIH grant [P30 AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	University of Washington Center for AIDS Research, International Pilot Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the University of Washington Center for AIDS Research, International Pilot Grant. NIH grant P30 AI027757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Birbeck GL, 2011, AM J TROP MED HYG, V85, P782, DOI 10.4269/ajtmh.2011.11-0187; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Coates Jennifer S A, 2007, HOUSEHOLD FOOD INSEC; Conseil National de Lutte contre le Sida, 2014, RAPP SIT RIP NAT EP; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; Ene-Obong HN, 2001, J HEALTH POPUL NUTR, V19, P320; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Evans D, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-111; FAO & WFP, 2014, STAT FOOD INS WORLD; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fielden SJ, 2014, AIDS BEHAV, V18, pS490, DOI 10.1007/s10461-013-0669-8; Gebrehiwot T, 2014, ECOL FOOD NUTR, V53, P214, DOI 10.1080/03670244.2013.811387; Gewa CA, 2013, PUBLIC HEALTH NUTR, V16, P1575, DOI 10.1017/S136898001200451X; Hadgu TH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-943; Hailemariam S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-13; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hong SY, 2014, JAIDS-J ACQ IMM DEF, V67, pE115, DOI 10.1097/QAI.0000000000000308; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; KANKI P, 1992, AM J EPIDEMIOL, V136, P895, DOI 10.1093/aje/136.7.895; Kazybayeva S., 2006, LIVESTOCK PRODUCTION; Kennedy Gina B T, GUID MEAS HOUS IND D; Kiefer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029625; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Koethe JR, 2010, AIDS, V24, P2117, DOI 10.1097/QAD.0b013e32833b784a; Lankowski AJ, 2014, AIDS BEHAV, V18, P1199, DOI 10.1007/s10461-014-0729-8; Letamo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102675; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Msaki MM, 2014, ECOL FOOD NUTR, V53, P193, DOI 10.1080/03670244.2013.811386; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; Oliveira I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001587; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Partners IG, 2012, INTEGRATED FOOD SECU; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Rawat R, 2013, JAIDS-J ACQ IMM DEF, V62, P246, DOI 10.1097/QAI.0b013e3182797363; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tang A.M., 2013, USE CUTOFFS MIDUPPER; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNOCHA, 2013, SAH REG STRAT MID YE; Uthman OA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-226; Van Dyk AC, 2010, AJAR-AFR J AIDS RES, V9, P235, DOI 10.2989/16085906.2010.530177; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; World Food Program, 2014, AN GLOB VULN SEC AL; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	56	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141819	10.1371/journal.pone.0141819	http://dx.doi.org/10.1371/journal.pone.0141819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529509	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600063
J	Lazopulo, S; Lopez, JA; Levy, P; Syed, S				Lazopulo, Stanislav; Lopez, Juan A.; Levy, Paul; Syed, Sheyum			A Stochastic Burst Follows the Periodic Morning Peak in Individual Drosophila Locomotion	PLOS ONE			English	Article							CIRCADIAN CLOCK; FUNCTIONAL-ANALYSIS; NATURAL CONDITIONS; GENE-EXPRESSION; TIME-SERIES; SPACED DATA; MELANOGASTER; LIGHT; NEURONS; CRYPTOCHROME	Coupling between cyclically varying external light and an endogenous biochemical oscillator known as the circadian clock, modulates a rhythmic pattern with two prominent peaks in the locomotion of Drosophila melanogaster. A morning peak appears around the time lights turn on and an evening peak appears just before lights turn off. The close association between the peaks and the external 12:12 hour light/dark photoperiod means that respective morning and evening peaks of individual flies are well-synchronized in time and, consequently, feature prominently in population-averaged data. Here, we report on a brief but strong stochastic burst in fly activity that, in contrast to morning and evening peaks, is detectable only in single fly recordings. This burst was observed across 3 wild-type strains of Drosophila melanogaster. In a single fly recording, the burst is likely to appear once randomly within 0.5-5 hours after lights turn on, last for only 2-3 minutes and yet show 5 times greater activity compared to the maximum of morning peak with data binned in 3 minutes. Owing to its variable timing and short duration, the burst is virtually undetectable in population-averaged data. We use a locally-built illumination system to study the burst and find that its incidence in a population correlates with light intensity, with similar to 85% of control flies showing the behavior at 8000 lux (1942 mu W/cm(2)). Consistent with that finding, several mutant flies with impaired vision show substantially reduced frequency of the burst. Additionally, we find that genetic ablation of the clock has insignificant effect on burst frequency. Together, these data suggest that the pronounced burst is likely generated by a light-activated circuit that is independent of the circadian clock.	[Lazopulo, Stanislav; Lopez, Juan A.; Levy, Paul; Syed, Sheyum] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA	University of Miami	Syed, S (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33124 USA.	s.syed@miami.edu	Lazopulo, Stanislav/AAA-5669-2020		University of Miami	University of Miami	This work was supported by funds from the University of Miami. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Harbison ST, 2009, TRENDS GENET, V25, P262, DOI 10.1016/j.tig.2009.04.003; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Kobayashi Y, 2015, NEURON, V86, P264, DOI 10.1016/j.neuron.2015.02.036; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Menegazzi P, 2013, J BIOL RHYTHM, V28, P3, DOI 10.1177/0748730412471303; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nall AH, 2013, J NEUROSCI, V33, P8534, DOI 10.1523/JNEUROSCI.0253-13.2013; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Pittendrigh CS, 1976, J COMP PHYSIOL A, V331, P291; Prabhakaran PM, 2014, J COMP PHYSIOL A, V200, P849, DOI 10.1007/s00359-014-0927-x; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Rode F, 2007, EUR J PHARMACOL, V564, P103, DOI 10.1016/j.ejphar.2007.02.009; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tataroglu O, 2014, METHODS, V68, P140, DOI 10.1016/j.ymeth.2014.01.001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2011, FLY, V5, P333, DOI 10.4161/fly.5.4.16419; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140481	10.1371/journal.pone.0140481	http://dx.doi.org/10.1371/journal.pone.0140481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528813	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600007
J	Lucertini, F; Ponzio, E; Di Palma, M; Galati, C; Federici, A; Barbadoro, P; D'Errico, MM; Prospero, E; Ambrogini, P; Cuppini, R; Lattanzi, D; Minelli, A				Lucertini, Francesco; Ponzio, Elisa; Di Palma, Michael; Galati, Claudia; Federici, Ario; Barbadoro, Pamela; D'Errico, Marcello M.; Prospero, Emilia; Ambrogini, Patrizia; Cuppini, Riccardo; Lattanzi, Davide; Minelli, Andrea			High Cardiorespiratory Fitness Is Negatively Associated with Daily Cortisol Output in Healthy Aging Men	PLOS ONE			English	Article							ADRENAL HPA AXIS; UNDER-THE-CURVE; SALIVARY CORTISOL; DIURNAL CORTISOL; PSYCHOSOCIAL STRESS; PHYSICAL PERFORMANCE; PSYCHOLOGICAL STRESS; POSTMENOPAUSAL WOMEN; COGNITIVE FUNCTION; GENDER-DIFFERENCES	Physical fitness has salutary psychological and physical effects in older adults by promoting neuroplasticity and adaptation to stress. In aging, however, the effects of fitness on the hypothalamic-pituitary-adrenal (HPA) axis are mixed. We investigated the association between cardiorespiratory fitness and HPA activity in healthy elderly men (n = 22, mean age 68 y; smokers, obese subjects, those taking drugs or reporting recent stressful events were excluded), by measuring in saliva: i) daily pattern of cortisol secretion (6 samples: 30' post-awakening, and at 12.00, 15.00, 18.00, 21.00, 24.00 h); and ii) the cortisol response to a mental challenge. Cardiorespiratory fitness (VO2max) was estimated using the Rockport Walking Test and the participants were assigned to high-fit (HF, >= 60 degrees, n = 10) and low-fit (LF, <= 35 degrees, n = 12) groups according to age-specific percentiles of VO2max distribution in the general population. At all daytimes, basal cortisol levels were lower in the HF than the LF group, most notably in the evening and midnight samples, with a significant main effect of physical fitness for cortisol levels overall; the area-under-the-curve for total daily cortisol output was significantly smaller in the HF group. Among the subjects who responded to mental stress (baseline-to-peak increment > 1.5 nmol/L; n = 13, 5 LF, 8 HF), the amplitude of cortisol response and the steepness of recovery decline displayed an increasing trend in the HF subjects, although between-group differences failed to reach the threshold for significance. In conclusion, cardiorespiratory fitness in healthy aging men is negatively correlated with daily cortisol output and contributes to buffering the HPA dysregulation that occurs with advancing age, thus possibly playing a beneficial role in contrasting age-related cognitive and physical decline.	[Lucertini, Francesco; Federici, Ario] Univ Urbino Carlo Bo, Div Exercise & Hlth Sci, Dept Biomol Sci, Urbino, Italy; [Ponzio, Elisa; Barbadoro, Pamela; D'Errico, Marcello M.; Prospero, Emilia] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Di Palma, Michael; Galati, Claudia; Ambrogini, Patrizia; Cuppini, Riccardo; Lattanzi, Davide; Minelli, Andrea] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci DiSTeVA, Urbino, Italy	University of Urbino; Marche Polytechnic University; University of Urbino	Minelli, A (corresponding author), Univ Urbino Carlo Bo, Div Exercise & Hlth Sci, Dept Biomol Sci, Urbino, Italy.	andrea.minelli@uniurb.it	Di Palma, Michael/AAL-2413-2020; barbadoro, pamela/AAC-5041-2022; Lucertini, Francesco/F-6603-2012	Di Palma, Michael/0000-0002-9190-6128; Lucertini, Francesco/0000-0003-3134-4511; Prospero, Emilia/0000-0002-2387-8639; Ponzio, Elisa/0000-0003-0850-8864; Lattanzi, Davide/0000-0002-1621-2900; Federici, Ario/0000-0003-0878-4949; BARBADORO, Pamela/0000-0003-1495-0165	Universita Politecnica delle Marche; University of Urbino Carlo Bo	Universita Politecnica delle Marche; University of Urbino Carlo Bo	Sources of funding for this work came from the Universita Politecnica delle Marche (to EP and PB) and University of Urbino Carlo Bo (to RC and AM).	Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bakke M, 2004, GERONTOLOGY, V50, P383, DOI 10.1159/000080176; Barbadoro P, 2013, MOL NUTR FOOD RES, V57, P1110, DOI 10.1002/mnfr.201200676; Bellingrath S, 2008, PSYCHONEUROENDOCRINO, V33, P1335, DOI 10.1016/j.psyneuen.2008.07.008; Beluche I, 2010, PSYCHOL MED, V40, P1039, DOI 10.1017/S0033291709991103; Childs E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00161; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; COLLINS A, 1985, PSYCHOSOM MED, V47, P512, DOI 10.1097/00006842-198511000-00002; Comijs HC, 2010, AM J GERIAT PSYCHIAT, V18, P42, DOI 10.1097/JGP.0b013e3181b970ae; Conrad CD, 2010, PROG BRAIN RES, V182, P31, DOI 10.1016/S0079-6123(10)82002-3; Holanda CMD, 2012, ARCH GERONTOL GERIAT, V54, pE146, DOI 10.1016/j.archger.2011.11.006; Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0; Edwards S, 2001, PSYCHONEUROENDOCRINO, V26, P613, DOI 10.1016/S0306-4530(01)00015-4; Erickson Kirk I, 2013, Dialogues Clin Neurosci, V15, P99; Fekedulegn DB, 2007, PSYCHOSOM MED, V69, P651, DOI 10.1097/PSY.0b013e31814c405c; FENSTERMAKER KL, 1992, RES Q EXERCISE SPORT, V63, P322, DOI 10.1080/02701367.1992.10608749; Franz CE, 2011, PSYCHONEUROENDOCRINO, V36, P1040, DOI 10.1016/j.psyneuen.2011.01.002; Gardner MP, 2013, PSYCHONEUROENDOCRINO, V38, P40, DOI 10.1016/j.psyneuen.2012.04.016; Gardner MP, 2011, INT J EPIDEMIOL, V40, P1693, DOI 10.1093/ije/dyr113; GOTTHARDT U, 1995, AM J PHYSIOL-REG I, V268, pR865, DOI 10.1152/ajpregu.1995.268.4.R865; Guptaand D, 2014, COMPR PHYSIOL, V4, P1495, DOI 10.1002/cphy.c130049; Hayes LD, 2015, AGING MALE, V18, P22, DOI 10.3109/13685538.2014.977246; Hayes LD, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-18; Hayes LD, 2013, RES SPORTS MED, V21, P343, DOI 10.1080/15438627.2013.825799; Heaney JLJ, 2014, J AGING PHYS ACTIV, V22, P465, DOI [10.1123/JAPA.2012-0082, 10.1123/japa.2012-0082]; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Huang CJ, 2014, APPL PHYSIOL NUTR ME, V39, P375, DOI 10.1139/apnm-2013-0297; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Karlamangla AS, 2013, PSYCHONEUROENDOCRINO, V38, P2585, DOI 10.1016/j.psyneuen.2013.06.010; Karlamangla AS, 2005, NEUROBIOL AGING, V26, pS80, DOI 10.1016/j.neurobiolaging.2005.09.037; Kirschbaum C, 2001, PSYCHOSOM MED, V63, P161; KLINE GM, 1987, MED SCI SPORT EXER, V19, P253; Koltyn KF, 2001, WOMEN HEALTH ISS, V11, P471, DOI 10.1016/S1049-3867(01)00128-1; Kremen WS, 2010, NEUROIMAGE, V53, P1093, DOI 10.1016/j.neuroimage.2010.02.026; Kudielka B M, 2000, Stress, V3, P229, DOI 10.3109/10253890009001127; Kudielka BM, 1999, NEUROENDOCRINOLOGY, V70, P422, DOI 10.1159/000054504; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Kumari M, 2010, PSYCHONEUROENDOCRINO, V35, P1091, DOI 10.1016/j.psyneuen.2010.01.010; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; LINDHEIM SR, 1992, AM J OBSTET GYNECOL, V167, P1831, DOI 10.1016/0002-9378(92)91783-7; Liu SY, 2014, PSYCHONEUROENDOCRINO, V41, P111, DOI 10.1016/j.psyneuen.2013.12.010; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MacLullich AMJ, 2005, PSYCHONEUROENDOCRINO, V30, P505, DOI 10.1016/j.psyneuen.2004.12.005; Magri F, 2006, AGING CLIN EXP RES, V18, P167, DOI 10.1007/BF03327435; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; Miller R, 2013, PSYCHOSOM MED, V75, P832, DOI 10.1097/PSY.0000000000000002; Murri MB, 2014, PSYCHONEUROENDOCRINO, V41, P46, DOI 10.1016/j.psyneuen.2013.12.004; Nater UM, 2013, PSYCHONEUROENDOCRINO, V38, P3167, DOI 10.1016/j.psyneuen.2013.09.008; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; O'Hara R, 2007, MOL PSYCHIATR, V12, P544, DOI 10.1038/sj.mp.4001978; Peeters GMEE, 2007, CLIN ENDOCRINOL, V67, P398, DOI 10.1111/j.1365-2265.2007.02900.x; Piazza JR, 2013, PSYCHOL AGING, V28, P47, DOI 10.1037/a0029983; Pober DM, 2002, CAN J APPL PHYSIOL, V27, P575, DOI 10.1139/h02-033; Prenderville JA, 2015, TRENDS NEUROSCI, V38, P13, DOI 10.1016/j.tins.2014.11.001; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Renoir T, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00158; Rueggeberg R, 2012, PSYCHONEUROENDOCRINO, V37, P1029, DOI 10.1016/j.psyneuen.2011.11.012; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Seeman TE, 2001, PSYCHONEUROENDOCRINO, V26, P225, DOI 10.1016/S0306-4530(00)00043-3; Singh-Manoux A, 2014, NEUROBIOL AGING, V35, P2239, DOI 10.1016/j.neurobiolaging.2014.03.015; Sjors A, 2010, PSYCHONEUROENDOCRINO, V35, P674, DOI 10.1016/j.psyneuen.2009.10.007; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Stalder T, 2009, PSYCHONEUROENDOCRINO, V34, P607, DOI 10.1016/j.psyneuen.2008.10.023; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; The Cooper Institute, 2009, PHYS FITN ASS NORMS; Thompson W.R., 2010, ACSMS GUIDELINES EXE; Traustadottir T, 2005, PSYCHONEUROENDOCRINO, V30, P392, DOI 10.1016/j.psyneuen.2004.11.002; Traustadottir T, 2003, STRESS, V6, P133, DOI 10.1080/1025389031000111302; Van Cauter E, 1995, ENDOCRINOLOGY; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Varadhan R, 2008, J GERONTOL A-BIOL, V63, P190, DOI 10.1093/gerona/63.2.190; Yen SSC, 1998, EXP GERONTOL, V33, P897, DOI 10.1016/S0531-5565(98)00046-1	77	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141970	10.1371/journal.pone.0141970	http://dx.doi.org/10.1371/journal.pone.0141970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529517	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600083
J	Niemeyer, JC; Moreira-Santos, M; Ribeiro, R; Rutgers, M; Nogueira, MA; da Silva, EM; Sousa, JP				Niemeyer, Julia Carina; Moreira-Santos, Matilde; Ribeiro, Rui; Rutgers, Michiel; Nogueira, Marco Antonio; da Silva, Eduardo Mendes; Sousa, Jose Paulo			Ecological Risk Assessment of a Metal-Contaminated Area in the Tropics. Tier II: Detailed Assessment	PLOS ONE			English	Article							SOIL RESPIRATION; SITE MANAGEMENT; HEAVY-METALS; TOXICITY; POLLUTION; GROWTH; BIOAVAILABILITY; COMMUNITY; TESTS; DECOMPOSITION	This study presents data on the detailed evaluation (tier 2) of a site-specific ecological risk assessment (ssERA) in a former smelter area contaminated with metals (Santo Amaro, Bahia, Brazil). Combining information from three lines of evidence (LoE), chemical (ChemLoE), ecotoxicological (EcotoxLoE) and ecological (EcoLoE), in the Triad approach, integrated risk values were calculated to rank sites and confirm the potential risk disclosed with tier 1. Risk values were calculated for the habitat and for the retention functions in each sampling point. Habitat function included the ChemLoE calculated from total metal concentrations. The EcotoxLoE was based on reproduction tests with terrestrial invertebrates (Folsomia candida, Enchytraeus crypticus, Eisenia andrei), shoot length and plant biomass (Avena sativa, Brassica rapa). For the EcoLoE, ecological parameters (microbial parameters, soil invertebrate community, litter breakdown) were used to derive risk values. Retention function included the ChemLoE, calculated from extractable metal concentrations, and the EcotoxLoE based on eluate tests with aquatic organisms (Daphnia magna reproduction and Pseudokirchneriella subcapitata growth). Results related to the habitat function indicated that the metal residues are sufficient to cause risk to biota, while the low metal levels in extracts and the general lack of toxicity in aquatic tests indicated a high soil retention capacity in most sampling points. Integrated risk of tier 2 showed the same trend of tier 1, suggesting the need to proceed with remediation actions. The high risk levels were related to direct toxicity to organisms and indirect effects, such as failure in the establishment of vegetation and the consequent loss of habitat quality for microorganisms and soil fauna. This study shed some light on the selection of tools for the tier 2 of an ssERA in tropical metal-contaminated sites, focusing on ecological receptors at risk and using available chemical methods, ecological surveys and ecotoxicity tests.	[Niemeyer, Julia Carina; Moreira-Santos, Matilde; Ribeiro, Rui; Sousa, Jose Paulo] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Niemeyer, Julia Carina] Univ Fed Santa Catarina, Curitibanos, SC, Brazil; [Rutgers, Michiel] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Nogueira, Marco Antonio] Embrapa Soybean, Lab Soil Biotechnol, Londrina, Parana, Brazil; [da Silva, Eduardo Mendes] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil	Universidade de Coimbra; Universidade Federal de Santa Catarina (UFSC); Netherlands National Institute for Public Health & the Environment; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal da Bahia	Niemeyer, JC (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	juliacarina@gmail.com	Niemeyer, Julia/E-5838-2013; Moreira-Santos, Matilde/J-2609-2013; Nogueira, Marco A./B-8768-2016; Sousa, Jose Paulo FA/H-5407-2011; Ribeiro, Rui/C-7788-2012; Niemeyer, Julia/AAG-3466-2020	Niemeyer, Julia/0000-0001-6606-0338; Moreira-Santos, Matilde/0000-0001-7067-5028; Nogueira, Marco A./0000-0001-7747-9839; Sousa, Jose Paulo FA/0000-0001-8045-4296; Ribeiro, Rui/0000-0002-0883-1939; Niemeyer, Julia/0000-0001-6606-0338	Program Alban (Brazil) [E05D058118BR]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [SFRH/BD/28796/2006]; Ciencia FSE fund (FCT, Portugal); POPH fund (FCT, Portugal); QREN fund (FCT, Portugal); Brazilian Research Council (CNPq); Department of Life Sciences	Program Alban (Brazil); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Ciencia FSE fund (FCT, Portugal); POPH fund (FCT, Portugal); QREN fund (FCT, Portugal); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Life Sciences	The study was partially supported through two PhD grants to JCN, from Program Alban (Brazil; E05D058118BR) and Fundacao para a Ciencia e a Tecnologia (FCT, Portugal; SFRH/BD/28796/2006) and through Ciencia 2007-FSE and POPH and QREN funds (FCT, Portugal). EMS and MAN acknowledge receiving a grant from the Brazilian Research Council (CNPq). The work was supported by Department of Life Sciences own funds and facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi Rudolf K., 2002, Journal of Soils and Sediments, V2, P174, DOI 10.1007/BF02991037; Alvarenga P, 2008, ENVIRON GEOCHEM HLTH, V30, P95, DOI 10.1007/s10653-008-9147-z; An YJ, 2006, CHEMOSPHERE, V62, P1359, DOI 10.1016/j.chemosphere.2005.07.044; Anjos J.S.A., 2003, THESIS U SAO PAULO B; Anjos JSA., 1998, THESIS U SAO PAULO S; [Anonymous], 1998, 11274 ISO; [Anonymous], 2003, 15799 ISO; [Anonymous], 1994, 11260 ISO; ASTM International, 2018, STANDARD TEST METHOD; BAIRD DJ, 1989, HYDROBIOLOGIA, V188, P403, DOI 10.1007/BF00027806; Ben Ghnaya A, 2009, CR BIOL, V332, P363, DOI 10.1016/j.crvi.2008.12.001; Boivin MEY, 2006, APPL SOIL ECOL, V34, P103, DOI 10.1016/j.apsoil.2006.03.009; Broos K, 2005, ENVIRON TOXICOL CHEM, V24, P634, DOI 10.1897/04-036R.1; Buch AC, 2013, APPL SOIL ECOL, V69, P32, DOI 10.1016/j.apsoil.2012.12.011; Carvalho Fernando Martins, 2003, Rev Panam Salud Publica, V13, P19, DOI 10.1590/S1020-49892003000100003; Chelinho S, 2011, ENVIRON TOXICOL CHEM, V30, P1050, DOI 10.1002/etc.480; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Cortez J, 1998, SOIL BIOL BIOCHEM, V30, P783, DOI 10.1016/S0038-0717(97)00163-6; Costa A.C.A., 2001, THESIS FEDERAL U BAH; Creamer RE, 2008, SOIL USE MANAGE, V24, P37, DOI 10.1111/j.1475-2743.2007.00131.x; Critto A, 2007, SCI TOTAL ENVIRON, V379, P16, DOI 10.1016/j.scitotenv.2007.02.035; Lima LRPD, 2011, J HAZARD MATER, V189, P692, DOI 10.1016/j.jhazmat.2011.02.091; De Zwart D, 2005, ENVIRON TOXICOL CHEM, V24, P2665, DOI 10.1897/04-639R.1; Dinter A, 2008, J SOIL SEDIMENT, V8, P333, DOI 10.1007/s11368-008-0028-y; Environment Canada, 1992, 1RM25 EC EPS; Everhart JL, 2006, SCI TOTAL ENVIRON, V367, P732, DOI 10.1016/j.scitotenv.2005.12.029; Forster B, 2006, EUR J SOIL BIOL, V42, pS171, DOI 10.1016/j.ejsobi.2006.07.011; Fountain MT, 2001, ECOTOX ENVIRON SAFE, V48, P275, DOI 10.1006/eesa.2000.2007; Gong P, 2001, CHEMOSPHERE, V44, P491, DOI 10.1016/S0045-6535(00)00280-0; Gonzalez V, 2011, J SOIL SEDIMENT, V11, P1199, DOI 10.1007/s11368-011-0391-y; Grzes IM, 2010, B ENVIRON CONTAM TOX, V84, P61, DOI 10.1007/s00128-009-9893-3; Grzes IM, 2009, PEDOBIOLOGIA, V53, P65, DOI 10.1016/j.pedobi.2009.03.002; Gulser F, 2008, ENVIRON MONIT ASSESS, V145, P127, DOI 10.1007/s10661-007-0022-7; Heimbach F, 1997, SOIL BIOL BIOCHEM, V29, P671, DOI 10.1016/S0038-0717(96)00194-0; International Organization for Standardization I., 1998, 112682 ISO; *ISO, 2005, 112692 ISO; ISO, 1999, 11267 ISO; [ISO] International Organization for Standardization, 2005, 10390 ISO; ISO-International Organization for Standardization, 2003, 16387 ISO; Jaensch S., 2005, Environmental Reviews, V13, P51; Jensen J, 2006, 711701047 RIVM; Jiang JP, 2010, EUR J SOIL BIOL, V46, P18, DOI 10.1016/j.ejsobi.2009.10.001; Kapustka LA, 1999, HUM ECOL RISK ASSESS, V5, P691, DOI 10.1080/10807039.1999.9657733; Kaulbach ES, 2005, ENVIRON SCI TECHNOL, V39, P4060, DOI 10.1021/es0481833; LNEC, 1970, 239 LNECE; LONG ER, 1985, MAR POLLUT BULL, V16, P405, DOI 10.1016/0025-326X(85)90290-5; Loureiro S, 2006, ARCH ENVIRON CON TOX, V50, P182, DOI 10.1007/s00244-004-0261-3; Machado S.L., 2002, RELATORIO FINAL PROJ; Machado S.L., 2004, ENG SANIT AMBIENT, V9, P140; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; MONTAGNINI F, 1989, FOREST ECOL MANAG, V26, P77, DOI 10.1016/0378-1127(89)90037-6; Natal da Luz T., 2011, ECOTOX ENVIRON SAFE, V74, P1715, DOI DOI 10.1016/J.ECOENV.2011.05.017; Natal-da-Luz T, 2012, ECOTOXICOLOGY, V21, P2163, DOI 10.1007/s10646-012-0970-8; Niemeyer JC, 2012, ECOTOX ENVIRON SAFE, V86, P188, DOI 10.1016/j.ecoenv.2012.09.013; Niemeyer JC, 2010, J SOIL SEDIMENT, V10, P1557, DOI 10.1007/s11368-010-0255-x; Niemeyer JC, 2012, APPL SOIL ECOL, V59, P96, DOI 10.1016/j.apsoil.2012.03.019; Nogueira MA, 2006, AGR ECOSYST ENVIRON, V115, P237, DOI 10.1016/j.agee.2006.01.008; OECD, 2006, BREAKD ORG MATT LITT; OECD, 1998, DAPHN MAGN REPR TEST; OECD, 1984, ALG GROWTH INH TEST; OECD (Organisation for Economic Co-operation and Development), 1984, EARTHW AC TOX TESTS; Oncel I, 2000, ENVIRON POLLUT, V107, P315, DOI 10.1016/S0269-7491(99)00177-3; Pandard P, 2006, SCI TOTAL ENVIRON, V363, P114, DOI 10.1016/j.scitotenv.2005.12.016; Podgaiski LR, 2010, EUR J SOIL BIOL, V46, P394, DOI 10.1016/j.ejsobi.2010.09.001; Posthuma L, 2008, SCI TOTAL ENVIRON, V406, P503, DOI 10.1016/j.scitotenv.2008.06.065; Rombke J, 2006, ENVIRON TOXICOL CHEM, V25, P776, DOI 10.1897/04-584R.1; Rombke Jorg, 2003, EFFECTS PLANT PROTEC; Rosa R, 2010, ENVIRON MONIT ASSESS, V161, P439, DOI 10.1007/s10661-009-0759-2; ROY D, 1993, J ENVIRON SCI HEAL A, VA28, P37, DOI 10.1080/10934529309375861; Rutgers M., 2008, 711701072 RIVM; Rutgers M, 2011, DEALING WITH CONTAMINATED SITES: FROM THEORY TOWARDS PRACTICAL APPLICATION, P693, DOI 10.1007/978-90-481-9757-6_15; Schultz E, 2004, SCI TOTAL ENVIRON, V326, P71, DOI 10.1016/j.scitotenv.2003.12.008; Semenzin E, 2008, SCI TOTAL ENVIRON, V389, P71, DOI 10.1016/j.scitotenv.2007.08.032; Stein J., 1973, HDB PHYCOLOGICAL MET; Suter II G. W., 2000, ECOLOGICAL RISK ASSE; Swartjes FA, 2012, SCI TOTAL ENVIRON, V427, P1, DOI 10.1016/j.scitotenv.2012.02.078; USEPA, 2004, EPA630P04068B; Van den Brink PJ, 2008, ENVIRON SCI TECHNOL, V42, P8999, DOI 10.1021/es801991c; van Gestel CAM, 2001, ENVIRON TOXICOL CHEM, V20, P1438, DOI [10.1897/1551-5028(2001)020&lt;1438:TUOAAC&gt;2.0.CO;2, 10.1002/etc.5620200705]; van Gestel CAM, 2009, ENVIRON POLLUT, V157, P895, DOI 10.1016/j.envpol.2008.11.002; Vasseur P, 2008, ENVIRON TOXICOL, V23, P652, DOI 10.1002/tox.20401; Vijver M, 2001, ENVIRON TOXICOL CHEM, V20, P712, DOI [10.1002/etc.5620200404, 10.1897/1551-5028(2001)020&lt;0712:IOMPAS&gt;2.0.CO;2]; VROM, 2000, CIRC TARG VAL INT VA; Wagelmans M, 2009, EVALUATION IMPLEMENT; Weeks J.M., 2004, P5069TR1 ENV AG ENGL; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zimakowska-Gnoinska D, 2000, ENVIRON MONIT ASSESS, V61, P301, DOI 10.1023/A:1006105329210	87	25	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141772	10.1371/journal.pone.0141772	http://dx.doi.org/10.1371/journal.pone.0141772			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528915	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600058
J	de la Pena, AH; Suarez, A; Duong-ly, KC; Schoeffield, AJ; Pizarro-Dupuy, MA; Zarr, M; Pineiro, SA; Amzel, LM; Gabelli, SB				de la Pena, Andres H.; Suarez, Allison; Duong-ly, Krisna C.; Schoeffield, Andrew J.; Pizarro-Dupuy, Mario A.; Zarr, Melissa; Pineiro, Silvia A.; Amzel, L. Mario; Gabelli, Sandra B.			Structural and Enzymatic Characterization of a Nucleoside Diphosphate Sugar Hydrolase from Bdellovibrio bacteriovorus	PLOS ONE			English	Article							ADP-RIBOSE PYROPHOSPHATASE; NUDIX HYDROLASE; DEINOCOCCUS-RADIODURANS; CRYSTAL-STRUCTURES; MECHANISM; PROTEIN; IDENTIFICATION; ARABIDOPSIS; REGULATOR; REVEALS	Given the broad range of substrates hydrolyzed by Nudix (nucleoside diphosphate linked to X) enzymes, identification of sequence and structural elements that correctly predict a Nudix substrate or characterize a family is key to correctly annotate the myriad of Nudix enzymes. Here, we present the structure determination and characterization of Bd3179 - a Nudix hydrolase from Bdellovibrio bacteriovorus-that we show localized in the periplasmic space of this obligate Gram-negative predator. We demonstrate that the enzyme is a nucleoside diphosphate sugar hydrolase (NDPSase) and has a high degree of sequence and structural similarity to a canonical ADP-ribose hydrolase and to a nucleoside diphosphate sugar hydrolase (1.4 and 1.3 angstrom C alpha RMSD respectively). Examination of the structural elements conserved in both types of enzymes confirms that an aspartate-X-lysine motif on the C-terminal helix of the alpha-beta-alpha NDPSase fold differentiates NDPSases from ADPRases.	[de la Pena, Andres H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [de la Pena, Andres H.; Suarez, Allison; Duong-ly, Krisna C.; Pizarro-Dupuy, Mario A.; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Struct Enzymol & Thermodynam Grp, Baltimore, MD 21205 USA; [Schoeffield, Andrew J.] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA; [Zarr, Melissa] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Pineiro, Silvia A.] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Loyola University Maryland; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University	Amzel, LM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Struct Enzymol & Thermodynam Grp, Baltimore, MD 21205 USA.	mamzel@jhmi.edu; gabelli@jhmi.edu	Gabelli, Sandra B/A-3705-2008	Gabelli, Sandra B/0000-0003-1205-5204; Duong-Ly, Krisna/0000-0002-4593-8145; Amzel, L. Mario/0000-0002-0129-9572; de la Pena, Andres H./0000-0002-2368-6944	Stewart Trust Fellowship; NIGMS grant [GM066895]; National Science Foundation [DGE-0707427, P50 CA062924]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895] Funding Source: NIH RePORTER	Stewart Trust Fellowship; NIGMS grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.B.G. is funded by a Stewart Trust Fellowship. This work was partially supported by NIGMS grant GM066895 to L.M.A; National Science Foundation Graduate Research Fellowships to A.H.P under grant No. DGE-0707427 and P50 CA062924 to S.B.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1960, J BIOL CHEM, V235, P769; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; Boto AN, 2011, PROTEINS, V79, P2455, DOI 10.1002/prot.23069; BULLIONS LC, 1994, J BIOL CHEM, V269, P12339; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Fisher DI, 2006, ARCH MICROBIOL, V186, P415, DOI 10.1007/s00203-006-0155-z; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hong MK, 2014, ACTA CRYSTALLOGR D, V70, P1297, DOI 10.1107/S1399004714002570; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; Karunker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061850; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Lambert C, 2010, CURR MICROBIOL, V60, P419, DOI 10.1007/s00284-009-9559-8; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSSON A, 1988, SCAND J IMMUNOL, V27, P305, DOI 10.1111/j.1365-3083.1988.tb02351.x; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; MATHEW N, 1995, BIOCHEM J, V311, P717, DOI 10.1042/bj3110717; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Okuda K, 2004, BBA-PROTEINS PROTEOM, V1699, P245, DOI 10.1016/j.bbapap.2004.03.004; Ooga T, 2005, BIOCHEMISTRY-US, V44, P9320, DOI 10.1021/bi050078y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Szurmak B, 2008, ACTA BIOCHIM POL, V55, P151, DOI 10.18388/abp.2008_3173; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P6, DOI 10.1107/S0108767387099987; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolff KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004839; Xu WL, 2004, J BIOL CHEM, V279, P24861, DOI 10.1074/jbc.M403272200; Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200	59	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141716	10.1371/journal.pone.0141716	http://dx.doi.org/10.1371/journal.pone.0141716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524597	Green Submitted, Green Published, gold			2022-12-27	WOS:000364029800019
J	Dalu, T; Wasserman, RJ; Jordaan, M; Froneman, WP; Weyl, OLF				Dalu, Tatenda; Wasserman, Ryan J.; Jordaan, Martine; Froneman, William P.; Weyl, Olaf L. F.			An Assessment of the Effect of Rotenone on Selected Non-Target Aquatic Fauna	PLOS ONE			English	Article							CAPE FLORISTIC REGION; RAINBOW-TROUT; RESTING EGGS; ERADICATION; TOXICITY; RIVER; FIELD; INVERTEBRATES; ZOOPLANKTON; DIVERSITY	Rotenone, a naturally occurring ketone, is widely employed for the management of invasive fish species. The use of rotenone poses serious challenges to conservation practitioners due to its impacts on non-target organisms including amphibians and macroinvertebrates. Using laboratory studies, we investigated the effects of different rotenone concentrations (0, 12.5, 25, 37.5, 50, 100 mu g L-1) on selected invertebrate groups; Aeshnidae, Belostomatids, Decapods, Ephemeroptera, Pulmonata and zooplankton over a period of 18 hours. Based on field observations and body size, we hypothesized that Ephemeropterans and zooplankton would be more susceptible to rotenone than Decapods, Belostomatids and snails. Experimental results supported this hypothesis and mortality and behaviour effects varied considerably between taxa, ranging from no effect (crab Potamonuates sidneyi) to 100% mortality (Daphnia pulex and Paradiaptomus lamellatus). Planktonic invertebrates were particularly sensitive to rotenone even at very low concentrations. Future research should investigate the recovery time of invertebrate communities after the application of rotenone and conduct field assessments assessing the longer term effects of rotenone exposure on the population dynamics of those less sensitive organisms.	[Dalu, Tatenda; Froneman, William P.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Wasserman, Ryan J.; Jordaan, Martine; Weyl, Olaf L. F.] South African Inst Aquat Biodivers, Grahamstown, Eastern Cape, South Africa; [Wasserman, Ryan J.; Weyl, Olaf L. F.] South African Inst Aquat Biodivers, Ctr Invas Biol, Grahamstown, Eastern Cape, South Africa; [Jordaan, Martine] CapeNature, Sci Serv Dept, Stellenbosch, Western Cape, South Africa	Rhodes University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Dalu, T (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	dalutatenda@yahoo.co.uk	Froneman, William/GLS-0460-2022; Dalu, Tatenda/K-3089-2012; Froneman, William/C-9085-2012	Froneman, William/0000-0003-0615-1355; Dalu, Tatenda/0000-0002-9019-7702; Weyl, Olaf/0000-0002-8935-3296; Wasserman, Ryan/0000-0002-4162-1503	Water Research Commission [K5/2261]; National Research Foundation of South Africa (NRF) [UID: 77444, 88746]; Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB)	Water Research Commission; National Research Foundation of South Africa (NRF)(National Research Foundation - South Africa); Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB)	This work was supported by the Water Research Commission (K5/2261) (www.wrc.org.za); the National Research Foundation of South Africa (NRF, UID: 77444 [OLFW], 88746 [RJW]) (www.nrf.ac.za); and the Department of Science and Technology-NRF Centre of Excellence in Invasion Biology (CIB) (www.academic.sun.ac.za/cib/). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almquist E., 1959, Report Institute of Freshwater Research Drottningholm, VNo. 40, P146; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON RS, 1970, J FISH RES BOARD CAN, V27, P1335, DOI 10.1139/f70-159; Arnekleiv J.V., 2001, P77; BEAL DL, 1993, B ENVIRON CONTAM TOX, V51, P551; Bellingan TA, 2015, AFR J AQUAT SCI, V40, P89, DOI 10.2989/16085914.2014.984651; Billman HG, 2012, N AM J FISH MANAGE, V32, P781, DOI 10.1080/02755947.2012.692349; Blakely TJ, 2005, RES DEV SERIES NZ DE, V220; Booth AJ, 2015, AFR J AQUAT SCI, V40, P95, DOI 10.2989/16085914.2014.986432; Britton JR, 2008, AQUAT CONSERV, V18, P867, DOI 10.1002/aqc.919; CHANDLER JH, 1982, PROG FISH CULT, V44, P78, DOI 10.1577/1548-8659(1982)44[78:TORTSA]2.0.CO;2; Cohen AN, 2002, DISPERSAL ECOLOGY, P374; Cooman K, 2005, ARCH ENVIRON CON TOX, V48, P191, DOI 10.1007/s00244-004-0218-6; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duggan IC, 2015, NZ J MAR FRESH; Eilers J, 2010, DIAMOND LAKE RECOVER, P23; Ellender BR, 2015, BIOL INVASIONS, V17, P57, DOI 10.1007/s10530-014-0744-8; Finlayson B., 2010, PLANNING STANDARD OP; Finlayson BJ, 2001, CHEM RESIDUES SURFAC; Finlayson B, 2010, N AM J FISH MANAGE, V30, P102, DOI 10.1577/M09-078.1; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hamilton BT, 2009, N AM J FISH MANAGE, V29, P1620, DOI 10.1577/M08-178.1; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jordaan MS, 2013, AFR J AQUAT SCI, V38, P91, DOI 10.2989/16085914.2013.784699; Kiser RW., 1963, T AM FISH SOC, V92, P17, DOI [10.1577/1548-8659(1963)92[17:TEOROZ, DOI 10.1577/1548-8659(1963)92[17:TEOROZ]; Kjaerstad G, 2011, INT REV HYDROBIOL, V96, P58, DOI 10.1002/iroh.201111261; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Ling N, 2003, ROTENONE REV ITS TOX; Lintermans M, 2000, MAR FRESHWATER RES, V51, P799, DOI 10.1071/MF00019; Lintermans M, 2001, P WORKSH HOST DEP CO, P10; Mangum FA, 1999, J FRESHWATER ECOL, V14, P125, DOI 10.1080/02705060.1999.9663661; MARCUS NH, 1994, LIMNOL OCEANOGR, V39, P154, DOI 10.4319/lo.1994.39.1.0154; Marr SM, 2012, AFR J AQUAT SCI, V37, P131, DOI 10.2989/16085914.2012.666654; Melaas CL, 2001, HYDROBIOLOGIA, V459, P177, DOI 10.1023/A:1012514124430; MORRISON BRS, 1977, FISHERIES MANAGEMENT, V8, P128; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; NAESS T, 1991, MAR BIOL, V111, P455, DOI 10.1007/BF01319418; OBERG KE, 1967, EXP CELL RES, V45, P590, DOI 10.1016/0014-4827(67)90162-0; Organisation for Economic Co-operation and Development [OECD], 2005, OECD ENV HLTH SAF PU; Pham L, 2012, THESIS U OTAGO DUNED; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rach JJ, 1988, ACUTE CHRONIC TOXICI; Recsetar MS, 2015, N AM J FISH MANAGE, V35, P616, DOI 10.1080/02755947.2015.1017127; Shuhaimi-Othman M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/136104; Skorupski JA., 2011, THESIS U N TEXAS; Slabbert E, 2014, AFR J AQUAT SCI, V39, P467, DOI 10.2989/16085914.2014.981144; Vander Zanden MJ, 2008, CAN J FISH AQUAT SCI, V65, P1512, DOI 10.1139/F08-099; Vinson MR, 2010, FISHERIES, V35, P61, DOI 10.1577/1548-8446-35.2.61; Ward DJ, 2011, ARCH ENVIRON CON TOX, V61, P414, DOI 10.1007/s00244-011-9646-2; Weyl OLF, 2014, FISHERIES, V39, P270, DOI 10.1080/03632415.2014.914924; Winterbourn MJ, 1981, WATER SOIL PUBLICATI, V22, P5; Woodford DJ, 2013, J INSECT CONSERV, V17, P959, DOI 10.1007/s10841-013-9578-4; Wujtewicz D, 1997, J WORLD AQUACULT SOC, V28, P249, DOI 10.1111/j.1749-7345.1997.tb00640.x	57	23	25	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142140	10.1371/journal.pone.0142140	http://dx.doi.org/10.1371/journal.pone.0142140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540301	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800057
J	Jafar, TH; Jehan, I; Liang, F; Barbier, S; Islam, M; Bux, R; Khan, AH; Nadkarni, N; Poulter, N; Chaturvedi, N; Ebrahim, S				Jafar, Tazeen H.; Jehan, Imtiaz; Liang, Feng; Barbier, Sylvaine; Islam, Muhammad; Bux, Rasool; Khan, Aamir Hameed; Nadkarni, Nivedita; Poulter, Neil; Chaturvedi, Nish; Ebrahim, Shah			Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups	PLOS ONE			English	Article							DISEASE; HYPERTENSION; MORTALITY; PAKISTAN; SOCIETY; SODIUM	Background Evidence on long term effectiveness of public health strategies for lowering blood pressure (BP) is scarce. In the Control of Blood Pressure and Risk Attenuation (COBRA) Trial, a 2 x 2 factorial, cluster randomized controlled trial, the combined home health education (HHE) and trained general practitioner (GP) intervention delivered over 2 years was more effective than no intervention (usual care) in lowering systolic BP among adults with hypertension in urban Pakistan. However, it was not clear whether the effect would be sustained after the cessation of intervention. We conducted 7 years follow-up inclusive of 5 years of post intervention period of COBRA trial participants to assess the effectiveness of the interventions on BP during extended follow-up. Methods A total of 1341 individuals 40 years or older with hypertension (systolic BP 140 mm Hg or greater, diastolic BP 90 mm Hg or greater, or already receiving treatment) were followed by trained research staff masked to randomization status. BP was measured thrice with a calibrated automated device (Omron HEM-737 IntelliSense) in the sitting position after 5 minutes of rest. BP measurements were repeated after two weeks. Generalized estimating equations (GEE) were used to analyze the primary outcome of change in systolic BP from baseline to 7-year follow-up. The multivariable model was adjusted for clustering, age at baseline, sex, baseline systolic and diastolic BP, and presence of diabetes. Findings After 7 years of follow-up, systolic BP levels among those randomised to combined HHE plus trained GP intervention were significantly lower (2.1 [4.1-0.1] mm Hg) compared to those randomised to usual care, (P = 0.04). Participants receiving the combined intervention compared to usual care had a greater reduction in LDL-cholesterol (2.7 [4.8 to 0.6] mg/dl. Conclusions The benefit in systolic BP reduction observed in the original cohort assigned to the combined intervention was attenuated but still evident at 7-year follow-up. These findings highlight the potential for scaling-up simple strategies for cardiovascular risk reduction in low- and middle-income countries.	[Jafar, Tazeen H.; Liang, Feng] Duke NUS Grad Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Jafar, Tazeen H.; Jehan, Imtiaz; Islam, Muhammad; Bux, Rasool] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Jafar, Tazeen H.] Aga Khan Univ, Nephrol Sect, Dept Med, Karachi, Pakistan; [Barbier, Sylvaine; Nadkarni, Nivedita] Duke NUS Grad Med Sch, Ctr Quantitat Med, Off Clin Sci, Singapore, Singapore; [Khan, Aamir Hameed] Aga Khan Univ, Dept Med, Cardiol Sect, Karachi, Pakistan; [Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Chaturvedi, Nish] UCL, Inst Cardiovasc Sci, London, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	National University of Singapore; Aga Khan University; Aga Khan University; National University of Singapore; Aga Khan University; Imperial College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore.	tazeen.jafar@duke-nus.edu.sg			Wellcome Trust, UK [093382/Z/10/Z]	Wellcome Trust, UK(Wellcome Trust)	This work was supported by the Wellcome Trust, UK 093382/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcazar H, 2009, PREV CHRONIC DIS, V6; Basu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044037; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cushman WC, 2012, J CLIN HYPERTENS, V14, P20, DOI 10.1111/j.1751-7176.2011.00568.x; Ellard D, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-116; Enders C. K., 2010, APPL MISSING DATA AN; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Jafar TH, 2013, LANCET, V381, P2281, DOI 10.1016/S0140-6736(13)60646-7; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Jessani S, 2008, AM J HYPERTENS, V21, P1238, DOI 10.1038/ajh.2008.256; Kjelsberg MO, 1996, CIRCULATION, V94, P946; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Whelton PK, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0465-5; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; WOODHOUSE PR, 1993, J HYPERTENS, V11, P1267; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	27	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0140550	10.1371/journal.pone.0140550	http://dx.doi.org/10.1371/journal.pone.0140550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540210	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000364303800004
J	Beydoun, MA; Fanelli-Kuczmarski, MT; Allen, A; Beydoun, HA; Popkin, BM; Evans, MK; Zonderman, AB				Beydoun, May A.; Fanelli-Kuczmarski, Marie T.; Allen, Allyssa; Beydoun, Hind A.; Popkin, Barry M.; Evans, Michele K.; Zonderman, Alan B.			Monetary Value of Diet Is Associated with Dietary Quality and Nutrient Adequacy among Urban Adults, Differentially by Sex, Race and Poverty Status	PLOS ONE			English	Article							ENERGY-DENSE DIETS; SOCIOECONOMIC-STATUS; UNITED-STATES; FRENCH ADULTS; NUTRITIONAL QUALITY; FOOD EXPENDITURE; COST CONSTRAINT; HEALTHY DIET; US ADULTS; WOMEN	Objective The association between monetary value of the diet (MVD, $/day) with dietary quality was examined using a large sample of urban US adults, differentially by socio-demographic factors. Methods This was a cross-sectional study of 2,111 participants, aged 30-64y, using data from the Healthy Aging in Neighborhoods of Diversity across the Life Span Study. Dietary quality indices included Healthy Eating Index-2010 (HEI-2010) and Mean Adequacy Ratio (MAR), (two 24-hr recalls). A national food price database was used to estimate MVD. Multiple linear/logistic regression analyses were conducted stratifying separately by sex, race and poverty status. Results Women had significantly higher HEI-2010 scores than men (43.35 vs 41.57 out of 100, respectively), whereas MAR scores were higher for men (76.8 vs 69.9, out of 100), reflecting energy intake gender differentials. Importantly, a $3/day higher MVD (IQR: $3.70/d (Q1) to $6.62/d (Q4)) was associated with a 4.98 +/- 0.35 higher total HEI-2010 and a 3.88 +/- 0.37 higher MAR score, after energy-adjustment and control for key confounders. For HEI-2010 and MAR, stronger associations were observed among participants above poverty and among women, whilethe MVD vs. HEI-2010 association was additionally stronger among Whites. Sex and poverty status differentials were observed for many MAR and some HEI2010 components. Conclusions Despite positive associations between measures of dietary quality and MVD, particularly above poverty and among women, approaching compliance with the Dietary Guidelines (80 or more for HEI-2010) requires a substantially higher MVD. Thus, nutrition education may further improve people's decision-making regarding food venues and dietary choices.	[Beydoun, May A.; Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fanelli-Kuczmarski, Marie T.] Univ Delaware, Dept Behav Hlth & Nutr, Newark, DE USA; [Allen, Allyssa] Univ Maryland Baltimore Cty, Baltimore, MD 21228 USA; [Beydoun, Hind A.] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [Popkin, Barry M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Popkin, Barry M.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Delaware; University System of Maryland; University of Maryland Baltimore County; Eastern Virginia Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Beydoun, MA (corresponding author), NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Evans, Michele Kim/AAE-4776-2019; Popkin, Barry/T-6633-2019	Evans, Michele/0000-0002-8546-2831; Zonderman, Alan B/0000-0002-6523-4778	National Institute on Aging, NIA/NIH/IRP; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER	National Institute on Aging, NIA/NIH/IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was fully supported by the Intramural Research Program of the National Institute on Aging, NIA/NIH/IRP.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Aggarwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037533; Agriculture. USDo, 2011, FOOD SPEND ADJ REC T; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; Appelhans BM, 2012, AM J PREV MED, V42, P398, DOI 10.1016/j.amepre.2011.12.007; Banks Jonathan, 2012, Br J Gen Pract, V62, pe1, DOI 10.3399/bjgp12X616300; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1197, DOI 10.3945/ajcn.2010.29854; Beydoun MA, 2008, SOC SCI MED, V66, P2218, DOI 10.1016/j.socscimed.2008.01.018; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Beydoun MA, 2011, J NUTR, V141, P304, DOI 10.3945/jn.110.132613; Beydoun MA, 2009, PUBLIC HEALTH NUTR, V12, P369, DOI 10.1017/S1368980008002140; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; [Cancer Control and Population Sciences National Cancer Institute AR], 2014, HEI TOOLS RES; Caplovitz David., 1967, THE POOR PAY MORE; Carlson A, 2014, PHYSIOL BEHAV, V134, P20, DOI 10.1016/j.physbeh.2014.03.001; Carlson A, 2014, J AGR RESOUR ECON, V39, P47; Carroll RJ, 1998, ADV EXP MED BIOL, V445, P139; Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x; Cleary J, 2012, NUTRIENTS, V4, P1759, DOI 10.3390/nu4111759; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2004, PUBLIC HEALTH NUTR, V7, P21, DOI 10.1079/PHN2003512; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Denny S, 2012, J ACAD NUTR DIET, V112, P1504, DOI 10.1016/j.jand.2012.07.018; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2015, J HUM HYPERTENS, V29, P14, DOI 10.1038/jhh.2014.38; Drewnowski A, 2009, EUR J CLIN NUTR, V63, P674, DOI 10.1038/ejcn.2008.16; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1028, DOI 10.1016/j.jada.2007.03.013; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Evans MK, 2010, ETHNIC DIS, V20, P267; [Food Surveys Research Group US Department of Agriculture ARS], USDA FOOD NUTR DAT B; [Food Surveys Research Group US Department of Agriculture ARS], 2013, USDA FOOD PLANS COST; [Food Surveys Research Group US Department of Agriculture ARS], 2014, Q FOOD AW FROM HOM P; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; *I MED FANB, 2000, DIET REF INT VIT C V; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Katz DL, 2011, PUBLIC HEALTH NUTR, V14, P1693, DOI 10.1017/S1368980011000048; Lipsky LM, 2009, AM J CLIN NUTR, V90, P1397, DOI 10.3945/ajcn.2008.27384; Lopez CN, 2009, J EPIDEMIOL COMMUN H, V63, P920, DOI 10.1136/jech.2008.081208; Maillot M, 2007, AM J CLIN NUTR, V86, P690; McDermott AJ, 2010, FAM MED, V42, P280; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; Monsivais P, 2013, EUR J CLIN NUTR, V67, P1220, DOI 10.1038/ejcn.2013.176; Monsivais P, 2013, JAMA INTERN MED, V173, P1922, DOI 10.1001/jamainternmed.2013.9479; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Morris MA, 2014, J EPIDEMIOL COMMUN H, V68, P1043, DOI 10.1136/jech-2014-204039; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Murakami K, 2009, PUBLIC HEALTH NUTR, V12, P1290, DOI 10.1017/S1368980008003923; Murphy SP, 2006, J AM DIET ASSOC, V106, P425, DOI 10.1016/j.jada.2005.12.003; National Institute on Aging NNI Laboratory of Epidemiology and Population Sciences, 2014, HLTH EAT IND 2010 CA; Powell LM, 2009, HEALTH PLACE, V15, P1064, DOI 10.1016/j.healthplace.2009.05.002; Raffensperger S, 2010, J NATL MED ASSOC, V102, P923, DOI 10.1016/S0027-9684(15)30711-2; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Rauber F, 2009, J PEDIAT-BRAZIL, V85, P536, DOI [10.2223/JPED.1955, 10.1590/S0021-75572009000600011]; Rehm CD, 2015, PREV MED, V73, P70, DOI 10.1016/j.ypmed.2015.01.019; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Smith LPNS, EMERGING RO IN PRESS; STATA, 2013, STAT DAT AN REL 13 0; The Center for Nutrition Policy and Promotion (CNPP), 2008, FOOD PRIC DAT; Townsend MS, 2009, AM J CLIN NUTR, V89, P1220, DOI 10.3945/ajcn.2008.26916; Wang J, 2010, PUBLIC HEALTH NUTR, V13, P1049, DOI 10.1017/S1368980009991595; Waterlander WE, 2010, PUBLIC HEALTH NUTR, V13, P1599, DOI 10.1017/S1368980009992989; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME	73	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140905	10.1371/journal.pone.0140905	http://dx.doi.org/10.1371/journal.pone.0140905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536243	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400044
J	Han, B; Wang, CB; Tang, ZH; Ren, YK; Li, YL; Zhang, DY; Dong, YH; Zhao, XH				Han, Bin; Wang, Changbiao; Tang, Zhaohui; Ren, Yongkang; Li, Yali; Zhang, Dayong; Dong, Yanhui; Zhao, Xinghua			Genome-Wide Analysis of Microsatellite Markers Based on Sequenced Database in Chinese Spring Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SSR MARKERS; POLYMORPHISM MARKERS; ARABIDOPSIS-THALIANA; MOLECULAR MARKERS; DRAFT GENOME; REPEATS; MAIZE; TRANSFERABILITY; COLLECTION; FEATURES	Microsatellites or simple sequence repeats (SSRs) are distributed across both prokaryotic and eukaryotic genomes and have been widely used for genetic studies and molecular marker-assisted breeding in crops. Though an ordered draft sequence of hexaploid bread wheat have been announced, the researches about systemic analysis of SSRs for wheat still have not been reported so far. In the present study, we identified 364,347 SSRs from among 10,603,760 sequences of the Chinese spring wheat (CSW) genome, which were present at a density of 36.68 SSR/Mb. In total, we detected 488 types of motifs ranging from di-to hexanucleotides, among which dinucleotide repeats dominated, accounting for approximately 42.52% of the genome. The density of tri- to hexanucleotide repeats was 24.97%, 4.62%, 3.25% and 24.65%, respectively. AG/CT, AAG/CTT, AGAT/ATCT, AAAAG/CTTTT and AAAATT/AATTTT were the most frequent repeats among di-to hexanucleotide repeats. Among the 21 chromosomes of CSW, the density of repeats was highest on chromosome 2D and lowest on chromosome 3A. The proportions of di-, tri-, tetra-, penta-and hexanucleotide repeats on each chromosome, and even on the whole genome, were almost identical. In addition, 295,267 SSR markers were successfully developed from the 21 chromosomes of CSW, which cover the entire genome at a density of 29.73 per Mb. All of the SSR markers were validated by reverse electronic-Polymerase Chain Reaction (re-PCR); 70,564 (23.9%) were found to be monomorphic and 224,703 (76.1%) were found to be polymorphic. A total of 45 monomorphic markers were selected randomly for validation purposes; 24 (53.3%) amplified one locus, 8 (17.8%) amplified multiple identical loci, and 13 (28.9%) did not amplify any fragments from the genomic DNA of CSW. Then a den-drogram was generated based on the 24 monomorphic SSR markers among 20 wheat cultivars and three species of its diploid ancestors showing that monomorphic SSR markers represented a promising source to increase the number of genetic markers available for the wheat genome. The results of this study will be useful for investigating the genetic diversity and evolution among wheat and related species. At the same time, the results will facilitate comparative genomic studies and marker-assisted breeding (MAS) in plants.	[Han, Bin] Shanxi Univ, Coll Bioengn, Taiyuan 030006, Peoples R China; [Wang, Changbiao; Tang, Zhaohui; Li, Yali; Dong, Yanhui; Zhao, Xinghua] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China; [Ren, Yongkang] Shanxi Acad Agr Sci, Inst Crop Sci, Taiyuan, Peoples R China; [Zhang, Dayong] Jiangsu Acad Agr Sci, Inst Biotechnol, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China	Shanxi University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University; Jiangsu Academy of Agricultural Sciences	Wang, CB (corresponding author), Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Peoples R China.	wcbksl@126.com; tzhhui126@126.com; cotton.z@126.com	Wang, Changbiao/S-8473-2019		Twelfth Five-year-plan in National Science and Technology for the Rural Development in China [2011AA100501]; Shanxi Provincial Scientific and Technological Research Projects [20130311001-8]; Shanxi Academy of Agricultural Sciences Breeding Project [11yzgc028]; Shanxi Academy of Agricultural Sciences Breeding Base Project [yzjc1201]; Shanxi Academy of Agricultural Science Scientific and Technological Research Projects [2013GG51]; Natural Science Foundation of Shanxi [2009021032-1]	Twelfth Five-year-plan in National Science and Technology for the Rural Development in China; Shanxi Provincial Scientific and Technological Research Projects; Shanxi Academy of Agricultural Sciences Breeding Project; Shanxi Academy of Agricultural Sciences Breeding Base Project; Shanxi Academy of Agricultural Science Scientific and Technological Research Projects; Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province)	This work was financially supported in part by grants from the Twelfth Five-year-plan in National Science and Technology for the Rural Development in China (2011AA100501), Shanxi Provincial Scientific and Technological Research Projects (20130311001-8), Shanxi Academy of Agricultural Sciences Breeding Project (11yzgc028), Shanxi Academy of Agricultural Sciences Breeding Base Project (yzjc1201), Shanxi Academy of Agricultural Science Scientific and Technological Research Projects (2013GG51), the Natural Science Foundation of Shanxi (2009021032-1).	Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Baenziger PS, 2006, CROP SCI, V46, P2230, DOI 10.2135/cropsci2005.11.0404gas; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Biswas MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104182; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Hong CP, 2007, MOL CELLS, V23, P349; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Landjeva S, 2007, EUPHYTICA, V156, P271, DOI 10.1007/s10681-007-9371-0; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li L, 2008, PROG NAT SCI-MATER, V18, P1485, DOI 10.1016/j.pnsc.2008.05.012; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lucas SJ, 2012, FUNCT INTEGR GENOMIC, V12, P173, DOI 10.1007/s10142-011-0250-3; Mahmood A, 2004, THEOR APPL GENET, V109, P1494, DOI 10.1007/s00122-004-1766-x; Makharia GK, 2014, J GASTROEN HEPATOL, V29, P666, DOI 10.1111/jgh.12514; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Metzgar D, 2000, GENOME RES, V10, P72; Mian MAR, 2005, GENOME, V48, P637, DOI [10.1139/g05-029, 10.1139/G05-029]; Nazareno AG, 2011, AM J BOT, V98, pE265, DOI 10.3732/ajb.1100163; Olango TM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0250-8; Paux E, 2012, BIOTECHNOL ADV, V30, P1071, DOI 10.1016/j.biotechadv.2011.09.015; Qu Jingtao, 2013, BMC Res Notes, V6, P403, DOI 10.1186/1756-0500-6-403; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Severson DW, 2014, DNA RES; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang Y, 2014, J INTEGRATIVE PLANT; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yadav HK, 2011, TREE GENET GENOMES, V7, P207, DOI 10.1007/s11295-010-0326-6; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhao XY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-435	37	32	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141540	10.1371/journal.pone.0141540	http://dx.doi.org/10.1371/journal.pone.0141540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536014	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400069
J	Ihn, HJ; Lee, D; Lee, T; Kim, SH; Shin, HI; Bae, YC; Hong, JM; Park, EK				Ihn, Hye Jung; Lee, Doohyun; Lee, Taeho; Kim, Sang-Hyun; Shin, Hong-In; Bae, Yong Chul; Hong, Jung Min; Park, Eui Kyun			Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; RESORPTION; DISEASE; DESIGN; NFATC1	Abnormally elevated formation and activation of osteoclasts are primary causes for a majority of skeletal diseases. In this study, we found that KP-A159, a newly synthesized thiazolopyridine derivative, inhibited osteoclast differentiation and function in vitro, and inflammatory bone loss in vivo. KP-A159 did not cause a cytotoxic response in bone marrow macrophages (BMMs), but significantly inhibited the formation of multinucleated tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts induced by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL). KP-A159 also dramatically inhibited the expression of marker genes related to osteoclast differentiation, including TRAP (Acp5), cathepsin K (Ctsk), dendritic cell-specific transmembrane protein (Dcstamp), matrix metallopeptidase 9 (Mmp9), and nuclear factor of activated T-cells, cytoplasmic 1 (Nfatc1). Moreover, actin ring and resorption pit formation were inhibited by KP-A159. Analysis of the signaling pathway involved showed that KP-A159 inhibited RANKL-induced activation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and mitogen-activated protein kinase kinase1/2 (MEK1/2). In a mouse inflammatory bone loss model, KP-A159 significantly rescued lipopolysaccharide (LPS)-induced bone loss by suppressing osteoclast numbers. Therefore, KP-A159 targets osteoclasts, and may be a potential candidate compound for prevention and/or treatment of inflammatory bone loss.	[Ihn, Hye Jung; Kim, Sang-Hyun] Kyungpook Natl Univ, Dept Pharmacol, Sch Med, Daegu, South Korea; [Lee, Doohyun; Lee, Taeho] Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea; [Shin, Hong-In; Park, Eui Kyun] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea; [Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, Daegu, South Korea; [Hong, Jung Min] Kyungpook Natl Univ Hosp, Skeletal Dis Genome Res Ctr, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Park, EK (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol & Regenerat Med, IHBR, Daegu, South Korea.	epark@knu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2008-0062282]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2008-0062282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Body JJ, 2002, BONE, V30, p75S; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghayor C, 2011, J BIOL CHEM, V286, P24458, DOI 10.1074/jbc.M111.223297; Hamade E, 2012, MED CHEM, V8, P401, DOI 10.2174/1573406411208030401; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hong JM, 2014, BONE, V62, P99, DOI 10.1016/j.bone.2014.02.005; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Lee T, 2010, J COMB CHEM, V12, P95, DOI 10.1021/cc900147y; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Park HR, 2013, BIOORGAN MED CHEM, V21, P5480, DOI 10.1016/j.bmc.2013.05.066; Park JY, 2009, BIOCHEM BIOPH RES CO, V378, P645, DOI 10.1016/j.bbrc.2008.11.115; Qin YJ, 2014, BIOORG MED CHEM LETT, V24, P5279, DOI 10.1016/j.bmcl.2014.09.054; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Rao AU, 2009, BIOORG MED CHEM LETT, V19, P6176, DOI 10.1016/j.bmcl.2009.09.006; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Sharma RN, 2009, J ENZYM INHIB MED CH, V24, P890, DOI 10.1080/14756360802519558; Shi F, 2009, BIOORG MED CHEM LETT, V19, P5565, DOI 10.1016/j.bmcl.2009.08.046; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walczynski K, 2005, EUR J MED CHEM, V40, P15, DOI 10.1016/j.ejmech.2004.09.010; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	32	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142201	10.1371/journal.pone.0142201	http://dx.doi.org/10.1371/journal.pone.0142201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536233	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400143
J	Wilcox, TM; Carim, KJ; McKelvey, KS; Young, MK; Schwartz, MK				Wilcox, Taylor M.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			The Dual Challenges of Generality and Specificity When Developing Environmental DNA Markers for Species and Subspecies of Oncorhynchus	PLOS ONE			English	Article							CUTTHROAT TROUT; CONSERVATION	Environmental DNA (eDNA) sampling is a powerful tool for detecting invasive and native aquatic species. Often, species of conservation interest co-occur with other, closely related taxa. Here, we developed qPCR (quantitative PCR) markers which distinguish westslope cutthroat trout (Oncorhynchus clarkii lewsi), Yellowstone cutthroat trout (O. clarkii bouvieri), and rainbow trout (O. mykiss), which are of conservation interest both as native species and as invasive species across each other's native ranges. We found that local polymorphisms within westslope cutthroat trout and rainbow trout posed a challenge to designing assays that are generally applicable across the range of these widely-distributed species. Further, poorly-resolved taxonomies of Yellowstone cutthroat trout and Bonneville cutthroat trout (O. c. utah) prevented design of an assay that distinguishes these recognized taxa. The issues of intraspecific polymorphism and unresolved taxonomy for eDNA assay design addressed in this study are likely to be general problems for closely-related taxa. Prior to field application, we recommend that future studies sample populations and test assays more broadly than has been typical of published eDNA assays to date.	[Wilcox, Taylor M.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59812 USA; [Wilcox, Taylor M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Wilcox, TM (corresponding author), US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59812 USA.	taylor.wilcox@umontana.edu	Wilcox, Taylor/P-7064-2019	Wilcox, Taylor/0000-0003-3341-7374	National Science Foundation [DGE-1313190]	National Science Foundation(National Science Foundation (NSF))	Region 1 of the U.S. Forest Service provided funding for this work. TMW is supported by a fellowship from the National Science Foundation (Grant No. DGE-1313190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2000, PHYLOGEOGRAPHY; Behnke R. J., 1992, AM FISHERIES SOC MON, V6; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell MR, 2011, T AM FISH SOC, V140, P91, DOI 10.1080/00028487.2011.557001; Drinan DP, 2011, CONSERV GENET, V12, P1513, DOI 10.1007/s10592-011-0249-2; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Gresswell RE, 2011, N AM J FISH MANAGE, V31, P782, DOI 10.1080/02755947.2011.608980; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kruse Carter G., 2000, North American Journal of Fisheries Management, V20, P693, DOI 10.1577/1548-8675(2000)020<0693:SOYCTI>2.3.CO;2; Lea R.N., 2013, COMMON SCI NAMES FIS, V7; Loxterman JL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-38; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Moyle P.B., 2002, INLAND FISHES CALIFO; Muhlfeld CC, 2015, N AM J FISH MANAGE, V35, P31, DOI 10.1080/02755947.2014.951807; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; R Core Development Team, 2013, R LANG ENV STAT COMP; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259; Young MK, 2013, MOL ECOL RESOUR, V13, P583, DOI 10.1111/1755-0998.12091	29	45	47	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142008	10.1371/journal.pone.0142008	http://dx.doi.org/10.1371/journal.pone.0142008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536367	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400117
J	Meng, ZG; Meng, ZH; Zhang, R; Liang, CZ; Wan, JM; Wang, YL; Zhai, HH; Guo, SD				Meng, Zhigang; Meng, Zhaohong; Zhang, Rui; Liang, Chengzhen; Wan, Jianmin; Wang, Yanling; Zhai, Honghong; Guo, Sandui			Expression of the Rice Arginase Gene OsARG in Cotton Influences the Morphology and Nitrogen Transition of Seedlings	PLOS ONE			English	Article							ROOT DEVELOPMENT; ARGININE METABOLISM; LEAF SENESCENCE; USE EFFICIENCY; ARABIDOPSIS; PLANT; SEEDS; REMOBILIZATION; L.; FERTILIZATION	Arginase is the only enzyme capable of producing urea in plants. This enzyme also contributes to many important biological functions during plant growth and development, such as seed development, root development and plant nitrogen using. The unique rice arginase gene OsARG is known to affect nitrogen use efficiency and is also associated with higher yields in rice. In this study, we transformed OsARG into upland cotton R18 by Agrobacterium- mediated genetic transformation and analyzed the function of OsARG in transgenic cotton. Two independent OsARG expression transgenic cotton lines, ARG-26 and ARG-38, were obtained via transformation. Southern blot analysis indicated that two copies and one copy of the OsARG gene were integrated into the ARG-26 and ARG-38 genomes, respectively. Enzyme activity and RNA transcription analysis revealed that the OsARG gene is highly expressed in cotton. The nitric oxide content and the morphology of ARG-26 and ARG-38 seedlings were both affected by expression of the OsARG gene. Field experiments indicated that the polyamine and nitrogen content increased by more than two-fold in the T3 generation plants of the transgenic cotton lines ARG-26-2, ARG-26-7, ARG-38-8, and ARG-38-11, as compared with the control plants. After harvesting cotton fibers grown in field conditions, we analyzed the quality of fiber and found that the fiber length was increased in the transgenic lines. The average cotton fiber length for all of the transgenic cotton lines was two millimeters longer than the fibers of the control plants; the average cotton fiber lengths were 31.94 mm, 32.00 mm, 32.68 mm and 32.84 mm in the ARG-26ARG-26- 2, ARG-26-7, ARG-38-8 and ARG-38-11 lines, respectively, but the average fiber length of the control plants was 29.36mm. Our results indicate that the OsARG gene could potentially be used to improve cotton fiber length traits.	[Meng, Zhigang; Meng, Zhaohong; Zhang, Rui; Liang, Chengzhen; Wang, Yanling; Zhai, Honghong; Guo, Sandui] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Wang, Yanling] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Anhui Agricultural University	Guo, SD (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	guosandui@caas.cn	Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	Meng, ZhiGang/0000-0001-8959-5685	National Natural Science Foundation of China [31301373]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 31301373).	Ando T, 1997, DEV PLANT SOIL SCI, V78, P51; CAGAMPANG GB, 1971, CEREAL CHEM, V48, P533; Canton FR, 2005, PHOTOSYNTH RES, V83, P265, DOI 10.1007/s11120-004-9366-9; Chen YG, 2008, J CHEM ECOL, V34, P1553, DOI 10.1007/s10886-008-9560-x; Cheng L, 2004, TREE PHYSIOL, V24, P91, DOI 10.1093/treephys/24.1.91; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Lombardo MC, 2006, PLANT SIGNAL BEHAV, V1, P28, DOI 10.4161/psb.1.1.2398; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Draper J, 1988, ISOLATION PLANT NUCL, P212; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; Flores T, 2008, PLANT PHYSIOL, V147, P1936, DOI 10.1104/pp.108.121459; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hao YJ, 2005, J EXP BOT, V56, P1105, DOI 10.1093/jxb/eri102; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Jubault M, 2008, PLANT PHYSIOL, V146, P2008, DOI 10.1104/pp.108.117432; King JE, 1997, PLANT PHYSIOL, V113, P1125, DOI 10.1104/pp.113.4.1125; Lattanzi FA, 2005, PLANT PHYSIOL, V137, P383, DOI 10.1104/pp.104.051375; Ma XF, 2013, PLANT J, V73, P190, DOI 10.1111/j.1365-313x.2012.05122.x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Meng ZH, 2007, IN VITRO CELL DEV-PL, V43, P111, DOI 10.1007/s11627-007-9031-z; MICALLEF BJ, 1989, PLANT PHYSIOL, V90, P631, DOI 10.1104/pp.90.2.631; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Thu TT, 2007, PLANT CELL TISS ORG, V91, P135, DOI 10.1007/s11240-007-9227-2; VANETTEN CH, 1963, J AGR FOOD CHEM, V11, P399, DOI 10.1021/jf60129a016; WALTER HJP, 1987, PLANT PHYSIOL, V83, P232, DOI 10.1104/pp.83.2.232; ZONIA LE, 1995, PLANT PHYSIOL, V107, P1097, DOI 10.1104/pp.107.4.1097	35	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141530	10.1371/journal.pone.0141530	http://dx.doi.org/10.1371/journal.pone.0141530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528551	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600035
J	Rowlands, IJ; Dobson, AJ; Mishra, GD				Rowlands, Ingrid J.; Dobson, Annette J.; Mishra, Gita D.			Physical Health of Young, Australian Women: A Comparison of Two National Cohorts Surveyed 17 Years Apart	PLOS ONE			English	Article							MENTAL-HEALTH; TRANSITIONS; STRESS; ADULTHOOD; MORTALITY	Introduction Very little is known about the extent of physical health issues among young women in early adulthood and whether this is changing over time. Methods We used data from two national samples of young women aged 18-23 years, surveyed 17 years apart, who participated in the Australian Longitudinal Study on Women's Health. We used multinomial logistic regression to compare the women's physical health (i.e., self-rated health, common symptoms and conditions) and identify whether sociodemographic factors, health behaviours and stress explained any physical health differences between the samples. Results Women aged 18-23 years in 2013 (N = 17,069) were more likely to report poor self-rated health and physical symptoms (particularly urogenital and bowel symptoms) than women aged 18-23 years in 1996 (N = 14,247). Stress accounted for a large proportion of the physical health differences between the cohorts, particularly for allergies, headaches, self-rated health, severe tiredness, skin problems, severe period pain and hypertension. Conclusions Women's health appears to be changing, with young women born in more recent decades reporting greater physical symptom levels. Changing socio-cultural and economic conditions may place pressure on young adults, negatively affecting their health and wellbeing. Assessing the extent to which social structures and health care policies are offering adequate support to young women may offer avenues for promoting positive health and wellbeing.	[Rowlands, Ingrid J.; Dobson, Annette J.; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Herston, Qld 4006, Australia	University of Queensland	Rowlands, IJ (corresponding author), Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Herston, Qld 4006, Australia.	i.rowlands@uq.edu.au			Department of Health [G0189875]; Australian National Health and Medical Research Council [APP1000986]; Australian Research Council Future Fellowship [FT120100812]	Department of Health; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	The Australian Longitudinal Study on Women's Health was funded by the Department of Health (G0189875), http://www.health.gov.au/. IJR was supported by the Australian National Health and Medical Research Council (grant number: APP1000986; http://www.nhmrc.gov.au/). GDM is funded by the Australian Research Council Future Fellowship (grant number: FT120100812; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECHN REP SER; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Australian Bureau of Statistics (ABS), 2013, 4364055003 ABS; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Basnov M, 2009, INFORM HEALTH SOC CA, V34, P53, DOI 10.1080/17538150902779527; Bell S, 2003, PSYCHOL HEALTH MED, V8, P343, DOI DOI 10.1080/1354850031000135786; Bell S, 2002, PSYCHOL HEALTH MED, V7, P189; Bell S, 2006, INT J BEHAV MED, V13, P265, DOI 10.1207/s15327558ijbm1303_11; Bell S, 2008, INT J BEHAV MED, V15, P280, DOI 10.1080/10705500802365482; Bor W, 2014, AUST NZ J PSYCHIAT, V48, P606, DOI 10.1177/0004867414533834; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Carver C.S., 2011, OXFORD HDB HLTH PSYC, P162, DOI DOI 10.1093/OXFORDHB/9780195342819.013.0008; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Dorner TE, 2010, WIEN KLIN WOCHENSCHR, V122, P103, DOI 10.1007/s00508-010-1312-6; Double D., 2002, LIMITS PSYCHIAT, P900; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Eckersley R, 2011, J YOUTH STUD, V14, P627, DOI 10.1080/13676261.2011.565043; Eckersley Richard M, 2007, Int J Adolesc Med Health, V19, P217; Friberg P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000681; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kaplan G, 2003, SOC SCI MED, V56, P1669, DOI 10.1016/S0277-9536(02)00179-X; Laftman SB, 2014, SCANDINAVIAN J PUBLI; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lee C, 2007, DEV PSYCHOL, V43, P877, DOI 10.1037/0012-1649.43.4.877; Loxton D, RECRUITING YOU UNPUB; MacLean A, 2013, SOC SCI MED, V78, P96, DOI 10.1016/j.socscimed.2012.11.039; Marks D F, 1996, J Health Psychol, V1, P7, DOI 10.1177/135910539600100102; Mishra GD, 2014, J MED INTERNET RES, V15, pe279; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; Ostberg V, 2014, CHILD IND RES   0419, P1; Reither EN, 2009, SOC SCI MED, V69, P1439, DOI 10.1016/j.socscimed.2009.08.040; SAS Institute Inc, 2014, SAS STAT 13 2 US GUI; Sweeting H, 2010, SOC SCI MED, V71, P1819, DOI 10.1016/j.socscimed.2010.08.012; Thacker SB, 2006, PUBLIC HEALTH REP, V121, P14, DOI 10.1177/003335490612100107; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; Ussher JM, 2010, FEM PSYCHOL, V20, P9, DOI 10.1177/0959353509350213; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wiklund M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-993; Wiklund M, 2010, SOC SCI MED, V71, P1567, DOI 10.1016/j.socscimed.2010.08.004; Wolff LS, 2010, SOC SCI MED, V70, P2019, DOI 10.1016/j.socscimed.2010.02.033	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142088	10.1371/journal.pone.0142088	http://dx.doi.org/10.1371/journal.pone.0142088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26528902	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600098
J	Yang, HX; Zhang, M; Wang, X; Zhang, HY; Zhang, J; Jing, L; Liao, LF; Wang, MQ				Yang, Hongxu; Zhang, Mian; Wang, Xin; Zhang, Hongyun; Zhang, Jing; Jing, Lei; Liao, Lifan; Wang, Meiqing			TNF Accelerates Death of Mandibular Condyle Chondrocytes in Rats with Biomechanical Stimulation-Induced Temporomandibular Joint Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; CARTILAGE; APOPTOSIS; OSTEOARTHRITIS; CYTOKINES; EXPRESSION; MATRIX; INTERLEUKIN-1-BETA	Objective To determine if temporomandibular joint chondrocyte apoptosis is induced in rats with dental biomechanical stimulation and what a role TNF takes. Methods Thirty-two rats were divided into 4 groups (n = 8/group) and exposed to incisor mal-occlusion induced by unilateral anterior crossbite biomechanical stimulation. Two groups were sampled at 2 or 4 weeks. The other two groups were treated with local injections of a TNF inhibitor or PBS into the temporomandibular joints area at 2 weeks and then sampled at 4 weeks. Twenty-four rats either served as unilateral anterior crossbite mock operation controls (n = 8/group) with sampling at 2 or 4 weeks or received a local injection of the TNF inhibitor at 2 weeks with sampling at 4 weeks. Chondrocytes were isolated from the temporomandibular joints of 6 additional rats and treated with TNF in vitro. Joint samples were assessed using Hematoxylin&eosin, Safranin O, TUNEL and immunohistochemistry staining, real-time PCR, fluorogenic activity assays and Western blot analyses. The isolated chondrocytes were also analyzed by flow cytometry. Results Unilateral anterior crossbite stimulation led to temporomandibular joint cartilage degradation, associated with an increase in TUNEL-positive chondrocytes number, caspase-9 expression levels, and the release of cytochrome c from mitochondria at 2 weeks without changes in TNF and caspase-8 levels until after 4 weeks. TNF stimulated apoptosis of the isolated chondrocytes and up-regulated caspase-8 expression, but did not change caspase-9 expression levels. Local injection of TNF inhibitor down-regulated caspase-8 expression and reduced TUNEL-positive cell number, but did not reverse cartilage thickness reduction, caspase-9 up-regulation or cytochrome c release. Conclusions Unilateral anterior crossbite stimulation induces mitochondrion-mediated apoptosis of articular chondrocytes. TNF accelerated the unilateral anterior crossbite induced chondrocytes apoptosis via death-receptor pathway. However, anti-TNF therapy does not prevent cartilage loss in this model of temporomandibular joint.	[Yang, Hongxu; Zhang, Mian; Wang, Xin; Zhang, Hongyun; Zhang, Jing; Jing, Lei; Liao, Lifan; Wang, Meiqing] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Oral Anat & Physiol & TMD, Sch Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, MQ (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Oral Anat & Physiol & TMD, Sch Stomatol, 145 Changle West Rd, Xian 710032, Peoples R China.	mqwang@fmmu.edu.cn	Wang, Meiqing/K-3584-2019		National Natural Science Foundation of China [81271169, 81470762, 81500875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China No. 81271169, 81470762, 81500875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan N, 2013, J CLIN INVEST, V123, P3902, DOI 10.1172/JCI69485; Aigner T, 2002, ARTHRITIS RHEUM-US, V46, P1986, DOI 10.1002/art.10554; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006; Chen J, 2012, CELLS TISSUES ORGANS, V195, P232, DOI 10.1159/000325148; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; D'Lima D, 2006, ARTHRITIS RHEUM-US, V54, P1814, DOI 10.1002/art.21874; Delatte M, 2004, EUR J ORAL SCI, V112, P156, DOI 10.1111/j.0909-8836.2004.00108.x; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fisher BAC, 2006, J RHEUMATOL, V33, P1934; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grunke M, 2006, ANN RHEUM DIS, V65, P555, DOI 10.1136/ard.2006.053272; Guilak F, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000131233.83640.91; Gupta S., 2001, Current Molecular Medicine (Hilversum), V1, P317, DOI 10.2174/1566524013363780; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Gupta S, 2006, AUTOIMMUN REV, V5, P264, DOI 10.1016/j.autrev.2005.09.007; Heyninck Karen, 2001, Molecular Cell Biology Research Communications, V4, P259, DOI 10.1006/mcbr.2001.0295; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kim HA, 2007, CURR DRUG TARGETS, V8, P333, DOI 10.2174/138945007779940025; Klinge RF, 2001, MICRON, V32, P551, DOI 10.1016/S0968-4328(00)00060-3; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110539; Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; Liu YD, 2014, OSTEOARTHR CARTILAGE, V22, P302, DOI 10.1016/j.joca.2013.11.014; Liu ZB, 2014, J BIOMED MATER RES A, V102, P665, DOI 10.1002/jbm.a.34729; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Lu L, J DENT RES; Lu XJ, 2013, J CELL MOL MED, V17, P664, DOI 10.1111/jcmm.12049; Magnano MD, 2007, J RHEUMATOL, V34, P1323; Maksymowych WP, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4044; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Ohno S, 2006, OSTEOARTHR CARTILAGE, V14, P807, DOI 10.1016/j.joca.2006.02.002; Ohtani T, 2012, J ORAL PATHOL MED, V41, P96, DOI 10.1111/j.1600-0714.2011.01056.x; Pulsatelli L, 1999, J RHEUMATOL, V26, P1992; Qin J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4085; Rocha FAC, 2011, BRIT J PHARMACOL, V164, P828, DOI 10.1111/j.1476-5381.2011.01469.x; Ruggiero L, 2015, ANN BIOMED ENG, V43, P2652, DOI 10.1007/s10439-015-1320-9; Schuerwegh AJ, 2003, OSTEOARTHR CARTILAGE, V11, P681, DOI 10.1016/S1063-4584(03)00156-0; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020; Suzuki S, 2004, J Orthod, V31, P138, DOI 10.1179/146531204225020436; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Wang GW, 2010, ARCH ORAL BIOL, V55, P887, DOI 10.1016/j.archoralbio.2010.07.013; Wang M, 2013, J ORAL REHABIL, V40, P69, DOI 10.1111/j.1365-2842.2012.02333.x; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Wang YL, 2014, ORAL DIS, V20, P301, DOI 10.1111/odi.12112; WeberNordt RM, 1996, BLOOD, V88, P2549, DOI 10.1182/blood.V88.7.2549.bloodjournal8872549; Zhang HY, 2015, J ORAL REHABIL, V42, P685, DOI 10.1111/joor.12304; Zhang J, 2014, OSTEOARTHR CARTILAGE, V22, P822, DOI 10.1016/j.joca.2014.03.017; Zhang J, 2013, J DENT RES, V92, P253, DOI 10.1177/0022034512473482; Zhang X, 2013, J ORAL REHABIL, V40, P500, DOI 10.1111/joor.12072	59	23	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141774	10.1371/journal.pone.0141774	http://dx.doi.org/10.1371/journal.pone.0141774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529096	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600059
J	Yin, P; Ji, QN; Li, TT; Li, JT; Li, ZR; Liu, JH; Wang, GQ; Wang, S; Zhang, LH; Mao, Z; Tang, PF				Yin, Peng; Ji, Qiunan; Li, Tongtong; Li, Jiantao; Li, Zhirui; Liu, Jianheng; Wang, Guoqi; Wang, Song; Zhang, Lihai; Mao, Zhi; Tang, Peifu			A Systematic Review and Meta-Analysis of Ilizarov Methods in the Treatment of Infected Nonunion of Tibia and Femur	PLOS ONE			English	Review							DISTRACTION OSTEOGENESIS; EXTERNAL FIXATION; BONE TRANSPORT; LARGE DEFECTS; COMPLICATIONS; DEBRIDEMENT; MANAGEMENT; SALVAGE	Background Infected nonunion of tibia and femur are common in clinical practice, however, the treatment of these diseases has still been a challenge for orthopaedic surgeons. Ilizarov methods can eradicate infection, compensate bone defects and promote the bone union through progressive bone histogenesis. The objective of this systematic review was to review current available studies reporting on Ilizarov methods in the treatment of infected nonunion of tibia and femur, and to perform meta-analysis of bone and functional results and complications to evaluate the efficacy of Ilizarov methods. Methods A comprehensive literature search was performed from the SCI, PubMed, Cochrane Library; and Embase between January 1995 and August 2015. Some major data were statistically analyzed using weighted means based on the sample size in each study by SPSS 13.0, including number of patients, mean age, mean previous surgical procedures, mean bone defects, mean length of follow-up, bone union, complications per patient, external fixation time, and external fixation index(EFI). Bone results (excellent, good, fair and poor rate), functional results (excellent, good, fair and poor rate) and complications were analyzed by Stata 9.0. Findings A total of 590 patients from 24 studies were included in this systematic review. The average of bone union rate was 97.26% in all included studies. The poor rate in bone results and functional results was 8% (95% CI, 0.04-0.12; I-2 = 44.1%, P = 0.065) and 10% (95% CI, 0.05-0.14; I-2 = 34.7%, P = 0.121) in patients with infected nonunion of tibia and femur treated by Ilizarov methods. The rate of refracture, malunion, infectious recurrence, knee stiffness, amputation, limb edema and peroneal nerve palsy was respectively 4%, 7%, 5%, 12%, 4%, 13% and 13%. Conclusions Our systematic review showed that the patients with infected nonunion of tibia and femur treated by Ilizarov methods had a low rate of poor bone and functional results. Therefore, Ilizarov methods may be a good choice for the treatment of infected nonunion of tibia and femur.	[Yin, Peng; Li, Tongtong; Li, Jiantao; Li, Zhirui; Liu, Jianheng; Wang, Guoqi; Wang, Song; Zhang, Lihai; Mao, Zhi; Tang, Peifu] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China; [Yin, Peng; Li, Tongtong; Wang, Song] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ji, Qiunan] Chinese Univ Hong Kong, Sch Med, Shatin, Hong Kong, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Chinese University of Hong Kong	Zhang, LH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, 28 Fuxin Rd, Beijing 100853, Peoples R China.	zhanglihai74@126.com; maozhiys@sina.com; pftang301@sina.cn	Mao, Zhi/AAZ-1629-2020	Tang, Peifu/0000-0003-4279-1704				Abdel-Aal AM, 2006, ORTHOPEDICS, V29, P70, DOI 10.3928/01477447-20060101-10; Arora RK, 2003, JK SCI, V5, P22; Atesalp AS, 2002, MIL MED, V167, P978; Barbarossa V, 2001, CROAT MED J, V42, P634; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P15, DOI 10.2106/00004623-200101000-00003; Blum ALL, 2010, J BONE JOINT SURG BR, V92B, P565, DOI 10.1302/0301-620X.92B4.23475; Bumbasirevic M, 2010, ARCH ORTHOP TRAUM SU, V130, P739, DOI 10.1007/s00402-009-1014-6; CATTANEO R, 1992, CLIN ORTHOP RELAT R, P143; DENDRINOS GK, 1995, J BONE JOINT SURG AM, V77A, P835, DOI 10.2106/00004623-199506000-00004; Dhar SA, 2008, INT ORTHOP, V32, P559, DOI 10.1007/s00264-007-0353-6; Egger M, 1998, BRIT MED J, V316, P140; Emara KM, 2008, J TRAUMA, V65, P685, DOI 10.1097/TA.0b013e3181569ecc; Feng ZH, 2013, SAUDI MED J, V34, P316; Hosny G, 1998, INT ORTHOP, V22, P298, DOI 10.1007/s002640050264; Jain AK, 2005, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000152868.29134.92; Khan MS, 2015, J ORTHOP SURG-HONG K, V23, P52, DOI 10.1177/230949901502300112; Krishnan A, 2006, J Orthop Surg (Hong Kong), V14, P265; Laursen M B, 2000, Acta Orthop Belg, V66, P279; Madhusudhan Thayur R, 2008, J Trauma Manag Outcomes, V2, P6, DOI 10.1186/1752-2897-2-6; Magadum M P, 2006, J Orthop Surg (Hong Kong), V14, P273; Maini L, 2000, INJURY, V31, P509, DOI 10.1016/S0020-1383(00)00036-X; McHale KA, 2004, MIL MED, V169, P728, DOI 10.7205/MILMED.169.9.728; Megas P, 2010, INJURY, V41, P294, DOI 10.1016/j.injury.2009.09.013; Montori VM, 2003, CLIN ORTHOP RELAT R, P43, DOI 10.1097/01.blo.0000079322.41006.5b; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; Papakostidis C, 2013, BONE JOINT J, V95B, P1673, DOI 10.1302/0301-620X.95B12.32385; Peng J, 2015, INT J CLIN EXP MED, V8, P10058; Ring D, 1999, CLIN ORTHOP RELAT R, P302; Rose REC, 2007, W INDIAN MED J, V56, P246; Saridis A, 2006, J BONE JOINT SURG BR, V88B, P232, DOI 10.1302/0301-620X.88B2.16976; Selhi HS, 2012, J ORTHOP TRAUMA, V26, P184, DOI 10.1097/BOT.0b013e318225f77c; Struijs PAA, 2007, J ORTHOP TRAUMA, V21, P507, DOI 10.1097/BOT.0b013e31812e5578; Wei DH, 2012, J ORTHOP TRAUMA, V26, P386, DOI 10.1097/BOT.0b013e318225f63c; Wu CC, 2011, J ORTHOP TRAUMA, V25, P156, DOI 10.1097/BOT.0b013e3181eaaa35; Xu K, 2014, IRISH J MED SCI, V183, P423, DOI 10.1007/s11845-013-1032-9; Yin P, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0189-5	36	53	64	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141973	10.1371/journal.pone.0141973	http://dx.doi.org/10.1371/journal.pone.0141973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529606	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600084
J	El Andari, J; Altegoer, F; Bange, G; Graumann, PL				El Andari, Jihad; Altegoer, Florian; Bange, Gert; Graumann, Peter L.			Bacillus subtilis Bactofilins Are Essential for Flagellar Hook- and Filament Assembly and Dynamically Localize into Structures of Less than 100 nm Diameter underneath the Cell Membrane	PLOS ONE			English	Article							III SECRETION; BACTERIAL; CHAPERONE; EXPORT; MOTILITY; POLYMERIZATION; IDENTIFICATION; LOCATION; ATPASE; SWITCH	Bactofilins are a widely conserved protein family implicated in cell shape maintenance and in bacterial motility. We show that the bactofilins BacE and BacF from Bacillus subtilis are essential for motility. The proteins are required for the establishment of flagellar hook- and filament structures, but apparently not for the formation of basal bodies. Functional YFP fusions to BacE and to BacF localize as discrete assemblies at the B. subtilis cell membrane, and have a diameter of 60 to 70 nm. BacF assemblies are relatively static, and partially colocalize with flagellar basal bodies, while BacE assemblies are fewer per cell than those of BacF and are highly mobile. Tracking of BacE foci showed that the assemblies arrest at a single point for a few hundred milliseconds, showing that a putative interaction with flagellar structures would be transient and fast. When overexpressed or expressed in a heterologous cell system, bactofilins can form filamentous structures, and also form multimers as purified proteins. Our data reveal a propensity for bactofilins to form filaments, however, in B. subtilis cells, bactofilins assemble into defined size assemblies that show a dynamic localization pattern and play a role in flagellar assembly.	[El Andari, Jihad; Altegoer, Florian; Bange, Gert; Graumann, Peter L.] Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany; [El Andari, Jihad] Univ Marburg, Dept Chem, SYNMIKRO, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Graumann, PL (corresponding author), Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany.	gert.bange@synmikro.uni-marburg.de; peter.graumann@synmikro.uni-marburg.de	Altegoer, Florian/AAM-1354-2020; Bange, Gert/AAB-3734-2021	EL Andari, Jihad (Josef)/0000-0001-5502-6214; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932; Graumann, Peter/0000-0002-8033-5171	Deutsche Akademischer Austauschdienst (DAAD); Deutsche Forschungsgemeinschaft (DFG); LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO); BMBF	Deutsche Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO); BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by the Deutsche Akademischer Austauschdienst (DAAD), the Deutsche Forschungsgemeinschaft (DFG), and by the LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO), as well as by the BMBF funded graduate program NANOKAT.	Altegoer F, 2014, BIOTECHNOL GENET ENG, V30, P49, DOI 10.1080/02648725.2014.921500; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017; Calvo RA, 2015, J BACTERIOL, V197, P81, DOI 10.1128/JB.02324-14; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; CLARK WA, 1976, J CLIN MICROBIOL, V3, P632; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Dempwolff F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027035; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; JAACKS KJ, 1989, J BACTERIOL, V171, P4121, DOI 10.1128/JB.171.8.4121-4129.1989; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kinoshita M, 2013, MOL MICROBIOL, V90, P1249, DOI 10.1111/mmi.12430; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Lin L, 2013, CYTOSKELETON, V70, P409, DOI 10.1002/cm.21126; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Muskotal A, 2006, FEBS LETT, V580, P3916, DOI 10.1016/j.febslet.2006.06.024; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pena A, 2013, J MOL MICROB BIOTECH, V23, P357, DOI 10.1159/000351360; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Reimold C, 2013, MOL BIOL CELL, V24, P2340, DOI 10.1091/mbc.E12-10-0728; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Sircar R, 2013, J BIOL CHEM, V288, P13493, DOI 10.1074/jbc.M112.445171; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Vasa S, 2015, P NATL ACAD SCI USA, V112, pE127, DOI 10.1073/pnas.1418450112; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141546	10.1371/journal.pone.0141546	http://dx.doi.org/10.1371/journal.pone.0141546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517549	gold, Green Submitted, Green Published			2022-12-27	WOS:000363920800051
J	Fourrier, M; Lester, K; Markussen, T; Falk, K; Secombes, CJ; McBeath, A; Collet, B				Fourrier, Mickael; Lester, Katherine; Markussen, Turhan; Falk, Knut; Secombes, Christopher J.; McBeath, Alastair; Collet, Bertrand			Dual Mutation Events in the Haemagglutinin-Esterase and Fusion Protein from an Infectious Salmon Anaemia Virus HPR0 Genotype Promote Viral Fusion and Activation by an Ubiquitous Host Protease	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; AVIAN INFLUENZA-VIRUS; POLYMORPHIC REGION HPR; HEMATOPOIETIC NECROSIS VIRUS; CLEAVAGE-SITE SEQUENCE; SINGLE AMINO-ACID; ATLANTIC SALMON; PROPROTEIN CONVERTASES; VIRULENCE MECHANISMS; ENDOTHELIAL-CELLS	In Infectious salmon anaemia virus (ISAV), deletions in the highly polymorphic region (HPR) in the near membrane domain of the haemagglutinin-esterase (HE) stalk, influence viral fusion. It is suspected that selected mutations in the associated Fusion (F) protein may also be important in regulating fusion activity. To better understand the underlying mechanisms involved in ISAV fusion, several mutated F proteins were generated from the Scottish Nevis and Norwegian SK779/06 HPR0. Co-transfection with constructs encoding HE and F were performed, fusion activity assessed by content mixing assay and the degree of proteolytic cleavage by western blot. Substitutions in Nevis F demonstrated that K276 was the most likely cleavage site in the protein. Furthermore, amino acid substitutions at three sites and two insertions, all slightly upstream of K276, increased fusion activity. Co-expression with HE harbouring a full-length HPR produced high fusion activities when trypsin and low pH were applied. In comparison, under normal culture conditions, groups containing a mutated HE with an HPR deletion were able to generate moderate fusion levels, while those with a full length HPR HE could not induce fusion. This suggested that HPR length may influence how the HE primes the F protein and promotes fusion activation by an ubiquitous host protease and/or facilitate subsequent post-cleavage refolding steps. Variations in fusion activity through accumulated mutations on surface glycoproteins have also been reported in other orthomyxoviruses and paramyxoviruses. This may in part contribute to the different virulence and tissue tropism reported for HPR0 and HPR deleted ISAV genotypes.	[Fourrier, Mickael; Lester, Katherine; McBeath, Alastair; Collet, Bertrand] Marine Scotland Sci, Aquaculture & Fish Hlth, Aberdeen, Scotland; [Markussen, Turhan; Falk, Knut] Norwegian Vet Inst, Epidemiol, Oslo, Norway; [Secombes, Christopher J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Marine Scotland Science (MSS); Norwegian Veterinary Institute; University of Aberdeen	Fourrier, M (corresponding author), Marine Scotland Sci, Aquaculture & Fish Hlth, Aberdeen, Scotland.	Mickael.Fourrier@gov.scot	Falk, Knut/D-2952-2012; Collet, Bertrand/C-1113-2012	Falk, Knut/0000-0002-9830-3493; Collet, Bertrand/0000-0003-2795-2653	Scottish Government	Scottish Government	The Scottish Government funded this work, as part of their global budget on aquaculture research. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Betts M.J., 2003, BIOINFORMATIC GENETI; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bolt G, 1998, VIROLOGY, V252, P387, DOI 10.1006/viro.1998.9464; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; Bouchard D, 1999, DIS AQUAT ORGAN, V35, P131, DOI 10.3354/dao035131; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; Brindley MA, 2012, P NATL ACAD SCI USA, V109, pE3018, DOI 10.1073/pnas.1210925109; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Cardenas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087832; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; Cook-Versloot M, 2004, B EUR ASSOC FISH PAT, V24, P203; Cottet L, 2010, J VIROL, V84, P11916, DOI 10.1128/JVI.01202-10; Craft WW, 2005, VIROLOGY, V341, P130, DOI 10.1016/j.virol.2005.07.004; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; DESHPANDE KL, 1985, VIROLOGY, V147, P49, DOI 10.1016/0042-6822(85)90226-0; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000; Fourrier M, 2014, J GEN VIROL, V95, P1015, DOI 10.1099/vir.0.061648-0; Fuller JA, 2009, INVEST OPHTH VIS SCI, V50, P5759, DOI 10.1167/iovs.08-2616; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Garcia-Rosado E, 2008, VIRUS RES, V133, P228, DOI 10.1016/j.virusres.2008.01.008; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; GARTEN W, 1980, J GEN VIROL, V50, P135, DOI 10.1099/0022-1317-50-1-135; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Hastings T, 1999, BULL EUR ASSN FISH P, V19, P286; Hellebo A, 2004, J VIROL, V78, P3055, DOI 10.1128/JVI.78.6.3055-3062.2004; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Kibenge FSB, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-34; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KLENK HD, 1984, EMBO J, V3, P2911, DOI 10.1002/j.1460-2075.1984.tb02231.x; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Li ZJ, 1998, J VIROL, V72, P3789, DOI 10.1128/JVI.72.5.3789-3795.1998; Lu XS, 2012, J VIROL, V86, P12861, DOI 10.1128/JVI.01606-12; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081571; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Maurer-Stroh S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-139; McBeath AJA, 2006, VIRUS RES, V115, P176, DOI 10.1016/j.virusres.2005.08.005; McBeath A, 2011, ARCH VIROL, V156, P2285, DOI 10.1007/s00705-011-1106-9; McBeath AJA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0083-x; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; MCGRATH ME, 1989, BIOCHEMISTRY-US, V28, P9264, DOI 10.1021/bi00450a005; Mikalsen AB, 2005, ARCH VIROL, V150, P1621, DOI 10.1007/s00705-005-0502-4; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1977, VIROLOGY, V77, P125, DOI 10.1016/0042-6822(77)90412-3; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Nylund A, 2003, DIS AQUAT ORGAN, V56, P11, DOI 10.3354/dao056011; Nylund A, 2007, ARCH VIROL, V152, P151, DOI 10.1007/s00705-006-0825-9; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; PATERSON RG, 1989, J VIROL, V63, P1293, DOI 10.1128/JVI.63.3.1293-1301.1989; Penaranda MMD, 2009, J GEN VIROL, V90, P2172, DOI 10.1099/vir.0.012286-0; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Pratt C.W., 2008, FUNDAMENTALS BIOCH L; Purcell MK, 2009, J FISH DIS, V32, P619, DOI 10.1111/j.1365-2761.2009.01045.x; Ramly RB, 2013, VIRUS RES, V177, P1, DOI 10.1016/j.virusres.2013.07.001; Rimstad E, 1999, DIS AQUAT ORGAN, V36, P107, DOI 10.3354/dao036107; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tan LK, 2014, J VIROL, V88, P14116, DOI 10.1128/JVI.01736-14; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wargo AR, 2011, J VIROL, V85, P3959, DOI 10.1128/JVI.01891-10; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhang Y, 2012, J VIROL, V86, P6924, DOI 10.1128/JVI.07142-11; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	107	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142020	10.1371/journal.pone.0142020	http://dx.doi.org/10.1371/journal.pone.0142020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517828	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800101
J	Magner, D; Biala, E; Lisowiec-Wachnicka, J; Kierzek, E; Kierzek, R				Magner, Dorota; Biala, Ewa; Lisowiec-Wachnicka, Jolanta; Kierzek, Elzbieta; Kierzek, Ryszard			A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides	PLOS ONE			English	Article							PRECURSOR PROTEIN GENE; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALZHEIMERS-DISEASE GENES; MUTANT HUNTINGTIN; RNA/DNA DUPLEXES; INTERNAL LOOPS; NUCLEIC-ACIDS; CAG REPEATS; ALLELE; MISMATCHES	Antisense oligonucleotides have been studied for many years as a tool for gene silencing. One of the most difficult cases of selective RNA silencing involves the alleles of single nucleotide polymorphisms, in which the allele sequence is differentiated by a single nucleotide. A new approach to improve the performance of allele selectivity for antisense oligonucleotides is proposed. It is based on the simultaneous application of two oligonucleotides. One is complementary to the mutated form of the targeted RNA and is able to activate RNase H to cleave the RNA. The other oligonucleotide, which is complementary to the wild type allele of the targeted RNA, is able to inhibit RNase H cleavage. Five types of SNPs, C/G, G/C, G/A, A/G, and C/U, were analyzed within the sequence context of genes associated with neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, ALS (Amyotrophic Lateral Sclerosis), and Machado-Joseph disease. For most analyzed cases, the application of the tandem approach increased allele-selective RNA degradation 1.5-15 fold relative to the use of a single antisense oligonucleotide. The presented study proves that differentiation between single substitution is highly dependent on the nature of the SNP and surrounding nucleotides. These variables are crucial for determining the proper length of the inhibitor antisense oligonucleotide. In the tandem approach, the comparison of thermodynamic stability of the favorable duplexes WT RNA-inhibitor and Mut RNA-gapmer with the other possible duplexes allows for the evaluation of chances for the allele-selective degradation of RNA. A larger difference in thermodynamic stability between favorable duplexes and those that could possibly form, usually results in the better allele selectivity of RNA degradation.	[Magner, Dorota; Biala, Ewa; Lisowiec-Wachnicka, Jolanta; Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl	Lisowiec-Wachnicka, Jolanta J./O-4323-2015; Lisowiec-Wąchnicka, Jolanta/U-7618-2019	Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016; Lisowiec-Wachnicka, Jolanta/0000-0002-3910-9682	National Science Centre Poland [UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295, UMO-2013/08/M/NZ1/01062]; National Institute of Health [1R03TW008739-01]; Polish Ministry of Science and Higher Education under the KNOW Program; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER	National Science Centre Poland(National Science Centre, Poland); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education under the KNOW Program(Ministry of Science and Higher Education, Poland); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding provided by National Science Centre Poland, https://www.ncn.gov.pl/?language = en, grants no: UMO-2011/03/B/NZ1/00576 (RK), UMO-2011/03/B/ST5/01098 (RK), UMO-2013/08/A/ST5/00295 (RK), UMO-2013/08/M/NZ1/01062 (EK) and National Institute of Health, http://www.nih.gov/, grant no: 1R03TW008739-01 (EK). This publication was also supported by the Polish Ministry of Science and Higher Education under the KNOW Program.	Aiba Y, 2013, BIOCHEMISTRY-US, V52, P9329, DOI 10.1021/bi4014209; Albrecht-Buehlel G, 2009, BIOESSAYS, V31, P98, DOI 10.1002/bies.080081; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Bilanges B, 2005, BIOCHEM J, V388, P573, DOI 10.1042/BJ20041956; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Davis AR, 2011, NUCLEIC ACIDS RES, V39, P1081, DOI 10.1093/nar/gkq793; Davis AR, 2010, BIOCHEMISTRY-US, V49, P8669, DOI 10.1021/bi100146z; Dean NM, 2003, ONCOGENE, V22, P9087, DOI 10.1038/sj.onc.1207231; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Drake JW, 1998, GENETICS, V148, P1667; Fasman GD, 1975, HDB BIOCH MOL BIOL N, V1, P596; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hu JX, 2012, NUCLEIC ACIDS RES, V40, P11270, DOI 10.1093/nar/gks907; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Nakano S, 2014, CHEM REV, V114, P2733, DOI 10.1021/cr400113m; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SANTALUCIA J, 1991, BIOCHEMISTRY-US, V30, P8242, DOI 10.1021/bi00247a021; SANTALUCIA J, 1991, J AM CHEM SOC, V113, P4313, DOI 10.1021/ja00011a039; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sierant M, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/809218; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; STEPHENSON ML, 1978, P NATL ACAD SCI USA, V75, P285, DOI 10.1073/pnas.75.1.285; STULL RA, 1995, PHARM RES-DORDR, V12, P465, DOI 10.1023/A:1016281324761; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Sugimoto N, 2014, INT REV CEL MOL BIO, V307, P205, DOI 10.1016/B978-0-12-800046-5.00008-4; Turner D. H, 2000, NUCL ACIDS STRUCTURE, P259; Vickers TA, 2000, NUCLEIC ACIDS RES, V28, P1340, DOI 10.1093/nar/28.6.1340; Watkins NE, 2011, NUCLEIC ACIDS RES, V39, P1894, DOI 10.1093/nar/gkq905; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Yazbeck DR, 2002, NUCLEIC ACIDS RES, V30, P3015, DOI 10.1093/nar/gkf429; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	61	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142139	10.1371/journal.pone.0142139	http://dx.doi.org/10.1371/journal.pone.0142139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544037	gold, Green Published			2022-12-27	WOS:000364398700085
J	Aouinti, S; Malouche, D; Giudicelli, V; Kossida, S; Lefranc, MP				Aouinti, Safa; Malouche, Dhafer; Giudicelli, Veronique; Kossida, Sofia; Lefranc, Marie-Paule			IMGT/HighV-QUEST Statistical Significance of IMGT Clonotype (AA) Diversity per Gene for Standardized Comparisons of Next Generation Sequencing Immunoprofiles of Immunoglobulins and T Cell Receptors	PLOS ONE			English	Article							FALSE DISCOVERY RATE; V-J; MULTIPLE; CONFIDENCE; BONFERRONI; ONTOLOGY	The adaptive immune responses of humans and of other jawed vertebrate species (gnasthostomata) are characterized by the B and T cells and their specific antigen receptors, the immunoglobulins (IG) or antibodies and the T cell receptors (TR) (up to 2.10(12) different IG and TR per individual). IMGT, the international ImMunoGeneTics information system (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc (Montpellier University and CNRS) to manage the huge and complex diversity of these antigen receptors. IMGT built on IMGT-ONTOLOGY concepts of identification (keywords), description (labels), classification (gene and allele nomenclature) and numerotation (IMGT unique numbering), is at the origin of immunoinformatics, a science at the interface between immunogenetics and bioinformatics. IMGT/HighV-QUEST, the first web portal, and so far the only one, for the next generation sequencing (NGS) analysis of IG and TR, is the paradigm for immune repertoire standardized outputs and immunoprofiles of the adaptive immune responses. It provides the identification of the variable (V), diversity (D) and joining (J) genes and alleles, analysis of the V-(D)-J junction and complementarity determining region 3 (CDR3) and the characterization of the 'IMGT clonotype (AA)' (AA for amino acid) diversity and expression. IMGT/HighV-QUEST compares outputs of different batches, up to one million nucleotide sequencesfor the statistical module. These high throughput IG and TR repertoire immunoprofiles are of prime importance in vaccination, cancer, infectious diseases, autoimmunity and lymphoproliferative disorders, however their comparative statistical analysis still remains a challenge. We present a standardized statistical procedure to analyze IMGT/HighV-QUEST outputs for the evaluation of the significance of the IMGT clonotype (AA) diversity differences in proportions, per gene of a given group, between NGS IG and TR	[Aouinti, Safa; Giudicelli, Veronique; Kossida, Sofia; Lefranc, Marie-Paule] Univ Montpellier, Inst Genet Humaine IGH, LIGM,Int ImMunoGeneT Informat Syst, IMGT,UPR CNRS 1142, F-34059 Montpellier 5, France; [Aouinti, Safa; Malouche, Dhafer] Univ Carthage, Higher Sch Stat & Informat Anal, Tunis, Tunisia; [Aouinti, Safa; Malouche, Dhafer] Univ Tunis El Manar, Natl Sch Engn Tunis, Informat Technol & Commun Dept, Lab U2S, Tunis, Tunisia	Ecole des Ponts ParisTech; Universite de Montpellier; Universite de Carthage; Universite de Tunis-El-Manar; Ecole Nationale d'Ingenieurs de Tunis (ENIT)	Kossida, S (corresponding author), Univ Montpellier, Inst Genet Humaine IGH, LIGM,Int ImMunoGeneT Informat Syst, IMGT,UPR CNRS 1142, F-34059 Montpellier 5, France.	sofia.kossida@igh.cnrs.fr; marie-paule.lefranc@igh.cnrs.fr	Kossida, Sofia/ABG-3526-2020	Giudicelli, Veronique/0000-0002-2258-468X; Malouche, Dhafer/0000-0002-0494-7141	IMGT; international ImMunoGeneTics information system (Montpellier University); international ImMunoGeneTics information system (CNRS)	IMGT; international ImMunoGeneTics information system (Montpellier University); international ImMunoGeneTics information system (CNRS)	The authors received no specific funding for this work. Authors Safa Aouinti, Veronique Giudicelli, Sofia Kossida and Marie-Paule Lefranc are affiliated to IMGT, the international ImMunoGeneTics information system (Montpellier University and CNRS). IMGT, the international ImMunoGeneTics information system (Montpellier University and CNRS) provided support in the form of salaries for authors SA, VG, SK and M-PL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; De Muth JE, 2006, PHARM ED SERIES; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S, 2008, SPRINGER SER STAT, P1; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Giudicelli V, 2005, NEW RESEARCH ON IMMUNOLOGY, P77; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Giudicelli V., 2009, IMMUNOGLOBULIN GENE, P33; Giudicelli V, 2015, AUTOIMMUN INFEC DIS, V1; Giudicelli V., 2003, P EUR C COMP BIOL EC, P103; Giudicelli V, 2005, STUD HEALTH TECHNOL, V116, P3; Giudicelli Veronique, 2012, Frontiers in Genetics, V3, P79, DOI 10.3389/fgene.2012.00079; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Goeman JJ, 2012, STAT MED, V00, P1; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOLM S, 1979, SCAND J STAT, V6, P65; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; LeBlanc D.C., 2004, STAT CONCEPTS APPL S; Lefranc M.-P., 2000, CURRENT PROTOCOLS IM, pA1O1; Lefranc M-P, 2000, CURRENT PROTOCOLS IM; Lefranc M-P, 2001, IMMUNOGLOBULIN FACTS, P1; Lefranc M-P, 2001, T CELL RECEPTOR FACT, P1; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Pires AM, 2008, REVSTAT-STAT J, V6, P165; Pollard K. S., 2005, BIOINFORMATICS COMPU, DOI DOI 10.1007/0-387-29362-0_23; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Tukey J.W., 1953, PROBLEM MULTIP UNPUB; Zhang HW, 2010, REV COLOMB ESTAD, V33, P63; Zhong S, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P425	41	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142353	10.1371/journal.pone.0142353	http://dx.doi.org/10.1371/journal.pone.0142353			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540440	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800088
J	Campos, C; Cardoso, H; Nogales, A; Svensson, J; Lopez-Raez, JA; Pozo, MJ; Nobre, T; Schneider, C; Arnholdt-Schmitt, B				Campos, Catarina; Cardoso, Helia; Nogales, Amaia; Svensson, Jan; Lopez-Raez, Juan Antonio; Jose Pozo, Maria; Nobre, Tania; Schneider, Carolin; Arnholdt-Schmitt, Birgit			Intra and Inter-Spore Variability in Rhizophagus irregularis AOX Gene	PLOS ONE			English	Article							MITOCHONDRIAL ALTERNATIVE OXIDASE; ARBUSCULAR MYCORRHIZAL FUNGI; EXPRESSION; ACID; RESPIRATION; EVOLUTION; FUSION; ACTIVATION; SELECTION; INSIGHTS	Arbuscular mycorrhizal fungi (AMF) are root-inhabiting fungi that form mutualistic symbioses with their host plants. AMF symbiosis improves nutrient uptake and buffers the plant against a diversity of stresses. Rhizophagus irregularis is one of the most widespread AMF species in the world, and its application in agricultural systems for yield improvement has increased over the last years. Still, from the inoculum production perspective, a lack of consistency of inoculum quality is referred to, which partially may be due to a high genetic variability of the fungus. The alternative oxidase (AOX) is an enzyme of the alternative respiratory chain already described in different taxa, including various fungi, which decreases the damage caused by oxidative stress. Nevertheless, virtually nothing is known on the involvement of AMF AOX on symbiosis establishment, as well on the existence of AOX variability that could affect AMF effectiveness and consequently plant performance. Here, we report the isolation and characterisation of the AOX gene of R. irregularis (RiAOX), and show that it is highly expressed during early phases of the symbiosis with plant roots. Phylogenetic analysis clustered RiAOX sequence with ancient fungi, and multiple sequence alignment revealed the lack of several regulatory motifs which are present in plant AOX. The analysis of RiAOX polymorphisms in single spores of three different isolates showed a reduced variability in one spore relatively to a group of spores. A high number of polymorphisms occurred in introns; nevertheless, some putative amino acid changes resulting from non-synonymous variants were found, offering a basis for selective pressure to occur within the populations. Given the AOX relatedness with stress responses, differences in gene variants amongst R. irregularis isolates are likely to be related with its origin and environmental constraints and might have a potential impact on inoculum production.	[Campos, Catarina; Cardoso, Helia; Nogales, Amaia; Nobre, Tania; Arnholdt-Schmitt, Birgit] Univ Evora, IIFA Inst Formacao & Invest Avancada, ICAAM, EU Marie Curie Chair, Evora, Portugal; [Svensson, Jan] Nord Genet Resource Ctr, Alnarp, Sweden; [Lopez-Raez, Juan Antonio; Jose Pozo, Maria] EEZ CSIC, Dept Soil Microbiol & Symbiot Syst, Granada, Spain; [Schneider, Carolin] Inoq GmbH, Solkau, Schnega, Germany	University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Arnholdt-Schmitt, B (corresponding author), Univ Evora, IIFA Inst Formacao & Invest Avancada, ICAAM, EU Marie Curie Chair, Evora, Portugal.	eu_chair@uevora.pt	Campos, Catarina/O-7518-2018; López-Ráez, Juan A./H-1468-2015; Pozo, Maria J./K-7775-2014; Nobre, Tania/C-9925-2012; Cardoso, Hélia/O-7562-2018; Nogales, Amaia/L-9765-2016; svensson, jan/D-1815-2009	Campos, Catarina/0000-0002-5347-1338; López-Ráez, Juan A./0000-0001-7973-9251; Pozo, Maria J./0000-0003-2780-9793; Nobre, Tania/0000-0002-1855-7451; Cardoso, Hélia/0000-0003-3688-607X; Nogales, Amaia/0000-0001-8260-6580; svensson, jan/0000-0003-2913-2990	European Commission; Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN) [AGL2012-39923]; Marie Curie fellowship [321725]; Portuguese Foundation for Science and Technology - FCT [SFRH/BCC/52187/2013]; program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE; national funds through FCT [PEst-C/AGR/UI0115/2011, PEst-OE/AGR/UI0115/2014]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)); Marie Curie fellowship(European Commission); Portuguese Foundation for Science and Technology - FCT(Portuguese Foundation for Science and Technology); program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE; national funds through FCT(Portuguese Foundation for Science and Technology)	This work was supported by the European Commission through the project AGRO-AMF-AOX within the program Industry-Academia Partnerships and Pathways (IAPP, FP7). Still in the frame of the AGRO-AMF-AOX project, JS further acknowledges his recruitment, and CC, HC, AN, CS and BAS appreciate the further support given in the form of a secondment. Inoq GmbH provided support in the form of salary for CS, but did not have any additional role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript. The specific role of CS is articulated in the 'author contributions' section. Part of this work was also supported by grant AGL2012-39923 from the Spanish National R&D Plant of the Ministry of Science and Innovation (MICINN). TN was supported by a Marie Curie fellowship (FP7-PEOPLE-2012-CIG Project Reference 321725) and by the Portuguese Foundation for Science and Technology - FCT (SFRH/BCC/52187/2013). The authors further thank the program POPH-Operational Program for Human Potential-and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Program for Competitiveness Factors-COMPETE, and national funds through FCT under the strategic project PEst-C/AGR/UI0115/2011 and PEst-OE/AGR/UI0115/2014.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Arnholdt-Schmitt B, 2006, TRENDS PLANT SCI, V11, P281, DOI 10.1016/j.tplants.2006.05.001; Arnholdt-Schmitt B, 2016, BRIEF FUNCT GENOMICS, V15, P10, DOI 10.1093/bfgp/elv008; Arnholdt-Schmitt B, 2016, BRIEF FUNCT GENOMICS, V15, P16, DOI 10.1093/bfgp/elu049; Baar J, 2008, MYCORRHIZA, P361, DOI DOI 10.1007/978-3-540-78826-3_18; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besserer A, 2009, PLANT SIGNAL BEHAV, V4, P75, DOI 10.4161/psb.4.1.7419; Bever JD, 2005, NATURE, V433, pE3, DOI 10.1038/nature03294; Boon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083301; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Camprubi A, 1996, HORTSCIENCE, V31, P366, DOI 10.21273/HORTSCI.31.3.366; Cardenas-Flores A, 2010, MYCORRHIZA, V20, P415, DOI 10.1007/s00572-009-0295-5; Cardoso H. G., 2013, DIAGNOSTICS PLANT BR, V21, P467, DOI DOI 10.1007/978-94-007-5687-8_21; Cardoso HG, 2015, ALTERNATIVE RESPIRATORY PATHWAYS IN HIGHER PLANTS, P241; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Colard A, 2011, APPL ENVIRON MICROB, V77, P6510, DOI 10.1128/AEM.05696-11; Considine MJ, 2002, PLANT PHYSIOL, V129, P949, DOI 10.1104/pp.004150; Costa JH, 2014, MITOCHONDRION, V19, P172, DOI 10.1016/j.mito.2014.04.007; Crichton PG, 2005, FEBS LETT, V579, P331, DOI 10.1016/j.febslet.2004.10.107; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; Croll D, 2012, GENOME BIOL EVOL, V4, P1148, DOI 10.1093/gbe/evs091; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Dolgikh VV, 2011, EUKARYOT CELL, V10, P588, DOI 10.1128/EC.00283-10; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Finnegan PM, 2003, FEBS LETT, V555, P425, DOI 10.1016/S0014-5793(03)01309-7; Fung RWM, 2006, J PLANT PHYSIOL, V163, P1049, DOI 10.1016/j.jplph.2005.11.003; Garg N, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P907, DOI 10.1007/978-94-007-0394-0_40; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; HEWITT E. J., 1952; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Holtzapffel RC, 2003, BBA-BIOENERGETICS, V1606, P153, DOI 10.1016/S0005-2728(03)00112-9; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; KARLIN S, 1993, P NATL ACAD SCI USA, V90, P5873, DOI 10.1073/pnas.90.12.5873; Keeling PJ, 2004, EUKARYOT CELL, V3, P1363, DOI 10.1128/EC.3.6.1363-1369.2004; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lin K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004078; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; Marleau J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-51; Rodriguez JAM, 2010, J PLANT PHYSIOL, V167, P606, DOI 10.1016/j.jplph.2009.11.014; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; McDonald AE, 2009, J EXP BIOL, V212, P2627, DOI 10.1242/jeb.032151; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Morin E, 2013, P NATL ACAD SCI USA, V110, P4146, DOI 10.1073/pnas.1300201110; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Polidoros AN, 2009, PHYSIOL PLANTARUM, V137, P342, DOI 10.1111/j.1399-3054.2009.01284.x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rhoads DM, 1998, J BIOL CHEM, V273, P30750, DOI 10.1074/jbc.273.46.30750; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEODOROU ME, 1991, PLANT PHYSIOL, V95, P1089, DOI 10.1104/pp.95.4.1089; Thomazella DPT, 2012, NEW PHYTOL, V194, P1025, DOI 10.1111/j.1469-8137.2012.04119.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Umbach AL, 2000, ARCH BIOCHEM BIOPHYS, V378, P234, DOI 10.1006/abbi.2000.1834; Umbach AL, 2002, BBA-BIOENERGETICS, V1554, P118, DOI 10.1016/S0005-2728(02)00219-0; Umbach AL, 1996, J BIOL CHEM, V271, P25019, DOI 10.1074/jbc.271.40.25019; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vicente C, 2008, 1 INT AOX S, P58; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Xu T, 2012, J MICROBIOL, V50, P594, DOI 10.1007/s12275-012-2015-7; Yip JYH, 2001, PHYSIOL PLANTARUM, V112, P327, DOI 10.1034/j.1399-3054.2001.1120305.x	78	15	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142339	10.1371/journal.pone.0142339	http://dx.doi.org/10.1371/journal.pone.0142339			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540237	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800085
J	Fujita, A; Kimura, K; Yokoyama, S; Jin, W; Wachino, J; Yamada, K; Suematsu, H; Yamagishi, Y; Mikamo, H; Arakawa, Y				Fujita, Ai; Kimura, Kouji; Yokoyama, Satoru; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Suematsu, Hiroyuki; Yamagishi, Yuka; Mikamo, Hiroshige; Arakawa, Yoshichika			Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak	PLoS One			English	Article							SPECTRUM BETA-LACTAMASE; HEMORRHAGIC COLITIS; STRAINS; ENTEROBACTERIACEAE; OVERPRODUCTION; EPIDEMIOLOGY; TAZOBACTAM; PNEUMONIAE; PROMOTERS; HOSPITALS	We characterized 12 clinical isolates of Klebsiella oxytoca with the extended-spectrum beta-lactamase (ESBL) phenotype (high minimum inhibitory concentration [MIC] values of ceftriaxone) recovered over 9 months at a university hospital in Japan. To determine the clonality of the isolates, we used pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and PCR analyses to detect bla(RBI), which encodes the beta-lactamase RbiA, OXY-2-4 with overproduce-type promoter. Moreover, we performed the isoelectric focusing (IEF) of beta-lactamases, and the determination of the MICs of beta-lactams including piperacillin/tazobactam for 12 clinical isolates and E. coli HB101 with pKOB23, which contains blaRBI, by the agar dilution method. Finally, we performed the initial screening and phenotypic confirmatory tests for ESBLs. Each of the 12 clinical isolates had an identical PFGE pulsotype and MLST sequence type (ST9). All 12 clinical isolates harbored identical blaRBI. The IEF revealed that the clinical isolate produced only one beta-lactamase. E. coli HB101 (pKOB23) and all 12 isolates demonstrated equally resistance to piperacillin/tazobactam (MICs, > 128 mu g/ml). The phenotypic confirmatory test after the initial screening test for ESBLs can discriminate beta-lactamase RbiA-producing K. oxytoca from beta-lactamase CTX-M-producing K. oxytoca. Twelve clinical isolates of K. oxytoca, which were recovered from an outbreak at one university hospital, had identical genotypes and produced beta-lactamase RbiA that conferred resistance to piperacillin/tazobactam. In order to detect K. oxytoca isolates that produce RbiA to promote research concerning beta-lactamase RbiA-producing K. oxytoca, the phenotypic confirmatory test after the initial screening test for ESBLs would be useful.	[Fujita, Ai; Kimura, Kouji; Yokoyama, Satoru; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Suematsu, Hiroyuki; Yamagishi, Yuka; Mikamo, Hiroshige] Aichi Med Univ, Grad Sch Med, Dept Clin Infect Dis, Nagakute, Aichi 4801195, Japan	Nagoya University; Aichi Medical University	Kimura, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	koujikim@med.nagoya-u.ac.jp	Arakawa, Yoshichika/P-5997-2015; Wachino, Jun-ichi/A-1346-2016; jin, wanchun/B-8463-2016; Kimura, Kouji/C-1847-2015	Yamada, Keiko/0000-0003-4510-0948	Ministry of Health, Labour and Welfare of Japan [H21-Shinkou-Ippan-008, H24-Shinkou-Ippan-010]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants H21-Shinkou-Ippan-008 and H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare of Japan and, in part, by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ARAKAWA Y, 1989, ANTIMICROB AGENTS CH, V33, P63, DOI 10.1128/AAC.33.1.63; CHEN HY, 1993, J ANTIMICROB CHEMOTH, V32, P247, DOI 10.1093/jac/32.2.247; Clinical Laboratory Standards Institute, 2010, M100S20 CLIN LAB S S; Decre D, 2004, J ANTIMICROB CHEMOTH, V54, P881, DOI 10.1093/jac/dkh440; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P3453, DOI 10.1128/AAC.49.8.3453-3462.2005; Fournier B, 1997, ANTIMICROB AGENTS CH, V41, P1641, DOI 10.1128/AAC.41.8.1641; Fournier B, 1999, ANTIMICROB AGENTS CH, V43, P850, DOI 10.1128/AAC.43.4.850; FOURNIER B, 1994, FEMS MICROBIOL LETT, V116, P31, DOI 10.1016/0378-1097(94)90103-1; FOURNIER B, 1995, ANTIMICROB AGENTS CH, V39, P1365, DOI 10.1128/AAC.39.6.1365; Fournier B, 1996, ANTIMICROB AGENTS CH, V40, P460, DOI 10.1128/AAC.40.2.460; Fournier B, 1996, ANTIMICROB AGENTS CH, V40, P454, DOI 10.1128/AAC.40.2.454; Granier SA, 2003, ANTIMICROB AGENTS CH, V47, P2922, DOI 10.1128/AAC.47.9.2922-2928.2003; Herzog KAT, 2014, J CLIN MICROBIOL, V52, P1607, DOI 10.1128/JCM.03373-13; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Hoenigl M, 2012, ANTIMICROB AGENTS CH, V56, P2158, DOI 10.1128/AAC.05440-11; Kimura K, 1996, ANTIMICROB AGENTS CH, V40, P1988, DOI 10.1128/AAC.40.9.1988; Leitner E, 2015, ANTIMICROB AGENTS CH, V59, P714, DOI 10.1128/AAC.04306-14; Li H, 2015, ANTIMICROB AGENTS CH, V59, P1794, DOI 10.1128/AAC.04191-14; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Livermore DM, 1996, J ANTIMICROB CHEMOTH, V38, P409, DOI 10.1093/jac/38.3.409; Marchese A, 1998, ANTIMICROB AGENTS CH, V42, P464; MATTHEW M, 1976, J GEN MICROBIOL, V94, P55, DOI 10.1099/00221287-94-1-55; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Potz NAC, 2004, J ANTIMICROB CHEMOTH, V53, P545, DOI 10.1093/jac/dkh112; Sirot D, 1998, ANTIMICROB AGENTS CH, V42, P2184, DOI 10.1128/AAC.42.9.2184; SYKES RB, 1982, ANTIMICROB AGENTS CH, V21, P85, DOI 10.1128/AAC.21.1.85; Thomson KS, 2001, ANTIMICROB AGENTS CH, V45, P3548, DOI 10.1128/AAC.45.12.3548-3554.2001; Wu SW, 1999, ANTIMICROB AGENTS CH, V43, P1350, DOI 10.1128/AAC.43.6.1350; Wu SW, 1999, ANTIMICROB AGENTS CH, V43, P1294, DOI 10.1128/AAC.43.5.1294; Yigit H, 2003, ANTIMICROB AGENTS CH, V47, P3881, DOI 10.1128/AAC.47.12.3881-3889.2003; Zarate MS, 2008, J CLIN MICROBIOL, V46, P2099, DOI 10.1128/JCM.00194-08	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142366	10.1371/journal.pone.0142366	http://dx.doi.org/10.1371/journal.pone.0142366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539828	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800090
J	Hasegawa, S; Goto, S; Tsuji, H; Okuno, T; Asahara, T; Nomoto, K; Shibata, A; Fujisawa, Y; Minato, T; Okamoto, A; Ohno, K; Hirayama, M				Hasegawa, Satoru; Goto, Sae; Tsuji, Hirokazu; Okuno, Tatsuya; Asahara, Takashi; Nomoto, Koji; Shibata, Akihide; Fujisawa, Yoshiro; Minato, Tomomi; Okamoto, Akira; Ohno, Kinji; Hirayama, Masaaki			Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease	PLOS ONE			English	Article							BACTERIAL OVERGROWTH; FECAL MICROBIOTA; MOUSE MODEL; HYDROGEN; LACTULOSE; MARKER; SYSTEM; WATER; RISK	Background The intestine is one of the first affected organs in Parkinson's disease (PD). PD subjects show abnormal staining for Escherichia coli and a-synuclein in the colon. Methods We recruited 52 PD patients and 36 healthy cohabitants. We measured serum markers and quantified the numbers of 19 fecal bacterial groups/genera/species by quantitative RT-PCR of 16S or 23S rRNA. Although the six most predominant bacterial groups/genera/species covered on average 71.3% of total intestinal bacteria, our analysis was not comprehensive compared to metagenome analysis or 16S rRNA amplicon sequencing. Results In PD, the number of Lactobacillus was higher, while the sum of analyzed bacteria, Clostridium coccoides group, and Bacteroides fragilis group were lower than controls. Additionally, the sum of putative hydrogen-producing bacteria was lower in PD. A linear regression model to predict disease durations demonstrated that C. coccoides group and Lactobacillus gasseri subgroup had the largest negative and positive coefficients, respectively. As a linear regression model to predict stool frequencies showed that these bacteria were not associated with constipation, changes in these bacteria were unlikely to represent worsening of constipation in the course of progression of PD. In PD, the serum lipopolysaccharide (LPS)binding protein levels were lower than controls, while the levels of serum diamine oxidase, a marker for intestinal mucosal integrity, remained unchanged in PD. Conclusions The permeability to LPS is likely to be increased without compromising the integrity of intestinal mucosa in PD. The increased intestinal permeability in PD may make the patients susceptible to intestinal dysbiosis. Conversely, intestinal dysbiosis may lead to the increased intestinal permeability. One or both of the two mechanisms may be operational in development and progression of PD.	[Hasegawa, Satoru; Goto, Sae; Fujisawa, Yoshiro; Minato, Tomomi; Hirayama, Masaaki] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Hasegawa, Satoru; Okuno, Tatsuya; Shibata, Akihide; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Tsuji, Hirokazu; Asahara, Takashi; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Okamoto, Akira] Aichi Univ Educ, Dept Sch Hlth Sci, Kariya, Aichi 448, Japan	Nagoya University; Nagoya University; Yakult Honsha Company, Limited; Aichi University Education	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp; hirasan@met.nagoya-u.ac.jp	Okuno, Tatsuya/ABD-6927-2020; Hirayama, Masaaki/ABH-2669-2020; Ohno, Kinji/ABD-5787-2020; Hirayama, Masaaki/I-9341-2018; Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750; Hirayama, Masaaki/0000-0003-0092-7837; Ohno, Kinji/0000-0002-1529-2750; Hirokazu, Tsuji/0000-0003-2856-6447	MEXT; MHLW of Japan; Yakult Central Institute; Grants-in-Aid for Scientific Research [25870317] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MHLW of Japan; Yakult Central Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Grants-in-Aid from the MEXT and MHLW of Japan, as well as Yakult Central Institute. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Yakult Central Institute provided support in the form of salaries for authors [HT, TA, and KN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Baranowska B, 1997, METABOLISM, V46, P1384, DOI 10.1016/S0026-0495(97)90136-0; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Fasano A, 2013, MOVEMENT DISORD, V28, P1241, DOI 10.1002/mds.25522; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; FROON AHM, 1995, J INFECT DIS, V171, P1250, DOI 10.1093/infdis/171.5.1250; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Gabrielli M, 2011, MOVEMENT DISORD, V26, P889, DOI 10.1002/mds.23566; Gasbarrini A, 2007, DIGEST DIS, V25, P237, DOI 10.1159/000103892; Goldman SM, 2014, MOVEMENT DISORD, V29, P1171, DOI 10.1002/mds.25895; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; HIRAYAMA M, 1995, J AUTONOM NERV SYST, V53, P230, DOI 10.1016/0165-1838(95)00002-F; Ito M, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-15; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kobayashi M, 2006, CHEM SENSES, V31, P335, DOI 10.1093/chemse/bjj037; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; LUK GD, 1980, J CLIN INVEST, V66, P66, DOI 10.1172/JCI109836; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Mitsuoka T, 1996, Asia Pac J Clin Nutr, V5, P2; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Parkinson J., ESSAY SHAKING PALSY1; Pierantozzi M, 2006, NEUROLOGY, V66, P1824, DOI 10.1212/01.wnl.0000221672.01272.ba; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Tan AH, 2015, PARKINSONISM RELAT D, V21, P221, DOI 10.1016/j.parkreldis.2014.12.009; Tan AH, 2014, PARKINSONISM RELAT D, V20, P535, DOI 10.1016/j.parkreldis.2014.02.019; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Yoritaka A, 2013, MOVEMENT DISORD, V28, P836, DOI 10.1002/mds.25375	52	261	271	10	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142164	10.1371/journal.pone.0142164	http://dx.doi.org/10.1371/journal.pone.0142164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539989	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800061
J	Liu, QH; Pan, DH; Cheng, C; Zhang, DZ; Zhang, AY; Wang, LZ; Jiang, HD; Wang, T; Liu, HR; Xu, YP; Yang, RL; Chen, F; Yang, M; Zuo, CJ				Liu, Qinghua; Pan, Donghui; Cheng, Chao; Zhang, Dazhi; Zhang, Anyu; Wang, Lizhen; Jiang, Hongdie; Wang, Tao; Liu, Hongrui; Xu, Yuping; Yang, Runlin; Chen, Fei; Yang, Min; Zuo, Changjing			Development of a Novel PET Tracer [F-18]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; PROSTATE-CANCER; GELATINASE ACTIVITY; INHIBITOR; MATRIX-METALLOPROTEINASE-2; PROGRESSION; PROGNOSIS; PEPTIDE; DESIGN; CELLS	Background and Objective The overexpression of gelatinases, that is, matrix metalloproteinase MMP2 and MMP9, has been associated with tumor progression, invasion, and metastasis. To image MMP2 in tumors, we developed a novel ligand termed [F-18] AlF-NOTA-C6, with consideration that: c (KAHWGFTLD)NH2 (herein, C6) is a selective gelatinase inhibitor; Cy5.5-C6 has been visualized in many in vivo tumor models; positron emission tomography (PET) has a higher detection sensitivity and a wider field of view than optical imaging; fluorine-18 (F-18) is the optimal PET radioisotope, and the creation of a [F-18] AlF-peptide complex is a simple procedure. Methods C6 was conjugated to the bifunctional chelator NOTA (1, 4, 7-triazacyclononanetriacetic acid) for radiolabeling [F-18] AlF conjugation. The MMP2-binding characteristics and tumor-targeting efficacy of [F-18] AlF-NOTA-C6 were tested in vitro and in vivo. Results The non-decay corrected yield of [F-18] AlF-NOTA-C6 was 46.2-64.2%, and the radiochemical purity exceeded 95%. [F-18] AlF-NOTA-C6 was favorably retained in SKOV3 and PC3 cells, determined by cell uptake. Using NOTA-C6 as a competitive ligand, the uptake of [F-18] AlF-NOTA-C6 in SKOV3 cells decreased in a dose-dependent manner. In biodistribution and PET imaging studies, higher radioactivity concentrations were observed in tumors. Pre-injection of C6 caused a marked reduction in tumor tissue uptake. Immunohistochemistry showed MMP2 in tumor tissues. Conclusions [F-18]AlF-NOTA-C6 was easy to synthesize and has substantial potential as an imaging agent that targets MMP2 in tumors.	[Liu, Qinghua; Cheng, Chao; Zhang, Anyu; Jiang, Hongdie; Wang, Tao; Zuo, Changjing] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China; [Pan, Donghui; Wang, Lizhen; Xu, Yuping; Yang, Runlin; Chen, Fei; Yang, Min] Minist Hlth, Key Lab Nucl Med, Jiangsu Inst Nucl Med, Wuxi 214063, Peoples R China; [Zhang, Dazhi] Second Mil Med Univ, Sch Pharm, Dept Organ Chem, Shanghai 200433, Peoples R China; [Liu, Hongrui] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Liu, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China.	shlqh@126.com; ymzfk@163.com; changjing.zuo@qq.com		Yang, Min/0000-0001-6976-8526	Shanghai Municipal Natural Science Foundation of China [13ZR1409100]; National Nature Science Foundation of China [81471714]	Shanghai Municipal Natural Science Foundation of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Shanghai Municipal Natural Science Foundation of China (grant no. 13ZR1409100) and the National Nature Science Foundation of China (grant no. 81471714).	Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Garzetti GG, 1995, ANTICANCER RES, V15, P2799; Gohji K, 1998, INT J CANCER, V79, P96, DOI 10.1002/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Hanaoka H, 2007, NUCL MED BIOL, V34, P503, DOI 10.1016/j.nucmedbio.2007.04.002; Higashi S, 2013, J BIOL CHEM, V288, P9066, DOI 10.1074/jbc.M112.441758; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Karakiulakis George, 1997, Invasion and Metastasis, V17, P158; Kawano T, 2015, INT J MOL SCI, V16, P148, DOI 10.3390/ijms16010148; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346; Kuhnast B, 2004, NUCL MED BIOL, V31, P337, DOI 10.1016/j.nucmedbio.2003.10.011; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Laverman P, 2010, J NUCL MED, V51, P454, DOI 10.2967/jnumed.109.066902; Lee CM, 2012, INT J CANCER, V131, P1846, DOI 10.1002/ijc.27451; Liu ZB, 2014, ANGEW CHEM INT EDIT, V53, P11876, DOI 10.1002/anie.201406258; Liu ZB, 2014, J NUCL MED, V55, P1499, DOI 10.2967/jnumed.114.137836; McBride WJ, 2009, J NUCL MED, V50, P991, DOI 10.2967/jnumed.108.060418; Medina OP, 2005, ANTICANCER RES, V25, P33; Mehta RK, 2014, J BIOL CHEM, V289, P3555, DOI [10.1074/jbc.M113.486530, 10.4331/wjbc.v5.i3.355]; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shao YH, 2014, MOLECULES, V19, P11600, DOI 10.3390/molecules190811600; Sprague JE, 2006, NUCL MED BIOL, V33, P227, DOI 10.1016/j.nucmedbio.2005.10.011; Trudel D, 2008, HUM PATHOL, V39, P731, DOI 10.1016/j.humpath.2007.09.021; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vijayababu MR, 2006, MOL CELL BIOCHEM, V287, P109, DOI 10.1007/s11010-005-9085-3; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; W01ngler C, 2012, NATURE PROTOCOLS, P7; Wang W, 2009, MOL IMAGING BIOL, V11, P424, DOI 10.1007/s11307-009-0219-y; Xu YP, 2014, MOL IMAGING BIOL, V16, P578, DOI 10.1007/s11307-013-0712-1; Zhang J, 2014, NUCL MED BIOL, V41, P268, DOI 10.1016/j.nucmedbio.2013.12.008	37	7	7	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141668	10.1371/journal.pone.0141668	http://dx.doi.org/10.1371/journal.pone.0141668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540114	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800022
J	Laplana, C; Sevilla, P; Arsuaga, JL; Arriaza, MC; Baquedano, E; Perez-Gonzalez, A; Lopez-Martinez, N				Laplana, Cesar; Sevilla, Paloma; Luis Arsuaga, Juan; Carmen Arriaza, Mari; Baquedano, Enrique; Perez-Gonzalez, Alfredo; Lopez-Martinez, Nieves			How Far into Europe Did Pikas (Lagomorpha: Ochotonidae) Go during the Pleistocene? New Evidence from Central Iberia	PLOS ONE			English	Article							MAMMALIA; CAVE; EURASIA; RECORD; GENUS	This paper reports the first find of pika remains in the Iberian Peninsula, at a site in central Spain. A fragmented mandible of Ochotona cf. pusilla was unearthed from Layer 3 (deposited some 63.4 +/- 5.5 ka ago as determined by thermoluminescence) of the Buena Pinta Cave. This record establishes new limits for the genus geographic distribution during the Pleistocene, shifting the previous edge of its known range southwest by some 500 km. It also supports the idea that, even though Europe's alpine mountain ranges represented a barrier that prevented the dispersal into the south to this and other taxa of small mammals from central and eastern Europe, they were crossed or circumvented at the coldest time intervals of the end of the Middle Pleistocene and of the Late Pleistocene. During those periods both the reduction of the forest cover and the emersion of large areas of the continental shelf due to the drop of the sea level probably provided these species a way to surpass this barrier. The pika mandible was found accompanying the remains of other small mammals adapted to cold climates, indicating the presence of steppe environments in central Iberia during the Late Pleistocene.	[Laplana, Cesar; Baquedano, Enrique] Museo Arqueol Reg Comunidad Madrid, Madrid, Spain; [Sevilla, Paloma; Luis Arsuaga, Juan; Lopez-Martinez, Nieves] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Luis Arsuaga, Juan] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid, Spain; [Carmen Arriaza, Mari] Univ Alcala de Henares, Dept Geol Geog & Medio Ambiente, E-28871 Alcala De Henares, Spain; [Carmen Arriaza, Mari; Baquedano, Enrique] Inst Evoluc Africa IDEA, Madrid, Spain; [Perez-Gonzalez, Alfredo] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain	Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH)	Laplana, C (corresponding author), Museo Arqueol Reg Comunidad Madrid, Madrid, Spain.	cesar.laplana@gmail.com	del Carmen Arriaza Dorado, María/AAB-3468-2021; Sevilla, Paloma/Q-2813-2019; Baquedano, Enrique/ABE-9997-2020; Laplana, César/H-6532-2015	del Carmen Arriaza Dorado, María/0000-0003-1393-4323; Sevilla, Paloma/0000-0001-7425-7173; Laplana, César/0000-0002-2067-4091; Arsuaga, Juan Luis/0000-0001-5361-2295	Madrid Regional Government's Consejeria de Educacion I+D activities programme [S2010/BMD-2330]; Museo Arqueologico Regional de la Comunidad de Madrid; Grupo Mahou	Madrid Regional Government's Consejeria de Educacion I+D activities programme; Museo Arqueologico Regional de la Comunidad de Madrid; Grupo Mahou	Funding: This research was funded by the Madrid Regional Government's Consejeria de Educacion I+D activities programme for research groups (project number S2010/BMD-2330), and also by the Museo Arqueologico Regional de la Comunidad de Madrid and Grupo Mahou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuna J., 1992, LATE QUATERNARY W PY, P15; Alvarez-Lao DJ, 2010, QUATERN INT, V212, P120, DOI 10.1016/j.quaint.2009.02.029; Angelone C, 2009, J PALEONTOL, V83, P80, DOI 10.1666/07-067R2.1; [Anonymous], PLEISTOCENE HOLOCENE; [Anonymous], 2005, NEANDERTALES CANTABR; Argant Jacqueline, 2007, Geoloshki Anali Balkanskoga Poluostrva, V68, P73; Arribas O., 2004, FAUNA PAISAJE PIRINE; Bartolomei G, 1982, ANN U FERRARA, V3, P61; Callou C., 1990, DIAGNOSE DIFFERENT B; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Chaline J., 1975, NOUV ARCH MUS HIST N, V13, P3; Desclaux Emmanuel, 1997, Quaternaire, V8, P213; Desnoyers J., 1842, B SOC GEOL FR, V13, P290; Dimitrijevic V., 1988, ANN GEOL PENINS, V51, P379; Dimitrijevic Vesna, 1996, Acta Zoologica Cracoviensia, V39, P117; Dimitrijevic Vesna, 2002, Srpska Akademija Nauka i Umetnosti Posebna Izdanja, V650, P113; Erbajeva MA, 2005, PALEONTOL J+, V39, P318; Erbajeva MA, 2008, 6 M EUR ASS VERT PAL, P38; Erbajeva Margarita A., 2001, Geodiversitas, V23, P395; Erbajeva MA, 2011, PALAEONTOL ELECTRON, V14; Fisher CT, 2004, MAMMAL REV, V34, P320, DOI 10.1111/j.1365-2907.2004.00052.x; Fladerer FA, 1997, MITT KOMM QUARTARFOR, V10, P320; Fladerer FA, 1992, MITT KOMM QUARTARFOR, V8, P189; Fostowicz-Frelik L, 2008, MAMMALIA, V72, P71, DOI 10.1515/MAMM.2008.011; Frank C, 1997, MITT KOMM QUARTARFOR, V10, P275; Frank C, 1997, MITT KOMM QUARTARFOR, V10, P157; Garda Ibaibarriaga N., 2012, EST CUAT, V2, P71; Ge DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059668; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Guadelli JL, 2006, RAPPORT MISSION PREH, P238; Hanquet C, 2011, QUATERNAIRE, V22, P35; Harle E., 1913, B SOC PREHIST FR, V10, P337; Jeannet M, 2009, MEM SOC PREHIST FR, V50, P87; Kahlke RD, 2014, QUATERNARY SCI REV, V96, P32, DOI 10.1016/j.quascirev.2013.01.012; Koby F. E., 1958, Bulletin de la Societe Prehistorique de l'Ariege, V13, P49; Koby FE, 1960, MAM PLEIST S1, V1, P101; Kozlowski JK, 1982, EXCAVATION BACHO KIR, P52; Laplana C, 2013, 29 JORNADAS PALEONTO, P87; Laplana C, 2016, CR PALEVOL, V15, P696, DOI 10.1016/j.crpv.2015.05.010; Laplana C, 2013, QUATERNAIRE, V24, P207, DOI 10.4000/quaternaire.6617; Laplana C, 2009, J VERTEBR PALEONTOL, V29, p132A; Lavocat R, 1966, FAUNES FLORES PREHIS, P397; Lister AM, 1997, NATO ASI SER SER I, V47, P287; Lopez-Garcfa JM, 2011, MICROMAMIFEROS PLEIS; Lopez-Martinez N., 1989, MEM MUSEO PALEONTOL, V3, P1; Lopez-Martinez Nieves, 2001, Lynx (Prague), V32, P215; Malez M., 1969, Museo Civico di Storia Naturale di Verona Memorie Fuori Serie, V3, P67; MALEZ M., 1966, BULL SCI CONS ACAD RSF YOUGOSLAVIE SECT A SCI NATUR TECH MED, V11, P5; Malez M., 1979, RAD JAZU, V383, P345; Marquet J.-C., 1988, Etudes et Recherches Archeologiques de l'Universite de Liege, P105; Marquet J-C., 1993, CAHIERS CLAISE S2, V2, P1; Marquet J-C., 1982, B AFEQ, V2-3, P105; Marquet Jean-Claude, 1998, Quaternaire, V9, P303; MAYHEW DF, 1978, P K NED AKAD B PHYS, V81, P302; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; Motll M., 1953, MITT MUS BERGBAU GEO, V11, P14; Paunesco Alexandra-Cristina, 2000, Travaux de l'Institut de Speologie "Emile Racovitza", V36, P135; Pavlovic G, 1991, ANN GEOL PENINS BALK, V55, P221; Pokines JT, 1998, BAR INT SER, V713, P1; POPOV V V, 1988, Acta Zoologica Cracoviensia, V31, P193; Popov V.V, 1985, ACTA ZOOL BULGAR, V26, P23; Popov Vasil, 2001, Acta Zoologica Bulgarica, V53, P79; Popov VV, 2007, COUR FOR SEKENBG, V259, P79; Popov Vasil V., 1994, Historical Biology, V8, P261; Prieto Cana D., 1995, SERIE DOCUMENTOS CTR, V17, P1; Purez-GonzuYlez A., 2010, ZONA ARQUEOLOGICA, V13, P404; Pushkina D, 2007, MAMMAL REV, V37, P224, DOI 10.1111/j.1365-2907.2007.00109.x; Rabeder G, 1974, HOHLE, V25, P142; Reiner G., 1995, MITT ABT GEOL PALAON, V52-53, P135; Reiner G, 1996, MITT ABT GEOL PALAON, V54, P43; Rodriguez J, 2011, QUATERNARY SCI REV, V30, P1396, DOI 10.1016/j.quascirev.2010.02.021; Rofes J, 2012, PALAEOGEOGR PALAEOCL, V348, P67, DOI 10.1016/j.palaeo.2012.06.016; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Ruiz Bustos A., 2000, AYUNTAMIENTO PINAR; Ruiz-Zapata B., 2008, GEOGACETA, V44, P83; Schmidt RR, 1912, DILUVIALE VORZEIT DE, P159; Smith Andrew T., 2008, P89, DOI 10.1007/978-3-540-72446-9_6; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stampfli HR, 1983, RISLISBERGHOHLE ARCH, P69; Stehlin HG, 1924, DENKSCHRIFTEN SCHWEI, V61, P1; Stuart A.J., 1985, P221; Sych L., 1980, FOLIA QUATERNARIA, V51, P57; Thenius E, 1959, MITT PRAHIST KOMM OS, V8, P133; von Koenigswald Wighart, 2003, Deinsea (Rotterdam), V10, P305; von Koenigswald W, 2010, J MAMM EVOL, V17, P275, DOI 10.1007/s10914-010-9140-z; Woldrich JN, 1893, DENKSCHR KAISERL AKA, V60, P565	87	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140513	10.1371/journal.pone.0140513	http://dx.doi.org/10.1371/journal.pone.0140513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535576	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400022
J	Mahony, D; Mody, KT; Cavallaro, AS; Hu, QH; Mahony, TJ; Qiao, SZ; Mitter, N				Mahony, Donna; Mody, Karishma T.; Cavallaro, Antonino S.; Hu, Qiuhong; Mahony, Timothy J.; Qiao, Shizhang; Mitter, Neena			Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation	PLOS ONE			English	Article							SYSTEMIC IMMUNE-RESPONSES; ADJUVANT; ANTIBODY; ANTIGEN; VACCINATION; PROTECTION; EFFICACY; DELIVERY; CARRIERS	Bovine viral diarrhoea virus 1 (BVDV-1) is arguably the most important viral disease of cattle. It is associated with reproductive, respiratory and chronic diseases in cattle across the world. In this study we have investigated the capacity of the major immunological determinant of BVDV-1, the E2 protein combined with hollow type mesoporous silica nanoparticles with surface amino functionalisation (HMSA), to stimulate immune responses in sheep. The current work also investigated the immunogenicity of the E2 nanoformulation before and after freeze-drying processes. The optimal excipient formulation for freeze-drying of the E2 nanoformulation was determined to be 5% trehalose and 1% glycine. This excipient formulation preserved both the E2 protein integrity and HMSA particle structure. Sheep were immunised three times at three week intervals by subcutaneous injection with 500 mu g E2 adsorbed to 6.2 mg HMSA as either a non-freeze-dried or freeze-dried nanoformulation. The capacity of both nanovaccine formulations to generate humoral (antibody) and cell-mediated responses in sheep were compared to the responses in sheep immunisation with Opti-E2 (500 mu g) together with the conventional adjuvant Quil-A (1 mg), a saponin from the Molina tree (Quillaja saponira). The level of the antibody responses detected to both the non-freeze-dried and freeze-dried Opti-E2/HMSA nanoformulations were similar to those obtained for Opti-E2 plus Quil-A, demonstrating the E2 nanoformulations were immunogenic in a large animal, and freeze-drying did not affect the immunogenicity of the E2 antigen. Importantly, it was demonstrated that the long term cell-mediated immune responses were detectable up to four months after immunisation. The cell-mediated immune responses were consistently high in all sheep immunised with the freeze-dried Opti-E2/HMSA nanovaccine formulation (> 2,290 SFU/million cells) compared to the non-freeze-dried nanovaccine formulation (213-500 SFU/million cells). This study is the first to demonstrate that a freeze-dried silica mesoporous nanovaccine formulation gives balanced immune responses in a production animal.	[Mahony, Donna; Mody, Karishma T.; Cavallaro, Antonino S.; Mahony, Timothy J.; Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia; [Hu, Qiuhong; Qiao, Shizhang] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia	University of Queensland; University of Adelaide	Mitter, N (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia.	n.mitter@uq.edu.au	Qiao, Shizhang/A-6057-2010; Mahony, Timothy J./C-9307-2013; mitter, neena/D-1862-2013	Qiao, Shizhang/0000-0002-4568-8422; Mahony, Timothy J./0000-0003-4573-7906; mitter, neena/0000-0001-6146-6179; Mody, Karishma/0000-0002-7499-7988; Cavallaro, Tony/0000-0002-3601-3386	Queensland Government through Department of Agriculture, Fisheries and Forestry's Reinvestment Fund	Queensland Government through Department of Agriculture, Fisheries and Forestry's Reinvestment Fund	This work was funded by the Queensland Government through The Department of Agriculture, Fisheries and Forestry's Reinvestment Fund.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Bruschke CJM, 1997, VACCINE, V15, P1940, DOI 10.1016/S0264-410X(97)00125-4; Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; De Rose R, 2002, VET IMMUNOL IMMUNOP, V90, P55, DOI 10.1016/S0165-2427(02)00221-0; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Guo HC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-108; Gupta R K, 1995, Pharm Biotechnol, V6, P229; Horwood PF, 2011, J VIROL METHODS, V171, P360, DOI 10.1016/j.jviromet.2010.11.020; Liu W, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060223; Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; Mahony TJ., 2012, DRUG DELIV LETT, V2, P83, DOI [DOI 10.2174/2210304X11202020083, 10.2174/2210304x11202020083]; Mercuri LP, 2006, SMALL, V2, P254, DOI 10.1002/smll.200500274; Mody KT, 2014, BIOMATERIALS, V35, P9972, DOI 10.1016/j.biomaterials.2014.08.044; Mody KT, 2014, INT J PHARMACEUT, V465, P325, DOI 10.1016/j.ijpharm.2014.01.037; Mody KT, 2013, NANOSCALE, V5, P5167, DOI 10.1039/c3nr00357d; Nelson G, 2012, VACCINE, V30, P4499, DOI 10.1016/j.vaccine.2012.04.068; Pecora A, 2012, VET RES COMMUN, V36, P157, DOI 10.1007/s11259-012-9526-x; Aguirreburualde MSP, 2012, REPROD DOMEST ANIM, V47, P915, DOI 10.1111/j.1439-0531.2012.01991.x; Popat A, 2011, NANOSCALE, V3, P2801, DOI 10.1039/c1nr10224a; Rothel JS, 1998, VET IMMUNOL IMMUNOP, V63, P167, DOI 10.1016/S0165-2427(98)00093-2; Sameti M, 2003, INT J PHARMACEUT, V266, P51, DOI 10.1016/S0378-5173(03)00380-6; Scheerlinck JPY, 2006, VACCINE, V24, P1124, DOI 10.1016/j.vaccine.2005.09.009; Snider M, 2014, VACCINE, V32, P6758, DOI 10.1016/j.vaccine.2014.10.010; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Thomas C, 2009, VACCINE, V27, P2387, DOI 10.1016/j.vaccine.2009.02.010; vanRijn PA, 1997, VIROLOGY, V237, P337, DOI 10.1006/viro.1997.8792; Wang TY, 2012, INT J PHARMACEUT, V436, P351, DOI 10.1016/j.ijpharm.2012.06.028	29	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141870	10.1371/journal.pone.0141870	http://dx.doi.org/10.1371/journal.pone.0141870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535891	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400095
J	Pang, W; Kim, YY; Li, X; Choi, SR; Wang, Y; Sung, CK; Im, S; Ramchiary, N; Zhou, GS; Lim, YP				Pang, Wenxing; Kim, Yoon-Young; Li, Xiaonan; Choi, Su Ryun; Wang, Yunbo; Sung, Chang-keun; Im, Subin; Ramchiary, Nirala; Zhou, Guangsheng; Lim, Yong Pyo			Anatomic Characteristics Associated with Head Splitting in Cabbage (Brassica oleracea var. capitata L.)	PLOS ONE			English	Article							DIAMONDBACK MOTH; EXPANSIN GENE; RESISTANCE; CRACKING; EXPRESSION	Cabbage belonging to Brassicaceae family is one of the most important vegetables cultivated worldwide. The economically important part of cabbage crop is head, formed by leaves which may be of splitting and non-splitting types. Cabbage varieties showing head splitting causes huge loss to the farmers and therefore finding the molecular and structural basis of splitting types would be helpful to breeders. To determine which anatomical characteristics were related to head-splitting in cabbage, we analyzed two contrasting cabbage lines and their offspring using a field emission scanning electron microscope. The inbred line "747" is an early head-splitting type, while the inbred line "748" is a head-splitting-resistant type. The petiole cells of "747" seems to be larger than those of "748" at maturity; however, there was no significant difference in petiole cell size at both pre-heading and maturity stages. The lower epidermis cells of "747" were larger than those of "748" at the pre-heading and maturity stages. "747" had thinner epidermis cell wall than "748" at maturity stage, however, there was no difference of the epidermis cell wall thickness in the two lines at the pre-heading stage. The head-splitting plants in the F-1 and F-2 population inherited the larger cell size and thinner cell walls of epidermis cells in the petiole. In the petiole cell walls of "747" and the F-1 and F-2 plants that formed splitting heads, the cellulose microfibrils were loose and had separated from each other. These findings verified that anomalous cellulose microfibrils, larger cell size and thinner-walled epidermis cells are important genetic factors that make cabbage heads prone to splitting.	[Pang, Wenxing; Kim, Yoon-Young; Li, Xiaonan; Choi, Su Ryun; Im, Subin; Lim, Yong Pyo] Chungnam Natl Univ, Mol Genet & Genom Lab, Dept Hort, Daejeon, South Korea; [Pang, Wenxing; Li, Xiaonan] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Wang, Yunbo; Sung, Chang-keun] Chungnam Natl Univ, Dept Food Sci & Technol, Coll Agr & Biotechnol, Daejeon, South Korea; [Ramchiary, Nirala] Jawaharlal Nehru Univ, Sch Life Sci, Translat & Evolutionary Genom Lab, New Delhi 110067, India; [Zhou, Guangsheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Chungnam National University; Shenyang Agricultural University; Chungnam National University; Jawaharlal Nehru University, New Delhi; Huazhong Agricultural University	Lim, YP (corresponding author), Chungnam Natl Univ, Mol Genet & Genom Lab, Dept Hort, Daejeon, South Korea.	yplim@cnu.ac.kr	Ramchiary, Nirala/AAM-7695-2021; Pang, Wenxing/GLR-9367-2022; 최, 수련/AHE-1934-2022	Sung, Changkeun/0000-0001-7929-9567; Kim, Yoon-Young/0000-0003-4954-6365	Golden Seed Project [213002-04-1-SB110]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This work was supported by the Golden Seed Project (No. 213002-04-1-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	Balbontin C, 2013, CHIL J AGR RES, V73, P66, DOI 10.4067/S0718-58392013000100010; CHIANG MS, 1972, EUPHYTICA, V21, P507, DOI 10.1007/BF00039347; Christensen JV, 1976, DAN J PLANT SOIL SCI, V80, P289; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; DICKSON MH, 1980, J AM SOC HORTIC SCI, V105, P782; EIGENBRODE SD, 1991, J ECON ENTOMOL, V84, P1609, DOI 10.1093/jee/84.5.1609; Fujita M, 2014, PROTOPLASMA, V251, P687, DOI 10.1007/s00709-013-0571-2; Gomez-Campo C, 1999, ANN BOT-LONDON, V83, P515, DOI 10.1006/anbo.1999.0849; Kasai S, 2008, SCI HORTIC-AMSTERDAM, V116, P194, DOI 10.1016/j.scienta.2007.12.002; Matas AJ, 2004, HORTSCIENCE, V39, P1354, DOI 10.21273/HORTSCI.39.6.1354; Niu Na, 2010, China Vegetables, P44; Pang W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0318-1; Peet M. M., 1992, HortTechnology, V2, P216; PROCTOR JTA, 1980, CAN PLANT DIS SURV, V60, P55; Ramchiary N, 2015, THEOR APPL GENET, V128, P1209, DOI 10.1007/s00122-015-2501-5; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Rose JKC, 1997, P NATL ACAD SCI USA, V94, P5955, DOI 10.1073/pnas.94.11.5955; Su YanBin, 2012, Acta Horticulturae Sinica, V39, P1482; Weijschede J, 2008, AM J BOT, V95, P41, DOI 10.3732/ajb.95.1.41; Wolfmeier U., 2000, ULLMANNS ENCY IND CH; Yong W, 2006, J AM SOC HORTIC SCI, V131, P118, DOI 10.21273/JASHS.131.1.118; Zeng A., 2009, ACTA AGR BOREALI SIN, V24, P41; Znidarcic D., 2008, Acta Agriculturae Slovenica, V91, P361, DOI 10.2478/v10014-008-0016-3	24	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142202	10.1371/journal.pone.0142202	http://dx.doi.org/10.1371/journal.pone.0142202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536356	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400144
J	Zhang, L; Wu, CY; Hoffman, RM				Zhang, Lei; Wu, Chengyu; Hoffman, Robert M.			Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells	PLOS ONE			English	Article							FLUORESCENT PROTEINS; MOUSE MODEL; IN-VIVO; TUMOR; CULTURE; LQ	In order to further understand the role of tumor heterogeneity in metastasis and chemoresistance, high metastatic PC-3 human prostate cancer variants were selected by injecting parental PC-3 cells, expressing green fluorescent protein (GFP) in the footpad of nude mice, which then metastasize to inguinal lymph nodes. The PC-3-GFP cells which metastasized to the inguinal lymph nodes were collected and were re-injected to the footpad. After 6 such cycles, the PC-3-GFP cells collected from inguinal lymph nodes (PC-3-GFP-LN) were again injected to the footpad. PC-3-GFP-LN showed 100% metastasis to major lymph nodes (popliteal, inguinal, axillary, and cervical), and 100% metastasis to bone and lung. The percent of giant cell variants was enriched in PC-3-GFP-LN-6 compared to parental cells and increased with each cycle of selection, which in turn had increased metastasis. PC-3-GFP-LN-6 cells were resistant to 5-fluorouracil, doxorubicin and cisplatinum, compared to parental PC-3. However, PC-3-GFP-LN-6 was sensitive to the traditional Chinese medicine (TCM) herbal mixture LQ, similar to the parental cells. These results suggest that PC-3 tumors are heterogenous and that subpopulations of highly metastatic, drug-resistant cells can be step-wise selected using a mouse model of tumor progression.	[Zhang, Lei; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Wu, Chengyu] Nanjing Univ Tradit Chinese Med, Dept Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Anti Cancer Inc; Nanjing University of Chinese Medicine; University of California System; University of California San Diego	Wu, CY (corresponding author), Nanjing Univ Tradit Chinese Med, Dept Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.	chengyu720@yahoo.com.cn; all@anticancer.com			AntiCancer Inc.	AntiCancer Inc.(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR))	Funding: The authors received no specific funding for this work. AntiCancer Inc., provided support in the form of salary for an author [LZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bhatia S, 2012, NAT BIOTECHNOL, V30, P604, DOI 10.1038/nbt.2294; Bobek V, 2013, DIAGN CYTOPATHOL, V41, P413, DOI 10.1002/dc.22843; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Glinskii AB, 2003, CANCER RES, V63, P4239; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kolostova K, 2011, ANTICANCER RES, V31, P1535; Luo Jan, 1997, Pathol Oncol Res, V3, P264; Menen R, 2012, ANTICANCER RES, V32, P2881; Menen R, 2012, ANTICANCER RES, V32, P1573; Menen RS, 2011, ANTICANCER RES, V31, P3125; Miwa S, 2015, CELL CYCLE, V14, P621, DOI 10.4161/15384101.2014.991604; Yang M, 2005, PROSTATE, V62, P374, DOI 10.1002/pros.20125; Yang M, 1999, CANCER RES, V59, P781; Zhang L, 2015, ONCOTARGET, V6, P5292, DOI 10.18632/oncotarget.2983; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109814; Zhang L, 2013, J CELL BIOCHEM, V114, P2131, DOI 10.1002/jcb.24561	19	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140721	10.1371/journal.pone.0140721	http://dx.doi.org/10.1371/journal.pone.0140721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536025	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400033
J	Chen, GS; Wang, XM; Hao, JJ; Yan, JB; Ding, JQ				Chen, Gengshen; Wang, Xiaoming; Hao, Junjie; Yan, Jianbing; Ding, Junqiang			Genome-Wide Association Implicates Candidate Genes Conferring Resistance to Maize Rough Dwarf Disease in Maize	PLOS ONE			English	Article							ANTIFREEZE PROTEINS; POPULATION; VIRUS; ACTIVATION; EXPRESSION; FIJIVIRUS	Maize rough dwarf disease (MRDD) is a destructive viral disease in China, which results in 20-30% of the maize yield losses in affected areas and even as high as 100% in severely infected fields. Understanding the genetic basis of resistance will provide important insights for maize breeding program. In this study, a diverse maize population comprising of 527 inbred lines was evaluated in four environments and a genome-wide association study (GWAS) was undertaken with over 556000 SNP markers. Fifteen candidate genes associated with MRDD resistance were identified, including ten genes with annotated protein encoding functions. The homologous of nine candidate genes were predicted to relate to plant defense in different species based on published results. Significant correlation (R-2 = 0.79) between the MRDD severity and the number of resistance alleles was observed. Consequently, we have broadened the resistant germplasm to MRDD and identified a number of resistance alleles by GWAS. The results in present study also imply the candidate genes in defense pathway play an important role in resistance to MRDD in maize.	[Chen, Gengshen; Yan, Jianbing; Ding, Junqiang] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Wang, Xiaoming] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Hao, Junjie] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou 450002, Peoples R China; [Ding, Junqiang] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Ding, Junqiang] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Henan Academy of Agricultural Sciences; Henan Agricultural University; Henan Agricultural University	Ding, JQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	dingjunqiang1203@163.com			National Natural Science Foundation of China [31161140347]; DuPont Pioneer Company; Dunhuang Pioneer Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DuPont Pioneer Company; Dunhuang Pioneer Company	This work was supported by a grant from the National Natural Science Foundation of China (31161140347) and financially supported by DuPont Pioneer Company and Dunhuang Pioneer Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon MA, 2013, CROP PROT, V47, P1, DOI 10.1016/j.cropro.2013.01.002; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chen Y, 2010, J HEBEI AGR SCI, V14, P42; Chen YongKun, 2006, Acta Agronomica Sinica, V32, P1848; Di Renzo MA, 2004, J AGR SCI-CAMBRIDGE, V142, P289, DOI 10.1017/S0021859604004307; Dovas CI, 2004, PLANT PATHOL, V53, P238, DOI 10.1111/j.0032-0862.2004.00973.x; Fang S, 2001, ARCH VIROL, V146, P167, DOI 10.1007/s007050170200; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; GRAU CR, 1982, PLANT DIS, V66, P506, DOI 10.1094/PD-66-506; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Guo QuTang, 1995, Plant Protection, P21; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hao DR, 2015, EUPHYTICA, V203, P109, DOI 10.1007/s10681-014-1277-z; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Harpaz I, 1958, FAO PLANT PROTECT B, V7, P43; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Lenardon SL, 1998, PLANT DIS, V82, P448, DOI 10.1094/PDIS.1998.82.4.448C; Li TT, 2013, PLANT CELL, V25, P4725, DOI 10.1105/tpc.113.118802; Liu CL, 2014, EUR J PLANT PATHOL, V139, P205, DOI 10.1007/s10658-014-0383-z; Liu Z. Z., 1996, J MAIZE SCI, V4, P68; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Louie R., 1999, COMPENDIUM CORN DIS, P49; Lu S, 2013, MOL PLANT, V6, P1592, DOI 10.1093/mp/sst047; [吕鹏 LV Peng], 2010, [玉米科学, Maize Science], V18, P113; Miao HQ, 2005, J NW SCI TECH U AGR, V33, P1; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Pritchard JK, 2000, GENETICS, V155, P945; Redinbaugh Margaret G., 2009, P251, DOI 10.1007/978-0-387-79418-1_13; Rossi E.A., 2015, OPEN AGR J, P48, DOI [10.2174/1874331501509010048, DOI 10.2174/1874331501509010048]; Scharte J, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0812902106; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Sood S., 2014, GENOMICS PLANT GENET, P615, DOI [10.1007/978-94-007-7572-5_25, DOI 10.1007/978-94-007-7572-5_25]; Wang AnLe, 2005, Journal of Maize Sciences, V13, P114; Wang F., 2007, MOL PLANT BREED, V5, P178; Wang GuiYue, 2011, Acta Agriculturae Zhejiangensis, V23, P564; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou YiJun, 2000, Jiangsu Journal of Agricultural Sciences, V16, P159; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	61	55	58	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142001	10.1371/journal.pone.0142001	http://dx.doi.org/10.1371/journal.pone.0142001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529245	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600090
J	Chin, JH; Kim, WJ; Choi, JH; Han, YA; Kim, SO; Choi, WJ				Chin, Ji-Hyun; Kim, Wook-Jong; Choi, Jeong-Hyun; Han, Yun A.; Kim, Seon-Ok; Choi, Woo-Jong			Unreliable Tracking Ability of the Third-Generation FloTrac/Vigileo (TM) System for Changes in Stroke Volume after Fluid Administration in Patients with High Systemic Vascular Resistance during Laparoscopic Surgery	PLOS ONE			English	Article							CARDIAC-OUTPUT MEASUREMENT; EFFECTIVE ARTERIAL ELASTANCE; PULSE CONTOUR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ESOPHAGEAL DOPPLER; CIRRHOTIC-PATIENTS; VIGILEO-FLOTRAC; PRESSURE; IMPACT; WAVE	Background The FloTrac/Vigileo (TM) system does not thoroughly reflect variable arterial tones, due to a lack of external calibration. The ability of this system to measure stroke volume and track its changes after fluid administration has not been fully evaluated in patients with the high systemic vascular resistance that can develop during laparoscopic surgery. Methods In 42 patients undergoing laparoscopic prostatectomy, the stroke volume derived by the third-generation FloTrac/Vigileo (TM) system (SV-Vigileo), the stroke volume measured using transesophageal echocardiography (SV-TEE) as a reference method, and total systemic vascular resistance were evaluated before and after 500 ml fluid administration during pneumoperitoneum combined with the Trendelenburg position. Results Total systemic vascular resistance was 2159.4 +/- 523.5 dyn.s/cm(5) before fluid administration. The SV-Vigileo was significantly higher than the SV-TEE both before (68.8 +/- 15.9 vs. 57.0 +/- 11.0 ml, P < 0.001) and after (73.0 +/- 14.8 vs. 64.9 +/- 12.2 ml, P = 0.003) fluid administration. During pneumoperitoneum combined with the Trendelenburg position, Bland-Altman analysis for repeated measures showed a 53.8% of percentage error between the SV-Vigileo and the SV-TEE. Four-quadrant plot (69.2% of a concordance rate) and polar plot analysis (20.6 degrees of a mean polar angle, 16.4 degrees of the SD of a polar angle, and +/- 51.5 degrees of a radial sector containing 95% of the data points) did not indicate a good trending ability of the FloTrac/Vigileo (TM) system. Conclusions The third-generation FloTrac/Vigileo (TM) system may not be useful in patients undergoing laparoscopic surgery, based on unreliable performance in measuring the stroke volume and in tracking changes in the stroke volume after fluid administration during pneumoperitoneum combined with the Trendelenburg position.	[Chin, Ji-Hyun; Kim, Wook-Jong; Han, Yun A.; Choi, Woo-Jong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, Jeong-Hyun] Kyung Hee Univ, Sch Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea	University of Ulsan; Asan Medical Center; Kyung Hee University; University of Ulsan; Asan Medical Center	Choi, WJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	woojongchoi@amc.seoul.kr	Choi, Jeong-Hyun/AAI-1864-2020	Choi, Jeong-Hyun/0000-0003-1995-1220; Choi, Woo-Jong/0000-0002-5392-398X; Kim, Seonok/0000-0001-9010-5460				Alhashemi JA, 2011, CRIT CARE, V15, DOI 10.1186/cc9996; Biancofiore G, 2009, BRIT J ANAESTH, V102, P47, DOI 10.1093/bja/aen343; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Cecconi M, 2013, CRIT CARE, V17, DOI 10.1186/cc11823; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129; Chemla D, 2003, AM J PHYSIOL-HEART C, V285, pH614, DOI 10.1152/ajpheart.00823.2002; Chin JH, 2013, ANAESTH INTENS CARE, V41, P515, DOI 10.1177/0310057X1304100413; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; DARMON PL, 1994, ANESTHESIOLOGY, V80, P796, DOI 10.1097/00000542-199404000-00011; De Backer D, 2011, INTENS CARE MED, V37, P233, DOI 10.1007/s00134-010-2098-8; Hamzaoui O, 2008, CRIT CARE MED, V36, P434, DOI 10.1097/01.CCM.OB013E318161FEC4; INTAGLIETTA M, 1994, ARTIF CELL BLOOD SUB, V22, P137, DOI 10.3109/10731199409117409; Ji FH, 2015, J CLIN MONIT COMPUT, V29, P467, DOI 10.1007/s10877-014-9624-0; KASHTAN J, 1981, J SURG RES, V30, P249, DOI 10.1016/0022-4804(81)90156-6; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Manecke GR, 2005, EXPERT REV MED DEVIC, V2, P523, DOI 10.1586/17434440.2.5.523; Matthieu B, 2008, ANESTH ANALG, V106, P1480, DOI 10.1213/ane.0b013e318168b309; Mehta Y, 2014, WORLD J CARDIOL, V6, P1022, DOI 10.4330/wjc.v6.i9.1022; Meng LZ, 2011, ANESTH ANALG, V113, P751, DOI 10.1213/ANE.0b013e31822649fb; Metzelder S, 2011, BRIT J ANAESTH, V106, P776, DOI 10.1093/bja/aer066; Garcia MIM, 2013, CRIT CARE, V17, DOI 10.1186/cc12785; Monnet X, 2012, BRIT J ANAESTH, V108, P615, DOI 10.1093/bja/aer491; Mora B, 2011, ANAESTHESIA, V66, P675, DOI 10.1111/j.1365-2044.2011.06754.x; Perrino AC, 1998, ANESTHESIOLOGY, V89, P350, DOI 10.1097/00000542-199808000-00010; ROBSON SC, 1988, BRIT HEART J, V59, P680; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Suehiro K, 2013, BRIT J ANAESTH, V111, P170, DOI 10.1093/bja/aet022; Suehiro K, 2015, J CARDIOTHOR VASC AN, V29, P656, DOI 10.1053/j.jvca.2014.07.022; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026	31	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142125	10.1371/journal.pone.0142125	http://dx.doi.org/10.1371/journal.pone.0142125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529592	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600104
J	Faria-Schutzer, DB; Surita, FGD; Alves, VLP; Vieira, CM; Turato, ER				Faria-Schuetzer, Debora Bicudo; de Castro Surita, Fernanda Garanhani; Pereira Alves, Vera Lucia; Vieira, Carla Maria; Turato, Egberto Ribeiro			Emotional Experiences of Obese Women with Adequate Gestational Weight Variation: A Qualitative Study	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANT-WOMEN; HEALTH; ANXIETY; COHORT	Background As a result of the growth of the obese population, the number of obese women of fertile age has increased in the last few years. Obesity in pregnancy is related to greater levels of anxiety, depression and physical harm. However, pregnancy is an opportune moment for the intervention of health care professionals to address obesity. The objective of this study was to describe how obese pregnant women emotionally experience success in adequate weight control. Methods and Findings Using a qualitative design that seeks to understand content in the field of health, the sample of subjects was deliberated, with thirteen obese pregnant women selected to participate in an individual interview. Data was analysed by inductive content analysis and includes complete transcription of the interviews, re-readings using suspended attention, categorization in discussion topics and the qualitative and inductive analysis of the content. The analysis revealed four categories, three of which show the trajectory of body care that obese women experience during pregnancy: 1) The obese pregnant woman starts to think about her body; 2) The challenge of the diet for the obese pregnant woman; 3) The relation of the obese pregnant woman with the team of antenatal professionals. The fourth category reveals the origin of the motivation for the change: 4) The potentializing factors for change: the motivation of the obese woman while pregnant. Conclusions During pregnancy, obese women are more in touch with themselves and with their emotional conflicts. Through the transformations of their bodies, women can start a more refined self-care process and experience of the body-mind unit. The fear for their own and their baby's life, due to the risks posed by obesity, appears to be a great potentializing factor for change. The relationship with the professionals of the health care team plays an important role in the motivational support of the obese pregnant woman.	[Faria-Schuetzer, Debora Bicudo; de Castro Surita, Fernanda Garanhani] Univ Estadual Campinas, Sch Med Sci, Dept Gynecol & Obstet, Campinas, SP, Brazil; [Faria-Schuetzer, Debora Bicudo; de Castro Surita, Fernanda Garanhani; Pereira Alves, Vera Lucia; Vieira, Carla Maria; Turato, Egberto Ribeiro] Univ Estadual Campinas, Sch Med Sci, Clin Qualitat Res Lab, Campinas, SP, Brazil; [Pereira Alves, Vera Lucia; Vieira, Carla Maria; Turato, Egberto Ribeiro] Univ Estadual Campinas, Sch Med Sci, Dept Med Psychol & Psychiat, Campinas, SP, Brazil; [Vieira, Carla Maria] Univ Metodista Piracicaba, Dept Nutr, Piracicaba, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Metodista de Piracicaba	Faria-Schutzer, DB (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Gynecol & Obstet, Campinas, SP, Brazil.	defarbic@gmail.com	Faria-Schützer, Débora Bicudo/B-1505-2017; Surita, Fernanda Garanhani/H-9575-2012	Faria-Schützer, Débora Bicudo/0000-0001-7918-6714; Surita, Fernanda Garanhani/0000-0003-4335-0337	FAPESP [Sao Paulo Research Foundation] [2012/23121-5]	FAPESP [Sao Paulo Research Foundation](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support was provided by Regular research from FAPESP [Sao Paulo Research Foundation], process number 2012/23121-5.	Abram J., 2007, LANGUAGE WINNICOTT D; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Azerkan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107624; Fontanella BJ, 2008, CAD SAUDE PUBLICA, V24, P17, DOI 10.1590/S0102-311X2008000100003; Bardin L., 1977, LANALYSE DE CONTENU; Bianchedi ET, 1988, INTERNATIONAL JOURNA, V69, P359; Bodnar LM, 2009, J CLIN PSYCHIAT, V70, P1290, DOI 10.4088/JCP.08m04651; Bogaerts AFL, 2013, OBESITY FACTS, V6, P152, DOI 10.1159/000346315; Bogdan R., 1992, QUALITATIVE RES ED I; Campos Claudinei José Gomes, 2004, Rev. Bras. Enferm., V57, P611, DOI 10.1590/S0034-71672004000500019; Carter AS, 2000, PSYCHOSOM MED, V62, P264, DOI 10.1097/00006842-200003000-00019; Chamond J., 2009, NATUREZA HUMANA REV, V11, P7; Checchia C, 2015, PSYCHIAT PRAXIS; Clandinin DJ., 1994, HDB QUALITATIVE RES, P413; Coelho Junior N, 2010, REV BRASILEIRA PSICA, V44, P51; Coutinho WF., 1999, ARQ BRAS ENDOCRINOL, V43, P21; Daolio Jocimar, 2012, Pro-Posições, V23, P179, DOI 10.1590/S0103-73072012000300011; Figueiredo LC., 1995, CORPO MENTE FRONTEIR, P127; Freud S., 1922, PLEASURE PRINCIPLE; Furber CM, 2011, MIDWIFERY, V27, P437, DOI 10.1016/j.midw.2010.04.001; Furness PJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-69; Gavard JA, 2014, MATERN CHILD HLTH J, V18, P1038, DOI 10.1007/s10995-013-1356-0; Glaser B., 1999, DISCOVERY GROUNDED T; Godoy AC, 2014, PHYSL J, V2014, DOI [10.1155/2014/956960., DOI 10.1155/2014/956960]; Campos CJG, 2009, REV LAT-AM ENFERM, V17, P259, DOI 10.1590/S0104-11692009000200019; GOODMAN A, 1990, BRIT J ADDICT, V85, P1403; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hinshelwood R.D., 1989, DICT KLEINIAN THOUGH; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Klein M., 1952, DEV PSYCHOANALYSIS, P271; Laraia BA, 2009, OBESITY, V17, P550, DOI 10.1038/oby.2008.585; Lewis G., 2007, 7 CONFIDENTIAL ENQUI; Lincoln Y. S., 2000, HDB QUALITATIVE RE E, P163; Magdaleno R, 2011, OBES SURG, V21, P336, DOI 10.1007/s11695-009-9824-8; Magdaleno R, 2010, OBES SURG, V20, P1086, DOI 10.1007/s11695-008-9697-2; Maldonado MTP, 2005, PSYCHOL OBESITY; Mattar R, 2009, REV BRAS GINECOL OBS, V31, P107; McDougall J., 1986, THEATRES MIND ILLUSI; McDougall J., 1989, THEATRES BODY PSYCHO; Mehta UJ, 2011, BREASTFEED MED, V6, P369, DOI 10.1089/bfm.2010.0052; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Michaelis C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008075; Minayo MCS, 2014, THE CHALLENGE OF KNO; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; Moore M, 2015, PEDIAT CRIT CARE MED; Morse J. M., 1995, QUALITATIVE RES METH; Nyman VMK, 2010, MIDWIFERY, V26, P424, DOI 10.1016/j.midw.2008.10.008; Piccinini CA, 2012, VER PSICOLOGIA TEORI, V28, P27; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Raja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126708; ROTTER JB, 1990, AM PSYCHOL, V45, P489, DOI 10.1037/0003-066X.45.4.489; Sedinger-Leibovitz FM, 2015, PSYCHOLOGY, V6, P788; Smith D, 2011, BJOG-INT J OBSTET GY, V118, P779, DOI 10.1111/j.1471-0528.2011.02924.x; Tamayo A., 1989, PSICOL-TEOR PESQUI, V5, P111; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turato E.R, 2011, TRATADO METODOLOGIA; Turato ER, 2005, REV SAUDE PUBL, V39, P507, DOI 10.1590/S0034-89102005000300025; Vieira CM, 2014, PSYCHOL HEALTH MED, V19, P635, DOI 10.1080/13548506.2013.861601; Wanderley EN, 2010, OBESITY PLURAL PERSP; WHO, 2014, OB OV; Winnicott D. W., 1945, PEDIAT PSYCHOANALYSI; Winnicott DW., 1992, HUMAN NATURE	62	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141879	10.1371/journal.pone.0141879	http://dx.doi.org/10.1371/journal.pone.0141879			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529600	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600074
J	McKinnon, EA; Stanley, CQ; Stutchbury, BJM				McKinnon, Emily A.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.			Carry-Over Effects of Nonbreeding Habitat on Start-to-Finish Spring Migration Performance of a Songbird	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; WINTER HABITAT; FITNESS CONSEQUENCES; ENERGETIC CONDITION; AMERICAN REDSTARTS; SEASONAL-VARIATION; BIRD MIGRATION; STOPOVER SITE; ARRIVAL DATE; QUALITY	For migratory animals, conditions during the nonbreeding period may carry-over to influence spring migration performance. Animals in low-quality habitats are predicted to be in poorer condition, show later migration timing, and travel at slower speeds. This can result in subsequent negative effects on fitness. We tested the hypothesis that nonbreeding season body condition and habitat quality carry-over to affect spring migration performance of a long-distance migratory songbird, the Wood Thrush (Hylocichla mustelina). We tracked individual birds between multiple breeding sites in North America and nonbreeding sites in Central America. First, we compared body condition of nonbreeding birds migrating to the same general region of the breeding range with spring migration performance (timing, speed, and duration) obtained from light-level geolocators. Second, we assessed the Normalized Difference Vegetation Index (NDVI) as a proxy for nonbreeding habitat quality, and predicted that birds from wetter habitat or in wetter years (higher NDVI) would show improved migration performance relative to birds from drier sites. We found no evidence of individual-level carry-over effects of nonbreeding season body condition on spring migration performance. Lower NDVI of nonbreeding habitat resulted in delayed spring migration departure, but this effect disappeared by arrival at breeding sites. Birds occupying drier nonbreeding sites migrated faster and for fewer days, compensating for their relatively late departure. We also documented a broader pattern in NDVI and migration timing and distance, in that birds that occupied the wettest areas in the southern part of the nonbreeding range departed significantly later and migrated farther. Our results suggest that individual carry-over effects of nonbreeding habitat quality may be compensated for by a faster and shorter migration strategy. At a broad scale, consistently later spring timing and longer migration distances were associated with the wettest areas (the highest quality habitats) of the Wood Thrush nonbreeding range. This supports the theory that high-quality habitats offset the costs of farther migration, resulting in a leap-frog migration pattern.	[McKinnon, Emily A.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	McKinnon, EA (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada.	emilymckinnon12@gmail.com		Stanley, Calandra Q./0000-0003-1588-2248	Natural Sciences and Engineering Research Council of Canada; Schad Foundation; Molson Foundation; U.S. Fish and Wildlife Service Migratory Bird Grant	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Schad Foundation; Molson Foundation; U.S. Fish and Wildlife Service Migratory Bird Grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to BJMS (http://www.nserc-crsng.gc.ca/index_eng.asp), Schad Foundation grant to BJMS, Molson Foundation grant to BJMS (http://www.kennethmolsonfoundation.ca), and U.S. Fish and Wildlife Service Migratory Bird Grant to BJMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERSTAM T, 1980, ORNIS SCAND, V11, P196, DOI 10.2307/3676124; Alves JA, 2013, ECOLOGY, V94, P11, DOI 10.1890/12-0737.1; Angelier F, 2009, P ROY SOC B-BIOL SCI, V276, P3545, DOI 10.1098/rspb.2009.0868; Bayly NJ, 2013, IBIS, V155, P271, DOI 10.1111/ibi.12029; Bell Christopher Paul, 2005, P41; Bell CP, 1997, CONDOR, V99, P470, DOI 10.2307/1369953; Berthold P, 2001, AUK, V2nd; Boone AT, 2010, CONDOR, V112, P115, DOI 10.1525/cond.2010.090098; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Chin S, 2014, WILSON J ORNITHOL, V126, P599, DOI 10.1676/13-187.1; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; DESANTE D. F., 2009, MOSI MONITOREO SOBRE; Drake A, 2014, POLAR BIOL, V37, P181, DOI 10.1007/s00300-013-1421-6; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Evans M, 2011, BIRDS N AM ONLINE; Fuentes-Franco R, 2015, CLIM DYNAM, V45, P425, DOI 10.1007/s00382-014-2258-6; Gallo PA, 2013, AUK, V130, P240, DOI 10.1525/auk.2013.12213; Gomez C, 2013, J ORNITHOL, V154, P107, DOI 10.1007/s10336-012-0876-5; Gonzalez-Prieto AM, 2013, J ORNITHOL, V154, P1067, DOI 10.1007/s10336-013-0975-y; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hidalgo HG, 2013, J HYDROL, V495, P94, DOI 10.1016/j.jhydrol.2013.05.004; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Kuznetsova A., 2014, PACKAGE LMERTEST TES; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; LUNDBERG S, 1986, J THEOR BIOL, V123, P403, DOI 10.1016/S0022-5193(86)80210-7; Madsen J, 2001, ARDEA, V89, P43; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; McKinnon EA, 2015, OECOLOGIA, V179, P363, DOI 10.1007/s00442-015-3343-1; McKinnon EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105605; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paxton KL, 2015, J AVIAN BIOL, V46, P495, DOI 10.1111/jav.00614; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pyle P, 1997, IDENTIFICATION GUIDE, VI; R Development Core Team, 2014, R LANG ENV STAT COMP; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; Rushing CS, 2014, ECOL APPL, V24, P445, DOI 10.1890/13-1091.1; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sauer JR, 2012, N AM BREEDING BIRD S; Senner NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086588; Stanley CQ, 2015, CONSERV BIOL, V29, P164, DOI 10.1111/cobi.12352; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Taylor CM, 2015, ECOL APPL IN PRESS; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290	58	34	34	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141580	10.1371/journal.pone.0141580	http://dx.doi.org/10.1371/journal.pone.0141580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529241	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600040
J	Yoon, BI; Han, KD; Lee, KW; Kwon, HS; Kim, SW; Sohn, DW; Cho, YH; Ha, US				Yoon, Byung Il; Han, Kyung-Do; Lee, Kyu Won; Kwon, Hyuk Sang; Kim, Sun Wook; Sohn, Dong Wan; Cho, Yong-Hyun; Ha, U-Syn			Insulin Resistance Is Associated with Prevalence of Physician-Diagnosed Urinary Incontinence in Postmenopausal Non-Diabetic Adult Women: Data from the Fourth Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; BENIGN PROSTATIC ENLARGEMENT; HOMEOSTASIS MODEL ASSESSMENT; TRACT SYMPTOMS; RISK-FACTORS; METABOLIC SYNDROME; DIABETES-MELLITUS; DYSFUNCTION; GLUCOSE; IMPACT	Objective To investigate the association between insulin resistance (IR) and urinary incontinence in Korean adult women by analyzing the data from the Korea National Health and Nutrition Examination Survey IV (KNHANES) 2007-2009 Methods A nationally representative sample of 5318 non-diabetic Korean women >= 19-years-of-age (3043 premenopausal and 2275 postmenopausal women) was included from KNHANES 2008-2010. IR was measured using the homeostasis model assessment of IR (HOMA-IR). Participants in the highest and lowest quartile of HOMA-IR were defined as insulin-resistant and insulin-sensitive respectively. Women who have current physician-diagnosed urinary incontinence were classified as having urinary incontinence. Results Incontinence was found in 9.18% of the total population, 8.51% of the premenopausal population, and 10.86% of the postmenopausal population. The prevalence of incontinence increased with age, reaching a peak at 60-69-years-of-age. The prevalence of urinary incontinence increased significantly with higher HOMA-IR quartiles in pre-and post-menopausal women (p for linear association = 0.0458 and 0.0009 respectively). Among post-menopausal women, those in the highest quartile of HOMA-IR were significantly more likely to have urinary incontinence compared to those in the lowest quartile [adjusted odds ratio, 1.72; 95% confidence interval, 1.07-2.77]. However premenopausal population exhibited no association between incontinence and HOMA-IR quartiles Conclusion Our results suggest that the prevalence of incontinence increased across HOMA-IR in nondiabetic adult women, and especially, IR might be a risk factor for incontinence in postmenopausal non-diabetic women.	[Yoon, Byung Il] Catholic Kwandong Univ Korea, Int St Marys Hosp, Dept Urol, Inchon, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Kyu Won] Catholic Univ Korea, St Pauls Hosp, Dept Urol, Coll Med, Seoul, South Korea; [Kwon, Hyuk Sang] Catholic Univ Korea, Yeoido St Marys Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Sun Wook; Sohn, Dong Wan; Cho, Yong-Hyun; Ha, U-Syn] Catholic Univ Korea, Yeoido St Marys Hosp, Dept Urol, Coll Med, Seoul, South Korea	Catholic Kwandong University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ha, US (corresponding author), Catholic Univ Korea, Yeoido St Marys Hosp, Dept Urol, Coll Med, Seoul, South Korea.	ushamd@catholic.ac.kr	Kim, Sun/GSN-4867-2022		Institute of clinical medicine research in the Catholic University of Korea, Yeouido St. Mary's Hospital	Institute of clinical medicine research in the Catholic University of Korea, Yeouido St. Mary's Hospital	This study was funded by research grant from Institute of clinical medicine research in the Catholic University of Korea, Yeouido St. Mary's Hospital.	Anger JT, 2006, J UROLOGY, V175, P601, DOI 10.1016/S0022-5347(05)00242-9; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; De Nunzio C, 2014, UROLOGY, V84, P1181, DOI 10.1016/j.urology.2014.07.018; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; Gacci M, 2015, BJU INT, V115, P24, DOI 10.1111/bju.12728; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Hu TW, 2004, UROLOGY, V63, P461, DOI 10.1016/j.urology.2003.10.037; Hunskaar S, 2004, BJU INT, V93, P324, DOI 10.1111/j.1464-410X.2003.04609.x; Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730; Kaplan S, 2006, BJU INT, V97, P44, DOI 10.1111/j.1464-410X.2006.06106.x; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon CS, 2014, INT NEUROUROL J, V18, P31, DOI 10.5213/inj.2014.18.1.31; Lasserre A, 2009, EUR UROL, V56, P177, DOI 10.1016/j.eururo.2009.04.006; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Lee SW, 2015, DIABETES METAB J, V39, P37, DOI 10.4093/dmj.2015.39.1.37; Leiria LO, 2013, J PHYSIOL-LONDON, V591, P2259, DOI 10.1113/jphysiol.2013.251843; Lifford KL, 2005, J AM GERIATR SOC, V53, P1851, DOI 10.1111/j.1532-5415.2005.53565.x; Madill SJ, 2013, NEUROUROL URODYNAM, V32, P1086, DOI 10.1002/nau.22370; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Morin M, 2004, NEUROUROL URODYNAM, V23, P668, DOI 10.1002/nau.20069; Nocchi L, 2014, AGING CELL, V13, P540, DOI 10.1111/acel.12208; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Russo GI, 2014, J SEX MED, V11, P2074, DOI 10.1111/jsm.12587; Schulze Burti J, 2014, NEUROUROL URODYN; Sensoy N, 2013, PAK J MED SCI, V29, P818, DOI 10.12669/pjms.293.3404; Sze EHM, 2002, OBSTET GYNECOL, V99, P572, DOI 10.1016/S0029-7844(01)01781-1; Tosun OC, 2015, CLIN REHABIL, V29, P525, DOI 10.1177/0269215514546768; Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065; Weinberg AE, 2015, J UROLOGY, V194, P1668, DOI 10.1016/j.juro.2015.06.074; Xu QG, 2004, EXP NEUROL, V188, P43, DOI 10.1016/j.expneurol.2004.03.008	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141720	10.1371/journal.pone.0141720	http://dx.doi.org/10.1371/journal.pone.0141720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529410	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600052
J	De Clercq, B; Clays, E; Janssens, H; De Bacquer, D; Casini, A; Kittel, F; Braeckman, L				De Clercq, Bart; Clays, Els; Janssens, Heidi; De Bacquer, Dirk; Casini, Annalisa; Kittel, France; Braeckman, Lutgart			Health Behaviours As a Mechanism in the Prospective Relation between Workplace Reciprocity and Absenteeism: A Bridge too Far ?	PLOS ONE			English	Article							SICKNESS ABSENCE; POLITICAL-ECONOMY; SOCIAL-THEORY; ASSOCIATION; MORTALITY; SMOKING; DEPRESSION; PREDICTOR; CESSATION; SUPPORT	Background The persistent lack of evidence on causal mechanisms between social capital and health threatens the credibility of the social capital-health association. The present study aims to address this ongoing problem by investigating whether health behaviours (i.e. smoking, alcohol consumption, and physical activity) mediate the prospective relation between workplace reciprocity and future sickness absence. Methods A cohort of 24,402 Belgian employees was followed up during 12 months for sickness absence. Workplace reciprocity was measured with four indicators-colleague help, colleague interest, supervisor help, and supervisor concern. Three types of multilevel mediation models were applied. Results Overall, workplace reciprocity negatively related to high sickness absence (>= 10 days) mainly independently from health behaviours. Uniquely, colleague interest positively related to smoking (OR = 1.058, 95% CI = 1.019, 1.098) and smoking in turn, positively related to sickness absence (OR = 1.074, 95% CI = 1.047, 1.101). No behavioural pathways could be identified between company-level reciprocity and sickness absence, and company-level health-related behaviours did not mediate the relation between company-level reciprocity and individual sickness absence. Conclusions These results suggest that both social capital and health behaviours are relevant for employee health, but health behaviours seem not to be the underlying explanatory mechanism between workplace reciprocity and health.	[De Clercq, Bart; Clays, Els; Janssens, Heidi; De Bacquer, Dirk; Braeckman, Lutgart] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Casini, Annalisa; Kittel, France] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium	Ghent University; Universite Catholique Louvain	De Clercq, B (corresponding author), Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.	b.declercq@ugent.be	De Bacquer, Dirk/HGU-3191-2022; Casini, Annalisa/ABG-2250-2020	Casini, Annalisa/0000-0002-3539-4500; De Bacquer, Dirk/0000-0002-3202-7238; Clays, Els/0000-0002-1092-945X	Belgian Federal Public Service Employment, Labor and Social Dialogue; European Social Fund	Belgian Federal Public Service Employment, Labor and Social Dialogue; European Social Fund(European Social Fund (ESF))	This work was supported by the Belgian Federal Public Service Employment, Labor and Social Dialogue and the European Social Fund.	Abbott S, 2008, J HEALTH PSYCHOL, V13, P874, DOI 10.1177/1359105308095060; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer DJ, 2003, J EDUC BEHAV STAT, V28, P135, DOI 10.3102/10769986028002135; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choi M, 2014, INT J EPIDEMIOL, V43, P1895, DOI 10.1093/ije/dyu212; Clays E, 2013, EUR J EPIDEMIOL, V28, P241, DOI 10.1007/s10654-013-9764-4; Clays E, 2009, J OCCUP ENVIRON MED, V51, P879, DOI 10.1097/JOM.0b013e3181aa5070; De Clercq B, 2014, SOC SCI MED, V119, P81, DOI 10.1016/j.socscimed.2014.08.018; De Clercq B, 2013, J OCCUP ENVIRON MED, V55, P824, DOI 10.1097/JOM.0b013e31828dc8cd; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Dirken JM, 1969, ARBEID GEZONDHEID; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; House JS, 1981, WORK STRESS SOCIAL S; Hystad P, 2012, J EPIDEMIOL COMMUN H, V66, P277, DOI 10.1136/jech.2009.103556; International Labor Office [ILO], 1990, ISCO88 ILO; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Janssens H, 2012, J OCCUP ENVIRON MED, V54, P604, DOI 10.1097/JOM.0b013e31824b2133; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY; Kawachi I, 2006, INT J EPIDEMIOL, V35, P989, DOI 10.1093/ije/dyl117; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Lindstrom M, 2008, AM J EPIDEMIOL, V167, P1152, DOI 10.1093/aje/kwn070; Lynch J, 2000, J EPIDEMIOL COMMUN H, V54, P404, DOI 10.1136/jech.54.6.404; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Mohan J, 2005, SOC SCI MED, V60, P1267, DOI 10.1016/j.socscimed.2004.06.050; Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116; Moore S, 2009, HEALTH PLACE, V15, P1071, DOI 10.1016/j.healthplace.2009.05.005; Moreau M, 2004, J EPIDEMIOL COMMUN H, V58, P507, DOI 10.1136/jech.2003.007518; Muntaner C, 2004, INT J EPIDEMIOL, V33, P674, DOI 10.1093/ije/dyh200; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Muthen B., 2010, MPLUS USERS GUIDE; Muthen B, 2009, CH CRC HANDB MOD STA, P143; Nieminen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-613; Oksanen T, 2013, GLOBAL PERSPECTIVES; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Pelfrene E, 2001, WORK STRESS, V15, P297, DOI 10.1080/02678370110086399; Poortinga W, 2006, PREV MED, V43, P488, DOI 10.1016/j.ypmed.2006.06.004; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Royal College of Physicians RCoP Royal College of general practicioners, 1995, ALC HEART PERSP SENS; Shortt SED, 2004, HEALTH POLICY, V70, P11, DOI 10.1016/j.healthpol.2004.01.007; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023; Vaananen A, 2009, OCCUP ENVIRON MED, V66, P432, DOI 10.1136/oem.2008.042044; WESTMAN M, 1985, SOC SCI MED, V20, P637, DOI 10.1016/0277-9536(85)90402-2	59	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141608	10.1371/journal.pone.0141608	http://dx.doi.org/10.1371/journal.pone.0141608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1PG	26524011	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800015
J	Kepes, S; McDaniel, MA				Kepes, Sven; McDaniel, Michael A.			The Validity of Conscientiousness Is Overestimated in the Prediction of Job Performance	PLOS ONE			English	Article							PUBLICATION BIAS; METAANALYSIS; SELECTION; MANAGEMENT; OUTLIER; IMPACT	Introduction Sensitivity analyses refer to investigations of the degree to which the results of a meta-analysis remain stable when conditions of the data or the analysis change. To the extent that results remain stable, one can refer to them as robust. Sensitivity analyses are rarely conducted in the organizational science literature. Despite conscientiousness being a valued predictor in employment selection, sensitivity analyses have not been conducted with respect to meta-analytic estimates of the correlation (i.e., validity) between conscientiousness and job performance. Methods To address this deficiency, we reanalyzed the largest collection of conscientiousness validity data in the personnel selection literature and conducted a variety of sensitivity analyses. Results Publication bias analyses demonstrated that the validity of conscientiousness is moderately overestimated (by around 30%; a correlation difference of about.06). The misestimation of the validity appears to be due primarily to suppression of small effects sizes in the journal literature. These inflated validity estimates result in an overestimate of the dollar utility of personnel selection by millions of dollars and should be of considerable concern for organizations. Conclusion The fields of management and applied psychology seldom conduct sensitivity analyses. Through the use of sensitivity analyses, this paper documents that the existing literature overestimates the validity of conscientiousness in the prediction of job performance. Our data show that effect sizes from journal articles are largely responsible for this overestimation.	[Kepes, Sven; McDaniel, Michael A.] Virginia Commonwealth Univ, Dept Management, Sch Business, Richmond, VA 23284 USA	Virginia Commonwealth University	Kepes, S (corresponding author), Virginia Commonwealth Univ, Dept Management, Sch Business, Richmond, VA 23284 USA.	skepes@vcu.edu						Aguinis H, 2011, ORGAN RES METHODS, V14, P306, DOI 10.1177/1094428110375720; Aguinis H, 2010, ORGAN RES METHODS, V13, P515, DOI 10.1177/1094428109333339; APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; Aytug ZG, 2012, ORGAN RES METHODS, V15, P103, DOI 10.1177/1094428111403495; Banks GC, 2015, MORE STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS, P36; Banks GC, 2012, INT J SELECT ASSESS, V20, P182, DOI 10.1111/j.1468-2389.2012.00591.x; Banks GC, 2011, IND ORGAN PSYCHOL-US, V4, P40, DOI 10.1111/j.1754-9434.2010.01292.x; Beal DJ, 2002, J APPL PSYCHOL, V87, P583, DOI 10.1037//0021-9010.87.3.583; Borenstein M, 2009, INTRO META ANAL; Briner RB, 2011, IND ORGAN PSYCHOL-US, V4, P3, DOI 10.1111/j.1754-9434.2010.01287.x; Chalmers Iain, 2013, F1000Res, V2, P1, DOI 10.12688/f1000research.2-1.v1; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Costa PT, 2007, REVISED NEO PERSONAL; Dalton DR, 2012, PERS PSYCHOL, V65, P221, DOI 10.1111/j.1744-6570.2012.01243.x; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Duval S, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P127, DOI 10.1002/0470870168.ch8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelou E, 2005, FASEB J, V19, P1943, DOI 10.1096/fj.05-4784lsf; Fiedler K, 2011, PERSPECT PSYCHOL SCI, V6, P163, DOI 10.1177/1745691611400237; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Francis G, 2014, PSYCHON B REV, V21, P1180, DOI 10.3758/s13423-014-0601-x; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Geyskens I, 2009, J MANAGE, V35, P393, DOI 10.1177/0149206308328501; Gilboa S, 2008, PERS PSYCHOL, V61, P227, DOI 10.1111/j.1744-6570.2008.00113.x; Hartshorne JK, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00008; Hedges LV, 2014, STAT METHODS META AN; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; HIRSH HR, 1986, PERS PSYCHOL, V39, P399, DOI 10.1111/j.1744-6570.1986.tb00589.x; HUFFCUTT AI, 1995, J APPL PSYCHOL, V80, P327, DOI 10.1037/0021-9010.80.2.327; HUNTER JE, 1983, AM PSYCHOL, V38, P473, DOI 10.1037/0003-066X.38.4.473; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Iyengar S., 2009, HDB RES SYNTHESIS ME, P417; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Kepes S, 2014, ACAD MANAG LEARN EDU, V13, P446, DOI 10.5465/amle.2013.0193; Kepes S, 2013, IND ORGAN PSYCHOL-US, V6, P252, DOI 10.1111/iops.12045; Kepes S, 2014, J BUS PSYCHOL, V29, P183, DOI 10.1007/s10869-012-9279-0; Kepes S, 2013, J BUS PSYCHOL, V28, P123, DOI 10.1007/s10869-013-9300-2; Kepes S, 2012, ORGAN RES METHODS, V15, P624, DOI 10.1177/1094428112452760; Kicinski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081823; Lao RY, 2001, THESIS N CAROLINA ST; Le H, 2007, ACAD MANAGE PERSPECT, V21, P6; Lounsbury J., 2006, PERSONAL STYLE INVEN; McDaniel MA, 2006, PERS PSYCHOL, V59, P927, DOI 10.1111/j.1744-6570.2006.00059.x; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Mount MK, 2007, PERSONAL CHARACTERIS; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; O'Boyle EH, 2014, J BUS VENTURING, V29, P773, DOI 10.1016/j.jbusvent.2013.10.001; Orlitzky M, 2012, ORGAN RES METHODS, V15, P199, DOI 10.1177/1094428111428356; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Rothstein H, 2005, COMPREHENSIVE META A, P104; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Scandura TA, 2000, ACAD MANAGE J, V43, P1248, DOI 10.2307/1556348; Schmidt F.L., 2015, METHODS META ANAL CO; SCHMIDT FL, 1979, J APPL PSYCHOL, V64, P609, DOI 10.1037/0021-9010.64.6.609; SCHMIDT FL, 1993, J APPL PSYCHOL, V78, P3, DOI 10.1037/0021-9010.78.1.3; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shaffer JA, 2012, PERS PSYCHOL, V65, P445, DOI 10.1111/j.1744-6570.2012.01250.x; Social Security Administration, 2013, NAT AV WAG IND; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P75, DOI 10.1002/0470870168.ch5; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sutton AJ, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P175; ter Riet G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043404; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; van Aert RCM, 2015, COMMUNICATION; van Assen MALM, 2015, PSYCHOL METHODS, V20, P293, DOI 10.1037/met0000025; van Lent M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104846; Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428; Viechtbauer W., 2015, METAANALYSIS PACKAGE; Viechtbauer W, 2010, RES SYNTH METHODS, V1, P112, DOI 10.1002/jrsm.11; VISWESVARAN C, 1993, PERS PSYCHOL, V46, P551, DOI 10.1111/j.1744-6570.1993.tb00884.x	76	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141468	10.1371/journal.pone.0141468	http://dx.doi.org/10.1371/journal.pone.0141468			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517553	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800043
J	Sipieter, F; Cappe, B; Pisfil, MG; Spriet, C; Bodart, JF; Cailliau-Maggio, K; Vandenabeele, P; Heliot, L; Riquet, FB				Sipieter, Francois; Cappe, Benjamin; Pisfil, Mariano Gonzalez; Spriet, Corentin; Bodart, Jean-Francois; Cailliau-Maggio, Katia; Vandenabeele, Peter; Heliot, Laurent; Riquet, Franck B.			Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; MAP KINASE; NUCLEAR TRANSLOCATION; IN-VIVO; CASCADE; LOCALIZATION; SPECIFICITY; MECHANISMS; EXPRESSION	Uncoupling of ERK1/2 phosphorylation from subcellular localization is essential towards the understanding of molecular mechanisms that control ERK1/2-mediated cell-fate decision. ERK1/2 non-catalytic functions and discoveries of new specific anchors responsible of the subcellular compartmentalization of ERK1/2 signaling pathway have been proposed as regulation mechanisms for which dynamic monitoring of ERK1/2 localization is necessary. However, studying the spatiotemporal features of ERK2, for instance, in different cellular processes in living cells and tissues requires a tool that can faithfully report on its subcellular distribution. We developed a novel molecular tool, ERK2-LOC, based on the T2A-mediated coexpression of strictly equimolar levels of eGFP-ERK2 and MEK1, to faithfully visualize ERK2 localization patterns. MEK1 and eGFP-ERK2 were expressed reliably and functionally both in vitro and in single living cells. We then assessed the subcellular distribution and mobility of ERK2-LOC using fluorescence microscopy in non-stimulated conditions and after activation/inhibition of the MAPK/ERK1/2 signaling pathway. Finally, we used our coexpression system in Xenopus laevis embryos during the early stages of development. This is the first report on MEK1/ERK2 T2A-mediated coexpression in living embryos, and we show that there is a strong correlation between the spatiotemporal subcellular distribution of ERK2-LOC and the phosphorylation patterns of ERK1/2. Our approach can be used to study the spatiotemporal localization of ERK2 and its dynamics in a variety of processes in living cells and embryonic tissues.	[Sipieter, Francois; Cappe, Benjamin; Vandenabeele, Peter; Riquet, Franck B.] Univ Ghent, Dept Biomed Mol Biol, Mol Signaling & Cell Death Unit, B-9000 Ghent, Belgium; [Sipieter, Francois; Cappe, Benjamin; Vandenabeele, Peter; Riquet, Franck B.] VIB, IRC, Mol Signaling & Cell Death Unit, Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9000 Ghent, Belgium; [Sipieter, Francois; Pisfil, Mariano Gonzalez; Heliot, Laurent] CNRS UMR 8523, Equipe Biophoton Cellulaire Fonct, Lab Phys Lasers Atomes & Mol PhLAM, Villeneuve Dascq, France; [Sipieter, Francois; Bodart, Jean-Francois; Cailliau-Maggio, Katia] Univ Lille 1, Regulat Signal Div Team, Struct & Funct Glycobiol Unit UGSF, CNRS UMR 8576, F-59655 Villeneuve Dascq, France; [Riquet, Franck B.] Univ Lille 1, Struct & Funct Glycobiol Unit UGSF, CNRS UMR 8576, F-59655 Villeneuve Dascq, France; [Spriet, Corentin] Univ Lille 1, Struct & Funct Glycobiol Unit UGSF, TISBio, CNRS UMR 8576,FR3688, F-59655 Villeneuve Dascq, France; [Sipieter, Francois; Cappe, Benjamin; Pisfil, Mariano Gonzalez; Heliot, Laurent; Riquet, Franck B.] GDR2588 MIV CNRS, Groupement Rech Microscopie Imagerie Vivant, Villeneuve Dascq, France	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Riquet, FB (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Mol Signaling & Cell Death Unit, B-9000 Ghent, Belgium.	franck.riquet@irc.vib-ugent.be	Vandenabeele, Peter/AAD-5793-2022; Spriet, Corentin/ABE-4215-2021; Bodart, Jean-François Laurent/AAZ-2075-2021; CAPPE, Benjamin/ABG-5598-2020; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; Spriet, Corentin/0000-0002-5805-3426; Bodart, Jean-François Laurent/0000-0002-6113-7700; CAPPE, Benjamin/0000-0002-8162-9788; cailliau, katia/0000-0003-1772-1034; SIPIETER, FRANCOIS/0000-0002-1332-400X; Cailliau, Katia/0000-0001-7993-8437	Lille 1 University; Centre National de la Recherche Scientifique (CNRS); Fonds Wetenschappelijk Onderzoek [FWO G.0875.11]; Methusalem grant (Bijzonder Onderzoeksfonds) [BOF09/01M00709]; Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]; Flemish grant [FWO G.0973.11, FWO G.0A45.12N, FWO G.0172.12, FWO G.0787.13N, FWO G.0C31.14N]; Ghent University grant; Foundation against Cancer [2012-188]; Vlaams Instituut voor Biotechnologie (VIB); Agence Nationale pour la Recherche (ANR) [ANR-13-BSV2-0016-02]; contrat Plan Etat-Region "Campus Intelligent"; ANR "Multimodal" and DynamIC; Leica Microsystems	Lille 1 University; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fonds Wetenschappelijk Onderzoek(FWO); Methusalem grant (Bijzonder Onderzoeksfonds); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grant; Ghent University grant; Foundation against Cancer; Vlaams Instituut voor Biotechnologie (VIB); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); contrat Plan Etat-Region "Campus Intelligent"; ANR "Multimodal" and DynamIC(French National Research Agency (ANR)); Leica Microsystems	FS is a joint PhD student between Lille1 University and Ghent University, and is funded by Lille 1 University, the Centre National de la Recherche Scientifique (CNRS), and Vandenabeele's group research funding: Fonds Wetenschappelijk Onderzoek (FWO G.0875.11) and Methusalem grant (Bijzonder Onderzoeksfonds, BOF09/01M00709). PV is senior full professor at Ghent University. FR is a visiting research professor at Ghent University and full associate professor at Lille 1 University. Research in the Vandenabeele group is further supported by Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (FWO G.0973.11, FWO G.0A45.12N, FWO G.0172.12, FWO G.0787.13N, FWO G.0C31.14N), Ghent University grants (Multidisciplinary Research Platforms (MRP), Ghent Researchers On Unfolded Proteins in Inflammatory Disease (GROUP-ID) consortium), grant from the Foundation against Cancer, 2012-188) and grants from Vlaams Instituut voor Biotechnologie (VIB). This research is supported by the Agence Nationale pour la Recherche (ANR): G2Progress program (ANR-13-BSV2-0016-02). This work was funded by grants from contrat Plan Etat-Region "Campus Intelligent" and ANR "Multimodal" and DynamIC and supported by contrat with Leica Microsystems.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Christen B, 1999, DEVELOPMENT, V126, P119; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dehennaut V, 2008, MOL CELL PROTEOMICS, V7, P2229, DOI 10.1074/mcp.M700494-MCP200; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LaBonne C, 1997, DEV BIOL, V183, P9, DOI 10.1006/dbio.1996.8497; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Minskaia E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291730; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shaul Yoav, 2006, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1812s73; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sipieter F, 2013, PROG MOL BIOL TRANSL, V113, P145, DOI 10.1016/B978-0-12-386932-6.00005-3; Smith JC, 1997, COLD SPRING HARB SYM, V62, P337; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tomida T, 2015, J PHYSIOL SCI, V65, P37, DOI 10.1007/s12576-014-0332-9; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Volmat V, 2001, J CELL SCI, V114, P3433; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917	76	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140924	10.1371/journal.pone.0140924	http://dx.doi.org/10.1371/journal.pone.0140924			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517832	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800013
J	Szelid, Z; Lux, A; Kolossvary, M; Toth, A; Vago, H; Lendvai, Z; Kiss, L; Maurovich-Horvat, P; Bagyura, Z; Merkely, B				Szelid, Zsolt; Lux, Arpad; Kolossvary, Marton; Toth, Attila; Vago, Hajnalka; Lendvai, Zsuzsanna; Kiss, Loretta; Maurovich-Horvat, Pal; Bagyura, Zsolt; Merkely, Bela			Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDURANCE EXERCISE; COMMON VARIANT; HEART-FAILURE; RISK-FACTOR; POLYMORPHISMS; DISEASE; METAANALYSIS; INDIVIDUALS; ARRHYTHMIAS	Nitric oxide (NO), an important endogenous pulmonary vasodilator is synthetized by the endothelial NO synthase (NOS3). Reduced NO bioavailability and thus the Glu298Asp polymorphism of NOS3 may enhance right ventricular (RV) afterload and hypertrophic remodeling and influence athletic performance. To test this hypothesis world class level athletes (water polo players, kayakers, canoeists, rowers, swimmers, n = 126) with a VO2 maximum greater than 50ml/kg/min were compared with non-athletic volunteers (n = 155). Cardiopulmonary exercise tests and cardiac magnetic resonance imaging (cMRI) were performed to determine structural or functional changes. Genotype distribution of the NOS3 Glu298Asp polymorphism was not affected by gender or physical performance. Cardiac MRI showed increased stroke volume with eccentric hypertrophy in all athletes regardless of their genotype. However, the Asp allelic variant carriers had increased RV mass index (32 +/- 6g versus 27 +/- 6g, p<0.01) and larger RV stroke volume index (71 +/- 10ml versus 64 +/- 10ml, p<0.01) than athletes with a Glu/Glu genotype. Genotype was not significantly associated with athletic performance. In the non-athletic group no genotype related differences were detected. The association between the NOS3 Glu298Asp polymorphism and RV structure and dimension in elite athletes emphasizes the importance of NOS3 gene function and NO bioavailability in sport related cardiac adaptation.	[Szelid, Zsolt; Lux, Arpad; Kolossvary, Marton; Toth, Attila; Vago, Hajnalka; Lendvai, Zsuzsanna; Kiss, Loretta; Maurovich-Horvat, Pal; Bagyura, Zsolt; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Kolossvary, Marton; Maurovich-Horvat, Pal] Semmelweis Univ, Heart & Vasc Ctr, MTA SE Cardiovasc Imaging Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University	Szelid, Z (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary.	szelid.zsolt@kardio.sote.hu	Toth, Attila/AAM-1031-2020; Vago, Hajnalka/AAG-2647-2019; Maurovich-Horvat, Pal/J-8003-2017; Kolossváry, Márton/R-1138-2016; Kiss, Loretta/P-5994-2019	Toth, Attila/0000-0002-4081-7168; Maurovich-Horvat, Pal/0000-0003-0885-736X; Kolossváry, Márton/0000-0002-5570-991X; Kiss, Loretta/0000-0002-9209-3552; Vago, Hajnalka/0000-0002-3568-3572	Hungarian TAMOP (Social Renewal Operational Program) [4.2.1.B-09/1/KMR]	Hungarian TAMOP (Social Renewal Operational Program)	This work was supported by the Hungarian TAMOP (Social Renewal Operational Program)-4.2.1.B-09/1/KMR research grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron CP, 2011, AM J RESP CRIT CARE, V183, P396, DOI 10.1164/rccm.201003-0469OC; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bito V, 2010, CARDIOVASC RES, V86, P72, DOI 10.1093/cvr/cvp381; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Booz GW, 2005, HYPERTENSION, V45, P341, DOI 10.1161/01.HYP.0000156878.17006.02; Casas JP, 2004, CIRCULATION, V109, P1359, DOI 10.1161/01.CIR.0000121357.76910.A3; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Claessen G, 2014, MED SCI SPORT EXER, V46, P1717, DOI 10.1249/MSS.0000000000000282; Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018; Dell'Omo G, 2007, J HYPERTENS, V25, P1389, DOI 10.1097/HJH.0b013e3281268548; Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Feletou M, 2001, AM J PHYSIOL-LUNG C, V281, pL258, DOI 10.1152/ajplung.2001.281.1.L258; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Hand BD, 2006, INT J SPORTS MED, V27, P951, DOI 10.1055/s-2006-923901; Heidbuchel H, 2003, EUR HEART J, V24, P1473, DOI 10.1016/S0195-668X(03)00282-3; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; La Gerche A, 2014, PULM CIRC, V4, P407, DOI 10.1086/677355; La Gerche A, 2013, JACC-CARDIOVASC IMAG, V6, P993, DOI 10.1016/j.jcmg.2013.06.003; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3; La Gerche A, 2010, J AM COLL CARDIOL, V56, P1263, DOI 10.1016/j.jacc.2010.05.036; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; MARON BJ, 1986, J AM COLL CARDIOL, V7, P190, DOI 10.1016/S0735-1097(86)80282-0; Matsa LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070523; Matter CM, 1999, CIRCULATION, V99, P2396, DOI 10.1161/01.CIR.99.18.2396; Mcnamara DM, 2009, J CARD FAIL, V15, P191, DOI 10.1016/j.cardfail.2008.10.028; Modesti PA, 2004, HYPERTENSION, V43, P101, DOI 10.1161/01.HYP.0000104720.76179.18; Pereira TV, 2007, J HYPERTENS, V25, P1763, DOI 10.1097/HJH.0b013e3281de740d; Perseghin G, 2007, AM HEART J, V154, P937, DOI 10.1016/j.ahj.2007.06.039; Rankinen T, 2000, HYPERTENSION, V36, P885, DOI 10.1161/01.HYP.36.5.885; Saunders CJ, 2006, HUM MOL GENET, V15, P979, DOI 10.1093/hmg/ddl014; Scharf M, 2010, AM HEART J, V159, P911, DOI 10.1016/j.ahj.2010.02.027; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Steding K, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-8; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Wolfarth B, 2008, SCAND J MED SCI SPOR, V18, P485, DOI 10.1111/j.1600-0838.2007.00717.x	40	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141680	10.1371/journal.pone.0141680	http://dx.doi.org/10.1371/journal.pone.0141680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517550	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800067
J	Kurz, FT; Kampf, T; Buschle, LR; Schlemmer, HP; Heiland, S; Bendszus, M; Ziener, CH				Kurz, Felix T.; Kampf, Thomas; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.			Microstructural Analysis of Peripheral Lung Tissue through CPMG Inter-Echo Time R2 Dispersion	PLOS ONE			English	Article							HE-3 DIFFUSION MRI; MAGNETIC-RESONANCE BEHAVIOR; HYPERPOLARIZED HE-3; TRANSVERSE RELAXATION; BESSEL-FUNCTIONS; SELF-DIFFUSION; ALVEOLAR; FIELD; MORPHOMETRY; NUMBER	Since changes in lung microstructure are important indicators for (early stage) lung pathology, there is a need for quantifiable information of diagnostically challenging cases in a clinical setting, e.g. to evaluate early emphysematous changes in peripheral lung tissue. Considering alveoli as spherical air-spaces surrounded by a thin film of lung tissue allows deriving an expression for Carr-Purcell-Meiboom-Gill transverse relaxation rates R-2 with a dependence on inter-echo time, local air-tissue volume fraction, diffusion coefficient and alveolar diameter, within a weak field approximation. The model relaxation rate exhibits the same hyperbolic tangent dependency as seen in the Luz-Meiboom model and limiting cases agree with Brooks et al. and Jensen et al. In addition, the model is tested against experimental data for passively deflated rat lungs: the resulting mean alveolar radius of RA = 31.46 +/- 13.15 mu m is very close to the literature value (similar to 34 mu m). Also, modeled radii obtained from relaxometer measurements of ageing hydrogel foam (that mimics peripheral lung tissue) are in good agreement with those obtained from mu CT images of the same foam (mean relative error: 0.06 +/- 0.01). The model's ability to determine the alveolar radius and/or air volume fraction will be useful in quantifying peripheral lung microstructure.	[Kurz, Felix T.; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Kurz, Felix T.; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Ziener, Christian H.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Kampf, Thomas] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg	Kurz, FT (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	felix.kurz@med.uni-heidelberg.de	Ziener, Christian/AAN-8411-2021	Ziener, Christian/0000-0001-8854-7358; Buschle, Lukas/0000-0002-1770-4878	Deutsche Forschungsgemeinschaft [DFG ZI 1295/2-1]; medical faculty of Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); medical faculty of Heidelberg University	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (contract grant number: DFG ZI 1295/2-1) and by a postdoctoral fellowship granted to F.T.K. from the medical faculty of Heidelberg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PW, 1953, REV MOD PHYS, V25, P269, DOI 10.1103/RevModPhys.25.269; Baete SH, 2008, J MAGN RESON, V193, P286, DOI 10.1016/j.jmr.2008.05.010; Bauer WR, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.053412; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; BERTOLINA JA, 1992, J MAGN RESON, V99, P161, DOI 10.1016/0022-2364(92)90162-Z; Brooks RA, 2001, MAGN RESON MED, V45, P1014, DOI 10.1002/mrm.1135; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Buschle LR, 2015, MAGN RESON IMAGING, V33, P1126, DOI 10.1016/j.mri.2015.06.001; CAMPBELL H, 1952, NATURE, V170, P117, DOI 10.1038/170117a0; Carinci F, 2013, MAGN RESON MATER PHY, V26; Carinci F, 2015, J MAGN RESON IMAGING, V41, P1454, DOI 10.1002/jmri.24669; Christman RA, 1996, MAGNET RESON MED, V35, P6, DOI 10.1002/mrm.1910350103; Condorelli P, 1999, ANN BIOMED ENG, V27, P326, DOI 10.1114/1.145; CUTILLO AG, 1991, J APPL PHYSIOL, V70, P2145, DOI 10.1152/jappl.1991.70.5.2145; Cutillo AG., 1996, APPL MAGNETIC RESONA; Durand E, 2002, MAGNET RESON MED, V47, P75, DOI 10.1002/mrm.10047; Durney CH, 2000, J APPL PHYSIOL, V88, P1155, DOI 10.1152/jappl.2000.88.4.1155; Fischer A, 2008, J MAGN RESON IMAGING, V27, P63, DOI 10.1002/jmri.21235; FRASER RS, 1999, DIAGNOSIS DIS CHEST; GOTTLIEB HPW, 1985, Z ANGEW MATH PHYS, V36, P491, DOI 10.1007/BF00944640; Grebenkov DS, 2007, REV MOD PHYS, V79, P1077, DOI 10.1103/RevModPhys.79.1077; Hill WG, 2005, AM J PHYSIOL-CELL PH, V289, pC33, DOI 10.1152/ajpcell.00046.2005; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Hutzler S, 1999, THE PHYS OF FOAM; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P; Jensen JH, 2000, MAGN RESON MED, V44, P144, DOI 10.1002/1522-2594(200007)44:1<144::AID-MRM21>3.0.CO;2-O; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kolem H, 1989, P ANN M SOC MAGN RES, P783; KRYNICKI K, 1978, FARADAY DISCUSS, V66, P199, DOI 10.1039/dc9786600199; Kurz FT, 2014, MAGN RESON MED, V71, P1888, DOI 10.1002/mrm.25196; Laicher G, 1996, J MAGN RESON SER B, V111, P243, DOI 10.1006/jmrb.1996.0090; Lee SM, 2013, J THORAC IMAG, V28, P160, DOI 10.1097/RTI.0b013e31828d4087; Liu ZY, 2014, EUR J RADIOL, V83, P1282, DOI 10.1016/j.ejrad.2014.04.014; LUM H, 1987, J APPL PHYSIOL, V62, P1865, DOI 10.1152/jappl.1987.62.5.1865; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Mezer A, 2013, NAT MED, V19, P1667, DOI 10.1038/nm.3390; Miller G., 2010, FUNDAMENTALS BIOMEDI; Miura N., 1999, AM J PHYSIOL, V276, P207; Mulkern R, 2014, CONCEPT MAGN RESON A, V43, P29, DOI 10.1002/cmr.a.21297; MURATA K, 1986, RADIOLOGY, V161, P641, DOI 10.1148/radiology.161.3.3786710; NADLER W, 1985, J CHEM PHYS, V82, P151, DOI 10.1063/1.448788; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ortony JH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015006; Pauwels R A, 2001, Respir Care, V46, P798; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; Puderbach M, 2007, EUR J RADIOL, V64, P345, DOI 10.1016/j.ejrad.2007.08.009; Quirk JD, 2015, MAGN RESON MED, V73, P1252, DOI 10.1002/mrm.25241; Quirk JD, 2011, RADIOLOGY, V260, P866, DOI 10.1148/radiol.11102226; Scarpelli EM, 1998, ANAT RECORD, V251, P491; SEN PN, 1994, PHYS REV B, V49, P215, DOI 10.1103/PhysRevB.49.215; Shioya Sumie, 1997, Tokai Journal of Experimental and Clinical Medicine, V22, P27; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Sukstanskii AL, 2008, J MAGN RESON, V190, P200, DOI 10.1016/j.jmr.2007.10.015; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; TOMKEIEFF SI, 1945, NATURE, V155, P24, DOI 10.1038/155024a0; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Wolfram S., 2003, MATH BOOK; Yablonskiy DA, 2002, P NATL ACAD SCI USA, V99, P3111, DOI 10.1073/pnas.052594699; Yuan R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-153; Ziener CH, 2007, J MAGN RESON, V184, P169, DOI 10.1016/j.jmr.2006.09.018; Ziener CH, 2010, J MAGN RESON, V202, P38, DOI 10.1016/j.jmr.2009.09.016; Ziener CH, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2949097; Ziener CH, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046701; Ziener CH, 2005, MAGNET RESON MED, V54, P702, DOI 10.1002/mrm.20634; Ziener CH, 2006, MAGN RESON IMAGING, V24, P1341, DOI 10.1016/j.mri.2006.08.005; Ziener CH, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1142-0; Ziener CH, 2012, MAGN RESON IMAGING, V30, P540, DOI 10.1016/j.mri.2011.12.006	72	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141894	10.1371/journal.pone.0141894	http://dx.doi.org/10.1371/journal.pone.0141894			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544068	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700061
J	Nikolic, N; Duthoy, S; Destombes, A; Bodin, N; West, W; Puech, A; Bourjea, J				Nikolic, Natacha; Duthoy, Stephanie; Destombes, Antoine; Bodin, Nathalie; West, Wendy; Puech, Alexis; Bourjea, Jerome			Discovery of Genome-Wide Microsatellite Markers in Scombridae: A Pilot Study on Albacore Tuna	PLOS ONE			English	Article							THUNNUS-THYNNUS-THYNNUS; POPULATION-STRUCTURE; GENETIC DIVERSITY; ATLANTIC-OCEAN; DNA MARKERS; R-PACKAGE; ALALUNGA; MITOCHONDRIAL; MARINE; DIFFERENTIATION	Recent developments in sequencing technologies and bioinformatics analysis provide a greater amount of DNA sequencing reads at a low cost. Microsatellites are the markers of choice for a variety of population genetic studies, and high quality markers can be discovered in non-model organisms, such as tuna, with these recent developments. Here, we use a high-throughput method to isolate microsatellite markers in albacore tuna, Thunnus alalunga, based on coupling multiplex enrichment and next-generation sequencing on 454 GS-FLX Titanium pyrosequencing. The crucial minimum number of polymorphic markers to infer evolutionary and ecological processes for this species has been described for the first time. We provide 1670 microsatellite design primer pairs, and technical and molecular genetics selection resulting in 43 polymorphic microsatellite markers. On this panel, we characterized 34 random and selectively neutralmarkers ("neutral") and 9 "non-neutral" markers. The variability of "neutral" markers was screened with 136 individuals of albacore tuna from southwest Indian Ocean (42), northwest Indian Ocean (31), South Africa (31), and southeast Atlantic Ocean (32). Power analysis demonstrated that the panel of genetic markers can be applied in diversity and population genetics studies. Global genetic diversity for albacore was high with a mean number of alleles at 16.94; observed heterozygosity 66% and expected heterozygosity 77%. The number of individuals was insufficient to provide accurate results on differentiation. Of the 9 "non-neutral" markers, 3 were linked to a sequence of known function. The one is located to a sequence having an immunity function (ThuAla-Tcell-01) and the other to a sequence having energy allocation function (ThuAla-Hki-01). These two markers were genotyped on the 136 individuals and presented different diversity levels. ThuAla-Tcell-01 has a high number of alleles (20), heterozygosity (87-90%), and assignment index. ThuAla-Hki-01 has a lower number of alleles (9), low heterozygosity (24-27%), low assignment index and significant inbreeding. Finally, the 34 "neutral" and 3 "non-neutral" microsatellites markers were tested on four economically important Scombridae species-Thunnus albacares, Thunnus thynnus, Thunnus obesus, and Acanthocybium solandri.	[Nikolic, Natacha; Puech, Alexis; Bourjea, Jerome] IFREMER, Inst Francais Rech Exploitat Mer, Delegat La Reunion, Rue Jean Bertho,BP 60, F-97822 Le Port, Reunion, France; [Duthoy, Stephanie; Destombes, Antoine] GENOSCREEN, F-59000 Lille, France; [Bodin, Nathalie] IRD, UMR EME 212, Mahe, Seychelles; [West, Wendy] Dept Agr Forestry & Fisheries, ZA-8012 Cape Town, South Africa	Ifremer; Institut de Recherche pour le Developpement (IRD)	Nikolic, N (corresponding author), IFREMER, Inst Francais Rech Exploitat Mer, Delegat La Reunion, Rue Jean Bertho,BP 60, F-97822 Le Port, Reunion, France.	natacha.nikolic@ifremer.fr	Bodin, Nathalie/D-2184-2009	DESTOMBES, Antoine/0000-0002-6227-8556; Bodin, Nathalie/0000-0001-8464-0213; Bourjea, Jerome/0000-0001-7149-3648	European Fisheries Funds EU FEP [759/DMSOI/2013]; IFREMER; GENOSCREEN	European Fisheries Funds EU FEP; IFREMER; GENOSCREEN	This work was developed under the project Germon "No759/DMSOI/2013" funded by European Fisheries Funds EU FEP 2013-2015 and IFREMER. GENOSCREEN provided support in the form of salaries for authors SD and AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SD and AD provided technical assistance and expertise on 454 pyrosequencing. They also helped in writing the Materials and Methods section of this manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Abdul-Muneer PM, 2014, GENET RES INT, V2014, DOI 10.1155/2014/691759; Albaina A, 2013, ANIM GENET, V44, P678, DOI 10.1111/age.12051; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; [Anonymous], 2014, IOTC2014WPTMT05RE; Arrizabalaga H, 2007, FISH B-NOAA, V105, P140; Barker JSF, 1993, INTEGRATED GLOBAL PR; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; BEARDSLE.GL, 1969, T AM FISH SOC, V98, P589, DOI 10.1577/1548-8659(1969)98[589:PMOATA]2.0.CO;2; Bekkevold D, 2005, EVOLUTION, V59, P2656; Belkhir K, 1996, 5000 CNRS UMR; Bourjea J, 2013, SCRS2013126; Bremer JRA, 1998, MAR BIOL, V132, P547, DOI 10.1007/s002270050420; BROOKER AL, 1994, CAN J FISH AQUAT SCI, V51, P1959, DOI 10.1139/f94-198; Carlsson J, 2013, J FISH BIOL, V82, P944, DOI 10.1111/jfb.12034; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2006, ICES J MAR SCI, V63, P1111, DOI 10.1016/j.icesjms.2006.04.009; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Chevalet C, 2010, THEOR POPUL BIOL, V77, P152, DOI 10.1016/j.tpb.2010.01.001; CHOW S, 1995, MAR BIOL, V123, P39, DOI 10.1007/BF00350321; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciftci Yilmaz, 2002, Turkish Journal of Fisheries and Aquatic Sciences, V2, P145; Clark TB, 2004, MOL ECOL NOTES, V4, P70, DOI 10.1046/j.1471-8286.2004.00572.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Dos Santos SMR, 2008, MOL ECOL RESOUR, V8, P1065, DOI 10.1111/j.1755-0998.2008.02156.x; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Gonzalez EG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-197; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025; IOTC, 2012, 15 SESS IOTC SCI COM; Iranawati F, 2012, INT J MOL SCI, V13, P10807, DOI 10.3390/ijms130910807; ISSF, 2014, 201409 ISSF; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kolody D, 2013, IOTC2013WPTT1513; Laconcha U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128247; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Limborg MT, 2012, HEREDITY, V109, P96, DOI 10.1038/hdy.2012.18; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Miyake MP, 2004, FAO FISHERIES TECHNI; Montes I, 2012, MAR ECOL PROG SER, V471, P183, DOI 10.3354/meps09991; Muths D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063558; Nakadate M, 2005, J FISH BIOL, V66, P1545, DOI 10.1111/j.0022-1112.2005.00705.x; Nakamura I., 1985, FAO SPECIES CATALOGU, V5, P65; NEI M, 1978, GENETICS, V89, P583; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nikolic N, 2009, GENET RES, V91, P1; Nikolic N, 2014, EVOL APPL, V7, P663, DOI 10.1111/eva.12170; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Okumus Ibrahim, 2003, Turkish Journal of Fisheries and Aquatic Sciences, V3, P51; Oleksiak MF, 2010, J FISH BIOL, V76, P1067, DOI 10.1111/j.1095-8649.2010.02563.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Takagi M, 2001, FISH B-NOAA, V99, P697; Takagi M, 1999, FISHERIES SCI, V65, P571, DOI 10.2331/fishsci.65.571; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Wang JJ, 2012, INT J MOL SCI, V13, P3009, DOI 10.3390/ijms13033009; Waples RS, 2009, FISH FISH SER, V31, P427, DOI 10.1007/978-1-4020-9210-7_23; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward SM, 2009, WEED SCI, V57, P593, DOI 10.1614/WS-09-082.1; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; Yeh S.Y., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P152; Yu HT, 2002, MAR BIOTECHNOL, V4, P471, DOI 10.1007/s10126-002-0035-8	82	2	2	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141830	10.1371/journal.pone.0141830	http://dx.doi.org/10.1371/journal.pone.0141830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544051	Green Published, gold			2022-12-27	WOS:000364398700053
J	Zhu, MJ; Li, JL; Chen, B; Mei, L; Yao, L; Tian, JH; Li, H				Zhu, Mengjiao; Li, Jialing; Chen, Bin; Mei, Li; Yao, Liang; Tian, Jinhui; Li, Huang			The Effect of Calcium Sodium Phosphosilicate on Dentin Hypersensitivity: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; POTASSIUM-NITRATE; INDUSTRY SPONSORSHIP; PROPHYLAXIS PASTE; OF-INTEREST; DENTIFRICE; EFFICACY; SENSITIVITY; PAIN; TOOTHPASTES	Objective To investigate the effect of calcium sodium phosphosilicate (CSPS) in treating dentin hypersensitivity (DH) and to compare this effect to that of a negative (placebo) control. Materials and Methods Several databases, including Medline, EMBASE, Web of Science, The Cochrane Library, and the Chinese Biomedical Literature Database, were searched to identify relevant articles published through January 2015; grey literature (i.e., academic literature that is not formally published) was also searched. Two authors performed data extraction independently and jointly using data collection forms. The primary outcome was the DH pain response to routine activities or to thermal, tactile, evaporative, or electrical stimuli, and the secondary outcome was the side effects of CSPS use. Each study was evaluated using the Cochrane Collaboration tool for assessing risk bias. Meta-analysis of studies with the same participant demographics, interventions, controls, assessment methods and follow-up periods was performed. The Grading of Recommendations Assessment Development and Evaluation System was used to assess the quality of the evidence and the risk of bias across studies. Results Meta-analysis demonstrated that toothpaste containing 5% CSPS was more effective than the negative control at relieving dentin sensitivity, with the level of evidence classified as "moderate". In addition, prophylaxis paste containing 15% calcium sodium phosphosilicate was favored over the negative control at reducing post-periodontal therapy hypersensitivity, with the level of evidence categorized as "low". Only two studies reported side effects of CSPS use. Conclusions The majority of studies found that calcium sodium phosphosilicate was more effective than the negative control at alleviating DH. Because strong evidence is scarce, high-quality, well-designed clinical trials are required in the future before definitive recommendations can be made.	[Zhu, Mengjiao; Li, Huang] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Bin] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Periodont, Nanjing, Jiangsu, Peoples R China; [Mei, Li] Univ Otago, Fac Dent, Dept Oral Sci, Discipline Orthodont, Dunedin, New Zealand; [Yao, Liang; Tian, Jinhui] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China	Nanjing University; Nanjing University; University of Otago; Lanzhou University	Li, H (corresponding author), Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral Sci, Nanjing, Jiangsu, Peoples R China.	Lihuang76@nju.edu.cn		Chen, Bin/0000-0001-8690-1835	National Natural Science Foundation of China [81470712, 81070807]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This systematic review was supported by the National Natural Science Foundation of China (No. 81470712, 81070807) (http://www.nsfc.gov.cn/). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bae JH, 2015, J CLIN PERIODONTOL, V42, P131, DOI 10.1111/jcpe.12347; Bahreini M, 2015, J EMERG MED, V48, P10, DOI 10.1016/j.jemermed.2014.07.039; Bero L, 2013, JAMA INTERN MED, V173, P580, DOI 10.1001/jamainternmed.2013.4190; Brannstrom M, 1967, Caries Res, V1, P310; BRANNSTROM M, 1972, INT DENT J, V22, P219; Burwell Anora, 2010, J Clin Dent, V21, P66; Du MQ, 2008, AM J DENT, V21, P210; FISCHER C, 1991, ENDOD DENT TRAUMATOL, V7, P259; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Greenspan David C, 2010, J Clin Dent, V21, P61; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Holland GR, 1997, J CLIN PERIODONTOL, V24, P808, DOI 10.1111/j.1600-051X.1997.tb01194.x; KANOUSE MC, 1969, J PERIODONTOL, V40, P38, DOI 10.1902/jop.1969.40.1.38; Karim BFA, 2013, INT J DENT, V2013, DOI 10.1155/2013/573258; KIM S, 1986, J ENDODONT, V12, P482, DOI 10.1016/S0099-2399(86)80203-5; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; [李婵秀 Li Chanxiu], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P6846; Litkowski Leonard, 2010, J Clin Dent, V21, P77; Litkowski LJ, 1997, BIOCERAMICS, V10, P411; Mantzourani M, 2013, J DENT, V41, pS3, DOI 10.1016/S0300-5712(13)70002-2; Martens LC, 2013, CLIN ORAL INVEST, V17, pS77, DOI 10.1007/s00784-012-0898-7; Milleman JL, 2012, AM J DENT, V25, P262; Morris MF, 1999, AM J DENT, V12, P72; NAGATA T, 1994, J CLIN PERIODONTOL, V21, P217, DOI 10.1111/j.1600-051X.1994.tb00307.x; Neuhaus KW, 2013, J CLIN PERIODONTOL, V40, P349, DOI 10.1111/jcpe.12057; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; PEACOCK JM, 1995, J DENT RES, V74, P634, DOI 10.1177/00220345950740020301; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; Poulsen S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001476.pub2; Pradeep AR, 2012, AUST DENT J, V57, P429, DOI 10.1111/j.1834-7819.2012.01726.x; Pradeep AR, 2010, J PERIODONTOL, V81, P1167, DOI 10.1902/jop.2010.100056; Que KH, 2010, J CLIN PERIODONTOL, V37, P631, DOI 10.1111/j.1600-051X.2009.01513.x; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Salian Sowmya, 2010, J Clin Dent, V21, P82; Scaramucci T, 2014, CLIN ORAL INVEST, V18, P651, DOI 10.1007/s00784-013-1008-1; Schiff T, 2000, AM J DENT, V13, P111; Schiff Thomas, 1994, Journal of Clinical Dentistry, V5, P87; Schmidlin PR, 2013, CLIN ORAL INVEST, V17, pS55, DOI 10.1007/s00784-012-0912-0; Sharma Neeru, 2010, J Clin Dent, V21, P88; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Splieth CH, 2013, CLIN ORAL INVEST, V17, pS3, DOI 10.1007/s00784-012-0889-8; Sykes L M, 2007, SADJ, V62, P066; Tai BJ, 2006, J CLIN PERIODONTOL, V33, P86, DOI 10.1111/j.1600-051X.2005.00876.x; Talioti E, 2014, ISRN Dent, V2014, P865761, DOI 10.1155/2014/865761; von Troil B, 2002, J CLIN PERIODONTOL, V29, P173, DOI 10.1034/j.1600-051X.29.s3.10.x; Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007; West NX, 2013, CLIN ORAL INVEST, V17, pS9, DOI 10.1007/s00784-012-0887-x; West NX, 2015, J CLIN PERIODONTOL, V42, pS256, DOI 10.1111/jcpe.12336; Yu Xiao qian, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P40	53	55	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140176	10.1371/journal.pone.0140176	http://dx.doi.org/10.1371/journal.pone.0140176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544035	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700005
J	Betancourt, TS; Zuilkowski, SS; Ravichandran, A; Einhorn, H; Arora, N; Chakravarty, AB; Brennan, RT				Betancourt, Theresa S.; Zuilkowski, Stephanie S.; Ravichandran, Arathi; Einhorn, Honora; Arora, Nikita; Chakravarty, Aruna Bhattacharya; Brennan, Robert T.			Development of the SAFE Checklist Tool for Assessing Site-Level Threats to Child Protection: Use of Delphi Methods and Application to Two Sites in India	PLOS ONE			English	Article							STREET CHILDREN; HEALTH; RECOMMENDATIONS; INTERVENTION; MALTREATMENT; EXPERIENCES; GUIDELINES; MODEL	Background The child protection community is increasingly focused on developing tools to assess threats to child protection and the basic security needs and rights of children and families living in adverse circumstances. Although tremendous advances have been made to improve measurement of individual child health status or household functioning for use in low-resource settings, little attention has been paid to a more diverse array of settings in which many children in adversity spend time and how context contributes to threats to child protection. The SAFE model posits that insecurity in any of the following fundamental domains threatens security in the others: Safety/freedom from harm; Access to basic physiological needs and healthcare; Family and connection to others; Education and economic security. Site-level tools are needed in order to monitor the conditions that can dramatically undermine or support healthy child growth, development and emotional and behavioral health. From refugee camps and orphanages to schools and housing complexes, site-level threats exist that are not well captured by commonly used measures of child health and well-being or assessments of single households (e.g., SDQ, HOME). Methods The present study presents a methodology and the development of a scale for assessing site-level child protection threats in various settings of adversity. A modified Delphi panel process was enhanced with two stages of expert review in core content areas as well as review by experts in instrument development, and field pilot testing. Results Field testing in two diverse sites in India-a construction site and a railway station-revealed that the resulting SAFE instrument was sensitive to the differences between the sites from the standpoint of core child protection issues.	[Betancourt, Theresa S.; Brennan, Robert T.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA; [Zuilkowski, Stephanie S.] Florida State Univ, Learning Syst Inst, Univ Ctr C4600, Tallahassee, FL 32306 USA; [Zuilkowski, Stephanie S.] Florida State Univ, Dept Educ Leadership & Policy Studies, Univ Ctr C4600, Tallahassee, FL 32306 USA; [Ravichandran, Arathi; Einhorn, Honora] Harvard Univ, FXB Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Arora, Nikita; Chakravarty, Aruna Bhattacharya] Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Inst Area 122002, Gurgaon, India	Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Harvard University; Public Health Foundation of India	Betancourt, TS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	theresa_betancourt@harvard.edu		Arora, Nikita/0000-0001-5123-7751; Zuilkowski, Stephanie/0000-0001-6616-2764	Oak Foundation	Oak Foundation	This study was supported by the Oak Foundation (http://www.oakfnd.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the Oak Foundation for sponsoring this project. We also extend our gratitude to Mobile Creches and the Public Health Foundation of India for their collaboration in making this work possible.	Ager A, 2010, CHILD DEV, V81, P1271, DOI 10.1111/j.1467-8624.2010.01467.x; Ager A, 2007, INTERVENTION, V5, P124, DOI 10.1097/WTF.0b013e3280b08436; [Anonymous], 2008, SYSTAT 13; Betancourt T, 2012, J AM ACAD CHILD PSY, V51, P1284, DOI 10.1016/j.jaac.2012.09.003; Betancourt TS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-858; Betancourt TS, 2012, SOC SCI MED, V74, P1504, DOI 10.1016/j.socscimed.2012.01.030; Betancourt TS, 2010, PSYCHOL HEALTH MED, V15, P243, DOI 10.1080/13548501003623997; Betancourt TS, 2013, COMING AGE CONTEXT W, P134; Clay R, 2012, LANCET, V379, pE6, DOI 10.1016/S0140-6736(11)61821-7; Clifford R., 2010, RELIABILITY VALIDITY; Coben JH, 2002, ACAD EMERG MED, V9, P1176, DOI 10.1111/j.1553-2712.2002.tb01573.x; De Haan A, 1997, Hist Fam, V2, P481, DOI 10.1016/S1081-602X(97)90026-9; Deshingkar P, 2009, MIGRATION HUMAN DEV, V13; Endacott R, 1999, J ADV NURS, V30, P665, DOI 10.1046/j.1365-2648.1999.01116.x; Evans K., 2010, ASSISTANCE RUSSIAN O; Geist MR, 2010, EVAL PROGRAM PLANN, V33, P147, DOI 10.1016/j.evalprogplan.2009.06.006; Gordan T, RT DELPHI EFFICIENT; Hallowell MR, 2010, J CONSTR ENG M, V136, P99, DOI 10.1061/(ASCE)CO.1943-7862.0000137; Hardy DJ, 2004, J ADV NURS, V46, P95, DOI 10.1111/j.1365-2648.2003.02969.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Humbert S, 2007, INT J LIFE CYCLE ASS, V12, P46, DOI 10.1065/lca2006.12.291; IMA K, 1991, J INTERPERS VIOLENCE, V6, P267, DOI 10.1177/088626091006003001; Jirapramukpitak T, 1991, J INTERPERS VIOLENCE, V6, P267; Jirapramukpitak T, 1991, J INTERPERS VIOLENCE, V26, P607; Kombarakaran FA, 2004, CHILD YOUTH SERV REV, V26, P853, DOI 10.1016/j.childyouth.2004.02.025; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; LARSON OW, 1990, CHILD ABUSE NEGLECT, V14, P375, DOI 10.1016/0145-2134(90)90009-I; Mathur M, 2009, CHILD ABUSE NEGLECT, V33, P907, DOI 10.1016/j.chiabu.2009.01.003; Ministry of Women and Child Development, 2001, CHILD ABUSE NEGLECT, V25, P231; Mobile Creches, 2008, DISTR MIGR ID ENT ST; Mosse D, 2002, J DEV STUD, V38, P59, DOI 10.1080/00220380412331322511; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Olsen W. K., 2000, J SOCIAL POLITICAL T, V1, P1; Porter A.L., 1998, ENV METHODS REV RETO; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Roer-Strier D, 2001, CHILD ABUSE NEGLECT, V25, P231, DOI 10.1016/S0145-2134(00)00242-8; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Sarde S., 2008, MIGRATION INDIA TRAD; Sharma S, 2011, SUBST USE MISUSE, V46, P46, DOI 10.3109/10826084.2011.580206; StatXact, 2008, CYT SOFTW; Strong LL, 2004, AM J IND MED, V46, P599, DOI 10.1002/ajim.20095; Surabi KS., 2007, 16 CYR SOC ENV STUD; Thompson M, 2009, FAM PRACT, V26, P420, DOI 10.1093/fampra/cmp051; Tomlinson M, 2009, LANCET, V374, P1857, DOI 10.1016/S0140-6736(09)61910-3; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Tyler KA, 2003, J RES ADOLESCENCE, V13, P457, DOI 10.1046/j.1532-7795.2003.01304003.x; *UNDP, 1993, HUM DEV REP; UNICEF, 2011, INT GUID EV PSYCH PR; UNICEF, DEV CHILD PROT RAP A; Whitehead D, 2008, J CLIN NURS, V17, P891, DOI 10.1111/j.1365-2702.2007.02079.x; World Health Organization, LAUNCH WHO QUAL RIGH; Wulczyn F, 2010, ADAPTING SYSTE UNPUB	53	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141222	10.1371/journal.pone.0141222	http://dx.doi.org/10.1371/journal.pone.0141222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540159	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800013
J	Bonnet, A; Servin, B; Mulsant, P; Mandon-Pepin, B				Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe; Mandon-Pepin, Beatrice			Spatio-Temporal Gene Expression Profiling during In Vivo Early Ovarian Folliculogenesis: Integrated Transcriptomic Study and Molecular Signature of Early Follicular Growth	PLOS ONE			English	Article							GRANULOSA-CELLS; VITRO DEVELOPMENT; OOCYTES; FOLLICLES; IDENTIFICATION; AUTOPHAGY; APOPTOSIS; PROTEINS; FAMILY; PATHWAY	Background The successful achievement of early ovarian folliculogenesis is important for fertility and reproductive life span. This complex biological process requires the appropriate expression of numerous genes at each developmental stage, in each follicular compartment. Relatively little is known at present about the molecular mechanisms that drive this process, and most gene expression studies have been performed in rodents and without considering the different follicular compartments. Results We used RNA-seq technology to explore the sheep transcriptome during early ovarian follicular development in the two main compartments: oocytes and granulosa cells. We documented the differential expression of 3,015 genes during this phase and described the gene expression dynamic specific to these compartments. We showed that important steps occurred during primary/secondary transition in sheep. We also described the in vivo molecular course of a number of pathways. In oocytes, these pathways documented the chronology of the acquisition of meiotic competence, migration and cellular organization, while in granulosa cells they concerned adhesion, the formation of cytoplasmic projections and steroid synthesis. This study proposes the involvement in this process of several members of the integrin and BMP families. The expression of genes such as Kruppel-like factor 9 (KLF9) and BMP binding endothelial regulator (BMPER) was highlighted for the first time during early follicular development, and their proteins were also predicted to be involved in gene regulation. Finally, we selected a data set of 24 biomarkers that enabled the discrimination of early follicular stages and thus offer a molecular signature of early follicular growth. This set of biomarkers includes known genes such as SPO11 meiotic protein covalently bound to DSB (SPO11), bone morphogenetic protein 15 (BMP15) and WEE1 homolog 2 (S. pombe)(WEE2) which play critical roles in follicular development but other biomarkers are also likely to play significant roles in this process. Conclusions To our knowledge, this is the first in vivo spatio-temporal exploration of transcriptomes derived from early follicles in sheep.	[Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] INRA, UMR GenPhySE Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France; [Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] Univ Toulouse, INP, ENSAT, GenPhySE Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Bonnet, Agnes; Servin, Bertrand; Mulsant, Philippe] Univ Toulouse, INP, ENVT, GenPhySE Genet Physiol & Syst Elevage, F-31076 Toulouse, France; [Mandon-Pepin, Beatrice] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bonnet, A (corresponding author), INRA, UMR GenPhySE Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France.	agnes.bonnet@toulouse.inra.fr	Servin, Bertrand/B-2206-2008	Servin, Bertrand/0000-0001-5141-0913; Mandon-Pepin, Beatrice/0000-0002-5424-0822	"Bioressources" grant under INRA programmes; AB	"Bioressources" grant under INRA programmes; AB	This work "BioFoll: transcrits caracteristiques ou "biomarqueurs" de la croissance folliculaire basale chez la brebis" was supported by "Bioressources 2010" grant under INRA programmes. The funding was received by AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Beltowski J, 2004, POL J PHARMACOL, V56, P5; Bonnet A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-904; Bonnet A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-417; Boutin C, 2012, CURR TOP DEV BIOL, V101, P161, DOI 10.1016/B978-0-12-394592-1.00010-7; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Cacciola G, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105726; CAHILL LP, 1980, J REPROD FERTIL, V58, P321, DOI 10.1530/jrf.0.0580321; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Dharma SJ, 2009, FERTIL STERIL, V91, P2025, DOI 10.1016/j.fertnstert.2008.02.088; Diaz E, 2012, J PHYSIOL-LONDON, V590, P33, DOI 10.1113/jphysiol.2011.213884; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Escobar ML, 2008, APOPTOSIS, V13, P1253, DOI 10.1007/s10495-008-0248-z; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Fenwick MA, 2011, ENDOCRINOLOGY, V152, P3515, DOI 10.1210/en.2011-0229; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fujiwara H, 1996, HORM RES, V46, P24, DOI 10.1159/000185177; Giebel J, 1997, TISSUE CELL, V29, P525, DOI 10.1016/S0040-8166(97)80053-5; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Gowri PM, 2003, MOL CELL BIOL, V23, P815, DOI 10.1128/MCB.23.3.815-825.2003; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hamatani T, 2008, REPRODUCTION, V135, P581, DOI 10.1530/REP-07-0430; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Hanna CB, 2010, BIOL REPROD, V82, P1190, DOI 10.1095/biolreprod.109.081984; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hur CG, 2009, REPRODUCTION, V137, P237, DOI 10.1530/REP-08-0035; Kanninen TT, 2013, EUR J OBSTET GYN R B, V171, P3, DOI 10.1016/j.ejogrb.2013.07.020; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; Kozyulina PY, 2015, MOL CANCER RES, V13, P423, DOI 10.1158/1541-7786.MCR-14-0353; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045212; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Magalhaes-Padilha DM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106096; Markholt S, 2012, MOL HUM REPROD, V18, P96, DOI 10.1093/molehr/gar083; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Moreau C, 2006, BIOL REPROD, V74, P75, DOI 10.1095/biolreprod.105.044545; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Natesampillai S, 2008, AM J PHYSIOL-ENDOC M, V294, pE385, DOI 10.1152/ajpendo.00480.2007; Oh JS, 2013, J CELL SCI, V126, P1081, DOI 10.1242/jcs.115592; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Pennetier S, 2005, BIOL REPROD, V73, P713, DOI 10.1095/biolreprod.105.041574; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Rosales-Torres AM, 2000, MOL REPROD DEV, V55, P270, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;270::AID-MRD5&gt;3.0.CO;2-H; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shuttleworth G, 2002, REPRODUCTION, V123, P807, DOI 10.1530/reprod/123.6.807; Simmen FA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-41; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Stumpff J, 2012, DEV CELL, V22, P1017, DOI 10.1016/j.devcel.2012.02.013; Tasaki H, 2013, THERIOGENOLOGY, V79, P809, DOI 10.1016/j.theriogenology.2012.12.009; Tieri P, 2013, MOL BIOSYST, V9, P2401, DOI 10.1039/c3mb70242a; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Vallee M, 2005, BIOL REPROD, V73, P63, DOI 10.1095/biolreprod.104.037069; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velentzas AD, 2007, AUTOPHAGY, V3, P130, DOI 10.4161/auto.3582; Wei Z, 2013, TUMOR BIOL, V34, P181, DOI 10.1007/s13277-012-0527-8; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yoon SJ, 2006, FERTIL STERIL, V85, P193, DOI 10.1016/j.fertnstert.2005.07.1296; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025; Zhang XL, 2001, MOL CELL ENDOCRINOL, V181, P81, DOI 10.1016/S0303-7207(01)00536-6	72	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141482	10.1371/journal.pone.0141482	http://dx.doi.org/10.1371/journal.pone.0141482			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540452	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800017
J	Adamo, HH; Stromvall, K; Nilsson, M; Bergstrom, SH; Bergh, A				Adamo, Hanibal Hani; Stromvall, Kerstin; Nilsson, Maria; Bergstrom, Sofia Halin; Bergh, Anders			Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness	PLOS ONE			English	Article							RAT PROSTATE; CANCER; CELLS; MACROPHAGES; GROWTH; TISSUE; STROMA; ANGIOGENESIS; PROGRESSION; CASTRATION	In order to grow, tumors need to induce supportive alterations in the tumor-bearing organ, by us named tumor instructed normal tissue (TINT) changes. We now examined if the nature and magnitude of these responses were related to tumor size and aggressiveness. Three different Dunning rat prostate tumor cells were implanted into the prostate of immune-competent rats; 1) fast growing and metastatic MatLyLu tumor cells 2) fast growing and poorly metastatic AT-1 tumor cells, and 3) slow growing and non-metastatic G tumor cells. All tumor types induced increases in macrophage, mast cell and vascular densities and in vascular cell-proliferation in the tumor-bearing prostate lobe compared to controls. These increases occurred in parallel with tumor growth. The most pronounced and rapid responses were seen in the prostate tissue surrounding MatLyLu tumors. They were, also when small, particularly effective in attracting macrophages and stimulating growth of not only micro-vessels but also small arteries and veins compared to the less aggressive AT-1 and G tumors. The nature and magnitude of tumor-induced changes in the tumor-bearing organ are related to tumor size but also to tumor aggressiveness. These findings, supported by previous observation in patient samples, suggest that one additional way to evaluate prostate tumor aggressiveness could be to monitor its effect on adjacent tissues.	[Adamo, Hanibal Hani; Stromvall, Kerstin; Nilsson, Maria; Bergstrom, Sofia Halin; Bergh, Anders] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden	Umea University	Bergh, A (corresponding author), Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden.	anders.bergh@medbio.umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [65X-05935-32-3]; Swedish Cancer Foundation [CAN 2013/327]; Lions Cancer Research Foundation; County of Vasterbotten; Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lions Cancer Research Foundation; County of Vasterbotten; Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse	This work was supported by grants from the Swedish Research Council (65X-05935-32-3), The Swedish Cancer Foundation (CAN 2013/327), The Lions Cancer Research Foundation, The County of Vasterbotten and Konung Gustaf V:s och Drottning Victorias Frimurare Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Byun JS, 2013, AM J PATHOL, V182, P1055, DOI 10.1016/j.ajpath.2013.01.009; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2006, CLIN CANCER RES, V12, P7431, DOI 10.1158/1078-0432.CCR-06-1895; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Khmelewski E, 2004, CIRC RES, V95, pE56, DOI 10.1161/01.RES.0000143013.04985.E7; Lundholm M, SECRETED FACTO UNPUB; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rohan TE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju136; Rudolfsson SH, 2008, J ENDOCRINOL, V196, P11, DOI 10.1677/JOE-07-0272; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Thomasson M, 2011, INT J CANCER, V128, P2843, DOI 10.1002/ijc.25820; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141601	10.1371/journal.pone.0141601	http://dx.doi.org/10.1371/journal.pone.0141601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536349	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400072
J	Bodirsky, BL; Rolinski, S; Biewald, A; Weindl, I; Popp, A; Lotze-Campen, H				Bodirsky, Benjamin Leon; Rolinski, Susanne; Biewald, Anne; Weindl, Isabelle; Popp, Alexander; Lotze-Campen, Hermann			Global Food Demand Scenarios for the 21st Century	PLOS ONE			English	Article							MEAT INTAKE; AGRICULTURE; TRANSITION; MORTALITY; SECURITY; FUTURE; CANCER; TRENDS; RED	Long-term food demand scenarios are an important tool for studying global food security and for analysing the environmental impacts of agriculture. We provide a simple and transparent method to create scenarios for future plant-based and animal-based calorie demand, using time-dependent regression models between calorie demand and income. The scenarios can be customized to a specific storyline by using different input data for gross domestic product (GDP) and population projections and by assuming different functional forms of the regressions. Our results confirm that total calorie demand increases with income, but we also found a non-income related positive time-trend. The share of animal-based calories is estimated to rise strongly with income for low-income groups. For high income groups, two ambiguous relations between income and the share of animal-based products are consistent with historical data: First, a positive relation with a strong negative time-trend and second a negative relation with a slight negative time-trend. The fits of our regressions are highly significant and our results compare well to other food demand estimates. The method is exemplarily used to construct four food demand scenarios until the year 2100 based on the storylines of the IPCC Special Report on Emissions Scenarios (SRES). We find in all scenarios a strong increase of global food demand until 2050 with an increasing share of animal-based products, especially in developing countries.	[Bodirsky, Benjamin Leon; Rolinski, Susanne; Biewald, Anne; Weindl, Isabelle; Lotze-Campen, Hermann] Potsdam Inst Climate Impact Res, Dept Climate Impacts & Vulnerabilites, Potsdam, Germany; [Bodirsky, Benjamin Leon] CSIRO, St Lucia, Qld, Australia; [Popp, Alexander] Potsdam Inst Climate Impact Res, Dept Sustainable Solut, Potsdam, Germany; [Weindl, Isabelle; Lotze-Campen, Hermann] Humboldt Univ, Dept Agr Econ, D-10099 Berlin, Germany	Potsdam Institut fur Klimafolgenforschung; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin	Rolinski, S (corresponding author), Potsdam Inst Climate Impact Res, Dept Climate Impacts & Vulnerabilites, Potsdam, Germany.	Susanne.Rolinski@pik-potsdam.de	Lotze-Campen, Hermann/AAA-5093-2020; Bodirsky, Benjamin Leon/ABH-9170-2020; Popp, Alexander/N-7064-2014	Lotze-Campen, Hermann/0000-0002-0003-5508; Bodirsky, Benjamin Leon/0000-0002-8242-6712; Popp, Alexander/0000-0001-9500-1986	GLUES (Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services) [01LL0901A]; CARBO-Extreme [FP7/226701]; Volante [FP7/265104]; FUME [FP7/243888]; NaWaMa (Sustainable Water Management in a Globalized World) [BMBF 01UN1009]	GLUES (Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services); CARBO-Extreme; Volante; FUME; NaWaMa (Sustainable Water Management in a Globalized World)	BLB, IW, and AP were supported by GLUES (Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services), 01LL0901A (http://modul-a.nachhaltiges-landmanagement.de/de/wissenschaftlichebegleitung-glues/). SR was supported by CARBO-Extreme FP7/226701 (http://www.carbo-extreme.eu/), Volante FP7/265104 (http://www.volante-project.eu/), and FUME FP7/243888 (http://fumeproject.uclm.es/). AB was supported by NaWaMa (Sustainable Water Management in a Globalized World) BMBF 01UN1009 (https://www.pik-potsdam.de/nawama).	Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; Alexandratos N, 2012, 1203 FAO ESA; Alexandratos N, 2006, WORLD AGR 2030 2050; Andrews M, 2003, HOUSEHOLD FOOD SECUR; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2002, COUNTR LEV GDP DOWNS; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; [Anonymous], AGRIMONDE SCENARIOS; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENNETT M. K., 1941, Wheat Studies of the Food Res. Inst., Stanford Univ., California, V18, P37; Blandford D, 2005, AGR ECON-BLACKWELL, V33, P127, DOI 10.1111/j.0169-5150.2005.20050603_1.x; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Center for International Earth Science Information Network (CIESIN), 2002, COUNTR LEV POP DOWNS; Cirera X, 2010, PHILOS T R SOC B, V365, P2821, DOI 10.1098/rstb.2010.0164; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Engel C.L.E., 1857, B I INT STAT, P8; FAO, 2004, STAT FOOD INS WORLD; FAO, 1996, WORLD FOOD SUMMIT; FAOSTAT, 2011, DAT COLL FOOD AGR OR; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; HERRMANN R, 1995, EUR REV AGRIC ECON, V22, P400, DOI 10.1093/erae/22.3.400; IPCC, 1990, CLIM CHANG IPCC SCI; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kriegler E, 2014, CLIMATIC CHANGE, V122, P401, DOI 10.1007/s10584-013-0971-5; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Kruse J., 2010, ESTIMATING DEMAND AG; Leggett J, 1992, EMISSIONS SCENARIOS; Liefert WM, 2012, APPL ECON PERSPECT P, V34, P37, DOI 10.1093/aepp/ppr046; Lotze-Campen H, 2008, AGR ECON-BLACKWELL, V39, P325, DOI 10.1111/j.1574-0862.2008.00336.x; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; Nakicenovic N., 2000, SPECIAL REPORT EMISS; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Oborn I, 2011, 5 SCENARIOS 2050 CON; Organization WH, 2009, GLOB HLTH RISKS MORT; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Ringler C, 2012, 2012 GLOBAL HUNGER I; Schmitz Christoph, 2013, Water Resources Research, V49, P3601, DOI 10.1002/wrcr.20188; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Smil V., 2000, FEEDING WORLD CHALLE; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Svedberg P, 1999, WORLD DEV, V27, P2081, DOI 10.1016/S0305-750X(99)00102-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Trewavas AJ, 2001, PLANT PHYSIOL, V125, P174, DOI 10.1104/pp.125.1.174; Unnevehr LJ, 2005, CONVERGENCE DIVERGEN, P24687; UNSTATS, 2011, NAT ACC MAIN AGGR DA; Valin H, 2010, CLIMATE CHANGE MITIG; Valin H, 2014, AGR ECON-BLACKWELL, V45, P51, DOI 10.1111/agec.12089; Vervoort JM, 2014, GLOBAL ENVIRON CHANG, V28, P383, DOI 10.1016/j.gloenvcha.2014.03.001; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wirsenius, 2000, HUMAN USE LAND ORGAN; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005; WORLDBANK, 2011, WORLD DEV IND; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60	62	126	128	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139201	10.1371/journal.pone.0139201	http://dx.doi.org/10.1371/journal.pone.0139201			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536124	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400007
J	Docherty, KM; Borton, HM; Espinosa, N; Gebhardt, M; Gil-Loaiza, J; Gutknecht, JLM; Maes, PW; Mott, BM; Parnell, JJ; Purdy, G; Rodrigues, PAP; Stanish, LF; Walser, ON; Gallery, RE				Docherty, Kathryn M.; Borton, Hannah M.; Espinosa, Noelle; Gebhardt, Martha; Gil-Loaiza, Juliana; Gutknecht, Jessica L. M.; Maes, Patrick W.; Mott, Brendon M.; Parnell, John Jacob; Purdy, Gayle; Rodrigues, Pedro A. P.; Stanish, Lee F.; Walser, Olivia N.; Gallery, Rachel E.			Key Edaphic Properties Largely Explain Temporal and Geographic Variation in Soil Microbial Communities across Four Biomes	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DIVERSITY; BIOMASS; BIOGEOGRAPHY; GRASSLAND; SEQUENCES; DYNAMICS; PH	Soil microbial communities play a critical role in nutrient transformation and storage in all ecosystems. Quantifying the seasonal and long-term temporal extent of genetic and functional variation of soil microorganisms in response to biotic and abiotic changes within and across ecosystems will inform our understanding of the effect of climate change on these processes. We examined spatial and seasonal variation in microbial communities based on 16S rRNA gene sequencing and phospholipid fatty acid (PLFA) composition across four biomes: a tropical broadleaf forest (Hawaii), taiga (Alaska), semiarid grassland-shrubland (Utah), and a subtropical coniferous forest (Florida). In this study, we used a team-based instructional approach leveraging the iPlant Collaborative to examine publicly available National Ecological Observatory Network (NEON) 16S gene and PLFA measurements that quantify microbial diversity, composition, and growth. Both profiling techniques revealed that microbial communities grouped strongly by ecosystem and were predominately influenced by three edaphic factors: pH, soil water content, and cation exchange capacity. Temporal variability of microbial communities differed by profiling technique; 16S-based community measurements showed significant temporal variability only in the subtropical coniferous forest communities, specifically through changes within subgroups of Acidobacteria. Conversely, PLFA-based community measurements showed seasonal shifts in taiga and tropical broadleaf forest systems. These differences may be due to the premise that 16S-based measurements are predominantly influenced by large shifts in the abiotic soil environment, while PLFA-based analyses reflect the metabolically active fraction of the microbial community, which is more sensitive to local disturbances and biotic interactions.	[Docherty, Kathryn M.; Borton, Hannah M.; Walser, Olivia N.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Espinosa, Noelle; Gebhardt, Martha; Purdy, Gayle; Gallery, Rachel E.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Gil-Loaiza, Juliana] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA; [Gutknecht, Jessica L. M.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Maes, Patrick W.; Rodrigues, Pedro A. P.] Univ Arizona, Grad Interdisciplinary Program Entomol & Insect S, Tucson, AZ USA; [Mott, Brendon M.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Parnell, John Jacob; Stanish, Lee F.] Natl Ecol Observ Network, Boulder, CO USA; [Gallery, Rachel E.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Western Michigan University; University of Arizona; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona; United States Department of Agriculture (USDA); University of Arizona	Gallery, RE (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	rgallery@email.arizona.edu	Harmanani, Haidar/Q-7755-2019; Gutknecht, Jessica/AAI-3682-2021; Harmanani, Haidar M/U-6841-2018; Gallery, Rachel E/I-2169-2014	Harmanani, Haidar/0000-0001-5416-4383; Harmanani, Haidar M/0000-0001-5416-4383; Rodrigues, Pedro/0000-0002-3280-7576; Farella, Martha/0000-0002-2925-4093; Gallery, Rachel/0000-0002-9159-8778	National Science Foundation-EAR [1331408]; National Institute of Food and Agriculture [ARZT-1360540H12-199]; Division Of Environmental Biology [1257139] Funding Source: National Science Foundation	National Science Foundation-EAR; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors received no specific funding for this work. REG acknowledges the National Science Foundation-EAR Award Number 1331408: Transformative Behavior of Energy, Water and Carbon in the Critical Zone II and National Institute of Food and Agriculture Award Number ARZT-1360540H12-199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; Balser TC, 2006, PLANT SOIL, V289, P59, DOI 10.1007/s11104-006-9104-5; Balser TC, 2005, SOIL BIOL BIOCHEM, V37, P601, DOI 10.1016/j.soilbio.2004.08.019; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bossio DA, 1998, MICROB ECOL, V49, P50; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chambers JQ, 2004, ECOL APPL, V14; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V82, P229, DOI 10.1007/s10533-006-9065-z; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer Noah, 2008, P95; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HILL TCJ, 1993, SOIL BIOL BIOCHEM, V25, P1779, DOI 10.1016/0038-0717(93)90183-C; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kao-Kniffin J, 2008, MICROB ECOL, V56, P55, DOI 10.1007/s00248-007-9323-1; Khodadad CLM, 2011, SOIL BIOL BIOCHEM, V43, P385, DOI 10.1016/j.soilbio.2010.11.005; Kluber LA, 2011, SOIL BIOL BIOCHEM, V43, P1042, DOI 10.1016/j.soilbio.2011.01.022; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Mau RL, 2015, ISME J, V9, P1477, DOI 10.1038/ismej.2014.205; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Miller S, 2008, SCIENCE, V322, P1329, DOI 10.1126/science.1166032; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Oksanan J, 2011, VEGAN COMMUNITY ECOL; ORNL DAAC, 2014, MODIS SUBS LAND PROD; Prevost-Boure NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111667; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rubin BER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070460; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2014, MBIO, V5, DOI 10.1128/mBio.01371-14; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Uksa M, 2014, SOIL BIOL BIOCHEM, V75, P197, DOI 10.1016/j.soilbio.2014.04.018; Valentin-Vargas A, 2014, SCI TOTAL ENVIRON, V500, P314, DOI 10.1016/j.scitotenv.2014.08.107; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkinson SC, 2002, SOIL BIOL BIOCHEM, V34, P189, DOI 10.1016/S0038-0717(01)00168-7; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x	66	64	67	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0135352	10.1371/journal.pone.0135352	http://dx.doi.org/10.1371/journal.pone.0135352			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536666	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400003
J	Gabriel, MW; Woods, LW; Wengert, GM; Stephenson, N; Higley, JM; Thompson, C; Matthews, SM; Sweitzer, RA; Purcell, K; Barrett, RH; Keller, SM; Gaffney, P; Jones, M; Poppenga, R; Foley, JE; Brown, RN; Clifford, DL; Sacks, BN				Gabriel, Mourad W.; Woods, Leslie W.; Wengert, Greta M.; Stephenson, Nicole; Higley, J. Mark; Thompson, Craig; Matthews, Sean M.; Sweitzer, Rick A.; Purcell, Kathryn; Barrett, Reginald H.; Keller, Stefan M.; Gaffney, Patricia; Jones, Megan; Poppenga, Robert; Foley, Janet E.; Brown, Richard N.; Clifford, Deana L.; Sacks, Benjamin N.			Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the Fisher (Pekania pennanti) in California	PLOS ONE			English	Article							MOUNTAIN LION PREDATION; MARTES-PENNANTI; TOXOPLASMA-GONDII; CANINE-DISTEMPER; DNA; RISK	Wildlife populations of conservation concern are limited in distribution, population size and persistence by various factors, including mortality. The fisher (Pekania pennanti), a North American mid-sized carnivore whose range in the western Pacific United States has retracted considerably in the past century, was proposed for threatened status protection in late 2014 under the United States Endangered Species Act by the United States Fish and Wildlife Service in its West Coast Distinct Population Segment. We investigated mortality in 167 fishers from two genetically and geographically distinct sub-populations in California within this West Coast Distinct Population Segment using a combination of gross necropsy, histology, toxicology and molecular methods. Overall, predation (70%), natural disease (16%), toxicant poisoning (10%) and, less commonly, vehicular strike (2%) and other anthropogenic causes (2%) were causes of mortality observed. We documented both an increase in mortality to (57% increase) and exposure (6%) from pesticides in fishers in just the past three years, highlighting further that toxicants from marijuana cultivation still pose a threat. Additionally, exposure to multiple rodenticides significantly increased the likelihood of mortality from rodenticide poisoning. Poisoning was significantly more common in male than female fishers and was 7 times more likely than disease to kill males. Based on necropsy findings, suspected causes of mortality based on field evidence alone tended to underestimate the frequency of disease-related mortalities. This study is the first comprehensive investigation of mortality causes of fishers and provides essential information to assist in the conservation of this species.	[Gabriel, Mourad W.; Wengert, Greta M.] Integral Ecol Res Ctr, Blue Lake, CA 95525 USA; [Gabriel, Mourad W.; Sacks, Benjamin N.] Univ Calif Davis, Mammalian Ecol & Conservat Unit, Vet Genet Lab, Davis, CA 95616 USA; [Woods, Leslie W.; Poppenga, Robert] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Davis, CA 95616 USA; [Stephenson, Nicole; Foley, Janet E.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Higley, J. Mark] Hoopa Tribal Forestry, Dept Wildlife, Hoopa, CA USA; [Thompson, Craig; Purcell, Kathryn] US Forest Serv, Pacific Southwest Res Stn, Sierra Nevada Res Ctr, Fresno, CA USA; [Matthews, Sean M.] Wildlife Conservat Soc, Hoopa, CA USA; [Sweitzer, Rick A.; Barrett, Reginald H.] Univ Calif Berkeley, Sierra Nevada Adapt Management Project, Berkeley, CA 94720 USA; [Keller, Stefan M.; Gaffney, Patricia; Jones, Megan] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Brown, Richard N.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Sacks, Benjamin N.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service; Wildlife Conservation Society; University of California System; University of California Berkeley; University of California System; University of California Davis; California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Davis	Gabriel, MW (corresponding author), Integral Ecol Res Ctr, Blue Lake, CA 95525 USA.	mgabriel@IERCecology.org	Purcell, Kathryn L/S-2592-2016; Barrett, Reginald Haughton/AAC-2608-2020	Higley, Mark/0000-0002-7722-3785; Keller, Stefan/0000-0002-5428-2985	Integral Ecology Research Center; California Animal Health and Food Safety Laboratory System; Hoopa Valley Tribal Forestry; United States Forest Service; National Park Service; United States Fish and Wildlife Service; California Department of Water Resources; California Department of Fish and Wildlife; California Department of Forestry and Fire Protection; Sierra Nevada Conservancy; Sierra Nevada Adaptive Management Project; Bureau of Indian Affairs	Integral Ecology Research Center; California Animal Health and Food Safety Laboratory System; Hoopa Valley Tribal Forestry; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service); National Park Service; United States Fish and Wildlife Service(US Fish & Wildlife Service); California Department of Water Resources; California Department of Fish and Wildlife; California Department of Forestry and Fire Protection; Sierra Nevada Conservancy; Sierra Nevada Adaptive Management Project; Bureau of Indian Affairs	Funding: This work was supported by the Integral Ecology Research Center, California Animal Health and Food Safety Laboratory System, Hoopa Valley Tribal Forestry, United States Forest Service, National Park Service, United States Fish and Wildlife Service, California Department of Water Resources, California Department of Fish and Wildlife, California Department of Forestry and Fire Protection, The Sierra Nevada Conservancy, Sierra Nevada Adaptive Management Project and the Bureau of Indian Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; [Anonymous], 2013, EPIDEMIOLOGY; [Anonymous], 2014, R LANG ENV STAT COMP; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; BRAND CJ, 1976, J WILDLIFE MANAGE, V40, P416, DOI 10.2307/3799943; Buck S. G., 1982, THESIS; Burnham K. P., 1998, MODEL SELECTION INFE; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Croissant Yves, 2012, ESTIMATION MULTINOMI; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Eason C, 1998, P NZ PLANT PROT C NZ; Erickson W., 2004, POTENTIAL RISKS 9 RO, P230; Ernest HB, 2002, J WILDLIFE MANAGE, V66, P75, DOI 10.2307/3802873; Fuller MR, 2012, TECH ECOL CONSERVAT, P152; Gabriel M, 2005, W SECT WILDL SOC ANN; Gabriel M.W., 2013, WILDL PROF, P46; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Gabriel MW, 2010, J WILDLIFE DIS, V46, P966, DOI 10.7589/0090-3558-46.3.966; Gabriel MW, 2012, BIOL CONSERVATION MA, P138; Gabriel MW, 2007, 813335G021 US FISH W, P48; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Janeway C.A., 2007, IMMUNOBIOLOGY, V7th; Keller SM, 2012, J WILDLIFE DIS, V48, P1035, DOI 10.7589/2011-12-350; KNICK ST, 1990, WILDLIFE MONOGR, P1; Kreuder C, 2003, J WILDLIFE DIS, V39, P495, DOI 10.7589/0090-3558-39.3.495; Lewis JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032726; Lofroth EC, 2010, CONSERVATION FISHERS, P174; Lyver PO, 2000, MAMMAL REV, V30, P31, DOI 10.1046/j.1365-2907.2000.00055.x; Mallery M, 2011, BERKELEY UNDERGRADUA, V23, P1; Onorato D, 2006, WILDLIFE SOC B, V34, P815, DOI 10.2193/0091-7648(2006)34[815:DOPPAE]2.0.CO;2; Origgi FC, 2012, VET PATHOL, V49, P913, DOI 10.1177/0300985812436743; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; Powell R.A., 1994, SCI BASIS CONSERVING; Raley CM, 2006, ECOLOGICAL CHARACTER, P32; Rosas-Rosas OC, 2008, RANGELAND ECOL MANAG, V61, P554, DOI 10.2111/08-038.1; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Thompson C, 2014, CONSERV LETT, V7, P91, DOI 10.1111/conl.12038; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; Truex RL, 1998, WILDLIFE MANAGEMENT, P118; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; TURNER JW, 1992, CAN J ZOOL, V70, P929, DOI 10.1139/z92-132; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Viera AJ, 2005, FAM MED, V37, P360; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Wengert GM, 2013, THESIS; Wengert GM, 2013, WILDLIFE SOC B, V37, P659, DOI 10.1002/wsb.287; Wengert GM, 2014, J WILDLIFE MANAGE, V78, P603, DOI 10.1002/jwmg.698; Wengert GM, 2012, TECH ECOL CONSERVAT, P294; Wilbert JC, 1992, THESIS; Wisely SM, 2004, J MAMMAL, V85, P640, DOI 10.1644/BEL-011; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Wobeser GA, 2007, DIS WILD ANIMALS INV; Zielinski WJ, 2012, J FISH WILDL MANAG, P3	54	30	32	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140640	10.1371/journal.pone.0140640	http://dx.doi.org/10.1371/journal.pone.0140640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536481	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400028
J	Gonzalez, JM; Rodriguez, CA; Zuluaga, AF; Agudelo, M; Vesga, O				Gonzalez, Javier M.; Rodriguez, Carlos A.; Zuluaga, Andres F.; Agudelo, Maria; Vesga, Omar			Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; VANCOMYCIN PRODUCTS; INFECTIOUS-DISEASES; ANTIFUNGAL THERAPY; AMPHOTERICIN-B; ANIMAL-MODELS; BIOEQUIVALENCE; SURVEILLANCE; FORMULATIONS; VOLUNTEERS	Some generics of antibacterials fail therapeutic equivalence despite being pharmaceutical equivalents of their innovators, but data are scarce with antifungals. We used the neutropenic mice model of disseminated candidiasis to challenge the therapeutic equivalence of three generic products of fluconazole compared with the innovator in terms of concentration of the active pharmaceutical ingredient, analytical chemistry (liquid chromatography/mass spectrometry), in vitro susceptibility testing, single-dose serum pharmacokinetics in infected mice, and in vivo pharmacodynamics. Neutropenic, five week-old, murine pathogen free male mice of the strain Udea: ICR(CD-2) were injected in the tail vein with Candida albicans GRP-0144 (MIC = 0.25 mg/L) or Candida albicans CIB-19177 (MIC = 4 mg/L). Subcutaneous therapy with fluconazole (generics or innovator) and sterile saline (untreated controls) started 2 h after infection and ended 24 h later, with doses ranging from no effect to maximal effect (1 to 128 mg/kg per day) divided every 3 or 6 hours. The Hill's model was fitted to the data by nonlinear regression, and results from each group compared by curve fitting analysis. All products were identical in terms of concentration, chromatographic and spectrographic profiles, MICs, mouse pharmacokinetics, and in vivo pharmacodynamic parameters. In conclusion, the generic products studied were pharmaceutically and therapeutically equivalent to the innovator of fluconazole.	[Gonzalez, Javier M.; Rodriguez, Carlos A.; Zuluaga, Andres F.; Agudelo, Maria; Vesga, Omar] Univ Antioquia, GRIPE Grp Investigador Problemas Enfermedades Inf, Medellin, Colombia; [Gonzalez, Javier M.] Clin Cardio VID, Sci Direct, Medellin, Colombia; [Agudelo, Maria; Vesga, Omar] Hosp Univ San Vicente Fdn, Infect Dis Unit, Medellin, Colombia	Universidad de Antioquia	Vesga, O (corresponding author), Univ Antioquia, GRIPE Grp Investigador Problemas Enfermedades Inf, Medellin, Colombia.	omar.vesga@udea.edu.co	Rodriguez, Carlos A./P-8324-2019; Zuluaga, Andres F./K-7366-2016	Rodriguez, Carlos A./0000-0002-4042-4313; Zuluaga, Andres F./0000-0001-5656-4153	University of Antioquia (CODI); University of Antioquia (Estrategia de Sostenibilidad); Sistema General Regalias of Colombia [BPIN: 2013000100183]; Rodrigo Vesga-Meneses Scientific Foundation	University of Antioquia (CODI); University of Antioquia (Estrategia de Sostenibilidad); Sistema General Regalias of Colombia; Rodrigo Vesga-Meneses Scientific Foundation	Funding for this project came from the University of Antioquia (CODI and Estrategia de Sostenibilidad 2013-2014), Sistema General Regalias of Colombia (BPIN: 2013000100183) and the Rodrigo Vesga-Meneses Scientific Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2014, ANTIMICROB AGENTS CH, V58, P1005, DOI 10.1128/AAC.00350-13; Agudelo M, 2012, ANTIMICROB AGENTS CH, V56, P2659, DOI 10.1128/AAC.06012-11; Agudelo M, 2014, 54 INT C ANT AG CHEM; Agudelo M, 2011, 51 INT C ANT AG CHEM; Agudelo M, 2015, INT J ANTIMICROB AG, V45, P161, DOI 10.1016/j.ijantimicag.2014.10.014; Andes D, 2005, METH MOLEC MED, V118, P111; ANTLEY PP, 1988, INFECT IMMUN, V56, P2884, DOI 10.1128/IAI.56.11.2884-2890.1988; Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Blot S, 2006, J ANTIMICROB CHEMOTH, V58, P474, DOI 10.1093/jac/dkl241; Bulitta JB, 2011, AAPS J, V13, P201, DOI 10.1208/s12248-011-9257-x; Centers for Disease Control and Prevention, 2010, NUMB RAT AV LENGTH S; Cleary JD, 2003, PHARMACOTHERAPY, V23, P572, DOI 10.1592/phco.23.5.572.32209; CLSI, 2008, M27A3 CLSI; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Eggimann P, 2012, MYCOSES, V55, P65, DOI 10.1111/j.1439-0507.2011.02151.x; Gonzalez JM, 2012, INT C ANT AG CHEM 20; Hadwiger ME, 2012, ANTIMICROB AGENTS CH, V56, P2824, DOI 10.1128/AAC.00164-12; Hoharitanon Saowanee, 2005, J Med Assoc Thai, V88 Suppl 4, pS167; HUMPHREY MJ, 1985, ANTIMICROB AGENTS CH, V28, P648, DOI 10.1128/AAC.28.5.648; Jovanovic D, 2005, CLIN THER, V27, P1588, DOI 10.1016/j.clinthera.2005.10.016; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Lewis PO, 2014, AM J HEALTH-SYST PH, V71, P1029, DOI 10.2146/ajhp130516; Manorot M, 2000, INT J CLIN PHARM TH, V38, P355; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; Molter CM, 2014, J ZOO WILDLIFE MED, V45, P127, DOI 10.1638/2013-0042R1.1; Nambiar S, 2012, ANTIMICROB AGENTS CH, V56, P2819, DOI 10.1128/AAC.05344-11; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perez-Casas C, 2000, LANCET, V356, P2102, DOI 10.1016/S0140-6736(05)74314-2; Petraitis V, 2005, ANTIMICROB AGENTS CH, V49, P1642, DOI 10.1128/AAC.49.4.1642-1645.2005; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Richardson K., 1983, U.S. Patent, Patent No. 4404216; Rodriguez CA, 2015, ANTIMICROB AGENTS CH, V59, P53, DOI 10.1128/AAC.03633-14; Rodriguez CA, 2009, J INFECTION, V59, P277, DOI 10.1016/j.jinf.2009.08.005; Rodriguez-Tudela JL, 2007, ANTIMICROB AGENTS CH, V51, P3599, DOI 10.1128/AAC.00296-07; Slinker BK, 2001, PRIMER APPL REGRESSI, Vxxvii; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Valerio M, 2014, J ANTIMICROB CHEMOTH, V69, P1993, DOI 10.1093/jac/dku053; Vesga O, 2010, ANTIMICROB AGENTS CH, V54, P3271, DOI 10.1128/AAC.01044-09; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga AF, 2010, IATREIA, V16, P115; Zuluaga AF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0124-4; Zuluaga AF, 2014, CLIN INFECT DIS, V59, P459, DOI 10.1093/cid/ciu306; Zuluaga AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010744	45	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141872	10.1371/journal.pone.0141872	http://dx.doi.org/10.1371/journal.pone.0141872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536105	Green Submitted, gold, Green Published			2022-12-27	WOS:000364298400097
J	Jensen, HH; Pedersen, HN; Stenkjaer, E; Pedersen, GA; Login, FH; Nejsum, LN				Jensen, Helene H.; Pedersen, Hans N.; Stenkjaer, Eva; Pedersen, Gitte A.; Login, Frederic H.; Nejsum, Lene N.			Tir Is Essential for the Recruitment of Tks5 to Enteropathogenic Escherichia coli Pedestals	PLOS ONE			English	Article							III SECRETION SYSTEM; FOCAL ADHESIONS; PODOSOME FORMATION; EFFACING LESIONS; PX DOMAIN; ACTIN; PROTEIN; NCK; RECEPTOR; WASP	Enteropathogenic Escherichia coli (EPEC) is a bacterial pathogen that infects the epithelial lining of the small intestine and causes diarrhea. Upon attachment to the intestinal epithelium, EPEC uses a Type III Secretion System to inject its own high affinity receptor Translocated intimin receptor (Tir) into the host cell. Tir facilitates tight adhesion and recruitment of actin-regulating proteins leading to formation of an actin pedestal beneath the infecting bacterium. The pedestal has several similarities with podosomes, which are basolateral actin-rich extensions found in some migrating animal cells. Formation of podosomes is dependent upon the early podosome-specific scavenger protein Tks5, which is involved in actin recruitment. Although Tks5 is expressed in epithelial cells, and podosomes and EPEC pedestals share many components in their structure and mechanism of formation, the potential role of Tks5 in EPEC infections has not been studied. The aim of this study was to determine the subcellular localization of Tks5 in epithelial cells and to investigate if Tks5 is recruited to the EPEC pedestal. In an epithelial MDCK cell line stably expressing Tks5-EGFP, Tks5 localized to actin bundles. Upon infection, EPEC recruited Tks5-EGFP. Tir, but not Tir phosphorylation was essential for the recruitment. Time-lapse microscopy revealed that Tks5-EGFP was recruited instantly upon EPEC attachment to host cells, simultaneously with actin and N-WASp. EPEC infection of cells expressing a Delta PX-Tks5 deletion version of Tks5 showed that EPEC was able to both infect and form pedestals when the PX domain was deleted from Tks5. Future investigations will clarify the role of Tks5 in EPEC infection and pedestal formation.	[Nejsum, Lene N.] Aarhus Univ, Inst Mol Biol & Genet, Aarhus, Denmark; Aarhus Univ, Interdiciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Nejsum, LN (corresponding author), Aarhus Univ, Inst Mol Biol & Genet, CF Moellers Alle 3, Aarhus, Denmark.	nejsum@mbg.au.dk	Jensen, Helene H/V-5038-2018; Jensen, Helene/GZK-5914-2022	Jensen, Helene H/0000-0002-8426-9802; Nejsum, Lene Niemann/0000-0003-4368-8821	Lundbeck Foundation; Carlsberg Foundation; MEMBRANES	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); MEMBRANES	This work was supported by the Lundbeck Foundation, http://lundbeckfoundation.com/; the Carlsberg Foundation, http://www.carlsbergfondet.dk/; and MEMBRANES, http://membranes.au.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Bai L, 2008, INFECT IMMUN, V76, P361, DOI 10.1128/IAI.01199-07; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Campellone KG, 2010, FEBS J, V277, P2390, DOI 10.1111/j.1742-4658.2010.07653.x; Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; Cantarelli VV, 2002, INFECT IMMUN, V70, P2206, DOI 10.1128/IAI.70.4.2206-2209.2002; Cejudo-Martin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107674; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Ellson CD, 2002, J CELL SCI, V115, P1099; FINLAY BB, 1992, INFECT IMMUN, V60, P2541, DOI 10.1128/IAI.60.6.2541-2543.1992; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kundu K, 2013, BIOINFORMATICS; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Marches O, 2005, INFECT IMMUN, V73, P8411, DOI 10.1128/IAI.73.12.8411-8417.2005; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Muza-Moons MM, 2003, INFECT IMMUN, V71, P7069, DOI 10.1128/IAI.71.12.7069-7078.2003; Navarro-Garcia F, 2014, INFECT IMMUN, V82, P2255, DOI 10.1128/IAI.01386-13; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Peralta-Ramirez J, 2008, INFECT IMMUN, V76, P3854, DOI 10.1128/IAI.00072-08; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Reilein A, 2005, J CELL BIOL, V171, P845, DOI 10.1083/jcb.200505071; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Shaner NC, 2005, CELL MOTIL CYTOSKEL, V60, P104, DOI 10.1002/cm.20047; Shifrin Y, 2002, CELL MICROBIOL, V4, P235, DOI 10.1046/j.1462-5822.2002.00188.x; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Wong ARC, 2012, CELL MICROBIOL, V14, P1051, DOI 10.1111/j.1462-5822.2012.01778.x; Yogo K, 2006, ENDOCRINOLOGY, V147, P3307, DOI 10.1210/en.2005-1309	56	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141871	10.1371/journal.pone.0141871	http://dx.doi.org/10.1371/journal.pone.0141871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536015	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400096
J	Posid, T; Fazio, A; Cordes, S				Posid, Tasha; Fazio, Allyse; Cordes, Sara			Being Sticker Rich: Numerical Context Influences Children's Sharing Behavior	PLOS ONE			English	Article							JUDGMENTS; RESOURCE; FAIRNESS; INFANTS; ADULTS; STAKES	Young children spontaneously share resources with anonymous recipients, but little is known about the specific circumstances that promote or hinder these prosocial tendencies. Children (ages 3-11) received a small (12) or large (30) number of stickers, and were then given the opportunity to share their windfall with either one or multiple anonymous recipients (Dictator Game). Whether a child chose to share or not varied as a function of age, but was uninfluenced by numerical context. Moreover, children's giving was consistent with a proportion-based account, such that children typically donated a similar proportion (but different absolute number) of the resources given to them, regardless of whether they originally received a small or large windfall. The proportion of resources donated, however, did vary based on the number of recipients with whom they were allowed to share, such that on average, children shared more when there were more recipients available, particularly when they had more resources, suggesting they take others into consideration when making prosocial decisions. Finally, results indicated that a child's gender also predicted sharing behavior, with males generally sharing more resources than females. Together, findings suggest that the numerical contexts under which children are asked to share, as well as the quantity of resources that they have to share, may interact to promote (or hinder) altruistic behaviors throughout childhood.	[Posid, Tasha] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Fazio, Allyse; Cordes, Sara] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	University System of Ohio; Ohio State University; Boston College	Posid, T (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	posid.1@osu.edu			Alfred P. Sloan Fellowship; Division Of Research On Learning [1113648] Funding Source: National Science Foundation	Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Division Of Research On Learning(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	An Alfred P. Sloan Fellowship was awarded to Sara Cordes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the members of the Boston College Infant and Child Cognition Lab, especially Alison Goldstein, Alexandra Pierce, and Emily Kubota, who assisted in data collection. We would also like to thank all of the families who participated in our study, as well as Boston Children's Museum and the Living Laboratory at the Museum of Science, Boston. Finally, we would like to thank the reviewers for their helpful feedback on previous versions of this manuscript. Funding was provided by an Alfred P. Sloan Fellowship to S. C.	Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Boyer TW, 2008, DEV PSYCHOL, V44, P1478, DOI 10.1037/a0013110; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Cordes S., 2015, J EXPT PSYCHOL HUMAN; Cordes S., 2015, UNPUB; Droit-Volet S., 2007, Q J EXP PSYCHOL, V61, P1827; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gummerum M., 2009, EVOL PSYCHOL-US, V7, DOI [10.1177/147470490900700212, DOI 10.1177/147470490900700212]; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hsee CK, 2013, PSYCHOL SCI, V24, P1801, DOI 10.1177/0956797613482947; Jeong Y, 2007, J COGN DEV, V8, P237, DOI 10.1080/15248370701202471; Jordan KE, 2006, J EXP CHILD PSYCHOL, V95, P215, DOI 10.1016/j.jecp.2006.05.004; List JA, 2008, J ECON BEHAV ORGAN, V65, P1, DOI 10.1016/j.jebo.2003.09.021; McAuliffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080966; McCrink K, 2007, PSYCHOL SCI, V18, P740, DOI 10.1111/j.1467-9280.2007.01969.x; McCrink K, 2010, DEVELOPMENTAL SCI, V13, P37, DOI 10.1111/j.1467-7687.2009.00859.x; Ng R, 2011, DEV PSYCHOL, V47, P1230, DOI 10.1037/a0024923; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OFFENBACH SI, 1984, CHILD DEV, V55, P963, DOI 10.2307/1130148; Ongley S.F., 2011, FRONT PSYCHOL, V5, P458; Paulus M, 2014, CHILD DEV PERSPECT, V8, P77, DOI 10.1111/cdep.12066; Paulus M, 2013, J EXP CHILD PSYCHOL, V116, P78, DOI 10.1016/j.jecp.2012.12.014; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; Reyna VF, 2008, LEARN INDIVID DIFFER, V18, P89, DOI 10.1016/j.lindif.2007.03.011; Shaw A, 2014, J EXP CHILD PSYCHOL, V119, P40, DOI 10.1016/j.jecp.2013.10.007; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Shaw A, 2013, CURR DIR PSYCHOL SCI, V22, P413, DOI 10.1177/0963721413484467; Shaw A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00393; Shaw A, 2012, EVOL HUM BEHAV, V33, P736, DOI 10.1016/j.evolhumbehav.2012.06.001; Shaw A, 2012, J EXP PSYCHOL GEN, V141, P382, DOI 10.1037/a0025907; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; SPINILLO AG, 1991, CHILD DEV, V62, P427, DOI 10.2307/1131121; Stewart SM, 2000, J CROSS CULT PSYCHOL, V31, P333, DOI 10.1177/0022022100031003003; [辛自强 Xin Ziqiang], 2014, [心理学报, Acta Psychologica Sinica], V46, P791; [辛自强 Xin Ziqiang], 2011, [心理科学, Psychological Science], V34, P520; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Xu F, 2009, COGNITION, V112, P97, DOI 10.1016/j.cognition.2009.04.006	47	13	13	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0138928	10.1371/journal.pone.0138928	http://dx.doi.org/10.1371/journal.pone.0138928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535900	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400005
J	Sun, Y; Sahbaie, P; Liang, DY; Li, WW; Shi, XY; Kingery, P; Clark, JD				Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Li, Wenwu; Shi, Xiaoyou; Kingery, Paige; Clark, J. David			DNA Methylation Modulates Nociceptive Sensitization after Incision	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; CPG-BINDING PROTEIN-2; CELL LUNG-CANCER; NEUROPATHIC PAIN; EPIGENETIC REGULATION; NERVE INJURY; T-CELLS; SUBSTANCE-P; SPINAL-CORD; EXPRESSION	DNA methylation is a key epigenetic mechanism controlling DNA accessibility and gene expression. Blockade of DNA methylation can significantly affect pain behaviors implicated in neuropathic and inflammatory pain. However, the role of DNA methylation with regard to postoperative pain has not yet been explored. In this study we sought to investigate the role of DNA methylation in modulating incisional pain and identify possible targets under DNA methylation and contributing to incisional pain. DNA methyltranferase (DNMT) inhibitor 5-Aza-2'-deoxycytidine significantly reduced incision-induced mechanical allodynia and thermal sensitivity. Aza-2'-deoxycytidine also reduced hindpaw swelling after incision, suggesting an anti-inflammatory effect. Global DNA methylation and DNMT3b expression were increased in skin after incision, but none of DNMT1, DNMT3a or DNMT3b was altered in spinal cord or DRG. The expression of proopiomelanocortin Pomc encoding beta-endorphin and Oprm1 encoding the mu-opioid receptor were upregulated peripherally after incision; moreover, Oprm1 expression was further increased under DNMT inhibitor treatment. Finally, local peripheral injection of the opioid receptor antagonist naloxone significantly exacerbated incision-induced mechanical hypersensitivity. These results suggest that DNA methylation is functionally relevant to incisional nociceptive sensitization, and that mu-opioid receptor signaling might be one methylation regulated pathway controlling sensitization after incision.	[Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Li, Wenwu; Shi, Xiaoyou; Kingery, Paige; Clark, J. David] Stanford Univ, Dept Anesthesiol, Sch Med, Stanford, CA 94305 USA; [Sun, Yuan; Sahbaie, Peyman; Liang, DeYong; Kingery, Paige; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Clark, JD (corresponding author), Stanford Univ, Dept Anesthesiol, Sch Med, Stanford, CA 94305 USA.	djclark@stanford.edu	liang, dy/GZA-4770-2022		NIH (Bethesda, MD, USA) [GM079126]; VA Merit Review award (Washington D.C., USA) [5I01BX000881]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079126] Funding Source: NIH RePORTER	NIH (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review award (Washington D.C., USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH award GM079126 (Bethesda, MD, USA) and VA Merit Review award 5I01BX000881 (Washington D.C., USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Bilinski P, 2012, ANN AGR ENV MED, V19, P491; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; CHUANG TK, 1995, BIOCHEM BIOPH RES CO, V216, P922, DOI 10.1006/bbrc.1995.2709; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Fu LH, 2011, ACTA PHARMACOL SIN, V32, P1373, DOI 10.1038/aps.2011.98; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Grouzmann E, 2002, FASEB J, V16, P1132, DOI 10.1096/fj.01-0939fje; Guan Y, 2008, PAIN, V138, P318, DOI 10.1016/j.pain.2008.01.004; Han L, 2007, CANCER BIOL THER, V6, P1284; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hong SS, 2015, GASTROENTEROLOGY, V148, P148, DOI 10.1053/j.gastro.2014.09.032; Hwang CK, 2010, MOL PHARMACOL, V78, P58, DOI 10.1124/mol.110.064311; Jang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-80; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; Kato T, 2014, NEUROPHARMACOLOGY, V80, P133, DOI 10.1016/j.neuropharm.2013.12.019; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Kingery WS, 2003, PAIN, V104, P75, DOI 10.1016/S0304-3959(02)00467-0; Klengel T, 2014, NEUROPHARMACOLOGY, V80, P115, DOI 10.1016/j.neuropharm.2014.01.013; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; Knight LJ, 2009, INT J ONCOL, V34, P465, DOI 10.3892/ijo_00000171; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Kraus J, 2010, MOL IMMUNOL, V48, P257, DOI 10.1016/j.molimm.2010.08.002; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Ma XT, 2013, EPIGENOMICS-UK, V5, P301, DOI [10.2217/EPI.13.26, 10.2217/epi.13.26]; Marsit CJ, 2015, J EXP BIOL, V218, P71, DOI 10.1242/jeb.106971; Mauck M, 2014, CURR OPIN ANESTHESIO, V27, P1, DOI 10.1097/ACO.0000000000000030; Meller R, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00102; Mi XB, 2008, ACTA PHARMACOL SIN, V29, P105, DOI 10.1111/j.1745-7254.2008.00739.x; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pollema-Mays SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00217; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Pyati S, 2007, CNS DRUGS, V21, P185, DOI 10.2165/00023210-200721030-00002; Qi FH, 2013, PAIN, V154, P34, DOI 10.1016/j.pain.2012.07.031; RAZIN A, 1994, PROG NUCLEIC ACID RE, V48, P53, DOI 10.1016/S0079-6603(08)60853-3; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Schmidt Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079099; Spofford CM, 2012, ANESTHESIOLOGY, V117, P161, DOI 10.1097/ALN.0b013e31825a2a2b; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Sun Y, 2012, ANESTHESIOLOGY, V117, P626, DOI 10.1097/ALN.0b013e31826571aa; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tochiki KK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-14; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Tuesta LM, 2014, EMBO J, V33, P1091, DOI 10.1002/embj.201488106; Turcot V, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-4; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; van Rietschoten JGI, 2006, BLOOD, V108, P2143, DOI 10.1182/blood-2006-01-021147; Viet CT, 2014, CLIN CANCER RES, V20, P4882, DOI 10.1158/1078-0432.CCR-14-0901; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wachman EM, 2014, J PEDIATR-US, V165, P472, DOI 10.1016/j.jpeds.2014.05.040; Wang L, 2006, INT J ONCOL, V29, P201; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; WILSON VL, 1983, CANCER RES, V43, P3493; Wood Emily J., 2012, Frontiers in Genetics, V3, P241, DOI 10.3389/fgene.2012.00241; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037621; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	73	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142046	10.1371/journal.pone.0142046	http://dx.doi.org/10.1371/journal.pone.0142046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535894	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400122
J	An, H; Kim, JY; Oh, E; Lee, N; Cho, Y; Seo, JH				An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong			Salinomycin Promotes Anoikis and Decreases the CD44(+)/CD24(-) Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells	PLOS ONE			English	Article							IN-VITRO PROPAGATION; BREAST-CANCER CELLS; ELEVATED LEVELS; PATHWAY; GROWTH; IDENTIFICATION; METASTASIS; RESISTANCE; CYCLIN-D1; APOPTOSIS	Triple-negative breast cancer (TNBC) is an aggressive tumor subtype with an enriched CD44(+)/CD24(-) stem-like population. Salinomycin is an antibiotic that has been shown to target cancer stem cells (CSC); however, the mechanisms of action involved have not been well characterized. The objective of the present study was to investigate the effect of salinomycin on cell death, migration, and invasion, as well as CSC-like properties in MDA-MB-231 breast cancer cells. Salinomycin significantly induced anoikis-sensitivity, accompanied by caspase-3 and caspase-8 activation and PARP cleavage, during anchorage-independent growth. Salinomycin treatment also caused a marked suppression of cell migration and invasion with concomitant downregulation of MMP-9 and MMP-2 mRNA levels. Notably, salinomycin inhibited the formation of mammospheres and effectively reduced the CD44(+)/CD24(-) stem-like population during anchorage-independent growth. These observations were associated with the inhibition of STAT3 phosphorylation (Tyr705). Furthermore, interleukin-6 (IL-6)-induced STAT3 activation was strongly suppressed by salinomycin challenge. These findings support the notion that salinomycin may be potentially efficacious for targeting breast cancer stem-like cells through the inhibition of STAT3 activation.	[An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong] Korea Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul 152703, South Korea; [An, Hyunsook; Kim, Ji Young; Oh, Eunhye; Lee, Nahyun; Cho, Youngkwan; Seo, Jae Hong] Korea Univ, Coll Med, Brain Korea Program Biomed Sci 21, Seoul 152703, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Seo, JH (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul 152703, South Korea.	cancer@korea.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1852]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-317; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fofaria NM, 2015, CARCINOGENESIS, V36, P142, DOI 10.1093/carcin/bgu233; Fofaria NM, 2014, ONCOTARGET, V5, P7051, DOI 10.18632/oncotarget.2251; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grotenhuis BA, 2012, J SURG ONCOL, V106, P209, DOI 10.1002/jso.23069; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Koo KH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.223; Kruyt FAE, 2010, BIOCHEM PHARMACOL, V80, P423, DOI 10.1016/j.bcp.2010.04.010; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082821; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ma F, 2014, CANCER LETT, V353, P153, DOI 10.1016/j.canlet.2014.06.022; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou J, 2013, TOXICOL LETT, V222, P139, DOI 10.1016/j.toxlet.2013.07.022	48	66	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141919	10.1371/journal.pone.0141919	http://dx.doi.org/10.1371/journal.pone.0141919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528725	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600076
J	Berton, L; Bano, G; Carraro, S; Veronese, N; Pizzato, S; Bolzetta, F; De Rui, M; Valmorbida, E; De Ronch, I; Perissinotto, E; Coin, A; Manzato, E; Sergi, G				Berton, Linda; Bano, Giulia; Carraro, Sara; Veronese, Nicola; Pizzato, Simona; Bolzetta, Francesco; De Rui, Marina; Valmorbida, Elena; De Ronch, Irene; Perissinotto, Egle; Coin, Alessandra; Manzato, Enzo; Sergi, Giuseppe			Effect of Oral Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Physical Performance in Healthy Old Women Over 65 Years: An Open Label Randomized Controlled Trial	PLOS ONE			English	Article							PROTEIN-METABOLISM; BODY-COMPOSITION; DOUBLE-BLIND; HANDGRIP STRENGTH; MUSCLE STRENGTH; ASSOCIATION; ARGININE; ADULTS; MEN; SARCOPENIA	Although older people are particularly liable to sarcopenia, limited research is available on beta-hydroxy-beta-methylbutyrate (HMB) supplementation in this population, particularly in healthy subjects. In this parallel-group, randomized, controlled, open-label trial, we aimed to evaluate whether an oral supplement containing 1.5 g of calcium HMB for 8 weeks could improve physical performance and muscle strength parameters in a group of communitydwelling healthy older women. Eighty healthy women attending a twice-weekly mild fitness program were divided into two equal groups of 40, and 32 of the treated women and 33 control completed the study. We considered a change in the Short Physical Performance Battery (SPPB) score as the primary outcome and changes in the peak torque (PT) isometric and isokinetic strength of the lower limbs, 6-minute walking test (6MWT), handgrip strength and endurance as secondary outcomes. Body composition was assessed with dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computerized tomography (pQCT). The mean difference between the two groups on pre-post change were finally calculated (delta) for each outcome. After 8 weeks, there were no significant differences between the groups' SPPB, handgrip strength or DXA parameters. The group treated with HMB scored significantly better than the control group for PT isokinetic flexion (delta = 1.56+/-1.56 Nm; p = 0.03) and extension (delta = 3.32+/-2.61 Nm; p = 0.03), PT isometric strength (delta = 9.74 +/-3.90 Nm; p = 0.02), 6MWT (delta = 7.67+/-8.29 m; p = 0.04), handgrip endurance (delta = 21.41+/-16.28 s; p = 0.02), and muscle density assessed with pQCT. No serious adverse effects were reported in either group. In conclusion, a nutritional supplement containing 1.5 g of calcium HMB for 8 weeks in healthy elderly women had no significant effects on SPPB, but did significantly improve several muscle strength and physical performance parameters.	[Berton, Linda; Bano, Giulia; Carraro, Sara; Veronese, Nicola; Pizzato, Simona; Bolzetta, Francesco; De Rui, Marina; Valmorbida, Elena; De Ronch, Irene; Coin, Alessandra; Manzato, Enzo; Sergi, Giuseppe] Univ Padua, Dept Med DIMED, Div Geriatr, I-35128 Padua, Italy; [Perissinotto, Egle] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostat Epidemiol & Publ Hlth Unit, I-35128 Padua, Italy	University of Padua; University of Padua	Sergi, G (corresponding author), Univ Padua, Dept Med DIMED, Div Geriatr, Via Giustiniani 2, I-35128 Padua, Italy.	giuseppe.sergi@unipd.it	SERGI, GIUSEPPE/J-9396-2018; De Rui, Marina/AAA-6029-2022; Coin, Alessandra/J-9256-2018; Veronese, Nicola/K-4343-2018	SERGI, GIUSEPPE/0000-0001-9757-856X; De Rui, Marina/0000-0003-4966-1312; Coin, Alessandra/0000-0003-1687-4493; Veronese, Nicola/0000-0002-9328-289X				Baier S, 2009, JPEN-PARENTER ENTER, V33, P71, DOI 10.1177/0148607108322403; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; Cameron ME, 1988, MANUAL METHODOLOGY F; Carnovale E., 1989, TABELLE COMPOSIZIONE; Chan OYA, 2014, AGE, V36, DOI 10.1007/s11357-014-9714-4; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Deutz NE, 2010, CLIN NUTR, V32, P704; Farr JN, 2013, MED SCI SPORT EXER, V45, P2332, DOI 10.1249/MSS.0b013e31829c32fe; Fitschen PJ, 2013, NUTRITION, V29, P29, DOI 10.1016/j.nut.2012.05.005; Flakoll P, 2004, NUTRITION, V20, P445, DOI 10.1016/j.nut.2004.01.009; Frontera WR, 2000, AM J PHYSIOL-CELL PH, V279, pC611, DOI 10.1152/ajpcell.2000.279.3.C611; Guerra RS, 2015, EUR J CLIN NUTR, V69, P187, DOI 10.1038/ejcn.2014.242; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Hsieh LC, 2006, ASIA PAC J CLIN NUTR, V15, P544; Hsieh LC, 2010, ASIA PAC J CLIN NUTR, V19, P200; Jakobsen LH, 2010, NUTRITION, V26, P542, DOI 10.1016/j.nut.2009.06.015; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kuhls DA, 2007, J TRAUMA, V62, P125, DOI 10.1097/TA.0b013e31802dca93; Landi F, 2012, J AM MED DIR ASSOC, V13, P121, DOI 10.1016/j.jamda.2011.07.004; Legrand D, 2014, J AM GERIATR SOC, V62, P1030, DOI 10.1111/jgs.12840; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; May PE, 2002, AM J SURG, V183, P471, DOI 10.1016/S0002-9610(02)00823-1; Molfino A, 2013, AMINO ACIDS, V45, P1273, DOI 10.1007/s00726-013-1592-z; Mosele M, 2013, J GERONTOL A-BIOL, V68, P992, DOI 10.1093/gerona/glt008; NES M, 1991, EUR J CLIN NUTR, V45, P97; Reid KF, 2008, J NUTR HEALTH AGING, V12, P493, DOI 10.1007/BF02982711; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sergi G, 2011, EXP GERONTOL, V46, P929, DOI 10.1016/j.exger.2011.08.008; Sergi G, 2011, DRUG AGING, V28, P509, DOI 10.2165/11592010-000000000-00000; Stout JR, 2015, EXP GERONTOL, V64, P33, DOI 10.1016/j.exger.2015.02.012; Stout JR, 2013, EXP GERONTOL, V48, P1303, DOI 10.1016/j.exger.2013.08.007; Van Kan GA, 2009, J NUTR HEALTH AGING, V13, P708, DOI 10.1007/s12603-009-0201-z; Veronese N, 2014, AM J CLIN NUTR, V100, P974, DOI 10.3945/ajcn.113.080168; Veronese N, 2014, REJUV RES, V17, P276, DOI 10.1089/rej.2013.1491; Vukovich MD, 2001, J NUTR, V131, P2049, DOI 10.1093/jn/131.7.2049; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	42	36	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141757	10.1371/journal.pone.0141757	http://dx.doi.org/10.1371/journal.pone.0141757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529601	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600054
J	Calton, EK; Keane, KN; Newsholme, P; Soares, MJ				Calton, Emily K.; Keane, Kevin N.; Newsholme, Philip; Soares, Mario J.			The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies	PLOS ONE			English	Review							BLOOD MONONUCLEAR-CELLS; TOLL-LIKE RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; CYTOKINE EXPRESSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MONOCYTES; ASSOCIATION; MARKERS; RISK	Chronic low-grade inflammation accompanies obesity and its related chronic conditions. Both peripheral blood mononuclear cells (PBMCs) and cell lines have been used to study whether vitamin D has immune modulating effects; however, to date a detailed systematic review describing the published evidence has not been completed. We therefore conducted a systematic review on the effect of vitamin D on the protein expression and secretion of inflammatory markers by human-derived immune cells. The review was registered at the International Prospective Register for Systematic Reviews (PROSPERO, Registration number CRD42015023222). A literature search was conducted using Pubmed, Science Direct, Scopus, Web of Science and Medline. The search strategy used the following search terms: Vitamin D or cholecalciferol or 1,25-dihydroxyvitamin or 25-hydroxy-Vitamin D and Inflam* or cytokine* and supplement* or cell*. These terms were searched in the abstract, title and keywords. Inclusion criteria for study selection consisted of human-derived immune cell lines or cellular studies where PBMCs were obtained from humans, reported in the English language, and within the time period of 2000 to 2015. The selection protocol was mapped according to PRISMA guidelines. Twenty three studies (7 cell line and 16 PBMCs studies) met our criteria. All studies selected except one used the active metabolite 1,25(OH) 2, with one study using cholecalciferol and two studies also using 25 (OH) D. Four out of seven cell line studies showed an anti-inflammatory effect where suppression of key markers such as macrophage chemotactic protein 1, interleukin 6 and interleukin 8 were observed. Fourteen of sixteen PBMC studies also showed a similar anti-inflammatory effect based on common inflammatory endpoints. Mechanisms for such effects included decreased protein expression of toll-like receptor-2 and toll-like receptor-4; lower levels of phosphorylated p38 and p42/42; reduced expression of phosphorylated signal transducer and activator of transcription 5 and decreased reactive oxygen species. This review demonstrates that an anti-inflammatory effect of vitamin D is a consistent observation in studies of cell lines and human derived PBMCs.	[Calton, Emily K.; Soares, Mario J.] Curtin Univ, Sch Publ Hlth, Directorate Nutr Dietet & Food Technol, CHIRI Metab Hlth, Perth, WA 6845, Australia; [Keane, Kevin N.; Newsholme, Philip] Curtin Univ, CHIRI Biosci, Sch Biomed Sci, Perth, WA 6845, Australia	Curtin University; Curtin University	Newsholme, P (corresponding author), Curtin Univ, CHIRI Biosci, Sch Biomed Sci, Perth, WA 6845, Australia.	philip.newsholme@curtin.edu.au	Keane, Kevin N/M-3149-2017; Newsholme, Philip/D-4939-2016; calton, emily/AFR-3320-2022; Soares, Mario J/P-3519-2019	Keane, Kevin N/0000-0001-6248-7705; Newsholme, Philip/0000-0002-0500-6984; calton, emily/0000-0002-8482-233X; Soares, Mario J/0000-0001-6071-0272	Australian Government; Curtin Schools of Biomedical Sciences and Public Health	Australian Government(Australian GovernmentCGIAR); Curtin Schools of Biomedical Sciences and Public Health	EKC is the recipient of an Australian Postgraduate Award provided by the Australian Government. The authors thank the Curtin Schools of Biomedical Sciences and Public Health for research support.	Abe JI, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/953463; Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Ahmad R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-48; Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Badenhoop K, 2012, CURR DIABETES REP, V12, P635, DOI 10.1007/s11892-012-0322-3; Bonakdaran S, 2009, SAUDI MED J, V30, P509; Bouillon R, 2014, NAT REV ENDOCRINOL, V10, P79, DOI 10.1038/nrendo.2013.226; Calton EK, 2015, CURR OPIN CLIN NUTR, V18, P367, DOI 10.1097/MCO.0000000000000186; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Chandler PD, 2014, CANCER PREV RES, V7, P218, DOI 10.1158/1940-6207.CAPR-13-0338-T; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; De Vita F, 2014, AGE, V36, DOI 10.1007/s11357-014-9694-4; Di Rosa M, 2012, CELL IMMUNOL, V280, P36, DOI 10.1016/j.cellimm.2012.10.009; Du T, 2009, DIABETES RES CLIN PR, V83, P208, DOI 10.1016/j.diabres.2008.09.046; Edfeldt K, 2004, EUR HEART J, V25, P1447, DOI 10.1016/j.ehj.2004.05.004; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Giovannini L, 2001, TRANSPLANT P, V33, P2366, DOI 10.1016/S0041-1345(01)02023-1; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gonzalez-Molero I, 2013, EUR J CLIN NUTR, V67, P680, DOI 10.1038/ejcn.2013.48; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hossein-Nezhad A, 2013, MINERVA MED, V104, P295; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Jain SK, 2013, BIOCHEM BIOPH RES CO, V437, P7, DOI 10.1016/j.bbrc.2013.06.004; Jayaratne N, 2013, NUTRITION, V29, P1048, DOI 10.1016/j.nut.2013.02.011; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Jirapongsananuruk O, 2000, J ALLERGY CLIN IMMUN, V106, P981, DOI 10.1067/mai.2000.110101; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Lee BNR, 2011, MOL BIOL REP, V38, P2193, DOI 10.1007/s11033-010-0348-z; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Liu J, 2012, PHOTOCH PHOTOBIO SCI, V11, P1802, DOI 10.1039/c2pp25150g; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Luft VC, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-31; Mason C, 2014, AM J CLIN NUTR, V99, P1015, DOI 10.3945/ajcn.113.073734; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; Mellenthin L, 2014, METABOLISM, V63, P1056, DOI 10.1016/j.metabol.2014.05.002; Menezes AR, 2014, CURR OPIN CARDIOL, V29, P571, DOI 10.1097/HCO.0000000000000108; Mocanu V, 2013, MED-SURG J, V117, P965; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ojaimi S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-176; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Pecht T, 2014, OBES REV, V15, P322, DOI 10.1111/obr.12133; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pilz S, 2013, CURR DIABETES REP, V13, P261, DOI 10.1007/s11892-012-0358-4; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Rausch-Fan X, 2002, INT ARCH ALLERGY IMM, V128, P33, DOI 10.1159/000058001; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Stepien M, 2014, METABOLITES, V4, P248, DOI 10.3390/metabo4020248; Sundaram K, 2014, HORM CANCER-US, V5, P90, DOI 10.1007/s12672-014-0170-5; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P1, DOI 10.1081/IPH-120003399; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Thien R, 2005, J ALLERGY CLIN IMMUN, V116, P683, DOI 10.1016/j.jaci.2005.05.013; Tran B, 2013, CLIN ENDOCRINOL, V79, P631, DOI 10.1111/cen.12203; Tulk SE, 2015, J CELL BIOCHEM, V116, P711, DOI 10.1002/jcb.24985; Vitseva OI, 2008, OBESITY, V16, P932, DOI 10.1038/oby.2008.25; Vuolo Laura, 2012, Front Endocrinol (Lausanne), V3, P58, DOI 10.3389/fendo.2012.00058; Wang YC, 2014, ACTA CARDIOL SIN, V30, P144; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Yang MX, 2012, INFLAMM RES, V61, P511, DOI 10.1007/s00011-012-0441-y; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x; Zhang AB, 2006, CHINESE MED J-PEKING, V119, P2090, DOI 10.1097/00029330-200612020-00011; Zhang Y, 2013, J BIOL CHEM, V288, P14544, DOI 10.1074/jbc.M112.427054; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	69	211	225	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141770	10.1371/journal.pone.0141770	http://dx.doi.org/10.1371/journal.pone.0141770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528817	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600057
J	Katiyar, SP; Jain, A; Dhanjal, JK; Sundar, D				Katiyar, Shashank Prakash; Jain, Arpit; Dhanjal, Jaspreet Kaur; Sundar, Durai			Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft	PLOS ONE			English	Article							FLEMINGIA-VESTITA FABACEAE; ANTHELMINTIC EFFICACY; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ADIPOSE-TISSUE; RAILLIETINA-ECHINOBOTHRIDA; MOLECULAR-DYNAMICS; ISOFLAVONE GENISTEIN; INSULIN SENSITIVITY; GLYCERIDE-GLYCEROL; FASCIOLOPSIS-BUSKI	Cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) is a critical enzyme involved in gluconeogenesis, glyceroneogenesis and cataplerosis. cPEPCK converts oxaloacetic acid (OAA) into phosphoenol pyruvate (PEP) in the presence of GTP. cPEPCK is known to be associated with type 2 diabetes. Genistein is an isoflavone compound that shows anti-diabetic and anti-obesitic properties. Experimental studies have shown a decrease in the blood glucose level in the presence of genistein by lowering the functional activity of cPEPCK, an enzyme of gluconeogenesis. Using computational techniques such as molecular modeling, molecular docking, molecular dynamics simulation and binding free energy calculations, we identified cPEPCK as a direct target of genistein. We studied the molecular interactions of genistein with three possible conformations of cPEPCK-unbound cPEPCK (u_cPEPCK), GTP bound cPEPCK (GTP_cPEPCK) and GDP bound cPEPCK (GDP_cPEPCK). Binding of genistein was also compared with an already known cPEPCK inhibitor. We analyzed the interactions of genistein with cPEPCK enzyme and compared them with its natural substrate (OAA), product (PEP) and known inhibitor (3-MPA). Our results demonstrate that genistein uses the mechanism of mixed inhibition to block the functional activity of cPEPCK and thus can serve as a potential anti-diabetic and anti-obesity drug candidate. We also identified an extended binding site in the catalytic cleft of cPEPCK which is used by 3-MPA to inhibit cPEPCK non-competitively. We demonstrate that extended binding site of cPEPCK can further be exploited for designing new drugs against cPEPCK.	[Katiyar, Shashank Prakash; Jain, Arpit; Dhanjal, Jaspreet Kaur; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sundar, D (corresponding author), Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in	Dhanjal, Jaspreet Kaur/AAQ-3504-2020	Dhanjal, Jaspreet Kaur/0000-0003-4226-3063; Jain, Arpit/0000-0003-3437-3350; Katiyar, Shashank/0000-0002-8496-5103; Sundar, Durai/0000-0002-6549-6663				[Anonymous], 2013, SCHROD REL 2013 3 MA; [Anonymous], 2013, DESMOND MOL DYNAMICS; Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Beale EG, 2002, FASEB J, V16, P1695, DOI 10.1096/fj.02-0407rev; Behloul N, 2013, EUR J PHARMACOL, V698, P31, DOI 10.1016/j.ejphar.2012.11.013; Borras C, 2006, FASEB J, V20, P2136, DOI 10.1096/fj.05-5522fje; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choi MS, 2008, DIABETES-METAB RES, V24, P74, DOI 10.1002/dmrr.780; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; Das B, 2004, PARASITOL RES, V93, P253, DOI 10.1007/s00436-004-1122-8; de Lemos ML, 2001, ANN PHARMACOTHER, V35, P1118, DOI 10.1345/aph.10257; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Gilbert ER, 2013, FOOD FUNCT, V4, P200, DOI 10.1039/c2fo30199g; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; GORIN E, 1969, EUR J BIOCHEM, V8, P370, DOI 10.1111/j.1432-1033.1969.tb00537.x; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hanson RW, 1994, PYME P ENOLPYRUVATE; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar PK, 2004, PARASITOL INT, V53, P287, DOI 10.1016/j.parint.2004.04.001; Kar PK, 2002, PARASITOL INT, V51, P249, DOI 10.1016/S1383-5769(02)00032-6; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Liu HX, 2010, MOL PHARMACEUT, V7, P894, DOI 10.1021/mp100041b; Madadkar-Sobhani A, 2013, NUCL ACIDS RES; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pal P, 1998, J BIOSCIENCE, V23, P25, DOI 10.1007/BF02728520; Pal Papri, 1998, Parasitology International, V47, P233, DOI 10.1016/S1383-5769(98)00025-7; Park SA, 2006, LIFE SCI, V79, P1207, DOI 10.1016/j.lfs.2006.03.022; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; RECORD IR, 1995, J NUTR BIOCHEM, V6, P481, DOI 10.1016/0955-2863(95)00076-C; RESHEF L, 1969, J BIOL CHEM, V244, P1994; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakamoto T, 2010, J NUTR BIOCHEM, V21, P856, DOI 10.1016/j.jnutbio.2009.06.010; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Tandon V, 2003, PARASITOL INT, V52, P179, DOI 10.1016/S1383-5769(03)00006-0; Tandon V, 1997, PARASITOL RES, V83, P492, DOI 10.1007/s004360050286; Tilghman SM, 1976, HORMONAL REGULATION; Toner E, 2008, PARASITOLOGY, V135, P1189, DOI 10.1017/S0031182008004630; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEI HC, 1995, P SOC EXP BIOL MED, V208, P124; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	63	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141987	10.1371/journal.pone.0141987	http://dx.doi.org/10.1371/journal.pone.0141987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528723	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600086
J	Li, XW; Hu, GX; Li, XH; Wang, YY; Hu, YY; Zhou, HY; Latif, SA; Morris, DJ; Chu, YH; Zheng, ZQ; Ge, RS				Li, Xingwang; Hu, Guoxin; Li, Xiaoheng; Wang, Yi-Yan; Hu, Yuan-Yuan; Zhou, Hongyu; Latif, Syed A.; Morris, David J.; Chu, Yanhui; Zheng, Zhiqiang; Ge, Ren-Shan			Metabolic Coupling Determines the Activity: Comparison of 11 beta-Hydroxysteroid Dehydrogenase 1 and Its Coupling between Liver Parenchymal Cells and Testicular Leydig Cells	PLOS ONE			English	Article							HEXOSE-6-PHOSPHATE DEHYDROGENASE; ENDOPLASMIC-RETICULUM; TISSUE DISTRIBUTION; HUMAN GENE; RAT; TYPE-1; RECEPTORS; REDUCTASE; LUMEN	Background 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) interconverts active 11 beta-hydroxyl glucocorticoids and inactive 11keto forms. However, its directionality is determined by availability of NADP+/NADPH. In liver cells, 11 beta-HSD1 behaves as a primary reductase, while in Leydig cells it acts as a primary oxidase. However, the exact mechanism is not clear. The direction of 11 beta-HSD1 has been proposed to be regulated by hexose-6-phosphate dehydrogenase (H6PDH), which catalyzes glucose-6-phosphate (G6P) to generate NADPH that drives 11 beta-HSD1 towards reduction. Methodology To examine the coupling between 11 beta-HSD1 and H6PDH, we added G6P to rat and human liver and testis or Leydig cell microsomes, and 11 beta-HSD1 activity was measured by radiometry. Results and Conclusions G6P stimulated 11 beta-HSD1 reductase activity in rat (3 fold) or human liver (1.5 fold), but not at all in testis. S3483, a G6P transporter inhibitor, reversed the G6P-mediated increases of 11 beta-HSD1 reductase activity. We compared the extent to which 11 beta-HSD1 in rat Leydig and liver cells might be coupled to H6PDH. In order to clarify the location of H6PDH within the testis, we used the Leydig cell toxicant ethane dimethanesulfonate (EDS) to selectively deplete Leydig cells. The depletion of Leydig cells eliminated Hsd11b1 (encoding 11 beta-HSD1) expression but did not affect the expression of H6pd (encoding H6PDH) and Slc37a4 (encoding G6P transporter). H6pd mRNA level and H6PDH activity were barely detectable in purified rat Leydig cells. In conclusion, the availability of H6PDH determines the different direction of 11 beta-HSD1 in liver and Leydig cells.	[Li, Xingwang; Wang, Yi-Yan; Hu, Yuan-Yuan; Zheng, Zhiqiang; Ge, Ren-Shan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, ZJ, Peoples R China; [Li, Xingwang; Wang, Yi-Yan; Hu, Yuan-Yuan; Zheng, Zhiqiang; Ge, Ren-Shan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, ZJ, Peoples R China; [Hu, Guoxin; Li, Xiaoheng; Zhou, Hongyu; Ge, Ren-Shan] Wenzhou Med Univ, Res Acad Reprod Biomed, Wenzhou 325000, ZJ, Peoples R China; [Latif, Syed A.; Morris, David J.] Brown Univ, Sch Med, Miriam Hosp, Dept Pathol & Lab Med, Providence, RI 02906 USA; [Chu, Yanhui] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang, Heilongjiang, Peoples R China; [Ge, Ren-Shan] Populat Council, New York, NY 10065 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Mudanjiang Medical University; Population Council	Zheng, ZQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, ZJ, Peoples R China.	zhe_zhi2000@yahoo.com.cn; r_ge@yahoo.com			Wenzhou Science Technology [Y20090003, 2008H0121]; NSFC [81102149]; Health Bureau of Zhejiang Province [WKJ2011-2-012, 11-CX29]	Wenzhou Science Technology; NSFC(National Natural Science Foundation of China (NSFC)); Health Bureau of Zhejiang Province	Funding provided by Wenzhou Science & Technology Funding (Y20090003 to R.S.G. 2008H0121 to H.Y.Z.), NSFC (81102149 to Y.H.C.), and Health Bureau of Zhejiang Province (WKJ2011-2-012 & 11-CX29).	Agarwal AK, 1995, J STEROID BIOCHEM, V55, P473, DOI 10.1016/0960-0760(95)00196-4; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; BAILLIE AH, 1965, J ENDOCRINOL, V33, P119, DOI 10.1677/joe.0.0330119; Banhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200; Banhegyi G, 2009, J MOL ENDOCRINOL, V42, P283, DOI 10.1677/JME-08-0156; Berger SA, 1996, STEROIDS, V61, P236, DOI 10.1016/0039-128X(96)00029-3; Bujalska IJ, 2005, J MOL ENDOCRINOL, V34, P675, DOI 10.1677/jme.1.01718; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Finken MJJ, 1999, J CLIN ENDOCR METAB, V84, P3316, DOI 10.1210/jc.84.9.3316; FULCERI R, 1994, ARCH BIOCHEM BIOPHYS, V309, P43, DOI 10.1006/abbi.1994.1081; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; Ge RS, 2005, ENDOCRINOLOGY, V146, P2657, DOI 10.1210/en.2005-0046; Ge RS, 1997, ENDOCRINOLOGY, V138, P2435, DOI 10.1210/en.138.6.2435; Ge RS, 2000, J ANDROL, V21, P303; Gomez-Sanchez EP, 2008, ENDOCRINOLOGY, V149, P525, DOI 10.1210/en.2007-0328; Gong R, 2008, LIFE SCI, V82, P631, DOI 10.1016/j.lfs.2007.12.019; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; Hong D, 2009, BIOCHEM BIOPH RES CO, V389, P305, DOI 10.1016/j.bbrc.2009.08.134; LAKSHMI V, 1985, J STEROID BIOCHEM, V22, P331, DOI 10.1016/0022-4731(85)90435-2; Latif SA, 2011, STEROIDS, V76, P682, DOI 10.1016/j.steroids.2011.03.007; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; MONDER C, 1994, STEROIDS, V59, P69, DOI 10.1016/0039-128X(94)90078-7; MONDER C, 1993, VITAM HORM, V47, P187, DOI 10.1016/S0083-6729(08)60447-1; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; PHILLIPS DM, 1989, ENDOCRINOLOGY, V125, P209, DOI 10.1210/endo-125-1-209; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Salva A, 2001, J ANDROL, V22, P665; SAWADA H, 1980, J BIOCHEM-TOKYO, V87, P985, DOI 10.1093/oxfordjournals.jbchem.a132829; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; Teerds K. J., 1996, LEYDIG CELL, P203; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141767	10.1371/journal.pone.0141767	http://dx.doi.org/10.1371/journal.pone.0141767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528718	gold, Green Submitted, Green Published			2022-12-27	WOS:000364032600056
J	Rehman, YAU; Tariq, M; Khan, OU				Rehman, Yasar Abbas Ur; Tariq, Muhammad; Khan, Omar Usman			Improved Object Localization Using Accurate Distance Estimation in Wireless Multimedia Sensor Networks	PLOS ONE			English	Article							CAMERA SENSOR	Object localization plays a key role in many popular applications of Wireless Multimedia Sensor Networks (WMSN) and as a result, it has acquired a significant status for the research community. A significant body of research performs this task without considering node orientation, object geometry and environmental variations. As a result, the localized object does not reflect the real world scenarios. In this paper, a novel object localization scheme for WMSN has been proposed that utilizes range free localization, computer vision, and principle component analysis based algorithms. The proposed approach provides the best possible approximation of distance between a wmsn sink and an object, and the orientation of the object using image based information. Simulation results report 99% efficiency and an error ratio of 0.01 (around 1 ft) when compared to other popular techniques.	[Rehman, Yasar Abbas Ur; Tariq, Muhammad; Khan, Omar Usman] Natl Univ Comp & Emerging Sci, NUSys Lab, Peshawar, Kpk, Pakistan; [Rehman, Yasar Abbas Ur] City Univ Sci & Informat Technol, Dept Elect Engn, Peshawar, Kpk, Pakistan		Tariq, M (corresponding author), Natl Univ Comp & Emerging Sci, NUSys Lab, Peshawar, Kpk, Pakistan.	tariq.khan@nu.edu.pk	Tariq, Muhammad/P-7695-2019; Khan, Omar Usman/H-3734-2012	Tariq, Muhammad/0000-0003-1296-2058; Khan, Omar Usman/0000-0003-2605-0623; rehman, yasar/0000-0002-2945-7181				Akyildiz IF, 2007, COMPUT NETW, V51, P921, DOI 10.1016/j.comnet.2006.10.002; Alaei M, 2012, EUROPEAN WIRELESS 20, P1; Assaf A. E., 2014, VEH TECHN C VTC FALL, P1, DOI [10.1109/VTCFa11.2014.6966149, DOI 10.1109/VTCFA11.2014.6966149]; Boulanouar I., 2011, P IFIP WIR DAYS WD N, P1; Bouwmans T, 2014, COMPUT SCI REV, V11-12, P31, DOI 10.1016/j.cosrev.2014.04.001; Chandrasekhar V., 2006, P 1 ACM INT WORKSH U, DOI DOI 10.1145/1161039.1161047; Costa DG, 2014, SENSORS-BASEL, V14, P2795, DOI 10.3390/s140202795; De D, 2012, PROC TECH, V1, P674, DOI 10.1016/j.protcy.2012.10.081; Gao DY, 2014, INT J COMMUN SYST, V27, P606, DOI 10.1002/dac.2492; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; Huang QQ, 2006, IEEE VTS VEH TECHNOL, P349; Joo-Kwan Lee, 2011, Proceedings of the 2011 International Conference on Ubiquitious Computing and Multimedia Applications (UCMA 2011), P30, DOI 10.1109/UCMA.2011.15; Kimura N, 2005, ITCC 2005: International Conference on Information Technology: Coding and Computing, Vol 2, P8, DOI 10.1109/ITCC.2005.43; Langendoen K, 2003, COMPUT NETW, V43, P499, DOI 10.1016/S1389-1286(03)00356-6; Li W, 2011, IEEE IND ELEC, P3814, DOI 10.1109/IECON.2011.6119931; Liu C, 2005, IEEE IPCCC, P59; Liu X.:, 2014, LECT NOTES ELECT ENG, V269, P1085, DOI DOI 10.1007/9789400776180_106; Martinez J R, 2011, SENSOR FUSION FDN AP; OROURKE D, 2009, INF PROC SENS NETW 2, P401; Oztarak H, 2012, COMPUTER AND INFORMATION SCIENCES II, P185, DOI 10.1007/978-1-4471-2155-8_23; Oztarak H, 2009, GLOB TELECOMM CONF, P649; Paul AK, 2011, P INT JOINT C BIOM O, P1, DOI DOI 10.1109/PACC.2011.5979044; Paul AK, 2013, J SENS ACTUAR NETW, V2, P25, DOI 10.3390/jsan2010025; Tavli B, 2012, MULTIMED TOOLS APPL, V60, P689, DOI 10.1007/s11042-011-0840-z; Nguyen TV, 2014, IEEE WIREL COMMUN, V21, P28, DOI 10.1109/MWC.2014.6882293; Tran DA, 2008, IEEE T PARALL DISTR, V19, P981, DOI 10.1109/TPDS.2007.70800; Vittal K. P., 2010, Proceedings of the 2010 Second International Conference on Computer and Network Technology (ICCNT 2010), P289, DOI 10.1109/ICCNT.2010.32; Wang C, 2006, IEEE INFOCOM SER, P1645; WANG LS, 2009, IM PROC ICIP 2009 16, P1113	30	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141558	10.1371/journal.pone.0141558	http://dx.doi.org/10.1371/journal.pone.0141558			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528919	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600038
J	Zhou, Z; Huang, JF; Wang, J; Zhang, KY; Kuang, ZM; Zhong, SQ; Song, XD				Zhou, Zhen; Huang, Jingfeng; Wang, Jing; Zhang, Kangyu; Kuang, Zhaomin; Zhong, Shiquan; Song, Xiaodong			Object-Oriented Classification of Sugarcane Using Time-Series Middle-Resolution Remote Sensing Data Based on AdaBoost	PLOS ONE			English	Article							LAND-COVER; VEGETATION INDEXES; CROP PHENOLOGY; ALGORITHMS	Most areas planted with sugarcane are located in southern China. However, remote sensing of sugarcane has been limited because useable remote sensing data are limited due to the cloudy climate of this region during the growing season and severe spectral mixing with other crops. In this study, we developed a methodology for automatically mapping sugarcane over large areas using time-series middle-resolution remote sensing data. For this purpose, two major techniques were used, the object-oriented method (OOM) and data mining (DM). In addition, time-series Chinese HJ-1 CCD images were obtained during the sugarcane growing period. Image objects were generated using a multi-resolution segmentation algorithm, and DM was implemented using the AdaBoost algorithm, which generated the prediction model. The prediction model was applied to the HJ-1 CCD time-series image objects, and then a map of the sugarcane planting area was produced. The classification accuracy was evaluated using independent field survey sampling points. The confusion matrix analysis showed that the overall classification accuracy reached 93.6% and that the Kappa coefficient was 0.85. Thus, the results showed that this method is feasible, efficient, and applicable for extrapolating the classification of other crops in large areas where the application of high-resolution remote sensing data is impractical due to financial considerations or because qualified images are limited.	[Zhou, Zhen; Huang, Jingfeng; Wang, Jing; Zhang, Kangyu; Song, Xiaodong] Zhejiang Univ, Inst Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhen; Wang, Jing; Zhang, Kangyu; Song, Xiaodong] Key Lab Agr Remote Sensing & Informat Syst, Hangzhou, Zhejiang, Peoples R China; [Huang, Jingfeng] Zhejiang Univ, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Kuang, Zhaomin; Zhong, Shiquan] Guangxi Zhuang Autonomous Reg Inst Meteorol & Dis, Nanning, Peoples R China	Zhejiang University; Zhejiang University	Song, XD (corresponding author), Zhejiang Univ, Inst Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China.	xdsongy@zju.edu.cn		Song, Xiaodong/0000-0003-4174-7162; Huang, Jingfeng/0000-0003-4627-6021	National Special Research Fund for Public Welfare (Meteorology) of China [GYHY201406030]; Fundamental Research Funds for the Central Universities	National Special Research Fund for Public Welfare (Meteorology) of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors received funding from the National Special Research Fund for Public Welfare (Meteorology) of China (GYHY201406030) to XDS and the Fundamental Research Funds for the Central Universities to XDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro E, 2013, J STAT SOFTW, V54, P1; Almeida TIR, 2006, INT J REMOTE SENS, V27, P4057, DOI 10.1080/01431160600857451; [Anonymous], 2008, ESTIMATION OPTIMAL I; Baatz M., 2004, ECOGNITION PROFESSIO; Bock Michael, 2005, Journal for Nature Conservation (Jena), V13, P75, DOI 10.1016/j.jnc.2004.12.002; Boschetti M, 2009, INT J REMOTE SENS, V30, P4643, DOI 10.1080/01431160802632249; Definiens AG, 2009, DEFINIENS ECOGNITION; Silva MPD, 2008, INT J REMOTE SENS, V29, P4803, DOI 10.1080/01431160801950634; El Hajj M, 2009, REMOTE SENS ENVIRON, V113, P2052, DOI 10.1016/j.rse.2009.04.009; Fayyad U, 1996, AI MAG, V17, P37; Fortes C, 2006, INT J REMOTE SENS, V27, P1395, DOI 10.1080/01431160500383863; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Li CC, 2014, REMOTE SENS-BASEL, V6, P964, DOI 10.3390/rs6020964; Lin H, 2009, IEEE T GEOSCI REMOTE, V47, P2572, DOI 10.1109/TGRS.2009.2015769; Lu L, 2005, INT J REMOTE SENS, V26, P4471, DOI 10.1080/01431160500114938; Miao X, 2012, INT J REMOTE SENS, V33, P1823, DOI 10.1080/01431161.2011.602651; NAVULUR K, 2006, MULTISPECTRAL IMAGE; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Sakamoto T, 2005, REMOTE SENS ENVIRON, V96, P366, DOI 10.1016/j.rse.2005.03.008; Schapire Robert E., 2013, EXPLAINING ADABOOST, P37, DOI DOI 10.1007/978-3-642-41136-6_5; SK Lodha D F, 2007, AERIAL LIDAR DATA CL; Steele BM, 2005, REMOTE SENS ENVIRON, V99, P254, DOI 10.1016/j.rse.2005.09.001; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; TOWNSHEND JRG, 1987, INT J REMOTE SENS, V8, P1189, DOI 10.1080/01431168708954764; Vieira MA, 2012, REMOTE SENS ENVIRON, V123, P553, DOI 10.1016/j.rse.2012.04.011; Wang J, 2015, REMOTE SENS-BASEL, V7, P3467, DOI 10.3390/rs70403467; Witten I. H., 2005, DATA MINING PRACTICA; WOLTER PT, 1995, PHOTOGRAMM ENG REM S, V61, P1129; Xavier AC, 2006, INT J REMOTE SENS, V27, P755, DOI 10.1080/01431160500296735	36	22	22	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142069	10.1371/journal.pone.0142069	http://dx.doi.org/10.1371/journal.pone.0142069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528811	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600097
J	Kudryashova, NN; Kazbanov, IV; Panfilov, AV; Agladze, KI				Kudryashova, Nina N.; Kazbanov, Ivan V.; Panfilov, Alexander V.; Agladze, Konstantin I.			Conditions for Waveblock Due to Anisotropy in a Model of Human Ventricular Tissue	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; WAVE-FRONT CURVATURE; SPIRAL WAVES; IONIC CURRENTS; EXCITABILITY; CONDUCTION; DYNAMICS; BREAKUP; ONSET	Waveblock formation is the main cause of reentry. We have performed a comprehensive numerical modeling study of block formation due to anisotropy in Ten Tusscher and Panfilov (2006) ionic model for human ventricular tissue. We have examined the border between different areas of myocardial fiber alignment and have shown that blockage can occur for a wave traveling from a transverse fiber area to a longitudinal one. Such blockage occurs for reasonable values of the anisotropy ratio (AR): from 2.4 to 6.2 with respect to propagation velocities. This critical AR decreases by the suppression of I-Na and I-Ca, slightly decreases by the suppression of I-Kr and I-Ks, and substantially increases by the suppression of I-K1. Hyperkalemia affects the block formation in a complex, biphasic way. We provide examples of reentry formation due to the studied effects and have concluded that the suppression of I-K1 should be the most effective way to prevent waveblock at the areas of abrupt change in anisotropy.	[Kudryashova, Nina N.; Panfilov, Alexander V.; Agladze, Konstantin I.] Moscow Inst Phys & Technol, Life Sci Ctr, Dolgoprudnyi, Russia; [Kudryashova, Nina N.; Kazbanov, Ivan V.; Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium	Moscow Institute of Physics & Technology; Ghent University	Agladze, KI (corresponding author), Moscow Inst Phys & Technol, Life Sci Ctr, Dolgoprudnyi, Russia.	kagladze@gmail.com	Kudryashova, Nina/O-1036-2014; Agladze, Konstantin/X-5496-2019; Panfilov, Alexander/G-8459-2016; Agladze, Konstantin/J-6142-2012	Kudryashova, Nina/0000-0001-8529-7250; Agladze, Konstantin/0000-0002-9258-436X; Panfilov, Alexander/0000-0003-2643-642X; Agladze, Konstantin/0000-0002-9258-436X	Ministry of Education and Science of the Russian Federation (Federal Program "5top100"); FWO-Flanders	Ministry of Education and Science of the Russian Federation (Federal Program "5top100"); FWO-Flanders(FWO)	The research was fully supported by two sources: the Ministry of Education and Science of the Russian Federation (Federal Program "5top100") and FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLADZE K, 1994, SCIENCE, V264, P1746, DOI 10.1126/science.264.5166.1746; Cabo C, 1996, BIOPHYS J, V70, P1105, DOI 10.1016/S0006-3495(96)79691-1; CABO C, 1994, CIRC RES, V75, P1014, DOI 10.1161/01.RES.75.6.1014; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Cranefield BPF, 1973, CIRCULATION, VXLVII; CRANEFIELD PF, 1972, J GEN PHYSIOL, V59, P227, DOI 10.1085/jgp.59.2.227; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dierckx H, 2011, PHYS REV LETT, V2, P1; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kazbanov IV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003891; KEENER JP, 1986, SIAM J APPL MATH, V46, P1039, DOI 10.1137/0146062; Krinsky V.I., 1984, SPRINGER SERIES SYNE, VVolume 28, P9; Kudryashova NN, 2014, J MOL CELL CARDIOL, V76, P227, DOI 10.1016/j.yjmcc.2014.09.003; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Majumder R, 2014, AM J PHYSIOL-HEART C, V307, pH1024, DOI 10.1152/ajpheart.00593.2013; Mayer AG, 1916, P NATL ACAD SCI USA, V2, P721, DOI 10.1073/pnas.2.12.721; MOE GK, 1959, AM HEART J, V58, P59, DOI 10.1016/0002-8703(59)90274-1; PANFILOV AV, 1982, BIOFIZIKA+, V27, P886; PANFILOV AV, 1990, PHYS LETT A, V151, P23, DOI 10.1016/0375-9601(90)90840-K; Panfilov AV, 2009, CARDIAC ELECTROPHYSI, P329; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Rohr S, 1997, SCIENCE          FEB, P275; Rudy Y, 2011, PLOS COMPUTATIONAL B, V7, P5; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WATANABE Y, 1971, AM HEART J, V81, P451, DOI 10.1016/0002-8703(71)90359-0; Zemlin CW, 2007, EUROPACE, V9, P59, DOI 10.1093/europace/eum205; Zemlin CW, 2009, PHYSICA D, V238, P969, DOI 10.1016/j.physd.2008.12.004; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	39	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141832	10.1371/journal.pone.0141832	http://dx.doi.org/10.1371/journal.pone.0141832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523734	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800024
J	Dussourd, DE				Dussourd, David E.			Theroa zethus Caterpillars Use Acid Secretion of Anti-Predator Gland to Deactivate Plant Defense	PLOS ONE			English	Article							VENTRAL EVERSIBLE GLAND; HOST-PLANT; EUPHORBIA; NOTODONTIDAE; LEPIDOPTERA; LATICIFERS; MORPHOLOGY; GROWTH; ELONGATION; DIVERSITY	In North America, notodontid caterpillars feed almost exclusively on hardwood trees. One notable exception, Theroa zethus feeds instead on herbaceous plants in the Euphorbiaceae protected by laticifers. These elongate canals follow leaf veins and contain latex under pressure; rupture causes the immediate release of sticky poisonous exudate. T. zethus larvae deactivate the latex defense of poinsettia and other euphorbs by applying acid from their ventral eversible gland, thereby creating furrows in the veins. The acid secretion softens the veins allowing larvae to compress even large veins with their mandibles and to disrupt laticifers internally often without contacting latex. Acid secretion collected from caterpillars and applied to the vein surface sufficed to create a furrow and to reduce latex exudation distal to the furrow where T. zethus larvae invariably feed. Larvae with their ventral eversible gland blocked were unable to create furrows and suffered reduced growth on poinsettia. The ventral eversible gland in T. zethus and other notodontids ordinarily serves to deter predators; when threatened, larvae spray acid from the gland orifice located between the mouthparts and first pair of legs. To my knowledge, T. zethus is the first caterpillar found to use an anti-predator gland for disabling plant defenses. The novel combination of acid application and vein constriction allows T. zethus to exploit its unusual latex-bearing hosts.	Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA	University of Central Arkansas	Dussourd, DE (corresponding author), Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA.	dussourd@uca.edu			University of Central Arkansas Research Council; Arkansas Center for Plant-Powered Production (P3); National Science Foundation [EPS-0701890, EPS-1003970]; Arkansas Science and Technology Authority	University of Central Arkansas Research Council; Arkansas Center for Plant-Powered Production (P3); National Science Foundation(National Science Foundation (NSF)); Arkansas Science and Technology Authority	This study was supported by the University of Central Arkansas Research Council and by the Arkansas Center for Plant-Powered Production (P3). The P3 Center (http://www.plantpoweredproduction.com/) is funded through the RII: Arkansas ASSET Initiatives (AR EPSCoR) I (EPS-0701890) and II (EPS-1003970) by the National Science Foundation and the Arkansas Science and Technology Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHEM DEFENSES ARTHRO; ATTYGALLE AB, 1993, J CHEM ECOL, V19, P2089, DOI 10.1007/BF00979649; Bauer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113336; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Becker Vitor O., 2014, Lepidoptera Novae, V7, P1; Bernays EA, 2004, J INSECT BEHAV, V17, P41, DOI 10.1023/B:JOIR.0000025131.16275.0f; Bowers M. Deane, 1993, P331; BUTTERY BR, 1976, WATER DEFICITS PLANT, V4, P233; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; d'Auzac J., 1989, PHYSL RUBBER TREE LA; Detwiler J. D., 1922, Canadian Entomologist, V54, P176; DILLON PM, 1983, BIOTROPICA, V15, P112, DOI 10.2307/2387953; Dussourd DE, 2009, BIOL J LINN SOC, V96, P715, DOI 10.1111/j.1095-8312.2008.01168.x; DUSSOURD DE, 1991, ECOLOGY, V72, P1383, DOI 10.2307/1941110; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EISNER T, 1972, ANN ENTOMOL SOC AM, V65, P765, DOI 10.1093/aesa/65.3.765; Eisner T., 2005, SECRET WEAPONS DEFEN; Fahn A., 1979, SECRETORY TISSUES PL; Fatope MO, 1996, J MED CHEM, V39, P1005, DOI 10.1021/jm950509i; Felton GW, 2014, ANNU PLANT REV, V47, P37, DOI 10.1002/9781118472507.ch2; FINERAN BA, 1983, ANN BOT-LONDON, V52, P279, DOI 10.1093/oxfordjournals.aob.a086576; FINERAN BA, 1982, ANN BOT-LONDON, V50, P207, DOI 10.1093/oxfordjournals.aob.a086358; Frederickson ME, 2005, NATURE, V437, P495, DOI 10.1038/437495a; Ganong CN, 2012, ARTHROPOD-PLANT INTE, V6, P621, DOI 10.1007/s11829-012-9214-3; Greeney HF, 2012, ISJ-INVERT SURVIV J, V9, P7; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Herrick G. W., 1919, Annals of the Entomological Society of America, V12; Holldobler B., 1990, pi; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; LeBrun EG, 2014, SCIENCE, V343, P1014, DOI 10.1126/science.1245833; Lewinsohn TM, 2000, SERIE OECOLOGIA BRAS, VVIII, P281; Metcalfe C.R., 1983, NORD J BOT, V4, P668; MILLER JS, 1992, BIOSCIENCE, V42, P50, DOI 10.2307/1311628; Mitter C., 1991, P35; Musser RO, 2006, J CHEM ECOL, V32, P981, DOI 10.1007/s10886-006-9049-4; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; O'Donovan A., 2013, BIOFUEL TECHNOLOGIES, P97, DOI [10.1007/978-3-642-34519-7_4, DOI 10.1007/978-3-642-34519-7_4]; Oppel CB, 2009, J CHEM ECOL, V35, P625, DOI 10.1007/s10886-009-9643-3; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; RAYLE DL, 1980, PLANT PHYSIOL, V66, P433, DOI 10.1104/pp.66.3.433; ROSOWSKI JR, 1968, BOT GAZ, V129, P113, DOI 10.1086/336422; RUDALL PJ, 1987, BOT J LINN SOC, V94, P143, DOI 10.1111/j.1095-8339.1987.tb01043.x; Schintlmeister A., 2013, NOTODONTIDAE OENOSAN; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Van Valkenburg M, 2014, THESIS U CENTRAL ARK; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; Villanueva J, 2015, PHYTOMEDICINE, V22, P689, DOI 10.1016/j.phymed.2015.04.006; Wagner DL, 2015, CATERPILLARS E N AM; WEATHERSTON I, 1986, J CHEM ECOL, V12, P2039, DOI 10.1007/BF01041995; WEATHERSTON J, 1979, J CHEM ECOL, V5, P165, DOI 10.1007/BF00988232; WELLER S J, 1987, Journal of the Lepidopterists' Society, V41, P187; Zebelo S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-140; Zebelo SA, 2012, ARTHROPOD-PLANT INTE, V6, P543, DOI 10.1007/s11829-012-9200-9	54	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141924	10.1371/journal.pone.0141924	http://dx.doi.org/10.1371/journal.pone.0141924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517872	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800094
J	Malhis, N; Wong, ETC; Nassar, R; Gsponer, J				Malhis, Nawar; Wong, Eric T. C.; Nassar, Roy; Gsponer, Joerg			Computational Identification of MoRFs in Protein Sequences Using Hierarchical Application of Bayes Rule	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; INTRINSICALLY DISORDERED REGIONS; BINDING REGIONS; PREDICTION; ACCURATE; SERVER	Motivation Intrinsically disordered regions of proteins play an essential role in the regulation of various biological processes. Key to their regulatory function is often the binding to globular protein domains via sequence elements known as molecular recognition features (MoRFs). Development of computational tools for the identification of candidate MoRF locations in amino acid sequences is an important task and an area of growing interest. Given the relative sparseness of MoRFs in protein sequences, the accuracy of the available MoRF predictors is often inadequate for practical usage, which leaves a significant need and room for improvement. In this work, we introduce MoRFCHiBi_Web, which predicts MoRF locations in protein sequences with higher accuracy compared to current MoRF predictors. Methods Three distinct and largely independent property scores are computed with component predictors and then combined to generate the final MoRF propensity scores. The first score reflects the likelihood of sequence windows to harbour MoRFs and is based on amino acid composition and sequence similarity information. It is generated by MoRFCHiBi using small windows of up to 40 residues in size. The second score identifies long stretches of protein disorder and is generated by ESpritz with the DisProt option. Lastly, the third score reflects residue conservation and is assembled from PSSM files generated by PSI-BLAST. These propensity scores are processed and then hierarchically combined using Bayes rule to generate the final MoRFCHiBi_Web predictions. Results MoRFCHiBi_Web was tested on three datasets. Results show that MoRFCHiBi_Web outperforms previously developed predictors by generating less than half the false positive rate for the same true positive rate at practical threshold values. This level of accuracy paired with its relatively high processing speed makes MoRFCHiBi_Web a practical tool for MoRF prediction.	[Malhis, Nawar; Wong, Eric T. C.; Nassar, Roy; Gsponer, Joerg] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Wong, Eric T. C.; Gsponer, Joerg] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Malhis, N (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	nmalhis@chibi.ubc.ca; gsponer@chibi.ubc.ca		Malhis, Nawar/0000-0002-1317-833X	Canadian Institute of Health Research (CIHR) [BOP-130835]; Genome BC [Genome BC 175REG]; Michael Smith Foundation for Health Research (MSFHR) [CI-SCH-03020(11-1)]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) (BOP-130835, to JG); Genome BC (http://www.genomebc.ca/) (Genome BC 175REG, to JG); and Michael Smith Foundation for Health Research (MSFHR) (http://www.msfhr.org/) (CI-SCH-03020(11-1), to JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babu M. M., 2011, CURR OPIN STRUC BIOL, V21, P1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Fang C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-300; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Han H, 2014, CANCER INFORM, V13, P145, DOI 10.4137/CIN.S13875; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; R Core Team, 2021, R LANGUAGE ENV STAT; Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weatheritt RJ, 2012, TRENDS BIOCHEM SCI, V37, P333, DOI 10.1016/j.tibs.2012.05.001; Wong ETC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003192; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022	33	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141603	10.1371/journal.pone.0141603	http://dx.doi.org/10.1371/journal.pone.0141603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517836	Green Submitted, Green Published, gold			2022-12-27	WOS:000363920800061
J	Sapi, J; Kovacs, L; Drexler, DA; Kocsis, P; Gajari, D; Sapi, Z				Sapi, Johanna; Kovacs, Levente; Drexler, Daniel Andras; Kocsis, Pal; Gajari, David; Sapi, Zoltan			Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy	PLOS ONE			English	Article							CONTROLLED PHASE-III; CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; VASCULAR NORMALIZATION; ANTIANGIOGENIC THERAPY; 1ST-LINE TREATMENT; BREAST-CANCER; DOUBLE-BLIND; PLACEBO; TRIAL	Background Bevacizumab is an exogenous inhibitor which inhibits the biological activity of human VEGF. Several studies have investigated the effectiveness of bevacizumab therapy according to different cancer types but these days there is an intense debate on its utility. We have investigated different methods to find the best tumor volume estimation since it creates the possibility for precise and effective drug administration with a much lower dose than in the protocol. Materials and Methods We have examined C38 mouse colon adenocarcinoma and HT-29 human colorectal adenocarcinoma. In both cases, three groups were compared in the experiments. The first group did not receive therapy, the second group received one 200 mu g bevacizumab dose for a treatment period (protocol-based therapy), and the third group received 1.1 mu g bevacizumab every day (quasi-continuous therapy). Tumor volume measurement was performed by digital caliper and small animal MRI. The mathematical relationship between MRI-measured tumor volume and mass was investigated to estimate accurate tumor volume using caliper-measured data. A two-dimensional mathematical model was applied for tumor volume evaluation, and tumor-and therapy-specific constants were calculated for the three different groups. The effectiveness of bevacizumab administration was examined by statistical analysis. Results In the case of C38 adenocarcinoma, protocol-based treatment did not result in significantly smaller tumor volume compared to the no treatment group; however, there was a significant difference between untreated mice and mice who received quasi-continuous therapy (p = 0.002). In the case of HT-29 adenocarcinoma, the daily treatment with one-twelfth total dose resulted in significantly smaller tumors than the protocol-based treatment (p = 0.038). When the tumor has a symmetrical, solid closed shape (typically without treatment), volume can be evaluated accurately from caliper-measured data with the applied two-dimensional mathematical model. Conclusion Our results provide a theoretical background for a much more effective bevacizumab treatment using optimized administration.	[Sapi, Johanna; Kovacs, Levente] Obuda Univ, Res & Innovat Ctr, Physiol Controls Grp, Budapest, Hungary; [Drexler, Daniel Andras] Budapest Univ Technol & Econ, Dept Control Engn & Informat Technol, Budapest, Hungary; [Kocsis, Pal; Gajari, David] Gedeon Richter Plc, Preclin Imaging Ctr, Budapest, Hungary; [Sapi, Zoltan] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary	Obuda University; Budapest University of Technology & Economics; Gedeon Richter Chemistry Works; Semmelweis University	Sapi, Z (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	sapi.zoltan.dr@gmail.com	Kovacs, Levente/AAA-1781-2019	Kovacs, Levente/0000-0002-3188-0800	Hungarian Scientific Research Fund (OTKA) [K-112993]; Bolyai Research Scholarship of the Hungarian Academy of Sciences [425_12]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by Hungarian Scientific Research Fund (OTKA), http://www.otka.hu/en, No: K-112993 (Janos) and Bolyai Research Scholarship of the Hungarian Academy of Sciences, http://mta.hu/cikkek/?node_id=26057, No: 425_12. Coauthors PK and DG are employed by Gedeon Richter Ltd. Gedeon Richter Ltd. provided support in the form of salaries for authors PK and DG, and in the form of using the resources of Preclinical Imaging Center of Gedeon Richter Ltd., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; [Anonymous], 2005, XEN TUM MOD PROT; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Carey K., 2012, NAT BIOTECHNOL, V30, P6; Cobelli C, 2014, LANCET DIABETES ENDO, V2, P679, DOI 10.1016/S2213-8587(14)70126-3; Drexler D. A., 2012, SCI B POLITEHNICA U, V57, P113; European Medicines Agency, 2005, SCI DISC AV; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Genentech, 2013, PRESCR INF AV BEV; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Heiduschka P, 2008, RETINA-J RET VIT DIS, V28, P46, DOI 10.1097/IAE.0b013e31815e9368; HEITJAN DF, 1993, CANCER RES, V53, P6042; Hollanders K, 2014, CURR EYE RES, V12, P1; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen M, 2008, BMC MED IMAGING, P8; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kim KB, 2012, J CLIN ONCOL, V30, P34, DOI 10.1200/JCO.2011.34.6270; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kiss B., 2013, 2013 IEEE 11th International Symposium on Intelligent Systems and Informatics (SISY), P271, DOI 10.1109/SISY.2013.6662584; Koo V, 2006, CELL ONCOL, V28, P127; Kovacs L, 2014, COMPUT METH PROG BIO, V114, pE98, DOI 10.1016/j.cmpb.2014.01.002; Kovacs L, 2011, COMPUT METH PROG BIO, V102, P105, DOI 10.1016/j.cmpb.2010.06.019; Kumaran GC, 2009, BRIT J CANCER, V100, P1, DOI 10.1038/sj.bjc.6604767; McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]; Monk BJ, 2009, J CLIN ONCOL, V27, P1069, DOI 10.1200/JCO.2008.18.9043; Montero AJ, 2012, NEW ENGL J MED, V366, P374, DOI 10.1056/NEJMe1113368; Mukherji SK, 2010, AM J NEURORADIOL, V31, P235, DOI 10.3174/ajnr.A1987; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Pachghare V. K., 2005, COMPREHENSIVE COMPUT; Reinacher-Schick A, 2008, NAT CLIN PRACT GASTR, V5, P250, DOI 10.1038/ncpgasthep1097; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sapi J, 2016, OPTIM CONTR APPL MET, V37, P848, DOI 10.1002/oca.2196; Sapi J, 2014, INT SYMP COMP INTELL, P443, DOI 10.1109/CINTI.2014.7028716; Sapi J, 2013, 2013 IEEE 8TH INTERNATIONAL SYMPOSIUM ON APPLIED COMPUTATIONAL INTELLIGENCE AND INFORMATICS (SACI 2013), P303, DOI 10.1109/SACI.2013.6608987; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Szeles A., 2014, PERIODICA POLYTECHNI, V58, P29; Targeson, 2012, MOUSE TAIL VEIN INJE; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vokes EE, 2013, ANN ONCOL, V24, P6, DOI 10.1093/annonc/mds608; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Zhang QY, 2006, BIOCHEM BIOPH RES CO, V342, P824, DOI 10.1016/j.bbrc.2006.02.044	47	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142190	10.1371/journal.pone.0142190	http://dx.doi.org/10.1371/journal.pone.0142190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540189	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800064
J	Cohen, E; Bernard, JY; Ponty, A; Ndao, A; Amougou, N; Said-Mohamed, R; Pasquet, P				Cohen, Emmanuel; Bernard, Jonathan Y.; Ponty, Amandine; Ndao, Amadou; Amougou, Norbert; Said-Mohamed, Rihlat; Pasquet, Patrick			Development and Validation of the Body Size Scale for Assessing Body Weight Perception in African Populations	PLOS ONE			English	Article							IMAGE; WOMEN; OBESITY; ATTRACTIVENESS; BMI; MEN; PREFERENCES; RELIABILITY; DISCREPANCY; TRANSITION	Background The social valorisation of overweight in African populations could promote high-risk eating behaviours and therefore become a risk factor of obesity. However, existing scales to assess body image are usually not accurate enough to allow comparative studies of body weight perception in different African populations. This study aimed to develop and validate the Body Size Scale (BSS) to estimate African body weight perception. Methods Anthropometric measures of 80 Cameroonians and 81 Senegalese were used to evaluate three criteria of adiposity: body mass index (BMI), overall percentage of fat, and endomorphy (fat component of the somatotype). To develop the BSS, the participants were photographed in full face and profile positions. Models were selected for their representativeness of the wide variability in adiposity with a progressive increase along the scale. Then, for the validation protocol, participants self-administered the BSS to assess self-perceived current body size (CBS), desired body size (DBS) and provide a "body self-satisfaction index." This protocol included construct validity, test-retest reliability and convergent validity and was carried out with three independent samples of respectively 201, 103 and 1115 Cameroonians. Results The BSS comprises two sex-specific scales of photos of 9 models each, and ordered by increasing adiposity. Most participants were able to correctly order the BSS by increasing adiposity, using three different words to define body size. Test-retest reliability was consistent in estimating CBS, DBS and the "body self-satisfaction index." The CBS was highly correlated to the objective BMI, and two different indexes assessed with the BSS were consistent with declarations obtained in interviews. Conclusion The BSS is the first scale with photos of real African models taken in both full face and profile and representing a wide and representative variability in adiposity. The validation protocol proved its reliability for estimating body weight perception in Africans.	[Cohen, Emmanuel] Fac Med Sect Nord, CNRS, UMI Environm Sante Soc 3189, Marseille, France; [Cohen, Emmanuel; Bernard, Jonathan Y.; Ponty, Amandine; Ndao, Amadou; Amougou, Norbert; Said-Mohamed, Rihlat; Pasquet, Patrick] Museum Natl Hist Nat, Musee Homme, UMR Ecoanthropol & Ethnobiol 7206, CNRS, F-75231 Paris, France; [Said-Mohamed, Rihlat] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University of Witwatersrand	Cohen, E (corresponding author), Fac Med Sect Nord, CNRS, UMI Environm Sante Soc 3189, Marseille, France.	ecohen@mnhn.fr	Cohen, Emmanuel/ABE-1916-2021; Bernard, Jonathan/T-7064-2017; AMOUGOU, Norbert/GXW-3348-2022	Cohen, Emmanuel/0000-0001-5643-1473; Bernard, Jonathan/0000-0002-6418-983X; Patrick, Pasquet/0000-0002-7017-3068; SAID MOHAMED, Rihlat/0000-0003-1592-5412	"Agence Nationale de la Recherche" in France [ANR-08-BLAN-0004]	"Agence Nationale de la Recherche" in France(French National Research Agency (ANR))	This work was supported by: ANR-08-BLAN-0004, http://www.agence-nationale-recherche.fr/projet-anr/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-08-BLAN-0004, "Agence Nationale de la Recherche" in France. PP was director of the project: "Anthropologie Nutritionnelle des migrants d'Afrique Centrale a la ville et en France" (ANTRAC).	[Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Bayer AM, 2005, ADOLESC MED CLIN; Becker Diane M., 1999, Ethnicity and Disease, V9, P377; Blench R, 2013, MOTHER TONGUE; Bush HM, 2001, APPETITE, V37, P207, DOI 10.1006/appe.2001.0424; Cachelin FM, 2002, OBES RES, V10, P158, DOI 10.1038/oby.2002.25; Carter J. E. L., 1990, SOMATOTYPING DEV APP; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; Cohen E, 2013, SOC SCI MED, V96, P24, DOI 10.1016/j.socscimed.2013.07.004; Cohen E, 2015, BMC PUBLIC IN PRESS; Cohen Emmanuel, 2011, Ethn Dis, V21, P288; Dave D, 2009, SOC SCI MED, V68, P1685, DOI 10.1016/j.socscimed.2009.02.015; Dixson BJ, 2007, ARCH SEX BEHAV, V36, P369, DOI 10.1007/s10508-006-9093-8; Duda RB, 2008, AFR J HLTH SCI, V14, P54, DOI [10.4314/ajhs.v14i1.30847, DOI 10.4314/AJHS.V14I1.30847]; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Flynn K, 1996, J YOUTH ADOLESCENCE, V25, P615, DOI 10.1007/BF01537357; Flynn KJ, 1998, ANN BEHAV MED, V20, P13, DOI 10.1007/BF02893804; FROMENT A, 1984, ANN HUM BIOL, V11, P189, DOI 10.1080/03014468400007061; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Gardner RM, 1998, PERCEPT MOTOR SKILL, V86, P387, DOI 10.2466/pms.1998.86.2.387; Gitau TM, 2014, J CHILD ADOLESC MENT, V26, P193, DOI [10.1371/journal.pone.0109709, 10.2989/17280583.2014.901224]; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harris CV, 2008, INT J OBESITY, V32, P336, DOI 10.1038/sj.ijo.0803704; Hendley Y, 2011, J WOMENS HEALTH, V20, P1805, DOI 10.1089/jwh.2010.2262; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Lo WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050017; Madowitz J, 2006, IL FAULT MANGER EATI; Marlowe FW, 2005, EVOL HUM BEHAV, V26, P458, DOI 10.1016/j.evolhumbehav.2005.07.005; Maupin JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-973; Mciza Z, 2005, PUBLIC HEALTH NUTR, V8, P509, DOI [10.1097/PHN2005814, 10.1079/PHN2005814]; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Mvo Z, 1999, Curationis, V22, P27; Patt Madhavi R., 2002, Ethnicity and Disease, V12, P54; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Pulvers K, 2013, EAT BEHAV, V14, P437, DOI 10.1016/j.eatbeh.2013.07.005; Pulvers KM, 2004, OBES RES, V12, P1641, DOI 10.1038/oby.2004.204; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Puoane T, 2010, ETHN DIS; Rguibi Mohamed, 2006, Body Image, V3, P395, DOI 10.1016/j.bodyim.2006.07.007; Ritenbaugh C, 1991, Med Anthropol, V13, P173; Stewart AD, 2003, J SPORT SCI, V21, P815, DOI 10.1080/0264041031000140338; Stewart TM, 2009, BODY IMAGE, V6, P67, DOI 10.1016/j.bodyim.2009.01.006; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Swami V, 2008, PERS INDIV DIFFER, V44, P1752, DOI 10.1016/j.paid.2008.02.002; Swami V, 2007, BODY IMAGE, V4, P391, DOI 10.1016/j.bodyim.2007.07.002; Swami V, 2012, BODY IMAGE, V9, P559, DOI 10.1016/j.bodyim.2012.05.006; Tovee MJ, 2002, P ROY SOC B-BIOL SCI, V269, P2205, DOI 10.1098/rspb.2002.2133; Vuron, 2007, POPULATION SOC, V435, P1; WADDEN TA, 1985, ANN INTERN MED, V103, P1062, DOI 10.7326/0003-4819-103-6-1062; Weiner J.S., 1981, PRACTICAL HUMAN BIOL; Williamson DA, 2000, INT J OBESITY, V24, P1326, DOI 10.1038/sj.ijo.0801363; WILLIAMSON DA, 1993, J PSYCHOPATHOL BEHAV, V15, P57, DOI 10.1007/BF00964324	53	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0138983	10.1371/journal.pone.0138983	http://dx.doi.org/10.1371/journal.pone.0138983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536030	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400006
J	Crookes, K; Ewing, L; Gildenhuys, JD; Kloth, N; Hayward, WG; Oxner, M; Pond, S; Rhodes, G				Crookes, Kate; Ewing, Louise; Gildenhuys, Ju-dith; Kloth, Nadine; Hayward, William G.; Oxner, Matt; Pond, Stephen; Rhodes, Gillian			How Well Do Computer-Generated Faces Tap Face Expertise?	PLOS ONE			English	Article							RECOGNITION; RACE; MEMORY; LIFE; IDENTIFICATION; PROSOPAGNOSIA; ADVANTAGE; ANIMACY; OBJECTS; IMAGES	The use of computer-generated (CG) stimuli in face processing research is proliferating due to the ease with which faces can be generated, standardised and manipulated. However there has been surprisingly little research into whether CG faces are processed in the same way as photographs of real faces. The present study assessed how well CG faces tap face identity expertise by investigating whether two indicators of face expertise are reduced for CG faces when compared to face photographs. These indicators were accuracy for identification of own-race faces and the other-race effect (ORE)-the well-established finding that own-race faces are recognised more accurately than other-race faces. In Experiment 1 Caucasian and Asian participants completed a recognition memory task for own-and other-race real and CG faces. Overall accuracy for own-race faces was dramatically reduced for CG compared to real faces and the ORE was significantly and substantially attenuated for CG faces. Experiment 2 investigated perceptual discrimination for own-and other-race real and CG faces with Caucasian and Asian participants. Here again, accuracy for own-race faces was significantly reduced for CG compared to real faces. However the ORE was not affected by format. Together these results signal that CG faces of the type tested here do not fully tap face expertise. Technological advancement may, in the future, produce CG faces that are equivalent to real photographs. Until then caution is advised when interpreting results obtained using CG faces.	[Crookes, Kate; Ewing, Louise; Gildenhuys, Ju-dith; Kloth, Nadine; Hayward, William G.; Pond, Stephen; Rhodes, Gillian] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia; [Ewing, Louise] Univ London, Dept Psychol Sci, London, England; [Hayward, William G.; Oxner, Matt] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Hayward, William G.; Oxner, Matt] Univ Auckland, Sch Psychol, Auckland 1, New Zealand	University of Western Australia; University of London; University of Hong Kong; University of Auckland	Ewing, L (corresponding author), Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	l.ewing@bbk.ac.uk	Kloth, Nadine/H-5207-2014; Crookes, Kate/H-8011-2013	Crookes, Kate/0000-0001-6887-6197; Pond, Stephen/0000-0002-9565-7480; Kloth, Nadine/0000-0003-1473-303X; Oxner, Matt/0000-0002-4419-6020; Hayward, William/0000-0002-7248-0301; Rhodes, Gillian/0000-0002-3631-8518; Ewing, Louise/0000-0001-5263-1267	Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC [DP0877379, DP130102300]; Hong Kong Research Council [HKU744911H]	Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC(Australian Research Council); Hong Kong Research Council(Hong Kong Research Grants Council)	This research was supported by the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders (CE110001021); ARC Professorial Fellowship to Rhodes (DP0877379); ARC Discovery Outstanding Researcher Award to Rhodes (DP130102300); and Hong Kong Research Council (HKU744911H) to Hayward.	Balas B, 2015, COMPUT HUM BEHAV, V52, P331, DOI 10.1016/j.chb.2015.06.018; Balas B, 2010, NEUROPSYCHOLOGIA, V48, P498, DOI 10.1016/j.neuropsychologia.2009.10.007; Bate S, 2014, CORTEX, V50, P55, DOI 10.1016/j.cortex.2013.08.006; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Bird GD, 2012, VISION RES, V60, P16, DOI 10.1016/j.visres.2012.02.014; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Corneille O, 2007, J PERS SOC PSYCHOL, V93, P335, DOI 10.1037/0022-3514.93.3.335; DeGutis J, 2014, BRAIN; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; Havard C, 2013, APPL COGNITIVE PSYCH, V27, P50, DOI 10.1002/acp.2870; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Koldewyn K, 2014, PSYCHON B REV, V21, P969, DOI 10.3758/s13423-013-0562-5; Looser CE, 2013, SOC COGN AFFECT NEUR, V8, P799, DOI 10.1093/scan/nss078; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Macmillan N. A., 1991, DETECTION THEORY USE; Matheson HE, 2012, CAN J EXP PSYCHOL, V66, P51, DOI 10.1037/a0026062; Matheson HE, 2011, BEHAV RES METHODS, V43, P224, DOI 10.3758/s13428-010-0029-9; McCarthy G, NEUROPSYCHO IN PRESS, DOI [10.1016/j.neuropsychologia.2014.05.019, DOI 10.1016/J.NEUR0PSYCH0L0GIA.2014.05.019]; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Megreya AM, 2011, Q J EXP PSYCHOL, V64, P1473, DOI 10.1080/17470218.2011.575228; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2013, VIS COGN, V21, P1202, DOI 10.1080/13506285.2013.823141; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; O'Toole AJ, 1999, VISION RES, V39, P3145, DOI 10.1016/S0042-6989(99)00034-6; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Papesh MH, 2010, COGNITION, V116, P283, DOI 10.1016/j.cognition.2010.05.001; Papesh MH, 2009, CAN J EXP PSYCHOL, V63, P253, DOI 10.1037/a0015802; Pauker K, 2009, J PERS SOC PSYCHOL, V96, P795, DOI 10.1037/a0013265; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Rezlescu C, 2012, COGN NEUROPSYCHOL, V29, P325, DOI 10.1080/02643294.2012.749223; RHODES G, 1993, BRAIN COGNITION, V22, P19, DOI 10.1006/brcg.1993.1022; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B., 2011, OXFORD HDB FACE PERC, P215, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0012; Russell R, 2007, PERCEPTION, V36, P1368, DOI 10.1068/p5779; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Wheatley T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017960; Wilson JP, 2013, SOC COGNITION, V31, P636, DOI 10.1521/soco.2013.31.6.636; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	44	46	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141353	10.1371/journal.pone.0141353	http://dx.doi.org/10.1371/journal.pone.0141353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535910	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000364298400059
J	Jugulam, M; Ziauddin, A; So, KKY; Chen, S; Hall, JC				Jugulam, M.; Ziauddin, Asma; So, Kenny K. Y.; Chen, Shu; Hall, J. Christopher			Transfer of Dicamba Tolerance from Sinapis arvensis to Brassica napus via Embryo Rescue and Recurrent Backcross Breeding	PLOS ONE			English	Article							AUXINIC HERBICIDE RESISTANCE; WILD MUSTARD; WEED MANAGEMENT; IDENTIFICATION; INHERITANCE; BROADLEAF; HYBRIDS	Auxinic herbicides (e.g. dicamba) are extensively used in agriculture to selectively control broadleaf weeds. Although cultivated species of Brassicaceae (e.g. Canola) are susceptible to auxinic herbicides, some biotypes of Sinapis arvensis (wild mustard) were found dicamba resistant in Canada. In this research, dicamba tolerance from wild mustard was introgressed into canola through embryo rescue followed by conventional breeding. Intergeneric hybrids between S. arvensis (2n = 18) and B. napus (2n = 38) were produced through embryo rescue. Embryo formation and hybrid plant regeneration was achieved. Transfer of dicamba tolerance from S. arvensis into the hybrid plants was determined by molecular analysis and at the whole plant level. Dicamba tolerance was introgressed into B. napus by backcrossing for seven generations. Homozygous dicamba-tolerant B. napus lines were identified. The ploidy of the hybrid progeny was assessed by flow cytometry. Finally, introgression of the piece of DNA possibly containing the dicamba tolerance gene into B. napus was confirmed using florescence in situ hybridization (FISH). This research demonstrates for the first time stable introgression of dicamba tolerance from S. arvensis into B. napus via in vitro embryo rescue followed by repeated backcross breeding. Creation of dicamba-tolerant B. napus varieties by this approach may have potential to provide options to growers to choose a desirable herbicide-tolerant technology. Furthermore, adoption of such technology facilitates effective weed control, less tillage, and possibly minimize evolution of herbicide resistant weeds.	[Jugulam, M.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Ziauddin, Asma; So, Kenny K. Y.; Hall, J. Christopher] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Chen, Shu] Univ Guelph, Lab Serv Div, Guelph, ON N1G 2W1, Canada	Kansas State University; University of Guelph; University of Guelph	Jugulam, M (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	mithila@ksu.edu; jchall@uoguelph.ca			Natural Science and Engineering Research Council of Canada; BASF Company (NC, USA) through NSERC-CRD grant	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); BASF Company (NC, USA) through NSERC-CRD grant(BASF)	This work was supported by a grant to JCH from the Natural Science and Engineering Research Council of Canada and BASF Company (NC, USA) through NSERC-CRD grant is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TRENDS NEW CROPS NEW; Beckie HJ, 2004, WEED SCI, V52, P152, DOI 10.1614/P2002-163; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Bing DJ, 1995, PLANT BREEDING, V114, P481, DOI 10.1111/j.1439-0523.1995.tb00840.x; Cao MX, 2011, J AGR FOOD CHEM, V59, P5830, DOI 10.1021/jf104233h; Chandler JM, 1984, WEED SCI SOC AM ANN; Figueroa DM, 2010, BRIEF FUNCT GENOMICS, V9, P95, DOI 10.1093/bfgp/elp058; Hall JC, 1996, ACS SYM SER, V645, P28; Heap I, INT SURVEY HERBICIDE; Heap I.M., 1992, WEED SCI SOC AM ANN, V32, P164; Hu Q, 2002, PLANT CELL REP, V21, P147, DOI 10.1007/s00299-002-0491-7; Inomata N, 1998, EUCARPIA CRUCIFERAE, V13, P22; JASIENIUK M, 1995, WEED SCI, V43, P192, DOI 10.1017/S0043174500081054; Jugulam M, 2005, WEED SCI, V53, P417, DOI 10.1614/WS-04-149R; Kato A, 2005, CURR OPIN PLANT BIOL, V8, P148, DOI 10.1016/j.pbi.2005.01.014; KERLAN MC, 1993, GENOME, V36, P1099, DOI 10.1139/g93-146; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Mason AS, 2014, NEW PHYTOL, V202, P964, DOI 10.1111/nph.12706; Mithila J, 2013, IN VITRO CELL DEV-PL, V49, P461, DOI 10.1007/s11627-013-9515-y; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Mithila J, 2012, PEST MANAG SCI, V68, P548, DOI 10.1002/ps.2289; Mizushima U., 1980, Brassica crops and wild allies. [I]., P89; MIZUSHIMA USABURO, 1950, TOHOKU JOUR AGRIC RES, V1, P1; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; PENIUK MG, 1993, WEED RES, V33, P431, DOI 10.1111/j.1365-3180.1993.tb01959.x; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; PRAKASH S, 1980, OPERA BOT, V55, P3; Schwarzacher Trude, 2009, V478, P227, DOI 10.1007/978-1-59745-379-0_14; Wright TR, 2010, P NATL ACAD SCI USA, V107, P20240, DOI 10.1073/pnas.1013154107; Zheng HG, 2001, WEED SCI, V49, P276, DOI 10.1614/0043-1745(2001)049[0276:UAHRIW]2.0.CO;2	30	6	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141418	10.1371/journal.pone.0141418	http://dx.doi.org/10.1371/journal.pone.0141418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536372	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400063
J	Lane, J; van Eeden, SF; Obeidat, M; Sin, DD; Tebbutt, SJ; Timens, W; Postma, DS; Laviolette, M; Pare, PD; Bosse, Y				Lane, Jerome; van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Timens, Wim; Postma, Dirkje S.; Laviolette, Michel; Pare, Peter D.; Bosse, Yohan			Impact of Statins on Gene Expression in Human Lung Tissues	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; MORTALITY; COPD; SIMVASTATIN; REDUCE; CANCER; RISK; HOSPITALIZATION; EXACERBATIONS	Statins are 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors that alter the synthesis of cholesterol. Some studies have shown a significant association of statins with improved respiratory health outcomes of patients with asthma, chronic obstructive pulmonary disease and lung cancer. Here we hypothesize that statins impact gene expression in human lungs and may reveal the pleiotropic effects of statins that are taking place directly in lung tissues. Human lung tissues were obtained from patients who underwent lung resection or transplantation. Gene expression was measured on a custom Affymetrix array in a discovery cohort (n = 408) and two replication sets (n = 341 and 282). Gene expression was evaluated by linear regression between statin users and non-users, adjusting for age, gender, smoking status, and other covariables. The results of each cohort were combined in a meta-analysis and biological pathways were studied using Gene Set Enrichment Analysis. The discovery set included 141 statin users. The lung mRNA expression levels of eighteen and three genes were up-regulated and down-regulated in statin users (FDR < 0.05), respectively. Twelve of the up-regulated genes were replicated in the first replication set, but none in the second (p-value < 0.05). Combining the discovery and replication sets into a meta-analysis improved the significance of the 12 up-regulated genes, which includes genes encoding enzymes and membrane proteins involved in cholesterol biosynthesis. Canonical biological pathways altered by statins in the lung include cholesterol, steroid, and terpenoid backbone biosynthesis. No genes encoding inflammatory, proteases, pro-fibrotic or growth factors were altered by statins, suggesting that the direct effect of statin in the lung do not go beyond its antilipidemic action. Although more studies are needed with specific lung cell types and different classes and doses of statins, the improved health outcomes and survival observed in statin users with chronic lung diseases do not seem to be mediated through direct regulation of gene expression in the lung.	[Lane, Jerome; Laviolette, Michel; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Pare, Peter D.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [van Eeden, Stephan F.; Obeidat, Ma'en; Sin, Don D.; Tebbutt, Scott J.; Pare, Peter D.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada; [Tebbutt, Scott J.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Timens, Wim; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Groningen; Laval University	Bosse, Y (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	yohan.bosse@criucpq.ulaval.ca	Timens, Wim/K-5570-2013; Sin, Don/AAC-2219-2021; Pare, Peter D/C-7425-2011	Timens, Wim/0000-0002-4146-6363; Tebbutt, Scott/0000-0002-7908-1581	Canadian Gene Cure Foundation; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Cancer Research Society and Read for the Cure; Canadian Institutes of Health Research [MOP - 123369]	Canadian Gene Cure Foundation; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Cancer Research Society and Read for the Cure; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by Canadian Gene Cure Foundation, the Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval, the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, the Respiratory Health Network of the FRQS, the Cancer Research Society and Read for the Cure, and the Canadian Institutes of Health Research (MOP - 123369).	Alexeeff SE, 2007, AM J RESP CRIT CARE, V176, P742, DOI 10.1164/rccm.200705-656OC; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bartziokas K, 2011, PULM PHARMACOL THER, V24, P625, DOI 10.1016/j.pupt.2011.06.003; Blamoun AI, 2008, INT J CLIN PRACT, V62, P1373, DOI 10.1111/j.1742-1241.2008.01731.x; Bolstad B.M, 2001, PROBE LEVEL QUANTILE; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Gachotte D, 2001, J LIPID RES, V42, P150; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hafner M, 2011, PHARMACOGENET GENOM, V21, P741, DOI 10.1097/FPC.0b013e32834a5585; Horita N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-80; Huang CC, 2011, CLIN THER, V33, P1365, DOI 10.1016/j.clinthera.2011.08.010; Huang CC, 2011, EUR J CLIN INVEST, V41, P507, DOI 10.1111/j.1365-2362.2010.02434.x; Ingebrigtsen TS, 2015, THORAX, V70, P33, DOI 10.1136/thoraxjnl-2014-205795; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishida W, 2007, TOHOKU J EXP MED, V212, P265, DOI 10.1620/tjem.212.265; John S, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.027; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamio K, 2010, EUR RESPIR J, V35, P637, DOI 10.1183/09031936.00134707; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keddissi JI, 2007, CHEST, V132, P1764, DOI 10.1378/chest.07-0298; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kugler KG, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-3; Lahousse L, 2013, PULM PHARMACOL THER, V26, P212, DOI 10.1016/j.pupt.2012.10.008; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Lee TM, 2008, AM J CARDIOL, V101, P530, DOI 10.1016/j.amjcard.2007.09.102; Lee TM, 2009, CLIN SCI, V116, P497, DOI 10.1042/CS20080241; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lokhandwala T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001279; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ou XM, 2009, RESPIROLOGY, V14, P734, DOI 10.1111/j.1440-1843.2009.01549.x; Reed RM, 2011, COPD, V8, P96, DOI 10.3109/15412555.2011.558545; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakamoto N, 2009, INT J TOXICOL, V28, P17, DOI 10.1177/1091581809333140; Schaafsma D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-113; Shannon CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095224; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suda K, 2011, J APPL PHYSIOL, V111, P1118, DOI 10.1152/japplphysiol.00158.2011; Tse SM, 2014, CURR MED RES OPIN, V30, P685, DOI 10.1185/03007995.2013.865599; Tse SM, 2013, AM J RESP CRIT CARE, V188, P1076, DOI 10.1164/rccm.201306-1017OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Young RP, 2013, EXPERT REV RESP MED, V7, P533, DOI 10.1586/17476348.2013.838018	57	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142037	10.1371/journal.pone.0142037	http://dx.doi.org/10.1371/journal.pone.0142037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535575	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400121
J	Li, Y; Zhang, B; Cheng, HS; Zheng, JM				Li, Yu; Zhang, Bin; Cheng, Huansheng; Zheng, Jianming			The Earliest Chinese Proto-Porcelain Excavated from Kiln Sites: An Elemental Analysis	PLOS ONE			English	Article							NONDESTRUCTIVE ANALYSIS; PIXE; IDENTIFICATION; PROVENANCE	In June 2012, the Piaoshan kiln site was excavated in Huzhou, Zhejiang Province, which hitherto proved to be the earliest known Chinese proto-porcelain kiln. Judging from the decorative patterns of unearthed impressed stoneware and proto-porcelain sherds, the site was determined to date to the late Xia (c.2070-c. 1600 BC), the first dynasty of China. Here, we report on proton-induced X-ray emission analyses of 118 proto-porcelain and 35 impressed stoneware sherds from Piaoshan and five subsequent kiln sites in the vicinity. Using principal components analysis on the major chemical compositions, we reveal the relationships between impressed stoneware and proto-porcelain samples from the six kiln sites. The sherds from different sites have distinctive chemical profiles. The results indicate that the raw materials were procured locally. We find a developmental tendency for early glazes towards mature calcium-based glaze. It is most likely that woody plant ashes with increased calcia-potash ratios were applied to the formula.	[Li, Yu; Zhang, Bin; Cheng, Huansheng] Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China; [Zheng, Jianming] Zhejiang Prov Inst Cultural Rel & Archaeol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Fudan University	Zhang, B (corresponding author), Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China.	binzhang@fudan.edu.cn		Li, Yu/0000-0002-3636-4872	State Administration of Cultural Heritage of China	State Administration of Cultural Heritage of China	Funding: This work was sponsored by the Compass Special Plan from the State Administration of Cultural Heritage of China (http://www.sach.gov.cn/art/2012/7/19/art_1328_97968.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	An J, 1999, JINHUAI ANS COLLECTE; An J.H., 1960, CULTURAL RELICS, V8, P68; Bin Z, 2014, NUCL TECH, V37; Campbell JL, 2000, NUCL INSTRUM METH B, V170, P193, DOI 10.1016/S0168-583X(00)00156-7; Chang K. -C, 1986, ARCHAEOLOGY ANCIENT; CHEN JX, 1980, NUCL INSTRUM METHODS, V168, P437, DOI 10.1016/0029-554X(80)91290-2; Chen T, 1999, J ARCHAEOL SCI, V26, P1003, DOI 10.1006/jasc.1999.0418; Cheng HS, 2004, NUCL INSTRUM METH B, V219, P30, DOI 10.1016/j.nimb.2004.01.023; Cheng HS, 2004, NUCL INSTRUM METH B, V219, P16, DOI 10.1016/j.nimb.2004.01.020; Cheng HS, 2002, NUCL INSTRUM METH B, V190, P488, DOI 10.1016/S0168-583X(01)01280-0; Cheng HS, 1996, NUCL INSTRUM METH B, V118, P377, DOI 10.1016/0168-583X(95)01084-X; Feng Xianming, 1982, ZHONGGUO TAOCI SHI; GOVINDARAJU K, 1984, GEOSTANDARD NEWSLETT, V8, P3, DOI 10.1111/j.1751-908X.1984.tb01069.x; GUO YY, 1987, ARCHAEOMETRY, V29, P3; Guozhen L, 1988, TECHNICAL FDN FAMOUS; HALL GEM, 1986, ANALYST, V111, P1255, DOI 10.1039/an9861101255; Hongjie L, 1996, GUISUANYAN XUEBAO, V24, P297; Jianming Z, 2012, ARCHAEOLOGY, V11, P4; Jianming Z, 2011, ARCHAEOLOGY, V7, P3; Jianming Z, 2012, ARCHAEOLOGY, V11, P61; Jiazhi L, 1992, MRS P, P571; Junming W, 2011, J CERAM, V32, P376; Kerr R., 2004, J NEEDHAM SCI TEC 12, V5; Li J, 1998, ARCHAEOLOGY, V7, P69; Li J., 1998, HIST SCI TECHNOLOGY; [李其江 Li Qijiang], 2012, [中国陶瓷, China's Ceramics], V48, P13; LIN SL, 1990, J ANAL ATOM SPECTROM, V5, P509, DOI 10.1039/ja9900500509; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Luo Z.W., 2001, CHINESE ANCIENT ARCH; Medley Margaret, 1976, CHINESE POTTER PRACT; Mino Y, 1975, JSTOR, V37, P39; Qian H, 2012, PALACE MUSEUM J, V5, P151; STOCKLI R., 2005, BLUE MARBLE NEXT GEN; Thorp RL, 1991, JSTOR, P1; Tichane R, 1998, ASH GLAZES; Tiemei C, 2003, ARCHAEOLOGY, V7, P11; Wenquan H, 1997, ION BEAM ANAL ARCHAE; Wu J, 2002, X-RAY SPECTROM, V31, P408, DOI 10.1002/xrs.571; [吴隽 Wu Juan], 2012, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V29, P3284; Wu JA, 2011, SCI CHINA TECHNOL SC, V54, P99, DOI 10.1007/s11431-010-4195-x; [吴军明 Wu Junming], 2011, [中国陶瓷, China's Ceramics], V47, P66; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; XIONG Ying-fei, 2010, SCI CONSERVATION ARC, V22, P28, DOI DOI 10.16334/J.CNKI.CN31-1652/K.2010.04.002; Yaocheng C, 2002, P INT S ANC CER ISAC, P32; YAP CT, 1995, APPL SPECTROSC, V49, P981, DOI 10.1366/0003702953964831; YAP CT, 1994, Z NATURFORSCH A, V49, P759; Yuanfu C, 2010, CULT REIL E, V34, P6; Yueming S, 2014, CHINA CULTURAL  0801; Yuyun T, 2012, CULT RELI CENT CHINA, V1, P12; Zhang B, 2005, NUCL INSTRUM METH B, V240, P559, DOI 10.1016/j.nimb.2005.06.154; Zhang B, 2014, NUCL SCI TECH, V25; Zhang ZW, 2011, NUCL INSTRUM METH B, V269, P460, DOI 10.1016/j.nimb.2010.12.038; Zhu J, 2006, RES PROVENANCE PROTO	53	6	7	14	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139970	10.1371/journal.pone.0139970	http://dx.doi.org/10.1371/journal.pone.0139970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CV5GZ	26535583	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400013
J	Santamarina, AB; Oliveira, JL; Silva, FP; Carnier, J; Mennitti, LV; Santana, AA; de Souza, GHI; Ribeiro, EB; do Nascimento, CMO; Lira, FS; Oyama, LM				Santamarina, Aline B.; Oliveira, Juliana L.; Silva, Fernanda P.; Carnier, June; Mennitti, Lais V.; Santana, Aline A.; de Souza, Gabriel H. I.; Ribeiro, Eliane B.; Oller do Nascimento, Claudia M.; Lira, Fabio S.; Oyama, Lila M.			Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							PROTEIN-KINASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; ENERGY-METABOLISM; LIPID-METABOLISM; RECENT PROGRESS; RAT MODEL	Supplementation with epigallocatechin-3-gallate has been determined to aid in the prevention of obesity. Decaffeinated green tea extract appears to restore a normal hepatic metabolic profile and attenuate high-fat diet (HFD)-induced effects, thereby preventing nonalcoholic fatty liver disease in mice. Mice were maintained on either a control diet (CD) or HFD for 16 weeks and supplemented with either water or green tea extract (50 mg/kg/day). The body mass increase, serum adiponectin level, and lipid profile were measured over the course of the treatment. Furthermore, the AMPK pathway protein expression in the liver was measured. From the fourth week, the weight gain in the CD + green tea extract (CE) group was lower than that in the CD + water (CW) group. From the eighth week, the weight gain in the HFD + water (HFW) group was found to be higher than that in the CW group. Moreover, the weight gain in the HFD + green tea extract (HFE) group was found to be lower than that in the HFW group. Carcass lipid content was found to be higher in the HFW group than that in the CW and HFE groups. Serum analysis showed reduced non-esterified fatty acid level in the CE and HFE groups as compared with their corresponding placebo groups. Increased adiponectin level was observed in the same groups. Increased VLDL-TG secretion was observed in the HFW group as compared with the CW and HFE groups. Increased protein expression of AdipoR2, SIRT1, pLKB1, and pAMPK was observed in the HFE group, which explained the reduced expression of ACC, FAS, SREBP-1, and ChREBP in this group. These results indicate that the effects of decaffeinated green tea extract may be related to the activation of AMPK via LKB1 in the liver of HFD-fed mice.	[Santamarina, Aline B.; Oliveira, Juliana L.; Silva, Fernanda P.; Carnier, June; Santana, Aline A.; Ribeiro, Eliane B.; Oller do Nascimento, Claudia M.; Oyama, Lila M.] Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil; [Mennitti, Lais V.] Univ Fed Sao Paulo, Programa Posgrad Interdisciplinar Ciencias Saude, Santos, Brazil; [de Souza, Gabriel H. I.] Univ Sao Judas Tadeu, Lab Movimento Humano, Sao Paulo, Brazil; [Lira, Fabio S.] Univ Estadual Paulista, UNESP, Dept Phys Educ, Exercise & Immunometab Res Grp, Presidente Prudente, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Sao Judas Tadeu; Universidade Estadual Paulista	Oyama, LM (corresponding author), Univ Fed Sao Paulo, Dept Fisiol, Sao Paulo, Brazil.	lmoyama@gmail.com	Lira, Fábio/N-7299-2019; Ribeiro, Eliane B/C-8124-2012; Lira, Fábio Santos/Q-7581-2016; Oyama, Lila M/B-7609-2012; Santamarina, Aline/AAI-7639-2020	Lira, Fábio/0000-0002-9645-1003; Ribeiro, Eliane B/0000-0002-3071-9134; Lira, Fábio Santos/0000-0002-9645-1003; Silva, Fernanda/0000-0003-3758-5797; Lopez de Oliveira, Juliana/0000-0003-2841-5980; Mennitti, Lais Vales/0000-0002-9326-7649	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/19508-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/19508-7 - grant to: Dr Lila Missae Oyama and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - grant to Aline Boveto Santamarina.	Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Bollheimer LC, 2012, BIOGERONTOLOGY, V13, P609, DOI 10.1007/s10522-012-9405-4; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; BRAZIL C, 2013, DIRETRIZ BRASILEIRA, P1; Buettner R, 2006, J MOL ENDOCRINOL; Burd N, 2014, PUBLIC HEALTH NUTR, P1; Byrne CD, 2013, P NUTR SOC, P1; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carillon J, 2013, FREE RADICAL BIO MED, V65, P254, DOI 10.1016/j.freeradbiomed.2013.06.022; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016; Choi KM, 2014, J CELL BIOCH; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Costa S, 2007, FOOD CHEM TOXICOL, V45, P1910, DOI 10.1016/j.fct.2007.04.008; Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Davaatseren M, 2013, FOOD CHEM TOXICOL, V58, P30, DOI 10.1016/j.fct.2013.04.023; De Rosa E, 2014, NUTRITION; Derdemezis CS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/285618; DONASCIMENTO CMO, 1986, BIOCHEM J, V239, P233; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fellner C, 2014, GERONTOLOGY, V60, P530, DOI 10.1159/000360289; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037942; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Henriksen BS, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-29; Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628; Horton JD, 2004, MOL MEDIATORS HEPATI, P114; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Jiang ZA, 2015, ALCOHOL CLIN EXP RES, V39, P424, DOI 10.1111/acer.12641; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kim EY, 2011, J AGR FOOD CHEM, V59, P3606, DOI 10.1021/jf104260j; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219; Kohjima M, 2008, INT J MOL MED, V21, P507; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Latif R, 2013, NETH J MED, V71, P63; Lee J, 2012, DIABETES METAB J, V36, P262, DOI 10.4093/dmj.2012.36.4.262; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Ma QY, 2011, J FOOD SCI, V76, pH143, DOI 10.1111/j.1750-3841.2011.02184.x; Martins SV, 2010, BRIT J NUTR, V103, P869, DOI 10.1017/S000711450999256X; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ratto E, 2006, J AM SOC NEPHROL, V17, pS120, DOI 10.1681/ASN.2005121328; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109; Seo HY, 2013, ENDOCRINOLOGY, V154, P1722, DOI 10.1210/en.2012-2009; Seo MS, 2015, TOXICOL APPL PHARM, V284, P113, DOI 10.1016/j.taap.2015.02.020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shafiei MS, 2011, AM J PATHOL, V178, P2690, DOI 10.1016/j.ajpath.2011.02.035; Shearn CT, 2013, J NUTR BIOCH, V1, P1, DOI DOI 10.1016/J.JNUTBI0.2012.12.002; Shen L, 2013, J LIPID RES, V54, P1430, DOI 10.1194/jlr.M035907; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shiniada M, 2007, BIOSCI BIOTECH BIOCH, V71, P2079, DOI 10.1271/bbb.70174; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song CY, 2013, TOXICOL IN VITRO, V27, P1065, DOI 10.1016/j.tiv.2013.01.020; Stanhope KL, 2008, CURR OPIN LIPIDOL, V19, P16, DOI 10.1097/MOL.0b013e3282f2b24a; STANSBIE D, 1976, BIOCHEM J, V154, P225, DOI 10.1042/bj1540225; Tachibana H, 2011, P JPN ACAD B-PHYS, V87, P66, DOI 10.2183/pjab.87.66; Tian C, 2013, PLOS ONE, P8; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Vigouroux C, 2011, INT J BIOCHEM CELL B, V43, P862, DOI 10.1016/j.biocel.2011.03.002; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Weng SY, 2013, J HEPATOL, V58, P619, DOI 10.1016/j.jhep.2012.09.031; Wu AH, 2011, NUTR CANCER, V63, P549, DOI 10.1080/01635581.2011.551986; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang WY, 2012, DIABETES, V61, P3114, DOI 10.2337/db11-1373; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]	90	58	62	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141227	10.1371/journal.pone.0141227	http://dx.doi.org/10.1371/journal.pone.0141227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536464	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400055
J	Su, LJ; Wang, QJ; Wang, CX; Shan, YY				Su, Lijun; Wang, Quanjiu; Wang, Chunxia; Shan, Yuyang			Simulation Models of Leaf Area Index and Yield for Cotton Grown with Different Soil Conditioners	PLOS ONE			English	Article							EXTENDED LOGISTIC MODEL; FORAGE GRASS RESPONSE; SANDY SOIL; APPLIED NITROGEN; COLLECTION; STABILITY; MATTER; MANURE	Simulation models of leaf area index (LAI) and yield for cotton can provide a theoretical foundation for predicting future variations in yield. This paper analyses the increase in LAI and the relationships between LAI, dry matter, and yield for cotton under three soil conditioners near Korla, Xinjiang, China. Dynamic changes in cotton LAI were evaluated using modified logistic, Gaussian, modified Gaussian, log normal, and cubic polynomial models. Universal models for simulating the relative leaf area index (RLAI) were established in which the application rate of soil conditioner was used to estimate the maximum LAI (LAI(m)). In addition, the relationships between LAI(m) and dry matter mass, yield, and the harvest index were investigated, and a simulation model for yield is proposed. A feasibility analysis of the models indicated that the cubic polynomial and Gaussian models were less accurate than the other three models for simulating increases in RLAI. Despite significant differences in LAIs under the type and amount of soil conditioner applied, LAI(m) could be described by aboveground dry matter using Michaelis-Menten kinetics. Moreover, the simulation model for cotton yield based on LAI(m) and the harvest index presented in this work provided important theoretical insights for improving water use efficiency in cotton cultivation and for identifying optimal application rates of soil conditioners.	[Su, Lijun] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Su, Lijun; Wang, Quanjiu; Shan, Yuyang] Xian Univ Technol, Inst Water Resources & Hydroelect Engn, Xian, Shaanxi, Peoples R China; [Wang, Chunxia] Shihezi Univ, Shihezi, Xinjiang, Peoples R China	Xi'an University of Technology; Xi'an University of Technology; Shihezi University	Su, LJ (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	sljun11@163.com			National Natural Science Foundation of China [51239009, 51409212, 51409213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (Grant No. 51239009 to Wang Quanjiu); by the National Natural Science Foundation of China (Grant No. 51409212 to Su Lijun); and by the National Natural Science Foundation of China (Grant No. 51409213 to Shan Yuyang).	AlDarby AM, 1996, SOIL TECHNOL, V9, P15, DOI 10.1016/0933-3630(95)00030-5; Arkin GF, 1977, P CROP MOD WORKSH US; Asghari S, 2011, BIOSYST ENG, V109, P90, DOI 10.1016/j.biosystemseng.2011.02.005; Asghari S, 2009, TURK J AGRIC FOR, V33, P47, DOI 10.3906/tar-0804-20; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Baez-Gonzalez AD, 2002, CROP SCI, V42, P1943, DOI 10.2135/cropsci2002.1943; Barns MB, 1997, 1997 ASAE ANN INT M; Behera SK, 2010, AGR FOREST METEOROL, V150, P307, DOI 10.1016/j.agrformet.2009.11.009; De Kauwe MG, 2011, REMOTE SENS ENVIRON, V115, P767, DOI 10.1016/j.rse.2010.11.004; DEGAETANO AT, 1993, AGR FOREST METEOROL, V66, P1, DOI 10.1016/0168-1923(93)90079-W; Demarez V, 2008, AGR FOREST METEOROL, V148, P644, DOI 10.1016/j.agrformet.2007.11.015; FELTON GK, 1992, T ASAE, V35, P1153; GUPTA SC, 1977, SOIL SCI SOC AM J, V41, P601, DOI 10.2136/sssaj1977.03615995004100030035x; Hasegawa K, 2010, REMOTE SENS ENVIRON, V114, P514, DOI 10.1016/j.rse.2009.10.005; Ishihara MI, 2011, AGR FOREST METEOROL, V151, P1016, DOI 10.1016/j.agrformet.2011.02.007; Li Wen-feng, 2009, Yingyong Shengtai Xuebao, V20, P879; Li XiangLing, 2011, Acta Agronomica Sinica, V37, P321, DOI 10.3724/SP.J.1006.2011.00321; [林忠辉 Lin Zhonghui], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P69; Lindsay BJ, 1998, J ENVIRON QUAL, V27, P534, DOI 10.2134/jeq1998.00472425002700030009x; Liu JianJun, 2010, Acta Pedologica Sinica, V47, P568; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Maas S. J., 1978, 781 RES CTR PROGR MO, P78; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Michael MC, 1982, LEHNINGER PRINCIPLES; Nyamangara J, 2001, SOIL TILL RES, V62, P157, DOI 10.1016/S0167-1987(01)00215-X; Otter S, 1985, ARS38 NAT TECHN INF; OVERMAN AR, 1994, AGRON J, V86, P617, DOI 10.2134/agronj1994.00021962008600040007x; Overman AR, 1995, J PLANT NUTR, V18, P2629, DOI 10.1080/01904169509365089; Overman AR, 2003, COMMUN SOIL SCI PLAN, V34, P851, DOI 10.1081/CSS-120018979; OVERMAN AR, 1995, T ASAE, V38, P103, DOI 10.13031/2013.27817; OVERMAN AR, 1995, J PLANT NUTR, V18, P995, DOI 10.1080/01904169509364956; Rosenthal WD, 1989, MP1969 TEX AGR EXP S; Ruml M, 2010, INT J BIOMETEOROL, V54, P411, DOI 10.1007/s00484-009-0292-6; SABRAH REA, 1994, J ARID ENVIRON, V27, P363, DOI 10.1006/jare.1994.1071; Sadegian N, 2006, IRAN J AGR SCI, V37, P341; SCHJONNING P, 1994, EUR J SOIL SCI, V45, P257, DOI 10.1111/j.1365-2389.1994.tb00508.x; Schleppi P, 2011, FOREST ECOL MANAG, V261, P601, DOI 10.1016/j.foreco.2010.11.013; Setiyono TD, 2008, FIELD CROP RES, V108, P82, DOI 10.1016/j.fcr.2008.03.005; Thimonier A, 2010, EUR J FOREST RES, V129, P543, DOI 10.1007/s10342-009-0353-8; Wang CX, 2010, J SOIL WATER CONSERV, V24, P59063; Wang RuiJun, 2008, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V16, P139, DOI 10.3724/SP.J.1011.2008.00139; [王声锋 Wang Shengfeng], 2010, [灌溉排水学报, Journal of Irrigation and Drainage], V29, P29; Wang SS., 1990, J BIOMATH, V01, P21; Wang XL, 1989, CHINESE J AGROMETEOR, V10, P11; Wilkerson GG, 1985, SOYGRO V5 0 SOYBEAN; Willcutts JF, 1998, HORTSCIENCE, V33, P833, DOI 10.21273/HORTSCI.33.5.833; Williams LE, 2005, AGR FOREST METEOROL, V132, P201, DOI 10.1016/j.agrformet.2005.07.010; Wu ZhongDong, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P63; Yang Lili, 2008, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V39, P81	49	17	19	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141835	10.1371/journal.pone.0141835	http://dx.doi.org/10.1371/journal.pone.0141835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536468	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400091
J	Dareng, EO; Jedy-Agba, E; Bamisaye, P; Modibbo, FI; Oyeneyin, LO; Adewole, AS; Olaniyan, OB; Dakum, PS; Pharoah, PD; Adebamowo, CA				Dareng, Eileen O.; Jedy-Agba, Elima; Bamisaye, Patience; Modibbo, Fatima Isa; Oyeneyin, Lawal O.; Adewole, Ayodele S.; Olaniyan, Olayinka B.; Dakum, Patrick S.; Pharoah, Paul D.; Adebamowo, Clement A.			Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; WOMEN; HPV; RELIGION; HEALTH; BARRIERS; ACCEPTABILITY; PREVENTION; SERVICES; DELIVERY	Introduction Whereas systematic screening programs have reduced the incidence of cervical cancer in developed countries, the incidence remains high in developing countries. Among several barriers to uptake of cervical cancer screening, the roles of religious and cultural factors such as modesty have been poorly studied. Knowledge about these factors is important because of the potential to overcome them using strategies such as self-collection of cervico-vaginal samples. In this study we evaluate the influence of spirituality and modesty on the acceptance of self-sampling for cervical cancer screening. Methodology We enrolled 600 participants in Nigeria between August and October 2014 and collected information on spirituality and modesty using two scales. We used principal component analysis to extract scores for spirituality and modesty and logistic regression models to evaluate the association between spirituality, modesty and preference for self-sampling. All analyses were performed using STATA 12 (Stata Corporation, College Station, Texas, USA). Results Some 581 (97%) women had complete data for analysis. Most (69%) were married, 50% were Christian and 44% were from the south western part of Nigeria. Overall, 19% (110/581) of the women preferred self-sampling to being sampled by a health care provider. Adjusting for age and socioeconomic status, spirituality, religious affiliation and geographic location were significantly associated with preference for self-sampling, while modesty was not significantly associated. The multivariable OR (95% CI, p-value) for association with self-sampling were 0.88 (0.78-0.99, 0.03) for spirituality, 1.69 (1.09-2.64, 0.02) for religious affiliation and 0.96 (0.86-1.08, 0.51) for modesty. Conclusion Our results show the importance of taking cultural and religious beliefs and practices into consideration in planning health interventions like cervical cancer screening. To succeed, public health interventions and the education to promote it must be related to the target population and its preferences.	[Dareng, Eileen O.; Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Dareng, Eileen O.; Jedy-Agba, Elima; Bamisaye, Patience; Dakum, Patrick S.] Inst Human Virol Nigeria, Abuja, Nigeria; [Jedy-Agba, Elima] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Bamisaye, Patience] Natl Hosp, Dept Nursing Serv, Abuja, Nigeria; [Modibbo, Fatima Isa] Natl Hosp, Dept Med Microbiol & Parasitol, Abuja, Nigeria; [Oyeneyin, Lawal O.; Adewole, Ayodele S.] Mother & Child Hosp Ondo, Ondo, Nigeria; [Olaniyan, Olayinka B.] Natl Hosp, Dept Obstet & Gynaecol, Abuja, Nigeria; [Adebamowo, Clement A.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Adebamowo, Clement A.] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Adebamowo, Clement A.] Univ Maryland, Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dareng, EO (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	eod21@medschl.cam.ac.uk	Adebamowo, Clement/C-8778-2011; Pharoah, Paul/V-6658-2019	Adebamowo, Clement/0000-0002-6571-2880; Pharoah, Paul/0000-0001-8494-732X; Dareng, Eileen/0000-0003-0802-419X	UM-Capacity Development for Research in AIDS Associated Malignancy Grant (National Institutes of Health (US) - National Cancer Institute) [1D43CA153792-01]; H3Africa-African Collaborative Center for Genomics and Microbiome Research Grant (National Institutes of Health (US) -National Human Genome Research Institute) [1U54HG006947-01A1]; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [D43CA153792] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006947] Funding Source: NIH RePORTER	UM-Capacity Development for Research in AIDS Associated Malignancy Grant (National Institutes of Health (US) - National Cancer Institute); H3Africa-African Collaborative Center for Genomics and Microbiome Research Grant (National Institutes of Health (US) -National Human Genome Research Institute); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by UM-Capacity Development for Research in AIDS Associated Malignancy Grant (National Institutes of Health (US) - National Cancer Institute 1D43CA153792-01) to CAA; and H3Africa-African Collaborative Center for Genomics and Microbiome Research Grant (National Institutes of Health (US) -National Human Genome Research Institute 1U54HG006947-01A1) to CAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Risasi C, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-30; Andrew CL., 1973, 1 COURSE FACTOR ANAL; Andrews CS, 2011, J RELIG HEALTH, V50, P818, DOI 10.1007/s10943-010-9435-7; Arbyn M, 2015, CANCER EPIDEM BIOMAR, V24, P769, DOI 10.1158/1055-9965.EPI-14-1417; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Azaiza F, 2008, PSYCHO-ONCOLOGY, V17, P34, DOI 10.1002/pon.1180; Bansil P, 2015, J LOW GENIT TRACT DI, V19, P215, DOI 10.1097/LGT.0000000000000090; Bansil P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-596; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Berner A, 2013, J LOW GENIT TRACT DI, V17, P235, DOI 10.1097/LGT.0b013e31826b7b51; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Ezeonwu M, 2014, HEALTH CARE WOMEN IN, V35, P828, DOI 10.1080/07399332.2014.925454; Ferlay J, 2014, IARC CANCERBASE; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Forrest S, 2004, J MED SCREEN, V11, P85, DOI 10.1258/096914104774061065; Gregg AP, 2008, PERS SOC PSYCHOL B, V34, P978, DOI 10.1177/0146167208316734; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HORTON R, 1966, CALIF MED, V104, P366; Howard M, 2009, CAN J PUBLIC HEALTH, V100, P365, DOI 10.1007/BF03405272; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Jackson J. E., 1991, USERS GUIDE PRINCIPA; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Labani S, 2014, EUR J OBSTET GYN R B, V181, P233, DOI 10.1016/j.ejogrb.2014.08.005; Lack N, 2005, SEX TRANSM INFECT, V81, P239, DOI 10.1136/sti.2004.010413; Lazcano-Ponce E, 2011, LANCET, V378, P1868, DOI 10.1016/S0140-6736(11)61522-5; Levin J, 2005, J NATL MED ASSOC, V97, P237; Mitchell S, 2011, INT J GYNECOL OBSTET, V114, P111, DOI 10.1016/j.ijgo.2011.01.028; Munthali AC, 2015, PATIENT PREFER ADHER, V9, P501, DOI 10.2147/PPA.S69286; Ndayisaba G, 2013, SEX TRANSM DIS, V40, P552, DOI 10.1097/OLQ.0b013e31828e5aa5; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Padela AI, 2014, J LOW GENIT TRACT DI, V18, P326, DOI 10.1097/LGT.0000000000000026; Padela AI, 2013, J RELIG HEALTH, V52, P1333, DOI 10.1007/s10943-012-9620-y; Parkin DM, 2014, CANCER EPIDEM BIOMAR, V23, P953, DOI 10.1158/1055-9965.EPI-14-0281; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sapnas Kathryn G, 2002, J Nurs Meas, V10, P135; Sewali B, 2015, CANCER MED-US, V4, P620, DOI 10.1002/cam4.429; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Teng FF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004783; Waller J, 2006, J MED SCREEN, V13, P208, DOI 10.1177/096914130601300409; YEOMANS KA, 1982, STATISTICIAN, V31, P221	45	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141679	10.1371/journal.pone.0141679	http://dx.doi.org/10.1371/journal.pone.0141679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CV1QH	26529098	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600049
J	Elashi, FB; Mills, CM				Elashi, Fadwa B.; Mills, Candice M.			Developing the Bias Blind Spot: Increasing Skepticism towards Others	PLOS ONE			English	Article							INTROSPECTION ILLUSION; FALSE BELIEF; PERCEPTIONS; JUDGMENTS; SELF; CHILDREN; TRAITS; MIND	Two experiments with eighty-eight 7- to 10-year-olds examined the bias blind spot in children. Both younger and older children rated themselves as less likely than a specific other (Experiment 1) or an average child (Experiment 2) to commit various biases. These self-other differences were also more extreme for biased behaviors than for other behaviors. At times, older children demonstrated stronger self-other differences than younger children, which seemed primarily driven by older children's judgments about bias in others. These findings suggest that, although the bias blind spot exists as soon as children recognize other-committed biases, what changes over development is how skeptical children are towards others.	[Elashi, Fadwa B.] Arab Open Univ, Educ Studies, Amman, Jordan; [Mills, Candice M.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75230 USA	University of Texas System; University of Texas Dallas	Elashi, FB (corresponding author), Arab Open Univ, Educ Studies, Amman, Jordan.	f_elashi@aou.edu.jo		Mills, Candice/0000-0002-0820-9162				Apfelbaum EP, 2008, DEV PSYCHOL, V44, P1513, DOI 10.1037/a0012835; BIGLER RS, 1993, CHILD DEV, V64, P1507, DOI 10.1111/j.1467-8624.1993.tb02967.x; Brown CS, 2010, J EXP CHILD PSYCHOL, V107, P100, DOI 10.1016/j.jecp.2010.04.010; Brown CS, 2005, CHILD DEV, V76, P533, DOI 10.1111/j.1467-8624.2005.00862.x; Carpendale JI, 1996, CHILD DEV, V67, P1686, DOI 10.2307/1131725; Carpusor GA, 2006, J APPL SOC PSYCHOL, V36, P934, DOI [10.1111/j.0021-9029.2006.00050.x, DOI 10.1111/J.0021-9029.2006.00050.X]; Diesendruck G, 2009, SOC DEV, V18, P946, DOI 10.1111/j.1467-9507.2008.00494.x; Heyman GD, 2005, DEV PSYCHOL, V41, P636, DOI 10.1037/0012-1649.41.4.636; McCaslin MJ, 2010, J EXP SOC PSYCHOL, V46, P830, DOI 10.1016/j.jesp.2010.05.002; Mills CM, 2008, COGNITION, V107, P528, DOI 10.1016/j.cognition.2007.11.003; Mills CM, 2014, J EXP CHILD PSYCHOL, V124, P1, DOI 10.1016/j.jecp.2014.01.015; Mills CM, 2012, J COGN DEV, V13, P111, DOI 10.1080/15248372.2010.547236; Mills CM, 2009, DEVELOPMENTAL SCI, V12, P784, DOI 10.1111/j.1467-7687.2009.00836.x; Mills CM, 2005, PSYCHOL SCI, V16, P385, DOI 10.1111/j.0956-7976.2005.01545.x; MOKROS J, 1995, J RES MATH EDUC, V26, P20, DOI 10.2307/749226; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Pronin E, 2002, PERS SOC PSYCHOL B, V28, P369, DOI 10.1177/0146167202286008; Pronin E, 2007, TRENDS COGN SCI, V11, P37, DOI 10.1016/j.tics.2006.11.001; Pronin E, 2007, J PERS SOC PSYCHOL, V92, P585, DOI 10.1037/0022-3514.92.4.585; Pronin E, 2007, J EXP SOC PSYCHOL, V43, P565, DOI 10.1016/j.jesp.2006.05.011; SIGELMAN CK, 1986, J APPL SOC PSYCHOL, V16, P229, DOI 10.1111/j.1559-1816.1986.tb01137.x; Wainryb C, 2004, CHILD DEV, V75, P687, DOI 10.1111/j.1467-8624.2004.00701.x; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WILSON TD, 1994, PSYCHOL BULL, V116, P117, DOI 10.1037/0033-2909.116.1.117	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141809	10.1371/journal.pone.0141809	http://dx.doi.org/10.1371/journal.pone.0141809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1PG	26523603	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800023
J	Ross, BN; Rojas-Lopez, M; Cieza, RJ; McWilliams, BD; Torres, AG				Ross, Brittany N.; Rojas-Lopez, Maricarmen; Cieza, Roberto J.; McWilliams, Brian D.; Torres, Alfredo G.			The Role of Long Polar Fimbriae in Escherichia coli O104:H4 Adhesion and Colonization	PLOS ONE			English	Article							AGGREGATIVE ADHERENCE; EXPRESSION; O157/H7; CELLS; IDENTIFICATION; MARKERS; OPERON	A renewed interest in Shiga toxin-producing Escherichia coli (STEC) strains was sparked due to the appearance of an outbreak in 2011, causing 3,816 diarrheal cases and some deaths in Europe. The causative strain was classified as enteroaggregative E. coli of serotype O104:H4 that had acquired Shiga toxin genes. The ability of STEC O104:H4 to cause disease relies greatly on the bacteria's capacity to colonize, persist, and produce Shiga toxin. However, not much is known about the colonization factors of this strain. Because long polar fimbriae (lpf) lpf1 and lpf2 operons encode important colonization factors in other STEC isolates and E. coli O104:H4 possesses both loci, we hypothesized that Lpf is required for adhesion and colonization. In this study, isogenic lpfA1 and lpfA2 major fimbrial subunit mutants were constructed. To determine their role in O104:H4' s virulence, we assessed their ability to adhere to non-polarized and polarized intestinal epithelial cells. The.lpfA1 showed decreased adherence in both cell systems, while the.lpfA2 only showed a decrease in adherence to polarized Caco-2 cells. We also tested the O104:H4 mutants' ability to form biofilm and found that the.lpfA1 was unable to form a stable biofilm. In an in vivo murine model of intestinal colonization, the.lpfA1 had a reduced ability to colonize the cecum and large intestine, consistent with the in vitro data. Further, we tested the lpfA1 mutants' ability to compete against the wild type. We found that in the in vitro and in vivo models, the presence of the wild type O104:H4 facilitates increased adherence of the.lpfA1 to levels exceeding that of the wild type. Overall, our data demonstrated that Lpf1 is one of the factors responsible for O104:H4 intestinal adhesion and colonization.	[Ross, Brittany N.; Rojas-Lopez, Maricarmen; Cieza, Roberto J.; McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Torres, AG (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	altorres@utmb.edu		Ross, Brittany/0000-0002-9129-0693; Rojas-Lopez, Maricarmen/0000-0001-7710-2572; Torres, Alfredo/0000-0001-6450-0643	NIH/NIAID [AI079154]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079154] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported partially by NIH/NIAID grant AI079154 to A.G.T. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NIH.	Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2014, J INFECT DIS, V210, P1909, DOI 10.1093/infdis/jiu399; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; CHANTRET I, 1988, CANCER RES, V48, P1936; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Farfan MJ, 2013, VET IMMUNOL IMMUNOP, V152, P126, DOI 10.1016/j.vetimm.2012.09.017; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Fitzhenry R, 2006, MICROBES INFECT, V8, P1741, DOI 10.1016/j.micinf.2006.02.012; Frank C, 2011, EURO SURVEILL, V16; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Hicks S, 1996, INFECT IMMUN, V64, P4751, DOI 10.1128/IAI.64.11.4751-4760.1996; Holden NJ, 2004, J MED MICROBIOL, V53, P585, DOI 10.1099/jmm.0.05491-0; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Lloyd SJ, 2012, GUT MICROBES, V3, P272, DOI 10.4161/gmic.20661; Lloyd SJ, 2012, INFECT IMMUN, V80, P914, DOI 10.1128/IAI.05945-11; McWilliams BD, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiospec.EHEC-0003-2013, DOI 10.1128/MICR0BI0SPEC.EHEC-0003-2013]; Munera D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4080; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 1998, EMERG INFECT DIS, V4, P251, DOI 10.3201/eid0402.980212; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Scheutz F, 2011, EURO SURVEILL, V16; Struelens MJ, 2011, EURO SURVEILL, V16; Torres AG, 2004, FEMS MICROBIOL LETT, V238, P333, DOI 10.1016/j.femsle.2004.07.053; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Torres AG, 2007, INT J MED MICROBIOL, V297, P177, DOI 10.1016/j.ijmm.2007.01.005; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Vergara AF, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00185; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066717	38	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141845	10.1371/journal.pone.0141845	http://dx.doi.org/10.1371/journal.pone.0141845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517878	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800086
J	Fan, B; Li, L; Chao, YJ; Forstner, K; Vogel, J; Borriss, R; Wu, XQ				Fan, Ben; Li, Lei; Chao, Yanjie; Foerstner, Konrad; Vogel, Joerg; Borriss, Rainer; Wu, Xiao-Qin			dRNA-Seq Reveals Genomewide TSSs and Noncoding RNAs of Plant Beneficial Rhizobacterium Bacillus amyloliquefaciens FZB42	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SMALL REGULATORY RNAS; BINDING PROTEIN HFQ; ESCHERICHIA-COLI; MESSENGER-RNA; TRANSCRIPTIONAL LANDSCAPE; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; SUBTILIS GENOME	Bacillus amyloliquefaciens subsp. plantarum FZB42 is a representative of Gram-positive plant-growth-promoting rhizobacteria (PGPR) that inhabit plant root environments. In order to better understand the molecular mechanisms of bacteria-plant symbiosis, we have systematically analyzed the primary transcriptome of strain FZB42 grown under rhizospheremimicking conditions using differential RNA sequencing (dRNA-seq). Our analysis revealed 4,877 transcription start sites for protein-coding genes, identified genes differentially expressed under different growth conditions, and corrected many previously mis-annotated genes. We also identified a large number of riboswitches and cis-encoded antisense RNAs, as well as trans-encoded small noncoding RNAs that may play important roles in the gene regulation of Bacillus. Overall, our analyses provided a landscape of Bacillus primary transcriptome and improved the knowledge of rhizobacteria-host interactions.	[Fan, Ben; Wu, Xiao-Qin] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China; [Li, Lei; Chao, Yanjie; Foerstner, Konrad; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, RNA Biol Grp, D-97080 Wurzburg, Germany; [Borriss, Rainer] Humboldt Univ, Fachgebiet Phytomed, Albrecht Daniel Thaer Inst Agr & Gartenbauwissens, Lebenswissensch Fak, D-14195 Berlin, Germany	Nanjing Forestry University; University of Wurzburg; Humboldt University of Berlin	Fan, B (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China.	fanben2000@gmail.com; xqwu2000@gmail.com	Chao, Yanjie/J-1931-2014; Borriss, Rainer/C-5026-2012; Vogel, Jörg/D-5574-2011; Förstner, Konrad U./B-1531-2010; Li, Lei/S-9028-2016	Chao, Yanjie/0000-0002-5735-7954; Borriss, Rainer/0000-0003-3726-1004; Vogel, Jörg/0000-0003-2220-1404; Förstner, Konrad U./0000-0002-1481-2996; Li, Lei/0000-0003-3924-2544; Fan, Ben/0000-0001-8532-1281	National Natural Science Foundation of China [31100081]; Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents [YJ2012-03]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province [BK20151514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The financial support by the National Natural Science Foundation of China (No. 31100081) and Scientific Research Foundation of Nanjing Forestry University for Introduction of High Level Talents (YJ2012-03) is gratefully acknowledged, as well as the financial support given by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. This study was further supported by the Natural Science Foundation of Jiangsu Province (No. BK20151514).	Adamson DN, 2013, P NATL ACAD SCI USA, V110, P13120, DOI 10.1073/pnas.1308476110; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Brantl S, 2014, RNA BIOL, V11, P443, DOI 10.4161/rna.28036; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Eijlander RT, 2014, NUCLEIC ACIDS RES, V42, pD685, DOI 10.1093/nar/gkt1007; Fan B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-116; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gimpel M, 2010, MOL MICROBIOL, V76, P990, DOI 10.1111/j.1365-2958.2010.07158.x; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hammerle H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098661; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kalyon B, 2011, ORG LETT, V13, P2996, DOI 10.1021/ol200809m; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuwana R, 2003, MICROBIOL-SGM, V149, P3011, DOI 10.1099/mic.0.26432-0; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; Mariappan A, 2012, J MOL MICROB BIOTECH, V22, P114, DOI 10.1159/000338804; Mars RAT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005046; Mika F, 2014, RNA BIOL, V11, P494, DOI 10.4161/rna.28867; Moszer I, 2002, NUCLEIC ACIDS RES, V30, P62, DOI 10.1093/nar/30.1.62; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; RYTER A, 1965, ANN I PASTEUR PARIS, V108, P40; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Scholz R, 2014, J BACTERIOL, V196, P1842, DOI 10.1128/JB.01474-14; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; TAYLOR CB, 1951, NATURE, V168, P115, DOI 10.1038/168115a0; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Zhao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117414	91	19	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142002	10.1371/journal.pone.0142002	http://dx.doi.org/10.1371/journal.pone.0142002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540162	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800043
J	Lee, SH; Lee, JH; Ahn, SE; Park, MJ; Lee, DH				Lee, Soon-Hyuck; Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji; Lee, Dae-Hee			Correlation between Quadriceps Endurance and Adduction Moment in Medial Knee Osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; MUSCLE STRENGTH; FUNCTIONAL-CAPACITY; TIBIOFEMORAL JOINT; GRAVITY CORRECTION; STATIC ALIGNMENT; WALKING SPEED; DYNAMIC LOAD; GAIT; HIP	It is not clear whether the strength or endurance of thigh muscles (quadriceps and hamstring) is positively or negatively correlated with the adduction moment of osteoarthritic knees. This study therefore assessed the relationships between the strength and endurance of the quadriceps and hamstring muscles and adduction moment in osteoarthritic knees and evaluated predictors of the adduction moment. The study cohort comprised 35 patients with unilateral medial osteoarthritis and varus deformity who were candidates for open wedge osteotomy. The maximal torque (60 degrees/sec) and total work (180 degrees/sec) of the quadriceps and hamstring muscles and knee adduction moment were evaluated using an isokinetic testing device and gait analysis system. The total work of the quadriceps (r = 0.429, P = 0.037) and hamstring (r = 0.426, P = 0.045) muscles at 180 degrees/sec each correlated with knee adduction moment. Preoperative varus deformity was positively correlated with adduction moment (r = 0.421, P = 0.041). Multiple linear regression analysis showed that quadriceps endurance at 180 degrees/sec was the only factor independently associated with adduction moment (beta = 0.790, P = 0.032). The adduction moment of osteoarthritic knees correlated with the endurance, but not the strength, of the quadriceps muscle. However, knee adduction moment did not correlate with the strength or endurance of the hamstring muscle.	[Lee, Soon-Hyuck] Korea Univ, Coll Med, Anam Hosp, Dept Orthopaed Surg, Seoul 136705, South Korea; [Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji] Korea Univ, Coll Med, Anam Hosp, Dept Sports Med Ctr, Seoul 136705, South Korea; [Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017					AAGAARD P, 1995, ACTA PHYSIOL SCAND, V154, P421, DOI 10.1111/j.1748-1716.1995.tb09927.x; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Anderson DE, 2010, J BIOMECH, V43, P1220, DOI 10.1016/j.jbiomech.2009.11.036; Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Calder KM, 2014, ARTHRIT CARE RES, V66, P687, DOI 10.1002/acr.22223; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Chang AH, 2015, OSTEOARTHR CARTILAGE, V23, P1099, DOI 10.1016/j.joca.2015.02.005; CHATTERJEE S, 1991, REGRESSION ANAL EXAM, P191; Cho Y, 2015, J PHYS THER SCI, V27, P265, DOI 10.1589/jpts.27.265; Eitzen I, 2010, J ORTHOP SPORT PHYS, V40, P705, DOI 10.2519/jospt.2010.3345; Engel K, 2015, KNEE, V22, P68, DOI 10.1016/j.knee.2014.12.003; Gur H, 2003, ARCH PHYS MED REHAB, V84, P1534, DOI 10.1016/S0003-9993(03)00288-0; Gur H, 2002, ARCH PHYS MED REHAB, V83, P308, DOI 10.1053/apmr.2002.30620; Ha Jeong Ku, 2012, Knee Surg Relat Res, V24, P151, DOI 10.5792/ksrr.2012.24.3.151; Hall M, 2014, CLIN ORTHOP RELAT R, V472, P3114, DOI 10.1007/s11999-014-3737-0; Hunt MA, 2010, KNEE, V17, P296, DOI 10.1016/j.knee.2010.02.010; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Hurwitz DE, 2000, J ORTHOPAED RES, V18, P572, DOI 10.1002/jor.1100180409; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kean CO, 2015, CLIN BIOMECH, V30, P226, DOI 10.1016/j.clinbiomech.2015.01.008; Keating JL, 1996, J ORTHOP SPORT PHYS, V24, P142, DOI 10.2519/jospt.1996.24.3.142; Lee Dae-Hee, 2015, Knee Surg Relat Res, V27, P101, DOI 10.5792/ksrr.2015.27.2.101; Lee TQ, 2014, CLIN ORTHOP SURG, V6, P117, DOI 10.4055/cios.2014.6.2.117; Lim BW, 2008, ARTHRIT RHEUM-ARTHR, V59, P935, DOI 10.1002/art.23820; Lim BW, 2009, ARTHRIT RHEUM-ARTHR, V61, P451, DOI 10.1002/art.24278; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Mundermann A, 2004, ARTHRITIS RHEUM-US, V50, P1172, DOI 10.1002/art.20132; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; Reider B, 2003, ARTHROSCOPY, V19, P2, DOI 10.1053/jars.2003.50006; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; Segawa H, 2002, ARTHROSCOPY, V18, P177, DOI 10.1053/jars.2002.29894; Sharma L, 1998, AGE, V4, P13; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; Tsepis E, 2004, KNEE SURG SPORT TR A, V12, P22, DOI 10.1007/s00167-003-0377-4; van der Esch M, 2014, ARCH PHYS MED REHAB, V95, P1962, DOI 10.1016/j.apmr.2014.06.007; Wada M, 2001, RHEUMATOLOGY, V40, P499, DOI 10.1093/rheumatology/40.5.499; Walter JP, 2015, J ORTHOP RES; WANG JW, 1990, J BONE JOINT SURG AM, V72A, P905, DOI 10.2106/00004623-199072060-00017; Willen C, 2004, ARCH PHYS MED REHAB, V85, P1923, DOI 10.1016/j.apmr.2003.11.040; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yaari L, 2015, CLIN ORTHOP SURG, V7, P191, DOI 10.4055/cios.2015.7.2.191; Yamada H, 2001, CLIN ORTHOP RELAT R, P179	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141972	10.1371/journal.pone.0141972	http://dx.doi.org/10.1371/journal.pone.0141972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539830	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800040
J	Moy, FM; Hoe, VCW; Hairi, NN; Chu, AHY; Bulgiba, A; Koh, D				Moy, Foong Ming; Hoe, Victor Chee Wai; Hairi, Noran Naqiah; Chu, Anne Hin Yee; Bulgiba, Awang; Koh, David			Determinants and Effects of Voice Disorders among Secondary School Teachers in Peninsular Malaysia Using a Validated Malay Version of VHI-10	PLOS ONE			English	Article							OCCUPATIONAL RISK-FACTORS; HANDICAP INDEX-10 VHI-10; QUALITY-OF-LIFE; HEALTH SURVEY; PREVALENCE; AMPLIFICATION; ADAPTATION; DYSPHONIA; TESTS; RATIO	Objectives To establish the prevalence of voice disorder using the Malay-Voice Handicap Index 10 (Malay-VHI-10) and to study the determinants, quality of life, depression, anxiety and stress associated with voice disorder among secondary school teachers in Peninsular Malaysia. Methods This study was divided into two phases. Phase I tested the reliability of the Malay-VHI-10 while Phase II was a cross-sectional study with two-stage sampling. In Phase II, a self-administered questionnaire was used to collect socio-demographic and teaching characteristics, depression, anxiety and stress scale (Malay version of DASS-21); and health-related quality of life (Malay version of SF12-v2). Complex sample analysis was conducted using multivariate Poisson regression with robust variance. Results In Phase I, the Spearman correlation coefficient and Cronbach alpha for total VHI-10 score was 0.72 (p < 0.001) and 0.77 respectively; showing good correlation and internal consistency. The ICCs ranged from 0.65 to 0.78 showing fair to good reliability and demonstrating the subscales to be reliable and stable. A total of 6039 teachers participated in Phase II. They were primarily Malays, females, married, had completed tertiary education and aged between 30 to 50 years. A total of 10.4%(95% CI 7.1, 14.9) of the teachers had voice disorder (VHI-10 score > 11). Compared to Malays, a greater proportion of ethnic Chinese teachers reported voice disorder while ethnic Indian teachers were less likely to report this problem. There was a higher prevalence ratio (PR) of voice disorder among single or divorced/widowed teachers. Teachers with voice disorder were more likely to report higher rates of absenteeism (PR: 1.70, 95% CI 1.33, 2.19), lower quality of life with lower SF12-v2 physical (0.98, 95% CI 0.96, 0.99) and mental (0.97, 95% CI 0.96, 0.98) component summary scales; and higher anxiety levels (1.04, 95% CI 1.02, 1.06). Conclusions The Malay-VHI-10 is valid and reliable. Voice disorder was associated with increased absenteeism, marginally associated with reduced health-related quality of life as well as increased anxiety among teachers.	[Moy, Foong Ming; Hairi, Noran Naqiah; Chu, Anne Hin Yee; Bulgiba, Awang] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Hoe, Victor Chee Wai] Univ Malaya, Fac Med, Ctr Occupat & Environm Hlth UM, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Koh, David] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Brunei, Brunei Darussal, Brunei; [Chu, Anne Hin Yee; Koh, David] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Universiti Malaya; Universiti Malaya; University Brunei Darussalam; National University of Singapore	Moy, FM (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	moyfm@ummc.edu.my	HAIRI, NORAN/B-9339-2010; Hoe, VICTOR CW/B-5190-2010; Moy, Foong Ming/B-7899-2010; Bulgiba, Awang/B-8271-2010	HAIRI, NORAN/0000-0002-2692-9016; Hoe, VICTOR CW/0000-0002-8073-157X; Moy, Foong Ming/0000-0002-0306-4419; Koh, David/0000-0001-6803-7879; Bulgiba, Awang/0000-0002-5313-0445	Ministry of Education High Impact Research Grant [H-20001-00-E2000069]	Ministry of Education High Impact Research Grant	This study is funded by the Ministry of Education High Impact Research Grant (H-20001-00-E2000069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2006, OTOLARYNG HEAD NECK, V135, P603, DOI 10.1016/j.otohns.2006.06.1252; Angelillo M, 2009, J Prev Med Hyg, V50, P26; Arffa RE, 2012, J VOICE, V26, P462, DOI 10.1016/j.jvoice.2011.04.006; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bassi IB, 2011, J VOICE, V25, P192, DOI 10.1016/j.jvoice.2009.10.013; Behlau M, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.09.010; Behrens T, 2004, METHOD INFORM MED, V43, P505; Charn TC, 2012, J VOICE, V26, pE141, DOI 10.1016/j.jvoice.2011.05.004; Chen SH, 2010, J VOICE, V24, P183, DOI 10.1016/j.jvoice.2008.07.008; Costa T, 2013, CODAS, V25, P482, DOI 10.1590/S2317-17822013000500013; Cutiva LCC, 2013, J COMMUN DISORD, V46, P143, DOI 10.1016/j.jcomdis.2013.01.001; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hogikyan ND, 2002, OTOLARYNG HEAD NECK, V126, P562, DOI 10.1067/mhn.2002.124850; Hsiung MW, 2002, EUR ARCH OTO-RHINO-L, V259, P97, DOI 10.1007/s004050100405; Kooijman PGC, 2006, FOLIA PHONIATR LOGO, V58, P159, DOI 10.1159/000091730; Lam PKY, 2006, LARYNGOSCOPE, V116, P1192, DOI 10.1097/01.mlg.0000224539.41003.93; Larsen JB, 2008, LANG SPEECH HEAR SER, V39, P451, DOI 10.1044/0161-1461(2008/07-0032); Martins RH, 2014, J VOICE; Mattiske JA, 1998, J VOICE, V12, P489, DOI 10.1016/S0892-1997(98)80058-1; Ministry of Education, 2010, MAL ED STAT 2010; Moy FM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-611; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Nunez-Batalla F, 2007, ACTA OTORRINOLAR ESP, V58, P386, DOI 10.1016/S0001-6519(07)74954-3; Romak JJ, 2014, J VOICE, V28, P237, DOI 10.1016/j.jvoice.2013.07.015; Rosen CA, 2004, LARYNGOSCOPE, V114, P1549, DOI 10.1097/00005537-200409000-00009; Roy N, 2004, J SPEECH LANG HEAR R, V47, P281, DOI 10.1044/1092-4388(2004/023); Roy N, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/050); Roy N, 2003, J SPEECH LANG HEAR R, V46, P670, DOI 10.1044/1092-4388(2003/053); Sampaio MC, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.06.003; Shoeib RM, 2012, EGYPT J OTOLARYNGOL, V28, P142, DOI 10.7123/01.EJO.0000413577.72909.80; Sliwinska-Kowalska M, 2006, FOLIA PHONIATR LOGO, V58, P85, DOI 10.1159/000089610; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tavares ELM, 2007, J VOICE, V21, P407, DOI 10.1016/j.jvoice.2006.04.001; Thibeault SL, 2004, ANN EPIDEMIOL, V14, P786, DOI 10.1016/j.annepidem.2004.03.004; Titze IR, 1997, J VOICE, V11, P254, DOI 10.1016/S0892-1997(97)80002-1; van Houtte E, 2012, LOGOP PHONIATR VOCO, V37, P107, DOI 10.3109/14015439.2012.660499; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams NR, 2003, OCCUP MED-OXFORD, V53, P456, DOI 10.1093/occmed/kqg113	38	17	19	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141963	10.1371/journal.pone.0141963	http://dx.doi.org/10.1371/journal.pone.0141963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540291	gold, Green Submitted, Green Published			2022-12-27	WOS:000364303800037
J	van der Slik, FWP; van Hout, RWNM; Schepens, JJ				van der Slik, Frans W. P.; van Hout, Roeland W. N. M.; Schepens, Job J.			The Gender Gap in Second Language Acquisition: Gender Differences in the Acquisition of Dutch among Immigrants from 88 Countries with 49 Mother Tongues	PLOS ONE			English	Article							MALE-FEMALE DIFFERENCES; SEX-DIFFERENCES; LANGUAGE; COMPREHENSION; PROFICIENCY; SCIENCE; ACCULTURATION; METAANALYSIS; STRATEGIES; VOCABULARY	Gender differences were analyzed across countries of origin and continents, and across mother tongues and language families, using a large-scale database, containing information on 27,119 adult learners of Dutch as a second language. Female learners consistently outperformed male learners in speaking and writing proficiency in Dutch as a second language. This gender gap remained remarkably robust and constant when other learner characteristics were taken into account, such as education, age of arrival, length of residence and hours studying Dutch. For reading and listening skills in Dutch, no gender gap was found. In addition, we found a general gender by education effect for all four language skills in Dutch for speaking, writing, reading, and listening. Female language learners turned out to profit more from higher educational training than male learners do in adult second language acquisition. These findings do not seem to match nurture-oriented explanatory frameworks based for instance on a human capital approach or gender-specific acculturation processes. Rather, they seem to corroborate a nature-based, gene-environment correlational framework in which language proficiency being a genetically-influenced ability interacting with environmental factors such as motivation, orientation, education, and learner strategies that still mediate between endowment and acquiring language proficiency at an adult stage.	[van der Slik, Frans W. P.; van Hout, Roeland W. N. M.] Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands; [Schepens, Job J.] Max Planck Inst Human Dev, Berlin, Germany	Radboud University Nijmegen; Max Planck Society	van der Slik, FWP (corresponding author), Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands.	f.v.d.slik@let.ru.nl	Schepens, Job/HHS-5741-2022; Schepens, Job/AAB-8753-2019	Schepens, Job/0000-0003-1271-2526				Ambridge B, 2010, DEV PSYCHOL, V46, P1497, DOI 10.1037/a0020668; [Anonymous], 1996, ARE GIRLS BETTER REA; BACON SM, 1992, MOD LANG J, V76, P160, DOI 10.2307/329769; BACON SMC, 1992, LANG LEARN, V42, P471, DOI 10.1111/j.1467-1770.1992.tb01041.x; Beiser M, 2000, CAN PUBLIC POL, V26, P311, DOI 10.2307/3552403; BOYLE JP, 1987, LANG LEARN, V37, P273, DOI 10.1111/j.1467-1770.1987.tb00568.x; Buchmann C, 2006, AM SOCIOL REV, V71, P515, DOI 10.1177/000312240607100401; BURSTALL C, 1975, EDUC RES, V17, P193, DOI 10.1080/0013188750170304; Carliner G, 2000, INT MIGR REV, V34, P158, DOI 10.2307/2676016; Cohen A.D., 2002, INTRO APPL LINGUISTI, P170; Cole NS, 1997, TS GENDER STUDY FEMA; Council of Europe, 2001, COMM EUR FRAM REF LA; Davies B., 2004, LANGUAGE LEARNING J, V29, P53, DOI DOI 10.1080/09571730485200111; de Bot K., 2005, 2 LANGUAGE ACQUISITI; de Bot K, 2007, BILING-LANG COGN, V10, P7, DOI 10.1017/S1366728906002732; Dediu D, 2001, HUM BIOL, V83, P279; Dornyei Z., 2001, MOTIVATION 2 LANGUAG, V23, P399; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Duff P.A., 2013, ROUTLEDGE HDB 2 LANG, P428; Ellis R., 1994, STUDY 2 LANGUAGE ACQ; Estabrooke IV, 2002, BRAIN LANG, V83, P143; FARHADY H, 1982, TESOL QUART, V16, P43, DOI 10.2307/3586562; Finnie R, 2005, APPL ECON, V37, P1935, DOI 10.1080/00036840500244519; GAL S, 1978, LANG SOC, V7, P1, DOI 10.1017/S0047404500005303; Gal S, 1979, LANGUAGE SHIFT DETER; Gardner R.C., 1972, ATTITUDES MOTIVATION; Gardner RC, 1979, LANGUAGE SOCIAL PSYC, P287; Gobel P., 2006, SYSTEM, V34, P194, DOI DOI 10.1016/J.SYSTEM.2005.11.002; GOLDBERG P, 1968, TRANS-ACT-SOC SCI MO, V5, P28; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; GREEN JM, 1995, TESOL QUART, V29, P261, DOI 10.2307/3587625; Gu Yongqi, 2002, RELC J, V33, P35, DOI DOI 10.1177/003368820203300102; Halpern D. F., 2002, SEX DIFFERENCES COGN; Heck RH, 2010, QUANT METH SER, P1; Herschensohn J., 2013, CAMBRIDGE HDB 2 LANG; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Jiang M, 2009, J MULTILING MULTICUL, V30, P481, DOI 10.1080/01434630903147898; Kidd E, 2008, DEVELOPMENTAL SCI, V11, P882, DOI 10.1111/j.1467-7687.2008.00744.x; Kimura Doreen, 1999, SEX COGNITION; Krashen S. D., 1982, PRINCIPLES PRACTICE; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Kuijper H, 2004, STAATSEXAMEN NT2 GEW; LarsenFreeman D, 1997, APPL LINGUIST, V18, P141, DOI 10.1093/applin/18.2.141; Lietz P., 2006, STUDIES ED EVALUATIO, V32, P317, DOI DOI 10.1016/J.STUEDUC.2006.10.002; LUMSDEN KG, 1987, J ECON EDUC, V18, P365, DOI 10.2307/1182118; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Masgoret AM, 2003, LANG LEARN, V53, P167, DOI 10.1111/1467-9922.00227; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Narusyte J, 2008, DEV PSYCHOL, V44, P1591, DOI 10.1037/a0013911; Oxford Rebecca, 1990, LANGUAGE LEARNING ST; Pae T-l, 2004, SYSTEM, V32, P265, DOI [10.1016/j.system.2003.09.009, DOI 10.1016/J.SYSTEM.2003.09.009]; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Polat N, 2010, J LANG IDENTITY EDUC, V9, P17, DOI 10.1080/15348450903476832; RAMER ALH, 1976, J CHILD LANG, V3, P49, DOI 10.1017/S0305000900001306; Rosen M, 2001, READ WRIT, V14, P1, DOI 10.1023/A:1007995107442; Rua P.L., 2006, PORTA LINGUARUM, V6, P99, DOI DOI 10.1353/PLA.2006.0014; RUBIN J, 1994, MOD LANG J, V78, P199, DOI 10.2307/329010; Saville-Troike M., 2005, INTRO 2 LANGUAGE ACQ; Schepens JJ, LANGUAGE LE IN PRESS; Schepens J, 2013, LANG DYN CHANG, V3, P218, DOI 10.1163/22105832-13030203; Schumann J., 1978, 2 LANGUAGE ACQUISITI, P27; Spezzini S., 2004, INT J BILING EDUC BI, V7, P412, DOI [DOI 10.1080/13670050408667823, 10.1080/13670050408667823]; Stevens G, 1999, LANG SOC, V28, P555; Stromswold K, 2001, LANGUAGE, V77, P647, DOI 10.1353/lan.2001.0247; THOMPSON I, 1991, LANG LEARN, V41, P177, DOI 10.1111/j.1467-1770.1991.tb00683.x; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman MT, 2002, BRAIN LANG, V83, P141; Van der Silk FWP, 2010, STUD SECOND LANG ACQ, V32, P401, DOI 10.1017/S0272263110000021; Verhelst N. D., 1995, ONE PARAMETER LOGIST; Vinkhuyzen AAE, 2010, GENES BRAIN BEHAV, V9, P276, DOI 10.1111/j.1601-183X.2009.00554.x; Walstad WB, 1997, J ECON EDUC, V28, P155, DOI 10.2307/1182910; Willingham W. W., 1997, GENDER FAIR ASSESSME; World Economic Forum, 2014, GLOBAL GENDER GAP RE; Young D., 1997, APPL LANGUAGE LEARNI, V8, P43	77	51	52	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142056	10.1371/journal.pone.0142056	http://dx.doi.org/10.1371/journal.pone.0142056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540465	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800048
J	Binka, M; Paintsil, E; Patel, A; Lindenbach, BD; Heimer, R				Binka, Mawuena; Paintsil, Elijah; Patel, Amisha; Lindenbach, Brett D.; Heimer, Robert			Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume	PLOS ONE			English	Article							INJECTION EQUIPMENT; HCV INFECTION; RISK; HIV; TRANSMISSION; EPIDEMIOLOGY; PEOPLE; DRUGS	Background Many people who inject drugs (PWID) use syringes with detachable needles, which have high dead space (HDS). Contaminated HDS blood may substantially contribute to the transmission of HIV, hepatitis C (HCV), and other blood-borne viruses within this population. Newly designed low dead space (LDS) syringe-needle combinations seek to reduce blood-borne virus transmission among PWID. We evaluated the infectivity of HCV-contaminated residual volumes recovered from two LDS syringe-needle combinations. Methods We tested two different design approaches to reducing the dead space. One added a piston to the plunger; the other reduced the dead space within the needle. The two approaches cannot be combined. Recovery of genotype-2a reporter HCV from LDS syringe-needle combinations was compared to recovery from insulin syringes with fixed needles and standard HDS syringe-needle combinations. Recovery of HCV from syringes was determined immediately following their contamination with HCV-spiked plasma, after storage at 22 degrees C for up to 1 week, or after rinsing with water. Results Insulin syringes with fixed needles had the lowest proportion of HCV-positive syringes before and after storage. HCV recovery after immediate use ranged from 47%+/- 4% HCV-positive 1 mL insulin syringes with 27-gauge 1/2 inch needles to 98%+/- 1% HCV-positive HDS 2 mL syringes with 23-gauge 11/4 inch detachable needles. LDS combinations yielded recoveries ranging from 65%+/- 5% to 93%+/- 3%. Recovery was lower in combinations containing LDS needles than LDS syringes. After 3 days of storage, as much as 6-fold differences in virus recovery was observed, with HCV recovery being lower in combinations containing LDS needles. Most combinations with detachable needles required multiple rinses to reduce HCV infectivity to undetectable levels whereas a single rinse of insulin syringes was sufficient. Conclusions Our study, the first to assess the infectivity of HCV in residual volumes of LDS syringes and needles available to PWID, demonstrates that LDS syringe-needle combination still has the greater potential for HCV transmission than insulin syringes with fixed needles. Improved LDS designs may be able to further reduce HCV recovery, but based on the designed tested, LDS needles and syringes remain intermediate between fixed-needle syringes and HDS combinations in reducing exposure to HCV.	[Binka, Mawuena; Paintsil, Elijah; Patel, Amisha; Heimer, Robert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Paintsil, Elijah] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Paintsil, Elijah] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Paintsil, Elijah; Heimer, Robert] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Heimer, R (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	robert.heimer@yale.edu		Binka, Mawuena/0000-0002-9370-1708	US National Institute on Drug Abuse [1R01DA030420]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030420] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This work was funded by the US National Institute on Drug Abuse 1R01DA030420 to RH, Grant Title: Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HEP C HDB DORCHESTER; Binka M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv017; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; De P, 2008, J VIRAL HEPATITIS, V15, P279, DOI 10.1111/j.1365-2893.2007.00942.x; Doerrbecker J, 2013, J VIRAL HEPATITIS, V20, P478, DOI 10.1111/jvh.12055; Ellendon N., HEPATITIS C COUNSELI; Gray R, 2012, RAPID ASSESSMENT NEE; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Ibragimov U, 2012, NEEDLE SYRINGE TYPES; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Paintsil E, 2014, J INFECT DIS, V209, P1205, DOI 10.1093/infdis/jit648; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Paintsil E, 2009, ADDICTION, V104, P1881, DOI 10.1111/j.1360-0443.2009.02687.x; Palmateer N, 2014, J VIRAL HEPATITIS, V21, P25, DOI 10.1111/jvh.12117; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sigma-Aldrich, SYR NEEDL GAUG CHART; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Zule WA, 1997, J ACQ IMMUN DEF SYND, V14, P294; Zule WA, 1997, J ACQ IMMUN DEF SYND, V16, P309, DOI 10.1097/00042560-199712010-00015; Zule WA, 2013, INT J DRUG POLICY, V24, P1, DOI 10.1016/j.drugpo.2012.07.002; Zule WA, 2009, DRUG ALCOHOL DEPEN, V100, P204, DOI 10.1016/j.drugalcdep.2008.08.017	26	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139737	10.1371/journal.pone.0139737	http://dx.doi.org/10.1371/journal.pone.0139737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536599	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400011
J	Boyle, SA; Roberts, B; Pope, BM; Blake, MR; Leavelle, SE; Marshall, JJ; Smith, A; Hadicke, A; Falcone, JF; Knott, K; Kouba, AJ				Boyle, Sarah A.; Roberts, Beth; Pope, Brittany M.; Blake, Margaret R.; Leavelle, Stephen E.; Marshall, Jennifer J.; Smith, Andrew; Hadicke, Amanda; Falcone, Josephine F.; Knott, Katrina; Kouba, Andrew J.			Assessment of Flooring Renovations on African Elephant (Loxodonta africana) Behavior and Glucocorticoid Response	PLOS ONE			English	Article							NOCTURNAL BEHAVIOR; CAPTIVE ELEPHANTS; SERUM CORTISOL; ASIAN ELEPHANT; ZOO ELEPHANTS; WALKING RATES; NATIONAL-PARK; STRESS; MAXIMUS; ENDOCRINOLOGY	Captive African (Loxodonta africana) and Asian (Elephas maximus) elephants can experience foot pathologies and arthritis. As a preventative measure against these pathologies and to alleviate the potential discomfort due to concrete substrates, some zoological institutions have renovated elephant housing to increase the amount of natural or shock-absorbent substrates. The objective of this study was to compare behavioral (diurnal and nocturnal) and glucorticoid (e.g., serum cortisol) responses of three female African elephants before, during, and after renovation to their indoor housing floor to assess whether renovations had short-term effects on the elephants' behavior and stress physiology. Behavioral data were collected using scan-sampling methods, and activity budgets were constructed for each of the three elephants. In addition, the duration of all lying rest activities were recorded. Weekly serum cortisol concentrations were determined with enzyme immunoassay (EIA). Overall, eating was the most prevalent behavior exhibited outdoors during the day, while resting (either in a lying or standing position) were most common during the indoor, nocturnal periods. Although variation existed among the three elephants, all three females spent significantly more time walking and less time eating during the day after the completion of the renovations. The extent to which the three elephants exhibited nocturnal lying rest behavior varied among the elephants, with the oldest elephant exhibiting the least amount (an average of 13.2 +/- 2.8% of the nightly behavioral scans) compared to the two younger elephants (an average of 34.5 +/- 2.1% and 56.6 +/- 2.8% of the nightly behavioral scans). There was a significant increase in lying rest behavior for one elephant and standing rest for a second elephant following renovations. Baseline cortisol concentrations prior to renovations were 3.0 +/- 0.4 ng/ml, 4.5 +/- 0.5 ng/ml, and 4.9 +/- 0.5 ng/ml for the three elephants. Cortisol concentrations remained baseline for two of the elephants throughout and after the renovation period, while one elephant that was pregnant had elevated cortisol during construction. Cortisol concentrations for the pregnant elephant remained higher than baseline once she was introduced to the new flooring and allowed back into the building, but these values were closer to the cortisol concentrations before renovations than during construction. Our findings demonstrate that individual elephants can vary in their behavioral and physiological responses to exhibit modifications. Given that the elephants walked more during the day, two of the three elephants had an increase in rest behavior during the night, and there were minimal changes in cortisol response after the flooring renovations, we conclude that the flooring renovations overall had a positive impact on animal welfare.	[Boyle, Sarah A.; Pope, Brittany M.; Blake, Margaret R.; Leavelle, Stephen E.; Marshall, Jennifer J.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Roberts, Beth; Smith, Andrew; Hadicke, Amanda; Falcone, Josephine F.; Knott, Katrina; Kouba, Andrew J.] Memphis Zool Soc, Conservat & Res Dept, Memphis, TN USA		Boyle, SA (corresponding author), Rhodes Coll, Dept Biol, Memphis, TN 38112 USA.	sarahannboyle@gmail.com	AICP, Jennifer J. Marshall,/DQS-9128-2022; Boyle, Sarah/AAQ-6815-2021		Institute of Museum and Library Service within Museums for America Division [IC-05-11-0252-11]; Memphis Zoological Society; Rhodes College	Institute of Museum and Library Service within Museums for America Division; Memphis Zoological Society; Rhodes College	Funding: Funding was provided by the Institute of Museum and Library Service (www.imls.gov) for the Collections Stewardship Grant within the Museums for America Division (grant #IC-05-11-0252-11). The Memphis Zoological Society (www.memphiszoo.org) and Rhodes College (www.rhodes.edu) also provided financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1980, APPL ANIM ETHOL, V6, P257, DOI 10.1016/0304-3762(80)90027-9; Ahlering MA, 2013, CONSERV BIOL, V27, P569, DOI 10.1111/cobi.12061; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; Brown JL, 2010, ZOO BIOL, V29, P274, DOI 10.1002/zoo.20268; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Buckley C, 2001, ELEPHANT'S FOOT, P53; Chosy J, 2014, ZOO BIOL, V33, P267, DOI 10.1002/zoo.21142; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Fanson KV, 2013, EUR J WILDLIFE RES, V59, P655, DOI 10.1007/s10344-013-0718-7; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Grand AP, 2012, APPL ANIM BEHAV SCI, V142, P69, DOI 10.1016/j.applanim.2012.09.002; Hodges Keith, 2010, P447; Horback KM, 2014, ZOO BIOL, V33, P403, DOI 10.1002/zoo.21160; Kelling A.S., 2008, THESIS GEORGIA I TEC; Kuhar CW, 2006, ZOO BIOL, V25, P339, DOI 10.1002/zoo.20089; Leggett K, 2008, PACHYDERM, P20; Leighty KA, 2009, ZOO BIOL, V28, P16, DOI 10.1002/zoo.20199; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; MCKNIGHT BL, 1995, AFR J ECOL, V33, P242, DOI 10.1111/j.1365-2028.1995.tb00802.x; Meller CL, 2007, ZOO BIOL, V26, P51, DOI 10.1002/zoo.20119; Menargues A, 2008, ANIM WELFARE, V17, P305; Meyer JM, 2004, GEN COMP ENDOCR, V138, P263, DOI 10.1016/j.ygcen.2004.06.010; Miller LJ, 2012, ANIM WELFARE, V21, P577, DOI 10.7120/09627286.21.4.577; Moreira N, 2001, ZOO BIOL, V20, P103, DOI 10.1002/zoo.1010; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Oliveira CA, 2008, RES VET SCI, V84, P361, DOI 10.1016/j.rvsc.2007.05.009; Posta B., 2013, INT J COMP PSYCHOL, V26, P37, DOI [DOI 10.46867/IJCP.2013.26.01.05, 10.46867/ijcp.2013.26.01.05]; Powell DM, 2006, ZOO BIOL, V25, P391, DOI 10.1002/zoo.20098; Roocroft A, 2001, ELEPHANT'S FOOT, P21; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; TOBLER I, 1992, SLEEP, V15, P1; Veasey J., 2006, International Zoo Yearbook, V40, P63, DOI 10.1111/j.1748-1090.2006.00063.x; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wiese RJ, 2004, ZOO BIOL, V23, P365, DOI 10.1002/zoo.20011; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; Wilson ML, 2004, ANIM WELFARE, V13, P39; Woolley LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003233; Wyatt J. R., 1974, AFR J ECOL, V12, P273, DOI DOI 10.1111/J.1365-2028.1974.TB01037.X.; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; [No title captured]	45	13	13	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141009	10.1371/journal.pone.0141009	http://dx.doi.org/10.1371/journal.pone.0141009			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535582	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400049
J	Cusack, M; Vezenkova, N; Gottschalk, C; Calin-Jageman, RJ				Cusack, Margaret; Vezenkova, Nadya; Gottschalk, Christopher; Calin-Jageman, Robert J.			Direct and Conceptual Replications of Burgmer & Englich (2012): Power May Have Little to No Effect on Motor Performance	PLOS ONE			English	Article							INCREASES; SUPERSTITION; EXPERIENCE	Burgmer and Englich (2012) have reported that manipulating feelings of power can substantially improve performance on two motor tasks: golf and darts. We conducted two high-powered direct replications of the effects of power on golf, two online conceptual replications using mirror-tracing as a performance measure, and an additional conceptual replication using a cognitive performance measure (word-search). Overall, we found little to no effect of power on motor skill (d = 0.09, 95% CI[-0.07, 0.22], n = 603). We varied task difficulty, re-analyzed data without participants showing weak responses on manipulation checks, and tried adjusting performance scores for age, gender, and initial task skill. None of these secondary analyses revealed a strong effect of power on performance. A meta-analysis integrating our data with Burgmer & Englich leaves open the possibility that manipulating power could provide a modest boost in motor skill (d = 0.19, 95% CI [0.001, 0.38], n = 685). Unfortunately, the pattern of performance changes we observed was unrelated to group differences in perceived and rated power, suggesting that what motor effects do occur with this protocol may not be directly related to the construct of power. [Burgmer, P., & Englich, B. (2012). Bullseye!: How Power Improves Motor Performance. Social Psychological and Personality Science, 4(2), 224-232.]	[Cusack, Margaret; Vezenkova, Nadya; Gottschalk, Christopher; Calin-Jageman, Robert J.] Dominican Univ, Dept Psychol, River Forest, IL 60305 USA		Calin-Jageman, RJ (corresponding author), Dominican Univ, Dept Psychol, River Forest, IL 60305 USA.	rcalinjageman@dom.edu	Calin-Jageman, Robert/K-1311-2019	Calin-Jageman, Robert/0000-0002-9837-6529				Acton JD, HIST ESSAYS STUDIES; Anderson C, 2006, EUR J SOC PSYCHOL, V36, P511, DOI 10.1002/ejsp.324; Burgmer P, 2013, SOC PSYCHOL PERS SCI, V4, P224, DOI 10.1177/1948550612452014; Calin-Jageman RJ, 2014, SOC PSYCHOL-GERMANY, V45, P239, DOI 10.1027/1864-9335/a000190; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Chen S, 2001, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514.80.2.173, DOI 10.1037/0022-3514.80.2.173]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Cumming G., 2013, UNDERSTANDING NEW ST; Damisch L, 2010, PSYCHOL SCI, V21, P1014, DOI 10.1177/0956797610372631; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Gigerenzer G., 1993, HDB DATA ANAL BEHAV, V1, P311, DOI DOI 10.1093/ACPROF:OSO/9780195153729.003.0013; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gravelin CR, 2010, IMPACT POWER COMMUNA; Guinote A, 2008, J PERS SOC PSYCHOL, V95, P237, DOI 10.1037/a0012518; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; Guinote A, 2007, PERS SOC PSYCHOL B, V33, P1076, DOI 10.1177/0146167207301011; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Karremans JC, 2010, PERS SOC PSYCHOL B, V36, P1010, DOI 10.1177/0146167210376761; Kifer Y, 2013, PSYCHOL SCI, V24, P280, DOI 10.1177/0956797612450891; Klein R., 2014, J OPEN PSYCHOL DATA, V2, pE4, DOI [10.5334/jopd.ad, DOI 10.5334/J0PD.AD]; Lammers J, 2013, J EXP SOC PSYCHOL, V49, P776, DOI 10.1016/j.jesp.2013.02.008; Oppenheimer DM, 2009, JUDGM DECIS MAK, V4, P326; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Slabu L, 2010, J EXP SOC PSYCHOL, V46, P344, DOI 10.1016/j.jesp.2009.10.013; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Weick M, 2008, J PERS SOC PSYCHOL, V94, P956, DOI 10.1037/0022-3514.94.6.956; Wilkinson D, 2010, PSYCHON B REV, V17, P910, DOI 10.3758/PBR.17.6.910; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140806	10.1371/journal.pone.0140806	http://dx.doi.org/10.1371/journal.pone.0140806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26536592	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400038
J	Leroy, S; Hendrickson, M; Delque-Kolic, E; Vega, E; Dillmann, P				Leroy, Stephanie; Hendrickson, Mitch; Delque-Kolic, Emmanuelle; Vega, Enrique; Dillmann, Philippe			First Direct Dating for the Construction and Modification of the Baphuon Temple Mountain in Angkor, Cambodia	PLOS ONE			English	Article							RADIOCARBON; REINFORCEMENTS; AMS	Architecture represents key evidence of dynastic practice and change in the archaeological world. Chronologies for many important buildings and sequences, including the iconic temples of medieval Angkor in Cambodia, are based solely on indirect associations from inscriptions and architectural styles. The Baphuon temple, one of the last major buildings in Angkor without textual or scientifically-derived chronological evidence, is crucial both for the context and date of its construction and the period when its western facade was modified into a unique, gigantic Reclining Buddha. Its construction was part of a major dynastic change and florescence of the Hindu-Mahayana Buddhist state and the modification is the key evidence of Theravada Buddhist power after Angkor's decline in the 15th century. Using a newly-developed approach based on AMS radiocarbon dating to directly date four iron crampons integrated into the structure we present the first direct evidence for the history of the Baphuon. Comprehensive study of ferrous elements shows that both construction and modification were critically earlier than expected. The Baphuon can now be considered as the major temple associated with the imperial reformations and territorial consolidation of Suryavarman I (1010-1050 AD) for whom no previous building to legitimize his reign could be identified. The Theravada Buddhist modification is a hundred years prior to the conventional 16th century estimation and is not associated with renewed use of Angkor. Instead it relates to the enigmatic Ayutthayan occupation of Angkor in the 1430s and 40s during a major period of climatic instability. Accurately dating iron with relatively low carbon content is a decisive step to test long-standing assumptions about architectural histories and political processes for states that incorporated iron into buildings (e.g., Ancient Greece, medieval India). Furthermore, this new approach has the potential to revise chronologies related to iron consumption practices since the origins of ferrous metallurgy three millennia ago.	[Leroy, Stephanie; Vega, Enrique; Dillmann, Philippe] CEA Saclay, CNRS, LAPA, LMC IRAMAT NIMBE UMR3685 UMR5060, Gif Sur Yvette, France; [Hendrickson, Mitch] Univ Illinois, Dept Anthropol, Chicago, IL USA; [Delque-Kolic, Emmanuelle] CEA Saclay, CNRS, LMC14, Natl Platform,LSCE UMR8212, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CEA; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay	Leroy, S (corresponding author), CEA Saclay, CNRS, LAPA, LMC IRAMAT NIMBE UMR3685 UMR5060, Gif Sur Yvette, France.	stephanie.leroy@cea.fr			French National Research Agency (IRANGKOR) [ANR-14-CE31-0007]; Australian Research Council [DP0987878]	French National Research Agency (IRANGKOR)(French National Research Agency (ANR)); Australian Research Council(Australian Research Council)	Funding: Funding for this project was provided by the French National Research Agency (IRANGKOR project, ANR-14-CE31-0007), http://www.agence-nationale-recherche.fr/?Project=ANR-14-CE31-0007 (received the funding: SL) and the Australian Research Council Discovery Project (DP0987878), https://researchdata.ands.org.au/industries-angkor-material-centuries-ce/65492 (received the funding: MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aymonier E, 1904, GROUPE ANGKOR HIST; Buckley BM, 2014, QUATERNARY SCI REV, V95, P1, DOI 10.1016/j.quascirev.2014.04.022; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Charlton ME, 2012, J ARCHAEOL SCI, V39, P2280, DOI 10.1016/j.jas.2012.02.037; Coedes G, 1934, B ECOLE FRANCAISE EX, V34, P417; Coedes G., 1942, INSCRIPTIONS CAMBODG, V2; Cottereau E, 2007, RADIOCARBON, V49, P291, DOI 10.1017/S0033822200042211; Craddock PT, 2002, RADIOCARBON, V44, P717, DOI 10.1017/S0033822200032173; Dillmann P, 2007, J ARCHAEOL SCI, V34, P1810, DOI 10.1016/j.jas.2006.12.022; Dinsmoor William Bell, 1973, ARCHITECTURE ANCIENT; Disser A, 2014, J ARCHAEOL SCI, V42, P315, DOI 10.1016/j.jas.2013.10.034; Dumarcay J., 2001, CAMBODIAN ARCHITECTU; Evans D. C., 2007, THESIS; Freeman M, 1999, ANCIENT ANGKOR RIVER; Groslier Bernard Philippe, 1958, ANGKOR CAMBODGE 16 S; Hua Q, 2004, NUCL INSTRUM METH B, V223, P489, DOI 10.1016/j.nimb.2004.04.092; Leroy S, 2015, J ARCHAEOL SCI, V53, P190, DOI 10.1016/j.jas.2014.10.016; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Michell G, 1988, HINDU TEMPLE INTRO I; Mikaelian G, 2011, PENINSULE, V63, P5; Pages G, 2011, J ARCHAEOL SCI, V38, P1234, DOI 10.1016/j.jas.2010.12.017; Polkinghorne M, 2013, J ASIATIQUE, V301, P575; Pryce TO, 2014, J ARCHAEOL SCI, V47, P142, DOI 10.1016/j.jas.2014.04.009; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Royere P, 2005, B ECOLE FRANCAISE EX, P92; Royere P, 2006, NOTES ARCHITECTURALE, P245; Royere P, 1999, ARTS ASIATIQUES, V54, P153, DOI DOI 10.3406/arasi.1999.1441; Southworth WA, 2008, INTERPRETING SE ASIA, V2, P25; Stern Philippe., 1927, BAYON ANGKOR EVOLUTI; Uchida E, 2008, RADIOCARBON, V50, P437, DOI 10.1017/S0033822200053534; Vickery M., 1977, THESIS; Vickery M., 1977, JSS, V65, P1	34	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141052	10.1371/journal.pone.0141052	http://dx.doi.org/10.1371/journal.pone.0141052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535895	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400050
J	Nishino, K; Kushima, M; Matsuo, Y; Matsuo, Y; Kawamukai, M				Nishino, Kohei; Kushima, Misaki; Matsuo, Yuzy; Matsuo, Yasuhiro; Kawamukai, Makoto			Cell Lysis in S-pombe ura4 Mutants Is Suppressed by Loss of Functional Pub1, Which Regulates the Uracil Transporter Fur4	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; SCHIZOSACCHAROMYCES-POMBE; DOWN-REGULATION; PERMEASE; GENE; ENDOCYTOSIS; TRAFFICKING; DEGRADATION; EXPRESSION; CLONING	Schizosaccharomyces pombe Delta ura4 cells lyse when grown on YPD medium. A S. pombe non-essential gene deletion library was screened to determine suppressors of the lysis phenotype. Deletion of the pub1 gene, which encoded E3 ubiquitin ligase, strongly suppressed cell lysis in Delta ura4 cells. The Delta pub1 cells displayed high sensitivity to 5-fluorouracil, a toxic analog of uracil, and this sensitivity was suppressed by deletion of fur4, which encoded a uracil transporter. Fur4 localized primarily to the Golgi apparatus and vacuoles in wild-type cells, but localization was predominantly at the plasma membrane in Delta pub1 cells. Fur4 was necessary for the utilization of extracellular uracil, cytosine, or UMP. Uracil uptake activity increased in the Delta pub1 strain in a Fur4-dependent manner. In addition, uracil starvation was critical for induction of cell lysis of Delta ura4 strains and uracil supplementation suppressed lysis. In summary, the increased uracil uptake ability of Delta pub1 cells, where Fur4 was predominantly localized to the plasma membrane, resulted in suppression of cell lysis in the Delta ura4 background.	[Nishino, Kohei; Kushima, Misaki; Matsuo, Yuzy; Matsuo, Yasuhiro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan	Shimane University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimanen-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Matsuo, Yasuhiro/AAT-6220-2021	Kawamukai, Makoto/0000-0003-2929-8798; Matsuo, Yasuhiro/0000-0002-2858-7179	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25660059]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by #25660059, the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; CHEVALLIER MR, 1982, MOL CELL BIOL, V2, P977, DOI 10.1128/MCB.2.8.977; CHEVALLIER MR, 1982, EMBO J, V1, P375, DOI 10.1002/j.1460-2075.1982.tb01177.x; De Montigny J, 1998, YEAST, V14, P1051, DOI 10.1002/(SICI)1097-0061(199808)14:11<1051::AID-YEA287>3.0.CO;2-1; Egel R, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P1; Fang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085238; GALAN JM, 1994, BIOCHEM BIOPH RES CO, V201, P769, DOI 10.1006/bbrc.1994.1767; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099038; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kato H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080572; Kawamukai M, 2016, BIOSCI BIOTECH BIOCH, V80, P23, DOI 10.1080/09168451.2015.1065172; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kitamura K, 2012, EUKARYOT CELL, V11, P302, DOI 10.1128/EC.05253-11; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; MORENO S, 1991, P795; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Seron K, 1999, J BACTERIOL, V181, P1793; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; Tamai KK, 2002, J CELL SCI, V115, P1847; Tanae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030472; Tanaka N, 2001, YEAST, V18, P745, DOI 10.1002/yea.725	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141796	10.1371/journal.pone.0141796	http://dx.doi.org/10.1371/journal.pone.0141796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536126	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400088
J	Yokoo, M; Kubota, Y; Motoyama, K; Higashi, T; Taniyoshi, M; Tokumaru, H; Nishiyama, R; Tabe, Y; Mochinaga, S; Sato, A; Sueoka-Aragane, N; Sueoka, E; Arima, H; Irie, T; Kimura, S				Yokoo, Masako; Kubota, Yasushi; Motoyama, Keiichi; Higashi, Taishi; Taniyoshi, Masatoshi; Tokumaru, Hiroko; Nishiyama, Rena; Tabe, Yoko; Mochinaga, Sakiko; Sato, Akemi; Sueoka-Aragane, Naoko; Sueoka, Eisaburo; Arima, Hidetoshi; Irie, Tetsumi; Kimura, Shinya			2-Hydroxypropyl-beta-Cyclodextrin Acts as a Novel Anticancer Agent	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; METHYL-BETA-CYCLODEXTRIN; TYROSINE KINASE INHIBITOR; LIPID RAFTS; BCR-ABL; CELL-LINE; CHOLESTEROL DEPLETION; MYELOGENOUS LEUKEMIA; CANCER-CELLS; IN-VIVO	2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) is a cyclic oligosaccharide that is widely used as an enabling excipient in pharmaceutical formulations, but also as a cholesterol modifier. HP-beta-CyD has recently been approved for the treatment of Niemann-Pick Type C disease, a lysosomal lipid storage disorder, and is used in clinical practice. Since cholesterol accumulation and/or dysregulated cholesterol metabolism has been described in various malignancies, including leukemia, we hypothesized that HP-beta-CyD itself might have anticancer effects. This study provides evidence that HP-beta-CyD inhibits leukemic cell proliferation at physiologically available doses. First, we identified the potency of HP-beta-CyD in vitro against various leukemic cell lines derived from acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia (CML). HP-beta-CyD treatment reduced intracellular cholesterol resulting in significant leukemic cell growth inhibition through G(2)/M cell-cycle arrest and apoptosis. Intraperitoneal injection of HP-beta-CyD significantly improved survival in leukemia mouse models. Importantly, HP-beta-CyD also showed anticancer effects against CML cells expressing a T315I BCR-ABL mutation (that confers resistance to most ABL tyrosine kinase inhibitors), and hypoxia-adapted CML cells that have characteristics of leukemic stem cells. In addition, colony forming ability of human primary AML and CML cells was inhibited by HP-beta-CyD. Systemic administration of HP-beta-CyD to mice had no significant adverse effects. These data suggest that HP-beta-CyD is a promising anticancer agent regardless of disease or cellular characteristics.	[Yokoo, Masako; Kubota, Yasushi; Sato, Akemi; Sueoka-Aragane, Naoko; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Kubota, Yasushi; Sueoka, Eisaburo] Saga Univ Hosp, Dept Transfus Med, Saga, Japan; [Motoyama, Keiichi; Higashi, Taishi; Taniyoshi, Masatoshi; Tokumaru, Hiroko; Nishiyama, Rena; Arima, Hidetoshi; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Tabe, Yoko] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo 113, Japan; [Mochinaga, Sakiko] Saga Univ Hosp, Dept Pharm, Saga, Japan; [Sueoka, Eisaburo] Saga Univ, Fac Med, Dept Clin Lab Med, Saga 840, Japan; [Arima, Hidetoshi; Irie, Tetsumi] Kumamoto Univ, HIGO Program, Program Leading Grad Sch, Kumamoto, Japan	Saga University; Saga University; Kumamoto University; Juntendo University; Saga University; Saga University; Kumamoto University	Kubota, Y (corresponding author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan.	kubotay@cc.saga-u.ac.jp		Irie, Tetsumi/0000-0001-8664-7048	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25670452]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research 25670452 (YK) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Banker DE, 2004, BLOOD, V104, P1816, DOI 10.1182/blood-2004-01-0395; Bearss DJ, 2002, CANCER RES, V62, P2077; Caliceti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041246; Chien YH, 2013, MOL GENET METAB, V109, P231, DOI 10.1016/j.ymgme.2013.04.003; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; De Beule K, 2001, DRUGS, V61, P27, DOI 10.2165/00003495-200161001-00003; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P44, DOI 10.1016/0005-2736(74)90331-9; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fromming KH, 1996, BUDAPEST, P33; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Ghalaut VS, 2006, CLIN CHIM ACTA, V366, P239, DOI 10.1016/j.cca.2005.10.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Hinzey AH, 2012, INDIAN J BIOCHEM BIO, V49, P329; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Kitaura J, 2007, J IMMUNOL, V178, P455, DOI 10.4049/jimmunol.178.1.455; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kuroda J, 2003, BLOOD, V102, P2229, DOI 10.1182/blood-2003-01-0305; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maksumova L, 2000, LEUKEMIA, V14, P1444, DOI 10.1038/sj.leu.2401856; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Matsuo M, 2013, MOL GENET METAB, V109, P233, DOI 10.1016/j.ymgme.2013.04.010; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Minden MD, 2001, LEUKEMIA LYMPHOMA, V40, P659, DOI 10.3109/10428190109097663; Motoyama K, 2009, BIOL PHARM BULL, V32, P700, DOI 10.1248/bpb.32.700; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Naito H, 2006, LEUKEMIA RES, V30, P1443, DOI 10.1016/j.leukres.2006.01.006; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Onodera R, 2013, INT J PHARMACEUT, V452, P116, DOI 10.1016/j.ijpharm.2013.04.071; Onodera R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01104; Orlandi L, 1999, BRIT J CANCER, V81, P252, DOI 10.1038/sj.bjc.6690685; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; PEGORARO L, 1983, J NATL CANCER I, V70, P447; Perl A, 2011, J CLIN INVEST, V121, P22, DOI 10.1172/JCI43605; Plazzo AP, 2012, CHEM PHYS LIPIDS, V165, P505, DOI 10.1016/j.chemphyslip.2012.03.007; Ricci C, 2002, CANCER RES, V62, P5995; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rudling M, 1998, AM J PATHOL, V153, P1923, DOI 10.1016/S0002-9440(10)65706-9; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Slavova-Azmanova NS, 2014, BIOCHEM J, V459, P455, DOI 10.1042/BJ20130903; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Tabe Y, 2012, LEUKEMIA, V26, P883, DOI 10.1038/leu.2011.291; Takeuchi M, 2010, CELL DEATH DIFFER, V17, P1211, DOI 10.1038/cdd.2010.6; Tanaka Y, 2015, BIOL PHARM BULL, V38, P844, DOI 10.1248/bpb.b14-00726; Tilbrook PA, 2001, CANCER RES, V61, P2453; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; VITOLS S, 1994, BLOOD, V84, P2689; Vitols S, 1997, LIPIDS, V32, P255, DOI 10.1007/s11745-997-0032-1; Wakeling AE, 2002, CANCER RES, V62, P5749; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wu Q, 2002, J BIOL CHEM, V277, P36329, DOI 10.1074/jbc.M204962200; Yan J, 2012, ANTI-CANCER DRUG, V23, P22, DOI 10.1097/CAD.0b013e32834a099c; Yang WC, 2001, CANCER RES, V61, P565; Yokoo M, 2015, BIOL PHARM BULL, V38, P411, DOI 10.1248/bpb.b14-00652; Yunomae K, 2003, FEBS LETT, V536, P225, DOI 10.1016/S0014-5793(03)00059-0	76	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141946	10.1371/journal.pone.0141946	http://dx.doi.org/10.1371/journal.pone.0141946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535909	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400104
J	Tricoire, H; Rera, M				Tricoire, Herve; Rera, Michael			A New, Discontinuous 2 Phases of Aging Model: Lessons from Drosophila melanogaster	PLOS ONE			English	Article							INTESTINAL BARRIER; RISK	Aging is commonly described as being a continuous process affecting progressively organisms as time passes. This process results in a progressive decrease in individuals fitness through a wide range of both organismal-decreased motor activity, fertility, resistance to stress-and molecular phenotypes-decreased protein and energy homeostasis, impairment of insulin signaling. In the past 20 years, numerous genes have been identified as playing a major role in the aging process, yet little is known about the events leading to that loss of fitness. We recently described an event characterized by a dramatic increase of intestinal permeability to a blue food dye in aging flies committed to die within a few days. Importantly, flies showing this so called `Smurf' phenotype are the only ones, among a population, to show various age-related changes and exhibit a high-risk of impending death whatever their chronological age. Thus, these observations suggest that instead of being one continuous phenomenon, aging may be a discontinuous process well described by at least two distinguishable phases. In this paper we addressed this hypothesis by implementing a new 2 Phases of Aging mathematiCal model (2PAC model) to simulate longevity curves based on the simple hypothesis of two consecutive phases of lifetime presenting different properties. We first present a unique equation for each phase and discuss the biological significance of the 3 associated parameters. Then we evaluate the influence of each parameter on the shape of survival curves. Overall, this new mathematical model, based on simple biological observations, is able to reproduce many experimental longevity curves, supporting the existence of 2 phases of aging exhibiting specific properties and separated by a dramatic transition that remains to be characterized. Moreover, it indicates that Smurf survival can be approximated by one single constant parameter for a broad range of genotypes that we have tested under our environmental conditions.	[Tricoire, Herve; Rera, Michael] Univ Paris Diderot, UMR8251, Lab Degenerat Proc Stress & Aging, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Rera, M (corresponding author), Univ Paris Diderot, UMR8251, Lab Degenerat Proc Stress & Aging, F-75013 Paris, France.	michael.rera@univ-paris-diderot.fr	Rera, Michael/AAS-5456-2021; TRICOIRE, Herve/AAP-7889-2020	Rera, Michael/0000-0002-6574-6511; TRICOIRE, Herve/0000-0001-9404-5282				Coburn C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001613; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Frechet M, 1927, ANN SOC POLON MATH; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARRIS CE, 1992, INTENS CARE MED, V18, P38, DOI 10.1007/BF01706424; Horne BD, 2009, AM J MED, V122, P550, DOI 10.1016/j.amjmed.2008.10.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Medawar PB, 1952, MED J AUSTRALIA, V1, P854; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Pearl R, 1922, THE BIOL DEATH; Pinto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107541; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Sandek A, 2008, CURR OPIN CLIN NUTR, V11, P632, DOI 10.1097/MCO.0b013e32830a4c6e; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	21	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141920	10.1371/journal.pone.0141920	http://dx.doi.org/10.1371/journal.pone.0141920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528826	Green Published, Green Submitted, gold			2022-12-27	WOS:000364032600077
J	Lim, YM; Yagi, Y; Tsuda, L				Lim, Young-Mi; Yagi, Yoshimasa; Tsuda, Leo			Cellular Defense and Sensory Cell Survival Require Distinct Functions of ebi in Drosophila	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; COREPRESSOR COMPLEX; SIGNALING PATHWAYS; DOWN-REGULATION; GENE; ACTIVATION; REPRESSION; RECEPTOR; PROTEIN	The innate immune response and stress-induced apoptosis are well-established signaling pathways related to cellular defense. NF-kappa B and AP-1 are redox-sensitive transcription factors that play important roles in those pathways. Here we show that Ebi, a Drosophila homolog of the mammalian co-repressor molecule transducin beta-like 1 (TBL1), variously regulates the expression of specific genes that are targets of redox-sensitive transcription factors. In response to different stimuli, Ebi activated gene expression to support the acute immune response in fat bodies, whereas Ebi repressed genes that are involved in apoptosis in photoreceptor cells. Thus, Ebi seems to act as a regulatory switch for genes that are activated or repressed in response to different external stimuli. Our results offer clear in vivo evidence that the Ebi-containing co-repressor complex acts in a distinct manner to regulate transcription that is required for modulating the output of various processes during Drosophila development.	[Lim, Young-Mi; Tsuda, Leo] NCGG, Ctr Dev Adv Med Dementia CAMD, Anim Models Aging Project Team, Obu, Aichi, Japan; [Yagi, Yoshimasa] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan	Nagoya University	Tsuda, L (corresponding author), NCGG, Ctr Dev Adv Med Dementia CAMD, Anim Models Aging Project Team, Obu, Aichi, Japan.	ltsuda@ncgg.go.jp						Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Berger I, 1998, GENE, V211, P375, DOI 10.1016/S0378-1119(98)00120-6; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Guenther MG, 2000, GENE DEV, V14, P1048; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; HSU JC, 1993, CANCER RES, V53, P3789; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Lim YM, 2013, GENES CELLS, V18, P909, DOI 10.1111/gtc.12088; Lim YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037028; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Piette J, 1997, BIOL CHEM, V378, P1237; Pott J, 2012, EMBO REP, V13, P684, DOI 10.1038/embor.2012.96; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Yagi Y, 2005, EMBO REP, V6, P1088, DOI 10.1038/sj.embor.7400542; Yagi Y, 2013, GENES CELLS, V18, P934, DOI 10.1111/gtc.12085; Yan JH, 2007, MOL ENDOCRINOL, V21, P1630, DOI 10.1210/me.2007-0072; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	44	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141457	10.1371/journal.pone.0141457	http://dx.doi.org/10.1371/journal.pone.0141457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524764	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800009
J	Feng, JL; Dai, ZY; Zhang, YP; Meng, L; Ye, J; Ma, XT				Feng, Junli; Dai, Zhiyuan; Zhang, Yanping; Meng, Lu; Ye, Jian; Ma, Xuting			Alteration of Gene Expression Profile in Kidney of Spontaneously Hypertensive Rats Treated with Protein Hydrolysate of Blue Mussel (Mytilus edulis) by DNA Microarray Analysis	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; ANTIHYPERTENSIVE PEPTIDES; BIOACTIVE PEPTIDES; BLOOD-PRESSURE; MATRIX METALLOPROTEINASE-7; UNCOUPLING PROTEIN-3; DYSFUNCTION; 5-HYDROXYTRYPTOPHAN; PURIFICATION; INCREASES	Marine organisms are rich sources of bioactive components, which are often reported to have antihypertensive effects. However, the underlying mechanisms have yet to be fully identified. The aim of this study was to investigate the antihypertensive effect of enzymatic hydrolysis of blue mussel protein (HBMP) in rats. Peptides with in vitro ACE inhibitory activity were purified from HBMP by ultrafiltration, gel filtration chromatography and reversed-phase high performance liquid chromatography. And the amino acid sequences of isolated peptides were estimated to be Val-Trp, Leu-Gly-Trp, and Met-Val-Trp-Thr. To study its in vivo action, spontaneously hypertensive rats (SHRs) were orally administration with high-or low-dose of HBMP for 28 days. Major components of the renin-angiotensin (RAS) system in serum of SHRs from different groups were analyzed, and gene expression profiling were performed in the kidney of SHRs, using the Whole Rat Genome Oligonucleotide Microarray. Results indicated although genes involved in RAS system were not significantly altered, those related to blood coagulation system, cytokine and growth factor, and fatty acids metabolism were remarkablely changed. Several genes which were seldom reported to be implicated in pathogenesis of hypertension also showed significant expression alterations after oral administration of HBMP. These data provided valuable information for our understanding of the molecular mechanisms that underlie the potential antihypertensive activities of HBMP, and will contribute towards increased value-added utilization of blue mussel protein.	[Feng, Junli; Dai, Zhiyuan; Meng, Lu; Ye, Jian; Ma, Xuting] Zhejiang Gongshang Univ, Inst Seafood, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanping] Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University; Zhejiang University of Science & Technology	Dai, ZY (corresponding author), Zhejiang Gongshang Univ, Inst Seafood, Hangzhou, Zhejiang, Peoples R China.	dzy@mail.zjgsu.edu.cn			Scientific Research Fund of Zhejiang Provincial Education Department [Y201534380]; Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau [2014-ZKZ-010]; National High Technology Research and Development Program of China [2012AA092302]; Major Science and Technology Projects of Zhejiang Province [2012C03009-3]	Scientific Research Fund of Zhejiang Provincial Education Department; Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major Science and Technology Projects of Zhejiang Province	This work was supported by the Scientific Research Fund of Zhejiang Provincial Education Department (Y201534380), the Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau (Grant No. 2014-ZKZ-010), the National High Technology Research and Development Program of China (Grant No. 2012AA092302), and the Major Science and Technology Projects of Zhejiang Province (Grant No. 2012C03009-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; de la Rosa APB, 2010, NITRIC OXIDE-BIOL CH, V23, P106, DOI 10.1016/j.niox.2010.04.006; BARON A, 1991, PHARMACOLOGY, V42, P15, DOI 10.1159/000138763; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Chen ZY, 2009, J AGR FOOD CHEM, V57, P4485, DOI 10.1021/jf900803r; Ngo DH, 2012, INT J BIOL MACROMOL, V51, P378, DOI 10.1016/j.ijbiomac.2012.06.001; Daien V, 2012, AM J HYPERTENS, V25, P126, DOI 10.1038/ajh.2011.180; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DING XR, 1989, AM J MED SCI, V297, P290, DOI 10.1097/00000441-198905000-00004; Estruch R, 2005, J HYPERTENS, V23, P226, DOI 10.1097/00004872-200501000-00039; Ewart HS, 2009, EUR FOOD RES TECHNOL, V229, P561, DOI 10.1007/s00217-009-1083-3; FREGLY MJ, 1987, J HYPERTENS, V5, P621, DOI 10.1097/00004872-198710000-00018; Fu MQ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-106; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Gehring CK, 2009, CURR NUTR FOOD SCI, V5, P17, DOI 10.2174/157340109787314703; Gregorio-King CC, 2002, GENE, V286, P249, DOI 10.1016/S0378-1119(02)00434-1; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Harnedy PA, 2012, J FUNCT FOODS, V4, P6, DOI 10.1016/j.jff.2011.09.001; Hellsten Y, 2007, FREE RADICAL BIO MED, V43, P353, DOI 10.1016/j.freeradbiomed.2007.02.029; Hu C, 2015, FASEB J S811, V29, P8116; ITSKOVITZ HD, 1989, J HYPERTENS, V7, P311; Je JY, 2005, BIORESOURCE TECHNOL, V96, P1624, DOI 10.1016/j.biortech.2005.01.001; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Johns EJ, 2014, J HYPERTENS, V32, P735, DOI 10.1097/HJH.0000000000000121; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kim Sung-Rae, 2012, Fisheries and Aquatic Sciences, V15, P183, DOI 10.5657/FAS.2012.0183; Kim Yeon-Kye, 2011, Fisheries and Aquatic Sciences, V14, P283; Korhonen H, 2003, CURR PHARM DESIGN, V9, P1297, DOI 10.2174/1381612033454892; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Lee KM, 2013, INT J MOL MED, V31, P179, DOI 10.3892/ijmm.2012.1183; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; Matsukawa R, 2014, J HYPERTENS, V32, P817, DOI 10.1097/HJH.0000000000000072; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nakada TA, 2011, CHEST, V139, P1042, DOI 10.1378/chest.10-2517; Norris R., 2013, BIOACTIVE FOOD PEPTI, P45, DOI [10.1146/annurev-food-022814-015520, DOI 10.5772/32009]; Ortega FJ, 2010, INT J OBESITY, V34, P487, DOI 10.1038/ijo.2009.263; Pereira NL, 2010, J MOL CELL CARDIOL, V49, P864, DOI 10.1016/j.yjmcc.2010.07.020; Perros F, 2015, J AM COLL CARDIOL, V65, P668, DOI 10.1016/j.jacc.2014.11.050; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Sainz-Perez A, 2008, J IMMUNOL, V181, P6051, DOI 10.4049/jimmunol.181.9.6051; Segall L, 2007, NEPHROL DIAL TRANSPL, V22, P2435, DOI 10.1093/ndt/gfm363; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Tanaka M, 2008, LIFE SCI, V82, P869, DOI 10.1016/j.lfs.2008.02.001; Udenigwe CC, 2014, J FUNCT FOODS, V8, P45, DOI 10.1016/j.jff.2014.03.002; Vercruysse L, 2005, J AGR FOOD CHEM, V53, P8106, DOI 10.1021/jf0508908; Wang B, 2013, FOOD CHEM, V138, P1713, DOI 10.1016/j.foodchem.2012.12.002; Wang JP, 2008, FOOD CHEM, V111, P302, DOI 10.1016/j.foodchem.2008.03.059; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Watts SW, 2011, CARDIOVASC THER, V29, P54, DOI 10.1111/j.1755-5922.2010.00173.x; Yamaguchi N, 2009, EUR J PHARMACOL, V620, P71, DOI 10.1016/j.ejphar.2009.08.005; Yamamoto N, 2003, CURR PHARM DESIGN, V9, P1345, DOI 10.2174/1381612033454801; Zhang JL, 2003, DIABETIC MED, V20, P828, DOI 10.1046/j.1464-5491.2003.01057.x	58	4	5	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142016	10.1371/journal.pone.0142016	http://dx.doi.org/10.1371/journal.pone.0142016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517713	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800100
J	Lavielle, P; Talavera, JO; Reynoso, N; Gonzalez, M; Gomez-Diaz, RA; Cruz, M; Vazquez, F; Wacher, NH				Lavielle, Pilar; Talavera, Juan O.; Reynoso, Nancy; Gonzalez, Marissa; Gomez-Diaz, Rita A.; Cruz, Miguel; Vazquez, Felipe; Wacher, Niels H.		DIMSS Study Grp	Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; UNITED-STATES; RISK-FACTORS; DEMENTIA; MELLITUS; MORTALITY; PEOPLE; SCREEN	Objective To estimate the prevalence of cognitive impairment (CI) among patients recently diagnosed with type 2 diabetes (RDD) and to identify any relationships between CI and RDD comorbidities. Methods: One thousand seven hundred twelve patients with RDD participated in a cross-sectional study. The patients' sociodemographic and clinical data were registered. Results The sample population had an average age of 51 +/- 11 years, and 63.26% of the patients were female. CI was diagnosed in 38 patients (2.2%) and was more common among both females (2.8% vs. 1.3%, rho = 0.063) and the elderly (0% at an age <= 30 years vs. 10.4% at an age > 70 years, rho = 0.0001). Rheumatoid arthritis (present in 15.8% vs. absent in 2.1%) and asthma (13% vs. 2.1%) correlated significantly with CI based on the results of our logistic regression analysis. Conclusion Age, female gender, rheumatoid arthritis and asthma are risk factors for CI in the setting of RDD.	[Lavielle, Pilar; Talavera, Juan O.; Reynoso, Nancy; Gonzalez, Marissa; Gomez-Diaz, Rita A.; Vazquez, Felipe; Wacher, Niels H.] IMSS, Unidad Invest Epidemiol Clin, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico; [Cruz, Miguel] IMSS, Unidad Invest Bioquim, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Wacher, NH (corresponding author), IMSS, Unidad Invest Epidemiol Clin, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico.	wacherniels@gmail.com	Lopez, Miguel Cruz/O-5493-2018; gomez-diaz, rita/AAS-4030-2021	Lopez, Miguel Cruz/0000-0001-9985-6172; gomez-diaz, rita/0000-0002-2191-4931; wacher, niels/0000-0002-7717-6704				Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; American Psychiatric Association DSM- IV, 1993, DIAGN STAT MAN MENT; Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Barnes DE, 2009, FUTUR NEUROL, V4, P555, DOI 10.2217/FNL.09.43; Barnes DE, 2010, ALZHEIMERS DEMENT, V6, P138, DOI 10.1016/j.jalz.2010.01.005; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brodaty H, 1997, INT J GERIATR PSYCH, V12, P619, DOI 10.1002/(SICI)1099-1166(199706)12:6<619::AID-GPS554>3.0.CO;2-H; Chen YM, 2010, JOINT BONE SPINE, V77, P366, DOI 10.1016/j.jbspin.2010.01.017; Choi SH, 2011, INT PSYCHOGERIATR, V23, P593, DOI 10.1017/S1041610210001626; Di Carlo A, 2000, J AM GERIATR SOC, V48, P775, DOI 10.1111/j.1532-5415.2000.tb04752.x; Ebady SA, 2008, DIABETES RES CLIN PR, V82, P305, DOI 10.1016/j.diabres.2008.08.020; Eknoyan D, 2012, J NEUROPSYCHIATRY CL, V24, P3; Etgen T, 2011, DTSCH ARZTEBL INT, V108, P743, DOI 10.3238/arztebl.2011.0743; Goh DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096874; HOFFMAN RG, 1989, DIABETES CARE, V12, P193, DOI 10.2337/diacare.12.3.193; Hunt BJ, 2000, LUPUS, V9, P189, DOI 10.1191/096120300678828244; JACOBSSON LTH, 1993, ARTHRITIS RHEUM-US, V36, P1045, DOI 10.1002/art.1780360804; Juncos-Rabadan O, 2013, INT PSYCHOGERIATR, V25, P627, DOI 10.1017/S1041610212002207; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Kozora E, 2001, J INT NEUROPSYCH SOC, V7, P745, DOI 10.1017/S1355617701766106; Kwasny-Krochin B, 2010, THROMB RES, V126, pE11, DOI 10.1016/j.thromres.2010.04.007; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; LANGAN SJ, 1991, DIABETOLOGIA, V34, P337, DOI 10.1007/BF00405006; Llewellyn DJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-12; Luchsinger JA, 2010, J NEUROL SCI, V299, P35, DOI 10.1016/j.jns.2010.08.063; Marioni RE, 2009, PSYCHOSOM MED, V71, P901, DOI 10.1097/PSY.0b013e3181b1e538; Mejía-Arango Silvia, 2007, Salud pública Méx, V49, ps475; Melzer D, 1997, BRIT MED J, V315, P462, DOI 10.1136/bmj.315.7106.462; Moss M, 2005, J CLIN EXP NEUROPSYC, V27, P139, DOI 10.1080/13803390490515450; O'Caoimh R, 2013, AGE AGEING, V42, P324, DOI 10.1093/ageing/aft044; O'Caoimh R, 2012, AGE AGEING, V41, P624, DOI 10.1093/ageing/afs059; Pendlebury ST, 2013, STROKE, V44, P227, DOI 10.1161/STROKEAHA.112.673384; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Roberts RO, 2008, ARCH NEUROL-CHICAGO, V65, P1066, DOI 10.1001/archneur.65.8.1066; Strachan MWJ, 2003, DIABETIC MED, V20, P1, DOI 10.1046/j.1464-5491.2003.00855.x; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x	42	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141325	10.1371/journal.pone.0141325	http://dx.doi.org/10.1371/journal.pone.0141325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517541	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800035
J	Liu, FX; Guo, J; Zhang, Q; Liu, DW; Wen, L; Yang, Y; Yang, L; Liu, ZS				Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo			The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy	PLOS ONE			English	Article							MESSENGER-RNA; INFLAMMATION; CYTOKINES; CANCER; CELLS; MICE	Objective Tristetraprolin (TTP), also known as zinc finger protein 36, is an RNA binding protein that has a significant role in regulating the expression of mRNAs containing AU-rich elements. We postulated that TTP might regulate interleukin (IL)-6 and IL-18 expression in diabetes. This study aimed to test the hypothesis that the levels of TTP are correlated with nephropathy in patients with type 2 diabetes. Methods Eighty-seven patients (61.3 +/- 9.6 years old) who had been diagnosed with type 2 diabetes mellitus and 41 age and sex matched healthy control subjects were enrolled. The diabetes patients were classified into those without proteinuria, with microalbuminuria, and with clinical proteinuria groups according to the ratio of urinary excretion of albumin/creatinine (ACR). Results Serum and urinary levels of IL-6 and IL-18 were significantly elevated, but those of TTP were significantly decreased in patients with diabetes as compared with control subjects. In addition, serum and urinary levels of IL-6 and IL-18 were significantly higher, but those of TTP were significantly lower in patients with proteinuria than in patients without proteinuria or with microalbuminuria. There was a significant correlation between serum TTP and IL-6/IL-18 (correlation coefficients of -0.572 and -0.685, P < 0.05). Conclusion These results show that diabetes with clinical proteinuria is accompanied by decreased urinary and serum level of TTP and increased levels of IL-6 and IL-18. Decreased TTP expression might occur prior to the increase in IL-6 and IL-18, and decrease of TTP might provide an earlier marker for glomerular dysfunction than IL-6 and IL-18.	[Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Zhengzhou Univ, Nephropathy Res Inst, Zhengzhou 450052, Peoples R China; [Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Key Disciplines Lab Clin Med Henan, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Liu, ZS (corresponding author), Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China.	zhangsuoliu@sina.com			National Basic Research Program of China 973 [2012CB517600, 2012CB517606]; National Natural Science Foundation of China [81270807]	National Basic Research Program of China 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Basic Research Program of China 973, Program No. 2012CB517600 (No. 2012CB517606) (http://www.cas.cn/ky/kyxm/973xm/), and the National Natural Science Foundation of China (No. 81270807) (http://www.nsfc.gov.cn/).	Cansby E, 2014, MOL CELL ENDOCRINOL, V393, P143, DOI 10.1016/j.mce.2014.06.014; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; El Mesallamy HO, 2012, CLIN BIOCHEM, V45, P646, DOI 10.1016/j.clinbiochem.2012.02.021; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8; Joe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088776; Lee HH, 2013, MOL CELLS, V36, P571, DOI 10.1007/s10059-013-0268-6; Lee SH, 2005, NEPHROLOGY, V10, pS32, DOI 10.1111/j.1440-1797.2005.00454.x; Luis-Rodriguez D, 2012, WORLD J DIABETES, V3, P7, DOI 10.4239/wjd.v3.i1.7; Mensah-Brown EPK, 2005, CYTOKINE, V31, P180, DOI 10.1016/j.cyto.2005.04.006; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Ray D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057290; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393	17	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141471	10.1371/journal.pone.0141471	http://dx.doi.org/10.1371/journal.pone.0141471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517838	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800045
J	Zhou, J; Zhang, N; Wang, P; Zhang, SC; Li, DQ; Liu, KY; Wang, GX; Wang, XP; Ai, H				Zhou, Jing; Zhang, Na; Wang, Pan; Zhang, Shichang; Li, Daiqin; Liu, Kaiyu; Wang, Guoxiu; Wang, Xiaoping; Ai, Hui			Identification of Host-Plant Volatiles and Characterization of Two Novel General Odorant-Binding Proteins from the Legume Pod Borer, Maruca vitrata Fabricius (Lepidoptera: Crambidae)	PLOS ONE			English	Article							FEMALE SEX-PHEROMONE; BEHAVIORAL-RESPONSES; VIGNA-UNGUICULATA; MANDUCA-SEXTA; EXPRESSION; POPULATIONS; RESISTANCE; PYRALIDAE	Chemoreception is a key feature in selection of host plant by phytophagous insects, and odorant-binding proteins (OBPs) are involved in chemical communication of both insects and vertebrates. The legume pod borer, Maruca vitrata Fabricius (Lepidoptera: Crambidae) is one of the key pest species of cowpea and widely distributed throughout tropical and subtropical regions, causing up to 80% of yield loss. In this study, we investigated the electrophysiological responses of femaleM. vitrata to floral volatiles from V. unguiculata. Seventeen electroantennogram- active compounds were identified from floral volatiles of V. unguiculata by coupled gas chromatography-electroantennography (GC-EAD) and gas chromatography-mass spectrometry (GC-MS). Then, we cloned two novel full-length GOBP genes (MvitGOBP1 and MvitGOBP2) from the antennae ofM. vitrata using reverse transcription PCR. Protein sequence analysis indicated that they shared high sequence similarity with other Pyralididae insect GOBPs and had the typical six-cysteine signature. Real-time PCR analysis indicated that MvitGOBP1-2 mRNA was highly expressed in the antennae of female adult with several thousands-fold difference compare to other tissue. Next, the recombinant MvitGOBP1-2 was expressed in Escherichia coli and purified using Ni ion affinity chromatography. Fluorescence binding assays demonstrated thatMvitGOBP1-2 had different binding affinities with 17 volatile odorant molecules including butanoic acid butyl ester, limonene, 4-ethylpropiophenone, 1H-indol-4-ol, butanoic acid octyl ester and 2-methyl-3-phenylpropanal. In the field trapping experiment, these six floral volatiles could effectively attract femalemoths and showed significant difference compared with the blank lure. These results suggested that MvitGOBPs and the seventeen floral volatiles are likely to function in the olfactory behavior response of female moths, which may have played crucial roles in the selection of oviposition sites. The six compounds that we have identified from the volatiles of V. unguiculata may provide useful information for exploring efficiency monitoring and integrated pest management strategies of this legume pod borer in the field.	[Zhou, Jing; Zhang, Na; Liu, Kaiyu; Wang, Guoxiu; Ai, Hui] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Wang, Pan; Wang, Xiaoping] Huazhong Agr Univ, Coll Plant Sci & Technol, Key Lab Insect Resource Utilizat & Sustainable Pe, Wuhan 430070, Peoples R China; [Zhang, Shichang; Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Central China Normal University; Huazhong Agricultural University; National University of Singapore	Ai, H (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	aihui@mail.ccnu.edu.cn	Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734	Chinese National Natural Science Foundation of China [31472052, 31172162, 30971911]; National Higher-education Institution General Research and Development Funding of Central China Normal University [20205130077]	Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Higher-education Institution General Research and Development Funding of Central China Normal University	This work was supported by Chinese National Natural Science Foundation of China (31472052, 31172162, 30971911) and National Higher-education Institution General Research and Development Funding of Central China Normal University (20205130077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin P, 2009, INSECT BIOCHEM MOLEC, V39, P11, DOI 10.1016/j.ibmb.2008.09.007; Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; Allmann S, 2013, ELIFE, V2, DOI 10.7554/eLife.00421; Anfora G, 2009, J CHEM ECOL, V35, P1054, DOI 10.1007/s10886-009-9686-5; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Dannon EA, 2010, J CHEM ECOL, V36, P1083, DOI 10.1007/s10886-010-9859-2; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; Ekesi S, 1999, INT J PEST MANAGE, V45, P57, DOI 10.1080/096708799228058; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; JACKAI LEN, 1986, ANNU REV ENTOMOL, V31, P95, DOI 10.1146/annurev.en.31.010186.000523; Liu NY, 2015, INSECT MOL BIOL, V24, P167, DOI 10.1111/imb.12143; Liu NY, 2015, COMP BIOCHEM PHYS A, V180, P23, DOI 10.1016/j.cbpa.2014.11.005; Liu SJ, 2012, ARCH INSECT BIOCHEM, V80, P123, DOI 10.1002/arch.21036; Lu PF, 2013, Z NATURFORSCH C, V68, P416; Lu PF, 2008, CHINESE BULL ENTOMOL, V2, P017; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pinero JC, 2007, ENTOMOL EXP APPL, V125, P185, DOI 10.1111/j.1570-7458.2007.00614.x; Qiao HL, 2012, ENTOMOL EXP APPL, V143, P269, DOI 10.1111/j.1570-7458.2012.01264.x; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Steinbrecht RA, 1996, ENTOMOL EXP APPL, V80, P15, DOI 10.1007/BF00194714; Sun YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055132; Tasin M, 2005, J CHEM ECOL, V31, P77, DOI 10.1007/s10886-005-0975-3; Tasin M, 2010, CHEM SENSES, V35, P57, DOI 10.1093/chemse/bjp082; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wang HL, 2010, J CHEM ECOL, V36, P305, DOI 10.1007/s10886-010-9754-x; Wang Lin, 2003, Natural Enemies of Insects, V25, P83; Wang P, 2014, ENTOMOL EXP APPL, V152, P248, DOI 10.1111/eea.12216; Wang P, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12101; [王攀 Wang Pan], 2011, [植物保护, Plant Protection], V37, P33; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Yule S, 2013, J ASIA-PAC ENTOMOL, V16, P357, DOI 10.1016/j.aspen.2013.05.001; Zeng FF, 2013, BIOCHEM BIOPH RES CO, V433, P463, DOI 10.1016/j.bbrc.2013.03.038; Zhang GH, 2012, J CHEM ECOL, V38, P427, DOI 10.1007/s10886-012-0102-1; Zhang ZC, 2009, J CHEM ECOL, V35, P1188, DOI 10.1007/s10886-009-9697-2	39	25	30	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141208	10.1371/journal.pone.0141208	http://dx.doi.org/10.1371/journal.pone.0141208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517714	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800028
J	Wang, ZH; Zhou, J; Luo, XL; Xu, Y; She, X; Chen, L; Yin, HH; Wang, XY				Wang, Zonghua; Zhou, Juan; Luo, Xingli; Xu, Yan; She, Xi; Chen, Ling; Yin, Honghua; Wang, Xianyuan			Rasch Analysis of the Adult Strabismus Quality of Life Questionnaire (AS-20) among Chinese Adult Patients with Strabismus	PLoS One			English	Article							PSYCHOSOCIAL-ASPECTS; VERSION; VISION	Background The impact of strabismus on visual function, self-image, self-esteem, and social interactions decrease health-related quality of life (HRQoL). The purpose of this study was to evaluate and refine the adult strabismus quality of life questionnaire (AS-20) by using Rasch analysis among Chinese adult patients with strabismus. Methods We evaluated the fitness of the AS-20 with Rasch model in Chinese population by assessing unidimensionality, infit and outfit, person and item separation index and reliability, response ordering, targeting and differential item functioning (DIF). Results The overall AS-20 did not demonstrate unidimensional; however, it was achieved separately in the two Rasch-revised subscales: the psychosocial subscale (11 items) and the function subscale (9 items). The features of good targeting, optimal item infit and outfit, and no notable local dependence were found for each of the subscales. The rating scale was appropriate for the psychosocial subscale but a reduction to four response categories was required for the function subscale. No significant DIF were revealed for any demographic and clinical factors (e.g., age, gender, and strabismus types). Conclusion The AS-20 was demonstrated by Rasch analysis to be a rigorous instrument for measuring health-related quality of life in Chinese strabismus patents if some revisions were made regarding the subscale construct and response options.	[Wang, Zonghua; Zhou, Juan; Wang, Xianyuan] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China; [Luo, Xingli; Yin, Honghua] Third Mil Med Univ, Daping Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [Xu, Yan] Third Mil Med Univ, Southwest Eye Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [She, Xi] Third Mil Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China; [Chen, Ling] PLA, Hosp 324, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Wang, XY (corresponding author), Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China.	xywang_tmmu@sina.cn			 [cstc2013jcsf10014];  [cstc2012jjA10145]	; 	This work was supported by cstc2013jcsf10014 and cstc2012jjA10145 (http://www.ctin.ac.cn). The funder provided the analysis tool, and helped with data analysis and interpretation.	Beaton DE, 2003, CLIN ORTHOP RELAT R, P90, DOI 10.1097/01.blo.0000079772.06654.c8; Bian W, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0269-6; Gothwal VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127064; Gothwal VK, 2013, INVEST OPHTH VIS SCI, V54, P4871, DOI 10.1167/iovs.13-11892; Gunton KB, 2014, CURR OPIN OPHTHALMOL, V25, P406, DOI 10.1097/ICU.0000000000000087; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hambleton RK, 2006, MED CARE, V44, pS182, DOI 10.1097/01.mlr.0000245443.86671.c4; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Khadka J, 2014, INVEST OPHTH VIS SCI, V55, P4413, DOI 10.1167/iovs.14-14017; Khadka J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-80; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Leske DA, 2012, INVEST OPHTH VIS SCI, V53, P2630, DOI 10.1167/iovs.11-8308; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Wang CW, 2008, OPTOMETRY VISION SCI, V85, P1091, DOI 10.1097/OPX.0b013e31818b9f23; Wang ZH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-180; Wang ZH, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-139; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771; Zammit AR, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-64	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142188	10.1371/journal.pone.0142188	http://dx.doi.org/10.1371/journal.pone.0142188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544048	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700093
J	Henrich, N; Holmes, B; Prystajecky, N				Henrich, Natalie; Holmes, Bev; Prystajecky, Natalie			Looking Upstream: Findings from Focus Groups on Public Perceptions of Source Water Quality in British Columbia, Canada	PLOS ONE			English	Article							DRINKING-WATER; PARTICIPATION; MANAGEMENT; ENGAGEMENT; READINESS; KNOWLEDGE; SCALE	In association with the development of new microbial tests for source water quality (SWQ), focus groups with members of the public were conducted to gain insight into their perceptions of SWQ, behaviours and contaminants they think pose the greatest threat to its quality, and what/how they want to know about SWQ. Discussions revealed a low concern about SWQ in general, and in particular about microbial contamination. Participants identified behaviours that threaten SWQ, barriers to changing behaviour and suggestions for inducing change. A strong desire was expressed for water quality information to be interpreted and communicated in terms of how SWQ may impact human health and how their actions should be altered in response to test results. The information can be used to inform communication strategies and possibly impact policies associated with water quality testing and implementation of new tests. More broadly, awareness of the public's understanding and beliefs about source water can be used in working with the public to adopt water-friendly behaviours, influence the content and methods of communicating with the public about water issues and water quality, and could contribute to the direction of future research and investment into water technologies to align with the public's priorities.	[Henrich, Natalie] Providence Hlth Care Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Holmes, Bev] Michael Smith Fdn Hlth Res, Vancouver, BC, Canada; [Prystajecky, Natalie] BC Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Prystajecky, Natalie] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Henrich, N (corresponding author), Providence Hlth Care Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	natalie.henrich@gmail.com			Genome British Columbia; Genome Canada [LSARP-165WAT]	Genome British Columbia; Genome Canada(Genome Canada)	Research for this article was conducted as part of the research project, 'Applied Metagenomics of the Watershed Microbiome' and was funded by Genome British Columbia (www.genomebc.ca) and Genome Canada (www.genomecanada.ca) [Grant #LSARP-165WAT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz WV, 2004, J TOXICOL ENV HEAL A, V67, P1825, DOI 10.1080/15287390490491161; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ashbolt NJ, 2004, TOXICOLOGY, V198, P255, DOI 10.1016/j.tox.2004.01.034; Attieh R, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-138; Benjoe K, 2006, LEADER POST; Best A, 2010, EVID POLICY, V6, P145, DOI 10.1332/174426410X502284; Canadian Council of Ministers of the Environment, 2002, SOURC TAP MULT APPR; Chopyak J., 2002, TECHN SOC, V24, P155, DOI [10.1016/S0160-791X(01)00051-3, DOI 10.1016/S0160-791X(01)00051-3]; Chudek M, HDB EVOLUTI IN PRESS; Craun G. F, 1993, SAFETY WATER DISINFE; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Downs TJ, 1999, ENVIRON HEALTH PERSP, V107, P553, DOI 10.2307/3434397; Dube D, 2002, PHYS CHEM EARTH, V27, P867, DOI 10.1016/S1474-7065(02)00085-2; Durrenberger G., 1999, SCI PUBL POLICY, V26, P341; Ehrhart MG, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0157-1; Einsiedel EF, COMMUNICATION UNPUB; Fayerman P, 2011, LAW GOVERNING DISPOS; Fischer Frank., 1999, SCI PUBL POLICY, V26, P294, DOI [10.3152/147154399781782293, DOI 10.3152/147154399781782293]; Gockeritz S, 2010, EUR J SOC PSYCHOL, V40, P514, DOI 10.1002/ejsp.643; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Health Canada, 2000, RISK BEN PERC BIOT P; HealthCanada, 2000, RISK BEN PERC BIOT P; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich N., 2007, WHY HUMANS COOPERATE; Henrich N, 2009, EMERGING HLTH THREAT, V2, P2; House of Lords Select Committee on Science and Technology, 2000, SCI SOC; Issa AM, 2009, PUBLIC HEALTH GENOM, V12, P163, DOI 10.1159/000189629; Jasanoff S, 2011, SCI ENG ETHICS, V17, P621, DOI 10.1007/s11948-011-9302-2; Jonsson A, 2005, AMBIO, V34, P495, DOI 10.1639/0044-7447(2005)034[0495:PPIWRM]2.0.CO;2; Joss S., 1999, SCI PUBL POLICY, V26, P290, DOI [DOI 10.3152/147154399781782338, 10.3152/147154399781782338]; Krewski D, 1995, HUM ECOL RISK ASSESS, V1, P53; Krewski D, 2006, HUM ECOL RISK ASSESS, V12, P626, DOI 10.1080/10807030600561832; Meredith LS, 2007, J HEALTH COMMUN, V12, P217, DOI 10.1080/10810730701265978; Pieczka M, 2013, SCI PUBL POLICY, V40, P113, DOI 10.1093/scipol/scs073; PILISUK M, 1987, SOC SCI J, V24, P403, DOI 10.1016/0362-3319(87)90056-5; RBC and Unilever Canada, 2010, 2010 CAN WAT ATT STU; RBC and Unilever Canada, 2011, 2011 CAN WAT ATT STU; Slovic P, 1993, HLTH RISK PERCEPTION; Sofoulis Z., 2005, CONTINUUM-J MEDIA CU, P19, DOI [DOI 10.1080/10304310500322685, 10.1080/10304310500322685]; van Est R, 2011, SCI ENG ETHICS, V17, P639, DOI 10.1007/s11948-011-9296-9; Wilson MG, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-36; Wynne B, 2011, SCI ENG ETHICS, V17, P791, DOI 10.1007/s11948-011-9316-9; Yim Y, 2005, PUBLIC PERCEPTIONS D	43	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141533	10.1371/journal.pone.0141533	http://dx.doi.org/10.1371/journal.pone.0141533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540561	Green Submitted, Green Published, gold			2022-12-27	WOS:000364303800018
J	Lee, S; Evans, MA; Chu, HX; Kim, HA; Widdop, RE; Drummond, GR; Sobey, CG				Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.			Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo	PLOS ONE			English	Article							ANGIOTENSIN-(1-7) RECEPTOR; CAUSES NEUROPROTECTION; COMPOUND 21; BRAIN; MODEL; EXPRESSION; PATHWAY; STROKE; MOUSE; CEREBROPROTECTION	Functional modulation of the non-AT(1)R arm of the renin-angiotensin system, such as via AT(2)R activation, is known to improve stroke outcome. However, the relevance of the Mas receptor, which along with the AT(2)R forms the protective arm of the renin-angiotensin system, as a target in stroke is unclear. Here we tested the efficacy of a selective MasR agonist, AVE0991, in in vitro and in vivo models of ischemic stroke. Primary cortical neurons were cultured from E15-17 mouse embryos for 7-9 d, subjected to glucose deprivation for 24 h alone or with test drugs, and percentage cell death was determined using trypan blue exclusion assay. Additionally, adult male mice were subjected to 1 h middle cerebral artery occlusion and were administered either vehicle or AVE0991 (20 mg/kg i.p.) at the commencement of 23 h reperfusion. Some animals were also treated with the MasR antagonist, A779 (80 mg/kg i.p.) 1 h prior to surgery. Twenty-four h after MCAo, neurological deficits, locomotor activity and motor coordination were assessed in vivo, and infarct and edema volumes estimated from brain sections. Following glucose deprivation, application of AVE0991 (10(-8) M to 10(-6) M) reduced neuronal cell death by similar to 60% (P<0.05), an effect prevented by the MasR antagonist. By contrast, AVE0991 administration in vivo had no effect on functional or histological outcomes at 24 h following stroke. These findings indicate that the classical MasR agonist, AVE0991, can directly protect neurons from injury following glucose-deprivation. However, this effect does not translate into an improved outcome in vivo when administered systemically following stroke.	[Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3800, Australia; [Lee, Seyoung; Evans, Megan A.; Chu, Hannah X.; Kim, Hyun Ah; Widdop, Robert E.; Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic 3800, Australia; [Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Dept Surg, Southern Clin Sch, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Sobey, CG (corresponding author), Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3800, Australia.	chris.sobey@monash.edu	Sobey, Christopher G/A-2786-2008	Sobey, Christopher G/0000-0001-6525-9097; Drummond, Grant/0000-0001-8556-9738; Kim, Hyun Ah/0000-0002-3175-9218; Widdop, Robert/0000-0002-6515-0435	National Health and Medical Research Council of Australia (NHMRC) [APP1041326, APP1064686, APP1062721]; NHMRC Senior Research Fellowships [CGS: APP1079467, GRD: APP1006017]; Monash Faculty Postgraduate Scholarship; Australian Postgraduate Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Monash Faculty Postgraduate Scholarship; Australian Postgraduate Award(Australian Government)	These studies were supported by Project Grants from the National Health and Medical Research Council of Australia (NHMRC) (APP1041326; APP1064686; APP1062721). The authors also acknowledge support from NHMRC Senior Research Fellowships (CGS: APP1079467; GRD: APP1006017), a Monash Faculty Postgraduate Scholarship (MAE), and an Australian Postgraduate Award (HXC).	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Barroso L. C., 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/808726; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Calo LA, 2010, J NEPHROL, V23, P472; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Der Sarkissian S, 2006, PROG BIOPHYS MOL BIO, V91, P163, DOI 10.1016/j.pbiomolbio.2005.05.011; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; Iwata M, 2011, J MOL CELL CARDIOL, V51, P542, DOI 10.1016/j.yjmcc.2010.12.003; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jew CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070415; Jiang T, 2014, BRIT J PHARMACOL, V171, P4222, DOI 10.1111/bph.12770; Jiang T, 2012, BRIT J PHARMACOL, V167, P1520, DOI 10.1111/j.1476-5381.2012.02105.x; Joseph JP, 2014, NEUROPHARMACOLOGY, V81, P134, DOI 10.1016/j.neuropharm.2014.01.044; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P253, DOI 10.1111/j.1601-183X.2004.00100.x; Lee Seyoung, 2012, Exp Transl Stroke Med, V4, P16, DOI 10.1186/2040-7378-4-16; Lu J, 2013, NEUROPEPTIDES, V47, P289, DOI 10.1016/j.npep.2013.09.002; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2012, HYPERTENSION, V60, P1531, DOI 10.1161/HYPERTENSIONAHA.112.199646; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; METZGER R, 1995, FEBS LETT, V357, P27, DOI 10.1016/0014-5793(94)01292-9; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Savergnini SQ, 2010, HYPERTENSION, V56, P112, DOI 10.1161/HYPERTENSIONAHA.110.152942; Switonski PM, 2015, NEUROBIOL DIS, V73, P174, DOI 10.1016/j.nbd.2014.09.020; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Wiemer G, 2002, HYPERTENSION, V40, P847, DOI 10.1161/01.HYP.0000037979.53963.8F; Xia HJ, 2008, J NEUROCHEM, V107, P1482, DOI 10.1111/j.1471-4159.2008.05723.x; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Zhang YD, 2008, NEUROPEPTIDES, V42, P593, DOI 10.1016/j.npep.2008.09.005; Zhao Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00010	35	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142087	10.1371/journal.pone.0142087	http://dx.doi.org/10.1371/journal.pone.0142087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540167	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800053
J	Lee, S; Godwin, OP; Kim, K; Lee, E				Lee, Sunkyung; Godwin, Onyeka Peter; Kim, Kyungah; Lee, Euni			Predictive Factors of Patient Satisfaction with Pharmacy Services in South Korea: A Cross-Sectional Study of National Level Data	PLOS ONE			English	Article							COMMUNITY PHARMACY; HEALTH-STATUS; MEDICATION	Objectives Patient satisfaction has emerged as a prerequisite to improving patients' health behaviors leading to better health care outcomes. This study was to identify predictive determinants for patient satisfaction with pharmacy services using national-level data. Methods A cross-sectional evaluation was conducted using 2008 Korean National Health and Nutrition Examination Survey (KNHANES) data. To assess the predictive factors for patient satisfaction with pharmacy services, an ordinal logistic regression model was conducted adjusting for patient characteristics, clinical comorbidities, and perception of health. Results A total of 9,744 people, a representative sample of 48.2 million Koreans, participated in the 2008 KNHANES, of whom 2,188 (23.6%) reported visits to pharmacy within the last 2 weeks prior to the survey. Of the patients who visited the pharmacy, 74.6% reported to be either "very satisfied" or "satisfied," and 25.4% responded as being "neutral," "dissatisfied," or "very dissatisfied." A multivariate ordinal logistic regression analysis with weighted observations revealed that patients with fair perception of health (adjusted OR 1.32; 95% CI 1.01-1.74; p<0.05) and those with middle to low family incomes (adjusted OR 1.34; 95% CI 1.02-1.76; p<0.05) were more likely to be satisfied with pharmacy services, and employment-based insurers were less likely to be satisfied with pharmacy services (adjusted OR 0.80; 95% CI 0.65-0.97; p<0.05). Conclusion Our findings indicated that three out of four patients expressed satisfaction toward pharmacy services. Middle to low family incomes, fair perception of health, and employee insured individuals were significant predictors of patient satisfaction with pharmacy services.	[Lee, Sunkyung] Howard Univ, Coll Pharm, Ctr Minor Hlth Serv Res, Washington, DC 20059 USA; [Godwin, Onyeka Peter] Chapman Univ, Sch Pharm, Dept Clin & Adm Pharm Sci, Irvine, CA USA; [Kim, Kyungah] Degge Grp Ltd, Fairfax, VA USA; [Lee, Euni] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Howard University; Chapman University System; Chapman University; Seoul National University (SNU)	Lee, E (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	eunilee@snu.ac.kr			Graduate School, Howard University	Graduate School, Howard University	SL received a travel grant from the Graduate School, Howard University.	Accreditation Council for Pharmacy Education (ACPE), 2011, ACCR STAND GUID PROF; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Collignon U, 2010, PHARM WORLD SCI, V32, P90, DOI 10.1007/s11096-009-9347-3; Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P149, DOI 10.1331/108658003321480696; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Hale A, 2016, HEALTH EXPECT, V19, P49, DOI 10.1111/hex.12329; Hasan S, 2013, RES SOC ADMIN PHARM, V9, P841, DOI 10.1016/j.sapharm.2012.10.002; Kamei M, 2001, YAKUGAKU ZASSHI, V121, P215, DOI 10.1248/yakushi.121.215; Kelly CW, 2008, J CLIN NURS, V17, P188, DOI 10.1111/j.1365-2702.2007.02121.x; Khudair IF, 2013, INT J HEALTH CARE Q, V26, P398, DOI 10.1108/IJHCQA-03-2011-0025; Kim HJ, 2008, HEALTH AFFAIR, V27, pW260, DOI 10.1377/hlthaff.27.4.w260; Korea Centers for Disease Control and Prevention, 2008, 4 KOR NAT HLTH NUTR; Korea Centers for Disease Control and Prevention, KOR NAT HLTH NUTR EX; Malewski DF, 2015, RES SOC ADMIN PHARM, V11, P121, DOI 10.1016/j.sapharm.2014.05.001; Marquez-Peiro J F, 2008, Farm Hosp, V32, P71; Njilele AC, 2012, INT J CLIN PHARM-NET, V34, P98, DOI 10.1007/s11096-011-9596-9; Oparah Azuka C, 2006, Res Social Adm Pharm, V2, P499, DOI 10.1016/j.sapharm.2006.02.004; Paddison CAM, 1999, NEW ZEAL J PSYCHOL, V28, P133; Panvelkar PN, 2009, PHARM WORLD SCI, V31, P525, DOI 10.1007/s11096-009-9311-2; Papastergiou John, 2014, Can Pharm J (Ott), V147, P359, DOI 10.1177/1715163514552557; Rahmqvist M, 2001, INT J QUAL HEALTH C, V13, P385, DOI 10.1093/intqhc/13.5.385; Schuessler TJ, 2015, J PHARM PRACT; Shikiar R, 2004, VALUE HEALTH, V7, P204, DOI 10.1111/j.1524-4733.2004.72252.x; Social Survey, SOC SURV; Song Y.J., 2009, JAPAN MED ASS J, V52, P206, DOI 10.3345/kjp.2009.52.7.752; Szczesiul JM, 2009, AM J HEALTH-SYST PH, V66, P576, DOI 10.2146/ajhp080083; Tinelli M, 2007, ANN PHARMACOTHER, V41, P1962, DOI 10.1345/aph.1K242; Traverso ML, 2005, PHARM WORLD SCI, V27, P281, DOI 10.1007/s11096-005-7114-7; Viswanathan M, 2015, JAMA INTERN MED, V175, P76, DOI 10.1001/jamainternmed.2014.5841; Ware JE., 1993, HLTH SURVEY MANUAL I; Xiao H, 2008, VALUE HEALTH, V11, P719, DOI 10.1111/j.1524-4733.2007.00294.x	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142269	10.1371/journal.pone.0142269	http://dx.doi.org/10.1371/journal.pone.0142269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26540165	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800073
J	Lilly, MA; Kulkulka, NA; Firmiss, PR; Ross, MJ; Flum, AS; Delos Santos, GB; Bowen, DK; Dettman, RW; Gong, EM				Lilly, Meredith A.; Kulkulka, Natalie A.; Firmiss, Paula R.; Ross, Michael J.; Flum, Andrew S.; Delos Santos, Grace B.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.			The Murine Bladder Supports a Population of Stromal Sca-1(+)/CD34(+)/lin(-) Mesenchymal Stem Cells	PLoS One			English	Article							PROGENITOR CELLS; SMOOTH-MUSCLE; SCA-1; PROLIFERATION; REGENERATION; EXPRESSION; CONTRIBUTE; FAILURE; VESSELS; PLAYS	Bladder fibrosis is an undesired end point of injury of obstruction and often renders the smooth muscle layer noncompliant. In many cases, the long-term effect of bladder fibrosis is renal failure. Despite our understanding of the progression of this disease, little is known about the cellular mechanisms that lead to a remodeled bladder wall. Resident stem (progenitor) cells have been identified in various organs such as the brain, heart and lung. These cells function normally during organ homeostasis, but become dysregulated after organ injury. Here, we aimed to characterize a mesenchymal progenitor cell population as a first step in understanding its role in bladder fibrosis. Using fluorescence activated cell sorting (FACS), we identified a Sca-1(+)/CD34(+)/lin(-) (PECAM(-): CD45(-): Ter119(-)) population in the adult murine bladder. These cells were localized to the stromal layer of the adult bladder and appeared by postnatal day 1. Cultured Sca-1(+)/CD34(+)/lin(-) bladder cells self-renewed, formed colonies and spontaneously differentiated into cells expressing smooth muscle genes. These cells differentiated into other mesenchymal lineages (chondrocytes, adipocytes and osteocytes) upon culture in induction medium. Both acute and partial obstruction of the bladder reduced expression of CD34 and changed localization of Sca-1 to the urothelium. Partial obstruction resulted in upregulation of fibrosis genes within the Sca-1(+)/CD34(+)/lin(-) population. Our data indicate a resident, mesenchymal stem cell population in the bladder that is altered by bladder obstruction. These findings provide new information about the cellular changes in the bladder that may be associated with bladder fibrosis.	[Flum, Andrew S.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Lilly, Meredith A.; Kulkulka, Natalie A.; Firmiss, Paula R.; Flum, Andrew S.; Bowen, Diana K.; Dettman, Robert W.; Gong, Edward M.] Anne & Robert H Lurie Childrens Hosp Chicago, Dev Biol, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Ross, Michael J.; Delos Santos, Grace B.] Loyola Univ Hlth Syst, Dept Urol, Maywood, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Loyola University Chicago	Dettman, RW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,16-703, Chicago, IL 60611 USA.	r-dettman@northwestern.edu; emgong@northwestern.edu		Dettman, Robert/0000-0002-3074-5922	EMG's start-up funds; Hartwell Foundation Individual Biomedical Research Awards; Northwestern Department of Urology; Hartwell Individual Biomedical Research Award	EMG's start-up funds; Hartwell Foundation Individual Biomedical Research Awards; Northwestern Department of Urology; Hartwell Individual Biomedical Research Award	This work was funded by EMG's start-up funds given to him by Anne and Robert H Lurie Children's Hospital. Additional funding was provided by The Hartwell Foundation Individual Biomedical Research Awards and the Northwestern Department of Urology. EMG is a recipient of a Hartwell Individual Biomedical Research Award.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI 10.1089/ten.TEA.2009.0697; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Ghamra Ziad W, 2003, Cleve Clin J Med, V70 Suppl 1, pS2; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Jaureguizar Enrique, 2002, Curr Urol Rep, V3, P115, DOI 10.1007/s11934-002-0021-8; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Long KK, 2011, FASEB J, V25, P1156, DOI 10.1096/fj.10-170308; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Morris RK, 2011, EARLY HUM DEV, V87, P607, DOI 10.1016/j.earlhumdev.2011.07.004; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Peyton CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047414; Pfister O, 2010, METHODS MOL BIOL, V660, P53, DOI 10.1007/978-1-60761-705-1_4; Roth KS, 2002, CLIN PEDIATR, V41, P309, DOI 10.1177/000992280204100503; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Shiroyanagi Y, 2007, DIFFERENTIATION, V75, P968, DOI 10.1111/j.1432-0436.2007.00187.x; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Tanaka ST, 2009, J UROLOGY, V182, P1769, DOI 10.1016/j.juro.2009.02.081; Torsney E, 2005, TRENDS CARDIOVAS MED, V15, P64, DOI 10.1016/j.tcm.2005.02.003; Torsney E, 2007, ATHEROSCLEROSIS, V191, P259, DOI 10.1016/j.atherosclerosis.2006.05.033; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141437	10.1371/journal.pone.0141437	http://dx.doi.org/10.1371/journal.pone.0141437			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540309	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800016
J	Malasao, R; Okamoto, M; Chaimongkol, N; Imamura, T; Tohma, K; Dapat, I; Dapat, C; Suzuki, A; Saito, M; Saito, M; Tamaki, R; Pedrera-Rico, GAG; Aniceto, R; Quicho, RFN; Segubre-Mercado, E; Lupisan, S; Oshitani, H				Malasao, Rungnapa; Okamoto, Michiko; Chaimongkol, Natthawan; Imamura, Tadatsugu; Tohma, Kentaro; Dapat, Isolde; Dapat, Clyde; Suzuki, Akira; Saito, Mayuko; Saito, Mariko; Tamaki, Raita; Granada Pedrera-Rico, Gay Anne; Aniceto, Rapunzel; Negosa Quicho, Reynaldo Frederick; Segubre-Mercado, Edelwisa; Lupisan, Socorro; Oshitani, Hitoshi			Molecular Characterization of Human Respiratory Syncytial Virus in the Philippines, 2012-2013	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; GENOTYPE ON1; G-PROTEIN; HOSPITALIZED CHILDREN; 60-NUCLEOTIDE DUPLICATION; CIRCULATION PATTERNS; ATTACHMENT PROTEIN; B GENOTYPE; SUBGROUP; VARIABILITY	Human respiratory syncytial virus (HRSV) is a major cause of acute lower respiratory tract infections in infants and children worldwide. We performed molecular analysis of HRSV among infants and children with clinical diagnosis of severe pneumonia in four study sites in the Philippines, including Biliran, Leyte, Palawan, and Metro Manila from June 2012 to July 2013. Nasopharyngeal swabs were collected and screened for HRSV using real-time polymerase chain reaction (PCR). Positive samples were tested by conventional PCR and sequenced for the second hypervariable region (2nd HVR) of the G gene. Among a total of 1,505 samples, 423 samples were positive for HRSV (28.1%), of which 305 (72.1%) and 118 (27.9%) were identified as HRSV-A and HRSV-B, respectively. Two genotypes of HRSV-A, NA1 and ON1, were identified during the study period. The novel ON1 genotype with a 72-nucleotide duplication in 2nd HVR of the G gene increased rapidly and finally became the predominant genotype in 2013 with an evolutionary rate higher than the NA1 genotype. Moreover, in the ON1 genotype, we found positive selection at amino acid position 274 (p<0.05) and massive O- and N-glycosylation in the 2nd HVR of the G gene. Among HRSV-B, BA9 was the predominant genotype circulating in the Philippines. However, two sporadic cases of GB2 genotype were found, which might share a common ancestor with other Asian strains. These findings suggest that HRSV is an important cause of severe acute respiratory infection among children in the Philippines and revealed the emergence and subsequent predominance of the ON1 genotype and the sporadic detection of the GB2 genotype. Both genotypes were detected for the first time in the Philippines.	[Malasao, Rungnapa; Okamoto, Michiko; Chaimongkol, Natthawan; Imamura, Tadatsugu; Tohma, Kentaro; Dapat, Isolde; Dapat, Clyde; Suzuki, Akira; Saito, Mayuko; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Saito, Mariko; Tamaki, Raita] Tohoku RITM Collaborating Res Ctr Emerging & Reem, Muntinlupa, Philippines; [Granada Pedrera-Rico, Gay Anne] Biliran Prov Hosp, Naval City, Philippines; [Aniceto, Rapunzel] Eastern Visayas Reg Med Ctr, Tacloban City, Philippines; [Negosa Quicho, Reynaldo Frederick] Ospital Ng Palawan, Puerto Princesa, Philippines; [Segubre-Mercado, Edelwisa; Lupisan, Socorro] Res Inst Trop Med, Muntinlupa, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Oshitani, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Saito, Mayuko/J-4508-2018; Tohma, Kentaro/AAE-4751-2019; Oshitani, Hitoshi/AAE-4349-2019; Dapat, Clyde/B-4196-2009; Okamoto, Michiko/AAE-4373-2019	Saito, Mayuko/0000-0003-4622-7027; Tohma, Kentaro/0000-0002-0456-9355; Dapat, Clyde/0000-0002-7616-4680; Okamoto, Michiko/0000-0002-3505-5939; Malasao, Rungnapa/0000-0002-1280-8782; Suzuki, Akira/0000-0002-8223-0314	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [24249041]; Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Agency for Medical Research and Development (AMED); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED), the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (KAKENHI Grant Number 24249041), the Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST), Japan International Cooperation Agency (JICA) and Japan Agency for Medical Research and Development (AMED).	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Agoti CN, 2013, INFLUENZA OTHER RESP, V7, P1008, DOI 10.1111/irv.12131; AKERLIND B, 1988, J GEN VIROL, V69, P2145, DOI 10.1099/0022-1317-69-9-2145; Almajhdi FN, 2014, VIRUS GENES, V48, P252, DOI 10.1007/s11262-013-1030-z; [Anonymous], 2013, FIELDS VIROLOGY; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; CANE PA, 1993, J VIROL, V67, P1090, DOI 10.1128/JVI.67.2.1090-1093.1993; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Choudhary ML, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00165-13; Collins PL, 2013, FIELDS VIROLOGY, V1, P1087; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Forcic D, 2012, J MED VIROL, V84, P1985, DOI 10.1002/jmv.23425; GARCIA O, 1994, J VIROL, V68, P5448; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Imaz MS, 2000, J MED VIROL, V61, P76, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;76::AID-JMV12&gt;3.0.CO;2-P; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pierangeli A, 2014, EURO SURVEILLANCE BU, V19; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Ren L, 2015, J MED VIROL, V87, P1, DOI 10.1002/jmv.23960; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; WHO, 2013, RESEARCH NEEDS FOR T; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	63	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142192	10.1371/journal.pone.0142192	http://dx.doi.org/10.1371/journal.pone.0142192			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26540236	Green Published, gold, Green Submitted			2022-12-27	WOS:000364303800065
J	Afreen, N; Naqvi, IH; Broor, S; Ahmed, A; Parveen, S				Afreen, Nazia; Naqvi, Irshad H.; Broor, Shobha; Ahmed, Anwar; Parveen, Shama			Phylogenetic and Molecular Clock Analysis of Dengue Serotype 1 and 3 from New Delhi, India	PLOS ONE			English	Article							CO-CIRCULATION; VIRUS; INFECTION; EVOLUTION; GENOTYPE; OUTBREAK; TYPE-3; TAIWAN	Dengue fever is the most prevalent arboviral disease in the tropical and sub-tropical regions of the world. The present report describes molecular detection and serotyping of dengue viruses in acute phase blood samples collected from New Delhi, India. Phylogenetic and molecular clock analysis of dengue virus serotype 1 and 3 strains were also investigated. Dengue virus infection was detected in 68.87% out of 604 samples tested by RT-PCR between 2011 & 2014. Dengue serotype 1 was detected in 25.48% samples, dengue serotype 2 in 79.56% samples and dengue serotype 3 in 11.29% samples. Dengue serotype 4 was not detected. Co-infection by more than one dengue serotype was detected in 18.26% samples. Envelope gene of 29 DENV-1 and 14 DENV-3 strains were sequenced in the study. All the DENV-1 strains grouped with the American African genotype. All DENV-3 strains were found to belong to Genotype III. Nucleotide substitution rates of dengue 1 and 3 viruses were determined in the study. Time to the most recent common ancestor (TMRCA) of dengue 1 viruses was determined to be 132 years. TMRCA of DENV-3 viruses was estimated to be 149 years. Bayesian skyline plots were constructed for Indian DENV-1 and 3 strains which showed a decrease in population size since 2005 in case of DENV-1 strains while no change was observed in recent years in case of DENV-3 strains. The study also revealed a change in the dominating serotype in Delhi, India in recent years. The study will be helpful in formulating control strategies for the outbreaks. In addition, it will also assist in tracking the movement and evolution of this emerging virus.	[Afreen, Nazia; Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Naqvi, Irshad H.] Jamia Millia Islamia, Dr MA Ansari Hlth Ctr, New Delhi 110025, India; [Broor, Shobha] Shree Guru Gobind Singh Tricentenary Univ, Fac Med & Hlth Sci, Dept Microbiol, Gurgaon, Haryana, India; [Ahmed, Anwar] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia	Jamia Millia Islamia; Jamia Millia Islamia; King Saud University	Parveen, S (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	shamp25@yahoo.com	Broor, Shobha/AAX-4163-2021; Ahmed, Anwar/ADH-1445-2022; Ahmed, Anwar/AAL-7789-2021	Broor, Shobha/0000-0001-9679-4180; Ahmed, Anwar/0000-0001-8147-714X; 	University Grants Commission, Government of India;  [41-1287/2012 (SR)]	University Grants Commission, Government of India(University Grants Commission, India); 	Shama Parveen received funding from University Grants Commission, Government of India. The URL of the funder's website is http://www.ugc.ac. in. The grant number is 41-1287/2012 (SR). Nazia Afreen was supported by Senior Research Fellowship of University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen N, 2014, MOL INVESTIGATION 20; Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209; Anoop M, 2010, INDIAN J EXP BIOL, V48, P849; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Chakravarti A, 2013, ARCH VIROL, V158, P571, DOI 10.1007/s00705-012-1522-5; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Dash PK, 2015, VIRUS RES, V195, P124, DOI 10.1016/j.virusres.2014.08.018; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Kukreti H, 2008, INT J INFECT DIS, V12, P542, DOI 10.1016/j.ijid.2008.02.009; Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Mishra G, 2014, J MED VIROL, V2, P1; Nidhi Pandey, 2012, INDIAN J MED RES; Pandey A, 2007, J CLIN VIROL, V40, P87, DOI 10.1016/j.jcv.2007.05.011; Patil JA, 2012, INFECT GENET EVOL, V12, P1759, DOI 10.1016/j.meegid.2012.07.009; Patil JA, 2011, INFECT GENET EVOL, V11, P1443, DOI 10.1016/j.meegid.2011.05.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sharma S, 2011, J GEN VIROL, V92, P1595, DOI 10.1099/vir.0.030437-0; Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2009, WHO TECH REP SER, V958, P1; Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322	31	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141628	10.1371/journal.pone.0141628	http://dx.doi.org/10.1371/journal.pone.0141628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536458	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400073
J	Germer, J; Mann, K; Worheide, G; Jackson, DJ				Germer, Juliane; Mann, Karlheinz; Woerheide, Gert; Jackson, Daniel John			The Skeleton Forming Proteome of an Early Branching Metazoan: A Molecular Survey of the Biomineralization Components Employed by the Coralline Sponge Vaceletia Sp.	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEIN; ORGANIC MATRIX; IN-DEPTH; EVOLUTION; GENOME; CHITIN; CALCIFICATION; GENERATION; PREDICTION	The ability to construct a mineralized skeleton was a major innovation for the Metazoa during their evolution in the late Precambrian/early Cambrian. Porifera (sponges) hold an informative position for efforts aimed at unraveling the origins of this ability because they are widely regarded to be the earliest branching metazoans, and are among the first multi-cellular animals to display the ability to biomineralize in the fossil record. Very few biomineralization associated proteins have been identified in sponges so far, with no transcriptome or proteome scale surveys yet available. In order to understand what genetic repertoire may have been present in the last common ancestor of the Metazoa (LCAM), and that may have contributed to the evolution of the ability to biocalcify, we have studied the skeletal proteome of the coralline demosponge Vaceletia sp. and compare this to other metazoan biomineralizing proteomes. We bring some spatial resolution to this analysis by dividing Vaceletia's aragonitic calcium carbonate skeleton into "head" and "stalk" regions. With our approach we were able to identify 40 proteins from both the head and stalk regions, with many of these sharing some similarity to previously identified gene products from other organisms. Among these proteins are known biomineralization compounds, such as carbonic anhydrase, spherulin, extracellular matrix proteins and very acidic proteins. This report provides the first proteome scale analysis of a calcified poriferan skeletal proteome, and its composition clearly demonstrates that the LCAM contributed several key enzymes and matrix proteins to its descendants that supported the metazoan ability to biocalcify. However, lineage specific evolution is also likely to have contributed significantly to the ability of disparate metazoan lineages to biocalcify.	[Germer, Juliane; Jackson, Daniel John] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany; [Mann, Karlheinz] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Munich, Germany; [Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBioctr, Munich, Germany; [Woerheide, Gert] SNSB Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Gottingen; Max Planck Society; University of Munich; University of Munich	Jackson, DJ (corresponding author), Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany.	djackso@uni-goettingen.de	Jackson, Daniel J./J-5158-2012; Mann, Karlheinz/C-4254-2008; Wörheide, Gert/C-1080-2008	Jackson, Daniel J./0000-0001-9045-381X; Wörheide, Gert/0000-0002-6380-7421	German Excellence Initiative; Deutsche Forschungsmeinschaft (DFG) [JA2108/1-2]; DFG [Wo897/7, Wo896/7-1]; Deutsche Forschungsgemeinschaft [JA2108/1-2, JA2108/1-1]	German Excellence Initiative; Deutsche Forschungsmeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by funding to DJJ through the German Excellence Initiative and Deutsche Forschungsmeinschaft (DFG) project #JA2108/1-2, as well as DFG funding to GW through project Wo897/7 (Deep Downunder).; We would like to acknowledge Matthias Mann (MPI of Biochemistry, Martinsried), for generous support, Gaby Sowa (MPI) for preparing the capillary columns, Korbinian Mayr and Igor Paron (both MPI) for keeping the mass spectrometers in excellent condition. Dorothea Hause-Reitner provided expert SEM and TEM support and Wolfgang Drose assisted with histology work. This work was supported by Deutsche Forschungsgemeinschaft funding to DJJ (JA2108/1-1 and JA2108/1-2). Collection of specimens in the Coral Sea (Australia) during the Deep DownUnder expedition was supported by DFG project Wo896/7-1 to GW.	Allemand D, 1998, J EXP BIOL, V201, P2001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Debrenne F, 2001, PERS PALEOB, P301; Debrenne F., 2002, SYSTEMA PORIFERA GUI, V2, P1539; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Erpenbeck D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-591; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Fang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035715; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Immel F, 2015, J STRUCT BIOL, V190, P360, DOI 10.1016/j.jsb.2015.04.001; Isowa Y, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0077-2; Jackson DJ, 2010, GEOBIOLOGY, V8, P191, DOI 10.1111/j.1472-4669.2010.00236.x; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Jackson DJ, 2015, GENOME BIOL EVOL, V7, P1349, DOI 10.1093/gbe/evv074; Jackson DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-238; JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244; Karlinska-Batres K, 2013, ANTON LEEUW INT J G, V103, P1041, DOI 10.1007/s10482-013-9884-6; Kerner A, 2011, ZOOKEYS, P381, DOI 10.3897/zookeys.150.1566; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Le Roy N, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0075-8; Mann K, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-28; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin Frederic, 2007, P273, DOI 10.1002/9783527619443.ch16; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; Neuhauser N, 2012, MOL CELL PROTEOMICS, V11, P1500, DOI 10.1074/mcp.M112.020271; Palmer GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098388; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Rahman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058781; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Ramos-Silva P, 2013, P NATL ACAD SCI USA, V110, pE2144, DOI 10.1073/pnas.1303657110; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reitner J, 2002, SYSTEMA PORIFERA GUI, P52; Reitner J, 2001, B TOHOKU U MUSEUM, V1, P229; Reitner Joachim, 1997, Courier Forschungsinstitut Senckenberg, V201, P371; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Romeis B, 1989, MIKROSKOPISCHE TECHN, P443; Rowland SM, 2001, J PALEONTOL, V75, P1065, DOI 10.1666/0022-3360(2001)075<1065:AAHOPI>2.0.CO;2; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Scheltema RA, 2012, J PROTEOME RES, V11, P3458, DOI 10.1021/pr201219e; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer ELL, P 6 INT C INT SYST M; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Uriz MJ, 2012, EVOLUTION, V66, P2993, DOI 10.1111/j.1558-5646.2012.01676.x; VACELET J, 1977, CR ACAD SCI D NAT, V285, P509; Vacelet J, 2002, SYSTEMA PORIFERA GUI, P1097, DOI DOI 10.1007/978-1-4615-0747-5; Voigt O, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0230-z; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Whelan NV, 2015, INTEGR COMP BIOL, V55, P1084, DOI 10.1093/icb/icv037; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Worheide G, 2008, MOL PHYLOGENET EVOL, V47, P433, DOI 10.1016/j.ympev.2008.01.021; Worheide Gert, 1996, P145	81	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140100	10.1371/journal.pone.0140100	http://dx.doi.org/10.1371/journal.pone.0140100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536128	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400016
J	Toy, M; Hutton, DW; So, SK				Toy, Mehlika; Hutton, David W.; So, Samuel K.			Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; NUCLEOSIDE-NAIVE PATIENTS; E-ANTIGEN SEROCONVERSION; ADEFOVIR DIPIVOXIL; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; HBSAG SEROCLEARANCE; SUSTAINED RESPONSE; VIRUS INFECTION; RESCUE THERAPY	Chronic liver disease and liver cancer associated with chronic hepatitis B (CHB) are leading causes of death among adults in China. Although newborn hepatitis B immunization has successfully reduced the prevalence of CHB in children, about 100 million Chinese adults remain chronically infected. If left unmanaged, 15-25% will die from liver cancer or liver cirrhosis. Antiviral treatment is not necessary for all patients with CHB, but when it is indicated, good response to treatment would prevent disease progression and reduce disease mortality and morbidity, and costly complications. The aim of this study is to analyze the cost-effectiveness of generic and brand antiviral drugs for CHB treatment in China, and assessing various thresholds at which a highly potent, low resistance antiviral drug would be cost-saving and/or cost-effective to introduce in a national treatment program. We developed a Markov simulation model of disease progression using effectiveness and cost data from the medical literature. We measured life-time costs, quality adjusted life years (QALYs), incremental cost-effectiveness ratios (ICERs), and clinical outcomes. The no treatment strategy incurred the highest health care costs ($12,932-$25,293) per patient, and the worst health outcomes, compared to the antiviral treatment strategies. Monotherapy with either entecavir or tenofovir yielded the most QALYs (14.10-19.02) for both HBeAg-positive and negative patients, with or without cirrhosis. Threshold analysis showed entercavir or tenofovir treatment would be cost saving if the drug price is $32-75 (195-460 RMB) per month, highly cost-effective at $62-110 (379-670 RMB) per month and cost-effective at $63-120 (384-734 RMB) per month. This study can support policy decisions regarding the implementation of a national health program for chronic hepatitis B treatment in China at the population level.	[Toy, Mehlika; So, Samuel K.] Stanford Univ, Sch Med, Dept Surg, Asian Liver Ctr, Stanford, CA 94305 USA; [Hutton, David W.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan	Toy, M (corresponding author), Stanford Univ, Sch Med, Dept Surg, Asian Liver Ctr, Stanford, CA 94305 USA.	mtoy@stanford.edu		Toy, Mehlika/0000-0001-7848-4816	Stanford Asian Liver Center; Stanford University	Stanford Asian Liver Center; Stanford University(Stanford University)	Funding: This study was supported by the Stanford Asian Liver Center and the CJ Huang and Ha Lin Yip Huang research funds from Stanford University.	Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CH, 2006, ANTIVIR THER, V11, P771; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Cho JY, 2014, GUT, V63, P1943, DOI 10.1136/gutjnl-2013-306409; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2009, AM J GASTROENTEROL, V104, P1693, DOI 10.1038/ajg.2009.187; Colonno RJ, 2007, J HEPATOL, V46, pS294, DOI 10.1016/S0168-8278(07)62379-4; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Gordon SC, 2013, HEPATOLOGY, V58, P505, DOI 10.1002/hep.26277; Guan ZQ, 2004, J CLIN GASTROENTEROL, V38, pS175, DOI 10.1097/00004836-200411003-00010; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Hutton DW, 2010, HEPATOLOGY, V51, P405, DOI 10.1002/hep.23310; Kanwal F, 2005, ANN INTERN MED, V142, P821, DOI 10.7326/0003-4819-142-10-200505170-00007; Ke WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098865; Kennedy PTF, 2008, LIVER INT, V28, P699, DOI 10.1111/j.1478-3231.2008.01717.x; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee CI, 2014, GUT LIVER, V8, P64, DOI 10.5009/gnl.2014.8.1.64; Lee YS, 2006, HEPATOLOGY, V43, P1385, DOI 10.1002/hep.21189; Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; LI N, 2012, CHINESE J HLTH POLIC, V5; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; Lin XM, 2005, J GASTROEN HEPATOL, V20, P833, DOI [10.1111/j.1440-1746.2005.03813.x, 10.1111/j.1400-1746.2005.03813.x]; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Moskovitz DN, 2005, J VIRAL HEPATITIS, V12, P398, DOI 10.1111/j.1365-2893.2005.00613.x; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Reijnders JGP, 2008, J HEPATOL, V48, P383, DOI 10.1016/j.jhep.2007.12.006; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Shouval D, 2009, J HEPATOL, V50, P289, DOI 10.1016/j.jhep.2008.10.017; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Toy M, 2014, HEPATOLOGY, V60, P46, DOI 10.1002/hep.26934; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; World Health Organization, 2003, WHO GUID COST EFF; Yeon JE, 2006, GUT, V55, DOI 10.1136/gut.2005.077099; Yin WY, 2009, CHINESE MED J-PEKING, V122, P1346, DOI 10.3760/cma.j.issn.0366-6999.2009.11.020; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139876	10.1371/journal.pone.0139876	http://dx.doi.org/10.1371/journal.pone.0139876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536626	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400012
J	David, S; Mateus, ARA; Duarte, EL; Albuquerque, J; Portugal, C; Sancho, L; Lavinha, J; Goncalves, G				David, Susana; Mateus, A. R. A.; Duarte, Elsa L.; Albuquerque, Jose; Portugal, Clara; Sancho, Luisa; Lavinha, Joao; Goncalves, Guilherme			Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; BRIEF EPIDEMIOLOGIC HISTORY; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; GLOBAL DISTRIBUTION; GENETIC DIVERSITY; MIRU-VNTRPLUS; SUSCEPTIBILITY; TRANSMISSION; SUBLINEAGE	Major contributions from pathogen genome analysis and host genetics have equated the possibility of Mycobacterium tuberculosis co-evolution with its human host leading to more stable sympatric host-pathogen relationships. However, the attribution to either sympatric or allopatric categories depends on the resolution or grain of genotypic characterization. We explored the influence on the sympatric host-pathogen relationship of clinical (HIV infection and multidrug-resistant tuberculosis [MDRTB]) and demographic (gender and age) factors in regards to the genotypic grain by using spacer oligonucleotide typing (spoligotyping) for classification of M. tuberculosis strains within the Euro-American lineage. We analyzed a total of 547 tuberculosis (TB) cases, from six year consecutive sampling in a setting with high TB-HIV coinfection (32.0%). Of these, 62.0% were caused by major circulating pathogen genotypes. The sympatric relationship was defined according to spoligotype in comparison to the international spoligotype database SpolDB4. While no significant association with Euro-American lineage was observed with any of the factors analyzed, increasing the resolution with spoligotyping evidenced a significant association of MDRTB with sympatric strains, regardless of the HIV status. Furthermore, distribution curves of the prevalence of sympatric and allopatric TB in relation to patients' age showed an accentuation of the relevance of the age of onset in the allopatric relationship, as reflected in the trimodal distribution. On the contrary, sympatric TB was characterized by the tendency towards a typical (standard) distribution curve. Our results suggest that within the Euro-American lineage a greater degree of genotyping fine-tuning is necessary in modeling the biological processes behind the host-pathogen interplay. Furthermore, prevalence distribution of sympatric TB to age was suggestive of host genetic determinisms driven by more common variants.	[David, Susana; Albuquerque, Jose; Lavinha, Joao] Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Genet Humana, Lisbon, Portugal; [Mateus, A. R. A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mateus, A. R. A.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Duarte, Elsa L.] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, Escola Ciencias & Tecnol, Evora, Portugal; [Portugal, Clara; Sancho, Luisa] Hosp Fernando Fonseca, Serv Patol Clin, Amadora, Portugal; [Goncalves, Guilherme] Inst Ciencias Biomed Abel Salazar, Unidade Multidisciplinar Invest Biomed, Oporto, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Instituto Gulbenkian de Ciencia; Leiden University; Leiden University - Excl LUMC; University of Evora; Hospital Professor Doutor Fernando Fonseca, EPE; Universidade do Porto	David, S (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Genet Humana, Lisbon, Portugal.	david.suzana@gmail.com		Goncalves, Guilherme/0000-0003-0030-3346; Portugal, Clara/0000-0003-3904-1486; David, Susana/0000-0001-6483-8660; Leclerc Duarte, Elsa/0000-0003-0589-3533	Luso-American Development Foundation (LACR Award program); Fundacao para a Ciencia e Tecnologia (FCT), Portugal [POCTI/ESP/44826/2002]; Fundação para a Ciência e a Tecnologia [POCTI/ESP/44826/2002] Funding Source: FCT	Luso-American Development Foundation (LACR Award program); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by the Luso-American Development Foundation (LACR Award program - 2007) and the Fundacao para a Ciencia e Tecnologia (FCT), Portugal, (grant reference: POCTI/ESP/44826/2002), coparticipated by the European Community fund FEDER.	Abel L, 2000, AM J HUM GENET, V67, P274, DOI 10.1086/303033; Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Alcais A., 2001, Sepsis, V4, P237, DOI 10.1023/A:1012917124511; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2008, EUR TB NAT COORD TUB; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Bellamy R, 1998, THORAX, V53, P588, DOI 10.1136/thx.53.7.588; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Briz T, 2009, REV PORTUGUESA SAUDE, V27, P19; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cobat A, 2013, PUBLIC HEALTH GENOM, V16, P44, DOI 10.1159/000341499; DAVID HL, 1978, INT J SYST BACTERIOL, V28, P467; David S, 2012, INFECT GENET EVOL, V12, P1362, DOI 10.1016/j.meegid.2012.04.021; David S, 2007, INFECT GENET EVOL, V7, P609, DOI 10.1016/j.meegid.2007.05.007; Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P426; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutierrez MC, 1998, J CLIN MICROBIOL, V36, P486; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hollo V, 2009, EUROSURVEILLANCE, V14; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Lipsitch M, 2002, GENETICS, V161, P1599; Maio JN, 2008, THESIS U PORTO PORTU; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Pasipanodya JG, 2013, INFECT GENET EVOL, V16, P433, DOI 10.1016/j.meegid.2013.02.015; Perdigao J, 2011, CLIN MICROBIOL INFEC, V17, P1397, DOI 10.1111/j.1469-0691.2010.03351.x; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Portugal I, 1999, INT J TUBERC LUNG D, V3, P207; Portugal INE, 2005, EST IM; Rahim Z., 2006, 27 ANN C EUR SOC MYC; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ribeiro JN, 2008, THESIS U PORTO PORTU; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 2015, TUBERCULOSIS, V95, pS159, DOI 10.1016/j.tube.2015.02.029; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; Stead WW, 1997, CLIN CHEST MED, V18, P65, DOI 10.1016/S0272-5231(05)70356-7; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; Stead WW, 1996, TUBERCULOSIS, P77; Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220; van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	70	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140625	10.1371/journal.pone.0140625	http://dx.doi.org/10.1371/journal.pone.0140625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529092	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600009
J	Gallego-Iradi, MC; Clare, AM; Brown, HH; Janus, C; Lewis, J; Borchelt, DR				Gallego-Iradi, M. Carolina; Clare, Alexis M.; Brown, Hilda H.; Janus, Christopher; Lewis, Jada; Borchelt, David R.			Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy	PLOS ONE			English	Article							STRESS GRANULES; MESSENGER-RNA; PROTEIN; TDP-43; PHOSPHORYLATION; HETEROGENEITY; ACTIVATION; PHENOTYPE; G3BP1	Background Mutations in Matrin 3 [MATR3], an RNA-and DNA-binding protein normally localized to the nucleus, have been linked to amyotrophic lateral sclerosis (ALS) and distal myopathies. In the present study, we have used transient transfection of cultured cell lines to examine the impact of different disease-causing mutations on the localization of Matrin 3 within cells. Results Using CHO and human H4 neuroglioma cell models, we find that ALS/myopathy mutations do not produce profound changes in the localization of the protein. Although we did observe variable levels of Matrin 3 in the cytoplasm either by immunostaining or visualization of fluorescently-tagged protein, the majority of cells expressing either wild-type (WT) or mutant Matrin 3 showed nuclear localization of the protein. When cytoplasmic immunostaining, or fusion protein fluorescence, was seen in the cytoplasm, the stronger intensity of staining or fluorescence was usually evident in the nucleus. In similar to 80% of cells treated with sodium arsenite (Ars) to induce cytoplasmic stress granules, the nuclear localization of WT and F115C mutant Matrin 3 was not disturbed. Notably, over-expression of mutant Matrin 3 did not induce the formation of obvious large inclusion-like structures in either the cytoplasm or nucleus. Conclusions Our findings indicate that mutations in Matrin 3 that are associated with ALS and myopathy do not dramatically alter the normal localization of the protein or readily induce inclusion formation.	[Gallego-Iradi, M. Carolina; Clare, Alexis M.; Brown, Hilda H.; Janus, Christopher; Lewis, Jada; Borchelt, David R.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Gallego-Iradi, M. Carolina; Brown, Hilda H.; Borchelt, David R.] Univ Florida, Santa Fe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	drb1@ufl.edu			McKnight Brain Institute at the University of Florida	McKnight Brain Institute at the University of Florida	Support was provided by the McKnight Brain Institute at the University of Florida [http://mbi.ufl.edu/].	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Coelho MB, 2015, EMBO J, V34, P653, DOI 10.15252/embj.201489852; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Depreux FF, 2015, HUM MOL GENET, V24, P4284, DOI 10.1093/hmg/ddv160; Erazo A, 2011, J VIROL, V85, P568, DOI 10.1128/JVI.01611-10; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Martelli AM, 1998, J HISTOCHEM CYTOCHEM, V46, P863, DOI 10.1177/002215549804600710; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Millecamps S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.016; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Muller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Palmio J, 2015, J NEUROL NEUROSURG P; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Tanaka T, 2014, BBA-GEN SUBJECTS, V1840, P985, DOI 10.1016/j.bbagen.2013.11.002; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	37	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142144	10.1371/journal.pone.0142144	http://dx.doi.org/10.1371/journal.pone.0142144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528920	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600108
J	Fahey, JW; Holtzclaw, WD; Wehage, SL; Wade, KL; Stephenson, KK; Talalay, P				Fahey, Jed W.; Holtzclaw, W. David; Wehage, Scott L.; Wade, Kristina L.; Stephenson, Katherine K.; Talalay, Paul			Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QUANTITATIVE-DETERMINATION; ISOTHIOCYANATES; ACTIVATION; SPROUTS; PHASE; CHEMOPREVENTION; IDENTIFICATION; PURIFICATION; METABOLISM	Glucoraphanin from broccoli and its sprouts and seeds is a water soluble and relatively inert precursor of sulforaphane, the reactive isothiocyanate that potently inhibits neoplastic cellular processes and prevents a number of disease states. Sulforaphane is difficult to deliver in an enriched and stable form for purposes of direct human consumption. We have focused upon evaluating the bioavailability of sulforaphane, either by direct administration of glucoraphanin (a glucosinolate, or beta-thioglucoside-N-hydroxysulfate), or by co-administering glucoraphanin and the enzyme myrosinase to catalyze its conversion to sulforaphane at economic, reproducible and sustainable yields. We show that following administration of glucoraphanin in a commercially prepared dietary supplement to a small number of human volunteers, the volunteers had equivalent output of sulforaphane metabolites in their urine to that which they produced when given an equimolar dose of glucoraphanin in a simple boiled and lyophilized extract of broccoli sprouts. Furthermore, when either broccoli sprouts or seeds are administered directly to subjects without prior extraction and consequent inactivation of endogenous myrosinase, regardless of the delivery matrix or dose, the sulforaphane in those preparations is 3- to 4-fold more bioavailable than sulforaphane from glucoraphanin delivered without active plant myrosinase. These data expand upon earlier reports of inter-and intra-individual variability, when glucoraphanin was delivered in either teas, juices, or gelatin capsules, and they confirm that a variety of delivery matrices may be equally suitable for glucoraphanin supplementation (e.g. fruit juices, water, or various types of capsules and tablets).	[Fahey, Jed W.; Holtzclaw, W. David; Wehage, Scott L.; Wade, Kristina L.; Stephenson, Katherine K.; Talalay, Paul] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Fahey, Jed W.; Talalay, Paul] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fahey, JW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jfahey@jhmi.edu		Wade, Kristina/0000-0003-0076-3895	Brassica Protection Products LLC; Lewis B. and Dorothy Cullman Foundation	Brassica Protection Products LLC; Lewis B. and Dorothy Cullman Foundation	This work was supported by a generous non-restricted donation from the Lewis B. and Dorothy Cullman Foundation. Funding to cover the cost of including a commercial supplement was provided by Brassica Protection Products LLC, and the supplements themselves were provided free of charge by their manufacturer (Xymogen) as detailed in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alumkal JJ, 2015, INVEST NEW DRUG, V33, P480, DOI 10.1007/s10637-014-0189-z; Bierwirth J. E., 2015, NFS Journal, V1, P24, DOI 10.1016/j.nfs.2015.07.001; Brown R, 2015, RESP RES IN PRESS; Cipolla BG, 2015, CANCER PREV RES, V8, P712, DOI 10.1158/1940-6207.CAPR-14-0459; Dinkova-Kostova AT, 2010, ACTA HORTIC, V867, P27, DOI 10.17660/ActaHortic.2010.867.2; Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; Fahey JW, 2007, CHEM RES TOXICOL, V20, P572, DOI 10.1021/tx7000459; Fahey Jed W, 2013, Virtual Mentor, V15, P311, DOI 10.1001/virtualmentor.2013.15.4.stas1-1304; Fahey JW, 2012, CANCER PREV RES, V5, P603, DOI 10.1158/1940-6207.CAPR-11-0538; Fahey JW, 2012, CANCER PREV RES, V5, P179, DOI 10.1158/1940-6207.CAPR-11-0572; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fisher D, 2005, J LIQ CHROMATOGR R T, V28, P1913, DOI 10.1081/JLC-200063563; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Knatko EV, 2015, CANCER PREV RES, V8, P475, DOI 10.1158/1940-6207.CAPR-14-0362; Poulton EJ, 2013, TOXICOL APPL PHARM, V266, P122, DOI 10.1016/j.taap.2012.10.029; Prestera T, 1996, ANAL BIOCHEM, V239, P168, DOI 10.1006/abio.1996.0312; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Shikita M, 1999, BIOCHEM J, V341, P725, DOI 10.1042/0264-6021:3410725; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Tang L, 2006, MOL CANCER THER, V5, P935, DOI 10.1158/1535-7163.MCT-05-0476; Wade KL, 2007, J CHROMATOGR A, V1154, P469, DOI 10.1016/j.chroma.2007.04.034; Wade KL, 2015, PHYTOCHEM ANALYSIS, V26, P47, DOI 10.1002/pca.2535; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 1996, ANAL BIOCHEM, V239, P160, DOI 10.1006/abio.1996.0311	31	95	97	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140963	10.1371/journal.pone.0140963	http://dx.doi.org/10.1371/journal.pone.0140963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524341	gold, Green Published, Green Submitted			2022-12-27	WOS:000364029800005
J	Berger, S; Schlather, M; Campos, GD; Weigend, S; Preisinger, R; Erbe, M; Simianer, H				Berger, Swetlana; Schlather, Martin; de los Campos, Gustavo; Weigend, Steffen; Preisinger, Rudolf; Erbe, Malena; Simianer, Henner			A Scale-Corrected Comparison of Linkage Disequilibrium Levels between Genic and Non-Genic Regions	PLOS ONE			English	Article							RECOMBINATION RATE VARIATION; R(2) MEASURE; ASSOCIATION; PATTERNS; GENOMICS; SEQUENCE; DESIGN	The understanding of non-random association between loci, termed linkage disequilibrium (LD), plays a central role in genomic research. Since causal mutations are generally not included in genomic marker data, LD between those and available markers is essential for capturing the effects of causal loci on localizing genes responsible for traits. Thus, the interpretation of association studies requires a detailed knowledge of LD patterns. It is well known that most LD measures depend on minor allele frequencies (MAF) of the considered loci and the magnitude of LD is influenced by the physical distances between loci. In the present study, a procedure to compare the LD structure between genomic regions comprising several markers each is suggested. The approach accounts for different scaling factors, namely the distribution of MAF, the distribution of pair-wise differences in MAF, and the physical extent of compared regions, reflected by the distribution of pair-wise physical distances. In the first step, genomic regions are matched based on similarity in these scaling factors. In the second step, chromosome-and genome-wide significance tests for differences in medians of LD measures in each pair are performed. The proposed framework was applied to test the hypothesis that the average LD is different in genic and non-genic regions. This was tested with a genome-wide approach with data sets for humans (Homo sapiens), a highly selected chicken line (Gallus gallus domesticus) and the model plant Arabidopsis thaliana. In all three data sets we found a significantly higher level of LD in genic regions compared to non-genic regions. About 31% more LD was detected genome-wide in genic compared to non-genic regions in Arabidopsis thaliana, followed by 13.6% in human and 6% chicken. Chromosome-wide comparison discovered significant differences on all 5 chromosomes in Arabidopsis thaliana and on one third of the human and of the chicken chromosomes.	[Berger, Swetlana; Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany; [Schlather, Martin] Univ Mannheim, Sch Business Informat & Math, D-68131 Mannheim, Germany; [de los Campos, Gustavo] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI USA; [Weigend, Steffen] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany; [Preisinger, Rudolf] Lohmann Tierzucht GmbH, Cuxhaven, Germany	University of Gottingen; University of Mannheim; Michigan State University; Friedrich Loeffler Institute	Berger, S (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany.	swmiller@gwdg.de			German Research Foundation (DFG); RTG [1644]; German 24 Federal Ministry of Education and Research [0315528C]	German Research Foundation (DFG)(German Research Foundation (DFG)); RTG; German 24 Federal Ministry of Education and Research	This study was financially supported by RTG 1644 'Scaling Problems in Statistics' 22, financed by the German Research Foundation (DFG). The funder provided support in the form of salaries for author (SB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Chicken genotypes were generated in the AgroClustEr 23 "Synbreed - Synergistic Plant and Animal Breeding" (Funding ID: 0315528C) funded by the German 24 Federal Ministry of Education and Research.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; [Anonymous], 2014, R LANG ENV STAT COMP; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; DOBRUSHIN RL, 1970, THEOR PROBAB APPL+, V15, P458, DOI 10.1137/1115049; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Flicek P, 2013, NUCLEIC ACIDS RES; Garner C, 2003, GENET EPIDEMIOL, V24, P57, DOI 10.1002/gepi.10217; Gianola D, 2012, ANIM GENET, V43, P19, DOI 10.1111/j.1365-2052.2012.02326.x; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Gulko B, 2014, BIORXIV; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hussin JG, 2015, NAT GENET, V47, P400, DOI 10.1038/ng.3216; Huttley GA, 1999, GENETICS, V152, P1711; Johnson PLF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000674; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kersey PJ, 2014, PLANT AN GEN 22 C PL; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Krakauer DC, 2000, EVOLUTION, V54, P731, DOI 10.1111/j.0014-3820.2000.tb00075.x; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LASKA EM, 1975, LANCET, V2, P296, DOI 10.1016/S0140-6736(75)92731-2; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; Li DF, 2012, POULTRY SCI, V91, P1804, DOI 10.3382/ps.2012-02275; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Meuwissen THE, 2002, GENETICS, V161, P373; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355; Nachman MW, 2012, PHILOS T R SOC B, V367, P409, DOI 10.1098/rstb.2011.0249; NEI M, 1981, GENETICS, V97, P145; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romiguier J, 2014, J EVOLUTION BIOL, V27, P593, DOI 10.1111/jeb.12331; Simianer H, 2014, J ANIM BREED GENET, V131, P83, DOI 10.1111/jbg.12072; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Smith EM, 2006, GENOMICS, V88, P407, DOI 10.1016/j.ygeno.2006.04.004; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Uimari P, 2005, TWIN RES HUM GENET, V8, P185, DOI 10.1375/1832427054253086; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; Vaserstein LN., 1969, PROBL PEREDACHI INF, V5, P64; Wickham H., 2013, GGPLOT2 IMPLEMENTATI; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Xu Y, 2013, CEREAL GENOMICS 2, P375; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhao JY, 2005, AM J HUM GENET, V77, P27, DOI 10.1086/431243; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	65	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141216	10.1371/journal.pone.0141216	http://dx.doi.org/10.1371/journal.pone.0141216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517830	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800029
J	Diabate, S; Druetz, T; Millogo, T; Ly, A; Fregonese, F; Kouanda, S; Haddad, S				Diabate, Souleymane; Druetz, Thomas; Millogo, Tieba; Ly, Antarou; Fregonese, Federica; Kouanda, Seni; Haddad, Slim			Domestic Larval Control Practices and Malaria Prevalence among Under-Five Children in Burkina Faso	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; COMMUNITY KNOWLEDGE; ANOPHELES-GAMBIAE; VECTORS; OWNERSHIP; KAYA; TOWN	Introduction Larval source management has contributed to malaria decline over the past years. However, little is known about the impact of larval control practices undertaken at the household level on malaria transmission. Methods The study was conducted in Kaya health district after the 2010 mass distribution of insecticide treated-nets and the initiation of malaria awareness campaigns in Burkina Faso. The aim was to (i) estimate the level of domestic larval control practices (cleaning of the house and its surroundings, eradication of larval sources, and elimination of hollow objects that might collect water); (ii) identify key determinants; and (iii) explore the structural relationships between these practices, participation in awareness-raising activities and mothers' knowledge/attitudes/practices, and malaria prevalence among under-five children. Results Overall, 2004 households were surveyed and 1,705 under-five children were examined. Half of the mothers undertook at least one action to control larval proliferation. Mothers who had gone to school had better knowledge about malaria and were more likely to undertake domestic larval control practices. Living in highly exposed rural areas significantly decreased the odds of undertaking larval control actions. Mothers' participation in malaria information sessions increased the adoption of vector control actions and bednet use. Malaria prevalence was statistically lower among children in households where mothers had undertaken at least one vector control action or used bed-nets. There was a 0.16 standard deviation decrease in malaria prevalence for every standard deviation increase in vector control practices. The effect of bednet use on malaria prevalence was of the same magnitude. Conclusion Cleaning the house and its surroundings, eradicating breeding sites, and eliminating hollow objects that might collect water play a substantial role in preventing malaria among under-five. There is a need for national malaria control programs to include or reinforce training activities for community health workers aimed at promoting domestic larval control practices.	[Diabate, Souleymane; Haddad, Slim] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Diabate, Souleymane; Haddad, Slim] St Sacrement Hosp, CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Druetz, Thomas; Fregonese, Federica] Univ Montreal Hosp Res Ctr CRCHUM, Montreal, PQ, Canada; [Millogo, Tieba] Inst Africain Sante Publ, Ouagadougou, Burkina Faso; [Ly, Antarou; Kouanda, Seni] IRSS CNRST, Ouagadougou, Burkina Faso	Laval University; Laval University; Universite de Montreal	Diabate, S (corresponding author), Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada.	dsouleym@hotmail.com	MILLOGO, Tieba/AAJ-6028-2020	MILLOGO, Tieba/0000-0003-3548-3789; Ly, Antarou/0000-0001-7111-4054; Druetz, Thomas/0000-0002-9234-4286	Canadian Institutes of Health Research (CIHR) [GIR-229157]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was carried out with a grant from the Canadian Institutes of Health Research (CIHR, grant # GIR-229157), [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Amoran Olorunfemi Emmanuel, 2013, Niger Med J, V54, P115, DOI 10.4103/0300-1652.110046; [Anonymous], 2008, MAL RAP DIAGN TEST P; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2010, MALAR RES TREAT; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Diabate S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-353; Druetz T, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0591-9; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x; Keating J, 2003, AM J TROP MED HYG, V68, P357; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kouanda S, 2013, INT J EPIDEMIOL, V42, P741, DOI 10.1093/ije/dyt076; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Menard S. W., 2010, SAGE, DOI DOI 10.4135/9781483348964; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Ministere de la sante, 2007, PLAN STRAT LUTT PAL; Ministere de la Sante, 2009, MOD FORM AG SANT COM; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Namountougou M, 2012, ACTA TROP, V7, P48412, DOI DOI 10.1371/J0URNAL.P0NE.0048412; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ridde V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069865; Roll Back Partenership, 2014, MAL BEH CHANG COMM B; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salkind N. J, 2010, ENCY RES DESIGN, V1, DOI 10.4135/9781412961288.n35.SAGEPublicationsInc; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Sichande M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-378; Singh Rupashree, 2014, J Family Med Prim Care, V3, P39, DOI 10.4103/2249-4863.130271; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; StataCorp, 2013, STAT REL 13 STAT SOF; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Tokponnon FT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-265; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2013, LARV SOURC MAN SUPPL; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141784	10.1371/journal.pone.0141784	http://dx.doi.org/10.1371/journal.pone.0141784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517727	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800076
J	Faigle, R; Marsh, EB; Llinas, RH; Urrutia, VC				Faigle, Roland; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.			Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA - Does One Size Fit All?	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GLOMERULAR-FILTRATION-RATE; TRANSIENT ISCHEMIC ATTACK; STROKE MIMICS; SERUM CREATININE; RT-PA; THROMBOLYSIS; RISK; ASSOCIATION; MANAGEMENT	Background and Purpose Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ischemic stroke are currently monitored in an intensive care unit (ICU) or a comparable stroke unit for at least 24 hours due to the high frequency of neurological exams and vital sign checks. The present study evaluates ICU needs in patients with diffusion-weighted imaging (DWI) negative MRI after IV tPA. Methods A retrospective chart review was performed for 209 patients who received IV tPA for acute stroke. Data on stroke risk factors, physiologic parameters, stroke severity, MRI characteristics, and final diagnosis were collected. The timing and nature of ICU interventions, if needed, was recorded. Multivariable logistic regression was used to determine factors associated with subsequent ICU needs. Results Patients with cerebral infarct on MRI after tPA had over 9 times higher odds of requiring ICU care compared to patients with DWI negative MRI (OR 9.2, 95% CI 2.49-34.15). All DWI negative patients requiring ICU care did so by the end of tPA infusion (p = 0.006). Among patients with DWI negative MRI, need for ICU interventions was associated with higher NIH Stroke Scale (NIHSS) scores (p < 0.001), uncontrolled hypertension (p < 0.001), seizure at onset (p = 0.002), and reduced estimated glomerular filtration rate (eGFR) (p = 0.010). Conclusions Only a small number of DWI negative patients required ICU care. In patients without critical care needs by the end of thrombolysis, post-tPA MRI may be considered for triaging DWI negative patients to a less resource intense monitoring environment.	[Faigle, Roland; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Faigle, R (corresponding author), Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA.	rfaigle1@jhmi.edu	Faigle, Roland/ABB-9082-2020; Urrutia, Victor/AAH-6683-2021	Faigle, Roland/0000-0002-9074-1915; Urrutia, Victor/0000-0002-4995-6949; Marsh, Elisabeth/0000-0002-2385-5074; Llinas, Rafael/0000-0002-9161-2699	R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery [RFA-NS-09-001]	R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery	RF was supported by a R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery (RFA-NS-09-001); (http://www.ninds.nih.gov/funding/r25_institutions.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernyshev OY, 2010, NEUROLOGY, V74, P1340, DOI 10.1212/WNL.0b013e3181dad5a6; Faigle R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088652; Freeman JW, 2013, STROKE, V44, P1629, DOI 10.1161/STROKEAHA.111.000486; Gensicke H, 2013, NEUROLOGY, V81, P1780, DOI 10.1212/01.wnl.0000435550.83200.9e; Giraldo EA, 2011, NEUROCRIT CARE, V15, P76, DOI 10.1007/s12028-011-9523-x; Hacke W, 2004, LANCET, V363, P768; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marsh EB, 2013, MEDICINE, V92, P317, DOI 10.1097/MD.0000000000000006; Naganuma M, 2011, CEREBROVASC DIS, V31, P123, DOI 10.1159/000321516; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Sylaja PN, 2008, STROKE, V39, P1898, DOI 10.1161/STROKEAHA.107.497453; Uchino K, 2010, CEREBROVASC DIS, V29, P57, DOI 10.1159/000255975; Winkler DT, 2009, STROKE, V40, P1522, DOI 10.1161/STROKEAHA.108.530352; Zinkstok SM, 2013, STROKE, V44, P1080, DOI 10.1161/STROKEAHA.111.000126	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141204	10.1371/journal.pone.0141204	http://dx.doi.org/10.1371/journal.pone.0141204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517543	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800027
J	Wang, WQ; Zhang, W; Wu, YR; Maliga, P; Messing, J				Wang, Wenqin; Zhang, Wei; Wu, Yongrui; Maliga, Pal; Messing, Joachim			RNA Editing in Chloroplasts of Spirodela polyrhiza, an Aquatic Monocotelydonous Species	PLOS ONE			English	Article							PLASTID RNA; PLANT; TRANSCRIPT; GENOME; DIVERGENCE; SITES; EXPRESSION; EVENTS	RNA editing is the post-transcriptional conversion from C to U before translation, providing a unique feature in the regulation of gene expression. Here, we used a robust and efficient method based on RNA-seq from non-ribosomal total RNA to simultaneously measure chloroplast-gene expression and RNA editing efficiency in the Greater Duckweed, Spirodela polyrhiza, a species that provides a new reference for the phylogenetic studies of monocoty-ledonous plants. We identified 66 editing sites at the genome-wide level, with an average editing efficiency of 76%. We found that the expression levels of chloroplast genes were relatively constant, but 11 RNA editing sites show significant changes in editing efficiency, when fronds turn into turions. Thus, RNA editing efficiency contributes more to the yield of translatable transcripts than steady state mRNA levels. Comparison of RNA editing sites in coconut, Spirodela, maize, and rice suggests that RNA editing originated from a common ancestor.	[Wang, Wenqin; Zhang, Wei; Wu, Yongrui; Maliga, Pal; Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Messing, J (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	messing@waksman.rutgers.edu	Wang, Wenqin/AAR-2970-2021	Wang, Wenqin/0000-0001-6427-6338; Messing, Joachim/0000-0001-8260-2643				BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Kuhn J, 2001, MOL CELL BIOL, V21, P731, DOI 10.1128/MCB.21.3.731-742.2001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lu BW, 1996, MOL CELL BIOL, V16, P1543; Maier RM, 1996, PLANT MOL BIOL, V32, P343, DOI 10.1007/BF00039390; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Phreaner CG, 1996, PLANT CELL, V8, P107, DOI 10.1105/tpc.8.1.107; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stomp AM, 2005, BIOTECHNOL ANN REV, V11, P69, DOI 10.1016/S1387-2656(05)11002-3; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang WQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-60; Wang WQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-5; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; ZELTZ P, 1993, EMBO J, V12, P4291, DOI 10.1002/j.1460-2075.1993.tb06113.x; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058	34	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140285	10.1371/journal.pone.0140285	http://dx.doi.org/10.1371/journal.pone.0140285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517707	Green Submitted, gold, Green Published			2022-12-27	WOS:000363920800004
J	Zhao, HM; Huang, G; Li, Y; Ma, J; Sheng, JD; Jia, HT; Li, CJ				Zhao, Hongmei; Huang, Gang; Li, Yan; Ma, Jian; Sheng, Jiandong; Jia, Hongtao; Li, Congjuan			Effects of Increased Summer Precipitation and Nitrogen Addition on Root Decomposition in a Temperate Desert	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; GLOBAL PATTERNS; CLIMATE-CHANGE; WATER PULSES; LAND-USE; RATES; DYNAMICS; NUTRIENT; PINE; AVAILABILITY	Background Climate change scenarios that include precipitation shifts and nitrogen (N) deposition are impacting carbon (C) budgets in arid ecosystems. Roots constitute an important part of the C cycle, but it is still unclear which factors control root mass loss and nutrient release in arid lands. Methodology/Principal Findings Litterbags were used to investigate the decomposition rate and nutrient dynamics in root litter with water and N-addition treatments in the Gurbantunggut Desert in China. Water and N addition had no significant effect on root mass loss and the N and phosphorus content of litter residue. The loss of root litter and nutrient releases were strongly controlled by the initial lignin content and the lignin: N ratio, as evidenced by the negative correlations between decomposition rate and litter lignin content and the lignin: N ratio. Fine roots of Seriphidium santolinum (with higher initial lignin content) had a slower decomposition rate in comparison to coarse roots. Conclusion/Significance Results from this study indicate that small and temporary changes in rainfall and N deposition do not affect root decomposition patterns in the Gurbantunggut Desert. Root decomposition rates were significantly different between species, and also between fine and coarse roots, and were determined by carbon components, especially lignin content, suggesting that root litter quality may be the primary driver of belowground carbon turnover.	[Zhao, Hongmei; Sheng, Jiandong; Jia, Hongtao] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China; [Huang, Gang; Li, Yan; Ma, Jian] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Huang, Gang; Li, Yan; Ma, Jian] Chinese Acad Sci, Fukang Stn Desert Ecol, Xinjiang, Fukang, Peoples R China; [Li, Congjuan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Natl Engn Technol Res Ctr Desert Oasis Ecol Const, Urumqi, Peoples R China	Xinjiang Agricultural University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Sheng, JD (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China.	sjd_2004@126.com	huang, gang/D-6427-2012; Li, Congjuan/ABH-8523-2020	huang, gang/0000-0002-8692-7856; 	Strategic Priority Research Program of Chinese Academic of Sciences [XDA05050400]; National Natural Science Foundation of China [31370010, 31300449]; Western Light Project of the Chinese Academy of Sciences [XBBS201205]	Strategic Priority Research Program of Chinese Academic of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Western Light Project of the Chinese Academy of Sciences	This research was supported by the Strategic Priority Research Program of Chinese Academic of Sciences (No. XDA05050400), the National Natural Science Foundation of China (No. 31370010,31300449), and the Western Light Project of the Chinese Academy of Sciences (No. XBBS201205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Jacobson TKB, 2011, ENVIRON POLLUT, V159, P2236, DOI 10.1016/j.envpol.2010.10.019; Bontti EE, 2009, GLOBAL CHANGE BIOL, V15, P1356, DOI 10.1111/j.1365-2486.2008.01815.x; Boyero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087426; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099018; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; Falster D.S., 2006, USERS GUIDE SMATR ST; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Fornara DA, 2009, J ECOL, V97, P48, DOI 10.1111/j.1365-2745.2008.01453.x; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Harmon ME, 1999, LT EC RES NETWK SER, V2, P143; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Jacobson KM, 1998, J ARID ENVIRON, V38, P571, DOI 10.1006/jare.1997.0358; King JS, 1997, PLANT SOIL, V195, P171, DOI 10.1023/A:1004248232450; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Langley JA, 2003, ECOLOGY, V84, P2302, DOI 10.1890/02-0282; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Ludovici KH, 2006, CAN J FOREST RES, V36, P105, DOI 10.1139/X05-227; Martinez-Yrizar A, 2007, ACTA OECOL, V32, P291, DOI 10.1016/j.actao.2007.05.010; MCCLAUGHERTY CA, 1984, OIKOS, V42, P378, DOI 10.2307/3544408; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Mun H.-T., 1998, Biology and Fertility of Soils, V26, P16, DOI 10.1007/s003740050336; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Osanai Y, 2012, PLANT SOIL, V350, P365, DOI 10.1007/s11104-011-0920-x; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PRESCOTT CE, 1995, PLANT SOIL, V168, P83, DOI 10.1007/BF00029316; Qian WH, 2001, CLIMATIC CHANGE, V50, P419, DOI 10.1023/A:1010673212131; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Solly EF, 2014, PLANT SOIL, V382, P203, DOI 10.1007/s11104-014-2151-4; Suseela V, 2013, NEW PHYTOL, V200, P122, DOI 10.1111/nph.12376; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; VANSOEST PJ, 1967, J ANIM SCI, V26, P119, DOI 10.2527/jas1967.261119x; Verburg PSJ, 2013, GLOBAL CHANGE BIOL, V19, P948, DOI 10.1111/gcb.12082; Vivanco L, 2006, OECOLOGIA, V150, P97, DOI 10.1007/s00442-006-0495-z; Walter J, 2013, SOIL BIOL BIOCHEM, V60, P10, DOI 10.1016/j.soilbio.2013.01.018; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; ZAK J, 1988, AGR ECOSYST ENVIRON, V24, P87, DOI 10.1016/0167-8809(88)90058-8	56	7	10	8	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142380	10.1371/journal.pone.0142380	http://dx.doi.org/10.1371/journal.pone.0142380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544050	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700125
J	Benoist, C; Guerin, C; Noirot, P; Dervyn, E				Benoist, Camille; Guerin, Cyprien; Noirot, Philippe; Dervyn, Etienne			Constitutive Stringent Response Restores Viability of Bacillus subtilis Lacking Structural Maintenance of Chromosome Protein	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; DNA-REPLICATION; SMC PROTEIN; RIBONUCLEOTIDE REDUCTASE; CONDENSIN COMPLEX; B. SUBTILIS; SEGREGATION; GENE; (P)PPGPP	Bacillus subtilis mutants lacking the SMC-ScpAB complex are severely impaired for chromosome condensation and partitioning, DNA repair, and cells are not viable under standard laboratory conditions. We isolated suppressor mutations that restored the capacity of a smc deletion mutant (Delta smc) to grow under standard conditions. These suppressor mutations reduced chromosome segregation defects and abrogated hypersensitivity to gyrase inhibitors of Delta smc. Three suppressor mutations were mapped in genes involved in tRNA aminoacylation and maturation pathways. A transcriptomic survey of isolated suppressor mutations pointed to a potential link between suppression of Delta smc and induction of the stringent response. This link was confirmed by (p) ppGpp quantification which indicated a constitutive induction of the stringent response in multiple suppressor strains. Furthermore, sublethal concentrations of arginine hydroxamate (RHX), a potent inducer of stringent response, restored growth of Delta smc under non permissive conditions. We showed that production of (p) ppGpp alone was sufficient to suppress the thermosensitivity exhibited by the Delta smc mutant. Our findings shed new light on the coordination between chromosome dynamics mediated by SMC-ScpAB and other cellular processes during rapid bacterial growth.	[Benoist, Camille; Noirot, Philippe; Dervyn, Etienne] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Benoist, Camille; Noirot, Philippe; Dervyn, Etienne] AgroParisTech, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Guerin, Cyprien] INRA, Math & Informat Appl Genome Environm, UR1404, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Dervyn, E (corresponding author), INRA, Micalis UMR1319, F-78350 Jouy En Josas, France.	etienne.dervyn@jouy.inra.fr		Guerin, Cyprien/0000-0001-6102-7002	Ministere de l'Enseignement Superieur et de la Recherche; European Commission BaSysBio [LSHG-CT-2006-037469]; INRA AIP BioRessources Solimut	Ministere de l'Enseignement Superieur et de la Recherche; European Commission BaSysBio(European CommissionEuropean Commission Joint Research Centre); INRA AIP BioRessources Solimut	This work was supported by a grant from Ministere de l'Enseignement Superieur et de la Recherche to CB, by the European Commission BaSysBio project LSHG-CT-2006-037469 to PN and by the INRA AIP BioRessources-2009 Solimut to ED.	ANAGNOSTOPOULOS C, 1961, P NATL ACAD SCI USA, V47, P378, DOI 10.1073/pnas.47.3.378; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Biller SJ, 2009, MOL MICROBIOL, V74, P790, DOI 10.1111/j.1365-2958.2009.06893.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Cashel M., 1996, STRINGENT RESPONSE; Cashell M, 1996, CELLULAR MOL BIOL, V1, P1458; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Delumeau O, 2011, PROTEOMICS, V11, P2992, DOI 10.1002/pmic.201000790; DeNapoli J, 2013, MOL MICROBIOL, V88, P93, DOI 10.1111/mmi.12172; Dervyn E, 2004, MOL MICROBIOL, V51, P1629, DOI 10.1111/j.1365-2958.2003.03951.x; Duigou S, 2005, MOL MICROBIOL, V57, P678, DOI 10.1111/j.1365-2958.2005.04725.x; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Fabret C, 2011, MOL MICROBIOL, V80, P1062, DOI 10.1111/j.1365-2958.2011.07630.x; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; GROS MF, 1987, EMBO J, V6, P3863, DOI 10.1002/j.1460-2075.1987.tb02724.x; Gruber S, 2014, CURR BIOL, V24, P293, DOI 10.1016/j.cub.2013.12.049; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Guthlein C, 2008, J BACTERIOL, V190, P452, DOI 10.1128/JB.01315-07; Harwood CR., 1990, MODERN MICROBIOLOGIC, P5; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Lindow JC, 2002, J BACTERIOL, V184, P5317, DOI 10.1128/JB.184.19.5317-5322.2002; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Petrushenko ZM, 2011, MOL MICROBIOL, V81, P881, DOI 10.1111/j.1365-2958.2011.07763.x; Potrykus K, 2002, BIOCHEM J, V364, P857, DOI 10.1042/BJ20011488; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rybenkov VV, 2014, J MOL MICROB BIOTECH, V24, P371, DOI 10.1159/000369099; Samarrai W, 2011, J BACTERIOL, V193, P723, DOI 10.1128/JB.00708-10; Sawitzke JA, 2000, P NATL ACAD SCI USA, V97, P1671, DOI 10.1073/pnas.030528397; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Sneeden JL, 2004, J BIOL CHEM, V279, P40723, DOI 10.1074/jbc.M402699200; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Tadesse S, 2005, MICROBIOL-SGM, V151, P3729, DOI 10.1099/mic.0.28234-0; Tanaka K, 2013, NUCLEIC ACIDS RES, V41, P687, DOI 10.1093/nar/gks963; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wang XD, 2014, CURR BIOL, V24, P287, DOI 10.1016/j.cub.2013.11.050; Weitao T, 1999, MOL MICROBIOL, V34, P157, DOI 10.1046/j.1365-2958.1999.01589.x; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Wolz C, 2010, INT J MED MICROBIOL, V300, P142, DOI 10.1016/j.ijmm.2009.08.017; YAMANAKA K, 1994, MOL MICROBIOL, V13, P301, DOI 10.1111/j.1365-2958.1994.tb00424.x; YANAGISAWA T, 1994, J BIOL CHEM, V269, P24304; Yu WQ, 2010, J BACTERIOL, V192, P4067, DOI 10.1128/JB.00010-10; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	76	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142308	10.1371/journal.pone.0142308	http://dx.doi.org/10.1371/journal.pone.0142308			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539825	Green Submitted, gold, Green Published			2022-12-27	WOS:000364303800080
J	Gifford, KA; Liu, DD; Hohman, TJ; Xu, M; Han, X; Romano, RR; Fritzsche, LR; Abel, T; Jefferson, AL				Gifford, Katherine A.; Liu, Dandan; Hohman, Timothy J.; Xu, Meng; Han, Xue; Romano, Raymond R., III; Fritzsche, Laura R.; Abel, Ty; Jefferson, Angela L.			A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment	PLOS ONE			English	Article							CENTER NACC DATABASE; MINI-MENTAL-STATE; UNIFORM DATA SET; ALZHEIMER-DISEASE; MEMORY COMPLAINTS; OLDER-ADULTS; DEMENTIA; INDIVIDUALS; PREDICTION; DIAGNOSIS	Background This study examines whether different sources of cognitive complaint (i.e., self and informant) predict Alzheimer's disease (AD) neuropathology in elders with mild cognitive impairment (MCI). Methods Data were drawn from the National Alzheimer's Coordinating Center Uniform and Neuropathology Datasets (observational studies) for participants with a clinical diagnosis of MCI and postmortem examination (n = 1843, 74 +/- 8 years, 52% female). Cognitive complaint (0.9 +/- 0.5 years prior to autopsy) was classified into four mutually exclusive groups: no complaint, self-only, informant-only, or mutual (both self and informant) complaint. Postmortem neuropathological outcomes included amyloid plaques and neurofibrillary tangles. Proportional odds regression related complaint to neuropathology, adjusting for age, sex, race, education, depressed mood, cognition, APOE4 status, and last clinical visit to death interval. Results Mutual complaint related to increased likelihood of meeting NIA/Reagan Institute (OR = 6.58, p = 0.004) and Consortium to Establish a Registry for Alzheimer's Disease criteria (OR = 5.82, p = 0.03), and increased neurofibrillary tangles (OR = 3.70, p = 0.03), neuritic plaques (OR = 3.52, p = 0.03), and diffuse plaques (OR = 4.35, p = 0.02). Informant-only and self-only complaint was not associated with any neuropathological outcome (all p-values>0.12). Conclusions In MCI, mutual cognitive complaint relates to AD pathology whereas self-only or informant-only complaint shows no relation to pathology. Findings support cognitive complaint as a marker of unhealthy brain aging and highlight the importance of obtaining informant corroboration to increase confidence of underlying pathological processes.	[Gifford, Katherine A.; Hohman, Timothy J.; Romano, Raymond R., III; Fritzsche, Laura R.; Jefferson, Angela L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37240 USA; [Liu, Dandan; Xu, Meng; Han, Xue] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Abel, Ty] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Jefferson, AL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN 37240 USA.	angela.jefferson@vanderbilt.edu	Hohman, Timothy/AFN-9053-2022	Hohman, Timothy/0000-0002-3377-7014; Jefferson, Angela/0000-0002-8245-0587; Romano, Raymond/0000-0001-6121-8263	Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Association [IIRG-08-88733]; Vanderbilt Memory & Alzheimer's Center; NIA/NIH [U01 AG016976]; NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051];  [K12-HD043483];  [NIRG-13-283276];  [K24-AG046373];  [R01-AG034962];  [R01-HL11516];  [P30 AG013854];  [P30 AG008017];  [P30 AG010161];  [P30 AG010129];  [P50 AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50 AG00568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043483] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG016976, K24AG046373, R01AG034962, K23AG045966] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Association(Alzheimer's Association); Vanderbilt Memory & Alzheimer's Center; NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by K12-HD043483 (KAG); NIRG-13-283276 (KAG); Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics (TJH); K24-AG046373 (ALJ); Alzheimer's Association IIRG-08-88733 (ALJ); R01-AG034962 (ALJ); R01-HL11516 (ALJ); and the Vanderbilt Memory & Alzheimer's Center. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI David Teplow, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), and P50 AG005681 (PI John Morris, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carr DB, 2000, NEUROLOGY, V55, P1724, DOI 10.1212/WNL.55.11.1724; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gifford KA, 2015, J ALZHEIMERS DIS, V43, P121, DOI 10.3233/JAD-131925; Gifford KA, 2014, ALZHEIMERS DEMENT, V10, P319, DOI 10.1016/j.jalz.2013.02.007; Glodzik-Sobanska L, 2007, DEMENT GERIATR COGN, V24, P177, DOI 10.1159/000105604; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jorm AF, 2004, NEUROLOGY, V63, P1960, DOI 10.1212/01.WNL.0000144348.70643.F2; Kryscio RJ, 2014, NEUROLOGY, V83, P1359, DOI 10.1212/WNL.0000000000000856; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Perrotin A, 2012, ARCH NEUROL-CHICAGO, V69, P223, DOI 10.1001/archneurol.2011.666; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Tierney MC, 1996, ARCH NEUROL-CHICAGO, V53, P423, DOI 10.1001/archneur.1996.00550050053023; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0141831	10.1371/journal.pone.0141831	http://dx.doi.org/10.1371/journal.pone.0141831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5IS	26539829	gold, Green Published, Green Submitted			2022-12-27	WOS:000364303800030
J	Benedetti, F; Dogue, S				Benedetti, Fabrizio; Dogue, Sara			Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials	PLOS ONE			English	Article							CLUSTER HEADACHE; DOUBLE-BLIND; PROSTAGLANDINS; ENDOTHELIUM; ANALGESIA; OXYGEN; VASODILATATION; PROPHYLAXIS; DILATION; AIR	Clinical trials use placebos with the assumption that they are inert, thus all placebos are considered to be equal. Here we show that this assumption is wrong and that different placebo procedures are associated to different therapeutic rituals which, in turn, trigger different mechanisms and produce different therapeutic outcomes. We studied high altitude, or hypobaric hypoxia, headache, in which two different placebos were administered. The first was placebo oxygen inhaled through a mask, whereas the second was placebo aspirin swallowed with a pill. Both placebos were given after a conditioning procedure, whereby either real oxygen or real aspirin was administered for three consecutive sessions to reduce headache pain. We found that after real oxygen conditioning, placebo oxygen induced pain relief along with a reduction in ventilation, blood alkalosis and salivary prostaglandin (PG) E2, yet without any increase in blood oxygen saturation (SO2). By contrast, after real aspirin conditioning, placebo aspirin induced pain relief through the inhibition of all the products of cyclooxygenase, that is, PGD2, PGE2, PGF2, PGI2, thromboxane (TX)A2, without affecting ventilation and blood alkalosis. Therefore, two different placebos, associated to two different therapeutic rituals, used two different pathways to reduce headache pain. The analgesic effect following placebo oxygen was superior to placebo aspirin. These findings show that different placebos may use different mechanisms to reduce high altitude headache, depending on the therapeutic ritual and the route of administration. In clinical trials, placebos and outcome measures should be selected very carefully in order not to incur in wrong interpretations.	[Benedetti, Fabrizio] Univ Turin, Sch Med, Dept Neurosci, Turin, Italy; [Benedetti, Fabrizio; Dogue, Sara] Plateau Rosa Labs, Breuil Cervinia, Italy; [Benedetti, Fabrizio; Dogue, Sara] Plateau Rosa Labs, Zermatt, Switzerland	University of Turin	Benedetti, F (corresponding author), Univ Turin, Sch Med, Dept Neurosci, Turin, Italy.	fabrizio.benedetti@unito.it			Compagnia di San Paolo Foundation; ICTH (Improving Clinical Trials & Healthcare) Initiative	Compagnia di San Paolo Foundation(Compagnia di San Paolo); ICTH (Improving Clinical Trials & Healthcare) Initiative	Funding: Support was provided by the Compagnia di San Paolo Foundation and the ICTH (Improving Clinical Trials & Healthcare) Initiative.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bannuru RR, 2015, ANN INTERN MED, V163, P365, DOI 10.7326/M15-0623; Baretella O, 2014, PFLUG ARCH EUR J PHY, V466, P295, DOI 10.1007/s00424-013-1323-z; BARTSCH P, 1990, LANCET, V336, P772, DOI 10.1016/0140-6736(90)93240-P; Benedetti F, 1998, PAIN, V75, P313, DOI 10.1016/S0304-3959(98)00010-4; Benedetti F, 1999, EUR J NEUROSCI, V11, P625, DOI 10.1046/j.1460-9568.1999.00465.x; Benedetti F, 2015, PAIN IN PRESS   0707; Benedetti F, 2014, NEURON, V84, P623, DOI 10.1016/j.neuron.2014.10.023; Benedetti F, 2014, PAIN, V155, P921, DOI 10.1016/j.pain.2014.01.016; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; Benedetti F, 2011, NAT MED, V17, P1228, DOI 10.1038/nm.2435; Burtscher M, 1998, BRIT MED J, V316, P1057; BUSSE R, 1984, PFLUG ARCH EUR J PHY, V401, P77, DOI 10.1007/BF00581536; Cohen AS, 2009, JAMA-J AM MED ASSOC, V302, P2451, DOI 10.1001/jama.2009.1855; Davis RJ, 2004, BRIT J PHARMACOL, V141, P580, DOI 10.1038/sj.bjp.0705645; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; FOGAN L, 1985, ARCH NEUROL-CHICAGO, V42, P362, DOI 10.1001/archneur.1985.04060040072015; FREDRICKS KT, 1994, AM J PHYSIOL, V267, pH580, DOI 10.1152/ajpheart.1994.267.2.H580; Gordon JB, 2003, AM J PHYSIOL-LUNG C, V284, pL799, DOI 10.1152/ajplung.00402.2002; Halla TR, 2000, AM J PHYSIOL-LUNG C, V278, pL968, DOI 10.1152/ajplung.2000.278.5.L968; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; ISHII Y, 1990, PROSTAGLANDINS, V39, P685, DOI 10.1016/0090-6980(90)90028-T; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Kong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067485; Leaf DE, 2007, J APPL PHYSIOL, V102, P1313, DOI 10.1152/japplphysiol.01572.2005; MESSINA EJ, 1992, CIRC RES, V71, P790, DOI 10.1161/01.RES.71.4.790; Ray CJ, 2002, J PHYSIOL-LONDON, V544, P195, DOI 10.1113/jphysiol.2002.023440; RICHALET JP, 1991, RESP PHYSIOL, V85, P205, DOI 10.1016/0034-5687(91)90062-N; ROSENTHAL TB, 1948, J BIOL CHEM, V173, P25; Sutton J., 1992, HYPOXIA MOUNTAIN MED, P327; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6	32	26	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140967	10.1371/journal.pone.0140967	http://dx.doi.org/10.1371/journal.pone.0140967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536471	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400046
J	Boiko, E; Maltsev, D; Savicheva, A; Shalepo, K; Khusnutdinova, T; Pozniak, A; Kvetnoi, I; Polyakova, V; Suetov, A				Boiko, Ernest; Maltsev, Dmitrii; Savicheva, Alevtina; Shalepo, Kira; Khusnutdinova, Tatyana; Pozniak, Alexei; Kvetnoi, Igor; Polyakova, Viktoria; Suetov, Alexei			Infection of Human Retinal Pigment Epithelium with Chlamydia trachomatis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTOR; CELL-PROLIFERATION; VIRUS RETINITIS; HERPES-SIMPLEX; EXPRESSION; INTERLEUKIN-8; PNEUMONIAE; CYTOKINES	Purpose Little is known about the susceptibility of posterior segment tissues, particularly the human retinal pigment epithelium (hRPE), to Chlamydia trachomatis. The purpose of the study was to investigate the possibility of infecting the hRPE with Chlamydia trachomatis, and to examine the infectivity of different Chlamydia trachomatis clinical isolates for hRPE cells and the hRPE cell response to the infection. Methods Cultured hRPE and McCoy cells were inoculated with eight Chlamydia trachomatis (serovar E) clinical isolates at multiplicity of infection (MOI) of 2.0 or 0.3. To detect Chlamydia trachomatis, samples were stained immunohistochemically with anti-major outer membrane protein antibodies at 24h, 48h, and 72h postinoculation (PI). The changes in the expression of signaling molecules and proteins of cytoskeleton and extracellular matrix in hRPE cells were examined immunohistochemically. Results All eight clinical isolates demonstrated ability to infect hRPE cells. At equal MOI of 0.3, the infectivity of Chlamydia trachomatis clinical isolates for RPE culture was found to be at least as high as that for McCoy cell culture. At 24h PI, the percentage of inclusion-containing cells varied from 1.5 +/- 0.52 to 14.6 +/- 3.3% in hRPE cell culture infected at MOI of 2.0 against 0.37 +/- 0.34 to 8.9 +/- 0.2% in McCoy cell culture infected at MOI of 0.3. Collagen type I, collagen type IV, basic fibroblast growth factor, transforming growth factor-beta and interleukin-8 expression at 48h PI were maximally increased, by 2.1-, 1.3-, 1.5-, 1.5- and 1.6-fold, respectively, in the Chlamydia trachomatis-infected compared with control hRPE cell culture specimens (P < 0.05). Conclusions This study, for the first time, proved the possibility of infecting hRPE cultured cells with Chlamydia trachomatis, which leads to proproliferative and proinflammatory changes in the expression of signaling molecules and extracellular matrix components.	[Boiko, Ernest; Maltsev, Dmitrii; Pozniak, Alexei; Suetov, Alexei] Mil Med Acad, Dept Ophthalmol, St Petersburg, Russia; [Boiko, Ernest] Academician S Fyodorov IRTC Eye Microsurg, St Petersburg Branch, St Petersburg, Russia; [Savicheva, Alevtina; Shalepo, Kira; Khusnutdinova, Tatyana] DO Ott Res Inst Obstet & Gynaecol, Microbiol Lab, St Petersburg, Russia; [Kvetnoi, Igor; Polyakova, Viktoria] DO Ott Res Inst Obstet & Gynaecol, Dept Pathol, St Petersburg, Russia	Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology	Maltsev, D (corresponding author), Mil Med Acad, Dept Ophthalmol, St Petersburg, Russia.	glaz.med@yandex.ru	Maltsev, Dmitrii/AAA-9100-2022; Khusnutdinova, Tatiana/K-1852-2018; Alexey, Suetov/AAI-4855-2020	Alexey, Suetov/0000-0002-8670-2964; Maltsev, Dmitrii/0000-0001-6598-3982; Khusnutdinova, Tatiana/0000-0002-2742-2655				Abu el-Asrar A M, 2001, Bull Soc Belge Ophtalmol, P73; Aksunger A, 1997, OPHTHALMOLOGICA, V211, P223, DOI 10.1159/000310794; Al-Mously N, 2007, J MED MICROBIOL, V56, P1025, DOI 10.1099/jmm.0.47241-0; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Boiko EV, 2014, INVEST OPHTH VIS SCI, V55, P1176, DOI 10.1167/iovs.13-13416; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; DUTT K, 1989, INVEST OPHTH VIS SCI, V30, P1535; Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0; Friedman A H, 1984, Trans Am Ophthalmol Soc, V82, P447; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Hoerster R, 2014, GRAEF ARCH CLIN EXP, V252, P11, DOI 10.1007/s00417-013-2377-5; Kaser T, 2015, VET IMMUNOL IMMUNOP, V166, P95, DOI 10.1016/j.vetimm.2015.06.003; Kaven C, 2000, CURR EYE RES, V20, P480, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT480; Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09; KUPPERMANN BD, 1994, AM J OPHTHALMOL, V118, P589, DOI 10.1016/S0002-9394(14)76574-2; Lou Bing-sheng, 2011, Zhonghua Yan Ke Za Zhi, V47, P1117; Luo C, 2013, EXP EYE RES, V112, P93, DOI 10.1016/j.exer.2013.04.016; Marangoni Antonella, 2014, BMC Res Notes, V7, P230, DOI 10.1186/1756-0500-7-230; Mazzoli S, 2007, EUR UROL, V51, P1385, DOI 10.1016/j.eururo.2006.10.059; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Momma Y, 2003, INVEST OPHTH VIS SCI, V44, P2026, DOI 10.1167/iovs.02-0980; Munoz-Erazo L, 2012, MOL VIS, V18, P730; Nie Yuhong, 2007, Yan Ke Xue Bao, V23, P212; PEPOSE JS, 1984, OPHTHALMOLOGY, V91, P1669; PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P160; Rodel J, 2000, INFECT IMMUN, V68, P3635, DOI 10.1128/IAI.68.6.3635-3641.2000; Rodel J, 1998, J RHEUMATOL, V25, P2161; Sellami H, 2014, MOL CELL PROBE, V28, P147, DOI 10.1016/j.mcp.2014.01.006; Steindl-Kuscher K, 2011, GRAEF ARCH CLIN EXP, V249, P1195, DOI 10.1007/s00417-011-1673-1; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P2047, DOI 10.1167/iovs.05-0005; Zheng M, 2005, INVEST OPHTH VIS SCI, V46, P1356, DOI 10.1167/iovs.04-1284; Zigangirova NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/489489	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141754	10.1371/journal.pone.0141754	http://dx.doi.org/10.1371/journal.pone.0141754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536616	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400084
J	Chai, SJ; Yap, YY; Foo, YC; Yap, LF; Ponniah, S; Teo, SH; Cheong, SC; Patel, V; Lim, KP				Chai, San Jiun; Yap, Yoke Yeow; Foo, Yoke Ching; Yap, Lee Fah; Ponniah, Sathibalan; Teo, Soo Hwang; Cheong, Sok Ching; Patel, Vyomesh; Lim, Kue Peng			Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER PATIENTS; REGULATORY T-CELLS; PHASE-I/II TRIAL; CLINICAL-TRIAL; IMMUNE-RESPONSE; TUMOR-CELLS; VACCINE; LINES	Nasopharyngeal carcinoma (NPC) is highly prevalent in South East Asia and China. The poor outcome is due to late presentation, recurrence, distant metastasis and limited therapeutic options. For improved treatment outcome, immunotherapeutic approaches focusing on dendritic and autologous cytotoxic T-cell based therapies have been developed, but cost and infrastructure remain barriers for implementing these in low-resource settings. As our prior observations had found that four-jointed box 1 (FJX1), a tumor antigen, is overexpressed in NPCs, we investigated if short 9-20 amino acid sequence specific peptides matching to FJX1 requiring only intramuscular immunization to train host immune systems would be a better treatment option for this disease. Thus, we designed 8 FJX1-specific peptides and implemented an assay system to first, assess the binding of these peptides to HLA-A2 molecules on T2 cells. After, ELISPOT assays were used to determine the peptides immunogenicity and ability to induce potential cytotoxicity activity towards cancer cells. Also, T-cell proliferation assay was used to evaluate the potential of MHC class II peptides to stimulate the expansion of isolated T-cells. Our results demonstrate that these peptides are immunogenic and peptide stimulated T-cells were able to induce peptide-specific cytolytic activity specifically against FJX1-expressing cancer cells. In addition, we demonstrated that the MHC class II peptides were capable of inducing T-cell proliferation. Our results suggest that these peptides are capable of inducing specific cytotoxic cytokines secretion against FJX1-expressing cancer cells and serve as a potential vaccine-based therapy for NPC patients.	[Chai, San Jiun; Yap, Lee Fah; Teo, Soo Hwang; Cheong, Sok Ching; Patel, Vyomesh; Lim, Kue Peng] Canc Res Initiat Fdn CARIF, Sime Darby Med Ctr, Subang Jaya, Selangor, Malaysia; [Yap, Yoke Yeow] Univ Putra Malaysia, Dept Surg, Clin Campus Fac Med & Hlth Sci, Hosp Kuala Lumpur, Kuala Lumpur, Malaysia; [Foo, Yoke Ching] Sime Darby Med Ctr, Dept Oncol, Subang Jaya, Selangor, Malaysia; [Ponniah, Sathibalan] Uniformed Serv Univ Hlth Sci, Dept Surg, Canc Vaccine Dev Program, Bethesda, MD 20814 USA	Universiti Putra Malaysia; Uniformed Services University of the Health Sciences - USA	Lim, KP (corresponding author), Canc Res Initiat Fdn CARIF, Sime Darby Med Ctr, Subang Jaya, Selangor, Malaysia.	kuepeng.lim@carif.com.my	Yap, Lee-Fah/M-1065-2016; Teo, Soo-hwang/H-2353-2014	Yap, Lee-Fah/0000-0002-6815-3607; 	Cancer Research Initiatives Foundation (CARIF)	Cancer Research Initiatives Foundation (CARIF)	This study was funded by sponsors of the Cancer Research Initiatives Foundation (CARIF). CARIF is a non-profit research organization committed to an understanding of cancer prevention, diagnosis and treatment through a fundamental research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Zabidi MM, 2011, THESIS; Al-Greene NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069660; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Alves PMS, 2003, CANCER RES, V63, P8476; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Brunsvig PF, 2011, CLIN CANCER RES, V17, P6847, DOI 10.1158/1078-0432.CCR-11-1385; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Erfani N, 2010, CANCER INVEST, V28, P828, DOI 10.3109/07357901003630934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; GEBBIA V, 1993, BRIT J CANCER, V68, P191, DOI 10.1038/bjc.1993.312; Guo Kun-yuan, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P247; Hamid S, 2007, INT J MOL MED, V19, P453; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; Lee CH, 2011, J VIROL, V85, P7333, DOI 10.1128/JVI.00182-11; Lee L. K., 2007, SMJ Singapore Medical Journal, V48, P632; Lewis JJ, 2000, INT J CANCER, V87, P391, DOI 10.1002/1097-0215(20000801)87:3<391::AID-IJC13>3.0.CO;2-K; Li Jia-Xin, 2010, Chin J Cancer, V29, P82; Lim KP, 2014, HUM VACCIN IMMUNOTHE, V10; Lin CL, 2002, CANCER RES, V62, P6952; Louis CU, 2010, J IMMUNOTHER, V33, P983, DOI 10.1097/CJI.0b013e3181f3cbf4; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Lutzky VP, 2014, CLIN VACCINE IMMUNOL, V21, P256, DOI 10.1128/CVI.00121-13; Marincola FM, 1996, J IMMUNOTHER, V19, P266, DOI 10.1097/00002371-199607000-00003; Marshall NA, 2003, J IMMUNOL, V170, P6183, DOI 10.4049/jimmunol.170.12.6183; Masmoudi A, 2007, CANCER TREAT REV, V33, P499, DOI 10.1016/j.ctrv.2007.04.007; Mittendorf EA, 2014, ANN ONCOL, V25, P1735, DOI 10.1093/annonc/mdu211; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; O'Sullivan B, 2007, INT J RADIAT ONCOL, V69, pS118, DOI 10.1016/j.ijrobp.2007.04.085; Omar ZA, 2011, NATL CANC REGISTRY R; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; PARKER KC, 1994, J IMMUNOL, V152, P163; Parmiani G, 2002, JNCI-J NATL CANCER I, V94, P805, DOI 10.1093/jnci/94.11.805; Patil R, 2010, J AM COLL SURGEONS, V210, P140, DOI 10.1016/j.jamcollsurg.2009.10.022; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Peoples GE, 2005, J CLIN ONCOL, V23, P7536, DOI 10.1200/JCO.2005.03.047; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Rock R, 2005, DEV DYNAM, V234, P602, DOI 10.1002/dvdy.20553; Scurr M, 2014, MUCOSAL IMMUNOL, V7, P428, DOI 10.1038/mi.2013.62; Shafer-Weaver Kimberly A, 2004, J Transl Med, V2, P31, DOI 10.1186/1479-5876-2-31; Shieh DC, 1996, TRANSFUSION, V36, P818, DOI 10.1046/j.1537-2995.1996.36996420761.x; Smith C, 2012, NASOPHARYNGEAL CARCI, P173; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Strong MJ, 2014, J VIROL, V88, P10696, DOI 10.1128/JVI.01457-14; STUBER G, 1994, EUR J IMMUNOL, V24, P765, DOI 10.1002/eji.1830240341; Tanaka T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/262967; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Titcomb C P Jr, 2001, J Insur Med, V33, P235; TRUMPER PA, 1977, INT J CANCER, V20, P655, DOI 10.1002/ijc.2910200503; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WIDMANN C, 1992, J IMMUNOL METHODS, V155, P95, DOI 10.1016/0022-1759(92)90275-X; WOLF H, 1973, NATURE-NEW BIOL, V244, P245, DOI 10.1038/newbio244245a0; Xu T, 2013, CURR ONCOL, V20, pE406, DOI 10.3747/co.20.1456; YAMASHITA S, 1985, ACTA ONCOL, V24, P315, DOI 10.3109/02841868509136058; Yang TS, 1996, AM J CLIN ONCOL-CANC, V19, P337, DOI 10.1097/00000421-199608000-00003; Yoshitake Y, 2014, CLIN CANC RES	73	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0130464	10.1371/journal.pone.0130464	http://dx.doi.org/10.1371/journal.pone.0130464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536470	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400001
J	Eppley, TM; Donati, G; Ramanamanjato, JB; Randriatafika, F; Andriamandimbiarisoa, LN; Rabehevitra, D; Ravelomanantsoa, R; Ganzhorn, JU				Eppley, Timothy M.; Donati, Giuseppe; Ramanamanjato, Jean-Baptiste; Randriatafika, Faly; Andriamandimbiarisoa, Laza N.; Rabehevitra, David; Ravelomanantsoa, Robertin; Ganzhorn, Joerg U.			The Use of an Invasive Species Habitat by a Small Folivorous Primate: Implications for Lemur Conservation in Madagascar	PLOS ONE			English	Article							FOREST FRAGMENTATION; LITTORAL FOREST; HAPALEMUR-MERIDIONALIS; RIPARIAN CORRIDORS; EASTERN MADAGASCAR; TREE PLANTATIONS; BIRD ASSEMBLAGES; FOOD SOURCES; MATRIX; BIODIVERSITY	The lemurs of Madagascar are among the most threatened mammalian taxa in the world, with habitat loss due to shifting cultivation and timber harvest heavily contributing to their precarious state. Deforestation often leads to fragmentation, resulting in mixed-habitat matrices throughout a landscape where disturbed areas are prone to invasion by exotic plants. Our study site, the Mandena littoral forest (southeast Madagascar), is a matrix of littoral forest, littoral swamp, and Melaleuca swamp habitats. Here, Melaleuca quinquenervia has invaded the wetland ecosystem, creating a mono-dominant habitat that currently provides the only potential habitat corridor between forest fragments. We sought to understand the role of this invasive Melaleuca swamp on the behavioral ecology of a threatened, small-bodied folivore, the southern bamboo lemur (Hapalemur meridionalis). We collected botanical and behavioral data on four groups of H. meridionalis between January and December 2013. Our results confirm Melaleuca swamp as an important part of their home range: while lemurs seasonally limited activities to certain habitats, all groups were capable of utilizing this invasive habitat for feeding and resting. Furthermore, the fact that Hapalemur use an invasive plant species as a dispersal corridor increases our knowledge of their ecological flexibility, and may be useful in the conservation management of remaining threatened populations.	[Eppley, Timothy M.; Ganzhorn, Joerg U.] Univ Hamburg, Dept Anim Ecol & Conservat, Biozentrum Grindel, Hamburg, Germany; [Eppley, Timothy M.; Donati, Giuseppe] Oxford Brookes Univ, Nocturnal Primate Res Grp, Dept Social Sci, Oxford OX3 0BP, England; [Ramanamanjato, Jean-Baptiste; Randriatafika, Faly; Andriamandimbiarisoa, Laza N.; Rabehevitra, David; Ravelomanantsoa, Robertin] QIT Madagascar Minerals, Rio Tinto, Tolagnaro, Madagascar	University of Hamburg; Oxford Brookes University; Rio Tinto	Eppley, TM (corresponding author), Univ Hamburg, Dept Anim Ecol & Conservat, Biozentrum Grindel, Hamburg, Germany.	eppleyti@gmail.com	Ganzhorn, Joerg/AAO-6955-2020	Ganzhorn, Joerg/0000-0003-1395-9758; Donati, Giuseppe/0000-0002-4803-0642; Eppley, Timothy/0000-0003-1456-6948	American Society of Primatologists; Conservation International's Primate Action Fund; IDEAWILD; Mohamed bin Zayed Species Conservation Fund [11253008]; Primate Conservation Inc.; Primate Society of Great Britain/Knowsley Safari Park; QIT Madagascar Minerals	American Society of Primatologists; Conservation International's Primate Action Fund; IDEAWILD; Mohamed bin Zayed Species Conservation Fund; Primate Conservation Inc.; Primate Society of Great Britain/Knowsley Safari Park; QIT Madagascar Minerals	Funding: This work received funding and in-kind support from American Society of Primatologists, Conservation International's Primate Action Fund, IDEAWILD, Mohamed bin Zayed Species Conservation Fund (Project Number: 11253008), Primate Conservation Inc., and the Primate Society of Great Britain/Knowsley Safari Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. QIT Madagascar Minerals provided support in the form of salaries for authors [JBR, FR, LNA, DR, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABERG J, 1995, OECOLOGIA, V103, P265, DOI 10.1007/BF00328613; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Andreone F, 2005, TROP ZOOL, V18, P209, DOI 10.1080/03946975.2005.10531221; Andriamandimbiarisoa L, MADAGASCAR IN PRESS; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Bakoariniaina LN, 2006, J AFR EARTH SCI, V44, P241, DOI 10.1016/j.jafrearsci.2005.10.013; Barbaro L, 2005, ECOSCIENCE, V12, P110, DOI 10.2980/i1195-6860-12-1-110.1; Barbaro L, 2008, BIODIVERS CONSERV, V17, P1073, DOI 10.1007/s10531-007-9241-z; Beattie J. C., 1998, International Zoo Yearbook, V36, P11, DOI 10.1111/j.1748-1090.1998.tb02880.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bevers M, 1999, THEOR POPUL BIOL, V55, P61, DOI 10.1006/tpbi.1998.1392; Beyer H. L, 2012, GEOSPATIAL MODELLING; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P209, DOI 10.1159/000156821; Birkinshaw C, 2003, NATURAL HIST MADAGAS, P1207; Bollen A, 2006, ORYX, V40, P57, DOI 10.1017/S0030605306000111; Bollen A, 2003, THESIS; BRAITHWAITE RW, 1989, BIOL CONSERV, V48, P189, DOI 10.1016/0006-3207(89)90118-3; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Campera M, 2014, INT J PRIMATOL, V35, P957, DOI 10.1007/s10764-014-9780-6; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dray FA, 2006, CASTANEA, V71, P210, DOI 10.2179/05-27.1; Dumetz N, 1999, BIODIVERS CONSERV, V8, P273, DOI 10.1023/A:1008880718889; Eppley TM, 2015, BEHAVIOUR, V152, P1041, DOI 10.1163/1568539X-00003267; Eppley TM, 2015, BEHAV ECOL SOCIOBIOL, V69, P991, DOI 10.1007/s00265-015-1911-3; Eppley TM, 2011, PRIMATES, V52, P7, DOI 10.1007/s10329-010-0225-3; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Ganzhorn JU, 2014, EARTH CONSERV DEV, P17; Ganzhorn JU, 1999, CONSERV BIOL, V13, P794, DOI 10.1046/j.1523-1739.1999.98245.x; GANZHORN JU, 1987, AM J PRIMATOL, V12, P205, DOI 10.1002/ajp.1350120208; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Ganzhorn JU, 1997, BIOTROPICA, V29, P331, DOI 10.1111/j.1744-7429.1997.tb00434.x; GANZHORN JU, 1991, FOLIA PRIMATOL, V56, P171, DOI 10.1159/000156544; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gautier L, 1994, P 13 PLEN M AETFAT, P1339; Gerard A, 2015, RESTOR ECOL, V23, P768, DOI 10.1111/rec.12246; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodman SM, 2003, URAL HIST MADAGASCAR, P1351; Grassi C, 2006, AM J PHYS ANTHROPOL, V131, P50, DOI 10.1002/ajpa.20423; Grimes K., 2000, American Journal of Primatology, V51, P59; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Haddad NM, 1999, ECOL APPL, V9, P612, DOI 10.1890/1051-0761(1999)009[0612:CADEOI]2.0.CO;2; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harcourt AH, 2005, J BIOGEOGR, V32, P565, DOI 10.1111/j.1365-2699.2004.01214.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hilty JA., 2012, CORRIDOR ECOLOGY SCI; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; Kamilar JM, 2008, AM J PRIMATOL, V70, P816, DOI 10.1002/ajp.20553; Keenan R, 1997, FOREST ECOL MANAG, V99, P117, DOI 10.1016/S0378-1127(97)00198-9; Kleinpaste R., 1990, P97; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Laurance SG, 1999, BIOL CONSERV, V91, P231, DOI 10.1016/S0006-3207(99)00077-4; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; Bonilla-Sanchez YM, 2012, INT J PRIMATOL, V33, P233, DOI 10.1007/s10764-011-9569-9; Martinez Barbara, 2008, Lemur News, V13, P11; Mech SG, 2001, CONSERV BIOL, V15, P467, DOI 10.1046/j.1523-1739.2001.015002467.x; Miandrimanana C., 2014, Madagascar Conservation and Development, V9, P49, DOI 10.4314/mcd.v9i1.6; Michon G, 1995, CONSERVING BIODIVERS, P90; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Nowak K, 2013, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/978-1-4614-8839-2_14; Olson ER, 2013, INT J PRIMATOL, V34, P486, DOI 10.1007/s10764-013-9674-z; Pardini R, 2004, BIODIVERS CONSERV, V13, P2567, DOI 10.1023/B:BIOC.0000048452.18878.2d; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramanamanjato JB, 2001, ANIM CONSERV, V4, P175, DOI 10.1017/S1367943001001202; Razafindratsima OH, 2015, ECOLOGY, V96, P24, DOI 10.1890/14-0684.1; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Simmen B, 2007, INT J PRIMATOL, V28, P1253, DOI 10.1007/s10764-007-9217-6; Virah-Sawmy M, 2009, GLOBAL ECOL BIOGEOGR, V18, P98, DOI 10.1111/j.1466-8238.2008.00429.x; Watson JEM, 2005, BIODIVERS CONSERV, V14, P523, DOI 10.1007/s10531-004-3913-8; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Wethered R, 2005, BIOL CONSERV, V123, P125, DOI 10.1016/j.biocon.2004.10.013; Wethered R, 2003, BIOL CONSERV, V114, P327, DOI 10.1016/S0006-3207(03)00052-1; Williams-Guillen K, 2006, ANIM CONSERV, V9, P331, DOI 10.1111/j.1469-1795.2006.00042.x; Wilme L, 1996, COLLOQ SEMI, P349; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright Patricia C., 2008, Primate Conservation, V23, P5, DOI 10.1896/052.023.0102	88	31	31	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140981	10.1371/journal.pone.0140981	http://dx.doi.org/10.1371/journal.pone.0140981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536667	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400048
J	Goldberg, JF; Tempa, T; Norbu, N; Hebblewhite, M; Mills, LS; Wangchuk, TR; Lukacs, P				Goldberg, Joshua F.; Tempa, Tshering; Norbu, Nawang; Hebblewhite, Mark; Mills, L. Scott; Wangchuk, Tshewang R.; Lukacs, Paul			Examining Temporal Sample Scale and Model Choice with Spatial Capture-Recapture Models in the Common Leopard Panthera pardus	PLOS ONE			English	Article							NATIONAL-PARK; LIVESTOCK PREDATION; HIERARCHICAL MODEL; ESTIMATING DENSITY; ACTIVITY PATTERNS; CAMERA-TRAP; POPULATION; SELECTION; INFORMATION; CARNIVORES	Many large carnivores occupy a wide geographic distribution, and face threats from habitat loss and fragmentation, poaching, prey depletion, and human wildlife-conflicts. Conservation requires robust techniques for estimating population densities and trends, but the elusive nature and low densities of many large carnivores make them difficult to detect. Spatial capture-recapture (SCR) models provide a means for handling imperfect detectability, while linking population estimates to individual movement patterns to provide more accurate estimates than standard approaches. Within this framework, we investigate the effect of different sample interval lengths on density estimates, using simulations and a common leopard (Panthera pardus) model system. We apply Bayesian SCR methods to 89 simulated datasets and camera-trapping data from 22 leopards captured 82 times during winter 20102011 in Royal Manas National Park, Bhutan. We show that sample interval length from daily, weekly, monthly or quarterly periods did not appreciably affect median abundance or density, but did influence precision. We observed the largest gains in precision when moving from quarterly to shorter intervals. We therefore recommend daily sampling intervals for monitoring rare or elusive species where practicable, but note that monthly or quarterly sample periods can have similar informative value. We further develop a novel application of Bayes factors to select models where multiple ecological factors are integrated into density estimation. Our simulations demonstrate that these methods can help identify the "true" explanatory mechanisms underlying the data. Using this method, we found strong evidence for sex-specific movement distributions in leopards, suggesting that sexual patterns of space-use influence density. This model estimated a density of 10.0 leopards/100 km(2) (95% credibility interval: 6.25-15.93), comparable to contemporary estimates in Asia. These SCR methods provide a guide to monitor and observe the effect of management interventions on leopards and other species of conservation interest.	[Goldberg, Joshua F.; Tempa, Tshering; Hebblewhite, Mark; Lukacs, Paul] Univ Montana, Coll Forestry & Conservat, Wildlife Biol Program, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Tempa, Tshering; Norbu, Nawang] Minist Agr & Forests, Ugyen Wangchuck Inst Conservat & Environm, Dept Forests & Pk Serv, Lamai Goempa, Bumthang, Bhutan; [Mills, L. Scott] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Wangchuk, Tshewang R.] Bhutan Fdn, Washington, DC USA	University of Montana System; University of Montana; University of North Carolina; North Carolina State University	Goldberg, JF (corresponding author), Univ Calif Riverside, Dept Biol, Evolut Ecol & Organismal Biol Program, Riverside, CA 92521 USA.	joshua.goldberg@umontana.edu	hebblewhite, mark/G-6164-2013; Hebblewhite, Mark/AAI-8101-2020	Hebblewhite, Mark/0000-0001-5382-1361	National Aeronautics and Space Administration [NNX11OA47G]; Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund; Bhutan Foundation	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund; Bhutan Foundation	Funding: National Aeronautics and Space Administration (grant # NNX11OA47G) to MH; Ugyen Wangchuck Institute for Conservation and Environment Jigme Singye Wangchuck Research and Training Fund to TT; Bhutan Foundation research grant to TT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ando T, 2010, INT J FORECASTING, V26, P744, DOI 10.1016/j.ijforecast.2009.08.001; Bailey, 1993, AFRICAN LEOPARD ECOL; Barker RJ, 2013, AM STAT, V67, P150, DOI 10.1080/00031305.2013.791644; Bischof R, 2014, METHODS ECOL EVOL, V5, P44, DOI 10.1111/2041-210X.12115; Borah J, 2013, ORYX, P1; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2014, METHODS ECOL EVOL, V5, P656, DOI 10.1111/2041-210X.12196; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Efford Murry, 2004, Oikos, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; GELFAND AE, 1994, J ROY STAT SOC B MET, V56, P501; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A, 1995, SOCIOL METHODOL, V25, P165, DOI 10.2307/271064; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gelman A, 2013, BRIT J MATH STAT PSY, V66, P8, DOI 10.1111/j.2044-8317.2011.02037.x; Green P.J., 1995, ANN STAT, V82, P711, DOI DOI 10.1093/BI0MET/82.4.711; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Ibrahim JG, 2001, STAT SINICA, V11, P419; Jeffreys H, 1935, P CAMBRIDGE PHILOS S; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kalle R, 2011, ACTA THERIOL, V56, P335, DOI 10.1007/s13364-011-0038-9; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Liu C, 2012, ECON LETT, V115, P200, DOI 10.1016/j.econlet.2011.12.034; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Mills L. S., 2013, CONSERVATION WILDLIF; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Proffitt K, ECOGRAPHY; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Sanei A, 2011, TROP ECOL, V52, P209; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; [Services DoFaP DoFPS], 2014, DEP REP WILDL CRIM B; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Tempa T, 2013, ORYX, V47, P207, DOI 10.1017/S0030605312001317; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Wang SW, 2006, BIOL CONSERV, V129, P558, DOI 10.1016/j.biocon.2005.11.024; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilton CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111257	67	26	28	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140757	10.1371/journal.pone.0140757	http://dx.doi.org/10.1371/journal.pone.0140757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536231	Green Submitted, gold, Green Published			2022-12-27	WOS:000364298400035
J	Myowa-Yamakoshi, M; Yoshida, C; Hirata, S				Myowa-Yamakoshi, Masako; Yoshida, Chisato; Hirata, Satoshi			Humans but Not Chimpanzees Vary Face-Scanning Patterns Depending on Contexts during Action Observation	PLOS ONE			English	Article							MIRROR; IMITATION; RECOGNITION; PREDICTION; MOVEMENT; CHILDREN; ABILITY; ATTEND; GOALS; GAZE	Human and nonhuman primates comprehend the actions of other individuals by detecting social cues, including others' goal-directed motor actions and faces. However, little is known about how this information is integrated with action understanding. Here, we present the ontogenetic and evolutionary foundations of this capacity by comparing face-scanning patterns of chimpanzees and humans as they viewed goal-directed human actions within contexts that differ in whether or not the predicted goal is achieved. Human adults and children attend to the actor's face during action sequences, and this tendency is particularly pronounced in adults when observing that the predicted goal is not achieved. Chimpanzees rarely attend to the actor's face during the goal-directed action, regardless of whether the predicted action goal is achieved or not. These results suggest that in humans, but not chimpanzees, attention to actor's faces conveying referential information toward the target object indicates the process of observers making inferences about the intentionality of an action. Furthermore, this remarkable predisposition to observe others' actions by integrating the prediction of action goals and the actor's intention is developmentally acquired.	[Myowa-Yamakoshi, Masako; Yoshida, Chisato] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan; [Myowa-Yamakoshi, Masako] RIKEN, ERATO, Japan Sci & Technol Agcy, Wako, Saitama 3510198, Japan; [Hirata, Satoshi] Kyoto Univ, Kumamoto Sanctuary, Kumamoto 8693201, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Kyoto University	Myowa-Yamakoshi, M (corresponding author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan.	myowa.masako.4x@kyoto-u.ac.jp	Myowa, Masako/E-8965-2010		Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [24000001, 24300103, 24119005, 26245069]; ERATO, Okanoya Emotional Information Project, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26245069] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO, Okanoya Emotional Information Project, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science and Technology (24000001, 24300103, 24119005, and 26245069), https://www.jsps.go.jp/english/e-grants/index.html; ERATO, the Okanoya Emotional Information Project, Japan Science and Technology Agency, http://www.jst.go.jp/erato/project/ojj_P/ojj_P.html.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Becchio C, 2012, NEUROIMAGE, V61, P240, DOI 10.1016/j.neuroimage.2012.03.013; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Buttelmann D, 2012, ANIM COGN, V15, P1037, DOI 10.1007/s10071-012-0528-4; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Falck-Ytter T, 2013, J AUTISM DEV DISORD, V43, P2249, DOI 10.1007/s10803-013-1776-0; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hecht EE, 2013, CEREB CORTEX, V23, P1014, DOI 10.1093/cercor/bhs097; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kano F, 2014, PSYCHOL SCI, V25, P1691, DOI 10.1177/0956797614536402; Kano F, 2011, ANIM COGN, V14, P879, DOI 10.1007/s10071-011-0422-5; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Krogh-Jespersen S, 2015, DEVELOPMENTAL SCI, V18, P815, DOI 10.1111/desc.12249; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Myowa-Yamakoshi M, 2000, J COMP PSYCHOL, V114, P381, DOI 10.1037/0735-7036.114.4.381; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; O'Connell S., 2003, EVOL COGN, V9, P131; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rochat MJ, 2008, CURR BIOL, V18, P227, DOI 10.1016/j.cub.2007.12.021; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Sodian B, 2004, J COGN DEV, V5, P289, DOI 10.1207/s15327647jcd0503_1; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002; Vaish A, 2010, INFANT BEHAV DEV, V33, P79, DOI 10.1016/j.infbeh.2009.11.003; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0139989	10.1371/journal.pone.0139989	http://dx.doi.org/10.1371/journal.pone.0139989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV5GZ	26535901	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400014
J	Bluml, V; Waldhor, T; Kapusta, ND; Vyssoki, B				Blueml, Victor; Waldhoer, Thomas; Kapusta, Nestor D.; Vyssoki, Benjamin			Psychiatric Hospital Bed Numbers and Prison Population Sizes in 26 European Countries: A Critical Reconsideration of the Penrose Hypothesis	PLOS ONE			English	Article							MENTAL-HEALTH-CARE; UNITED-STATES; INPATIENT CARE; DEINSTITUTIONALIZATION; DISORDERS; PEOPLE; STIGMATIZATION; VIOLENCE	Background Recently, there has been a revived interest in the validity of the Penrose hypothesis, which was originally postulated over 75 years ago. It suggests an inverse relationship between the numbers of psychiatric hospital beds and the sizes of prison population. This study aims to investigate the association between psychiatric hospital beds and prison populations in a large sample of 26 European countries between 1993 and 2011. Methods The association between prison population sizes and numbers of psychiatric hospital beds was assessed by means of Spearman correlations and modeled by a mixed random coefficient regression model. Socioeconomic variables were considered as covariates. Data were retrieved from Eurostat, the statistical office of the European Union. Outcomes Mean Spearman correlation coefficients between psychiatric beds and prison population showed a significant negative association (-0.35; p = <0.01). However, in the mixed regression model including socioeconomic covariates there were no significant fixed parameter estimates. Meanwhile, the covariance estimates for the random coefficients psychiatric beds (sigma(2) = 0.75, p = <0.01) and year (sigma(2) = 0.0007, p = 0.03) yielded significant results. Interpretation These findings do not support the general validity of the Penrose hypothesis. Notably, the results of the mixed-model show a significant variation in the magnitude and direction of the association of psychiatric hospital bed numbers and the prison population sizes between countries. In this sense, our results challenge the prevalent opinion that a reduction of psychiatric beds subsequently leads to increasing incarcerations. These findings also work against the potential stigmatization of individuals suffering from mental disorders as criminals, which could be an unintentional byproduct of the Penrose hypothesis.	[Blueml, Victor; Kapusta, Nestor D.] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Waldhoer, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Vyssoki, Benjamin] Med Univ Vienna, Dept Psychiat & Psychotherapy, Clin Div Social Psychiat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Vyssoki, B (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Clin Div Social Psychiat, Vienna, Austria.	benjamin.vyssoki@meduniwien.ac.at	Kapusta, Nestor D/C-9368-2009	Kapusta, Nestor D/0000-0002-0970-4341; Bluml, Victor/0000-0003-0226-0837; Vyssoki, Benjamin/0000-0003-1195-630X				Affairs UNDoEaS, 2015, WORLD EC SIT PROSP 2; Blader JC, 2011, ARCH GEN PSYCHIAT, V68, P1276, DOI 10.1001/archgenpsychiatry.2011.84; Ceccherini-Nelli A, 2007, INT J SOC ECON, V34, P788, DOI 10.1108/03068290710826396; Conacher GN, 1996, J NERV MENT DIS, V184, P708; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Cummins I, 2007, J SOC WELF FAM LAW, V28, P267, DOI 10.1080/09649060601119466; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fakhoury W, 2002, CURR OPIN PSYCHIATR, V15, P187, DOI 10.1097/00001504-200203000-00011; Freidl M, 2003, SOC PSYCH PSYCH EPID, V38, P269, DOI 10.1007/s00127-003-0626-3; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hartvig P, 2009, NORD J PSYCHIAT, V63, P51, DOI 10.1080/08039480802298697; Juven-Wetzler A, 2012, EUR PSYCHIAT, V27, P229, DOI 10.1016/j.eurpsy.2011.05.003; Kelly BD, 2007, IRISH MED J, V100; Lamb HR, 2015, JAMA PSYCHIAT, V72, P105, DOI 10.1001/jamapsychiatry.2014.2444; Large MM, 2009, PSYCHOL PSYCHOTHER-T, V82, P113, DOI 10.1348/147608308X320099; Mechanic D, 1998, New Dir Ment Health Serv, P7; Mechanic D, 1998, ARCH GEN PSYCHIAT, V55, P785, DOI 10.1001/archpsyc.55.9.785; Meise U, 2008, NEUROPSYCHIATRIE, V22, P230; Mundt AP, 2015, JAMA PSYCHIAT, V72, P112, DOI 10.1001/jamapsychiatry.2014.2433; Mundt AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038490; Pedersen Per Bernhard, 2009, Int J Ment Health Syst, V3, P28, DOI 10.1186/1752-4458-3-28; Penrose LS, 1939, BRIT J MED PSYCHOL, V18, P1, DOI 10.1111/j.2044-8341.1939.tb00704.x; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Priebe S, 2008, PSYCHIAT SERV, V59, P570, DOI 10.1176/ps.2008.59.5.570; Prins SJ, 2011, COMMUNITY MENT HLT J, V47, P716, DOI 10.1007/s10597-011-9420-y; Sartorius N, 2010, WORLD PSYCHIATRY, V9, P131; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; STEADMAN HJ, 1984, J CRIM LAW CRIM, V75, P474, DOI 10.2307/1143164; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Watt DC, 1998, BRIT J PSYCHIAT, V173, P458, DOI 10.1192/bjp.173.6.458	30	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142163	10.1371/journal.pone.0142163	http://dx.doi.org/10.1371/journal.pone.0142163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1QH	26529102	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600109
J	Faron, ML; Buchan, BW; Hyke, J; Madisen, N; Lillie, JL; Granato, PA; Wilson, DA; Procop, GW; Novak-Weekley, S; Marlowe, E; Cumpio, J; Griego-Fullbright, C; Kindig, S; Timm, K; Young, S; Ledeboer, NA				Faron, Matthew L.; Buchan, Blake W.; Hyke, Josh; Madisen, Neil; Lillie, Jennifer L.; Granato, Paul A.; Wilson, Deborah A.; Procop, Gary W.; Novak-Weekley, Susan; Marlowe, Elizabeth; Cumpio, Joven; Griego-Fullbright, Christen; Kindig, Sandra; Timm, Karen; Young, Stephen; Ledeboer, Nathan A.			Multicenter Evaluation of the Bruker MALDI Biotyper CA System for the Identification of Clinical Aerobic Gram-Negative Bacterial Isolates	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; VITEK MS; HAEMOPHILUS-INFLUENZAE; RAPID IDENTIFICATION; ROUTINE IDENTIFICATION; TOF MS; CULTURES; CLASSIFICATION	The prompt and accurate identification of bacterial pathogens is fundamental to patient health and outcome. Recent advances in matrix-assisted laser desorption/ionization time-of- flight mass spectrometry (MALDI-TOF MS) have revolutionized bacterial identification in the clinical laboratory, but uniform incorporation of this technology in the U.S. market has been delayed by a lack of FDA-cleared systems. In this study, we conducted a multicenter evaluation of the MALDI Biotyper CA (MBT-CA) System (Bruker Daltonics Inc, Billerica, MA) for the identification of aerobic gram-negative bacteria as part of a 510(k) submission to the FDA. A total of 2,263 aerobic gram negative bacterial isolates were tested representing 23 genera and 61 species. Isolates were collected from various clinical sources and results obtained from the MBT-CA System were compared to DNA sequencing and/or biochemical testing. Isolates that failed to report as a "high confidence species ID" [log(score) >= 2.00] were re-tested using an extraction method. The MBT-CA System identified 96.8% and 3.1% of isolates with either a "high confidence" or a "low confidence" [log(score) value between 1.70 and <2.00] species ID, respectively. Two isolates did not produce acceptable confidence scores after extraction. The MBT-CA System correctly identified 99.8% (2,258/ 2,263) to genus and 98.2%(2,222/2,263) to species level. These data demonstrate that the MBT-CA System provides accurate results for the identification of aerobic gram-negative bacteria.	[Faron, Matthew L.; Buchan, Blake W.; Ledeboer, Nathan A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Buchan, Blake W.; Hyke, Josh; Madisen, Neil; Ledeboer, Nathan A.] Wisconsin Diagnost Lab, Milwaukee, WI USA; [Lillie, Jennifer L.; Granato, Paul A.] Lab Alliance Cent New York, Fayetteville, AR USA; [Granato, Paul A.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Wilson, Deborah A.; Procop, Gary W.] Cleveland Clin, Cleveland, OH 44106 USA; [Novak-Weekley, Susan; Marlowe, Elizabeth; Cumpio, Joven] Kaiser Permanente SCPMG Reg Reference Labs, North Hollywood, CA USA; [Griego-Fullbright, Christen; Kindig, Sandra; Timm, Karen; Young, Stephen] Tricore Reference Labs, Albuquerque, NM USA; [Young, Stephen] Dept Pathol UNMHSC, Albuquerque, NM USA	Medical College of Wisconsin; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cleveland Clinic Foundation	Ledeboer, NA (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.	nledeboe@mcw.edu			Bruker Daltonics Inc.; Laboratory Alliance of Central New York; Kaiser Permanente SCPMG Regional Reference Laboratories; Tricore Reference Laboratories; Dynacare Laboratories	Bruker Daltonics Inc.; Laboratory Alliance of Central New York; Kaiser Permanente SCPMG Regional Reference Laboratories; Tricore Reference Laboratories; Dynacare Laboratories	This study was supported by materials and funding provided by Bruker Daltonics Inc. The funder approved design of the study but did not play a role in data collection and analysis, decision to publish, or preparation of the manuscript. Dynacare Laboratories, Laboratory Alliance of Central New York, Kaiser Permanente SCPMG Regional Reference Laboratories and Tricore Reference Laboratories provided support in the form of salaries for authors BWB, JH, NM, NAL, JLL, PAG, SNW, JC, CGF, SK, KT and SY respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; Bessede E, 2011, CLIN MICROBIOL INFEC, V17, P533, DOI 10.1111/j.1469-0691.2010.03274.x; Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10; Branda JA, 2014, DIAGN MICR INFEC DIS, V78, P129, DOI 10.1016/j.diagmicrobio.2013.08.013; Bruin JP, 2014, EUR J CLIN MICROBIOL, V33, P279, DOI 10.1007/s10096-013-1958-x; Buchan BW, 2014, AM J CLIN PATHOL, V141, P25, DOI 10.1309/AJCPBPUBUDEW2OAG; Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Cattoir V, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-21; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Dupont C, 2010, CLIN MICROBIOL INFEC, V16, P998, DOI 10.1111/j.1469-0691.2009.03036.x; Ford BA, 2013, J CLIN MICROBIOL, V51, P1412, DOI 10.1128/JCM.01803-12; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Jamal W, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0289-0; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Krishnamurthy T, 1996, RAPID COMMUN MASS SP, V10, P1992, DOI 10.1002/(SICI)1097-0231(199612)10:15<1992::AID-RCM789>3.0.CO;2-V; Leuschner RGK, 2004, LETT APPL MICROBIOL, V38, P24, DOI 10.1046/j.1472-765X.2003.01436.x; Manji R, 2014, EUR J CLIN MICROBIOL, V33, P337, DOI 10.1007/s10096-013-1961-2; Marko DC, 2012, J CLIN MICROBIOL, V50, P2034, DOI 10.1128/JCM.00330-12; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Peters RPH, 2006, J CLIN MICROBIOL, V44, P119, DOI 10.1128/JCM.44.1.119-123.2006; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Sedo O, 2013, RAPID COMMUN MASS SP, V27, P2729, DOI 10.1002/rcm.6741; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Shelly DB, 2000, J CLIN MICROBIOL, V38, P3112, DOI 10.1128/JCM.38.8.3112-3115.2000; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; TeKippe EM, 2014, EUR J CLIN MICROBIOL, V33, P2163, DOI 10.1007/s10096-014-2183-y; Ulanova M, 2014, LANCET INFECT DIS, V14, P70, DOI 10.1016/S1473-3099(13)70170-1; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Zbinden A, 2007, J CLIN MICROBIOL, V45, P2270, DOI 10.1128/JCM.02604-06; Zhu BQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056139	40	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141350	10.1371/journal.pone.0141350	http://dx.doi.org/10.1371/journal.pone.0141350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529504	gold, Green Published, Green Submitted			2022-12-27	WOS:000364032600023
J	Sheehan, S; Harris, SA; Satti, I; Hokey, DA; Dheenadhayalan, V; Stockdale, L; Thomas, ZRM; Minhinnick, A; Wilkie, M; Vermaak, S; Meyer, J; O'Shea, MK; Pau, MG; Versteege, I; Douoguih, M; Hendriks, J; Sadoff, J; Landry, B; Moss, P; McShane, H				Sheehan, Sharon; Harris, Stephanie A.; Satti, Iman; Hokey, David A.; Dheenadhayalan, Veerabadran; Stockdale, Lisa; Thomas, Zita-Rose Manjaly; Minhinnick, Alice; Wilkie, Morven; Vermaak, Samantha; Meyer, Joel; O'Shea, Matthew K.; Pau, Maria Grazia; Versteege, Isabella; Douoguih, Macaya; Hendriks, Jenny; Sadoff, Jerald; Landry, Bernard; Moss, Paul; McShane, Helen			A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults	PLOS ONE			English	Article							IMMUNITY; METAANALYSIS; MENINGITIS	Background MVA85A and AERAS-402 are two clinically advanced viral vectored TB vaccine candidates expressing Mycobacterium tuberculosis antigens designed to boost BCG-induced immunity. Clinical trials with candidate malaria vaccines have demonstrated that adenoviral vector based priming immunisation, followed by MVA vector boost, induced high levels of immunity. We present the safety and immunogenicity results of the first clinical trial to evaluate this immunisation strategy in TB. Methods In this phase 1, open-label trial, 40 healthy previously BCG-vaccinated participants were enrolled into three treatment groups and vaccinated with 1 or 2 doses of AERAS-402 followed by MVA85A; or 3 doses of AERAS-402. Results Most related adverse events (AEs) were mild and there were no vaccine related serious AEs. Boosting AERAS-402 with MVA85A significantly increased Ag85A-specific T-cell responses from day of vaccination. Two priming doses of AERAS-402 followed by MVA85A boost, resulted in a significantly higher AUC post-peak Ag85A response compared to three doses of AERAS-402 and historical data with MVA85A vaccination alone. The frequency of CD8+ T-cells producing IFN-gamma, TNF-alpha and IL-2 was highest in the group receiving two priming doses of AERAS-402 followed by MVA85A. Conclusions Vaccination with AERAS-402 followed by MVA85A was safe and increased the durability of antigen specific T-cell responses and the frequency and polyfunctionality of CD8+ T-cells, which may be important in protection against TB. Further clinical trials with adenoviral prime-MVA85A boost regimens are merited to optimise vaccination intervals, dose and route of immunisation and to evaluate this strategy in the target population in TB high burden countries.	[Sheehan, Sharon; Harris, Stephanie A.; Satti, Iman; Stockdale, Lisa; Thomas, Zita-Rose Manjaly; Minhinnick, Alice; Wilkie, Morven; Vermaak, Samantha; Meyer, Joel; O'Shea, Matthew K.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Hokey, David A.; Dheenadhayalan, Veerabadran; Landry, Bernard] Aeras Global TB Vaccine Fdn, Rockville, MD USA; [Pau, Maria Grazia; Versteege, Isabella; Douoguih, Macaya; Hendriks, Jenny; Sadoff, Jerald] Janssen Infect Dis & Vaccines, Crucell, Leiden, Netherlands; [Moss, Paul] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; Jenner Institute; Johnson & Johnson; University of Birmingham	McShane, H (corresponding author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.	helen.mcshane@ndm.ox.ac.uk	Moss, Paul/D-1728-2009	Moss, Paul/0000-0002-6895-1967; Satti, Iman/0000-0003-4760-4664; Vermaak, Samantha/0000-0003-4791-8364; O'Shea, Matthew/0000-0001-6414-8088; McShane, Helen/0000-0002-2126-5142	Aeras and Oxford-Emergent Tuberculosis Consortium grant to Oxford [TB032]; Bill & Melinda Gates Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, at Oxford University Hospitals NHS Trust; University of Oxford	Aeras and Oxford-Emergent Tuberculosis Consortium grant to Oxford; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, at Oxford University Hospitals NHS Trust; University of Oxford	This study was supported by an Aeras and Oxford-Emergent Tuberculosis Consortium grant to Oxford (TB032), and the Bill & Melinda Gates Foundation. HMcS is a Wellcome Trust Senior Clinical Research Fellow (095780/Z/11/Z). The research was also supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, based at Oxford University Hospitals NHS Trust and University of Oxford. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Encinales L, 2010, MOL IMMUNOL, V47, P1066, DOI 10.1016/j.molimm.2009.11.005; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Graves AJ, 2014, CYTOM PART A, V85A, P576, DOI 10.1002/cyto.a.22478; Hoft DF, 2012, VACCINE, V30, P2098, DOI 10.1016/j.vaccine.2012.01.048; Manivannan S, 2012, INDIAN J EXP BIOL, V50, P542; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rowland R, 2013, HUM VACC IMMUNOTHER, V9, P50, DOI 10.4161/hv.22464; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; WHO, GLOB TUB REP 2014; WHO, STOP TB STRAT; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x	19	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141687	10.1371/journal.pone.0141687	http://dx.doi.org/10.1371/journal.pone.0141687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529238	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600050
J	Benda, NMM; Seeger, JPH; Stevens, GGCF; Hijmans-Kersten, BTP; van Dijk, APJ; Bellersen, L; Lamfers, EJP; Hopman, MTE; Thijssen, DHJ				Benda, Nathalie M. M.; Seeger, Joost P. H.; Stevens, Guus G. C. F.; Hijmans-Kersten, Bregina T. P.; van Dijk, Arie P. J.; Bellersen, Louise; Lamfers, Evert J. P.; Hopman, Maria T. E.; Thijssen, Dick H. J.			Effects of High-Intensity Interval Training versus Continuous Training on Physical Fitness, Cardiovascular Function and Quality of Life in Heart Failure Patients	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FLOW-MEDIATED DILATION; CHRONOTROPIC INCOMPETENCE; ENDOTHELIAL DYSFUNCTION; EXERCISE CAPACITY; HEALTHY-ADULTS; OXYGEN-UPTAKE; METAANALYSIS; REHABILITATION; HUMANS	Introduction Physical fitness is an important prognostic factor in heart failure (HF). To improve fitness, different types of exercise have been explored, with recent focus on high-intensity interval training (HIT). We comprehensively compared effects of HIT versus continuous training (CT) in HF patients NYHA II-III on physical fitness, cardiovascular function and structure, and quality of life, and hypothesize that HIT leads to superior improvements compared to CT. Methods Twenty HF patients (male: female 19: 1, 64 +/- 8 yrs, ejection fraction 38 +/- 6%) were allocated to 12-weeks of HIT (10*1-minute at 90% maximal workload-alternated by 2.5 minutes at 30% maximal workload) or CT (30 minutes at 60-75% of maximal workload). Before and after intervention, we examined physical fitness (incremental cycling test), cardiac function and structure (echocardiography), vascular function and structure (ultrasound) and quality of life (SF-36, Minnesota living with HF questionnaire (MLHFQ)). Results Training improved maximal workload, peak oxygen uptake (VO2peak) related to the predicted VO2peak, oxygen uptake at the anaerobic threshold, and maximal oxygen pulse (all P < 0.05), whilst no differences were present between HIT and CT (N.S.). We found no major changes in resting cardiovascular function and structure. SF-36 physical function score improved after training (P < 0.05), whilst SF-36 total score and MLHFQ did not change after training (N.S.). Conclusion Training induced significant improvements in parameters of physical fitness, although no evidence for superiority of HIT over CT was demonstrated. No major effect of training was found on cardiovascular structure and function or quality of life in HF patients NYHA II-III.	[Benda, Nathalie M. M.; Seeger, Joost P. H.; Stevens, Guus G. C. F.; Hijmans-Kersten, Bregina T. P.; Hopman, Maria T. E.; Thijssen, Dick H. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Physiol, Nijmegen, Netherlands; [van Dijk, Arie P. J.; Bellersen, Louise] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Cardiol, Nijmegen, Netherlands; [Lamfers, Evert J. P.] Canisius Wilhelmina Hosp, Dept Cardiol, Nijmegen, Netherlands; [Seeger, Joost P. H.; Thijssen, Dick H. J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Liverpool John Moores University	Thijssen, DHJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Physiol, Nijmegen, Netherlands.	dick.thijssen@radboudumc.nl	Hopman, Maria/A-4205-2014; Stefanadis, Christodoulos/ABH-2232-2020; Thijssen, Dick HJ/E-8731-2016; Thijssen, Dick/D-3430-2009; van Dijk, Arie/L-4272-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; Thijssen, Dick HJ/0000-0002-7707-5567; van Dijk, Arie/0000-0002-7843-8251; Lamfers, Evert/0000-0002-5582-3720	Netherlands Heart Foundation [2009T064]	Netherlands Heart Foundation(Netherlands Heart Foundation)	DHJT is financially supported by the Netherlands Heart Foundation (E Dekker-stipend, 2009T064).	Aksoy S, 2015, AM J PHYS MED REHABI; Arena R, 2013, HEART FAIL REV, V18, P95, DOI 10.1007/s10741-012-9333-z; Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027; Barbour KA, 2008, HEART FAIL REV, V13, P81, DOI 10.1007/s10741-007-9054-x; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Belardinelli R, 2012, J AM COLL CARDIOL, V60, P1521, DOI 10.1016/j.jacc.2012.06.036; Benda NM, 2015, EXP PHYSL; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Briasoulis Alexandros, 2012, Recent Pat Cardiovasc Drug Discov, V7, P21; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Cahalin LP, 2013, HEART FAIL REV, V18, P79, DOI 10.1007/s10741-012-9332-0; Chrysohoou C, 2014, QJM-INT J MED, V107, P25, DOI 10.1093/qjmed/hct194; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Dimopoulos S, 2006, EUR J CARDIOV PREV R, V13, P67, DOI 10.1097/00149831-200602000-00010; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Green DJ, 2014, J APPL PHYSIOL, V117, P345, DOI 10.1152/japplphysiol.00354.2014; Hambrecht R, 2000, J AM COLL CARDIOL, V35, P706, DOI 10.1016/S0735-1097(99)00602-6; Haykowsky MJ, 2007, J AM COLL CARDIOL, V49, P2329, DOI 10.1016/j.jacc.2007.02.055; Haykowsky MJ, 2013, AM J CARDIOL, V111, P1466, DOI 10.1016/j.amjcard.2013.01.303; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; Iellamo F, 2014, INTERN EMERG MED, V9, P547, DOI 10.1007/s11739-013-0980-4; Iellamo F, 2013, INT J CARDIOL, V167, P2561, DOI 10.1016/j.ijcard.2012.06.057; Ismail H, 2013, JACC-HEART FAIL, V1, P514, DOI 10.1016/j.jchf.2013.08.006; Kemps HM, 2008, AM J CARDIOL, V102, P1073, DOI 10.1016/j.amjcard.2008.05.054; Koufaki P, 2014, J REHABIL MED, V46, P348, DOI 10.2340/16501977-1278; Koukoui F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000544; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Lavie CJ, 2013, J HEART LUNG TRANSPL, V32, P1056, DOI 10.1016/j.healun.2013.08.001; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Linke A, 2001, J AM COLL CARDIOL, V37, P392, DOI 10.1016/S0735-1097(00)01108-6; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Meyer K, 1997, AM J CARDIOL, V80, P56, DOI 10.1016/S0002-9149(97)00283-X; Myers J, 1998, ANN INTERN MED, V129, P286, DOI 10.7326/0003-4819-129-4-199808150-00004; Naylor LH, 2005, J APPL PHYSIOL, V98, P2311, DOI 10.1152/japplphysiol.01047.2004; Nilsson BB, 2008, AM J CARDIOL, V102, P1361, DOI 10.1016/j.amjcard.2008.07.016; Norton K, 2010, J SCI MED SPORT, V13, P496, DOI 10.1016/j.jsams.2009.09.008; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Roditis P, 2007, EUR J CARDIOV PREV R, V14, P304, DOI 10.1097/HJR.0b013e32808621a3; Schmid JP, 2013, EUR J PREV CARDIOL, V20, P585, DOI 10.1177/2047487312444368; Schreuder THA, 2014, HIGH ALT MED BIOL, V15, P349, DOI 10.1089/ham.2013.1144; Skaug EA, 2013, EUR J PREV CARDIOL, V20, P531, DOI 10.1177/2047487312444234; Smart NA, 2013, INT J CARDIOL, V166, P352, DOI 10.1016/j.ijcard.2011.10.075; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; van Tol BAF, 2006, EUR J HEART FAIL, V8, P841, DOI 10.1016/j.ejheart.2006.02.013; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserman K., 1987, PRINCIPLES EXERCISE; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Witte KKA, 2006, HEART, V92, P481, DOI 10.1136/hrt.2004.058073; Zarrinkoub R, 2013, EUR J HEART FAIL, V15, P995, DOI 10.1093/eurjhf/hft064	59	40	45	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141256	10.1371/journal.pone.0141256	http://dx.doi.org/10.1371/journal.pone.0141256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517867	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800030
J	Bennis, A; Gorgels, TGMF; ten Brink, JB; van der Spek, PJ; Bossers, K; Heine, VM; Bergen, AA				Bennis, Anna; Gorgels, Theo G. M. F.; ten Brink, Jacoline B.; van der Spek, Peter J.; Bossers, Koen; Heine, Vivi M.; Bergen, Arthur A.			Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							OXIDATIVE STRESS; STEM-CELLS; SUPEROXIDE-DISMUTASE; HUMAN RPE; ZINC; MODEL; DRUSEN; MICE; INFLAMMATION; PATHOGENESIS	Background The human retinal pigment epithelium (RPE) plays an important role in the pathogenesis of age related macular degeneration (AMD). AMD is the leading cause of blindness worldwide. There is currently no effective treatment available. Preclinical studies in AMD mouse models are essential to develop new therapeutics. This requires further in-depth knowledge of the similarities and differences between mouse and human RPE. Methods We performed a microarray study to identify and functionally annotate RPE specific gene expression in mouse and human RPE. We used a meticulous method to determine C57BL/6J mouse RPE signature genes, correcting for possible RNA contamination from its adjacent layers: the choroid and the photoreceptors. We compared the signature genes, gene expression profiles and functional annotations of the mouse and human RPE. Results We defined sets of mouse (64), human (171) and mouse-human interspecies (22) RPE signature genes. Not unexpectedly, our gene expression analysis and comparative functional annotation suggested that, in general, the mouse and human RPE are very similar. For example, we found similarities for general features, like "organ development" and "disorders related to neurological tissue". However, detailed analysis of the molecular pathways and networks associated with RPE functions, suggested also multiple species-specific differences, some of which may be relevant for the development of AMD. For example, CFHR1, most likely the main complement regulator in AMD pathogenesis was highly expressed in human RPE, but almost absent in mouse RPE. Furthermore, functions assigned to mouse and human RPE expression profiles indicate (patho-) biological differences related to AMD, such as oxidative stress, Bruch's membrane, immune-regulation and outer blood retina barrier. Conclusion These differences may be important for the development of new therapeutic strategies and translational studies in age-related macular degeneration.	[Bennis, Anna; ten Brink, Jacoline B.; Bergen, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Bennis, Anna; Gorgels, Theo G. M. F.; Bergen, Arthur A.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands; [Gorgels, Theo G. M. F.] Maastricht Univ, Univ Eye, Ctr Med, Clin Maastricht, Maastricht, Netherlands; [van der Spek, Peter J.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Bossers, Koen] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands; [Heine, Vivi M.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Child Neurol, Amsterdam, Netherlands; [Heine, Vivi M.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Bergen, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bergen, AA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	aabergen@amc.uva.nl	Heine, Vivi M/F-1741-2011	Heine, Vivi M/0000-0003-4416-3875; Bergen, Arthur/0000-0002-6333-9576	General Dutch Foundation Preventing Blindness; foundation Blinden-Penning; National Foundation for Blindness and Low Vision (LSBS); National Foundation of Macular Degeneration (MD); Netherlands Eye Foundation (Oogvereniging); Gelderse Foundation for the Blind; Retina Netherlands Foundation; Foundation Winckel-Sweep; Rotterdam Foundation for the Blind (RvB); Hague Foundation "Care for the Blind" [2011-6]	General Dutch Foundation Preventing Blindness; foundation Blinden-Penning; National Foundation for Blindness and Low Vision (LSBS); National Foundation of Macular Degeneration (MD); Netherlands Eye Foundation (Oogvereniging); Gelderse Foundation for the Blind; Retina Netherlands Foundation; Foundation Winckel-Sweep; Rotterdam Foundation for the Blind (RvB); Hague Foundation "Care for the Blind"	This study was supported by grants from the General Dutch Foundation Preventing Blindness, the foundation Blinden-Penning, the National Foundation for Blindness and Low Vision (LSBS); The National Foundation of Macular Degeneration (MD); The Netherlands Eye Foundation (Oogvereniging); The Gelderse Foundation for the Blind; Retina Netherlands Foundation; The Foundation Winckel-Sweep; The Rotterdam Foundation for the Blind (RvB); and The Hague Foundation "Care for the Blind" (all coordinated through the UitZicht platform, project 2011-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Buschini E, 2015, CLIN OPHTHALMOL, V9, P563, DOI 10.2147/OPTH.S59724; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Ervin JF, 2007, J NEUROPATH EXP NEUR, V66, P1093, DOI 10.1097/nen.0b013e31815c196a; Flinn JM, 2014, METALLOMICS, V6, P1223, DOI 10.1039/c4mt00058g; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hawkins BS, 1999, MOL VIS, V5; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Janssen SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083345; Janssen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044973; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Karunadharma PP, 2010, INVEST OPHTH VIS SCI, V51, P5470, DOI 10.1167/iovs.10-5429; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Kondo N, 2009, MOL VIS, V15, P1819; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Leung KW, 2008, INVEST OPHTH VIS SCI, V49, P1221, DOI 10.1167/iovs.07-0781; Luo C, 2011, MOL VIS, V17, P1588; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; NEWSOME DA, 1990, INVEST OPHTH VIS SCI, V31, P2508; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Nita M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930671; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Rizzolo LJ, 2014, EXP EYE RES, V126, P16, DOI 10.1016/j.exer.2013.12.018; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Schmidl D, 2015, ACTA OPHTHALMOL, V93, P105, DOI 10.1111/aos.12650; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seo SJ, 2012, EXP EYE RES, V101, P60, DOI 10.1016/j.exer.2012.05.013; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027433; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stanzel BV, 2014, STEM CELL REP, V2, P64, DOI 10.1016/j.stemcr.2013.11.005; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tokarz P, 2013, BIOGERONTOLOGY, V14, P461, DOI 10.1007/s10522-013-9463-2; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439	55	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141597	10.1371/journal.pone.0141597	http://dx.doi.org/10.1371/journal.pone.0141597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517551	gold, Green Published, Green Submitted			2022-12-27	WOS:000363920800059
J	Navarro, JJ; Garcia-Rubio, J; Olivares, PR				Navarro, Juan-Jose; Garcia-Rubio, Javier; Olivares, Pedro R.			The Relative Age Effect and Its Influence on Academic Performance	PLOS ONE			English	Article							ACHIEVEMENT; SCHOOL; BIRTH; SEASON; EDUCATION; CHILDREN; SPORT	Introduction and Purpose The policy of school organisation for grouping students in the same academic year is based on date of birth. The differences in the experiences and maturation of older students involve a relatively better performance in academic settings, which is known as the relative age effect (RAE). This effect is more important the younger the student is. The goal of this study is to identify the connections of influence that RAE, socioeconomic status (SES), and type of institution have on academic performance in a school population of eighth graders. Methods The study is based on a population-based, representative sample of 15,234 8th graders (50.4% female; average age = 13.61 years) in the 2011 National System of Quality Assessment in Education Survey (SIMCE) from Chile. The SIMCE for global academic performance consists of 4 tests: reading, mathematics, social studies, and science. All tests consist of multiple-choice and closed questions. In addition, in order to have the information of general academic performance, an extra variable expressing the average score of each student was created. Also, the SIMCE includes additional variables for the evaluation process such as SES or type of school. Students were assigned to one of five age groups in terms of date of birth (G1, G2, G3, G4, and G5), in which students belonging to G1 are the oldest and students belonging to G5 are the youngest. Results The results achieved in the structural equation modelling indicate a good global fit. Individual relationships show significant effects of the three variables observed on academic performance, although SES received the highest values. The influence of RAE took place both in the full sample and sub-samples composed according to the SES and academic performance, showing higher values for students with lower scores. Although the influence of RAE decreases when SES is controlled, its effect is still significant and contributes to additionally explain the performance. Conclusions The RAE remains, even with residual values, an explanatory factor in academic performance even in eighth graders. Since the RAE decreases as the influence of schooling increases, the potential adverse effects for some students would be placed in previous and initial moments of formal schooling. These findings may be useful into taking steps towards flexibilisation on age of entry in compulsory schooling. Moreover, the need to implement early, comprehensive evaluation systems which include aspects related to neurodevelopment in order to provide maximum information to parents and educators is also drawn.	[Navarro, Juan-Jose] Univ Autonoma Chile, Inst Estudios Ciencias Educ, Santiago, Chile; [Navarro, Juan-Jose] Univ Seville, Fac Psicol, Individual Differences Language & Cognit LAB, Seville, Spain; [Garcia-Rubio, Javier; Olivares, Pedro R.] Univ Autonoma Chile, Inst Act Fis & Salud, Santiago, Chile	Universidad Autonoma de Chile; University of Sevilla; Universidad Autonoma de Chile	Navarro, JJ (corresponding author), Univ Autonoma Chile, Inst Estudios Ciencias Educ, Santiago, Chile.	jjnavarro@us.es	Hidalgo, Juan José Navarro/J-4841-2014; García, Javier/AAA-9006-2019; Olivares, Pedro R/C-6287-2008; García-Rubio, Javier/H-3679-2016	Hidalgo, Juan José Navarro/0000-0002-3249-1479; Olivares, Pedro R/0000-0001-7371-343X; García-Rubio, Javier/0000-0001-6426-0002				Alvarez A, 2013, CULT EDUC, V25, P137, DOI 10.1174/113564013806631309; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Bickman L., 1998, HDB APPL SOCIAL RES, pIX; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; Cervera V, 2013, REV PSICOL DEPORTE, V22, P447; Chandler R.E., 2011, STAT METHODS TREND D; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Daniels S, 2000, OXFORD REV EDUC, V26, P207, DOI 10.1080/713688530; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Calero MD, 2013, PSYCHOL SCHOOLS, V50, P705, DOI 10.1002/pits.21701; Educacion Md, 2012, INF RES ED FIS SIMCE, P1; GLEDHILL J, 2002, RES EDUC, V68, P41, DOI DOI 10.7227/RIE.68.4; Hsieh CT, 2006, J PUBLIC ECON, V90, P1477, DOI 10.1016/j.jpubeco.2005.11.002; Garcia-Perez JI, 2014, APPL ECON, V46, P1373, DOI 10.1080/00036846.2013.872761; Jussim L, 2005, PERS SOC PSYCHOL REV, V9, P131, DOI 10.1207/s15327957pspr0902_3; Kline RB, 2005, PRINCIPLES PRACTICE; Lawlor DA, 2006, BRIT J EDUC PSYCHOL, V76, P481, DOI 10.1348/000709905X49700; Lien L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-102; Lukas J. F., 2004, EVALUACION ED; Luria A, 1983, FUNDAMENTOS PSICOFIS, P299; Marti E., 1999, DESARROLLO PSICOLOGI, VI, P329; Martin CM, 2006, EVALUACION SISTEMA E, P55; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; Moyano J, 2012, PRESENTACION GRUPOS; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; OCDE, 2009, PROGR INT STUD ASS; Palacios J., 1999, DESARROLLO PSICOLOGI, P23; Puhani PA, 2008, STUD EMPIRIC ECON, P105, DOI 10.1007/978-3-7908-2022-5_6; REYNOLDS AJ, 1992, J RES MATH EDUC, V23, P306, DOI 10.2307/749308; Rogoff B., 1990, APPRENTICESHIP THINK; RUSSELL RJH, 1986, PERS INDIV DIFFER, V7, P839, DOI 10.1016/0191-8869(86)90082-6; Seguel Ximena, 2012, Psykhe, V21, P87; SHARP C, 1994, EDUC RES, V36, P107, DOI 10.1080/0013188940360201; SIMCE, 2012, INF TECN SIMC 2011; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sternberg R. J., 2002, DYNAMIC TESTING NATU; Strom B., 2004, STUDENT ACHIEVEMENT; UNESCO, 2013, AG ED POST 2015; Veldhuizen S, 2014, J SPORTS SCI, P1; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Vygotski L. S., 1934, OBRAS ESCOGIDAS, VI, P133; Wattie N, 2014, EUROPEAN PHYS ED REV; Wattie N, 2008, J SPORT SCI, V26, P1403, DOI 10.1080/02640410802233034; Wenglinsky H, 1998, EDUC EVAL POLICY AN, V20, P269, DOI 10.2307/1164325	45	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141895	10.1371/journal.pone.0141895	http://dx.doi.org/10.1371/journal.pone.0141895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517552	Green Published, gold, Green Submitted			2022-12-27	WOS:000363920800091
J	Wu, J; Lu, CJ; Li, X; Fang, H; Wan, WC; Yang, QH; Sun, XS; Wang, ML; Hu, XH; Chen, CYO; Wei, XY				Wu, Jie; Lu, Chuanjun; Li, Xue; Fang, Hua; Wan, Wencheng; Yang, Qiaohong; Sun, Xiaosheng; Wang, Meiling; Hu, Xiaohong; Chen, C. -Y. Oliver; Wei, Xiaoyong			Synthesis and Biological Evaluation of Novel Gigantol Derivatives as Potential Agents in Prevention of Diabetic Cataract	PLOS ONE			English	Article							ALDOSE REDUCTASE INHIBITORS; EPITHELIAL-CELL APOPTOSIS; UNFOLDED PROTEIN RESPONSE; NITRIC-OXIDE SYNTHASE; SCAPHYGLOTTIS-LIVIDA; ANTIOXIDANT ACTIVITY; COMPLICATIONS; EXPRESSION; ANALOGS; DESIGN	As a continuation of our efforts directed towards the development of natural anti-diabetic cataract agents, gigantol was isolated from Herba dendrobii and was found to inhibit both aldose reductase (AR) and inducible nitric oxide synthase (iNOS) activity, which play a significant role in the development and progression of diabetic cataracts. To improve its bioefficacy and facilitate use as a therapeutic agent, gigantol (compound 14f) and a series of novel analogs were designed and synthesized. Analogs were formulated to have different substituents on the phenyl ring (compounds 4, 5, 8, 14a-e), substitute the phenyl ring with a larger steric hindrance ring (compounds 10, 17c) or modify the carbon chain (compounds 17a, 17b, 21, 23, 25). All of the analogs were tested for their effect on AR and iNOS activities and on D-galactose-induced apoptosis in cultured human lens epithelial cells. Compounds 5, 10, 14a, 14b, 14d, 14e, 14f, 17b, 17c, 23, and 25 inhibited AR activity, with IC50 values ranging from 5.02 to 288.8 mu M. Compounds 5, 10, 14b, and 14f inhibited iNOS activity with IC50 ranging from 432.6 to 1188.7 mu M. Compounds 5, 8, 10, 14b, 14f, and 17c protected the cells from D-galactose induced apoptosis with viability ranging from 55.2 to 76.26%. Of gigantol and its analogs, compound 10 showed the greatest bioefficacy and is warranted to be developed as a therapeutic agent for diabetic cataracts.	[Wu, Jie; Li, Xue; Fang, Hua; Wan, Wencheng; Yang, Qiaohong; Sun, Xiaosheng; Wang, Meiling; Hu, Xiaohong; Wei, Xiaoyong] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China; [Lu, Chuanjun] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou 310014, Zhejiang, Peoples R China; [Lu, Chuanjun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Drug Synth & Pharmaceut Proc, Guangzhou 510006, Guangdong, Peoples R China; [Chen, C. -Y. Oliver; Wei, Xiaoyong] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Antioxidants Res Lab, Boston, MA 02111 USA	Guangzhou University of Chinese Medicine; Zhejiang University of Technology; Sun Yat Sen University; Tufts University; United States Department of Agriculture (USDA)	Wei, XY (corresponding author), Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China.	jidewowxy@163.com			National Natural Science Foundation of China [81274157, 81102674]; Guangzhou Science & Technology Planning Project [2014J4100082]; Guangdong Natural Science Foundation [S2011010005661]; Guangdong Science & Technology Planning Project [2011B031700076, 2009B090300335]; U.S. Department of Agriculture (USDA)/Agricultural Research Service [1950-5100-087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science & Technology Planning Project; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science & Technology Planning Project; U.S. Department of Agriculture (USDA)/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the National Natural Science Foundation of China (81274157, 81102674), Guangzhou Science & Technology Planning Project (2014J4100082), Guangdong Natural Science Foundation (S2011010005661), Guangdong Science & Technology Planning Project (2011B031700076, 2009B090300335) and the U.S. Department of Agriculture (USDA)/Agricultural Research Service (Cooperative Agreement No. 1950-5100-087).	Alexiou P, 2010, J MED CHEM, V53, P7756, DOI 10.1021/jm101008m; BEN I, 1985, J ORG CHEM, V50, P2236, DOI 10.1021/jo00213a008; Bian Q, 2008, MOL VIS, V14, P403; Bode JW, 1996, J ORG CHEM, V61, P9146, DOI 10.1021/jo961607u; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chanvorachote P, 2013, NAT PROD COMMUN, V8, P115; Chen X, 2012, CURR MED CHEM, V19, P3578, DOI 10.2174/092986712801323225; Costantino L, 1999, MED RES REV, V19, P3, DOI 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.3.CO;2-Z; Estrada S, 1999, PLANTA MED, V65, P109, DOI 10.1055/s-1999-14056; Estrada-Soto S, 2006, FITOTERAPIA, V77, P236, DOI 10.1016/j.fitote.2006.02.006; Fan CQ, 2001, PHYTOCHEMISTRY, V57, P1255, DOI 10.1016/S0031-9422(01)00168-6; Fang H, 2015, J ETHNOPHARMACOL, V172, P238, DOI 10.1016/j.jep.2015.06.034; Frohlich LG, 1999, J MED CHEM, V42, P4108, DOI 10.1021/jm981129a; Gacche RN, 2011, FOOD CHEM TOXICOL, V49, P1806, DOI 10.1016/j.fct.2011.04.032; Halder N, 2003, J ETHNOPHARMACOL, V86, P113, DOI 10.1016/S0378-8741(03)00052-7; Harding JJ, 1998, BRIT J OPHTHALMOL, V82, P526, DOI 10.1136/bjo.82.5.526; HART JH, 1981, ANNU REV PHYTOPATHOL, V19, P437, DOI 10.1146/annurev.py.19.090181.002253; Hernandez-Romero Y, 2005, J AGR FOOD CHEM, V53, P6276, DOI 10.1021/jf0508044; Hofseth LJ, 2005, METHOD ENZYMOL, V396, P326, DOI 10.1016/S0076-6879(05)96027-8; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim J, 2010, GRAEF ARCH CLIN EXP, V248, P811, DOI 10.1007/s00417-010-1313-1; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; La Motta C, 2007, J MED CHEM, V50, P4917, DOI 10.1021/jm070398a; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Lu CJ, 2012, BIOORG MED CHEM LETT, V22, P7683, DOI 10.1016/j.bmcl.2012.09.105; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; MAYFIELD CA, 1989, INT J BIOCHEM, V21, P1275, DOI 10.1016/0020-711X(89)90015-3; Miyazawa M, 1997, J AGR FOOD CHEM, V45, P2849, DOI 10.1021/jf9603902; Morikawa T, 2014, J NAT MED-TOKYO, V68, P561, DOI 10.1007/s11418-014-0837-9; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Oguntibeju O. O, 2013, DIABETES MELLITUS IN; Olofsson EM, 2007, FREE RADICAL BIO MED, V42, P1098, DOI 10.1016/j.freeradbiomed.2007.01.012; Ou Y, 2012, TOXICOL LETT, V215, P25, DOI 10.1016/j.toxlet.2012.09.017; Pathania S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061327; Gutierrez RMP, 2009, J NAT MED-TOKYO, V63, P65, DOI 10.1007/s11418-008-0280-x; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Rao VR, 2012, EUR J MED CHEM, V57, P344, DOI 10.1016/j.ejmech.2012.09.014; Reyes-Ramirez A, 2011, EUR J MED CHEM, V46, P2699, DOI 10.1016/j.ejmech.2011.03.057; Saito R, 2009, TETRAHEDRON, V65, P3019, DOI 10.1016/j.tet.2009.01.020; Saraswat M, 2008, ASIA PAC J CLIN NUTR, V17, P558; Shinde, 2014, CURR ENZYM INHIB, V10, P2, DOI [10.2174/15734080113096660007, DOI 10.2174/15734080113096660007]; Simmler C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013713; Song JX, 2010, NEUROCHEM INT, V57, P676, DOI 10.1016/j.neuint.2010.08.007; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Steuber H, 2006, J MOL BIOL, V356, P45, DOI 10.1016/j.jmb.2005.10.067; Suzen S, 2003, CURR MED CHEM, V10, P1329, DOI 10.2174/0929867033457377; Tabin G, 2008, CURR OPIN OPHTHALMOL, V19, P55, DOI 10.1097/ICU.0b013e3282f154bd; TERASHIMA H, 1984, J PHARMACOL EXP THER, V229, P226; TEZUKA Y, 1991, CHEM PHARM BULL, V39, P593, DOI 10.1248/cpb.39.593; Won JH, 2006, PLANTA MED, V72, P1181, DOI 10.1055/s-2006-947201; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yang L, 2006, J CHROMATOGR A, V1104, P230, DOI 10.1016/j.chroma.2005.12.012	52	22	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141092	10.1371/journal.pone.0141092	http://dx.doi.org/10.1371/journal.pone.0141092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517726	Green Published, Green Submitted, gold			2022-12-27	WOS:000363920800020
J	Stewart, PA; Parapatics, K; Welsh, EA; Muller, AC; Cao, HY; Fang, B; Koomen, JM; Eschrich, SA; Bennett, KL; Haura, EB				Stewart, Paul A.; Parapatics, Katja; Welsh, Eric A.; Mueller, Andre C.; Cao, Haoyun; Fang, Bin; Koomen, John M.; Eschrich, Steven A.; Bennett, Keiryn L.; Haura, Eric B.			A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; SAMPLE PREPARATION; CANCER; EXPRESSION; GLUTATHIONE; SOFTWARE; PROTEIN; NORMALIZATION; METABOLISM; GLYCOLYSIS	We performed a pilot proteogenomic study to compare lung adenocarcinoma to lung squamous cell carcinoma using quantitative proteomics (6-plex TMT) combined with a customized Affymetrix GeneChip. Using MaxQuant software, we identified 51,001 unique peptides that mapped to 7,241 unique proteins and from these identified 6,373 genes with matching protein expression for further analysis. We found a minor correlation between gene expression and protein expression; both datasets were able to independently recapitulate known differences between the adenocarcinoma and squamous cell carcinoma subtypes. We found 565 proteins and 629 genes to be differentially expressed between adenocarcinoma and squamous cell carcinoma, with 113 of these consistently differentially expressed at both the gene and protein levels. We then compared our results to published adenocarcinoma versus squamous cell carcinoma proteomic data that we also processed with MaxQuant. We selected two proteins consistently overexpressed in squamous cell carcinoma in all studies, MCT1 (SLC16A1) and GLUT1 (SLC2A1), for further investigation. We found differential expression of these same proteins at the gene level in our study as well as in other public gene expression datasets. These findings combined with survival analysis of public datasets suggest that MCT1 and GLUT1 may be potential prognostic markers in adenocarcinoma and druggable targets in squamous cell carcinoma. Data are available via ProteomeXchange with identifier PXD002622.	[Stewart, Paul A.; Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Parapatics, Katja; Mueller, Andre C.; Bennett, Keiryn L.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Welsh, Eric A.; Eschrich, Steven A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Informat Core Facil, Tampa, FL 33612 USA; [Cao, Haoyun; Eschrich, Steven A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Fang, Bin; Koomen, John M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote Core Facil, Tampa, FL 33612 USA; [Koomen, John M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Haura, EB (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.	Eric.Haura@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788; Bennett, Keiryn L./0000-0001-9356-7708; Mueller, Andre/0000-0002-0608-8176	Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute [P30-CA76292]; DeBartolo Family; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute; DeBartolo Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by the Moffitt's Total Cancer Care Initiative and Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center, under grant number P30-CA76292. Total Cancer Care is enabled, in part, by the generous support of the DeBartolo Family. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JA, 2014, NAT METHODS, V11, P1107, DOI [10.1038/NMETH.3138, 10.1038/nmeth.3138]; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Boja ES, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-22; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Eilertsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105038; Eschrich SA, 2007, BIOINFORMATICS, V23, P1562, DOI 10.1093/bioinformatics/btm127; Eschrich SA, 2008, IEEE ENG MED BIO, P2419, DOI 10.1109/IEMBS.2008.4649687; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gomez-Morales M, 2013, HISTOPATHOLOGY, V63, P103, DOI 10.1111/his.12126; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Jagtap PD, 2014, J PROTEOME RES, V13, P5898, DOI 10.1021/pr500812t; Karpievitch YV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S5; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee GH, 2011, ONCOL LETT, V2, P831, DOI 10.3892/ol.2011.353; Lehtio J, 2010, J PROTEOMICS, V73, P1851, DOI 10.1016/j.jprot.2010.05.015; Li J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006536; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Linxweiler J, 2014, EUPA OPEN PROTEOMICS, V4, P25, DOI [10.1016/j.euprot.2014.05.004, DOI 10.1016/J.EUPROT.2014.05.004]; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pastor MD, 2013, CLIN TRANSL ONCOL, V15, P671, DOI 10.1007/s12094-013-1034-0; Pate KT, 2014, EMBO J, V33, P1454, DOI 10.15252/embj.201488598; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; R Core Team, 2014, R A LANGUAGE AND ENV; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; RStudio, 2014, RSTUDIO INTEGRATED D; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Sandberg A, 2014, J PROTEOMICS, V96, P133, DOI 10.1016/j.jprot.2013.10.035; Sanders WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-115; Schuurbiers OCJ, 2014, J THORAC ONCOL, V9, P1485, DOI 10.1097/JTO.0000000000000286; Shi I, 2011, CANCER INFORM, V10, P273, DOI 10.4137/CIN.S8283; Sun H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S5; Tanaka-Okamoto M, 2009, CANCER SCI, V100, P608, DOI 10.1111/j.1349-7006.2009.01091.x; Tanvetyanon T, 2014, CANCER CONTROL, V21, P32, DOI 10.1177/107327481402100105; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Tovchigrechko A, 2014, BIOINFORMATICS, V30, P1469, DOI 10.1093/bioinformatics/btu051; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wei YH, 2011, J PROTEOME RES, V10, P161, DOI 10.1021/pr100491e; Welsh EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-153; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Woo S, 2014, J PROTEOME RES, V13, P21, DOI 10.1021/pr400294c; Yang P, 2006, J CLIN ONCOL, V24, P1761, DOI 10.1200/JCO.2005.02.7110; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang W, 2014, PROTEOMICS, V14, P795, DOI 10.1002/pmic.201300382	65	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2015	10	11							e0142162	10.1371/journal.pone.0142162	http://dx.doi.org/10.1371/journal.pone.0142162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5IS	26539827	Green Published, Green Submitted, gold			2022-12-27	WOS:000364303800060
J	Chowdhury, UR; Bahler, CK; Holman, BH; Dosa, PI; Fautsch, MP				Chowdhury, Uttio Roy; Bahler, Cindy K.; Holman, Bradley H.; Dosa, Peter I.; Fautsch, Michael P.			Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; K+ CHANNEL; SULFONYLUREA RECEPTOR; SMOOTH-MUSCLE; MICE; RAT; HYPERTENSION; STRESS; LATANOPROST	Elevated intraocular pressure (IOP) is the most prevalent and only treatable risk factor for glaucoma, a leading cause of irreversible blindness worldwide. Unfortunately, all current therapeutics used to treat elevated IOP and glaucoma have significant and sometimes irreversible side effects necessitating the development of novel compounds. We evaluated the IOP lowering ability of the broad spectrum K-ATP channel opener cromakalim. Cultured human anterior segments when treated with 2 mu M cromakalim showed a decrease in pressure (19.33 +/- 2.78 mmHg at 0 hours to 13.22 +/- 2.64 mmHg at 24 hours; p<0.001) when compared to vehicle treated controls (15.89 +/- 5.33 mmHg at 0 h to 15.56 +/- 4.88 mmHg at 24 hours; p = 0.89). In wild-type C57BL/6 mice, cromakalim reduced IOP by 18.75 +/- 2.22% compared to vehicle treated contralateral eyes (17.01 +/- 0.32 mmHg at 0 hours to 13.82 +/- 0.37 mmHg at 24 hours; n = 10, p = 0.002). Cromakalim demonstrated an additive effect when used in conjunction with latanoprost free acid, a common ocular hypotensive drug prescribed to patients with elevated IOP. To examine K-ATP channel subunit specificity, K(ir)6.2((-/-)) mice were treated with cromakalim, but unlike wild-type animals, no change in IOP was noted. Histologic analysis of treated and control eyes in cultured human anterior segments and in mice showed similar cell numbers and extracellular matrix integrity within the trabecular meshwork, with no disruptions in the inner and outer walls of Schlemm's canal. Together, these studies suggest that cromakalim is a potent ocular hypotensive agent that lowers IOP via activation of Kir6.2 containing K-ATP channels, its effect is additive when used in combination with the commonly used glaucoma drug latanoprost, and is not toxic to cells and tissues of the aqueous humor outflow pathway, making it a candidate for future therapeutic development.	[Chowdhury, Uttio Roy; Bahler, Cindy K.; Holman, Bradley H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Dosa, Peter I.] Univ Minnesota, Inst Therapeut Discovery & Dev, Minneapolis, MN USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	fautsch.michael@mayo.edu		Dosa, Peter/0000-0002-0081-3867	NATIONAL EYE INSTITUTE [R01EY021727] Funding Source: NIH RePORTER; NEI NIH HHS [EY 21727, R01 EY021727] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akaishi T, 2009, J OCUL PHARMACOL TH, V25, P401, DOI 10.1089/jop.2009.0006; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Bahler CK, 2012, AM J OPHTHALMOL, V153, P1206, DOI 10.1016/j.ajo.2011.12.017; Bar-llan A, 1984, CURR EYE RES, V3, P1305; BITO LZ, 1983, INVEST OPHTH VIS SCI, V24, P312; Bodenstine TM, 2012, FEBS LETT, V586, P27, DOI 10.1016/j.febslet.2011.11.017; Boland M. V., 2012, TREATMENT GLAUCOMA C; Brayden JE, 2002, CLIN EXP PHARMACOL P, V29, P312, DOI 10.1046/j.1440-1681.2002.03650.x; Cecchetti V, 2006, CURR TOP MED CHEM, V6, P1049, DOI 10.2174/156802606777323683; Chatterjee S, 2006, MICROCIRCULATION, V13, P633, DOI 10.1080/10739680600930255; Chatterjee S, 2003, AM J PHYSIOL-CELL PH, V285, pC959, DOI 10.1152/ajpcell.00511.2002; Chatterjee S, 2014, AM J PHYSIOL-LUNG C, V307, pL668, DOI 10.1152/ajplung.00198.2014; CHIANG CH, 1995, J OCUL PHARMACOL TH, V11, P195, DOI 10.1089/jop.1995.11.195; Chowdhury UR, 2015, INVEST OPHTH VIS SCI, V56, P2993, DOI 10.1167/iovs.15-16744; Chowdhury UR, 2013, INVEST OPHTH VIS SCI, V54, P4892, DOI 10.1167/iovs.13-11872; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6435, DOI 10.1167/iovs.11-7523; Crooke A, 2012, CURR MED CHEM, V19, P3508, DOI 10.2174/092986712801323234; Diggory P, 1996, BRIT J OPHTHALMOL, V80, P85, DOI 10.1136/bjo.80.1.85; Du RH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-35; FRIEDEL HA, 1990, DRUGS, V39, P929, DOI 10.2165/00003495-199039060-00008; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Garlid KD, 1996, J BIOL CHEM, V271, P8796, DOI 10.1074/jbc.271.15.8796; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Huang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063337; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1998, JPN J PHYSIOL, V48, P397, DOI 10.2170/jjphysiol.48.397; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; INAGAKI N, 1995, GENOMICS, V30, P102, DOI 10.1006/geno.1995.0018; Jahangir A, 2005, J MOL CELL CARDIOL, V39, P99, DOI 10.1016/j.yjmcc.2005.04.006; Jons T, 2006, J CELL SCI, V119, P3087, DOI 10.1242/jcs.03041; Johnstone MA, 1997, AM J OPHTHALMOL, V124, P544, DOI 10.1016/S0002-9394(14)70870-0; Kane GC, 2006, HUM MOL GENET, V15, P2285, DOI 10.1093/hmg/ddl154; Kane GC, 2004, DIABETES, V53, pS169, DOI 10.2337/diabetes.53.suppl_3.S169; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kraljevic J, 2015, MED SCI SPORT EXER, V47, P2504, DOI 10.1249/MSS.0000000000000714; Kurna SA, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/460483; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; LANDRY DW, 1992, J CLIN INVEST, V89, P2071, DOI 10.1172/JCI115820; Lawson K, 2000, KIDNEY INT, V57, P838, DOI 10.1046/j.1523-1755.2000.00923.x; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MANDELL AI, 1988, ANN OPHTHALMOL, V20, P133; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nguyen QH, 2014, PATIENT PREFER ADHER, V8, P853, DOI 10.2147/PPA.S53162; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Ota T, 2005, INVEST OPHTH VIS SCI, V46, P2006, DOI 10.1167/iovs.04-1527; Ozcan C, 2007, J CARDIOVASC PHARM, V50, P411, DOI 10.1097/FJC.0b013e31812378df; Park YB, 2011, DIABETES METAB J, V35, P219, DOI 10.4093/dmj.2011.35.3.219; Parrish RK, 2009, AM J OPHTHALMOL, V147, P717, DOI 10.1016/j.ajo.2008.10.007; Prasad SM, 2006, ANN THORAC SURG, V81, P148, DOI 10.1016/j.athoracsur.2005.06.055; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rasmussen CA, 2014, CAN J OPHTHALMOL, V49, P534, DOI 10.1016/j.jcjo.2014.08.007; Remedi MS, 2006, DIABETOLOGIA, V49, P2368, DOI 10.1007/s00125-006-0367-4; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; Sebille S, 2004, CURR MED CHEM, V11, P1213, DOI 10.2174/0929867043365378; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shi L, 2009, PHYSIOL RES, V58, P645, DOI 10.33549/physiolres.931594; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; TOMAI F, 1994, CIRCULATION, V90, P700, DOI 10.1161/01.CIR.90.2.700; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3; Wu XF, 2011, PAIN, V152, P2605, DOI 10.1016/j.pain.2011.08.003; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yokoshiki H, 1998, AM J PHYSIOL-CELL PH, V274, pC25, DOI 10.1152/ajpcell.1998.274.1.C25; Zhang H, 2014, EXP EYE RES, V121, P86, DOI 10.1016/j.exer.2014.02.004; Zingman LV, 2003, MOL PSYCHIATR, V8, P253, DOI 10.1038/sj.mp.4001323; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	78	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141783	10.1371/journal.pone.0141783	http://dx.doi.org/10.1371/journal.pone.0141783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535899	gold, Green Submitted, Green Published			2022-12-27	WOS:000364298400086
J	Csosz, S; Heinze, J; Miko, I				Csosz, Sandor; Heinze, Juergen; Miko, Istvan			Taxonomic Synopsis of the Ponto-Mediterranean Ants of Temnothorax nylanderi Species-Group	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; NEST-SITE SELECTION; WORKER REPRODUCTION; HYMENOPTERA; COLONIES; FORMICIDAE	In the current revisionary work, the Temnothorax nylanderi species-group of myrmicine ants is characterized. Eighteen species belonging to this group in the Ponto-Mediterranean region are described or redefined based on an integrative approach that combines exploratory analyses of morphometric data and of a 658bp fragment of the mitochondrial gene for the cytochrome c oxidase subunit I (CO I). The species group is subdivided into five species complexes: T. angustifrons complex, T. lichtensteini complex, T. nylanderi complex, T. parvulus complex, T. sordidulus complex, and two species, T. angulinodis sp. n. and T. flavicornis (Emery, 1870) form their own lineages. We describe seven new species (T. angulinodis sp. n., T. angustifrons sp. n., T. ariadnae sp. n., T. helenae sp. n., T. lucidus sp. n., T. similis sp. n., T. subtilis sp. n.), raise T. tergestinus (FINZI, 1928) stat.n. to species level, and propose a new junior synonymy for T. saxonicus (SEIFERT, 1995) syn.n. (junior synonym of T. tergestinus). We describe the worker caste and provide high quality images and distributional maps for all eighteen species. Furthermore, we provide a decision tree as an alternative identification key that visually gives an overview of this species-group. We make the first application to Formicidae of the Semantic Phenotype approach that has been used in previous taxonomic revisions.	[Csosz, Sandor] Calif Acad Sci, Entomol, San Francisco, CA 94118 USA; [Heinze, Juergen] Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany; [Miko, Istvan] Penn State Univ, Frost Entomol Museum, University Pk, PA 16802 USA	California Academy of Sciences; University of Regensburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Csosz, S (corresponding author), Calif Acad Sci, Entomol, San Francisco, CA 94118 USA.	sandorcsosz2@gmail.com		Miko, Istvan/0000-0001-9719-0215	U. S. National Science Foundation [DBI-1356381]; Hungarian Eotvos scholarship	U. S. National Science Foundation(National Science Foundation (NSF)); Hungarian Eotvos scholarship	Funding: IM was supported by the U. S. National Science Foundation (grant DBI-1356381) and SC was supported by the Hungarian Eotvos scholarship, 2010.	Achenbach A, 2009, EVOLUTION, V63, P1068, DOI 10.1111/j.1558-5646.2009.00591.x; Aleksiev AS, 2008, NATURWISSENSCHAFTEN, V95, P301, DOI 10.1007/s00114-007-0329-9; Aleksiev AS, 2007, ANIM BEHAV, V74, P567, DOI 10.1016/j.anbehav.2006.12.023; [Anonymous], 2014, R LANG ENV STAT COMP; ARNOLDI K V, 1977, Entomologicheskoe Obozrenie, V56, P198; Balhoff JP, 2013, SYST BIOL, V62, P639, DOI 10.1093/sysbio/syt028; BERNARD FRANCIS, 1956, BULL SOC ZOOL FRANCE, V81, P151; Borowiec Lech, 2014, Genus (Wroclaw), V25, P1; Brandt M, 2005, BIOL REV, V80, P251, DOI 10.1017/S1464793104006669; Brunner E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-55; Csosz S, 2014, ORG DIVERS EVOL, V14, P75, DOI 10.1007/s13127-013-0153-3; Czechowski W, 2012, FAUNA POLONIAE, P4; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; El-Shehaby M, 2012, MYRMECOL NEWS, V17, P21; Evenhuis NL, 2013, INSECT SPIDER COLLEC; Foitzik S, 2001, P ROY SOC B-BIOL SCI, V268, P1139, DOI 10.1098/rspb.2001.1627; Fokuhl G, 2012, ACTA OECOL, V38, P71, DOI 10.1016/j.actao.2011.09.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Gratiashvili N, 2015, EUR J ENTOMOL, V112, P175, DOI 10.14411/eje.2015.025; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Heinze J, 1997, ANIM BEHAV, V54, P849, DOI 10.1006/anbe.1996.0511; Heinze J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P151, DOI 10.1007/978-3-642-02624-9_6; Heinze K, 2004, ADV STUD BEHAV, V34, P1, DOI 10.1016/S0065-3454(04)34001-5; Holldobler B., 1990, pi; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Miko I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094056; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Prebus M, 2015, ZOOKEYS, P23, DOI 10.3897/zookeys.483.9111; Pusch K, 2006, BIOL J LINN SOC, V88, P223, DOI 10.1111/j.1095-8312.2006.00618.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Radchenko A.G., 1995, Vestnik Zoologii, V4, P3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 2001, MOL CLONING LAB MANU; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schulz A, 2007, ZOOTAXA, P1; SEIFERT B, 1996, AMEISEN BEOBACHTEN B; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Seifert Bernhard, 1995, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V68, P1; Seifert B, 2015, ZOOKEYS, P37, DOI 10.3897/zookeys.479.8510; Seifert Bernhard, 2014, Beitraege zur Entomologie, V64, P47; Seifert Bernhard, 2014, Soil Organisms, V86, P85; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Seifert Bernhard, 2006, Myrmecologische Nachrichten, V8, P1; SENDOVAFRANKS AB, 1994, P ROY SOC B-BIOL SCI, V256, P305, DOI 10.1098/rspb.1994.0085; Stroeymeyt N, 2007, BEHAV ECOL SOCIOBIOL, V61, P1449, DOI 10.1007/s00265-007-0377-3; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Themeau TM, 2014, R PACKAGE VERSION 4; Tinaut A, 1995, ZOOLOGICA BAETICA, V5, P89; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Walter B, 2011, AM NAT, V177, P368, DOI 10.1086/658396; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1	55	28	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0140000	10.1371/journal.pone.0140000	http://dx.doi.org/10.1371/journal.pone.0140000			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536033	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400015
J	Geraldo, MV; Kimura, ET				Geraldo, Murilo V.; Kimura, Edna T.			Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators	PLOS ONE			English	Article							PAPILLARY CARCINOMAS; DOWN-REGULATION; BRAF MUTATIONS; AUTOCRINE PRODUCTION; MACROPHAGES PROMOTE; IN-VIVO; EXPRESSION; MICRORNA; GENE; INTERLEUKIN-4	Papillary thyroid carcinoma (PTC) is a well-differentiated thyroid tumor that accounts for approximately 80% of thyroid cancer cases. On other hand, anaplastic thyroid carcinoma (ATC) is a less frequent, but aggressive subtype, with poor prognosis. MicroRNAs (miRNAs), small non-coding RNAs, have emerged as potent post-transcriptional regulators of gene expression, which modulate the expression of cancer-related genes. Computational analyses estimate that a single miRNA may modulate hundreds of mRNA targets and, at the same time, cooperate with others to regulate one single mRNA transcript. Due to the large number of predicted targets and possible interactions, only a small number of miRNAs have characterized biological roles, and the panorama of miRNA-mediated regulation in thyroid cancer remains to be understood. Taking into consideration the large amount of gene expression data deposited in public databases we aligned miRNA target prediction and gene expression data from public PTC and ATC datasets to construct a network of post-transcriptional regulation in thyroid cancer. After a gene set enrichment analysis we identified signaling pathways and biological processes potentially modulated by the miRNAs deregulated in PTC and ATC. Our results show miRNA-mRNA interaction that could contribute with the de-regulation of key tumor-host mediators, such as extra-cellular matrix molecules, interleukins and interleukin receptors, which could drive a more aggressive behavior and tumor progression. Moreover, our analysis through The Cancer Genome Atlas (TCGA) database revealed that aberrant expression of ECM and cytokines genes is frequent in PTC and is associated with aggressive behavior and decreased overall survival rate. In conclusion, we shed light on the post-transcriptional regulation of gene expression in differentiated and undifferentiated thyroid cancers, revealing a potential role of miRNAs in modulation of tumor-host interaction molecules, particularly ECM molecules and immune system mediators, which could stimulate crosstalk between tumors and the immune system to generate a more aggressive behavior. We propose a novel putative miRNA: mRNA network that could lead to a new path toward functional studies.	[Geraldo, Murilo V.; Kimura, Edna T.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Geraldo, Murilo V.] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Kimura, ET (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	etkimura@usp.br	Geraldo, Murilo V/C-6427-2016; Geraldo, Murilo V/F-7211-2013; Kimura, Edna/D-7334-2012	Geraldo, Murilo V/0000-0002-9418-6103; Kimura, Edna/0000-0001-8403-4459	Sao Paulo Research Foundation [2011/52051-2, 2013/11019-4]; National Council for Scientific and Technological Development [308527/2013-5, 458505/2014-5]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Sao Paulo Research Foundation (http://fapesp.br/), grants 2011/52051-2 (MVG) and 2013/11019-4 (ETK), and the National Council for Scientific and Technological Development (http://cnpq.br/), grants 308527/2013-5; 458505/2014-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Bauerle KT, 2014, J CLIN ENDOCR METAB, V99, pE1436, DOI 10.1210/jc.2013-3636; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YT, 2008, MODERN PATHOL, V21, P1139, DOI 10.1038/modpathol.2008.105; Cheng SP, 2013, CELL BIOCHEM BIOPHYS, V65, P203, DOI 10.1007/s12013-012-9419-1; Cil E, 2014, MOL BIOL REP, V41, P3091, DOI 10.1007/s11033-014-3169-7; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; Gao LB, 2014, TUMOR BIOL, V35, P3861, DOI 10.1007/s13277-013-1512-6; Gao Y, 2010, ENDOCR J, V57, P81, DOI 10.1507/endocrj.K09E-220; Guan HY, 2013, J CLIN ENDOCR METAB, V98, pE1334, DOI 10.1210/jc.2013-1053; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hung JY, 2014, LAB INVEST, V94, P371, DOI 10.1038/labinvest.2014.1; Iwahashi N, 2002, BIOCHEM BIOPH RES CO, V294, P642, DOI 10.1016/S0006-291X(02)00528-4; Kimura ET, 2003, CANCER RES, V63, P1454; Kitano M, 2011, ANN SURG ONCOL, V18, P3443, DOI 10.1245/s10434-011-1766-4; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Liotti F, 2012, AM J CANCER RES, V2, P286; Mitsiades N, 2011, J CLIN ENDOCR METAB, V96, pE2023, DOI 10.1210/jc.2010-1908; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stassi G, 2003, CANCER RES, V63, P6784; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Tsujikawa T, 2013, INT J CANCER, V132, P2755, DOI 10.1002/ijc.27966; Vella V, 2004, J CLIN ENDOCR METAB, V89, P2880, DOI 10.1210/jc.2003-031639; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Ward LS, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/125450; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Xing M, 2014, J CLIN ONCOL; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024717	48	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141726	10.1371/journal.pone.0141726	http://dx.doi.org/10.1371/journal.pone.0141726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536459	gold, Green Published, Green Submitted			2022-12-27	WOS:000364298400082
J	Wang, YL; Zeng, C; Wei, J; Yang, T; Li, H; Deng, ZH; Yang, Y; Zhang, Y; Ding, X; Xie, DX; Yang, TB; Lei, GH				Wang, Yi-lun; Zeng, Chao; Wei, Jie; Yang, Tuo; Li, Hui; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Ding, Xiang; Xie, Dong-xing; Yang, Tu-bao; Lei, Guang-hua			Association between Dietary Magnesium Intake and Hyperuricemia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM URIC-ACID; NUTRITION EXAMINATION SURVEY; CHRONIC KIDNEY-DISEASE; 3RD NATIONAL-HEALTH; METABOLIC SYNDROME; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; OLDER-ADULTS; VITAMIN-C	Objective To examine the cross-sectional associations between dietary magnesium (Mg) intake and hyperuricemia (HU). Methods 5168 subjects were included in this study. Dietary intake was assessed using a validated semi-quantitative food frequency questionnaire. Hyperuricemia (HU) was defined as uric acid >= 416 mu mol/L for male population and >= 360 mu mol/L for female. A multivariable logistic analysis model was applied to test the associations after adjusting a number of potential confounding factors. Results The relative odds of the overall prevalence of HU were decreased by 0.57 times in the fourth quintile of Mg intake (OR 0.57, 95% CI 0.35-0.94) and 0.55 times in the fifth quintile (OR 0.55, 95% CI 0.30-1.01) comparing with the lowest quintile, and P for trend was 0.091. The results of multivariable linear regression also suggested a significant inverse association between serum uric acid and Mg intake (beta = -0.028, P = 0.022). For male, the relative odds of HU were decreased by 0.62 times in the third quintile of Mg intake (OR 0.62, 95% CI 0.40-0.97), 0.40 times in the fourth quintile (OR 0.40, 95% CI 0.23-0.72) and 0.35 times in the fifth quintile (OR 0.35, 95% CI 0.17-0.71) comparing with the lowest quintile, and P for trend was 0.006. Multivariable adjusted inverse association was also existed between serum uric acid and Mg intake in male population (beta = -0.061, P = 0.002). However, no significant association was observed between dietary Mg intake and HU for female. Conclusions The findings of this cross-sectional study indicated that dietary Mg intake is inversely associated with HU, independent of some major confounding factors. In addition, this association remains valid for the male subgroup, but not for the female subgroup. Level of Evidence LevelIII, cross-sectional study.	[Wang, Yi-lun; Zeng, Chao; Yang, Tuo; Li, Hui; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Ding, Xiang; Xie, Dong-xing; Lei, Guang-hua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China; [Wei, Jie; Yang, Tu-bao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University	Lei, GH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China.	lgh9640@sina.cn	Deng, Zhenhan/AAB-4968-2021; Wei, Jie/ACR-8087-2022; Wang, Yilun/W-6530-2019; Deng, Zhenhan/AAR-2420-2021	Wei, Jie/0000-0003-3510-8241; Deng, Zhenhan/0000-0003-0522-8269	Hunan Provincial Innovation Foundation for Postgraduate [CX2014A005]; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China [81201420, 81272034, 81472130]; Provincial Science Foundation of Hunan [14JJ3032]; Scientific Research Project of the Development and Reform Commission of Hunan Province [[2013]1199]; Scientific Research Project of Science and Technology Office of Hunan Province [2013SK2018]; Ministry of Education of China [20120162110036]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Science Foundation of Hunan; Scientific Research Project of the Development and Reform Commission of Hunan Province; Scientific Research Project of Science and Technology Office of Hunan Province; Ministry of Education of China(Ministry of Education, China)	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2014A005), the Fundamental Research Funds for the Central Universities of Central South University, the National Natural Science Foundation of China (No. 81201420, 81272034, 81472130), the Provincial Science Foundation of Hunan (No. 14JJ3032), the Scientific Research Project of the Development and Reform Commission of Hunan Province ([2013]1199), the Scientific Research Project of Science and Technology Office of Hunan Province (2013SK2018), the Doctoral Scientific Fund Project of the Ministry of Education of China (20120162110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bobulescu A, 2012, ADV CHRONIC KIDNEY D, V19, P358, DOI 10.1053/j.ackd.2012.07.009; Bonora E, 1996, INT J OBESITY, V20, P975; BRAUER GW, 1978, ANN RHEUM DIS, V37, P466, DOI 10.1136/ard.37.5.466; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Dalbeth N, 2010, ANN RHEUM DIS, V69, P1677, DOI 10.1136/ard.2009.124230; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; Dibaba DT, 2014, EUR J CLIN NUTR, V68, P510, DOI 10.1038/ejcn.2014.7; ELIN RJ, 1988, DM-DIS MON, V34, P163; Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Huang HY, 2005, ARTHRITIS RHEUM, V52, P1843, DOI 10.1002/art.21105; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kawano Y, 2011, CIRC J, V75, P2755, DOI 10.1253/circj.CJ-11-1222; King DE, 2007, MAGNESIUM RES, V20, P32; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Kirilmaz B, 2010, J CLIN HYPERTENS, V12, P136, DOI 10.1111/j.1751-7176.2009.00229.x; Lin KC, 2000, J RHEUMATOL, V27, P1501; Lin Shi-Dou, 2006, J Chin Med Assoc, V69, P512; Liu HT, 2014, J CHINESE LINGUIST, V42, P1; Lyngdoh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019901; MCNAIR P, 1984, MINER ELECTROL METAB, V10, P84; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Navin S, 2013, J CLIN DIAGN RES, V7, P1852, DOI 10.7860/JCDR/2013/6106.3332; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Nielsen FH, 2010, NUTR REV, V68, P333, DOI 10.1111/j.1753-4887.2010.00293.x; Noone DG, 2013, J PEDIATR-US, V162, P128, DOI 10.1016/j.jpeds.2012.06.008; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Pluta Ryszard M, 2012, JAMA, V308, P2161, DOI 10.1001/jama.2012.4095; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; Roddy E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3199; SEELIG MS, 1993, J AM COLL NUTR, V12, P442, DOI 10.1080/07315724.1993.10718335; Sluijs I, 2013, J NUTR, V143, P80, DOI 10.3945/jn.112.167221; Song YQ, 2007, AM J CLIN NUTR, V85, P1068, DOI 10.1093/ajcn/85.4.1068; Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438; STIRPE F, 1970, LANCET, V2, P1310; Tangney CC, 2004, J NUTR, V134, P927, DOI 10.1093/jn/134.4.927; TOKUNAGA K, 1991, INT J OBESITY, V15, P1; Trifio G, 2013, ANN RHEUM DIS, V72, P694, DOI 10.1136/annrheumdis-2011-201254; Uaratanawong S, 2011, CLIN RHEUMATOL, V30, P887, DOI 10.1007/s10067-011-1699-0; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Wei J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0007-2; Wood HC., 1900, THERAPEUTICS ITS PRI, V11th; Yang YX., 2009, CHINA FOOD COMPOSITI; Zeng C, 2014, OSTEOARTHR IN PRESS; Zhang YJ, 2015, ROUT RES INT ECON LA, P1; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	53	8	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141079	10.1371/journal.pone.0141079	http://dx.doi.org/10.1371/journal.pone.0141079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536119	Green Submitted, Green Published, gold			2022-12-27	WOS:000364298400052
J	Zappasodi, F; Marzetti, L; Olejarczyk, E; Tecchio, F; Pizzella, V				Zappasodi, Filippo; Marzetti, Laura; Olejarczyk, Elzbieta; Tecchio, Franca; Pizzella, Vittorio			Age-Related Changes in Electroencephalographic Signal Complexity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CLINICAL NEUROPHYSIOLOGY; HEMISPHERIC-ASYMMETRY; SENSORIMOTOR CORTEX; QUANTITATIVE EEG; BRAIN; HEALTHY; SYNCHRONIZATION; COHERENCE; ADULTS	The study of active and healthy aging is a primary focus for social and neuroscientific communities. Here, we move a step forward in assessing electrophysiological neuronal activity changes in the brain with healthy aging. To this end, electroencephalographic (EEG) resting state activity was acquired in 40 healthy subjects (age 16-85). We evaluated Fractal Dimension (FD) according to the Higuchi algorithm, a measure which quantifies the presence of statistical similarity at different scales in temporal fluctuations of EEG signals. Our results showed that FD increases from age twenty to age fifty and then decreases. The curve that best fits the changes in FD values across age over the whole sample is a parabola, with the vertex located around age fifty. Moreover, FD changes are site specific, with interhemispheric FD asymmetry being pronounced in elderly individuals in the frontal and central regions. The present results indicate that fractal dimension well describes the modulations of brain activity with age. Since fractal dimension has been proposed to be related to the complexity of the signal dynamics, our data demonstrate that the complexity of neuronal electric activity changes across the life span of an individual, with a steady increase during young adulthood and a decrease in the elderly population.	[Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Olejarczyk, Elzbieta] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Tecchio, Franca] Natl Res Council CNR, ISTC, LETS, Rome, Italy; [Tecchio, Franca] IRCCS San Raffale Pisana, Unit Imaging, Cassino, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); IRCCS San Raffaele Pisana	Zappasodi, F (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	f.zappasodi@unich.it	Marzetti, Laura/ABC-9763-2021; Olejarczyk, Elzbieta/ABG-5529-2020; Marzetti, Laura/AAA-4231-2020; Zappasodi, Filippo/AAL-4717-2020; Marzetti, Laura/Q-2909-2016; Zappasodi, Filippo/AAC-2414-2022; tecchio, franca/AAX-2770-2020	Marzetti, Laura/0000-0002-6481-3743; Marzetti, Laura/0000-0002-6481-3743; tecchio, franca/0000-0002-1325-5059; Olejarczyk, Elzbieta/0000-0002-6821-350X	Italian Ministry of Health Cod. [GR-2008-1138642]	Italian Ministry of Health Cod.	Funding for this work came from the Italian Ministry of Health Cod. GR-2008-1138642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 1997, BIOL CYBERN, V77, P339, DOI 10.1007/s004220050394; Anokhin AP, 1996, ELECTROEN CLIN NEURO, V99, P63, DOI 10.1016/0921-884X(96)95573-3; Assenza G, 2013, RESTOR NEUROL NEUROS, V31, P177, DOI 10.3233/RNN-120244; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Blais M, 2014, BEHAV BRAIN RES, V275, P34, DOI 10.1016/j.bbr.2014.08.043; BRENNER RP, 1995, ELECTROEN CLIN NEURO, V94, P1, DOI 10.1016/0013-4694(94)00234-C; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; Chiang AKI, 2011, CLIN NEUROPHYSIOL, V122, P1505, DOI 10.1016/j.clinph.2011.01.040; CHRISTIAN W, 1984, NERVENARZT, V55, P517; Cottone C, 2013, BRAIN TOPOGR, V26, P186, DOI 10.1007/s10548-012-0240-3; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; DUFFY FH, 1993, NEUROBIOL AGING, V14, P73, DOI 10.1016/0197-4580(93)90025-7; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GIAQUINTO S, 1986, ELECTROEN CLIN NEURO, V63, P540, DOI 10.1016/0013-4694(86)90141-0; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Graziadio S, 2012, EXP NEUROL, V238, P168, DOI 10.1016/j.expneurol.2012.08.031; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; MATEJCEK M, 1980, Revue d'Electroencephalographie et de Neurophysiologie Clinique, V10, P122, DOI 10.1016/S0370-4475(80)80044-X; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; McIntosh AR, 2014, CEREB CORTEX, V24, P1806, DOI 10.1093/cercor/bht030; Meador KJ, 2002, NEUROLOGY, V59, P847, DOI 10.1212/WNL.59.6.847; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; NETZ J, 1995, EXP BRAIN RES, V104, P527; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP, P229; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Pellegrino G, 2012, RESTOR NEUROL NEUROS, V30, P497, DOI 10.3233/RNN-2012-120227; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pierce TW, 2000, BRAIN TOPOGR, V13, P127, DOI 10.1023/A:1026659102713; Pizzella V, 2014, FUNCT NEUROL, V29, P241, DOI 10.11138/FNeur/2014.29.4.241; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Rossini PM, 2013, CURR PHARM DESIGN, V19, P6426, DOI 10.2174/1381612811319360004; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; SCHREITERGASSER U, 1993, ELECTROEN CLIN NEURO, V86, P15, DOI 10.1016/0013-4694(93)90063-2; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tecchio F, 2008, NEUROIMAGE, V40, P256, DOI 10.1016/j.neuroimage.2007.11.038; Tecchio F, 2007, NEUROIMAGE, V35, P185, DOI 10.1016/j.neuroimage.2006.12.002; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; van den Berg FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017742; WANG HS, 1969, J GERONTOL, V24, P419, DOI 10.1093/geronj/24.4.419; Weiss B, 2011, BRAIN RES BULL, V84, P359, DOI 10.1016/j.brainresbull.2010.12.005; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; WU X, 1993, CLIN ELECTROENCEPHAL, V24, P127, DOI 10.1177/155005949302400311; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zappasodi F, 2006, CLIN NEUROPHYSIOL, V117, P1518, DOI 10.1016/j.clinph.2006.03.016; Zappasodi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100199	75	54	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0141995	10.1371/journal.pone.0141995	http://dx.doi.org/10.1371/journal.pone.0141995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26536036	Green Published, gold, Green Submitted			2022-12-27	WOS:000364298400114
J	An, HY; Shin, HS; Choi, JS; Kim, HJ; Lim, JY; Kim, YM				An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Kim, Hun Jung; Lim, Jae-Yol; Kim, Young-Mo			Adipose Mesenchymal Stem Cell Secretome Modulated in Hypoxia for Remodeling of Radiation-Induced Salivary Gland Damage	PLOS ONE			English	Article							PARACRINE MECHANISMS; STROMAL CELLS; INJURY; HEAD; NECK; TRANSPLANTATION; XEROSTOMIA; CANCER; PROLIFERATION; HYPOFUNCTION	Background and Purpose This study was conducted to determine whether a secretome from mesenchymal stem cells (MSC) modulated by hypoxic conditions to contain therapeutic factors contributes to salivary gland (SG) tissue remodeling and has the potential to improve irradiation (IR)-induced salivary hypofunction in a mouse model. Materials and Methods Human adipose mesenchymal stem cells (hAdMSC) were isolated, expanded, and exposed to hypoxic conditions (O-2 < 5%). The hypoxia-conditioned medium was then filtered to a high molecular weight fraction and prepared as a hAdMSC secretome. The hAdMSC secretome was subsequently infused into the tail vein of C3H mice immediately after local IR once a day for seven consecutive days. The control group received equal volume (500 mu L) of vehicle (PBS) only. SG function and structural tissue remodeling by the hAdMSC secretome were investigated. Human parotid epithelial cells (HPEC) were obtained, expanded in vitro, and then irradiated and treated with either the hypoxia-conditioned medium or a normoxic control medium. Cell proliferation and IR-induced cell death were examined to determine the mechanism by which the hAdMSC secretome exerted its effects. Results The conditioned hAdMSC secretome contained high levels of GM-CSF, VEGF, IL-6, and IGF-1. Repeated systemic infusion with the hAdMSC secretome resulted in improved salivation capacity and increased levels of salivary proteins, including amylase and EGF, relative to the PBS group. The microscopic structural integrity of SG was maintained and salivary epithelial (AQP-5), endothelial (CD31), myoepithelial (alpha-SMA) and SG progenitor cells (c-Kit) were successfully protected from radiation damage and remodeled. The hAdMSC secretome strongly induced proliferation of HPEC and led to a significant decrease in cell death in vivo and in vitro. Moreover, the anti-apoptotic effects of the hAdMSC secretome were found to be promoted after hypoxia-preconditioning relative to normoxia-cultured hAdMSC secretome. Conclusion These results show that the hAdMSC secretome from hypoxic-conditioned medium may provide radioprotection and tissue remodeling via release of paracrine mediators.	[An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Lim, Jae-Yol; Kim, Young-Mo] Inha Univ, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [An, Hye-Young; Shin, Hyun-Soo; Choi, Jeong-Seok; Lim, Jae-Yol; Kim, Young-Mo] Inha Univ, Translat Res Ctr, Coll Med, Inchon, South Korea; [Kim, Hun Jung] Inha Univ, Coll Med, Dept Radiat Oncol, Inchon, South Korea	Inha University; Inha University; Inha University	Lim, JY (corresponding author), Inha Univ, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea.	jylim@inha.ac.kr; ymk416@inha.ac.kr	Kim, Ji-Youn/A-5779-2017	im, jaeyeol/0000-0002-9757-6414	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2012R1A1A2006712, 2015R1A2A2A01006528]; Inha Research Grant	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Inha Research Grant	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2012R1A1A2006712 and 2015R1A2A2A01006528), and an Inha Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; FRANZEN L, 1992, EUR J CANCER, V28A, P457, DOI 10.1016/S0959-8049(05)80076-0; Gao ZM, 2012, CYTOTHERAPY, V14, P267, DOI 10.3109/14653249.2011.616194; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6; Jeong D, 2014, BIOMATERIALS, V35, P9302, DOI 10.1016/j.biomaterials.2014.07.047; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kojima T, 2011, LARYNGOSCOPE, V121, P1864, DOI 10.1002/lary.22080; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017; Miah AB, 2013, RADIOTHER ONCOL, V106, P346, DOI 10.1016/j.radonc.2013.03.006; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Sasportas LS, 2013, COST EFFECTIVENESS L; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Vissink A, 2014, ORAL DIS; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031	29	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141862	10.1371/journal.pone.0141862	http://dx.doi.org/10.1371/journal.pone.0141862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529411	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600072
J	Awad, SF; Sgaier, SK; Ncube, G; Xaba, S; Mugurungi, OM; Mhangara, MM; Lau, FK; Mohamoud, YA; Abu-Raddad, LJ				Awad, Susanne F.; Sgaier, Sema K.; Ncube, Gertrude; Xaba, Sinokuthemba; Mugurungi, Owen M.; Mhangara, Mutsa M.; Lau, Fiona K.; Mohamoud, Yousra A.; Abu-Raddad, Laith J.			A Reevaluation of the Voluntary Medical Male Circumcision Scale-Up Plan in Zimbabwe	PLOS ONE			English	Article							MODELS	Background The voluntary medical male circumcision (VMMC) program in Zimbabwe aims to circumcise 80% of males aged 13-29 by 2017. We assessed the impact of actual VMMC scale-up to date and evaluated the impact of potential alterations to the program to enhance program efficiency, through prioritization of subpopulations. Methods and Findings We implemented a recently developed analytical approach: the age-structured mathematical (ASM) model and accompanying three-level conceptual framework to assess the impact of VMMC as an intervention. By September 2014, 364,185 males were circumcised, an initiative that is estimated to avert 40,301 HIV infections by 2025. Through age-group prioritization, the number of VMMCs needed to avert one infection (effectiveness) ranged between ten (20-24 age-group) and 53 (45-49 age-group). The cost per infection averted ranged between $ 811 (20-24 age-group) and $ 5,518 (45-49 age-group). By 2025, the largest reductions in HIV incidence rate (up to 27%) were achieved by prioritizing 10-14, 1519, or 20-24 year old. The greatest program efficiency was achieved by prioritizing 15-24, 15-29, or 15-34 year old. Prioritizing males 13-29 year old was programmatically efficient, but slightly inferior to the 15-24, 15-29, or 15-34 age groups. Through geographic prioritization, effectiveness varied from 9-12 VMMCs per infection averted across provinces. Through risk-group prioritization, effectiveness ranged from one (highest sexual risk-group) to 60 (lowest sexual risk-group) VMMCs per infection averted. Conclusion The current VMMC program plan in Zimbabwe is targeting an efficient and impactful age bracket (13-29 year old), but program efficiency can be improved by prioritizing a subset of males for demand creation and service availability. The greatest program efficiency can be attained by prioritizing young sexually active males and males whose sexual behavior puts them at higher risk for acquiring HIV.	[Awad, Susanne F.; Mohamoud, Yousra A.; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Sgaier, Sema K.; Lau, Fiona K.] Bill & Melinda Gates Fdn, Global Dev Program, Integrated Delivery, Seattle, WA USA; [Sgaier, Sema K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ncube, Gertrude; Xaba, Sinokuthemba; Mugurungi, Owen M.; Mhangara, Mutsa M.] Minist Hlth & Child Care, AIDS & TB Programme, Harare, Zimbabwe; [Abu-Raddad, Laith J.] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med Coll, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; Cornell University; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.	lja2002@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This publication is based on research funded by the Bill & Melinda Gates Foundation. The authors would like to thank the Government of Zimbabwe for providing them with the opportunity to undertake this research and share these findings. The authors are grateful for infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEM HLTH SURV; [Anonymous], 1999, METHODS EC EVALUATIO; Awad S, 2015, INVESTIGATING UNPUB; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Cuadros DF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-216; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Kagaayi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092015; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Mathworks, 2013, MATLAB LANG TECHN CO; Ministry of Health and Child Welfare (MoHCC), 2010, STRAT SAF MED MAL CI; Ncube G., 2014, ZIMBABWE VOLUNTARY M; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Sgaier SK, 2014, PERFORMED VOLUNTARY; U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2013, ZIMB OP PLAN REP FY; U. S. President's Emergency Plan for AIDS Relief (PEPFAR), 2010, ZIMB OP PLAN REP FY; UNAIDS, 2013, EP DAT HIV EST 1990; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Vandament L., 2013, PROGRAM CIRCUMCISION; WHO, 2013, GLOB UPD HIV TREATM; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	25	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140818	10.1371/journal.pone.0140818	http://dx.doi.org/10.1371/journal.pone.0140818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529596	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600014
J	Dancy, BCR; Chen, SW; Drechsler, R; Gafken, PR; Olsen, CP				Dancy, Blair C. R.; Chen, Shaw-Wen; Drechsler, Robin; Gafken, Philip R.; Olsen, Carissa Perez			C-13- and N-15-Labeling Strategies Combined with Mass Spectrometry Comprehensively Quantify Phospholipid Dynamics in C-elegans	PLOS ONE			English	Article							FATTY-ACID; STEAROYL-COENZYME; LC-MS; MEMBRANE; LIPIDS; DESATURASE-1; LIPOGENESIS; DISSECTION; METABOLISM; MECHANISMS	Membranes define cellular and organelle boundaries, a function that is critical to all living systems. Like other biomolecules, membrane lipids are dynamically maintained, but current methods are extremely limited for monitoring lipid dynamics in living animals. We developed novel strategies in C. elegans combining C-13 and N-15 stable isotopes with mass spectrometry to directly quantify the replenishment rates of the individual fatty acids and intact phospholipids of the membrane. Using multiple measurements of phospholipid dynamics, we found that the phospholipid pools are replaced rapidly and at rates nearly double the turnover measured for neutral lipid populations. In fact, our analysis shows that the majority of membrane lipids are replaced each day. Furthermore, we found that stearoyl-CoA desaturases (SCDs), critical enzymes in polyunsaturated fatty acid production, play an unexpected role in influencing the overall rates of membrane maintenance as SCD depletion affected the turnover of nearly all membrane lipids. Additionally, the compromised membrane maintenance as defined by LC-MS/MS with SCD RNAi resulted in active phospholipid remodeling that we predict is critical to alleviate the impact of reduced membrane maintenance in these animals. Not only have these combined methodologies identified new facets of the impact of SCDs on the membrane, but they also have great potential to reveal many undiscovered regulators of phospholipid metabolism.	[Dancy, Blair C. R.; Chen, Shaw-Wen; Drechsler, Robin; Olsen, Carissa Perez] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Olsen, CP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	cpolsen@fredhutch.org		Olsen, Carissa/0000-0003-1261-9364	Cancer Center Support Grant from the National Institutes of Health [P30CA015704]; National Institutes of Health Early Independence Award [5 DP5 OD009189]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009189] Funding Source: NIH RePORTER	Cancer Center Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Hutchinson Cancer Center's Proteomics Facility is partially funded by a Cancer Center Support Grant (P30CA015704) from the National Institutes of Health. CPO is supported by a National Institutes of Health Early Independence Award (5 DP5 OD009189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird SS, 2013, METABOLOMICS, V9, pS67, DOI 10.1007/s11306-012-0400-1; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Castro C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-36; DAWIDOWICZ EA, 1987, ANNU REV BIOCHEM, V56, P43, DOI 10.1146/annurev.bi.56.070187.000355; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; FOLCH J, 1957, J BIOL CHEM, V226, P497; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Lahiri S, 2015, CURR OPIN CELL BIOL, V33, P82, DOI 10.1016/j.ceb.2014.12.004; Ma DKK, 2015, CELL, V161, P1152, DOI 10.1016/j.cell.2015.04.026; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pino EC, 2013, JOVE-J VIS EXP, DOI 10.3791/50180; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Savory FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024550; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; SLEIGHT RG, 1987, ANNU REV PHYSIOL, V49, P193; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yang XG, 2010, MOL NEUROBIOL, V41, P138, DOI 10.1007/s12035-010-8121-9; Zhang ZH, 2014, J MED CHEM, V57, P5039, DOI 10.1021/jm401516c	38	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141850	10.1371/journal.pone.0141850	http://dx.doi.org/10.1371/journal.pone.0141850			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528916	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600068
J	Hussey, EK; Ward, N; Christianson, K; Kramer, AF				Hussey, Erika K.; Ward, Nathan; Christianson, Kiel; Kramer, Arthur F.			Language and Memory Improvements following tDCS of Left Lateral Prefrontal Cortex	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; GARDEN-PATH SENTENCES; LATENT-VARIABLE ANALYSIS; WORKING-MEMORY; COGNITIVE CONTROL; MOTOR CORTEX; BROCAS AREA; ELECTRICAL-STIMULATION; INTERFERENCE CONTROL	Recent research demonstrates that performance on executive-control measures can be enhanced through brain stimulation of lateral prefrontal regions. Separate psycholinguistic work emphasizes the importance of left lateral prefrontal cortex executive-control resources during sentence processing, especially when readers must override early, incorrect interpretations when faced with temporary ambiguity. Using transcranial direct current stimulation, we tested whether stimulation of left lateral prefrontal cortex had discriminate effects on language and memory conditions that rely on executive-control (versus cases with minimal executive-control demands, even in the face of task difficulty). Participants were randomly assigned to receive Anodal, Cathodal, or Sham stimulation of left lateral prefrontal cortex while they (1) processed ambiguous and unambiguous sentences in a word-by-word self-paced reading task and (2) performed an n-back memory task that, on some trials, contained interference lure items reputed to require executive-control. Across both tasks, we parametrically manipulated executive-control demands and task difficulty. Our results revealed that the Anodal group outperformed the remaining groups on (1) the sentence processing conditions requiring executive-control, and (2) only the most complex n-back conditions, regardless of executive-control demands. Together, these findings add to the mounting evidence for the selective causal role of left lateral prefrontal cortex for executive-control tasks in the language domain. Moreover, we provide the first evidence suggesting that brain stimulation is a promising method to mitigate processing demands encountered during online sentence processing.	[Hussey, Erika K.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Champaign, IL 61801 USA; [Christianson, Kiel] Univ Illinois, Dept Educ Psychol, Champaign, IL USA; [Hussey, Erika K.; Ward, Nathan; Christianson, Kiel; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hussey, EK (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61801 USA.	ehussey@illinois.edu	Ward, Nathan/AAB-5713-2021; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institutes of Health [T32-HD055272]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Institutes of Health Training Grant T32-HD055272 (PI: Sarah Brown-Schmidt) to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bartolotti J, 2012, COGNITIVE SCI, V36, P1129, DOI 10.1111/j.1551-6709.2012.01243.x; Berryhill ME, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00800; Bestmann S, 2015, TRENDS COGN SCI, V19, P13, DOI 10.1016/j.tics.2014.10.003; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bikson M, 2012, BRAIN STIMUL, V5, P430, DOI 10.1016/j.brs.2011.06.001; Blank I, 2014, J NEUROPHYSIOL, V112, P1105, DOI 10.1152/jn.00884.2013; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Capone F, 2014, NEUROBIOL LEARN MEM, V114, P51, DOI 10.1016/j.nlm.2014.04.013; Cappelletti M, 2013, J NEUROSCI, V33, P14899, DOI 10.1523/JNEUROSCI.1692-13.2013; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Christianson K, 2006, DISCOURSE PROCESS, V42, P205, DOI 10.1207/s15326950dp4202_6; Clifton C, 2003, J MEM LANG, V49, P317, DOI 10.1016/S0749-596X(03)00070-6; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Edwards D, 2013, NEUROIMAGE, V74, P266, DOI 10.1016/j.neuroimage.2013.01.042; Elmasry J, 2015, RESTOR NEUROL NEUROS, V33, P263, DOI 10.3233/RNN-140473; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Farmer T.A., 2012, CAMBRIDGE HDB PSYCHO, P353, DOI 10.1017/CBO9781139029377.018; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Fedorenko E, 2013, COGNITIVE SCI, V37, P378, DOI 10.1111/cogs.12021; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Ferreira F, 2001, J PSYCHOLINGUIST RES, V30, P3, DOI 10.1023/A:1005290706460; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gladwin TE, 2012, NEUROSCI LETT, V512, P33, DOI 10.1016/j.neulet.2012.01.056; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Holland R, 2012, APHASIOLOGY, V26, P1169, DOI 10.1080/02687038.2011.616925; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hussey EK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00158; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Janacsek K, 2015, BRAIN STIMUL, V8, P277, DOI 10.1016/j.brs.2014.11.008; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Jeon SY, 2012, ANN REHABIL MED-ARM, V36, P585, DOI 10.5535/arm.2012.36.5.585; Jones KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121904; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Jung YJ, 2013, BIOMED ENG LETT, V3, P39, DOI 10.1007/s13534-013-0087-x; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Linck JA, 2012, BILING-LANG COGN, V15, P651, DOI 10.1017/S136672891100054X; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Mason RA, 2003, J EXP PSYCHOL LEARN, V29, P1319, DOI 10.1037/0278-7393.29.6.1319; McKinley RA, 2013, BEHAV NEUROSCI, V127, P936, DOI 10.1037/a0034975; Meinzer M, 2014, CORTEX, V50, P137, DOI 10.1016/j.cortex.2013.07.013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minhas P, 2011, CLIN NEUROPHYSIOL, V122, P637, DOI 10.1016/j.clinph.2010.09.023; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mirman D., 2014, MINDING THE BRAIN; Mirman D., 2013, MINDING THE BRAIN; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; Nelson JK, 2003, P NATL ACAD SCI USA, V100, P11171, DOI 10.1073/pnas.1334125100; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Nozari N, 2014, BRAIN STIMUL, V7, P784, DOI 10.1016/j.brs.2014.07.035; Nozari N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084338; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Oberauer K, 2005, J EXP PSYCHOL GEN, V134, P368, DOI 10.1037/0096-3445.134.3.368; Oelhafen S, 2013, NEUROPSYCHOLOGIA, V51, P2781, DOI 10.1016/j.neuropsychologia.2013.08.012; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pereira JB, 2013, BRAIN STIMUL, V6, P16, DOI 10.1016/j.brs.2012.01.006; Perry LK, 2014, BRAIN LANG, V135, P66, DOI 10.1016/j.bandl.2014.05.005; Persson J, 2013, J COGNITIVE NEUROSCI, V25, P338, DOI 10.1162/jocn_a_00321; Pirulli C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00226; Pisoni A, 2015, NEUROPSYCHOLOGIA, V66, P267, DOI 10.1016/j.neuropsychologia.2014.11.025; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Richmond LL, 2014, J COGNITIVE NEUROSCI, V26, P2443, DOI 10.1162/jocn_a_00657; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Schlaug G, 2011, NEUROPSYCHOL REV, V21, P288, DOI 10.1007/s11065-011-9181-y; Schmiedek F, 2009, PSYCHOL AGING, V24, P203, DOI 10.1037/a0014685; Sela T, 2012, NEUROPSYCHOLOGIA, V50, P2271, DOI 10.1016/j.neuropsychologia.2012.05.031; Slattery TJ, 2013, J MEM LANG, V69, P104, DOI 10.1016/j.jml.2013.04.001; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Sturt P, 2007, COGNITION, V105, P477, DOI 10.1016/j.cognition.2006.10.009; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Thothathiri M, 2012, BRAIN LANG, V120, P259, DOI 10.1016/j.bandl.2011.12.004; Thothathiri M, 2012, J COGNITIVE NEUROSCI, V24, P212, DOI 10.1162/jocn_a_00118; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Turkeltaub PE, 2012, BRAIN STIMUL, V5, P201, DOI 10.1016/j.brs.2011.04.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Van Dyke JA, 2003, J MEM LANG, V49, P285, DOI 10.1016/S0749-596X(03)00081-0; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; Vuong LC, 2014, FRONT PSYCHOL, DOI [10.3389/conf.fpsyg.2014.64.00044, DOI 10.3389/CONF.FPSYG.2014.64.00044]; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wirth M, 2011, NEUROPSYCHOLOGIA, V49, P3989, DOI 10.1016/j.neuropsychologia.2011.10.015; Witzel N, 2012, J PSYCHOLINGUIST RES, V41, P105, DOI 10.1007/s10936-011-9179-x; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	151	32	32	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141417	10.1371/journal.pone.0141417	http://dx.doi.org/10.1371/journal.pone.0141417			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528814	Green Submitted, gold, Green Published			2022-12-27	WOS:000364032600027
J	Legarrea, S; Barman, A; Marchant, W; Diffie, S; Srinivasan, R				Legarrea, Saioa; Barman, Apurba; Marchant, Wendy; Diffie, Stan; Srinivasan, Rajagopalbabu			Temporal Effects of a Begomovirus Infection and Host Plant Resistance on the Preference and Development of an Insect Vector, Bemisia tabaci, and Implications for Epidemics	PLOS ONE			English	Article							LEAF-CURL-VIRUS; YELLOW-DWARF-VIRUS; RHOPALOSIPHUM-PADI HOMOPTERA; MYZUS-PERSICAE HOMOPTERA; WHITEFLY VECTOR; NITROGEN AVAILABILITY; SOLANUM-SARRACHOIDES; UNTRANSFORMED WHEAT; HAIRY NIGHTSHADE; TOBACCO PLANTS	Persistent plant viruses, by altering phenotypic and physiological traits of their hosts, could modulate the host preference and fitness of hemipteran vectors. A majority of such modulations increase vector preference for virus-infected plants and improve vector fitness, ultimately favouring virus spread. Nevertheless, it remains unclear how these virus-induced modulations on vectors vary temporally, and whether host resistance to the pathogen influences such effects. This study addressed the two questions using a Begomovirus-whitefly-tomato model pathosystem. Tomato yellow leaf curl virus (TYLCV)-susceptible and TYLCV-resistant tomato genotypes were evaluated by whitefly-mediated transmission assays. Quantitative PCR revealed that virus accumulation decreased after an initial spike in all genotypes. TYLCV accumulation was less in resistant than in susceptible genotypes at 3, 6, and 12 weeks post inoculation (WPI). TYLCV acquisition by whiteflies over time from resistant and susceptible genotypes was also consistent with virus accumulation in the host plant. Furthermore, preference assays indicated that non-viruliferous whiteflies preferred virus-infected plants, whereas viruliferous whiteflies preferred non-infected plants. However, this effect was prominent only with the susceptible genotype at 6WPI. The development of whiteflies on non-infected susceptible and resistant genotypes was not significantly different. However, developmental time was reduced when a susceptible genotype was infected with TYLCV. Together, these results suggest that vector preference and development could be affected by the timing of infection and by host resistance. These effects could play a crucial role in TYLCV epidemics.	[Legarrea, Saioa; Barman, Apurba; Marchant, Wendy; Diffie, Stan; Srinivasan, Rajagopalbabu] Univ Georgia, Dept Entomol, Tifton, GA 31793 USA	University System of Georgia; University of Georgia	Srinivasan, R (corresponding author), Univ Georgia, Dept Entomol, Tifton, GA 31793 USA.	babusri@uga.edu	Barman, Apurba/D-9687-2011; legarrea, saioa/I-3963-2014	legarrea, saioa/0000-0002-9127-2794; Barman, Apurba K/0000-0001-8309-9998	Georgia Commodity Commission for Vegetables; United States Department of Agriculture Southern Region IPM Center	Georgia Commodity Commission for Vegetables; United States Department of Agriculture Southern Region IPM Center	Support was provided by Georgia Commodity Commission for Vegetables and the United States Department of Agriculture Southern Region IPM Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI O, 1983, ANN APPL BIOL, V103, P1, DOI 10.1111/j.1744-7348.1983.tb02734.x; Diaz-Pendon JA, 2010, MOL PLANT PATHOL, V11, P441, DOI [10.1111/j.1364-3703.2010.00618.x, 10.1111/J.1364-3703.2010.00618.X]; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; CASTLE SJ, 1993, ENTOMOL EXP APPL, V69, P51, DOI 10.1007/BF02380673; Castle SJ, 1998, ANN ENTOMOL SOC AM, V91, P661, DOI 10.1093/aesa/91.5.661; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Fang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02876; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; He WB, 2015, SCI REP-UK, V5, DOI 10.1038/srep07682; Hoffland E, 2000, J CHEM ECOL, V26, P2697, DOI 10.1023/A:1026477423988; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Jahan SMH, 2014, J ASIA-PAC ENTOMOL, V17, P79, DOI 10.1016/j.aspen.2013.11.006; Jauset AM, 1998, ENTOMOL EXP APPL, V86, P175, DOI 10.1023/A:1003145813704; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Jimenez-Martinez ES, 2004, J ECON ENTOMOL, V97, P203, DOI 10.1603/0022-0493-97.2.203; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Karley AJ, 2002, J EXP BIOL, V205, P3009; KENNEDY JS, 1951, NATURE, V168, P825, DOI 10.1038/168825a0; Kollenberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111968; Lapidot M, 2002, ANN APPL BIOL, V140, P109, DOI 10.1111/j.1744-7348.2002.tb00163.x; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; Li M, 2011, INSECT SCI, V18, P40, DOI 10.1111/j.1744-7917.2010.01354.x; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu J, 2010, J ZHEJIANG UNIV-SC B, V11, P30, DOI 10.1631/jzus.B0900213; Luan JB, 2014, B ENTOMOL RES, V104, P267, DOI 10.1017/S000748531400011X; Luan JB, 2013, ECOL LETT, V16, P390, DOI 10.1111/ele.12055; Maluta NKP, 2014, NEOTROP ENTOMOL, V43, P385, DOI 10.1007/s13744-014-0223-z; MARKKULA M., 1964, Annales Agriculturae Fenniae, V3, P265; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Muiiiz M., 2001, FAIR6CT984303 EUR WH; Pakkianathan BC, 2015, J VIROL, V89, P9791, DOI 10.1128/JVI.00779-15; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Park Mi Kyung, 2009, Journal of Asia-Pacific Entomology, V12, P227, DOI 10.1016/j.aspen.2009.04.004; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; PONSEN M B, 1969, Netherlands Journal of Plant Pathology, V75, P360, DOI 10.1007/BF01975507; Rajabaskar D, 2014, VIRUS RES, V186, P32, DOI 10.1016/j.virusres.2013.11.005; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shi XB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05230; Srininvasan R, 2006, ENVIRON ENTOMOL, V35, P546, DOI 10.1603/0046-225X-35.2.546; Srinivasan R, 2008, ENVIRON ENTOMOL, V37, P592, DOI 10.1603/0046-225X(2008)37[592:EOAAWH]2.0.CO;2; Srinivasan R, 2012, J ECON ENTOMOL, V105, P1447, DOI 10.1603/EC11402; Stout MJ, 1998, J CHEM ECOL, V24, P945, DOI 10.1023/A:1022350100718; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	53	47	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142114	10.1371/journal.pone.0142114	http://dx.doi.org/10.1371/journal.pone.0142114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26529402	Green Published, gold, Green Submitted			2022-12-27	WOS:000364032600102
J	Tan, SL; Ahmad, TS; Ng, WM; Azlina, AA; Azhar, MM; Selvaratnam, L; Kamarul, T				Tan, Sik-Loo; Ahmad, Tunku Sara; Ng, Wuey-Min; Azlina, Amir Abbas; Azhar, Mahmood Merican; Selvaratnam, Lakshmi; Kamarul, Tunku			Identification of Pathways Mediating Growth Differentiation Factor5-Induced Tenogenic Differentiation in Human Bone Marrow Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH/DIFFERENTIATION FACTOR-5 GDF-5; STIMULATES OSTEOGENIC DIFFERENTIATION; IN-VITRO; TENDON; PROLIFERATION; TRANSITION; INCREASES; GTPASES; MARKER	To date, the molecular signalling mechanisms which regulate growth factors-induced MSCs tenogenic differentiation remain largely unknown. Therefore, a study to determine the global gene expression profile of tenogenic differentiation in human bone marrow stromal cells (hMSCs) using growth differentiation factor 5 (GDF5) was conducted. Microarray analyses were conducted on hMSCs cultures supplemented with 100 ng/ml of GDF5 and compared to undifferentiated hMSCs and adult tenocytes. Results of QuantiGene1Plex assay support the use and interpretation of the inferred gene expression profiles and pathways information. From the 27,216 genes assessed, 873 genes (3.21% of the overall human transcriptome) were significantly altered during the tenogenic differentiation process (corrected p<0.05). The genes identified as potentially associated with tenogenic differentiation were ARHGAP29, CCL2, integrin alpha 8 and neurofilament medium polypeptides. These genes, were mainly associated with cytoskeleton reorganization (stress fibers formation) signaling. Pathway analysis demonstrated the potential molecular pathways involved in tenogenic differentiation were: cytoskeleton reorganization related i.e. keratin filament signaling and activin A signaling; cell adhesion related i.e. chemokine and adhesion signaling; and extracellular matrix related i.e. arachidonic acid production signaling. Further investigation using atomic force microscopy and confocal laser scanning microscopy demonstrated apparent cytoskeleton reorganization in GDF5-induced hMSCs suggesting that cytoskeleton reorganization signaling is an important event involved in tenogenic differentiation. Besides, a reduced nucleostemin expression observed suggested a lower cell proliferation rate in hMSCs undergoing tenogenic differentiation. Understanding and elucidating the tenogenic differentiation signalling pathways are important for future optimization of tenogenic hMSCs for functional tendon cell-based therapy and tissue engineering.	[Tan, Sik-Loo; Ahmad, Tunku Sara; Ng, Wuey-Min; Azlina, Amir Abbas; Azhar, Mahmood Merican; Kamarul, Tunku] Univ Malaya, Fac Med, Tissue Engn Grp,Dept Orthopaed Surg, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur 50603, Malaysia; [Selvaratnam, Lakshmi] Monash Univ, Sch Med & Hlth Sci, Selangor, Malaysia	Universiti Malaya; Monash University; Monash University Sunway	Tan, SL (corresponding author), Univ Malaya, Fac Med, Tissue Engn Grp,Dept Orthopaed Surg, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur 50603, Malaysia.	tansikloo@gmail.com; tkzrea@um.edu.my	Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; Tunku Ahmad Yahaya, Tunku Sara/B-9979-2010; ABBAS, AZLINA AMIR/B-5405-2010; Selvaratnam, L/AAH-4066-2020; Tan, Sik Loo/K-5571-2013; Ng, Wuey Min/J-3196-2016	Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Tunku Ahmad Yahaya, Tunku Sara/0000-0002-7542-2860; ABBAS, AZLINA AMIR/0000-0003-4423-4653; Selvaratnam, L/0000-0002-2147-1616; Tan, Sik Loo/0000-0003-1723-8384; Ng, Wuey Min/0000-0002-3542-8993	HIRMOHE research grant initiative [A000003-50001]; eScience Grant [12-02-03-2017]; UMRG [RG093/09HTM]; University of Malaya [PS167/2008C, PS360/2009B, PS219/2010A]	HIRMOHE research grant initiative; eScience Grant; UMRG; University of Malaya(Universiti Malaya)	This study was supported by HIRMOHE research grant initiative (Grant number: A000003-50001), eScience Grant (12-02-03-2017), UMRG (RG093/09HTM) and University of Malaya postgraduate student grant (PS167/2008C, PS360/2009B and PS219/2010A). The University of Malaya provided a PhD thesis scholarship for the first author. Herein, the authors would like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Behr R, 2005, STEM CELLS, V23, P805, DOI 10.1634/stemcells.2004-0234; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidder M, 2000, J ORTHOPAED RES, V18, P247, DOI 10.1002/jor.1100180212; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Cilli F, 2004, CLIN J SPORT MED, V14, P232, DOI 10.1097/00042752-200407000-00006; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Farng E, 2008, CLIN ORTHOP RELAT R, V466, P1930, DOI 10.1007/s11999-008-0300-x; FILIPAK M, 1989, ENVIRON HEALTH PERSP, V80, P117, DOI 10.2307/3430737; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hutter JL, 2005, J MICROSC-OXFORD, V219, P61, DOI 10.1111/j.1365-2818.2005.01497.x; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaiser E, 1999, CRIT REV CL LAB SCI, V36, P65, DOI 10.1080/10408369991239187; Kamarul T., 2009, EUR CELL MAT S1, V18, P47; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Liu XB, 2008, ACTA PHARMACOL SIN, V29, P815, DOI 10.1111/j.1745-7254.2008.00811.x; Loranger A, 1997, AM J PATHOL, V151, P1673; Luo Q, 2009, CYTOTECHNOLOGY, V61, P1, DOI 10.1007/s10616-009-9233-9; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Morita Y, 2012, CELL BIOCH BIOPHYSIC; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Orlandini M, 2006, J BIOL CHEM, V281, P17961, DOI 10.1074/jbc.M600413200; Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shimaoka H, 2004, J BIOMED MATER RES A, V68A, P168, DOI 10.1002/jbm.a.20059; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su JA, 2010, INT J BIOCHEM CELL B, V42, P2047, DOI 10.1016/j.biocel.2010.09.009; Tan SL, 2013, J ANAT, V222, P437, DOI 10.1111/joa.12032; Tan SL, 2012, CELLS TISSUES ORGANS, V196, P325, DOI 10.1159/000335693; Tan SL, 2011, CELL TISSUE BANK, V12, P59, DOI 10.1007/s10561-009-9164-x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022	46	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140869	10.1371/journal.pone.0140869	http://dx.doi.org/10.1371/journal.pone.0140869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528540	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600015
J	Barnig, C; Alsaleh, G; Jung, N; Dembele, D; Paul, N; Poirot, A; Uring-Lambert, B; Georgel, P; de Blay, F; Bahram, S				Barnig, Cindy; Alsaleh, Ghada; Jung, Nicolas; Dembele, Doulaye; Paul, Nicodeme; Poirot, Anh; Uring-Lambert, Beatrice; Georgel, Philippe; de Blay, Frederic; Bahram, Seiamak			Circulating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders	PLOS ONE			English	Article							ACID LIPASE DEFICIENCY; RESPIRATORY INFLAMMATION; PERIPHERAL-BLOOD; MEPOLIZUMAB; CYTOKINE; PROTEINS; GENES; MICE; CLASSIFICATION; EXPRESSION	Eosinophils are leukocytes that are released into the peripheral blood in a phenotypically mature state and are capable of being recruited into tissues in response to appropriate stimuli. Eosinophils, traditionally considered cytotoxic effector cells, are leukocytes recruited into the airways of asthma patients where they are believed to contribute to the development of many features of the disease. This perception, however, has been challenged by recent findings suggesting that eosinophils have also immunomodulatory functions and may be involved in tissue homeostasis and wound healing. Here we describe a transcriptome-based approach-in a limited number of patients and controls-to investigate the activation state of circulating human eosinophils isolated by flow cytometry. We provide an overview of the global expression pattern in eosinophils in various relevant conditions, e.g., eosinophilic asthma, hypereosinophilic dermatological diseases, parasitosis and pulmonary aspergillosis. Compared to healthy subjects, circulating eosinophils isolated from asthma patients differed in their gene expression profile which is marked by downregulation of transcripts involved in antigen presentation, pathogen recognition and mucosal innate immunity, whereas up-regulated genes were involved in response to non-specific stimulation, wounding and maintenance of homeostasis. Eosinophils from other hypereosinophilic disorders displayed a very similar transcriptional profile. Taken together, these observations seem to indicate that eosinophils exhibit non-specific immunomodulatory functions important for tissue repair and homeostasis and suggest new roles for these cells in asthma immunobiology.	[Barnig, Cindy; Alsaleh, Ghada; Jung, Nicolas; Paul, Nicodeme; Georgel, Philippe; Bahram, Seiamak] Univ Strasbourg, Federat Med Translat Strasbourg, ImmunoRhumatol Mol, INSERM UMR S 1109,Labex Transplantex, F-67085 Strasbourg, France; [Barnig, Cindy; Poirot, Anh; de Blay, Frederic] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Pneumol, F-67091 Strasbourg, France; [Barnig, Cindy; Alsaleh, Ghada; Paul, Nicodeme; Poirot, Anh; Uring-Lambert, Beatrice; Georgel, Philippe; de Blay, Frederic; Bahram, Seiamak] Federat Hosp Univ, OMICARE, Ctr Rech Immunol & Hematol, F-67085 Strasbourg, France; [Jung, Nicolas] Univ Strasbourg, Labex IRMIA, IRMA, CNRS UMR 7501, F-67084 Strasbourg, France; [Dembele, Doulaye] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM U964, CNRS UMR 7104, F-67404 Illkirch Graffenstaden, France; [Uring-Lambert, Beatrice; Bahram, Seiamak] Hop Univ Strasbourg, Nouvel Hop Civil, Lab Cent Immunol, Pole Biol, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bahram, S (corresponding author), Univ Strasbourg, Federat Med Translat Strasbourg, ImmunoRhumatol Mol, INSERM UMR S 1109,Labex Transplantex, F-67085 Strasbourg, France.	siamak@unistra.fr	Bahram, Seiamak/GZA-7150-2022; georgel, philippe/P-5676-2016; Dembélé, Doulaye/O-6513-2017	georgel, philippe/0000-0001-6853-7080; Dembélé, Doulaye/0000-0003-3879-6940; alsaleh, ghada/0000-0002-4211-3420; Barnig, Cindy/0000-0001-8890-3236; Bahram, Seiamak/0000-0002-6928-9952; Paul, Nicodeme/0000-0003-4680-3012	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant (no number applicable) from the Institut National de la Sante et de la Recherche Medicale (INSERM), http://www.inserm.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; BISGAARD H, 1984, ALLERGY, V39, P413, DOI 10.1111/j.1398-9995.1984.tb01963.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Du H, 2001, HUM MOL GENET, V10, P1639, DOI 10.1093/hmg/10.16.1639; Esnault S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067560; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hogan SP, 1998, J IMMUNOL, V161, P1501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jacobsen EA, 2014, ALLERGY, V69, P315, DOI 10.1111/all.12321; Johnsson M, 2011, J INNATE IMMUN, V3, P594, DOI 10.1159/000331326; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Liang SQ, 2013, RESPIROLOGY, V18, P774, DOI 10.1111/resp.12097; Munoz NM, 2006, NAT PROTOC, V1, P2613, DOI 10.1038/nprot.2006.340; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Ogawa K, 2003, CLIN EXP IMMUNOL, V131, P436, DOI 10.1046/j.1365-2249.2003.02090.x; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sutherland DB, 2014, IMMUNITY, V40, P455, DOI 10.1016/j.immuni.2014.04.003; Temple R, 2001, AM J RESP CELL MOL, V25, P425, DOI 10.1165/ajrcmb.25.4.4456; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; Valent P, 2012, EXPERT REV HEMATOL, V5, P157, DOI [10.1586/EHM.11.81, 10.1586/ehm.11.81]; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141740	10.1371/journal.pone.0141740	http://dx.doi.org/10.1371/journal.pone.0141740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524763	Green Published, gold, Green Submitted			2022-12-27	WOS:000364029800021
J	Kocalevent, RD; Zenger, M; Heinen, I; Dwinger, S; Decker, O; Brahler, E				Kocalevent, Rueya-Daniela; Zenger, Markus; Heinen, Ines; Dwinger, Sarah; Decker, Oliver; Braehler, Elmar			Resilience in the General Population: Standardization of the Resilience Scale (RS-11)	PLOS ONE			English	Article							TESTING MEASUREMENT INVARIANCE; LIFE SATISFACTION; SELF-ESTEEM; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; ANXIETY DISORDER; CANADIAN YOUTH; MENTAL-HEALTH; FIT INDEXES; VALIDATION	Background The objectives of the study were to generate normative data for the RS-11 for different age groups for men and women and to further investigate the construct validity and factor structure in the general population. Methods Nationally representative face-to face household surveys were conducted in Germany in 2006 (n = 5,036). Results Normative data for the RS-11 were generated for men and women (53.7% female) and different age levels (mean age (SD) of 48.4 (18.0) years). Men had significantly higher mean scores compared with women (60.0 [SD = 10.2] vs. 59.3 [SD = 11.0]). Results of CFA supported a one-factor model of resilience. Self-esteem (standardized beta =.50) and life satisfaction (standardized beta =. 20) were associated with resilience. Conclusions The normative data provide a framework for the interpretation and comparisons of resilience with other populations. Results demonstrate a special importance of self-esteem in the understanding of resilience.	[Kocalevent, Rueya-Daniela; Heinen, Ines; Dwinger, Sarah] Univ Med Ctr Hamburg Eppendorf, Inst & Policlin Med Psychol, Hamburg, Germany; [Zenger, Markus; Decker, Oliver; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Zenger, Markus] Univ Appl Sci Magdeburg & Stendal, Fac Appl Human Studies, Stendal, Germany; [Braehler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Rhinland Palati, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Johannes Gutenberg University of Mainz	Zenger, M (corresponding author), Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany.	markus.zenger@hs-magdeburg.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728; Dwinger, Sarah/0000-0003-4868-5662				Abiola Tajudeen, 2011, BMC Res Notes, V4, P509, DOI 10.1186/1756-0500-4-509; Ahern NR, 2006, COMPR CHILD ADOLES N, V29, P103, DOI 10.1080/01460860600677643; APA, 2000, DIAGN STAT MAN MENT; Arbuckle JL, 2009, AMOS 18 USERS GUIDE; Bachman Desilva Mary, 2012, Int J Ment Health Promot, V14, P162; Barnes M, 2007, SOC POLICY SOC, V6, P193, DOI 10.1017/S1474746406003459; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Belcher AM, 2014, TRENDS COGN SCI, V18, P211, DOI 10.1016/j.tics.2014.01.010; Beutel ME, 2010, AGING MALE, V13, P32, DOI 10.3109/13685530903296698; Beutel ME, 2009, MENOPAUSE, V16, P1132, DOI 10.1097/gme.0b013e3181a857f8; Black C, 2004, J ADV NURS, V48, P351, DOI 10.1111/j.1365-2648.2004.03204.x; Bundesamt S, 2006, MIKROZENSUS 2005; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Crawford JR, 2009, BRIT J CLIN PSYCHOL, V48, P163, DOI 10.1348/014466508X377757; Currie CL, 2013, SOC SCI MED, V88, P1, DOI 10.1016/j.socscimed.2013.03.032; Daigneault I, 2013, CHILD ABUSE NEGLECT, V37, P160, DOI 10.1016/j.chiabu.2012.06.004; Ferring D, 1996, DIAGNOSTICA, V42, P284; Geschwind N, 2010, ACTA PSYCHIAT SCAND, V122, P129, DOI 10.1111/j.1600-0447.2009.01525.x; Geschwind N, 2011, EUR NEUROPSYCHOPHARM, V21, P241, DOI 10.1016/j.euroneuro.2010.11.004; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; Haase Joan E, 2004, J Pediatr Oncol Nurs, V21, P289, DOI 10.1177/1043454204267922; Henrich G, 2000, EUR J PSYCHOL ASSESS, V16, P150, DOI 10.1027//1015-5759.16.3.150; Holden KB, 2012, J NATL MED ASSOC, V104, P493, DOI 10.1016/S0027-9684(15)30215-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huppert FA, 2013, SOC INDIC RES, V110, P837, DOI 10.1007/s11205-011-9966-7; Joreskog K, 1993, TESTING STRUCTURAL E; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lamoureux BE, 2012, PSYCHOL TRAUMA-US, V4, P605, DOI 10.1037/a0026079; Las Hayas C, 2014, EAT BEHAV, V15, P460, DOI 10.1016/j.eatbeh.2014.06.010; Liebenberg L, 2012, RES SOCIAL WORK PRAC, V22, P219, DOI 10.1177/1049731511428619; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lossnitzer N, 2014, DEUT MED WOCHENSCHR, V139, P580, DOI 10.1055/s-0034-1369862; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Lundman B, 2011, INT J NURS STUD, V48, P1266, DOI 10.1016/j.ijnurstu.2011.03.006; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Masten A.S., 2003, RESILIENCE VULNERABI; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Merrell KW, 2011, J CHILD FAM STUD, V20, P529, DOI 10.1007/s10826-010-9425-0; Millar SL, 2013, J PUBLIC HLTH OXF; Mohaupt S, 2009, SOC POLICY SOC, V8, P63, DOI 10.1017/S1474746408004594; Nations U, 2005, WORLD C DIS RED, P1; Olowokere AE, 2013, J SCH NURS; Paris J, 2014, PERSONAL MENT HEALTH, V8, P199, DOI 10.1002/pmh.1261; Rosenberg AR, 2013, PEDIAT BLOOD CANC; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Roth M, 2008, EUR J PSYCHOL ASSESS, V24, P190, DOI 10.1027/1015-5759.24.3.190; Rotolone C, 2012, ARCH SUICIDE RES, V16, P147, DOI 10.1080/13811118.2012.667333; Rutten BPF, 2013, ACTA PSYCHIAT SCAND, V128, P3, DOI 10.1111/acps.12095; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; RUTTER M, 1993, J ADOLESCENT HEALTH, V14, P626, DOI 10.1016/1054-139X(93)90196-V; Rutter M., 1990, RISK PROTECTIVE FACT; Rutter M, 2013, J CHILD PSYCHOL PSYC, V54, P474, DOI 10.1111/j.1469-7610.2012.02615.x; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schuhmacher J, 2005, Z KLIN PSYCHIAT PSYC, P53; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stumblingbear-Riddle G, 2012, AM INDIAN ALASKA NAT, V19, P1, DOI 10.5820/aian.1902.2012.1; Updegraff KA, 2013, J FAM PSYCHOL, V27, P376, DOI 10.1037/a0032909; Van den Hove DLA, 2013, EUR NEUROPSYCHOPHARM, V23, P1226, DOI 10.1016/j.euroneuro.2012.09.011; von Eisenhart Rothe A, 2013, BMC PSYCHOL; von Eisenhart Rothe Alexander, 2013, BMC Psychol, V1, P25, DOI 10.1186/2050-7283-1-25; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; Wagnild GM, 2009, J PSYCHOSOC NURS MEN, V47, P28, DOI 10.3928/02793695-20091103-01; White JH, 2012, ANN FAM MED, V10, P435, DOI 10.1370/afm.1374; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wu M.L, 2010, STRUCTURAL EQUATION; Yi-Frazier JP, 2013, J HLTH PSYCHOL	75	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140322	10.1371/journal.pone.0140322	http://dx.doi.org/10.1371/journal.pone.0140322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV1PG	26523927	Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800002
J	Samothrakis, S; Fasli, M				Samothrakis, Spyridon; Fasli, Maria			Emotional Sentence Annotation Helps Predict Fiction Genre	PLOS ONE			English	Article								Fiction, a prime form of entertainment, has evolved into multiple genres which one can broadly attribute to different forms of stories. In this paper, we examine the hypothesis that works of fiction can be characterised by the emotions they portray. To investigate this hypothesis, we use the work of fictions in the Project Gutenberg and we attribute basic emotional content to each individual sentence using Ekman's model. A time-smoothed version of the emotional content for each basic emotion is used to train extremely randomized trees. We show through 10-fold Cross-Validation that the emotional content of each work of fiction can help identify each genre with significantly higher probability than random. We also show that the most important differentiator between genre novels is fear.	[Samothrakis, Spyridon; Fasli, Maria] Univ Essex, Inst Analyt & Data Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Samothrakis, S (corresponding author), Univ Essex, Inst Analyt & Data Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	ssamot@essex.ac.uk			Institute for Analytics and Data Science (IADS), University of Essex	Institute for Analytics and Data Science (IADS), University of Essex	All funding has been provided by the Institute for Analytics and Data Science (IADS), University of Essex.	Acerbi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059030; Agarwal A., 2011, P WORKSHOP LANGUAGES, P30; Bentley RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083147; Booth Wayne C, 1983, RHETORIC FICTION; Damasio A.R., 2000, FEELING WHAT HAPPENS; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Hart M, 1971, PROJECT GUTENBERG; Hughes JM, 2012, P NATL ACAD SCI USA, V109, P7682, DOI 10.1073/pnas.1115407109; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Loper, 2009, NATURAL LANGUAGE PRO; Mishne G, 2005, P ACM SIGIR 2005 WOR, V19; Mohammad S., 2011, P 5 ACL HLT WORKSH L, P105; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Strapparava C., 2004, P 4 INT C LANG RES E, P1083; Strapparava C., 2007, P 4 INT WORKSH SEM E, P70, DOI DOI 10.3115/1621474.1621487; Strapparava C, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P1556; Tukey JW, 1977, EXPLORATORY DATA ANA, V231, P32	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141922	10.1371/journal.pone.0141922	http://dx.doi.org/10.1371/journal.pone.0141922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524352	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000364029800029
J	Wang, X; Wang, J; Sun, H; Xia, SL; Duan, R; Liang, JR; Xiao, YC; Qiu, HY; Shan, GL; Jing, HQ				Wang, Xin; Wang, Jing; Sun, Hao; Xia, Shengli; Duan, Ran; Liang, Junrong; Xiao, Yuchun; Qiu, Haiyan; Shan, Guangliang; Jing, Huaiqi			Etiology of Childhood Infectious Diarrhea in a Developed Region of China: Compared to Childhood Diarrhea in a Developing Region and Adult Diarrhea in a Developed Region	PLOS ONE			English	Article							YOUNG-CHILDREN; GASTROENTERITIS; BACTERIA; 5-YEAR	In China, great differences in economy, social characteristics and hygiene exist between developing and developed regions. A comparative study of infectious diarrhea between two regions was needed. Three groups of diarrheal patients were collected: children <= 5 year-olds from Beijing (developed region) and Henan Province (developing region), and adults over 18 year-olds from Beijing. A questionnaire was used to survey and feces samples were examined for 16 enteropathogens. We enrolled 1422 children and 1047 adults from developed region and 755 children from developing region. Virus positive rates were 32.98% for children and 23.67% for adults in developed region. The most prevalent pathogen for children was rotavirus whereas for adults was norovirus. Bacterial isolation rates were 13.92% for children from developed region, while 29.14% for children from the developing regions. For the greatest difference, Shigella accounted for 50.79% and was the dominant pathogen in the developing region, whereas in the developed region it was only 1.45%. There was no significant relationship between the local levels of development with diarrheogenic Escherichia coli (DEC) categories. But it was seen the notable differences between the population with different age: enteropathogenic E. coli (EPEC) and enteroaggregative E. coli (EAggEC) were the primary classes of DEC in children from both regions, whereas it was enterotoxigenic E. coli (ETEC) in adults. The symptoms of Shigella and Salmonella infection, such as bloody stools, white blood cells (WBC) and red blood cells (RBC) positivity and fever were similar in children, which may lead to the misidentification. Yersinia enterocolitica and shiga toxin-producing E. coli (STEC) infections were firstly reported in Beijing. There was a large difference in etiology of bacterial diarrhea between children in developing and developed regions of China.	[Wang, Xin; Shan, Guangliang] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med, Beijing 100730, Peoples R China; [Wang, Xin; Duan, Ran; Liang, Junrong; Xiao, Yuchun; Qiu, Haiyan; Jing, Huaiqi] Natl Inst Communicable Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Wang, Jing; Sun, Hao] Dongcheng Ctr Dis Control & Prevent, Dept Infect Dis, Beijing, Peoples R China; [Xia, Shengli] Henan Prov Ctr Dis Control & Prevent, Dept Infect Dis, Zhengzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shan, GL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med, Beijing 100730, Peoples R China.	guangliang_shan@163.com; jinghuaiqi@icdc.cn	yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Science and Technology Major Project - Ministry of Science and Technology of the People's Republic of China [2013ZX10004203-002]	National Science and Technology Major Project - Ministry of Science and Technology of the People's Republic of China	This work was supported by the National Science and Technology Major Project (2013ZX10004203-002) which was funded by Ministry of Science and Technology of the People's Republic of China (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Chan SSW, 2003, EMERG MED J, V20, P335, DOI 10.1136/emj.20.4.335; Cheng AC, 2005, J CLIN GASTROENTEROL, V39, P757, DOI 10.1097/01.mcg.0000177231.13770.07; Dong BQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110876; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; DuPont HL, 1997, AM J GASTROENTEROL, V92, P1962; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li Hongwei, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P119; Maraki S, 2003, EUR J EPIDEMIOL, V18, P85, DOI 10.1023/A:1022528205793; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Okeke IN, 2000, J CLIN MICROBIOL, V38, P7; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Qu M, 2012, J INFECTION, V65, P214, DOI 10.1016/j.jinf.2012.04.010; Rathaur VK, 2014, J CLIN DIAGN RES, V8, pPC1, DOI 10.7860/JCDR/2014/6677.4319; Castro EDR, 2015, REV INST MED TROP SP, V57, P27, DOI 10.1590/S0036-46652015000100004; Sambe-Ba B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-580; Soli KW, 2014, INT J INFECT DIS, V27, P54, DOI 10.1016/j.ijid.2014.02.023; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001	25	47	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142136	10.1371/journal.pone.0142136	http://dx.doi.org/10.1371/journal.pone.0142136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26134510	Green Submitted, Green Published, gold			2022-12-27	WOS:000364032600107
J	Andrejevic, S; Korosec, P; Silar, M; Kosnik, M; Mijanovic, R; Bonaci-Nikolic, B; Rijavec, M				Andrejevic, Sladana; Korosec, Peter; Silar, Mira; Kosnik, Mitja; Mijanovic, Radovan; Bonaci-Nikolic, Branka; Rijavec, Matija			Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype Association	PLOS ONE			English	Article							GENE; SPECTRUM; FAMILIES; SEQUENCE; PATIENT	Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease characterized by recurrent life-threatening oedemas and/or abdominal pain and caused by mutations affecting the C1 inhibitor gene, SERPING1. We sought to investigate the spectrum of SERPING1 mutations in Serbia and the possible genotype-phenotype association. C1-INH-HAE was diagnosed on the basis of clinical and laboratory criteria in 40 patients from 27 families; four were asymptomatic. Mutational analysis of the SERPING1 gene was performed by sequencing and multiplex ligation-dependent probe amplification. Disease-causing mutations in SERPING1 were identified in all patients. In C1-INH-HAE type I, we identified 19 different mutations, including 6 missense mutations, 6 nonsense mutations, 2 small deletions, 1 small insertion, 2 splicing defects and 2 large deletions. Two of the mutations (c.300C>T and c.1184_1185insTA) are reported here for the first time. All C1-INH-HAE type II patients from three families harboured the same substitution (c.1396C>T). Based on the type of mutation identified in the SERPING1 gene, patients were divided into two groups: group 1 (nonsense, frameshift, large deletions/insertions, splicing defect, and mutations at Arg444) or group 2 (missense, excluding mutations at Arg444). Significant differences were found in the clinical severity score (P = 0.005), prevalence of laryngeal (P = 0.040) and facial (P = 0.013) oedema, and long-term prophylaxis (P = 0.023) between the groups with different types of mutations. Because our population consisted of related subjects, differences in the severity score between mutation groups were further confirmed using the generalized estimating equation (P = 0.038). Our study identified 20 different disease-causing mutations, including two novel mutations, in all C1-INH-HAE patients, highlighting the heterogeneity of mutations in the SERPING1 gene. Furthermore, it appears that mutations with a clear effect on C1-INH function might be responsible for a more severe disease phenotype.	[Andrejevic, Sladana; Mijanovic, Radovan; Bonaci-Nikolic, Branka] Clin Ctr Serbia, Clin Allergol & Immunol, Belgrade, Serbia; [Korosec, Peter; Silar, Mira; Kosnik, Mitja; Rijavec, Matija] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia	Clinical Centre of Serbia; University Clinic Golnik	Rijavec, M (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.	matija.rijavec@klinika-golnik.si	Shaw, Heather/GQA-5799-2022; Košnik, Mitja/AAI-2295-2019; Ellis, David/A-8322-2011	Košnik, Mitja/0000-0002-4701-7374; Shaw, Heather/0000-0002-9157-7790; Ellis, David/0000-0001-6172-3323; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599; Bonaci-Nikolic, Branka/0000-0003-3014-4075				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bafunno V, 2014, ANN HUM GENET, V78, P73, DOI 10.1111/ahg.12052; Bissler JJ, 1997, P ASSOC AM PHYSICIAN, V109, P164; Bors A, 2013, J ALLERGY CLIN IMMUN, V131, P1708, DOI 10.1016/j.jaci.2012.11.015; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Bygum A, 2009, BRIT J DERMATOL, V161, P1153, DOI 10.1111/j.1365-2133.2009.09366.x; Carey VR, 2015, GEN ESIMATION EQUATI; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Karadza-Lapic L, 2015, 9 C1 INH DEF WORKSH; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Martinho A, 2013, MOL IMMUNOL, V53, P431, DOI 10.1016/j.molimm.2012.09.003; Monnier N, 2006, MOL IMMUNOL, V43, P2161, DOI 10.1016/j.molimm.2006.01.006; Nordenfelt P, 2014, ALLERGY ASTHMA PROC, V35, P185, DOI 10.2500/aap.2014.35.3738; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rijavec M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056712; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498, DOI 10.1016/S1081-1206(10)61121-0; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; Speletas M, 2015, ALLERGY, V70, P1661, DOI 10.1111/all.12714; Speletas M, 2015, J ALLERGY CLIN IMMUN, V135, P570, DOI 10.1016/j.jaci.2014.08.007; STOPPALYONNET D, 1991, AM J HUM GENET, V49, P1055; Stray-Pedersen A, 2000, J CLIN IMMUNOL, V20, P477, DOI 10.1023/A:1026416017763; Verpy E, 1996, AM J HUM GENET, V59, P308; Xu YY, 2012, ALLERGY, V67, P1430, DOI 10.1111/all.12024; Zanichelli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0233-x; Zuraw BL, 2000, J ALLERGY CLIN IMMUN, V105, P541, DOI 10.1067/mai.2000.104780; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	35	216	219	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2015	10	11							e0142174	10.1371/journal.pone.0142174	http://dx.doi.org/10.1371/journal.pone.0142174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV5GZ	26535898	Green Published, Green Submitted, gold			2022-12-27	WOS:000364298400140
J	Andrews, S; Ellis, DA; Shaw, H; Piwek, L				Andrews, Sally; Ellis, David A.; Shaw, Heather; Piwek, Lukasz			Beyond Self-Report: Tools to Compare Estimated and Real-World Smartphone Use	PLOS ONE			English	Article							MOBILE PHONE; PERSONALITY; ADOLESCENTS; PREDICTORS; ADDICTION	Psychologists typically rely on self-report data when quantifying mobile phone usage, despite little evidence of its validity. In this paper we explore the accuracy of using self-reported estimates when compared with actual smartphone use. We also include source code to process and visualise these data. We compared 23 participants' actual smartphone use over a two-week period with self-reported estimates and the Mobile Phone Problem Use Scale. Our results indicate that estimated time spent using a smartphone may be an adequate measure of use, unless a greater resolution of data are required. Estimates concerning the number of times an individual used their phone across a typical day did not correlate with actual smartphone use. Neither estimated duration nor number of uses correlated with the Mobile Phone Problem Use Scale. We conclude that estimated smartphone use should be interpreted with caution in psychological research.	[Andrews, Sally] Nottingham Trent Univ, Div Psychol, Nottingham, England; [Ellis, David A.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Ellis, David A.; Shaw, Heather] Lincoln Univ, Sch Psychol, Lincoln, England; [Piwek, Lukasz] Univ W England, Fac Business & Law, Bristol BS16 1QY, Avon, England	Nottingham Trent University; Lancaster University; University of Lincoln; University of West England	Andrews, S (corresponding author), Nottingham Trent Univ, Div Psychol, Nottingham, England.	sally.andrews@ntu.ac.uk	Shaw, Heather/GQA-5799-2022; Košnik, Mitja/AAI-2295-2019; Ellis, David/A-8322-2011	Košnik, Mitja/0000-0002-4701-7374; Shaw, Heather/0000-0002-9157-7790; Ellis, David/0000-0001-6172-3323; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599; Bonaci-Nikolic, Branka/0000-0003-3014-4075	Research Investment Fund (University of Lincoln) [RIF2014-31]	Research Investment Fund (University of Lincoln)	This work was funded by RIF2014-31 Research Investment Fund (University of Lincoln) (http://www.lincoln.ac.uk/home/research/researchsupport/researchinvestment/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Bianchi A, 2005, CYBERPSYCHOL BEHAV, V8, P39, DOI 10.1089/cpb.2005.8.39; Billieux J, 2012, CURR PSYCHIATRY REV, V8, P299, DOI 10.2174/157340012803520522; Butt S, 2008, COMPUT HUM BEHAV, V24, P346, DOI 10.1016/j.chb.2007.01.019; Clayton RB, 2015, J COMPUT-MEDIAT COMM, V20, P119, DOI 10.1111/jcc4.12109; Dolev-Cohen M, 2013, COMPUT HUM BEHAV, V29, P58, DOI 10.1016/j.chb.2012.07.016; Ehrenberg A, 2008, CYBERPSYCHOL BEHAV, V11, P739, DOI 10.1089/cpb.2008.0030; Ellis DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134555; Feldman G, 2011, PERS INDIV DIFFER, V51, P856, DOI 10.1016/j.paid.2011.07.020; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Hadlington LJ, 2015, COMPUT HUM BEHAV, V51, P75, DOI 10.1016/j.chb.2015.04.036; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Leung L, 2008, J CHILD MEDIA, V2, P93, DOI 10.1080/17482790802078565; Lin TTC, 2015, SOC BEHAV PERSONAL, V43, P1209, DOI 10.2224/sbp.2015.43.7.1209; Lopez-Fernandez O., 2014, PERS INDIVIDUAL DIFF, V60, pS24, DOI [10.1016/j.paid.2013.07.024, DOI 10.1016/J.PAID.2013.07.024]; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; McIlroy T., 2015, ECONOMIST; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Mohammadi Kalhori Soroush, 2015, Iran J Psychiatry, V10, P25; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Oz F, 2015, INT J HUMAN SCI, V12, P226; Rachman S, 2002, BEHAV RES THER, V40, P625, DOI 10.1016/S0005-7967(01)00028-6; Smith A., 2015, PEW RES CTR INTERNET; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Trull TJ, 2014, CURR DIR PSYCHOL SCI, V23, P466, DOI 10.1177/0963721414550706; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; Walsh SP, 2008, J ADOLESCENCE, V31, P77, DOI 10.1016/j.adolescence.2007.04.004; Walsh SP, 2010, AUST J PSYCHOL, V62, P194, DOI 10.1080/00049530903567229; White AG., 2011, INT J HUMANITIES SOC, V1, P51	29	216	219	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139004	10.1371/journal.pone.0139004	http://dx.doi.org/10.1371/journal.pone.0139004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26535898	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000363918100007
J	Wang, XL; Qi, WW; Li, YM; Zhang, N; Dong, L; Sun, MJ; Cun, JJ; Zhang, Y; Lv, SG; Yang, QF				Wang, Xiaolong; Qi, Wenwen; Li, Yaming; Zhang, Ning; Dong, Lun; Sun, Mingjuan; Cun, Jinjing; Zhang, Yan; Lv, Shangge; Yang, Qifeng			Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells	PLOS ONE			English	Article							AQUEOUS EXTRACT; INDUCED APOPTOSIS; PROLIFERATION; ANTICANCER; DISEASE	Huaier extract is attracting increased attention due to its biological activities, including antitumor, anti-parasite and immunomodulatory effects. Here, we investigated the role of autophagy in Huaier-induced cytotoxicity in MDA-MB-231, MDA-MB-468 and MCF7 breast cancer cells. Huaier treatment inhibited cell viability in all three cell lines and induced various large membranous vacuoles in the cytoplasm. In addition, electron microscopy, MDC staining, accumulated expression of autophagy markers and flow cytometry revealed that Huaier extract triggered autophagy. Inhibition of autophagy attenuated Huaier-induced cell death. Furthermore, Huaier extract inhibited the mammalian target of the rapamycin (mTOR)/S6K pathway in breast cancer cells. After implanting MDA-MB-231 cells subcutaneously into the right flank of BALB/c nu/nu mice, Huaier extract induced autophagy and effectively inhibited xenograft tumor growth. This study is the first to show that Huaier-induced cytotoxicity is partially mediated through autophagic cell death in breast cancer cells through suppression of the mTOR/S6K pathway.	[Wang, Xiaolong; Zhang, Ning; Dong, Lun; Sun, Mingjuan; Cun, Jinjing; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Qi, Wenwen; Li, Yaming; Lv, Shangge] Shandong Univ, Sch Med, Jinan 250100, Shandong, Peoples R China; [Zhang, Yan] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Pathol Tissue Bank, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81272903, 81172529, 81072150]; Shandong Science and Technology Development Plan [2012GZC22115]; Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine [2013-160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan; Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine	This work was supported by National Natural Science Foundation of China (No. 81272903, No. 81172529, No. 81072150) and Shandong Science and Technology Development Plan (No. 2012GZC22115) to QY, Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine (No. 2013-160) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohamed O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024537; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Barnard G, 2007, PRION, V1, P121, DOI 10.4161/pri.1.2.4439; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Harun FB, 2012, SCI WORLD J, DOI 10.1100/2012/439479; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang J, 2010, J AGR FOOD CHEM, V58, P8119, DOI 10.1021/jf100901b; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kelekar A, 2005, ANN NY ACAD SCI, V1066, P259, DOI 10.1196/annals.1363.015; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lambert JD, 2010, J AGR FOOD CHEM, V58, P10016, DOI 10.1021/jf102311t; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CJ, 2014, TRENDS BIOTECHNOL, P1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lv HL, 2013, PARASITOL RES, V112, P193, DOI 10.1007/s00436-012-3125-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Olaku O, 2011, EUR J CANCER, V47, P508, DOI 10.1016/j.ejca.2010.11.018; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Sun Y, 2013, CARBOHYD POLYM, V92, P577, DOI 10.1016/j.carbpol.2012.09.006; Wang J, 2012, INT J ONCOL, V41, P1101, DOI 10.3892/ijo.2012.1534; Wang XL, 2013, INT J ONCOL, V43, P321, DOI 10.3892/ijo.2013.1947; Wang XL, 2012, ONCOL REP, V28, P1167, DOI 10.3892/or.2012.1961; Xu X, 2011, ASIAN PAC J CANCER P, V12, P2251; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zou Y, 2014, TUMOR BIOL, P1	41	47	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131771	10.1371/journal.pone.0131771	http://dx.doi.org/10.1371/journal.pone.0131771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134510	gold, Green Published, Green Submitted			2022-12-27	WOS:000358154400072
